DiseaseName	DiseaseID	AltDiseaseIDs	Definition	ParentIDs	TreeNumbers	ParentTreeNumbers	Synonyms	SlimMappings
AA amyloidosis	MESH:C000718787			MESH:D000686	C18.452.845.500/C000718787	C18.452.845.500	Amyloid A amyloidosis	Metabolic disease
Aagenaes syndrome	MESH:C535330	DO:DOID:6691|OMIM:214900		MESH:D002779|MESH:D008209	C06.130.120.135/C535330|C15.604.496/C535330	C06.130.120.135|C15.604.496	AAGENAES SYNDROME|CHLS|Cholestasis lymphedema syndrome|Cholestasis-Lymphedema Syndrome|LCS|LCS1|Lymphedema - cholestasis syndrome|Lymphedema-Cholestasis Syndrome	Digestive system disease|Lymphatic disease
abc disease	MESH:C579754			MESH:D009369	C04/C579754	C04		Cancer
Abdominal Abscess	MESH:D018784		An abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and the pelvis below. (From Dorland, 27th ed)	MESH:D000038	C01.830.025.020	C01.830.025	Abdominal Abscesses|Abscess, Abdominal|Abscesses, Abdominal|Abscesses, Intra-Abdominal|Abscess, Intra Abdominal|Abscess, Intra-Abdominal|Intra-Abdominal Abscess|Intra-Abdominal Abscesses	
Abdominal chemodectomas with cutaneous angiolipomas	MESH:C535552			MESH:D010236|MESH:D012878	C04.557.465.625.650.700.705/C535552|C04.557.580.625.650.700.705/C535552|C04.588.805/C535552|C17.800.882/C535552	C04.557.465.625.650.700.705|C04.557.580.625.650.700.705|C04.588.805|C17.800.882	Chemodectoma, Intraabdominal, with Cutaneous Angiolipomas|Familial abdominal chemodectomas with cutaneous angiolipomas	Cancer|Skin disease
Abdominal cystic lymphangioma	MESH:C535553			MESH:D012186|MESH:D018191	C04.557.375.450.450/C535553|C04.588.033.731/C535553	C04.557.375.450.450|C04.588.033.731	Abdominal retroperitoneal lymphangioma|Retroperitoneal cystic lymphangioma	Cancer
Abdominal Neoplasms	MESH:D000008		New abnormal growth of tissue in the ABDOMEN.	MESH:D009371	C04.588.033	C04.588	Abdominal Neoplasm|Neoplasm, Abdominal|Neoplasms, Abdominal	Cancer
Abdominal obesity metabolic syndrome	MESH:C535554			MESH:D024821	C18.452.394.968.500.570/C535554|C18.452.625/C535554	C18.452.394.968.500.570|C18.452.625	Abdominal Obesity-Metabolic Syndrome	Metabolic disease
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	OMIM:605552	DO:DOID:14221		MESH:C535554|MESH:D056128	C18.452.394.968.500.570/C535554/605552|C18.452.625/C535554/605552|C18.654.726.750.500.615/605552|C23.888.144.699.500.063/605552	C18.452.394.968.500.570/C535554|C18.452.625/C535554|C18.654.726.750.500.615|C23.888.144.699.500.063	AOMS1|METABOLIC SYNDROME, PROTECTION AGAINST, INCLUDED|METABOLIC SYNDROME X ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 1, INCLUDED	Metabolic disease|Nutrition disorder|Signs and symptoms
ABDOMINAL OBESITY-METABOLIC SYNDROME 3	OMIM:615812	DO:DOID:0060612		MESH:C535554|MESH:D056128	C18.452.394.968.500.570/C535554/615812|C18.452.625/C535554/615812|C18.654.726.750.500.615/615812|C23.888.144.699.500.063/615812	C18.452.394.968.500.570/C535554|C18.452.625/C535554|C18.654.726.750.500.615|C23.888.144.699.500.063	AOMS3|CENTRAL OBESITY, TYPE 2 DIABETES, HYPERTENSION, AND EARLY-ONSET CORONARY ARTERY DISEASE	Metabolic disease|Nutrition disorder|Signs and symptoms
Abducens Nerve Diseases	MESH:D020434	DO:DOID:10865	Diseases of the sixth cranial (abducens) nerve or its nucleus in the pons. The nerve may be injured along its course in the pons, intracranially as it travels along the base of the brain, in the cavernous sinus, or at the level of superior orbital fissure or orbit. Dysfunction of the nerve causes lateral rectus muscle weakness, resulting in horizontal diplopia that is maximal when the affected eye is abducted and ESOTROPIA. Common conditions associated with nerve injury include INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; ISCHEMIA; and INFRATENTORIAL NEOPLASMS.	MESH:D003389	C10.292.150	C10.292	6th Nerve Palsies|6th Nerve Palsy|Abducens Nerve Disease|Abducens Nerve Palsies|Abducens Nerve Palsy|Abducens Palsies|Abducens Palsy|Abducens Palsy, Childhood, Benign Recurrent|Benign Recurrent Abducens Palsy, Children|Benign Recurrent Abducens Palsy of Childhood|Cranial Nerve VI Diseases|Cranial Nerve VI Palsy|Lateral Rectus Palsies|Lateral Rectus Palsy|Palsies, 6th Nerve|Palsies, Abducens|Palsies, Abducens Nerve|Palsies, Lateral Rectus|Palsies, Sixth Nerve|Palsies, VI Nerve|Palsy, 6th Nerve|Palsy, Abducens|Palsy, Abducens Nerve|Palsy, Lateral Rectus|Palsy, Sixth Nerve|Palsy, VI Nerve|Sixth Cranial Nerve Diseases|Sixth Cranial Nerve Disorders|Sixth Cranial Nerve Palsy|Sixth Nerve Palsies|Sixth Nerve Palsy|VI Nerve Palsy|VIth Cranial Nerve Diseases	Nervous system disease
Abducens Nerve Injury	MESH:D020222		Traumatic injury to the abducens, or sixth, cranial nerve. Injury to this nerve results in lateral rectus muscle weakness or paralysis. The nerve may be damaged by closed or penetrating CRANIOCEREBRAL TRAUMA or by facial trauma involving the orbit.	MESH:D020209|MESH:D020434	C10.292.150.100|C10.292.200.200|C10.900.300.218.150|C26.915.300.400.100	C10.292.150|C10.292.200|C10.900.300.218|C26.915.300.400	Abducens Nerve Injuries|Abducens Nerve Trauma|Abducens Nerve Traumas|Abducens Neuropathies, Traumatic|Abducens Neuropathy, Traumatic|Cranial Nerve VI Injury|Injuries, Abducens Nerve|Injury, Abducens Nerve|Injury, Cranial Nerve VI|Injury, Sixth Cranial Nerve|Nerve Injuries, Abducens|Nerve Injury, Abducens|Nerve Trauma, Abducens|Nerve Traumas, Abducens|Sixth Cranial Nerve Injuries|Sixth Cranial Nerve Injury|Sixth-Nerve Palsies, Traumatic|Sixth Nerve Palsy, Traumatic|Sixth-Nerve Palsy, Traumatic|Sixth Nerve Trauma|Sixth-Nerve Trauma|Sixth-Nerve Traumas|Trauma, Abducens Nerve|Traumas, Abducens Nerve|Trauma, Sixth-Nerve|Traumas, Sixth-Nerve|Traumatic Abducens Neuropathies|Traumatic Abducens Neuropathy|Traumatic Sixth-Nerve Palsies|Traumatic Sixth Nerve Palsy|Traumatic Sixth-Nerve Palsy	Nervous system disease|Wounds and injuries
Aberrant Crypt Foci	MESH:D058739		Clusters of colonic crypts that appear different from the surrounding mucosa when visualized after staining. They are of interest as putative precursors to colorectal adenomas and potential biomarkers for colorectal carcinoma.	MESH:D011230	C04.834.020	C04.834	Crypt Foci, Aberrant|Foci, Aberrant Crypt	Cancer
Aberrant subclavian artery	MESH:C535555			MESH:D018376	C14.240/C535555|C16.131.240/C535555	C14.240|C16.131.240	Aberrant left subclavian artery|Aberrant right subclavian artery	Cardiovascular disease|Congenital abnormality
Abrikosov's tumor	MESH:C535558			MESH:D006106	C04.557.475.750.656/C535558|C04.588.322.455.398/C535558|C12.050.351.500.056.630.705.398/C535558|C12.050.351.937.418.685.398/C535558|C12.100.250.056.630.705.398/C535558|C12.900.418.685.398/C535558|C19.344.410.398/C535558|C19.391.630.705.398/C535558	C04.557.475.750.656|C04.588.322.455.398|C12.050.351.500.056.630.705.398|C12.050.351.937.418.685.398|C12.100.250.056.630.705.398|C12.900.418.685.398|C19.344.410.398|C19.391.630.705.398	Abrikosoff's granulous cell tumor|Abrikosoff's tumor|Giant granulo-cellular Abrikosov's tumor|Malignant variant of Abrikosov's tumor	Cancer|Endocrine system disease|Urogenital disease (female)
Absent radii and thrombocytopenia	MESH:C536940	DO:DOID:14699|OMIM:274000		MESH:D000080984|MESH:D013921|MESH:D038062	C05.660.585.988/C536940|C15.378.140.855/C536940|C15.378.190.223.500/C536940|C16.131.621.585.988/C536940|C16.614.183/C536940	C05.660.585.988|C15.378.140.855|C15.378.190.223.500|C16.131.621.585.988|C16.614.183	Chromosome 1q21.1 Deletion Syndrome, 200-Kb|Radial Aplasia-Amegakaryocytic Thrombocytopenia|Radial Aplasia-Thrombocytopenia Syndrome|TAR|TAR Syndrome|Thrombocytopenia Absent Radii|Thrombocytopenia absent radius syndrome|Thrombocytopenia-Absent Radius Syndrome	Blood disease|Congenital abnormality|Infant-newborn disease|Musculoskeletal disease
Acantholysis	MESH:D000051		Separation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer. It is seen in diseases such as pemphigus vulgaris (see PEMPHIGUS) and DARIER DISEASE.	MESH:D010335|MESH:D012872	C17.800.865.070|C23.550.035	C17.800.865|C23.550	Acantholyses	Pathology (process)|Skin disease
Acanthoma	MESH:D049309	DO:DOID:172|DO:DOID:174|DO:DOID:4322	A neoplasm composed of squamous or epidermal cells.	MESH:D012878|MESH:D018307	C04.557.470.700.040|C04.588.805.040	C04.557.470.700|C04.588.805	Acanthoma, Clear Cell|Acanthoma, Degos|Acanthoma, Pilar Sheath|Acanthomas|Acanthomas, Clear Cell|Acanthomas, Pilar Sheath|Clear Cell Acanthoma|Clear Cell Acanthomas|Degos Acanthoma|Pilar Sheath Acanthoma|Pilar Sheath Acanthomas	Cancer
Acanthosis Nigricans	MESH:D000052	DO:DOID:3138	A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.	MESH:D008548	C17.800.621.430.530.100	C17.800.621.430.530	Acanthosis Nigrican|Nigrican, Acanthosis|Nigricans, Acanthosis	Skin disease
Acanthosis nigricans muscle cramps acral enlargement	MESH:C536000			MESH:D000052|MESH:D006628|MESH:D009120	C05.651.475/C536000|C10.597.613.500/C536000|C17.800.329.750/C536000|C17.800.621.430.530.100/C536000|C23.888.592.608.500/C536000|C23.888.971.468/C536000	C05.651.475|C10.597.613.500|C17.800.329.750|C17.800.621.430.530.100|C23.888.592.608.500|C23.888.971.468	Acanthosis Nigricans With Muscle Cramps And Acral Enlargement	Musculoskeletal disease|Nervous system disease|Signs and symptoms|Skin disease
Accelerated Idioventricular Rhythm	MESH:D016170		A type of automatic, not reentrant, ectopic ventricular rhythm with episodes lasting from a few seconds to a minute which usually occurs in patients with acute myocardial infarction or with DIGITALIS toxicity. The ventricular rate is faster than normal but slower than tachycardia, with an upper limit of 100 -120 beats per minute. Suppressive therapy is rarely necessary.	MESH:D017180	C14.280.067.845.940.349|C14.280.123.875.940.349|C23.550.073.845.940.349	C14.280.067.845.940|C14.280.123.875.940|C23.550.073.845.940	Accelerated Idioventricular Rhythms|AIVR|Idioventricular Rhythm, Accelerated|Idioventricular Rhythms, Accelerated|Slow Ventricular Tachycardia|Slow Ventricular Tachycardias|Ventricular Tachycardia, Slow|Ventricular Tachycardias, Slow	Cardiovascular disease|Pathology (process)
Accessory deep peroneal nerve	MESH:C536001			MESH:D010523	C10.668.829/C536001	C10.668.829	Peroneal nerve, accessory deep	Nervous system disease
Accessory navicular bone	MESH:C536002			MESH:D005534	C05.360/C536002|C17.800.321/C536002	C05.360|C17.800.321	Navicular Bone, Accessory	Musculoskeletal disease|Skin disease
Accessory Nerve Diseases	MESH:D020436	DO:DOID:339	Diseases of the eleventh cranial (spinal accessory) nerve. This nerve originates from motor neurons in the lower medulla (accessory portion of nerve) and upper spinal cord (spinal portion of nerve). The two components of the nerve join and exit the skull via the jugular foramen, innervating the sternocleidomastoid and trapezius muscles, which become weak or paralyzed if the nerve is injured. The nerve is commonly involved in MOTOR NEURON DISEASE, and may be injured by trauma to the posterior triangle of the neck.	MESH:D003389	C10.292.175	C10.292	Accessory Nerve Disease|Cranial Nerve Eleven Diseases|Cranial Nerve Eleven Disorders|Cranial Nerve XI Diseases|Eleventh Cranial Nerve Disease|Spinal Accessory Nerve Diseases	Nervous system disease
Accessory Nerve Injuries	MESH:D061227		Traumatic injuries to the ACCESSORY NERVE. Damage to the nerve may produce weakness in head rotation and shoulder elevation.	MESH:D020209|MESH:D020436	C10.292.175.500|C10.292.200.350|C10.900.300.218.225|C26.915.300.400.200	C10.292.175|C10.292.200|C10.900.300.218|C26.915.300.400	Accessory Nerve Avulsion|Accessory Nerve Avulsions|Accessory Nerve Contusion|Accessory Nerve Contusions|Accessory Nerve Injury|Accessory Nerve Transection|Accessory Nerve Transections|Accessory Nerve Trauma|Accessory Nerve Traumas|Accessory Neuropathies, Traumatic|Accessory Neuropathy, Traumatic|Avulsion, Accessory Nerve|Avulsions, Accessory Nerve|Contusion, Accessory Nerve|Contusions, Accessory Nerve|Cranial Nerve XI Injury|Eleventh Cranial Nerve Injuries|Eleventh Cranial Nerve Injury|Eleventh-Nerve Palsies, Traumatic|Eleventh Nerve Palsy, Traumatic|Eleventh-Nerve Palsy, Traumatic|Eleventh Nerve Trauma|Eleventh-Nerve Trauma|Eleventh-Nerve Traumas|Injuries, Accessory Nerve|Injury, Accessory Nerve|Injury, Cranial Nerve XI|Injury, Eleventh Cranial Nerve|Nerve Avulsion, Accessory|Nerve Avulsions, Accessory|Nerve Contusion, Accessory|Nerve Contusions, Accessory|Nerve Injuries, Accessory|Nerve Injury, Accessory|Nerve Transection, Accessory|Nerve Transections, Accessory|Nerve Trauma, Accessory|Nerve Traumas, Accessory|Neuropathies, Traumatic Accessory|Neuropathy, Traumatic Accessory|Palsies, Traumatic Eleventh-Nerve|Palsy, Traumatic Eleventh-Nerve|Spinal Accessory Nerve Avulsion|Spinal Accessory Nerve Contusion|Spinal Accessory Nerve Injury|Spinal Accessory Nerve Transection|Spinal Accessory Nerve Trauma|Spinal Accessory Neuropathy, Traumatic|Transection, Accessory Nerve|Transections, Accessory Nerve|Trauma, Accessory Nerve|Trauma, Eleventh-Nerve|Traumas, Accessory Nerve|Traumas, Eleventh-Nerve|Traumatic Accessory Neuropathies|Traumatic Accessory Neuropathy|Traumatic Eleventh-Nerve Palsies|Traumatic Eleventh Nerve Palsy|Traumatic Eleventh-Nerve Palsy	Nervous system disease|Wounds and injuries
Achalasia Addisonianism Alacrimia syndrome	MESH:C536008	OMIM:231550		MESH:D000309|MESH:D004931	C06.405.117.119.500.432/C536008|C19.053.500/C536008	C06.405.117.119.500.432|C19.053.500	AAAS|Aaa Syndrome|Achalasia-Addisonianism-Alacrima Syndrome|Achalasia-Addisonian Syndrome|Achalasia-Alacrima Syndrome|Achalasia alacrimia syndrome|Acth-Resistant Adrenal Insufficiency, Achalasia And Alacrima|ACTH resistant adrenal insufficiency, achalasia and alacrima|ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMA ACHALASIA-ALACRIMA SYNDROME, INCLUDED|Addisonian achalasia syndrome|Addisonian-Achalasia Syndrome|Alacrima-Achalasia-Addisonianism|Alacrima-achalasia-adrenal insufficiency neurologic disorder|Allgrove syndrome|Glucocorticoid deficiency and achalasia|Hypoadrenalism with achalasia|Infantile achalasia with alacrima|Triple A syndrome|Triple-A Syndrome	Digestive system disease|Endocrine system disease
Achard-Thiers syndrome	MESH:C536013			MESH:D010051|MESH:D014770|MESH:D048909	C04.588.322.455/C536013|C12.050.351.500.056.630.705/C536013|C12.050.351.937.418.685/C536013|C12.100.250.056.630.705/C536013|C12.900.418.685/C536013|C19.246.099/C536013|C19.344.410/C536013|C19.391.630.705/C536013|C23.888.971/C536013	C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.246.099|C19.344.410|C19.391.630.705|C23.888.971	Adenoma associated virilism of older women|Bearded female with diabetes|Diabetes in bearded women|Diabetic-bearded woman syndrome	Cancer|Endocrine system disease|Signs and symptoms|Urogenital disease (female)
Achlorhydria	MESH:D000126		A lack of HYDROCHLORIC ACID in GASTRIC JUICE despite stimulation of gastric secretion.	MESH:D000137|MESH:D013272	C06.405.748.045|C18.452.076.087	C06.405.748|C18.452.076	Achylia Gastrica|Hypochlorhydria	Digestive system disease|Metabolic disease
Achondroplasia	MESH:D000130	DO:DOID:0111158|DO:DOID:4480|OMIM:100800|OMIM:616482	An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM					
Achromatopsia 1	MESH:C536021			MESH:D003117	C10.597.751.941.256/C536021|C11.270.151.500/C536021|C11.966.256/C536021|C23.888.592.763.941.256/C536021	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	Rod monochromacy|Rod monochromatism	Eye disease|Nervous system disease|Signs and symptoms
Achromatopsia 2	MESH:C536128	OMIM:216900		MESH:D003117	C10.597.751.941.256/C536128|C11.270.151.500/C536128|C11.966.256/C536128|C23.888.592.763.941.256/C536128	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	ACHM2|Colorblindness, Total|RMCH2|Rod monochromacy 2|Rod monochromatism 2|Total color blindness	Eye disease|Nervous system disease|Signs and symptoms
Achromatopsia 3	MESH:C536129	OMIM:262300		MESH:D003117	C10.597.751.941.256/C536129|C11.270.151.500/C536129|C11.966.256/C536129|C23.888.592.763.941.256/C536129	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	ACHM1, FORMERLY|Achm3|ACHM 3|Achromatopsia with myopia|Pingelapese|Pingelapese Blindness|RMCH1, FORMERLY|ROD MONOCHROMACY 1, FORMERLY|ROD MONOCHROMATISM 1, FORMERLY|Total colorblindness with myopia	Eye disease|Nervous system disease|Signs and symptoms
ACHROMATOPSIA 7	OMIM:616517	DO:DOID:0110009		MESH:D003117	C10.597.751.941.256/616517|C11.270.151.500/616517|C11.966.256/616517|C23.888.592.763.941.256/616517	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	ACHM7	Eye disease|Nervous system disease|Signs and symptoms
Acid-Base Imbalance	MESH:D000137		Disturbances in the ACID-BASE EQUILIBRIUM of the body.	MESH:D008659	C18.452.076	C18.452	Acid Base Imbalance|Acid-Base Imbalances|Imbalance, Acid-Base|Imbalances, Acid-Base	Metabolic disease
Acidosis	MESH:D000138		A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up.	MESH:D000137	C18.452.076.176	C18.452.076	Acidoses|Acidoses, Metabolic|Acidosis, Metabolic|Metabolic Acidoses|Metabolic Acidosis	Metabolic disease
Acidosis, Lactic	MESH:D000140	DO:DOID:3650	Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as DIABETES MELLITUS; LEUKEMIA; or LIVER FAILURE.	MESH:D000138	C18.452.076.176.180	C18.452.076.176	Lactic Acidosis	Metabolic disease
Acidosis, Respiratory	MESH:D000142		Respiratory retention of carbon dioxide. It may be chronic or acute.	MESH:D000138|MESH:D012131	C08.618.846.093|C18.452.076.176.310	C08.618.846|C18.452.076.176	Acidoses, Respiratory|Respiratory Acidoses|Respiratory Acidosis	Metabolic disease|Respiratory tract disease
Acne, Adult	MESH:C565791			MESH:D000152	C17.800.030.150/C565791|C17.800.794.111/C565791	C17.800.030.150|C17.800.794.111		Skin disease
Acne Conglobata	MESH:D000069316		Severe and chronic form of acne characterized by large, burrowing abscesses associated with disfigurement.	MESH:D000152	C17.800.030.150.500|C17.800.794.111.500	C17.800.030.150|C17.800.794.111	Acne Conglobatas|Conglobata, Acne|Conglobatas, Acne	Skin disease
Acneiform Eruptions	MESH:D017486		Visible efflorescent lesions of the skin caused by acne or resembling acne. (Dorland, 28th ed, p18, 575)	MESH:D012871	C17.800.030	C17.800	Acneiform Eruption|Eruption, Acneiform|Eruptions, Acneiform	Skin disease
Acne Keloid	MESH:D000153		A type of acneiform disorder in which secondary pyogenic infection in and around pilosebaceous structures ends in keloidal scarring. It manifests as persistent folliculitis of the back of the neck associated with occlusion of the follicular orifices. It is most often encountered in black or Asian men.	MESH:D005499|MESH:D007627|MESH:D017486	C17.300.200.425.125|C17.800.030.030|C17.800.329.500.261	C17.300.200.425|C17.800.030|C17.800.329.500	Acne, Keloidal|Acne Keloidalis|Acne Keloids|Acne, Nuchal Keloid|Acnes, Nuchal Keloid|Capillitii, Dermatitis Papillaris|Capillitius, Dermatitis Papillaris|Dermatitis Papillaris Capillitii|Dermatitis Papillaris Capillitius|Folliculitis Keloidalis|Folliculitis Keloidalis Nuchae|Keloid, Acne|Keloid Acne, Nuchal|Keloid Acnes, Nuchal|Keloidal Acne|Keloidal Acnes|Keloidalis Nuchae, Folliculitis|Keloidalis Nuchae, Lichen|Keloids, Acne|Lichen Keloidalis Nuchae|Nuchae, Folliculitis Keloidalis|Nuchae, Lichen Keloidalis|Nuchal Keloid Acne|Nuchal Keloid Acnes|Papillaris Capillitii, Dermatitis|Papillaris Capillitius, Dermatitis	Connective tissue disease|Skin disease
Acne Vulgaris	MESH:D000152	DO:DOID:6543	A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors.	MESH:D012625|MESH:D017486	C17.800.030.150|C17.800.794.111	C17.800.030|C17.800.794	Acne	Skin disease
Acquired agranulocytosis	MESH:C538171			MESH:D000380	C15.378.553.546.184/C538171	C15.378.553.546.184	Agranulocytic Angina|Granulocytopenia, Primary|Neutropenia, Malignant	Blood disease
Acquired amegakaryocytic thrombocytopenia	MESH:C538172			MESH:D001855|MESH:D011696	C15.378.100.802.687/C538172|C15.378.140.855.925.750/C538172|C15.378.190/C538172|C20.841/C538172|C23.550.414.950.687/C538172|C23.888.885.687.687/C538172	C15.378.100.802.687|C15.378.140.855.925.750|C15.378.190|C20.841|C23.550.414.950.687|C23.888.885.687.687		Blood disease|Immune system disease|Pathology (process)|Signs and symptoms
Acquired angioedema	MESH:C538173			MESH:D000799	C14.907.079/C538173|C17.800.862.945.066/C538173|C20.543.480.904.066/C538173	C14.907.079|C17.800.862.945.066|C20.543.480.904.066		Cardiovascular disease|Immune system disease|Skin disease
Acquired Hyperostosis Syndrome	MESH:D020083	DO:DOID:13677	Syndrome consisting of SYNOVITIS; ACNE CONGLOBATA; PALMOPLANTAR PUSTULOSIS; HYPEROSTOSIS; and OSTEITIS. The most common site of the disease is the upper anterior chest wall, characterized by predominantly osteosclerotic lesions, hyperostosis, and arthritis of the adjacent joints. The association of sterile inflammatory bone lesions and neutrophilic skin eruptions is indicative of this syndrome.	MESH:D010009	C05.116.099.708.025	C05.116.099.708	Acquired Hyperostosis Syndromes|Hyperostosis Syndrome, Acquired|Hyperostosis Syndromes, Acquired|SAPHO Syndrome|SAPHO Syndromes|Syndrome, Acquired Hyperostosis|Syndromes, Acquired Hyperostosis|Syndrome, SAPHO|Syndromes, SAPHO|Synovitis, Acne, Pustlosis, Hyperostosis, and Osteomyelitis	Musculoskeletal disease
Acquired Immunodeficiency Syndrome	MESH:D000163	DO:DOID:635	An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.	MESH:D012897|MESH:D015658	C01.221.250.875.040|C01.221.812.640.400.040|C01.778.640.400.040|C01.925.782.815.616.400.040|C01.925.813.400.040|C01.925.839.040|C12.100.937.640.400.040|C20.673.480.040	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C01.925.839|C12.100.937.640.400|C20.673.480	Acquired Immune Deficiency Syndrome|Acquired Immuno Deficiency Syndrome|Acquired Immuno-Deficiency Syndrome|Acquired Immunodeficiency Syndromes|Acquired Immuno-Deficiency Syndromes|AIDS|Immunodeficiency Syndrome, Acquired|Immuno-Deficiency Syndrome, Acquired|Immunodeficiency Syndromes, Acquired|Immuno-Deficiency Syndromes, Acquired|Immunologic Deficiency Syndrome, Acquired|Syndrome, Acquired Immunodeficiency|Syndrome, Acquired Immuno-Deficiency|Syndromes, Acquired Immunodeficiency|Syndromes, Acquired Immuno-Deficiency	Immune system disease|Viral disease
Acquired Protein S Deficiency	MESH:C567077			MESH:D018455	C15.378.100.800/C567077|C15.378.147.890/C567077|C15.378.925.800/C567077	C15.378.100.800|C15.378.147.890|C15.378.925.800		Blood disease
Acquired pure megakaryocytic aplasia	MESH:C538176			MESH:D001855|MESH:D013921	C15.378.140.855/C538176|C15.378.190/C538176	C15.378.140.855|C15.378.190		Blood disease
Acrodynia	MESH:D000170		A condition seen primarily in childhood, most often resulting from chronic exposure to MERCURY COMPOUNDS which may result in encephalopathy and POLYNEUROPATHY. Clinical features include pain, swelling and pinkish discoloration of the fingers and toes, weakness in the extremities, extreme irritability, HYPERESTHESIA, and alterations in level of consciousness. (From Menkes, Textbook of Child Neurology, 5th ed, p603)	MESH:D010523|MESH:D020262	C10.668.829.025|C10.720.475.600.150|C25.723.522.875.500.100	C10.668.829|C10.720.475.600|C25.723.522.875.500	Acrodynic Erythema|Childhood Mercurialism, Chronic|Childhood Mercurialisms, Chronic|Chronic Childhood Mercurialism|Chronic Childhood Mercurialisms|Erythema, Acrodynic|Feer Disease|Feer's Disease|Feers Disease|Mercurialism, Chronic Childhood|Pink Disease|Swift Disease|Swift's Disease|Swifts Disease	Nervous system disease
Acrokeratoderma, Hereditary Papulotranslucent	MESH:C566323	DO:DOID:0060360		MESH:D005533|MESH:D007642	C17.800.321.125/C566323|C17.800.428/C566323	C17.800.321.125|C17.800.428		Skin disease
Acroleukopathy, Symmetric	MESH:C566322			MESH:D010859	C17.800.621/C566322|C23.550.755/C566322	C17.800.621|C23.550.755		Pathology (process)|Skin disease
Acromegaly	MESH:D000172	DO:DOID:2449	A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)	MESH:D001849|MESH:D006964	C05.116.132.082|C10.228.140.617.738.250.100|C19.700.355.179	C05.116.132|C10.228.140.617.738.250|C19.700.355	Hypersecretion Syndrome, Somatotropin (Acromegaly)|Hypersecretion Syndromes, Somatotropin (Acromegaly)|Inappropriate GH Secretion Syndrome (Acromegaly)|Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)|Somatotropin Hypersecretion Syndrome (Acromegaly)|Somatotropin Hypersecretion Syndromes (Acromegaly)|Syndrome, Somatotropin Hypersecretion (Acromegaly)|Syndromes, Somatotropin Hypersecretion (Acromegaly)	Endocrine system disease|Musculoskeletal disease|Nervous system disease
Acromelic frontonasal dysplasia	MESH:C535657			MESH:D000172	C05.116.132.082/C535657|C10.228.140.617.738.250.100/C535657|C19.700.355.179/C535657	C05.116.132.082|C10.228.140.617.738.250.100|C19.700.355.179		Endocrine system disease|Musculoskeletal disease|Nervous system disease
Acromesomelic dysplasia, Maroteaux type	MESH:C535661	DO:DOID:0080050|OMIM:602875		MESH:D001848	C05.116.099/C535661	C05.116.099	Acromesomelic dwarfism Maroteux type|AMDM|ST. HELENA DYSPLASIA	Musculoskeletal disease
Acro-Osteolysis	MESH:D030981	DO:DOID:2736	A condition with congenital and acquired forms causing recurrent ulcers in the fingers and toes. The congenital form exhibits autosomal dominant inheritance; the acquired form is found in workers who handle VINYL CHLORIDE. When acro-osteolysis is accompanied by generalized OSTEOPOROSIS and skull deformations, it is called HAJDU-CHENEY SYNDROME.	MESH:D001848|MESH:D010014	C05.116.099.052|C05.116.264.579.052	C05.116.099|C05.116.264.579	Acroosteolysis|Acro Osteolysis|Acroosteolysis Syndrome|Acro-Osteolysis Syndrome|Acro-Osteolysis Syndromes	Musculoskeletal disease
Acroosteolysis dominant type	MESH:C535663			MESH:D030981	C05.116.099.052/C535663|C05.116.264.579.052/C535663	C05.116.099.052|C05.116.264.579.052		Musculoskeletal disease
Acrospiroma	MESH:D018250	DO:DOID:5442	A rare cutaneous tumor of apocrine or eccrine SWEAT GLAND origin. It is most commonly found on the extremities and is usually benign. It appears as a solitary nodule or cyst and may be solid or produce a watery discharge. It is related to POROMA except in acrospiroma it does not involve the epidermis. There is no indication that heredity or external agents cause these tumors.	MESH:D006607	C04.557.470.035.175.125|C04.557.470.550.175.125	C04.557.470.035.175|C04.557.470.550.175	Acrospiroma, Eccrine|Acrospiromas|Clear Cell Hidradrenoma|Clear-Cell Hidradrenoma|Clear-Cell Hidradrenomas|Cystic Hidradenoma|Cystic Hidradenomas|Eccrine Acrospiroma|Eccrine Acrospiromas|Eccrine Spiradenoma|Eccrine Spiradenomas|Hidradenoma|Hidradenoma, Cystic|Hidradenomas|Hidradenoma, Solid-Cystic|Hidradrenoma, Clear-Cell|Hidradrenoma, Nodular|Hidradrenomas, Nodular|Nodular Hidradrenoma|Nodular Hidradrenomas|Solid Cystic Hidradenoma|Solid-Cystic Hidradenoma|Solid-Cystic Hidradenomas|Spiradenoma|Spiradenoma, Eccrine|Spiradenomas|Spiradenomas, Eccrine	Cancer
ACTH-Secreting Pituitary Adenoma	MESH:D049913	DO:DOID:7004|OMIM:219090	A pituitary adenoma which secretes ADRENOCORTICOTROPIN, leading to CUSHING DISEASE.	MESH:D000236|MESH:D010911	C04.557.470.035.012|C04.588.322.609.145|C10.228.140.617.738.675.149|C19.344.609.145|C19.700.734.145	C04.557.470.035|C04.588.322.609|C10.228.140.617.738.675|C19.344.609|C19.700.734	ACTH Producing Pituitary Adenoma|ACTH-Producing Pituitary Adenoma|ACTH-Producing Pituitary Adenomas|ACTH Secreting Pituitary Adenoma|ACTH-Secreting Pituitary Adenomas|Adenoma, Corticotroph|Adenomas, Corticotroph|Corticotroph Adenoma|Corticotroph Adenomas|Corticotropin-Secreting Adenoma, Pituitary|Corticotropin-Secreting Adenomas, Pituitary|CUSHING DISEASE, PITUITARY|PITA4|PITUITARY ADENOMA 4, ACTH-SECRETING|Pituitary Adenoma, ACTH-Producing|Pituitary Adenoma, ACTH Secreting|Pituitary Adenoma, ACTH-Secreting|Pituitary Adenomas, ACTH-Producing|Pituitary Adenomas, ACTH-Secreting|Pituitary Corticotropin Secreting Adenoma|Pituitary Corticotropin-Secreting Adenoma|Pituitary Corticotropin-Secreting Adenomas	Cancer|Endocrine system disease|Nervous system disease
ACTH Syndrome, Ectopic	MESH:D000182		Symptom complex due to ACTH production by non-pituitary neoplasms.	MESH:D009384	C04.730.713.317	C04.730.713	ACTH Syndromes, Ectopic|Ectopic ACTH Syndrome|Ectopic ACTH Syndromes|Syndrome, Ectopic ACTH|Syndromes, Ectopic ACTH	Cancer
Actin-Accumulation Myopathy	MESH:C579880			MESH:D020914	C05.651.575/C579880|C10.668.491.550/C579880	C05.651.575|C10.668.491.550	Actin Filament Aggregate Myopathy|Actin Myopathy|Congenital Myopathy with Excess of Thin Filaments|Myopathy, Actin, Congenital, With Cores|Nemaline myopathy 3|Nemaline Myopathy 3, With Intranuclear Rods|Nemaline myopathy caused by mutation in the alpha-actin gene	Musculoskeletal disease|Nervous system disease
Acute brachial neuritis	MESH:C538620			MESH:D020968	C10.668.829.100.500/C538620|C10.668.829.650.250/C538620	C10.668.829.100.500|C10.668.829.650.250	Acute brachial neuritis syndrome|Acute brachial radiculitis syndrome|Acute shoulder neuritis	Nervous system disease
Acute cholinergic dysautonomia	MESH:C535672			MESH:D054969	C10.177.575/C535672	C10.177.575		Nervous system disease
Acute Coronary Syndrome	MESH:D054058		An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.	MESH:D017202	C14.280.647.124|C14.907.585.124	C14.280.647|C14.907.585	Acute Coronary Syndromes|Coronary Syndrome, Acute|Coronary Syndromes, Acute|Syndrome, Acute Coronary|Syndromes, Acute Coronary	Cardiovascular disease
Acute erythroleukemia	MESH:C535673			MESH:D004915	C04.557.337.539.275.325/C535673|C15.378.190.636.276/C535673	C04.557.337.539.275.325|C15.378.190.636.276	Acute erythroleukemia - M6a subtype|Acute erythroleukemia - M6b subtype|Acute myeloid leukemia FAB-M6|AML-M6 Acute myeloid leukemia M6	Blood disease|Cancer
Acute Febrile Encephalopathy	MESH:D000071072		Acute onset of fever accompanied by seizures, cerebral inflammation and a change in mental status (e.g., confusion, disorientation, and coma).	MESH:D001927	C10.228.140.021	C10.228.140	Acute Encephalitis Syndrome|Acute Encephalitis Syndromes|Acute Febrile Encephalopathies|Encephalopathies, Acute Febrile|Encephalopathies, Febrile|Encephalopathy, Acute Febrile|Encephalopathy, Febrile|Febrile Encephalopathies|Febrile Encephalopathies, Acute|Febrile Encephalopathy	Nervous system disease
acute flaccid myelitis	MESH:C000629404			MESH:D009187|MESH:D009468|MESH:D020805	C01.207.245/C000629404|C01.207.618/C000629404|C01.925.182/C000629404|C10.228.228.245/C000629404|C10.228.228.618/C000629404|C10.228.854.525/C000629404|C10.586.750/C000629404|C10.668/C000629404	C01.207.245|C01.207.618|C01.925.182|C10.228.228.245|C10.228.228.618|C10.228.854.525|C10.586.750|C10.668	acute flaccid paralysis|AFM syndrome	Nervous system disease|Viral disease
Acute Lung Injury	MESH:D055371		A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).	MESH:D055370	C08.381.520.500	C08.381.520	Acute Lung Injuries|Lung Injuries, Acute|Lung Injury, Acute	Respiratory tract disease
Acute Retroviral Syndrome	MESH:D000071297		Early stage of HIV infection. Symptoms resemble INFLUENZA or INFECTIOUS MONONUCLEOSIS.	MESH:D015658	C01.221.250.875.044|C01.221.812.640.400.044|C01.778.640.400.044|C01.925.782.815.616.400.044|C01.925.813.400.044|C12.100.937.640.400.044|C20.673.480.044	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C12.100.937.640.400|C20.673.480	Retroviral Syndrome, Acute	Immune system disease|Viral disease
Acute zonal occult outer retinopathy	MESH:C538223			MESH:D000080363|MESH:D012607	C10.597.751.941.811/C538223|C11.941.879.780.900.650/C538223|C11.966.811/C538223|C23.888.592.763.941.811/C538223	C10.597.751.941.811|C11.941.879.780.900.650|C11.966.811|C23.888.592.763.941.811		Eye disease|Nervous system disease|Signs and symptoms
Adamantinoma	MESH:D050398	DO:DOID:2775|DO:DOID:2776	A locally aggressive, osteolytic neoplasm of the long bones, probably of epithelial origin and most often involving the TIBIA.	MESH:D001859	C04.588.149.030|C05.116.231.030	C04.588.149|C05.116.231	Adamantinoma of Long Bones|Adamantinomas|Long Bones Adamantinoma|Long Bones Adamantinomas	Cancer|Musculoskeletal disease
Adams-Stokes Syndrome	MESH:D000219		A condition of fainting spells caused by heart block, often an atrioventricular block, that leads to BRADYCARDIA and drop in CARDIAC OUTPUT. When the cardiac output becomes too low, the patient faints (SYNCOPE). In some cases, the syncope attacks are transient and in others cases repetitive and persistent.	MESH:D006327	C14.280.067.558.137|C14.280.123.500.137|C23.550.073.425.025	C14.280.067.558|C14.280.123.500|C23.550.073.425	Adams Stokes Syndrome|Adam Stokes Attacks|Adam-Stokes Attacks|Attacks, Adam-Stokes|Attacks, Stokes-Adams|Stokes Adams Attacks|Stokes-Adams Attacks|Stokes Adams Syndrome|Stokes-Adams Syndrome|Syndrome, Adams-Stokes|Syndrome, Stokes-Adams	Cardiovascular disease|Pathology (process)
Addison Disease	MESH:D000224	DO:DOID:13774	An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.	MESH:D000309|MESH:D001327	C19.053.500.263|C20.111.163	C19.053.500|C20.111	Addison's Disease|Addisons Disease|Adrenal Insufficiency, Primary|Adrenocortical Insufficiencies, Primary|Adrenocortical Insufficiency, Primary|Disease, Addison|Hypoadrenalism, Primary|Hypoadrenalisms, Primary|Insufficiencies, Primary Adrenocortical|Insufficiency, Primary Adrenocortical|Primary Adrenal Insufficiency|Primary Adrenocortical Insufficiencies|Primary Adrenocortical Insufficiency|Primary Hypoadrenalism	Endocrine system disease|Immune system disease
Adenine Nucleotide Translocator Deficiency	MESH:C566309			MESH:D009886	C10.292.562.750/C566309|C10.597.622.447/C566309|C11.590.472/C566309|C23.888.592.636.447/C566309	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447		Eye disease|Nervous system disease|Signs and symptoms
Adenoameloblastoma	MESH:C538229			MESH:D000564	C04.557.695.065/C538229	C04.557.695.065	Adenomatoid ameloblastoma|Adenomatoid odontogenic tumor|Pleomorphic adenomatoid tumor	Cancer
Adenocarcinoid tumor	MESH:C538230			MESH:D000230	C04.557.470.200.025/C538230	C04.557.470.200.025		Cancer
Adenocarcinoma	MESH:D000230	DO:DOID:299|DO:DOID:4903|DO:DOID:4929|DO:DOID:5675	A malignant epithelial tumor with a glandular organization.	MESH:D002277	C04.557.470.200.025	C04.557.470.200	Adenocarcinoma, Basal Cell|Adenocarcinoma, Granular Cell|Adenocarcinoma, Oxyphilic|Adenocarcinomas|Adenocarcinomas, Basal Cell|Adenocarcinomas, Granular Cell|Adenocarcinomas, Oxyphilic|Adenocarcinomas, Tubular|Adenocarcinoma, Tubular|Adenoma, Malignant|Adenomas, Malignant|Basal Cell Adenocarcinoma|Basal Cell Adenocarcinomas|Carcinoma, Cribriform|Carcinoma, Granular Cell|Carcinomas, Cribriform|Carcinomas, Granular Cell|Carcinomas, Tubular|Carcinoma, Tubular|Cribriform Carcinoma|Cribriform Carcinomas|Granular Cell Adenocarcinoma|Granular Cell Adenocarcinomas|Granular Cell Carcinoma|Granular Cell Carcinomas|Malignant Adenoma|Malignant Adenomas|Oxyphilic Adenocarcinoma|Oxyphilic Adenocarcinomas|Tubular Adenocarcinoma|Tubular Adenocarcinomas|Tubular Carcinoma|Tubular Carcinomas	Cancer
Adenocarcinoma, Bronchiolo-Alveolar	MESH:D002282	DO:DOID:4926	A carcinoma derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed)	MESH:D000077192	C04.557.470.200.025.022.500|C04.588.894.797.520.055.500	C04.557.470.200.025.022|C04.588.894.797.520.055	Adenocarcinoma, Alveolar|Adenocarcinoma, Bronchiolo Alveolar|Adenocarcinomas, Alveolar|Adenocarcinomas, Bronchiolo-Alveolar|Alveolar Adenocarcinoma|Alveolar Adenocarcinomas|Alveolar Carcinoma|Alveolar Carcinomas|Alveolar Cell Carcinoma|Alveolar Cell Carcinomas|Bronchiolar Carcinoma|Bronchiolar Carcinomas|Bronchiolo-Alveolar Adenocarcinoma|Bronchiolo-Alveolar Adenocarcinomas|Bronchioloalveolar Carcinoma|Bronchiolo-Alveolar Carcinoma|Bronchioloalveolar Carcinomas|Bronchiolo-Alveolar Carcinomas|Carcinoma, Alveolar|Carcinoma, Alveolar Cell|Carcinoma, Bronchiolar|Carcinoma, Bronchioloalveolar|Carcinoma, Bronchiolo Alveolar|Carcinoma, Bronchiolo-Alveolar|Carcinomas, Alveolar|Carcinomas, Alveolar Cell|Carcinomas, Bronchiolar|Carcinomas, Bronchioloalveolar|Carcinomas, Bronchiolo-Alveolar	Cancer
Adenocarcinoma, Clear Cell	MESH:D018262	DO:DOID:4468	An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed)	MESH:D000230	C04.557.470.200.025.045	C04.557.470.200.025	Adenocarcinomas, Clear Cell|Clear Cell Adenocarcinoma|Clear Cell Adenocarcinomas	Cancer
Adenocarcinoma, Follicular	MESH:D018263	DO:DOID:3962	An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed)	MESH:D000230	C04.557.470.200.025.060	C04.557.470.200.025	Adenocarcinomas, Follicular|Carcinoma, Follicular Thyroid|Carcinomas, Follicular Thyroid|Follicular Adenocarcinoma|Follicular Adenocarcinomas|Follicular Thyroid Carcinoma|Follicular Thyroid Carcinomas|Thyroid Carcinoma, Follicular|Thyroid Carcinomas, Follicular	Cancer
Adenocarcinoma in Situ	MESH:D065311	DO:DOID:4943	A lesion with cytological characteristics associated with invasive adenocarcinoma but the tumor cells are confined to the GLANDULAR EPITHELIAL CELLS of origin. Adenocarcinoma in situ of the CERVIX and the LUNG are the most common.	MESH:D000230|MESH:D002278|MESH:D065308	C04.557.470.200.025.014|C04.557.470.200.240.124|C23.149.249	C04.557.470.200.025|C04.557.470.200.240|C23.149	Adenocarcinoma in Situs|Adenocarcinoma, Intraepithelial|Adenocarcinoma, Preinvasive|Adenocarcinomas, Intraepithelial|Adenocarcinomas, Preinvasive|in Situ, Adenocarcinoma|Intraepithelial Adenocarcinoma|Intraepithelial Adenocarcinomas|Preinvasive Adenocarcinoma|Preinvasive Adenocarcinomas|Situ, Adenocarcinoma in	Cancer
Adenocarcinoma, Mucinous	MESH:D002288	DO:DOID:3030	An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)	MESH:D000230|MESH:D018297	C04.557.470.200.025.075|C04.557.470.590.075	C04.557.470.200.025|C04.557.470.590	Adenocarcinomas, Mucinous|Carcinoma, Colloid|Carcinoma, Mucinous|Carcinomas, Colloid|Carcinomas, Mucinous|Colloid Carcinoma|Colloid Carcinomas|Mucinous Adenocarcinoma|Mucinous Adenocarcinomas|Mucinous Carcinoma|Mucinous Carcinomas	Cancer
Adenocarcinoma Of Esophagus	MESH:C562730	DO:DOID:4914		MESH:D000230|MESH:D004938	C04.557.470.200.025/C562730|C04.588.274.476.205/C562730|C04.588.443.353/C562730|C06.301.371.205/C562730|C06.405.117.430/C562730|C06.405.249.205/C562730	C04.557.470.200.025|C04.588.274.476.205|C04.588.443.353|C06.301.371.205|C06.405.117.430|C06.405.249.205		Cancer|Digestive system disease
Adenocarcinoma of Lung	MESH:D000077192	DO:DOID:3910	A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.	MESH:D000230|MESH:D008175	C04.557.470.200.025.022|C04.588.894.797.520.055	C04.557.470.200.025|C04.588.894.797.520	Adenocarcinoma, Lung|Adenocarcinomas, Lung|Lung Adenocarcinoma|Lung Adenocarcinomas	Cancer
Adenocarcinoma, Papillary	MESH:D000231	DO:DOID:3112	An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)	MESH:D000230	C04.557.470.200.025.085	C04.557.470.200.025	Adenocarcinomas, Papillary|Papillary Adenocarcinoma|Papillary Adenocarcinomas	Cancer
Adenocarcinoma, Scirrhous	MESH:D002293	DO:DOID:4024	An adenocarcinoma with a hard (Greek skirrhos, hard) structure owing to the formation of dense connective tissue in the stroma. (From Dorland, 27th ed)	MESH:D000230	C04.557.470.200.025.095	C04.557.470.200.025	Adenocarcinomas, Scirrhous|Carcinoma, Scirrhous|Carcinomas, Scirrhous|Scirrhous Adenocarcinoma|Scirrhous Adenocarcinomas|Scirrhous Carcinoma|Scirrhous Carcinomas	Cancer
Adenocarcinoma, Sebaceous	MESH:D018266	DO:DOID:4839	A malignant tumor composed of cells showing differentiation toward sebaceous epithelium. The tumor is solitary, firm, somewhat raised, more or less translucent, and covered with normal or slightly verrucose epidermis. It may be yellow or orange. The face and scalp are the commonest sites. The growth can be slow or rapid but metastasis is uncommon. Surgery cures most of the cases. (From Rook et al., Textbook of Dermatology, 4th ed, pp2403-4)	MESH:D000230|MESH:D018294	C04.557.470.200.025.105|C04.557.470.550.105	C04.557.470.200.025|C04.557.470.550	Adenocarcinomas, Sebaceous|Sebaceous Adenocarcinoma|Sebaceous Adenocarcinomas	Cancer
Adenofibroma	MESH:D000232	DO:DOID:2683	A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed)	MESH:D018225	C04.557.450.565.590.595.050|C04.557.470.625.050	C04.557.450.565.590.595|C04.557.470.625	Adenofibromas|Fibroadenosis	Cancer
Adenolymphoma	MESH:D000235		A benign tumor characterized histologically by tall columnar epithelium within a lymphoid tissue stroma. It is usually found in the salivary glands, especially the parotid.	MESH:D018193	C04.557.435.075	C04.557.435	Adenolymphomas|Cystadenoma Lymphomatosum, Papillary|Papillary Cystadenoma Lymphomatosum|Tumor, Warthin|Warthin Tumor	Cancer
Adenoma	MESH:D000236	DO:DOID:3172|DO:DOID:5403|DO:DOID:6204|DO:DOID:657	A benign epithelial tumor with a glandular organization.	MESH:D009375	C04.557.470.035	C04.557.470	Adenoma, Basal Cell|Adenoma, Follicular|Adenoma, Microcystic|Adenoma, Monomorphic|Adenoma, Papillary|Adenomas|Adenomas, Basal Cell|Adenomas, Follicular|Adenomas, Microcystic|Adenomas, Monomorphic|Adenomas, Papillary|Adenomas, Trabecular|Adenoma, Trabecular|Basal Cell Adenoma|Basal Cell Adenomas|Follicular Adenoma|Follicular Adenomas|Microcystic Adenoma|Microcystic Adenomas|Monomorphic Adenoma|Monomorphic Adenomas|Papillary Adenoma|Papillary Adenomas|Trabecular Adenoma|Trabecular Adenomas	Cancer
Adenoma, Acidophil	MESH:D000239	DO:DOID:5392	A benign tumor, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumors may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhea. (Dorland, 27th ed)	MESH:D000236|MESH:D018358	C04.557.465.625.650.025|C04.557.470.035.025|C04.557.580.625.650.025	C04.557.465.625.650|C04.557.470.035|C04.557.580.625.650	Acidophil Adenoma|Acidophil Adenomas|Acidophilic Adenoma|Acidophilic Adenomas|Adenoma, Acidophilic|Adenoma, Eosinophil|Adenoma, Eosinophilic|Adenomas, Acidophil|Adenomas, Acidophilic|Adenomas, Eosinophil|Adenomas, Eosinophilic|Eosinophil Adenoma|Eosinophil Adenomas|Eosinophilic Adenoma|Eosinophilic Adenomas	Cancer
Adenoma, Basophil	MESH:D000237	DO:DOID:4542	A small tumor of the anterior lobe of the pituitary gland whose cells stain with basic dyes. It may give rise to excessive secretion of ACTH, resulting in CUSHING SYNDROME. (Dorland, 27th ed)	MESH:D000236|MESH:D018358	C04.557.465.625.650.075|C04.557.470.035.075|C04.557.580.625.650.075	C04.557.465.625.650|C04.557.470.035|C04.557.580.625.650	Adenoma, Basophilic|Adenomas, Basophil|Adenomas, Basophilic|Basophil Adenoma|Basophil Adenomas|Basophilic Adenoma|Basophilic Adenomas	Cancer
Adenoma, Bile Duct	MESH:D002759	DO:DOID:5381	A benign tumor of the intrahepatic bile ducts.	MESH:D000236	C04.557.470.035.085	C04.557.470.035	Adenomas, Bile Duct|Bile Duct Adenoma|Bile Duct Adenomas|Cholangioma|Cholangiomas	Cancer
Adenoma, Chromophobe	MESH:D000238	DO:DOID:3828	A benign tumor of the anterior pituitary in which the cells do not stain with acidic or basic dyes.	MESH:D000236|MESH:D018358	C04.557.465.625.650.095|C04.557.470.035.095|C04.557.580.625.650.095	C04.557.465.625.650|C04.557.470.035|C04.557.580.625.650	Adenomas, Chromophobe|Chromophobe Adenoma|Chromophobe Adenomas	Cancer
Adenoma, Islet Cell	MESH:D007516	DO:DOID:1799|DO:DOID:3892	A benign tumor of the pancreatic ISLET CELLS. Usually it involves the INSULIN-producing PANCREATIC BETA CELLS, as in INSULINOMA, resulting in HYPERINSULINISM.	MESH:D000236|MESH:D010190	C04.557.470.035.100|C04.588.274.761.249|C04.588.322.475.249|C06.301.761.249|C06.689.667.249|C19.344.421.249	C04.557.470.035|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421	Adenomas, Islet Cell|Island Cell Tumor|Island Cell Tumors|Islet Cell Adenoma|Islet Cell Adenomas|Islet Cell Tumor|Islet Cell Tumors|Islet of Langerhans Tumor|Langerhans Tumor Islet|Nesidioblastoma|Nesidioblastomas|Pancreatic Islet Cell Tumors|Tumor, Island Cell|Tumor, Islet Cell|Tumor Islet, Langerhans|Tumors, Island Cell|Tumors, Islet Cell	Cancer|Digestive system disease|Endocrine system disease
Adenoma, Liver Cell	MESH:D018248		A benign epithelial tumor of the LIVER.	MESH:D000236|MESH:D008113	C04.557.470.035.120|C04.588.274.623.040|C06.301.623.040|C06.552.697.040	C04.557.470.035|C04.588.274.623|C06.301.623|C06.552.697	Adenoma, Hepatocellular|Adenomas, Hepatocellular|Adenomas, Liver Cell|Benign Hepatoma|Benign Hepatomas|Hepatocellular Adenoma|Hepatocellular Adenomas|Hepatoma, Benign|Hepatomas, Benign|Liver Cell Adenoma|Liver Cell Adenomas	Cancer|Digestive system disease
Adenoma, Oxyphilic	MESH:D018249	DO:DOID:5389	A usually benign glandular tumor composed of oxyphil cells, large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA. Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands. In the thyroid gland, oxyphil cells are known as Hurthle cells and Askanazy cells.	MESH:D000236	C04.557.470.035.140	C04.557.470.035	Huerthle Cell Tumor|Hurthle Cell Tumor|Oncocytoma|Oxyphilic Adenoma	Cancer
Adenoma, Pleomorphic	MESH:D008949	DO:DOID:452	A benign, slow-growing tumor, most commonly of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. (Dorland, 27th ed)	MESH:D000236|MESH:D018193	C04.557.435.090|C04.557.470.035.155	C04.557.435|C04.557.470.035	Adenomas, Pleomorphic|Chondroid Syringoma|Chondroid Syringomas|Mixed Salivary Gland Tumor|Pleomorphic Adenoma|Pleomorphic Adenomas|Salivary Gland Tumor, Mixed|Syringoma, Chondroid|Syringomas, Chondroid	Cancer
Adenoma, Sweat Gland	MESH:D006607	DO:DOID:3896	A benign neoplasm derived from epithelial cells of sweat glands. (Stedman, 25th ed)	MESH:D000236|MESH:D018294	C04.557.470.035.175|C04.557.470.550.175	C04.557.470.035|C04.557.470.550	Adenomas, Sweat Gland|Sweat Gland Adenoma|Sweat Gland Adenomas|Syringadenoma|Syringadenomas	Cancer
Adenomatoid Tumor	MESH:D018254	DO:DOID:746	A small, circumscribed, benign tumor of the genital tract, composed of small glandlike spaces lined by flattened or cuboidal mesothelium-like cells. (From Dorland, 27th ed)	MESH:D000236|MESH:D018301	C04.557.470.035.200|C04.557.470.660.200	C04.557.470.035|C04.557.470.660	Adenomatoid Tumors|Tumor, Adenomatoid|Tumors, Adenomatoid	Cancer
Adenomatosis, Pulmonary	MESH:D018255		A neoplastic disease in which the alveoli and distal bronchi are filled with mucus and mucus-secreting columnar epithelial cells. It is characterized by abundant, extremely tenacious sputum, chills, fever, cough, dyspnea, and pleuritic pain. (Stedman, 25th ed)	MESH:D000236	C04.557.470.035.210	C04.557.470.035	Adenomatoses, Pulmonary|Pulmonary Adenomatoses|Pulmonary Adenomatosis	Cancer
Adenomatous Polyps	MESH:D018256		Benign neoplasms derived from glandular epithelium. (From Stedman, 25th ed)	MESH:D000236	C04.557.470.035.215	C04.557.470.035	Adenomatous Polyp|Polyp, Adenomatous|Polyps, Adenomatous	Cancer
Adenoma, Villous	MESH:D018253		An adenoma of the large intestine. It is usually a solitary, sessile, often large, tumor of colonic mucosa composed of mucinous epithelium covering delicate vascular projections. Hypersecretion and malignant changes occur frequently. (Stedman, 25th ed)	MESH:D000236	C04.557.470.035.185	C04.557.470.035	Adenomas, Villous|Villous Adenoma|Villous Adenomas	Cancer
Adenomyoepithelioma	MESH:D055331		A mixed epithelial and myoepithelial neoplasm usually encountered within the breast. It is a multinodular lesion presenting with a bicellular pattern of proliferating epithelial and myoepithelial cells, which are regularly distributed in the glandular structures.	MESH:D018193	C04.557.435.108	C04.557.435	Adenomyoepitheliomas	Cancer
Adenomyoma	MESH:D018194	DO:DOID:2609	A benign neoplasm of muscle (usually smooth muscle) with glandular elements. It occurs most frequently in the uterus and uterine ligaments. (Stedman, 25th ed)	MESH:D018193	C04.557.435.110	C04.557.435	Adenomyomas	Cancer
Adenomyosis	MESH:D062788	DO:DOID:288	The extension of endometrial tissue (ENDOMETRIUM) into the MYOMETRIUM. It usually occurs in women in their reproductive years and may result in a diffusely enlarged uterus with ectopic and benign endometrial glands and stroma.	MESH:D014591	C12.050.351.500.852.113|C12.100.250.852.113	C12.050.351.500.852|C12.100.250.852	Adenomyoses	Urogenital disease (female)
Adenosarcoma	MESH:D018195	DO:DOID:1974	A malignant neoplasm arising simultaneously or consecutively in mesodermal tissue and glandular epithelium of the same part. (Stedman, 25th ed)	MESH:D012509|MESH:D018193	C04.557.435.135|C04.557.450.795.135	C04.557.435|C04.557.450.795	Adenosarcomas	Cancer
Adenosarcoma of the uterus	MESH:C538232			MESH:D014594|MESH:D018195	C04.557.435.135/C538232|C04.557.450.795.135/C538232|C04.588.945.418.948/C538232|C12.050.351.500.852.762/C538232|C12.050.351.937.418.875/C538232|C12.100.250.852.762/C538232|C12.900.418.875/C538232	C04.557.435.135|C04.557.450.795.135|C04.588.945.418.948|C12.050.351.500.852.762|C12.050.351.937.418.875|C12.100.250.852.762|C12.900.418.875	Mullerian adenosarcoma of the uterus|Uterine adenosarcoma	Cancer|Urogenital disease (female)
Adenosine Deaminase, Elevated, Hemolytic Anemia Due To	MESH:C566314			MESH:D000743	C15.378.071.141/C566314	C15.378.071.141		Blood disease
Adenosine Triphosphate, Elevated, Of Erythrocytes	MESH:C566310	OMIM:102900		MESH:D006402	C15.378/C566310	C15.378	Pyruvate Kinase Hyperactivity	Blood disease
Adenoviridae Infections	MESH:D000257		Virus diseases caused by the ADENOVIRIDAE.	MESH:D004266	C01.925.256.076	C01.925.256	Adenoviridae Infection|Adenovirus Infection|Adenovirus Infections|Infection, Adenoviridae|Infection, Adenovirus|Infections, Adenoviridae|Infections, Adenovirus	Viral disease
Adenovirus Infections, Human	MESH:D000258	DO:DOID:13801	Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses.	MESH:D000257	C01.925.256.076.045	C01.925.256.076	Adenovirus Infection, Human|Fever, Pharyngo-Conjunctival|Human Adenovirus Infection|Human Adenovirus Infections|Infection, Human Adenovirus|Infections, Human Adenovirus|Pharyngo Conjunctival Fever|Pharyngo-Conjunctival Fever	Viral disease
Adenylate Kinase Deficiency, Hemolytic Anemia Due To	MESH:C567228	OMIM:612631		MESH:D000743	C15.378.071.141/C567228	C15.378.071.141		Blood disease
Adie Syndrome	MESH:D000270	DO:DOID:11549	A syndrome characterized by a TONIC PUPIL that occurs in combination with decreased lower extremity reflexes. The affected pupil will respond more briskly to accommodation than to light (light-near dissociation) and is supersensitive to dilute pilocarpine eye drops, which induce pupillary constriction. Pathologic features include degeneration of the ciliary ganglion and postganglionic parasympathetic fibers that innervate the pupillary constrictor muscle. (From Adams et al., Principles of Neurology, 6th ed, p279)	MESH:D001342|MESH:D015840|MESH:D015845	C10.177.045|C10.292.562.700.250|C11.590.436.200|C11.710.800.180	C10.177|C10.292.562.700|C11.590.436|C11.710.800	Adie's Syndrome|Holmes Adie Syndrome|Holmes-Adie Syndrome|Poorly Reacting Pupil|Poorly Reacting Pupils|Pupil, Poorly Reacting|Pupils, Poorly Reacting|Syndrome, Adie|Syndrome, Adie's|Syndrome, Holmes-Adie	Eye disease|Nervous system disease
ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	OMIM:606770			MESH:D008659|MESH:D009765	C18.452/606770|C18.654.726.750.500/606770|C23.888.144.699.500/606770	C18.452|C18.654.726.750.500|C23.888.144.699.500	ADIPQTL2|CAQ5|CIRCULATING ADIPONECTIN QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 5	Metabolic disease|Nutrition disorder|Signs and symptoms
ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3	OMIM:606771			MESH:D008659|MESH:D009765	C18.452/606771|C18.654.726.750.500/606771|C23.888.144.699.500/606771	C18.452|C18.654.726.750.500|C23.888.144.699.500	ADIPQTL3|CAQ14|CIRCULATING ADIPONECTIN QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14	Metabolic disease|Nutrition disorder|Signs and symptoms
Adiposis Dolorosa	MESH:D000274	DO:DOID:3928	A rare disease characterized by multiple tumor-like fatty deposits that press on nerves in various sites causing pain and weakness. Often these lipoma-like structures are located on the trunk and limbs but not on the face and hands.	MESH:D008068	C17.800.463.249|C18.452.584.718.500	C17.800.463|C18.452.584.718	Adiposalgia|Adiposalgias|Adipose Tissue Rheumatism|Adipose Tissue Rheumatisms|Ander's Syndrome|Anders Syndrome|Anders Syndromes|Ander Syndrome|Decum Vitaut Syndrome|Decum-Vitaut Syndrome|Dercum Disease|Dercum, Morbus|Dercum's Disease|Dercums Disease|Dercums, Morbus|Disease, Dercum|Disease, Dercum's|Dolorosa, Lipomatosis|Dolorosas, Lipomatosis|Lipomatosis Dolorosa|Lipomatosis Dolorosas|Morbus Dercum|Morbus Dercums|Rheumatism, Adipose Tissue|Rheumatisms, Adipose Tissue|Syndrome, Anders|Syndrome, Ander's|Syndrome, Decum-Vitaut|Syndromes, Anders|Tissue Rheumatism, Adipose|Tissue Rheumatisms, Adipose	Metabolic disease|Skin disease
Adnexal Diseases	MESH:D000291		Diseases of the uterine appendages (ADNEXA UTERI) including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).	MESH:D005831	C12.050.351.500.056|C12.100.250.056	C12.050.351.500|C12.100.250	Adnexal Disease|Disease, Adnexal|Diseases, Adnexal	Urogenital disease (female)
Adrenal Cortex Neoplasms	MESH:D000306	DO:DOID:660	Tumors or cancers of the ADRENAL CORTEX.	MESH:D000303|MESH:D000310	C04.588.322.078.265|C19.053.098.265|C19.053.347.500|C19.344.078.265	C04.588.322.078|C19.053.098|C19.053.347|C19.344.078	Adrenal Cortex Cancer|Adrenal Cortex Cancers|Adrenal Cortex Neoplasm|Adrenocortical Cancer|Adrenocortical Cancers|Cancer, Adrenal Cortex|Cancer, Adrenocortical|Cancer of Adrenal Cortex|Cancer of the Adrenal Cortex|Cancers, Adrenal Cortex|Cancers, Adrenocortical|Neoplasm, Adrenal Cortex|Neoplasms, Adrenal Cortex	Cancer|Endocrine system disease
Adrenal Gland Neoplasms	MESH:D000310	DO:DOID:3953	Tumors or cancer of the ADRENAL GLANDS.	MESH:D000307|MESH:D004701	C04.588.322.078|C19.053.347|C19.344.078	C04.588.322|C19.053|C19.344	Adrenal Cancer|Adrenal Cancers|Adrenal Gland Cancer|Adrenal Gland Cancers|Adrenal Gland Neoplasm|Adrenal Neoplasm|Adrenal Neoplasms|Cancer, Adrenal|Cancer, Adrenal Gland|Cancer of the Adrenal Gland|Cancers, Adrenal|Cancers, Adrenal Gland|Neoplasm, Adrenal|Neoplasm, Adrenal Gland|Neoplasms, Adrenal|Neoplasms, Adrenal Gland	Cancer|Endocrine system disease
Adrenal incidentaloma	MESH:C538238			MESH:D000310	C04.588.322.078/C538238|C19.053.347/C538238|C19.344.078/C538238	C04.588.322.078|C19.053.347|C19.344.078	Adrenal incidentalomas	Cancer|Endocrine system disease
Adrenal Rest Tumor	MESH:D000314	DO:DOID:1786	Neoplasm derived from displaced cells (rest cells) of the primordial ADRENAL GLANDS, generally in patients with CONGENITAL ADRENAL HYPERPLASIA. Adrenal rest tumors have been identified in TESTES; LIVER; and other tissues. They are dependent on ADRENOCORTICOTROPIN for growth and adrenal steroid secretion.	MESH:D000236	C04.557.470.035.232	C04.557.470.035	Adrenal Cortical Rest Tumor|Adrenal Rest Tumors|Rest Tumor, Adrenal|Rest Tumors, Adrenal|Tumor, Adrenal Rest|Tumors, Adrenal Rest	Cancer
Adrenocortical Adenoma	MESH:D018246		A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE.	MESH:D000306	C04.588.322.078.265.500|C19.053.098.265.500|C19.053.347.500.500|C19.344.078.265.500	C04.588.322.078.265|C19.053.098.265|C19.053.347.500|C19.344.078.265	Adenoma, Adrenal Cortical|Adenoma, Adrenocortical|Adenoma, Conn|Adenomas, Adrenal Cortical|Adenomas, Adrenocortical|Adenomas, Conn|Adrenal Cortical Adenoma|Adrenal Cortical Adenomas|Adrenocortical Adenomas|Conn Adenoma|Conn Adenomas|Conn Disease|Conn's Disease|Conns Disease|Disease, Conn|Disease, Conn's	Cancer|Endocrine system disease
Adrenocortical Carcinoma	MESH:D018268	DO:DOID:3948	A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.	MESH:D000230|MESH:D000306	C04.557.470.200.025.152|C04.588.322.078.265.750|C19.053.098.265.750|C19.053.347.500.750|C19.344.078.265.750	C04.557.470.200.025|C04.588.322.078.265|C19.053.098.265|C19.053.347.500|C19.344.078.265	Adrenal Cortical Carcinoma|Adrenal Cortical Carcinomas|Adrenocortical Carcinomas|Carcinoma, Adrenal Cortical|Carcinoma, Adrenocortical|Carcinomas, Adrenal Cortical|Carcinomas, Adrenocortical	Cancer|Endocrine system disease
Adrenocortical Carcinoma, Hereditary	MESH:C565972	OMIM:202300		MESH:D018268	C04.557.470.200.025.152/C565972|C04.588.322.078.265.750/C565972|C19.053.098.265.750/C565972|C19.053.347.500.750/C565972|C19.344.078.265.750/C565972	C04.557.470.200.025.152|C04.588.322.078.265.750|C19.053.098.265.750|C19.053.347.500.750|C19.344.078.265.750	ADCC|ADRENOCORTICAL CARCINOMA, PEDIATRIC, INCLUDED	Cancer|Endocrine system disease
Adrenocortical Carcinoma, Pediatric	MESH:C565973			MESH:D018268	C04.557.470.200.025.152/C565973|C04.588.322.078.265.750/C565973|C19.053.098.265.750/C565973|C19.053.347.500.750/C565973|C19.344.078.265.750/C565973	C04.557.470.200.025.152|C04.588.322.078.265.750|C19.053.098.265.750|C19.053.347.500.750|C19.344.078.265.750		Cancer|Endocrine system disease
Adult i Blood Group with Congenital Cataract	MESH:C566214			MESH:D002386	C11.510.245/C566214	C11.510.245	Adult i Blood Group Phenotype|Adult i Blood Group without Congenital Cataract	Eye disease
adult multisystem inflammatory disease, COVID-19 related	MESH:C000718087			MESH:D000086382|MESH:D018746	C01.748.610.763.500/C000718087|C01.925.705.500/C000718087|C01.925.782.600.550.200.163/C000718087|C08.381.677.807.500/C000718087|C08.730.610.763.500/C000718087|C23.550.470.790/C000718087|C23.550.835.900/C000718087	C01.748.610.763.500|C01.925.705.500|C01.925.782.600.550.200.163|C08.381.677.807.500|C08.730.610.763.500|C23.550.470.790|C23.550.835.900	adult multi-system inflammatory disease, COVID-19 related|COVID-19-associated multi-system inflammatory syndrome in adults|COVID-19-associated multisystem inflammatory syndrome in adults|MIS-A|MIS-A associated with COVID-19|MISA associated with COVID-19|multi-system inflammatory disease, adult, COVID-19 related|multisystem inflammatory disease, adult, COVID-19 related|multi-system inflammatory syndrome in adults associated with COVID-19|multisystem inflammatory syndrome in adults associated with COVID-19	Pathology (process)|Respiratory tract disease|Viral disease
Afferent Loop Syndrome	MESH:D000343	DO:DOID:8438	A complication of gastrojejunostomy (BILLROTH II PROCEDURE), a reconstructive GASTROENTEROSTOMY. It is caused by acute (complete) or chronic (intermittent) obstruction of the afferent jejunal loop due to HERNIA, intussusception, kinking, VOLVULUS, etc. It is characterized by PAIN and VOMITING of BILE-stained fluid.	MESH:D007415|MESH:D011183	C06.405.469.531.099|C23.550.767.050	C06.405.469.531|C23.550.767	Afferent Loop Syndromes|Loop Syndrome, Afferent|Loop Syndromes, Afferent|Syndrome, Afferent Loop|Syndromes, Afferent Loop	Digestive system disease|Pathology (process)
African Hemochromatosis	MESH:C579887			MESH:D012806	C08.381.483.581.750/C579887|C08.381.520.702.750/C579887|C24.800.773/C579887	C08.381.483.581.750|C08.381.520.702.750|C24.800.773	African Siderosis	Occupational disease|Respiratory tract disease
Agammaglobulinemia	MESH:D000361	DO:DOID:2583|OMIM:601495|OMIM:612692|OMIM:613500|OMIM:613501|OMIM:613502|OMIM:613506|OMIM:616941	An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.	MESH:D001796|MESH:D007153|MESH:D008232	C15.378.147.142|C15.604.515.032|C20.673.088	C15.378.147|C15.604.515|C20.673	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE|AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE|AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE|AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE|AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT|AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE|AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT|AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT|AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO TCF3 DEFECT|AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO BLNK DEFECT|AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79A DEFECT|AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79B DEFECT|AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGHM DEFECT|AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGLL1 DEFECT|Agammaglobulinemias|AGM1|AGM2|AGM3|AGM4|AGM5|AGM6|AGM8|Hypogammaglobulinemia|Hypogammaglobulinemias	Blood disease|Immune system disease|Lymphatic disease
AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE	OMIM:615214	DO:DOID:2583		MESH:D000361	C15.378.147.142/615214|C15.604.515.032/615214|C20.673.088/615214	C15.378.147.142|C15.604.515.032|C20.673.088	AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO PIK3R1 DEFECT|AGM7	Blood disease|Immune system disease|Lymphatic disease
Agammaglobulinemia, microcephaly, and severe dermatitis	MESH:C538055			MESH:D000361|MESH:D003872|MESH:D008831	C05.660.207.620/C538055|C10.500.507.400.500/C538055|C15.378.147.142/C538055|C15.604.515.032/C538055|C16.131.621.207.620/C538055|C16.131.666.507.400.500/C538055|C17.800.174/C538055|C20.673.088/C538055	C05.660.207.620|C10.500.507.400.500|C15.378.147.142|C15.604.515.032|C16.131.621.207.620|C16.131.666.507.400.500|C17.800.174|C20.673.088		Blood disease|Congenital abnormality|Immune system disease|Lymphatic disease|Musculoskeletal disease|Nervous system disease|Skin disease
Agammaglobulinemia, non-Bruton type	MESH:C538056			MESH:D000361	C15.378.147.142/C538056|C15.604.515.032/C538056|C20.673.088/C538056	C15.378.147.142|C15.604.515.032|C20.673.088	Agammaglobulinemia, autosomal recessive|Agammaglobulinemia due to early proB cell defect|Agammaglobulinemia, Non-Bruton Type, Autosomal Recessive	Blood disease|Immune system disease|Lymphatic disease
Agammaglobulinemia, Non-Bruton Type, Autosomal Dominant	MESH:C563305			MESH:D000361	C15.378.147.142/C563305|C15.604.515.032/C563305|C20.673.088/C563305	C15.378.147.142|C15.604.515.032|C20.673.088		Blood disease|Immune system disease|Lymphatic disease
Age-Related Hearing Impairment 1	MESH:C567305	OMIM:612448		MESH:D011304	C09.218.458.341.887.772/C567305|C10.597.751.418.341.887.772/C567305|C23.888.592.763.393.341.887.772/C567305	C09.218.458.341.887.772|C10.597.751.418.341.887.772|C23.888.592.763.393.341.887.772	ARHI1|Presbycusis 1	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Ageusia	MESH:D000370		Complete or severe loss of the subjective sense of taste, frequently accompanied by OLFACTION DISORDERS.	MESH:D013651	C10.597.751.861.184|C23.888.592.763.861.184	C10.597.751.861|C23.888.592.763.861	Ageusia, Hysterical|Ageusias, Hysterical|Hypogeusia|Hypogeusias|Hysterical Ageusia|Hysterical Ageusias|Loss of Taste|Taste Blindness|Taste-Blindness|Taste Loss	Nervous system disease|Signs and symptoms
Agnosia	MESH:D000377	DO:DOID:4090	Loss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.	MESH:D010468	C10.597.606.762.100|C23.888.592.604.764.100	C10.597.606.762|C23.888.592.604.764	Agnosia, Auditory|Agnosia, Body-Image|Agnosia, Congenital Auditory|Agnosia, Developmental|Agnosia, Finger|Agnosia for Pain|Agnosia for Smell|Agnosia for Taste|Agnosia for Tastes|Agnosia for Temperature|Agnosia, Gustatory|Agnosia, Ideational|Agnosia, Olfactory|Agnosia, Position|Agnosias|Agnosias, Auditory|Agnosias, Body-Image|Agnosias, Congenital Auditory|Agnosias, Developmental|Agnosia, Sensory|Agnosias, Finger|Agnosias, Ideational|Agnosias, Olfactory|Agnosia, Somatosensory|Agnosias, Position|Agnosias, Sensory|Agnosias, Somatosensory|Agnosias, Tactile|Agnosias, Time|Agnosias, Topographical|Agnosias, Visual|Agnosias, Visuospatial|Agnosia, Tactile|Agnosia, Time|Agnosia, Topographical|Agnosia, Visual|Agnosia, Visuospatial|Anosognosia|Anosognosias|Auditory Agnosia|Auditory Agnosia, Congenital|Auditory Agnosias|Auditory Agnosias, Congenital|Body Image Agnosia|Body-Image Agnosia|Body-Image Agnosias|Congenital Auditory Agnosia|Congenital Auditory Agnosias|Developmental Agnosia|Developmental Agnosias|Finger Agnosia|Finger Agnosias|Gustatory Agnosia|Ideational Agnosia|Ideational Agnosias|Olfactory Agnosia|Olfactory Agnosias|Position Agnosia|Position Agnosias|Sensory Agnosia|Sensory Agnosias|Somatosensory Agnosia|Somatosensory Agnosias|Syndromes, Visual Disorientation|Syndrome, Visual Disorientation|Tactile Agnosia|Tactile Agnosias|Time Agnosia|Time Agnosias|Topographical Agnosia|Topographical Agnosias|Visual Agnosia|Visual Agnosia for Objects|Visual Agnosias|Visual Disorientation Syndrome|Visual Disorientation Syndromes|Visuospatial Agnosia|Visuospatial Agnosias	Nervous system disease|Signs and symptoms
Agranulocytosis	MESH:D000380	DO:DOID:12987	A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).	MESH:D007970	C15.378.553.546.184	C15.378.553.546	Agranulocytoses|Granulocytopenia|Granulocytopenias	Blood disease
Agraphia	MESH:D000381	DO:DOID:0060223|DO:DOID:4540	Loss or impairment of the ability to write (letters, syllables, words, or phrases) due to an injury to a specific cerebral area or occasionally due to emotional factors. This condition rarely occurs in isolation, and often accompanies APHASIA. (From Adams et al., Principles of Neurology, 6th ed, p485; APA, Thesaurus of Psychological Index Terms, 1994)	MESH:D007806	C10.597.606.150.500.050|C23.888.592.604.150.500.050	C10.597.606.150.500|C23.888.592.604.150.500	Acquired Agraphia|Acquired Agraphias|Acquired Dysgraphia|Acquired Dysgraphias|Agraphia, Acquired|Agraphia, Constructional|Agraphia, Developmental|Agraphia, Pure|Agraphias|Agraphias, Acquired|Agraphias, Constructional|Agraphias, Developmental|Agraphias, Pure|Constructional Agraphia|Constructional Agraphias|Developmental Agraphia|Developmental Agraphias|Developmental Dysgraphia|Developmental Dysgraphias|Dysgraphia|Dysgraphia, Acquired|Dysgraphia, Developmental|Dysgraphias|Dysgraphias, Acquired|Dysgraphias, Developmental|Pure Agraphia|Pure Agraphias	Nervous system disease|Signs and symptoms
AIDS Arteritis, Central Nervous System	MESH:D020943		Inflammation of ARTERIES in the CENTRAL NERVOUS SYSTEM that occurs in patients with ACQUIRED IMMUNODEFICIENCY SYNDROME or AIDS-RELATED OPPORTUNISTIC INFECTIONS.	MESH:D001167|MESH:D015658|MESH:D020293	C01.221.250.875.048|C01.221.812.640.400.048|C01.778.640.400.048|C01.925.782.815.616.400.048|C01.925.813.400.048|C10.114.875.175|C10.228.140.300.850.125|C12.100.937.640.400.048|C14.907.253.946.175|C14.907.940.090.170|C14.907.940.907.175|C20.673.480.048	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C10.114.875|C10.228.140.300.850|C12.100.937.640.400|C14.907.253.946|C14.907.940.090|C14.907.940.907|C20.673.480	AIDS Associated Cerebral Aneurysmal Arteriopathy|AIDS-Associated Cerebral Aneurysmal Arteriopathy|Central Nervous System AIDS Arteritis|Cerebral Aneurysmal Arteriopathy, AIDS Associated|Cerebral Aneurysmal Arteriopathy, AIDS-Associated|CNS Vasculitides, HIV-1-Associated|CNS Vasculitides, HIV-Associated|CNS Vasculitis, HIV-1-Associated|CNS Vasculitis, HIV Associated|CNS Vasculitis, HIV-Associated|HIV-1-Associated CNS Vasculitides|HIV 1 Associated CNS Vasculitis|HIV-1-Associated CNS Vasculitis|HIV-Associated CNS Vasculitides|HIV-Associated CNS Vasculitis|HIV Associated Vasculitis of the Central Nervous System|HIV-Associated Vasculitis of the Central Nervous System|Vasculitides, HIV-1-Associated CNS|Vasculitides, HIV-Associated CNS|Vasculitis, HIV-1-Associated CNS|Vasculitis, HIV-Associated CNS|Vasculitis of the Central Nervous System, HIV Associated|Vasculitis of the Central Nervous System, HIV-Associated	Cardiovascular disease|Immune system disease|Nervous system disease|Viral disease
AIDS-Associated Nephropathy	MESH:D016263		Renal syndrome in human immunodeficiency virus-infected patients characterized by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.	MESH:D007674|MESH:D015658	C01.221.250.875.050|C01.221.812.640.400.072|C01.778.640.400.072|C01.925.782.815.616.400.050|C01.925.813.400.072|C12.050.351.968.419.050|C12.100.937.640.400.072|C12.200.777.419.050|C12.950.419.050|C20.673.480.050	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C12.050.351.968.419|C12.100.937.640.400|C12.200.777.419|C12.950.419|C20.673.480	AIDS Associated Nephropathies|AIDS-Associated Nephropathies|AIDS Associated Nephropathy|AIDS Nephropathies|AIDS Nephropathy|HIV Associated Nephropathies|HIV-Associated Nephropathies|HIV Associated Nephropathy|HIV-Associated Nephropathy|HIV Related Nephropathies|HIV-Related Nephropathies|HIV Related Nephropathy|HIV-Related Nephropathy|Human Immunodeficiency Virus Associated Nephropathy|Human Immunodeficiency Virus-Associated Nephropathy|Nephropathies, AIDS|Nephropathies, AIDS Associated|Nephropathies, AIDS-Associated|Nephropathies, HIV Associated|Nephropathies, HIV-Associated|Nephropathies, HIV Related|Nephropathies, HIV-Related|Nephropathy, AIDS|Nephropathy, AIDS Associated|Nephropathy, AIDS-Associated|Nephropathy, HIV Associated|Nephropathy, HIV-Associated|Nephropathy, HIV Related|Nephropathy, HIV-Related	Immune system disease|Urogenital disease (female)|Urogenital disease (male)|Viral disease
AIDS Dementia Complex	MESH:D015526		A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)	MESH:D003704|MESH:D015658	C01.221.250.875.049|C01.221.812.640.400.070|C01.778.640.400.070|C01.925.782.815.616.400.049|C01.925.813.400.070|C10.228.140.380.070|C12.100.937.640.400.070|C20.673.480.070|F03.615.400.050	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C10.228.140.380|C12.100.937.640.400|C20.673.480|F03.615.400	Acquired-Immune Deficiency Syndrome Dementia Complex|AIDS Encephalopathies|AIDS Encephalopathy|AIDS Related Dementia Complex|AIDS-Related Dementia Complex|Complex, AIDS Dementia|Complex, AIDS-Related Dementia|Dementia Complex, Acquired Immune Deficiency Syndrome|Dementia Complex, AIDS|Dementia Complex, AIDS Related|Dementia Complex, AIDS-Related|Dementia, HIV|Dementias, HIV|Encephalopathies, AIDS|Encephalopathies, HIV|Encephalopathy, AIDS|Encephalopathy, HIV|HIV 1 Associated Cognitive Motor Complex|HIV-1-Associated Cognitive Motor Complex|HIV 1 Cognitive and Motor Complex|HIV-1 Cognitive and Motor Complex|HIV Associated Cognitive Motor Complex|HIV-Associated Cognitive Motor Complex|HIV Dementia|HIV Dementias|HIV Encephalopathies|HIV Encephalopathy	Immune system disease|Mental disorder|Nervous system disease|Viral disease
AIDS-Related Complex	MESH:D000386		A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS.	MESH:D012897|MESH:D015658	C01.221.250.875.080|C01.221.812.640.400.080|C01.778.640.400.080|C01.925.782.815.616.400.080|C01.925.813.400.080|C01.925.839.080|C12.100.937.640.400.080|C20.673.480.080	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C01.925.839|C12.100.937.640.400|C20.673.480	AIDS Related Complex|ARC|Complex, AIDS-Related|Lymphadenopathy Syndrome|Lymphadenopathy Syndromes|Syndrome, Lymphadenopathy|Syndromes, Lymphadenopathy	Immune system disease|Viral disease
AIDS-related Kaposi sarcoma	MESH:C554498			MESH:D012514|MESH:D017088	C01.221.250.875.100/C554498|C01.597.050/C554498|C01.610.684.050/C554498|C01.925.256.466.860/C554498|C01.925.597.050/C554498|C01.925.782.815.616.400.100/C554498|C04.557.450.795.850/C554498|C04.557.645.750/C554498|C20.673.480.100/C554498	C01.221.250.875.100|C01.597.050|C01.610.684.050|C01.925.256.466.860|C01.925.597.050|C01.925.782.815.616.400.100|C04.557.450.795.850|C04.557.645.750|C20.673.480.100		Cancer|Immune system disease|Parasitic disease|Viral disease
AIDS-Related Opportunistic Infections	MESH:D017088		Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.	MESH:D009894|MESH:D015658	C01.221.250.875.100|C01.597.050|C01.610.684.050|C01.925.597.050|C01.925.782.815.616.400.100|C20.673.480.100	C01.221.250.875|C01.597|C01.610.684|C01.925.597|C01.925.782.815.616.400|C20.673.480	AIDS-Related Opportunistic Infection|AIDS Related Opportunistic Infections|HIV-Related Opportunistic Infection|HIV Related Opportunistic Infections|HIV-Related Opportunistic Infections|Infection, HIV-Related Opportunistic|Infections, HIV-Related Opportunistic|Opportunistic Infection, AIDS-Related|Opportunistic Infection, HIV-Related|Opportunistic Infections, AIDS Related|Opportunistic Infections, AIDS-Related|Opportunistic Infections, HIV Related|Opportunistic Infections, HIV-Related	Immune system disease|Parasitic disease|Viral disease
Ainhum	MESH:D000387	DO:DOID:11329	Spontaneous autoamputation of the fourth or fifth toe.	MESH:D001862	C05.116.264.143	C05.116.264	Dactylolyses, Spontaneous|Dactylolysis Spontanea|Dactylolysis, Spontaneous|Spontaneous Dactylolyses|Spontaneous Dactylolysis	Musculoskeletal disease
Airway Obstruction	MESH:D000402		Any hindrance to the passage of air into and out of the lungs.	MESH:D012131	C08.618.846.185	C08.618.846	Airway Obstructions|Choking|Obstruction, Airway|Obstructions, Airway	Respiratory tract disease
Akathisia, Drug-Induced	MESH:D017109		A condition associated with the use of certain medications and characterized by an internal sense of motor restlessness often described as an inability to resist the urge to move.	MESH:D009069|MESH:D011595|MESH:D020258|MESH:D064420	C10.228.662.037|C10.720.075|C23.888.592.350.600.500|C25.100.249|C25.723.705.100	C10.228.662|C10.720|C23.888.592.350.600|C25.100|C25.723.705	Acathisia, Drug Induced|Acathisia, Drug-Induced|Akathisia, Drug Induced|Akathisia, Tardive|Drug-Induced Acathisia|Drug Induced Akathisia|Drug-Induced Akathisia|Pseudoakathisia|Tardive Akathisia	Nervous system disease|Signs and symptoms
Akesson syndrome	MESH:C535610			MESH:D008607|MESH:D012536|MESH:D013959	C10.597.606.360/C535610|C17.800.738/C535610|C19.874/C535610|C23.888.592.604.646/C535610|F03.625.539/C535610	C10.597.606.360|C17.800.738|C19.874|C23.888.592.604.646|F03.625.539	Cutis verticis gyrata, thyroaplasia and mental deficiency syndrome|Cutis Verticis Gyrata, Thyroid Aplasia, and Mental Retardation|Cutis verticis gyrata-thyroid aplasia-mental retardation syndrome	Endocrine system disease|Mental disorder|Nervous system disease|Signs and symptoms|Skin disease
Akinetic Mutism	MESH:D000405	DO:DOID:4267	A syndrome characterized by a silent and inert state without voluntary motor activity despite preserved sensorimotor pathways and vigilance. Bilateral FRONTAL LOBE dysfunction involving the anterior cingulate gyrus and related brain injuries are associated with this condition. This may result in impaired abilities to communicate and initiate motor activities. (From Adams et al., Principles of Neurology, 6th ed, p348; Fortschr Neurol Psychiatr 1995 Feb;63(2):59-67)	MESH:D001927	C10.228.140.042	C10.228.140	Akinetic Autism|Akinetic Mutisms|Autism, Akinetic|Coma Vigil|Coma Vigilans|Mutism, Akinetic|Vigil, Coma|Vigils, Coma	Nervous system disease
Alcoholic Neuropathy	MESH:D020269	DO:DOID:14183	A condition where damage to the peripheral nervous system (including the peripheral elements of the autonomic nervous system) is associated with chronic ingestion of alcoholic beverages. The disorder may be caused by a direct effect of alcohol, an associated nutritional deficiency, or a combination of factors. Clinical manifestations include variable degrees of weakness; ATROPHY; PARESTHESIAS; pain; loss of reflexes; sensory loss; diaphoresis; and postural hypotension. (From Arch Neurol 1995;52(1):45-51; Adams et al., Principles of Neurology, 6th ed, p1146)	MESH:D011115|MESH:D020268	C10.668.829.800.050|C10.720.112.400|C25.723.705.150.400|C25.775.100.087.193.400	C10.668.829.800|C10.720.112|C25.723.705.150|C25.775.100.087.193	Alcoholic Axonal Neuropathies|Alcoholic Axonal Neuropathy|Alcoholic Neuropathies|Alcoholic Polyneuritides|Alcoholic Polyneuritis|Alcoholic Polyneuropathies|Alcoholic Polyneuropathy|Alcohol-Induced Peripheral Neuropathies|Alcohol Induced Peripheral Neuropathy|Alcohol-Induced Peripheral Neuropathy|Alcohol-Induced Polyneuropathies|Alcohol Induced Polyneuropathy|Alcohol-Induced Polyneuropathy|Alcohol-Related Autonomic Polyneuropathies|Alcohol Related Autonomic Polyneuropathy|Alcohol-Related Autonomic Polyneuropathy|Alcohol-Related Polyneuropathies|Alcohol Related Polyneuropathy|Alcohol-Related Polyneuropathy|Autonomic Polyneuropathies, Alcohol-Related|Autonomic Polyneuropathy, Alcohol-Related|Axonal Neuropathies, Alcoholic|Axonal Neuropathy, Alcoholic|Neuropathies, Alcoholic|Neuropathies, Alcoholic Axonal|Neuropathies, Alcohol-Induced Peripheral|Neuropathy, Alcoholic|Neuropathy, Alcoholic Axonal|Neuropathy, Alcohol-Induced Peripheral|Peripheral Neuropathies, Alcohol-Induced|Peripheral Neuropathy, Alcohol Induced|Peripheral Neuropathy, Alcohol-Induced|Polyneuritides, Alcoholic|Polyneuritis, Alcoholic|Polyneuropathies, Alcoholic|Polyneuropathies, Alcohol-Induced|Polyneuropathies, Alcohol-Related|Polyneuropathies, Alcohol-Related Autonomic|Polyneuropathy, Alcoholic|Polyneuropathy, Alcohol-Induced|Polyneuropathy, Alcohol-Related|Polyneuropathy, Alcohol-Related Autonomic	Nervous system disease|Substance-related disorder
Alcohol-Induced Disorders, Nervous System	MESH:D020268		Acute and chronic neurologic disorders associated with the various neurologic effects of ETHANOL. Primary sites of injury include the brain and peripheral nerves.	MESH:D020258|MESH:D020751	C10.720.112|C25.723.705.150|C25.775.100.087.193	C10.720|C25.723.705|C25.775.100.087	Alcohol Abuse, Nervous System|Alcohol Induced Disorders, Nervous System|Ethanol Induced Disorders, Nervous System|Ethanol-Induced Disorders, Nervous System|Ethanol Induced Nervous System Disorders|Ethanol-Induced Nervous System Disorders|Ethyl Alcohol Abuse Neurologic Syndromes|Nervous System Disorders, Ethanol Induced|Nervous System Disorders, Ethanol-Induced	Nervous system disease|Substance-related disorder
Alcohol Withdrawal Seizures	MESH:D020270		A condition where seizures occur in association with ethanol abuse (ALCOHOLISM) without other identifiable causes. Seizures usually occur within the first 6-48 hours after the cessation of alcohol intake, but may occur during periods of alcohol intoxication. Single generalized tonic-clonic motor seizures are the most common subtype, however, STATUS EPILEPTICUS may occur. (Adams et al., Principles of Neurology, 6th ed, p1174)	MESH:D012640|MESH:D013375|MESH:D020268	C10.597.742.143|C10.720.112.300|C23.888.592.742.143|C25.723.705.150.300|C25.775.100.087.193.300|C25.775.835.500	C10.597.742|C10.720.112|C23.888.592.742|C25.723.705.150|C25.775.100.087.193|C25.775.835	Alcoholic Seizure|Alcoholic Seizures|Alcohol-Related Seizure|Alcohol Related Seizures|Alcohol-Related Seizures|Alcohol Withdrawal Induced Major Motor Seizure|Alcohol Withdrawal-Induced Major Motor Seizure|Alcohol Withdrawal Induced Seizure|Alcohol Withdrawal-Induced Seizure|Alcohol Withdrawal-Induced Seizures|Alcohol Withdrawal Induced Status Epilepticus|Alcohol Withdrawal-Induced Status Epilepticus|Alcohol Withdrawal Seizure|Major Motor Seizure, Alcohol Withdrawal-Induced|Seizure, Alcoholic|Seizure, Alcohol-Related|Seizure, Alcohol Withdrawal|Seizure, Alcohol Withdrawal-Induced|Seizures, Alcoholic|Seizures, Alcohol-Related|Seizures, Alcohol Withdrawal|Seizures, Alcohol Withdrawal-Induced|Status Epilepticus, Alcohol Withdrawal Induced|Status Epilepticus, Alcohol Withdrawal-Induced|Withdrawal-Induced Seizure, Alcohol|Withdrawal-Induced Seizures, Alcohol	Nervous system disease|Signs and symptoms|Substance-related disorder
Al Gazali Aziz Salem syndrome	MESH:C535613			MESH:D000015|MESH:D006330|MESH:D008607|MESH:D019066	C10.597.606.360/C535613|C14.240.400/C535613|C14.280.400/C535613|C16.131.077/C535613|C16.131.240.400/C535613|C23.550.291.812/C535613|C23.888.592.604.646/C535613|F03.625.539/C535613	C10.597.606.360|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C23.550.291.812|C23.888.592.604.646|F03.625.539		Cardiovascular disease|Congenital abnormality|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Alice in Wonderland Syndrome	MESH:D062026		Neurological condition characterized by disturbances in VISUAL PERCEPTION, most often of BODY SCHEMA, TIME PERCEPTION and HALLUCINATIONS. It is associated with MIGRAINE, infections (e.g., INFECTIOUS MONONUCLEOSIS), FEVER, EPILEPSY, and other neurological and psychiatric disorders.	MESH:D008881|MESH:D010468|MESH:D014786	C10.228.140.546.399.750.124|C10.597.606.762.150|C10.597.751.941.036|C23.888.592.604.764.150|C23.888.592.763.941.036	C10.228.140.546.399.750|C10.597.606.762|C10.597.751.941|C23.888.592.604.764|C23.888.592.763.941		Nervous system disease|Signs and symptoms
Alien Hand Syndrome	MESH:D055964		An apraxia characterized by the affected limb having involuntary, autonomous, and purposeful behaviors that are perceived as being controlled by an external force. Often the affected limb interferes with the actions of the normal limb. Symptoms develop from lesions in the CORPUS CALLOSUM or medial frontal cortex, stroke, infarction, and neurodegenerative diseases (e.g., CREUTZFELDT-JAKOB SYNDROME, corticobasal degeneration).	MESH:D001072	C10.597.606.881.350.099|C23.888.592.604.882.350.099	C10.597.606.881.350|C23.888.592.604.882.350	Alien Hand Syndromes|Anarchic Hand Syndrome|Anarchic Hand Syndromes|Hand Syndrome, Alien|Hand Syndrome, Anarchic|Hand Syndromes, Alien|Hand Syndromes, Anarchic|Syndrome, Alien Hand|Syndrome, Anarchic Hand|Syndromes, Alien Hand|Syndromes, Anarchic Hand	Nervous system disease|Signs and symptoms
Alkalosis	MESH:D000471		A pathological condition that removes acid or adds base to the body fluids.	MESH:D000137	C18.452.076.354	C18.452.076	Alkaloses	Metabolic disease
Alkalosis, Respiratory	MESH:D000472		A state due to excess loss of carbon dioxide from the body. (Dorland, 27th ed)	MESH:D000471|MESH:D006985	C08.618.501.271|C18.452.076.354.271	C08.618.501|C18.452.076.354	Alkaloses, Respiratory|Respiratory Alkaloses|Respiratory Alkalosis	Metabolic disease|Respiratory tract disease
Allesthesia	MESH:D066190		A neurological disorder in which a sensory stimulus, usually tactile but more rarely other sensory modalities, is misperceived in a location distant from the original stimulus.	MESH:D010468	C10.597.606.762.175|C23.888.592.604.764.175	C10.597.606.762|C23.888.592.604.764	Allachesthesia|Allachesthesias|Allesthesias|Allochiria|Allochirias|Alloesthesia|Alloesthesias|Dyschiria|Dyschirias	Nervous system disease|Signs and symptoms
Alopecia	MESH:D000505	DO:DOID:987|OMIM:109200	Absence of hair from areas where it is normally present.	MESH:D007039|MESH:D020763	C17.800.329.937.122|C23.300.035	C17.800.329.937|C23.300	AGA1|Alopecia, Androgenetic|ALOPECIA, ANDROGENETIC, 1|Alopecia, Androgenic|Alopecia Cicatrisata|Alopecia Cicatrisatas|Alopecia, Male Pattern|Alopecias, Androgenic|Androgenetic Alopecia|ANDROGENETIC ALOPECIA;AGA  BALDNESS, MALE PATTERN, INCLUDED|Androgenic Alopecia|Androgenic Alopecias|Baldness|Baldness, Female Pattern|Baldness, Male Pattern|Baldness, Pattern|Female Pattern Baldness|Hair Loss|Hair Losses|Losses, Hair|Loss, Hair|Male Pattern Alopecia|Male Pattern Baldness|MPB, INCLUDED|Pattern Baldness|Pseudopelade	Pathology (anatomical condition)|Skin disease
Alopecia, Androgenetic, 2	MESH:C567473	OMIM:300710		MESH:D000505	C17.800.329.937.122/C567473|C23.300.035/C567473	C17.800.329.937.122|C23.300.035	AGA2	Pathology (anatomical condition)|Skin disease
Alopecia, Androgenetic, 3	MESH:C567317	OMIM:612421		MESH:D000505	C17.800.329.937.122/C567317|C23.300.035/C567317	C17.800.329.937.122|C23.300.035	AGA3	Pathology (anatomical condition)|Skin disease
Alopecia Areata	MESH:D000506	DO:DOID:986	Loss of scalp and body hair involving microscopically inflammatory patchy areas.	MESH:D000505	C17.800.329.937.122.147	C17.800.329.937.122	Alopecia Circumscripta	Skin disease
Alopecia Areata 1	MESH:C566303	OMIM:104000		MESH:D000506	C17.800.329.937.122.147/C566303	C17.800.329.937.122.147	AA1|ALOPECIA UNIVERSALIS, INCLUDED|AU, INCLUDED	Skin disease
Alopecia Areata 2	MESH:C565186	OMIM:610753		MESH:D000506	C17.800.329.937.122.147/C565186	C17.800.329.937.122.147	AA2	Skin disease
Alopecia, Familial Focal	MESH:C566301			MESH:D000505	C17.800.329.937.122/C566301|C23.300.035/C566301	C17.800.329.937.122|C23.300.035		Pathology (anatomical condition)|Skin disease
Alopecia hypogonadism extrapyramidal disorder	MESH:C537053			MESH:D000505|MESH:D001480|MESH:D007006	C10.228.140.079/C537053|C17.800.329.937.122/C537053|C19.391.482/C537053|C23.300.035/C537053	C10.228.140.079|C17.800.329.937.122|C19.391.482|C23.300.035	Progressive extrapyramidal disorder with primary hypogonadism and alopecia	Endocrine system disease|Nervous system disease|Pathology (anatomical condition)|Skin disease
Alopecia-Mental Retardation Syndrome with Convulsions and Hypergonadotropic Hypogonadism	MESH:C563370			MESH:D000505|MESH:D007006|MESH:D008607|MESH:D012640	C10.597.606.360/C563370|C10.597.742/C563370|C17.800.329.937.122/C563370|C19.391.482/C563370|C23.300.035/C563370|C23.888.592.604.646/C563370|C23.888.592.742/C563370|F03.625.539/C563370	C10.597.606.360|C10.597.742|C17.800.329.937.122|C19.391.482|C23.300.035|C23.888.592.604.646|C23.888.592.742|F03.625.539		Endocrine system disease|Mental disorder|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms|Skin disease
Alopecia, Neurologic Defects, and Endocrinopathy Syndrome	MESH:C567425	OMIM:612079		MESH:D000505|MESH:D004700|MESH:D008607	C10.597.606.360/C567425|C17.800.329.937.122/C567425|C19/C567425|C23.300.035/C567425|C23.888.592.604.646/C567425|F03.625.539/C567425	C10.597.606.360|C17.800.329.937.122|C19|C23.300.035|C23.888.592.604.646|F03.625.539	ANES|ANE Syndrome	Endocrine system disease|Mental disorder|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms|Skin disease
Alopecia universalis	MESH:C537055	OMIM:203655		MESH:D000505	C17.800.329.937.122/C537055|C23.300.035/C537055	C17.800.329.937.122|C23.300.035	Alopecia universalis congenita|ALUNC|ALUNC Alopecia universalis congenitalis|Atrichia, Generalized|Generalized Atrichia	Pathology (anatomical condition)|Skin disease
Alopecia universalis onychodystrophy vitiligo	MESH:C537056			MESH:D000505|MESH:D009264|MESH:D014820	C17.800.329.937.122/C537056|C17.800.621.440.895/C537056|C23.300.035/C537056|C23.300.820/C537056	C17.800.329.937.122|C17.800.621.440.895|C23.300.035|C23.300.820	Alopecia universalis, onychodystrophy, and total vitiligo	Pathology (anatomical condition)|Skin disease
alpha-2-Macroglobulin Deficiency	MESH:C566304	OMIM:614036		MESH:D008171	C08.381/C566304	C08.381	A2MD	Respiratory tract disease
Alpha-B Crystallinopathy	MESH:C563848	OMIM:608810		MESH:D002386|MESH:D009135|MESH:D009202	C05.651/C563848|C10.668.491/C563848|C11.510.245/C563848|C14.280.238/C563848	C05.651|C10.668.491|C11.510.245|C14.280.238	ALPHA-B CRYSTALLINOPATHY|MFM2|Myopathy, Cardioskeletal, Desmin-Related, with Cataract|Myopathy, Desmin-Related, associated with Mutation in the CRYAB Gene|MYOPATHY, MYOFIBRILLAR, 2|Myopathy, Myofibrillar, Alpha-B Crystallin-Related|MYOPATHY, MYOFIBRILLAR, WITH OR WITHOUT CATARACT AND/OR CARDIOMYOPATHY	Cardiovascular disease|Eye disease|Musculoskeletal disease|Nervous system disease
Alpha-Beta T-Cell Lymphopenia with Gamma-Delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity	MESH:C563691	OMIM:609889		MESH:D001327|MESH:D003586|MESH:D008231	C01.925.256.466.245/C563691|C15.378.553.546.605/C563691|C20.111/C563691|C20.673.627/C563691	C01.925.256.466.245|C15.378.553.546.605|C20.111|C20.673.627	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY	Blood disease|Immune system disease|Viral disease
Alphavirus Infections	MESH:D018354		Virus diseases caused by members of the ALPHAVIRUS genus of the family TOGAVIRIDAE.	MESH:D001102|MESH:D014036	C01.920.500.078|C01.925.782.930.100	C01.920.500|C01.925.782.930	Alphavirus Infection|Alpha Virus Infection|Alpha Virus Infections|Barmah Forest Virus Infection|Infection, Alphavirus|Infection, Mayaro Virus|Infection, O'nyong-nyong Virus|Infections, Alphavirus|Mayaro Virus Infection|Mayaro Virus Infections|O'nyong nyong Virus Infection|O'nyong-nyong Virus Infection|O'nyong-nyong Virus Infections|Ross River Virus Infection|Virus Infection, Alpha|Virus Infection, Mayaro|Virus Infection, O'nyong-nyong	Viral disease
Alternating hemiplegia of childhood	MESH:C536589	DO:DOID:0050635|OMIM:104290|OMIM:614820		MESH:D006429	C10.597.622.295/C536589|C23.888.592.636.312/C536589	C10.597.622.295|C23.888.592.636.312	AHC1|AHC2|Alternating hemiplegia|ALTERNATING HEMIPLEGIA OF CHILDHOOD 1|ALTERNATING HEMIPLEGIA OF CHILDHOOD 2|Alternating hemiplegia syndrome	Nervous system disease|Signs and symptoms
Altitude Sickness	MESH:D000532		Multiple symptoms associated with reduced oxygen at high ALTITUDE.	MESH:D012120	C08.618.020	C08.618	Altitude Hypoxia|Altitude Hypoxias|Hypoxia, Altitude|Mountain Sickness|Sickness, Altitude|Sickness, Mountain	Respiratory tract disease
Alveolar Bone Loss	MESH:D016301		Resorption or wasting of the tooth-supporting bone (ALVEOLAR PROCESS) in the MAXILLA or MANDIBLE.	MESH:D001862|MESH:D055093	C05.116.264.150|C07.465.714.354.500	C05.116.264|C07.465.714.354	Alveolar Bone Atrophies|Alveolar Bone Atrophy|Alveolar Bone Losses|Alveolar Process Atrophies|Alveolar Process Atrophy|Alveolar Resorption|Alveolar Resorptions|Bone Atrophies, Alveolar|Bone Atrophy, Alveolar|Bone Loss, Alveolar|Bone Losses, Periodontal|Bone Loss, Periodontal|Periodontal Bone Loss|Periodontal Bone Losses|Periodontal Resorption|Periodontal Resorptions|Resorption, Alveolar|Resorption, Periodontal|Resorptions, Alveolar	Mouth disease|Musculoskeletal disease
Alveolitis, Extrinsic Allergic	MESH:D000542	DO:DOID:841	A common interstitial lung disease caused by hypersensitivity reactions of PULMONARY ALVEOLI after inhalation of and sensitization to environmental antigens of microbial, animal, or chemical sources. The disease is characterized by lymphocytic alveolitis and granulomatous pneumonitis.	MESH:D012130|MESH:D017563	C08.381.483.125|C08.674.055|C20.543.480.680.075	C08.381.483|C08.674|C20.543.480.680	Allergic Alveolitides, Extrinsic|Allergic Alveolitis, Extrinsic|Alveolitides, Extrinsic Allergic|Extrinsic Allergic Alveolitides|Extrinsic Allergic Alveolitis|Hypersensitivity Pneumonitides|Hypersensitivity Pneumonitis|Pneumonitides, Hypersensitivity|Pneumonitis, Hypersensitivity	Immune system disease|Respiratory tract disease
Amastia	MESH:C562989			MESH:D001941	C17.800.090/C562989	C17.800.090	Absent breasts and nipples|absent nipple|Amazia|Athelia|Complete absence of breasts	Skin disease
Amastia, Bilateral, With Ureteral Triplication And Dysmorphism	MESH:C566295			MESH:D000015|MESH:D006330	C14.240.400/C566295|C14.280.400/C566295|C16.131.077/C566295|C16.131.240.400/C566295	C14.240.400|C14.280.400|C16.131.077|C16.131.240.400		Cardiovascular disease|Congenital abnormality
Amaurosis congenita of Leber, type 1	MESH:C536600	OMIM:204000		MESH:D057130	C11.270.516/C536600|C11.768.364/C536600	C11.270.516|C11.768.364	Amaurosis Congenita Of Leber I|CRB|LCA|LCA1|Leber Congenital Amaurosis 1|Leber congenital amaurosis, type 1|Retinal blindness, congenital	Eye disease
Amaurosis congenita of Leber, type 2	MESH:C536601	OMIM:204100		MESH:D057130	C11.270.516/C536601|C11.768.364/C536601	C11.270.516|C11.768.364	Amaurosis Congenita Of Leber Ii|LCA2|Leber Congenital Amaurosis 2|Leber congenital amaurosis type 2	Eye disease
Amaurosis congenita of Leber, type 5	MESH:C536602	OMIM:604537		MESH:D057130	C11.270.516/C536602|C11.768.364/C536602	C11.270.516|C11.768.364	LCA5|Leber Congenital Amaurosis 5|Leber congenital amaurosis, type 5	Eye disease
Amaurosis congenita of Leber, type 9	MESH:C536603	OMIM:608553		MESH:D057130	C11.270.516/C536603|C11.768.364/C536603	C11.270.516|C11.768.364	LCA9|Leber Congenital Amaurosis 9|Leber congenital amaurosis, type 9	Eye disease
Amaurosis Fugax	MESH:D020757		Transient complete or partial monocular blindness due to retinal ischemia. This may be caused by emboli from the CAROTID ARTERY (usually in association with CAROTID STENOSIS) and other locations that enter the central RETINAL ARTERY. (From Adams et al., Principles of Neurology, 6th ed, p245)	MESH:D001766	C10.597.751.941.162.125|C11.966.075.125|C23.888.592.763.941.162.125	C10.597.751.941.162|C11.966.075|C23.888.592.763.941.162	Blindness, Monocular, Transient|Blindness, Transient Monocular|Monocular Blindness, Transient|Transient Monocular Blindness	Eye disease|Nervous system disease|Signs and symptoms
Amblyopia	MESH:D000550	DO:DOID:10376	A nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.	MESH:D001927|MESH:D014786	C10.228.140.055|C10.597.751.941.073|C11.966.073|C23.888.592.763.941.073	C10.228.140|C10.597.751.941|C11.966|C23.888.592.763.941	Amblyopia, Anisometropic|Amblyopia, Developmental|Amblyopias|Amblyopias, Anisometropic|Amblyopias, Developmental|Amblyopias, Stimulus Deprivation-Induced|Amblyopias, Suppression|Amblyopia, Stimulus Deprivation Induced|Amblyopia, Stimulus Deprivation-Induced|Amblyopia, Suppression|Anisometropic Amblyopia|Anisometropic Amblyopias|Deprivation-Induced Amblyopias, Stimulus|Deprivation-Induced Amblyopia, Stimulus|Developmental Amblyopia|Developmental Amblyopias|Eye, Lazy|Eyes, Lazy|Lazy Eye|Lazy Eyes|Stimulus Deprivation Induced Amblyopia|Stimulus Deprivation-Induced Amblyopia|Stimulus Deprivation-Induced Amblyopias|Suppression Amblyopia|Suppression Amblyopias	Eye disease|Nervous system disease|Signs and symptoms
Ambras syndrome	MESH:C536605	DO:DOID:0111060|OMIM:145701		MESH:D006983	C17.800.329.875/C536605	C17.800.329.875	AMBRAS SYNDROME|HTC1|HYPERTRICHOSIS, CONGENITAL GENERALIZED|Hypertrichosis universalis congenita Ambras type|Hypertrichosis Universalis Congenita, Ambras Type	Skin disease
Ameloblastoma	MESH:D000564		An immature epithelial tumor of the JAW originating from the epithelial rests of Malassez or from other epithelial remnants of the ENAMEL from the developmental period. It is a slowly growing tumor, usually benign, but displays a marked propensity for invasive growth.	MESH:D009808	C04.557.695.065	C04.557.695	Ameloblastomas	Cancer
Amish Infantile Epilepsy Syndrome	MESH:C563799	OMIM:609056		MESH:D004827	C10.228.140.490/C563799	C10.228.140.490	AMISH INFANTILE EPILEPSY SYNDROME|Epilepsy Syndrome, Infantile-Onset Symptomatic|GM3 Synthase Deficiency|SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME|SALT AND PEPPER MENTAL RETARDATION SYNDROME|SPDRS	Nervous system disease
Amoebic dysentery due to Entamoeba histolytica	MESH:C539067			MESH:D004404	C01.610.432.396/C539067|C01.610.752.049.328/C539067|C06.405.205.331.312/C539067|C06.405.469.300.312/C539067|C06.405.469.452.396/C539067	C01.610.432.396|C01.610.752.049.328|C06.405.205.331.312|C06.405.469.300.312|C06.405.469.452.396		Digestive system disease|Parasitic disease
Amyloid angiopathy	MESH:C538248			MESH:D016657	C10.228.140.300.510.200.200/C538248|C14.907.253.560.200.200/C538248|C18.452.845.500.100/C538248	C10.228.140.300.510.200.200|C14.907.253.560.200.200|C18.452.845.500.100	Amyloidosis - cerebral|Senile cerebral amyloid angiopathy	Cardiovascular disease|Metabolic disease|Nervous system disease
Amyloid Neuropathies	MESH:D017772		Disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. Familial, primary (nonfamilial), and secondary forms have been described. Some familial subtypes demonstrate an autosomal dominant pattern of inheritance. Clinical manifestations include sensory loss, mild weakness, autonomic dysfunction, and CARPAL TUNNEL SYNDROME. (Adams et al., Principles of Neurology, 6th ed, p1349)	MESH:D000686|MESH:D010523	C10.668.829.050|C18.452.845.500.050	C10.668.829|C18.452.845.500	Amyloid Neuropathies, Secondary|Amyloid Neuropathy|Amyloid Neuropathy, Secondary|Amyloid Polyneuropathies|Amyloid Polyneuropathy|Neuropathies, Amyloid|Neuropathies, Secondary Amyloid|Neuropathy, Amyloid|Neuropathy, Secondary Amyloid|Polyneuropathies, Amyloid|Polyneuropathy, Amyloid|Secondary Amyloid Neuropathies|Secondary Amyloid Neuropathy	Metabolic disease|Nervous system disease
Amyloid Neuropathies, Primary (nonfamilial)	MESH:C531615			MESH:D017772	C10.668.829.050/C531615|C18.452.845.500.050/C531615	C10.668.829.050|C18.452.845.500.050		Metabolic disease|Nervous system disease
Amyloidosis	MESH:D000686	DO:DOID:9120	A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.	MESH:D057165	C18.452.845.500	C18.452.845	Amyloidoses	Metabolic disease
Amyopathic dermatomyositis	MESH:C538250			MESH:D003882	C05.651.594.819.500/C538250|C10.668.491.562.575.500/C538250|C17.300.250/C538250|C17.800.185/C538250	C05.651.594.819.500|C10.668.491.562.575.500|C17.300.250|C17.800.185		Connective tissue disease|Musculoskeletal disease|Nervous system disease|Skin disease
Amyotrophic Lateral Sclerosis	MESH:D000690	DO:DOID:0111246|DO:DOID:332	A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)	MESH:D013118|MESH:D016472|MESH:D057177	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	C10.228.854|C10.574.562|C10.574.950|C10.668.467|C18.452.845.800	ALS - Amyotrophic Lateral Sclerosis|ALS Amyotrophic Lateral Sclerosis|Amyotrophic Lateral Sclerosis, Guam Form|Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1|Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1|Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam|Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam|Amyotrophic Lateral Sclerosis With Dementia|Charcot Disease|Dementia With Amyotrophic Lateral Sclerosis|Disease, Guam|Disease, Lou-Gehrigs|Gehrig Disease|Gehrig's Disease|Gehrigs Disease|Guam Disease|Guam Form of Amyotrophic Lateral Sclerosis|Lou Gehrig Disease|Lou Gehrig's Disease|Lou-Gehrigs Disease|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|Sclerosis, Amyotrophic Lateral	Metabolic disease|Nervous system disease
Amyotrophic lateral sclerosis 1	MESH:C531617	OMIM:105400		MESH:D000690	C10.228.854.139/C531617|C10.574.562.250/C531617|C10.574.950.050/C531617|C10.668.467.250/C531617|C18.452.845.800.050/C531617	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS1|AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, INCLUDED|AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL|Amyotrophic Lateral Sclerosis, Autosomal Dominant|Amyotrophic Lateral Sclerosis, Familial|Amyotrophic Lateral Sclerosis, Sporadic|AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, INCLUDED|FALS	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis 10	MESH:C567429	OMIM:612069		MESH:D000690	C10.228.854.139/C567429|C10.574.562.250/C567429|C10.574.950.050/C567429|C10.668.467.250/C567429|C18.452.845.800.050/C567429	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS10 FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED,|FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED, INCLUDED|FTLD-TDP, TARDBP-RELATED, INCLUDED|INCLUDED	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis 11	MESH:C567244	OMIM:612577		MESH:D000690	C10.228.854.139/C567244|C10.574.562.250/C567244|C10.574.950.050/C567244|C10.668.467.250/C567244|C18.452.845.800.050/C567244	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS11	Metabolic disease|Nervous system disease
AMYOTROPHIC LATERAL SCLEROSIS 12 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	OMIM:613435	DO:DOID:0060203		MESH:D000690	C10.228.854.139/613435|C10.574.562.250/613435|C10.574.950.050/613435|C10.668.467.250/613435|C18.452.845.800.050/613435	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS12	Metabolic disease|Nervous system disease
AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE	OMIM:614373	DO:DOID:0060207		MESH:D000690	C10.228.854.139/614373|C10.574.562.250/614373|C10.574.950.050/614373|C10.668.467.250/614373|C18.452.845.800.050/614373	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS16	Metabolic disease|Nervous system disease
AMYOTROPHIC LATERAL SCLEROSIS 18	OMIM:614808	DO:DOID:0060209		MESH:D000690	C10.228.854.139/614808|C10.574.562.250/614808|C10.574.950.050/614808|C10.668.467.250/614808|C18.452.845.800.050/614808	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS18	Metabolic disease|Nervous system disease
AMYOTROPHIC LATERAL SCLEROSIS 19	OMIM:615515	DO:DOID:0060210		MESH:D000690	C10.228.854.139/615515|C10.574.562.250/615515|C10.574.950.050/615515|C10.668.467.250/615515|C18.452.845.800.050/615515	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS19	Metabolic disease|Nervous system disease
AMYOTROPHIC LATERAL SCLEROSIS 20	OMIM:615426	DO:DOID:0060211		MESH:D000690	C10.228.854.139/615426|C10.574.562.250/615426|C10.574.950.050/615426|C10.668.467.250/615426|C18.452.845.800.050/615426	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS20	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis 2, Juvenile	MESH:C565957	OMIM:205100		MESH:D000690	C10.228.854.139/C565957|C10.574.562.250/C565957|C10.574.950.050/C565957|C10.668.467.250/C565957|C18.452.845.800.050/C565957	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS2|ALSJ|ALS, Juvenile	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis 3	MESH:C564688	OMIM:606640		MESH:D000690	C10.228.854.139/C564688|C10.574.562.250/C564688|C10.574.950.050/C564688|C10.668.467.250/C564688|C18.452.845.800.050/C564688	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS3	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis 4, Juvenile	MESH:C566550	OMIM:602433		MESH:D000690	C10.228.854.139/C566550|C10.574.562.250/C566550|C10.574.950.050/C566550|C10.668.467.250/C566550|C18.452.845.800.050/C566550	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS4|Neuronopathy, Distal Hereditary Motor, With Pyramidal Features	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis 5	MESH:C566576	OMIM:602099		MESH:D000690	C10.228.854.139/C566576|C10.574.562.250/C566576|C10.574.950.050/C566576|C10.668.467.250/C566576|C18.452.845.800.050/C566576	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS5|AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis 7	MESH:C564300	OMIM:608031		MESH:D000690	C10.228.854.139/C564300|C10.574.562.250/C564300|C10.574.950.050/C564300|C10.668.467.250/C564300|C18.452.845.800.050/C564300	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS7	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis 8	MESH:C563895	OMIM:608627		MESH:D000690	C10.228.854.139/C563895|C10.574.562.250/C563895|C10.574.950.050/C563895|C10.668.467.250/C563895|C18.452.845.800.050/C563895	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS8	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis 9	MESH:C567499	OMIM:611895		MESH:D000690	C10.228.854.139/C567499|C10.574.562.250/C567499|C10.574.950.050/C567499|C10.668.467.250/C567499|C18.452.845.800.050/C567499	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	ALS9	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis, Autosomal Recessive	MESH:C566290			MESH:D000690	C10.228.854.139/C566290|C10.574.562.250/C566290|C10.574.950.050/C566290|C10.668.467.250/C566290|C18.452.845.800.050/C566290	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050		Metabolic disease|Nervous system disease
Amyotrophic lateral sclerosis, type 6	MESH:C538251			MESH:D000690	C10.228.854.139/C538251|C10.574.562.250/C538251|C10.574.950.050/C538251|C10.668.467.250/C538251|C18.452.845.800.050/C538251	C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050	Amyotrophic Lateral Sclerosis 6	Metabolic disease|Nervous system disease
Amyotrophic Lateral Sclerosis With Polyglucosan Bodies	MESH:C565955			MESH:D000690|MESH:D020191	C10.228.140.490.375.130.650/C565955|C10.228.140.490.493.063.650/C565955|C10.228.854.139/C565955|C10.574.562.250/C565955|C10.574.950.050/C565955|C10.668.467.250/C565955|C18.452.845.800.050/C565955	C10.228.140.490.375.130.650|C10.228.140.490.493.063.650|C10.228.854.139|C10.574.562.250|C10.574.950.050|C10.668.467.250|C18.452.845.800.050		Metabolic disease|Nervous system disease
Anal Canal Carcinoma	MESH:C563020	DO:DOID:6126|OMIM:105580		MESH:D001005	C04.588.274.476.411.307.790.040/C563020|C06.301.371.411.307.790.040/C563020|C06.405.249.411.307.790.040/C563020|C06.405.469.491.307.790.040/C563020|C06.405.469.860.101.163/C563020|C06.405.469.860.180.500.040/C563020	C04.588.274.476.411.307.790.040|C06.301.371.411.307.790.040|C06.405.249.411.307.790.040|C06.405.469.491.307.790.040|C06.405.469.860.101.163|C06.405.469.860.180.500.040	Cloacogenic Carcinoma|CLOACOGENIC CARCINOMA, INCLUDED	Cancer|Digestive system disease
Anal Sphincter Myopathy, Internal	MESH:C566287			MESH:D009135	C05.651/C566287|C10.668.491/C566287	C05.651|C10.668.491	Proctalgia Fugax due to Anal Sphincter Myopathy	Musculoskeletal disease|Nervous system disease
Anaphylaxis	MESH:D000707		An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.	MESH:D006969	C20.543.480.099	C20.543.480	Anaphylactic Reaction|Anaphylactic Reactions|Anaphylactic Shock|Anaphylactoid Reaction|Anaphylactoid Reactions|Anaphylactoid Shock|Reaction, Anaphylactic|Reaction, Anaphylactoid|Shock, Anaphylactic|Shock, Anaphylactoid	Immune system disease
Anaplasia	MESH:D000708		Loss of structural differentiation and useful function of neoplastic cells.	MESH:D009385	C04.697.045|C23.550.727.045	C04.697|C23.550.727	Anaplasias	Cancer|Pathology (process)
Anaplastic small cell lymphoma	MESH:C538255			MESH:D008228	C04.557.386.480/C538255|C15.604.515.569.480/C538255|C20.683.515.761.480/C538255	C04.557.386.480|C15.604.515.569.480|C20.683.515.761.480	Small cell variant of anaplastic large cell lymphoma	Cancer|Immune system disease|Lymphatic disease
Androblastoma of ovary	MESH:C537588			MESH:D018310	C04.557.475.750.847/C537588|C04.588.322.455.648/C537588|C04.588.322.762.500/C537588|C04.588.945.440.915.500/C537588|C12.050.351.500.056.630.705.648/C537588|C12.050.351.937.418.685.648/C537588|C12.100.250.056.630.705.648/C537588|C12.100.500.260.937.500/C537588|C12.200.294.260.937.500/C537588|C12.200.758.409.937.500/C537588|C12.900.418.685.648/C537588|C12.900.619.937.500/C537588|C19.344.410.648/C537588|C19.344.762.500/C537588|C19.391.630.705.648/C537588|C19.391.829.782.500/C537588	C04.557.475.750.847|C04.588.322.455.648|C04.588.322.762.500|C04.588.945.440.915.500|C12.050.351.500.056.630.705.648|C12.050.351.937.418.685.648|C12.100.250.056.630.705.648|C12.100.500.260.937.500|C12.200.294.260.937.500|C12.200.758.409.937.500|C12.900.418.685.648|C12.900.619.937.500|C19.344.410.648|C19.344.762.500|C19.391.630.705.648|C19.391.829.782.500	Sertoli-leydig cell tumor of the ovary	Cancer|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Anemia	MESH:D000740	DO:DOID:2355	A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.	MESH:D006402	C15.378.071	C15.378	Anemias	Blood disease
Anemia, Aplastic	MESH:D000741	DO:DOID:12449|OMIM:609135	A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.	MESH:D000080983|MESH:D000740	C15.378.071.085|C15.378.190.223.250	C15.378.071|C15.378.190.223	Anaemia, Aplastic|Anemia, Hypoplastic|Aplastic Anaemia|Aplastic Anaemias|Aplastic Anemia|Aplastic Anemias|APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED|Hypoplastic Anemia|Hypoplastic Anemias	Blood disease
Anemia, Congenital Hypoplastic, with Multiple Congenital Anomalies-Mental Retardation Syndrome	MESH:C565796			MESH:D000015|MESH:D000741|MESH:D008607	C10.597.606.360/C565796|C15.378.071.085/C565796|C15.378.190.223.250/C565796|C16.131.077/C565796|C23.888.592.604.646/C565796|F03.625.539/C565796	C10.597.606.360|C15.378.071.085|C15.378.190.223.250|C16.131.077|C23.888.592.604.646|F03.625.539		Blood disease|Congenital abnormality|Mental disorder|Nervous system disease|Signs and symptoms
Anemia, Hemolytic	MESH:D000743	DO:DOID:583	A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).	MESH:D000740	C15.378.071.141	C15.378.071	Acquired Hemolytic Anemia|Anaemia, Haemolytic|Anemia, Acquired Hemolytic|Anemia, Hemolytic, Acquired|Anemia, Microangiopathic|Anemia, Microangiopathic Hemolytic|Haemolytic Anaemia|Haemolytic Anaemias|Hemolytic Anemia|Hemolytic Anemia, Acquired|Hemolytic Anemia, Microangiopathic|Microangiopathic Anemia|Microangiopathic Hemolytic Anemia|Microangiopathic Hemolytic Anemias	Blood disease
Anemia, Hemolytic, Autoimmune	MESH:D000744	DO:DOID:718|OMIM:205700	Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.	MESH:D000743|MESH:D001327	C15.378.071.141.125|C20.111.175	C15.378.071.141|C20.111	Acquired Autoimmune Hemolytic Anemia|Agglutinin Disease, Cold|Anaemia, Autoimmune Haemolytic|Anemia, Autoimmune Hemolytic|Anemia, Hemolytic, Cold Antibody|Anemia, Hemolytic, Idiopathic Acquired|Autoimmune Haemolytic Anaemia|Autoimmune Haemolytic Anaemias|Autoimmune Hemolytic Anemia|Autoimmune Hemolytic Anemias|Cold Agglutinin Disease|Cold Agglutinin Diseases|Cold Antibody Disease|Cold Antibody Diseases|Cold Antibody Hemolytic Anemia|Haemolytic Anaemia, Autoimmune|Hemolytic Anemia, Autoimmune|Idiopathic Autoimmune Hemolytic Anemia	Blood disease|Immune system disease
Anemia, Hypochromic	MESH:D000747	DO:DOID:11759	Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)	MESH:D000740	C15.378.071.196	C15.378.071	Anemias, Hypochromic|Chloroses|Chlorosis|Hypochromic Anemia|Hypochromic Anemias	Blood disease
Anemia, hypochromic microcytic	MESH:C536357			MESH:D000747	C15.378.071.196/C536357	C15.378.071.196		Blood disease
Anemia, Hypochromic Microcytic, With Iron Overload	MESH:C567144	OMIM:206100|OMIM:615234		MESH:D000756	C15.378.071.419/C567144|C15.378.190.625.070/C567144	C15.378.071.419|C15.378.190.625.070	AHMIO1|AHMIO2|ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1|ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2	Blood disease
Anemia, Iron-Deficiency	MESH:D018798		Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.	MESH:D000090463|MESH:D000747	C15.378.071.196.300|C18.452.565.400.500	C15.378.071.196|C18.452.565.400	Anemia, Iron Deficiency|Anemias, Iron Deficiency|Anemias, Iron-Deficiency|Iron Deficiency Anemia|Iron-Deficiency Anemia|Iron Deficiency Anemias|Iron-Deficiency Anemias	Blood disease|Metabolic disease
Anemia, Macrocytic	MESH:D000748	DO:DOID:2361	Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).	MESH:D000740	C15.378.071.252	C15.378.071	Anemias, Macrocytic|Macrocytic Anemia|Macrocytic Anemias	Blood disease
Anemia, Megaloblastic	MESH:D000749	DO:DOID:13382	A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.	MESH:D000748	C15.378.071.252.196	C15.378.071.252	Anemias, Megaloblastic|Megaloblastic Anemia|Megaloblastic Anemias	Blood disease
Anemia, Myelophthisic	MESH:D000750	DO:DOID:2354	Anemia characterized by appearance of immature myeloid and nucleated erythrocytes in the peripheral blood, resulting from infiltration of the bone marrow by foreign or abnormal tissue.	MESH:D000740|MESH:D009196	C15.378.071.307|C15.378.190.636.085	C15.378.071|C15.378.190.636	Anemia, Leukoerythroblastic|Anemias, Leukoerythroblastic|Anemias, Myelophthisic|Leukoerythroblastic Anemia|Leukoerythroblastic Anemias|Myelophthisic Anemia|Myelophthisic Anemias	Blood disease
Anemia, Neonatal	MESH:D000751	DO:DOID:11244	The mildest form of erythroblastosis fetalis in which anemia is the chief manifestation.	MESH:D000740|MESH:D007232	C15.378.071.363|C16.614.053	C15.378.071|C16.614	Anemia Neonatorum|Anemias, Neonatal|Neonatal Anemia|Neonatal Anemias	Blood disease|Infant-newborn disease
Anemia, Pernicious	MESH:D000752	DO:DOID:13381	A megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. (Dorland, 27th ed)	MESH:D000749|MESH:D014806	C15.378.071.252.196.500|C18.654.521.500.133.699.923.280	C15.378.071.252.196|C18.654.521.500.133.699.923	Addison Anemia|Addison's Anemia|Addisons Anemia|Anemia, Addison|Anemia, Addisons|Anemia, Addison's|Pernicious Anemia	Blood disease|Nutrition disorder
Anemia, Refractory	MESH:D000753		A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy.	MESH:D000740|MESH:D009190	C15.378.071.400|C15.378.190.625.062	C15.378.071|C15.378.190.625	Anemias, Refractory|Refractory Anemia|Refractory Anemias	Blood disease
Anemia, Refractory, with Excess of Blasts	MESH:D000754		Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.	MESH:D000753	C15.378.071.400.080|C15.378.190.625.062.080	C15.378.071.400|C15.378.190.625.062	Leukemia, Smoldering|Leukemia, Smouldering|Leukemias, Smoldering|RAEB|RAEM|Refractory Anemia with Excess of Blasts|Smoldering Leukemia|Smoldering Leukemias|Smouldering Leukemia	Blood disease
Anemia, Sideroblastic	MESH:D000756	DO:DOID:8955|OMIM:182170	Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow.	MESH:D000740|MESH:D009190	C15.378.071.419|C15.378.190.625.070	C15.378.071|C15.378.190.625	ANEMIA, SIDEROBLASTIC, 4|Anemias, Sideroblastic|SIDBA4|Sideroblastic Anemia|Sideroblastic Anemias	Blood disease
Anemia, Sideroblastic, Autosomal Dominant	MESH:C567160			MESH:D000756	C15.378.071.419/C567160|C15.378.190.625.070/C567160	C15.378.071.419|C15.378.190.625.070		Blood disease
Anemia, Sideroblastic, Pyridoxine-Refractory, Autosomal Recessive	MESH:C567145	OMIM:205950|OMIM:616860		MESH:D000756	C15.378.071.419/C567145|C15.378.190.625.070/C567145	C15.378.071.419|C15.378.190.625.070	ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY|ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY|SIDBA2|SIDBA3	Blood disease
Anemia, Sideroblastic, Pyridoxine-Responsive, Autosomal Recessive	MESH:C565954			MESH:D000756	C15.378.071.419/C565954|C15.378.190.625.070/C565954	C15.378.071.419|C15.378.190.625.070	Anemia, Congenital Sideroblastic, B6-Responsive	Blood disease
ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES	OMIM:300835	DO:DOID:0112156		MESH:D000740|MESH:D001791|MESH:D009503	C15.378.071/300835|C15.378.140/300835|C15.378.553.546.184.564/300835	C15.378.071|C15.378.140|C15.378.553.546.184.564	XLANP	Blood disease
Anetoderma	MESH:D057088		Benign DERMATOSIS caused by a loss of dermal ELASTIC TISSUE resulting in localized sac-like areas of flaccid skin. It can be either primary (idiopathic) or secondary to other skin conditions, PENICILLAMINE use, or premature birth.	MESH:D003240|MESH:D012868	C17.300.116|C17.800.804.108	C17.300|C17.800.804	Anetoderma, Primary|Anetodermas|Anetoderma, Secondary|Anetodermas, Primary|Anetodermas, Secondary|Primary Anetoderma|Primary Anetodermas|Secondary Anetoderma|Secondary Anetodermas	Connective tissue disease|Skin disease
Aneurysm	MESH:D000783	DO:DOID:178	Pathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later rupture. Aneurysms are classified by location, etiology, or other characteristics.	MESH:D014652	C14.907.055	C14.907	Aneurysm, Fusiform|Aneurysms|Aneurysms, Fusiform|Fusiform Aneurysm|Fusiform Aneurysms|Saccular Aneurysm	Cardiovascular disease
Aneurysm, Dissecting	MESH:D000784		An aneurysm caused by a tear in the TUNICA INTIMA of a blood vessel leading to interstitial HEMORRHAGE, and splitting (dissecting) of the vessel wall, often involving the AORTA. Dissection between the tunica intima and TUNICA MEDIA causes luminal occlusion. Dissection at the media, or between the media and the outer ADVENTITIA causes aneurismal dilation.	MESH:D000783	C14.907.055.050	C14.907.055	Aneurysms, Dissecting|Aortic Dissection|Aortic Dissections|Blood Vessel Dissection|Dissecting Aneurysm|Dissecting Aneurysms|Dissection, Aortic|Dissection, Blood Vessel|Dissections, Aortic	Cardiovascular disease
Aneurysm, False	MESH:D017541		Not an aneurysm but a well-defined collection of blood and CONNECTIVE TISSUE outside the wall of a blood vessel or the heart. It is the containment of a ruptured blood vessel or heart, such as sealing a rupture of the left ventricle. False aneurysm is formed by organized THROMBUS and HEMATOMA in surrounding tissue.	MESH:D000783	C14.907.055.090	C14.907.055	Aneurysms, False|False Aneurysm|False Aneurysms|Pseudoaneurysm|Pseudoaneurysms	Cardiovascular disease
Aneurysm, Infected	MESH:D000785		Aneurysm due to growth of microorganisms in the arterial wall, or infection arising within preexisting arteriosclerotic aneurysms.	MESH:D000783|MESH:D007239	C01.069|C14.907.055.131	C01|C14.907.055	Aneurysm, Bacterial|Aneurysm, Fungal|Aneurysm, Mycotic|Aneurysms, Bacterial|Aneurysms, Fungal|Aneurysms, Infected|Aneurysms, Mycotic|Bacterial Aneurysm|Bacterial Aneurysms|Fungal Aneurysm|Fungal Aneurysms|Infected Aneurysm|Infected Aneurysms|Mycotic Aneurysm|Mycotic Aneurysms	Cardiovascular disease
Aneurysm, Intracranial Berry, 1	MESH:C566284	OMIM:105800		MESH:D002532|MESH:D013345	C10.228.140.300.510.600/C566284|C10.228.140.300.535.800/C566284|C14.907.055.635/C566284|C14.907.253.560.300/C566284|C14.907.253.573.800/C566284|C23.550.414.913.850/C566284	C10.228.140.300.510.600|C10.228.140.300.535.800|C14.907.055.635|C14.907.253.560.300|C14.907.253.573.800|C23.550.414.913.850	Aneurysmal Subarachnoid Hemorrhage, Familial|ANIB1	Cardiovascular disease|Nervous system disease|Pathology (process)
Aneurysm, Intracranial Berry, 10	MESH:C567237	OMIM:612587		MESH:D002532	C10.228.140.300.510.600/C567237|C14.907.055.635/C567237|C14.907.253.560.300/C567237	C10.228.140.300.510.600|C14.907.055.635|C14.907.253.560.300	ANIB10	Cardiovascular disease|Nervous system disease
Aneurysm, intracranial berry, 2	MESH:C536360	OMIM:608542		MESH:D002532	C10.228.140.300.510.600/C536360|C14.907.055.635/C536360|C14.907.253.560.300/C536360	C10.228.140.300.510.600|C14.907.055.635|C14.907.253.560.300	ANIB2	Cardiovascular disease|Nervous system disease
Aneurysm, Intracranial Berry, 3	MESH:C563792	OMIM:609122		MESH:D002532	C10.228.140.300.510.600/C563792|C14.907.055.635/C563792|C14.907.253.560.300/C563792	C10.228.140.300.510.600|C14.907.055.635|C14.907.253.560.300	ANIB3	Cardiovascular disease|Nervous system disease
Aneurysm, Intracranial Berry, 4	MESH:C565700	OMIM:610213		MESH:D002532|MESH:D013345	C10.228.140.300.510.600/C565700|C10.228.140.300.535.800/C565700|C14.907.055.635/C565700|C14.907.253.560.300/C565700|C14.907.253.573.800/C565700|C23.550.414.913.850/C565700	C10.228.140.300.510.600|C10.228.140.300.535.800|C14.907.055.635|C14.907.253.560.300|C14.907.253.573.800|C23.550.414.913.850	ANIB4	Cardiovascular disease|Nervous system disease|Pathology (process)
Aneurysm, Intracranial Berry, 6	MESH:C567500	OMIM:611892		MESH:D002532|MESH:D013345	C10.228.140.300.510.600/C567500|C10.228.140.300.535.800/C567500|C14.907.055.635/C567500|C14.907.253.560.300/C567500|C14.907.253.573.800/C567500|C23.550.414.913.850/C567500	C10.228.140.300.510.600|C10.228.140.300.535.800|C14.907.055.635|C14.907.253.560.300|C14.907.253.573.800|C23.550.414.913.850	ANIB6	Cardiovascular disease|Nervous system disease|Pathology (process)
Aneurysm, Intracranial Berry, 7	MESH:C567406	OMIM:612161		MESH:D002532|MESH:D013345	C10.228.140.300.510.600/C567406|C10.228.140.300.535.800/C567406|C14.907.055.635/C567406|C14.907.253.560.300/C567406|C14.907.253.573.800/C567406|C23.550.414.913.850/C567406	C10.228.140.300.510.600|C10.228.140.300.535.800|C14.907.055.635|C14.907.253.560.300|C14.907.253.573.800|C23.550.414.913.850	ANIB7	Cardiovascular disease|Nervous system disease|Pathology (process)
Aneurysm, Intracranial Berry, 8	MESH:C567405	OMIM:612162		MESH:D002532|MESH:D013345	C10.228.140.300.510.600/C567405|C10.228.140.300.535.800/C567405|C14.907.055.635/C567405|C14.907.253.560.300/C567405|C14.907.253.573.800/C567405|C23.550.414.913.850/C567405	C10.228.140.300.510.600|C10.228.140.300.535.800|C14.907.055.635|C14.907.253.560.300|C14.907.253.573.800|C23.550.414.913.850	ANIB8	Cardiovascular disease|Nervous system disease|Pathology (process)
Aneurysm, Intracranial Berry, 9	MESH:C567238	OMIM:612586		MESH:D002532|MESH:D013345	C10.228.140.300.510.600/C567238|C10.228.140.300.535.800/C567238|C14.907.055.635/C567238|C14.907.253.560.300/C567238|C14.907.253.573.800/C567238|C23.550.414.913.850/C567238	C10.228.140.300.510.600|C10.228.140.300.535.800|C14.907.055.635|C14.907.253.560.300|C14.907.253.573.800|C23.550.414.913.850	Anib9	Cardiovascular disease|Nervous system disease|Pathology (process)
Aneurysm Of Interventricular Septum	MESH:C563239			MESH:D006345	C14.240.400.560.540/C563239|C14.280.400.560.540/C563239|C16.131.240.400.560.540/C563239	C14.240.400.560.540|C14.280.400.560.540|C16.131.240.400.560.540		Cardiovascular disease|Congenital abnormality
Aneurysm, Ruptured	MESH:D017542		The tearing or bursting of the weakened wall of the aneurysmal sac, usually heralded by sudden worsening pain. The great danger of a ruptured aneurysm is the large amount of blood spilling into the surrounding tissues and cavities, causing HEMORRHAGIC SHOCK.	MESH:D000783	C14.907.055.185	C14.907.055	Aneurysms, Ruptured|Ruptured Aneurysm|Ruptured Aneurysms	Cardiovascular disease
Angel shaped phalangoepiphyseal dysplasia	MESH:C536361			MESH:D001848	C05.116.099/C536361	C05.116.099	Angel-shaped phalango-epiphyseal dysplasia|Angel-Shaped Phalangoepiphyseal Dysplasia	Musculoskeletal disease
Angina Pectoris	MESH:D000787		The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.	MESH:D002637|MESH:D017202	C14.280.647.187|C14.907.585.187|C23.888.592.612.233.500	C14.280.647|C14.907.585|C23.888.592.612.233	Angor Pectoris|Stenocardia|Stenocardias	Cardiovascular disease|Signs and symptoms
Angina Pectoris, Variant	MESH:D000788	DO:DOID:0111151	A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.	MESH:D000789	C14.280.647.187.150.150|C14.907.585.187.150.500|C23.888.592.612.233.500.150.150	C14.280.647.187.150|C14.907.585.187.150|C23.888.592.612.233.500.150	Angina, Prinzmetal|Angina, Prinzmetal's|Prinzmetal Angina|Prinzmetal's Angina|Prinzmetals Angina|Variant Angina Pectoris	Cardiovascular disease|Signs and symptoms
Angina, Stable	MESH:D060050		Persistent and reproducible chest discomfort usually precipitated by a physical exertion that dissipates upon cessation of such an activity. The symptoms are manifestations of MYOCARDIAL ISCHEMIA.	MESH:D000787	C14.280.647.187.362|C14.907.585.187.362|C23.888.592.612.233.500.575	C14.280.647.187|C14.907.585.187|C23.888.592.612.233.500	Angina, Chronic Stable|Angina Pectoris, Stable|Angina Pectori, Stable|Anginas, Chronic Stable|Anginas, Stable|Chronic Stable Angina|Chronic Stable Anginas|Pectoris, Stable Angina|Pectori, Stable Angina|Stable Angina|Stable Angina, Chronic|Stable Angina Pectori|Stable Angina Pectoris|Stable Anginas|Stable Anginas, Chronic	Cardiovascular disease|Signs and symptoms
Angina, Unstable	MESH:D000789	DO:DOID:8805	Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.	MESH:D000787	C14.280.647.187.150|C14.907.585.187.150|C23.888.592.612.233.500.150	C14.280.647.187|C14.907.585.187|C23.888.592.612.233.500	Angina at Rest|Angina Pectoris, Unstable|Angina Pectori, Unstable|Angina, Preinfarction|Anginas, Preinfarction|Anginas, Unstable|Myocardial Preinfarction Syndrome|Myocardial Preinfarction Syndromes|Preinfarction Angina|Preinfarction Anginas|Preinfarction Syndrome, Myocardial|Preinfarction Syndromes, Myocardial|Syndrome, Myocardial Preinfarction|Syndromes, Myocardial Preinfarction|Unstable Angina|Unstable Angina Pectori|Unstable Angina Pectoris|Unstable Anginas	Cardiovascular disease|Signs and symptoms
Angiodysplasia	MESH:D016888	DO:DOID:2494	Acquired degenerative dilation or expansion (ectasia) of normal BLOOD VESSELS, often associated with aging. They are isolated, tortuous, thin-walled vessels and sources of bleeding. They occur most often in mucosal capillaries of the GASTROINTESTINAL TRACT leading to GASTROINTESTINAL HEMORRHAGE and ANEMIA.	MESH:D014652	C14.907.075	C14.907	Angiodysplasias	Cardiovascular disease
Angioedema	MESH:D000799	DO:DOID:1558	Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.	MESH:D014581|MESH:D014652	C14.907.079|C17.800.862.945.066|C20.543.480.904.066	C14.907|C17.800.862.945|C20.543.480.904	Angioedemas|Angioneurotic Edema|Angioneurotic Edemas|Edema, Angioneurotic|Edema, Quincke's|Edemas, Angioneurotic|Giant Urticaria|Giant Urticarias|Quincke Edema|Quincke's Edema|Quinckes Edema|Urticaria, Giant|Urticarias, Giant	Cardiovascular disease|Immune system disease|Skin disease
ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO	OMIM:300909			MESH:D000799	C14.907.079/300909|C17.800.862.945.066/300909|C20.543.480.904.066/300909	C14.907.079|C17.800.862.945.066|C20.543.480.904.066	AEACEI	Cardiovascular disease|Immune system disease|Skin disease
Angiofibroma	MESH:D018322		A benign neoplasm of fibrous tissue in which there are numerous small and large, frequently dilated, vascular channels. (Stedman, 25th ed)	MESH:D009383	C04.557.645.100	C04.557.645	Angiofibromas	Cancer
Angiofollicular ganglionic hyperplasia	MESH:C536362	DO:DOID:0111157		MESH:D005871	C15.604.515.245/C536362|C20.683.515.250/C536362	C15.604.515.245|C20.683.515.250		Immune system disease|Lymphatic disease
Angioid Streaks	MESH:D000793	DO:DOID:13401	Small breaks in the elastin-filled tissue of the retina.	MESH:D012164	C11.768.094	C11.768	Angioid Streak|Streak, Angioid|Streaks, Angioid	Eye disease
Angiokeratoma	MESH:D000794	DO:DOID:479	A vascular, horny neoplasm of the skin characterized by TELANGIECTASIS and secondary epithelial changes including acanthosis and hyperkeratosis.	MESH:D009383	C04.557.645.115	C04.557.645	Angiokeratomas	Cancer
Angiolipoma	MESH:D018206	DO:DOID:3616	A benign neoplasm composed of a mixture of adipose tissue and blood vessels. (Dorland, 27th ed)	MESH:D018205	C04.557.450.550.100	C04.557.450.550	Angiolipomas	Cancer
Angiolipomatosis, Familial	MESH:C565951			MESH:D018206	C04.557.450.550.100/C565951	C04.557.450.550.100	Angiolipoma Microthromboticum	Cancer
Angiolymphoid Hyperplasia with Eosinophilia	MESH:D000796	DO:DOID:14308	Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.	MESH:D004802|MESH:D006099|MESH:D012871	C15.378.553.231.085|C15.604.515.292.007|C17.800.060	C15.378.553.231|C15.604.515.292|C17.800	Granuloma, Pseudopyogenic|Granulomas, Pseudopyogenic|Pseudopyogenic Granuloma|Pseudopyogenic Granulomas	Blood disease|Lymphatic disease|Skin disease
Angioma serpiginosum, autosomal dominant	MESH:C536365			MESH:D017445	C17.800.862/C536365	C17.800.862	Autosomal dominant angioma serpiginosum	Skin disease
Angiomatosis	MESH:D000798		A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.	MESH:D014652	C14.907.077	C14.907	Angiomatoses	Cardiovascular disease
Angiomatosis, diffuse corticomeningeal, of Divry and Van Bogaert	MESH:C536367			MESH:D000798|MESH:D001932	C04.588.614.250.195/C536367|C10.228.140.211/C536367|C10.551.240.250/C536367|C14.907.077/C536367	C04.588.614.250.195|C10.228.140.211|C10.551.240.250|C14.907.077		Cancer|Cardiovascular disease|Nervous system disease
Angiomyolipoma	MESH:D018207	DO:DOID:3314	A benign tumor containing vascular, adipose, and muscle elements. It occurs most often in the kidney with smooth muscle elements (angiolipoleiomyoma) in association with tuberous sclerosis. (Dorland, 27th ed)	MESH:D018205|MESH:D054973	C04.557.450.550.125|C04.557.450.692.249	C04.557.450.550|C04.557.450.692	Angiomyolipomas	Cancer
Angiomyoma	MESH:D018229	DO:DOID:4265	A benign tumor consisting of vascular and smooth muscle elements.	MESH:D007889	C04.557.450.590.450.125	C04.557.450.590.450	Angioleiomyoma|Angioleiomyomas|Angiomyomas|Leiomyomas, Vascular|Leiomyoma, Vascular|Vascular Leiomyoma|Vascular Leiomyomas	Cancer
Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps	MESH:C567088	OMIM:611773		MESH:D009120|MESH:D011928	C05.651.475/C567088|C10.597.613.500/C567088|C14.907.617.812/C567088|C23.888.592.608.500/C567088	C05.651.475|C10.597.613.500|C14.907.617.812|C23.888.592.608.500	Autosomal Dominant Familial Hematuria, Retinal Arteriolar Tortuosity, Contractures|Hanac|Hanac Syndrome|Hereditary Angiopathy with Nephropathy, Aneurysm, and Muscle Cramps Syndrome|Hereditary Angiopathy with Nephropathy, Aneurysms, and Muscle Cramps Syndrome	Cardiovascular disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Angiosarcoma of the breast	MESH:C536368	DO:DOID:4511		MESH:D001943|MESH:D006394	C04.557.450.795.390/C536368|C04.557.645.390/C536368|C04.588.180/C536368|C17.800.090.500/C536368	C04.557.450.795.390|C04.557.645.390|C04.588.180|C17.800.090.500	Breast angiosarcoma	Cancer|Skin disease
Anhedonia	MESH:D059445		Inability to experience pleasure due to impairment or dysfunction of normal psychological and neurobiological mechanisms. It is a symptom of many PSYCHOTIC DISORDERS (e.g., DEPRESSIVE DISORDER, MAJOR; and SCHIZOPHRENIA).	MESH:D019954	C10.597.606.057|C23.888.592.604.039	C10.597.606|C23.888.592.604	Anhedonia, Physical|Anhedonias|Anhedonia, Social|Anhedonias, Physical|Anhedonias, Social|Physical Anhedonia|Physical Anhedonias|Social Anhedonia|Social Anhedonias	Nervous system disease|Signs and symptoms
ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS	OMIM:106190	DO:DOID:0060603		MESH:D007007	C17.800.946.370/106190	C17.800.946.370	ANHD|DANN-EPSTEIN-SOHAR SYNDROME	Skin disease
Anisakiasis	MESH:D017129	DO:DOID:7033	Infection with roundworms of the genus ANISAKIS. Human infection results from the consumption of fish harboring roundworm larvae. The worms may cause acute NAUSEA; VOMITING; or penetrate into the wall of the DIGESTIVE TRACT where they give rise to EOSINOPHILIC GRANULOMA in the STOMACH; INTESTINES; or the OMENTUM.	MESH:D007411|MESH:D017191	C01.610.335.508.700.100.060|C01.610.432.060|C06.405.469.452.060	C01.610.335.508.700.100|C01.610.432|C06.405.469.452	Anisakiases|Anisakis Infection|Anisakis Infections|Infection, Anisakis|Infections, Anisakis	Digestive system disease|Parasitic disease
Aniseikonia	MESH:D000839	DO:DOID:0050304	A condition in which the ocular image of an object as seen by one eye differs in size and shape from that seen by the other.	MESH:D012030	C11.744.116	C11.744		Eye disease
Anisocoria	MESH:D015875		Unequal pupil size, which may represent a benign physiologic variant or a manifestation of disease. Pathologic anisocoria reflects an abnormality in the musculature of the iris (IRIS DISEASES) or in the parasympathetic or sympathetic pathways that innervate the pupil. Physiologic anisocoria refers to an asymmetry of pupil diameter, usually less than 2mm, that is not associated with disease.	MESH:D011681	C10.597.690.150|C11.710.090|C23.888.592.708.150	C10.597.690|C11.710|C23.888.592.708	Anisocoria, Physiologic|Inequality, Pupillary Size|Physiologic Anisocoria|Pupil Diameter Unequal|Pupillary Size Inequality	Eye disease|Nervous system disease|Signs and symptoms
Anisometropia	MESH:D015858	DO:DOID:12273	A condition of an inequality of refractive power of the two eyes.	MESH:D012030	C11.744.126	C11.744		Eye disease
Ankylosis	MESH:D000844	DO:DOID:227	Fixation and immobility of a joint.	MESH:D007592	C05.550.069	C05.550	Ankyloses	Musculoskeletal disease
Anomalous Left Coronary Artery	MESH:D000080038		Malformations of left CORONARY ARTERY where it is connected to the PULMONARY ARTERY instead of the AORTA.	MESH:D003330	C14.240.400.210.125|C14.280.400.210.125|C16.131.240.400.210.125	C14.240.400.210|C14.280.400.210|C16.131.240.400.210		Cardiovascular disease|Congenital abnormality
Anomia	MESH:D000849	DO:DOID:4541	A language dysfunction characterized by the inability to name people and objects that are correctly perceived. The individual is able to describe the object in question, but cannot provide the name. This condition is associated with lesions of the dominant hemisphere involving the language areas, in particular the TEMPORAL LOBE. (From Adams et al., Principles of Neurology, 6th ed, p484)	MESH:D007806	C10.597.606.150.500.090|C23.888.592.604.150.500.090	C10.597.606.150.500|C23.888.592.604.150.500	Amnesic Aphasia|Anomia, Color|Anomias, Color|Anomic Aphasia|Anomic Dysphasia|Anomic Dysphasias|Aphasia, Amnesic|Aphasia, Anomic|Aphasia, Nominal|Color Anomia|Color Anomias|Dysnomia|Dysnomias|Dysphasia, Anomic|Dysphasia, Nominal|Dysphasias, Anomic|Dysphasias, Nominal|Nominal Aphasia|Nominal Dysphasia|Nominal Dysphasias	Nervous system disease|Signs and symptoms
Anosmia	MESH:D000086582		Complete or severe loss of the subjective sense of smell. Loss of smell may be caused by many factors such as a cold, allergy, OLFACTORY NERVE DISEASES, viral RESPIRATORY TRACT INFECTIONS (e.g., COVID-19), aging and various neurological disorders (e.g., ALZHEIMER DISEASE).	MESH:D000857	C10.597.751.600.500|C23.888.592.763.550.500	C10.597.751.600|C23.888.592.763.550	Hyposmia|Loss of Smell|Smell Loss	Nervous system disease|Signs and symptoms
Anovulation	MESH:D000858	DO:DOID:3781	Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.	MESH:D010049	C12.050.351.500.056.630.050|C12.100.250.056.630.050|C19.391.630.050	C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	Anovulations	Endocrine system disease|Urogenital disease (female)
Ansell Bywaters Elderking syndrome	MESH:C537773			MESH:D001177|MESH:D008607|MESH:D014605	C05.550.186/C537773|C10.597.606.360/C537773|C11.941.879/C537773|C23.888.592.604.646/C537773|F03.625.539/C537773	C05.550.186|C10.597.606.360|C11.941.879|C23.888.592.604.646|F03.625.539		Eye disease|Mental disorder|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Anterior Capsular Rupture, Ocular	MESH:D057971		A breach in the continuity of the ANTERIOR CHAMBER of the eyeball.	MESH:D005131	C11.297.249	C11.297		Eye disease
Anterior Compartment Syndrome	MESH:D000868	DO:DOID:3933	Rapid swelling, increased tension, pain, and ischemic necrosis of the muscles of the anterior tibial compartment of the leg, often following excessive PHYSICAL EXERTION.	MESH:D003161	C05.651.180.063|C14.907.303.063	C05.651.180|C14.907.303	Anterior Compartment Syndromes|Anterior Tibial Syndrome|Anterior Tibial Syndromes|Compartment Syndrome, Anterior|Compartment Syndromes, Anterior|Syndrome, Anterior Compartment|Syndrome, Anterior Tibial|Syndromes, Anterior Compartment|Syndromes, Anterior Tibial|Tibial Syndrome, Anterior|Tibial Syndromes, Anterior	Cardiovascular disease|Musculoskeletal disease
Anterior polar cataract 2	MESH:C537774	OMIM:601202		MESH:D002386	C11.510.245/C537774	C11.510.245	CATARACT 24|CATARACT 24, ANTERIOR POLAR|Cataract, anterior polar 2|Cataract, Anterior Polar, 2|CTAA2|CTRCT24	Eye disease
Anterior spinal artery stroke	MESH:C537776			MESH:D020760	C10.228.854.785.650/C537776|C14.907.790.550/C537776	C10.228.854.785.650|C14.907.790.550		Cardiovascular disease|Nervous system disease
Anterior Spinal Artery Syndrome	MESH:D020759	DO:DOID:6712	Ischemia or infarction of the spinal cord in the distribution of the anterior spinal artery, which supplies the ventral two-thirds of the spinal cord. This condition is usually associated with ATHEROSCLEROSIS of the aorta and may result from dissection of an AORTIC ANEURYSM or rarely dissection of the anterior spinal artery. Clinical features include weakness and loss of pain and temperature sensation below the level of injury, with relative sparing of position and vibratory sensation. (From Adams et al., Principles of Neurology, 6th ed, pp1249-50)	MESH:D020760	C10.228.854.785.650.100|C14.907.790.550.100	C10.228.854.785.650|C14.907.790.550	Anterior Spinal Artery Dissection|Dissection, Anterior Spinal Artery|Syndrome, Anterior Spinal Artery	Cardiovascular disease|Nervous system disease
Anterior Wall Myocardial Infarction	MESH:D056988	DO:DOID:5845|DO:DOID:5855	MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.	MESH:D009203	C14.280.647.500.093|C14.907.585.500.093|C23.550.513.355.750.093|C23.550.717.489.750.093	C14.280.647.500|C14.907.585.500|C23.550.513.355.750|C23.550.717.489.750	Acute Anterior Wall Myocardial Infarction|Anterolateral Myocardial Infarction|Anterolateral Myocardial Infarctions|Anteroseptal Myocardial Infarction|Anteroseptal Myocardial Infarctions|Infarction, Anterolateral Myocardial|Infarction, Anteroseptal Myocardial|Infarctions, Anterolateral Myocardial|Infarctions, Anteroseptal Myocardial|Myocardial Infarction, Anterior Wall|Myocardial Infarction, Anterolateral|Myocardial Infarction, Anteroseptal|Myocardial Infarctions, Anterolateral|Myocardial Infarctions, Anteroseptal	Cardiovascular disease|Pathology (process)
Anthracosilicosis	MESH:D000874	DO:DOID:10324	A form of pneumoconiosis caused by inhalation of dust that contains both CARBON and crystalline SILICON DIOXIDE. These foreign matters induce fibrous nodule formation in the lung.	MESH:D012829|MESH:D055008	C08.381.483.581.062.500|C08.381.483.581.760.125|C08.381.520.702.062.500|C08.381.520.702.760.125|C24.800.834.201	C08.381.483.581.062|C08.381.483.581.760|C08.381.520.702.062|C08.381.520.702.760|C24.800.834	Anthracosilicoses	Occupational disease|Respiratory tract disease
Anthracosis	MESH:D055008	DO:DOID:10327	A diffuse parenchymal lung disease caused by accumulation of inhaled CARBON or coal dust. The disease can progress from asymptomatic anthracosis to massive lung fibrosis. This lung lesion usually occurs in coal MINERS, but can be seen in urban dwellers and tobacco smokers.	MESH:D011009	C08.381.483.581.062|C08.381.520.702.062	C08.381.483.581|C08.381.520.702	Anthracoses|Black Lung|Black Lung Disease|Black Lung Diseases|Black Lungs|Coal Miner Lung|Coal Miner's Lung|Coal Miners Lung|Coal Miner's Lungs|Coalworker Pneumoconiosis|Coal Worker Pneumoconiosis|Coalworker's Pneumoconioses|Coal Worker's Pneumoconioses|Coalworker's Pneumoconiosis|Coalworkers Pneumoconiosis|Coal Worker's Pneumoconiosis|Coal Workers Pneumoconiosis|Lung, Black|Lungs, Black|Miner's Lung, Coal|Miner's Lungs, Coal|Pneumoconioses, Coalworker's|Pneumoconioses, Coal Worker's|Pneumoconiosis, Coal Worker|Pneumoconiosis, Coalworker's|Pneumoconiosis, Coal Workers|Pneumoconiosis, Coal Worker's	Respiratory tract disease
Anticholinergic Syndrome	MESH:D064807		Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome.	MESH:D064420	C25.100.311	C25.100	Anticholinergic Syndrome, Central|Anticholinergic Syndrome, Peripheral|Anticholinergic Syndromes|Anticholinergic Syndromes, Central|Anticholinergic Syndromes, Peripheral|Central Anticholinergic Syndrome|Central Anticholinergic Syndromes|Peripheral Anticholinergic Syndrome|Peripheral Anticholinergic Syndromes|Syndrome, Anticholinergic|Syndrome, Central Anticholinergic|Syndrome, Peripheral Anticholinergic|Syndromes, Anticholinergic|Syndromes, Central Anticholinergic|Syndromes, Peripheral Anticholinergic	
Anti-Glomerular Basement Membrane Disease	MESH:D019867	DO:DOID:9808	An autoimmune disease of the KIDNEY and the LUNG. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of COLLAGEN TYPE IV in the basement membranes of kidney glomeruli (KIDNEY GLOMERULUS) and lung alveoli (PULMONARY ALVEOLI), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.	MESH:D001327|MESH:D005921|MESH:D017563	C08.381.483.156|C12.050.351.968.419.570.363.304|C12.200.777.419.570.363.304|C12.950.419.570.363.304|C20.111.190	C08.381.483|C12.050.351.968.419.570.363|C12.200.777.419.570.363|C12.950.419.570.363|C20.111	Anti GBM Disease|Anti-GBM Disease|Anti Glomerular Basement Membrane Disease|Goodpasture's Syndrome|Goodpastures Syndrome|Goodpasture Syndrome|Lung Purpura with Nephritis|Syndrome, Goodpasture|Syndrome, Goodpasture's	Immune system disease|Respiratory tract disease|Urogenital disease (female)|Urogenital disease (male)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	MESH:D056648		Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.	MESH:D001327|MESH:D056647	C14.907.940.897.249|C20.111.193	C14.907.940.897|C20.111	ANCA-Associated Vasculitide|ANCA Associated Vasculitides|ANCA-Associated Vasculitides|ANCA Associated Vasculitis|ANCA-Associated Vasculitis|Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis|Pauci-Immune Vasculitides|Pauci Immune Vasculitis|Pauci-Immune Vasculitis|Vasculitide, ANCA-Associated|Vasculitides, ANCA-Associated|Vasculitides, Pauci-Immune|Vasculitis, ANCA-Associated|Vasculitis, Pauci-Immune	Cardiovascular disease|Immune system disease
Anti-N-Methyl-D-Aspartate Receptor Encephalitis	MESH:D060426		Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.	MESH:D004660|MESH:D020274|MESH:D020361	C04.588.614.550.112|C04.730.856.112|C10.228.140.430.124|C10.574.781.249|C10.586.250.124|C20.111.258.124	C04.588.614.550|C04.730.856|C10.228.140.430|C10.574.781|C10.586.250|C20.111.258	Anti-NMDA Receptor Encephalitides|Anti NMDA Receptor Encephalitis|Anti-NMDA Receptor Encephalitis|Anti-NMDAR Encephalitides|Anti-NMDAR Encephalitides, Non-paraneoplastic|Anti-NMDAR Encephalitides, Paraneoplastic|Anti NMDAR Encephalitis|Anti-NMDAR Encephalitis|Anti-NMDAR Encephalitis, Non-paraneoplastic|Anti-NMDAR Encephalitis, Paraneoplastic|Anti-N-Methyl-D-Aspartate Receptor Encephalitides|Anti N Methyl D Aspartate Receptor Encephalitis|Encephalitides, Anti-NMDAR|Encephalitides, Anti-NMDA Receptor|Encephalitides, Anti-N-Methyl-D-Aspartate Receptor|Encephalitides, Non-paraneoplastic Anti-NMDAR|Encephalitides, Paraneoplastic Anti-NMDAR|Encephalitis, Anti-NMDAR|Encephalitis, Anti-NMDA Receptor|Encephalitis, Anti-N-Methyl-D-Aspartate Receptor|Encephalitis, Non-paraneoplastic Anti-NMDAR|Encephalitis, Paraneoplastic Anti-NMDAR|Non paraneoplastic Anti NMDA Receptor Encephalitis|Non-paraneoplastic Anti-NMDA Receptor Encephalitis|Non-paraneoplastic Anti-NMDAR Encephalitides|Non paraneoplastic Anti NMDAR Encephalitis|Non-paraneoplastic Anti-NMDAR Encephalitis|Non paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis|Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis|Paraneoplastic Anti NMDA Receptor Encephalitis|Paraneoplastic Anti-NMDA Receptor Encephalitis|Paraneoplastic Anti-NMDAR Encephalitides|Paraneoplastic Anti NMDAR Encephalitis|Paraneoplastic Anti-NMDAR Encephalitis|Paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis|Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis|Receptor Encephalitides, Anti-NMDA|Receptor Encephalitis, Anti-NMDA	Cancer|Immune system disease|Nervous system disease
Antiphospholipid Syndrome	MESH:D016736	DO:DOID:2988	The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).	MESH:D001327	C20.111.197	C20.111	Antibody Syndrome, Antiphospholipid|Antibody Syndrome, Anti-Phospholipid|Antiphospholipid Antibody Syndrome|Anti Phospholipid Antibody Syndrome|Anti-Phospholipid Antibody Syndrome|Antiphospholipid Antibody Syndromes|Anti Phospholipid Syndrome|Anti-Phospholipid Syndrome|Hughes Syndrome|Syndrome, Antiphospholipid|Syndrome, Anti-Phospholipid|Syndrome, Antiphospholipid Antibody|Syndrome, Anti-Phospholipid Antibody|Syndrome, Hughes	Immune system disease
Anti-plasmin deficiency, congenital	MESH:C537777	OMIM:262850		MESH:D006474	C15.378.463/C537777	C15.378.463	Alpha-2-plasmin inhibitor deficiency|Antiplasmin Deficiency|Antiplasmin deficiency, congenital|Plasmin Inhibitor Deficiency	Blood disease
Antisynthetase syndrome	MESH:C537778			MESH:D009220	C05.651.594/C537778|C10.668.491.562/C537778	C05.651.594|C10.668.491.562		Musculoskeletal disease|Nervous system disease
Antithrombin deficiency type 2	MESH:C537779			MESH:D019851	C15.378.925/C537779	C15.378.925		Blood disease
Antithrombin, Familial Hemorrhagic Diathesis due to	MESH:C565947			MESH:D006474	C15.378.463/C565947	C15.378.463		Blood disease
Anus Neoplasms	MESH:D001005	DO:DOID:4551|DO:DOID:4908	Tumors or cancer of the ANAL CANAL.	MESH:D001004|MESH:D012004	C04.588.274.476.411.307.790.040|C06.301.371.411.307.790.040|C06.405.249.411.307.790.040|C06.405.469.491.307.790.040|C06.405.469.860.101.163|C06.405.469.860.180.500.040	C04.588.274.476.411.307.790|C06.301.371.411.307.790|C06.405.249.411.307.790|C06.405.469.491.307.790|C06.405.469.860.101|C06.405.469.860.180.500	Anal Cancer|Anal Cancers|Anal Neoplasm|Anal Neoplasms|Anus Cancer|Anus Cancers|Anus Neoplasm|Cancer, Anal|Cancer of Anus|Cancer of the Anus|Cancers, Anal|Neoplasm, Anal|Neoplasm, Anus|Neoplasms, Anal|Neoplasms, Anus	Cancer|Digestive system disease
Aortic Aneurysm	MESH:D001014	DO:DOID:3627	An abnormal balloon- or sac-like dilatation in the wall of AORTA.	MESH:D000783|MESH:D001018	C14.907.055.239|C14.907.109.139	C14.907.055|C14.907.109	Aneurysm, Aortic|Aneurysms, Aortic|Aortic Aneurysms	Cardiovascular disease
Aortic Aneurysm, Abdominal	MESH:D017544	DO:DOID:7693	An abnormal balloon- or sac-like dilatation in the wall of the ABDOMINAL AORTA which gives rise to the visceral, the parietal, and the terminal (iliac) branches below the aortic hiatus at the diaphragm.	MESH:D001014	C14.907.055.239.075|C14.907.109.139.075	C14.907.055.239|C14.907.109.139	Abdominal Aortic Aneurysm|Abdominal Aortic Aneurysms|Aneurysm, Abdominal Aortic|Aneurysms, Abdominal Aortic|Aortic Aneurysms, Abdominal	Cardiovascular disease
Aortic Aneurysm, Familial Abdominal 1	MESH:C565230	OMIM:100070		MESH:D017544	C14.907.055.239.075/C565230|C14.907.109.139.075/C565230	C14.907.055.239.075|C14.907.109.139.075	AAA|AAA1|ABDOMINAL AORTIC ANEURYSM|ANEURYSM, ABDOMINAL AORTIC|AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1	Cardiovascular disease
Aortic Aneurysm, Familial Abdominal 2	MESH:C565229	OMIM:609782		MESH:D017544	C14.907.055.239.075/C565229|C14.907.109.139.075/C565229	C14.907.055.239.075|C14.907.109.139.075	AAA2|AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 2	Cardiovascular disease
Aortic Aneurysm, Familial Abdominal 3	MESH:C567501	OMIM:611891		MESH:D017544	C14.907.055.239.075/C567501|C14.907.109.139.075/C567501	C14.907.055.239.075|C14.907.109.139.075	Aaa3|AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 3	Cardiovascular disease
Aortic Aneurysm, Familial Thoracic 1	MESH:C562834	OMIM:607086		MESH:D017545	C14.907.055.239.125/C562834|C14.907.109.139.125/C562834	C14.907.055.239.125|C14.907.109.139.125	AAT1|ANEURYSM, THORACIC AORTIC ERDHEIM CYSTIC MEDIAL NECROSIS OF AORTA, INCLUDED|Annuloaortic Ectasia|Aortic Aneurysm, Familial Thoracic|Aortic Dissection, Familial|FAA1|Familial Aortic Aneurysm|Familial Aortic Dissection|Familial Taad|Familial Thoracic Aortic Aneurysm|Familial Thoracic Aortic Aneurysm and Dissection	Cardiovascular disease
AORTIC ANEURYSM, FAMILIAL THORACIC 10	OMIM:617168			MESH:D017545	C14.907.055.239.125/617168|C14.907.109.139.125/617168	C14.907.055.239.125|C14.907.109.139.125	AAT10|AORTIC ANEURYSM, THORACIC, WITH OR WITHOUT AORTIC DISSECTION	Cardiovascular disease
AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO	OMIM:617349			MESH:D017545	C14.907.055.239.125/617349|C14.907.109.139.125/617349	C14.907.055.239.125|C14.907.109.139.125	AAT11	Cardiovascular disease
Aortic Aneurysm, Familial Thoracic 2	MESH:C564627	OMIM:607087		MESH:D017545	C14.907.055.239.125/C564627|C14.907.109.139.125/C564627	C14.907.055.239.125|C14.907.109.139.125	AAT2|FAA2	Cardiovascular disease
Aortic aneurysm, familial thoracic 4	MESH:C537784	OMIM:132900		MESH:D004374|MESH:D017545	C14.240.400.340/C537784|C14.280.400.340/C537784|C14.907.055.239.125/C537784|C14.907.109.139.125/C537784|C16.131.240.400.340/C537784	C14.240.400.340|C14.280.400.340|C14.907.055.239.125|C14.907.109.139.125|C16.131.240.400.340	AAT4|Aortic aneurysm-aortic dissection and patent ductus arteriosus|AORTIC ANEURYSM/AORTIC DISSECTION AND PATENT DUCTUS ARTERIOSUS|FAA4	Cardiovascular disease|Congenital abnormality
Aortic Aneurysm, Familial Thoracic 6	MESH:C567085	OMIM:611788		MESH:D017545|MESH:D054068	C14.907.055.239.125/C567085|C14.907.109.139.125/C567085|C14.907.617.625/C567085|C17.800.862.355/C567085|C23.888.885.437/C567085	C14.907.055.239.125|C14.907.109.139.125|C14.907.617.625|C17.800.862.355|C23.888.885.437	Aat6|Familial Thoracic Aortic Aneurysm With Livedo Reticularis And Iris Flocculi	Cardiovascular disease|Signs and symptoms|Skin disease
AORTIC ANEURYSM, FAMILIAL THORACIC 7	OMIM:613780	DO:DOID:14004		MESH:D017545	C14.907.055.239.125/613780|C14.907.109.139.125/613780	C14.907.055.239.125|C14.907.109.139.125	AAT7|AORTIC DISSECTION, FAMILIAL, WITH OR WITHOUT AORTIC ANEURYSM	Cardiovascular disease
AORTIC ANEURYSM, FAMILIAL THORACIC 8	OMIM:615436	DO:DOID:14004		MESH:D017545	C14.907.055.239.125/615436|C14.907.109.139.125/615436	C14.907.055.239.125|C14.907.109.139.125	AAT8	Cardiovascular disease
AORTIC ANEURYSM, FAMILIAL THORACIC 9	OMIM:616166			MESH:D017545	C14.907.055.239.125/616166|C14.907.109.139.125/616166	C14.907.055.239.125|C14.907.109.139.125	AAT9|AORTIC ANEURYSM, THORACIC, WITH OR WITHOUT AORTIC DISSECTION	Cardiovascular disease
Aortic Aneurysm, Giant Congenital	MESH:C565758			MESH:D001014	C14.907.055.239/C565758|C14.907.109.139/C565758	C14.907.055.239|C14.907.109.139		Cardiovascular disease
Aortic Aneurysm, Thoracic	MESH:D017545	DO:DOID:14004	An abnormal balloon- or sac-like dilatation in the wall of the THORACIC AORTA. This proximal descending portion of aorta gives rise to the visceral and the parietal branches above the aortic hiatus at the diaphragm.	MESH:D001014	C14.907.055.239.125|C14.907.109.139.125	C14.907.055.239|C14.907.109.139	Aneurysms, Thoracoabdominal Aortic|Aneurysm, Thoracic Aortic|Aneurysm, Thoracoabdominal Aortic|Aortic Aneurysms, Thoracic|Aortic Aneurysms, Thoracoabdominal|Aortic Aneurysm, Thoracoabdominal|Thoracic Aortic Aneurysm|Thoracic Aortic Aneurysms|Thoracoabdominal Aortic Aneurysm|Thoracoabdominal Aortic Aneurysms	Cardiovascular disease
Aortic Arch Syndromes	MESH:D001015	DO:DOID:2508	Conditions resulting from abnormalities in the arteries branching from the ASCENDING AORTA, the curved portion of the aorta. These syndromes are results of occlusion or abnormal blood flow to the head-neck or arm region leading to neurological defects and weakness in an arm. These syndromes are associated with vascular malformations; ATHEROSCLEROSIS; TRAUMA; and blood clots.	MESH:D001018	C14.907.109.239	C14.907.109	Aortic Arch Syndrome|Syndrome, Aortic Arch|Syndromes, Aortic Arch	Cardiovascular disease
Aortic Coarctation	MESH:D001017		A birth defect characterized by the narrowing of the AORTA that can be of varying degree and at any point from the transverse arch to the iliac bifurcation. Aortic coarctation causes arterial HYPERTENSION before the point of narrowing and arterial HYPOTENSION beyond the narrowed portion.	MESH:D006330	C14.240.400.090|C14.280.400.090|C16.131.240.400.090	C14.240.400|C14.280.400|C16.131.240.400	Aorta Coarctation|Aorta Coarctations|Aorta Dominant Coarctation|Aorta Dominant Coarctations|Aortic Coarctations|Coarctation, Aortic|Coarctation of Aorta|Coarctation of Aorta Dominant|Coarctation of the Aorta|Coarctations, Aortic	Cardiovascular disease|Congenital abnormality
Aortic Diseases	MESH:D001018	DO:DOID:520	Pathological processes involving any part of the AORTA.	MESH:D014652	C14.907.109	C14.907	Aortic Disease|Disease, Aortic|Diseases, Aortic	Cardiovascular disease
Aortico-Ventricular Tunnel	MESH:D000082903		Congenital anomaly characterized by an extra-cardiac channel connecting the AORTA either to the right or left HEART VENTRICLE.	MESH:D006330	C14.240.400.118|C14.280.400.118|C16.131.240.400.118	C14.240.400|C14.280.400|C16.131.240.400	Aortic Left Ventricular Tunnel|Aortic-Left Ventricular Tunnel|Aortic-Left Ventricular Tunnels|Aortico Left Ventricular Tunnel|Aortico-Left Ventricular Tunnel|Aortico-Left Ventricular Tunnels|Aortico Right Ventricular Tunnel|Aortico-Right Ventricular Tunnel|Aortico-Right Ventricular Tunnels|Aorticoventricular Tunnel|Aortico Ventricular Tunnel|Aorticoventricular Tunnels|Aortico-Ventricular Tunnels|Aortic Right Ventricular Tunnel|Aortic-Right Ventricular Tunnel|Aortic-Right Ventricular Tunnels|Aortic Ventricular Tunnel|Aortic-Ventricular Tunnel|Aortic-Ventricular Tunnels|Aorto Left Ventricular Tunnel|Aorto-Left Ventricular Tunnel|Aorto-Left Ventricular Tunnels|Aorto Right Ventricular Tunnel|Aorto-Right Ventricular Tunnel|Aorto-Right Ventricular Tunnels|Aortoventricular Tunnel|Aorto Ventricular Tunnel|Aorto-Ventricular Tunnel|Aortoventricular Tunnels|Aorto-Ventricular Tunnels|Tunnel, Aorticoventricular|Ventricular Tunnel, Aortic-Left|Ventricular Tunnel, Aortic-Right|Ventricular Tunnels, Aortic-Left|Ventricular Tunnels, Aortic-Right	Cardiovascular disease|Congenital abnormality
Aortic Rupture	MESH:D001019	DO:DOID:3627	The tearing or bursting of the wall along any portion of the AORTA, such as thoracic or abdominal. It may result from the rupture of an aneurysm or it may be due to TRAUMA.	MESH:D001014|MESH:D012421|MESH:D017542	C14.907.055.185.125|C14.907.055.239.175|C14.907.109.139.175|C26.761.125	C14.907.055.185|C14.907.055.239|C14.907.109.139|C26.761	Aneurysm, Ruptured Aortic|Aneurysms, Ruptured Aortic|Aortic Aneurysm, Ruptured|Aortic Aneurysms, Ruptured|Aortic Ruptures|Rupture, Aortic|Ruptured Aortic Aneurysm|Ruptured Aortic Aneurysms|Ruptures, Aortic	Cardiovascular disease|Wounds and injuries
Aortic Stenosis, Subvalvular	MESH:D001020	DO:DOID:5805	A pathological constriction occurring in the region below the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.	MESH:D001024	C14.280.484.048.750.070|C14.280.955.249.070	C14.280.484.048.750|C14.280.955.249	Aortic Stenoses, Subvalvular|Aortic Subvalvular Stenoses|Aortic Subvalvular Stenosis|Stenoses, Aortic Subvalvular|Stenoses, Subvalvular Aortic|Stenosis, Aortic Subvalvular|Stenosis, Subvalvular Aortic|Subvalvular Aortic Stenoses|Subvalvular Aortic Stenosis|Subvalvular Stenoses, Aortic|Subvalvular Stenosis, Aortic	Cardiovascular disease
Aortic Stenosis, Supravalvular	MESH:D021921	DO:DOID:1929|OMIM:185500	A pathological constriction occurring in the region above the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.	MESH:D001024	C14.280.484.048.750.535|C14.280.955.249.535	C14.280.484.048.750|C14.280.955.249	Aortic Supravalvular Stenoses|Aortic Supravalvular Stenosis|Stenoses, Aortic Supravalvular|Stenosis, Aortic Supravalvular|Stenosis, Supravalvular Aortic|Supravalvar Aortic Stenosis|SUPRAVALVAR AORTIC STENOSIS, EISENBERG TYPE|Supravalvular Aortic Stenosis|Supravalvular Stenoses, Aortic|Supravalvular Stenosis, Aortic|SVAS	Cardiovascular disease
Aortic Valve, Calcification of	MESH:C562942			MESH:D001024|MESH:D002114	C14.280.484.048.750/C562942|C14.280.955.249/C562942|C18.452.174.130/C562942	C14.280.484.048.750|C14.280.955.249|C18.452.174.130	Aortic Stenosis, Calcific	Cardiovascular disease|Metabolic disease
Aortic Valve Disease	MESH:D000082862	DO:DOID:62	Diseases involving the AORTIC VALVE functionality. Aortic valve disease often results in a backward and/or regurgitated blood flow into the LEFT VENTRICLE or a decreased blood flow from the heart. It includes congenital (e.g., bicuspid aortic valve), syndromic, and acquired (e.g., age-related, infection-associated) conditions.	MESH:D006349	C14.280.484.048	C14.280.484	Aortic Heart Disease|Aortic Heart Diseases|Aortic Valve Diseases|Aortic Valve Disorder|Aortic Valve Disorders|Aortic Valvular Heart Disease|Aortic Valvular Heart Disorder|Heart Disease, Aortic|Valve Disease, Aortic|Valve Disorder, Aortic	Cardiovascular disease
AORTIC VALVE DISEASE 1	OMIM:109730	DO:DOID:0080333		MESH:C562942|MESH:D000082882	C14.240.400.186/109730|C14.280.400.186/109730|C14.280.484.048.750/C562942/109730|C14.280.484.048.875/109730|C14.280.955.249/C562942/109730|C16.131.240.400.186/109730|C18.452.174.130/C562942/109730	C14.240.400.186|C14.280.400.186|C14.280.484.048.750/C562942|C14.280.484.048.875|C14.280.955.249/C562942|C16.131.240.400.186|C18.452.174.130/C562942	AORTIC STENOSIS, CALCIFIC|AORTIC VALVE, BICUSPID|AORTIC VALVE, CALCIFICATION OF|AORTIC VALVE DISEASE|AOVD|AOVD1|BAV|BICUSPID AORTIC VALVE	Cardiovascular disease|Congenital abnormality|Metabolic disease
AORTIC VALVE DISEASE 2	OMIM:614823	DO:DOID:0080334		MESH:D006349	C14.280.484/614823	C14.280.484	AORTIC VALVE STENOSIS|AOVD2|BICUSPID AORTIC VALVE	Cardiovascular disease
Aortic Valve Insufficiency	MESH:D001022	DO:DOID:57	Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).	MESH:D000082862	C14.280.484.048.500	C14.280.484.048	Aortic Incompetence|Aortic Regurgitation|Aortic Valve Incompetence|Incompetence, Aortic|Incompetence, Aortic Valve|Insufficiency, Aortic Valve|Regurgitation, Aortic|Regurgitation, Aortic Valve	Cardiovascular disease
Aortic Valve Prolapse	MESH:D001023	DO:DOID:5232	The downward displacement of the cuspal or pointed end of the trileaflet AORTIC VALVE causing misalignment of the cusps. Severe valve distortion can cause leakage and allow the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to aortic regurgitation.	MESH:D000082862|MESH:D016127	C14.280.484.048.625|C14.280.484.400.100	C14.280.484.048|C14.280.484.400	Aortic Valve Prolapses|Prolapse, Aortic Valve|Prolapses, Aortic Valve|Valve Prolapse, Aortic|Valve Prolapses, Aortic	Cardiovascular disease
Aortic Valve Stenosis	MESH:D001024	DO:DOID:1712	A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.	MESH:D000082862|MESH:D014694	C14.280.484.048.750|C14.280.955.249	C14.280.484.048|C14.280.955	Aortic Stenosis|Aortic Valve Stenoses|Stenoses, Aortic|Stenoses, Aortic Valve|Stenosis, Aortic|Stenosis, Aortic Valve|Valve Stenoses, Aortic|Valve Stenosis, Aortic	Cardiovascular disease
Aortitis	MESH:D001025	DO:DOID:519	Inflammation of the wall of the AORTA.	MESH:D001018|MESH:D014657	C14.907.109.320|C14.907.940.080	C14.907.109|C14.907.940	Aortitides	Cardiovascular disease
aorto-atrial tunnel	MESH:C000655384			MESH:D006330	C14.240.400/C000655384|C14.280.400/C000655384|C16.131.240.400/C000655384	C14.240.400|C14.280.400|C16.131.240.400	aorta-atrial tunnel|aorta-left atrial tunnel|aorta-right atrial tunnel|aorto-left atrial tunnel|aorto-right atrial tunnel	Cardiovascular disease|Congenital abnormality
Aortopulmonary Septal Defect	MESH:D001028		A developmental abnormality in which the spiral (aortopulmonary) septum failed to completely divide the TRUNCUS ARTERIOSUS into ASCENDING AORTA and PULMONARY ARTERY. This abnormal communication between the two major vessels usually lies above their respective valves (AORTIC VALVE; PULMONARY VALVE).	MESH:D006343	C14.240.400.560.098|C14.280.400.560.098|C16.131.240.400.560.098	C14.240.400.560|C14.280.400.560|C16.131.240.400.560	Aorticopulmonary Septal Defect|Aorticopulmonary Septal Defects|Aortopulmonary Septal Defects|Septal Defect, Aorticopulmonary|Septal Defect, Aortopulmonary|Septal Defects, Aorticopulmonary|Septal Defects, Aortopulmonary	Cardiovascular disease|Congenital abnormality
Aphakia	MESH:D001035		Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION.	MESH:D007905	C11.510.103	C11.510	Aphakias|Aphakic Eye|Aphakic Eye, Post traumatic|Aphakic Eye, Post-traumatic|Aphakic Eyes|Aphakic Eyes, Post-traumatic|Aphakic Eye, Traumatic|Eye, Aphakic|Eye, Traumatic Aphakic|Post-traumatic Aphakic Eye|Post-traumatic Aphakic Eyes|Traumatic Aphakic Eye|Traumatic Aphakic Eyes	Eye disease
Aphakia, congenital primary	MESH:C537786	OMIM:610256		MESH:D001035	C11.510.103/C537786	C11.510.103	ANTERIOR SEGMENT DYSGENESIS 2|APHAKIA, CONGENITAL PRIMARY|ASGD2|Congenital primary aphakia|CPA|CPAK	Eye disease
Aphakia, Postcataract	MESH:D001036		Absence of the crystalline lens resulting from cataract extraction.	MESH:D001035	C11.510.103.110	C11.510.103	Aphakias, Postcataract|Aphakic Eye, Postcataract|Postcataract Aphakia|Postcataract Aphakias|Postcataract Aphakic Eye|Postcataract Aphakic Eyes	Eye disease
Aphasia	MESH:D001037		A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.	MESH:D013064	C10.597.606.150.500.800.100|C23.888.592.604.150.500.800.100	C10.597.606.150.500.800|C23.888.592.604.150.500.800	Acquired Aphasia|Ageusic Aphasia|Ageusic Aphasias|Alogia|Alogias|Anepia|Anepias|Aphasia, Acquired|Aphasia, Ageusic|Aphasia, Auditory Discriminatory|Aphasia, Commisural|Aphasia, Functional|Aphasia, Global|Aphasia, Graphomotor|Aphasia, Intellectual|Aphasia, Mixed|Aphasia, Post Ictal|Aphasia, Post-Ictal|Aphasia, Post Traumatic|Aphasia, Post-Traumatic|Aphasia, Progressive|Aphasias, Commisural|Aphasia, Semantic|Aphasia, Syntactical|Auditory Discriminatory Aphasia|Auditory Discriminatory Aphasias|Commisural Aphasia|Commisural Aphasias|Deafness, Word|Dejerine Lichtheim Phenomenon|Dejerine-Lichtheim Phenomenon|Discriminatory Aphasia, Auditory|Discriminatory Aphasias, Auditory|Dysphasia|Dysphasia, Global|Functional Aphasia|Functional Aphasias|Global Aphasia|Global Aphasias|Global Dysphasia|Global Dysphasias|Graphomotor Aphasia|Graphomotor Aphasias|Intellectual Aphasia|Intellectual Aphasias|Lichtheim Sign|Lichtheim's Sign|Lichtheims Sign|Logagnosia|Logagnosias|Logamnesia|Logamnesias|Logasthenia|Logasthenias|Mixed Aphasia|Mixed Aphasias|Phenomenon, Dejerine-Lichtheim|Post-Ictal Aphasia|Post-Ictal Aphasias|Post-Traumatic Aphasia|Post-Traumatic Aphasias|Progressive Aphasia|Progressive Aphasias|Semantic Aphasia|Semantic Aphasias|Sign, Lichtheim's|Syntactical Aphasia|Syntactical Aphasias|Word Deafness	Nervous system disease|Signs and symptoms
Aphasia, Broca	MESH:D001039		An aphasia characterized by impairment of expressive LANGUAGE (speech, writing, signs) and relative preservation of receptive language abilities (i.e., comprehension). This condition is caused by lesions of the motor association cortex in the FRONTAL LOBE (BROCA AREA and adjacent cortical and white matter regions).	MESH:D001037	C10.597.606.150.500.800.100.100|C23.888.592.604.150.500.800.100.100	C10.597.606.150.500.800.100|C23.888.592.604.150.500.800.100	Agrammatic Broca Aphasia|Agrammatic Broca Aphasias|Agrammatic Broca's Aphasia|Agrammatic Brocas Aphasia|Agrammatic Broca's Aphasias|Agrammatism|Anterior Aphasia|Anterior Aphasias|Aphasia, Agrammatic Broca|Aphasia, Agrammatic Broca's|Aphasia, Anterior|Aphasia, Ataxic|Aphasia, Expressive|Aphasia, Frontocortical|Aphasia, Motor|Aphasia, Nonfluent|Aphasias, Agrammatic Broca|Aphasias, Agrammatic Broca's|Aphasias, Anterior|Aphasias, Ataxic|Aphasias, Broca|Aphasias, Frontocortical|Aphasia Syndromes, Verbal|Aphasia Syndrome, Verbal|Ataxic Aphasia|Ataxic Aphasias|Broca Aphasia|Broca Aphasia, Agrammatic|Broca Aphasias|Broca Aphasias, Agrammatic|Broca Dysphasia|Broca's Aphasia, Agrammatic|Broca's Aphasias, Agrammatic|Broca's Dysphasia|Dysphasia, Broca|Dysphasia, Brocas|Dysphasia, Broca's|Expressive Aphasia|Frontocortical Aphasia|Frontocortical Aphasias|Motor Aphasia|Nonfluent Aphasia|Syndromes, Verbal Aphasia|Syndrome, Verbal Aphasia|Verbal Aphasia Syndrome|Verbal Aphasia Syndromes	Nervous system disease|Signs and symptoms
Aphasia, Conduction	MESH:D018886		A type of fluent aphasia characterized by an impaired ability to repeat one and two word phrases, despite retained comprehension. This condition is associated with dominant hemisphere lesions involving the arcuate fasciculus (a white matter projection between Broca's and Wernicke's areas) and adjacent structures. Like patients with Wernicke aphasia (APHASIA, WERNICKE), patients with conduction aphasia are fluent but commit paraphasic errors during attempts at written and oral forms of communication. (From Adams et al., Principles of Neurology, 6th ed, p482; Brain & Bannister, Clinical Neurology, 7th ed, p142; Kandel et al., Principles of Neural Science, 3d ed, p848)	MESH:D001037	C10.597.606.150.500.800.100.111|C23.888.592.604.150.500.800.100.111	C10.597.606.150.500.800.100|C23.888.592.604.150.500.800.100	Aphasia, Associative|Aphasias, Associative|Aphasias, Conduction|Associative Aphasia|Associative Aphasias|Associative Dysphasia|Associative Dysphasias|Conduction Aphasia|Conduction Aphasias|Conduction Dysphasia|Conduction Dysphasias|Dysphasia, Associative|Dysphasia, Conduction|Dysphasias, Associative|Dysphasias, Conduction	Nervous system disease|Signs and symptoms
Aphasia, Wernicke	MESH:D001041		Impairment in the comprehension of speech and meaning of words, both spoken and written, and of the meanings conveyed by their grammatical relationships in sentences. It is caused by lesions that primarily affect Wernicke's area, which lies in the posterior perisylvian region of the temporal lobe of the dominant hemisphere. (From Brain & Bannister, Clinical Neurology, 7th ed, p141; Kandel et al., Principles of Neural Science, 3d ed, p846)	MESH:D001037	C10.597.606.150.500.800.100.166|C23.888.592.604.150.500.800.100.166	C10.597.606.150.500.800.100|C23.888.592.604.150.500.800.100	Aphasia, Fluent|Aphasia, Jargon|Aphasia, Posterior|Aphasia, Psychosensory|Aphasia, Receptive|Aphasia, Sensory|Aphasias, Jargon|Aphasias, Posterior|Aphasias, Psychosensory|Aphasias, Wernicke|Aphasia, Wernicke's Fluent|Dysphasia, Fluent|Dysphasia, Receptive|Dysphasia, Sensory|Dysphasias, Fluent|Dysphasias, Receptive|Dysphasias, Sensory|Dysphasia, Wernicke|Dysphasia, Wernickes|Dysphasia, Wernicke's|Fluent Aphasia|Fluent Aphasia, Wernicke|Fluent Aphasia, Wernickes|Fluent Aphasia, Wernicke's|Fluent Dysphasia|Fluent Dysphasias|Jargon Aphasia|Jargon Aphasias|Posterior Aphasia|Posterior Aphasias|Psychosensory Aphasia|Psychosensory Aphasias|Receptive Aphasia|Receptive Dysphasia|Receptive Dysphasias|Sensory Aphasia|Sensory Dysphasia|Sensory Dysphasias|Wernicke Aphasia|Wernicke Aphasias|Wernicke Dysphasia|Wernicke's Dysphasia|Wernicke's Fluent Aphasia	Nervous system disease|Signs and symptoms
Aphonia	MESH:D001044		Complete loss of phonation due to organic disease of the larynx or to nonorganic (i.e., psychogenic) causes.	MESH:D014832	C08.360.940.160|C09.400.940.160|C10.597.975.100|C23.888.592.979.100	C08.360.940|C09.400.940|C10.597.975|C23.888.592.979	Absence of Voice|Aphonia, Functional|Aphonia, Nonorganic|Aphonia Paralytica|Aphonias, Functional|Aphonias, Nonorganic|Aphonia, Spastic|Aphonias, Spastic|Functional Aphonia|Functional Aphonias|Nonorganic Aphonia|Nonorganic Aphonias|Paralytica, Aphonia|Spastic Aphonia|Spastic Aphonias|Voice Absence|Voice Absences	Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Aplasia of Lacrimal and Salivary Glands	MESH:C562407	DO:DOID:0111549|OMIM:180920		MESH:D007766|MESH:D012466	C07.465.815/C562407|C11.496/C562407	C07.465.815|C11.496	ALSG|PAROTID APLASIA OR HYPOPLASIA, INCLUDED|Salivary Glands, Absence of|SALIVARY GLANDS, ABSENCE OF, INCLUDED	Eye disease|Mouth disease
Aplastic anemia, idiopathic	MESH:C538494			MESH:D000741	C15.378.071.085/C538494|C15.378.190.223.250/C538494	C15.378.071.085|C15.378.190.223.250		Blood disease
Apnea	MESH:D001049		A transient absence of spontaneous respiration.	MESH:D012120|MESH:D012818	C08.618.085|C23.888.852.130	C08.618|C23.888.852	Apneas	Respiratory tract disease|Signs and symptoms
Apolipoprotein C-III Deficiency	MESH:C566270	OMIM:614028		MESH:D006951	C18.452.584.500.500.644/C566270	C18.452.584.500.500.644	HALP2|HYPERALPHALIPOPROTEINEMIA 2	Metabolic disease
Appendiceal Neoplasms	MESH:D001063	DO:DOID:11239|DO:DOID:11240	Tumors or cancer of the APPENDIX.	MESH:D002430	C04.588.274.476.411.184.290|C06.301.371.411.184.290|C06.405.249.411.184.290|C06.405.469.110.417.290|C06.405.469.491.184.290	C04.588.274.476.411.184|C06.301.371.411.184|C06.405.249.411.184|C06.405.469.110.417|C06.405.469.491.184	Appendiceal Cancer|Appendiceal Neoplasm|Appendix Cancer|Cancer, Appendiceal|Cancer, Appendix|Cancer of Appendix|Cancer of the Appendix|Neoplasm, Appendiceal|Neoplasms, Appendiceal	Cancer|Digestive system disease
Apraxia, Ideomotor	MESH:D020240	DO:DOID:4627	A form of apraxia characterized by an acquired inability to carry out a complex motor activity despite the ability to mentally formulate the action. This condition has been attributed to a disruption of connections between the dominant parietal cortex and supplementary and premotor cortical regions in both hemispheres. (From Adams et al., Principles of Neurology, 6th ed, p57)	MESH:D001072	C10.597.606.881.350.200|C23.888.592.604.882.350.200	C10.597.606.881.350|C23.888.592.604.882.350	Apraxia, Classic|Apraxia, Ideokinetic|Apraxia, Limb Kinetic|Apraxias, Classic|Apraxias, Ideokinetic|Apraxias, Ideomotor|Apraxias, Limb Kinetic|Apraxias, Transcortical|Apraxia, Transcortical|Classic Apraxia|Classic Apraxias|Dyspraxia, Ideomotor|Dyspraxias, Ideomotor|Ideokinetic Apraxia|Ideokinetic Apraxias|Ideomotor Apraxia|Ideomotor Apraxias|Ideomotor Dyspraxia|Ideomotor Dyspraxias|Kinetic Apraxia, Limb|Kinetic Apraxias, Limb|Limb Kinetic Apraxia|Limb Kinetic Apraxias|Transcortical Apraxia|Transcortical Apraxias	Nervous system disease|Signs and symptoms
Apraxia, oculomotor, Cogan type	MESH:C537423	OMIM:257550		MESH:D001072|MESH:D055952	C10.292.910.299/C537423|C10.597.606.881.350/C537423|C11.180/C537423|C14.907.940.320/C537423|C23.888.592.604.882.350/C537423	C10.292.910.299|C10.597.606.881.350|C11.180|C14.907.940.320|C23.888.592.604.882.350	Cogan's syndrome, type 2|COMA|Congenital Oculomotor Apraxia|Ocular Motor Apraxia|Oculomotor Apraxia, Cogan Type|Saccade initiation failure, congenital	Cardiovascular disease|Eye disease|Nervous system disease|Signs and symptoms
Apraxias	MESH:D001072	DO:DOID:0060135|OMIM:602081	A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor (see APRAXIA, IDEOMOTOR) and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. (From Adams et al., Principles of Neurology, 6th ed, pp56-7)	MESH:D011596	C10.597.606.881.350|C23.888.592.604.882.350	C10.597.606.881|C23.888.592.604.882	1s, Speech-Language Disorder|Apraxia|Apraxia, Articulatory|Apraxia, Developmental Verbal|Apraxia, Dressing|Apraxia, Facial Oral|Apraxia, Facial-Oral|Apraxia, Gestural|Apraxia, Ideational|Apraxia, Motor|Apraxia of Phonation|Apraxia, Oral|Apraxias, Articulatory|Apraxias, Developmental Verbal|Apraxias, Dressing|Apraxias, Facial-Oral|Apraxias, Gestural|Apraxias, Ideational|Apraxias, Motor|Apraxias, Oral|Apraxias, Verbal|Apraxia, Verbal|Articulatory Apraxia|Articulatory Apraxias|Articulatory Dyspraxia|Articulatory Dyspraxias|CAS|CHILDHOOD APRAXIA OF SPEECH|Developmental Verbal Apraxia|Developmental Verbal Apraxias|Developmental Verbal Dyspraxia|Developmental Verbal Dyspraxias|Disorder 1, Speech-Language|Disorder 1s, Speech-Language|Dressing Apraxia|Dressing Apraxias|DVD|Dyspraxia|Dyspraxia, Articulatory|Dyspraxia, Developmental Verbal|Dyspraxia, Oral|Dyspraxias|Dyspraxias, Articulatory|Dyspraxias, Developmental Verbal|Dyspraxias, Oral|Dyspraxias, Verbal|Dyspraxia, Verbal|Facial-Oral Apraxia|Facial-Oral Apraxias|Gestural Apraxia|Gestural Apraxias|Ideational Apraxia|Ideational Apraxias|Motor Apraxia|Motor Apraxias|Oral Apraxia|Oral Apraxias|Oral Dyspraxia|Oral Dyspraxias|Phonation Apraxia|Phonation Apraxias|SPCH1|Speech And Language Disorder With Orofacial Dyspraxia|Speech Language Disorder 1|Speech-Language Disorder 1|Speech-Language Disorder 1s|Verbal Apraxia|Verbal Apraxia, Developmental|Verbal Apraxias|Verbal Apraxias, Developmental|Verbal Dyspraxia|Verbal Dyspraxia, Developmental|Verbal Dyspraxias|Verbal Dyspraxias, Developmental	Nervous system disease|Signs and symptoms
Apudoma	MESH:D001079		A general term collectively applied to tumors associated with the APUD CELLS series, irrespective of their specific identification.	MESH:D000236|MESH:D018358	C04.557.465.625.650.135|C04.557.470.035.250|C04.557.580.625.650.135	C04.557.465.625.650|C04.557.470.035|C04.557.580.625.650	Apudomas	Cancer
Arachnoid Cysts	MESH:D016080		Intracranial or spinal cavities containing a cerebrospinal-like fluid, the wall of which is composed of arachnoidal cells. They are most often developmental or related to trauma. Intracranial arachnoid cysts usually occur adjacent to arachnoidal cistern and may present with HYDROCEPHALUS; HEADACHE; SEIZURES; and focal neurologic signs. (From Joynt, Clinical Neurology, 1994, Ch44, pp105-115)	MESH:D003560|MESH:D020863	C04.182.044|C04.588.614.250.387.100|C10.500.142.100|C10.551.240.375.100|C16.131.666.142.100	C04.182|C04.588.614.250.387|C10.500.142|C10.551.240.375|C16.131.666.142	Arachnoid Cyst, Intracranial|Arachnoid Cysts, Intracranial|Arachnoid Diverticula|Arachnoid Diverticulas|Cyst, Arachnoid|Cyst, Intracranial Arachnoid|Cyst, Leptomeningeal|Cysts, Arachnoid|Cysts, Intracranial Arachnoid|Cysts, Leptomeningeal|Diverticula, Arachnoid|Diverticulas, Arachnoid|Intracranial Arachnoid Cyst|Intracranial Arachnoid Cysts|Leptomeningeal Cyst|Leptomeningeal Cysts	Cancer|Congenital abnormality|Nervous system disease
Arachnoiditis	MESH:D001100	DO:DOID:12156	Acute or chronic inflammation of the arachnoid membrane of the meninges most often involving the spinal cord or base of the brain. This term generally refers to a persistent inflammatory process characterized by thickening of the ARACHNOID membrane and dural adhesions. Associated conditions include prior surgery, infections, trauma, SUBARACHNOID HEMORRHAGE, and chemical irritation. Clinical features vary with the site of inflammation, but include cranial neuropathies, radiculopathies, and myelopathies. (From Joynt, Clinical Neurology, 1997, Ch48, p25)	MESH:D008581	C10.586.625.097	C10.586.625	Arachnoiditides|Arachnoid Membrane Inflammation|Arachnoid Membrane Inflammations|Inflammation, Arachnoid Membrane|Inflammations, Arachnoid Membrane	Nervous system disease
ARBOLEDA-THAM SYNDROME	OMIM:616268	DO:DOID:0070062		MESH:D006330|MESH:D007805|MESH:D008607|MESH:D008831	C05.660.207.620/616268|C10.500.507.400.500/616268|C10.597.606.150.500.550/616268|C10.597.606.360/616268|C14.240.400/616268|C14.280.400/616268|C16.131.240.400/616268|C16.131.621.207.620/616268|C16.131.666.507.400.500/616268|C23.888.592.604.150.500.550/616268|C23.888.592.604.646/616268|F03.625.539/616268	C05.660.207.620|C10.500.507.400.500|C10.597.606.150.500.550|C10.597.606.360|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.620|C16.131.666.507.400.500|C23.888.592.604.150.500.550|C23.888.592.604.646|F03.625.539	ARTHS|KAT6A SYNDROME|MENTAL RETARDATION, AUTOSOMAL DOMINANT 32, FORMERLY|MRD32, FORMERLY	Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Arbovirus Infections	MESH:D001102	DO:DOID:934	Infections caused by arthropod-borne viruses, general or unspecified.	MESH:D000079426|MESH:D014777	C01.920.500|C01.925.081	C01.920|C01.925	Arbovirus Infection|Infection, Arbovirus|Infections, Arbovirus	Viral disease
Arcus Senilis	MESH:D001112	DO:DOID:11342	A corneal disease in which there is a deposition of phospholipid and cholesterol in the corneal stroma and anterior sclera.	MESH:D003318	C11.204.299.070	C11.204.299	Arcus Corneae|Arcus, Corneal|Corneal Arcus	Eye disease
Arenaviridae Infections	MESH:D001117		Virus diseases caused by the ARENAVIRIDAE.	MESH:D012327	C01.925.782.082	C01.925.782	Arenaviridae Infection|Arenavirus Infection|Arenavirus Infections|Infection, Arenaviridae|Infection, Arenavirus|Infections, Arenaviridae|Infections, Arenavirus	Viral disease
Argyria	MESH:D001129		A permanent ashen-gray discoloration of the skin, conjunctiva, and internal organs resulting from long-continued use of silver salts. (Dorland, 27th ed)	MESH:D000075322|MESH:D010859	C17.800.621.166|C25.723.522.313	C17.800.621|C25.723.522	Argyrias	Skin disease
Arnold Stickler Bourne syndrome	MESH:C537431			MESH:D003316|MESH:D007674|MESH:D009133	C10.597.613.612/C537431|C11.204/C537431|C12.050.351.968.419/C537431|C12.200.777.419/C537431|C12.950.419/C537431|C23.300.070.500/C537431|C23.888.592.608.612/C537431	C10.597.613.612|C11.204|C12.050.351.968.419|C12.200.777.419|C12.950.419|C23.300.070.500|C23.888.592.608.612	Corneal crystals myopathy and nephropathy	Eye disease|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Arrhenoblastoma--Thyroid Adenoma	MESH:C566256			MESH:D006044|MESH:D018310	C04.557.475.750.847/C566256|C04.588.322.455.648/C566256|C04.588.322.762.500/C566256|C04.588.945.440.915.500/C566256|C12.050.351.500.056.630.705.648/C566256|C12.050.351.937.418.685.648/C566256|C12.100.250.056.630.705.648/C566256|C12.100.500.260.937.500/C566256|C12.200.294.260.937.500/C566256|C12.200.758.409.937.500/C566256|C12.900.418.685.648/C566256|C12.900.619.937.500/C566256|C19.344.410.648/C566256|C19.344.762.500/C566256|C19.391.630.705.648/C566256|C19.391.829.782.500/C566256|C19.874.283.501/C566256	C04.557.475.750.847|C04.588.322.455.648|C04.588.322.762.500|C04.588.945.440.915.500|C12.050.351.500.056.630.705.648|C12.050.351.937.418.685.648|C12.100.250.056.630.705.648|C12.100.500.260.937.500|C12.200.294.260.937.500|C12.200.758.409.937.500|C12.900.418.685.648|C12.900.619.937.500|C19.344.410.648|C19.344.762.500|C19.391.630.705.648|C19.391.829.782.500|C19.874.283.501		Cancer|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Arrhythmias, Cardiac	MESH:D001145	OMIM:115000	Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.	MESH:D006331|MESH:D010335	C14.280.067|C23.550.073	C14.280|C23.550	Arrhythmia|Arrhythmia, Cardiac|Arrythmia|Cardiac Arrhythmia|Cardiac Arrhythmias|Cardiac Dysrhythmia|Dysrhythmia, Cardiac|RYR2 CALCIUM RELEASE DEFICIENCY SYNDROME|VACRDS|VENTRICULAR ARRYTHMIAS DUE TO CARDIAC RYANODINE RECEPTOR CALCIUM RELEASE DEFICIENCY SYNDROME	Cardiovascular disease|Pathology (process)
Arrhythmia, Sinus	MESH:D001146		Irregular HEART RATE caused by abnormal function of the SINOATRIAL NODE. It is characterized by a greater than 10% change between the maximum and the minimum sinus cycle length or 120 milliseconds.	MESH:D001145	C14.280.067.093|C23.550.073.093	C14.280.067|C23.550.073	Arrhythmia, Sinoatrial|Arrhythmias, Sinoatrial|Arrhythmias, Sinus|Sinoatrial Arrhythmia|Sinoatrial Arrhythmias|Sinus Arrhythmia|Sinus Arrhythmias	Cardiovascular disease|Pathology (process)
Arrhythmogenic Right Ventricular Dysplasia	MESH:D019571	DO:DOID:0050431	A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.	MESH:D006330|MESH:D009202	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	C14.240.400|C14.280.238|C14.280.400|C16.131.240.400	Arrhythmogenic Right Ventricular Cardiomyopathy|Arrhythmogenic Right Ventricular Cardiomyopathy Dysplasia|Arrhythmogenic Right Ventricular Cardiomyopathy-Dysplasia|Arrhythmogenic Right Ventricular Dysplasia-Cardiomyopathy|ARVD-C|Right Ventricular Dysplasia, Arrhythmogenic|Ventricular Dysplasia, Right, Arrhythmogenic	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 1	MESH:C566254	OMIM:107970		MESH:D019571	C14.240.400.145/C566254|C14.280.238.028/C566254|C14.280.400.145/C566254|C16.131.240.400.145/C566254	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 1|ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 1;ARVC1 UHL ANOMALY, INCLUDED|ARVD1|CARDIOMYOPATHY, RIGHT VENTRICULAR DILATED, INCLUDED	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 10	MESH:C565707	OMIM:610193		MESH:D019571	C14.240.400.145/C565707|C14.280.238.028/C565707|C14.280.400.145/C565707|C16.131.240.400.145/C565707	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 10|ARVC10|ARVD10	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 11	MESH:C566471	OMIM:610476		MESH:D019571	C14.240.400.145/C566471|C14.280.238.028/C566471|C14.280.400.145/C566471|C16.131.240.400.145/C566471	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 11|ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 11;ARVC11  ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11, AND MILD PALMOPLANTAR KERATODERMA WITH OR WITHOUT WOOLLY HAIR, INCLUDED|ARVD11	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 12	MESH:C566925	OMIM:611528		MESH:D019571	C14.240.400.145/C566925|C14.280.238.028/C566925|C14.280.400.145/C566925|C16.131.240.400.145/C566925	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 12|ARVC12|ARVD12	Cardiovascular disease|Congenital abnormality
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13	OMIM:615616	DO:DOID:0110084		MESH:D019571	C14.240.400.145/615616|C14.280.238.028/615616|C14.280.400.145/615616|C16.131.240.400.145/615616	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 13|ARVC13|ARVD13	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 2	MESH:C563409	OMIM:600996		MESH:D019571	C14.240.400.145/C563409|C14.280.238.028/C563409|C14.280.400.145/C563409|C16.131.240.400.145/C563409	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 2|ARVC2|ARVD2	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 3	MESH:C566584	OMIM:602086		MESH:D019571	C14.240.400.145/C566584|C14.280.238.028/C566584|C14.280.400.145/C566584|C16.131.240.400.145/C566584	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 3|ARVC3|ARVD3	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 4	MESH:C566583	OMIM:602087		MESH:D019571	C14.240.400.145/C566583|C14.280.238.028/C566583|C14.280.400.145/C566583|C16.131.240.400.145/C566583	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 4|ARVC4|ARVD4	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 5	MESH:C565776	OMIM:604400		MESH:D019571	C14.240.400.145/C565776|C14.280.238.028/C565776|C14.280.400.145/C565776|C16.131.240.400.145/C565776	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 5|ARVC5|ARVD5	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 6	MESH:C565775	OMIM:604401		MESH:D019571	C14.240.400.145/C565775|C14.280.238.028/C565775|C14.280.400.145/C565775|C16.131.240.400.145/C565775	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 6|ARVC6|ARVD6	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 7	MESH:C563784			MESH:D019571	C14.240.400.145/C563784|C14.280.238.028/C563784|C14.280.400.145/C563784|C16.131.240.400.145/C563784	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 7|Desmin-Related Myopathy with Arrhythmogenic Right Ventricular Cardiomyopathy|Myofibrillar Myopathy with Arrhythmogenic Right Ventricular Cardiomyopathy|Myopathy, Desmin-Related, with Arrhythmogenic Right Ventricular Cardiomyopathy	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 8	MESH:C564400	OMIM:607450		MESH:D019571	C14.240.400.145/C564400|C14.280.238.028/C564400|C14.280.400.145/C564400|C16.131.240.400.145/C564400	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 8|ARVC8|ARVD8	Cardiovascular disease|Congenital abnormality
Arrhythmogenic Right Ventricular Dysplasia, Familial, 9	MESH:C563808	OMIM:609040		MESH:D019571	C14.240.400.145/C563808|C14.280.238.028/C563808|C14.280.400.145/C563808|C16.131.240.400.145/C563808	C14.240.400.145|C14.280.238.028|C14.280.400.145|C16.131.240.400.145	Arrhythmogenic Right Ventricular Cardiomyopathy 9|ARVC9|ARVD9	Cardiovascular disease|Congenital abnormality
Arsenic Poisoning	MESH:D020261		Disorders associated with acute or chronic exposure to compounds containing ARSENIC (ARSENICALS) which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse (Mees) lines in the fingernails. (Adams et al., Principles of Neurology, 6th ed, p1212)	MESH:D011041|MESH:D020260	C10.720.475.150|C25.723.098	C10.720.475|C25.723	Arsenical Neurotoxicity Syndrome|Arsenical Neurotoxicity Syndromes|Arsenic Encephalopathies|Arsenic Encephalopathy|Arsenic-Induced Polyneuropathies|Arsenic Induced Polyneuropathy|Arsenic-Induced Polyneuropathy|Arsenic Poisoning, Inorganic|Arsenic Poisoning, Nervous System|Arsenic Poisoning, Organic|Arsenic Poisonings|Arsenic Poisonings, Inorganic|Arsenic Poisonings, Organic|Encephalopathies, Arsenic|Encephalopathy, Arsenic|Inorganic Arsenic Poisoning|Inorganic Arsenic Poisonings|Nervous System, Organic Arsenic Poisoning|Nervous System Poisoning, Arsenic|Neurotoxicity Syndrome, Arsenical|Neurotoxicity Syndromes, Arsenical|Organic Arsenic Poisoning|Organic Arsenic Poisoning, Nervous System|Organic Arsenic Poisonings|Poisoning, Arsenic|Poisoning, Arsenic, Nervous System|Poisoning, Inorganic Arsenic|Poisoning, Organic Arsenic|Poisonings, Arsenic|Poisonings, Inorganic Arsenic|Poisonings, Organic Arsenic|Polyneuropathy, Arsenic Induced|Polyneuropathy, Arsenic-Induced|Syndrome, Arsenical Neurotoxicity|Syndromes, Arsenical Neurotoxicity	Nervous system disease
Arterial calcification of infancy	MESH:C537440	DO:DOID:0050644|OMIM:208000|OMIM:614473		MESH:D061205	C18.452.174.130.780/C537440	C18.452.174.130.780	Arterial Calcification, Generalized, Of Infancy|ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1|ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2|Arterial Calcification, Idiopathic Infantile|Arteriopathy, Occlusive Infantile|ARTERIOPATHY, OCCLUSIVE INFANTILE CORONARY SCLEROSIS, MEDIAL, OF INFANCY, INCLUDED|GACI|GACI1|GACI2|Generalized arterial calcification in infancy|Idiopathic infantile arterial calcification|IIAC|Occlusive infantile arteriopathy	Metabolic disease
Arterial Dissection with Lentiginosis	MESH:C563937			MESH:D007911|MESH:D014652	C14.907/C563937|C17.800.621.430.530.550/C563937	C14.907|C17.800.621.430.530.550		Cardiovascular disease|Skin disease
Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly	MESH:C566529	OMIM:602531		MESH:D001157|MESH:D006330|MESH:D006973|MESH:D013576|MESH:D059327	C05.116.099.370.894.819/C566529|C05.660.585.262/C566529|C05.660.585.800/C566529|C05.660.906.819/C566529|C14.240.400/C566529|C14.280.400/C566529|C14.907.137/C566529|C14.907.489/C566529|C16.131.240.400/C566529|C16.131.621.585.262/C566529|C16.131.621.585.800/C566529|C16.131.621.906.819/C566529	C05.116.099.370.894.819|C05.660.585.262|C05.660.585.800|C05.660.906.819|C14.240.400|C14.280.400|C14.907.137|C14.907.489|C16.131.240.400|C16.131.621.585.262|C16.131.621.585.800|C16.131.621.906.819	ARTERIAL OCCLUSIVE DISEASE, PROGRESSIVE, WITH HYPERTENSION, HEART DEFECTS, BONE FRAGILITY, AND BRACHYSYNDACTYLY|Grange Occlusive Arterial Syndrome|GRANGE SYNDROME|GRNG	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Arterial Occlusive Diseases	MESH:D001157	DO:DOID:341	Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.	MESH:D014652	C14.907.137	C14.907	Arterial Obstructive Disease|Arterial Obstructive Diseases|Arterial Occlusive Disease|Disease, Arterial Obstructive|Disease, Arterial Occlusive|Diseases, Arterial Obstructive|Diseases, Arterial Occlusive|Obstructive Disease, Arterial|Obstructive Diseases, Arterial|Occlusive Disease, Arterial|Occlusive Diseases, Arterial	Cardiovascular disease
Arteriolosclerosis	MESH:D050379	DO:DOID:5162	Thickening of the walls of small ARTERIES or ARTERIOLES due to cell proliferation or HYALINE deposition.	MESH:D001161	C14.907.137.126.056	C14.907.137.126	Arterioloscleroses	Cardiovascular disease
Arteriosclerosis	MESH:D001161	DO:DOID:2349	Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.	MESH:D001157	C14.907.137.126	C14.907.137	Arterioscleroses	Cardiovascular disease
Arteriosclerosis Obliterans	MESH:D001162	DO:DOID:5160	Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.	MESH:D001161	C14.907.137.126.114	C14.907.137.126	Obliterans, Arteriosclerosis	Cardiovascular disease
Arteriosclerosis, Severe Juvenile	MESH:C565941			MESH:D001161	C14.907.137.126/C565941	C14.907.137.126		Cardiovascular disease
Arteriovenous Malformations	MESH:D001165		Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.	MESH:D014652|MESH:D054079	C14.240.850.750|C14.907.150|C16.131.240.850.750	C14.240.850|C14.907|C16.131.240.850	Arteriovenous Malformation|Malformation, Arteriovenous|Malformations, Arteriovenous	Cardiovascular disease|Congenital abnormality
Arteritis	MESH:D001167		INFLAMMATION of any ARTERIES.	MESH:D014657	C14.907.940.090	C14.907.940	Arterial Inflammation|Arteritides|Inflammation, Arterial	Cardiovascular disease
Arteritis, Familial Granulomatous, with Juvenile Polyarthritis	MESH:C566253			MESH:D001171|MESH:D020293	C05.550.114.122/C566253|C05.799.056/C566253|C10.114.875/C566253|C10.228.140.300.850/C566253|C14.907.253.946/C566253|C14.907.940.907/C566253|C17.300.775.049/C566253|C20.111.198/C566253|C20.111.258.962/C566253	C05.550.114.122|C05.799.056|C10.114.875|C10.228.140.300.850|C14.907.253.946|C14.907.940.907|C17.300.775.049|C20.111.198|C20.111.258.962		Cardiovascular disease|Connective tissue disease|Immune system disease|Musculoskeletal disease|Nervous system disease
Arterivirus Infections	MESH:D018174		Infections caused by viruses of the genus ARTERIVIRUS.	MESH:D030341	C01.925.782.600.100	C01.925.782.600	Arterivirus Infection|Infection, Arterivirus|Infections, Arterivirus	Viral disease
Arthralgia	MESH:D018771		Pain in the joint.	MESH:D007592|MESH:D010146	C05.550.091|C23.888.592.612.094	C05.550|C23.888.592.612	Arthralgias|Joint Pain|Joint Pains|Pain, Joint|Pains, Joint|Polyarthralgia|Polyarthralgias	Musculoskeletal disease|Signs and symptoms
Arthritis	MESH:D001168	DO:DOID:848	Acute or chronic inflammation of JOINTS.	MESH:D007592	C05.550.114	C05.550	Arthritides|Polyarthritides|Polyarthritis	Musculoskeletal disease
Arthritis, Experimental	MESH:D001169		ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN.	MESH:D001168	C05.550.114.015	C05.550.114	Adjuvant Arthritis|Arthritides, Collagen|Arthritis, Adjuvant|Arthritis, Adjuvant-Induced|Arthritis, Collagen|Arthritis, Collagen-Induced|Collagen Arthritides|Collagen Arthritis|Collagen-Induced Arthritides|Collagen-Induced Arthritis	Musculoskeletal disease
Arthritis, Infectious	MESH:D001170	DO:DOID:813	Arthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES.	MESH:D001168|MESH:D007239	C01.100|C05.550.114.099	C01|C05.550.114	Arthritides, Bacterial|Arthritis, Bacterial|Arthritis, Septic|Arthritis, Suppurative|Arthritis, Viral|Bacterial Arthritides|Bacterial Arthritis|Infectious Arthritis|Septic Arthritis|Suppurative Arthritis|Viral Arthritis	Musculoskeletal disease
Arthritis, Juvenile	MESH:D001171		Arthritis in children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.	MESH:D001168|MESH:D001327|MESH:D012216	C05.550.114.122|C05.799.056|C17.300.775.049|C20.111.198	C05.550.114|C05.799|C17.300.775|C20.111	Arthritis, Juvenile Chronic|Arthritis, Juvenile Enthesitis-Related|Arthritis, Juvenile Idiopathic|Arthritis, Juvenile Psoriatic|Arthritis, Juvenile Rheumatoid|Arthritis, Juvenile Systemic|Chronic Arthritis, Juvenile|Enthesitis Related Arthritis, Juvenile|Enthesitis-Related Arthritis, Juvenile|Idiopathic Arthritis, Juvenile|Juvenile Arthritis|Juvenile Chronic Arthritis|Juvenile Enthesitis-Related Arthritis|Juvenile Idiopathic Arthritis|Juvenile Oligoarthritis|Juvenile Onset Still Disease|Juvenile-Onset Still Disease|Juvenile Onset Stills Disease|Juvenile-Onset Still's Disease|Juvenile-Onset Stills Disease|Juvenile Psoriatic Arthritis|Juvenile Rheumatoid Arthritis|Juvenile Systemic Arthritis|Oligoarthritis, Juvenile|Polyarthritis, Juvenile, Rheumatoid Factor Negative|Polyarthritis, Juvenile, Rheumatoid Factor Positive|Psoriatic Arthritis, Juvenile|Rheumatoid Arthritis, Juvenile|Still Disease, Juvenile Onset|Still Disease, Juvenile-Onset|Still's Disease, Juvenile Onset|Still's Disease, Juvenile-Onset|Stills Disease, Juvenile-Onset|Systemic Arthritis, Juvenile	Connective tissue disease|Immune system disease|Musculoskeletal disease
Arthritis, Psoriatic	MESH:D015535	DO:DOID:9008|OMIM:607507	A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.	MESH:D001168|MESH:D011565|MESH:D025242	C05.116.900.853.625.800.424|C05.550.114.145|C05.550.114.865.800.424|C17.800.859.675.175	C05.116.900.853.625.800|C05.550.114|C05.550.114.865.800|C17.800.859.675	Arthritic Psoriasis|Arthropathies, Psoriatic|Arthropathy, Psoriatic|PSORAS1,|PSORAS1, INCLUDED|Psoriasis, Arthritic|Psoriasis Arthropathica|Psoriatic Arthritis|PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, 1, INCLUDED|Psoriatic Arthropathies|Psoriatic Arthropathy	Musculoskeletal disease|Skin disease
Arthritis, Reactive	MESH:D016918	DO:DOID:6196	An aseptic, inflammatory arthritis developing secondary to a primary extra-articular infection, most typically of the GASTROINTESTINAL TRACT or UROGENITAL SYSTEM. The initiating trigger pathogens are usually SHIGELLA; SALMONELLA; YERSINIA; CAMPYLOBACTER; or CHLAMYDIA TRACHOMATIS. Reactive arthritis is strongly associated with HLA-B27 ANTIGEN.	MESH:D001170|MESH:D025242	C01.100.500|C05.116.900.853.625.800.637|C05.550.114.099.500|C05.550.114.865.800.637	C01.100|C05.116.900.853.625.800|C05.550.114.099|C05.550.114.865.800	Arthritides, Postinfectious|Arthritides, Post-Infectious|Arthritides, Reactive|Arthritis, Postinfectious|Arthritis, Post Infectious|Arthritis, Post-Infectious|Postinfectious Arthritides|Post-Infectious Arthritides|Postinfectious Arthritis|Post Infectious Arthritis|Post-Infectious Arthritis|Reactive Arthritides|Reactive Arthritis|Reiter Disease|Reiter's Disease|Reiters Disease|Reiter's Syndrome|Reiters Syndrome|Reiter Syndrome	Musculoskeletal disease
Arthritis, Rheumatoid	MESH:D001172	DO:DOID:7148|OMIM:180300	A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.	MESH:D001168|MESH:D001327|MESH:D012216	C05.550.114.154|C05.799.114|C17.300.775.099|C20.111.199	C05.550.114|C05.799|C17.300.775|C20.111	RA|Rheumatoid Arthritis|RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO	Connective tissue disease|Immune system disease|Musculoskeletal disease
Arthritis, Sacroiliac	MESH:C563037			MESH:D001168	C05.550.114/C563037	C05.550.114	Sacroiliac arthritis	Musculoskeletal disease
Arthropathy, Neurogenic	MESH:D001177	DO:DOID:14286	Chronic progressive degeneration of the stress-bearing portion of a joint, with bizarre hypertrophic changes at the periphery. It is probably a complication of a variety of neurologic disorders, particularly TABES DORSALIS, involving loss of sensation, which leads to relaxation of supporting structures and chronic instability of the joint. (Dorland, 27th ed)	MESH:D007592	C05.550.186	C05.550	Arthropathies, Neurogenic|Charcot Joint|Charcot's Joint|Charcots Joint|Joint, Charcot's|Neurogenic Arthropathies|Neurogenic Arthropathy	Musculoskeletal disease
Arthropathy, progressive pseudorheumatoid, of childhood	MESH:C535387	OMIM:208230		MESH:D007592	C05.550/C535387	C05.550	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD|PPAC|PPD|PPRD|Progressive pseudorheumatoid arthropathy of childhood|Progressive pseudorheumatoid dysplasia|SEDT-PA|Spondyloepiphyseal dysplasia tarda with progressive arthropathy	Musculoskeletal disease
Arthus Reaction	MESH:D001183	DO:DOID:1556	A dermal inflammatory reaction produced under conditions of antibody excess, when a second injection of antigen produces intravascular antigen-antibody complexes which bind complement, causing cell clumping, endothelial damage, and vascular necrosis.	MESH:D007105	C20.543.520.100	C20.543.520	Arthus Phenomenon|Phenomenon, Arthus|Reaction, Arthus	Immune system disease
Articulation Disorders	MESH:D001184	DO:DOID:4186	Disorders of the quality of speech characterized by the substitution, omission, distortion, and addition of phonemes.	MESH:D013064	C10.597.606.150.500.800.150|C23.888.592.604.150.500.800.150	C10.597.606.150.500.800|C23.888.592.604.150.500.800	Articulation Disorder|Articulation Disorder, Developmental|Articulation Disorders, Developmental|Articulation Disorder, Speech|Articulation Disorders, Speech|Articulations, Unintelligible|Articulation, Unintelligible|Developmental Articulation Disorder|Developmental Articulation Disorders|Disarticulation Disorder|Disarticulation Disorders|Disorder, Disarticulation|Disorders, Disarticulation|Impairment, Phonological|Impairment, Phonology|Impairments, Phonological|Impairments, Phonology|Misarticulation|Phonological Impairment|Phonological Impairments|Phonology Impairment|Phonology Impairments|Speech Articulation Disorder|Speech Articulation Disorders|Unintelligible Articulation|Unintelligible Articulations	Nervous system disease|Signs and symptoms
Artificial Lens Implant Migration	MESH:D060437		The shifting and or tilting of implanted artificial lens resulting in impaired vision.	MESH:D005548|MESH:D007905	C11.510.174|C26.392.500.249	C11.510|C26.392.500	Artificial Intra ocular Implant Dislocation|Artificial Intra-ocular Implant Dislocation|Artificial Lens Implant Dislocation	Eye disease|Wounds and injuries
Asbestosis	MESH:D001195	DO:DOID:10320	A form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. The disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium.	MESH:D011009	C08.381.483.581.125|C08.381.520.702.125|C24.800.127	C08.381.483.581|C08.381.520.702|C24.800	Asbestoses|Idiopathic Interstitial Pneumonitis - from Asbestos Exposure|Pulmonary Fibrosis - from Asbestos Exposure	Occupational disease|Respiratory tract disease
Askin Tumor	MESH:C563168	DO:DOID:3369		MESH:D001859|MESH:D012512	C04.557.450.565.575.650.800/C563168|C04.557.450.795.620.800/C563168|C04.588.149/C563168|C05.116.231/C563168	C04.557.450.565.575.650.800|C04.557.450.795.620.800|C04.588.149|C05.116.231		Cancer|Musculoskeletal disease
Asrar Facharzt Haque syndrome	MESH:C535391			MESH:D006685|MESH:D007818|MESH:D015618	C08.360.940.490/C535391|C08.360/C535391|C08.618.490/C535391|C09.400.940.490/C535391|C09.400/C535391|C10.597.975.550/C535391|C15.604.250.410.450/C535391|C23.888.592.979.550/C535391|C23.888.852.490/C535391	C08.360|C08.360.940.490|C08.618.490|C09.400|C09.400.940.490|C10.597.975.550|C15.604.250.410.450|C23.888.592.979.550|C23.888.852.490		Ear-nose-throat disease|Lymphatic disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Asthenopia	MESH:D001248		Term generally used to describe complaints related to refractive error, ocular muscle imbalance, including pain or aching around the eyes, burning and itchiness of the eyelids, ocular fatigue, and headaches.	MESH:D005128	C11.093	C11	Eye Fatigue|Eyestrain|Fatigue, Eye|Fatigue, Visual|Visual Fatigue	Eye disease
Asthma	MESH:D001249	DO:DOID:2841|OMIM:600807	A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).	MESH:D001982|MESH:D008173|MESH:D012130	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	C08.127|C08.381.495|C08.674|C20.543.480.680	Asthma, Bronchial|ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED|ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED|Asthmas|ASTHMA, SUSCEPTIBILITY TO|Bronchial Asthma	Immune system disease|Respiratory tract disease
Asthma and Nasal Polyps	MESH:C565739			MESH:D001249|MESH:D009298	C08.127.108/C565739|C08.381.495.108/C565739|C08.460.572/C565739|C08.674.095/C565739|C09.603.557/C565739|C20.543.480.680.095/C565739|C23.300.825.557/C565739	C08.127.108|C08.381.495.108|C08.460.572|C08.674.095|C09.603.557|C20.543.480.680.095|C23.300.825.557		Ear-nose-throat disease|Immune system disease|Pathology (anatomical condition)|Respiratory tract disease
Asthma, Aspirin-Induced	MESH:D055963		Asthmatic adverse reaction (e.g., BRONCHOCONSTRICTION) to conventional NSAIDS including aspirin use.	MESH:D001249|MESH:D004342|MESH:D006969	C08.127.108.054|C08.674.095.054|C20.543.206.189|C20.543.480.149|C25.100.468.189	C08.127.108|C08.674.095|C20.543.206|C20.543.480|C25.100.468	Aspirin Induced Asthma|Aspirin-Induced Asthma|Aspirin Induced Asthmas|Aspirin-Induced Asthmas|Aspirin Induced Asthma Syndrome|Aspirin-Induced Asthma Syndrome|Aspirin-Induced Asthma Syndromes|Asthma, Aspirin Induced|Asthma, NSAID induced|Asthma, NSAID-induced|Asthmas, Aspirin Induced|Asthmas, Aspirin-Induced|Asthmas, NSAID-induced|Asthma Syndrome, Aspirin-Induced|Asthma Syndromes, Aspirin-Induced|Induced Asthma, Aspirin|Induced Asthmas, Aspirin|NSAID-induced Asthma|NSAID-induced Asthmas|Syndrome, Aspirin-Induced Asthma|Syndromes, Aspirin-Induced Asthma	Immune system disease|Respiratory tract disease
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome	MESH:D000080445		Syndrome with clinical features of both ASTHMA and COPD.	MESH:D001249|MESH:D006967|MESH:D029424	C08.127.108.688|C08.381.495.108.500|C08.381.495.389.250|C08.674.095.688|C20.543.103|C23.550.291.500.875.500	C08.127.108|C08.381.495.108|C08.381.495.389|C08.674.095|C20.543|C23.550.291.500.875	Asthma Chronic Obstructive Pulmonary Disease Overlap Syndrome|Asthma COPD Overlap Syndrome|Asthma-COPD Overlap Syndrome|Asthma-COPD Overlap Syndromes|Overlap Syndrome, Asthma-COPD	Immune system disease|Pathology (process)|Respiratory tract disease
Asthma, Exercise-Induced	MESH:D001250		Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it).	MESH:D001249	C08.127.108.110|C08.674.095.110|C20.543.480.680.095.110	C08.127.108|C08.674.095|C20.543.480.680.095	Asthma, Exercise Induced|Asthmas, Exercise-Induced|Bronchospasm, Exercise Induced|Bronchospasm, Exercise-Induced|Bronchospasms, Exercise-Induced|Exercise Induced Asthma|Exercise-Induced Asthma|Exercise-Induced Asthmas|Exercise Induced Bronchospasm|Exercise-Induced Bronchospasm|Exercise-Induced Bronchospasms	Immune system disease|Respiratory tract disease
Asthma, Nasal Polyps, And Aspirin Intolerance	MESH:C565935	OMIM:208550		MESH:D009298|MESH:D055963	C08.127.108.054/C565935|C08.460.572/C565935|C08.674.095.054/C565935|C09.603.557/C565935|C20.543.206.189/C565935|C20.543.480.149/C565935|C23.300.825.557/C565935|C25.100.468.189/C565935	C08.127.108.054|C08.460.572|C08.674.095.054|C09.603.557|C20.543.206.189|C20.543.480.149|C23.300.825.557|C25.100.468.189	ASA Triad|ASA TRIAD ASTHMA, ASPIRIN-INDUCED, SUSCEPTIBILITY TO, INCLUDED|ASTHMA AND NASAL POLYPS, INCLUDED	Ear-nose-throat disease|Immune system disease|Pathology (anatomical condition)|Respiratory tract disease
Asthma, Occupational	MESH:D059366		Asthma attacks caused, triggered, or exacerbated by OCCUPATIONAL EXPOSURE.	MESH:D001249|MESH:D009784	C08.127.108.495|C08.674.095.495|C20.543.480.680.095.495|C24.102	C08.127.108|C08.674.095|C20.543.480.680.095|C24	Asthmas, Occupational|Occupational Asthma|Occupational Asthmas	Immune system disease|Occupational disease|Respiratory tract disease
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1	OMIM:607277			MESH:D001249	C08.127.108/607277|C08.381.495.108/607277|C08.674.095/607277|C20.543.480.680.095/607277	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	AS1|ASRT1	Immune system disease|Respiratory tract disease
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2	OMIM:608584			MESH:D001249	C08.127.108/608584|C08.381.495.108/608584|C08.674.095/608584|C20.543.480.680.095/608584	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	ASRT2	Immune system disease|Respiratory tract disease
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3	OMIM:609958			MESH:D001249	C08.127.108/609958|C08.381.495.108/609958|C08.674.095/609958|C20.543.480.680.095/609958	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	ASRT3	Immune system disease|Respiratory tract disease
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4	OMIM:610906			MESH:D001249	C08.127.108/610906|C08.381.495.108/610906|C08.674.095/610906|C20.543.480.680.095/610906	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	ASRT4|ASTHMA AND ALLERGIC RHINITIS, SUSCEPTIBILITY TO	Immune system disease|Respiratory tract disease
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5	OMIM:611064			MESH:D001249	C08.127.108/611064|C08.381.495.108/611064|C08.674.095/611064|C20.543.480.680.095/611064	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	ASRT5	Immune system disease|Respiratory tract disease
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6	OMIM:611403			MESH:D001249	C08.127.108/611403|C08.381.495.108/611403|C08.674.095/611403|C20.543.480.680.095/611403	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	ASRT6	Immune system disease|Respiratory tract disease
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7	OMIM:611960			MESH:D001249	C08.127.108/611960|C08.381.495.108/611960|C08.674.095/611960|C20.543.480.680.095/611960	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	ASRT7	Immune system disease|Respiratory tract disease
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8	OMIM:613207			MESH:D001249	C08.127.108/613207|C08.381.495.108/613207|C08.674.095/613207|C20.543.480.680.095/613207	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	ASRT8|RHINOCONJUNCTIVITIS, SUSCEPTIBILITY TO, INCLUDED	Immune system disease|Respiratory tract disease
Asthma, Short Stature, and Elevated IgA	MESH:C565934			MESH:D001249	C08.127.108/C565934|C08.381.495.108/C565934|C08.674.095/C565934|C20.543.480.680.095/C565934	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095		Immune system disease|Respiratory tract disease
Astigmatism	MESH:D001251	DO:DOID:11782	Unequal curvature of the refractive surfaces of the eye. Thus a point source of light cannot be brought to a point focus on the retina but is spread over a more or less diffuse area. This results from the radius of curvature in one plane being longer or shorter than the radius at right angles to it. (Dorland, 27th ed)	MESH:D012030	C11.744.212	C11.744		Eye disease
Astrocytoma	MESH:D001254	DO:DOID:3069|DO:DOID:3078|DO:DOID:4851|DO:DOID:5077|DO:DOID:6726|DO:DOID:6811|DO:DOID:7005|DO:DOID:7007|DO:DOID:7008	Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)	MESH:D005910	C04.557.465.625.600.380.080|C04.557.470.670.380.080|C04.557.580.625.600.380.080	C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380	Anaplastic Astrocytoma|Anaplastic Astrocytomas|Astrocytic Glioma|Astrocytic Gliomas|Astrocytoma, Anaplastic|Astrocytoma, Cerebral|Astrocytoma, Childhood Cerebral|Astrocytoma, Fibrillary|Astrocytoma, Gemistocytic|Astrocytoma, Grade I|Astrocytoma, Grade II|Astrocytoma, Grade III|Astrocytoma, Intracranial|Astrocytoma, Juvenile Pilocytic|Astrocytoma, Pilocytic|Astrocytoma, Protoplasmic|Astrocytomas|Astrocytomas, Anaplastic|Astrocytomas, Cerebral|Astrocytomas, Childhood Cerebral|Astrocytomas, Fibrillary|Astrocytomas, Gemistocytic|Astrocytomas, Grade I|Astrocytomas, Grade II|Astrocytomas, Grade III|Astrocytomas, Intracranial|Astrocytomas, Juvenile Pilocytic|Astrocytomas, Pilocytic|Astrocytomas, Protoplasmic|Astrocytoma, Subependymal Giant Cell|Astroglioma|Astrogliomas|Cerebral Astrocytoma|Cerebral Astrocytoma, Childhood|Cerebral Astrocytomas|Cerebral Astrocytomas, Childhood|Childhood Cerebral Astrocytoma|Childhood Cerebral Astrocytomas|Fibrillary Astrocytoma|Fibrillary Astrocytomas|Gemistocytic Astrocytoma|Gemistocytic Astrocytomas|Glioma, Astrocytic|Gliomas, Astrocytic|Grade I Astrocytoma|Grade I Astrocytomas|Grade II Astrocytoma|Grade II Astrocytomas|Grade III Astrocytoma|Grade III Astrocytomas|Intracranial Astrocytoma|Intracranial Astrocytomas|Juvenile Pilocytic Astrocytoma|Juvenile Pilocytic Astrocytomas|Mixed Oligoastrocytoma|Mixed Oligoastrocytomas|Oligoastrocytoma, Mixed|Oligoastrocytomas, Mixed|Pilocytic Astrocytoma|Pilocytic Astrocytoma, Juvenile|Pilocytic Astrocytomas|Pilocytic Astrocytomas, Juvenile|Protoplasmic Astrocytoma|Protoplasmic Astrocytomas|Subependymal Giant Cell Astrocytoma	Cancer
Astroviridae Infections	MESH:D019350		Infections with ASTROVIRIDAE, causing gastroenteritis in human infants, calves, lambs, and piglets.	MESH:D012327	C01.925.782.105	C01.925.782	Astroviridae Infection|Infection, Astroviridae|Infections, Astroviridae	Viral disease
Ataxia	MESH:D001259		Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.	MESH:D020820	C10.597.350.090|C23.888.592.350.090	C10.597.350|C23.888.592.350	Appendicular Ataxia|Appendicular Ataxias|Ataxia, Appendicular|Ataxia, Limb|Ataxia, Motor|Ataxias|Ataxias, Appendicular|Ataxia, Sensory|Ataxias, Limb|Ataxias, Motor|Ataxias, Sensory|Ataxias, Truncal|Ataxia, Truncal|Ataxy|Coordination Impairment|Coordination Impairments|Coordination Lack|Dyscoordination|Dyssynergia|Impairment, Coordination|Impairments, Coordination|Incoordination|Incoordinations|Lack of Coordination|Limb Ataxia|Limb Ataxias|Motor Ataxia|Motor Ataxias|Rubral Tremor|Rubral Tremors|Sensory Ataxia|Sensory Ataxias|Tremor, Rubral|Tremors, Rubral|Truncal Ataxia|Truncal Ataxias	Nervous system disease|Signs and symptoms
Ataxia and Polyneuropathy, Adult-Onset	MESH:C564020			MESH:D001259|MESH:D011115|MESH:D028361	C10.597.350.090/C564020|C10.668.829.800/C564020|C18.452.660/C564020|C23.888.592.350.090/C564020	C10.597.350.090|C10.668.829.800|C18.452.660|C23.888.592.350.090		Metabolic disease|Nervous system disease|Signs and symptoms
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS	OMIM:616192			MESH:D002524|MESH:D003920|MESH:D034381	C09.218.458.341/616192|C10.228.140.252.190/616192|C10.597.350.090.500/616192|C10.597.751.418.341/616192|C18.452.394.750/616192|C19.246/616192|C23.888.592.350.090.200/616192|C23.888.592.763.393.341/616192	C09.218.458.341|C10.228.140.252.190|C10.597.350.090.500|C10.597.751.418.341|C18.452.394.750|C19.246|C23.888.592.350.090.200|C23.888.592.763.393.341	ACPHD	Ear-nose-throat disease|Endocrine system disease|Metabolic disease|Nervous system disease|Signs and symptoms
Ataxia, Deafness, and Cardiomyopathy	MESH:C565932			MESH:D001259|MESH:D006319|MESH:D009202	C09.218.458.341.887/C565932|C10.597.350.090/C565932|C10.597.751.418.341.887/C565932|C14.280.238/C565932|C23.888.592.350.090/C565932|C23.888.592.763.393.341.887/C565932	C09.218.458.341.887|C10.597.350.090|C10.597.751.418.341.887|C14.280.238|C23.888.592.350.090|C23.888.592.763.393.341.887		Cardiovascular disease|Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Ataxia Neuropathy Spectrum	MESH:C579922			MESH:D028361	C18.452.660/C579922	C18.452.660	MIRAS|Mitochondrial Recessive Ataxia Syndrome|SANDO|Sensory Ataxia Neuropathy Dysarthria and Ophthalmoplegia	Metabolic disease
ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT	OMIM:608984	DO:DOID:0111170		MESH:D001259	C10.597.350.090/608984|C23.888.592.350.090/608984	C10.597.350.090|C23.888.592.350.090	ADSA|SNAX1	Nervous system disease|Signs and symptoms
Ataxia, Sensory, Autosomal Dominant	MESH:C563818			MESH:D001259	C10.597.350.090/C563818|C23.888.592.350.090/C563818	C10.597.350.090|C23.888.592.350.090		Nervous system disease|Signs and symptoms
Ataxia, Spastic, with Congenital Miosis	MESH:C566247			MESH:D001259|MESH:D009128|MESH:D015877	C05.651.512/C566247|C10.597.350.090/C566247|C10.597.613.550.550/C566247|C10.597.690.362/C566247|C11.710.528/C566247|C23.888.592.350.090/C566247|C23.888.592.608.550.550/C566247|C23.888.592.708.362/C566247	C05.651.512|C10.597.350.090|C10.597.613.550.550|C10.597.690.362|C11.710.528|C23.888.592.350.090|C23.888.592.608.550.550|C23.888.592.708.362	Miosis, Congenital, with Spastic Ataxia	Eye disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Ataxia with Fasciculations	MESH:C566246			MESH:D001259|MESH:D005207	C10.597.350.090/C566246|C10.597.613.250/C566246|C23.888.592.350.090/C566246|C23.888.592.608.250/C566246	C10.597.350.090|C10.597.613.250|C23.888.592.350.090|C23.888.592.608.250		Nervous system disease|Signs and symptoms
Ataxia with vitamin E deficiency	MESH:C535393	DO:DOID:0090028|OMIM:277460		MESH:D001259|MESH:D014811	C10.597.350.090/C535393|C18.654.521.500.133.841/C535393|C23.888.592.350.090/C535393	C10.597.350.090|C18.654.521.500.133.841|C23.888.592.350.090	Ataxia, Friedreich-Like, with Selective Vitamin E Deficiency|Ataxia with isolated vitamin E deficiency|ATAXIA WITH VITAMIN 3 DEFICIENCY|AVED|Familial isolated deficiency of vitamin E|Familial Isolated Vitamin E Deficiency|Friedreich Ataxia Phenotype with Selective Vitamin E Deficiency|Friedreich-Like Ataxia|Friedreich-like ataxia with selective vitamin E deficiency|VED|VITAMIN E DEFICIENCY, FAMILIAL ISOLATED|Vitamin E, Familial Isolated Deficiency of	Nervous system disease|Nutrition disorder|Signs and symptoms
Atherosclerosis	MESH:D050197	DO:DOID:1936|DO:DOID:2348|OMIM:108725	A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.	MESH:D001161	C14.907.137.126.307	C14.907.137.126	ALP|Atherogenesis|ATHEROGENIC LIPOPROTEIN PHENOTYPE|Atheroscleroses|ATHEROSCLEROSIS SUSCEPTIBILITY|ATHS	Cardiovascular disease
Athetosis	MESH:D001264		A dyskinesia characterized by an inability to maintain the fingers, toes, tongue, or other body parts in a stable position, resulting in continuous slow, sinusoidal, and flowing involuntary movements. This condition is frequently accompanied by CHOREA, where it is referred to as choreoathetosis. Athetosis may occur as a manifestation of BASAL GANGLIA DISEASES or DRUG TOXICITY. (From Adams et al., Principles of Neurology, 6th ed, p76)	MESH:D020820	C10.597.350.110|C23.888.592.350.110	C10.597.350|C23.888.592.350	Athetoid Movement|Athetoid Movements|Athetoses|Disease, Hammond|Disease, Hammond's|Diseases, Hammond|Diseases, Hammond's|Hammond Disease|Hammond Diseases|Hammond's Disease|Hammonds Disease|Hammond's Diseases|Movement, Athetoid|Movements, Athetoid	Nervous system disease|Signs and symptoms
Atonic-Astatic Syndrome of Foerster	MESH:C565926			MESH:D001259|MESH:D009123|MESH:D013064	C10.597.350.090/C565926|C10.597.606.150.500.800/C565926|C10.597.613.575/C565926|C23.888.592.350.090/C565926|C23.888.592.604.150.500.800/C565926|C23.888.592.608.575/C565926	C10.597.350.090|C10.597.606.150.500.800|C10.597.613.575|C23.888.592.350.090|C23.888.592.604.150.500.800|C23.888.592.608.575		Nervous system disease|Signs and symptoms
Atrial Fibrillation	MESH:D001281	DO:DOID:0060224	Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.	MESH:D001145	C14.280.067.198|C23.550.073.198	C14.280.067|C23.550.073	Atrial Fibrillation, Familial|Atrial Fibrillation, Paroxysmal|Atrial Fibrillation, Persistent|Atrial Fibrillations|Atrial Fibrillations, Familial|Atrial Fibrillations, Paroxysmal|Atrial Fibrillations, Persistent|Auricular Fibrillation|Auricular Fibrillations|Familial Atrial Fibrillation|Familial Atrial Fibrillations|Fibrillation, Atrial|Fibrillation, Auricular|Fibrillation, Familial Atrial|Fibrillation, Paroxysmal Atrial|Fibrillation, Persistent Atrial|Fibrillations, Atrial|Fibrillations, Auricular|Fibrillations, Familial Atrial|Fibrillations, Paroxysmal Atrial|Fibrillations, Persistent Atrial|Paroxysmal Atrial Fibrillation|Paroxysmal Atrial Fibrillations|Persistent Atrial Fibrillation|Persistent Atrial Fibrillations	Cardiovascular disease|Pathology (process)
Atrial fibrillation, familial 1	MESH:C538261	OMIM:608583		MESH:D001281	C14.280.067.198/C538261|C23.550.073.198/C538261	C14.280.067.198|C23.550.073.198	Atfb1|Atrial fibrillation, autosomal dominant|Atrial Fibrillation, Familial, 1|Autosomal dominant atrial fibrillation	Cardiovascular disease|Pathology (process)
ATRIAL FIBRILLATION, FAMILIAL, 10	OMIM:614022	DO:DOID:0050650		MESH:D001281	C14.280.067.198/614022|C23.550.073.198/614022	C14.280.067.198|C23.550.073.198	ATFB10	Cardiovascular disease|Pathology (process)
ATRIAL FIBRILLATION, FAMILIAL, 11	OMIM:614049	DO:DOID:0050650		MESH:D001281	C14.280.067.198/614049|C23.550.073.198/614049	C14.280.067.198|C23.550.073.198	ATFB11	Cardiovascular disease|Pathology (process)
ATRIAL FIBRILLATION, FAMILIAL, 12	OMIM:614050	DO:DOID:0050650		MESH:D001281	C14.280.067.198/614050|C23.550.073.198/614050	C14.280.067.198|C23.550.073.198	ATFB12	Cardiovascular disease|Pathology (process)
ATRIAL FIBRILLATION, FAMILIAL, 13	OMIM:615377	DO:DOID:0050650		MESH:D001281	C14.280.067.198/615377|C23.550.073.198/615377	C14.280.067.198|C23.550.073.198	ATFB13	Cardiovascular disease|Pathology (process)
ATRIAL FIBRILLATION, FAMILIAL, 14	OMIM:615378	DO:DOID:0050650		MESH:D001281	C14.280.067.198/615378|C23.550.073.198/615378	C14.280.067.198|C23.550.073.198	ATFB14	Cardiovascular disease|Pathology (process)
ATRIAL FIBRILLATION, FAMILIAL, 15	OMIM:615770	DO:DOID:0050650		MESH:D001281	C14.280.067.198/615770|C23.550.073.198/615770	C14.280.067.198|C23.550.073.198	ATFB15	Cardiovascular disease|Pathology (process)
ATRIAL FIBRILLATION, FAMILIAL, 18	OMIM:617280			MESH:D001281	C14.280.067.198/617280|C23.550.073.198/617280	C14.280.067.198|C23.550.073.198	ATFB18	Cardiovascular disease|Pathology (process)
Atrial Fibrillation, Familial, 2	MESH:C563903	OMIM:608988		MESH:D001281	C14.280.067.198/C563903|C23.550.073.198/C563903	C14.280.067.198|C23.550.073.198	ATFB2	Cardiovascular disease|Pathology (process)
Atrial Fibrillation, Familial, 3	MESH:C563817	OMIM:607554		MESH:D001281	C14.280.067.198/C563817|C23.550.073.198/C563817	C14.280.067.198|C23.550.073.198	ATFB3	Cardiovascular disease|Pathology (process)
Atrial Fibrillation, Familial, 4	MESH:C566244	OMIM:611493		MESH:D001281	C14.280.067.198/C566244|C23.550.073.198/C566244	C14.280.067.198|C23.550.073.198	ATFB4	Cardiovascular disease|Pathology (process)
Atrial Fibrillation, Familial, 5	MESH:C566932	OMIM:611494		MESH:D001281	C14.280.067.198/C566932|C23.550.073.198/C566932	C14.280.067.198|C23.550.073.198	ATFB5	Cardiovascular disease|Pathology (process)
Atrial Fibrillation, Familial, 6	MESH:C567400	OMIM:612201		MESH:D001281	C14.280.067.198/C567400|C23.550.073.198/C567400	C14.280.067.198|C23.550.073.198	ATFB6	Cardiovascular disease|Pathology (process)
Atrial Fibrillation, Familial, 7	MESH:C567389	OMIM:612240		MESH:D001281	C14.280.067.198/C567389|C23.550.073.198/C567389	C14.280.067.198|C23.550.073.198	ATFB7	Cardiovascular disease|Pathology (process)
Atrial Fibrillation, Familial, 8	MESH:C567802	OMIM:613055		MESH:D001281	C14.280.067.198/C567802|C23.550.073.198/C567802	C14.280.067.198|C23.550.073.198	ATFB8	Cardiovascular disease|Pathology (process)
ATRIAL FIBRILLATION, FAMILIAL, 9	OMIM:613980	DO:DOID:0050650		MESH:D001281	C14.280.067.198/613980|C23.550.073.198/613980	C14.280.067.198|C23.550.073.198	ATFB9	Cardiovascular disease|Pathology (process)
Atrial Flutter	MESH:D001282		Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).	MESH:D001145	C14.280.067.248|C23.550.073.248	C14.280.067|C23.550.073	Atrial Flutters|Auricular Flutter|Auricular Flutters|Flutter, Atrial|Flutter, Auricular|Flutters, Atrial|Flutters, Auricular	Cardiovascular disease|Pathology (process)
Atrial myxoma, familial	MESH:C538262	OMIM:255960		MESH:D006338|MESH:D009232	C04.557.450.565.550/C538262|C04.588.894.309/C538262|C14.280.459/C538262	C04.557.450.565.550|C04.588.894.309|C14.280.459	ATRIAL MYXOMA, FAMILIAL|Intracardiac myxoma|Myxoma, Intracardiac	Cancer|Cardiovascular disease
Atrial Premature Complexes	MESH:D018880		A type of cardiac arrhythmia with premature atrial contractions or beats caused by signals originating from ectopic atrial sites. The ectopic signals may or may not conduct to the HEART VENTRICLES. Atrial premature complexes are characterized by premature P waves on ECG which are different in configuration from the P waves generated by the normal pacemaker complex in the SINOATRIAL NODE.	MESH:D005117	C14.280.067.325.250|C14.280.123.375.250|C23.550.073.325.050	C14.280.067.325|C14.280.123.375|C23.550.073.325	Atrial Beat, Premature|Atrial Beats, Premature|Atrial Complex, Premature|Atrial Complices, Premature|Atrial Contraction, Premature|Atrial Contractions, Premature|Atrial Ectopic Beat|Atrial Ectopic Beats|Atrial Extrasystole|Atrial Extrasystoles|Atrial Premature Complex|Atrial Premature Complices|Ectopic Beat, Atrial|Ectopic Beats, Atrial|Extrasystole, Atrial|Extrasystoles, Atrial|Premature Atrial Beat|Premature Atrial Beats|Premature Atrial Complex|Premature Atrial Complices|Premature Atrial Contraction|Premature Atrial Contractions|Premature Complex, Atrial|Premature Complexes, Atrial|Premature Complices, Atrial|Premature Supraventricular Beat|Premature Supraventricular Beats|Supraventricular Beat, Premature|Supraventricular Beats, Premature	Cardiovascular disease|Pathology (process)
Atrial Septal Defect 1	MESH:C566239	OMIM:108800		MESH:D006344	C14.240.400.560.375/C566239|C14.280.400.560.375/C566239|C16.131.240.400.560.375/C566239	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	ASD1|ASD  ATRIAL SEPTAL DEFECT, PRIMUM TYPE, INCLUDED|ASD II, INCLUDED|ASD I, INCLUDED|ATRIAL SEPTAL DEFECT, SECUNDUM TYPE, INCLUDED	Cardiovascular disease|Congenital abnormality
Atrial septal defect 2	MESH:C538263	OMIM:607941		MESH:D006344	C14.240.400.560.375/C538263|C14.280.400.560.375/C538263|C16.131.240.400.560.375/C538263	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	ASD2	Cardiovascular disease|Congenital abnormality
Atrial Septal Defect 3	MESH:C563540	OMIM:614089		MESH:D006344	C14.240.400.560.375/C563540|C14.280.400.560.375/C563540|C16.131.240.400.560.375/C563540	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	ASD3	Cardiovascular disease|Congenital abnormality
Atrial Septal Defect 4	MESH:C566963	OMIM:611363		MESH:D006344	C14.240.400.560.375/C566963|C14.280.400.560.375/C566963|C16.131.240.400.560.375/C566963	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	ASD4	Cardiovascular disease|Congenital abnormality
Atrial Septal Defect 5	MESH:C567561	OMIM:612794		MESH:D006344	C14.240.400.560.375/C567561|C14.280.400.560.375/C567561|C16.131.240.400.560.375/C567561	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	ASD5	Cardiovascular disease|Congenital abnormality
Atrial Septal Defect 6	MESH:C567764	OMIM:613087		MESH:D006344	C14.240.400.560.375/C567764|C14.280.400.560.375/C567764|C16.131.240.400.560.375/C567764	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	ASD6	Cardiovascular disease|Congenital abnormality
ATRIAL SEPTAL DEFECT 8	OMIM:614433	DO:DOID:0110113		MESH:D006344	C14.240.400.560.375/614433|C14.280.400.560.375/614433|C16.131.240.400.560.375/614433	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	ASD8	Cardiovascular disease|Congenital abnormality
ATRIAL SEPTAL DEFECT 9	OMIM:614475	DO:DOID:0110114		MESH:D006344	C14.240.400.560.375/614475|C14.280.400.560.375/614475|C16.131.240.400.560.375/614475	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	ASD9	Cardiovascular disease|Congenital abnormality
Atrial Septal Defect, Secundum Type	MESH:C566241			MESH:D006344	C14.240.400.560.375/C566241|C14.280.400.560.375/C566241|C16.131.240.400.560.375/C566241	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375		Cardiovascular disease|Congenital abnormality
Atrial Septal Defect, Secundum, with Various Cardiac and Noncardiac Defects	MESH:C566351			MESH:D001145|MESH:D002971|MESH:D005660|MESH:D006344|MESH:D006972	C05.116.099.370.231.480/C566351|C05.116.099.386/C566351|C05.660.207.231.480/C566351|C05.660.386/C566351|C07.465.409.225/C566351|C07.465.525.164/C566351|C07.650.525.164/C566351|C14.240.400.560.375/C566351|C14.280.067/C566351|C14.280.400.560.375/C566351|C16.131.240.400.560.375/C566351|C16.131.621.207.231.480/C566351|C16.131.621.386/C566351|C16.131.850.525.164/C566351|C23.550.073/C566351	C05.116.099.370.231.480|C05.116.099.386|C05.660.207.231.480|C05.660.386|C07.465.409.225|C07.465.525.164|C07.650.525.164|C14.240.400.560.375|C14.280.067|C14.280.400.560.375|C16.131.240.400.560.375|C16.131.621.207.231.480|C16.131.621.386|C16.131.850.525.164|C23.550.073		Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease|Pathology (process)
Atrial Septal Defect Sinus Venosus	MESH:C548009			MESH:D006344	C14.240.400.560.375/C548009|C14.280.400.560.375/C548009|C16.131.240.400.560.375/C548009	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375		Cardiovascular disease|Congenital abnormality
Atrial Tachyarrhythmia with Short PR Interval	MESH:C566237			MESH:D013610	C14.280.067.845/C566237|C14.280.123.875/C566237|C23.550.073.845/C566237	C14.280.067.845|C14.280.123.875|C23.550.073.845		Cardiovascular disease|Pathology (process)
Atrichia with Papular Lesions	MESH:C565924	OMIM:209500		MESH:D000505|MESH:D012872	C17.800.329.937.122/C565924|C17.800.865/C565924|C23.300.035/C565924	C17.800.329.937.122|C17.800.865|C23.300.035	APL|Papular Atrichia	Pathology (anatomical condition)|Skin disease
Atrioventricular Block	MESH:D054537	DO:DOID:0050820	Impaired impulse conduction from HEART ATRIA to HEART VENTRICLES. AV block can mean delayed or completely blocked impulse conduction.	MESH:D006327	C14.280.067.558.230|C14.280.123.500.230|C23.550.073.425.062	C14.280.067.558|C14.280.123.500|C23.550.073.425	Atrioventricular Blocks|Atrioventricular Conduction Block|Atrioventricular Conduction Blocks|AV Block|AV Blocks|Block, AV|Blocks, AV|Conduction Block, Atrioventricular|Conduction Blocks, Atrioventricular	Cardiovascular disease|Pathology (process)
Atrioventricular Septal Defect	MESH:C562831	OMIM:600309|OMIM:606215|OMIM:614430|OMIM:614474		MESH:D006343	C14.240.400.560/C562831|C14.280.400.560/C562831|C16.131.240.400.560/C562831	C14.240.400.560|C14.280.400.560|C16.131.240.400.560	Atrioventricular Canal Defect|ATRIOVENTRICULAR SEPTAL DEFECT 3|ATRIOVENTRICULAR SEPTAL DEFECT 4|ATRIOVENTRICULAR SEPTAL DEFECT 5|AVCD|AVC Defect|AVSD|AVSD1, INCLUDED|AVSD3|AVSD4|AVSD5|ENDOCARDIAL CUSHION DEFECT;ECD ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 1, INCLUDED	Cardiovascular disease|Congenital abnormality
Atrioventricular Septal Defect, Partial, with Heterotaxy Syndrome	MESH:C565249	OMIM:606217		MESH:D006343|MESH:D059446	C14.240.400.560/C565249|C14.240.400.592/C565249|C14.280.400.560/C565249|C14.280.400.592/C565249|C15.604.744.146/C565249|C16.131.077.401/C565249|C16.131.240.400.560/C565249|C16.131.240.400.592/C565249	C14.240.400.560|C14.240.400.592|C14.280.400.560|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.560|C16.131.240.400.592	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2;AVSD2 ATRIOVENTRICULAR SEPTAL DEFECT, PARTIAL, WITH HETEROTAXY SYNDROME,|INCLUDED	Cardiovascular disease|Congenital abnormality|Lymphatic disease
Atrioventricular Septal Defect with Blepharophimosis and Anal and Radial Defects	MESH:C563994			MESH:D006343|MESH:D014564|MESH:D016569	C11.250.090/C563994|C11.338.190/C563994|C12.050.351.875/C563994|C12.200.706/C563994|C12.800/C563994|C14.240.400.560/C563994|C14.280.400.560/C563994|C16.131.240.400.560/C563994|C16.131.384.190/C563994|C16.131.939/C563994	C11.250.090|C11.338.190|C12.050.351.875|C12.200.706|C12.800|C14.240.400.560|C14.280.400.560|C16.131.240.400.560|C16.131.384.190|C16.131.939		Cardiovascular disease|Congenital abnormality|Eye disease|Urogenital disease (female)|Urogenital disease (male)
Atrophic Vaginitis	MESH:D059268		Inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at MENOPAUSE.	MESH:D014627	C12.050.351.500.894.906.316|C12.100.250.894.906.316	C12.050.351.500.894.906|C12.100.250.894.906	Atrophic Vaginitides|Vaginitides, Atrophic|Vaginitis, Atrophic	Urogenital disease (female)
Atypical Hemolytic Uremic Syndrome	MESH:D065766	DO:DOID:0080301|OMIM:235400|OMIM:612922|OMIM:612923|OMIM:612924|OMIM:612925|OMIM:612926	An hereditary hemolytic uremic syndrome associated with variations in the gene that encodes COMPLEMENT FACTOR H, or the related proteins CFHR1 and CFHR3. Disease often progresses to CHRONIC KIDNEY FAILURE without the prodromal symptoms of ENTEROCOLITIS and DIARRHEA that characterize typical hemolytic uremic syndrome.	MESH:D006463	C12.050.351.968.419.936.463.500|C12.200.777.419.936.463.500|C12.950.419.936.463.500|C15.378.071.141.610.500|C15.378.140.855.925.500.500	C12.050.351.968.419.936.463|C12.200.777.419.936.463|C12.950.419.936.463|C15.378.071.141.610|C15.378.140.855.925.500	AHUS1|AHUS2|AHUS3|AHUS4|AHUS5|AHUS6|AHUS, SUSCEPTIBILITY TO, 1 HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED|AHUS, SUSCEPTIBILITY TO, 2|AHUS, SUSCEPTIBILITY TO, 3|AHUS, SUSCEPTIBILITY TO, 4|AHUS, SUSCEPTIBILITY TO, 5|AHUS, SUSCEPTIBILITY TO, 6|Atypical Hemolytic-Uremic Syndrome|Atypical Hemolytic-Uremic Syndromes|Hemolytic Uremic Syndrome, Atypical|Hemolytic-Uremic Syndrome, Atypical|HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1|HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2|HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3|HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4|HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5|HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6|Hemolytic-Uremic Syndromes, Atypical|HUS, Nonenteropathic|HUS, Non-Shiga-Like Toxin-Associated|HUSs, Nonenteropathic|HUSs, Non-Shiga-Like Toxin-Associated|Nonenteropathic HUS|Nonenteropathic HUSs|Non Shiga Like Toxin Associated HUS|Non-Shiga-Like Toxin-Associated HUS|Non-Shiga-Like Toxin-Associated HUSs|Non Stx Hus|Non-Stx-Hus|Syndrome, Atypical Hemolytic-Uremic|Syndromes, Atypical Hemolytic-Uremic|Toxin-Associated HUS, Non-Shiga-Like|Toxin-Associated HUSs, Non-Shiga-Like	Blood disease|Urogenital disease (female)|Urogenital disease (male)
Atypical Squamous Cells of the Cervix	MESH:D065309		Morphological abnormalities of the cervical EPITHELIUM, usually revealed in PAP SMEAR, which do not meet the criteria for squamous CERVICAL INTRAEPITHELIAL NEOPLASIA or SQUAMOUS CELL CARCINOMAS of the CERVIX . It may be a sign of infection with certain types of human papillomavirus (HPV).or sign of a benign (not cancer) growth, such as a cyst or polyp or, in menopausal women, of low hormone levels. More testing, such as HPV test, may be needed.	MESH:D002578|MESH:D065308	C04.834.818.249|C12.050.351.500.852.593.074.249|C12.100.250.852.593.074.249|C23.149.500	C04.834.818|C12.050.351.500.852.593.074|C12.100.250.852.593.074|C23.149	ASC Atypical Squamous Cells|ASC H Atypical Squamous Cells, Cannot Rule Out High Grade Squamous Intra epithelial Lesion|ASC-H Atypical Squamous Cells, Cannot Rule Out High-Grade Squamous Intra-epithelial Lesion|ASCUS|ASC-US|Atypical Cervical Squamous Cells|Atypical Squamous Cell|Atypical Squamous Cells|Atypical Squamous Cells, Cannot Rule Out High Grade Squamous Intra Epithelial Lesion|Atypical Squamous Cells, Cannot Rule Out High-Grade Squamous Intra-Epithelial Lesion|Atypical Squamous Cells of Undetermined Significance|Cell, Atypical Squamous|Cells, Atypical Squamous|Squamous Cell, Atypical|Squamous Cells, Atypical	Cancer|Urogenital disease (female)
Auditory Diseases, Central	MESH:D001304		Disorders of hearing or auditory perception due to pathological processes of the AUDITORY PATHWAYS in the CENTRAL NERVOUS SYSTEM. These include CENTRAL HEARING LOSS and AUDITORY PERCEPTUAL DISORDERS.	MESH:D001927|MESH:D012181	C09.218.807.186|C10.228.140.068	C09.218.807|C10.228.140	Auditory Cortex Disorder|Auditory Cortex Disorders|Auditory Disease, Central|Auditory Dysfunction, Central|Auditory Pathway Disorders, Central|Central Auditory Disease|Central Auditory Diseases|Central Auditory Dysfunction|Central Auditory Pathway Disorders|Cortex Disorder, Auditory|Cortex Disorders, Auditory|Dysfunction, Central Auditory|Dysfunctions, Central Auditory	Ear-nose-throat disease|Nervous system disease
Auditory neuropathy	MESH:C538268			MESH:D006313	C09.218.458.341.887.432/C538268|C09.218.807.186.432/C538268|C10.228.140.068.432/C538268|C10.597.751.418.341.887.432/C538268|C23.888.592.763.393.341.887.432/C538268	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C23.888.592.763.393.341.887.432	Auditory dys-synchrony|Familial auditory neuropathy|Progressive auditory neuropathy	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Auditory Neuropathy, Autosomal Dominant, 1	MESH:C563790	OMIM:609129		MESH:D006313	C09.218.458.341.887.432/C563790|C09.218.807.186.432/C563790|C10.228.140.068.432/C563790|C10.597.751.418.341.887.432/C563790|C23.888.592.763.393.341.887.432/C563790	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C23.888.592.763.393.341.887.432	Auditory Neuropathy, Nonsyndromic Dominant|AUNA1|NSDAN	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Auditory Neuropathy, Nonsyndromic Recessive	MESH:C563398			MESH:D006319	C09.218.458.341.887/C563398|C10.597.751.418.341.887/C563398|C23.888.592.763.393.341.887/C563398	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Auditory Perceptual Disorders	MESH:D001308		Acquired or developmental cognitive disorders of AUDITORY PERCEPTION characterized by a reduced ability to perceive information contained in auditory stimuli despite intact auditory pathways. Affected individuals have difficulty with speech perception, sound localization, and comprehending the meaning of inflections of speech.	MESH:D001304|MESH:D003072|MESH:D010468	C09.218.807.186.094|C10.228.140.068.094|C10.597.606.762.200|C23.888.592.604.764.200|F03.615.250.100	C09.218.807.186|C10.228.140.068|C10.597.606.762|C23.888.592.604.764|F03.615.250	Acoustic Perceptual Disorder|Acoustic Perceptual Disorders|Auditory Comprehension Disorder|Auditory Comprehension Disorders|Auditory Inattention|Auditory Inattentions|Auditory Perceptual Disorder|Auditory Processing Disorder|Auditory Processing Disorders|Comprehension Disorder, Auditory|Comprehension Disorders, Auditory|Disorder, Acoustic Perceptual|Disorder, Auditory Comprehension|Disorder, Auditory Processing|Disorder, Psychoacoustical|Disorders, Acoustic Perceptual|Disorders, Auditory Comprehension|Disorders, Auditory Processing|Disorders, Psychoacoustical|Inattention, Auditory|Inattentions, Auditory|Perceptual Disorder, Acoustic|Perceptual Disorder, Auditory|Perceptual Disorders, Acoustic|Perceptual Disorders, Auditory|Processing Disorder, Auditory|Processing Disorders, Auditory|Psychoacoustical Disorder|Psychoacoustical Disorders	Ear-nose-throat disease|Mental disorder|Nervous system disease|Signs and symptoms
Auditory perceptual impairment	MESH:C538436			MESH:D004401	C10.597.606.150.500.800.150.200/C538436|C23.888.592.604.150.500.800.150.200/C538436	C10.597.606.150.500.800.150.200|C23.888.592.604.150.500.800.150.200		Nervous system disease|Signs and symptoms
Aughton syndrome	MESH:C538269			MESH:D000015|MESH:D002972|MESH:D003914|MESH:D008607|MESH:D008850	C05.500.460.185/C538269|C05.660.207.540.460.185/C538269|C07.320.440.185/C538269|C07.465.525.185/C538269|C07.650.500.460.185/C538269|C07.650.525.185/C538269|C10.597.606.360/C538269|C11.250.566/C538269|C14.240.400.280/C538269|C14.280.400.280/C538269|C16.131.077/C538269|C16.131.240.400.280/C538269|C16.131.384.666/C538269|C16.131.621.207.540.460.185/C538269|C16.131.810.250/C538269|C16.131.850.500.460.185/C538269|C16.131.850.525.185/C538269|C23.888.592.604.646/C538269|F03.625.539/C538269	C05.500.460.185|C05.660.207.540.460.185|C07.320.440.185|C07.465.525.185|C07.650.500.460.185|C07.650.525.185|C10.597.606.360|C11.250.566|C14.240.400.280|C14.280.400.280|C16.131.077|C16.131.240.400.280|C16.131.384.666|C16.131.621.207.540.460.185|C16.131.810.250|C16.131.850.500.460.185|C16.131.850.525.185|C23.888.592.604.646|F03.625.539	Dextrocardia, microphthalmia, cleft palate, and mental retardation|Dextrocardia with unusual facies and microphthalmia	Cardiovascular disease|Congenital abnormality|Eye disease|Mental disorder|Mouth disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Auriculo-condylar syndrome	MESH:C538270	OMIM:602483|OMIM:612798|OMIM:614669|OMIM:615706		MESH:D004427	C09.218/C538270	C09.218	ARCND1|ARCND2|ARCND3|AURICULAR CLEFT, CONGENITAL|Auriculocondylar syndrome|Auriculocondylar syndrome 1|AURICULOCONDYLAR SYNDROME 2|AURICULOCONDYLAR SYNDROME 3|COSMAN DEFORMITY OF THE AURICLE|Cosman ear|Ears prominent and constricted|EARS, PROMINENT AND CONSTRICTED|QME|Question mark ear|QUESTION MARK EARS, ISOLATED|Question Mark Ears Syndrome|Question-Mark Ear Syndrome	Ear-nose-throat disease
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1	OMIM:615952			MESH:D001327	C20.111/615952	C20.111	ADMIO1	Immune system disease
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2	OMIM:617006			MESH:D001327	C20.111/617006	C20.111	ADMIO2	Immune system disease
Autoimmune Diseases	MESH:D001327	OMIM:109100|OMIM:613551	Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.	MESH:D007154	C20.111	C20	AIS6|Autoimmune Disease|AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6|Disease, Autoimmune|Diseases, Autoimmune	Immune system disease
Autoimmune Diseases of the Nervous System	MESH:D020274	DO:DOID:438	Disorders caused by cellular or humoral immune responses primarily directed towards nervous system autoantigens. The immune response may be directed towards specific tissue components (e.g., myelin) and may be limited to the central nervous system (e.g., MULTIPLE SCLEROSIS) or the peripheral nervous system (e.g., GUILLAIN-BARRE SYNDROME).	MESH:D001327|MESH:D009422	C10.114|C20.111.258	C10|C20.111	Autoimmune Disease, Neurologic|Autoimmune Diseases, Nervous System|Autoimmune Diseases, Neurologic|Autoimmune Disorders, Nervous System|Autoimmune Disorders of the Nervous System|Autoimmune Nervous System Diseases|Disease, Neurologic Autoimmune|Diseases, Neurologic Autoimmune|Immune Diseases, Nervous System|Immune Disorders, Nervous System|Nervous System Autoimmune Diseases|Nervous System Immune Diseases|Nervous System Immune Disorders|Neurologic Autoimmune Disease|Neurologic Autoimmune Diseases	Immune system disease|Nervous system disease
Autoimmune enteropathy	MESH:C538273			MESH:D016884	C19.787/C538273|C20.111.750/C538273	C19.787|C20.111.750		Endocrine system disease|Immune system disease
Autoimmune Hypophysitis	MESH:D000069281		Immune-mediated inflammation of the PITUITARY GLAND often associated with other autoimmune diseases (e.g., HASHIMOTO DISEASE; GRAVES DISEASE; and ADDISON DISEASE).	MESH:D000072659|MESH:D001327	C10.228.140.617.738.275.500|C19.700.419.500|C20.111.273	C10.228.140.617.738.275|C19.700.419|C20.111	Adenohypophysitides, Lymphocytic|Adenohypophysitis, Lymphocytic|Antibody Syndrome, Anti-PIT-1|Antibody Syndromes, Anti-PIT-1|Anti PIT 1 Antibody Syndrome|Anti-PIT-1 Antibody Syndrome|Anti-PIT-1 Antibody Syndromes|Autoimmune Hypophysitides|Granulomatous Hypophysitides, Idiopathic|Granulomatous Hypophysitis, Idiopathic|Hypophysitides, Autoimmune|Hypophysitides, Idiopathic Granulomatous|Hypophysitides, IgG4-Related|Hypophysitides, Lymphocytic|Hypophysitides, Lymphoid|Hypophysitis, Autoimmune|Hypophysitis, Idiopathic Granulomatous|Hypophysitis, IgG4-Related|Hypophysitis, Lymphocytic|Hypophysitis, Lymphoid|Idiopathic Granulomatous Hypophysitides|Idiopathic Granulomatous Hypophysitis|IgG4-Related Hypophysitides|IgG4 Related Hypophysitis|IgG4-Related Hypophysitis|Infundibuloneurohypophysitides, Lymphocytic|Infundibuloneurohypophysitis, Lymphocytic|Lymphocytic Adenohypophysitides|Lymphocytic Adenohypophysitis|Lymphocytic Hypophysitides|Lymphocytic Hypophysitis|Lymphocytic Infundibuloneurohypophysitides|Lymphocytic Infundibuloneurohypophysitis|Lymphocytic Panhypophysitides|Lymphocytic Panhypophysitis|Lymphoid Hypophysitides|Lymphoid Hypophysitis|Panhypophysitides, Lymphocytic|Panhypophysitis, Lymphocytic|Syndrome, Anti-PIT-1 Antibody|Syndromes, Anti-PIT-1 Antibody	Endocrine system disease|Immune system disease|Nervous system disease
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE	OMIM:616414			MESH:D001168|MESH:D001327|MESH:D007674|MESH:D017563	C05.550.114/616414|C08.381.483/616414|C12.050.351.968.419/616414|C12.200.777.419/616414|C12.950.419/616414|C20.111/616414	C05.550.114|C08.381.483|C12.050.351.968.419|C12.200.777.419|C12.950.419|C20.111	AILJK	Immune system disease|Musculoskeletal disease|Respiratory tract disease|Urogenital disease (female)|Urogenital disease (male)
Autoimmune limbic encephalitis	MESH:C531729			MESH:D001327|MESH:D020363	C01.207.245.700/C531729|C04.588.614.550.450/C531729|C04.730.856.437/C531729|C10.228.140.430.525/C531729|C10.228.228.245.700/C531729|C10.574.781.550/C531729|C10.586.250.525/C531729|C20.111/C531729	C01.207.245.700|C04.588.614.550.450|C04.730.856.437|C10.228.140.430.525|C10.228.228.245.700|C10.574.781.550|C10.586.250.525|C20.111		Cancer|Immune system disease|Nervous system disease
Autoimmune oophoritis	MESH:C538274			MESH:D009869|MESH:D016884	C12.050.351.500.056.630.450/C538274|C12.050.351.500.056.750.500/C538274|C12.100.250.056.630.450/C538274|C12.100.250.056.750.500/C538274|C19.391.630.450/C538274|C19.787/C538274|C20.111.750/C538274	C12.050.351.500.056.630.450|C12.050.351.500.056.750.500|C12.100.250.056.630.450|C12.100.250.056.750.500|C19.391.630.450|C19.787|C20.111.750		Endocrine system disease|Immune system disease|Urogenital disease (female)
Autoimmune Pancreatitis	MESH:D000081012	DO:DOID:0040091	Chronic pancreatitis associated with autoimmune diseases.	MESH:D001327|MESH:D050500	C06.689.750.830.500|C20.111.296|C23.550.291.500.750.500	C06.689.750.830|C20.111|C23.550.291.500.750	Autoimmune Pancreatitides|Duct-centric Pancreatitis, Idiopathic|Idiopathic Duct-centric Pancreatitides|Idiopathic Duct centric Pancreatitis|Idiopathic Duct-centric Pancreatitis|IgG4-related Pancreatitides|IgG4 related Pancreatitis|IgG4-related Pancreatitis|Pancreatitis, Autoimmune|Pancreatitis, Idiopathic Duct-centric|Pancreatitis, IgG4-related|Type 1 AIP|Type 1 Autoimmune Pancreatitis|Type 2 AIP|Type 2 Autoimmune Pancreatitis	Digestive system disease|Immune system disease|Pathology (process)
Autoimmune polyendocrinopathy syndrome, type 1	MESH:C538275	OMIM:240300		MESH:D016884	C19.787/C538275|C20.111.750/C538275	C19.787|C20.111.750	APECED|APS1|APS I|Autoimmune polyendocrine syndrome, type 1|AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA|AUTOIMMUNE POLYENDOCRINOPATHY-CANDIDIASIS-ECTODERMAL DYSTROPHY|Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)|Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant|Autoimmune Polyendocrinopathy Syndrome, Type I, With Reversible Metaphyseal Dysplasia|AUTOIMMUNE POLYGLANDULAR SYNDROME, TYPE I|Hypoadrenocorticism with hypoparathyroidism and superficial moniliasis|HYPOADRENOCORTICISM WITH HYPOPARATHYROIDISM AND SUPERFICIAL MONILIASIS AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I, AUTOSOMAL DOMINANT, INCLUDED|PGA I|POLYGLANDULAR AUTOIMMUNE SYNDROME, TYPE I|Polyglandular Deficiency Syndrome, Persian-Jewish Type|POLYGLANDULAR DEFICIENCY SYNDROME, PERSIAN-JEWISH TYPE, INCLUDED	Endocrine system disease|Immune system disease
Autonomic Dysreflexia	MESH:D020211		A syndrome associated with damage to the spinal cord above the mid thoracic level (see SPINAL CORD INJURIES) characterized by a marked increase in the sympathetic response to minor stimuli such as bladder or rectal distention. Manifestations include HYPERTENSION; TACHYCARDIA (or reflex bradycardia); FEVER; FLUSHING; and HYPERHIDROSIS. Extreme hypertension may be associated with a STROKE. (From Adams et al., Principles of Neurology, 6th ed, pp538 and 1232; J Spinal Cord Med 1997;20(3):355-60)	MESH:D001342|MESH:D013119	C10.177.090|C10.900.850.250	C10.177|C10.900.850	Autonomic Dysreflexias|Autonomic Dysreflexia, Spinal|Autonomic Dysreflexias, Spinal|Autonomic Hyperreflexia|Autonomic Hyperreflexias|Dysreflexia, Autonomic|Dysreflexias, Autonomic|Dysreflexia, Spinal Autonomic|Dysreflexias, Spinal Autonomic|Hyperreflexia, Autonomic|Hyperreflexias, Autonomic|Spinal Autonomic Dysreflexia|Spinal Autonomic Dysreflexias	Nervous system disease
Autonomic Nervous System Diseases	MESH:D001342		Diseases of the parasympathetic or sympathetic divisions of the AUTONOMIC NERVOUS SYSTEM; which has components located in the CENTRAL NERVOUS SYSTEM and PERIPHERAL NERVOUS SYSTEM. Autonomic dysfunction may be associated with HYPOTHALAMIC DISEASES; BRAIN STEM disorders; SPINAL CORD DISEASES; and PERIPHERAL NERVOUS SYSTEM DISEASES. Manifestations include impairments of vegetative functions including the maintenance of BLOOD PRESSURE; HEART RATE; pupil function; SWEATING; REPRODUCTIVE AND URINARY PHYSIOLOGY; and DIGESTION.	MESH:D009422	C10.177	C10	ANS (Autonomic Nervous System) Diseases|ANS Disease|ANS Diseases|Autonomic Central Nervous System Diseases|Autonomic Disease|Autonomic Diseases|Autonomic Dysfunction, Segmental|Autonomic Dysfunctions, Segmental|Autonomic Nervous System Disorders|Autonomic Peripheral Nervous System Diseases|Central Autonomic Nervous System Diseases|Disorders of the Autonomic Nervous System|Nervous System Diseases, Autonomic|Nervous System Diseases, Parasympathetic|Nervous System Diseases, Sympathetic|Parasympathetic Nervous System Diseases|Peripheral Autonomic Nervous System Diseases|Segmental Autonomic Dysfunction|Segmental Autonomic Dysfunctions|Sympathetic Nervous System Diseases	Nervous system disease
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy	MESH:C579932			MESH:D017034	C10.228.140.490.360.270/C579932|C10.228.140.490.493.188/C579932	C10.228.140.490.360.270|C10.228.140.490.493.188	Adnfle	Nervous system disease
Autosomal Recessive Cerebellar Ataxia Type 1	MESH:C579934			MESH:D002524	C10.228.140.252.190/C579934|C10.597.350.090.500/C579934|C23.888.592.350.090.200/C579934	C10.228.140.252.190|C10.597.350.090.500|C23.888.592.350.090.200	Arca1|Autosomal Recessive Spinocerebellar Ataxia 8|Recessive Ataxia of Beauce	Nervous system disease|Signs and symptoms
Autosomal recessive nonsyndromic congenital nuclear cataract	MESH:C537298			MESH:D002386	C11.510.245/C537298	C11.510.245	Congenital nuclear cataract, autosomal recessive	Eye disease
Avulavirus Infections	MESH:D045463		Infections with viruses of the genus AVULAVIRUS, family PARAMYXOVIRIDAE. This includes NEWCASTLE DISEASE and other infections of domestic fowl.	MESH:D018184	C01.925.782.580.600.080	C01.925.782.580.600	Avulavirus Infection|Infection, Avulavirus|Infections, Avulavirus	Viral disease
Axenfeld-Rieger anomaly with cardiac defects and sensorineural hearing loss	MESH:C537789			MESH:D000015|MESH:D005124|MESH:D006319|MESH:D006344	C09.218.458.341.887/C537789|C10.597.751.418.341.887/C537789|C11.250/C537789|C14.240.400.560.375/C537789|C14.280.400.560.375/C537789|C16.131.077/C537789|C16.131.240.400.560.375/C537789|C16.131.384/C537789|C23.888.592.763.393.341.887/C537789	C09.218.458.341.887|C10.597.751.418.341.887|C11.250|C14.240.400.560.375|C14.280.400.560.375|C16.131.077|C16.131.240.400.560.375|C16.131.384|C23.888.592.763.393.341.887	Axenfeld-Rieger anomaly with atrial septal defect and sensorineural hearing loss	Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Eye disease|Nervous system disease|Signs and symptoms
Axial osteomalacia	MESH:C537791			MESH:D010018	C05.116.198.816.640/C537791|C18.452.104.816.640/C537791|C18.452.174.845.640/C537791|C18.654.521.500.133.770.734.640/C537791	C05.116.198.816.640|C18.452.104.816.640|C18.452.174.845.640|C18.654.521.500.133.770.734.640	Atypical osteomalacia involving the axial skeleton	Metabolic disease|Musculoskeletal disease|Nutrition disorder
Axial osteosclerosis	MESH:C537792			MESH:D010026	C05.116.099.708.702/C537792	C05.116.099.708.702	Osteomesopyknosis	Musculoskeletal disease
Axial Spondyloarthritis	MESH:D000089183		A spectrum of chronic inflammatory conditions affecting the axial joints (e.g., SPINE), characterized by pain, stiffness of joints (ANKYLOSIS), reduced mobility and inflammation. When joint inflammation and damage are visible on regular X-rays it is called ANKYLOSING SPONDYLITIS; otherwise it is referred to as NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. HLA-B27 ANTIGEN is a biomarker and IL-23/IL-17 pathway a potential therapeutic target for axial and other related spondyloarthritis.	MESH:D000844|MESH:D025242	C05.116.900.853.625.800.744|C05.550.069.340|C05.550.114.865.800.744	C05.116.900.853.625.800|C05.550.069|C05.550.114.865.800	Axial Spondyloarthritides|AxSpA|Spondyloarthritides, Axial|Spondyloarthritis, Axial	Musculoskeletal disease
Azotemia	MESH:D053099		A biochemical abnormality referring to an elevation of BLOOD UREA NITROGEN and CREATININE. Azotemia can be produced by KIDNEY DISEASES or other extrarenal disorders. When azotemia becomes associated with a constellation of clinical signs, it is termed UREMIA.	MESH:D010335|MESH:D014511	C12.050.351.968.419.936.231|C12.200.777.419.936.231|C12.950.419.936.231|C23.550.145	C12.050.351.968.419.936|C12.200.777.419.936|C12.950.419.936|C23.550	Azotaemia	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Baby Rattle Pelvis Dysplasia	MESH:C565282			MESH:D001848	C05.116.099/C565282	C05.116.099		Musculoskeletal disease
BADS Syndrome	MESH:C562663			MESH:D006319|MESH:D010859	C09.218.458.341.887/C562663|C10.597.751.418.341.887/C562663|C17.800.621/C562663|C23.550.755/C562663|C23.888.592.763.393.341.887/C562663	C09.218.458.341.887|C10.597.751.418.341.887|C17.800.621|C23.550.755|C23.888.592.763.393.341.887	Black Locks with Albinism and Deafness Syndrome	Ear-nose-throat disease|Nervous system disease|Pathology (process)|Signs and symptoms|Skin disease
Baetz-Greenwalt syndrome	MESH:C537795			MESH:D002972|MESH:D006330|MESH:D008831|MESH:D008844	C05.500.460.185/C537795|C05.500.460.457/C537795|C05.660.207.540.460.185/C537795|C05.660.207.540.460.457/C537795|C05.660.207.620/C537795|C07.320.440.185/C537795|C07.320.440.457/C537795|C07.465.525.185/C537795|C07.650.500.460.185/C537795|C07.650.500.460.457/C537795|C07.650.525.185/C537795|C10.500.507.400.500/C537795|C14.240.400/C537795|C14.280.400/C537795|C16.131.240.400/C537795|C16.131.621.207.540.460.185/C537795|C16.131.621.207.540.460.457/C537795|C16.131.621.207.620/C537795|C16.131.666.507.400.500/C537795|C16.131.850.500.460.185/C537795|C16.131.850.500.460.457/C537795|C16.131.850.525.185/C537795	C05.500.460.185|C05.500.460.457|C05.660.207.540.460.185|C05.660.207.540.460.457|C05.660.207.620|C07.320.440.185|C07.320.440.457|C07.465.525.185|C07.650.500.460.185|C07.650.500.460.457|C07.650.525.185|C10.500.507.400.500|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.540.460.185|C16.131.621.207.540.460.457|C16.131.621.207.620|C16.131.666.507.400.500|C16.131.850.500.460.185|C16.131.850.500.460.457|C16.131.850.525.185	Hypoplastic right-sided heart complex	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease|Nervous system disease
Balantidiasis	MESH:D001447	DO:DOID:12386	Infection by parasites of the genus BALANTIDIUM. The presence of Balantidium in the LARGE INTESTINE leads to DIARRHEA; DYSENTERY; and occasionally ULCER.	MESH:D007411|MESH:D016770	C01.610.432.146|C01.610.752.200.146|C06.405.469.452.146	C01.610.432|C01.610.752.200|C06.405.469.452	Balantidiases|Balantidium coli Infection|Balantidium coli Infections|Balantidium Infection|Balantidium Infections|B. coli Infection|B. coli Infections|Infection, B. coli	Digestive system disease|Parasitic disease
Banti's syndrome	MESH:C537903			MESH:D006975|MESH:D008103|MESH:D010198|MESH:D013163	C06.552.494/C537903|C06.552.630/C537903|C15.378.700/C537903|C23.300.775.750/C537903|C23.550.355.412/C537903	C06.552.494|C06.552.630|C15.378.700|C23.300.775.750|C23.550.355.412	Banti's disease|Idiopathic congestive splenomegaly|Idiopathic portal hypertension	Blood disease|Digestive system disease|Pathology (anatomical condition)|Pathology (process)
Bantu siderosis	MESH:C537904			MESH:D000756	C15.378.071.419/C537904|C15.378.190.625.070/C537904	C15.378.071.419|C15.378.190.625.070	African iron overload|Hereditary iron overload and African Americans|Iron overload in Africa	Blood disease
Barakat syndrome	MESH:C537907	DO:DOID:0060878|OMIM:146255		MESH:D006319|MESH:D007011|MESH:D009401	C09.218.458.341.887/C537907|C10.597.751.418.341.887/C537907|C12.050.351.968.419.630/C537907|C12.200.777.419.630/C537907|C12.950.419.630/C537907|C19.642.482/C537907|C23.888.592.763.393.341.887/C537907	C09.218.458.341.887|C10.597.751.418.341.887|C12.050.351.968.419.630|C12.200.777.419.630|C12.950.419.630|C19.642.482|C23.888.592.763.393.341.887	BARAKAT SYNDROME|HDR|HDRS|HDR syndrome|Hypoparathyroidism, Sensorineural Deafness, And Renal Disease|HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME|Nephrosis, nerve deafness, and hypoparathyroidism	Ear-nose-throat disease|Endocrine system disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Baritosis	MESH:C537080	DO:DOID:10321		MESH:D011009	C08.381.483.581/C537080|C08.381.520.702/C537080|C24.800/C537080	C08.381.483.581|C08.381.520.702|C24.800	Deposition of barium in the lungs|Inhalation of barytes	Occupational disease|Respiratory tract disease
Barlow syndrome	MESH:C537478			MESH:D008945	C14.280.484.400.500/C537478	C14.280.484.400.500	Mitral regurgitation, familial|Mitral valve prolapse, familial, X-linked|Myxomatous valvular disease, familial	Cardiovascular disease
Barrett Esophagus	MESH:D001471	DO:DOID:9206|OMIM:614266	A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.	MESH:D004935|MESH:D011230	C04.834.154|C06.405.117.102	C04.834|C06.405.117	Barrett Epithelium|Barrett Metaplasia|BARRETT METAPLASIA  ADENOCARCINOMA OF ESOPHAGUS, INCLUDED|Barrett Metaplasias|Barrett's Esophagus|Barretts Esophagus|Barrett's Syndrome|Barretts Syndrome|Barrett Syndrome|Epithelium, Barrett|Esophagus, Barrett|Esophagus, Barrett's|Metaplasia, Barrett|Metaplasias, Barrett	Cancer|Digestive system disease
Bartter Syndrome	MESH:D001477	DO:DOID:445	A group of disorders caused by defective salt reabsorption in the ascending LOOP OF HENLE. It is characterized by severe salt-wasting, HYPOKALEMIA; HYPERCALCIURIA; metabolic ALKALOSIS, and hyper-reninemic HYPERALDOSTERONISM without HYPERTENSION. There are several subtypes including ones due to mutations in the renal specific SODIUM-POTASSIUM-CHLORIDE SYMPORTERS.	MESH:D006929|MESH:D015499	C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C19.053.800.604.249	C12.050.351.968.419.815|C12.200.777.419.815|C12.950.419.815|C19.053.800.604	Aldosteronism with Hyperplasia of the Adrenal Cortex|Bartter Disease|Bartter's Disease|Bartters Disease|Bartter's Syndrome|Bartters Syndrome|Juxtaglomerular Hyperplasia with Secondary Aldosteronism|Syndrome, Bartter|Syndrome, Bartter's	Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Bartter syndrome, antenatal type 1	MESH:C537652	OMIM:601678		MESH:D001477	C12.050.351.968.419.815.279/C537652|C12.200.777.419.815.279/C537652|C12.950.419.815.279/C537652|C19.053.800.604.249/C537652	C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C19.053.800.604.249	Antenatal Bartter syndrome type 1|BARTS1|Bartter Syndrome, Antenatal, Type 1|BARTTER SYNDROME, TYPE 1, ANTENATAL|Hyperprostaglandin E syndrome 1|HYPOKALEMIC ALKALOSIS WITH HYPERCALCIURIA 1, ANTENATAL|Hypokalemic alkalosis with hypercalciuria, antenatal|Hypokalemic Alkalosis With Hypercalciuria, Antenatal, 1	Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Bartter syndrome, antenatal , type 2	MESH:C537651	OMIM:241200		MESH:D001477	C12.050.351.968.419.815.279/C537651|C12.200.777.419.815.279/C537651|C12.950.419.815.279/C537651|C19.053.800.604.249/C537651	C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C19.053.800.604.249	BARTS2|Bartter Syndrome, Antenatal, Type 2|BARTTER SYNDROME, TYPE 2, ANTENATAL|Hyperprostaglandin E syndrome 2|HYPOKALEMIC ALKALOSIS WITH HYPERCALCIURIA 2, ANTENATAL|Hypokalemic alkalosis with hypercalciuria, antenatal 2|Hypokalemic Alkalosis With Hypercalciuria, Antenatal, 2	Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Bartter syndrome, type 3	MESH:C537653	OMIM:607364		MESH:D001477	C12.050.351.968.419.815.279/C537653|C12.200.777.419.815.279/C537653|C12.950.419.815.279/C537653|C19.053.800.604.249/C537653	C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C19.053.800.604.249	BARTS3|Bartter syndrome, classic|BARTTER SYNDROME, CLASSIC BARTTER SYNDROME, TYPE 3, WITH HYPOCALCIURIA, INCLUDED	Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Bartter Syndrome, Type 3, with Hypocalciuria	MESH:C564578			MESH:D001477	C12.050.351.968.419.815.279/C564578|C12.200.777.419.815.279/C564578|C12.950.419.815.279/C564578|C19.053.800.604.249/C564578	C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C19.053.800.604.249		Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Bartter Syndrome, Type 4A	MESH:C566530	OMIM:602522		MESH:D001477|MESH:D006319	C09.218.458.341.887/C566530|C10.597.751.418.341.887/C566530|C12.050.351.968.419.815.279/C566530|C12.200.777.419.815.279/C566530|C12.950.419.815.279/C566530|C19.053.800.604.249/C566530|C23.888.592.763.393.341.887/C566530	C09.218.458.341.887|C10.597.751.418.341.887|C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C19.053.800.604.249|C23.888.592.763.393.341.887	BARTS4A|BARTTER SYNDROME, NEONATAL, WITH SENSORINEURAL DEAFNESS;BSND  SENSORINEURAL DEAFNESS WITH MILD RENAL DYSFUNCTION, INCLUDED|BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	Ear-nose-throat disease|Endocrine system disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Bartter Syndrome, Type 4b	MESH:C567762	OMIM:613090		MESH:D001477|MESH:D006319	C09.218.458.341.887/C567762|C10.597.751.418.341.887/C567762|C12.050.351.968.419.815.279/C567762|C12.200.777.419.815.279/C567762|C12.950.419.815.279/C567762|C19.053.800.604.249/C567762|C23.888.592.763.393.341.887/C567762	C09.218.458.341.887|C10.597.751.418.341.887|C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C19.053.800.604.249|C23.888.592.763.393.341.887	BARTS4B|Bartter Syndrome, Infantile, with Sensorineural Deafness|BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	Ear-nose-throat disease|Endocrine system disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	OMIM:300971	DO:DOID:0110147		MESH:D001477	C12.050.351.968.419.815.279/300971|C12.200.777.419.815.279/300971|C12.950.419.815.279/300971|C19.053.800.604.249/300971	C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C19.053.800.604.249	BARTS5	Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Basal cell carcinoma, infundibulocystic	MESH:C537655			MESH:D002280	C04.557.470.200.165/C537655|C04.557.470.565.165/C537655	C04.557.470.200.165|C04.557.470.565.165	Basal cell carcinoma with follicular differentiation|Infundibulocystic basal cell carcinoma	Cancer
Basal Cell Carcinoma, Nonsyndromic	MESH:C567789			MESH:D002280	C04.557.470.200.165/C567789|C04.557.470.565.165/C567789	C04.557.470.200.165|C04.557.470.565.165		Cancer
Basal ganglia calcification, idiopathic 2	MESH:C537657			MESH:D001480|MESH:D002114	C10.228.140.079/C537657|C18.452.174.130/C537657	C10.228.140.079|C18.452.174.130	Basal Ganglia Calcification, Idiopathic, 2	Metabolic disease|Nervous system disease
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4	OMIM:615007	DO:DOID:0060230		MESH:D001480|MESH:D002114	C10.228.140.079/615007|C18.452.174.130/615007	C10.228.140.079|C18.452.174.130	IBGC4	Metabolic disease|Nervous system disease
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5	OMIM:615483	DO:DOID:0060230		MESH:D001480|MESH:D002114	C10.228.140.079/615483|C18.452.174.130/615483	C10.228.140.079|C18.452.174.130	IBGC5	Metabolic disease|Nervous system disease
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6	OMIM:616413			MESH:D001480|MESH:D002114	C10.228.140.079/616413|C18.452.174.130/616413	C10.228.140.079|C18.452.174.130	IBGC6	Metabolic disease|Nervous system disease
Basal Ganglia Cerebrovascular Disease	MESH:D020144	DO:DOID:10991	A pathological condition caused by impaired blood flow in the basal regions of cerebral hemispheres (BASAL GANGLIA), such as INFARCTION; HEMORRHAGE; or ISCHEMIA in vessels of this brain region including the lateral lenticulostriate arteries. Primary clinical manifestations include involuntary movements (DYSKINESIAS) and muscle weakness (HEMIPARESIS).	MESH:D001480|MESH:D002561	C10.228.140.079.127|C10.228.140.300.100|C14.907.253.061	C10.228.140.079|C10.228.140.300|C14.907.253	Basal Ganglia Vascular Disease|Cerebrovascular Disease, Basal Ganglia|Lenticulostriate Diseases, Vascular|Lenticulostriate Vascular Disease|Lenticulostriate Vascular Diseases|Lenticulostriate Vasculopathies|Lenticulostriate Vasculopathy|Vascular Disease, Basal Ganglia|Vascular Disease, Lenticulostriate|Vascular Diseases, Basal Ganglia|Vascular Diseases, Lenticulostriate|Vascular Lenticulostriate Diseases|Vasculopathies, Lenticulostriate|Vasculopathy, Lenticulostriate	Cardiovascular disease|Nervous system disease
Basal ganglia disease, biotin-responsive	MESH:C537658	DO:DOID:0050659|OMIM:607483		MESH:D001480	C10.228.140.079/C537658	C10.228.140.079	BASAL GANGLIA DISEASE, BIOTIN-RESPONSIVE|BBGD|Biotin-responsive basal ganglia disease|BTBGD|ENCEPHALOPATHY, THIAMINE-RESPONSIVE|THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)|THMD2	Nervous system disease
Basal Ganglia Diseases	MESH:D001480	DO:DOID:679	Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.	MESH:D001927	C10.228.140.079	C10.228.140	Basal Ganglia Disease|Basal Ganglia Disorder|Basal Ganglia Disorders|Extrapyramidal Disorder|Extrapyramidal Disorders|Lenticulostriate Disorder|Lenticulostriate Disorders	Nervous system disease
Basal Ganglia Hemorrhage	MESH:D020145		Bleeding within the subcortical regions of cerebral hemispheres (BASAL GANGLIA). It is often associated with HYPERTENSION or ARTERIOVENOUS MALFORMATIONS. Clinical manifestations may include HEADACHE; DYSKINESIAS; and HEMIPARESIS.	MESH:D002543|MESH:D020144	C10.228.140.079.127.500|C10.228.140.300.100.200|C10.228.140.300.535.200.150|C14.907.253.061.200|C14.907.253.573.200.150|C23.550.414.913.100.200	C10.228.140.079.127|C10.228.140.300.100|C10.228.140.300.535.200|C14.907.253.061|C14.907.253.573.200|C23.550.414.913.100	Basal Ganglionic Hemorrhage|Ganglionic Hemorrhage, Basal|Hematoma, Basal Ganglia|Hemorrhage, Basal Ganglia|Hemorrhage, Basal Ganglionic	Cardiovascular disease|Nervous system disease|Pathology (process)
Bazex-Dupre-Christol syndrome	MESH:C537663	OMIM:301845		MESH:D002280|MESH:D007039|MESH:D012878	C04.557.470.200.165/C537663|C04.557.470.565.165/C537663|C04.588.805/C537663|C17.800.329.937/C537663|C17.800.882/C537663	C04.557.470.200.165|C04.557.470.565.165|C04.588.805|C17.800.329.937|C17.800.882	BAZEX-DUPRE-CHRISTOL SYNDROME|Bazex syndrome|BDCS|BZX|Follicular atrophoderma and basal cell carcinomas|Follicular atrophoderma-basal cell carcinoma syndrome|Follicular atrophoderma-basocellular proliferations-hypotrichosis syndrome	Cancer|Skin disease
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY	OMIM:616452			MESH:C564707	C15.378.553.475.604/C564707/616452	C15.378.553.475.604/C564707	BENTA	Blood disease
BEAULIEU-BOYCOTT-INNES SYNDROME	OMIM:613680			MESH:D002658|MESH:D006330|MESH:D008607|MESH:D008831|MESH:D014564|MESH:D019066	C05.660.207.620/613680|C10.500.507.400.500/613680|C10.597.606.360/613680|C12.050.351.875/613680|C12.200.706/613680|C12.800/613680|C14.240.400/613680|C14.280.400/613680|C16.131.240.400/613680|C16.131.621.207.620/613680|C16.131.666.507.400.500/613680|C16.131.939/613680|C23.550.291.812/613680|C23.888.592.604.646/613680|F03.625.421/613680|F03.625.539/613680	C05.660.207.620|C10.500.507.400.500|C10.597.606.360|C12.050.351.875|C12.200.706|C12.800|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.620|C16.131.666.507.400.500|C16.131.939|C23.550.291.812|C23.888.592.604.646|F03.625.421|F03.625.539	BBIS|MICROCEPHALY, MENTAL RETARDATION, AND DISTINCTIVE FACIES, WITH CARDIAC AND GENITOURINARY MALFORMATIONS	Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Becker Nevus Syndrome	MESH:C565735			MESH:D009506|MESH:D012878	C04.557.665.560/C565735|C04.588.805/C565735|C17.800.882/C565735	C04.557.665.560|C04.588.805|C17.800.882		Cancer|Skin disease
Beemer Ertbruggen syndrome	MESH:C537668			MESH:D006330|MESH:D006849|MESH:D019066	C10.228.140.602/C537668|C14.240.400/C537668|C14.280.400/C537668|C16.131.240.400/C537668|C23.550.291.812/C537668	C10.228.140.602|C14.240.400|C14.280.400|C16.131.240.400|C23.550.291.812	Beemer lethal malformation syndrome	Cardiovascular disease|Congenital abnormality|Nervous system disease|Pathology (process)
Behr syndrome	MESH:C537669	DO:DOID:0111580|OMIM:210000		MESH:D001259|MESH:D008607|MESH:D009896|MESH:D013035|MESH:D034381	C09.218.458.341/C537669|C10.292.700.225/C537669|C10.597.350.090/C537669|C10.597.606.360/C537669|C10.597.613.750/C537669|C10.597.751.418.341/C537669|C11.640.451/C537669|C23.888.592.350.090/C537669|C23.888.592.604.646/C537669|C23.888.592.608.750/C537669|C23.888.592.763.393.341/C537669|F03.625.539/C537669	C09.218.458.341|C10.292.700.225|C10.597.350.090|C10.597.606.360|C10.597.613.750|C10.597.751.418.341|C11.640.451|C23.888.592.350.090|C23.888.592.604.646|C23.888.592.608.750|C23.888.592.763.393.341|F03.625.539	BEHRS|Optic atrophy, infantile hereditary, Behr complicated form of|Optic Atrophy, Infantile Hereditary, With Neurologic Abnormalities	Ear-nose-throat disease|Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Bell Palsy	MESH:D020330	DO:DOID:12506	A syndrome characterized by the acute onset of unilateral FACIAL PARALYSIS which progresses over a 2-5 day period. Weakness of the orbicularis oculi muscle and resulting incomplete eye closure may be associated with corneal injury. Pain behind the ear often precedes the onset of paralysis. This condition may be associated with HERPESVIRUS 1, HUMAN infection of the facial nerve. (Adams et al., Principles of Neurology, 6th ed, p1376)	MESH:D005155|MESH:D006566|MESH:D009059	C01.925.256.466.087|C07.465.094|C07.465.299.250|C10.292.319.250	C01.925.256.466|C07.465|C07.465.299|C10.292.319	Acute Idiopathic Facial Neuropathy|Acute Inflammatory Facial Neuropathy|Bell Palsies|Bell's Palsies|Bell's Palsy|Bells Palsy|Facial Neuropathy, Idiopathic Acute|Facial Neuropathy, Inflammatory, Acute|Facial Paralyses, Herpetic|Facial Paralyses, Idiopathic|Facial Paralysis, Herpetic|Facial Paralysis, Idiopathic|Herpetic Facial Paralyses|Herpetic Facial Paralysis|Idiopathic Acute Facial Neuropathy|Idiopathic Facial Paralyses|Idiopathic Facial Paralysis|Inflammatory Facial Neuropathy, Acute|Palsies, Bell|Palsies, Bell's|Palsy, Bell|Palsy, Bell's|Paralyses, Herpetic Facial|Paralyses, Idiopathic Facial|Paralysis, Herpetic Facial|Paralysis, Idiopathic Facial	Mouth disease|Nervous system disease|Viral disease
Benign essential blepharospasm	MESH:C535428	OMIM:606798		MESH:D001764	C11.338.250/C535428	C11.338.250	Blepharospasm, Benign Essential|BLEPHAROSPASM, BENIGN ESSENTIAL, SUSCEPTIBILITY TO|Essential Blepharospasm|Eyelid Twitching|Primary Blepharospasm|Spasm of Eyelids	Eye disease
Benign non-infected urachal cyst	MESH:C531841			MESH:D014496	C04.182.946/C531841	C04.182.946	Giant urachal cyst|Infected urachal cyst|Inflamed urachal cyst	Cancer
Benign Paroxysmal Positional Vertigo	MESH:D065635	DO:DOID:13941|OMIM:193007	Idiopathic recurrent VERTIGO associated with POSITIONAL NYSTAGMUS. It is associated with a vestibular loss without other neurological or auditory signs. Unlike in LABYRINTHITIS and VESTIBULAR NEURONITIS, inflammation in the ear is not observed.	MESH:D014717	C09.218.568.900.883.500|C10.597.951.500|C23.888.592.958.500	C09.218.568.900.883|C10.597.951|C23.888.592.958	Benign Recurrent Vertigo|Benign Recurrent Vertigos|BPPV|BRV|BRV1, INCLUDED|Familial Benign Recurrent Vertigo|Familial Vestibulopathies|Familial Vestibulopathy|Recurrent Vertigo, Benign|Recurrent Vertigos, Benign|Vertigo, Benign Paroxysmal Positional|Vertigo, Benign Recurrent|Vestibulopathies, Familial|Vestibulopathy, Familial|VESTIBULOPATHY, FAMILIAL  VERTIGO, BENIGN RECURRENT, 1, INCLUDED	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
BENT BONE DYSPLASIA SYNDROME	OMIM:614592	DO:DOID:10591		MESH:D001848	C05.116.099/614592	C05.116.099	BBDS	Musculoskeletal disease
Berry Aneurysm, Cirrhosis, Pulmonary Emphysema, and Cerebral Calcification	MESH:C565905			MESH:D002114|MESH:D002532|MESH:D011656	C08.381.495.389.750/C565905|C10.228.140.300.510.600/C565905|C14.907.055.635/C565905|C14.907.253.560.300/C565905|C18.452.174.130/C565905|C23.550.291.500.875.875/C565905	C08.381.495.389.750|C10.228.140.300.510.600|C14.907.055.635|C14.907.253.560.300|C18.452.174.130|C23.550.291.500.875.875	Cerebral Aneurysm-Cirrhosis Syndrome	Cardiovascular disease|Metabolic disease|Nervous system disease|Pathology (process)|Respiratory tract disease
Berylliosis	MESH:D001607	DO:DOID:10322	A form of pneumoconiosis caused by inhaled rare metal BERYLLIUM or its soluble salts which are used in a wide variety of industry including alloys, ceramics, radiographic equipment, and vacuum tubes. Berylliosis is characterized by an acute inflammatory reaction in the upper airway leading to BRONCHIOLITIS; PULMONARY EDEMA; and pneumonia.	MESH:D011009	C08.381.483.581.225|C08.381.520.702.225|C24.800.225	C08.381.483.581|C08.381.520.702|C24.800	Beryllioses|Beryllium Disease	Occupational disease|Respiratory tract disease
BESTROPHINOPATHY, AUTOSOMAL RECESSIVE	OMIM:611809	DO:DOID:0050662		MESH:D012164	C11.768/611809	C11.768	ARB	Eye disease
Bicuspid Aortic Valve Disease	MESH:D000082882		Congenital heart valve defects where the AORTIC VALVE has two instead of normal three cusps. It is often associated with AORTIC REGURGITATION and AORTIC INSUFFICIENCY.	MESH:D000082862|MESH:D006330	C14.240.400.186|C14.280.400.186|C14.280.484.048.875|C16.131.240.400.186	C14.240.400|C14.280.400|C14.280.484.048|C16.131.240.400	Aortic Valve, Bicuspid|Aortic Valve Disease 1|Bicuspid Aortic Valve|Bicuspid Aortic Valves|Valve, Bicuspid Aortic	Cardiovascular disease|Congenital abnormality
Bidirectional tachycardia	MESH:C535438			MESH:D013610	C14.280.067.845/C535438|C14.280.123.875/C535438|C23.550.073.845/C535438	C14.280.067.845|C14.280.123.875|C23.550.073.845	Bidirectional ventricular tachycardia	Cardiovascular disease|Pathology (process)
Bifid nose	MESH:C535441			MESH:D009668	C08.460/C535441|C09.603/C535441	C08.460|C09.603	Bifid Nose, Autosomal Dominant|Bifid Nose, Autosomal Recessive|Median fissure of nose|Nose, median cleft of	Ear-nose-throat disease|Respiratory tract disease
Bifid Nose With Or Without Anorectal And Renal Anomalies	MESH:C567672	OMIM:608980		MESH:D007674|MESH:D012002	C06.405.469.860/C567672|C12.050.351.968.419/C567672|C12.200.777.419/C567672|C12.950.419/C567672	C06.405.469.860|C12.050.351.968.419|C12.200.777.419|C12.950.419	BNAR	Digestive system disease|Urogenital disease (female)|Urogenital disease (male)
Bilateral Kienbock's disease	MESH:C538558			MESH:D010020	C05.116.852/C538558|C23.550.717.732/C538558	C05.116.852|C23.550.717.732		Musculoskeletal disease|Pathology (process)
Bilateral Optic Nerve Meningioma	MESH:C000608854	DO:DOID:6335		MESH:D008579|MESH:D019574	C04.557.580.520/C000608854|C04.557.645.520/C000608854|C04.588.614.250.580.500/C000608854|C04.588.614.300.600/C000608854|C04.588.614.596.240.240/C000608854|C10.292.225.800/C000608854|C10.292.700.500/C000608854|C10.551.240.500.500/C000608854|C10.551.360.500/C000608854|C10.551.775.250.500/C000608854|C11.640.544/C000608854	C04.557.580.520|C04.557.645.520|C04.588.614.250.580.500|C04.588.614.300.600|C04.588.614.596.240.240|C10.292.225.800|C10.292.700.500|C10.551.240.500.500|C10.551.360.500|C10.551.775.250.500|C11.640.544	Bilateral Meningioma of the Optic Nerve	Cancer|Eye disease|Nervous system disease
Bilateral Vestibulopathy	MESH:D000071699		Impairment of the vestibular function of both inner ears which can cause difficulties with balance, gait, VERTIGO, and visual blurring.	MESH:D009461|MESH:D015837	C09.218.568.900.442|C10.597.057|C23.888.592.057	C09.218.568.900|C10.597|C23.888.592	Bilateral Vestibular Deficiency|Bilateral Vestibular Insufficiency|Bilateral Vestibular Loss|Vestibular Areflexia|Vestibular Deficiency, Bilateral|Vestibular Insufficiency, Bilateral|Vestibular Loss, Bilateral|Vestibulopathy, Bilateral	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Bile Acid Malabsorption, Primary	MESH:C567652	OMIM:613291		MESH:D003967|MESH:D045602	C06.405.469.637.887/C567652|C18.452.603.887/C567652|C23.888.821.214/C567652	C06.405.469.637.887|C18.452.603.887|C23.888.821.214	BILE ACID MALABSORPTION, PRIMARY, 1|PBAM|PBAM1	Digestive system disease|Metabolic disease|Signs and symptoms
Bile Duct Neoplasms	MESH:D001650	DO:DOID:4606|DO:DOID:4897	Tumors or cancer of the BILE DUCTS.	MESH:D001649|MESH:D001661	C04.588.274.120.250|C06.130.120.120|C06.130.320.120|C06.301.120.250	C04.588.274.120|C06.130.120|C06.130.320|C06.301.120	Bile Duct Cancer|Bile Duct Cancers|Bile Duct Neoplasm|Cancer, Bile Duct|Cancer of Bile Duct|Cancer of the Bile Duct|Cancers, Bile Duct|Neoplasm, Bile Duct|Neoplasms, Bile Duct	Cancer|Digestive system disease
Biliary Cirrhosis, Primary, 2	MESH:C567817	OMIM:613007		MESH:D008105	C06.130.120.135.250.250/C567817|C06.552.150.250/C567817|C06.552.630.400/C567817|C23.550.355.412.400/C567817	C06.130.120.135.250.250|C06.552.150.250|C06.552.630.400|C23.550.355.412.400	PBC2	Digestive system disease|Pathology (process)
Biliary Cirrhosis, Primary, 3	MESH:C567816	OMIM:613008		MESH:D008105	C06.130.120.135.250.250/C567816|C06.552.150.250/C567816|C06.552.630.400/C567816|C23.550.355.412.400/C567816	C06.130.120.135.250.250|C06.552.150.250|C06.552.630.400|C23.550.355.412.400	PBC3	Digestive system disease|Pathology (process)
Biliary Fistula	MESH:D001658		Abnormal passage in any organ of the biliary tract or between biliary organs and other organs.	MESH:D016154	C06.267.150|C23.300.575.185.150	C06.267|C23.300.575.185	Biliary Fistulas|Fistula, Biliary|Fistulas, Biliary	Digestive system disease|Pathology (anatomical condition)
Biliary Tract Neoplasms	MESH:D001661	DO:DOID:4607	Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.	MESH:D001660|MESH:D004067	C04.588.274.120|C06.130.320|C06.301.120	C04.588.274|C06.130|C06.301	Biliary Tract Cancer|Biliary Tract Cancers|Biliary Tract Neoplasm|Cancer, Biliary Tract|Cancer of Biliary Tract|Cancer of the Biliary Tract|Cancers, Biliary Tract|Neoplasm, Biliary Tract|Neoplasms, Biliary Tract	Cancer|Digestive system disease
Bird Fancier's Lung	MESH:D001716	DO:DOID:13891	A form of alveolitis or pneumonitis due to an acquired hypersensitivity to inhaled avian antigens, usually proteins in the dust of bird feathers and droppings.	MESH:D000542|MESH:D009784	C08.381.483.125.125|C08.674.055.125|C20.543.480.680.075.125|C24.125	C08.381.483.125|C08.674.055|C20.543.480.680.075|C24	Avian Hypersensitivity Pneumonitides|Avian Hypersensitivity Pneumonitis|Bird Fancier Lung|Bird Fanciers Lung|Bird Fancier's Lungs|Budgerigar Fancier Lung|Budgerigar Fancier's Lung|Budgerigar Fanciers Lung|Budgerigar Fancier's Lungs|Hypersensitivity Pneumonitides, Avian|Hypersensitivity Pneumonitis, Avian|Lung, Bird Fancier's|Lung, Budgerigar Fancier's|Lung, Pigeon Breeder's|Lungs, Bird Fancier's|Lungs, Budgerigar Fancier's|Lungs, Pigeon Breeder's|Pigeon Breeder Lung|Pigeon Breeder's Lung|Pigeon Breeders Lung|Pigeon Breeder's Lungs|Pneumonitides, Avian Hypersensitivity|Pneumonitis, Avian Hypersensitivity|Pneumonitis, Hypersensitivity, Avian	Immune system disease|Occupational disease|Respiratory tract disease
Birdshot Chorioretinopathy	MESH:D000080365	DO:DOID:0111079	A form of chorioretinitis characterized by multiple small, cream-colored LESIONS, symmetrically scattered mainly around the OPTIC DISK. These lesions are the most distinctive sign and often appear at the level of the RETINAL PIGMENT EPITHELIUM but, on occasion, suggest an even deeper infiltration and may ultimately lead to visual loss. An association with HLA-A29 antigen (see HLA-A ANTIGENS) has been observed in nearly all patients.	MESH:D000080363|MESH:D001327|MESH:D002825	C11.768.773.348.500|C11.941.160.478.400.500|C11.941.879.780.900.300.318.500|C11.941.879.780.900.650.250|C20.111.303	C11.768.773.348|C11.941.160.478.400|C11.941.879.780.900.300.318|C11.941.879.780.900.650|C20.111	Birdshot Chorioretinitis|Birdshot Chorioretinopathies|Birdshot Retinochoroiditides|Birdshot Retinochoroiditis|Birdshot Retinochoroidopathies|Birdshot Retinochoroidopathy|Chorioretinitis, Birdshot|Chorioretinopathy, Birdshot|Retinochoroiditis, Birdshot|Retinochoroidopathy, Birdshot	Eye disease|Immune system disease
Birnaviridae Infections	MESH:D018175		Virus diseases caused by the BIRNAVIRIDAE.	MESH:D012327	C01.925.782.123	C01.925.782	Birnaviridae Infection|Infection, Birnaviridae|Infections, Birnaviridae	Viral disease
Bisphosphonate-Associated Osteonecrosis of the Jaw	MESH:D059266		Necrotic jaws or other maxillofacial skeleton necrosis associated with bisphosphonate use (see BISPHOSPHONATES). Injury, dental procedures, and trauma can trigger the necrotic process.	MESH:D007571|MESH:D010020	C05.116.852.087|C05.500.086|C07.320.086|C23.550.717.732.183	C05.116.852|C05.500|C07.320|C23.550.717.732	Bisphosphonate-Associated Osteonecroses|Bisphosphonate Associated Osteonecrosis|Bisphosphonate-Associated Osteonecrosis|Bisphosphonate Associated Osteonecrosis of the Jaw|Bisphosphonate Associated Osteonecrosis of the Jaws|Bisphosphonate-Associated Osteonecrosis of the Jaws|Bisphosphonate Induced Osteonecrosis of the Jaw|Bisphosphonate-Induced Osteonecrosis of the Jaw|Bisphosphonate Induced Osteonecrosis of the Jaws|Bisphosphonate-Induced Osteonecrosis of the Jaws|Bisphosphonate Osteonecroses|Bisphosphonate Osteonecrosis|Bisphosphonate Related Osteonecrosis of the Jaw|Bisphosphonate-Related Osteonecrosis of the Jaw|Osteonecroses, Bisphosphonate|Osteonecroses, Bisphosphonate-Associated|Osteonecrosis, Bisphosphonate|Osteonecrosis, Bisphosphonate-Associated|Osteonecrosis of the Jaw, Bisphosphonate Associated|Osteonecrosis of the Jaw, Bisphosphonate-Associated|Osteonecrosis of the Jaw, Bisphosphonate Induced|Osteonecrosis of the Jaw, Bisphosphonate-Induced|Osteonecrosis of the Jaw, Bisphosphonate Related|Osteonecrosis of the Jaw, Bisphosphonate-Related|Osteonecrosis of the Jaws, Bisphosphonate Associated|Osteonecrosis of the Jaws, Bisphosphonate-Associated|Osteonecrosis of the Jaws, Bisphosphonate Induced|Osteonecrosis of the Jaws, Bisphosphonate-Induced|Osteonecrosis of the Jaws, Bisphosphonate Related|Osteonecrosis of the Jaws, Bisphosphonate-Related	Mouth disease|Musculoskeletal disease|Pathology (process)
Bixler Christian Gorlin syndrome	MESH:C537632	DO:DOID:14670		MESH:D002971|MESH:D002972|MESH:D006330|MESH:D008831|MESH:D065817	C05.500.460.185/C537632|C05.660.207.540.460.185/C537632|C05.660.207.620/C537632|C07.320.440.185/C537632|C07.465.409.225/C537632|C07.465.525.164/C537632|C07.465.525.185/C537632|C07.650.500.460.185/C537632|C07.650.525.164/C537632|C07.650.525.185/C537632|C09.218.235/C537632|C10.500.507.400.500/C537632|C14.240.400/C537632|C14.280.400/C537632|C16.131.240.400/C537632|C16.131.287/C537632|C16.131.621.207.540.460.185/C537632|C16.131.621.207.620/C537632|C16.131.666.507.400.500/C537632|C16.131.850.500.460.185/C537632|C16.131.850.525.164/C537632|C16.131.850.525.185/C537632	C05.500.460.185|C05.660.207.540.460.185|C05.660.207.620|C07.320.440.185|C07.465.409.225|C07.465.525.164|C07.465.525.185|C07.650.500.460.185|C07.650.525.164|C07.650.525.185|C09.218.235|C10.500.507.400.500|C14.240.400|C14.280.400|C16.131.240.400|C16.131.287|C16.131.621.207.540.460.185|C16.131.621.207.620|C16.131.666.507.400.500|C16.131.850.500.460.185|C16.131.850.525.164|C16.131.850.525.185	HMC Syndrome|Hypertelorism microtia facial clefting syndrome|Hypertelorism, Microtia, Facial Clefting Syndrome	Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Mouth disease|Musculoskeletal disease|Nervous system disease
Bjornstad syndrome	MESH:C537633	DO:DOID:0050677|OMIM:262000		MESH:D006201|MESH:D006319|MESH:D028361	C09.218.458.341.887/C537633|C10.597.751.418.341.887/C537633|C17.800.329/C537633|C18.452.660/C537633|C23.888.592.763.393.341.887/C537633	C09.218.458.341.887|C10.597.751.418.341.887|C17.800.329|C18.452.660|C23.888.592.763.393.341.887	BJS|Deafness and pili torti, Bjornstad type|Pili torti and nerve deafness|Pili torti-sensorineural hearing loss|PTD	Ear-nose-throat disease|Metabolic disease|Nervous system disease|Signs and symptoms|Skin disease
Bladder Diverticulum	MESH:C562406	DO:DOID:11353		MESH:D004240	C06.405.205.282.750/C562406|C23.300.415/C562406	C06.405.205.282.750|C23.300.415		Digestive system disease|Pathology (anatomical condition)
Blast Crisis	MESH:D001752		An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%.	MESH:D002471|MESH:D015464	C04.557.337.539.250.100|C04.697.098.500.110|C15.378.190.636.370.100|C23.550.291.500.485.100|C23.550.727.098.500.110	C04.557.337.539.250|C04.697.098.500|C15.378.190.636.370|C23.550.291.500.485|C23.550.727.098.500	Blast Crises|Blast Phase|Blast Phases|Crises, Blast|Crisis, Blast|Phase, Blast|Phases, Blast	Blood disease|Cancer|Pathology (process)
Blastocystis Infections	MESH:D016776		Infections with organisms of the genus BLASTOCYSTIS. The species B. hominis is responsible for most infections. Parasitologic surveys have generally found small numbers of this species in human stools, but higher positivity rates and organism numbers in AIDS patients and other immunosuppressed patients (IMMUNOCOMPROMISED HOST). Symptoms include ABDOMINAL PAIN; DIARRHEA; CONSTIPATION; VOMITING; and FATIGUE.	MESH:D000562|MESH:D007411	C01.610.432.250|C01.610.752.049.250|C06.405.469.452.250	C01.610.432|C01.610.752.049|C06.405.469.452	Blastocystis hominis Infection|Blastocystis hominis Infections|Blastocystis Infection|Infection, Blastocystis|Infection, Blastocystis hominis|Infections, Blastocystis|Infections, Blastocystis hominis	Digestive system disease|Parasitic disease
Blau syndrome	MESH:C538157	OMIM:186580		MESH:D001168|MESH:D012507|MESH:D013585|MESH:D014605	C05.550.114/C538157|C05.550.870/C538157|C11.941.879/C538157|C15.604.515.827/C538157	C05.550.114|C05.550.870|C11.941.879|C15.604.515.827	ACUG|Arthrocutaneouveal granulomatosis|BLAUS|Early-Onset Sarcoidosis|EOS|Familial Granulomatosis, Blau Type|Familial Juvenile Systemic Granulomatosis|Granulomatosis, familial, Blau type|Granulomatosis, familial juvenile systemic|Granulomatous inflammatory arthritis, dermatitis, and uveitis, familial|Jabs syndrome|Pediatric Granulomatous Arthritis|Sarcoidosis, Early-Onset|Synovitis granulomatous with uveitis and cranial neuropathies|Synovitis, Granulomatous, With Uveitis And Cranial Neuropathies	Eye disease|Lymphatic disease|Musculoskeletal disease
Bleeding Disorder due to Defective Thromboxane A2 Receptor	MESH:C566055	OMIM:614009		MESH:D001778	C15.378.100/C566055	C15.378.100	BDPLT13|BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO|BLEEDING DISORDER, SUSCEPTIBILITY TO, DUE TO DEFECTIVE PLATELET THROMBOXANE A2 RECEPTOR	Blood disease
Bleeding Disorder, East Texas Type	MESH:C565275	OMIM:605913		MESH:D001778	C15.378.100/C565275	C15.378.100	BDET	Blood disease
BLEEDING DISORDER, PLATELET-TYPE, 11	OMIM:614201	DO:DOID:0111057		MESH:D001791|MESH:D006470	C15.378.140/614201|C23.550.414/614201	C15.378.140|C23.550.414	BDPLT11|GLYCOPROTEIN VI DEFICIENCY|GP VI DEFICIENCY	Blood disease|Pathology (process)
BLEEDING DISORDER, PLATELET-TYPE, 15	OMIM:615193	DO:DOID:0111053		MESH:D013921	C15.378.140.855/615193	C15.378.140.855	BDPLT15|MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, ACTN1-RELATED	Blood disease
BLEEDING DISORDER, PLATELET-TYPE, 18	OMIM:615888	DO:DOID:0111051		MESH:D001791|MESH:D006470	C15.378.140/615888|C23.550.414/615888	C15.378.140|C23.550.414	BDPLT18	Blood disease|Pathology (process)
BLEEDING DISORDER, PLATELET-TYPE, 19	OMIM:616176	DO:DOID:0111048		MESH:D001791|MESH:D006470	C15.378.140/616176|C23.550.414/616176	C15.378.140|C23.550.414	BDPLT19	Blood disease|Pathology (process)
BLEEDING DISORDER, PLATELET-TYPE, 20	OMIM:616913	DO:DOID:0111055		MESH:D001791|MESH:D006470	C15.378.140/616913|C23.550.414/616913	C15.378.140|C23.550.414	BDPLT20	Blood disease|Pathology (process)
BLEEDING DISORDER, PLATELET-TYPE, 21	OMIM:617443			MESH:D001791|MESH:D006470	C15.378.140/617443|C23.550.414/617443	C15.378.140|C23.550.414	BDPLT21	Blood disease|Pathology (process)
BLEEDING DISORDER, PLATELET-TYPE, 8	OMIM:609821	DO:DOID:0060692		MESH:D001791|MESH:D006470	C15.378.140/609821|C23.550.414/609821	C15.378.140|C23.550.414	BDPLT8|BLEEDING DISORDER DUE TO P2RY12 DEFECT	Blood disease|Pathology (process)
BLEEDING DISORDER, PLATELET-TYPE, 9	OMIM:614200	DO:DOID:0111045		MESH:D001791|MESH:D006470	C15.378.140/614200|C23.550.414/614200	C15.378.140|C23.550.414	BDPLT9|COLLAGEN PLATELET RECEPTOR DEFICIENCY|GLYCOPROTEIN Ia DEFICIENCY|GP Ia DEFICIENCY	Blood disease|Pathology (process)
Blepharitis	MESH:D001762	DO:DOID:9423	Inflammation of the eyelids.	MESH:D005141	C11.338.133	C11.338	Blepharitides	Eye disease
Blepharochalasis, Superior	MESH:C566223			MESH:D005141	C11.338/C566223	C11.338		Eye disease
Blepharophimosis syndrome Ohdo type	MESH:C536232	DO:DOID:0060289|OMIM:300895		MESH:D000015|MESH:D001763|MESH:D006330|MESH:D008607|MESH:D016569	C10.597.606.360/C536232|C11.250.090/C536232|C11.338.190/C536232|C11.338.204/C536232|C14.240.400/C536232|C14.280.400/C536232|C16.131.077/C536232|C16.131.240.400/C536232|C16.131.384.190/C536232|C23.888.592.604.646/C536232|F03.625.539/C536232	C10.597.606.360|C11.250.090|C11.338.190|C11.338.204|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.384.190|C23.888.592.604.646|F03.625.539	BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNER TYPE|Mental retardation, congenital heart disease, blepharophimosis, blepharoptosis and hypoplastic teeth|Mental Retardation, Congenital Heart Disease, Blepharophimosis, Blepharoptosis, And Hypoplastic Teeth|Ohdo Blepharophimosis syndrome|Ohdo Madokoro Sonoda syndrome|OHDO SYNDROME, X-LINKED|OHDOX	Cardiovascular disease|Congenital abnormality|Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Blepharoptosis	MESH:D001763	DO:DOID:0060260	Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.	MESH:D005141	C11.338.204	C11.338	Blepharoptoses|Eyelid Ptoses|Eyelid Ptosis|Ptoses, Eyelid|Ptosis, Eyelid	Eye disease
Blepharospasm	MESH:D001764	DO:DOID:529	Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.	MESH:D005141	C11.338.250	C11.338	Blepharospasms	Eye disease
Blind Loop Syndrome	MESH:D001765	DO:DOID:10606	A malabsorption syndrome that is associated with a blind loop in the upper SMALL INTESTINE that is characterized by the lack of peristaltic movement, stasis of INTESTINAL CONTENTS, and the overgrowth of BACTERIA. Such bacterial overgrowth interferes with BILE SALTS action, FATTY ACIDS processing, MICROVILLI integrity, and the ABSORPTION of nutrients such as VITAMIN B12 and FOLIC ACID.	MESH:D008286	C06.405.469.637.145|C18.452.603.145	C06.405.469.637|C18.452.603	Bacterial Overgrowth Syndrome|Loop Syndromes, Stagnant|Loop Syndrome, Stagnant|Stagnant Loop Syndrome|Stagnant Loop Syndromes|Syndrome, Bacterial Overgrowth|Syndrome, Blind Loop|Syndromes, Stagnant Loop|Syndrome, Stagnant Loop	Digestive system disease|Metabolic disease
Blindness	MESH:D001766		The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.	MESH:D014786	C10.597.751.941.162|C11.966.075|C23.888.592.763.941.162	C10.597.751.941|C11.966|C23.888.592.763.941	Acquired Blindness|Amauroses|Amaurosis|Bilateral Blindness|Bilateral Blindnesses|Blindness, Acquired|Blindness, Bilateral|Blindness, Complete|Blindness, Hysterical|Blindness, Legal|Blindness, Monocular|Blindness, Transient|Blindness, Unilateral|Complete Blindness|Hysterical Blindness|Legal Blindness|Monocular Blindness|Sudden Visual Loss|Sudden Visual Losses|Transient Blindness|Unilateral Blindness|Visual Loss, Sudden	Eye disease|Nervous system disease|Signs and symptoms
Blindness, Cortical	MESH:D019575	DO:DOID:11831	Total loss of vision in all or part of the visual field due to bilateral OCCIPITAL LOBE (i.e., VISUAL CORTEX) damage or dysfunction. Anton syndrome is characterized by the psychic denial of true, organic cortical blindness. (Adams et al., Principles of Neurology, 6th ed, p460)	MESH:D001766	C10.597.751.941.162.250|C11.966.075.250|C23.888.592.763.941.162.250	C10.597.751.941.162|C11.966.075|C23.888.592.763.941.162	Anton Babinski Syndrome|Anton-Babinski Syndrome|Anton's Syndrome|Antons Syndrome|Anton's Syndrome, Transient|Anton Syndrome|Blindness, Cortical, Post-Ictal|Blindness, Cortical, Transient|Blindnesses, Reversible Cortical|Blindness, Reversible Cortical|Cortical Blindness|Cortical Blindnesses, Reversible|Cortical Blindness, Reversible|Psychic Denial of Blindness|Reversible Cortical Blindness|Reversible Cortical Blindnesses|Syndrome, Anton|Syndrome, Anton-Babinski|Syndrome, Anton's|Syndrome, Transient Anton's|Transient Anton's Syndrome|Transient Antons Syndrome|Transient Anton Syndrome	Eye disease|Nervous system disease|Signs and symptoms
Blister	MESH:D001768		Visible accumulations of fluid within or beneath the epidermis.	MESH:D012872|MESH:D020763	C17.800.865.187|C23.300.122	C17.800.865|C23.300	Bleb|Blebs|Blisters|Bulla|Bullae|Bullous Lesion|Bullous Lesions|Lesion, Bullous|Lesions, Bullous|Vesication|Vesications	Pathology (anatomical condition)|Skin disease
Blood Coagulation Disorders	MESH:D001778	DO:DOID:1247	Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.	MESH:D006402	C15.378.100	C15.378	Blood Coagulation Disorder|Coagulation Disorder, Blood|Coagulation Disorders, Blood|Disorder, Blood Coagulation|Disorders, Blood Coagulation	Blood disease
Blood Platelet Disorders	MESH:D001791	DO:DOID:2218	Disorders caused by abnormalities in platelet count or function.	MESH:D006402	C15.378.140	C15.378	Blood Platelet Disorder|Disorder, Blood Platelet|Disorders, Blood Platelet|Platelet Disorder, Blood|Platelet Disorders, Blood|Thrombocytopathies|Thrombocytopathy	Blood disease
Blood Protein Disorders	MESH:D001796	DO:DOID:620	Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS.	MESH:D006402	C15.378.147	C15.378	Blood Protein Disorder|Disorder, Blood Protein|Disorders, Blood Protein|Protein Disorder, Blood|Protein Disorders, Blood	Blood disease
Blount disease	MESH:C536237			MESH:D001848|MESH:D055034	C05.116.099/C536237|C05.116.821/C536237	C05.116.099|C05.116.821	Osteochondrosis Deformans Tibiae|Osteochondrosis deformans tibiae, familial infantile type|Tibia vara	Musculoskeletal disease
Blue cone monochromatism	MESH:C536238	OMIM:303700		MESH:D003117	C10.597.751.941.256/C536238|C11.270.151.500/C536238|C11.966.256/C536238|C23.888.592.763.941.256/C536238	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	BCM|Blue cone monochromacy|BLUE CONE MONOCHROMATISM|COD5, INCLUDED|Color blindness blue mono cone monochromatic type|Colorblindness, Blue-Mono-Cone-Monochromatic Type|COLORBLINDNESS, BLUE-MONO-CONE-MONOCHROMATIC TYPE;CBBM CONE DYSTROPHY 5, X-LINKED, INCLUDED	Eye disease|Nervous system disease|Signs and symptoms
Blue Nevi, Familial Multiple	MESH:C566346			MESH:D018329	C04.557.665.560.615.550/C566346	C04.557.665.560.615.550		Cancer
Blue rubber bleb nevus syndrome	MESH:C536240			MESH:D005770|MESH:D012878|MESH:D018329	C04.557.665.560.615.550/C536240|C04.588.274.476/C536240|C04.588.805/C536240|C06.301.371/C536240|C06.405.249/C536240|C17.800.882/C536240	C04.557.665.560.615.550|C04.588.274.476|C04.588.805|C06.301.371|C06.405.249|C17.800.882	Bean syndrome|Blue rubber bleb nevus	Cancer|Digestive system disease|Skin disease
Blue Toe Syndrome	MESH:D018438	DO:DOID:14121	A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually the first, fourth, and fifth toes. Discoloration may extend to the lateral aspect of the foot. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation.	MESH:D016491|MESH:D017700	C14.907.355.350.454.500.200|C14.907.617.249	C14.907.355.350.454.500|C14.907.617	Syndrome, Blue Toe	Cardiovascular disease
Bobble-head doll syndrome	MESH:C536241			MESH:D016080|MESH:D020820	C04.182.044/C536241|C04.588.614.250.387.100/C536241|C10.228.662.262/C536241|C10.500.142.100/C536241|C10.551.240.375.100/C536241|C10.597.350/C536241|C16.131.666.142.100/C536241|C23.888.592.350/C536241	C04.182.044|C04.588.614.250.387.100|C10.228.662.262|C10.500.142.100|C10.551.240.375.100|C10.597.350|C16.131.666.142.100|C23.888.592.350	Bobble head doll syndrome	Cancer|Congenital abnormality|Nervous system disease|Signs and symptoms
Boerhaave syndrome	MESH:C536571			MESH:D004939|MESH:D008477	C06.405.117.468/C536571|C08.846.187/C536571|C26.348/C536571	C06.405.117.468|C08.846.187|C26.348	Boerhaave's syndrome|Boerhave syndrome	Digestive system disease|Respiratory tract disease|Wounds and injuries
Bone Cysts	MESH:D001845		Benign unilocular lytic areas in the proximal end of a long bone with well defined and narrow endosteal margins. The cysts contain fluid and the cyst walls may contain some giant cells. Bone cysts usually occur in males between the ages 3-15 years.	MESH:D001847|MESH:D003560	C04.182.089|C05.116.070	C04.182|C05.116	Bone Cyst|Cyst, Bone|Cysts, Bone|Cyst, Solitary|Cysts, Solitary|Cysts, Subchondral|Cyst, Subchondral|Ganglia, Intraosseous|Ganglia, Intra Osseous|Ganglia, Intra-Osseous|Ganglias, Intraosseous|Ganglias, Intra-Osseous|Ganglion, Intraosseous|Ganglion, Intra Osseous|Ganglion, Intra-Osseous|Ganglions, Intra-Osseous|Intraosseous Ganglia|Intra Osseous Ganglia|Intra-Osseous Ganglia|Intraosseous Ganglias|Intra-Osseous Ganglias|Intraosseous Ganglion|Intra Osseous Ganglion|Intra-Osseous Ganglion|Intraosseous Ganglions|Intra-Osseous Ganglions|Solitary Cyst|Solitary Cysts|Subchondral Cyst|Subchondral Cysts	Cancer|Musculoskeletal disease
Bone Cysts, Aneurysmal	MESH:D017824	OMIM:606179	Fibrous blood-filled cyst in the bone. Although benign it can be destructive causing deformity and fractures.	MESH:D001845	C04.182.089.265|C05.116.070.265	C04.182.089|C05.116.070	Aneurysmal Bone Cysts|Bone Cyst, Aneurysmal|Cyst, Aneurysmal Bone|Cysts, Aneurysmal Bone	Cancer|Musculoskeletal disease
Bone Demineralization, Pathologic	MESH:D018488		Decrease, loss, or removal of the mineral constituents of bones. Temporary loss of bone mineral content is especially associated with space flight, weightlessness, and extended immobilization. OSTEOPOROSIS is permanent, includes reduction of total bone mass, and is associated with increased rate of fractures. CALCIFICATION, PHYSIOLOGIC is the process of bone remineralizing. (From Dorland, 27th ed; Stedman, 25th ed; Nicogossian, Space Physiology and Medicine, 2d ed, pp327-33)	MESH:D001851	C05.116.198.247|C18.452.104.247	C05.116.198|C18.452.104	Pathologic Bone Demineralization	Metabolic disease|Musculoskeletal disease
Bone Diseases	MESH:D001847	DO:DOID:0080001	Diseases of BONES.	MESH:D009140	C05.116	C05	Bone Disease|Disease, Bone|Diseases, Bone	Musculoskeletal disease
Bone Diseases, Developmental	MESH:D001848		Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.	MESH:D001847	C05.116.099	C05.116	Bone Disease, Developmental|Bone Dysplasia|Bone Dysplasias|Developmental Bone Disease|Developmental Bone Diseases|Dysplasia, Bone|Dysplasias, Bone	Musculoskeletal disease
Bone Diseases, Endocrine	MESH:D001849		Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands.	MESH:D001847|MESH:D004700	C05.116.132|C19.149	C05.116|C19	Bone Disease, Endocrine|Disease, Endocrine Bone|Diseases, Endocrine Bone|Endocrine Bone Disease|Endocrine Bone Diseases	Endocrine system disease|Musculoskeletal disease
Bone Diseases, Infectious	MESH:D001850		Bone diseases caused by pathogenic microorganisms.	MESH:D001847|MESH:D007239	C01.160|C05.116.165	C01|C05.116	Bone Disease, Infectious|Disease, Infectious Bone|Diseases, Infectious Bone|Infectious Bone Disease|Infectious Bone Diseases	Musculoskeletal disease
Bone Diseases, Metabolic	MESH:D001851		Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.	MESH:D001847|MESH:D008659	C05.116.198|C18.452.104	C05.116|C18.452	Bone Density, Low|Bone Disease, Metabolic|Low Bone Densities|Low Bone Density|Low Bone Mineral Density|Metabolic Bone Disease|Metabolic Bone Diseases|Osteopenia|Osteopenias	Metabolic disease|Musculoskeletal disease
Bone Dysplasia, Lethal, Holmgren Type	MESH:C565896			MESH:D001848	C05.116.099/C565896	C05.116.099		Musculoskeletal disease
Bone Fragility with Contractures, Arterial Rupture, and Deafness	MESH:C567320	OMIM:612394		MESH:D003240|MESH:D003286|MESH:D012422	C05.550.323/C567320|C05.651.197/C567320|C17.300/C567320|C23.300.909/C567320	C05.550.323|C05.651.197|C17.300|C23.300.909	LH3 Deficiency|Lysyl Hydroxylase 3 Deficiency	Connective tissue disease|Musculoskeletal disease|Pathology (anatomical condition)
Bone Malalignment	MESH:D017760		Displacement of bones out of line in relation to joints. It may be congenital or traumatic in origin.	MESH:D001847	C05.116.214	C05.116	Bone Malalignments|Bone Malposition|Bone Malpositions|Bone Misalignment|Bone Misalignments|Malalignment, Bone|Malposition, Bone|Misalignment, Bone	Musculoskeletal disease
Bone Marrow Diseases	MESH:D001855	DO:DOID:4961	Diseases involving the BONE MARROW.	MESH:D006402	C15.378.190	C15.378	Bone Marrow Disease|Disease, Bone Marrow|Diseases, Bone Marrow|Marrow Disease, Bone|Marrow Diseases, Bone	Blood disease
Bone Marrow Failure Disorders	MESH:D000080983		Inherited or acquired diseases characterized by insufficient and/or dysplastic blood cells.	MESH:D001855	C15.378.190.223	C15.378.190	Bone Marrow Failure|Bone Marrow Failure Syndrome|Bone Marrow Failure Syndromes|Failure, Bone Marrow	Blood disease
Bone Marrow Neoplasms	MESH:D019046		Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.	MESH:D001855|MESH:D019337	C04.588.448.200|C15.378.190.250|C15.378.400.200	C04.588.448|C15.378.190|C15.378.400	Bone Marrow Neoplasm|Neoplasm, Bone Marrow|Neoplasms, Bone Marrow	Blood disease|Cancer
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12	OMIM:612560			MESH:D010024|MESH:D058866	C05.116.198.579/612560|C18.452.104.579/612560|C26.404.545/612560	C05.116.198.579|C18.452.104.579|C26.404.545	BMND12	Metabolic disease|Musculoskeletal disease|Wounds and injuries
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15	OMIM:613418			MESH:D010024|MESH:D050815	C05.116.198.579/613418|C18.452.104.579/613418|C26.404.195/613418	C05.116.198.579|C18.452.104.579|C26.404.195	BMND15|COMPRESSION FRACTURE, SUSCEPTIBILITY TO|METAPHYSEAL FRACTURE, SUSCEPTIBILITY TO|OSTEOPOROSIS, SUSCEPTIBILITY TO	Metabolic disease|Musculoskeletal disease|Wounds and injuries
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17	OMIM:615311			MESH:D010024|MESH:D058866	C05.116.198.579/615311|C18.452.104.579/615311|C26.404.545/615311	C05.116.198.579|C18.452.104.579|C26.404.545	BMND17|BONE MINERAL DENSITY, LOW, SUSCEPTIBILITY TO	Metabolic disease|Musculoskeletal disease|Wounds and injuries
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	OMIM:300910			MESH:D010024|MESH:D058866	C05.116.198.579/300910|C18.452.104.579/300910|C26.404.545/300910	C05.116.198.579|C18.452.104.579|C26.404.545	BMND18|OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES, SUSCEPTIBILITY TO	Metabolic disease|Musculoskeletal disease|Wounds and injuries
Bone Neoplasms	MESH:D001859	DO:DOID:184	Tumors or cancer located in bone tissue or specific BONES.	MESH:D001847|MESH:D009371	C04.588.149|C05.116.231	C04.588|C05.116	Bone Cancer|Bone Neoplasm|Cancer of Bone|Cancer of the Bone|Neoplasm, Bone|Neoplasms, Bone	Cancer|Musculoskeletal disease
Bone Resorption	MESH:D001862	DO:DOID:0080011	Bone loss due to osteoclastic activity.	MESH:D001847	C05.116.264	C05.116	Bone Losses, Osteoclastic|Bone Loss, Osteoclastic|Bone Resorptions|Losses, Osteoclastic Bone|Loss, Osteoclastic Bone|Osteoclastic Bone Loss|Osteoclastic Bone Losses|Resorption, Bone|Resorptions, Bone	Musculoskeletal disease
Bonneau Syndrome	MESH:C564875			MESH:D006330|MESH:D013576	C05.116.099.370.894.819/C564875|C05.660.585.800/C564875|C05.660.906.819/C564875|C14.240.400/C564875|C14.280.400/C564875|C16.131.240.400/C564875|C16.131.621.585.800/C564875|C16.131.621.906.819/C564875	C05.116.099.370.894.819|C05.660.585.800|C05.660.906.819|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.585.800|C16.131.621.906.819	Polysyndactyly with Cardiac Malformation	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Borrone Di Rocco Crovato syndrome	MESH:C536577			MESH:D001847|MESH:D007592|MESH:D008945|MESH:D012871	C05.116/C536577|C05.550/C536577|C14.280.484.400.500/C536577|C17.800/C536577	C05.116|C05.550|C14.280.484.400.500|C17.800	Borrone dermatocardioskeletal syndrome	Cardiovascular disease|Musculoskeletal disease|Skin disease
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME	OMIM:615722	DO:DOID:0112226		MESH:D002658|MESH:D008607|MESH:D009896	C10.292.700.225/615722|C10.597.606.360/615722|C11.640.451/615722|C23.888.592.604.646/615722|F03.625.421/615722|F03.625.539/615722	C10.292.700.225|C10.597.606.360|C11.640.451|C23.888.592.604.646|F03.625.421|F03.625.539	BBSOAS	Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Bowen's Disease	MESH:D001913		A persistent progressive non-elevated red scaly or crusted plaque which is due to an intradermal carcinoma and is potentially malignant. Atypical squamous cells proliferate through the whole thickness of the epidermis. The lesions may occur anywhere on the skin surface or on mucosal surfaces. The cause most frequently found is trivalent arsenic compounds. Freezing, cauterization or diathermy coagulation is often effective. (From Rook et al., Textbook of Dermatology, 4th ed, pp2428-9)	MESH:D002294	C04.557.470.200.400.130|C04.557.470.700.400.130	C04.557.470.200.400|C04.557.470.700.400	Bowen Disease|Bowens Disease|Disease, Bowen|Disease, Bowen's	Cancer
Brachial Palsy, Familial Congenital	MESH:C563901			MESH:D020516	C10.668.829.100/C563901	C10.668.829.100		Nervous system disease
Brachial Plexus Neuritis	MESH:D020968	DO:DOID:3689|OMIM:162100	A syndrome associated with inflammation of the BRACHIAL PLEXUS. Clinical features include severe pain in the shoulder region which may be accompanied by MUSCLE WEAKNESS and loss of sensation in the upper extremity. This condition may be associated with VIRUS DISEASES; IMMUNIZATION; SURGERY; heroin use (see HEROIN DEPENDENCE); and other conditions. The term brachial neuralgia generally refers to pain associated with brachial plexus injury. (From Adams et al., Principles of Neurology, 6th ed, pp1355-6)	MESH:D009443|MESH:D020516	C10.668.829.100.500|C10.668.829.650.250	C10.668.829.100|C10.668.829.650	Amyotrophic Neuralgia|Amyotrophic Neuralgias|Amyotrophies, Hereditary Neuralgic|Amyotrophies, Neuralgic|Amyotrophy, Hereditary Neuralgic|Amyotrophy, Hereditary Neuralgic, with Predilection for Brachial Plexus|Amyotrophy, Neuralgic|Brachial Neuralgia|Brachial Neuralgias|Brachial Neuritides|Brachial Neuritis|Brachial Plexus Neuritides|Brachial Plexus Neuropathy, Hereditary|Cervicobrachial Neuralgia|Cervico Brachial Neuralgia|Cervico-Brachial Neuralgia|Cervicobrachial Neuralgias|Cervico-Brachial Neuralgias|Familial Brachial Plexus Neuritis|Girdle Neuropathies, Shoulder|Girdle Neuropathy, Shoulder|Hereditary Brachial Plexus Neuropathy|Hereditary Neuralgic Amyotrophies|Hereditary Neuralgic Amyotrophy|Heredofamilial Neuritis with Brachial Plexus Predilection|HNA|NAPB|Neuralgia, Amyotrophic|Neuralgia, Brachial|Neuralgia, Cervicobrachial|Neuralgia, Cervico-Brachial|Neuralgias, Amyotrophic|Neuralgias, Brachial|Neuralgias, Cervicobrachial|Neuralgias, Cervico-Brachial|Neuralgic Amyotrophies|Neuralgic Amyotrophies, Hereditary|Neuralgic Amyotrophy|Neuralgic Amyotrophy, Hereditary|Neuritides, Brachial|Neuritides, Brachial Plexus|Neuritis, Brachial|Neuritis, Brachial Plexus|Neuritis With Brachial Predilection|Neuropathies, Shoulder Girdle|Neuropathies, Shoulder-Girdle|Neuropathy, Shoulder Girdle|Neuropathy, Shoulder-Girdle|Parsonage Aldren Turner Syndrome|Parsonage-Aldren-Turner Syndrome|Parsonage Turner Syndrome|Parsonage-Turner Syndrome|Shoulder Girdle Neuropathies|Shoulder-Girdle Neuropathies|Shoulder Girdle Neuropathy|Shoulder-Girdle Neuropathy|Syndrome, Parsonage-Aldren-Turner|Syndrome, Parsonage-Turner	Nervous system disease
Brachial Plexus Neuropathies	MESH:D020516	DO:DOID:3690	Diseases of the cervical (and first thoracic) roots, nerve trunks, cords, and peripheral nerve components of the BRACHIAL PLEXUS. Clinical manifestations include regional pain, PARESTHESIA; MUSCLE WEAKNESS, and decreased sensation (HYPESTHESIA) in the upper extremity. These disorders may be associated with trauma (including BIRTH INJURIES); THORACIC OUTLET SYNDROME; NEOPLASMS; NEURITIS; RADIOTHERAPY; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp1351-2)	MESH:D010523	C10.668.829.100	C10.668.829	Brachial Plexopathy|Brachial Plexus Disease|Brachial Plexus Diseases|Brachial Plexus Disorder|Brachial Plexus Disorders|Brachial Plexus Neuropathy|Dejerine Klumpke Palsy|Dejerine-Klumpke Palsy|Erb-Duchenne Paralyses|Erb Duchenne Paralysis|Erb-Duchenne Paralysis|Erb Palsy|Erb Paralyses|Erb Paralysis|Erb's Palsies|Erb's Palsy|Erbs Palsy|Klumpke Palsy|Klumpke Paralysis|Klumpke's Palsy|Klumpkes Palsy|Lower Brachial Plexus Neuropathy|Lower Brachial Plexus Palsy|Middle Brachial Plexus Neuropathy|Neuropathies, Brachial Plexus|Neuropathy, Brachial Plexus|Palsies, Erb's|Palsy, Dejerine-Klumpke|Palsy, Erb's|Palsy, Klumpke's|Paralyses, Erb|Paralyses, Erb-Duchenne|Paralysis, Erb|Paralysis, Erb-Duchenne|Paralysis, Klumpke|Paralysis of the Lower Brachial Plexus|Plexopathies, Brachial|Plexopathy, Brachial|Plexus Disease, Brachial|Plexus Diseases, Brachial|Plexus Disorder, Brachial|Plexus Disorders, Brachial|Plexus Neuropathies, Brachial|Plexus Neuropathy, Brachial|Upper Brachial Plexus Neuropathy	Nervous system disease
Brachioskeletogenital syndrome	MESH:C537084			MESH:D001848	C05.116.099/C537084	C05.116.099		Musculoskeletal disease
Brachydactyly, Intraventricular Septal Defect, And Deafness	MESH:C566521			MESH:D000015|MESH:D006319|MESH:D006345|MESH:D059327	C05.660.585.262/C566521|C09.218.458.341.887/C566521|C10.597.751.418.341.887/C566521|C14.240.400.560.540/C566521|C14.280.400.560.540/C566521|C16.131.077/C566521|C16.131.240.400.560.540/C566521|C16.131.621.585.262/C566521|C23.888.592.763.393.341.887/C566521	C05.660.585.262|C09.218.458.341.887|C10.597.751.418.341.887|C14.240.400.560.540|C14.280.400.560.540|C16.131.077|C16.131.240.400.560.540|C16.131.621.585.262|C23.888.592.763.393.341.887		Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Brachydactyly with hypertension	MESH:C537095	DO:DOID:0111247|OMIM:112410		MESH:D006973|MESH:D059327	C05.660.585.262/C537095|C14.907.489/C537095|C16.131.621.585.262/C537095	C05.660.585.262|C14.907.489|C16.131.621.585.262	Bilginturan syndrome|Brachydactyly type E with short stature and hypertension|Brachydactyly, Type E, With Short Stature And Hypertension|BRACHYDACTYLY WITH HYPERTENSION|HTNB|HYPERTENSION AND BRACHYDACTYLY SYNDROME|Hypertension With Brachydactyly	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Brachytelephalangic Chondrodysplasia Punctata	MESH:C000705207			MESH:D002806	C05.116.099.708.195/C000705207	C05.116.099.708.195	Chondrodysplasia punctata, brachytelephalangic	Musculoskeletal disease
Bradycardia	MESH:D001919		Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.	MESH:D001145	C14.280.067.319|C23.550.073.300	C14.280.067|C23.550.073	Bradyarrhythmia|Bradyarrhythmias|Bradycardias	Cardiovascular disease|Pathology (process)
Brain Abscess	MESH:D001922		A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear (see EAR, MIDDLE); HEART (see also ENDOCARDITIS, BACTERIAL), and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. (Adams et al., Principles of Neurology, 6th ed, pp712-6)	MESH:D000038|MESH:D001927|MESH:D002494	C01.207.090|C01.830.025.160|C10.228.140.116|C10.228.228.090	C01.207|C01.830.025|C10.228.140|C10.228.228	Abscess, Brain|Abscess, Cerebral|Abscess, Child Brain|Abscesses, Cerebral|Abscesses, Multiple Brain|Abscess, Multiple Brain|Abscess, Pyogenic Brain|Brain Abscess, Child|Brain Abscesses|Brain Abscesses, Multiple|Brain Abscesses, Pyogenic|Brain Abscesses, Sterile|Brain Abscess, Multiple|Brain Abscess, Pyogenic|Brain Abscess, Sterile|Cerebral Abscess|Cerebral Abscesses|Child Brain Abscess|Multiple Brain Abscess|Multiple Brain Abscesses|Pyogenic Brain Abscess|Pyogenic Brain Abscesses|Sterile Brain Abscess|Sterile Brain Abscesses	Nervous system disease
Brain Concussion	MESH:D001924		A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness (often defined as greater than 6 hours in duration) may be referred to as post-traumatic coma (COMA, POST-HEAD INJURY). (From Rowland, Merritt's Textbook of Neurology, 9th ed, p418)	MESH:D000070642|MESH:D016489	C10.228.140.199.444.250|C10.900.300.087.235.250|C10.900.300.350.300|C26.915.300.200.194.250|C26.915.300.450.500|C26.974.382.200	C10.228.140.199.444|C10.900.300.087.235|C10.900.300.350|C26.915.300.200.194|C26.915.300.450|C26.974.382	Brain Concussions|Cerebral Concussion|Cerebral Concussions|Commotio Cerebri|Concussion, Brain|Concussion, Cerebral|Concussion, Intermediate|Concussion, Mild|Concussion, Severe|Intermediate Concussion|Intermediate Concussions|Mild Concussion|Mild Concussions|Mild Traumatic Brain Injury|Severe Concussion|Severe Concussions	Nervous system disease|Wounds and injuries
Brain Contusion	MESH:D000070624		A bruise of the brain from an impact of the skull.	MESH:D000070642|MESH:D003288	C10.228.140.199.444.375|C10.900.300.087.235.375|C26.915.300.200.194.375|C26.974.250.500	C10.228.140.199.444|C10.900.300.087.235|C26.915.300.200.194|C26.974.250	Brain Contusions|Cerebellar Contusion|Cerebellar Contusions|Cerebral Contusion|Cerebral Contusions|Contusio Cerebri|Contusion, Brain|Contusion, Cerebellar|Contusion, Cerebral|Contusion, Cortical|Contusions, Brain|Contusions, Cerebellar|Contusions, Cerebral|Contusions, Cortical|Cortical Contusion|Cortical Contusions	Nervous system disease|Wounds and injuries
Brain Diseases	MESH:D001927	DO:DOID:936	Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.	MESH:D002493	C10.228.140	C10.228	Brain Disease|Brain Disorder|Brain Disorders|Central Nervous System Disorders, Intracranial|Central Nervous System Intracranial Disorders|CNS Disorder, Intracranial|CNS Disorders, Intracranial|Encephalon Disease|Encephalon Diseases|Encephalopathies|Encephalopathy|Intracranial Central Nervous System Disorders|Intracranial CNS Disorder|Intracranial CNS Disorders	Nervous system disease
Brain Diseases, Metabolic	MESH:D001928		Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function.	MESH:D001927|MESH:D008659	C10.228.140.163|C18.452.132	C10.228.140|C18.452	Acquired Metabolic Diseases, Brain|Acquired Metabolic Diseases, Nervous System|Acquired Metabolic Encephalopathies|Acquired Metabolic Encephalopathy|Brain Disease, Metabolic|Brain Diseases, Metabolic, Acquired|Brain Disorder, Metabolic|Brain Disorders, Metabolic|Brain Disorders, Metabolic, Acquired|Brain Metabolic Disorder|Brain Metabolic Disorders|Brain Syndrome, Metabolic|Brain Syndrome, Metabolic, Acquired|Central Nervous System Metabolic Disorders|CNS Metabolic Disorder|CNS Metabolic Disorders|CNS Metabolic Disorders, Acquired|Encephalopathies, Acquired Metabolic|Encephalopathies, Metabolic|Encephalopathy, Acquired Metabolic|Encephalopathy, Metabolic|Encephalopathy, Metabolic, Acquired|Metabolic Brain Disease|Metabolic Brain Diseases|Metabolic Brain Diseases, Acquired|Metabolic Brain Disorder|Metabolic Brain Disorders|Metabolic Brain Syndrome|Metabolic Brain Syndrome, Acquired|Metabolic Brain Syndromes|Metabolic Brain Syndromes, Acquired|Metabolic Diseases, Acquired, Nervous System|Metabolic Disorder, Brain|Metabolic Disorder, Central Nervous System, Acquired|Metabolic Disorder, CNS|Metabolic Disorders, Brain|Metabolic Disorders, Central Nervous System|Metabolic Disorders, CNS|Metabolic Disorders, CNS, Acquired|Metabolic Encephalopathies|Metabolic Encephalopathies, Acquired|Metabolic Encephalopathy|Metabolic Encephalopathy, Acquired|Nervous System Acquired Metabolic Diseases	Metabolic disease|Nervous system disease
Brain Edema	MESH:D001929	DO:DOID:4724	Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)	MESH:D001927	C10.228.140.187	C10.228.140	Brain Edema, Cytotoxic|Brain Edema, Vasogenic|Brain Swelling|Brain Swellings|Cerebral Edema|Cerebral Edema, Cytotoxic|Cerebral Edemas, Vasogenic|Cerebral Edema, Vasogenic|Cytotoxic Brain Edema|Cytotoxic Cerebral Edema|Edema, Brain|Edema, Cerebral|Edema, Cytotoxic Brain|Edema, Cytotoxic Cerebral|Edema, Intracranial|Edema, Vasogenic Brain|Edema, Vasogenic Cerebral|Intracranial Edema|Swelling, Brain|Vasogenic Brain Edema|Vasogenic Cerebral Edema	Nervous system disease
Brain Hemorrhage, Traumatic	MESH:D020201		Bleeding within the brain as a result of penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA. Traumatically induced hemorrhages may occur in any area of the brain, including the CEREBRUM; BRAIN STEM (see BRAIN STEM HEMORRHAGE, TRAUMATIC); and CEREBELLUM.	MESH:D001930|MESH:D020198	C10.228.140.199.275|C10.228.140.300.535.450.200|C10.900.300.087.187|C10.900.300.837.150|C14.907.253.573.400.150|C26.915.300.200.175|C26.915.300.490.150	C10.228.140.199|C10.228.140.300.535.450|C10.900.300.087|C10.900.300.837|C14.907.253.573.400|C26.915.300.200|C26.915.300.490	Brain Hemorrhages, Traumatic|Cerebellar Hemorrhages, Traumatic|Cerebellar Hemorrhage, Traumatic|Hemorrhages, Traumatic Cerebellar|Hemorrhage, Traumatic Brain|Hemorrhage, Traumatic Cerebellar|Traumatic Brain Hemorrhage|Traumatic Brain Hemorrhages|Traumatic Cerebellar Hemorrhage|Traumatic Cerebellar Hemorrhages	Cardiovascular disease|Nervous system disease|Wounds and injuries
Brain Infarction	MESH:D020520	DO:DOID:3454	Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.	MESH:D002545|MESH:D007238|MESH:D020521	C10.228.140.300.150.477|C10.228.140.300.775.200|C14.907.253.092.477|C14.907.253.855.200|C23.550.513.355.250|C23.550.717.489.250	C10.228.140.300.150|C10.228.140.300.775|C14.907.253.092|C14.907.253.855|C23.550.513.355|C23.550.717.489	Anterior Cerebral Circulation Infarction|Anterior Circulation Brain Infarction|Anterior Circulation Infarction, Brain|Brain Infarct|Brain Infarction, Anterior Circulation|Brain Infarction, Posterior Circulation|Brain Infarctions|Brain Infarctions, Venous|Brain Infarction, Venous|Brain Infarcts|Brain Venous Infarction|Brain Venous Infarctions|Infarct, Brain|Infarction, Anterior Cerebral Circulation|Infarction, Anterior Circulation, Brain|Infarction, Brain|Infarction, Brain, Anterior Circulation|Infarction, Brain, Posterior Circulation|Infarction, Brain Venous|Infarction, Posterior Circulation, Brain|Infarctions, Brain|Infarctions, Brain Venous|Infarctions, Venous Brain|Infarction, Venous Brain|Infarcts, Brain|Posterior Circulation Brain Infarction|Posterior Circulation Infarction, Brain|Venous Brain Infarction|Venous Brain Infarctions|Venous Infarction, Brain|Venous Infarctions, Brain	Cardiovascular disease|Nervous system disease|Pathology (process)
Brain Injuries	MESH:D001930		Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.	MESH:D001927|MESH:D006259	C10.228.140.199|C10.900.300.087|C26.915.300.200	C10.228.140|C10.900.300|C26.915.300	Acute Brain Injuries|Acute Brain Injury|Brain Injuries, Acute|Brain Injuries, Focal|Brain Injury|Brain Injury, Acute|Brain Injury, Focal|Brain Laceration|Brain Lacerations|Focal Brain Injuries|Focal Brain Injury|Injuries, Acute Brain|Injuries, Brain|Injuries, Focal Brain|Injury, Acute Brain|Injury, Brain|Injury, Focal Brain|Laceration, Brain|Lacerations, Brain	Nervous system disease|Wounds and injuries
Brain Injuries, Diffuse	MESH:D000070625		Brain injuries occurring over a wide area instead of specific focal area.	MESH:D001930	C10.228.140.199.388|C10.900.300.087.219|C26.915.300.200.188	C10.228.140.199|C10.900.300.087|C26.915.300.200	Brain Injury, Diffuse|Cerebral Injuries, Diffuse|Cerebral Injury, Diffuse|Diffuse Axonal Brain Injury|Diffuse Brain Injuries|Diffuse Brain Injury|Diffuse Cerebral Injuries|Diffuse Cerebral Injury	Nervous system disease|Wounds and injuries
Brain Injuries, Traumatic	MESH:D000070642		A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.	MESH:D001930	C10.228.140.199.444|C10.900.300.087.235|C26.915.300.200.194	C10.228.140.199|C10.900.300.087|C26.915.300.200	Brain Injury, Traumatic|Brain Trauma|Brain Traumas|Encephalopathies, Traumatic|Encephalopathy, Traumatic|Injury, Brain, Traumatic|TBIs (Traumatic Brain Injuries)|TBI (Traumatic Brain Injuries)|TBI (Traumatic Brain Injury)|Trauma, Brain|Traumas, Brain|Traumatic Brain Injuries|Traumatic Brain Injury|Traumatic Encephalopathies|Traumatic Encephalopathy	Nervous system disease|Wounds and injuries
Brain Injury, Chronic	MESH:D020208		Conditions characterized by persistent brain damage or dysfunction as sequelae of cranial trauma. This disorder may result from DIFFUSE AXONAL INJURY; INTRACRANIAL HEMORRHAGES; BRAIN EDEMA; and other conditions. Clinical features may include DEMENTIA; focal neurologic deficits; PERSISTENT VEGETATIVE STATE; AKINETIC MUTISM; or COMA.	MESH:D001925|MESH:D001930	C10.228.140.140.127|C10.228.140.199.500|C10.900.300.087.250|C23.550.291.500.063.500|C26.915.300.200.200	C10.228.140.140|C10.228.140.199|C10.900.300.087|C23.550.291.500.063|C26.915.300.200	Brain Injuries, Chronic|Chronic Brain Injuries|Chronic Brain Injury	Nervous system disease|Pathology (process)|Wounds and injuries
Brain Ischemia	MESH:D002545	DO:DOID:2316	Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.	MESH:D002561	C10.228.140.300.150|C14.907.253.092	C10.228.140.300|C14.907.253	Brain Ischemias|Cerebral Ischemia|Cerebral Ischemias|Encephalopathy, Ischemic|Ischemia, Brain|Ischemia, Cerebral|Ischemias, Cerebral|Ischemic Encephalopathies|Ischemic Encephalopathy	Cardiovascular disease|Nervous system disease
Brain Neoplasms	MESH:D001932	DO:DOID:1319	Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.	MESH:D001927|MESH:D016543	C04.588.614.250.195|C10.228.140.211|C10.551.240.250	C04.588.614.250|C10.228.140|C10.551.240	Benign Brain Neoplasm|Benign Brain Neoplasms|Benign Neoplasm, Brain|Benign Neoplasms, Brain|Brain Benign Neoplasm|Brain Benign Neoplasms|Brain Cancer|Brain Cancers|Brain Malignant Neoplasm|Brain Malignant Neoplasms|Brain Metastase|Brain Metastases|Brain Neoplasm|Brain Neoplasm, Benign|Brain Neoplasm, Malignant|Brain Neoplasm, Primary|Brain Neoplasms, Benign|Brain Neoplasms, Malignant|Brain Neoplasms, Malignant, Primary|Brain Neoplasms, Primary|Brain Neoplasms, Primary Malignant|Brain Tumor|Brain Tumor, Primary|Brain Tumor, Recurrent|Brain Tumors|Brain Tumors, Recurrent|Cancer, Brain|Cancer of Brain|Cancer of the Brain|Intracranial Neoplasm|Intracranial Neoplasms|Malignant Brain Neoplasm|Malignant Brain Neoplasms|Malignant Neoplasm, Brain|Malignant Neoplasms, Brain|Malignant Primary Brain Neoplasms|Malignant Primary Brain Tumors|Neoplasm, Brain|Neoplasm, Intracranial|Neoplasms, Brain|Neoplasms, Brain, Benign|Neoplasms, Brain, Malignant|Neoplasms, Brain, Primary|Neoplasms, Intracranial|Primary Brain Neoplasm|Primary Brain Neoplasms|Primary Brain Tumor|Primary Brain Tumors|Primary Malignant Brain Neoplasms|Primary Malignant Brain Tumors|Recurrent Brain Tumor|Recurrent Brain Tumors|Tumor, Brain	Cancer|Nervous system disease
Brain Stem Hemorrhage, Traumatic	MESH:D020203		Bleeding into structures of BRAIN STEM, including the MIDBRAIN; PONS; or MEDULLA OBLONGATA, as the result of CRANIOCEREBRAL TRAUMA. DIFFUSE AXONAL INJURY is commonly associated. Clinical manifestations may include OCULAR MOTILITY DISORDERS; ATAXIA; PARALYSIS; PERSISTENT VEGETATIVE STATE; and COMA.	MESH:D020201	C10.228.140.199.275.200|C10.228.140.300.535.450.200.500|C10.900.300.087.187.200|C10.900.300.837.150.300|C14.907.253.573.400.150.200|C26.915.300.200.175.200|C26.915.300.490.150.200	C10.228.140.199.275|C10.228.140.300.535.450.200|C10.900.300.087.187|C10.900.300.837.150|C14.907.253.573.400.150|C26.915.300.200.175|C26.915.300.490.150	Brainstem Hematomas, Traumatic|Brainstem Hematoma, Traumatic|Brain Stem Hematoma, Traumatic|Brainstem Hemorrhage, Post-Traumatic|Brain Stem Hemorrhage, Post Traumatic|Brain Stem Hemorrhage, Post-Traumatic|Brainstem Hemorrhage, Traumatic|Bulbar Hemorrhage, Traumatic|Hemorrhage, Brain Stem, Traumatic|Hemorrhage, Post-Traumatic Brainstem|Hemorrhage, Traumatic Bulbar|Hemorrhage, Traumatic Medullary|Medullary Hemorrhage, Traumatic|Midbrain Hemorrhage, Traumatic|Pontine Hemorrhage, Traumatic|Post Traumatic Brainstem Hemorrhage|Post-Traumatic Brainstem Hemorrhage|Post Traumatic Brain Stem Hemorrhage|Post-Traumatic Brain Stem Hemorrhage|Traumatic Brainstem Hematoma|Traumatic Brain Stem Hematoma|Traumatic Brainstem Hematomas|Traumatic Brainstem Hemorrhage|Traumatic Brain Stem Hemorrhage|Traumatic Bulbar Hemorrhage|Traumatic Medullary Hemorrhage|Traumatic Midbrain Hemorrhage|Traumatic Pontine Hemorrhage	Cardiovascular disease|Nervous system disease|Wounds and injuries
Brain Stem Infarctions	MESH:D020526	DO:DOID:3523	Infarctions that occur in the BRAIN STEM which is comprised of the MIDBRAIN; PONS; and MEDULLA OBLONGATA. There are several named syndromes characterized by their distinctive clinical manifestations and specific sites of ischemic injury.	MESH:D020520	C10.228.140.300.150.477.100|C10.228.140.300.775.200.100|C14.907.253.092.477.100|C14.907.253.855.200.100|C23.550.513.355.250.100|C23.550.717.489.250.100	C10.228.140.300.150.477|C10.228.140.300.775.200|C14.907.253.092.477|C14.907.253.855.200|C23.550.513.355.250|C23.550.717.489.250	Benedict Syndrome|Brain Stem Infarct|Brainstem Infarction|Brain Stem Infarction|Brainstem Infarctions|Brain Stem Infarcts|Brainstem Stroke|Claude Syndrome|Foville Syndrome|Infarct, Brain Stem|Infarction, Brainstem|Infarction, Brain Stem|Infarctions, Brainstem|Infarctions, Brain Stem|Infarcts, Brain Stem|Millard Gublar Syndrome|Millard-Gublar Syndrome|Stem Infarct, Brain|Stem Infarcts, Brain|Stroke, Brainstem|Syndrome, Millard-Gublar|Top of the Basilar Syndrome|Weber Syndrome	Cardiovascular disease|Nervous system disease|Pathology (process)
Brain Stem Neoplasms	MESH:D020295	DO:DOID:4203	Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.	MESH:D015192	C04.588.614.250.195.411.100|C10.228.140.211.500.100|C10.551.240.250.400.200	C04.588.614.250.195.411|C10.228.140.211.500|C10.551.240.250.400	Brainstem Neoplasm|Brain Stem Neoplasm|Brainstem Neoplasm, Primary|Brainstem Neoplasms|Brainstem Neoplasms, Primary|Brain Stem Neoplasms, Primary|Brainstem Tumor|Brain Stem Tumor|Brainstem Tumors|Brain Stem Tumors|Medullary Neoplasm|Medullary Neoplasms|Medullary Tumor|Medullary Tumors|Mesencephalic Neoplasm|Mesencephalic Neoplasms|Midbrain Neoplasm|Midbrain Neoplasms|Midbrain Tumor|Midbrain Tumors|Neoplasm, Brainstem|Neoplasm, Brain Stem|Neoplasm, Medullary|Neoplasm, Mesencephalic|Neoplasm, Midbrain|Neoplasm, Pontine|Neoplasm, Primary Brainstem|Neoplasms, Brainstem|Neoplasms, Brain Stem|Neoplasms, Brainstem, Primary|Neoplasms, Medullary|Neoplasms, Mesencephalic|Neoplasms, Midbrain|Neoplasms, Pontine|Neoplasms, Primary Brainstem|Pontine Neoplasm|Pontine Neoplasms|Pontine Tumor|Pontine Tumors|Primary Brainstem Neoplasm|Primary Brainstem Neoplasms|Primary Brain Stem Neoplasms|Tumor, Brain Stem|Tumor, Medullary|Tumor, Midbrain|Tumor, Pontine|Tumors, Medullary|Tumors, Midbrain|Tumors, Pontine	Cancer|Nervous system disease
Branchial Myoclonus with Spastic Paraparesis and Cerebellar Ataxia	MESH:C566188			MESH:D002524|MESH:D009207|MESH:D020336	C10.228.140.252.190/C566188|C10.597.350.090.500/C566188|C10.597.350.500/C566188|C10.597.636.500.500/C566188|C23.888.592.350.090.200/C566188|C23.888.592.350.500/C566188|C23.888.592.643.500.500/C566188	C10.228.140.252.190|C10.597.350.090.500|C10.597.350.500|C10.597.636.500.500|C23.888.592.350.090.200|C23.888.592.350.500|C23.888.592.643.500.500		Nervous system disease|Signs and symptoms
Branchioma	MESH:D001935		A tumor derived from branchial epithelium or branchial rests. (Dorland, 27th ed)	MESH:D003560	C04.182.117	C04.182	Branchial Cleft Cyst|Branchial Cleft Cysts|Branchial Cyst|Branchial Cysts|Branchiomas|Cleft Cyst, Branchial|Cleft Cysts, Branchial|Cyst, Branchial|Cyst, Branchial Cleft|Cysts, Branchial|Cysts, Branchial Cleft	Cancer
Breast Cancer 3	MESH:C565336			MESH:D001943	C04.588.180/C565336|C17.800.090.500/C565336	C04.588.180|C17.800.090.500		Cancer|Skin disease
Breast Cancer, Familial	MESH:C562840			MESH:D001943	C04.588.180/C562840|C17.800.090.500/C562840	C04.588.180|C17.800.090.500		Cancer|Skin disease
Breast Cancer, Familial Male	MESH:C566178			MESH:D018567	C04.588.180.260/C566178|C17.800.090.500.260/C566178	C04.588.180.260|C17.800.090.500.260		Cancer|Skin disease
Breast Cancer Lymphedema	MESH:D000072656		Abnormal accumulation of lymph in the arm, shoulder and breast area associated with surgical treatment (e.g., MASTECTOMY) or radiation treatment of breast cancer.	MESH:D008209|MESH:D011183	C15.604.496.160|C23.550.767.082	C15.604.496|C23.550.767	Breast Cancer Lymphedemas|Breast Cancer Related Arm Lymphedema|Breast Cancer-Related Arm Lymphedema|Breast Cancer Related Lymphedema|Breast Cancer Treatment Related Lymphedema|Breast Cancer Treatment-Related Lymphedema|Lymphedema, Breast Cancer|Lymphedema, Postmastectomy|Lymphedema, Post-mastectomy|Lymphedemas, Postmastectomy|Post mastectomy Lymphedema|Post-mastectomy Lymphedema|Postmastectomy Lymphedema|Post-mastectomy Lymphedemas|Postmastectomy Lymphedemas	Lymphatic disease|Pathology (process)
Breast Carcinoma In Situ	MESH:D000071960	DO:DOID:8791	A condition in which abnormal cells have not spread outside the duct, lobule, or nipple to other tissues of the breast. There are 3 types of breast carcinoma in situ: DUCTAL CARCINOMA IN SITU; LOBULAR CARCINOMA IN SITU; and PAGET DISEASE OF THE NIPPLE.	MESH:D001943|MESH:D002278	C04.557.470.200.240.187|C04.588.180.130|C17.800.090.500.130	C04.557.470.200.240|C04.588.180|C17.800.090.500	LCIS, Lobular Carcinoma In Situ|Lobular Carcinoma In Situ	Cancer|Skin disease
Breast Cyst	MESH:D047688	DO:DOID:10350	A fluid-filled closed cavity or sac that is lined by an EPITHELIUM and found in the BREAST. It may appear as a single large cyst in one breast, multifocal, or bilateral in FIBROCYSTIC BREAST DISEASE.	MESH:D001941|MESH:D003560	C04.182.156|C17.800.090.249	C04.182|C17.800.090	Breast Cysts|Cyst, Breast|Cysts, Breast	Cancer|Skin disease
Breast Diseases	MESH:D001941	DO:DOID:3463	Pathological processes of the BREAST.	MESH:D012871	C17.800.090	C17.800	Breast Disease|Breast Disease, Endocrine|Breast Diseases, Endocrine|Disease, Breast|Disease, Endocrine Breast|Diseases, Breast|Diseases, Endocrine Breast|Endocrine Breast Disease|Endocrine Breast Diseases	Skin disease
Breast Neoplasms	MESH:D001943	DO:DOID:1612|DO:DOID:3459|OMIM:114480	Tumors or cancer of the human BREAST.	MESH:D001941|MESH:D009371	C04.588.180|C17.800.090.500	C04.588|C17.800.090	Breast Cancer|BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED|Breast Carcinoma|Breast Carcinomas|Breast Malignant Neoplasm|Breast Malignant Neoplasms|Breast Malignant Tumor|Breast Malignant Tumors|Breast Neoplasm|Breast Tumor|Breast Tumors|Cancer, Breast|Cancer, Mammary|Cancer of Breast|Cancer of the Breast|Cancers, Mammary|Carcinoma, Breast|Carcinoma, Human Mammary|Carcinomas, Breast|Carcinomas, Human Mammary|Human Mammary Carcinoma|Human Mammary Carcinomas|Human Mammary Neoplasm|Human Mammary Neoplasms|Malignant Neoplasm of Breast|Malignant Tumor of Breast|Mammary Cancer|Mammary Cancers|Mammary Carcinoma, Human|Mammary Carcinomas, Human|Mammary Neoplasm, Human|Mammary Neoplasms, Human|Neoplasm, Breast|Neoplasm, Human Mammary|Neoplasms, Breast|Neoplasms, Human Mammary|Tumor, Breast|Tumors, Breast	Cancer|Skin disease
Breast Neoplasms, Male	MESH:D018567	DO:DOID:1614	Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females.	MESH:D001943	C04.588.180.260|C17.800.090.500.260	C04.588.180|C17.800.090.500	Breast Cancer, Male|Breast Carcinoma, Male|Breast Neoplasm, Male|Breast Tumor, Male|Breast Tumors, Male|Cancer, Male Breast|Carcinoma, Male Breast|Male Breast Cancer|Male Breast Carcinoma|Male Breast Neoplasm|Male Breast Neoplasms|Male Breast Tumor|Male Breast Tumors|Neoplasm, Male Breast|Neoplasms, Breast, Male|Neoplasms, Male Breast|Tumor, Male Breast|Tumors, Breast, Male|Tumors, Male Breast	Cancer|Skin disease
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	OMIM:604370			MESH:D001943|MESH:D010051	C04.588.180/604370|C04.588.322.455/604370|C12.050.351.500.056.630.705/604370|C12.050.351.937.418.685/604370|C12.100.250.056.630.705/604370|C12.900.418.685/604370|C17.800.090.500/604370|C19.344.410/604370|C19.391.630.705/604370	C04.588.180|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C17.800.090.500|C19.344.410|C19.391.630.705	BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED|BROVCA1|OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED	Cancer|Endocrine system disease|Skin disease|Urogenital disease (female)
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	OMIM:612555			MESH:D001943|MESH:D010051	C04.588.180/612555|C04.588.322.455/612555|C12.050.351.500.056.630.705/612555|C12.050.351.937.418.685/612555|C12.100.250.056.630.705/612555|C12.900.418.685/612555|C17.800.090.500/612555|C19.344.410/612555|C19.391.630.705/612555	C04.588.180|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C17.800.090.500|C19.344.410|C19.391.630.705	BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2, INCLUDED|BROVCA2|OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2, INCLUDED	Cancer|Endocrine system disease|Skin disease|Urogenital disease (female)
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3	OMIM:613399			MESH:D001943|MESH:D010051	C04.588.180/613399|C04.588.322.455/613399|C12.050.351.500.056.630.705/613399|C12.050.351.937.418.685/613399|C12.100.250.056.630.705/613399|C12.900.418.685/613399|C17.800.090.500/613399|C19.344.410/613399|C19.391.630.705/613399	C04.588.180|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C17.800.090.500|C19.344.410|C19.391.630.705	BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3, INCLUDED|BROVCA3|OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3, INCLUDED	Cancer|Endocrine system disease|Skin disease|Urogenital disease (female)
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	OMIM:614291			MESH:D001943|MESH:D010051	C04.588.180/614291|C04.588.322.455/614291|C12.050.351.500.056.630.705/614291|C12.050.351.937.418.685/614291|C12.100.250.056.630.705/614291|C12.900.418.685/614291|C17.800.090.500/614291|C19.344.410/614291|C19.391.630.705/614291	C04.588.180|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C17.800.090.500|C19.344.410|C19.391.630.705	BROVCA4	Cancer|Endocrine system disease|Skin disease|Urogenital disease (female)
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2	OMIM:616001			MESH:C562989	C17.800.090/C562989/616001	C17.800.090/C562989	BNAH2	Skin disease
Brenner Tumor	MESH:D001948	DO:DOID:2636|DO:DOID:4217	A smooth, solid or cystic fibroepithelial (FIBROEPITHELIAL NEOPLASMS) tumor, usually found in the OVARIES but can also be found in the adnexal region and the KIDNEYS. It consists of a fibrous stroma with nests of epithelial cells that sometimes resemble the transitional cells lining the urinary bladder. Brenner tumors generally are benign and asymptomatic. Malignant Brenner tumors have been reported.	MESH:D010051|MESH:D018225	C04.557.450.565.590.595.150|C04.557.470.625.150|C12.050.351.500.056.630.705.265|C12.050.351.937.418.685.265|C12.100.250.056.630.705.265|C12.900.418.685.265|C19.391.630.705.265	C04.557.450.565.590.595|C04.557.470.625|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.391.630.705	Benign Brenner Tumor|Brenner Tumor, Benign|Brenner Tumor, Malignant|Brenner Tumor of Ovary|Brenner Tumor, Proliferative|Malignant Brenner Tumor|Ovarian Brenner Tumor|Ovary Brenner Tumor|Proliferative Brenner Tumor	Cancer|Endocrine system disease|Urogenital disease (female)
Brief, Resolved, Unexplained Event	MESH:D057768		An event experienced by an infant or a child that is characterized by some combination of apnea, color change, change in muscle tone, choking, and gagging.	MESH:D003490|MESH:D012131|MESH:D012818	C08.618.846.600|C23.888.248.500|C23.888.852.700	C08.618.846|C23.888.248|C23.888.852	ALTE Apparent Life Threatening Event|ALTE Apparent Life-Threatening Event|Apparent Life Threatening Event|Apparent Life-Threatening Event|Apparent Life-Threatening Events|BRUE Brief, Resolved, Unexplained Event|Idiopathic Apparent Life Threatening Event|Idiopathic Apparent Life-Threatening Event|Infantile Apparent Life Threatening Event|Infantile Apparent Life-Threatening Event|Life-Threatening Event, Apparent|Life-Threatening Events, Apparent	Respiratory tract disease|Signs and symptoms
Brittle Bone Disorder	MESH:C565842			MESH:D001848	C05.116.099/C565842	C05.116.099		Musculoskeletal disease
BRITTLE CORNEA SYNDROME 2	OMIM:614170	DO:DOID:0080729		MESH:D003240|MESH:D003316|MESH:D007593|MESH:D015422	C05.550.521/614170|C11.204/614170|C11.790/614170|C17.300/614170	C05.550.521|C11.204|C11.790|C17.300	BCS2	Connective tissue disease|Eye disease|Musculoskeletal disease
Broad-Betalipoproteinemia	MESH:C566264			MESH:D050171	C18.452.584.500/C566264	C18.452.584.500		Metabolic disease
Bronchial Diseases	MESH:D001982	DO:DOID:1176	Diseases involving the BRONCHI.	MESH:D012140	C08.127	C08	Bronchial Disease|Disease, Bronchial|Diseases, Bronchial	Respiratory tract disease
Bronchial Fistula	MESH:D001983		An abnormal passage or communication between a bronchus and another part of the body.	MESH:D001982|MESH:D016156	C08.127.196|C08.702.196|C23.300.575.687.225	C08.127|C08.702|C23.300.575.687	Bronchial Fistulas|Fistula, Bronchial|Fistulas, Bronchial	Pathology (anatomical condition)|Respiratory tract disease
Bronchial Hyperreactivity	MESH:D016535		Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.	MESH:D001982	C08.127.210	C08.127	Bronchial Hyperreactivities|Hyperreactivities, Bronchial|Hyperreactivity, Bronchial	Respiratory tract disease
Bronchial Neoplasms	MESH:D001984	DO:DOID:3906	Tumors or cancer of the BRONCHI.	MESH:D001982|MESH:D008175	C04.588.894.797.520.109|C08.127.265|C08.785.520.100	C04.588.894.797.520|C08.127|C08.785.520	Bronchial Neoplasm|Neoplasm, Bronchial|Neoplasms, Bronchial	Cancer|Respiratory tract disease
Bronchial Spasm	MESH:D001986		Spasmodic contraction of the smooth muscle of the bronchi.	MESH:D001982	C08.127.321	C08.127	Bronchial Spasms|Bronchospasm|Bronchospasms|Spasm, Bronchial|Spasms, Bronchial	Respiratory tract disease
Bronchiectasis	MESH:D001987	DO:DOID:9563	Persistent abnormal dilatation of the bronchi.	MESH:D001982	C08.127.384	C08.127	Bronchiectases	Respiratory tract disease
Bronchiectasis With Or Without Elevated Sweat Chloride 1	MESH:C567618	OMIM:211400		MESH:D001987	C08.127.384/C567618	C08.127.384	BESC1|CYSTIC FIBROSIS-LIKE SYNDROME	Respiratory tract disease
Bronchiectasis With Or Without Elevated Sweat Chloride 2	MESH:C567813	OMIM:613021		MESH:D001987	C08.127.384/C567813	C08.127.384	BESC2|CYSTIC FIBROSIS-LIKE SYNDROME	Respiratory tract disease
Bronchiectasis With Or Without Elevated Sweat Chloride 3	MESH:C567772	OMIM:613071		MESH:D001987	C08.127.384/C567772	C08.127.384	Besc3|CYSTIC FIBROSIS-LIKE SYNDROME	Respiratory tract disease
Bronchiolitis	MESH:D001988	DO:DOID:2942	Inflammation of the BRONCHIOLES.	MESH:D001991	C01.748.099.135|C08.127.446.135|C08.381.495.146.135|C08.730.099.135	C01.748.099|C08.127.446|C08.381.495.146|C08.730.099	Bronchiolitides	Respiratory tract disease
Bronchiolitis Obliterans	MESH:D001989	DO:DOID:2799	Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA.	MESH:D001988	C08.127.446.135.140|C08.381.495.146.135.140	C08.127.446.135|C08.381.495.146.135	Bronchiolitides, Constrictive|Bronchiolitides, Exudative|Bronchiolitides, Proliferative|Bronchiolitis, Constrictive|Bronchiolitis, Exudative|Bronchiolitis, Proliferative|Constrictive Bronchiolitides|Constrictive Bronchiolitis|Exudative Bronchiolitides|Exudative Bronchiolitis|Proliferative Bronchiolitides|Proliferative Bronchiolitis	Respiratory tract disease
Bronchiolitis, Viral	MESH:D001990		An acute inflammatory disease of the lower RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.	MESH:D001988|MESH:D014777	C01.748.099.135.321|C01.925.109|C08.127.446.135.321|C08.381.495.146.135.321|C08.730.099.135.321	C01.748.099.135|C01.925|C08.127.446.135|C08.381.495.146.135|C08.730.099.135	Bronchiolitides, Viral|Viral Bronchiolitides|Viral Bronchiolitis	Respiratory tract disease|Viral disease
Bronchitis	MESH:D001991	DO:DOID:6132	Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.	MESH:D001982|MESH:D008173|MESH:D012141	C01.748.099|C08.127.446|C08.381.495.146|C08.730.099	C01.748|C08.127|C08.381.495|C08.730	Bronchitides	Respiratory tract disease
Bronchitis, Chronic	MESH:D029481	DO:DOID:6132	A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic (more than 3 months in 2 consecutive years) productive cough. Infectious agents are a major cause of chronic bronchitis.	MESH:D001991|MESH:D029424	C01.748.099.567|C08.127.446.567|C08.381.495.146.567|C08.381.495.389.500|C08.730.099.567|C23.550.291.500.875.750	C01.748.099|C08.127.446|C08.381.495.146|C08.381.495.389|C08.730.099|C23.550.291.500.875	Chronic Bronchitis	Pathology (process)|Respiratory tract disease
Bronchogenic Cyst	MESH:D001994		A usually spherical cyst, arising as an embryonic out-pouching of the foregut or trachea. It is generally found in the mediastinum or lung and is usually asymptomatic unless it becomes infected.	MESH:D001982|MESH:D003560|MESH:D015619	C04.182.195|C08.127.480|C08.695.195|C16.131.740.195	C04.182|C08.127|C08.695|C16.131.740	Bronchial Cyst|Bronchial Cysts|Bronchogenic Cysts|Cyst, Bronchial|Cyst, Bronchogenic|Cysts, Bronchial|Cysts, Bronchogenic	Cancer|Congenital abnormality|Respiratory tract disease
Bronchopneumonia	MESH:D001996	DO:DOID:12375	Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches.	MESH:D001982|MESH:D011014	C01.748.610.127|C08.127.509|C08.381.677.127|C08.730.610.127	C01.748.610|C08.127|C08.381.677|C08.730.610	Bronchial Pneumonia|Bronchial Pneumonias|Bronchopneumonias|Pneumonia, Bronchial|Pneumonias, Bronchial	Respiratory tract disease
Brown-Sequard Syndrome	MESH:D018437	DO:DOID:606	A syndrome associated with injury to the lateral half of the spinal cord. The condition is characterized by the following clinical features (which are found below the level of the lesion): contralateral hemisensory anesthesia to pain and temperature, ipsilateral loss of propioception, and ipsilateral motor paralysis. Tactile sensation is generally spared. (From Adams et al., Principles of Neurology, 6th ed, p162).	MESH:D010264	C10.597.622.669.300|C23.888.592.636.637.300	C10.597.622.669|C23.888.592.636.637	Brown Sequard Disease|Brown-Sequard Disease|Brown-Sequard Paralysis|Brown Sequard's Disease|Brown-Sequard's Disease|Brown-Sequards Disease|Brown Sequard's Paralysis|Brown-Sequard's Paralysis|Brown-Sequards Paralysis|Brown Sequard's Syndrome|Brown-Sequard's Syndrome|Brown-Sequards Syndrome|Brown Sequard Syndrome|Hemicord Syndrome|Hemicord Syndromes|Hemiparaplegic Syndrome|Hemiparaplegic Syndromes|Hemispinal Cord Syndrome|Hemispinal Cord Syndromes|Paralysis, Brown-Sequard's|Spastic Spinal Monoplegia Syndrome|Syndrome, Brown-Sequard|Syndrome, Brown-Sequard's|Syndrome, Hemicord|Syndrome, Hemiparaplegic|Syndrome, Hemispinal Cord|Syndromes, Hemicord|Syndromes, Hemiparaplegic|Syndromes, Hemispinal Cord	Nervous system disease|Signs and symptoms
Brown-Vialetto-Van Laere syndrome	MESH:C537111	DO:DOID:0050694|OMIM:211530|OMIM:614707		MESH:D006319|MESH:D010244	C09.218.458.341.887/C537111|C10.574.562.300/C537111|C10.597.751.418.341.887/C537111|C10.668.467.300/C537111|C23.888.592.763.393.341.887/C537111	C09.218.458.341.887|C10.574.562.300|C10.597.751.418.341.887|C10.668.467.300|C23.888.592.763.393.341.887	BROWN-VIALETTO-VAN LAERE SYNDROME 1|BROWN-VIALETTO-VAN LAERE SYNDROME 2|Bulbar Palsy, Progressive, With Sensorineural Deafness|BVVLS1|BVVLS2|Pontobulbar palsy and neurosensory deafness|Pontobulbar Palsy With Deafness|Progressive Bulbar Palsy with Sensorineural Deafness	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Budd-Chiari Syndrome	MESH:D006502	DO:DOID:11512|OMIM:600880	A condition in which the hepatic venous outflow is obstructed anywhere from the small HEPATIC VEINS to the junction of the INFERIOR VENA CAVA and the RIGHT ATRIUM. Usually the blockage is extrahepatic and caused by blood clots (THROMBUS) or fibrous webs. Parenchymal FIBROSIS is uncommon.	MESH:D008107|MESH:D020246	C06.552.347|C14.907.355.830.925.275	C06.552|C14.907.355.830.925	BDCHS|Budd Chiari Syndrome|Chiari's Syndrome|Chiaris Syndrome|Chiari Syndrome|Hepatic Vein Thromboses|Hepatic Vein Thrombosis|Hepatic Venous Outflow Obstruction|MEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED|MOVC, INCLUDED|Thromboses, Hepatic Vein|Thrombosis, Hepatic Vein|Vein Thromboses, Hepatic|Vein Thrombosis, Hepatic	Cardiovascular disease|Digestive system disease
Bulbar Palsy, Progressive	MESH:D010244	DO:DOID:681|OMIM:211500	A motor neuron disease marked by progressive weakness of the muscles innervated by cranial nerves of the lower brain stem. Clinical manifestations include dysarthria, dysphagia, facial weakness, tongue weakness, and fasciculations of the tongue and facial muscles. The adult form of the disease is marked initially by bulbar weakness which progresses to involve motor neurons throughout the neuroaxis. Eventually this condition may become indistinguishable from AMYOTROPHIC LATERAL SCLEROSIS. Fazio-Londe syndrome is an inherited form of this illness which occurs in children and young adults. (Adams et al., Principles of Neurology, 6th ed, p1091; Brain 1992 Dec;115(Pt 6):1889-1900)	MESH:D016472	C10.574.562.300|C10.668.467.300	C10.574.562|C10.668.467	Bulbar Palsies|Bulbar Palsies, Progressive|Bulbar Palsy|Bulbar Palsy, Progressive, Of Childhood|Bulbar Paralyses|Bulbar Paralysis|Childhood Progressive Bulbar Palsy|Fazio Londe Disease|Fazio-Londe Disease|Fazio Londe Syndrome|Fazio-Londe Syndrome|Palsies, Bulbar|Palsies, Progressive Bulbar|Palsy, Bulbar|Palsy, Progressive Bulbar|Paralysis, Bulbar|Progressive Bulbar Palsies|Progressive Bulbar Palsy|Progressive Bulbar Palsy of Childhood	Nervous system disease
Bundle-Branch Block	MESH:D002037		A form of heart block in which the electrical stimulation of HEART VENTRICLES is interrupted at either one of the branches of BUNDLE OF HIS thus preventing the simultaneous depolarization of the two ventricles.	MESH:D006327	C14.280.067.558.323|C14.280.123.500.323|C23.550.073.425.100	C14.280.067.558|C14.280.123.500|C23.550.073.425	Anterior Fascicular Block|Anterior Fascicular Blocks|Block, Anterior Fascicular|Block, Bundle Branch|Block, Bundle-Branch|Block, Fascicular|Block, Left Bundle-Branch|Block, Posterior Fascicular|Block, Right Bundle-Branch|Blocks, Anterior Fascicular|Blocks, Bundle Branch|Blocks, Bundle-Branch|Blocks, Fascicular|Blocks, Left Bundle-Branch|Blocks, Posterior Fascicular|Blocks, Right Bundle-Branch|Branch Block, Bundle|Branch Blocks, Bundle|Bundle Branch Block|Bundle-Branch Block, Left|Bundle-Branch Block, Right|Bundle Branch Blocks|Bundle-Branch Blocks|Bundle-Branch Blocks, Left|Bundle-Branch Blocks, Right|Fascicular Block|Fascicular Block, Anterior|Fascicular Block, Posterior|Fascicular Blocks|Fascicular Blocks, Anterior|Fascicular Blocks, Posterior|Left Bundle Branch Block|Left Bundle-Branch Block|Left Bundle-Branch Blocks|Posterior Fascicular Block|Posterior Fascicular Blocks|Right Bundle Branch Block|Right Bundle-Branch Block|Right Bundle-Branch Blocks	Cardiovascular disease|Pathology (process)
Bundle Branch Block, Familial Isolated Complete Right	MESH:C562759			MESH:D002037	C14.280.067.558.323/C562759|C14.280.123.500.323/C562759|C23.550.073.425.100/C562759	C14.280.067.558.323|C14.280.123.500.323|C23.550.073.425.100		Cardiovascular disease|Pathology (process)
Bunion	MESH:D000071378		Abnormal swelling of the inner aspect of the first metatarsal head affecting the first METATARSOPHALANGEAL JOINT.	MESH:D005531	C05.330.488.050	C05.330.488	Bunions	Musculoskeletal disease
Bunion, Tailor's	MESH:D050489		Abnormal swelling of the outer aspect of the fifth metatarsal head affecting the fifth METATARSOPHALANGEAL JOINT.	MESH:D000071378	C05.330.488.050.500	C05.330.488.050	Bunionette|Bunionettes|Bunions, Tailor's|Bunion, Tailors|Tailor's Bunion|Tailors Bunion|Tailor's Bunions	Musculoskeletal disease
Bunyaviridae Infections	MESH:D002044		Virus diseases caused by the BUNYAVIRIDAE.	MESH:D012327	C01.925.782.147	C01.925.782	Bunyaviridae Infection|Bunyavirus Infection|Bunyavirus Infections|Infections, Bunyaviridae|Infections, Bunyavirus|Oropouche Fever|Oropouche Fevers|Oropouche Infection|Oropouche Orthobunyavirus Infection|Oropouche Virus Infection|Orthobunyavirus Infection|Orthobunyavirus Infection, Oropouche|Orthobunyavirus Infections|Virus Infection, Oropouche	Viral disease
Burkitt Lymphoma	MESH:D002051	DO:DOID:8584|OMIM:113970	A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.	MESH:D016393|MESH:D020031	C01.925.256.466.313.165|C01.925.928.313.165|C04.557.386.480.150.165|C15.604.515.569.480.150.165|C20.683.515.761.480.150.165	C01.925.256.466.313|C01.925.928.313|C04.557.386.480.150|C15.604.515.569.480.150|C20.683.515.761.480.150	African Lymphoma|BL|Burkitt Cell Leukemia|Burkitt Leukemia|Burkitt's Leukemia|Burkitts Leukemia|Burkitt's Lymphoma|Burkitts Lymphoma|Burkitt's Tumor|Burkitts Tumor|Burkitt Tumor|L3 Lymphocytic Leukemia|L3 Lymphocytic Leukemias|Leukemia, Burkitt|Leukemia, Burkitt Cell|Leukemia, Burkitt's|Leukemia, L3 Lymphocytic|Leukemia, Lymphoblastic, Burkitt-Type|Leukemia, Lymphocytic, L3|Lymphocytic Leukemia, L3|Lymphoma, African|Lymphoma, Burkitt|Lymphoma, Burkitt's|Tumor, Burkitt|Tumor, Burkitt's	Cancer|Immune system disease|Lymphatic disease|Viral disease
Burn-Mckeown syndrome	MESH:C537411	OMIM:608572		MESH:D002754|MESH:D003638|MESH:D006330|MESH:D019066	C08.460.171/C537411|C08.695.271/C537411|C09.218.458.341.186/C537411|C09.603.171/C537411|C10.597.751.418.341.186/C537411|C14.240.400/C537411|C14.280.400/C537411|C16.131.240.400/C537411|C16.131.740.271/C537411|C23.550.291.812/C537411|C23.888.592.763.393.341.186/C537411	C08.460.171|C08.695.271|C09.218.458.341.186|C09.603.171|C10.597.751.418.341.186|C14.240.400|C14.280.400|C16.131.240.400|C16.131.740.271|C23.550.291.812|C23.888.592.763.393.341.186	Bilateral choanal atresia, cardiac defects, deafness, and dysmorphic appearance|BMKS|OCULOOTOFACIAL DYSPLASIA|OOFD	Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Nervous system disease|Pathology (process)|Respiratory tract disease|Signs and symptoms
Bursitis	MESH:D002062	DO:DOID:14188|DO:DOID:2965	Inflammation or irritation of a SYNOVIAL BURSA, the fibrous sac that acts as a cushion between moving structures of bones, muscles, tendons or skin.	MESH:D007592	C05.550.251	C05.550	Adhesive Capsulitides|Adhesive Capsulitides, Shoulder|Adhesive Capsulitis|Adhesive Capsulitis of the Shoulder|Adhesive Capsulitis, Shoulder|Bursitides|Bursitides, Pes Anserine|Bursitis, Pes Anserine|Capsulitides|Capsulitides, Adhesive|Capsulitides, Shoulder Adhesive|Capsulitis|Capsulitis, Adhesive|Capsulitis, Shoulder Adhesive|Frozen Shoulder|Frozen Shoulders|Pes Anserine Bursitides|Pes Anserine Bursitis|Shoulder Adhesive Capsulitides|Shoulder Adhesive Capsulitis|Shoulder, Frozen	Musculoskeletal disease
Buschke-Lowenstein Tumor	MESH:D062688		Exophytic tumor of the anogenital region associated with HPV infections. It becomes a large cauliflower-like, hyperkeratotic, verrucous mass that is locally destructive with little atypical cells. Histologically, tumor cells are broad rete peg structures that tend to invade deeper than CONDYLOMATA ACUMINATA.	MESH:D003218|MESH:D018289	C01.221.812.640.220.500|C01.778.640.220.500|C01.925.256.650.810.217.500|C01.925.813.220.500|C01.925.825.810.110.500|C01.925.928.914.217.500|C04.557.470.200.450.500|C04.557.470.700.450.500|C12.100.937.640.220.500|C17.800.838.790.810.110.500	C01.221.812.640.220|C01.778.640.220|C01.925.256.650.810.217|C01.925.813.220|C01.925.825.810.110|C01.925.928.914.217|C04.557.470.200.450|C04.557.470.700.450|C12.100.937.640.220|C17.800.838.790.810.110	Anogenital Type Verrucous Carcinoma|Buschke Lowenstein Tumor|Buschke Löwenstein Tumor|Buschke-Löwenstein Tumor|Condyloma Acuminatum, Giant|Condyloma Acuminatums, Giant|Giant Condyloma Acuminatum|Giant Condyloma Acuminatums|Giant Condyloma of Buschke and Lowenstein|Giant Condyloma of Buschke and Löwenstein|Lowenstein Tumor, Buschke|Löwenstein Tumor, Buschke|Tumor, Buschke Lowenstein|Tumor, Buschke-Lowenstein|Tumor, Buschke Löwenstein|Tumor, Buschke-Löwenstein	Cancer|Skin disease|Viral disease
Byssinosis	MESH:D002095	DO:DOID:10323	A condition of BRONCHOCONSTRICTION resulting from hypersensitive reaction to inhaled dust during the initial processing of cotton, flax, or hemp in the textile industry. Symptoms include wheezing and tightness in the chest.	MESH:D011009	C08.381.483.581.275|C08.381.520.702.275|C24.800.323	C08.381.483.581|C08.381.520.702|C24.800	Brown Lung|Brown Lung Disease|Brown Lung Diseases|Brown Lungs|Byssinoses	Occupational disease|Respiratory tract disease
C3 GLOMERULOPATHY 3	OMIM:614809			MESH:D015432	C12.050.351.968.419.570.363.615/614809|C12.200.777.419.570.363.615/614809|C12.950.419.570.363.615/614809|C20.425/614809	C12.050.351.968.419.570.363.615|C12.200.777.419.570.363.615|C12.950.419.570.363.615|C20.425	C3G3|CFHR5 NEPHROPATHY	Immune system disease|Urogenital disease (female)|Urogenital disease (male)
Cadmium Poisoning	MESH:D002105		Poisoning occurring after exposure to cadmium compounds or fumes. It may cause gastrointestinal syndromes, anemia, or pneumonitis.	MESH:D000075322	C25.723.522.625	C25.723.522	Cadmium Poisonings|Itai Itai|Itai-Itai|Poisoning, Cadmium|Poisonings, Cadmium	
CAHMR syndrome	MESH:C537959			MESH:D002386|MESH:D006983|MESH:D008607	C10.597.606.360/C537959|C11.510.245/C537959|C17.800.329.875/C537959|C23.888.592.604.646/C537959|F03.625.539/C537959	C10.597.606.360|C11.510.245|C17.800.329.875|C23.888.592.604.646|F03.625.539	Cataract, Hypertrichosis, Mental Retardation syndrome	Eye disease|Mental disorder|Nervous system disease|Signs and symptoms|Skin disease
Calcific Aortic Disease with Immunologic Abnormalities, Familial	MESH:C566182			MESH:D001018|MESH:D002114	C14.907.109/C566182|C18.452.174.130/C566182	C14.907.109|C18.452.174.130		Cardiovascular disease|Metabolic disease
Calcification of Joints and Arteries	MESH:C565891	OMIM:211800		MESH:D002114|MESH:D007592|MESH:D014652	C05.550/C565891|C14.907/C565891|C18.452.174.130/C565891	C05.550|C14.907|C18.452.174.130	ACDC|ARTERIAL CALCIFICATION DUE TO DEFICIENCY OF CD73|CALJA	Cardiovascular disease|Metabolic disease|Musculoskeletal disease
calcifying aponeurotic fibroma	MESH:C000625499			MESH:D012983|MESH:D018214	C04.557.450.565.575.400/C000625499|C04.557.450.565.590.340.360/C000625499|C04.588.839/C000625499	C04.557.450.565.575.400|C04.557.450.565.590.340.360|C04.588.839		Cancer
Calcifying Epithelial Odontogenic Tumor	MESH:C537961			MESH:D009808|MESH:D012878	C04.557.695/C537961|C04.588.805/C537961|C17.800.882/C537961	C04.557.695|C04.588.805|C17.800.882	Pindborg tumor	Cancer|Skin disease
Calcinosis	MESH:D002114	DO:DOID:182	Pathologic deposition of calcium salts in tissues.	MESH:D002128	C18.452.174.130	C18.452.174	Calcification, Pathologic|Calcinoses|Calcinoses, Tumoral|Calcinosis, Tumoral|Microcalcification|Microcalcifications|Microcalcinoses|Microcalcinosis|Pathologic Calcification|Tumoral Calcinoses|Tumoral Calcinosis	Metabolic disease
Calciphylaxis	MESH:D002115	DO:DOID:4734	Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.	MESH:D002114	C18.452.174.130.186	C18.452.174.130	Calciphylaxes|Calciphylaxis, Idiopathic|Idiopathic Calciphylaxis	Metabolic disease
Calcium Metabolism Disorders	MESH:D002128	DO:DOID:10575	Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.	MESH:D008659	C18.452.174	C18.452	Calcium Metabolism Disorder|Disorder, Calcium Metabolism|Disorders, Calcium Metabolism	Metabolic disease
Caliciviridae Infections	MESH:D017250		Virus diseases caused by CALICIVIRIDAE. They include HEPATITIS E; VESICULAR EXANTHEMA OF SWINE; acute respiratory infections in felines, rabbit hemorrhagic disease, and some cases of gastroenteritis in humans.	MESH:D012327	C01.925.782.160	C01.925.782	Caliciviridae Infection|Calicivirus Infection|Calicivirus Infections|Infection, Caliciviridae|Infection, Calicivirus|Infection, Norovirus|Infections, Caliciviridae|Infections, Calicivirus|Infections, Norovirus|Norovirus Infection|Norovirus Infections	Viral disease
Callosities	MESH:D002145		Localized hyperplasia of the horny layer of the epidermis due to pressure or friction. (Dorland, 27th ed)	MESH:D007642	C17.800.428.200	C17.800.428	Callosity|Corns	Skin disease
Callosities, Hereditary Painful	MESH:C566180			MESH:D002145	C17.800.428.200/C566180	C17.800.428.200	Callosities, Painful Plantar	Skin disease
Campomelia Cumming type	MESH:C537966			MESH:D008210|MESH:D021782|MESH:D055036	C04.182.430/C537966|C05.660.142/C537966|C12.050.351.875.558/C537966|C12.050.351.968.419.403.750/C537966|C12.200.706.629/C537966|C12.200.777.419.403.750/C537966|C12.800.629/C537966|C12.950.419.403.750/C537966|C15.604.510/C537966|C16.131.621.142/C537966|C16.131.939.629/C537966	C04.182.430|C05.660.142|C12.050.351.875.558|C12.050.351.968.419.403.750|C12.200.706.629|C12.200.777.419.403.750|C12.800.629|C12.950.419.403.750|C15.604.510|C16.131.621.142|C16.131.939.629	Campomelia, Cumming Type|Cervical lymphocele with bowed long bones|Cumming syndrome	Cancer|Congenital abnormality|Lymphatic disease|Musculoskeletal disease|Urogenital disease (female)|Urogenital disease (male)
Camptocormia	MESH:C537968			MESH:D009134|MESH:D013121	C05.116.900.800/C537968|C10.228.854.468/C537968|C10.574.562.500/C537968|C10.668.467.500/C537968	C05.116.900.800|C10.228.854.468|C10.574.562.500|C10.668.467.500	Bent spine|Bent Spine Syndrome|Camptocormism	Musculoskeletal disease|Nervous system disease
Canaliculitis	MESH:D000069282		Inflammation and infection of the lacrimal canaliculus area in the LACRIMAL APPARATUS.	MESH:D003607	C11.496.221.500	C11.496.221	Canaliculitides|Canaliculitides, Lacrimal|Canaliculitis, Lacrimal|Lacrimal Canaliculitides|Lacrimal Canaliculitis	Eye disease
Cancer of the oviduct	MESH:C538511			MESH:D005185	C04.588.945.418.365/C538511|C12.050.351.500.056.390.390/C538511|C12.050.351.937.418.365/C538511|C12.100.250.056.390.390/C538511|C12.900.418.365/C538511	C04.588.945.418.365|C12.050.351.500.056.390.390|C12.050.351.937.418.365|C12.100.250.056.390.390|C12.900.418.365		Cancer|Urogenital disease (female)
CANOMAD syndrome	MESH:C537980			MESH:D000744|MESH:D001259|MESH:D009886	C10.292.562.750/C537980|C10.597.350.090/C537980|C10.597.622.447/C537980|C11.590.472/C537980|C15.378.071.141.125/C537980|C20.111.175/C537980|C23.888.592.350.090/C537980|C23.888.592.636.447/C537980	C10.292.562.750|C10.597.350.090|C10.597.622.447|C11.590.472|C15.378.071.141.125|C20.111.175|C23.888.592.350.090|C23.888.592.636.447		Blood disease|Eye disease|Immune system disease|Nervous system disease|Signs and symptoms
Cantalamessa Baldini Ambrosi syndrome	MESH:C537981			MESH:D006130|MESH:D007006|MESH:D008607|MESH:D008945	C10.597.606.360/C537981|C14.280.484.400.500/C537981|C19.391.482/C537981|C23.550.393/C537981|C23.888.592.604.646/C537981|F03.625.539/C537981	C10.597.606.360|C14.280.484.400.500|C19.391.482|C23.550.393|C23.888.592.604.646|F03.625.539	Primary gonadal failure, short stature, mitral valve prolapse, and mental retardation	Cardiovascular disease|Endocrine system disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Capillary Leak Syndrome	MESH:D019559	DO:DOID:14400	A condition characterized by recurring episodes of fluid leaking from capillaries into extra-vascular compartments causing hematocrit to rise precipitously. If not treated, generalized vascular leak can lead to generalized EDEMA; SHOCK; cardiovascular collapse; and MULTIPLE ORGAN FAILURE.	MESH:D014652	C14.907.218	C14.907	Capillary Leak Syndromes|Clarkson Disease|Clinical Capillary Leak Syndrome|Systemic Capillary Leak Syndrome	Cardiovascular disease
Capillary leak syndrome with monoclonal gammopathy	MESH:C535573			MESH:D006942|MESH:D019559	C14.907.218/C535573|C15.378.147.542/C535573|C20.683.460/C535573|C23.888.512/C535573	C14.907.218|C15.378.147.542|C20.683.460|C23.888.512	Periodic systemic capillary leak syndrome	Blood disease|Cardiovascular disease|Immune system disease|Signs and symptoms
Capillary Malformation-Arteriovenous Malformation	MESH:C564254	OMIM:608354		MESH:D001165|MESH:D019339	C14.240.850.750/C564254|C14.907.150/C564254|C16.131.240.850.750/C564254|C16.131.831.675/C564254|C17.800.804.675/C564254	C14.240.850.750|C14.907.150|C16.131.240.850.750|C16.131.831.675|C17.800.804.675	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION|CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1|Capillary Malformation-Arteriovenous Malformation Syndrome|Capillary Malformation Without Arteriovenous Malformation|Cm-Avm|CMAVM|CMAVM1|Cmavm Capillary malformation arteriovenous malformation syndrome|Cm-Avm Capillary malformation-arteriovenous malformation syndrome	Cardiovascular disease|Congenital abnormality|Skin disease
CAPILLARY MALFORMATIONS, CONGENITAL	OMIM:163000	DO:DOID:0111529		MESH:C562760|MESH:D019339	C14.240.850/C562760/163000|C16.131.240.850/C562760/163000|C16.131.831.675/163000|C17.800.804.675/163000	C14.240.850/C562760|C16.131.240.850/C562760|C16.131.831.675|C17.800.804.675	CAPILLARY MALFORMATIONS|CMAL|CMC|NEVI FLAMMEI, FAMILIAL MULTIPLE|PORT-WINE STAIN	Cardiovascular disease|Congenital abnormality|Skin disease
Capillary Malformations, Congenital, 1	MESH:C562760			MESH:D054079	C14.240.850/C562760|C16.131.240.850/C562760	C14.240.850|C16.131.240.850	Capillary Malformations	Cardiovascular disease|Congenital abnormality
Caplan Syndrome	MESH:D002205	DO:DOID:10326	A condition characterized by the presence of RHEUMATOID ARTHRITIS associated with a specific form of pneumoconiosis, often in coal miners and asbestos workers.	MESH:D001172|MESH:D011009	C05.550.114.154.219|C05.799.114.219|C08.381.483.581.300|C08.381.520.702.300|C17.300.775.099.219|C24.800.340	C05.550.114.154|C05.799.114|C08.381.483.581|C08.381.520.702|C17.300.775.099|C24.800	Caplan's Syndrome|Caplans Syndrome|Caplan Syndromes	Connective tissue disease|Musculoskeletal disease|Occupational disease|Respiratory tract disease
Cap Myopathy	MESH:C579969			MESH:D020914	C05.651.575/C579969|C10.668.491.550/C579969	C05.651.575|C10.668.491.550	Cap Disease|Congenital Myopathy with Caps	Musculoskeletal disease|Nervous system disease
Capsule Opacification	MESH:D058442		Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.	MESH:D002386	C11.510.245.500	C11.510.245	Capsule Opacifications|Cataract, Secondary|Cataracts, Secondary|Opacification, Capsule|Opacifications, Capsule|Secondary Cataract|Secondary Cataracts	Eye disease
Carbon Monoxide Poisoning	MESH:D002249		Toxic asphyxiation due to the displacement of oxygen from oxyhemoglobin by carbon monoxide.	MESH:D005739	C25.723.455.245	C25.723.455	Carbon Monoxide Poisonings|Gas Poisoning, Illuminating|Gas Poisonings, Illuminating|Illuminating Gas Poisoning|Illuminating Gas Poisonings|Monoxide Poisoning, Carbon|Monoxide Poisonings, Carbon|Poisoning, Carbon Monoxide|Poisoning, Illuminating Gas|Poisonings, Carbon Monoxide|Poisonings, Illuminating Gas	
Carbon Tetrachloride Poisoning	MESH:D002252		Poisoning that results from ingestion, injection, inhalation, or skin absorption of CARBON TETRACHLORIDE.	MESH:D011041	C25.723.177	C25.723	Carbon Tetrachloride Poisonings|CCl4 Poisoning|CCl4 Poisonings|Poisoning, Carbon Tetrachloride|Poisoning, CCl4|Poisonings, Carbon Tetrachloride	
Carcinogenesis	MESH:D063646		The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.	MESH:D009385	C04.697.098|C23.550.727.098	C04.697|C23.550.727	Carcinogeneses|Oncogeneses|Oncogenesis|Tumorigeneses|Tumorigenesis	Cancer|Pathology (process)
Carcinoid Heart Disease	MESH:D002275		Cardiac manifestation of gastrointestinal CARCINOID TUMOR that metastasizes to the liver. Substances secreted by the tumor cells, including SEROTONIN, promote fibrous plaque formation in ENDOCARDIUM and its underlying layers. These deposits cause distortion of the TRICUSPID VALVE and the PULMONARY VALVE eventually leading to STENOSIS and valve regurgitation.	MESH:D006331|MESH:D008303	C04.557.465.625.650.200.500.205|C04.557.470.200.025.200.500.205|C04.557.580.625.650.200.500.205|C14.280.104	C04.557.465.625.650.200.500|C04.557.470.200.025.200.500|C04.557.580.625.650.200.500|C14.280	Carcinoid Heart Diseases|Heart Disease, Carcinoid|Heart Diseases, Carcinoid	Cancer|Cardiovascular disease
Carcinoid Tumor	MESH:D002276		A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)	MESH:D000230|MESH:D018358	C04.557.465.625.650.200|C04.557.470.200.025.200|C04.557.580.625.650.200	C04.557.465.625.650|C04.557.470.200.025|C04.557.580.625.650	Argentaffinoma|Argentaffinomas|Carcinoid|Carcinoid, Goblet Cell|Carcinoids|Carcinoids, Goblet Cell|Carcinoid Tumors|Goblet Cell Carcinoid|Goblet Cell Carcinoids|Tumor, Carcinoid|Tumors, Carcinoid	Cancer
Carcinoid Tumors, Intestinal	MESH:C562842	OMIM:114900		MESH:D002276|MESH:D007414	C04.557.465.625.650.200/C562842|C04.557.470.200.025.200/C562842|C04.557.580.625.650.200/C562842|C04.588.274.476.411/C562842|C06.301.371.411/C562842|C06.405.249.411/C562842|C06.405.469.491/C562842	C04.557.465.625.650.200|C04.557.470.200.025.200|C04.557.580.625.650.200|C04.588.274.476.411|C06.301.371.411|C06.405.249.411|C06.405.469.491		Cancer|Digestive system disease
Carcinoma	MESH:D002277	DO:DOID:305|DO:DOID:4015	A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for 'cancer.'	MESH:D009375	C04.557.470.200	C04.557.470	Anaplastic Carcinoma|Anaplastic Carcinomas|Carcinoma, Anaplastic|Carcinomas|Carcinoma, Spindle Cell|Carcinoma, Spindle-Cell|Carcinomatoses|Carcinomatosis|Carcinoma, Undifferentiated|Epithelial Neoplasm, Malignant|Epithelial Neoplasms, Malignant|Epithelial Tumor, Malignant|Epithelial Tumors, Malignant|Epithelioma|Epitheliomas|Malignant Epithelial Neoplasm|Malignant Epithelial Neoplasms|Malignant Epithelial Tumor|Malignant Epithelial Tumors|Neoplasm, Malignant Epithelial|Neoplasms, Malignant Epithelial|Spindle-Cell Carcinoma|Spindle-Cell Carcinomas|Tumor, Malignant Epithelial|Undifferentiated Carcinoma|Undifferentiated Carcinomas	Cancer
Carcinoma 256, Walker	MESH:D002279		A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)	MESH:D002296|MESH:D009374	C04.557.435.290.210|C04.557.450.795.290.210|C04.619.045	C04.557.435.290|C04.557.450.795.290|C04.619	Carcinosarcoma 256, Walker|Walker Carcinoma 256|Walker Carcinosarcoma 256	Cancer
Carcinoma, Acinar Cell	MESH:D018267	DO:DOID:3025	A malignant tumor arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose (Latin racemosus, full of clusters) refers, as does acinar (Latin acinus, grape), to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16% of cases. Local recurrences and distant metastases many years after treatment are common. This tumor appears in all age groups and is most common in women. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1240; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575)	MESH:D000230	C04.557.470.200.025.215	C04.557.470.200.025	Acinar Carcinoma|Acinar Carcinomas|Acinar Cell Adenocarcinoma|Acinar Cell Adenocarcinomas|Acinar Cell Carcinoma|Acinar Cell Carcinomas|Acinic Cell Adenocarcinoma|Acinic Cell Adenocarcinomas|Acinic Cell Carcinoma|Acinic Cell Carcinomas|Acinic Cell Tumor|Acinic Cell Tumors|Adenocarcinoma, Acinar Cell|Adenocarcinoma, Acinic Cell|Adenocarcinomas, Acinar Cell|Adenocarcinomas, Acinic Cell|Carcinoma, Acinar|Carcinoma, Acinic Cell|Carcinomas, Acinar|Carcinomas, Acinar Cell|Carcinomas, Acinic Cell|Serous Acinar Adenoma|Tumor, Acinic Cell|Tumors, Acinic Cell	Cancer
Carcinoma, Adenoid Cystic	MESH:D003528	DO:DOID:0080202|DO:DOID:4866	Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed)	MESH:D000230	C04.557.470.200.025.220	C04.557.470.200.025	Adenocystic Carcinoma|Adenocystic Carcinomas|Adenoid Cystic Carcinoma|Adenoid Cystic Carcinomas|Carcinoma, Adenocystic|Carcinomas, Adenocystic|Carcinomas, Adenoid Cystic|Cylindroma|Cylindromas|Cystic Carcinoma, Adenoid|Cystic Carcinomas, Adenoid	Cancer
Carcinoma, Adenosquamous	MESH:D018196	DO:DOID:4830	A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.	MESH:D002277|MESH:D018193	C04.557.435.250|C04.557.470.200.150	C04.557.435|C04.557.470.200	Adenosquamous Carcinoma|Adenosquamous Carcinomas|Carcinomas, Adenosquamous	Cancer
Carcinoma, Basal Cell	MESH:D002280	OMIM:605462|OMIM:613058|OMIM:613059|OMIM:613061|OMIM:613062|OMIM:613063|OMIM:614740	A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)	MESH:D002277|MESH:D018295	C04.557.470.200.165|C04.557.470.565.165	C04.557.470.200|C04.557.470.565	Basal Cell Carcinoma|BASAL CELL CARCINOMA, MULTIPLE, INCLUDED|BASAL CELL CARCINOMA, NONSYNDROMIC, INCLUDED|Basal Cell Carcinomas|BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1|BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2|BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 3|BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 4|BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 5|BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 6|BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7|Basal Cell Epithelioma|Basal Cell Epitheliomas|BCC1|BCC2|BCC3|BCC4|BCC5|BCC6|BCC7|Carcinoma, Basal Cell, Pigmented|Carcinomas, Basal Cell|Epithelioma, Basal Cell|Epitheliomas, Basal Cell|Rodent Ulcer|Rodent Ulcers|Ulcer, Rodent|Ulcers, Rodent	Cancer
Carcinoma, Basosquamous	MESH:D002281	DO:DOID:5063	A skin carcinoma that histologically exhibits both basal and squamous elements. (From Dorland, 27th ed)	MESH:D002277|MESH:D018295	C04.557.470.200.170|C04.557.470.565.170	C04.557.470.200|C04.557.470.565	Basosquamous Carcinoma|Basosquamous Carcinomas|Carcinomas, Basosquamous	Cancer
Carcinoma, Bronchogenic	MESH:D002283	DO:DOID:3904	Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.	MESH:D001984|MESH:D008175	C04.588.894.797.520.109.220|C08.381.540.140|C08.785.520.100.220	C04.588.894.797.520.109|C08.381.540|C08.785.520.100	Bronchial Carcinoma|Bronchial Carcinomas|Bronchogenic Carcinoma|Bronchogenic Carcinomas|Carcinoma, Bronchial|Carcinomas, Bronchial|Carcinomas, Bronchogenic	Cancer|Respiratory tract disease
Carcinoma, Brown-Pearce	MESH:D002284		A transplantable EPITHELIAL CELL neoplasm of rabbits.	MESH:D009374	C04.619.124	C04.619	Brown-Pearce Carcinoma|Brown-Pearce Epithelioma|Carcinoma, Brown Pearce|Epithelioma, Brown Pearce|Epithelioma, Brown-Pearce	Cancer
Carcinoma, Ductal	MESH:D044584	DO:DOID:3007	Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.	MESH:D000230|MESH:D018299	C04.557.470.200.025.232|C04.557.470.615.132	C04.557.470.200.025|C04.557.470.615	Carcinomas, Ductal|Ductal Carcinoma|Ductal Carcinomas	Cancer
Carcinoma, Ductal, Breast	MESH:D018270	DO:DOID:3008	An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.	MESH:D001943|MESH:D044584	C04.557.470.200.025.232.500|C04.557.470.615.132.500|C04.588.180.390|C17.800.090.500.390	C04.557.470.200.025.232|C04.557.470.615.132|C04.588.180|C17.800.090.500	Carcinoma, Infiltrating Duct|Carcinoma, Invasive Ductal, Breast|Carcinoma, Mammary Ductal|Carcinomas, Infiltrating Duct|Carcinomas, Mammary Ductal|Invasive Ductal Carcinoma, Breast|Mammary Ductal Carcinoma|Mammary Ductal Carcinomas	Cancer|Skin disease
Carcinoma, Ehrlich Tumor	MESH:D002286	DO:DOID:5050	A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.	MESH:D002277|MESH:D009374	C04.557.470.200.200|C04.619.169	C04.557.470.200|C04.619	Ascites Tumor, Ehrlich|Ehrlich Ascites Tumor|Ehrlich Tumor Carcinoma|Tumor, Ehrlich Ascites	Cancer
Carcinoma, Embryonal	MESH:D018236	DO:DOID:3308	A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)	MESH:D009373	C04.557.465.200	C04.557.465	Carcinomas, Embryonal|Embryonal Carcinoma|Embryonal Carcinomas	Cancer
Carcinoma, Endometrioid	MESH:D018269	DO:DOID:2871	An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.	MESH:D000230|MESH:D010051|MESH:D016889	C04.557.470.200.025.240|C04.588.945.418.948.585.124|C12.050.351.500.056.630.705.331|C12.050.351.937.418.685.331|C12.050.351.937.418.875.200.124|C12.100.250.056.630.705.331|C12.900.418.685.331|C12.900.418.875.200.124|C19.391.630.705.331	C04.557.470.200.025|C04.588.945.418.948.585|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.050.351.937.418.875.200|C12.100.250.056.630.705|C12.900.418.685|C12.900.418.875.200|C19.391.630.705	Adenocarcinoma, Endometrioid|Adenocarcinomas, Endometrioid|Carcinomas, Endometrioid|Endometrioid Adenocarcinoma|Endometrioid Adenocarcinomas|Endometrioid Carcinoma|Endometrioid Carcinomas	Cancer|Endocrine system disease|Urogenital disease (female)
Carcinoma, Giant Cell	MESH:D018286	DO:DOID:5583	An epithelial neoplasm characterized by unusually large anaplastic cells. It is highly malignant with fulminant clinical course, bizarre histologic appearance and poor prognosis. It is most common in the lung and thyroid. (From Stedman, 25th ed & Segen, Dictionary of Modern Medicine, 1992)	MESH:D002277	C04.557.470.200.220	C04.557.470.200	Carcinomas, Giant Cell|Cell Carcinoma, Giant|Cell Carcinomas, Giant|Giant Cell Carcinoma|Giant Cell Carcinomas	Cancer
Carcinoma, Hepatocellular	MESH:D006528	OMIM:114550	A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.	MESH:D000230|MESH:D008113	C04.557.470.200.025.255|C04.588.274.623.160|C06.301.623.160|C06.552.697.160	C04.557.470.200.025|C04.588.274.623|C06.301.623|C06.552.697	Adult Liver Cancer|Adult Liver Cancers|Cancer, Adult Liver|CANCER, HEPATOCELLULAR|Cancers, Adult Liver|Carcinoma, Liver Cell|Carcinomas, Hepatocellular|Carcinomas, Liver Cell|Cell Carcinoma, Liver|Cell Carcinomas, Liver|HCC|HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED|Hepatocellular Carcinoma|Hepatocellular Carcinomas|Hepatoma|HEPATOMA HEPATOBLASTOMA, INCLUDED|Hepatomas|LCC|LIVER CANCER|Liver Cancer, Adult|Liver Cancers, Adult|Liver Cell Carcinoma|Liver Cell Carcinoma, Adult|Liver Cell Carcinomas	Cancer|Digestive system disease
Carcinoma in Situ	MESH:D002278	DO:DOID:8719	A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.	MESH:D002277	C04.557.470.200.240	C04.557.470.200	Carcinoma, Intraepithelial|Carcinoma, Preinvasive|Intraepithelial Carcinoma|Intraepithelial Neoplasm|Intraepithelial Neoplasms|Neoplasm, Intraepithelial|Neoplasms, Intraepithelial|Preinvasive Carcinoma	Cancer
Carcinoma, Intraductal, Noninfiltrating	MESH:D002285		A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.	MESH:D000071960|MESH:D000230|MESH:D018299	C04.557.470.200.025.275|C04.557.470.200.240.187.250|C04.557.470.615.275	C04.557.470.200.025|C04.557.470.200.240.187|C04.557.470.615	Atypical Ductal Hyperplasia|Atypical Ductal Hyperplasias|Carcinoma, Intraductal|Carcinoma, Noninfiltrating Intraductal|Carcinomas, Intraductal|Carcinomas, Noninfiltrating Intraductal|DCIS|Ductal Carcinoma In Situ|Ductal Hyperplasia, Atypical|Ductal Hyperplasias, Atypical|Hyperplasia, Atypical Ductal|Hyperplasias, Atypical Ductal|Intraductal Carcinoma|Intraductal Carcinoma, Noninfiltrating|Intraductal Carcinomas|Intraductal Carcinomas, Noninfiltrating|Noninfiltrating Intraductal Carcinoma|Noninfiltrating Intraductal Carcinomas	Cancer
Carcinoma, Islet Cell	MESH:D018273	DO:DOID:1798	A primary malignant neoplasm of the pancreatic ISLET CELLS. Usually it involves the non-INSULIN-producing cell types, the PANCREATIC ALPHA CELLS and the pancreatic delta cells (SOMATOSTATIN-SECRETING CELLS) in GLUCAGONOMA and SOMATOSTATINOMA, respectively.	MESH:D000230|MESH:D010190	C04.557.470.200.025.290|C04.588.274.761.500|C04.588.322.475.500|C06.301.761.500|C06.689.667.500|C19.344.421.500	C04.557.470.200.025|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421	Carcinomas, Islet Cell|Islet Cell Carcinoma|Islet Cell Carcinomas|Islet Cell Tumor, Malignant	Cancer|Digestive system disease|Endocrine system disease
Carcinoma, Krebs 2	MESH:D002287		A transplantable neoplasm of mice.	MESH:D002277|MESH:D009374	C04.557.470.200.255|C04.619.214	C04.557.470.200|C04.619	Krebs 2 Carcinoma	Cancer
Carcinoma, Large Cell	MESH:D018287	DO:DOID:4552	A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed)	MESH:D002277	C04.557.470.200.260	C04.557.470.200	Carcinomas, Large Cell|Cell Carcinoma, Large|Cell Carcinomas, Large|Large Cell Carcinoma|Large Cell Carcinomas	Cancer
Carcinoma, Lewis Lung	MESH:D018827		A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.	MESH:D002277|MESH:D009374	C04.557.470.200.280|C04.619.230	C04.557.470.200|C04.619	Lewis Lung Carcinoma|Lung Carcinoma, Lewis	Cancer
Carcinoma, Lobular	MESH:D018275	DO:DOID:3457	A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.	MESH:D000230|MESH:D001943|MESH:D018299	C04.557.470.200.025.305|C04.557.470.615.305|C04.588.180.437|C17.800.090.500.437	C04.557.470.200.025|C04.557.470.615|C04.588.180|C17.800.090.500	Carcinomas, Lobular|Lobular Carcinoma|Lobular Carcinomas	Cancer|Skin disease
Carcinoma, Medullary	MESH:D018276		A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)	MESH:D018278|MESH:D018299	C04.557.465.625.650.240.315|C04.557.470.200.025.370.315|C04.557.470.615.315|C04.557.580.625.650.240.315	C04.557.465.625.650.240|C04.557.470.200.025.370|C04.557.470.615|C04.557.580.625.650.240	Carcinomas, Medullary|Medullary Carcinoma|Medullary Carcinomas	Cancer
Carcinoma, Merkel Cell	MESH:D015266		A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. (Holland et al., Cancer Medicine, 3d ed, p1245)	MESH:D014412|MESH:D018278|MESH:D027601	C01.925.256.721.150|C01.925.928.216|C04.557.465.625.650.240.325|C04.557.470.200.025.370.325|C04.557.580.625.650.240.325	C01.925.256.721|C01.925.928|C04.557.465.625.650.240|C04.557.470.200.025.370|C04.557.580.625.650.240	Cancer, Merkel Cell|Cell Cancer, Merkel|Merkel Cell Cancer|Merkel Cell Carcinoma|Merkel Cell Tumor|Merkle Tumors|Tumor, Merkel Cell|Tumors, Merkle	Cancer|Viral disease
Carcinoma, Mucoepidermoid	MESH:D018277	DO:DOID:4531	A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)	MESH:D000230|MESH:D018297	C04.557.470.200.025.340|C04.557.470.590.340	C04.557.470.200.025|C04.557.470.590	Carcinomas, Mucoepidermoid|Mucoepidermoid Carcinoma|Mucoepidermoid Carcinomas	Cancer
Carcinoma, Neuroendocrine	MESH:D018278	DO:DOID:1800	A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round 'blue cells', granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ('oat') cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)	MESH:D000230|MESH:D018358	C04.557.465.625.650.240|C04.557.470.200.025.370|C04.557.580.625.650.240	C04.557.465.625.650|C04.557.470.200.025|C04.557.580.625.650	Carcinomas, Neuroendocrine|Neuroendocrine Carcinoma|Neuroendocrine Carcinomas	Cancer
Carcinoma, Non-Small-Cell Lung	MESH:D002289	DO:DOID:3908	A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.	MESH:D002283	C04.588.894.797.520.109.220.249|C08.381.540.140.500|C08.785.520.100.220.500	C04.588.894.797.520.109.220|C08.381.540.140|C08.785.520.100.220	Carcinoma, Non Small Cell Lung|Carcinoma, Non-Small Cell Lung|Carcinomas, Non-Small-Cell Lung|Lung Carcinoma, Non-Small-Cell|Lung Carcinomas, Non-Small-Cell|Nonsmall Cell Lung Cancer|Non-Small Cell Lung Cancer|Non Small Cell Lung Carcinoma|Non-Small Cell Lung Carcinoma|Non-Small-Cell Lung Carcinoma|Non-Small-Cell Lung Carcinomas	Cancer|Respiratory tract disease
Carcinoma, Ovarian Epithelial	MESH:D000077216		A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.	MESH:D002277|MESH:D010051	C04.557.470.200.295|C04.588.322.455.199|C12.050.351.500.056.630.705.350|C12.050.351.937.418.685.350|C12.100.250.056.630.705.350|C12.900.418.685.350|C19.344.410.199|C19.391.630.705.350	C04.557.470.200|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.344.410|C19.391.630.705	Cancer, Epithelial Ovarian|Cancer, Ovarian Epithelial|Cancers, Epithelial Ovarian|Cancers, Ovarian Epithelial|Carcinoma, Epithelial Ovarian|Carcinomas, Epithelial Ovarian|Carcinomas, Ovarian Epithelial|Epithelial Cancer, Ovarian|Epithelial Cancers, Ovarian|Epithelial Carcinoma, Ovarian|Epithelial Carcinomas, Ovarian|Epithelial Ovarian Cancer|Epithelial Ovarian Cancers|Epithelial Ovarian Carcinoma|Epithelial Ovarian Carcinomas|Ovarian Cancer, Epithelial|Ovarian Cancers, Epithelial|Ovarian Carcinoma, Epithelial|Ovarian Carcinomas, Epithelial|Ovarian Epithelial Cancer|Ovarian Epithelial Cancers|Ovarian Epithelial Carcinoma|Ovarian Epithelial Carcinomas	Cancer|Endocrine system disease|Urogenital disease (female)
Carcinoma, Pancreatic Ductal	MESH:D021441	DO:DOID:3587	Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.	MESH:D010190|MESH:D044584	C04.557.470.200.025.232.750|C04.557.470.615.132.750|C04.588.274.761.750|C04.588.322.475.750|C06.301.761.750|C06.689.667.625|C19.344.421.750	C04.557.470.200.025.232|C04.557.470.615.132|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421	Carcinoma, Ductal, Pancreatic|Carcinoma, Pancreas Duct-Cell|Carcinomas, Pancreas Duct-Cell|Carcinomas, Pancreatic Ductal|Ductal Carcinoma of the Pancreas|Ductal Carcinoma, Pancreatic|Ductal Carcinomas, Pancreatic|Duct Cell Carcinoma of the Pancreas|Duct-Cell Carcinoma of the Pancreas|Duct Cell Carcinoma, Pancreas|Duct-Cell Carcinoma, Pancreas|Duct-Cell Carcinomas, Pancreas|Pancreas Duct-Cell Carcinoma|Pancreas Duct-Cell Carcinomas|Pancreatic Ductal Carcinoma|Pancreatic Ductal Carcinomas|Pancreatic Duct Cell Carcinoma	Cancer|Digestive system disease|Endocrine system disease
Carcinoma, Papillary	MESH:D002291	DO:DOID:3113	A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)	MESH:D002277|MESH:D018307	C04.557.470.200.360|C04.557.470.700.360	C04.557.470.200|C04.557.470.700	Carcinomas, Papillary|Papillary Carcinoma|Papillary Carcinomas	Cancer
Carcinoma, Papillary, Follicular	MESH:D018265	DO:DOID:3968	A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1271)	MESH:D000231|MESH:D018263	C04.557.470.200.025.060.225|C04.557.470.200.025.085.225	C04.557.470.200.025.060|C04.557.470.200.025.085		Cancer
Carcinoma, Renal Cell	MESH:D002292	DO:DOID:4450|DO:DOID:4464|DO:DOID:4465|DO:DOID:4467|DO:DOID:4471|DO:DOID:4473|OMIM:144700|OMIM:300854|OMIM:605074	A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.	MESH:D000230|MESH:D007680	C04.557.470.200.025.390|C04.588.945.947.535.160|C12.050.351.937.820.535.160|C12.050.351.968.419.473.160|C12.200.758.820.750.160|C12.200.777.419.473.160|C12.900.820.535.160|C12.950.419.473.160|C12.950.983.535.160	C04.557.470.200.025|C04.588.945.947.535|C12.050.351.937.820.535|C12.050.351.968.419.473|C12.200.758.820.750|C12.200.777.419.473|C12.900.820.535|C12.950.419.473|C12.950.983.535	Adenocarcinoma Of Kidney|ADENOCARCINOMA OF KIDNEY NONPAPILLARY RENAL CARCINOMA 1 LOCUS, INCLUDED|Adenocarcinoma Of Kidneys|Adenocarcinoma, Renal|Adenocarcinoma, Renal Cell|Adenocarcinomas, Renal Cell|Cancer, Renal Cell|Carcinoma, Collecting Duct|Carcinoma, Collecting Duct (Kidney)|Carcinoma, Hypernephroid|Carcinoma, Nephroid|Carcinoma, Renal|Carcinomas, Collecting Duct|Carcinomas, Collecting Duct (Kidney)|Carcinomas, Renal Cell|Chromophil Renal Cell Carcinoma|Chromophobe Renal Cell Carcinoma|Clear Cell Renal Carcinoma|Clear Cell Renal Cell Carcinoma|Collecting Duct Carcinoma|Collecting Duct Carcinoma (Kidney)|Collecting Duct Carcinoma of the Kidney|Collecting Duct Carcinomas|Collecting Duct Carcinomas (Kidney)|Grawitz Tumor|Hypernephroid Carcinoma|Hypernephroid Carcinomas|Hypernephroma|Hypernephromas|Kidney, Adenocarcinoma Of|Nephroid Carcinoma|Nephroid Carcinomas|NRC1, INCLUDED|Papillary Renal Cell Carcinoma|RCC|RCCP1|RCCX1|Renal Adenocarcinoma|Renal Adenocarcinomas|Renal Carcinoma|Renal Carcinomas|Renal Cell Adenocarcinoma|Renal Cell Adenocarcinomas|Renal Cell Cancer|Renal Cell Cancers|Renal Cell Carcinoma|RENAL CELL CARCINOMA, NONPAPILLARY|Renal Cell Carcinoma, Papillary|RENAL CELL CARCINOMA, PAPILLARY, 1|Renal Cell Carcinomas|RENAL CELL CARCINOMA, Xp11-ASSOCIATED|Renal Collecting Duct Carcinoma|Sarcomatoid Renal Cell Carcinoma|Tumor, Grawitz	Cancer|Urogenital disease (female)|Urogenital disease (male)
Carcinoma, Signet Ring Cell	MESH:D018279	DO:DOID:3493	A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.	MESH:D000230|MESH:D018297	C04.557.470.200.025.415|C04.557.470.590.415	C04.557.470.200.025|C04.557.470.590	Signet Ring Cell Carcinoma	Cancer
Carcinoma, Skin Appendage	MESH:D018280		A malignant tumor of the skin appendages, which include the hair, nails, sebaceous glands, sweat glands, and the mammary glands. (From Dorland, 27th ed)	MESH:D000230|MESH:D018294	C04.557.470.200.025.420|C04.557.470.550.420	C04.557.470.200.025|C04.557.470.550	Appendage Carcinoma, Skin|Appendage Carcinomas, Skin|Carcinomas, Skin Appendage|Skin Appendage Carcinoma|Skin Appendage Carcinomas	Cancer
Carcinoma, Small Cell	MESH:D018288	DO:DOID:5411|OMIM:182280	An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)	MESH:D002277	C04.557.470.200.380	C04.557.470.200	Carcinoma, Oat Cell|Carcinomas, Oat Cell|Carcinomas, Small Cell|Oat Cell Carcinoma|Oat Cell Carcinomas|SCCL|SCLC|SCLC1|SMALL CELL CANCER OF THE LUNG|Small Cell Carcinoma|Small Cell Carcinomas	Cancer
Carcinoma, Squamous Cell	MESH:D002294	DO:DOID:1749	A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)	MESH:D002277|MESH:D018307	C04.557.470.200.400|C04.557.470.700.400	C04.557.470.200|C04.557.470.700	Carcinoma, Epidermoid|Carcinoma, Planocellular|Carcinomas, Epidermoid|Carcinomas, Planocellular|Carcinoma, Squamous|Carcinomas, Squamous|Carcinomas, Squamous Cell|Epidermoid Carcinoma|Epidermoid Carcinomas|Planocellular Carcinoma|Planocellular Carcinomas|Squamous Carcinoma|Squamous Carcinomas|Squamous Cell Carcinoma|Squamous Cell Carcinomas	Cancer
Carcinoma, Transitional Cell	MESH:D002295	DO:DOID:2671	A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.	MESH:D002277	C04.557.470.200.430	C04.557.470.200	Carcinomas, Transitional Cell|Cell Carcinomas, Transitional|Cell Carcinoma, Transitional|Transitional Cell Carcinoma|Transitional Cell Carcinomas	Cancer
Carcinoma, Verrucous	MESH:D018289	DO:DOID:3737	A variant of well-differentiated epidermoid carcinoma that is most common in the oral cavity, but also occurs in the larynx, nasal cavity, esophagus, penis, anorectal region, vulva, vagina, uterine cervix, and skin, especially on the sole of the foot. Most intraoral cases occur in elderly male abusers of smokeless tobacco. The treatment is surgical resection. Radiotherapy is not indicated, as up to 30% treated with radiation become highly aggressive within six months. (Segen, Dictionary of Modern Medicine, 1992)	MESH:D002277|MESH:D018307	C04.557.470.200.450|C04.557.470.700.450	C04.557.470.200|C04.557.470.700	Carcinomas, Verrucous|Verrucous Carcinoma|Verrucous Carcinomas	Cancer
Carcinosarcoma	MESH:D002296	DO:DOID:4236	A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)	MESH:D012509|MESH:D018193	C04.557.435.290|C04.557.450.795.290	C04.557.435|C04.557.450.795	Carcinosarcomas	Cancer
Cardiac Arrhythmia, Ankyrin-B-Related	MESH:C566996	OMIM:600919		MESH:D001145	C14.280.067/C566996|C23.550.073/C566996	C14.280.067|C23.550.073	Ankyrin-B Syndrome|ANKYRIN-B SYNDROME LONG QT SYNDROME 4, INCLUDED|LQT4, INCLUDED	Cardiovascular disease|Pathology (process)
CARDIAC ARRHYTHMIA SYNDROME, WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS	OMIM:615441	DO:DOID:0060679		MESH:C536334|MESH:D018908	C05.651.515/615441|C10.597.613.593/615441|C14.280.067.845.940/C536334/615441|C14.280.123.875.940/C536334/615441|C23.550.073.845.940/C536334/615441|C23.550.695/615441|C23.888.592.608.593/615441	C05.651.515|C10.597.613.593|C14.280.067.845.940/C536334|C14.280.123.875.940/C536334|C23.550.073.845.940/C536334|C23.550.695|C23.888.592.608.593	CARDAR|CPVT5|TRIADEN KNOCKOUT SYNDROME|VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS	Cardiovascular disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Cardiac Complexes, Premature	MESH:D005117		A group of cardiac arrhythmias in which the cardiac contractions are not initiated at the SINOATRIAL NODE. They include both atrial and ventricular premature beats, and are also known as extra or ectopic heartbeats. Their frequency is increased in heart diseases.	MESH:D000075224|MESH:D001145	C14.280.067.325|C14.280.123.375|C23.550.073.325	C14.280.067|C14.280.123|C23.550.073	Beat, Premature|Beats, Premature|Cardiac Complex, Premature|Complexes, Premature Cardiac|Ectopic Heartbeat|Ectopic Heartbeats|Extrasystole|Extrasystoles|Heartbeat, Ectopic|Heartbeats, Ectopic|Premature Beat|Premature Beats|Premature Cardiac Complex|Premature Cardiac Complexes|Premature Cardiac Complices	Cardiovascular disease|Pathology (process)
CARDIAC CONDUCTION DEFECT	OMIM:115080			MESH:D000075224|MESH:D016757	C14.280.123/115080|C14.280.383.220/115080|C23.550.260.322.250/115080	C14.280.123|C14.280.383.220|C23.550.260.322.250	FAMILIAL SUDDEN DEATH, INCLUDED|SCD, INCLUDED|SUDDEN CARDIAC DEATH, INCLUDED	Cardiovascular disease|Pathology (process)
Cardiac Conduction Defect, Nonprogressive	MESH:C566186			MESH:D000075224|MESH:D001145	C14.280.067/C566186|C14.280.123/C566186|C23.550.073/C566186	C14.280.067|C14.280.123|C23.550.073		Cardiovascular disease|Pathology (process)
Cardiac Conduction System Disease	MESH:D000075224		Diseases characterized by pathological irregularities in the HEART CONDUCTION SYSTEM. They may be associated with other heart diseases and syndromes (e.g., BRUGADA SYNDROME; NEUROMUSCULAR DISEASE, HEART BLOCKS), isolated or may result from injuries. You can have a conduction disorder without having an arrhythmia, but some arrhythmias arise from conduction disorders. OMIM: 601144.	MESH:D006331	C14.280.123	C14.280	Cardiac Conduction Defect|Cardiac Conduction Defects|Cardiac Conduction System Diseases|Conduction Defect, Cardiac|Defect, Cardiac Conduction	Cardiovascular disease
Cardiac Malformation, Cleft Lip-Palate, Microcephaly and Digital Anomalies	MESH:C563414	DO:DOID:0111697|OMIM:600987		MESH:D002971|MESH:D002972|MESH:D006330|MESH:D008831	C05.500.460.185/C563414|C05.660.207.540.460.185/C563414|C05.660.207.620/C563414|C07.320.440.185/C563414|C07.465.409.225/C563414|C07.465.525.164/C563414|C07.465.525.185/C563414|C07.650.500.460.185/C563414|C07.650.525.164/C563414|C07.650.525.185/C563414|C10.500.507.400.500/C563414|C14.240.400/C563414|C14.280.400/C563414|C16.131.240.400/C563414|C16.131.621.207.540.460.185/C563414|C16.131.621.207.620/C563414|C16.131.666.507.400.500/C563414|C16.131.850.500.460.185/C563414|C16.131.850.525.164/C563414|C16.131.850.525.185/C563414	C05.500.460.185|C05.660.207.540.460.185|C05.660.207.620|C07.320.440.185|C07.465.409.225|C07.465.525.164|C07.465.525.185|C07.650.500.460.185|C07.650.525.164|C07.650.525.185|C10.500.507.400.500|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.540.460.185|C16.131.621.207.620|C16.131.666.507.400.500|C16.131.850.500.460.185|C16.131.850.525.164|C16.131.850.525.185	CARDIAC MALFORMATION, CLEFT LIP/PALATE, MICROCEPHALY, AND DIGITAL ANOMALIES|CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION|CPCMR	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease|Nervous system disease
Cardiac Output, High	MESH:D016534		A state of elevated cardiac output due to conditions of either increased hemodynamic demand or reduced cardiac oxygen output. These conditions may include ANEMIA; ARTERIOVENOUS FISTULA; THYROTOXICOSIS; PREGNANCY; EXERCISE; FEVER; and HYPOXIA. In time, compensatory changes of the heart can lead to pathological form of high cardiac output and eventual HEART FAILURE.	MESH:D006331|MESH:D012816	C14.280.142|C23.888.176	C14.280|C23.888	Cardiac Outputs, High|High Cardiac Output|High Cardiac Outputs	Cardiovascular disease|Signs and symptoms
Cardiac Output, Low	MESH:D002303		A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.	MESH:D006331|MESH:D012816	C14.280.148|C23.888.192	C14.280|C23.888	Low Cardiac Output|Low Cardiac Output Syndrome|Output, Low Cardiac	Cardiovascular disease|Signs and symptoms
Cardiac Papillary Fibroelastoma	MESH:D000084122		Primary tumors, predominantly of the CARDIAC VALVES, characterized by multiple papillary frond structures. Although histologically benign, they may result in complications (e.g., valve dysfunction, EMBOLISM; STROKE; and SUDDEN DEATH).	MESH:D006338	C04.588.894.309.250|C14.280.459.250	C04.588.894.309|C14.280.459	Cardiac Papillary Fibroelastomas|Fibroelastoma, Cardiac Papillary|Fibroelastoma, Papillary|Papillary Fibroelastoma|Papillary Fibroelastoma, Cardiac|Papillary Fibroelastomas	Cancer|Cardiovascular disease
Cardiac Septal Defects with Coarctation of the Aorta	MESH:C565883			MESH:D001017|MESH:D006343	C14.240.400.090/C565883|C14.240.400.560/C565883|C14.280.400.090/C565883|C14.280.400.560/C565883|C16.131.240.400.090/C565883|C16.131.240.400.560/C565883	C14.240.400.090|C14.240.400.560|C14.280.400.090|C14.280.400.560|C16.131.240.400.090|C16.131.240.400.560		Cardiovascular disease|Congenital abnormality
Cardiac Tamponade	MESH:D002305	DO:DOID:115	Compression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.	MESH:D006331	C14.280.155	C14.280	Cardiac Tamponades|Pericardial Tamponade|Pericardial Tamponades|Tamponade, Cardiac|Tamponade, Pericardial|Tamponades, Cardiac|Tamponades, Pericardial	Cardiovascular disease
Cardiac Valvular Defect, Developmental	MESH:C565882			MESH:D006330|MESH:D006349	C14.240.400/C565882|C14.280.400/C565882|C14.280.484/C565882|C16.131.240.400/C565882	C14.240.400|C14.280.400|C14.280.484|C16.131.240.400		Cardiovascular disease|Congenital abnormality
Cardioauditory syndrome of Sanchez Cascos	MESH:C535577			MESH:D003638|MESH:D006330	C09.218.458.341.186/C535577|C10.597.751.418.341.186/C535577|C14.240.400/C535577|C14.280.400/C535577|C16.131.240.400/C535577|C23.888.592.763.393.341.186/C535577	C09.218.458.341.186|C10.597.751.418.341.186|C14.240.400|C14.280.400|C16.131.240.400|C23.888.592.763.393.341.186	Sanchez Cascos cardioauditory syndrome	Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Cardiocranial syndrome	MESH:C535578			MESH:D000168|MESH:D006330	C05.116.099.370.894.232.015/C535578|C05.116.099.370.894.819.100/C535578|C05.660.207.240.100/C535578|C05.660.585.800.100/C535578|C05.660.906.364.100/C535578|C05.660.906.819.100/C535578|C14.240.400/C535578|C14.280.400/C535578|C16.131.240.400/C535578|C16.131.621.207.240.100/C535578|C16.131.621.585.800.100/C535578|C16.131.621.906.364.100/C535578|C16.131.621.906.819.100/C535578	C05.116.099.370.894.232.015|C05.116.099.370.894.819.100|C05.660.207.240.100|C05.660.585.800.100|C05.660.906.364.100|C05.660.906.819.100|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.240.100|C16.131.621.585.800.100|C16.131.621.906.364.100|C16.131.621.906.819.100	Pfeiffer cardiocranial syndrome|Pfeiffer Singer Zschiesche syndrome|Pfeiffer syndrome 2|Pfeiffer-type cardiocranial syndrome	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Cardiomyopathies	MESH:D009202	DO:DOID:0050700	A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).	MESH:D006331	C14.280.238	C14.280	Cardiomyopathies, Primary|Cardiomyopathies, Secondary|Cardiomyopathy|Cardiomyopathy, Primary|Cardiomyopathy, Secondary|Disease, Myocardial|Disease, Primary Myocardial|Disease, Secondary Myocardial|Diseases, Myocardial|Diseases, Primary Myocardial|Diseases, Secondary Myocardial|Myocardial Disease|Myocardial Disease, Primary|Myocardial Diseases|Myocardial Disease, Secondary|Myocardial Diseases, Primary|Myocardial Diseases, Secondary|Myocardiopathies|Myocardiopathy|Primary Cardiomyopathies|Primary Cardiomyopathy|Primary Myocardial Disease|Primary Myocardial Diseases|Secondary Cardiomyopathies|Secondary Cardiomyopathy|Secondary Myocardial Disease|Secondary Myocardial Diseases	Cardiovascular disease
Cardiomyopathy, Alcoholic	MESH:D002310	DO:DOID:12935	Disease of CARDIAC MUSCLE resulting from chronic excessive alcohol consumption. Myocardial damage can be caused by: (1) a toxic effect of alcohol; (2) malnutrition in alcoholics such as THIAMINE DEFICIENCY; or (3) toxic effect of additives in alcoholic beverages such as COBALT. This disease is usually manifested by DYSPNEA and palpitations with CARDIOMEGALY and congestive heart failure (HEART FAILURE).	MESH:D009202|MESH:D020751	C14.280.238.057|C25.775.100.087.250	C14.280.238|C25.775.100.087	Alcoholic Cardiomyopathy	Cardiovascular disease|Substance-related disorder
Cardiomyopathy Associated With Myopathy And Sudden Death	MESH:C565881			MESH:D003645|MESH:D009202	C14.280.238/C565881|C23.550.260.322/C565881	C14.280.238|C23.550.260.322		Cardiovascular disease|Pathology (process)
Cardiomyopathy, Familial Restrictive, 1	MESH:C566168	OMIM:115210		MESH:D002313	C14.280.238.160/C566168	C14.280.238.160	RCM|RCM1	Cardiovascular disease
Cardiomyopathy, Familial Restrictive, 2	MESH:C566512	OMIM:609578		MESH:D002313	C14.280.238.160/C566512	C14.280.238.160	RCM2	Cardiovascular disease
Cardiomyopathy, Familial Restrictive, 3	MESH:C567316	OMIM:612422		MESH:D002313	C14.280.238.160/C567316	C14.280.238.160	Rcm3	Cardiovascular disease
Cardiomyopathy, fatal fetal, due to myocardial calcification	MESH:C543241			MESH:D002114|MESH:D005313|MESH:D009202	C12.050.703.223/C543241|C14.280.238/C543241|C18.452.174.130/C543241|C23.550.260.585/C543241	C12.050.703.223|C14.280.238|C18.452.174.130|C23.550.260.585	Myocardial calcifications resulting in intrauterine fetal death	Cardiovascular disease|Metabolic disease|Pathology (process)|Pregnancy complication
Cardiomyopathy, Hypertrophic	MESH:D002312	DO:DOID:11984	A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).	MESH:D001020|MESH:D009202	C14.280.238.100|C14.280.484.048.750.070.160	C14.280.238|C14.280.484.048.750.070	Cardiomyopathies, Hypertrophic|Cardiomyopathies, Hypertrophic Obstructive|Cardiomyopathy, Hypertrophic Obstructive|Hypertrophic Cardiomyopathies|Hypertrophic Cardiomyopathy|Hypertrophic Obstructive Cardiomyopathies|Hypertrophic Obstructive Cardiomyopathy|Obstructive Cardiomyopathies, Hypertrophic|Obstructive Cardiomyopathy, Hypertrophic	Cardiovascular disease
Cardiomyopathy hypogonadism collagenoma syndrome	MESH:C535582			MESH:D003095|MESH:D007006|MESH:D009202|MESH:D012878	C04.588.805/C535582|C14.280.238/C535582|C17.300.200/C535582|C17.800.882/C535582|C19.391.482/C535582	C04.588.805|C14.280.238|C17.300.200|C17.800.882|C19.391.482	Cardiomyopathy-Hypogonadism-Collagenoma Syndrome	Cancer|Cardiovascular disease|Connective tissue disease|Endocrine system disease|Skin disease
Cardiomyopathy, infantile histiocytoid	MESH:C535584			MESH:D009202	C14.280.238/C535584	C14.280.238	Cardiomyopathy, Focal Lipid|Cardiomyopathy, Infantile Xanthomatous|Cardiomyopathy, Oncocytic|Foamy myocardial transformation of infancy|Focal lipid cardiomyopathy|Infantile xanthomatous cardiomyopathy|Oncocytic cardiomyopathy	Cardiovascular disease
Cardiomyopathy, Restrictive	MESH:D002313	DO:DOID:397	A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases (ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS) causing interstitial fibrosis.	MESH:D009202	C14.280.238.160	C14.280.238	Cardiomyopathies, Restrictive|Familial Restrictive Cardiomyopathy|Restrictive Cardiomyopathies|Restrictive Cardiomyopathy	Cardiovascular disease
Cardio-Renal Syndrome	MESH:D059347		Condition where a primary dysfunction of either heart or kidney results in failure of the other organ (e.g., HEART FAILURE with worsening RENAL INSUFFICIENCY).	MESH:D006333|MESH:D051437	C12.050.351.968.419.780.400|C12.200.777.419.780.400|C12.950.419.780.400|C14.280.434.156	C12.050.351.968.419.780|C12.200.777.419.780|C12.950.419.780|C14.280.434	Cardiorenal Syndrome|Cardio Renal Syndrome|Cardiorenal Syndromes|Cardio-Renal Syndromes|Renocardiac Syndrome|Reno Cardiac Syndrome|Reno-Cardiac Syndrome|Renocardiac Syndromes|Reno-Cardiac Syndromes|Syndrome, Cardiorenal|Syndrome, Cardio-Renal|Syndrome, Renocardiac|Syndrome, Reno-Cardiac|Syndromes, Cardiorenal|Syndromes, Cardio-Renal|Syndromes, Renocardiac|Syndromes, Reno-Cardiac	Cardiovascular disease|Urogenital disease (female)|Urogenital disease (male)
Cardiotoxicity	MESH:D066126		Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.	MESH:D006331|MESH:D010335|MESH:D011832|MESH:D064420	C14.280.260|C23.550.161|C25.100.389|C26.733.266	C14.280|C23.550|C25.100|C26.733	Cardiac Toxicities|Cardiac Toxicity|Cardiotoxicities|Toxicity, Cardiac	Cardiovascular disease|Pathology (process)|Wounds and injuries
Cardiovascular Abnormalities	MESH:D018376		Congenital, inherited, or acquired anomalies of the CARDIOVASCULAR SYSTEM, including the HEART and BLOOD VESSELS.	MESH:D000013|MESH:D002318	C14.240|C16.131.240	C14|C16.131	Abnormalities, Cardiovascular|Abnormality, Cardiovascular|Cardiovascular Abnormality	Cardiovascular disease|Congenital abnormality
Cardiovascular Diseases	MESH:D002318	DO:DOID:1287	Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.	MESH:C	C14	C	Cardiovascular Disease|Disease, Cardiovascular|Diseases, Cardiovascular	Cardiovascular disease
Cardiovascular Infections	MESH:D053821		Pathological conditions of the CARDIOVASCULAR SYSTEM caused by infections.	MESH:D002318|MESH:D007239	C01.190|C14.260	C01|C14	Cardiovascular Infection|Infection, Cardiovascular|Infections, Cardiovascular	Cardiovascular disease
Cardiovirus Infections	MESH:D018188		Infections caused by viruses of the genus CARDIOVIRUS, family PICORNAVIRIDAE.	MESH:D010850	C01.925.782.687.150	C01.925.782.687	Cardiovirus Infection|Infection, Cardiovirus|Infections, Cardiovirus	Viral disease
Car Factor Deficiency	MESH:C566176			MESH:D001778	C15.378.100/C566176	C15.378.100	Car. Factor Deficiency	Blood disease
Carney Complex	MESH:D056733	DO:DOID:0050471|OMIM:160980|OMIM:605244	Autosomal dominant syndrome characterized by cardiac and cutaneous MYXOMAS; LENTIGINOSIS (spotty pigmentation of the skin), and endocrinopathy and its associated endocrine tumors. The cardiac myxomas may lead to SUDDEN CARDIAC DEATH and other complications in Carney complex patients. The gene coding for the PRKAR1A protein is one of the causative genetic loci (type 1). A second locus is at chromosome 2p16 (type 2).	MESH:D000015|MESH:D006338|MESH:D009232|MESH:D012868	C04.557.450.565.550.312|C04.588.894.309.500|C14.280.459.500|C16.131.077.229|C16.131.831.108	C04.557.450.565.550|C04.588.894.309|C14.280.459|C16.131.077|C16.131.831	CAR|Carney Complex, Type 1|Carney Complex, Type 2|Carney Complex, Type I|Carney Complex, Type II|Carney Myxoma Endocrine Complex|Carney Myxoma-Endocrine Complex|CARNEY MYXOMA-ENDOCRINE COMPLEX, TYPE 2|Carney Myxoma Endocrine Complex, Type II|Carney Myxoma-Endocrine Complex, Type II|Carney Syndrome|CNC1|CNC2|Complex, Carney|Complex, Carney Myxoma-Endocrine|LAMB - Lentigines, Atrial Myxoma, Mucocutaneous Myoma, Blue Nevus Syndrome|LAMB Syndrome|LAMB Syndromes|Myxoma-Endocrine Complex, Carney|Myxoma, Spotty Pigmentation, and Endocrine Overactivity|NAME Syndrome|NAME Syndromes|Nevi, Atrial Myxoma, Skin Myxoma, Ephelides Syndrome|Syndrome, Carney|Syndrome, LAMB|Syndromes, LAMB	Cancer|Cardiovascular disease|Congenital abnormality
Carney Complex Variant	MESH:C563845	OMIM:608837		MESH:D056733	C04.557.450.565.550.312/C563845|C04.588.894.309.500/C563845|C14.280.459.500/C563845|C16.131.077.229/C563845|C16.131.831.108/C563845	C04.557.450.565.550.312|C04.588.894.309.500|C14.280.459.500|C16.131.077.229|C16.131.831.108		Cancer|Cardiovascular disease|Congenital abnormality
Carney-Stratakis Syndrome	MESH:C564650	OMIM:606864		MESH:D010235|MESH:D046152	C04.557.450.565.370/C564650|C04.557.465.625.650.700/C564650|C04.557.580.625.650.700/C564650|C06.301.371.308/C564650|C06.405.249.308/C564650	C04.557.450.565.370|C04.557.465.625.650.700|C04.557.580.625.650.700|C06.301.371.308|C06.405.249.308	CARNEY-STRATAKIS SYNDROME|Paraganglioma and Gastric Stromal Sarcoma|Paraganglioma and Gastrointestinal Stromal Tumor	Cancer|Digestive system disease
Carney Triad	MESH:C565803			MESH:D002812|MESH:D007890|MESH:D008175|MESH:D010236|MESH:D013274	C04.557.450.565.265/C565803|C04.557.450.590.455/C565803|C04.557.450.795.455/C565803|C04.557.465.625.650.700.705/C565803|C04.557.580.625.650.700.705/C565803|C04.588.274.476.767/C565803|C04.588.894.797.520/C565803|C06.301.371.767/C565803|C06.405.249.767/C565803|C06.405.748.789/C565803|C08.381.540/C565803|C08.785.520/C565803	C04.557.450.565.265|C04.557.450.590.455|C04.557.450.795.455|C04.557.465.625.650.700.705|C04.557.580.625.650.700.705|C04.588.274.476.767|C04.588.894.797.520|C06.301.371.767|C06.405.249.767|C06.405.748.789|C08.381.540|C08.785.520	Gastric Leiomyosarcoma, Pulmonary Chondroma, and Extraadrenal Paraganglioma	Cancer|Digestive system disease|Respiratory tract disease
Carotid Artery Diseases	MESH:D002340	DO:DOID:3407	Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.	MESH:D002561	C10.228.140.300.200|C14.907.253.123	C10.228.140.300|C14.907.253	Arterial Disease, Carotid|Arterial Diseases, Carotid|Arterial Diseases, Common Carotid|Arterial Diseases, External Carotid|Arterial Diseases, Internal Carotid|Artery Disease, Carotid|Artery Diseases, Carotid|Artery Disorder, Carotid|Artery Disorders, Carotid|Atherosclerotic Disease, Carotid|Atherosclerotic Diseases, Carotid|Carotid Arterial Disease|Carotid Arterial Diseases|Carotid Artery Disease|Carotid Artery Disorder|Carotid Artery Disorders|Carotid Atheroscleroses|Carotid Atherosclerosis|Carotid Atherosclerotic Disease|Carotid Atherosclerotic Diseases|Common Carotid Artery Disease|Common Carotid Artery Diseases|Disorders, Carotid Artery|External Carotid Artery Diseases|Internal Carotid Artery Disease|Internal Carotid Artery Diseases	Cardiovascular disease|Nervous system disease
Carotid Artery Injuries	MESH:D020212		Damages to the CAROTID ARTERIES caused either by blunt force or penetrating trauma, such as CRANIOCEREBRAL TRAUMA; THORACIC INJURIES; and NECK INJURIES. Damaged carotid arteries can lead to CAROTID ARTERY THROMBOSIS; CAROTID-CAVERNOUS SINUS FISTULA; pseudoaneurysm formation; and INTERNAL CAROTID ARTERY DISSECTION. (From Am J Forensic Med Pathol 1997, 18:251; J Trauma 1994, 37:473)	MESH:D002340|MESH:D020214	C10.228.140.300.200.345|C10.228.140.300.350.500|C10.900.250.300|C14.907.253.123.345|C14.907.253.535.500|C26.915.200.200	C10.228.140.300.200|C10.228.140.300.350|C10.900.250|C14.907.253.123|C14.907.253.535|C26.915.200	Artery Injuries, Carotid|Artery Injury, Carotid|Artery Trauma, Carotid|Carotid Arteriopathies, Traumatic|Carotid Arteriopathy, Traumatic|Carotid Artery Injury|Carotid Artery Trauma|Carotid False Aneurysm|Carotid False Aneurysms|Carotid Pseudoaneurysm|False Aneurysm, Carotid|Injuries, Carotid Artery|Injury, Carotid Artery|Pseudoaneurysm, Carotid|Trauma, Carotid Artery|Traumatic Carotid Arteriopathy	Cardiovascular disease|Nervous system disease|Wounds and injuries
Carotid Artery, Internal, Dissection	MESH:D020215		The splitting of the vessel wall in one or both (left and right) internal carotid arteries (CAROTID ARTERY, INTERNAL). Interstitial hemorrhage into the media of the vessel wall can lead to occlusion of the internal carotid artery and aneurysm formation.	MESH:D000784|MESH:D020212	C10.228.140.300.200.345.300|C10.228.140.300.350.500.300|C10.900.250.300.300|C14.907.055.050.150|C14.907.253.123.345.300|C14.907.253.535.500.300|C26.915.200.200.500	C10.228.140.300.200.345|C10.228.140.300.350.500|C10.900.250.300|C14.907.055.050|C14.907.253.123.345|C14.907.253.535.500|C26.915.200.200	Carotid Artery Dissection, Internal|Dissection, Internal Carotid Artery|Internal Carotid Artery Dissection	Cardiovascular disease|Nervous system disease|Wounds and injuries
Carotid Artery Thrombosis	MESH:D002341	DO:DOID:3410	Blood clot formation in any part of the CAROTID ARTERIES. This may produce CAROTID STENOSIS or occlusion of the vessel, leading to TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; or AMAUROSIS FUGAX.	MESH:D002340|MESH:D002542	C10.228.140.300.200.355|C14.907.253.123.355|C14.907.253.566.206|C14.907.355.590.213.206	C10.228.140.300.200|C14.907.253.123|C14.907.253.566|C14.907.355.590.213	Carotid Artery Thromboses|Carotid Thrombosis|Common Carotid Artery Thrombosis|External Carotid Artery Thrombosis|Internal Carotid Artery Thrombosis|Thrombosis, Carotid|Thrombosis, Carotid Artery|Thrombosis, Common Carotid Artery|Thrombosis, External Carotid Artery|Thrombosis, Internal Carotid Artery	Cardiovascular disease|Nervous system disease
Carotid Body Tumor	MESH:D002345		Benign paraganglioma at the bifurcation of the COMMON CAROTID ARTERIES. It can encroach on the parapharyngeal space and produce dysphagia, pain, and cranial nerve palsies.	MESH:D010236	C04.557.465.625.650.700.705.220|C04.557.580.625.650.700.705.220	C04.557.465.625.650.700.705|C04.557.580.625.650.700.705	Carotid Body Paraganglioma|Carotid Body Paragangliomas|Carotid Body Tumors|Paraganglioma, Carotid Body|Paragangliomas, Carotid Body|Tumor, Carotid Body|Tumors, Carotid Body	Cancer
Carotid-Cavernous Sinus Fistula	MESH:D020216		An acquired or spontaneous abnormality in which there is communication between CAVERNOUS SINUS, a venous structure, and the CAROTID ARTERIES. It is often associated with HEAD TRAUMA, specifically basilar skull fractures (SKULL FRACTURE, BASILAR). Clinical signs often include VISION DISORDERS and INTRACRANIAL HYPERTENSION.	MESH:D001164|MESH:D002340|MESH:D020212	C10.228.140.300.200.480|C10.228.140.300.350.500.350|C10.900.250.300.400|C14.240.850.750.147.500|C14.240.850.984.750.500|C14.907.150.125.500|C14.907.253.123.357|C14.907.253.535.500.350|C14.907.933.555.500|C16.131.240.850.750.125.500|C23.300.575.950.250.500|C26.915.200.200.550	C10.228.140.300.200|C10.228.140.300.350.500|C10.900.250.300|C14.240.850.750.147|C14.240.850.984.750|C14.907.150.125|C14.907.253.123|C14.907.253.535.500|C14.907.933.555|C16.131.240.850.750.125|C23.300.575.950.250|C26.915.200.200	Carotid Artery Cavernous Sinus Fistula|Carotid Artery-Cavernous Sinus Fistula|Carotid Cavernous Sinus Fistula|Carotid-Cavernous Sinus Fistulas|C-C Fistula|C-C Fistulas|Fistula, Carotid Artery Cavernous Sinus|Fistula, Carotid Artery-Cavernous Sinus|Fistula, Carotid-Cavernous Sinus|Fistula, C-C|Fistulas, Carotid-Cavernous Sinus|Fistulas, C-C|Traumatic Carotid Cavernous Sinus Fistula|Traumatic Carotid-Cavernous Sinus Fistula	Cardiovascular disease|Congenital abnormality|Nervous system disease|Pathology (anatomical condition)|Wounds and injuries
Carotid Intimal Medial Thickness 1	MESH:C563733	OMIM:609338		MESH:D050197	C14.907.137.126.307/C563733	C14.907.137.126.307	CIMT1|Intimal Medial Thickness of Internal Carotid Artery	Cardiovascular disease
CAROTID INTIMAL MEDIAL THICKNESS 2	OMIM:608447			MESH:D014652	C14.907/608447	C14.907	CAROTID INTIMAL MEDIAL THICKNESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 12|CIMT2	Cardiovascular disease
Carotid Stenosis	MESH:D016893	DO:DOID:13001	Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)	MESH:D001157|MESH:D002340	C10.228.140.300.200.360|C14.907.137.230|C14.907.253.123.360	C10.228.140.300.200|C14.907.137|C14.907.253.123	Artery Narrowing, Carotid|Artery Narrowings, Carotid|Artery Plaque, Carotid|Artery Plaques, Carotid|Artery Stenoses, Carotid|Artery Stenosis, Carotid|Carotid Artery Narrowing|Carotid Artery Narrowings|Carotid Artery Plaque|Carotid Artery Plaques|Carotid Artery Stenoses|Carotid Artery Stenosis|Carotid Artery Ulcerating Plaque|Carotid Stenoses|Carotid Ulcer|Carotid Ulcers|Common Carotid Artery Stenosis|External Carotid Artery Stenosis|Internal Carotid Artery Stenosis|Narrowing, Carotid Artery|Narrowings, Carotid Artery|Plaque, Carotid Artery|Plaques, Carotid Artery|Plaque, Ulcerating, Carotid Artery|Stenoses, Carotid|Stenoses, Carotid Artery|Stenosis, Carotid|Stenosis, Carotid Artery|Stenosis, Common Carotid Artery|Stenosis, External Carotid Artery|Ulcerating Plaque, Carotid Artery|Ulcer, Carotid|Ulcers, Carotid	Cardiovascular disease|Nervous system disease
Carpal Tunnel Syndrome	MESH:D002349	DO:DOID:12169|OMIM:115430	Entrapment of the MEDIAN NERVE in the carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma (CUMULATIVE TRAUMA DISORDERS); wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis (see ARTHRITIS, RHEUMATOID); ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur. (Joynt, Clinical Neurology, 1995, Ch51, p45)	MESH:D009408|MESH:D012090|MESH:D020423	C10.668.829.500.500.200|C10.668.829.550.200|C26.844.150.206	C10.668.829.500.500|C10.668.829.550|C26.844.150	Amyotrophy, Thenar, Of Carpal Origin|Carpal Tunnel Syndromes|Compression Neuropathy, Carpal Tunnel|CTS|CTS1|Entrapment Neuropathy, Carpal Tunnel|Median Neuropathy, Carpal Tunnel|Syndrome, Carpal Tunnel|Syndromes, Carpal Tunnel	Nervous system disease|Wounds and injuries
Carrington syndrome	MESH:C535590			MESH:D011657	C08.381.750/C535590|C15.378.553.231.549.750/C535590	C08.381.750|C15.378.553.231.549.750	Carrington's Disease|Carrington's pulmonary eosinophilia|Chronic eosinophilic pneumonia (CEP)|Chronic idiopathic eosinophilic pneumonia|Eosinophilic idiopathic chronic pneumopathy	Blood disease|Respiratory tract disease
Castleman Disease	MESH:D005871	DO:DOID:0111157	Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.	MESH:D008232	C15.604.515.245|C20.683.515.250	C15.604.515|C20.683.515	Angiofollicular Lymph Hyperplasia|Angiofollicular Lymph Hyperplasias|Angiofollicular Lymph Node Hyperplasia|Angiofollicular Lymphoid Hyperplasia|Angiofollicular Lymphoid Hyperplasias|Castleman's Disease|Castlemans Disease|Castleman's Tumor|Castlemans Tumor|Castleman Tumor|Disease, Castlemans|Giant Lymph Node Hyperplasia|Hyperplasia, Angiofollicular Lymph|Hyperplasia, Angiofollicular Lymphoid|Hyperplasia, Giant Lymph Node|Lymph Hyperplasia, Angiofollicular|Lymph Node Hyperplasia, Giant|Lymphoid Hyperplasia, Angiofollicular|Tumor, Castleman's	Immune system disease|Lymphatic disease
Catalepsy	MESH:D002375		A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may be associated with PSYCHOTIC DISORDERS (e.g., SCHIZOPHRENIA, CATATONIC), nervous system drug toxicity, and other conditions.	MESH:D020820	C10.597.350.200|C23.888.592.350.200	C10.597.350|C23.888.592.350	Anochlesia|Anochlesias|Catalepsies|Cerea Flexibilitas|Flexibilitas, Cerea|Flexibilities, Waxy|Flexibility, Waxy|Waxy Flexibilities|Waxy Flexibility	Nervous system disease|Signs and symptoms
Catamenial pneumothorax	MESH:C538279			MESH:D011030	C08.528.778/C538279	C08.528.778		Respiratory tract disease
Cataract	MESH:D002386		Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)	MESH:D007905	C11.510.245	C11.510	Cataract, Membranous|Cataracts|Cataracts, Membranous|Lens Opacities|Lens Opacity|Membranous Cataract|Membranous Cataracts|Opacities, Lens|Opacity, Lens|Pseudoaphakia|Pseudoaphakias	Eye disease
CATARACT 13 WITH ADULT i PHENOTYPE	OMIM:116700	DO:DOID:0110242		MESH:D002386	C11.510.245/116700	C11.510.245	CTRCT13	Eye disease
CATARACT 15, MULTIPLE TYPES	OMIM:615274	DO:DOID:0110251		MESH:D002386	C11.510.245/615274	C11.510.245	CTRCT15	Eye disease
CATARACT 16, MULTIPLE TYPES	OMIM:613763	DO:DOID:0110250		MESH:D002386	C11.510.245/613763	C11.510.245	CATARACT, CONGENITAL LAMELLAR|CATARACT, POSTERIOR POLAR, 2|CTPP2|CTRCT16	Eye disease
CATARACT 19, MULTIPLE TYPES	OMIM:615277	DO:DOID:0110263		MESH:D002386	C11.510.245/615277	C11.510.245	CTRCT19	Eye disease
CATARACT 20, MULTIPLE TYPES	OMIM:116100	DO:DOID:0110240		MESH:D002386	C11.510.245/116100	C11.510.245	CTRCT20	Eye disease
CATARACT 23, MULTIPLE TYPES	OMIM:610425	DO:DOID:0110271		MESH:D002386	C11.510.245/610425	C11.510.245	CATARACT 23, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA|CTRCT23	Eye disease
CATARACT 32, MULTIPLE TYPES	OMIM:115650	DO:DOID:0110227		MESH:D002386	C11.510.245/115650	C11.510.245	CAP|CATARACT, ANTERIOR POLAR|CATARACT, ANTERIOR POLAR, 1|CATARACT, POSTERIOR POLAR, 5|CTAA1|CTPP5|CTRCT32	Eye disease
CATARACT 36	OMIM:613887	DO:DOID:0110247		MESH:D002386	C11.510.245/613887	C11.510.245	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4|CATC4|CTRCT36	Eye disease
CATARACT 38	OMIM:614691	DO:DOID:0110245		MESH:D002386	C11.510.245/614691	C11.510.245	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 5|CATC5|CTRCT38	Eye disease
CATARACT 39, MULTIPLE TYPES	OMIM:615188	DO:DOID:0110236		MESH:D002386	C11.510.245/615188	C11.510.245	CTRCT39	Eye disease
CATARACT 3, MULTIPLE TYPES	OMIM:601547	DO:DOID:0110269		MESH:D002386	C11.510.245/601547	C11.510.245	CATARACT 3, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA|CATARACT, CONGENITAL, CERULEAN TYPE, 2|CCA2|CTRCT3	Eye disease
CATARACT 41	OMIM:116400	DO:DOID:0110241		MESH:D002386	C11.510.245/116400	C11.510.245	CATARACT 41, CONGENITAL NUCLEAR TYPE|CTRCT41	Eye disease
CATARACT 42	OMIM:115900	DO:DOID:0110237		MESH:D002386	C11.510.245/115900	C11.510.245	CTRCT42	Eye disease
CATARACT 43	OMIM:616279	DO:DOID:0110259		MESH:D002386	C11.510.245/616279	C11.510.245	CTRCT43	Eye disease
CATARACT 44	OMIM:616509	DO:DOID:0110267		MESH:D002386	C11.510.245/616509	C11.510.245	CATARACT 44 AND HYPOTRICHOSIS|CTRCT44	Eye disease
CATARACT 45	OMIM:616851	DO:DOID:0110262		MESH:D002386	C11.510.245/616851	C11.510.245	CTRCT45	Eye disease
CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY	OMIM:212500	DO:DOID:0110243		MESH:D001145|MESH:D002386|MESH:D009202	C11.510.245/212500|C14.280.067/212500|C14.280.238/212500|C23.550.073/212500	C11.510.245|C14.280.067|C14.280.238|C23.550.073	CATARACT, JUVENILE, HUTTERITE TYPE|CTRCT46	Cardiovascular disease|Eye disease|Pathology (process)
CATARACT 4, MULTIPLE TYPES	OMIM:115700	DO:DOID:0110234		MESH:D002386	C11.510.245/115700	C11.510.245	CACA|CATARACT 4, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA|CATARACT, CONGENITAL, CERULEAN TYPE, 3|CATARACT, CRYSTALLINE ACULEIFORM|CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL|CATARACT, PUNCTATE, PROGRESSIVE JUVENILE-ONSET|CCA3|CTRCT4|PCC	Eye disease
CATARACT 6, MULTIPLE TYPES	OMIM:116600	DO:DOID:0110229		MESH:D002386	C11.510.245/116600	C11.510.245	ARCC2|CATARACT, AGE-RELATED CORTICAL, 2|CATARACT, POSTERIOR POLAR, 1|CTPP1|CTRCT6	Eye disease
Cataract, Age-Related Cortical, 1	MESH:C563812	OMIM:609026		MESH:D002386	C11.510.245/C563812	C11.510.245	ARCC1|CATARACT 28|CATARACT, AGE-RELATED CORTICAL, 1|CTRCT28	Eye disease
Cataract, Age-Related Nuclear	MESH:C563333			MESH:D002386	C11.510.245/C563333	C11.510.245	Nuclear Sclerosis of the Lens	Eye disease
Cataract, alopecia, sclerodactyly	MESH:C535336	DO:DOID:0111245		MESH:D000505|MESH:D002386|MESH:D012594	C11.510.245/C535336|C17.300.787/C535336|C17.800.329.937.122/C535336|C17.800.767/C535336|C23.300.035/C535336	C11.510.245|C17.300.787|C17.800.329.937.122|C17.800.767|C23.300.035	Cataract, alopecia, sclerodactyly syndrome|Cataract-Alopecia-Sclerodactyly Syndrome	Connective tissue disease|Eye disease|Pathology (anatomical condition)|Skin disease
Cataract and cardiomyopathy	MESH:C538280	DO:DOID:0080132|OMIM:212350		MESH:D002386|MESH:D009202	C11.510.245/C538280|C14.280.238/C538280	C11.510.245|C14.280.238	Cardiomyopathy and cataract|MITOCHONDRIAL DNA DEPLETION SYNDROME 10 (CARDIOMYOPATHIC TYPE)|MTDPS10|Sengers syndrome	Cardiovascular disease|Eye disease
Cataract anterior polar dominant	MESH:C538282			MESH:D002386	C11.510.245/C538282	C11.510.245	Anterior polar cataracts 1|Cataract anterior polar|Cataract, Anterior Polar|Cataract, Anterior Polar, 1	Eye disease
Cataract ataxia deafness	MESH:C538283			MESH:D001259|MESH:D002386|MESH:D006319|MESH:D010523	C09.218.458.341.887/C538283|C10.597.350.090/C538283|C10.597.751.418.341.887/C538283|C10.668.829/C538283|C11.510.245/C538283|C23.888.592.350.090/C538283|C23.888.592.763.393.341.887/C538283	C09.218.458.341.887|C10.597.350.090|C10.597.751.418.341.887|C10.668.829|C11.510.245|C23.888.592.350.090|C23.888.592.763.393.341.887	Begeer syndrome|Cataract-ataxia-deafness-retardation syndrome|Cataract ataxia deafness syndrome|Polyneuropathy, cataract, deafness syndrome|Polyneuropathy-Cataract-Deafness Syndrome	Ear-nose-throat disease|Eye disease|Nervous system disease|Signs and symptoms
Cataract, Autosomal Dominant	MESH:C565815	OMIM:604219		MESH:D002386	C11.510.245/C565815	C11.510.245	Cataract 9, Multiple Types|Cataract 9, multiple types, with or without microcornea|CATARACT, AUTOSOMAL DOMINANT|CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 1|CATC1|CTRCT9	Eye disease
Cataract, Autosomal Dominant, Multiple Types 1	MESH:C566909	OMIM:611597		MESH:D002386	C11.510.245/C566909	C11.510.245	CATARACT 12, MULTIPLE TYPES|CTRCT12	Eye disease
Cataract, Autosomal Dominant Nuclear	MESH:C565137			MESH:D002386	C11.510.245/C565137	C11.510.245		Eye disease
Cataract, Autosomal Recessive Congenital 1	MESH:C565136			MESH:D002386	C11.510.245/C565136	C11.510.245		Eye disease
Cataract, autosomal recessive congenital 2	MESH:C535337	OMIM:610019		MESH:D002386	C11.510.245/C535337	C11.510.245	CATARACT 18|CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 2|CATC2|CTRCT18	Eye disease
Cataract, Autosomal Recessive Congenital 3	MESH:C567835	OMIM:612968		MESH:D002386	C11.510.245/C567835	C11.510.245	CATARACT 34, MULTIPLE TYPES|CATARACT 34, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA|CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 3|CATC3|CTRCT34	Eye disease
Cataract, Autosomal Recessive, Early-Onset, Pulverulent	MESH:C565298	OMIM:605749		MESH:D002386	C11.510.245/C565298	C11.510.245	CAAR|CATARACT 26, MULTIPLE TYPES|CATARACT, AUTOSOMAL RECESSIVE, EARLY-ONSET, PULVERULENT|CTRCT26	Eye disease
Cataract, Central Saccular, With Sutural Opacities	MESH:C565301	OMIM:605728		MESH:D002386	C11.510.245/C565301	C11.510.245	CATARACT 25|Cataract, Central Pouch-Like, With Sutural Opacities|CATARACT, CENTRAL SACCULAR, WITH SUTURAL OPACITIES|CCSSO|CTRCT25	Eye disease
Cataract, Congenital, Cerulean Type, 2	MESH:C563294			MESH:D002386	C11.510.245/C563294	C11.510.245	Cataract, Congenital, Blue Dot Type, 2	Eye disease
Cataract, Congenital, Cerulean Type, 3	MESH:C563819			MESH:D002386	C11.510.245/C563819	C11.510.245	Cataract, Congenital Blue Dot Type, 3	Eye disease
Cataract congenital dominant non nuclear	MESH:C538284			MESH:D002386	C11.510.245/C538284	C11.510.245	Autosomal dominant nonnuclear polymorphic congenital cataract|Cataract, Nonnuclear Polymorphic Congenital, Autosomal Dominant|Cataract, polymorphic congenital	Eye disease
Cataract congenital Volkmann type	MESH:C538285	OMIM:115665		MESH:D002386	C11.510.245/C538285	C11.510.245	CATARACT 8, MULTIPLE TYPES|Cataract, Congenital, Volkmann Type|CCV|CTRCT8	Eye disease
Cataract, Congenital, with Mental Impairment and Dentate Gyrus Atrophy	MESH:C564353			MESH:D002386|MESH:D008607	C10.597.606.360/C564353|C11.510.245/C564353|C23.888.592.604.646/C564353|F03.625.539/C564353	C10.597.606.360|C11.510.245|C23.888.592.604.646|F03.625.539		Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Cataract, Congenital Zonular, with Sutural Opacities	MESH:C563435	OMIM:600881		MESH:D002386	C11.510.245/C563435	C11.510.245	CATARACT 10, MULTIPLE TYPES|CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES|CCZS|CTRCT10	Eye disease
Cataract, Coppock-Like	MESH:C565133	OMIM:604307		MESH:D002386	C11.510.245/C565133	C11.510.245	CATARACT 2, MULTIPLE TYPES|CATARACT 2, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA|CATARACT, COPPOCK-LIKE|Cataract, Embryonic Nuclear|CCL|CTRCT2	Eye disease
Cataract, Cortical, Juvenile-Onset	MESH:C566955	OMIM:611391		MESH:D002386	C11.510.245/C566955	C11.510.245	CATARACT 33, MULTIPLE TYPES|CTRCT33	Eye disease
Cataract, Cortical Pulverulent, Late-Onset	MESH:C563604			MESH:D002386	C11.510.245/C563604	C11.510.245		Eye disease
Cataract, Crystalline Aculeiform	MESH:C566162			MESH:D002386	C11.510.245/C566162	C11.510.245	Cataract, Aculeiform	Eye disease
Cataract, Crystalline Coralliform	MESH:C566161			MESH:D002386	C11.510.245/C566161	C11.510.245		Eye disease
Cataract Hutterite type	MESH:C538286			MESH:D002386	C11.510.245/C538286	C11.510.245		Eye disease
Cataract, Lamellar 2	MESH:C566481			MESH:D002386	C11.510.245/C566481	C11.510.245		Eye disease
Cataract microcornea syndrome	MESH:C538287			MESH:D002386|MESH:D003316	C11.204/C538287|C11.510.245/C538287	C11.204|C11.510.245	Cataract-Microcornea Syndrome|Microcornea cataract syndrome|Microcornea-Cataract Syndrome	Eye disease
Cataract, Nuclear Diffuse Nonprogressive	MESH:C566157	OMIM:116300		MESH:D002386	C11.510.245/C566157	C11.510.245	CATARACT 30, MULTIPLE TYPES|CTRCT30	Eye disease
Cataract, Nuclear Progressive	MESH:C564596	OMIM:607304		MESH:D002386	C11.510.245/C564596	C11.510.245	CATARACT 27|CATARACT 27, NUCLEAR PROGRESSIVE|Cataract, Congenital, Nuclear Progressive|CCNP|CTRCT27	Eye disease
Cataract, Nuclear Total	MESH:C566156			MESH:D002386	C11.510.245/C566156	C11.510.245		Eye disease
Cataract, Polymorphic and Lamellar	MESH:C563603			MESH:D002386	C11.510.245/C563603	C11.510.245		Eye disease
Cataract, posterior polar, 1	MESH:C535339			MESH:D002386	C11.510.245/C535339	C11.510.245	Arcc2|Cataract, Age-Related Cortical, 2|Posterior polar cataract, 1	Eye disease
Cataract, Posterior Polar, 2	MESH:C565134			MESH:D002386	C11.510.245/C565134	C11.510.245		Eye disease
Cataract, posterior polar, 3	MESH:C535343	OMIM:605387		MESH:D002386	C11.510.245/C535343	C11.510.245	CATARACT 31, MULTIPLE TYPES|CATARACT, POSTERIOR POLAR, 3|CPP3|CTPP3|CTRCT31	Eye disease
Cataract, posterior polar, 4	MESH:C535344	OMIM:610623		MESH:D002386	C11.510.245/C535344	C11.510.245	CATARACT 11, MULTIPLE TYPES|CATARACT, POSTERIOR POLAR, 4|Cataract, Posterior Polar, 4, With Microphthalmia And Neurodevelopmental Abnormalities|CPP4 CATARACT 11 WITH MICROPHTHALMIA AND NEURODEVELOPMENTAL ABNORMALITIES, INCLUDED|CTPP4|CTRCT11|Posterior polar cataract, 4	Eye disease
Cataract, posterior polar, 5	MESH:C535340			MESH:D002386	C11.510.245/C535340	C11.510.245		Eye disease
Cataract, Progressive Polymorphic Cortical	MESH:C565130			MESH:D002386	C11.510.245/C565130	C11.510.245		Eye disease
Cataract, Pulverulent, Juvenile-Onset	MESH:C565703	OMIM:610202		MESH:D002386	C11.510.245/C565703	C11.510.245	CATARACT 21, MULTIPLE TYPES|CATARACT 21, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA|Cataract, Congenital, Cerulean Type, 4|CATARACT, PULVERULENT, JUVENILE-ONSET|CCA4|CTRCT21	Eye disease
Cataract, Punctate, Progressive Juvenile-Onset	MESH:C565131			MESH:D002386	C11.510.245/C565131	C11.510.245		Eye disease
Cataracts, ataxia, short stature, and mental retardation	MESH:C535345			MESH:D001259|MESH:D002386|MESH:D006130|MESH:D008607	C10.597.350.090/C535345|C10.597.606.360/C535345|C11.510.245/C535345|C23.550.393/C535345|C23.888.592.350.090/C535345|C23.888.592.604.646/C535345|F03.625.539/C535345	C10.597.350.090|C10.597.606.360|C11.510.245|C23.550.393|C23.888.592.350.090|C23.888.592.604.646|F03.625.539	CASM Syndrome|Cataract, Ataxia, Short Stature, And Mental Retardation	Eye disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Cataracts, Congenital, with Sensorineural Deafness, Down Syndrome-Like Facial Appearance, Short Stature, and Mental Retardation	MESH:C563390	DO:DOID:0111688|OMIM:601088		MESH:D002386|MESH:D006130|MESH:D006319|MESH:D008607|MESH:D019066	C09.218.458.341.887/C563390|C10.597.606.360/C563390|C10.597.751.418.341.887/C563390|C11.510.245/C563390|C23.550.291.812/C563390|C23.550.393/C563390|C23.888.592.604.646/C563390|C23.888.592.763.393.341.887/C563390|F03.625.539/C563390	C09.218.458.341.887|C10.597.606.360|C10.597.751.418.341.887|C11.510.245|C23.550.291.812|C23.550.393|C23.888.592.604.646|C23.888.592.763.393.341.887|F03.625.539	AYGRP|AYME-GRIPP SYNDROME|CATARACTS, CONGENITAL, WITH SENSORINEURAL DEAFNESS, DOWN SYNDROME-LIKE FACIAL APPEARANCE, SHORT STATURE, AND MENTAL RETARDATION	Ear-nose-throat disease|Eye disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Cataract, Sutural, with Punctate and Cerulean Opacities	MESH:C564619			MESH:D002386	C11.510.245/C564619	C11.510.245		Eye disease
Cataract, Variable Zonular Pulverulent	MESH:C565132			MESH:D002386	C11.510.245/C565132	C11.510.245		Eye disease
Cataract, zonular	MESH:C535342	OMIM:116800		MESH:D002386	C11.510.245/C535342	C11.510.245	CAM|CATARACT 5, MULTIPLE TYPES|Cataract, lamellar|Cataract, Marner Type|CTM|CTRCT5|Perinuclear cataract	Eye disease
Cataract, Zonular Central Nuclear	MESH:C565135			MESH:D002386	C11.510.245/C565135	C11.510.245		Eye disease
Cataract, Zonular Pulverulent 1	MESH:C566158	OMIM:116200		MESH:D002386	C11.510.245/C566158	C11.510.245	CAE1|CATARACT 1, MULTIPLE TYPES|CATARACT 1, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA|Cataract, Duffy-Linked|CATARACT, ZONULAR PULVERULENT, 1|CTRCT1|CZP|CZP1|Pulverulent Zonular Cataract	Eye disease
Cataract, Zonular Pulverulent 3	MESH:C566608	OMIM:601885		MESH:D002386	C11.510.245/C566608	C11.510.245	CAE3|CATARACT 14, MULTIPLE TYPES|CATARACT, ZONULAR PULVERULENT 3|CTRCT14|CZP3	Eye disease
Catatonia	MESH:D002389		A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)	MESH:D019954	C10.597.606.115|C23.888.592.604.115	C10.597.606|C23.888.592.604	Catatonia, Lethal|Catatonia, Malignant|Catatonia, Organic|Catatonias|Catatonia, Schizophreniform|Catatonias, Lethal|Catatonias, Malignant|Catatonias, Organic|Catatonias, Schizophreniform|Catatonic Disorder, Organic|Catatonic Disorders, Organic|Lethal Catatonia|Lethal Catatonias|Malignant Catatonia|Malignant Catatonias|Organic Catatonia|Organic Catatonias|Organic Catatonic Disorder|Organic Catatonic Disorders|Schizophreniform Catatonia|Schizophreniform Catatonias	Nervous system disease|Signs and symptoms
Catatrichy	MESH:C535346			MESH:D006201	C17.800.329/C535346	C17.800.329	Forelock	Skin disease
Catheter-Related Infections	MESH:D055499		Infections resulting from the use of catheters. Proper aseptic technique, site of catheter placement, material composition, and virulence of the organism are all factors that can influence possible infection.	MESH:D007239	C01.195	C01	Associated Infection, Catheter|Associated Infections, Catheter|Catheter Associated Infection|Catheter-Associated Infection|Catheter Associated Infections|Catheter-Associated Infections|Catheter Related Infection|Catheter-Related Infection|Catheter Related Infections|Infection, Catheter Associated|Infection, Catheter-Associated|Infection, Catheter Related|Infection, Catheter-Related|Infections, Catheter Associated|Infections, Catheter-Associated|Infections, Catheter Related|Infections, Catheter-Related|Related Infection, Catheter|Related Infections, Catheter	
Cauda Equina Syndrome	MESH:D000077684	DO:DOID:11577	Compressive lesion affecting the nerve roots of the CAUDA EQUINA (e.g., compression, herniation, inflammation, rupture, or stenosis), which controls the function of the bladder and bowel. Symptoms may include neurological dysfunction of bladder or bowels, loss of sexual sensation and altered sensation or paralysis in the lower extremities.	MESH:D009408|MESH:D011129	C10.668.829.550.350|C10.668.829.800.750.150	C10.668.829.550|C10.668.829.800.750	Cauda Equina Syndromes	Nervous system disease
Causalgia	MESH:D002422	DO:DOID:3222	A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch (HYPERESTHESIA) in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor (i.e., sympathetic innervation to sweat glands), vasomotor, and trophic skin changes may also occur. (Adams et al., Principles of Neurology, 6th ed, p1359)	MESH:D009437|MESH:D020918	C10.177.195.200|C10.668.829.250.200|C10.668.829.600.200	C10.177.195|C10.668.829.250|C10.668.829.600	Causalgia Syndrome|Causalgia Syndromes|Complex Regional Pain Syndrome Type II|CRPS Type II|Deafferentation Pain|Pain, Deafferentation|Syndrome, Causalgia|Syndromes, Causalgia|Type II Complex Regional Pain Syndrome	Nervous system disease
Cavernous Malformations of CNS and Retina	MESH:C566152			MESH:D020785	C10.500.190/C566152|C14.240.850.875/C566152|C16.131.240.850.875/C566152|C16.131.666.190/C566152	C10.500.190|C14.240.850.875|C16.131.240.850.875|C16.131.666.190		Cardiovascular disease|Congenital abnormality|Nervous system disease
Cavernous Sinus Thrombosis	MESH:D020226	DO:DOID:3575	Formation or presence of a blood clot (THROMBUS) in the CAVERNOUS SINUS of the brain. Infections of the paranasal sinuses and adjacent structures, CRANIOCEREBRAL TRAUMA, and THROMBOPHILIA are associated conditions. Clinical manifestations include dysfunction of cranial nerves III, IV, V, and VI, marked periorbital swelling, chemosis, fever, and visual loss. (From Adams et al., Principles of Neurology, 6th ed, p711)	MESH:D012851	C10.228.140.300.525.425.500.375|C14.907.253.566.350.500.375|C14.907.355.590.213.350.500.375	C10.228.140.300.525.425.500|C14.907.253.566.350.500|C14.907.355.590.213.350.500	Cavernous Sinus, Phlebitis, Septic|Cavernous Sinus Thrombophlebitides|Cavernous Sinus Thrombophlebitis|Cavernous Sinus Thromboses|Caverous Sinus Septic Phlebitis|Phlebitis, Cavernous Sinus, Septic|Septic Phlebitis, Cavernous Sinus|Sinus Thrombophlebitides, Cavernous|Sinus Thrombophlebitis, Cavernous|Sinus Thromboses, Cavernous|Sinus Thrombosis, Cavernous|Thrombophlebitides, Cavernous Sinus|Thrombophlebitis, Cavernous Sinus|Thromboses, Cavernous Sinus|Thrombosis, Cavernous Sinus	Cardiovascular disease|Nervous system disease
Cayler cardiofacial syndrome	MESH:C535349	OMIM:125520		MESH:D005158	C07.465.327/C535349|C10.597.622.214/C535349|C23.888.592.636.214/C535349	C07.465.327|C10.597.622.214|C23.888.592.636.214	ACF|Asymmetric crying facies|Cayler's syndrome|Cayler syndrome|Depressor Anguli Oris Muscle, Hypoplasia Of|Facial paresis partial unilateral|Facial Paresis, Partial, Unilateral|Partial unilateral facial paralysis	Mouth disease|Nervous system disease|Signs and symptoms
Cd4+ Lymphocyte Deficiency	MESH:C566079			MESH:D007153|MESH:D007960	C15.378.553/C566079|C20.673/C566079	C15.378.553|C20.673		Blood disease|Immune system disease
CD59 Deficiency	MESH:C567355	OMIM:612300		MESH:D000743|MESH:D006456	C12.050.351.968.934.734.634/C567355|C12.200.777.934.734.634/C567355|C12.950.934.734.634/C567355|C15.378.071.141/C567355|C23.888.942.750.634/C567355	C12.050.351.968.934.734.634|C12.200.777.934.734.634|C12.950.934.734.634|C15.378.071.141|C23.888.942.750.634	CD59 DEFICIENCY|HACD59|HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY	Blood disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
CDKL5 deficiency disorder	MESH:C564064	OMIM:300672		MESH:D000073376|MESH:D013036	C10.228.140.490.375.760/C564064|C10.228.140.490.493.875/C564064|C10.228.140.490.493/C564064	C10.228.140.490.375.760|C10.228.140.490.493|C10.228.140.490.493.875	CDKL5 Disorder|DEE2|DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2|EIEE2|Epileptic Encephalopathy, Early Infantile, 2|Infantile Spasm Syndrome, X-Linked 2|ISSX2|Rett Syndrome, Atypical, Cdkl5-Related|Rett Syndrome, Variant, With Infantile Spasms	Nervous system disease
Cecal Neoplasms	MESH:D002430	DO:DOID:1517|DO:DOID:1521	Tumors or cancer of the CECUM.	MESH:D002429|MESH:D007414	C04.588.274.476.411.184|C06.301.371.411.184|C06.405.249.411.184|C06.405.469.110.417|C06.405.469.491.184	C04.588.274.476.411|C06.301.371.411|C06.405.249.411|C06.405.469.110|C06.405.469.491	Cancer, Cecal|Cancer of Cecum|Cancer of the Cecum|Cecal Cancer|Cecal Neoplasm|Neoplasm, Cecal|Neoplasms, Cecal	Cancer|Digestive system disease
Celiac Disease	MESH:D002446	DO:DOID:10608|OMIM:212750|OMIM:607202|OMIM:609753|OMIM:609754|OMIM:609755|OMIM:611598|OMIM:612005|OMIM:612006|OMIM:612007|OMIM:612008|OMIM:612009|OMIM:612010|OMIM:612011	A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.	MESH:D008286	C06.405.469.637.250|C18.452.603.250	C06.405.469.637|C18.452.603	AIS5, INCLUDED|CELIAC1|CELIAC10|CELIAC11|CELIAC12|CELIAC13|CELIAC2|CELIAC3|CELIAC4|CELIAC5|CELIAC6|CELIAC7|CELIAC8|CELIAC9|CELIAC DISEASE, SUSCEPTIBILITY TO, 1|CELIAC DISEASE, SUSCEPTIBILITY TO, 10|CELIAC DISEASE, SUSCEPTIBILITY TO, 11|CELIAC DISEASE, SUSCEPTIBILITY TO, 12|CELIAC DISEASE, SUSCEPTIBILITY TO, 13|CELIAC DISEASE, SUSCEPTIBILITY TO, 2|CELIAC DISEASE, SUSCEPTIBILITY TO, 3|CELIAC DISEASE, SUSCEPTIBILITY TO, 4|CELIAC DISEASE, SUSCEPTIBILITY TO, 5|CELIAC DISEASE, SUSCEPTIBILITY TO, 6|CELIAC DISEASE, SUSCEPTIBILITY TO, 7|CELIAC DISEASE, SUSCEPTIBILITY TO, 8|CELIAC DISEASE, SUSCEPTIBILITY TO, 9|Celiac Sprue|CELIAC SPRUE, SUSCEPTIBILITY TO, 1|Disease, Celiac|Enteropathies, Gluten|Enteropathies, Gluten-Sensitive|Enteropathy, Gluten|Enteropathy, Gluten-Sensitive|Gluten Enteropathies|Gluten Enteropathy|Gluten-Sensitive Enteropathies|Gluten Sensitive Enteropathy|Gluten-Sensitive Enteropathy|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 1|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 10|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 11|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 12|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 13|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 2|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 3|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 4|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 5|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 6  AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 5, INCLUDED|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 7|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 8|GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 9|GSES|Nontropical Sprue|Sprue|Sprue, Celiac|Sprue, Nontropical	Digestive system disease|Metabolic disease
Cell Transformation, Neoplastic	MESH:D002471	OMIM:614401	Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.	MESH:D063646	C04.697.098.500|C23.550.727.098.500	C04.697.098|C23.550.727.098	ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO|ACTFS|Cell Neoplastic Transformation|Cell Neoplastic Transformations|Cell Transformations, Neoplastic|Neoplastic Cell Transformation|Neoplastic Cell Transformations|Neoplastic Transformation, Cell|Neoplastic Transformations, Cell|Transformation, Cell Neoplastic|Transformation, Neoplastic Cell|Transformations, Cell Neoplastic|Transformations, Neoplastic Cell|Transformations, Tumorigenic|Transformation, Tumorigenic|Tumorigenic Transformation|Tumorigenic Transformations	Cancer|Pathology (process)
Cell Transformation, Viral	MESH:D002472		An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.	MESH:D002471	C04.697.098.500.160|C23.550.727.098.500.160	C04.697.098.500|C23.550.727.098.500	Cell Transformations, Viral|Transformations, Viral Cell|Transformation, Viral Cell|Viral Cell Transformation|Viral Cell Transformations	Cancer|Pathology (process)
Cementoma	MESH:D002485		An odontogenic fibroma in which cells have developed into cementoblasts and which consists largely of cementum.	MESH:D009808	C04.557.695.210	C04.557.695	Cementifying Fibroma, Mandibular|Cementifying Fibroma, Maxillary|Cementifying Fibroma of Mandible|Cementifying Fibroma of Maxilla|Cementifying Fibromas, Mandibular|Cementifying Fibromas, Maxillary|Cementomas|Cemento Ossifying Fibroma|Cemento-Ossifying Fibroma|Cemento-Ossifying Fibromas|Dysplasia, Periapical Fibrous|Fibroma, Cemento-Ossifying|Fibroma, Mandibular Cementifying|Fibroma, Maxillary Cementifying|Fibrous Dysplasia, Periapical|Fibrous Dysplasias, Periapical|Mandible Cementifying Fibroma|Mandible Cementifying Fibromas|Mandible Ossifying Fibroma|Mandible Ossifying Fibromas|Mandibular Cementifying Fibroma|Mandibular Cementifying Fibromas|Maxilla Cementifying Fibroma|Maxilla Cementifying Fibromas|Maxilla Ossifying Fibroma|Maxilla Ossifying Fibromas|Maxillary Cementifying Fibroma|Maxillary Cementifying Fibromas|Ossifying Fibroma of Mandible|Ossifying Fibroma of Maxilla|Periapical Fibrous Dysplasia|Periapical Fibrous Dysplasias	Cancer
Central Cord Syndrome	MESH:D020210		A syndrome associated with traumatic injury to the cervical or upper thoracic regions of the spinal cord characterized by weakness in the arms with relative sparing of the legs and variable sensory loss. This condition is associated with ischemia, hemorrhage, or necrosis involving the central portions of the spinal cord. Corticospinal fibers destined for the legs are spared due to their more external location in the spinal cord. This clinical pattern may emerge during recovery from spinal shock. Deficits may be transient or permanent.	MESH:D013119	C10.228.854.763.500|C10.900.850.625|C26.819.339	C10.228.854.763|C10.900.850|C26.819	Central Cord Injury Syndrome|Central Spinal Cord Syndrome	Nervous system disease|Wounds and injuries
Central Nervous System Cysts	MESH:D020863		Congenital or acquired cysts of the brain, spinal cord, or meninges which may remain stable in size or undergo progressive enlargement.	MESH:D009421|MESH:D016543	C04.588.614.250.387|C10.500.142|C10.551.240.375|C16.131.666.142	C04.588.614.250|C10.500|C10.551.240|C16.131.666	Cleft Cyst, Rathke|Cleft Cyst, Rathke's|Cleft Cysts, Rathke's|CNS Cyst|CNS Cysts|Cyst, CNS|Cyst, Rathke Cleft|Cyst, Rathke's Cleft|Cysts, Central Nervous System|Cysts, CNS|Cysts, Rathke Cleft|Cysts, Suprasellar|Cyst, Suprasellar|Rathke Cleft Cyst|Rathke Cleft Cysts|Rathke's Cleft Cyst|Rathkes Cleft Cyst|Rathke's Cleft Cysts|Rathkes Cleft Cysts|Suprasellar Cyst|Suprasellar Cysts	Cancer|Congenital abnormality|Nervous system disease
Central Nervous System Diseases	MESH:D002493	DO:DOID:331	Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.	MESH:D009422	C10.228	C10	Central Nervous System Disease|Central Nervous System Disorder|Central Nervous System Disorders|CNS Disease|CNS Diseases	Nervous system disease
Central Nervous System Helminthiasis	MESH:D020809		Infections of the BRAIN; SPINAL CORD; or MENINGES caused by HELMINTHS (parasitic worms).	MESH:D020807	C01.207.205.250|C01.610.105.250|C10.228.228.205.250	C01.207.205|C01.610.105|C10.228.228.205	Cerebral Helminthiasis|CNS Helminthiases|CNS Helminthiasis|Helminthiases, CNS|Helminthiasis, Central Nervous System|Helminthiasis, Cerebral|Helminthiasis, CNS	Nervous system disease|Parasitic disease
Central Nervous System Infections	MESH:D002494		Pathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process.	MESH:D002493|MESH:D007239	C01.207|C10.228.228	C01|C10.228	Central Nervous System Infection|CNS Infection|CNS Infections|Infection, CNS|Infections, Central Nervous System|Infections, CNS	Nervous system disease
Central Nervous System Neoplasms	MESH:D016543	DO:DOID:3620	Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.	MESH:D009423	C04.588.614.250|C10.551.240	C04.588.614|C10.551	Central Nervous System Neoplasm|Central Nervous System Neoplasms, Primary|Central Nervous System Tumor|Central Nervous System Tumors|CNS Neoplasm|CNS Neoplasms|Neoplasm, CNS|Neoplasms, Central Nervous System|Neoplasms, CNS|Primary Central Nervous System Neoplasm|Primary Central Nervous System Neoplasms|Tumors, Central Nervous System	Cancer|Nervous system disease
Central Nervous System Parasitic Infections	MESH:D020807		Infections of the brain, spinal cord, and meninges caused by parasites.	MESH:D002494|MESH:D010272	C01.207.205|C01.610.105|C10.228.228.205	C01.207|C01.610|C10.228.228	CNS Parasitic Infection|CNS Parasitic Infections|Infection, CNS Parasitic|Infections, Central Nervous System, Parasitic|Infections, CNS Parasitic|Infections, Parasitic, Central Nervous System|Parasitic Infection, CNS|Parasitic Infections, Central Nervous System|Parasitic Infections, CNS	Nervous system disease|Parasitic disease
Central Nervous System Protozoal Infections	MESH:D020808		Infections of the brain, spinal cord, or meninges by single celled organisms of the former subkingdom known as protozoa. The central nervous system may be the primary or secondary site of protozoal infection. These diseases may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts.	MESH:D011528|MESH:D020807	C01.207.205.300|C01.610.105.300|C01.610.752.100|C10.228.228.205.300	C01.207.205|C01.610.105|C01.610.752|C10.228.228.205	Acanthamoeba Meningoencephalitides|Acanthamoeba Meningoencephalitis|Amebic Meningoencephalitides|Amebic Meningoencephalitides, Primary|Amebic Meningoencephalitis|Amebic Meningoencephalitis, Primary|Balamuthia mandrillaris CNS Infection|Balamuthia mandrillaris Meningoencephalitides|Balamuthia mandrillaris Meningoencephalitis|Cerebral Protozoal Infection|Cerebral Protozoal Infections|CNS Protozoal Infection|CNS Protozoal Infections|Infection, Central Nervous System, Protozoal|Infection, Cerebral Protozoal|Infection, CNS Protozoal|Infection, Naegleria fowleri|Infections, CNS Protozoal|Infections, Protozoal, Central Nervous System|Meningoencephalitides, Acanthamoeba|Meningoencephalitides, Amebic|Meningoencephalitides, Balamuthia mandrillaris|Meningoencephalitides, Naegleria fowleri|Meningoencephalitides, Primary Amebic|Meningoencephalitides, Protozoal|Meningoencephalitides, Sappinia diploidea|Meningoencephalitis, Acanthamoeba|Meningoencephalitis, Amebic|Meningoencephalitis, Balamuthia mandrillaris|Meningoencephalitis, Naegleria fowleri|Meningoencephalitis, Primary Amebic|Meningoencephalitis, Protozoal|Meningoencephalitis, Sappinia diploidea|Naegleria fowleri Infection|Naegleria fowleri Infections|Naegleria fowleri Meningoencephalitides|Naegleria fowleri Meningoencephalitis|Primary Amebic Meningoencephalitides|Primary Amebic Meningoencephalitis|Protozoal Infection, Cerebral|Protozoal Infection, CNS|Protozoal Infections, Central Nervous System|Protozoal Infections, Cerebral|Protozoal Infections, CNS|Protozoal Meningoencephalitides|Protozoal Meningoencephalitis|Sappinia diploidea Meningoencephalitides|Sappinia diploidea Meningoencephalitis	Nervous system disease|Parasitic disease
Central Nervous System Vascular Malformations	MESH:D020785		Congenital, inherited, or acquired abnormalities involving ARTERIES; VEINS; or venous sinuses in the BRAIN; SPINAL CORD; and MENINGES.	MESH:D009421|MESH:D054079	C10.500.190|C14.240.850.875|C16.131.240.850.875|C16.131.666.190	C10.500|C14.240.850|C16.131.240.850|C16.131.666	Arteriovenous Fistula, Dural|Arteriovenous Fistulas, Dural|Brain Capillary Telangiectasia|Brain Capillary Telangiectasias|Brain Vascular Malformation|Brain Vascular Malformations|Capillary Telangiectasia, Brain|Capillary Telangiectasia, Pontine|Capillary Telangiectasias, Brain|Capillary Telangiectasias, Pontine|Central Nervous System Congenital Vascular Malformations|Central Nervous System Vascular Anomalies|Cerebral Embryonic Artery, Persistent|CNS Vascular Malformation|CNS Vascular Malformations|Congenital Vascular Malformations, Central Nervous System|Dural Arteriovenous Fistula|Dural Arteriovenous Fistulas|Embryonic Artery, Persistent, Cerebral|Malformation, Brain Vascular|Malformation, CNS Vascular|Malformations, Brain Vascular|Malformations, CNS Vascular|Persistent Cerebral Embryonic Artery|Pontine Capillary Telangiectasia|Pontine Capillary Telangiectasias|Telangiectasia, Brain Capillary|Telangiectasia, Pontine Capillary|Telangiectasias, Brain Capillary|Telangiectasias, Pontine Capillary|Vascular Anomalies, Central Nervous System|Vascular Malformation, Brain|Vascular Malformation, CNS|Vascular Malformations, Brain|Vascular Malformations, Central Nervous System|Vascular Malformations, CNS|Vascular Malformations, Congenital, Nervous System	Cardiovascular disease|Congenital abnormality|Nervous system disease
Central Nervous System Venous Angioma	MESH:D020787		A vascular anomaly characterized by a radial or wedge-shaped arrangement of dilated VEINS draining into a larger vein in the brain, spinal cord, or the meninges. Veins in a venous angioma are surrounded by normal nervous tissue, unlike a CENTRAL NERVOUS SYSTEM CAVERNOUS HEMANGIOMA that lacks intervening nervous tissue. Drainage of venous angioma is fully integrated with the body's venous system, therefore, in most cases there is no clinical signs and rare bleeding.	MESH:D006391|MESH:D020785	C04.557.645.375.185|C10.500.190.100|C14.240.850.875.124|C16.131.666.190.100	C04.557.645.375|C10.500.190|C14.240.850.875|C16.131.666.190	Angioma, Cerebral Venous|Angioma, CNS Venous|Angioma, Intracranial Venous|Angiomas, Cerebral Venous|Angiomas, CNS Venous|Angiomas, Intracranial Venous|Angioma, Venous, Central Nervous System|Cerebral Venous Angioma|Cerebral Venous Angiomas|CNS Venous Angioma|CNS Venous Angiomas|Intracranial Venous Angioma|Intracranial Venous Angiomas|Venous Angioma, Central Nervous System|Venous Angioma, Cerebral|Venous Angioma, CNS|Venous Angioma, Intracranial|Venous Angiomas, Cerebral|Venous Angiomas, CNS|Venous Angiomas, Intracranial	Cancer|Cardiovascular disease|Congenital abnormality|Nervous system disease
Central Nervous System Viral Diseases	MESH:D020805		Viral infections of the brain, spinal cord, meninges, or perimeningeal spaces.	MESH:D002494|MESH:D014777	C01.207.245|C01.925.182|C10.228.228.245	C01.207|C01.925|C10.228.228	Central Nervous System Viral Infections|CNS Infections, Viral|CNS Infection, Viral|CNS Viral Disease|CNS Viral Diseases|Disease, CNS Viral|Diseases, CNS Viral|Infections, CNS, Viral|Infections, Viral CNS|Infection, Viral CNS|Viral CNS Infection|Viral CNS Infections|Viral Disease, CNS|Viral Diseases, Central Nervous System|Viral Diseases, CNS|Viral Infections, Central Nervous System	Nervous system disease|Viral disease
Central Serous Chorioretinopathy	MESH:D056833		A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.	MESH:D012164	C11.768.175	C11.768	Central Serous Chorioretinopathies|Central Serous Retinopathies|Central Serous Retinopathy|Chorioretinopathies, Central Serous|Chorioretinopathy, Central Serous|Retinopathies, Central Serous|Retinopathy, Central Serous|Serous Chorioretinopathies, Central|Serous Chorioretinopathy, Central|Serous Retinopathies, Central|Serous Retinopathy, Central	Eye disease
Cerebellar Ataxia	MESH:D002524	DO:DOID:0050753	Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90)	MESH:D001259|MESH:D002526	C10.228.140.252.190|C10.597.350.090.500|C23.888.592.350.090.200	C10.228.140.252|C10.597.350.090|C23.888.592.350.090	Adiadochokineses|Adiadochokinesis|Ataxia, Cerebellar|Ataxias, Cerebellar|Cerebellar Ataxias|Cerebellar Dysmetria|Cerebellar Dysmetrias|Cerebellar Hemiataxia|Cerebellar Hemiataxias|Cerebellar Incoordination|Cerebellar Incoordinations|Dysmetria|Dysmetria, Cerebellar|Dysmetrias|Dysmetrias, Cerebellar|Hemiataxia, Cerebellar|Hemiataxias, Cerebellar|Hypermetria|Hypermetrias|Incoordination, Cerebellar|Incoordinations, Cerebellar	Nervous system disease|Signs and symptoms
Cerebellar Ataxia and Hypergonadotropic Hypogonadism	MESH:C565308			MESH:D002524|MESH:D006319|MESH:D007006	C09.218.458.341.887/C565308|C10.228.140.252.190/C565308|C10.597.350.090.500/C565308|C10.597.751.418.341.887/C565308|C19.391.482/C565308|C23.888.592.350.090.200/C565308|C23.888.592.763.393.341.887/C565308	C09.218.458.341.887|C10.228.140.252.190|C10.597.350.090.500|C10.597.751.418.341.887|C19.391.482|C23.888.592.350.090.200|C23.888.592.763.393.341.887		Ear-nose-throat disease|Endocrine system disease|Nervous system disease|Signs and symptoms
Cerebellar Ataxia and Hypogonadotropic Hypogonadism	MESH:C565870	DO:DOID:0111587|OMIM:212840		MESH:D002524|MESH:D007006	C10.228.140.252.190/C565870|C10.597.350.090.500/C565870|C19.391.482/C565870|C23.888.592.350.090.200/C565870	C10.228.140.252.190|C10.597.350.090.500|C19.391.482|C23.888.592.350.090.200	CAHH|CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM|GDHS|Gordon Holmes Syndrome|LHRH Deficiency and Ataxia|Luteinizing Hormone-Releasing Hormone, Deficiency of, with Ataxia	Endocrine system disease|Nervous system disease|Signs and symptoms
Cerebellar Ataxia and Neurosensory Deafness	MESH:C565869			MESH:D002524|MESH:D006319	C09.218.458.341.887/C565869|C10.228.140.252.190/C565869|C10.597.350.090.500/C565869|C10.597.751.418.341.887/C565869|C23.888.592.350.090.200/C565869|C23.888.592.763.393.341.887/C565869	C09.218.458.341.887|C10.228.140.252.190|C10.597.350.090.500|C10.597.751.418.341.887|C23.888.592.350.090.200|C23.888.592.763.393.341.887		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Cerebellar Ataxia, Benign, with Thermoanalgesia	MESH:C565868			MESH:D002524|MESH:D020886	C10.228.140.252.190/C565868|C10.597.350.090.500/C565868|C10.597.751.791/C565868|C23.888.592.350.090.200/C565868|C23.888.592.763.770/C565868	C10.228.140.252.190|C10.597.350.090.500|C10.597.751.791|C23.888.592.350.090.200|C23.888.592.763.770	Cerebellar Ataxia with Loss of Pain and Temperature Sensation	Nervous system disease|Signs and symptoms
Cerebellar Ataxia, Cayman Type	MESH:C563363	DO:DOID:0060694|OMIM:601238		MESH:D002524	C10.228.140.252.190/C563363|C10.597.350.090.500/C563363|C23.888.592.350.090.200/C563363	C10.228.140.252.190|C10.597.350.090.500|C23.888.592.350.090.200	ATCAY	Nervous system disease|Signs and symptoms
Cerebellar Ataxia, Deafness, and Narcolepsy	MESH:C565825	OMIM:604121		MESH:D002524|MESH:D006319|MESH:D009290	C09.218.458.341.887/C565825|C10.228.140.252.190/C565825|C10.597.350.090.500/C565825|C10.597.751.418.341.887/C565825|C10.886.425.800.200.750/C565825|C23.888.592.350.090.200/C565825|C23.888.592.763.393.341.887/C565825|F03.870.400.800.200.750/C565825	C09.218.458.341.887|C10.228.140.252.190|C10.597.350.090.500|C10.597.751.418.341.887|C10.886.425.800.200.750|C23.888.592.350.090.200|C23.888.592.763.393.341.887|F03.870.400.800.200.750	ADCADN|CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT	Ear-nose-throat disease|Mental disorder|Nervous system disease|Signs and symptoms
CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3	OMIM:602197			MESH:D002526	C10.228.140.252/602197	C10.228.140.252	CDR3	Nervous system disease
Cerebellar Diseases	MESH:D002526	DO:DOID:2786	Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.	MESH:D001927	C10.228.140.252	C10.228.140	Cerebellar Disease|Cerebellar Disorder|Cerebellar Disorders|Cerebellar Dysfunction|Cerebellar Dysfunctions|Cerebellar Syndrome|Cerebellar Syndromes|Cerebellum Disease|Cerebellum Diseases|Disease, Cerebellar|Disease, Cerebellum|Disorder, Cerebellar|Dysfunction, Cerebellar|Syndrome, Cerebellar	Nervous system disease
Cerebellar hypoplasia with endosteal sclerosis	MESH:C535353			MESH:D002524|MESH:D010026	C05.116.099.708.702/C535353|C10.228.140.252.190/C535353|C10.597.350.090.500/C535353|C23.888.592.350.090.200/C535353	C05.116.099.708.702|C10.228.140.252.190|C10.597.350.090.500|C23.888.592.350.090.200		Musculoskeletal disease|Nervous system disease|Signs and symptoms
Cerebellar Neoplasms	MESH:D002528	DO:DOID:4205	Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141)	MESH:D002526|MESH:D015192	C04.588.614.250.195.411.211|C10.228.140.211.500.200|C10.228.140.252.200|C10.551.240.250.400.300	C04.588.614.250.195.411|C10.228.140.211.500|C10.228.140.252|C10.551.240.250.400	Benign Cerebellar Neoplasm|Benign Cerebellar Neoplasms|Cancer, Cerebellar|Cerebellar Cancer|Cerebellar Cancers|Cerebellar Neoplasm|Cerebellar Neoplasm, Benign|Cerebellar Neoplasm, Malignant|Cerebellar Neoplasm, Primary|Cerebellar Neoplasms, Benign|Cerebellar Neoplasms, Malignant|Cerebellar Neoplasms, Primary|Cerebellar Tumor|Cerebellar Tumors|Cerebellum Primary Neoplasm|Cerebellum Primary Neoplasms|Malignant Cerebellar Neoplasm|Malignant Cerebellar Neoplasms|Neoplasm, Benign Cerebellar|Neoplasm, Cerebellar|Neoplasm, Cerebellum Primary|Neoplasm, Malignant Cerebellar|Neoplasms, Cerebellar|Neoplasms, Cerebellar, Benign|Neoplasms, Cerebellar, Malignant|Neoplasms, Cerebellar, Primary|Primary Cerebellar Neoplasm|Primary Cerebellar Neoplasms|Primary Neoplasm, Cerebellum|Primary Neoplasms, Cerebellum|Tumor, Cerebellar	Cancer|Nervous system disease
Cerebelloparenchymal Disorder II	MESH:C565866			MESH:D002524	C10.228.140.252.190/C565866|C10.597.350.090.500/C565866|C23.888.592.350.090.200/C565866	C10.228.140.252.190|C10.597.350.090.500|C23.888.592.350.090.200	Cpd, Late-Onset Recessive Type	Nervous system disease|Signs and symptoms
Cerebral Amyloid Angiopathy	MESH:D016657		A heterogeneous group of sporadic or familial disorders characterized by AMYLOID deposits in the walls of small and medium sized blood vessels of CEREBRAL CORTEX and MENINGES. Clinical features include multiple, small lobar CEREBRAL HEMORRHAGE; cerebral ischemia (BRAIN ISCHEMIA); and CEREBRAL INFARCTION. Cerebral amyloid angiopathy is unrelated to generalized AMYLOIDOSIS. Amyloidogenic peptides in this condition are nearly always the same ones found in ALZHEIMER DISEASE. (from Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005)	MESH:D000686|MESH:D002539	C10.228.140.300.510.200.200|C14.907.253.560.200.200|C18.452.845.500.100	C10.228.140.300.510.200|C14.907.253.560.200|C18.452.845.500	Amyloid Angiopathy, Cerebral|Angiopathy, Cerebral Amyloid|Angiopathy, Congophilic|Cerebral Amyloid Angiopathies|Congophilic Angiopathies|Congophilic Angiopathy|Sporadic Cerebral Amyloid Angiopathy	Cardiovascular disease|Metabolic disease|Nervous system disease
Cerebral Angiopathy, Dysphoric	MESH:C565864			MESH:D059345	C10.228.140.300.275/C565864|C14.907.253.329/C565864	C10.228.140.300.275|C14.907.253.329		Cardiovascular disease|Nervous system disease
Cerebral Arterial Diseases	MESH:D002539	DO:DOID:3527	Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.	MESH:D020765	C10.228.140.300.510.200|C14.907.253.560.200	C10.228.140.300.510|C14.907.253.560	Arterial Disease, Cerebral|Arterial Diseases, Cerebral|Artery Disease, Cerebral|Artery Diseases, Cerebral|Cerebral Arterial Disease|Cerebral Artery Disease|Cerebral Artery Diseases|Disease, Cerebral Arterial|Disease, Cerebral Artery|Diseases, Cerebral Arterial|Diseases, Cerebral Artery	Cardiovascular disease|Nervous system disease
Cerebral astrocytoma, adult	MESH:C535354			MESH:D001254|MESH:D001932	C04.557.465.625.600.380.080/C535354|C04.557.470.670.380.080/C535354|C04.557.580.625.600.380.080/C535354|C04.588.614.250.195/C535354|C10.228.140.211/C535354|C10.551.240.250/C535354	C04.557.465.625.600.380.080|C04.557.470.670.380.080|C04.557.580.625.600.380.080|C04.588.614.250.195|C10.228.140.211|C10.551.240.250	Adult cerebral astrocytoma	Cancer|Nervous system disease
Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy	MESH:C563990			MESH:D000505|MESH:D002544|MESH:D013122|MESH:D056784	C05.116.900/C563990|C10.228.140.300.150.477.200/C563990|C10.228.140.300.775.200.200/C563990|C10.228.140.695/C563990|C14.907.253.092.477.200/C563990|C14.907.253.855.200.200/C563990|C17.800.329.937.122/C563990|C23.300.035/C563990|C23.550.513.355.250.200/C563990|C23.550.717.489.250.200/C563990	C05.116.900|C10.228.140.300.150.477.200|C10.228.140.300.775.200.200|C10.228.140.695|C14.907.253.092.477.200|C14.907.253.855.200.200|C17.800.329.937.122|C23.300.035|C23.550.513.355.250.200|C23.550.717.489.250.200	CARASIL|Cerebrovascular Disease with Thin Skin, Alopecia, and Disc Disease|Familial Young-Adult-Onset Arteriosclerotic Leukoencephalopathy with Alopecia and Lumbago without Arterial Hypertension|MAEDA Syndrome|Nemoto Disease|Subcortical Vascular Encephalopathy, Progressive	Cardiovascular disease|Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)|Pathology (process)|Skin disease
Cerebral Cortical Thinning	MESH:D000082643		Decrease in CEREBRAL CORTICAL THICKNESS.	MESH:D009461|MESH:D020763	C10.597.210|C23.300.220|C23.888.592.206	C10.597|C23.300|C23.888.592	Cortical Thinning|Cortical Thinning, Cerebral|Thinning, Cerebral Cortical|Thinning, Cortical	Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Cerebral Hemorrhage	MESH:D002543	OMIM:614519	Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.	MESH:D020300	C10.228.140.300.535.200|C14.907.253.573.200|C23.550.414.913.100	C10.228.140.300.535|C14.907.253.573|C23.550.414.913	Brain Hemorrhage, Cerebral|Brain Hemorrhages, Cerebral|Cerebral Brain Hemorrhage|Cerebral Brain Hemorrhages|Cerebral Hemorrhages|Cerebral Parenchymal Hemorrhage|Cerebral Parenchymal Hemorrhages|Cerebrum Hemorrhage|Cerebrum Hemorrhages|Hemorrhage, Cerebral|Hemorrhage, Cerebral Brain|Hemorrhage, Cerebral Parenchymal|Hemorrhage, Cerebrum|Hemorrhage, Intracerebral|HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO|Hemorrhages, Cerebral|Hemorrhages, Cerebral Brain|Hemorrhages, Cerebral Parenchymal|Hemorrhages, Cerebrum|Hemorrhages, Intracerebral|ICH|Intracerebral Hemorrhage|Intracerebral Hemorrhages|Parenchymal Hemorrhage, Cerebral|Parenchymal Hemorrhages, Cerebral|STROKE, HEMORRHAGIC, SUSCEPTIBILITY TO	Cardiovascular disease|Nervous system disease|Pathology (process)
Cerebral Hemorrhage, Traumatic	MESH:D020202		Bleeding into one or both CEREBRAL HEMISPHERES due to TRAUMA. Hemorrhage may involve any part of the CEREBRAL CORTEX and the BASAL GANGLIA. Depending on the severity of bleeding, clinical features may include SEIZURES; APHASIA; VISION DISORDERS; MOVEMENT DISORDERS; PARALYSIS; and COMA.	MESH:D002543|MESH:D020201	C10.228.140.199.275.300|C10.228.140.300.535.200.200|C10.228.140.300.535.450.200.750|C10.900.300.087.187.300|C10.900.300.837.150.650|C14.907.253.573.200.200|C14.907.253.573.400.150.300|C26.915.300.200.175.300|C26.915.300.490.150.300	C10.228.140.199.275|C10.228.140.300.535.200|C10.228.140.300.535.450.200|C10.900.300.087.187|C10.900.300.837.150|C14.907.253.573.200|C14.907.253.573.400.150|C26.915.300.200.175|C26.915.300.490.150	Brain Hemorrhage, Cerebral, Traumatic|Cerebral Hematomas, Traumatic|Cerebral Hematoma, Traumatic|Cerebral Hemorrhages, Traumatic|Cerebral Intraparenchymal Hematoma, Traumatic|Cerebral Intraparenchymal Hemorrhage, Traumatic|Cerebral Parenchymal Hemorrhage, Traumatic|Hematomas, Traumatic Cerebral|Hematoma, Traumatic Cerebral|Hemorrhages, Traumatic Cerebral|Hemorrhages, Traumatic Intracerebral|Hemorrhage, Traumatic Cerebral|Hemorrhage, Traumatic Intracerebral|Intracerebral Hemorrhages, Traumatic|Intracerebral Hemorrhage, Traumatic|Traumatic Cerebral Hematoma|Traumatic Cerebral Hematomas|Traumatic Cerebral Hemorrhage|Traumatic Cerebral Hemorrhages|Traumatic Cerebral Intraparenchymal Hematoma|Traumatic Cerebral Intraparenchymal Hemorrhage|Traumatic Cerebral Parenchymal Hemorrhage|Traumatic Intracerebral Hemorrhage|Traumatic Intracerebral Hemorrhages	Cardiovascular disease|Nervous system disease|Wounds and injuries
Cerebral Infarction	MESH:D002544	DO:DOID:3526	The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).	MESH:D020520	C10.228.140.300.150.477.200|C10.228.140.300.775.200.200|C14.907.253.092.477.200|C14.907.253.855.200.200|C23.550.513.355.250.200|C23.550.717.489.250.200	C10.228.140.300.150.477|C10.228.140.300.775.200|C14.907.253.092.477|C14.907.253.855.200|C23.550.513.355.250|C23.550.717.489.250	Anterior Choroidal Artery Infarction|Cerebral Infarct|Cerebral Infarction, Left Hemisphere|Cerebral Infarction, Right Hemisphere|Cerebral Infarctions|Cerebral Infarcts|Cerebral, Left Hemisphere, Infarction|Cerebral, Right Hemisphere, Infarction|Infarct, Cerebral|Infarction, Cerebral|Infarction, Cerebral, Left Hemisphere|Infarction, Cerebral, Right Hemisphere|Infarction, Left Hemisphere, Cerebral|Infarction, Right Hemisphere, Cerebral|Infarctions, Cerebral|Infarctions, Subcortical|Infarction, Subcortical|Infarcts, Cerebral|Left Hemisphere, Cerebral Infarction|Left Hemisphere, Infarction, Cerebral|Posterior Choroidal Artery Infarction|Right Hemisphere, Cerebral Infarction|Right Hemisphere, Infarction, Cerebral|Subcortical Infarction|Subcortical Infarctions	Cardiovascular disease|Nervous system disease|Pathology (process)
Cerebral Intraventricular Hemorrhage	MESH:D000074042		Bleeding within the CEREBRAL VENTRICLES. It is associated with intraventricular trauma, aneurysm, vascular malformations, hypertension and in VERY LOW BIRTH WEIGHT infants.	MESH:D002543	C10.228.140.300.535.200.600|C14.907.253.573.200.600|C23.550.414.913.100.600	C10.228.140.300.535.200|C14.907.253.573.200|C23.550.414.913.100	Cerebral Intraventricular Haemorrhage|Cerebral Intraventricular Haemorrhages|Cerebral Intraventricular Hemorrhages|Haemorrhage, Cerebral Intraventricular|Hemorrhage, Cerebral Intraventricular|Intraventricular Haemorrhage, Cerebral|Intraventricular Haemorrhages, Cerebral|Intraventricular Hemorrhage, Cerebral	Cardiovascular disease|Nervous system disease|Pathology (process)
Cerebral Palsy	MESH:D002547	DO:DOID:10965|DO:DOID:10968|DO:DOID:10970|DO:DOID:1969	A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)	MESH:D001925	C10.228.140.140.254	C10.228.140.140	Athetoid Cerebral Palsy|Atonic Cerebral Palsy|Cerebral Palsies, Athetoid|Cerebral Palsies, Dyskinetic|Cerebral Palsies, Dystonic-Rigid|Cerebral Palsies, Monoplegic|Cerebral Palsy, Athetoid|Cerebral Palsy, Atonic|Cerebral Palsy, Congenital|Cerebral Palsy, Diplegic, Infantile|Cerebral Palsy, Dyskinetic|Cerebral Palsy, Dystonic Rigid|Cerebral Palsy, Dystonic-Rigid|Cerebral Palsy, Hypotonic|Cerebral Palsy, Mixed|Cerebral Palsy, Monoplegic|Cerebral Palsy, Monoplegic, Infantile|Cerebral Palsy, Quadriplegic, Infantile|Cerebral Palsy, Rolandic Type|Cerebral Palsy, Spastic|Congenital Cerebral Palsy|CP (Cerebral Palsy)|Diplegia, Spastic|Diplegias, Spastic|Diplegic Infantile Cerebral Palsy|Dyskinetic Cerebral Palsy|Dystonic-Rigid Cerebral Palsies|Dystonic-Rigid Cerebral Palsy|Hypotonic Cerebral Palsies|Hypotonic Cerebral Palsy|Infantile Cerebral Palsy, Diplegic|Infantile Cerebral Palsy, Monoplegic|Infantile Cerebral Palsy, Quadriplegic|Little Disease|Little's Disease|Mixed Cerebral Palsies|Mixed Cerebral Palsy|Monoplegic Cerebral Palsies|Monoplegic Cerebral Palsy|Monoplegic Infantile Cerebral Palsy|Quadriplegic Infantile Cerebral Palsy|Rolandic Type Cerebral Palsy|Spastic Cerebral Palsies|Spastic Cerebral Palsy|Spastic Diplegia|Spastic Diplegias	Nervous system disease
Cerebral palsy, spastic, diplegic	MESH:C537945			MESH:D002547	C10.228.140.140.254/C537945	C10.228.140.140.254	Spastic diplegia cerebral palsy	Nervous system disease
Cerebral Palsy, Spastic Quadriplegic, 1	MESH:C567853			MESH:D002547	C10.228.140.140.254/C567853	C10.228.140.140.254		Nervous system disease
Cerebral Palsy, Spastic Quadriplegic, 2	MESH:C567867	OMIM:612900		MESH:D002547	C10.228.140.140.254/C567867	C10.228.140.140.254	CPSQ2	Nervous system disease
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3	OMIM:617008			MESH:D002547	C10.228.140.140.254/617008	C10.228.140.140.254	CPSQ3	Nervous system disease
Cerebral sarcoma	MESH:C537946			MESH:D001932|MESH:D012509	C04.557.450.795/C537946|C04.588.614.250.195/C537946|C10.228.140.211/C537946|C10.551.240.250/C537946	C04.557.450.795|C04.588.614.250.195|C10.228.140.211|C10.551.240.250	Familial cerebral sarcomas	Cancer|Nervous system disease
Cerebral Small Vessel Diseases	MESH:D059345		Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE.	MESH:D002561	C10.228.140.300.275|C14.907.253.329	C10.228.140.300|C14.907.253	Cerebral Microangiopathies|Cerebral Microangiopathy|Cerebral Small Vessel Disease|Microangiopathies, Cerebral|Microangiopathy, Cerebral	Cardiovascular disease|Nervous system disease
Cerebral Ventricle Neoplasms	MESH:D002551	DO:DOID:3541	Neoplasms located in the brain ventricles, including the two lateral, the third, and the fourth ventricle. Ventricular tumors may be primary (e.g., CHOROID PLEXUS NEOPLASMS and GLIOMA, SUBEPENDYMAL), metastasize from distant organs, or occur as extensions of locally invasive tumors from adjacent brain structures.	MESH:D001932	C04.588.614.250.195.205|C10.228.140.211.280|C10.551.240.250.200	C04.588.614.250.195|C10.228.140.211|C10.551.240.250	Brain Ventricular Neoplasm|Brain Ventricular Neoplasms|Brain Ventricular Tumor|Brain Ventricular Tumors|Cerebral Ventricle Neoplasm|Cerebral Ventricle Tumor|Cerebral Ventricle Tumors|Cerebroventricular Neoplasm|Cerebroventricular Neoplasms|Intraventricular Neoplasm|Intraventricular Neoplasms|Neoplasm, Brain Ventricular|Neoplasm, Cerebral Ventricle|Neoplasm, Cerebroventricular|Neoplasm, Intraventricular|Neoplasms, Brain Ventricular|Neoplasms, Cerebral Ventricle|Neoplasms, Cerebroventricular|Neoplasms, Intraventricular|Neoplasms, Ventricular, Brain|Tumor, Brain Ventricular|Tumor, Cerebral Ventricle|Tumors, Brain Ventricular|Tumors, Cerebral Ventricle|Ventricle Tumor, Cerebral|Ventricle Tumors, Cerebral|Ventricular Neoplasm, Brain|Ventricular Neoplasms, Brain|Ventricular Tumor, Brain|Ventricular Tumors, Brain	Cancer|Nervous system disease
Cerebral Ventriculitis	MESH:D058565		Inflammation of CEREBRAL VENTRICLES.	MESH:D004660|MESH:D020805	C01.207.245.169|C10.228.140.430.249|C10.228.228.245.169|C10.586.250.249	C01.207.245|C10.228.140.430|C10.228.228.245|C10.586.250	Cerebral Ventriculitides|Infectious Ventriculitides|Infectious Ventriculitis|Ventriculitides, Cerebral|Ventriculitides, Infectious|Ventriculitis, Cerebral|Ventriculitis, Infectious	Nervous system disease
Cerebrospinal Fluid Leak	MESH:D065634		Discharge of cerebrospinal fluid through a hole through the skull bone most commonly draining from the nose (CEREBROSPINAL FLUID RHINORRHEA) or the ear (CEREBROSPINAL FLUID OTORRHEA).	MESH:D006259|MESH:D009461	C10.597.114|C10.900.300.109|C23.888.592.114|C26.915.300.225	C10.597|C10.900.300|C23.888.592|C26.915.300	Cerebrospinal Fluid Drainage|Cerebrospinal Fluid Drainage, Post Traumatic|Cerebrospinal Fluid Drainage, Post-Traumatic|Cerebrospinal Fluid Drainages|Cerebrospinal Fluid Drainage, Spontaneous|Cerebrospinal Fluid Drainage, Traumatic|Cerebrospinal Fluid Leakage|Cerebrospinal Fluid Leakage, Post Traumatic|Cerebrospinal Fluid Leakage, Post-Traumatic|Cerebrospinal Fluid Leakages|Cerebrospinal Fluid Leakage, Spontaneous|Cerebrospinal Fluid Leakage, Traumatic|Cerebrospinal Fluid Leak, Post Traumatic|Cerebrospinal Fluid Leak, Post-Traumatic|Cerebrospinal Fluid Leaks|Cerebrospinal Fluid Leak, Spontaneous|Cerebrospinal Fluid Leak, Traumatic|Drainage, Cerebrospinal Fluid|Drainages, Cerebrospinal Fluid|Fluid Drainage, Cerebrospinal|Fluid Drainages, Cerebrospinal|Fluid Leakage, Cerebrospinal|Fluid Leakages, Cerebrospinal|Fluid Leak, Cerebrospinal|Fluid Leaks, Cerebrospinal|Leakage, Cerebrospinal Fluid|Leakages, Cerebrospinal Fluid|Leak, Cerebrospinal Fluid|Leaks, Cerebrospinal Fluid|Spinal Cerebrospinal Fluid Leak|Spinal Cerebrospinal Fluid Leak, Post Traumatic|Spinal Cerebrospinal Fluid Leak, Post-Traumatic|Spinal Cerebrospinal Fluid Leak, Spontaneous|Spinal Cerebrospinal Fluid Leak, Traumatic	Nervous system disease|Signs and symptoms|Wounds and injuries
Cerebrospinal Fluid Otorrhea	MESH:D002558		Discharge of cerebrospinal fluid through the external auditory meatus or through the eustachian tube into the nasopharynx. This is usually associated with CRANIOCEREBRAL TRAUMA (e.g., SKULL FRACTURE involving the TEMPORAL BONE;), NEUROSURGICAL PROCEDURES; or other conditions, but may rarely occur spontaneously. (From Am J Otol 1995 Nov;16(6):765-71)	MESH:D065634	C10.597.114.500|C10.900.300.109.500|C23.888.592.114.249|C26.915.300.225.500	C10.597.114|C10.900.300.109|C23.888.592.114|C26.915.300.225	Cerebrospinal Fluid Otorrhea, Post Traumatic|Cerebrospinal Fluid Otorrhea, Post-Traumatic|Cerebrospinal Fluid Otorrheas|Cerebrospinal Fluid Otorrhea, Spontaneous|Cerebrospinal Fluid Otorrhea, Traumatic|Cerebrospinal Otorrhea|Otorrhea, Cerebrospinal|Otorrhea, Cerebrospinal Fluid|Otorrhea, Cerebrospinal Fluid, Post-Traumatic|Otorrhea, Cerebrospinal Fluid, Spontaneous|Otorrhea, Cerebrospinal Fluid, Traumatic|Otorrhea, Post-Traumatic, Cerebrospinal Fluid|Otorrhea, Spontaneous, Cerebrospinal Fluid|Otorrhea, Traumatic Cerebrospinal Fluid|Post Traumatic Cerebrospinal Fluid Otorrhea|Post-Traumatic Cerebrospinal Fluid Otorrhea|Post Traumatic Otorrhea, Cerebrospinal Fluid|Post-Traumatic Otorrhea, Cerebrospinal Fluid|Spontaneous Cerebrospinal Fluid Otorrhea|Spontaneous Otorrhea, Cerebrospinal Fluid|Traumatic Cerebrospinal Fluid Otorrhea|Traumatic Otorrhea, Cerebrospinal Fluid	Nervous system disease|Signs and symptoms|Wounds and injuries
Cerebrospinal Fluid Rhinorrhea	MESH:D002559		Discharge of cerebrospinal fluid through the nose. Common etiologies include trauma, neoplasms, and prior surgery, although the condition may occur spontaneously. (Otolaryngol Head Neck Surg 1997 Apr;116(4):442-9)	MESH:D000086722|MESH:D065634	C10.597.114.750|C10.900.300.109.750|C23.888.592.114.624|C23.888.852.834.500|C26.915.300.225.750	C10.597.114|C10.900.300.109|C23.888.592.114|C23.888.852.834|C26.915.300.225	Cerebrospinal Fluid Rhinorrhea, Post Traumatic|Cerebrospinal Fluid Rhinorrhea, Post-Traumatic|Cerebrospinal Fluid Rhinorrheas|Cerebrospinal Fluid Rhinorrhea, Spontaneous|Cerebrospinal Fluid Rhinorrhea, Traumatic|Cerebrospinal Rhinorrhea|Cerebrospinal Rhinorrheas|CSF Rhinorrhea|CSF Rhinorrheas|Post Traumatic Cerebrospinal Fluid Rhinorrhea|Post-Traumatic Cerebrospinal Fluid Rhinorrhea|Post Traumatic Rhinorrhea, Cerebrospinal Fluid|Post-Traumatic Rhinorrhea, Cerebrospinal Fluid|Rhinorrhea, Cerebrospinal|Rhinorrhea, Cerebrospinal Fluid|Rhinorrhea, Cerebrospinal Fluid, Post-Traumatic|Rhinorrhea, Cerebrospinal Fluid, Spontaneous|Rhinorrhea, Cerebrospinal Fluid, Traumatic|Rhinorrhea, CSF|Rhinorrhea, Post-Traumatic, Cerebrospinal Fluid|Rhinorrheas, Cerebrospinal|Rhinorrheas, Cerebrospinal Fluid|Rhinorrheas, CSF|Rhinorrhea, Spontaneous Cerebrospinal Fluid|Rhinorrhea, Traumatic Cerebrospinal Fluid|Spontaneous Cerebrospinal Fluid Rhinorrhea|Spontaneous Rhinorrhea, Cerebrospinal Fluid|Traumatic Cerebrospinal Fluid Rhinorrhea|Traumatic Rhinorrhea, Cerebrospinal Fluid	Nervous system disease|Signs and symptoms|Wounds and injuries
Cerebrovascular Disorders	MESH:D002561	DO:DOID:6713	A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.	MESH:D001927|MESH:D014652	C10.228.140.300|C14.907.253	C10.228.140|C14.907	Brain Vascular Disorder|Brain Vascular Disorders|Cerebrovascular Disease|Cerebrovascular Diseases|Cerebrovascular Disorder|Cerebrovascular Insufficiencies|Cerebrovascular Insufficiency|Cerebrovascular Occlusion|Cerebrovascular Occlusions|Disease, Cerebrovascular|Diseases, Cerebrovascular|Insufficiencies, Cerebrovascular|Insufficiency, Cerebrovascular|Intracranial Vascular Disease|Intracranial Vascular Diseases|Intracranial Vascular Disorder|Intracranial Vascular Disorders|Occlusion, Cerebrovascular|Occlusions, Cerebrovascular|Vascular Disease, Intracranial|Vascular Diseases, Intracranial|Vascular Disorder, Brain|Vascular Disorder, Intracranial|Vascular Disorders, Brain|Vascular Disorders, Intracranial	Cardiovascular disease|Nervous system disease
Cerebrovascular Trauma	MESH:D020214		Penetrating and nonpenetrating traumatic injuries to an extracranial or intracranial blood vessel that supplies the brain. This includes the CAROTID ARTERIES; VERTEBRAL ARTERIES; MENINGEAL ARTERIES; CEREBRAL ARTERIES; veins, and venous sinuses.	MESH:D002561|MESH:D020196	C10.228.140.300.350|C10.900.250|C14.907.253.535|C26.915.200	C10.228.140.300|C10.900|C14.907.253|C26.915	Brain Injuries, Vascular|Brain Injury, Vascular|Brain Vascular Injury|Brain Vascular Trauma|Injuries, Brain Vascular|Injury, Brain Vascular|Injury, Vascular, Brain|Trauma, Cerebrovascular|Vascular Brain Injuries|Vascular Brain Injury|Vascular Injury, Brain|Vascular Trauma, Brain|Vascular Traumas, Brain	Cardiovascular disease|Nervous system disease|Wounds and injuries
Cerulean cataract	MESH:C537955	OMIM:115660		MESH:D002386	C11.510.245/C537955	C11.510.245	CATARACT 7|CATARACT 7, CERULEAN TYPE|Cataract, congenital, blue dot type 1|Cataract, Congenital, Blue Dot Type, 1|Cataract, congenital, cerulean type 1|Cataract, Congenital, Cerulean Type, 1|CCA1|CTRCT7	Eye disease
Cervical Dystonia, Primary	MESH:C566572	OMIM:602124		MESH:D004421	C10.597.350.300/C566572|C23.888.592.350.300/C566572	C10.597.350.300|C23.888.592.350.300	Dystonia 7, Torsion|Dystonia, Primary Cervical|DYT7|Primary adult-onset torsion dystonia|Torsion dystonia 7|Torsion dystonia, focal adult-onset|TORSION DYSTONIA, FOCAL ADULT-ONSET  CERVICAL DYSTONIA, PRIMARY, INCLUDED	Nervous system disease|Signs and symptoms
Cervical Hypertrichosis with Underlying Kyphoscoliosis	MESH:C566142			MESH:D006983|MESH:D007738|MESH:D012600	C05.116.900.800.500/C566142|C05.116.900.800.875/C566142|C17.800.329.875/C566142	C05.116.900.800.500|C05.116.900.800.875|C17.800.329.875	Hypertrichosis, Posterior Cervical, with Underlying Kyphoscoliosis	Musculoskeletal disease|Skin disease
Cervical Intraepithelial Neoplasia	MESH:D018290	DO:DOID:8991	A malignancy arising in uterine cervical epithelium and confined thereto, representing a continuum of histological changes ranging from well-differentiated CIN 1 (formerly, mild dysplasia) to severe dysplasia/carcinoma in situ, CIN 3. The lesion arises at the squamocolumnar cell junction at the transformation zone of the endocervical canal, with a variable tendency to develop invasive epidermoid carcinoma, a tendency that is enhanced by concomitant human papillomaviral infection. (Segen, Dictionary of Modern Medicine, 1992)	MESH:D002278	C04.557.470.200.240.250	C04.557.470.200.240	Cervical Intraepithelial Neoplasia, Grade III|Cervical Intraepithelial Neoplasm|Cervical Intraepithelial Neoplasms|Intraepithelial Neoplasia, Cervical|Intraepithelial Neoplasm, Cervical|Intraepithelial Neoplasms, Cervical|Neoplasia, Cervical Intraepithelial|Neoplasm, Cervical Intraepithelial|Neoplasms, Cervical Intraepithelial	Cancer
Cervical Rib Syndrome	MESH:D002573		A condition associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the thoracic outlet and caused by a complete or incomplete anomalous CERVICAL RIB or fascial band connecting the tip of a cervical rib with the first thoracic rib. Clinical manifestations may include pain in the neck and shoulder which radiates into the upper extremity, PARESIS or PARALYSIS of brachial plexus innervated muscles; sensory loss; PARESTHESIAS; ISCHEMIA; and EDEMA. (Adams et al., Principles of Neurology, 6th ed, p214)	MESH:D009139|MESH:D013901	C10.668.829.550.850.200|C14.907.863.200|C16.131.621.174	C10.668.829.550.850|C14.907.863|C16.131.621	Anomalous Cervical Rib Syndrome|Cervical Rib Cervical Band Syndrome|Cervical-Rib-Cervical-Band Syndrome|Cervical Rib Syndromes|Naffziger's Syndrome|Naffziger's Syndromes|Naffziger Syndrome|Naffziger Syndromes|Syndrome, Cervical Rib|Syndrome, Cervical-Rib-Cervical-Band|Syndrome, Naffziger|Syndrome, Naffziger's|Syndromes, Cervical Rib|Syndromes, Naffziger|Syndromes, Naffziger's	Cardiovascular disease|Congenital abnormality|Nervous system disease
Cervical Vertebrae, Agenesis Of	MESH:C562952			MESH:D004413	C05.116.099.370/C562952	C05.116.099.370		Musculoskeletal disease
Cervical Vertebral Dysplasia	MESH:C566140			MESH:D001848	C05.116.099/C566140	C05.116.099		Musculoskeletal disease
Chagas Cardiomyopathy	MESH:D002598		A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.	MESH:D009202|MESH:D014355	C01.610.752.300.900.200.190|C01.920.625.190|C14.280.238.190	C01.610.752.300.900.200|C01.920.625|C14.280.238	Cardiomyopathy, Chagas|Cardiomyopathy, Chagas'|Cardiovascular Trypanosomiasis|Chagas' Cardiomyopathy|Myocarditis, Chagas|Trypanosomiasis, Cardiovascular	Cardiovascular disease|Parasitic disease
CHA heavy chain disease protein, human	MESH:C483999			MESH:D006362	C15.378.147.780.490/C483999|C15.604.515.435/C483999|C20.683.780.490/C483999	C15.378.147.780.490|C15.604.515.435|C20.683.780.490	gamma heavy chain disease protein CHA, human	Blood disease|Immune system disease|Lymphatic disease
Chalazion	MESH:D017043	DO:DOID:9903	A non-neoplastic cyst of the MEIBOMIAN GLANDS of the eyelid.	MESH:D003560|MESH:D005141	C04.182.197|C11.338.300	C04.182|C11.338	Chalazia|Cyst, Meibomian|Meibomian Cyst	Cancer|Eye disease
Charles Bonnet Syndrome	MESH:D000075562		Repetitive visual hallucinations experienced mostly by elderly with diminished visual acuity or visual field loss, with awareness of the fictional nature of their hallucinations. It is not associated with delusions and other sensory hallucinations.	MESH:D006212	C10.597.606.762.300.500|C23.888.592.604.764.300.500	C10.597.606.762.300|C23.888.592.604.764.300		Nervous system disease|Signs and symptoms
Char syndrome	MESH:C566815	DO:DOID:0060563|OMIM:169100		MESH:D000015|MESH:D004374	C14.240.400.340/C566815|C14.280.400.340/C566815|C16.131.077/C566815|C16.131.240.400.340/C566815	C14.240.400.340|C14.280.400.340|C16.131.077|C16.131.240.400.340	CHAR|Patent Ductus Arteriosus With Facial Dysmorphism And Abnormal Fifth Digits	Cardiovascular disease|Congenital abnormality
Chemical and Drug Induced Liver Injury, Chronic	MESH:D056487	DO:DOID:2044	Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.	MESH:D002908|MESH:D056486	C06.552.100.200|C23.550.291.500.266|C25.100.562.200|C25.723.260.200	C06.552.100|C23.550.291.500|C25.100.562|C25.723.260	Chemical Induced Liver Injury, Chronic|Chemical-Induced Liver Injury, Chronic|Chemically Induced Liver Injury, Chronic|Chemically-Induced Liver Injury, Chronic|Chronic Drug Induced Liver Injury|Chronic Drug-Induced Liver Injury|Drug Induced Liver Injury, Chronic|Drug-Induced Liver Injury, Chronic|Hepatitis, Chronic, Drug-Induced|Hepatitis, Chronic, Drug-Related|Liver Injury, Drug-Induced, Chronic	Digestive system disease|Pathology (process)
Chemically-Induced Disorders	MESH:D064419		Disorders caused by the intentional or unintentional ingestion or exposure to chemical substances such as PHARMACEUTICAL PREPARATIONS; NOXAE; and PESTICIDES.	MESH:C	C25	C	Chemically-Induced Disorder|Chemically Induced Disorders	
Chemotherapy-Induced Febrile Neutropenia	MESH:D064146		FEVER accompanied by a significant reduction in NEUTROPHIL count associated with CHEMOTHERAPY.	MESH:D064147	C15.378.553.546.184.564.750.500	C15.378.553.546.184.564.750	Chemotherapy Induced Febrile Neutropenia|Chemotherapy-Induced Febrile Neutropenias|Drug Induced Febrile Neutropenia|Drug-Induced Febrile Neutropenia|Drug-Induced Febrile Neutropenias|Febrile Neutropenia, Chemotherapy-Induced|Febrile Neutropenia, Drug-Induced|Febrile Neutropenias, Chemotherapy-Induced|Febrile Neutropenias, Drug-Induced|Neutropenia, Chemotherapy-Induced Febrile|Neutropenia, Drug-Induced Febrile|Neutropenias, Chemotherapy-Induced Febrile|Neutropenias, Drug-Induced Febrile	Blood disease
Cheyne-Stokes Respiration	MESH:D002639		An abnormal pattern of breathing characterized by alternating periods of apnea and deep, rapid breathing. The cycle begins with slow, shallow breaths that gradually increase in depth and rate and is then followed by a period of apnea. The period of apnea can last 5 to 30 seconds, then the cycle repeats every 45 seconds to 3 minutes.	MESH:D012120|MESH:D012818	C08.618.182|C23.888.852.227	C08.618|C23.888.852	Cheyne Stokes Respiration|Respiration, Cheyne-Stokes	Respiratory tract disease|Signs and symptoms
Chickenpox	MESH:D002644	DO:DOID:8659	A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed)	MESH:D000073618	C01.925.256.466.930.250	C01.925.256.466.930	Chicken Pox|Varicella	Viral disease
Chikungunya Fever	MESH:D065632		An acute infection caused by a mosquito-borne alphavirus CHIKUNGUNYA VIRUS characterized by RASH; FEVER; JOINT PAINS; CONJUNCTIVITIS; MENINGOENCEPHALITIS; LYMPHOPENIA; and THROMBOCYTOPENIA.	MESH:D001102|MESH:D018354	C01.920.500.078.184|C01.925.081.198|C01.925.782.930.100.184	C01.920.500.078|C01.925.081|C01.925.782.930.100	Chickungunya Fever|Chickungunya Fevers|Chikungunya Fevers|Chikungunya Virus Infection|Chikungunya Virus Infections|Fever, Chickungunya|Fever, Chikungunya|Infection, Chikungunya Virus	Viral disease
Chilblain lupus 1	MESH:C535924	DO:DOID:0060386|OMIM:610448		MESH:D002647|MESH:D008178	C17.300.475/C535924|C17.800.480/C535924|C26.212.500.217/C535924|C26.417.217/C535924	C17.300.475|C17.800.480|C26.212.500.217|C26.417.217	CHBL1|Chilblain lupus	Connective tissue disease|Skin disease|Wounds and injuries
Childhood Myocerebrohepatopathy Spectrum	MESH:C579990			MESH:D028361	C18.452.660/C579990	C18.452.660		Metabolic disease
Chitty Hall Baraitser syndrome	MESH:C535928			MESH:D001851|MESH:D006130|MESH:D006319|MESH:D007767	C05.116.198/C535928|C09.218.458.341.887/C535928|C10.597.751.418.341.887/C535928|C11.496.456/C535928|C18.452.104/C535928|C23.550.393/C535928|C23.888.592.763.393.341.887/C535928	C05.116.198|C09.218.458.341.887|C10.597.751.418.341.887|C11.496.456|C18.452.104|C23.550.393|C23.888.592.763.393.341.887	Deafness, femoral epiphyseal dysplasia, short stature and developmental delay|Growth retardation, deafness, femoral epiphyseal dysplasia, and lacrimal duct obstruction	Ear-nose-throat disease|Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Chloracne	MESH:D054506		ACNE-like skin eruptions caused by exposure to CHLORINE-containing compounds. Exposure can be by inhalation, ingestion, or through the skin. Chloracne is often seen in people who have occupational contact with chlorinated pesticides, wood preservatives, and sealants.	MESH:D017486	C17.800.030.575	C17.800.030	Acne, Chlorine|Acnes, Chlorine|Chloracnes|Chlorine Acne|Chlorine Acnes	Skin disease
chlorellosis	MESH:C000656804			MESH:D012874	C01.800/C000656804|C17.800.838/C000656804	C01.800|C17.800.838	Chlorellosis infection|Chlorellosis infections	Skin disease
Cholangiocarcinoma	MESH:D018281	DO:DOID:4928|DO:DOID:4947	A malignant tumor arising from the epithelium of the BILE DUCTS.	MESH:D000230	C04.557.470.200.025.450	C04.557.470.200.025	Carcinoma, Cholangiocellular|Carcinomas, Cholangiocellular|Cholangiocarcinoma, Extrahepatic|Cholangiocarcinoma, Intrahepatic|Cholangiocarcinomas|Cholangiocarcinomas, Extrahepatic|Cholangiocarcinomas, Intrahepatic|Cholangiocellular Carcinoma|Cholangiocellular Carcinomas|Extrahepatic Cholangiocarcinoma|Extrahepatic Cholangiocarcinomas|Intrahepatic Cholangiocarcinoma|Intrahepatic Cholangiocarcinomas	Cancer
Choledochal Cyst	MESH:D015529	DO:DOID:899	A congenital anatomic malformation of a bile duct, including cystic dilatation of the extrahepatic bile duct or the large intrahepatic bile duct. Classification is based on the site and type of dilatation. Type I is most common.	MESH:D001649|MESH:D003560|MESH:D004065	C04.182.198|C06.130.120.127|C06.198.184|C16.131.314.184	C04.182|C06.130.120|C06.198|C16.131.314	Bile Duct Cyst|Bile Duct Cysts|Biliary Dilatation, Congenital|Choledochal Cyst, Congenital|Choledochal Cyst, Diverticulum|Choledochal Cyst, Intrahepatic|Choledochal Cyst, Multiple|Choledochal Cysts|Choledochal Cysts, Diverticulum|Choledochal Cyst, Type I|Choledochal Cyst, Type II|Choledochal Cyst, Type III|Choledochal Cyst, Type IV|Choledochal Cyst, Type V|Choledochal Diverticulum|Choledochal Diverticulums|Choledochocele|Choledochoceles|Common Bile Duct Cyst|Congenital Biliary Dilatation|Congenital Biliary Dilatations|Congenital Choledochal Cyst|Congenital Choledochal Cysts|Cyst, Bile Duct|Cyst, Choledochal|Cyst, Common Bile Duct|Cyst, Congenital Choledochal|Cyst, Intrahepatic Choledochal|Cyst, Multiple Choledochal|Cysts, Common Bile Duct|Dilatation, Congenital Biliary|Diverticulum, Choledochal|Diverticulum Choledochal Cyst|Diverticulum Choledochal Cysts|Duct Cyst, Bile|Intrahepatic Choledochal Cyst|Intrahepatic Choledochal Cysts|Multiple Choledochal Cyst|Multiple Choledochal Cysts	Cancer|Congenital abnormality|Digestive system disease
Cholesteatoma	MESH:D002781	DO:DOID:869	A non-neoplastic mass of keratin-producing squamous EPITHELIUM, frequently occurring in the MENINGES; bones of the skull, and most commonly in the MIDDLE EAR and MASTOID region. Cholesteatoma can be congenital or acquired. Cholesteatoma is not a tumor nor is it associated with high CHOLESTEROL.	MESH:D007642	C17.800.428.260	C17.800.428	Cholesteatomas	Skin disease
Cholesteatoma, Congenital	MESH:C562858			MESH:D002781	C17.800.428.260/C562858	C17.800.428.260		Skin disease
Cholesteatoma, Middle Ear	MESH:D018424	DO:DOID:10964	A mass of KERATIN-producing squamous EPITHELIUM that resembles an inverted (suck-in) bag of skin in the MIDDLE EAR. It arises from the eardrum (TYMPANIC MEMBRANE) and grows into the MIDDLE EAR causing erosion of EAR OSSICLES and MASTOID that contains the INNER EAR.	MESH:D002781|MESH:D004427	C09.218.200|C17.800.428.260.300	C09.218|C17.800.428.260	Aural Cholesteatoma|Aural Cholesteatomas|Cholesteatoma, Aural|Cholesteatomas, Aural|Cholesteatomas, Middle Ear|Middle Ear Cholesteatoma|Middle Ear Cholesteatomas	Ear-nose-throat disease|Skin disease
CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	OMIM:604595			MESH:D006937	C18.452.584.500.500.396/604595	C18.452.584.500.500.396	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 13|CHOLESTEROL-LOWERING FACTOR|CLF|CLQTL1	Metabolic disease
Cholesterol pneumonia	MESH:C535937			MESH:D002779|MESH:D011014	C01.748.610/C535937|C06.130.120.135/C535937|C08.381.677/C535937|C08.730.610/C535937	C01.748.610|C06.130.120.135|C08.381.677|C08.730.610	Familiaere Cholesterin-Pneumonie	Digestive system disease|Respiratory tract disease
Chondroblastoma	MESH:D002804	DO:DOID:2649	A usually benign tumor composed of cells which arise from chondroblasts or their precursors and which tend to differentiate into cartilage cells. It occurs primarily in the epiphyses of adolescents. It is relatively rare and represents less than 2% of all primary bone tumors. The peak incidence is in the second decade of life; it is about twice as common in males as in females. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1846)	MESH:D009372	C04.557.450.565.250	C04.557.450.565	Chondroblastomas	Cancer
Chondrocalcinosis	MESH:D002805		Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of  joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.	MESH:D000070657|MESH:D001168	C05.550.114.264|C05.550.354.125	C05.550.114|C05.550.354	Calcium Pyrophosphate Deposition Disease|Calcium Pyrophosphate Dihydrate Deposition|Chondrocalcinoses|Pseudogout	Musculoskeletal disease
Chondrocalcinosis 1	MESH:C535938	OMIM:600668		MESH:D002805|MESH:D010003	C05.550.114.264/C535938|C05.550.114.606/C535938|C05.550.354.125/C535938|C05.799.613/C535938	C05.550.114.264|C05.550.114.606|C05.550.354.125|C05.799.613	CALCIUM PYROPHOSPHATE DIHYDRATE DEPOSITION DISEASE 1|CCAL1|Chondrocalcinosis with early-onset osteoarthritis|CPPDD1	Musculoskeletal disease
Chondrocalcinosis 2	MESH:C563162	OMIM:118600		MESH:D002805	C05.550.114.264/C563162|C05.550.354.125/C563162	C05.550.114.264|C05.550.354.125	Calcium Gout|Calcium Pyrophosphate Arthropathy|Calcium Pyrophosphate Dihydrate Deposition Disease|CALCIUM PYROPHOSPHATE DIHYDRATE DEPOSITION DISEASE 2|CCAL2|Chondrocalcinosis, Familial Articular|CPPDD|CPPDD2|CPPDD Calcium Pyrophosphate Dihydrate Deposition Disease	Musculoskeletal disease
Chondrocalcinosis due to Apatite crystal deposition	MESH:C535939			MESH:D002805	C05.550.114.264/C535939|C05.550.354.125/C535939	C05.550.114.264|C05.550.354.125	Familial Apatite disease	Musculoskeletal disease
Chondrodysplasia Punctata	MESH:D002806	DO:DOID:2581|OMIM:302960	A heterogeneous group of bone dysplasias, the common character of which is stippling of the epiphyses in infancy. The group includes a severe autosomal recessive form (CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC), an autosomal dominant form (Conradi-Hunermann syndrome), and a milder X-linked form. Metabolic defects associated with impaired peroxisomes are present only in the rhizomelic form.	MESH:D010009	C05.116.099.708.195	C05.116.099.708	CDPX2|CDPXD|Chondrodysplasia Punctata 2, X Linked|Chondrodysplasia Punctata 2, X-Linked|Chondrodysplasia Punctata 2, X Linked Dominant|Chondrodysplasia Punctata 2, X-Linked Dominant|Chondrodystrophia Calcificans Congenita|Conradi Hunermann Happle Syndrome|Conradi-Hunermann-Happle Syndrome|Conradi Hünermann Happle Syndrome|Conradi-Hünermann-Happle Syndrome|Conradi-Hunermann-Happle Syndromes|Conradi-Hünermann-Happle Syndromes|Conradi Hunermann Syndrome|Conradi-Hunermann Syndrome|Conradi Hünermann Syndrome|Conradi-Hünermann Syndrome|Conradi-Hünermann Syndromes|CPXD|Dysplasia Epiphysialis Punctata|Epiphyses, Stippled|Happle Syndrome|Hunermann Conradi Syndrome|Hunermann-Conradi Syndrome|Stippled Epiphyses|X Linked Chondrodysplasia Punctata 2|X-Linked Chondrodysplasia Punctata 2|X Linked Dominant Chondrodysplasia Punctata|X-Linked Dominant Chondrodysplasia Punctata	Musculoskeletal disease
Chondrodysplasia Punctata, Autosomal Dominant	MESH:C563248			MESH:D002806	C05.116.099.708.195/C563248	C05.116.099.708.195	Chondrodysplasia Punctata Due To Vitamin K Deficiency|Chondrodysplasia Punctata Due To Warfarin Teratogenicity	Musculoskeletal disease
Chondrodysplasia Punctata Syndrome	MESH:C565853			MESH:D002806	C05.116.099.708.195/C565853	C05.116.099.708.195		Musculoskeletal disease
Chondrodysplasia Punctata, Tibia-Metacarpal Type	MESH:C562961			MESH:D002806	C05.116.099.708.195/C562961	C05.116.099.708.195		Musculoskeletal disease
Chondrodysplasia Punctata with Coagulation Factor Deficiency	MESH:C564742			MESH:D002806|MESH:D020147	C05.116.099.708.195/C564742|C15.378.100.141/C564742	C05.116.099.708.195|C15.378.100.141		Blood disease|Musculoskeletal disease
Chondroma	MESH:D002812	DO:DOID:2602	A benign neoplasm derived from mesodermal cells that form cartilage. It may remain within the substance of a cartilage or bone (true chondroma or enchondroma) or may develop on the surface of a cartilage (ecchondroma or ecchondrosis). (Dorland, 27th ed; Stedman, 25th ed)	MESH:D009372	C04.557.450.565.265	C04.557.450.565	Chondromas|Enchondroma|Enchondromas	Cancer
Chondromatosis	MESH:D018210		Multiple formation of chondromas. (Dorland, 27th ed)	MESH:D002812	C04.557.450.565.265.270	C04.557.450.565.265	Chondromatoses	Cancer
Chondromatosis, Synovial	MESH:D015838		Rare, benign, chronic, progressive metaplasia in which cartilage is formed in the synovial membranes of joints, tendon sheaths, or bursae. Some of the metaplastic foci can become detached producing loose bodies. When the loose bodies undergo secondary calcification, the condition is called synovial osteochondromatosis.	MESH:D007592	C05.550.287	C05.550	Chondromatoses, Synovial|Chondrometaplasias, Synovial|Chondrometaplasia, Synovial|Henderson Jones Syndrome|Henderson-Jones Syndrome|Osteochondromatoses, Synovial|Osteochondromatosis, Synovial|Reichel's Syndrome|Reichels Syndrome|Reichel Syndrome|Syndrome, Henderson-Jones|Syndrome, Reichel's|Synovial Chondromatoses|Synovial Chondromatosis|Synovial Chondrometaplasia|Synovial Chondrometaplasias|Synovial Osteochondromatoses|Synovial Osteochondromatosis	Musculoskeletal disease
Chondrosarcoma	MESH:D002813	DO:DOID:3371|OMIM:215300	A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)	MESH:D009372|MESH:D012509	C04.557.450.565.280|C04.557.450.795.300	C04.557.450.565|C04.557.450.795	Chondrosarcomas	Cancer
Chondrosarcoma, Clear Cell	MESH:D000077207	DO:DOID:5867	A chondrosarcoma of adolescence to old age of the proximal EPIPHYSES of long bones. It has variably clear cytoplasm of the mostly neoplastic CHONDROCYTES with little intervening matrix.	MESH:D002813	C04.557.450.565.280.140|C04.557.450.795.300.140	C04.557.450.565.280|C04.557.450.795.300	Chondrosarcomas, Clear Cell|Clear Cell Chondrosarcoma|Clear Cell Chondrosarcomas	Cancer
Chondrosarcoma, Extraskeletal Myxoid	MESH:C563195	DO:DOID:6496|OMIM:612237		MESH:D002813|MESH:D018204	C04.557.450.565.280/C563195|C04.557.450.795.300/C563195|C04.557.450/C563195	C04.557.450|C04.557.450.565.280|C04.557.450.795.300	EMC	Cancer
Chondrosarcoma, Mesenchymal	MESH:D018211	DO:DOID:4545	A rare aggressive variant of chondrosarcoma, characterized by a biphasic histologic pattern of small compact cells intermixed with islands of cartilaginous matrix. Mesenchymal chondrosarcomas have a predilection for flat bones; long tubular bones are rarely affected. They tend to occur in the younger age group and are highly metastatic. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1456)	MESH:D002813	C04.557.450.565.280.280|C04.557.450.795.300.280	C04.557.450.565.280|C04.557.450.795.300	Chondrosarcomas, Mesenchymal|Mesenchymal Chondrosarcoma|Mesenchymal Chondrosarcomas	Cancer
CHOPS SYNDROME	OMIM:616368			MESH:D001848|MESH:D003072|MESH:D006343|MESH:D008171|MESH:D009765|MESH:D019066	C05.116.099/616368|C08.381/616368|C14.240.400.560/616368|C14.280.400.560/616368|C16.131.240.400.560/616368|C18.654.726.750.500/616368|C23.550.291.812/616368|C23.888.144.699.500/616368|F03.615.250/616368	C05.116.099|C08.381|C14.240.400.560|C14.280.400.560|C16.131.240.400.560|C18.654.726.750.500|C23.550.291.812|C23.888.144.699.500|F03.615.250	CHOPS|COGNITIVE IMPAIRMENT, COARSE FACIES, HEART DEFECTS, OBESITY, PULMONARY INVOLVEMENT, SHORT STATURE, AND SKELETAL DYSPLASIA	Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Nutrition disorder|Pathology (process)|Respiratory tract disease|Signs and symptoms
Chordoma	MESH:D002817	DO:DOID:3302|OMIM:215400	A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. (Dorland, 27th ed)	MESH:D009373	C04.557.465.220	C04.557.465	CHDM|Chordomas|CHORDOMA, SUSCEPTIBILITY TO	Cancer
Chorea	MESH:D002819	OMIM:118700	Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.	MESH:D020820	C10.228.662.262.249|C10.597.350.250|C23.888.592.350.250	C10.228.662.262|C10.597.350|C23.888.592.350	BCH|Benign Hereditary Chorea|Benign Hereditary Choreas|BHC|Chorea, Benign Hereditary|Chorea, Chronic Progressive|Chorea Disorder|Chorea Disorders|Chorea, Hereditary|Chorea, Rheumatic|Choreas|Choreas, Benign Hereditary|Choreas, Chronic Progressive|Chorea, Senile|Choreas, Hereditary|Choreas, Rheumatic|Choreas, Senile|Choreas, Sydenham|Chorea, Sydenham|Chorea, Sydenham's|Chorea Syndrome|Chorea Syndromes|Choreatic Disorder|Choreatic Disorders|Choreatic Syndrome|Choreatic Syndromes|Choreic Movement|Choreic Movements|Choreiform Movement|Choreiform Movements|Chronic Progressive Chorea|Chronic Progressive Choreas|Disorder, Chorea|Disorder, Choreatic|Disorders, Chorea|Disorders, Choreatic|Dyskinesia, Paroxysmal|Dyskinesias, Paroxysmal|Hereditary Chorea|Hereditary Chorea, Benign|Hereditary Choreas|Hereditary Choreas, Benign|Hereditary Progressive Chorea Without Dementia|Movement, Choreic|Movement, Choreiform|Movements, Choreic|Movements, Choreiform|Paroxysmal Dyskinesia|Paroxysmal Dyskinesias|Progressive Chorea, Chronic|Progressive Choreas, Chronic|Rheumatic Chorea|Rheumatic Choreas|Senile Chorea|Senile Choreas|St. Vitus Dance|St. Vitus's Dance|St. Vituss Dance|St. Vitus's Dances|Sydenham Chorea|Sydenham Choreas|Sydenham's Chorea|Sydenhams Chorea|Syndrome, Chorea|Syndrome, Choreatic|Syndromes, Chorea|Syndromes, Choreatic	Nervous system disease|Signs and symptoms
Chorea, Benign Familial	MESH:C565851			MESH:D002819	C10.228.662.262.249/C565851|C10.597.350.250/C565851|C23.888.592.350.250/C565851	C10.228.662.262.249|C10.597.350.250|C23.888.592.350.250		Nervous system disease|Signs and symptoms
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	OMIM:616939			MESH:D002819|MESH:D011596	C10.228.662.262.249/616939|C10.597.350.250/616939|C10.597.606.881/616939|C23.888.592.350.250/616939|C23.888.592.604.882/616939	C10.228.662.262.249|C10.597.350.250|C10.597.606.881|C23.888.592.350.250|C23.888.592.604.882	COCPMR	Nervous system disease|Signs and symptoms
Chorea Gravidarum	MESH:D020150	DO:DOID:14483	A rare movement disorder developed during PREGNANCY, characterized by involuntary jerky motion (CHOREA) and inability to maintain stable position of body parts (ATHETOSIS). RHEUMATIC FEVER and collagen vascular disorders are frequently associated with this disease. Chorea may vary from mild to severe and occurs in approximately 1 per 2,000 to 3,000 pregnancies. (From Md Med J 1997 Sep;46(8):436-9)	MESH:D001480|MESH:D002819|MESH:D011248	C10.228.140.079.294|C10.228.662.262.249.500|C12.050.703.141	C10.228.140.079|C10.228.662.262.249|C12.050.703	Chorea Gravidarums|Chorea, Pregnancy Induced|Chorea, Pregnancy-Induced|Choreas, Pregnancy-Induced|Choreoathetoses, Pregnancy-Associated|Choreoathetosis, Pregnancy Associated|Choreoathetosis, Pregnancy-Associated|Gravidarum, Chorea|Pregnancy-Associated Choreoathetoses|Pregnancy-Associated Choreoathetosis|Pregnancy-Induced Chorea|Pregnancy-Induced Choreas	Nervous system disease|Pregnancy complication
Chorea, remitting with nystagmus and cataracts	MESH:C535355			MESH:D002819	C10.228.662.262.249/C535355|C10.597.350.250/C535355|C23.888.592.350.250/C535355	C10.228.662.262.249|C10.597.350.250|C23.888.592.350.250	Chorea, Remitting, with Nystagmus and Cataract|Familial remitting chorea, nystagmus and cataracts	Nervous system disease|Signs and symptoms
Choreoathetosis, Familial Inverted	MESH:C566127			MESH:D001264|MESH:D002819	C10.228.662.262.249/C566127|C10.597.350.110/C566127|C10.597.350.250/C566127|C23.888.592.350.110/C566127|C23.888.592.350.250/C566127	C10.228.662.262.249|C10.597.350.110|C10.597.350.250|C23.888.592.350.110|C23.888.592.350.250	Infantile Choreoathetosis of Fisher	Nervous system disease|Signs and symptoms
Choreoathetosis-Spasticity, Episodic	MESH:C563401	OMIM:601042		MESH:D009128|MESH:D020820	C05.651.512/C563401|C10.228.662.262/C563401|C10.597.350/C563401|C10.597.613.550.550/C563401|C23.888.592.350/C563401|C23.888.592.608.550.550/C563401	C05.651.512|C10.228.662.262|C10.597.350|C10.597.613.550.550|C23.888.592.350|C23.888.592.608.550.550	Choreoathetosis, Kinesigenic, with Episodic Ataxia And Spasticity|Choreoathetosis, Paroxysmal, with Episodic Ataxia|CHOREOATHETOSIS/SPASTICITY, EPISODIC|CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA|Dystonia 9|DYT9	Musculoskeletal disease|Nervous system disease|Signs and symptoms
Choriocarcinoma	MESH:D002822	DO:DOID:3594	A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).	MESH:D000230|MESH:D014328	C04.557.465.955.207|C04.557.470.200.025.455|C04.850.908.208|C12.050.703.720.949.208	C04.557.465.955|C04.557.470.200.025|C04.850.908|C12.050.703.720.949	Choriocarcinomas	Cancer|Pregnancy complication
Choriocarcinoma, Non-gestational	MESH:D031954	DO:DOID:4320	A highly malignant CHORIOCARCINOMA derived from the non-placental origin such as the totipotent cells in the TESTIS, the OVARY, and the PINEAL GLAND. It produces high levels of CHORIONIC GONADOTROPIN and can metastasize widely through the bloodstream to the lungs, brain, liver, bone, and other viscera by the time of diagnosis.	MESH:D002822	C04.557.465.955.207.438|C04.557.470.200.025.455.750|C04.850.908.208.438|C12.050.703.720.949.208.438	C04.557.465.955.207|C04.557.470.200.025.455|C04.850.908.208|C12.050.703.720.949.208	Choriocarcinoma, Non gestational|Choriocarcinomas, Non-gestational|Non gestational Choriocarcinoma|Non-gestational Choriocarcinoma|Non-gestational Choriocarcinomas	Cancer|Pregnancy complication
Chorioretinitis	MESH:D002825	DO:DOID:8886	Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.	MESH:D002833|MESH:D012173	C11.768.773.348|C11.941.160.478.400|C11.941.879.780.900.300.318	C11.768.773|C11.941.160.478|C11.941.879.780.900.300	Chorioretinitides	Eye disease
Choroidal Dystrophy, Central Areolar 2	MESH:C567750	OMIM:613105		MESH:D015862	C11.941.160/C567750	C11.941.160	CACD2|Central Areolar Choroidal Dystrophy-2|Macular Dystrophy, Progressive	Eye disease
Choroidal Dystrophy, Central Areolar 3	MESH:C567729	OMIM:613144		MESH:D015862	C11.941.160/C567729	C11.941.160	CACD3|CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 3|Choroidal Dystrophy, Central Areolar, With Or Without Drusen	Eye disease
Choroidal Effusions	MESH:D000080324		Finding of fluid accumulation between the CHOROID and the SCLERA.	MESH:D005124|MESH:D015862	C11.250.105|C11.941.160.241	C11.250|C11.941.160	Choroidal Detachment|Choroidal Detachments|Choroidal Effusion|Ciliochoroidal Detachment|Ciliochoroidal Detachments|Ciliochoroidal Effusion|Ciliochoroidal Effusions|Effusion, Choroidal|Effusion, Ciliochoroidal|Suprachoroidal Space	Eye disease
Choroidal Neovascularization	MESH:D020256		A pathological process consisting of the formation of new blood vessels in the CHOROID.	MESH:D009389|MESH:D015862	C11.941.160.244|C23.550.589.500.145	C11.941.160|C23.550.589.500	Choroidal Neovascularizations|Choroid Neovascularization|Choroid Neovascularizations|Neovascularization, Choroid|Neovascularization, Choroidal	Eye disease|Pathology (process)
Choroidal Osteoma, Bilateral	MESH:C566124			MESH:D002828|MESH:D002830|MESH:D010016	C04.557.450.565.575.625/C566124|C04.588.364.978.223/C566124|C11.319.494.198/C566124|C11.941.160.238/C566124|C11.941.855.198/C566124|C23.300.250/C566124	C04.557.450.565.575.625|C04.588.364.978.223|C11.319.494.198|C11.941.160.238|C11.941.855.198|C23.300.250		Cancer|Eye disease|Pathology (anatomical condition)
Choroidal sclerosis	MESH:C535358	DO:DOID:980|OMIM:215500		MESH:D015862	C11.941.160/C535358	C11.941.160	CACD|CACD1|Central areolar choroidal sclerosis|Choroidal dystrophy central areolar|Choroidal Dystrophy, Central Areolar|Choroidal Dystrophy, Central Areolar 1|CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1|CHOROIDAL SCLEROSIS	Eye disease
Choroid Diseases	MESH:D015862	DO:DOID:1417	Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.	MESH:D014603	C11.941.160	C11.941	Choroidal Disease|Choroidal Diseases|Choroid Disease|Disease, Choroid|Disease, Choroidal|Diseases, Choroid|Diseases, Choroidal	Eye disease
Choroid Hemorrhage	MESH:D002832		Hemorrhage from the vessels of the choroid.	MESH:D005130|MESH:D015862	C11.290.195|C11.941.160.177|C23.550.414.756.300	C11.290|C11.941.160|C23.550.414.756	Choroidal Hemorrhage|Choroidal Hemorrhages|Hemorrhage, Choroid|Hemorrhage, Choroidal	Eye disease|Pathology (process)
Choroiditis	MESH:D002833	DO:DOID:11406	Inflammation of the choroid.	MESH:D015862|MESH:D015866	C11.941.160.478|C11.941.879.780.900.300	C11.941.160|C11.941.879.780.900	Choroiditides	Eye disease
Choroid Neoplasms	MESH:D002830	DO:DOID:12759	Tumors of the choroid; most common intraocular tumors are malignant melanomas of the choroid. These usually occur after puberty and increase in incidence with advancing age. Most malignant melanomas of the uveal tract develop from benign melanomas (nevi).	MESH:D014604|MESH:D015862	C04.588.364.978.223|C11.319.494.198|C11.941.160.238|C11.941.855.198	C04.588.364.978|C11.319.494|C11.941.160|C11.941.855	Choroidal Neoplasm|Choroidal Neoplasms|Choroid Neoplasm|Neoplasm, Choroid|Neoplasm, Choroidal|Neoplasms, Choroid|Neoplasms, Choroidal	Cancer|Eye disease
Choroid Plexus Carcinoma	MESH:C562943	DO:DOID:5648		MESH:D002277|MESH:D016545	C04.557.470.200/C562943|C04.588.614.250.195.205.200/C562943|C10.228.140.211.280.300/C562943|C10.551.240.250.200.200/C562943	C04.557.470.200|C04.588.614.250.195.205.200|C10.228.140.211.280.300|C10.551.240.250.200.200		Cancer|Nervous system disease
Choroid Plexus Neoplasms	MESH:D016545	DO:DOID:3540	Benign or malignant tumors which arise from the choroid plexus of the ventricles of the brain. Papillomas (see PAPILLOMA, CHOROID PLEXUS) and carcinomas are the most common histologic subtypes, and tend to seed throughout the ventricular and subarachnoid spaces. Clinical features include headaches, ataxia and alterations of consciousness, primarily resulting from associated HYDROCEPHALUS. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2072; J Neurosurg 1998 Mar;88(3):521-8)	MESH:D002551	C04.588.614.250.195.205.200|C10.228.140.211.280.300|C10.551.240.250.200.200	C04.588.614.250.195.205|C10.228.140.211.280|C10.551.240.250.200	Choroid Plexus Neoplasm|Choroid Plexus Neoplasms, Primary|Choroid Plexus Tumor|Choroid Plexus Tumors|Neoplasm, Choroid Plexus|Neoplasms, Choroid Plexus|Primary Choroid Plexus Neoplasms	Cancer|Nervous system disease
Chromosomal Instability with Tissue-Specific Radiosensitivity	MESH:C565848			MESH:D008831|MESH:D009369|MESH:D043171	C04/C565848|C05.660.207.620/C565848|C10.500.507.400.500/C565848|C16.131.621.207.620/C565848|C16.131.666.507.400.500/C565848|C23.550.210.110/C565848|C23.550.362.180/C565848	C04|C05.660.207.620|C10.500.507.400.500|C16.131.621.207.620|C16.131.666.507.400.500|C23.550.210.110|C23.550.362.180		Cancer|Congenital abnormality|Musculoskeletal disease|Nervous system disease|Pathology (process)
Chromosome 10q23 Deletion Syndrome	MESH:C567385	DO:DOID:0060389		MESH:D002872|MESH:D018256	C04.557.470.035.215/C567385|C23.550.210.050.500.500/C567385	C04.557.470.035.215|C23.550.210.050.500.500		Cancer|Pathology (process)
Chromosome 1q21.1 Duplication Syndrome	MESH:C567290			MESH:D001321|MESH:D002872|MESH:D006330|MESH:D008607	C10.597.606.360/C567290|C14.240.400/C567290|C14.280.400/C567290|C16.131.240.400/C567290|C23.550.210.050.500.500/C567290|C23.888.592.604.646/C567290|F03.625.164.113.500/C567290|F03.625.539/C567290	C10.597.606.360|C14.240.400|C14.280.400|C16.131.240.400|C23.550.210.050.500.500|C23.888.592.604.646|F03.625.164.113.500|F03.625.539		Cardiovascular disease|Congenital abnormality|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Chromosome 5q Deletion Syndrome	MESH:C535323	OMIM:153550		MESH:D000748|MESH:D002872	C15.378.071.252/C535323|C23.550.210.050.500.500/C535323	C15.378.071.252|C23.550.210.050.500.500	5q deletion syndrome|5q- syndrome|Macrocytic Anemia, Refractory, Due To 5q Deletion|MACROCYTIC ANEMIA, REFRACTORY, DUE TO 5q DELETION;MAR  MEGAKARYOCYTES, UNILOBULAR NUCLEATED, INCLUDED|Refractory macrocytic anemia due to 5q deletion	Blood disease|Pathology (process)
Chromosome 6pter-P24 Deletion Syndrome	MESH:C567239			MESH:D002872|MESH:D005124|MESH:D006330|MESH:D006972|MESH:D034381	C05.116.099.370.231.480/C567239|C05.660.207.231.480/C567239|C09.218.458.341/C567239|C10.597.751.418.341/C567239|C11.250/C567239|C14.240.400/C567239|C14.280.400/C567239|C16.131.240.400/C567239|C16.131.384/C567239|C16.131.621.207.231.480/C567239|C23.550.210.050.500.500/C567239|C23.888.592.763.393.341/C567239	C05.116.099.370.231.480|C05.660.207.231.480|C09.218.458.341|C10.597.751.418.341|C11.250|C14.240.400|C14.280.400|C16.131.240.400|C16.131.384|C16.131.621.207.231.480|C23.550.210.050.500.500|C23.888.592.763.393.341		Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Eye disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA	OMIM:616201	DO:DOID:0060339		MESH:D001145|MESH:D007418	C06.405.469.531.492.500/616201|C14.280.067/616201|C23.550.073/616201	C06.405.469.531.492.500|C14.280.067|C23.550.073	CAID	Cardiovascular disease|Digestive system disease|Pathology (process)
chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature	MESH:C000633744			MESH:D007153	C20.673/C000633744	C20.673	POMP-related autoinflammation|POMP-related autoinflammation and immune dysregulation disease|PRAID	Immune system disease
Chronic Exertional Compartment Syndrome	MESH:D000083182		Compartment syndrome characterized by pain in muscle groups with elevated compartment pressures due most often exercise training in athletes. Most often encountered chronic exertional compartment syndrome is in the anterior or deep posterior compartments of the lower leg in athletes in training similar to POPLITEAL ARTERY ENTRAPMENT SYNDROME.	MESH:D002908|MESH:D003161	C05.651.180.180|C14.907.303.180|C23.550.291.500.282	C05.651.180|C14.907.303|C23.550.291.500		Cardiovascular disease|Musculoskeletal disease|Pathology (process)
Chronic Kidney Disease-Mineral and Bone Disorder	MESH:D012080	DO:DOID:13068	Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.	MESH:D002908|MESH:D006962|MESH:D007674|MESH:D012279	C05.116.198.816.750|C12.050.351.968.419.795|C12.200.777.419.080|C12.950.419.795|C18.452.104.816.750|C18.452.174.845.750|C18.654.521.500.133.770.734.750|C19.642.355.480.500|C23.550.291.500.290	C05.116.198.816|C12.050.351.968.419|C12.200.777.419|C12.950.419|C18.452.104.816|C18.452.174.845|C18.654.521.500.133.770.734|C19.642.355.480|C23.550.291.500	Chronic Kidney Disease Mineral and Bone Disorder|CKD-MBD|Osteodystrophies, Renal|Osteodystrophy, Renal|Renal Osteodystrophies|Renal Osteodystrophy|Renal Rickets|Rickets, Renal	Endocrine system disease|Metabolic disease|Musculoskeletal disease|Nutrition disorder|Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Chronic Limb-Threatening Ischemia	MESH:D000089802		A severe form of peripheral artery disease in which a hypoperfusion of the BLOOD through an organ or tissue is caused by occlusion of peripheral arterial vessels. It is associated with the presence of chronic ischemic rest pain, ulceration or GANGRENE.	MESH:D002908|MESH:D007511|MESH:D058729	C14.907.137.126.307.500.500|C14.907.617.671.500|C23.550.291.500.298|C23.550.513.178	C14.907.137.126.307.500|C14.907.617.671|C23.550.291.500|C23.550.513	Chronic Limb Threatening Ischemia|Critical Limb Ischemia|Ischemia, Chronic Limb-Threatening|Ischemia, Critical Limb|Limb Ischemia, Critical|Limb-Threatening Ischemia, Chronic	Cardiovascular disease|Pathology (process)
Chronic Periodontitis	MESH:D055113		Chronic inflammation and loss of PERIODONTIUM that is associated with the amount of DENTAL PLAQUE or DENTAL CALCULUS present. Chronic periodontitis occurs mostly in adults and was called adult periodontitis, but this disease can appear in young people.	MESH:D002908|MESH:D010518	C07.465.714.533.324|C23.550.291.500.313	C07.465.714.533|C23.550.291.500	Adult Periodontitides|Adult Periodontitis|Chronic Periodontitides|Periodontitides, Adult|Periodontitides, Chronic|Periodontitis, Adult|Periodontitis, Chronic	Mouth disease|Pathology (process)
Chronic recurrent multifocal osteomyelitis	MESH:C535456	DO:DOID:0060645|OMIM:259680		MESH:D010019	C01.160.495/C535456|C05.116.165.495/C535456	C01.160.495|C05.116.165.495	Chronic multifocal osteomyelitis|CMO|CRMO|Multifocal osteomyelitis, chronic|Osteomyelitis, Chronic Multifocal	Musculoskeletal disease
Chronic Traumatic Encephalopathy	MESH:D000070627		Degenerative brain disease linked to repetitive brain trauma. Progressive symptoms may include MEMORY LOSS; AGGRESSION; or DEPRESSION.	MESH:D000070642|MESH:D019636|MESH:D020208	C10.228.140.199.444.500|C10.228.140.199.500.500|C10.574.250|C10.900.300.087.235.500|C10.900.300.087.250.500|C23.550.291.500.063.500.500|C26.915.300.200.194.500|C26.915.300.200.200.500	C10.228.140.199.444|C10.228.140.199.500|C10.574|C10.900.300.087.235|C10.900.300.087.250|C23.550.291.500.063.500|C26.915.300.200.194|C26.915.300.200.200	Chronic Encephalopathies, Post-Concussive|Chronic Encephalopathy, Post Concussive|Chronic Encephalopathy, Post-Concussive|Chronic Post-Concussive Encephalopathies|Chronic Post Concussive Encephalopathy|Chronic Post-Concussive Encephalopathy|Chronic Post-Traumatic Encephalopathies|Chronic Post Traumatic Encephalopathy|Chronic Post-Traumatic Encephalopathy|Encephalopathies, Post-Concussive|Encephalopathies, Post-Traumatic|Encephalopathy, Post Concussive|Encephalopathy, Post-Concussive|Encephalopathy, Post Traumatic|Encephalopathy, Post-Traumatic|Encephalopathy, Post-Traumatic, Chronic|Post-Concussive Chronic Encephalopathies|Post-Concussive Chronic Encephalopathy|Post-Concussive Encephalopathies|Post Concussive Encephalopathy|Post-Concussive Encephalopathy|Post-Traumatic Encephalopathies|Post Traumatic Encephalopathy|Post-Traumatic Encephalopathy|Traumatic Encephalopathy, Chronic	Nervous system disease|Pathology (process)|Wounds and injuries
Chronic Urticaria	MESH:D000080223		Wheals (urticaria) and/or angioedema presented with daily symptoms lasting for more than 6 weeks. It may be classified into chronic spontaneous and chronic inducible urticaria depending on whether a specific trigger can be linked to the development of vascular reaction.	MESH:D002908|MESH:D014581	C17.800.862.945.533|C20.543.480.904.533|C23.550.291.500.360	C17.800.862.945|C20.543.480.904|C23.550.291.500	Autoimmune Urticaria|Autoimmune Urticaria, Chronic|Autoimmune Urticarias|Chronic Autoimmune Urticaria|Chronic Autoimmune Urticarias|Chronic Idiopathic Urticaria|Chronic Idiopathic Urticarias|Chronic Inducible Urticaria|Chronic Inducible Urticarias|Chronic Spontaneous Urticaria|Chronic Spontaneous Urticarias|Chronic Urticaria, Idiopathic|Chronic Urticarias|CIndU|Idiopathic Chronic Urticaria|Idiopathic Chronic Urticarias|Idiopathic Urticaria, Chronic|Inducible Urticaria, Chronic|Spontaneous Urticaria, Chronic|Urticaria, Autoimmune|Urticaria, Chronic|Urticaria, Chronic Autoimmune|Urticaria, Chronic Idiopathic|Urticaria, Chronic Inducible|Urticaria, Chronic Spontaneous|Urticaria, Idiopathic Chronic	Immune system disease|Pathology (process)|Skin disease
Chronobiology Disorders	MESH:D021081		Disruptions of the rhythmic cycle of bodily functions or activities.	MESH:D009422	C10.281	C10	Biological Clock Disturbance|Biological Clock Disturbances|Chronobiology Disorder|Circadian Dysregulation|Circadian Rhythm Disorder|Circadian Rhythm Disorders|Disturbance, Biological Clock|Disturbances, Biological Clock|Dysregulation, Circadian|Inversion of Circadian Rhythm, Psychogenic|Psychogenic Inversion of Circadian Rhythm	Nervous system disease
Chudley-Mccullough syndrome	MESH:C535459	OMIM:604213		MESH:D006319|MESH:D016080|MESH:D061085	C04.182.044/C535459|C04.588.614.250.387.100/C535459|C09.218.458.341.887/C535459|C10.500.034/C535459|C10.500.142.100/C535459|C10.551.240.375.100/C535459|C10.597.751.418.341.887/C535459|C16.131.666.034/C535459|C16.131.666.142.100/C535459|C23.300.008/C535459|C23.888.592.763.393.341.887/C535459	C04.182.044|C04.588.614.250.387.100|C09.218.458.341.887|C10.500.034|C10.500.142.100|C10.551.240.375.100|C10.597.751.418.341.887|C16.131.666.034|C16.131.666.142.100|C23.300.008|C23.888.592.763.393.341.887	CMCS|DEAFNESS, AUTOSOMAL RECESSIVE 82, FORMERLY|Deafness, bilateral sensorineural, and hydrocephalus due to foramen of monro obstruction|Deafness, sensorineural, with partial agenesis of the corpus callosum and arachnoid cysts|DFNB82, FORMERLY	Cancer|Congenital abnormality|Ear-nose-throat disease|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Chudley-Rozdilsky syndrome	MESH:C535458			MESH:D007006|MESH:D008607|MESH:D020512	C05.651.575.300/C535458|C10.597.606.360/C535458|C10.668.491.550.300/C535458|C19.391.482/C535458|C23.888.592.604.646/C535458|F03.625.539/C535458	C05.651.575.300|C10.597.606.360|C10.668.491.550.300|C19.391.482|C23.888.592.604.646|F03.625.539	Chudley Rozdilsky syndrome|Chudley syndrome	Endocrine system disease|Mental disorder|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Churg-Strauss Syndrome	MESH:D015267	DO:DOID:3049	Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA.	MESH:D006099|MESH:D056648	C14.907.940.897.249.249|C15.604.515.292.015|C20.111.193.500	C14.907.940.897.249|C15.604.515.292|C20.111.193	Allergic Angiitides|Allergic Angiitides, Granulomatous|Allergic Angiitis|Allergic Angiitis and Granulomatosis|Allergic Angiitis, Granulomatous|Allergic Granulomatoses|Allergic Granulomatosis|Allergic Granulomatous and Angiitis|Allergic Granulomatous Angiitides|Allergic Granulomatous Angiitis|Angiitides, Allergic|Angiitides, Allergic Granulomatous|Angiitides, Granulomatous Allergic|Angiitis, Allergic|Angiitis, Allergic Granulomatous|Angiitis, Granulomatous Allergic|Churg Strauss Syndrome|Churg-Strauss Vasculitis|Eosinophilic Granulomatous Vasculitides|Eosinophilic Granulomatous Vasculitis|Granulomatoses, Allergic|Granulomatosis, Allergic|Granulomatous Allergic Angiitides|Granulomatous Allergic Angiitis|Granulomatous Angiitides, Allergic|Granulomatous Angiitis, Allergic|Granulomatous Vasculitides, Eosinophilic|Granulomatous Vasculitis, Eosinophilic|Syndrome, Churg-Strauss|Vasculitides, Eosinophilic Granulomatous|Vasculitis, Churg Strauss|Vasculitis, Churg-Strauss|Vasculitis, Eosinophilic Granulomatous	Cardiovascular disease|Immune system disease|Lymphatic disease
Chylomicronemia, Familial, due to Circulating Inhibitor of Lipoprotein Lipase	MESH:C566126			MESH:D006951	C18.452.584.500.500.644/C566126	C18.452.584.500.500.644	Hyperlipoproteinemia, Type IC	Metabolic disease
Chylothorax	MESH:D002916		The presence of chyle in the thoracic cavity. (Dorland, 27th ed)	MESH:D010995	C08.528.142	C08.528		Respiratory tract disease
Chylothorax, congenital	MESH:C535461	OMIM:603523		MESH:D002916	C08.528.142/C535461	C08.528.142	Hydrothorax, Congenital	Respiratory tract disease
Ciguatera Poisoning	MESH:D036841		Poisoning caused by ingestion of SEAFOOD containing microgram levels of CIGUATOXINS. The poisoning is characterized by gastrointestinal, neurological and cardiovascular disturbances.	MESH:D005517	C25.723.415.246	C25.723.415	Ciguatera|Ciguatera Fish Poisoning|Ciguatera Fish Poisonings|Ciguatera Poisonings|Poisoning, Ciguatera|Poisoning, Ciguatera Fish|Poisonings, Ciguatera|Poisonings, Ciguatera Fish	
Circoviridae Infections	MESH:D018173		Virus diseases caused by the CIRCOVIRIDAE.	MESH:D004266	C01.925.256.200	C01.925.256	Circoviridae Infection|Circovirus Infection|Circovirus Infections|Infection, Circoviridae|Infection, Circovirus|Infections, Circoviridae|Infections, Circovirus	Viral disease
Cirrhosis, Cryptogenic	MESH:C562577			MESH:D008103	C06.552.630/C562577|C23.550.355.412/C562577	C06.552.630|C23.550.355.412		Digestive system disease|Pathology (process)
Cirrhosis, Familial, with Pulmonary Hypertension	MESH:C562580			MESH:D006976|MESH:D008103	C06.552.630/C562580|C08.381.423/C562580|C14.907.489.556/C562580|C23.550.355.412/C562580	C06.552.630|C08.381.423|C14.907.489.556|C23.550.355.412	Indian Childhood Cirrhosis	Cardiovascular disease|Digestive system disease|Pathology (process)|Respiratory tract disease
Ciuffo Syndrome	MESH:C566733			MESH:D006344|MESH:D011666	C14.240.400.560.375/C566733|C14.280.400.560.375/C566733|C14.280.484.716/C566733|C14.280.955.750/C566733|C16.131.240.400.560.375/C566733	C14.240.400.560.375|C14.280.400.560.375|C14.280.484.716|C14.280.955.750|C16.131.240.400.560.375	Pulmonic Stenosis, Atrial Septal Defect, and Unique Electrocardiographic Abnormalities	Cardiovascular disease|Congenital abnormality
CLAPO Syndrome	MESH:C567763			MESH:D001165|MESH:D008206	C14.240.850.750/C567763|C14.907.150/C567763|C15.604/C567763|C16.131.240.850.750/C567763	C14.240.850.750|C14.907.150|C15.604|C16.131.240.850.750	Capillary Malformation Of The Lower Lip, Lymphatic Malformation Of Face And Neck, Asymmetry Of Face And Limbs, And Partial-Generalized Overgrowth|Clapo|Lopez-Gutierrez Syndrome	Cardiovascular disease|Congenital abnormality|Lymphatic disease
Clear-cell metastatic renal cell carcinoma	MESH:C538445			MESH:D002292	C04.557.470.200.025.390/C538445|C04.588.945.947.535.160/C538445|C12.050.351.937.820.535.160/C538445|C12.050.351.968.419.473.160/C538445|C12.200.758.820.750.160/C538445|C12.200.777.419.473.160/C538445|C12.900.820.535.160/C538445|C12.950.419.473.160/C538445|C12.950.983.535.160/C538445	C04.557.470.200.025.390|C04.588.945.947.535.160|C12.050.351.937.820.535.160|C12.050.351.968.419.473.160|C12.200.758.820.750.160|C12.200.777.419.473.160|C12.900.820.535.160|C12.950.419.473.160|C12.950.983.535.160		Cancer|Urogenital disease (female)|Urogenital disease (male)
Cleft Palate, Cardiac Defect, Genital Anomalies, and Ectrodactyly	MESH:C563936			MESH:D002972|MESH:D006228|MESH:D006330|MESH:D014564	C05.390.408/C563936|C05.500.460.185/C563936|C05.660.207.540.460.185/C563936|C05.660.585.988.425/C563936|C07.320.440.185/C563936|C07.465.525.185/C563936|C07.650.500.460.185/C563936|C07.650.525.185/C563936|C12.050.351.875/C563936|C12.200.706/C563936|C12.800/C563936|C14.240.400/C563936|C14.280.400/C563936|C16.131.240.400/C563936|C16.131.621.207.540.460.185/C563936|C16.131.621.585.988.500/C563936|C16.131.850.500.460.185/C563936|C16.131.850.525.185/C563936|C16.131.939/C563936	C05.390.408|C05.500.460.185|C05.660.207.540.460.185|C05.660.585.988.425|C07.320.440.185|C07.465.525.185|C07.650.500.460.185|C07.650.525.185|C12.050.351.875|C12.200.706|C12.800|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.540.460.185|C16.131.621.585.988.500|C16.131.850.500.460.185|C16.131.850.525.185|C16.131.939	Acrocardiofacial Syndrome	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease|Urogenital disease (female)|Urogenital disease (male)
Cluster Headache	MESH:D003027		A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)	MESH:D051303	C10.228.140.546.399.937.500	C10.228.140.546.399.937	Atypical Cluster Headache|Atypical Cluster Headaches|Cephalgia, Histamine|Cephalgias, Histamine|Chronic Cluster Headache|Chronic Cluster Headaches|Ciliary Neuralgia|Ciliary Neuralgias|Cluster Headache, Atypical|Cluster Headache, Chronic|Cluster Headache, Episodic|Cluster Headaches|Cluster Headaches, Atypical|Cluster Headaches, Chronic|Cluster Headaches, Episodic|Cluster Headache Syndrome|Cluster Headache Syndromes|Episodic Cluster Headache|Episodic Cluster Headaches|Headache, Atypical Cluster|Headache, Chronic Cluster|Headache, Cluster|Headache, Episodic Cluster|Headaches, Atypical Cluster|Headaches, Chronic Cluster|Headaches, Cluster|Headaches, Episodic Cluster|Headache Syndrome, Cluster|Headache Syndromes, Cluster|Histamine Cephalgia|Histamine Cephalgias|Horton's Syndrome|Hortons Syndrome|Horton Syndrome|Migraine, Neuralgic|Migraines, Neuralgic|Neuralgia, Ciliary|Neuralgias, Ciliary|Neuralgic Migraine|Neuralgic Migraines|Syndrome, Cluster Headache|Syndrome, Horton|Syndrome, Horton's|Syndromes, Cluster Headache	Nervous system disease
Cluster Headache, Familial	MESH:C566117			MESH:D003027	C10.228.140.546.399.937.500/C566117	C10.228.140.546.399.937.500		Nervous system disease
Coagulation Protein Disorders	MESH:D020147		Hemorrhagic and thrombotic disorders resulting from abnormalities or deficiencies of coagulation proteins.	MESH:D001778	C15.378.100.141	C15.378.100	Blood Coagulation Factor Deficiencies|Coagulation Protein Disorder|Coagulation Proteins Disorder|Coagulation Proteins Disorders|Disorder, Coagulation Protein|Disorder, Coagulation Proteins|Disorders, Coagulation Protein|Disorders, Coagulation Proteins|Protein Disorder, Coagulation|Protein Disorders, Coagulation|Proteins Disorder, Coagulation|Proteins Disorders, Coagulation	Blood disease
Cocarcinogenesis	MESH:D003043		The combination of two or more different factors in the production of cancer.	MESH:D063646	C04.697.098.875|C23.550.727.098.750	C04.697.098|C23.550.727.098	Cocarcinogeneses	Cancer|Pathology (process)
Cochlear Diseases	MESH:D015834	DO:DOID:5463	Pathological processes of the snail-like structure (COCHLEA) of the inner ear (LABYRINTH) which can involve its nervous tissue, blood vessels, or fluid (ENDOLYMPH).	MESH:D007759	C09.218.568.120	C09.218.568	Cochlear Disease|Disease, Cochlear|Diseases, Cochlear	Ear-nose-throat disease
Cochleosaccular degeneration of the inner ear and progressive cataracts	MESH:C536432			MESH:D002386|MESH:D006319	C09.218.458.341.887/C536432|C10.597.751.418.341.887/C536432|C11.510.245/C536432|C23.888.592.763.393.341.887/C536432	C09.218.458.341.887|C10.597.751.418.341.887|C11.510.245|C23.888.592.763.393.341.887	Cochleosaccular Degeneration|Cochleosaccular Degeneration of the Inner Ear with Progressive Cataracts	Ear-nose-throat disease|Eye disease|Nervous system disease|Signs and symptoms
Coenzyme Q10 Deficiency	MESH:C564403			MESH:D001259|MESH:D018908|MESH:D028361	C05.651.515/C564403|C10.597.350.090/C564403|C10.597.613.593/C564403|C18.452.660/C564403|C23.550.695/C564403|C23.888.592.350.090/C564403|C23.888.592.608.593/C564403	C05.651.515|C10.597.350.090|C10.597.613.593|C18.452.660|C23.550.695|C23.888.592.350.090|C23.888.592.608.593	Coenzyme Q Deficiency|Coq10 Deficiency, Primary|CoQ Deficiency|Ubiquinone Deficiency	Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
COENZYME Q10 DEFICIENCY, PRIMARY, 1	OMIM:607426	DO:DOID:0070238		MESH:C564403	C05.651.515/C564403/607426|C10.597.350.090/C564403/607426|C10.597.613.593/C564403/607426|C18.452.660/C564403/607426|C23.550.695/C564403/607426|C23.888.592.350.090/C564403/607426|C23.888.592.608.593/C564403/607426	C05.651.515/C564403|C10.597.350.090/C564403|C10.597.613.593/C564403|C18.452.660/C564403|C23.550.695/C564403|C23.888.592.350.090/C564403|C23.888.592.608.593/C564403	COENZYME Q DEFICIENCY 1|COQ10D1|CoQ10 DEFICIENCY, PRIMARY, 1|CoQ DEFICIENCY 1|UBIQUINONE DEFICIENCY 1	Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
COENZYME Q10 DEFICIENCY, PRIMARY, 2	OMIM:614651	DO:DOID:0070239		MESH:C564403	C05.651.515/C564403/614651|C10.597.350.090/C564403/614651|C10.597.613.593/C564403/614651|C18.452.660/C564403/614651|C23.550.695/C564403/614651|C23.888.592.350.090/C564403/614651|C23.888.592.608.593/C564403/614651	C05.651.515/C564403|C10.597.350.090/C564403|C10.597.613.593/C564403|C18.452.660/C564403|C23.550.695/C564403|C23.888.592.350.090/C564403|C23.888.592.608.593/C564403	COQ10D2	Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
COENZYME Q10 DEFICIENCY, PRIMARY, 3	OMIM:614652	DO:DOID:0070240		MESH:C564403	C05.651.515/C564403/614652|C10.597.350.090/C564403/614652|C10.597.613.593/C564403/614652|C18.452.660/C564403/614652|C23.550.695/C564403/614652|C23.888.592.350.090/C564403/614652|C23.888.592.608.593/C564403/614652	C05.651.515/C564403|C10.597.350.090/C564403|C10.597.613.593/C564403|C18.452.660/C564403|C23.550.695/C564403|C23.888.592.350.090/C564403|C23.888.592.608.593/C564403	COQ10D3	Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
COENZYME Q10 DEFICIENCY, PRIMARY, 5	OMIM:614654	DO:DOID:0070242		MESH:C564403	C05.651.515/C564403/614654|C10.597.350.090/C564403/614654|C10.597.613.593/C564403/614654|C18.452.660/C564403/614654|C23.550.695/C564403/614654|C23.888.592.350.090/C564403/614654|C23.888.592.608.593/C564403/614654	C05.651.515/C564403|C10.597.350.090/C564403|C10.597.613.593/C564403|C18.452.660/C564403|C23.550.695/C564403|C23.888.592.350.090/C564403|C23.888.592.608.593/C564403	COQ10D5	Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
COENZYME Q10 DEFICIENCY, PRIMARY, 6	OMIM:614650	DO:DOID:0070243		MESH:C564403	C05.651.515/C564403/614650|C10.597.350.090/C564403/614650|C10.597.613.593/C564403/614650|C18.452.660/C564403/614650|C23.550.695/C564403/614650|C23.888.592.350.090/C564403/614650|C23.888.592.608.593/C564403/614650	C05.651.515/C564403|C10.597.350.090/C564403|C10.597.613.593/C564403|C18.452.660/C564403|C23.550.695/C564403|C23.888.592.350.090/C564403|C23.888.592.608.593/C564403	COQ10D6	Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
COENZYME Q10 DEFICIENCY, PRIMARY, 7	OMIM:616276	DO:DOID:0070244		MESH:C564403	C05.651.515/C564403/616276|C10.597.350.090/C564403/616276|C10.597.613.593/C564403/616276|C18.452.660/C564403/616276|C23.550.695/C564403/616276|C23.888.592.350.090/C564403/616276|C23.888.592.608.593/C564403/616276	C05.651.515/C564403|C10.597.350.090/C564403|C10.597.613.593/C564403|C18.452.660/C564403|C23.550.695/C564403|C23.888.592.350.090/C564403|C23.888.592.608.593/C564403	COQ10D7	Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
COENZYME Q10 DEFICIENCY, PRIMARY, 8	OMIM:616733	DO:DOID:0070245		MESH:C564403	C05.651.515/C564403/616733|C10.597.350.090/C564403/616733|C10.597.613.593/C564403/616733|C18.452.660/C564403/616733|C23.550.695/C564403/616733|C23.888.592.350.090/C564403/616733|C23.888.592.608.593/C564403/616733	C05.651.515/C564403|C10.597.350.090/C564403|C10.597.613.593/C564403|C18.452.660/C564403|C23.550.695/C564403|C23.888.592.350.090/C564403|C23.888.592.608.593/C564403	COQ10D8	Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Cogan Syndrome	MESH:D055952	DO:DOID:0060216	A condition consisting of inflammatory eye disease usually presenting as interstitial KERATITIS, vestibuloauditory dysfunction, and large- to medium-vessel vasculitis.	MESH:D000160|MESH:D005128|MESH:D014657	C10.292.910.299|C11.180|C14.907.940.320	C10.292.910|C11|C14.907.940	Cogan's Syndrome|Cogans Syndrome|Syndrome, Cogan|Syndrome, Cogans|Syndrome, Cogan's	Cardiovascular disease|Eye disease|Nervous system disease
Coinfection	MESH:D060085		Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.	MESH:D007239	C01.218	C01	Co infection|Co-infection|Coinfections|Co-infections|Infection, Mixed|Infection, Polymicrobial|Infection, Secondary|Infections, Mixed|Infections, Polymicrobial|Infections, Secondary|Mixed Infection|Mixed Infections|Polymicrobial Infection|Polymicrobial Infections|Secondary Infection|Secondary Infections	
Colitis-Associated Neoplasms	MESH:D000083023		Colonic neoplasms associated with chronic inflammation conditions such as ULCERATIVE COLITIS and CROHN DISEASE.	MESH:D003110	C04.588.274.476.411.307.180.400|C06.301.371.411.307.180.400|C06.405.249.411.307.180.400|C06.405.469.158.356.180.400|C06.405.469.491.307.180.400	C04.588.274.476.411.307.180|C06.301.371.411.307.180|C06.405.249.411.307.180|C06.405.469.158.356.180|C06.405.469.491.307.180	Cancer, Colitis-Associated Colon|Cancer, Colitis-Associated Colorectal|Colitis Associated Cancer|Colitis-Associated Cancer|Colitis-Associated Cancers|Colitis Associated Colon Cancer|Colitis-Associated Colon Cancer|Colitis-Associated Colon Cancers|Colitis Associated Colorectal Cancer|Colitis-Associated Colorectal Cancer|Colitis-Associated Colorectal Cancers|Colitis-Associated Neoplasm|Colitis Associated Neoplasms|Colon Cancer, Colitis-Associated|Colorectal Cancer, Colitis-Associated|Neoplasm, Colitis-Associated	Cancer|Digestive system disease
Colitis, Ischemic	MESH:D017091	DO:DOID:0060181	Inflammation of the COLON due to colonic ISCHEMIA resulting from alterations in systemic circulation or local vasculature.	MESH:D003092|MESH:D014652	C06.405.205.265.115|C06.405.469.158.188.115|C14.907.286	C06.405.205.265|C06.405.469.158.188|C14.907	Ischemic Colitis	Cardiovascular disease|Digestive system disease
Collagen Diseases	MESH:D003095	DO:DOID:854	Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that 'collagen' was equivalent to 'connective tissue', but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term 'collagen diseases' now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed, p1494)	MESH:D003240	C17.300.200	C17.300	Collagen Disease|Disease, Collagen|Diseases, Collagen	Connective tissue disease
Collagenous Sprue	MESH:D064068		A malabsorption syndrome characterized by collagenous mucosal lesions of the SMALL INTESTINE, atrophy of MICROVILLI, severe malabsorption, diarrhea, and MALNUTRITION often refractory to a gluten-free diet.	MESH:D008286	C06.405.469.637.378|C18.452.603.314	C06.405.469.637|C18.452.603	Collagenous Sprues|Sprue, Collagenous|Sprues, Collagenous	Digestive system disease|Metabolic disease
Colles' Fracture	MESH:D003100		Fracture of the lower end of the radius in which the lower fragment is displaced posteriorly.	MESH:D000072039|MESH:D011885	C05.550.518.336.500|C26.289.336.500|C26.404.562.356	C05.550.518.336|C26.289.336|C26.404.562	Colles Fracture|Fracture, Colles'	Musculoskeletal disease|Wounds and injuries
Colloid Cysts	MESH:D056364		Benign, congenital, neuroepithelial cysts that are typically filled with a viscous mucus. They usually arise in the anterior portion of the THIRD VENTRICLE between the fornices.	MESH:D003560|MESH:D020863	C04.182.199|C04.588.614.250.387.200|C10.500.142.200|C10.551.240.375.200|C16.131.666.142.200	C04.182|C04.588.614.250.387|C10.500.142|C10.551.240.375|C16.131.666.142	Colloid Cyst|Cyst, Colloid|Cysts, Colloid	Cancer|Congenital abnormality|Nervous system disease
Colloid cysts of third ventricle	MESH:C535966			MESH:D056364	C04.182.199/C535966|C04.588.614.250.387.200/C535966|C10.500.142.200/C535966|C10.551.240.375.200/C535966|C16.131.666.142.200/C535966	C04.182.199|C04.588.614.250.387.200|C10.500.142.200|C10.551.240.375.200|C16.131.666.142.200	Neuroepithelial cysts of third ventricle	Cancer|Congenital abnormality|Nervous system disease
Colonic Neoplasms	MESH:D003110	DO:DOID:219|DO:DOID:234|DO:DOID:235	Tumors or cancer of the COLON.	MESH:D015179	C04.588.274.476.411.307.180|C06.301.371.411.307.180|C06.405.249.411.307.180|C06.405.469.158.356.180|C06.405.469.491.307.180	C04.588.274.476.411.307|C06.301.371.411.307|C06.405.249.411.307|C06.405.469.158.356|C06.405.469.491.307	Adenocarcinoma, Colon|Adenocarcinomas, Colon|Cancer, Colon|Cancer, Colonic|Cancer of Colon|Cancer of the Colon|Cancers, Colon|Cancers, Colonic|Colon Adenocarcinoma|Colon Adenocarcinomas|Colon Cancer|Colon Cancers|Colonic Cancer|Colonic Cancers|Colonic Neoplasm|Colon Neoplasm|Colon Neoplasms|Neoplasm, Colon|Neoplasm, Colonic|Neoplasms, Colon|Neoplasms, Colonic	Cancer|Digestive system disease
Colonic Varices without Portal Hypertension	MESH:C565172			MESH:D014648	C14.907.927/C565172	C14.907.927		Cardiovascular disease
Colorado Tick Fever	MESH:D003121	DO:DOID:4885	A febrile illness characterized by chills, aches, vomiting, leukopenia, and sometimes encephalitis. It is caused by the COLORADO TICK FEVER VIRUS, a reovirus transmitted by the tick Dermacentor andersoni.	MESH:D001102|MESH:D012088|MESH:D017282	C01.920.930.200|C01.925.081.234|C01.925.782.791.482	C01.920.930|C01.925.081|C01.925.782.791	Fever, Colorado Tick|Tick Fever, Colorado	Viral disease
COLORBLINDNESS, PARTIAL, DEUTAN SERIES	OMIM:303800	DO:DOID:13909		MESH:D003117	C10.597.751.941.256/303800|C11.270.151.500/303800|C11.966.256/303800|C23.888.592.763.941.256/303800	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	CBD|DCB|DEUTAN COLORBLINDNESS|DEUTERANOPIA|GREEN COLORBLINDNESS DEUTERANOMALY, INCLUDED	Eye disease|Nervous system disease|Signs and symptoms
COLORBLINDNESS, PARTIAL, PROTAN SERIES	OMIM:303900	DO:DOID:13910		MESH:D003117	C10.597.751.941.256/303900|C11.270.151.500/303900|C11.966.256/303900|C23.888.592.763.941.256/303900	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	CBP|PROTANOPIA|RED COLORBLINDNESS  PROTANOMALY, INCLUDED	Eye disease|Nervous system disease|Signs and symptoms
Colorblindness, Partial Tritanomaly	MESH:C564440			MESH:D003117	C10.597.751.941.256/C564440|C11.270.151.500/C564440|C11.966.256/C564440|C23.888.592.763.941.256/C564440	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	Tritanomalous Colorblindness	Eye disease|Nervous system disease|Signs and symptoms
Colorectal Neoplasms	MESH:D015179	DO:DOID:0080199|DO:DOID:9256|OMIM:114500|OMIM:608812|OMIM:611469|OMIM:612229|OMIM:612230|OMIM:612231|OMIM:612232|OMIM:612589|OMIM:612590|OMIM:612591|OMIM:612592|OMIM:615083	Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.	MESH:D003108|MESH:D007414|MESH:D012002	C04.588.274.476.411.307|C06.301.371.411.307|C06.405.249.411.307|C06.405.469.158.356|C06.405.469.491.307|C06.405.469.860.180	C04.588.274.476.411|C06.301.371.411|C06.405.249.411|C06.405.469.158|C06.405.469.491|C06.405.469.860	Cancer, Colorectal|Cancers, Colorectal|Carcinoma, Colorectal|Carcinomas, Colorectal|COLON CANCER|COLORECTAL ADENOMA AND CANCER, SUSCEPTIBILITY TO|Colorectal Cancer|Colorectal Cancers|COLORECTAL CANCER, SUSCEPTIBILITY TO, 1|COLORECTAL CANCER, SUSCEPTIBILITY TO, 10|COLORECTAL CANCER, SUSCEPTIBILITY TO, 11|COLORECTAL CANCER, SUSCEPTIBILITY TO, 12|COLORECTAL CANCER, SUSCEPTIBILITY TO, 2|COLORECTAL CANCER, SUSCEPTIBILITY TO, 3|COLORECTAL CANCER, SUSCEPTIBILITY TO, 5|COLORECTAL CANCER, SUSCEPTIBILITY TO, 6|COLORECTAL CANCER, SUSCEPTIBILITY TO, 7|COLORECTAL CANCER, SUSCEPTIBILITY TO, 8|COLORECTAL CANCER, SUSCEPTIBILITY TO, 9|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 10|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 11|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 12q24|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 14q|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 16q|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 18|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 19q|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 20p|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 8q23|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 8q24|COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 9|Colorectal Carcinoma|Colorectal Carcinomas|Colorectal Neoplasm|Colorectal Tumor|Colorectal Tumors|CRC|CRCS1|CRCS10|CRCS11|CRCS12|CRCS2|CRCS3|CRCS5|CRCS6|CRCS7|CRCS8|CRCS9|Neoplasm, Colorectal|Neoplasms, Colorectal|Tumor, Colorectal|Tumors, Colorectal	Cancer|Digestive system disease
Color Vision Defects	MESH:D003117	DO:DOID:11661|DO:DOID:13399|DO:DOID:13909|DO:DOID:13910|DO:DOID:13911|DO:DOID:13912	Defects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue.	MESH:D000077765|MESH:D014786	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	C10.597.751.941|C11.270.151|C11.966|C23.888.592.763.941	Achromatopsia|Achromatopsias|Acquired Color Blindness|Blindness, Color|Blue Color Blindness|Color Blindness|Color Blindness, Acquired|Color Blindness, Blue|Color Blindness, Green|Color Blindness, Inherited|Color Blindness, Red|Color Blindness, Red Green|Color Blindness, Red-Green|Color Vision Defect|Color Vision Deficiencies|Color Vision Deficiency|Defect, Color Vision|Defect, Deutan|Defects, Color Vision|Deficiencies, Color Vision|Deficiency, Color Vision|Deutan Defect|Green Color Blindness|Inherited Color Blindness|Monochromatopsia|Protan Defect|Red Color Blindness|Red-Green Color Blindness|Tritan Defect|Vision Defect, Color|Vision Defects, Color|Vision Deficiencies, Color|Vision Deficiency, Color	Eye disease|Nervous system disease|Signs and symptoms
Colpocephaly	MESH:C535973			MESH:D001927	C10.228.140/C535973	C10.228.140		Nervous system disease
Coma	MESH:D003128		A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.	MESH:D014474	C10.597.606.358.800.200|C23.888.592.604.359.800.200	C10.597.606.358.800|C23.888.592.604.359.800	Comas|Comatose|Pseudocoma|Pseudocomas	Nervous system disease|Signs and symptoms
Coma, Post-Head Injury	MESH:D020207		Prolonged unconsciousness from which the individual cannot be aroused, associated with traumatic injuries to the BRAIN. This may be defined as unconsciousness persisting for 6 hours or longer. Coma results from injury to both cerebral hemispheres or the RETICULAR FORMATION of the BRAIN STEM. Contributing mechanisms include DIFFUSE AXONAL INJURY and BRAIN EDEMA. (From J Neurotrauma 1997 Oct;14(10):699-713)	MESH:D003128|MESH:D006259	C10.597.606.358.800.200.200|C10.900.300.175|C26.915.300.350	C10.597.606.358.800.200|C10.900.300|C26.915.300	Coma, Post Concussive|Coma, Post-Concussive|Coma, Post Head Injury|Coma, Post Trauma|Coma, Post-Trauma|Coma, Post Traumatic|Coma, Post-Traumatic|Coma, Post-Traumatic, Prolonged|Comas, Post-Concussive|Comas, Post-Head Injury|Comas, Post-Trauma|Coma, Traumatic|Post-Concussive Coma|Post-Concussive Comas|Post Head Injury Coma|Post-Head Injury Coma|Post-Head Injury Comas|Post-Trauma Coma|Post-Trauma Comas|Post-Traumatic Coma|Traumatic Coma	Nervous system disease|Wounds and injuries
Combined Inflammatory and Immunologic Defect	MESH:C565684			MESH:D007153	C20.673/C565684	C20.673		Immune system disease
Combined Oxidative Phosphorylation Deficiency 3	MESH:C566467	DO:DOID:0111486|OMIM:610505		MESH:D000140|MESH:D009123|MESH:D017240	C05.651.460/C566467|C10.597.613.575/C566467|C10.668.491.500/C566467|C18.452.076.176.180/C566467|C18.452.660.560/C566467|C23.888.592.608.575/C566467	C05.651.460|C10.597.613.575|C10.668.491.500|C18.452.076.176.180|C18.452.660.560|C23.888.592.608.575	Concentric Cardiomyopathy, Hypotonia, And Lactic Acidosis|COXPD3|Encephalomyopathy, Respiratory Failure, And Lactic Acidosis	Metabolic disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6	OMIM:300816	DO:DOID:0111502		MESH:D017237	C05.651.460.620/300816|C10.228.140.163.540/300816|C10.668.491.500.500/300816|C18.452.132.540/300816|C18.452.660.560.620/300816	C05.651.460.620|C10.228.140.163.540|C10.668.491.500.500|C18.452.132.540|C18.452.660.560.620	COXPD6|ENCEPHALOMYOPATHY, MITOCHONDRIAL, X-LINKED	Metabolic disease|Musculoskeletal disease|Nervous system disease
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7	OMIM:613559	DO:DOID:0111487		MESH:D017237	C05.651.460.620/613559|C10.228.140.163.540/613559|C10.668.491.500.500/613559|C18.452.132.540/613559|C18.452.660.560.620/613559	C05.651.460.620|C10.228.140.163.540|C10.668.491.500.500|C18.452.132.540|C18.452.660.560.620	COXPD7	Metabolic disease|Musculoskeletal disease|Nervous system disease
Combined Pituitary Hormone Deficiency	MESH:C580003	DO:DOID:9410|OMIM:613986		MESH:D007018	C10.228.140.617.738.300/C580003|C19.700.482/C580003	C10.228.140.617.738.300|C19.700.482	CPHD6|Panhypopituitarism|PITUITARY HORMONE DEFICIENCY, COMBINED, 6	Endocrine system disease|Nervous system disease
Common Bile Duct Neoplasms	MESH:D003138	DO:DOID:4608	Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.	MESH:D001650|MESH:D003137	C04.588.274.120.250.250|C06.130.120.120.280|C06.130.120.250.280|C06.130.320.120.280|C06.301.120.250.250	C04.588.274.120.250|C06.130.120.120|C06.130.120.250|C06.130.320.120|C06.301.120.250		Cancer|Digestive system disease
Common Cold	MESH:D003139	DO:DOID:10459	A catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. It generally involves a runny nose, nasal congestion, and sneezing.	MESH:D010850|MESH:D012141	C01.748.162|C01.925.782.687.207|C08.730.162	C01.748|C01.925.782.687|C08.730	Acute Coryza|Catarrh|Catarrhs|Cold, Common|Colds, Common|Common Colds|Coryza, Acute	Respiratory tract disease|Viral disease
Common Variable Immunodeficiency	MESH:D017074	DO:DOID:12177|OMIM:240500|OMIM:607594|OMIM:613493|OMIM:613494|OMIM:613495|OMIM:613496|OMIM:614699|OMIM:615577|OMIM:615767|OMIM:616576|OMIM:616873	Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.	MESH:D007153	C20.673.330	C20.673	Acquired Hypogammaglobulinemia|Acquired Hypogammaglobulinemias|ANTIBODY DEFICIENCY DUE TO BAFFR DEFECT|ANTIBODY DEFICIENCY DUE TO CD19 DEFECT|ANTIBODY DEFICIENCY DUE TO CD20 DEFECT|ANTIBODY DEFICIENCY DUE TO CD81 DEFECT|ANTIBODY DEFICIENCY DUE TO ICOS DEFECT IMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED|ANTIBODY DEFICIENCY DUE TO TACI DEFECT|Common Variable Hypogammaglobulinemia|Common Variable Hypogammaglobulinemias|Common Variable Immune Deficiency|Common Variable Immunodeficiencies|CVID1|CVID10|CVID11|CVID12|CVID13|CVID2|CVID3|CVID4|CVID5|CVID6|CVID7|CVID, INCLUDED|DAVID|Deficiencies, Late-Onset Immunoglobulin|Deficiency, Late-Onset Immunoglobulin|DEFICIT IN ANTERIOR PITUITARY FUNCTION AND VARIABLE IMMUNODEFICIENCY|Hypogammaglobulinemia, Acquired|Hypogammaglobulinemia, Common Variable|HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY|Hypogammaglobulinemias, Acquired|Hypogammaglobulinemias, Common Variable|IL21 DEFICIENCY|Immunodeficiencies, Common Variable|Immunodeficiency, Common Variable|IMMUNODEFICIENCY, COMMON VARIABLE, 1|IMMUNODEFICIENCY, COMMON VARIABLE, 10|IMMUNODEFICIENCY, COMMON VARIABLE, 11|IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY|IMMUNODEFICIENCY, COMMON VARIABLE, 13|IMMUNODEFICIENCY, COMMON VARIABLE, 2|IMMUNODEFICIENCY, COMMON VARIABLE, 3|IMMUNODEFICIENCY, COMMON VARIABLE, 4|IMMUNODEFICIENCY, COMMON VARIABLE, 5|IMMUNODEFICIENCY, COMMON VARIABLE, 6|IMMUNODEFICIENCY, COMMON VARIABLE, 7|IMMUNODEFICIENCY, COMMON VARIABLE, WITH CENTRAL ADRENAL INSUFFICIENCY|Immunoglobulin Deficiencies, Late-Onset|Immunoglobulin Deficiency, Late Onset|Immunoglobulin Deficiency, Late-Onset|Late-Onset Immunoglobulin Deficiencies|Late-Onset Immunoglobulin Deficiency|NFKB1 DEFICIENCY|Variable Hypogammaglobulinemia, Common|Variable Hypogammaglobulinemias, Common	Immune system disease
Commotio Cordis	MESH:D056104		A sudden CARDIAC ARRHYTHMIA (e.g., VENTRICULAR FIBRILLATION) caused by a blunt, non-penetrating impact to the precordial region of chest wall. Commotio cordis often results in sudden death without prompt cardiopulmonary defibrillation.	MESH:D000071956|MESH:D001145	C14.280.067.441|C26.891.375.750.500|C26.974.250.875.500	C14.280.067|C26.891.375.750|C26.974.250.875	Cardiac Concussion|Cardiac Concussions|Concussion, Cardiac|Concussions, Cardiac	Cardiovascular disease|Wounds and injuries
Community-Acquired Infections	MESH:D017714		Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.	MESH:D007239	C01.234	C01	Acquired Infection, Community|Acquired Infections, Community|Community Acquired Infection|Community-Acquired Infection|Community Acquired Infections|Infection, Community Acquired|Infection, Community-Acquired|Infections, Community Acquired|Infections, Community-Acquired	
Compartment Syndromes	MESH:D003161	DO:DOID:682	Conditions in which increased pressure within a limited space compromises the BLOOD CIRCULATION and function of tissue within that space. Some of the causes of increased pressure are TRAUMA, tight dressings, HEMORRHAGE, and exercise. Sequelae include nerve compression (NERVE COMPRESSION SYNDROMES); PARALYSIS; and ISCHEMIC CONTRACTURE. FASCIOTOMY is often used to decompress increased pressure and eliminate pain associated with compartment syndromes.	MESH:D009135|MESH:D014652	C05.651.180|C14.907.303	C05.651|C14.907	Compartment Syndrome	Cardiovascular disease|Musculoskeletal disease
COMPLEMENT COMPONENT 2 DEFICIENCY	OMIM:217000	DO:DOID:0060295		MESH:D007153	C20.673/217000	C20.673	C2D|C2 DEFICIENCY	Immune system disease
COMPLEMENT COMPONENT 4B DEFICIENCY	OMIM:614379	DO:DOID:0060298		MESH:D007153	C20.673/614379	C20.673	C4BD|C4B DEFICIENCY	Immune system disease
COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I	OMIM:613790	DO:DOID:0060301		MESH:D007105	C20.543.520/613790	C20.543.520	C8AG DEFICIENCY|C8 ALPHA-GAMMA DEFICIENCY|C8D1|C8 DEFICIENCY, TYPE I	Immune system disease
COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II	OMIM:613789	DO:DOID:0060302		MESH:D007105	C20.543.520/613789	C20.543.520	C8B DEFICIENCY|C8 BETA DEFICIENCY|C8D2|C8 DEFICIENCY, TYPE II|COMPLEMENT COMPONENT 8B DEFICIENCY	Immune system disease
COMPLEMENT COMPONENT C1r/C1s DEFICIENCY	OMIM:216950			MESH:D007153	C20.673/216950	C20.673	C1r/C1s DEFICIENCY	Immune system disease
COMPLEMENT FACTOR B DEFICIENCY	OMIM:615561			MESH:D007153	C20.673/615561	C20.673	CFBD	Immune system disease
Complete atrioventricular septal defect	MESH:C535974			MESH:D006343	C14.240.400.560/C535974|C14.280.400.560/C535974|C16.131.240.400.560/C535974	C14.240.400.560|C14.280.400.560|C16.131.240.400.560	Common atrioventricular canal|Complete atrioventricular canal	Cardiovascular disease|Congenital abnormality
Complex Regional Pain Syndromes	MESH:D020918	DO:DOID:3223	Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity (i.e., changes in sweating due to altered sympathetic innervation) or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; (REFLEX SYMPATHETIC DYSTROPHY) and type II; (CAUSALGIA). (From Pain 1995 Oct;63(1):127-33)	MESH:D001342|MESH:D010523	C10.177.195|C10.668.829.250	C10.177|C10.668.829	Complex Regional Pain Syndrome|CRPS (Complex Regional Pain Syndromes)|Pain Syndromes, Regional Complex	Nervous system disease
Composite Lymphoma	MESH:D058617	DO:DOID:5820	Two or more distinct types of malignant lymphoid tumors occurring within a single organ or tissue at the same time. It may contain different types of non-Hodgkin lymphoma cells or both Hodgkin and non-Hodgkin lymphoma cells.	MESH:D008223|MESH:D018193	C04.557.386.150|C04.557.435.295|C15.604.515.569.150|C20.683.515.761.150	C04.557.386|C04.557.435|C15.604.515.569|C20.683.515.761	Composite Lymphomas|Lymphoma, Composite|Lymphomas, Composite	Cancer|Immune system disease|Lymphatic disease
Condylomata Acuminata	MESH:D003218	DO:DOID:11168	Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses.	MESH:D014860|MESH:D015229	C01.221.812.640.220|C01.778.640.220|C01.925.256.650.810.217|C01.925.813.220|C01.925.825.810.110|C01.925.928.914.217|C12.100.937.640.220|C17.800.838.790.810.110	C01.221.812.640|C01.778.640|C01.925.256.650.810|C01.925.813|C01.925.825.810|C01.925.928.914|C12.100.937.640|C17.800.838.790.810	Genital Wart|Genital Warts|Venereal Wart|Venereal Warts|Wart, Genital|Warts, Genital|Warts, Venereal|Wart, Venereal	Skin disease|Viral disease
Cone Dystrophy	MESH:D000077765	DO:DOID:0050795	A general term which describes a group of rare eye disorders that affect the cone cells of the RETINA. Cone dystrophy can cause a variety of symptoms including decreased visual clarity or acuity when looking straight ahead (central vision), a reduced ability to see colors, and an increased sensitivity to light (PHOTOPHOBIA).	MESH:D012164|MESH:D015785	C11.270.151|C11.768.216	C11.270|C11.768	Cone Dystrophies|Cone Dystrophies, Progressive|Cone Dystrophies, Stationary|Cone Dystrophy, Progressive|Cone Dystrophy, Stationary|Dystrophies, Cone|Dystrophies, Progressive Cone|Dystrophies, Stationary Cone|Dystrophy, Cone|Dystrophy, Progressive Cone|Dystrophy, Stationary Cone|Progressive Cone Dystrophies|Progressive Cone Dystrophy|Stationary Cone Dystrophies|Stationary Cone Dystrophy	Eye disease
CONE-ROD DYSTROPHY 15	OMIM:613660	DO:DOID:0111021		MESH:D058499	C11.768.585.658/613660	C11.768.585.658	CORD15|RETINITIS PIGMENTOSA 65, INCLUDED|RP65, INCLUDED	Eye disease
CONE-ROD DYSTROPHY 9	OMIM:612775	DO:DOID:0111020		MESH:D058499	C11.768.585.658/612775	C11.768.585.658	CORD9	Eye disease
CONE-ROD DYSTROPHY, X-LINKED, 1	OMIM:304020	DO:DOID:0111008		MESH:D058499	C11.768.585.658/304020	C11.768.585.658	COD1, INCLUDED|CONE DYSTROPHY 1, X-LINKED, INCLUDED|CORDX1	Eye disease
CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE	OMIM:610427			MESH:D009755	C11.966.671/610427	C11.966.671	CRSD|CSNB2B, FORMERLY|NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE, FORMERLY|NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY	Eye disease
Confusion	MESH:D003221		A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation.	MESH:D019954	C10.597.606.337|C23.888.592.604.339	C10.597.606|C23.888.592.604	Bewilderment|Confusional State|Confusional States|Confusion, Post Ictal|Confusion, Post-Ictal|Confusion, Reactive|Disorientation|Post-Ictal Confusion|Reactive Confusion|State, Confusional|States, Confusional	Nervous system disease|Signs and symptoms
Congenital agenesis of the tricuspid valve	MESH:C531836			MESH:D018785	C14.240.400.920/C531836|C14.280.400.920/C531836|C14.280.484.845/C531836|C16.131.240.400.920/C531836	C14.240.400.920|C14.280.400.920|C14.280.484.845|C16.131.240.400.920		Cardiovascular disease|Congenital abnormality
Congenital amegakaryocytic thrombocytopenia	MESH:C535982	DO:DOID:0090118|OMIM:604498		MESH:D000080984|MESH:D013921	C15.378.140.855/C535982|C15.378.190.223.500/C535982|C16.614.183/C535982	C15.378.140.855|C15.378.190.223.500|C16.614.183	Amegakaryocytic Thrombocytopenia, Congenital|CAMT	Blood disease|Infant-newborn disease
Congenital anosmia	MESH:C535983	OMIM:107200		MESH:D000857	C10.597.751.600/C535983|C23.888.592.763.550/C535983	C10.597.751.600|C23.888.592.763.550	ANIC|Anosmia, Congenital|Anosmia, Isolated Congenital|Isolated congenital anosmia	Nervous system disease|Signs and symptoms
Congenital Bone Marrow Failure Syndromes	MESH:D000080984	OMIM:614675|OMIM:615715|OMIM:617052	Inherited syndromes characterized by deficiency or absence of various blood cells due to mutations that affect HEMATOPOIETIC STEM CELLS development and proliferation.	MESH:D000080983|MESH:D007232	C15.378.190.223.500|C16.614.183	C15.378.190.223|C16.614	BMFS1|BMFS2|BMFS3|BMF Syndrome, Inherited|BONE MARROW FAILURE SYNDROME 1|BONE MARROW FAILURE SYNDROME 2|BONE MARROW FAILURE SYNDROME 3|Bone Marrow Failure Syndromes, Congenital|Bone Marrow Failure Syndromes, Inherited|CBMFS|Congenital Bone Marrow Failure Syndrome|IBMFS|Inherited BMF Syndrome|Inherited BMF Syndromes|Inherited Bone Marrow Failure Syndrome|Inherited Bone Marrow Failure Syndromes	Blood disease|Infant-newborn disease
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION	OMIM:614482			MESH:D002386|MESH:D011596|MESH:D034381	C09.218.458.341/614482|C10.597.606.881/614482|C10.597.751.418.341/614482|C11.510.245/614482|C23.888.592.604.882/614482|C23.888.592.763.393.341/614482	C09.218.458.341|C10.597.606.881|C10.597.751.418.341|C11.510.245|C23.888.592.604.882|C23.888.592.763.393.341	CCHLND	Ear-nose-throat disease|Eye disease|Nervous system disease|Signs and symptoms
Congenital central hypoventilation syndrome	MESH:C536209	DO:DOID:0060731|OMIM:209880		MESH:D007040|MESH:D020182	C08.618.085.852.800/C536209|C08.618.846.565/C536209|C10.886.425.800.750.800/C536209|C23.888.852.638/C536209	C08.618.085.852.800|C08.618.846.565|C10.886.425.800.750.800|C23.888.852.638	Autonomic Control, Congenital Failure of|CCHS|CCHS1|Cchs With Hirschsprung Disease|CCHS WITH HIRSCHSPRUNG DISEASE, INCLUDED|Central Hypoventilation Syndrome, Congenital|CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1|Congenital failure of autonomic control|Congenital Ondine curse|Haddad Syndrome|HADDAD SYNDROME, INCLUDED|Idiopathic congenital central alveolar hypoventilation|OHD, INCLUDED|Ondine Curse, Congenital|ONDINE CURSE, CONGENITAL ONDINE-HIRSCHSPRUNG DISEASE, INCLUDED|Ondine-Hirschsprung Disease|Primary alveolar hypoventilation	Nervous system disease|Respiratory tract disease|Signs and symptoms
Congenital Deficiency of Pulmonary Surfactant Protein B	MESH:C553654			MESH:D011649	C08.381.719/C553654	C08.381.719	Congenital Surfactant Protein-B Deficiency|Pulmonary Surfactant Protein B, Deficiency of|Surfactant Protein B Deficiency	Respiratory tract disease
Congenital dislocation of the patella	MESH:C538081			MESH:D031222	C05.550.518.625/C538081|C26.289.625/C538081|C26.558.554.750/C538081	C05.550.518.625|C26.289.625|C26.558.554.750	Congenital patellar dislocation	Musculoskeletal disease|Wounds and injuries
Congenital Fibrosis of the Extraocular Muscles	MESH:C580012			MESH:D005355|MESH:D009886	C10.292.562.750/C580012|C10.597.622.447/C580012|C11.590.472/C580012|C23.550.355/C580012|C23.888.592.636.447/C580012	C10.292.562.750|C10.597.622.447|C11.590.472|C23.550.355|C23.888.592.636.447	Cfeom|Congenital External Ophthalmoplegia|Congenital Fibrosis of Extraocular Muscles|Congenital Fibrosis Syndrome|General Fibrosis Syndrome	Eye disease|Nervous system disease|Pathology (process)|Signs and symptoms
Congenital heart block	MESH:C535758	DO:DOID:990		MESH:D006327	C14.280.067.558/C535758|C14.280.123.500/C535758|C23.550.073.425/C535758	C14.280.067.558|C14.280.123.500|C23.550.073.425	Congenital complete heart block|Congenital Heart Block, Isolated|Familial congenital heart block|Heart Block, Congenital|Isolated Congenital Heart Block|Isolated Heart Block, Congenital	Cardiovascular disease|Pathology (process)
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	OMIM:617360	DO:DOID:0112247		MESH:D002658|MESH:D006330|MESH:D008607|MESH:D019066|MESH:D019465	C05.660.207/617360|C10.597.606.360/617360|C14.240.400/617360|C14.280.400/617360|C16.131.240.400/617360|C16.131.621.207/617360|C23.550.291.812/617360|C23.888.592.604.646/617360|F03.625.421/617360|F03.625.539/617360	C05.660.207|C10.597.606.360|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207|C23.550.291.812|C23.888.592.604.646|F03.625.421|F03.625.539	CHDFIDD	Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2	OMIM:614980			MESH:D006330	C14.240.400/614980|C14.280.400/614980|C16.131.240.400/614980	C14.240.400|C14.280.400|C16.131.240.400	CHTD2	Cardiovascular disease|Congenital abnormality
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4	OMIM:615779			MESH:D006330	C14.240.400/615779|C14.280.400/615779|C16.131.240.400/615779	C14.240.400|C14.280.400|C16.131.240.400	CHTD4	Cardiovascular disease|Congenital abnormality
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6	OMIM:613854	DO:DOID:0060772		MESH:D014188	C14.240.400.915/613854|C14.280.400.915/613854|C16.131.240.400.915/613854	C14.240.400.915|C14.280.400.915|C16.131.240.400.915	CHTD6|DTGA3, FORMERLY|TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3, FORMERLY	Cardiovascular disease|Congenital abnormality
Congenital, Hereditary, and Neonatal Diseases and Abnormalities	MESH:D009358		Diseases existing at birth and often before birth, or that develop during the first month of life (INFANT, NEWBORN, DISEASES), regardless of causation. Of these diseases, those characterized by structural deformities are termed CONGENITAL ABNORMALITIES.	MESH:C	C16	C	Congenital Disorder|Congenital Disorders|Disorder, Congenital|Disorders, Congenital|Neonatal Diseases and Abnormalities	
Congenital Hyperinsulinism	MESH:D044903	OMIM:256450|OMIM:601820	A familial, nontransient HYPOGLYCEMIA with defects in negative feedback of GLUCOSE-regulated INSULIN release. Clinical phenotypes include HYPOGLYCEMIA; HYPERINSULINEMIA; SEIZURES; COMA; and often large BIRTH WEIGHT. Several sub-types exist with the most common, type 1, associated with mutations on an ATP-BINDING CASSETTE TRANSPORTERS (subfamily C, member 8).	MESH:D006946|MESH:D007003|MESH:D007232|MESH:D010182	C06.689.150|C16.614.200|C18.452.394.968.250|C18.452.394.984.200	C06.689|C16.614|C18.452.394.968|C18.452.394.984	Congenital Hyperinsulinisms|Familial Hyperinsulinemic Hypoglycemia 1|Familial Hyperinsulinism|Familial Hyperinsulinisms|HHF1|HHF2|Hyperinsulinemia Hypoglycemia of Infancy|Hyperinsulinemic Hypoglycemia Due to Focal Adenomatous Hyperplasia|Hyperinsulinemic Hypoglycemia, Familial, 1|Hyperinsulinemic Hypoglycemia, Familial, 2|Hyperinsulinemic Hypoglycemia, Persistent|Hyperinsulinemic Hypoglycemias, Persistent|Hyperinsulinism, Congenital|Hyperinsulinism, Familial|HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS|Hyperinsulinism, Neonatal|Hyperinsulinisms, Congenital|Hyperinsulinisms, Familial|Hyperinsulinisms, Neonatal|Hypoglycemia, Hyperinsulinemic, of Infancy|Hypoglycemia, Persistent Hyperinsulinemic|Hypoglycemia, PHHI|Hypoglycemias, Persistent Hyperinsulinemic|Hypoglycemias, PHHI|Infancy Hyperinsulinemia Hypoglycemia|Infancy Hyperinsulinemia Hypoglycemias|Neonatal Hyperinsulinism|Neonatal Hyperinsulinisms|NESIDIOBLASTOSIS|NESIDIOBLASTOSIS OF PANCREAS|Persistent Hyperinsulinemia Hypoglycemia of Infancy|Persistent Hyperinsulinemic Hypoglycemia|PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY|Persistent Hyperinsulinemic Hypoglycemias|PHHI|PHHI Hypoglycemia|PHHI Hypoglycemias	Digestive system disease|Infant-newborn disease|Metabolic disease
Congenital hypertrichosis lanuginosa	MESH:C538389	OMIM:145700		MESH:D006983	C17.800.329.875/C538389	C17.800.329.875	Hypertrichosis lanuginosa congenita|Hypertrichosis lanuginosa universalis|Hypertrichosis universalis	Skin disease
Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi	MESH:C567863	OMIM:612918		MESH:D008067|MESH:D009139|MESH:D009506|MESH:D054079	C04.557.450.550.400/C567863|C04.557.665.560/C567863|C05.660/C567863|C14.240.850/C567863|C16.131.240.850/C567863|C16.131.621/C567863	C04.557.450.550.400|C04.557.665.560|C05.660|C14.240.850|C16.131.240.850|C16.131.621	Cloves Syndrome|Clove Syndrome|Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Skeletal-Spinal Abnormalities|CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, EPIDERMAL NEVI, AND SKELETAL/SPINAL ABNORMALITIES	Cancer|Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Congenital lobar emphysema	MESH:C535735			MESH:D011656	C08.381.495.389.750/C535735|C23.550.291.500.875.875/C535735	C08.381.495.389.750|C23.550.291.500.875.875	Emphysema, congenital lobar	Pathology (process)|Respiratory tract disease
Congenitally Corrected Transposition of the Great Arteries	MESH:D000080041		A rare heart defect that occurs when the HEART VENTRICLES and attached valves, the MITRAL VALVE and the TRICUSPID VALVE are reversed so that the AORTA and the PULMONARY ARTERY are connected to the wrong ventricle. Although the heart valves and the two great arteries, the PULMONARY ARTERY and the AORTA are transposed, the blood flows to the correct place because the ventricles are also reversed and therefore corrects the transposition. It often occurs with other structural heart abnormalities.	MESH:D014188	C14.240.400.915.150|C14.280.400.915.150|C16.131.240.400.915.150	C14.240.400.915|C14.280.400.915|C16.131.240.400.915	Congenitally Corrected Transposition|Congenitally Corrected Transposition of the Great Vessels|Congenitally Corrected Transpositions|Corrected Transposition, Congenitally|Transposition, Congenitally Corrected	Cardiovascular disease|Congenital abnormality
Congenital Methemoglobinemia	MESH:C580280			MESH:D008708	C15.378.619/C580280	C15.378.619		Blood disease
Congenital myasthenic syndrome with episodic apnea	MESH:C535759	OMIM:254210		MESH:D001049|MESH:D009157	C04.588.614.550.500/C535759|C04.730.856.490/C535759|C08.618.085/C535759|C10.114.656/C535759|C10.574.781.588/C535759|C10.668.758.725/C535759|C20.111.258.500/C535759|C23.888.852.130/C535759	C04.588.614.550.500|C04.730.856.490|C08.618.085|C10.114.656|C10.574.781.588|C10.668.758.725|C20.111.258.500|C23.888.852.130	CMS1A2, FORMERLY|CMS6|CMSEA|CMS Ia2, FORMERLY|Congenital myasthenic syndrome type 1a|Congenital Myasthenic Syndrome Type Ia|CONGENITAL MYASTHENIC SYNDROME TYPE Ia2, FORMERLY|FIM, FORMERLY|FIMG2, FORMERLY|Myasthenia familial infantile|Myasthenia, Familial Infantile|MYASTHENIA, FAMILIAL INFANTILE, FORMERLY|MYASTHENIA GRAVIS, FAMILIAL INFANTILE, 2, FORMERLY|MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC|Myasthenic syndrome congenital associated with episodic apnea|Myasthenic Syndrome, Congenital, Associated With Episodic Apnea|Myasthenic syndrome, presynaptic, congenital, associated with episodic apnea	Cancer|Immune system disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Congenital Plasminogen Deficiency	MESH:C580017	DO:DOID:0111592		MESH:D020147	C15.378.100.141/C580017	C15.378.100.141	Hypoplasminogenemia	Blood disease
Congenital tracheal stenosis	MESH:C000715347			MESH:D014135	C08.907.663/C000715347	C08.907.663		Respiratory tract disease
Conjunctival Diseases	MESH:D003229	DO:DOID:4251	Diseases involving the CONJUNCTIVA.	MESH:D005128	C11.187	C11	Conjunctival Disease|Disease, Conjunctival|Diseases, Conjunctival	Eye disease
Conjunctival Neoplasms	MESH:D003230	DO:DOID:5467	Tumors or cancer of the CONJUNCTIVA.	MESH:D003229|MESH:D005134	C04.588.364.235|C11.187.169|C11.319.217	C04.588.364|C11.187|C11.319	Conjunctival Neoplasm|Neoplasm, Conjunctival|Neoplasms, Conjunctival	Cancer|Eye disease
Conjunctivitis	MESH:D003231	DO:DOID:6195	INFLAMMATION of the CONJUNCTIVA.	MESH:D003229	C11.187.183	C11.187	Conjunctivitides|Pink Eye|Pink Eyes	Eye disease
Conjunctivitis, Acute Hemorrhagic	MESH:D003232	DO:DOID:11227	A highly contagious disease characterized by subconjunctival hemorrhage, sudden swelling of the eyelids and congestion, redness, and pain in the eye. Epidemic conjunctivitis caused by Enterovirus 70 (EV-70) was first described in Africa in 1969. It is caused also by Coxsackievirus A24 variant (CA24v). Epidemics by this organism have appeared most frequently in Asia.	MESH:D003236|MESH:D004769	C01.375.725.250.250|C01.925.325.250.250|C01.925.782.687.359.201|C11.187.183.240.216|C11.294.800.250.250	C01.375.725.250|C01.925.325.250|C01.925.782.687.359|C11.187.183.240|C11.294.800.250	Acute Hemorrhagic Conjunctivitides|Acute Hemorrhagic Conjunctivitis|Conjunctivitides, Acute Hemorrhagic|Hemorrhagic Conjunctivitides, Acute|Hemorrhagic Conjunctivitis, Acute	Eye disease|Viral disease
Conjunctivitis, Allergic	MESH:D003233	DO:DOID:11204|DO:DOID:2457|DO:DOID:2474	Conjunctivitis due to hypersensitivity to various allergens.	MESH:D003231|MESH:D006969	C11.187.183.200|C20.543.480.200	C11.187.183|C20.543.480	Allergic Conjunctivitides|Allergic Conjunctivitis|Atopic Conjunctivitides|Atopic Conjunctivitis|Conjunctivitides, Allergic|Conjunctivitides, Atopic|Conjunctivitides, Giant Papillary|Conjunctivitides, Vernal|Conjunctivitis, Atopic|Conjunctivitis, Giant Papillary|Conjunctivitis, Vernal|Giant Papillary Conjunctivitides|Giant Papillary Conjunctivitis|Keratoconjunctivitides, Vernal|Keratoconjunctivitis, Vernal|Papillary Conjunctivitides, Giant|Papillary Conjunctivitis, Giant|Vernal Conjunctivitides|Vernal Conjunctivitis|Vernal Keratoconjunctivitides|Vernal Keratoconjunctivitis	Eye disease|Immune system disease
Conjunctivitis, Viral	MESH:D003236		Inflammation, often mild, of the conjunctiva caused by a variety of viral agents. Conjunctival involvement may be part of a systemic infection.	MESH:D003231|MESH:D015828	C01.375.725.250|C01.925.325.250|C11.187.183.240|C11.294.800.250	C01.375.725|C01.925.325|C11.187.183|C11.294.800	Conjunctivitides, Viral|Viral Conjunctivitides|Viral Conjunctivitis	Eye disease|Viral disease
Connective Tissue Diseases	MESH:D003240	DO:DOID:65	A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.	MESH:D017437	C17.300	C17	Connective Tissue Disease|Disease, Connective Tissue|Diseases, Connective Tissue	Connective tissue disease
Connective Tissue Nevus	MESH:C562737			MESH:D009506	C04.557.665.560/C562737	C04.557.665.560		Cancer
Conotruncal cardiac defects	MESH:C535464			MESH:D006330	C14.240.400/C535464|C14.280.400/C535464|C16.131.240.400/C535464	C14.240.400|C14.280.400|C16.131.240.400	Conotruncal heart malformations	Cardiovascular disease|Congenital abnormality
CONOTRUNCAL HEART MALFORMATIONS	OMIM:217095	DO:DOID:6406		MESH:C535464|MESH:D004310|MESH:D014339	C14.240.400.560.098.500/217095|C14.240.400.560.540.500/217095|C14.240.400.915.300/217095|C14.240.400/C535464/217095|C14.280.400.560.098.500/217095|C14.280.400.560.540.500/217095|C14.280.400.915.300/217095|C14.280.400/C535464/217095|C16.131.240.400.560.098.500/217095|C16.131.240.400.560.540.500/217095|C16.131.240.400.915.300/217095|C16.131.240.400/C535464/217095	C14.240.400.560.098.500|C14.240.400.560.540.500|C14.240.400.915.300|C14.240.400/C535464|C14.280.400.560.098.500|C14.280.400.560.540.500|C14.280.400.915.300|C14.280.400/C535464|C16.131.240.400.560.098.500|C16.131.240.400.560.540.500|C16.131.240.400.915.300|C16.131.240.400/C535464	CAFS, INCLUDED|CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED|CTHM|DORV, INCLUDED|DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED|INTERRUPTED AORTIC ARCH, INCLUDED|PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED|PTA, INCLUDED|TRUNCUS ARTERIOSUS COMMUNIS, INCLUDED	Cardiovascular disease|Congenital abnormality
Continuous diaphragm sign	MESH:C000721367			MESH:D011026	C14.280.763/C000721367	C14.280.763		Cardiovascular disease
Continuous Muscle Fiber Activity, Hereditary	MESH:C563545			MESH:D020385	C10.597.613.650/C563545|C23.888.592.608.650/C563545	C10.597.613.650|C23.888.592.608.650		Nervous system disease|Signs and symptoms
Contracture	MESH:D003286		Prolonged shortening of the muscle or other soft tissue around a joint, preventing movement of the joint.	MESH:D007592|MESH:D009135	C05.550.323|C05.651.197	C05.550|C05.651	Contractures	Musculoskeletal disease
Contrecoup Injury	MESH:D056886		An injury in which the damage is located on the opposite side of the primary impact site. A blow to the back of head which results in contrecoup injury to the frontal lobes of the brain is the most common type.	MESH:D001924|MESH:D014947	C10.900.300.350.300.250|C26.224|C26.915.300.450.500.250|C26.974.382.200.250	C10.900.300.350.300|C26|C26.915.300.450.500|C26.974.382.200	Contre-coup Injuries|Contrecoup Injuries|Contre coup Injury|Contre-coup Injury|Injuries, Contrecoup|Injuries, Contre-coup|Injury, Contrecoup|Injury, Contre-coup	Nervous system disease|Wounds and injuries
Convulsions, Benign Familial Infantile, 2	MESH:C565296			MESH:D013036	C10.228.140.490.375.760/C565296|C10.228.140.490.493.875/C565296	C10.228.140.490.375.760|C10.228.140.490.493.875	Seizures, Benign Familial Infantile, 2	Nervous system disease
Coracoclavicular Joint, Anomalous	MESH:C565161			MESH:D007592	C05.550/C565161	C05.550		Musculoskeletal disease
Corneal Diseases	MESH:D003316	DO:DOID:10124	Diseases of the cornea.	MESH:D005128	C11.204	C11	Corneal Disease|Disease, Corneal|Diseases, Corneal	Eye disease
Corneal dystrophy, epithelial basement membrane	MESH:C535477	DO:DOID:0060447|OMIM:121820		MESH:D055952	C10.292.910.299/C535477|C11.180/C535477|C14.907.940.320/C535477	C10.292.910.299|C11.180|C14.907.940.320	Cogan corneal dystrophy|Corneal dystrophy, anterior basement membrane|Corneal dystrophy, Cogan type|Corneal Dystrophy, Map-Dot-Fingerprint Type|Corneal Dystrophy, Microcystic|EBMD|Map-dot-fingerprint dystrophy of cornea|Microcystic dystrophy of the cornea	Cardiovascular disease|Eye disease|Nervous system disease
Corneal Edema	MESH:D015715	DO:DOID:11030	An excessive amount of fluid in the cornea due to damage of the epithelium or endothelium causing decreased visual acuity.	MESH:D003316	C11.204.267	C11.204	Corneal Edemas|Edema, Corneal|Edemas, Corneal	Eye disease
Corneal Endothelial Cell Loss	MESH:D055954		Loss of CORNEAL ENDOTHELIUM usually following intraocular surgery (e.g., cataract surgery) or due to FUCHS' ENDOTHELIAL DYSTROPHY; ANGLE-CLOSURE GLAUCOMA; IRITIS; or aging.	MESH:D003316|MESH:D005132|MESH:D011183	C11.204.278|C11.300.250|C23.550.767.093|C23.888.307.250	C11.204|C11.300|C23.550.767|C23.888.307	Corneal Endothelial Cell Damage|Endothelial Cell Loss, Corneal	Eye disease|Pathology (process)|Signs and symptoms
Corneal hypesthesia, familial	MESH:C536440			MESH:D003316|MESH:D006987	C10.597.751.791.500/C536440|C11.204/C536440|C23.888.592.763.770.500/C536440	C10.597.751.791.500|C11.204|C23.888.592.763.770.500	Trigeminal anesthesia, familial	Eye disease|Nervous system disease|Signs and symptoms
Corneal Injuries	MESH:D065306		Damage or trauma inflicted to the CORNEA by external means.	MESH:D003316|MESH:D005131	C10.900.300.284.250.124|C11.204.284|C11.297.374|C26.915.300.425.250.124	C10.900.300.284.250|C11.204|C11.297|C26.915.300.425.250	Abrasion, Corneal|Cornea Injuries|Cornea Injury|Corneal Abrasion|Corneal Abrasions|Corneal Damage|Corneal Damages|Corneal Injury|Corneal Scar|Corneal Scars|Corneal Trauma|Corneal Traumas|Damage, Corneal|Injury, Cornea|Injury, Corneal|Scar, Corneal|Trauma, Corneal	Eye disease|Nervous system disease|Wounds and injuries
Corneal Neovascularization	MESH:D016510	DO:DOID:11382	New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.	MESH:D003316|MESH:D009389	C11.204.290|C23.550.589.500.435	C11.204|C23.550.589.500	Angiogenesis, Corneal|Corneal Angiogenesis|Corneal Neovascularizations|Neovascularization, Corneal|Neovascularizations, Corneal	Eye disease|Pathology (process)
Corneal Opacity	MESH:D003318		Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.	MESH:D003316	C11.204.299	C11.204	Corneal Opacities|Leukoma|Leukomas|Opacities, Corneal|Opacity, Corneal	Eye disease
Corneal Perforation	MESH:D057112		A puncture or hole through the CORNEAL STROMA resulting from various diseases or trauma.	MESH:D065306	C10.900.300.284.250.124.500|C11.204.284.500|C11.297.374.500|C26.915.300.425.250.124.500	C10.900.300.284.250.124|C11.204.284|C11.297.374|C26.915.300.425.250.124	Corneal Perforations|Perforation, Corneal|Perforations, Corneal	Eye disease|Nervous system disease|Wounds and injuries
Corneal Ulcer	MESH:D003320	DO:DOID:8463	Loss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection.	MESH:D007634|MESH:D015817	C01.375.177|C11.204.564.225|C11.294.177	C01.375|C11.204.564|C11.294	Keratitides, Ulcerative|Keratitis, Ulcerative|Ulcerative Keratitides|Ulcerative Keratitis|Ulcer, Corneal	Eye disease
Corneal Wavefront Aberration	MESH:D057108		Asymmetries in the topography and refractive index of the corneal surface that affect visual acuity.	MESH:D003316|MESH:D012030	C11.204.431|C11.744.345	C11.204|C11.744	Aberration, Corneal Wavefront|Aberrations, Corneal Wavefront|Corneal Wavefront Aberrations|Wavefront Aberration, Corneal|Wavefront Aberrations, Corneal	Eye disease
Coronary Aneurysm	MESH:D003323	DO:DOID:3362	Abnormal balloon- or sac-like dilatation in the wall of CORONARY VESSELS. Most coronary aneurysms are due to CORONARY ATHEROSCLEROSIS, and the rest are due to inflammatory diseases, such as KAWASAKI DISEASE.	MESH:D000783|MESH:D003327	C14.280.647.250.250|C14.907.055.395|C14.907.585.250.250	C14.280.647.250|C14.907.055|C14.907.585.250	Aneurysm, Coronary|Aneurysms, Coronary|Coronary Aneurysms	Cardiovascular disease
Coronary Artery Disease	MESH:D003324	DO:DOID:3393	Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.	MESH:D001161|MESH:D003327	C14.280.647.250.260|C14.907.137.126.339|C14.907.585.250.260	C14.280.647.250|C14.907.137.126|C14.907.585.250	Arterioscleroses, Coronary|Arteriosclerosis, Coronary|Artery Disease, Coronary|Artery Diseases, Coronary|Atheroscleroses, Coronary|Atherosclerosis, Coronary|Coronary Arterioscleroses|Coronary Arteriosclerosis|Coronary Artery Diseases|Coronary Atheroscleroses|Coronary Atherosclerosis|Left Main Coronary Artery Disease|Left Main Coronary Disease|Left Main Disease|Left Main Diseases	Cardiovascular disease
Coronary Artery Disease, Autosomal Dominant, 1	MESH:C564258	OMIM:608320		MESH:D003324|MESH:D009203	C14.280.647.250.260/C564258|C14.280.647.500/C564258|C14.907.137.126.339/C564258|C14.907.585.250.260/C564258|C14.907.585.500/C564258|C23.550.513.355.750/C564258|C23.550.717.489.750/C564258	C14.280.647.250.260|C14.280.647.500|C14.907.137.126.339|C14.907.585.250.260|C14.907.585.500|C23.550.513.355.750|C23.550.717.489.750	ADCAD1|Coronary Artery Disease With Myocardial Infarction	Cardiovascular disease|Pathology (process)
Coronary Artery Disease, Autosomal Dominant 2	MESH:C567045	OMIM:610947		MESH:D003324|MESH:D009203	C14.280.647.250.260/C567045|C14.280.647.500/C567045|C14.907.137.126.339/C567045|C14.907.585.250.260/C567045|C14.907.585.500/C567045|C23.550.513.355.750/C567045|C23.550.717.489.750/C567045	C14.280.647.250.260|C14.280.647.500|C14.907.137.126.339|C14.907.585.250.260|C14.907.585.500|C23.550.513.355.750|C23.550.717.489.750	ADCAD2	Cardiovascular disease|Pathology (process)
Coronary Artery Disease, Development of, in HIV	MESH:C563569			MESH:D003324|MESH:D015658	C01.221.250.875/C563569|C01.221.812.640.400/C563569|C01.778.640.400/C563569|C01.925.782.815.616.400/C563569|C01.925.813.400/C563569|C12.100.937.640.400/C563569|C14.280.647.250.260/C563569|C14.907.137.126.339/C563569|C14.907.585.250.260/C563569|C20.673.480/C563569	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C12.100.937.640.400|C14.280.647.250.260|C14.907.137.126.339|C14.907.585.250.260|C20.673.480		Cardiovascular disease|Immune system disease|Viral disease
Coronary Artery Dissection, Spontaneous	MESH:C565153			MESH:D003330|MESH:D014652	C14.240.400.210/C565153|C14.280.400.210/C565153|C14.907/C565153|C16.131.240.400.210/C565153	C14.240.400.210|C14.280.400.210|C14.907|C16.131.240.400.210		Cardiovascular disease|Congenital abnormality
Coronary Disease	MESH:D003327	DO:DOID:3393|OMIM:300464|OMIM:607339|OMIM:608316|OMIM:608318|OMIM:608901|OMIM:610938|OMIM:611139|OMIM:612030|OMIM:614466	An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.	MESH:D017202	C14.280.647.250|C14.907.585.250	C14.280.647|C14.907.585	CHDS1|CHDS2|CHDS3|CHDS4|CHDS5|CHDS6|CHDS7|CHDS8|CHDS9|CORONARY ARTERY DISEASE, EARLY-ONSET|Coronary Diseases|Coronary Heart Disease|Coronary Heart Diseases|CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1|CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2|CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3|CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4|CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5|CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6|CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7|CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8|CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9|Disease, Coronary|Disease, Coronary Heart|Diseases, Coronary|Diseases, Coronary Heart|Heart Disease, Coronary|Heart Diseases, Coronary	Cardiovascular disease
Coronary Occlusion	MESH:D054059		Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.	MESH:D003327	C14.280.647.250.272|C14.907.585.250.272	C14.280.647.250|C14.907.585.250	Coronary Occlusions|Occlusion, Coronary|Occlusions, Coronary	Cardiovascular disease
Coronary Restenosis	MESH:D023903	DO:DOID:4247	Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.	MESH:D023921	C14.280.647.250.285.200|C14.907.585.250.285.200	C14.280.647.250.285|C14.907.585.250.285	Coronary Restenoses|Restenoses, Coronary|Restenosis, Coronary	Cardiovascular disease
Coronary Sclerosis, Medial, of Infancy	MESH:C565944			MESH:D002114|MESH:D003324	C14.280.647.250.260/C565944|C14.907.137.126.339/C565944|C14.907.585.250.260/C565944|C18.452.174.130/C565944	C14.280.647.250.260|C14.907.137.126.339|C14.907.585.250.260|C18.452.174.130		Cardiovascular disease|Metabolic disease
Coronary Stenosis	MESH:D023921	DO:DOID:4248	Narrowing or constriction of a coronary artery.	MESH:D003327	C14.280.647.250.285|C14.907.585.250.285	C14.280.647.250|C14.907.585.250	Artery Stenoses, Coronary|Artery Stenosis, Coronary|Coronary Artery Stenoses|Coronary Artery Stenosis|Coronary Stenoses|Stenoses, Coronary|Stenoses, Coronary Artery|Stenosis, Coronary|Stenosis, Coronary Artery	Cardiovascular disease
Coronary-Subclavian Steal Syndrome	MESH:D058686		A complication of INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS whereby an occlusion or stenosis of the proximal SUBCLAVIAN ARTERY causes a reversal of the blood flow away from the CORONARY CIRCULATION, through the grafted INTERNAL MAMMARY ARTERY (internal thoracic artery), and back to the distal subclavian distribution.	MESH:D003327|MESH:D011183	C14.280.647.250.647|C14.907.585.250.647|C23.550.767.115	C14.280.647.250|C14.907.585.250|C23.550.767	Coronary Subclavian Steal Syndrome|Syndrome, Coronary-Subclavian Steal|Syndromes, Coronary-Subclavian Steal	Cardiovascular disease|Pathology (process)
Coronary Thrombosis	MESH:D003328	DO:DOID:11847	Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.	MESH:D003327|MESH:D013927	C14.280.647.250.290|C14.907.355.830.220|C14.907.585.250.290	C14.280.647.250|C14.907.355.830|C14.907.585.250	Coronary Thromboses|Thromboses, Coronary|Thrombosis, Coronary	Cardiovascular disease
Coronary Vasospasm	MESH:D003329	DO:DOID:11840	Spasm of the large- or medium-sized coronary arteries.	MESH:D003327	C14.280.647.250.295|C14.907.585.250.295	C14.280.647.250|C14.907.585.250	Artery Vasospasm, Coronary|Artery Vasospasms, Coronary|Coronary Artery Vasospasm|Coronary Artery Vasospasms|Coronary Vasospasms|Vasospasm, Coronary|Vasospasm, Coronary Artery|Vasospasms, Coronary|Vasospasms, Coronary Artery	Cardiovascular disease
Coronary Vessel Anomalies	MESH:D003330		Malformations of CORONARY VESSELS, either arteries or veins. Included are anomalous origins of coronary arteries; ARTERIOVENOUS FISTULA; CORONARY ANEURYSM; MYOCARDIAL BRIDGING; and others.	MESH:D006330	C14.240.400.210|C14.280.400.210|C16.131.240.400.210	C14.240.400|C14.280.400|C16.131.240.400	Anomaly, Coronary Vessel|Coronary Vessel Anomaly	Cardiovascular disease|Congenital abnormality
Coronaviridae Infections	MESH:D003333	OMIM:122460	Virus diseases caused by CORONAVIRIDAE.	MESH:D030341	C01.925.782.600.550	C01.925.782.600	Coronaviridae Infection|CORONAVIRUS 229E SUSCEPTIBILITY|CVS|HCVS|HUMAN CORONAVIRUS SENSITIVITY|Infection, Coronaviridae|Infections, Coronaviridae	Viral disease
Coronavirus Infections	MESH:D018352		Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).	MESH:D003333	C01.925.782.600.550.200	C01.925.782.600.550	Coronavirus Infection|Infection, Coronavirus|Infections, Coronavirus|MERS (Middle East Respiratory Syndrome)|Middle East Respiratory Syndrome	Viral disease
Corpus Callosum, Agenesis of, with Facial Anomalies and Robin Sequence	MESH:C563127			MESH:D006330|MESH:D010855|MESH:D014564|MESH:D017880|MESH:D019465|MESH:D061085	C05.500.460.606/C563127|C05.660.207.540.460.606/C563127|C05.660.207/C563127|C05.660.585/C563127|C07.320.440.606/C563127|C07.650.500.460.606/C563127|C10.500.034/C563127|C12.050.351.875/C563127|C12.200.706/C563127|C12.800/C563127|C14.240.400/C563127|C14.280.400/C563127|C16.131.240.400/C563127|C16.131.621.207.540.460.606/C563127|C16.131.621.207/C563127|C16.131.621.585/C563127|C16.131.666.034/C563127|C16.131.850.500.460.606/C563127|C16.131.939/C563127|C23.300.008/C563127	C05.500.460.606|C05.660.207|C05.660.207.540.460.606|C05.660.585|C07.320.440.606|C07.650.500.460.606|C10.500.034|C12.050.351.875|C12.200.706|C12.800|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207|C16.131.621.207.540.460.606|C16.131.621.585|C16.131.666.034|C16.131.850.500.460.606|C16.131.939|C23.300.008	Toriello-Carey Syndrome	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Corticobasal Degeneration	MESH:D000088282		Rare progressive neurological disorder characterized by Parkinsonism, cortical atrophy of multiple areas of the brain including the cerebral cortex and the basal ganglia, cognitive dysfunction and eye movement abnormalities.	MESH:D024801	C10.574.945.312	C10.574.945	Cortico basal Degeneration|Cortico-basal Degeneration|Cortico basal Ganglionic Degeneration|Cortico-basal Ganglionic Degeneration|Corticobasal Syndrome	Nervous system disease
Corticosteroid-Binding Globulin, Elevated	MESH:C566934			MESH:D001796	C15.378.147/C566934	C15.378.147		Blood disease
Cor Triatriatum	MESH:D003310		A malformation of the heart in which the embryonic common PULMONARY VEIN was not incorporated into the LEFT ATRIUM leaving behind a perforated fibromuscular membrane bisecting the left atrium, a three-atrium heart. The opening between the two left atrium sections determines the degree of obstruction to pulmonary venous return, pulmonary venous and pulmonary arterial hypertension.	MESH:D006330	C14.240.400.200|C14.280.400.200|C16.131.240.400.200	C14.240.400|C14.280.400|C16.131.240.400	Atriums, Subdivided Left|Atrium, Subdivided Left|Cor Triatriatum Sinistrum|Hearts, Triatrial|Heart, Triatrial|Left Atriums, Subdivided|Left Atrium, Subdivided|Subdivided Left Atrium|Subdivided Left Atriums|Triatrial Heart|Triatrial Hearts	Cardiovascular disease|Congenital abnormality
Cough	MESH:D003371		A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.	MESH:D012120|MESH:D012818	C08.618.248|C23.888.852.293	C08.618|C23.888.852	Coughs	Respiratory tract disease|Signs and symptoms
COVID-19	MESH:D000086382	DO:DOID:0080600	A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.	MESH:D011024|MESH:D018352	C01.748.610.763.500|C01.925.705.500|C01.925.782.600.550.200.163|C08.381.677.807.500|C08.730.610.763.500	C01.748.610.763|C01.925.705|C01.925.782.600.550.200|C08.381.677.807|C08.730.610.763	2019 nCoV Disease|2019-nCoV Disease|2019-nCoV Diseases|2019 nCoV Infection|2019-nCoV Infection|2019-nCoV Infections|2019 Novel Coronavirus Disease|2019 Novel Coronavirus Infection|Coronavirus Disease 19|Coronavirus Disease-19|Coronavirus Disease 2019|COVID19|COVID 19|COVID 19 Pandemic|COVID-19 Pandemic|COVID-19 Pandemics|COVID 19 Virus Disease|COVID-19 Virus Disease|COVID-19 Virus Diseases|COVID 19 Virus Infection|COVID-19 Virus Infection|COVID-19 Virus Infections|Disease 2019, Coronavirus|Disease, 2019-nCoV|Disease, COVID-19 Virus|Infection, 2019-nCoV|Infection, COVID-19 Virus|Infection, SARS-CoV-2|Pandemic, COVID-19|SARS Coronavirus 2 Infection|SARS CoV 2 Infection|SARS-CoV-2 Infection|SARS-CoV-2 Infections|Severe Acute Respiratory Syndrome Coronavirus 2 Infection|Virus Disease, COVID-19|Virus Infection, COVID-19	Respiratory tract disease|Viral disease
COVID-19 breakthrough infections	MESH:C000718127			MESH:D000086382	C01.748.610.763.500/C000718127|C01.925.705.500/C000718127|C01.925.782.600.550.200.163/C000718127|C08.381.677.807.500/C000718127|C08.730.610.763.500/C000718127	C01.748.610.763.500|C01.925.705.500|C01.925.782.600.550.200.163|C08.381.677.807.500|C08.730.610.763.500	breakthrough COVID-19 infection|breakthrough COVID-19 infections|breakthrough infection COVID-19|breakthrough infections COVID-19|COVID-19 breakthrough|COVID-19 breakthrough infection	Respiratory tract disease|Viral disease
COVID-19 drug treatment	MESH:C000705127			MESH:D000086382	C01.748.610.763.500/C000705127|C01.925.705.500/C000705127|C01.925.782.600.550.200.163/C000705127|C08.381.677.807.500/C000705127|C08.730.610.763.500/C000705127	C01.748.610.763.500|C01.925.705.500|C01.925.782.600.550.200.163|C08.381.677.807.500|C08.730.610.763.500	coronavirus disease-19 drug treatment|coronavirus disease 2019 drug treatment|Covid-19 treatment|treatment of Covid-19 virus infection	Respiratory tract disease|Viral disease
COVID-19 post-intensive care syndrome	MESH:C000711429			MESH:D000086382	C01.748.610.763.500/C000711429|C01.925.705.500/C000711429|C01.925.782.600.550.200.163/C000711429|C08.381.677.807.500/C000711429|C08.730.610.763.500/C000711429	C01.748.610.763.500|C01.925.705.500|C01.925.782.600.550.200.163|C08.381.677.807.500|C08.730.610.763.500	COVID19 post-intensive care syndrome	Respiratory tract disease|Viral disease
COVID-19 serotherapy	MESH:C000705128			MESH:D000086382	C01.748.610.763.500/C000705128|C01.925.705.500/C000705128|C01.925.782.600.550.200.163/C000705128|C08.381.677.807.500/C000705128|C08.730.610.763.500/C000705128	C01.748.610.763.500|C01.925.705.500|C01.925.782.600.550.200.163|C08.381.677.807.500|C08.730.610.763.500	convalescent plasma treatment for Covid-19|convalescent serum treatment for Covid-19|coronavirus disease-19 serotherapy|coronavirus disease 2019 serotherapy|COVID-19 convalescent plasma treatment|Covid-19 convalescent sera treatment|COVID-19 convalescent serum treatment|COVID-19 hyperimmune globulin therapy|COVID19 hyperimmune globulin therapy|COVID19 serotherapy|COVID-19 serum therapy|COVID19 serum therapy|hyperimmune globulin therapy for COVID-19|SARS-CoV-2 convalescent plasma treatment|SARS-CoV-2 convalescent sera treatment|SARS-CoV-2 convalescent serum treatment	Respiratory tract disease|Viral disease
COVID-19 stress syndrome	MESH:C000711430			MESH:D000086382	C01.748.610.763.500/C000711430|C01.925.705.500/C000711430|C01.925.782.600.550.200.163/C000711430|C08.381.677.807.500/C000711430|C08.730.610.763.500/C000711430	C01.748.610.763.500|C01.925.705.500|C01.925.782.600.550.200.163|C08.381.677.807.500|C08.730.610.763.500	COVID19 stress syndrome|COVID stress syndrome	Respiratory tract disease|Viral disease
Cowpox	MESH:D015605	DO:DOID:8956	A mild, eruptive skin disease of milk cows caused by COWPOX VIRUS, with lesions occurring principally on the udder and teats. Human infection may occur while milking an infected animal.	MESH:D011213	C01.925.256.743.175	C01.925.256.743	Cow Pox|Pox, Cow	Viral disease
Coxa Magna	MESH:D000070603		Deformity of the hip characterized by enlargement and deformation of the FEMUR HEAD and FEMUR NECK, often with associated changes in the ACETABULUM. These changes may be secondary to other diseases (e.g.  LEGG-PERTHES DISEASE; ARTHRITIS; HIP DISLOCATION, CONGENITAL) or TRAUMA.	MESH:D001847	C05.116.296	C05.116	Coxa Magnas|Deformities, Femoral Head|Deformity, Femoral Head|Femoral Head Deformities|Femoral Head Deformity	Musculoskeletal disease
COXSACKIEVIRUS B3 SUSCEPTIBILITY	OMIM:120050			MESH:D003384	C01.925.782.687.359.213/120050	C01.925.782.687.359.213	CB3S|CXB3S	Viral disease
Coxsackievirus Infections	MESH:D003384		A heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis (MENINGITIS, ASEPTIC), a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia (PLEURODYNIA, EPIDEMIC) and a serious MYOCARDITIS.	MESH:D004769	C01.925.782.687.359.213	C01.925.782.687.359	Coxsackievirus Infection|Coxsackie Virus Infection|Coxsackie Virus Infections|Infections, Coxsackievirus|Infections, Coxsackie Virus	Viral disease
Cracked Tooth Syndrome	MESH:D003387		Incomplete fracture of any part of a tooth, characterized by pain during mastication and sensitivity to heat, cold, sweet or sour tastes, and alcohol; it is often undiagnosed because the tooth is usually X-ray negative and normal to pulp vitality tests.	MESH:D014082	C07.793.850.750.300|C26.900.750.300	C07.793.850.750|C26.900.750	Cracked Tooth Syndromes|Syndrome, Cracked Tooth|Syndromes, Cracked Tooth	Mouth disease|Wounds and injuries
Cranial Nerve Diseases	MESH:D003389	DO:DOID:3817|DO:DOID:5656	Disorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate.	MESH:D009422	C10.292	C10	Cranial Nerve Disease|Cranial Nerve Disorder|Cranial Nerve Disorders|Cranial Nerve Palsies|Cranial Nerve Palsy|Cranial Neuropathies|Cranial Neuropathies, Multiple|Cranial Neuropathy|Cranial Neuropathy, Multiple|Multiple Cranial Neuropathies|Multiple Cranial Neuropathy|Nervus Cranialis Disorder|Nervus Cranialis Disorders|Neuropathies, Cranial|Neuropathies, Multiple Cranial|Neuropathy, Cranial|Neuropathy, Multiple Cranial|Palsies, Cranial Nerve|Palsy, Cranial Nerve	Nervous system disease
Cranial Nerve Injuries	MESH:D020209		Dysfunction of one or more cranial nerves causally related to a traumatic injury. Penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA; NECK INJURIES; and trauma to the facial region are conditions associated with cranial nerve injuries.	MESH:D003389|MESH:D006259	C10.292.200|C10.900.300.218|C26.915.300.400	C10.292|C10.900.300|C26.915.300	Cranial Nerve Injury|Cranial Neuropathies, Traumatic|Cranial Neuropathy, Traumatic|Injuries, Cranial Nerve|Injury, Cranial Nerve|Nerve Injuries, Cranial|Nerve Injury, Cranial|Neuropathies, Traumatic Cranial|Neuropathy, Traumatic Cranial|Traumatic Cranial Neuropathies|Traumatic Cranial Neuropathy	Nervous system disease|Wounds and injuries
Cranial Nerve Neoplasms	MESH:D003390	DO:DOID:2815	Benign and malignant neoplasms that arise from one or more of the twelve cranial nerves.	MESH:D003389|MESH:D009423|MESH:D010524	C04.588.614.300|C04.588.614.596.240|C10.292.225|C10.551.360|C10.551.775.250	C04.588.614|C04.588.614.596|C10.292|C10.551|C10.551.775	Benign Cranial Nerve Neoplasms|Benign Cranial Nerve Tumors|Benign Cranial Neuroma|Benign Cranial Neuromas|Cranial Nerve Neoplasm|Cranial Nerve Neoplasms, Benign|Cranial Nerve Neoplasms, Malignant|Cranial Nerve Tumors, Benign|Cranial Nerve Tumors, Malignant|Cranial Neuroma, Benign|Cranial Neuromas, Benign|Malignant Cranial Nerve Neoplasms|Malignant Cranial Nerve Tumors|Neoplasm, Cranial Nerve|Neoplasms, Cranial Nerve|Neoplasms, Cranial Nerve, Benign|Neoplasms, Cranial Nerve, Malignant|Neuroma, Benign Cranial|Neuromas, Benign Cranial|Tumors, Cranial Nerve, Benign|Tumors, Cranial Nerve, Malignant	Cancer|Nervous system disease
Cranial Nerves, Congenital Paresis Of	MESH:C565673			MESH:D003389	C10.292/C565673	C10.292		Nervous system disease
Cranial Nerves, Recurrent Paresis Of	MESH:C565672			MESH:D003389	C10.292/C565672	C10.292		Nervous system disease
Cranioacrofacial Syndrome	MESH:C565147			MESH:D006228|MESH:D006330|MESH:D019465	C05.390.408/C565147|C05.660.207/C565147|C05.660.585.988.425/C565147|C14.240.400/C565147|C14.280.400/C565147|C16.131.240.400/C565147|C16.131.621.207/C565147|C16.131.621.585.988.500/C565147	C05.390.408|C05.660.207|C05.660.585.988.425|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207|C16.131.621.585.988.500		Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Craniocerebral Trauma	MESH:D006259		Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.	MESH:D020196	C10.900.300|C26.915.300	C10.900|C26.915	Craniocerebral Injuries|Craniocerebral Injury|Craniocerebral Traumas|Crushing Skull Injuries|Crushing Skull Injury|Forehead Trauma|Forehead Traumas|Frontal Region Trauma|Frontal Region Traumas|Head Injuries|Head Injuries, Minor|Head Injuries, Multiple|Head Injuries, Open|Head Injuries, Superficial|Head Injury|Head Injury, Minor|Head Injury, Multiple|Head Injury, Open|Head Injury, Superficial|Head Trauma|Head Traumas|Injuries, Craniocerebral|Injuries, Head|Injuries, Minor Head|Injuries, Multiple Head|Injuries, Open Head|Injuries, Superficial Head|Injury, Craniocerebral|Injury, Head|Injury, Minor Head|Injury, Multiple Head|Injury, Open Head|Injury, Superficial Head|Minor Head Injuries|Minor Head Injury|Multiple Head Injuries|Multiple Head Injury|Occipital Region Trauma|Occipital Region Traumas|Occipital Trauma|Occipital Traumas|Open Head Injuries|Open Head Injury|Parietal Region Trauma|Parietal Region Traumas|Region Trauma, Frontal|Region Trauma, Occipital|Region Trauma, Parietal|Region Traumas, Frontal|Region Traumas, Occipital|Region Traumas, Parietal|Skull Injuries, Crushing|Skull Injury, Crushing|Superficial Head Injuries|Superficial Head Injury|Temporal Region Trauma|Temporal Region Traumas|Trauma, Craniocerebral|Trauma, Forehead|Trauma, Frontal Region|Trauma, Head|Trauma, Occipital|Trauma, Occipital Region|Trauma, Parietal Region|Traumas, Craniocerebral|Traumas, Forehead|Traumas, Frontal Region|Traumas, Head|Traumas, Occipital|Traumas, Occipital Region|Traumas, Parietal Region|Traumas, Temporal Region|Trauma, Temporal Region	Nervous system disease|Wounds and injuries
Craniofacial Abnormalities, Cataracts, Congenital Heart Disease, Sacral Neural Tube Defects, and Growth and Developmental Retardation	MESH:C564271			MESH:D002386|MESH:D002658|MESH:D006130|MESH:D006330|MESH:D009436|MESH:D019465	C05.660.207/C564271|C10.500.680/C564271|C11.510.245/C564271|C14.240.400/C564271|C14.280.400/C564271|C16.131.240.400/C564271|C16.131.621.207/C564271|C16.131.666.680/C564271|C23.550.393/C564271|F03.625.421/C564271	C05.660.207|C10.500.680|C11.510.245|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207|C16.131.666.680|C23.550.393|F03.625.421		Cardiovascular disease|Congenital abnormality|Eye disease|Mental disorder|Musculoskeletal disease|Nervous system disease|Pathology (process)
Craniofacial Fibrous Dysplasia	MESH:D000077275		Mostly benign fibro-osseous proliferation of the facial bones and skull. It can be either monostotic (localized to a single bone) or polyostotic (localized to more than one bone) type.	MESH:D005357	C05.116.099.708.375.286	C05.116.099.708.375	Craniofacial Fibrous Dysplasias|Craniomaxillofacial Fibrous Dysplasia|Craniomaxillofacial Fibrous Dysplasias|Dysplasia, Maxillary Fibrous|Fibrous Dysplasia, Craniofacial|Fibrous Dysplasia, Craniomaxillofacial|Fibrous Dysplasia, Maxillary|Fibrous Dysplasia of Skull|Maxillary Fibrous Dysplasia|Maxillary Fibrous Dysplasias|Skull Fibrous Dysplasia|Skull Fibrous Dysplasias	Musculoskeletal disease
Craniofaciofrontodigital Syndrome	MESH:C567298			MESH:D000015|MESH:D006330|MESH:D008607	C10.597.606.360/C567298|C14.240.400/C567298|C14.280.400/C567298|C16.131.077/C567298|C16.131.240.400/C567298|C23.888.592.604.646/C567298|F03.625.539/C567298	C10.597.606.360|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C23.888.592.604.646|F03.625.539	Cantu Craniofaciofrontodigital Syndrome	Cardiovascular disease|Congenital abnormality|Mental disorder|Nervous system disease|Signs and symptoms
Craniomandibular Disorders	MESH:D017271		Diseases or disorders of the muscles of the head and neck, with special reference to the masticatory muscles. The most notable examples are TEMPOROMANDIBULAR JOINT DISORDERS and TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.	MESH:D008336|MESH:D009135	C05.500.607.221|C05.651.243|C07.320.610.291	C05.500.607|C05.651|C07.320.610	Craniomandibular Disease|Craniomandibular Diseases|Craniomandibular Disorder|Disease, Craniomandibular|Diseases, Craniomandibular|Disorder, Craniomandibular|Disorders, Craniomandibular	Mouth disease|Musculoskeletal disease
Craniometaphyseal Dysplasia, Autosomal Dominant	MESH:C565145	OMIM:123000		MESH:D017271	C05.500.607.221/C565145|C05.651.243/C565145|C07.320.610.291/C565145	C05.500.607.221|C05.651.243|C07.320.610.291	Autosomal Dominant Craniometaphyseal Dysplasia|CMD|CMDD|CMDJ|Craniometaphyseal dysplasia autosomal dominant|Craniometaphyseal dysplasia dominant type|Craniometaphyseal dysplasia Jackson type|Craniometaphyseal Dysplasia, Jackson Type	Mouth disease|Musculoskeletal disease
Craniopharyngioma	MESH:D003397	DO:DOID:3840|DO:DOID:3846|DO:DOID:3847	A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)	MESH:D017599	C04.557.465.625.200|C04.557.580.625.200	C04.557.465.625|C04.557.580.625	Adamantinous Craniopharyngioma|Adamantinous Craniopharyngiomas|Adult Craniopharyngioma|Adult Craniopharyngiomas|Child Craniopharyngioma|Child Craniopharyngiomas|Craniopharyngioma, Adamantinous|Craniopharyngioma, Adult|Craniopharyngioma, Child|Craniopharyngioma, Papillary|Craniopharyngiomas|Craniopharyngiomas, Adamantinous|Craniopharyngiomas, Adult|Craniopharyngiomas, Child|Craniopharyngiomas, Papillary|Neoplasm, Rathke Cleft|Neoplasm, Rathke's Cleft|Neoplasm, Rathkes Cleft|Papillary Craniopharyngioma|Papillary Craniopharyngiomas|Rathke Cleft Neoplasm|Rathke Pouch Tumor|Rathke's Cleft Neoplasm|Rathkes Cleft Neoplasm|Rathke's Pouch Tumor|Rathkes Pouch Tumor|Tumor, Rathke Pouch|Tumor, Rathke's Pouch	Cancer
Crazy paving pattern	MESH:C000721427			MESH:D017563	C08.381.483/C000721427	C08.381.483	Crazy paving appearance|Crazy-paving pattern|Crazy paving sign|GGO and reticulation|Ground glass opacity with reticulation	Respiratory tract disease
Creases, Infra-Auricular Cutaneous, with Tall Stature and Advanced Bone Age	MESH:C566543			MESH:D006130|MESH:D009123|MESH:D019066	C10.597.613.575/C566543|C23.550.291.812/C566543|C23.550.393/C566543|C23.888.592.608.575/C566543	C10.597.613.575|C23.550.291.812|C23.550.393|C23.888.592.608.575		Nervous system disease|Pathology (process)|Signs and symptoms
CREST Syndrome	MESH:D017675	DO:DOID:0060218	A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.	MESH:D002114|MESH:D011928|MESH:D013684|MESH:D015154|MESH:D045745	C06.405.117.119.500.204|C14.907.617.812.500|C14.907.823.225|C17.300.799.801.500|C17.800.784.801.500|C18.452.174.130.204	C06.405.117.119.500|C14.907.617.812|C14.907.823|C17.300.799.801|C17.800.784.801|C18.452.174.130	Calcinosis Raynaud Phenomenon Sclerodactyly Telangiectasia|Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia|Calcinosis, Raynaud's phenomenon, Esophageal dismobility, Sclerodactyly, Telangiectasia Syndrome|CREST Syndromes|CRST Syndrome|CRST Syndromes|Phenomenon-Sclerodactyly-Telangiectasia, Calcinosis-Raynaud|Syndrome, CREST|Syndrome, CRST	Cardiovascular disease|Connective tissue disease|Digestive system disease|Metabolic disease|Skin disease
Creutzfeldt-Jakob Disease, Heidenhain Variant	MESH:C566981			MESH:D007562|MESH:D014786	C01.207.800.230/C566981|C10.228.140.380.165/C566981|C10.228.228.800.230/C566981|C10.597.751.941/C566981|C11.966/C566981|C23.888.592.763.941/C566981|F03.615.400.300/C566981	C01.207.800.230|C10.228.140.380.165|C10.228.228.800.230|C10.597.751.941|C11.966|C23.888.592.763.941|F03.615.400.300		Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Crisscross Heart	MESH:D003420		A developmental malformation of the heart characterized by a twisted but not defective atrioventicular connection. The abnormal rotation of the ventricular mass around its long axis results in the crossing of the inflow streams of the two ventricles. Other features include hypoplasia of the TRICUSPID VALVE and RIGHT VENTRICLE.	MESH:D006330	C14.240.400.220|C14.280.400.220|C16.131.240.400.220	C14.240.400|C14.280.400|C16.131.240.400	Criss cross Heart|Criss-cross Heart|Criss-cross Hearts|Crisscross Hearts|Heart, Crisscross|Heart, Criss-cross|Hearts, Crisscross|Hearts, Criss-cross	Cardiovascular disease|Congenital abnormality
Crome syndrome	MESH:C536216			MESH:D001927|MESH:D002386|MESH:D058186	C10.228.140/C536216|C11.510.245/C536216|C12.050.351.968.419.780.050/C536216|C12.200.777.419.780.050/C536216|C12.950.419.780.050/C536216	C10.228.140|C11.510.245|C12.050.351.968.419.780.050|C12.200.777.419.780.050|C12.950.419.780.050		Eye disease|Nervous system disease|Urogenital disease (female)|Urogenital disease (male)
Croup	MESH:D003440	DO:DOID:9395	Inflammation involving the GLOTTIS or VOCAL CORDS and the subglottic larynx. Croup is characterized by a barking cough, HOARSENESS, and persistent inspiratory STRIDOR (a high-pitched breathing sound). It occurs chiefly in infants and children.	MESH:D007827	C08.360.535.365|C09.400.535.365	C08.360.535|C09.400.535	Croup, Postintubation|Croup, Spasmodic|Croup, Viral|Postintubation Croup|Spasmodic Croup|Viral Croup	Ear-nose-throat disease|Respiratory tract disease
Cryofibrinogenemia	MESH:C536218			MESH:D003449	C14.907.454.140/C536218|C15.378.147.780.243/C536218|C15.378.463.515.140/C536218|C20.683.780.250/C536218	C14.907.454.140|C15.378.147.780.243|C15.378.463.515.140|C20.683.780.250		Blood disease|Cardiovascular disease|Immune system disease
Cryofibrinogenemia, Familial Primary	MESH:C565142			MESH:D003449	C14.907.454.140/C565142|C15.378.147.780.243/C565142|C15.378.463.515.140/C565142|C20.683.780.250/C565142	C14.907.454.140|C15.378.147.780.243|C15.378.463.515.140|C20.683.780.250		Blood disease|Cardiovascular disease|Immune system disease
Cryoglobulinemia	MESH:D003449	DO:DOID:2917	A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.	MESH:D010265|MESH:D020141	C14.907.454.140|C15.378.147.780.243|C15.378.463.515.140|C20.683.780.250	C14.907.454|C15.378.147.780|C15.378.463.515|C20.683.780	Cryoglobulinemias	Blood disease|Cardiovascular disease|Immune system disease
Cryohydrocytosis, Stomatin-Deficient, with Mental Retardation, Seizures, Cataracts, and Massive Hepatosplenomegaly	MESH:C563840	OMIM:608885		MESH:D002386|MESH:D006529|MESH:D006947|MESH:D008607|MESH:D012640|MESH:D013163	C06.552.416/C563840|C10.597.606.360/C563840|C10.597.742/C563840|C11.510.245/C563840|C18.452.950.396/C563840|C23.300.775.525/C563840|C23.300.775.750/C563840|C23.888.592.604.646/C563840|C23.888.592.742/C563840|F03.625.539/C563840	C06.552.416|C10.597.606.360|C10.597.742|C11.510.245|C18.452.950.396|C23.300.775.525|C23.300.775.750|C23.888.592.604.646|C23.888.592.742|F03.625.539	CRYOHYDROCYTOSIS, STOMATIN-DEFICIENT, WITH MENTAL RETARDATION, SEIZURES, CATARACTS, AND MASSIVE HEPATOSPLENOMEGALY|GLUT1 DEFICIENCY SYNDROME WITH PSEUDOHYPERKALEMIA AND HEMOLYSIS|SDCHCN|Stomatin-Deficient Cryohydrocytosis with Neurologic Defects	Digestive system disease|Eye disease|Mental disorder|Metabolic disease|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Cryptogenic Organizing Pneumonia	MESH:D018549	DO:DOID:0050157	An interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a 'pneumonia-like' illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts.	MESH:D001989|MESH:D054988	C08.127.446.135.140.200|C08.381.483.652.500.750.249|C08.381.495.146.135.140.200	C08.127.446.135.140|C08.381.483.652.500.750|C08.381.495.146.135.140	BOOP|Bronchiolitis Obliterans Organizing Pneumonia|Cryptogenic Organizing Pneumonias|Organizing Pneumonia, Cryptogenic|Organizing Pneumonias, Cryptogenic|Pneumonia, Cryptogenic Organizing|Pneumonias, Cryptogenic Organizing	Respiratory tract disease
Crystal Arthropathies	MESH:D000070657		Joint disorders that are characterized by accumulation of microcrystals in and around the joint including in the SYNOVIAL FLUID. They are classified according to the chemical nature of the crystals such as CALCIUM PYROPHOSPHATE; basic CALCIUM PHOSPHATES; and monosodium urate (see URIC ACID).	MESH:D007592	C05.550.354	C05.550	Arthritides, Crystal|Arthritides, Crystalline|Arthritis, Crystal|Arthritis, Crystalline|Arthropathies, Crystal|Arthropathies, Crystalline|Arthropathy, Crystal|Arthropathy, Crystalline|Crystal Arthritides|Crystal Arthritis|Crystal Arthropathy|Crystalline Arthritides|Crystalline Arthritis|Crystalline Arthropathies|Crystalline Arthropathy	Musculoskeletal disease
Cubital Tunnel Syndrome	MESH:D020430		Compression of the ULNAR NERVE in the cubital tunnel, which is formed by the two heads of the flexor carpi ulnaris muscle, humeral-ulnar aponeurosis, and medial ligaments of the elbow. This condition may follow trauma or occur in association with processes which produce nerve enlargement or narrowing of the canal. Manifestations include elbow pain and PARESTHESIA radiating distally, weakness of ulnar innervated intrinsic hand muscles, and loss of sensation over the hypothenar region, fifth finger, and ulnar aspect of the ring finger. (Joynt, Clinical Neurology, 1995, Ch51, p43)	MESH:D017769|MESH:D020424	C10.668.829.500.850.200|C10.668.829.550.925.200|C26.844.150.957.200	C10.668.829.500.850|C10.668.829.550.925|C26.844.150.957	Cubital Tunnel Syndromes|Syndrome, Cubital Tunnel|Syndromes, Cubital Tunnel|Tunnel Syndrome, Cubital|Tunnel Syndromes, Cubital|Ulnar Nerve Compression, Cubital Tunnel|Ulnar Nerve Entrapment, Elbow	Nervous system disease|Wounds and injuries
CULLER-JONES SYNDROME	OMIM:615849	DO:DOID:0080328		MESH:D054975	C04.445.622/615849|C04.588.614.250.195.885.500.299/615849|C05.660.585.600.374/615849|C10.228.140.211.885.500.299/615849|C10.228.140.617.477.299/615849|C10.551.240.250.700.500.249/615849|C16.131.077.690/615849|C16.131.621.585.600.374/615849	C04.445.622|C04.588.614.250.195.885.500.299|C05.660.585.600.374|C10.228.140.211.885.500.299|C10.228.140.617.477.299|C10.551.240.250.700.500.249|C16.131.077.690|C16.131.621.585.600.374	CJS|PALLISTER-HALL SYNDROME 2, FORMERLY|PHS2, FORMERLY	Cancer|Congenital abnormality|Musculoskeletal disease|Nervous system disease
Curly hair-ankyloblepharon-nail dysplasia syndrome	MESH:C538074			MESH:D005141|MESH:D006201|MESH:D009264	C11.338/C538074|C17.800.329/C538074|C23.300.820/C538074	C11.338|C17.800.329|C23.300.820	CHANDS	Eye disease|Pathology (anatomical condition)|Skin disease
Cushing's symphalangism	MESH:C536223	OMIM:185800		MESH:D007592	C05.550/C536223	C05.550	Cushing Symphalangism|Hereditary absence of proximal interphalangeal joints|Hereditary Absence of the Proximal Interphalangeal Joints|Strasburger-Hawkins-Eldridge-Hargrave-McKusick syndrome|Strasburger-Hawkins-Eldridge syndrome|SYM1|SYM1A|Symphalangism, Proximal|SYMPHALANGISM, PROXIMAL, 1A|Vessel's syndrome	Musculoskeletal disease
Cutaneous Fistula	MESH:D017577		An abnormal passage or communication leading from an internal organ to the surface of the body.	MESH:D005402|MESH:D012871	C17.800.135|C23.300.575.150	C17.800|C23.300.575	Cutaneous Fistulas|External Fistula|External Fistulas|Fistula, Cutaneous|Fistula, External|Fistulas, Cutaneous|Fistulas, External|Fistula, Skin|Fistulas, Skin|Skin Fistula|Skin Fistulas	Pathology (anatomical condition)|Skin disease
Cutaneous photosensitivity and colitis, lethal	MESH:C536224			MESH:D003092|MESH:D010787	C06.405.205.265/C536224|C06.405.469.158.188/C536224|C17.800.600/C536224	C06.405.205.265|C06.405.469.158.188|C17.800.600	Early cutaneous photosensitivity and severe colitis	Digestive system disease|Skin disease
CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL	OMIM:614564			MESH:D000505|MESH:D009959|MESH:D013684	C04.588.443.665.710.684/614564|C07.550.745.671/614564|C09.647.710.685/614564|C09.775.549.685/614564|C14.907.823/614564|C17.800.329.937.122/614564|C23.300.035/614564	C04.588.443.665.710.684|C07.550.745.671|C09.647.710.685|C09.775.549.685|C14.907.823|C17.800.329.937.122|C23.300.035	FCTCS|TELANGIECTASIA, CUTANEOUS, AND CANCER SYNDROME, FAMILIAL	Cancer|Cardiovascular disease|Ear-nose-throat disease|Mouth disease|Pathology (anatomical condition)|Skin disease
Cutis marmorata telangiectatica congenita	MESH:C536226			MESH:D013684|MESH:D054068	C14.907.617.625/C536226|C14.907.823/C536226|C17.800.862.355/C536226|C23.888.885.437/C536226	C14.907.617.625|C14.907.823|C17.800.862.355|C23.888.885.437	Hereditary cutis marmorata telangiectatica congenita	Cardiovascular disease|Signs and symptoms|Skin disease
Cyanosis and Hepatic Disease	MESH:C565660			MESH:D003490|MESH:D008107	C06.552/C565660|C23.888.248/C565660	C06.552|C23.888.248		Digestive system disease|Signs and symptoms
Cyclic neutropenia	MESH:C536227	DO:DOID:5339|OMIM:162800		MESH:D009503	C15.378.553.546.184.564/C536227	C15.378.553.546.184.564	Cyclic Hematopoesis|Cyclic hematopoiesis|Cyclic Leucopenia|Neutropenia, cyclic|Periodic Neutropenia	Blood disease
Cyclic Vomiting Syndrome with Neuromuscular Disease	MESH:C564022			MESH:D009468|MESH:D014839	C10.668/C564022|C23.888.821.937/C564022	C10.668|C23.888.821.937		Nervous system disease|Signs and symptoms
Cyclodialysis Clefts	MESH:D000080322		Finding of a separation of the CILIARY BODY in the SCLERAL SPUR region, creating aqueous outflow from the ANTERIOR CHAMBER into suprachoroidal space between the CHOROID and the SCLERA. Persistent cyclodialysis clefts may be associated with OCULAR HYPOTENSION and OPTIC DISC EDEMA.	MESH:D000080324	C11.250.105.250|C11.941.160.241.250	C11.250.105|C11.941.160.241	Cleft, Cyclodialysis|Cleft, Persistent Cyclodialysis|Cyclodialyses, Traumatic|Cyclodialysis Cleft|Cyclodialysis Cleft, Persistent|Cyclodialysis, Traumatic|Persistent Cyclodialysis Cleft|Persistent Cyclodialysis Clefts|Traumatic Cyclodialysis	Eye disease
Cystadenocarcinoma	MESH:D003536	DO:DOID:3111	A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)	MESH:D000230|MESH:D018297	C04.557.470.200.025.480|C04.557.470.590.480	C04.557.470.200.025|C04.557.470.590	Cystadenocarcinomas	Cancer
Cystadenocarcinoma, Mucinous	MESH:D018282	DO:DOID:3603	A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)	MESH:D003536	C04.557.470.200.025.480.225|C04.557.470.590.480.225	C04.557.470.200.025.480|C04.557.470.590.480	Cystadenocarcinomas, Mucinous|Mucinous Cystadenocarcinoma|Mucinous Cystadenocarcinomas	Cancer
Cystadenocarcinoma, Papillary	MESH:D018283	DO:DOID:3110	An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.	MESH:D003536	C04.557.470.200.025.480.230|C04.557.470.590.480.230	C04.557.470.200.025.480|C04.557.470.590.480	Cystadenocarcinomas, Papillary|Papillary Cystadenocarcinoma|Papillary Cystadenocarcinomas	Cancer
Cystadenocarcinoma, Serous	MESH:D018284	DO:DOID:3114	A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)	MESH:D003536	C04.557.470.200.025.480.240|C04.557.470.590.480.240	C04.557.470.200.025.480|C04.557.470.590.480	Cystadenocarcinomas, Serous|Serous Cystadenocarcinoma|Serous Cystadenocarcinomas	Cancer
Cystadenofibroma	MESH:D062625	DO:DOID:5477|DO:DOID:5482	Benign or borderline malignant neoplasm of the ovary and surrounding tissues. It is characterized by tumor(s) with cystic glands which are lined by cuboidal EPITHELIAL CELLS with clear cytoplasm, resembling ENDOMETRIUM cells. The glands are separated by fibroblastic STROMAL CELLS.	MESH:D000232|MESH:D018297	C04.557.450.565.590.595.050.500|C04.557.470.590.482|C04.557.470.625.050.500	C04.557.450.565.590.595.050|C04.557.470.590|C04.557.470.625.050	Adenofibroma, Clear Cell|Adenofibromas, Clear Cell|Benign Clear Cell Adenofibroma|Benign Cystadenofibroma|Benign Cystadenofibromas|Borderline Clear Cell Adenofibroma|Borderline Cystadenofibroma|Borderline Cystadenofibromas|Clear Cell Adenofibroma|Clear Cell Adenofibromas|Cystadenofibroma, Benign|Cystadenofibroma, Borderline|Cystadenofibromas|Cystadenofibromas, Benign|Cystadenofibromas, Borderline	Cancer
Cystadenoma	MESH:D003537	DO:DOID:2634	A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)	MESH:D000236|MESH:D018297	C04.557.470.035.320|C04.557.470.590.485	C04.557.470.035|C04.557.470.590	Cystadenomas	Cancer
Cystadenoma, Mucinous	MESH:D018291		A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.	MESH:D003537	C04.557.470.035.320.225|C04.557.470.590.485.225	C04.557.470.035.320|C04.557.470.590.485	Cystadenomas, Mucinous|Mucinous Cystadenoma|Mucinous Cystadenomas	Cancer
Cystadenoma, Papillary	MESH:D018292		A benign neoplasm of the ovary.	MESH:D003537	C04.557.470.035.320.230|C04.557.470.590.485.230	C04.557.470.035.320|C04.557.470.590.485	Cystadenomas, Papillary|Papillary Cystadenoma|Papillary Cystadenomas	Cancer
Cystadenoma, Serous	MESH:D018293		A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)	MESH:D003537	C04.557.470.035.320.240|C04.557.470.590.485.240	C04.557.470.035.320|C04.557.470.590.485	Cystadenomas, Serous|Serous Cystadenoma|Serous Cystadenomas	Cancer
Cystic Disease Of Lung	MESH:C563237			MESH:D008171	C08.381/C563237	C08.381		Respiratory tract disease
Cystic Kidney Disease with Ventriculomegaly	MESH:C565657	DO:DOID:0111625|OMIM:219730		MESH:D006849|MESH:D052177	C10.228.140.602/C565657|C12.050.351.968.419.403/C565657|C12.200.777.419.403/C565657|C12.950.419.403/C565657	C10.228.140.602|C12.050.351.968.419.403|C12.200.777.419.403|C12.950.419.403	VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE|VMCKD	Nervous system disease|Urogenital disease (female)|Urogenital disease (male)
Cystic medial necrosis of aorta	MESH:C536230			MESH:D003560|MESH:D017545	C04.182/C536230|C14.907.055.239.125/C536230|C14.907.109.139.125/C536230|C23.300.306/C536230	C04.182|C14.907.055.239.125|C14.907.109.139.125|C23.300.306	Erdheim Cystic medial necrosis of aorta	Cancer|Cardiovascular disease|Pathology (anatomical condition)
Cystocele	MESH:D052858		A HERNIA-like condition in which the weakened pelvic muscles cause the URINARY BLADDER to drop from its normal position. Fallen urinary bladder is more common in females with the bladder dropping into the VAGINA and less common in males with the bladder dropping into the SCROTUM.	MESH:D001745|MESH:D056887	C12.050.351.968.829.508|C12.200.777.829.707|C12.950.829.508|C23.300.842.624.249	C12.050.351.968.829|C12.200.777.829|C12.950.829|C23.300.842.624	Fallen Urinary Bladder|Prolapse, Urinary Bladder|Urinary Bladder Prolapse	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Cysts	MESH:D003560		Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.	MESH:D009369|MESH:D020763	C04.182|C23.300.306	C04|C23.300	Cyst	Cancer|Pathology (anatomical condition)
Cytochrome-c Oxidase Deficiency	MESH:D030401	DO:DOID:3762|OMIM:220110	A disease that results from a congenital defect in ELECTRON TRANSPORT COMPLEX IV. Defects in ELECTRON TRANSPORT COMPLEX IV can be caused by mutations in the SURF1, SCO2, COX10, or SCO1 genes. ELECTRON TRANSPORT COMPLEX IV deficiency caused by mutation in SURF1 manifests itself as LEIGH DISEASE; that caused by mutation in SCO2 as fatal infantile cardioencephalomyopathy; that caused by mutation in COX10 as tubulopathy and leukodystrophy; and that caused by mutation in SCO1 as early-onset hepatic failure and neurologic disorder. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM					
Cytomegalic inclusion body disease	MESH:C538505			MESH:D003586	C01.925.256.466.245/C538505	C01.925.256.466.245		Viral disease
Cytomegalovirus Infections	MESH:D003586		Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.	MESH:D006566	C01.925.256.466.245	C01.925.256.466	Cytomegalic Inclusion Disease|Cytomegalic Inclusion Diseases|Cytomegalovirus Infection|Disease, Cytomegalic Inclusion|Diseases, Cytomegalic Inclusion|Inclusion Disease|Inclusion Disease, Cytomegalic|Inclusion Diseases|Inclusion Diseases, Cytomegalic|Infection, Cytomegalovirus|Infections, Cytomegalovirus|Salivary Gland Virus Disease	Viral disease
Cytomegalovirus Retinitis	MESH:D017726	DO:DOID:0080160	Infection of the retina by cytomegalovirus characterized by retinal necrosis, hemorrhage, vessel sheathing, and retinal edema. Cytomegalovirus retinitis is a major opportunistic infection in AIDS patients and can cause blindness.	MESH:D003586|MESH:D012173|MESH:D015828	C01.375.725.270|C01.925.256.466.245.150|C01.925.325.270|C11.294.800.270|C11.768.773.360	C01.375.725|C01.925.256.466.245|C01.925.325|C11.294.800|C11.768.773	Cytomegaloviral Retinitis|Retinitis, Cytomegaloviral|Retinitis, Cytomegalovirus	Eye disease|Viral disease
Dacryocystitis	MESH:D003607	DO:DOID:950|DO:DOID:9938	Inflammation of the lacrimal sac. (Dorland, 27th ed)	MESH:D007766	C11.496.221	C11.496	Dacryoadenitides|Dacryoadenitis|Dacryocystitides	Eye disease
Dahlberg Borer Newcomer syndrome	MESH:C535769			MESH:D007011|MESH:D008209	C15.604.496/C535769|C19.642.482/C535769	C15.604.496|C19.642.482	Hypoparathyroidism Lymphedema syndrome|Hypoparathyroidism-Lymphedema Syndrome|Lymphedema hypoparathyroidism syndrome|Lymphedema-Hypoparathyroidism Syndrome	Endocrine system disease|Lymphatic disease
Daish Hardman Lamont syndrome	MESH:C535770			MESH:D006130|MESH:D006849|MESH:D007593|MESH:D007738|MESH:D012600	C05.116.900.800.500/C535770|C05.116.900.800.875/C535770|C05.550.521/C535770|C10.228.140.602/C535770|C23.550.393/C535770	C05.116.900.800.500|C05.116.900.800.875|C05.550.521|C10.228.140.602|C23.550.393	Hydrocephalus, tall stature, joint laxity, and kyphoscoliosis	Musculoskeletal disease|Nervous system disease|Pathology (process)
Dandruff	MESH:D063807	DO:DOID:8941	Excessive shedding of dry scaly material from the scalp in humans.	MESH:D003872|MESH:D012536	C17.800.174.146|C17.800.738.353	C17.800.174|C17.800.738	Scurf	Skin disease
Davenport Donlan syndrome	MESH:C535988			MESH:D003286|MESH:D003638|MESH:D007153|MESH:D010212|MESH:D012878	C04.557.470.700.600/C535988|C04.588.805/C535988|C05.550.323/C535988|C05.651.197/C535988|C09.218.458.341.186/C535988|C10.597.751.418.341.186/C535988|C17.800.882/C535988|C20.673/C535988|C23.888.592.763.393.341.186/C535988	C04.557.470.700.600|C04.588.805|C05.550.323|C05.651.197|C09.218.458.341.186|C10.597.751.418.341.186|C17.800.882|C20.673|C23.888.592.763.393.341.186	Dominant hearing loss, white hair, contractures, hyperkeratotic papillomata, and depressed chemotaxis	Cancer|Ear-nose-throat disease|Immune system disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms|Skin disease
Deafness	MESH:D003638		A general term for the complete loss of the ability to hear from both ears.	MESH:D034381	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	Acquired Deafness|Complete Hearing Loss|Deaf Mutism|Deaf-Mutism|Deafness, Acquired|Deafness Permanent|Deafness, Prelingual|Extreme Hearing Loss|Hearing Loss, Complete|Hearing Loss, Extreme|Hearing Loss Permanent|Permanent, Deafness|Permanent, Hearing Loss|Permanents, Deafness|Prelingual Deafness	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Aminoglycoside-Induced	MESH:C564013	OMIM:580000		MESH:D006319	C09.218.458.341.887/C564013|C10.597.751.418.341.887/C564013|C23.888.592.763.393.341.887/C564013	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Deafness, Streptomycin-Induced|Streptomycin Ototoxicity	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS AND MYOPIA	OMIM:221200	DO:DOID:0111628		MESH:D003638|MESH:D009216	C09.218.458.341.186/221200|C10.597.751.418.341.186/221200|C11.744.636/221200|C23.888.592.763.393.341.186/221200	C09.218.458.341.186|C10.597.751.418.341.186|C11.744.636|C23.888.592.763.393.341.186	DFNMYP	Ear-nose-throat disease|Eye disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 1	MESH:C565121	OMIM:124900		MESH:D006319	C09.218.458.341.887/C565121|C10.597.751.418.341.887/C565121|C23.888.592.763.393.341.887/C565121	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA|Deafness, Progressive Low Tone|DFNA1|Hereditary Low Frequency Hearing Loss|Konigsmark Syndrome	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 10	MESH:C563354	OMIM:601316		MESH:D006319	C09.218.458.341.887/C563354|C10.597.751.418.341.887/C563354|C23.888.592.763.393.341.887/C563354	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA10	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 11	MESH:C563353	OMIM:601317		MESH:D006319	C09.218.458.341.887/C563353|C10.597.751.418.341.887/C563353|C23.888.592.763.393.341.887/C563353	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA11	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 12	MESH:C563295	OMIM:601543		MESH:D006319	C09.218.458.341.887/C563295|C10.597.751.418.341.887/C563295|C23.888.592.763.393.341.887/C563295	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Deafness, Autosomal Dominant 8|DFNA12|DFNA8	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 13	MESH:C566612	OMIM:601868		MESH:D006319	C09.218.458.341.887/C566612|C10.597.751.418.341.887/C566612|C23.888.592.763.393.341.887/C566612	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA13	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 15	MESH:C566545	OMIM:602459		MESH:D006319	C09.218.458.341.887/C566545|C10.597.751.418.341.887/C566545|C23.888.592.763.393.341.887/C566545	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA15	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 16	MESH:C565832	OMIM:603964		MESH:D006319	C09.218.458.341.887/C565832|C10.597.751.418.341.887/C565832|C23.888.592.763.393.341.887/C565832	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA16	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 18	MESH:C565267	OMIM:606012		MESH:D006319	C09.218.458.341.887/C565267|C10.597.751.418.341.887/C565267|C23.888.592.763.393.341.887/C565267	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA18	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 20	MESH:C565754	OMIM:604717		MESH:D006319	C09.218.458.341.887/C565754|C10.597.751.418.341.887/C565754|C23.888.592.763.393.341.887/C565754	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA20|DFNA26	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 21	MESH:C564634	OMIM:607017		MESH:D006319	C09.218.458.341.887/C564634|C10.597.751.418.341.887/C564634|C23.888.592.763.393.341.887/C564634	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA21	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 23	MESH:C565357	OMIM:605192		MESH:D006319	C09.218.458.341.887/C565357|C10.597.751.418.341.887/C565357|C23.888.592.763.393.341.887/C565357	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA23	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 24	MESH:C565239	OMIM:606282		MESH:D006319	C09.218.458.341.887/C565239|C10.597.751.418.341.887/C565239|C23.888.592.763.393.341.887/C565239	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA24	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 25	MESH:C565319	OMIM:605583		MESH:D006319	C09.218.458.341.887/C565319|C10.597.751.418.341.887/C565319|C23.888.592.763.393.341.887/C565319	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA25	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 27	OMIM:612431	DO:DOID:0110556		MESH:D003638	C09.218.458.341.186/612431|C10.597.751.418.341.186/612431|C23.888.592.763.393.341.186/612431	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA27	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 28	MESH:C563890	OMIM:608641		MESH:D006319	C09.218.458.341.887/C563890|C10.597.751.418.341.887/C563890|C23.888.592.763.393.341.887/C563890	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA28	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 2A	MESH:C567441	OMIM:600101		MESH:D006319	C09.218.458.341.887/C567441|C10.597.751.418.341.887/C567441|C23.888.592.763.393.341.887/C567441	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA2A	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 2B	MESH:C567214	OMIM:612644		MESH:D006319	C09.218.458.341.887/C567214|C10.597.751.418.341.887/C567214|C23.888.592.763.393.341.887/C567214	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA2B	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 30	MESH:C564706	OMIM:606451		MESH:D006319	C09.218.458.341.887/C564706|C10.597.751.418.341.887/C564706|C23.888.592.763.393.341.887/C564706	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA30	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 31	MESH:C563888	OMIM:608645		MESH:D006319	C09.218.458.341.887/C563888|C10.597.751.418.341.887/C563888|C23.888.592.763.393.341.887/C563888	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA31	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 33	OMIM:614211	DO:DOID:0110562		MESH:D003638	C09.218.458.341.186/614211|C10.597.751.418.341.186/614211|C23.888.592.763.393.341.186/614211	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA33	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 36	MESH:C564675	OMIM:606705		MESH:D006319	C09.218.458.341.887/C564675|C10.597.751.418.341.887/C564675|C23.888.592.763.393.341.887/C564675	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA36	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 3A	MESH:C567277	OMIM:601544		MESH:D006319	C09.218.458.341.887/C567277|C10.597.751.418.341.887/C567277|C23.888.592.763.393.341.887/C567277	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA3A	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 3B	MESH:C567215	OMIM:612643		MESH:D006319	C09.218.458.341.887/C567215|C10.597.751.418.341.887/C567215|C23.888.592.763.393.341.887/C567215	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA3B	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 4	MESH:C563460			MESH:D006319	C09.218.458.341.887/C563460|C10.597.751.418.341.887/C563460|C23.888.592.763.393.341.887/C563460	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 40	OMIM:616357	DO:DOID:0110566		MESH:D003638	C09.218.458.341.186/616357|C10.597.751.418.341.186/616357|C23.888.592.763.393.341.186/616357	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA40	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 41	MESH:C564272	OMIM:608224		MESH:D006319	C09.218.458.341.887/C564272|C10.597.751.418.341.887/C564272|C23.888.592.763.393.341.887/C564272	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA41	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 43	MESH:C564246	OMIM:608394		MESH:D006319	C09.218.458.341.887/C564246|C10.597.751.418.341.887/C564246|C23.888.592.763.393.341.887/C564246	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA43	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 44	MESH:C564399	OMIM:607453		MESH:D006319	C09.218.458.341.887/C564399|C10.597.751.418.341.887/C564399|C23.888.592.763.393.341.887/C564399	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA44	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 47	MESH:C563885	OMIM:608652		MESH:D006319	C09.218.458.341.887/C563885|C10.597.751.418.341.887/C563885|C23.888.592.763.393.341.887/C563885	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA47	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 48	MESH:C564322	OMIM:607841		MESH:D006319	C09.218.458.341.887/C564322|C10.597.751.418.341.887/C564322|C23.888.592.763.393.341.887/C564322	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA48	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 49	MESH:C564250	OMIM:608372		MESH:D006319	C09.218.458.341.887/C564250|C10.597.751.418.341.887/C564250|C23.888.592.763.393.341.887/C564250	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA49	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 4A	OMIM:600652	DO:DOID:0110573		MESH:D003638	C09.218.458.341.186/600652|C10.597.751.418.341.186/600652|C23.888.592.763.393.341.186/600652	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DEAFNESS, AUTOSOMAL DOMINANT 4|DFNA4|DFNA4A	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 4B	OMIM:614614	DO:DOID:0110574		MESH:D003638	C09.218.458.341.186/614614|C10.597.751.418.341.186/614614|C23.888.592.763.393.341.186/614614	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA4B	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 5	MESH:C563410	OMIM:600994		MESH:D006319	C09.218.458.341.887/C563410|C10.597.751.418.341.887/C563410|C23.888.592.763.393.341.887/C563410	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA5	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 50	OMIM:613074	DO:DOID:0110576		MESH:D003638	C09.218.458.341.186/613074|C10.597.751.418.341.186/613074|C23.888.592.763.393.341.186/613074	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA50	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 51	OMIM:613558	DO:DOID:0110577		MESH:D003638	C09.218.458.341.186/613558|C10.597.751.418.341.186/613558|C23.888.592.763.393.341.186/613558	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	CHROMOSOME 9q21.11 DUPLICATION SYNDROME|DFNA51	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 52	MESH:C564348	OMIM:607683		MESH:D006319	C09.218.458.341.887/C564348|C10.597.751.418.341.887/C564348|C23.888.592.763.393.341.887/C564348	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DEAFNESS, AUTOSOMAL DOMINANT 42|DFNA42|DFNA52	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 53	MESH:C566495	OMIM:609965		MESH:D006319	C09.218.458.341.887/C566495|C10.597.751.418.341.887/C566495|C23.888.592.763.393.341.887/C566495	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA53	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 56	OMIM:615629	DO:DOID:0110581		MESH:D003638	C09.218.458.341.186/615629|C10.597.751.418.341.186/615629|C23.888.592.763.393.341.186/615629	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA56	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 59	MESH:C567216	OMIM:612642		MESH:D006319	C09.218.458.341.887/C567216|C10.597.751.418.341.887/C567216|C23.888.592.763.393.341.887/C567216	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA59	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 6	MESH:C563421	OMIM:600965		MESH:D006319	C09.218.458.341.887/C563421|C10.597.751.418.341.887/C563421|C23.888.592.763.393.341.887/C563421	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Deafness, Autosomal Dominant 14|Deafness, Autosomal Dominant 38|DFNA14|DFNA38|DFNA6	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 64	OMIM:614152	DO:DOID:0110585		MESH:D003638	C09.218.458.341.186/614152|C10.597.751.418.341.186/614152|C23.888.592.763.393.341.186/614152	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA64	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 65	OMIM:616044	DO:DOID:0110586		MESH:D003638	C09.218.458.341.186/616044|C10.597.751.418.341.186/616044|C23.888.592.763.393.341.186/616044	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA65	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 66	OMIM:616969	DO:DOID:0110587		MESH:D003638	C09.218.458.341.186/616969|C10.597.751.418.341.186/616969|C23.888.592.763.393.341.186/616969	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA66	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 67	OMIM:616340	DO:DOID:0110588		MESH:D003638	C09.218.458.341.186/616340|C10.597.751.418.341.186/616340|C23.888.592.763.393.341.186/616340	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA67	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 68	OMIM:616707	DO:DOID:0110589		MESH:D003638	C09.218.458.341.186/616707|C10.597.751.418.341.186/616707|C23.888.592.763.393.341.186/616707	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA68	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 69	OMIM:616697	DO:DOID:0110590		MESH:D003638	C09.218.458.341.186/616697|C10.597.751.418.341.186/616697|C23.888.592.763.393.341.186/616697	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DCUA|DEAFNESS, CONGENITAL, UNILATERAL OR ASYMMETRIC|DFNA69	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 7	MESH:C563321	OMIM:601412		MESH:D006319	C09.218.458.341.887/C563321|C10.597.751.418.341.887/C563321|C23.888.592.763.393.341.887/C563321	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA7	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL DOMINANT 70	OMIM:616968	DO:DOID:0110592		MESH:D003638	C09.218.458.341.186/616968|C10.597.751.418.341.186/616968|C23.888.592.763.393.341.186/616968	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNA70	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant 9	MESH:C563335	OMIM:601369		MESH:D006319	C09.218.458.341.887/C563335|C10.597.751.418.341.887/C563335|C23.888.592.763.393.341.887/C563335	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNA9	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Dominant, Due To Mutation In Myo1a	MESH:C567266			MESH:D034381	C09.218.458.341/C567266|C10.597.751.418.341/C567266|C23.888.592.763.393.341/C567266	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, autosomal dominant nonsyndromic sensorineural 17	MESH:C538050	OMIM:603622		MESH:D006319	C09.218.458.341.887/C538050|C10.597.751.418.341.887/C538050|C23.888.592.763.393.341.887/C538050	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	COCHLEOSACCULAR DEGENERATION, INCLUDED|DEAFNESS, AUTOSOMAL DOMINANT 17|DFNA17|Late-onset progressive hereditary hearing impairment due to cochleosaccular degeneration	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, autosomal dominant nonsyndromic sensorineural 22	MESH:C538197			MESH:D006319	C09.218.458.341.887/C538197|C10.597.751.418.341.887/C538197|C23.888.592.763.393.341.887/C538197	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Deafness, Autosomal Dominant 22|DFNA22|DFNA 22	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, autosomal dominant nonsyndromic sensorineural 23	MESH:C538198			MESH:D006319	C09.218.458.341.887/C538198|C10.597.751.418.341.887/C538198|C23.888.592.763.393.341.887/C538198	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, autosomal dominant nonsyndromic sensorineural 24	MESH:C538199			MESH:D006319	C09.218.458.341.887/C538199|C10.597.751.418.341.887/C538199|C23.888.592.763.393.341.887/C538199	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, autosomal dominant nonsyndromic sensorineural 3	MESH:C538200			MESH:D006313	C09.218.458.341.887.432/C538200|C09.218.807.186.432/C538200|C10.228.140.068.432/C538200|C10.597.751.418.341.887.432/C538200|C23.888.592.763.393.341.887.432/C538200	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C23.888.592.763.393.341.887.432	Neurosensory nonsyndromic dominant deafness 1	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, autosomal dominant nonsyndromic sensorineural 53	MESH:C538201			MESH:D006313	C09.218.458.341.887.432/C538201|C09.218.807.186.432/C538201|C10.228.140.068.432/C538201|C10.597.751.418.341.887.432/C538201|C23.888.592.763.393.341.887.432/C538201	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C23.888.592.763.393.341.887.432		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive	MESH:C564609			MESH:D006319	C09.218.458.341.887/C564609|C10.597.751.418.341.887/C564609|C23.888.592.763.393.341.887/C564609	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 10	MESH:C565341			MESH:D006319	C09.218.458.341.887/C565341|C10.597.751.418.341.887/C565341|C23.888.592.763.393.341.887/C565341	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB10	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 101	OMIM:615837	DO:DOID:0110462		MESH:C566580	C09.218.458.341.887/C566580/615837|C10.597.751.418.341.887/C566580/615837|C23.888.592.763.393.341.887/C566580/615837	C09.218.458.341.887/C566580|C10.597.751.418.341.887/C566580|C23.888.592.763.393.341.887/C566580	DFNB101	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 102	OMIM:615974	DO:DOID:0110463		MESH:D003638	C09.218.458.341.186/615974|C10.597.751.418.341.186/615974|C23.888.592.763.393.341.186/615974	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB102	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 103	OMIM:616042	DO:DOID:0110464		MESH:D003638	C09.218.458.341.186/616042|C10.597.751.418.341.186/616042|C23.888.592.763.393.341.186/616042	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB103	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 104	OMIM:616515	DO:DOID:0110465		MESH:D003638	C09.218.458.341.186/616515|C10.597.751.418.341.186/616515|C23.888.592.763.393.341.186/616515	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB104	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 12	MESH:C563327	OMIM:601386		MESH:D006319	C09.218.458.341.887/C563327|C10.597.751.418.341.887/C563327|C23.888.592.763.393.341.887/C563327	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB12	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 13	MESH:C566410	OMIM:603098		MESH:D006319	C09.218.458.341.887/C566410|C10.597.751.418.341.887/C566410|C23.888.592.763.393.341.887/C566410	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB13	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 14	MESH:C566344	OMIM:603678		MESH:D006319	C09.218.458.341.887/C566344|C10.597.751.418.341.887/C566344|C23.888.592.763.393.341.887/C566344	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB14	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 15	MESH:C566611	OMIM:601869		MESH:D006319	C09.218.458.341.887/C566611|C10.597.751.418.341.887/C566611|C23.888.592.763.393.341.887/C566611	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DEAFNESS, AUTOSOMAL RECESSIVE 72|DEAFNESS, AUTOSOMAL RECESSIVE 95|DFMB15|DFNB15|DFNB72|DFNB95	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 16	MESH:C566339	OMIM:603720		MESH:D006319	C09.218.458.341.887/C566339|C10.597.751.418.341.887/C566339|C23.888.592.763.393.341.887/C566339	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB16	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 17	MESH:C566418	OMIM:603010		MESH:D006319	C09.218.458.341.887/C566418|C10.597.751.418.341.887/C566418|C23.888.592.763.393.341.887/C566418	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB17	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 18	MESH:C566580			MESH:D006319	C09.218.458.341.887/C566580|C10.597.751.418.341.887/C566580|C23.888.592.763.393.341.887/C566580	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB18	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 18A	OMIM:602092	DO:DOID:0110473		MESH:C566580|MESH:D003638	C09.218.458.341.186/602092|C09.218.458.341.887/C566580/602092|C10.597.751.418.341.186/602092|C10.597.751.418.341.887/C566580/602092|C23.888.592.763.393.341.186/602092|C23.888.592.763.393.341.887/C566580/602092	C09.218.458.341.186|C09.218.458.341.887/C566580|C10.597.751.418.341.186|C10.597.751.418.341.887/C566580|C23.888.592.763.393.341.186|C23.888.592.763.393.341.887/C566580	DEAFNESS, AUTOSOMAL RECESSIVE 18|DFNB18|DFNB18A	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 18B	OMIM:614945	DO:DOID:0110474		MESH:D003638	C09.218.458.341.186/614945|C10.597.751.418.341.186/614945|C23.888.592.763.393.341.186/614945	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB18B	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 1A	MESH:C567134	OMIM:220290		MESH:D006319	C09.218.458.341.887/C567134|C10.597.751.418.341.887/C567134|C23.888.592.763.393.341.887/C567134	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Deafness, Digenic, Gjb2-Gjb3|DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED|Deafness, Digenic, Gjb2-Gjb6|DEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED|DFNB1A	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 1b	MESH:C567213	OMIM:612645		MESH:D006319	C09.218.458.341.887/C567213|C10.597.751.418.341.887/C567213|C23.888.592.763.393.341.887/C567213	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB1B	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 2	MESH:C564007	OMIM:600060		MESH:D006319	C09.218.458.341.887/C564007|C10.597.751.418.341.887/C564007|C23.888.592.763.393.341.887/C564007	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB2|Neurosensory Nonsyndromic Recessive Deafness 2|NSRD2	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 20	MESH:C565828	OMIM:604060		MESH:D006319	C09.218.458.341.887/C565828|C10.597.751.418.341.887/C565828|C23.888.592.763.393.341.887/C565828	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB20	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 21	MESH:C566353	OMIM:603629		MESH:D006319	C09.218.458.341.887/C566353|C10.597.751.418.341.887/C566353|C23.888.592.763.393.341.887/C566353	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB21	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 22	MESH:C564633	OMIM:607039		MESH:D006319	C09.218.458.341.887/C564633|C10.597.751.418.341.887/C564633|C23.888.592.763.393.341.887/C564633	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB22	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 23	MESH:C563705	OMIM:609533		MESH:D006319	C09.218.458.341.887/C563705|C10.597.751.418.341.887/C563705|C23.888.592.763.393.341.887/C563705	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB23	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive, 24	MESH:C567027	OMIM:611022		MESH:D006319	C09.218.458.341.887/C567027|C10.597.751.418.341.887/C567027|C23.888.592.763.393.341.887/C567027	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DEAFNESS, AUTOSOMAL RECESSIVE 24|DFNB24	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 25	OMIM:613285	DO:DOID:0110483		MESH:D003638	C09.218.458.341.186/613285|C10.597.751.418.341.186/613285|C23.888.592.763.393.341.186/613285	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB25	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 26	MESH:C565329	OMIM:605428		MESH:D006319	C09.218.458.341.887/C565329|C10.597.751.418.341.887/C565329|C23.888.592.763.393.341.887/C565329	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB26	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF	OMIM:605429			MESH:C565329|MESH:D003638	C09.218.458.341.186/605429|C09.218.458.341.887/C565329/605429|C10.597.751.418.341.186/605429|C10.597.751.418.341.887/C565329/605429|C23.888.592.763.393.341.186/605429|C23.888.592.763.393.341.887/C565329/605429	C09.218.458.341.186|C09.218.458.341.887/C565329|C10.597.751.418.341.186|C10.597.751.418.341.887/C565329|C23.888.592.763.393.341.186|C23.888.592.763.393.341.887/C565329	DEAFNESS, NONSYNDROMIC, MODIFIER OF, 1|DFNB26M|DFNB26, MODIFIER OF|DFNB26, SUPPRESSOR OF|DFNM1	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 27	MESH:C565287	OMIM:605818		MESH:D006319	C09.218.458.341.887/C565287|C10.597.751.418.341.887/C565287|C23.888.592.763.393.341.887/C565287	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB27	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 28	MESH:C565218	OMIM:609823		MESH:D006319	C09.218.458.341.887/C565218|C10.597.751.418.341.887/C565218|C23.888.592.763.393.341.887/C565218	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB28	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 29	OMIM:614035	DO:DOID:0110487		MESH:D003638	C09.218.458.341.186/614035|C10.597.751.418.341.186/614035|C23.888.592.763.393.341.186/614035	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB29	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 3	MESH:C563961	OMIM:600316		MESH:D006319	C09.218.458.341.887/C563961|C10.597.751.418.341.887/C563961|C23.888.592.763.393.341.887/C563961	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB3|Neurosensory Nonsyndromic Recessive Deafness 3|NSRD3	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 30	MESH:C564624	OMIM:607101		MESH:D006319	C09.218.458.341.887/C564624|C10.597.751.418.341.887/C564624|C23.888.592.763.393.341.887/C564624	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB30	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 31	MESH:C564629	OMIM:607084		MESH:D006319	C09.218.458.341.887/C564629|C10.597.751.418.341.887/C564629|C23.888.592.763.393.341.887/C564629	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB31|Whirler, Mouse, Homolog Of	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 32	MESH:C563884	OMIM:608653		MESH:D006319	C09.218.458.341.887/C563884|C10.597.751.418.341.887/C563884|C23.888.592.763.393.341.887/C563884	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DEAFNESS, AUTOSOMAL RECESSIVE 105, FORMERLY|DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM|DFNB105, FORMERLY|DFNB32|HEARING IMPAIRMENT INFERTILE MALE SYNDROME|HIIMS	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 33	MESH:C564602	OMIM:607239		MESH:D006319	C09.218.458.341.887/C564602|C10.597.751.418.341.887/C564602|C23.888.592.763.393.341.887/C564602	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB33	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 35	MESH:C563908	OMIM:608565		MESH:D006319	C09.218.458.341.887/C563908|C10.597.751.418.341.887/C563908|C23.888.592.763.393.341.887/C563908	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB35	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 36	MESH:C563815			MESH:D006319	C09.218.458.341.887/C563815|C10.597.751.418.341.887/C563815|C23.888.592.763.393.341.887/C563815	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB36	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;DFNB36 DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT,	OMIM:609006	DO:DOID:0110494		MESH:C567219|MESH:D003638	C09.218.458.341.186/609006|C09.218.458.341/C567219/609006|C10.597.751.418.341.186/609006|C10.597.751.418.341/C567219/609006|C23.888.592.763.393.341.186/609006|C23.888.592.763.393.341/C567219/609006	C09.218.458.341.186|C09.218.458.341/C567219|C10.597.751.418.341.186|C10.597.751.418.341/C567219|C23.888.592.763.393.341.186|C23.888.592.763.393.341/C567219	INCLUDED	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 36, Without Vestibular Involvement	MESH:C567219			MESH:D034381	C09.218.458.341/C567219|C10.597.751.418.341/C567219|C23.888.592.763.393.341/C567219	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 37	MESH:C564331	OMIM:607821		MESH:D006319	C09.218.458.341.887/C564331|C10.597.751.418.341.887/C564331|C23.888.592.763.393.341.887/C564331	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB37	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 38	MESH:C564273	OMIM:608219		MESH:D006319	C09.218.458.341.887/C564273|C10.597.751.418.341.887/C564273|C23.888.592.763.393.341.887/C564273	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB38	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 39	MESH:C564265	OMIM:608265		MESH:D006319	C09.218.458.341.887/C564265|C10.597.751.418.341.887/C564265|C23.888.592.763.393.341.887/C564265	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB39	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 4	MESH:C566366			MESH:D006319	C09.218.458.341.887/C566366|C10.597.751.418.341.887/C566366|C23.888.592.763.393.341.887/C566366	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Dilated Vestibular Aqueduct|Enlarged Vestibular Aqueduct|Neurosensory Nonsyndromic Recessive Deafness 4	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 40	MESH:C564266	OMIM:608264		MESH:D006319	C09.218.458.341.887/C564266|C10.597.751.418.341.887/C564266|C23.888.592.763.393.341.887/C564266	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB40	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 42	MESH:C566460	OMIM:609646		MESH:D006319	C09.218.458.341.887/C566460|C10.597.751.418.341.887/C566460|C23.888.592.763.393.341.887/C566460	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB42	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 44	MESH:C565716	OMIM:610154		MESH:D006319	C09.218.458.341.887/C565716|C10.597.751.418.341.887/C565716|C23.888.592.763.393.341.887/C565716	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB44	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 45	OMIM:612433	DO:DOID:0110502		MESH:D003638	C09.218.458.341.186/612433|C10.597.751.418.341.186/612433|C23.888.592.763.393.341.186/612433	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB45	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 46	MESH:C566459	OMIM:609647		MESH:D006319	C09.218.458.341.887/C566459|C10.597.751.418.341.887/C566459|C23.888.592.763.393.341.887/C566459	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB46	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 47	MESH:C566498	OMIM:609946		MESH:D006319	C09.218.458.341.887/C566498|C10.597.751.418.341.887/C566498|C23.888.592.763.393.341.887/C566498	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB47	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 48	MESH:C563720	OMIM:609439		MESH:D006319	C09.218.458.341.887/C563720|C10.597.751.418.341.887/C563720|C23.888.592.763.393.341.887/C563720	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB48	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 49	MESH:C565717	OMIM:610153		MESH:D006319	C09.218.458.341.887/C565717|C10.597.751.418.341.887/C565717|C23.888.592.763.393.341.887/C565717	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB49	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	OMIM:600791	DO:DOID:0110498		MESH:D003638	C09.218.458.341.186/600791|C10.597.751.418.341.186/600791|C23.888.592.763.393.341.186/600791	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB4|DILATED VESTIBULAR AQUEDUCT|DVA|NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 4|NSRD4	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 5	MESH:C563444	OMIM:600792		MESH:D006319	C09.218.458.341.887/C563444|C10.597.751.418.341.887/C563444|C23.888.592.763.393.341.887/C563444	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB5|Neurosensory Nonsyndromic Recessive Deafness 5|NSRD5	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, autosomal recessive 51	MESH:C538202	OMIM:609941		MESH:D006313	C09.218.458.341.887.432/C538202|C09.218.807.186.432/C538202|C10.228.140.068.432/C538202|C10.597.751.418.341.887.432/C538202|C23.888.592.763.393.341.887.432/C538202	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C23.888.592.763.393.341.887.432	DFNB51	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 53	MESH:C566453	OMIM:609706		MESH:D006319	C09.218.458.341.887/C566453|C10.597.751.418.341.887/C566453|C23.888.592.763.393.341.887/C566453	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB53	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, autosomal recessive 55	MESH:C538203	OMIM:609952		MESH:D006313	C09.218.458.341.887.432/C538203|C09.218.807.186.432/C538203|C10.228.140.068.432/C538203|C10.597.751.418.341.887.432/C538203|C23.888.592.763.393.341.887.432/C538203	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C23.888.592.763.393.341.887.432	DFNB55	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 59	MESH:C565698	OMIM:610220		MESH:D006319	C09.218.458.341.887/C565698|C10.597.751.418.341.887/C565698|C23.888.592.763.393.341.887/C565698	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB59	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 6	MESH:C563418	OMIM:600971		MESH:D006319	C09.218.458.341.887/C563418|C10.597.751.418.341.887/C563418|C23.888.592.763.393.341.887/C563418	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB6|Neurosensory Nonsyndromic Recessive Deafness 6|NSRD6	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 61	OMIM:613865	DO:DOID:0110513		MESH:D003638	C09.218.458.341.186/613865|C10.597.751.418.341.186/613865|C23.888.592.763.393.341.186/613865	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB61	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 62	MESH:C565719	OMIM:610143		MESH:D006319	C09.218.458.341.887/C565719|C10.597.751.418.341.887/C565719|C23.888.592.763.393.341.887/C565719	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB62	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 63	MESH:C566951	OMIM:611451		MESH:D006319	C09.218.458.341.887/C566951|C10.597.751.418.341.887/C566951|C23.888.592.763.393.341.887/C566951	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB63	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 65	MESH:C565211	OMIM:610248		MESH:D006319	C09.218.458.341.887/C565211|C10.597.751.418.341.887/C565211|C23.888.592.763.393.341.887/C565211	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB65	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 66	MESH:C565701	OMIM:610212		MESH:D006319	C09.218.458.341.887/C565701|C10.597.751.418.341.887/C565701|C23.888.592.763.393.341.887/C565701	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB66	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 67	MESH:C565207	OMIM:610265		MESH:D006319	C09.218.458.341.887/C565207|C10.597.751.418.341.887/C565207|C23.888.592.763.393.341.887/C565207	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB67	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 68	MESH:C563669	OMIM:610419		MESH:D006319	C09.218.458.341.887/C563669|C10.597.751.418.341.887/C563669|C23.888.592.763.393.341.887/C563669	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB68	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 7	MESH:C563417	OMIM:600974		MESH:D006319	C09.218.458.341.887/C563417|C10.597.751.418.341.887/C563417|C23.888.592.763.393.341.887/C563417	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Deafness, Autosomal Recessive 11|DFNB11|Dfnb7	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 70	OMIM:614934	DO:DOID:0110521		MESH:D003638	C09.218.458.341.186/614934|C10.597.751.418.341.186/614934|C23.888.592.763.393.341.186/614934	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB70	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 71	MESH:C567562	OMIM:612789		MESH:D006319	C09.218.458.341.887/C567562|C10.597.751.418.341.887/C567562|C23.888.592.763.393.341.887/C567562	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB71	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 74	OMIM:613718	DO:DOID:0110523		MESH:D003638	C09.218.458.341.186/613718|C10.597.751.418.341.186/613718|C23.888.592.763.393.341.186/613718	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB74	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 76	OMIM:615540	DO:DOID:0110524		MESH:D003638	C09.218.458.341.186/615540|C10.597.751.418.341.186/615540|C23.888.592.763.393.341.186/615540	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB76	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 77	MESH:C567543	OMIM:613079		MESH:D006319	C09.218.458.341.887/C567543|C10.597.751.418.341.887/C567543|C23.888.592.763.393.341.887/C567543	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB77	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 79	MESH:C567651	OMIM:613307		MESH:D006319	C09.218.458.341.887/C567651|C10.597.751.418.341.887/C567651|C23.888.592.763.393.341.887/C567651	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DFNB79	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 8	OMIM:601072	DO:DOID:0110527		MESH:C563395|MESH:C565341	C09.218.458.341.887/C563395/601072|C09.218.458.341.887/C565341/601072|C10.597.751.418.341.887/C563395/601072|C10.597.751.418.341.887/C565341/601072|C23.888.592.763.393.341.887/C563395/601072|C23.888.592.763.393.341.887/C565341/601072	C09.218.458.341.887/C563395|C09.218.458.341.887/C565341|C10.597.751.418.341.887/C563395|C10.597.751.418.341.887/C565341|C23.888.592.763.393.341.887/C563395|C23.888.592.763.393.341.887/C565341	DEAFNESS, AUTOSOMAL RECESSIVE 10|DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8|DFNB10|DFNB8|NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 8|NSRD8	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 83	OMIM:613685	DO:DOID:0110528		MESH:D003638	C09.218.458.341.186/613685|C10.597.751.418.341.186/613685|C23.888.592.763.393.341.186/613685	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB83	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 84A	OMIM:613391	DO:DOID:0110529		MESH:D003638	C09.218.458.341.186/613391|C10.597.751.418.341.186/613391|C23.888.592.763.393.341.186/613391	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DEAFNESS, AUTOSOMAL RECESSIVE 84|DEAFNESS, AUTOSOMAL RECESSIVE 84A, WITH VESTIBULAR DYSFUNCTION|DFNB84|DFNB84A	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 84B	OMIM:614944	DO:DOID:0110530		MESH:D003638	C09.218.458.341.186/614944|C10.597.751.418.341.186/614944|C23.888.592.763.393.341.186/614944	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB84B	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 85	OMIM:613392	DO:DOID:0110531		MESH:D003638	C09.218.458.341.186/613392|C10.597.751.418.341.186/613392|C23.888.592.763.393.341.186/613392	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB85	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 86	OMIM:614617	DO:DOID:0110532		MESH:D003638	C09.218.458.341.186/614617|C10.597.751.418.341.186/614617|C23.888.592.763.393.341.186/614617	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB86	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 88	OMIM:615429	DO:DOID:0110533		MESH:D003638	C09.218.458.341.186/615429|C10.597.751.418.341.186/615429|C23.888.592.763.393.341.186/615429	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB88	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 89	OMIM:613916	DO:DOID:0110534		MESH:D003638	C09.218.458.341.186/613916|C10.597.751.418.341.186/613916|C23.888.592.763.393.341.186/613916	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB89	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Autosomal Recessive 9	MESH:C563396	OMIM:601071		MESH:D006319	C09.218.458.341.887/C563396|C10.597.751.418.341.887/C563396|C23.888.592.763.393.341.887/C563396	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Auditory Neuropathy, Autosomal Recessive, 1|AUDITORY NEUROPATHY, NONSYNDROMIC RECESSIVE, INCLUDED|AUNB1, INCLUDED|DFNB9|Neurosensory Nonsyndromic Recessive Deafness 9|NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 9;NSRD9 AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1, INCLUDED|NSRAN, INCLUDED	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 91	OMIM:613453	DO:DOID:0110536		MESH:D003638	C09.218.458.341.186/613453|C10.597.751.418.341.186/613453|C23.888.592.763.393.341.186/613453	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB91	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 93	OMIM:614899	DO:DOID:0110537		MESH:D003638	C09.218.458.341.186/614899|C10.597.751.418.341.186/614899|C23.888.592.763.393.341.186/614899	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB93	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 97	OMIM:616705	DO:DOID:0110539		MESH:D003638	C09.218.458.341.186/616705|C10.597.751.418.341.186/616705|C23.888.592.763.393.341.186/616705	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB97	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, AUTOSOMAL RECESSIVE 98	OMIM:614861	DO:DOID:0110540		MESH:D003638	C09.218.458.341.186/614861|C10.597.751.418.341.186/614861|C23.888.592.763.393.341.186/614861	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNB98	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8	MESH:C563395			MESH:D006319	C09.218.458.341.887/C563395|C10.597.751.418.341.887/C563395|C23.888.592.763.393.341.887/C563395	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Neurosensory Nonsyndromic Recessive Deafness 8	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Cochlear, with Myopia and Intellectual Impairment	MESH:C565645			MESH:D006314|MESH:D008607|MESH:D009216	C09.218.458.341.562/C565645|C10.597.606.360/C565645|C10.597.751.418.341.562/C565645|C11.744.636/C565645|C23.888.592.604.646/C565645|C23.888.592.763.393.341.562/C565645|F03.625.539/C565645	C09.218.458.341.562|C10.597.606.360|C10.597.751.418.341.562|C11.744.636|C23.888.592.604.646|C23.888.592.763.393.341.562|F03.625.539		Ear-nose-throat disease|Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Deafness conductive ptosis skeletal anomalies	MESH:C535993			MESH:D001763|MESH:D001848|MESH:D006314	C05.116.099/C535993|C09.218.458.341.562/C535993|C10.597.751.418.341.562/C535993|C11.338.204/C535993|C23.888.592.763.393.341.562/C535993	C05.116.099|C09.218.458.341.562|C10.597.751.418.341.562|C11.338.204|C23.888.592.763.393.341.562	Deafness, Conductive, with Ptosis and Skeletal Anomalies|Jackson Barr syndrome	Ear-nose-throat disease|Eye disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Deafness, Conductive Stapedial, with Ear Malformation and Facial Palsy	MESH:C565123			MESH:D005155|MESH:D006314	C07.465.299/C565123|C09.218.458.341.562/C565123|C10.292.319/C565123|C10.597.751.418.341.562/C565123|C23.888.592.763.393.341.562/C565123	C07.465.299|C09.218.458.341.562|C10.292.319|C10.597.751.418.341.562|C23.888.592.763.393.341.562		Ear-nose-throat disease|Mouth disease|Nervous system disease|Signs and symptoms
Deafness, Conductive, with Malformed External Ear	MESH:C565644			MESH:D006314	C09.218.458.341.562/C565644|C10.597.751.418.341.562/C565644|C23.888.592.763.393.341.562/C565644	C09.218.458.341.562|C10.597.751.418.341.562|C23.888.592.763.393.341.562		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Congenital, and Familial Myoclonic Epilepsy	MESH:C565649			MESH:D003638|MESH:D004831	C09.218.458.341.186/C565649|C10.228.140.490.375.130/C565649|C10.228.140.490.493.063/C565649|C10.597.751.418.341.186/C565649|C23.888.592.763.393.341.186/C565649	C09.218.458.341.186|C10.228.140.490.375.130|C10.228.140.490.493.063|C10.597.751.418.341.186|C23.888.592.763.393.341.186		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Congenital Heart Defects, and Posterior Embryotoxon	MESH:C566604			MESH:D006330|MESH:D034381	C09.218.458.341/C566604|C10.597.751.418.341/C566604|C14.240.400/C566604|C14.280.400/C566604|C16.131.240.400/C566604|C23.888.592.763.393.341/C566604	C09.218.458.341|C10.597.751.418.341|C14.240.400|C14.280.400|C16.131.240.400|C23.888.592.763.393.341		Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Congenital, with Vitiligo and Achalasia	MESH:C565642			MESH:D003638|MESH:D004931|MESH:D014820	C06.405.117.119.500.432/C565642|C09.218.458.341.186/C565642|C10.597.751.418.341.186/C565642|C17.800.621.440.895/C565642|C23.888.592.763.393.341.186/C565642	C06.405.117.119.500.432|C09.218.458.341.186|C10.597.751.418.341.186|C17.800.621.440.895|C23.888.592.763.393.341.186		Digestive system disease|Ear-nose-throat disease|Nervous system disease|Signs and symptoms|Skin disease
Deafness-Craniofacial Syndrome	MESH:C565118			MESH:D019066|MESH:D034381	C09.218.458.341/C565118|C10.597.751.418.341/C565118|C23.550.291.812/C565118|C23.888.592.763.393.341/C565118	C09.218.458.341|C10.597.751.418.341|C23.550.291.812|C23.888.592.763.393.341		Ear-nose-throat disease|Nervous system disease|Pathology (process)|Signs and symptoms
Deafness-Hypogonadism Syndrome	MESH:C564435			MESH:D007006|MESH:D046089	C09.218.458.341.849/C564435|C10.597.751.418.341.849/C564435|C19.391.482/C564435|C23.888.592.763.393.341.849/C564435	C09.218.458.341.849|C10.597.751.418.341.849|C19.391.482|C23.888.592.763.393.341.849		Ear-nose-throat disease|Endocrine system disease|Nervous system disease|Signs and symptoms
Deafness, Mid-Tone Neural	MESH:C565122			MESH:D006319	C09.218.458.341.887/C565122|C10.597.751.418.341.887/C565122|C23.888.592.763.393.341.887/C565122	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Neural, Congenital Moderate	MESH:C565640			MESH:D006313	C09.218.458.341.887.432/C565640|C09.218.807.186.432/C565640|C10.228.140.068.432/C565640|C10.597.751.418.341.887.432/C565640|C23.888.592.763.393.341.887.432/C565640	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C23.888.592.763.393.341.887.432		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, neurosensory, autosomal recessive 47	MESH:C538205			MESH:D006313	C09.218.458.341.887.432/C538205|C09.218.807.186.432/C538205|C10.228.140.068.432/C538205|C10.597.751.418.341.887.432/C538205|C23.888.592.763.393.341.887.432/C538205	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C23.888.592.763.393.341.887.432		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Progressive High-Tone Neural	MESH:C562423			MESH:D006319	C09.218.458.341.887/C562423|C10.597.751.418.341.887/C562423|C23.888.592.763.393.341.887/C562423	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Progressive, With Stapes Fixation	MESH:C563316			MESH:D006314	C09.218.458.341.562/C563316|C10.597.751.418.341.562/C563316|C23.888.592.763.393.341.562/C563316	C09.218.458.341.562|C10.597.751.418.341.562|C23.888.592.763.393.341.562		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Sensorineural, And Male Infertility	MESH:C567010	OMIM:611102		MESH:D002872|MESH:D006319|MESH:D007248	C09.218.458.341.887/C567010|C10.597.751.418.341.887/C567010|C12.100.500.430/C567010|C12.100.750.700/C567010|C12.200.294.430/C567010|C23.550.210.050.500.500/C567010|C23.888.592.763.393.341.887/C567010	C09.218.458.341.887|C10.597.751.418.341.887|C12.100.500.430|C12.100.750.700|C12.200.294.430|C23.550.210.050.500.500|C23.888.592.763.393.341.887	Chromosome 15q15.3 Deletion Syndrome|Deafness-Infertility Syndrome|DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY|DIS|Sensorineural Deafness and Male Infertility	Ear-nose-throat disease|Nervous system disease|Pathology (process)|Signs and symptoms|Urogenital disease (male)
Deafness, Sensorineural, Autosomal-Mitochondrial Type	MESH:C565637	OMIM:500008		MESH:D006319	C09.218.458.341.887/C565637|C10.597.751.418.341.887/C565637|C23.888.592.763.393.341.887/C565637	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Sensorineural, with Hypertrophic Cardiomyopathy	MESH:C565236			MESH:D002312|MESH:D006319	C09.218.458.341.887/C565236|C10.597.751.418.341.887/C565236|C14.280.238.100/C565236|C14.280.484.048.750.070.160/C565236|C23.888.592.763.393.341.887/C565236	C09.218.458.341.887|C10.597.751.418.341.887|C14.280.238.100|C14.280.484.048.750.070.160|C23.888.592.763.393.341.887		Cardiovascular disease|Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Sensorineural, with Peripheral Neuropathy and Arterial Disease	MESH:C565120			MESH:D006319|MESH:D011115|MESH:D058729	C09.218.458.341.887/C565120|C10.597.751.418.341.887/C565120|C10.668.829.800/C565120|C14.907.137.126.307.500/C565120|C14.907.617.671/C565120|C23.888.592.763.393.341.887/C565120	C09.218.458.341.887|C10.597.751.418.341.887|C10.668.829.800|C14.907.137.126.307.500|C14.907.617.671|C23.888.592.763.393.341.887		Cardiovascular disease|Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Deafness, Unilateral, With Delayed Endolymphatic Hydrops	MESH:C567420			MESH:D034381	C09.218.458.341/C567420|C10.597.751.418.341/C567420|C23.888.592.763.393.341/C567420	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, X-LINKED 6	OMIM:300914	DO:DOID:0111740		MESH:D003638	C09.218.458.341.186/300914|C10.597.751.418.341.186/300914|C23.888.592.763.393.341.186/300914	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNX6	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
DEAFNESS, Y-LINKED 1	OMIM:400043	DO:DOID:0111759		MESH:D003638	C09.218.458.341.186/400043|C10.597.751.418.341.186/400043|C23.888.592.763.393.341.186/400043	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DFNY1	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Death, Sudden, Cardiac	MESH:D016757		Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)	MESH:D003645|MESH:D006323	C14.280.383.220|C23.550.260.322.250	C14.280.383|C23.550.260.322	Arrest, Sudden Cardiac|Cardiac Arrests, Sudden|Cardiac Arrest, Sudden|Cardiac Death, Sudden|Cardiac Sudden Death|Death, Cardiac Sudden|Death, Sudden Cardiac|Sudden Cardiac Arrest|Sudden Cardiac Death|Sudden Death, Cardiac	Cardiovascular disease|Pathology (process)
Decalcification, Pathologic	MESH:D003649		The loss of calcium salts from bones and teeth. Bacteria may be responsible for this occurrence in teeth. Old age may be a factor contributing to calcium loss, as is the presence of diseases such as rheumatoid arthritis.	MESH:D002128|MESH:D018488	C05.116.198.247.400|C18.452.104.247.400|C18.452.174.289	C05.116.198.247|C18.452.104.247|C18.452.174	Decalcification, Pathological|Pathological Decalcification|Pathologic Decalcification	Metabolic disease|Musculoskeletal disease
Decerebrate State	MESH:D003655		A condition characterized by abnormal posturing of the limbs that is associated with injury to the brainstem. This may occur as a clinical manifestation or induced experimentally in animals. The extensor reflexes are exaggerated leading to rigid extension of the limbs accompanied by hyperreflexia and opisthotonus. This condition is usually caused by lesions which occur in the region of the brainstem that lies between the red nuclei and the vestibular nuclei. In contrast, decorticate rigidity is characterized by flexion of the elbows and wrists with extension of the legs and feet. The causative lesion for this condition is located above the red nuclei and usually consists of diffuse cerebral damage. (From Adams et al., Principles of Neurology, 6th ed, p358)	MESH:D009461	C10.597.305|C23.888.592.298	C10.597|C23.888.592	Decerebrate Posturing|Decerebrate Posturings|Decerebrate Rigidity|Decerebrate States|Decorticate Rigidities|Decorticate Rigidity|Decorticate State|Decorticate States|Posturing, Decerebrate|Posturings, Decerebrate|Rigidities, Decorticate|Rigidity, Decerebrate|Rigidity, Decorticate|State, Decerebrate|States, Decerebrate	Nervous system disease|Signs and symptoms
Deglutition Disorders	MESH:D003680		Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.	MESH:D004935|MESH:D010608	C06.405.117.119|C09.775.174	C06.405.117|C09.775	Deglutition Disorder|Disorders, Deglutition|Dysphagia|Dysphagia, Esophageal|Dysphagia, Oropharyngeal|Esophageal Dysphagia|Oropharyngeal Dysphagia|Swallowing Disorder|Swallowing Disorders	Digestive system disease|Ear-nose-throat disease
Dehydration	MESH:D003681		The condition that results from excessive loss of water from a living organism.	MESH:D010335|MESH:D014883	C18.452.950.179|C23.550.274	C18.452.950|C23.550	Stress, Water|Water Stress	Metabolic disease|Pathology (process)
Deltaretrovirus Infections	MESH:D006800		Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED).	MESH:D007153|MESH:D012192	C01.925.782.815.200|C20.673.483	C01.925.782.815|C20.673	BLV Infection|BLV Infections|Deltaretrovirus Infection|HTLV-BLV Infection|HTLV BLV Infections|HTLV-BLV Infections|HTLV Infection|HTLV Infections|Infection, Deltaretrovirus|Infections, Deltaretrovirus	Immune system disease|Viral disease
Dementia, familial Danish	MESH:C538209	OMIM:117300		MESH:D002386|MESH:D002524|MESH:D003638|MESH:D003704	C09.218.458.341.186/C538209|C10.228.140.252.190/C538209|C10.228.140.380/C538209|C10.597.350.090.500/C538209|C10.597.751.418.341.186/C538209|C11.510.245/C538209|C23.888.592.350.090.200/C538209|C23.888.592.763.393.341.186/C538209|F03.615.400/C538209	C09.218.458.341.186|C10.228.140.252.190|C10.228.140.380|C10.597.350.090.500|C10.597.751.418.341.186|C11.510.245|C23.888.592.350.090.200|C23.888.592.763.393.341.186|F03.615.400	CEREBELLAR ATAXIA, CATARACT, DEAFNESS, AND DEMENTIA OR PSYCHOSIS|Cerebral Amyloid Angiopathy, Itm2b-Related, 2|DEMENTIA, FAMILIAL DANISH|Familial Danish dementia|FDD|Heredopathia ophthalmootoencephalica|HOOE	Ear-nose-throat disease|Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Dementia, Multi-Infarct	MESH:D015161	DO:DOID:8725	Loss of higher cortical functions with retained awareness due to multiple cortical or subcortical CEREBRAL INFARCTION. Memory, judgment, attention span, and impulse control are often impaired, and may be accompanied by PSEUDOBULBAR PALSY; HEMIPARESIS; reflex abnormalities, and other signs of localized neurologic dysfunction. (From Adams et al., Principles of Neurology, 6th ed, p1060)	MESH:D002544|MESH:D015140	C10.228.140.300.150.477.200.199|C10.228.140.300.400.408|C10.228.140.300.775.200.200.199|C10.228.140.380.230.250|C14.907.253.092.477.200.199|C14.907.253.855.200.200.199|C23.550.513.355.250.200.199|C23.550.717.489.250.200.199|F03.615.400.350.400	C10.228.140.300.150.477.200|C10.228.140.300.400|C10.228.140.300.775.200.200|C10.228.140.380.230|C14.907.253.092.477.200|C14.907.253.855.200.200|C23.550.513.355.250.200|C23.550.717.489.250.200|F03.615.400.350	Dementia, Lacunar|Dementia, Multiinfarct|Dementia Multi Infarct|Dementia Multi-Infarct|Dementia, Multi Infarct|Dementia Multi-Infarcts|Dementias, Lacunar|Dementias, Multiinfarct|Dementias, Multi-Infarct|Lacunar Dementia|Lacunar Dementias|Multiinfarct Dementia|Multi Infarct Dementia|Multi-Infarct Dementia|Multi-Infarct, Dementia|Multiinfarct Dementias|Multi-Infarct Dementias|Multi-Infarcts, Dementia	Cardiovascular disease|Mental disorder|Nervous system disease|Pathology (process)
Dementia, Vascular	MESH:D015140	DO:DOID:8725	An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)	MESH:D002537|MESH:D002561|MESH:D003704|MESH:D056784	C10.228.140.300.400|C10.228.140.300.510.800.500|C10.228.140.380.230|C10.228.140.695.500|C14.907.137.126.372.500|C14.907.253.560.350.500|F03.615.400.350	C10.228.140.300|C10.228.140.300.510.800|C10.228.140.380|C10.228.140.695|C14.907.137.126.372|C14.907.253.560.350|F03.615.400	Acute Onset Vascular Dementia|Arteriosclerotic Dementia|Arteriosclerotic Dementias|Arteriosclerotic Encephalopathies, Subcortical|Arteriosclerotic Encephalopathy, Subcortical|Binswanger Disease|Binswanger Encephalopathy|Binswanger's Disease|Binswangers Disease|Binswanger's Encephalopathy|Chronic Progressive Subcortical Encephalopathy|Dementia, Arteriosclerotic|Dementias, Arteriosclerotic|Dementias, Subcortical Vascular|Dementia, Subcortical Vascular|Dementias, Vascular|Disease, Binswanger|Disease, Binswanger's|Encephalopathies, Subcortical Arteriosclerotic|Encephalopathy, Binswanger|Encephalopathy, Binswangers|Encephalopathy, Binswanger's|Encephalopathy, Chronic Progressive Subcortical|Encephalopathy, Subcortical Arteriosclerotic|Encephalopathy, Subcortical, Chronic Progressive|Leukoencephalopathies, Subcortical|Leukoencephalopathy, Subcortical|Subcortical Arteriosclerotic Encephalopathies|Subcortical Arteriosclerotic Encephalopathy|Subcortical Encephalopathy, Chronic Progressive|Subcortical Leukoencephalopathies|Subcortical Leukoencephalopathy|Subcortical Vascular Dementia|Subcortical Vascular Dementias|Vascular Dementia|Vascular Dementia, Acute Onset|Vascular Dementias|Vascular Dementias, Subcortical|Vascular Dementia, Subcortical	Cardiovascular disease|Mental disorder|Nervous system disease
Demyelinating Autoimmune Diseases, CNS	MESH:D020278		Conditions characterized by loss or dysfunction of myelin (see MYELIN SHEATH) in the brain, spinal cord, or optic nerves secondary to autoimmune mediated processes. This may take the form of a humoral or cellular immune response directed toward myelin or OLIGODENDROGLIA associated autoantigens.	MESH:D003711|MESH:D020274|MESH:D056784	C10.114.375|C10.228.140.695.562|C10.314.350|C20.111.258.250	C10.114|C10.228.140.695|C10.314|C20.111.258	Autoimmune Demyelinating Diseases, Central Nervous System|Autoimmune Demyelinating Diseases, Cerebral|Autoimmune Demyelinating Diseases, CNS|Autoimmune Demyelinating Diseases, Spinal Cord|Autoimmune Demyelinating Disorders, CNS|Autoimmune Diseases, Demyelinating, Brain|Brain Autoimmune Demyelinating Diseases|Cerebral Demyelinating Diseases, Autoimmune|CNS Autoimmune Demyelinating Disorders|CNS Demyelinating Autoimmune Diseases|Demyelinating Autoimmune Diseases, Brain|Demyelinating Autoimmune Diseases, Central Nervous System|Demyelinating Autoimmune Diseases, Cerebral|Demyelinating Autoimmune Diseases, Spinal Cord|Demyelinating Autoimmune Disorders, CNS|Demyelinating Disease, Autoimmune, CNS|Spinal Cord Demyelinating Autoimmune Diseases	Immune system disease|Nervous system disease
Demyelinating Diseases	MESH:D003711	DO:DOID:3213	Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.	MESH:D009422	C10.314	C10	Clinically Isolated CNS Demyelinating Syndrome|Clinically Isolated Syndrome, CNS Demyelinating|Demyelinating Disease|Demyelinating Disorder|Demyelinating Disorders|Demyelination|Demyelinations	Nervous system disease
Dendritic Cell Sarcoma, Follicular	MESH:D054740	DO:DOID:6262	Sarcoma of FOLLICULAR DENDRITIC CELLS most often found in the lymph nodes. This rare neoplasm occurs predominately in adults.	MESH:D015620	C04.557.227.190|C15.604.250.390.190	C04.557.227|C15.604.250.390	Follicular Dendritic Cell Sarcoma	Cancer|Lymphatic disease
Dendritic Cell Sarcoma, Interdigitating	MESH:D054739	DO:DOID:7848	A rare sarcoma of INTERDIGITATING CELLS found in the lymph nodes and non-lymphoid organs. They exhibit a variable immunophenotype and lack Birbeck granules.	MESH:D015620	C04.557.227.199|C15.604.250.390.199	C04.557.227|C15.604.250.390	Interdigitating Cell Sarcoma|Interdigitating Cell Sarcomas|Interdigitating Dendritic Cell Sarcoma|Sarcoma, Interdigitating Cell|Sarcomas, Interdigitating Cell	Cancer|Lymphatic disease
Dengue	MESH:D003715	DO:DOID:12205|OMIM:614371	An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.	MESH:D001102|MESH:D006482|MESH:D018177	C01.920.500.270|C01.925.081.270|C01.925.782.350.250.214|C01.925.782.417.214	C01.920.500|C01.925.081|C01.925.782.350.250|C01.925.782.417	Breakbone Fever|Break Bone Fever|Break-Bone Fever|Classical Dengue|Classical Dengue Fever|Classical Dengue Fevers|Classical Dengues|Dengue, Classical|Dengue Fever|Dengue Fever, Classical|DENGUE FEVER, PROTECTION AGAINST, INCLUDED|DENGUE FEVER, SUSCEPTIBILITY TO, INCLUDED|DENGUE HEMORRHAGIC FEVER, SUSCEPTIBILITY TO, INCLUDED|DENGUE SHOCK SYNDROME, SUSCEPTIBILITY TO, INCLUDED|DENGUE VIRUS, SUSCEPTIBILITY TO|Fever, Breakbone|Fever, Break-Bone|Fever, Dengue	Viral disease
Dental Pulp Necrosis	MESH:D003790	DO:DOID:11623	Death of pulp tissue with or without bacterial invasion. When the necrosis is due to ischemia with superimposed bacterial infection, it is referred to as pulp gangrene. When the necrosis is non-bacterial in origin, it is called pulp mummification.	MESH:D003788|MESH:D009336	C07.793.237.315|C23.550.717.182	C07.793.237|C23.550.717	Autolyses, Dental Pulp|Autolysis, Dental Pulp|Dental Pulp Autolyses|Dental Pulp Autolysis|Dental Pulp Gangrene|Dental Pulp Necroses|Gangrene, Dental Pulp|Gangrene, Pulp|Gangrenes, Pulp|Mummification, Pulp|Mummifications, Pulp|Necroses, Dental Pulp|Necroses, Pulp|Necrosis, Dental Pulp|Necrosis, Pulp|Pulp Autolyses, Dental|Pulp Autolysis, Dental|Pulp Gangrene|Pulp Gangrene, Dental|Pulp Gangrenes|Pulp Mummification|Pulp Mummifications|Pulp Necroses|Pulp Necroses, Dental|Pulp Necrosis|Pulp Necrosis, Dental	Mouth disease|Pathology (process)
Dentigerous Cyst	MESH:D003803		Most common follicular odontogenic cyst. Occurs in relation to a partially erupted or unerupted tooth with at least the crown of the tooth to which the cyst is attached protruding into the cystic cavity. May give rise to an ameloblastoma and, in rare instances, undergo malignant transformation.	MESH:D009807	C04.182.089.530.690.310|C05.500.470.690.310|C07.320.450.670.275	C04.182.089.530.690|C05.500.470.690|C07.320.450.670	Cyst, Dentigerous|Cysts, Dentigerous|Dentigerous Cysts	Cancer|Mouth disease|Musculoskeletal disease
Deoxyguanosine Kinase Deficiency	MESH:C580039	DO:DOID:0080121		MESH:D028361	C18.452.660/C580039	C18.452.660	Dguok-Related Mitochondrial Dna Depletion Syndrome|Hepatocerebral Mitochondrial Dna Depletion Syndrome|Mitochondrial Dna Depletion Syndrome, Hepatocerebral Form	Metabolic disease
De Quervain Disease	MESH:D053684	DO:DOID:14107	Stenosing tenosynovitis of the abductor pollicis longus and extensor pollicis brevis tendons in the first dorsal wrist compartment. The presenting symptoms are usually pain and tenderness at the radial styloid. The cause is almost always related to OVERUSE INJURY or is associated with RHEUMATOID ARTHRITIS.	MESH:D053682	C05.651.869.816.200	C05.651.869.816	De Quervain's Disease|De Quervains Disease|De Quervain Stenosing Tenosynovitis|Disease, De Quervain|Stenosing Tenosynovitis, De Quervain	Musculoskeletal disease
Dermatitis	MESH:D003872	DO:DOID:2723	Any inflammation of the skin.	MESH:D012871	C17.800.174	C17.800	Dermatitides	Skin disease
Dermatitis, Contact	MESH:D003877	DO:DOID:2773	A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.	MESH:D003872|MESH:D017443	C17.800.174.255|C17.800.815.255	C17.800.174|C17.800.815	Contact Dermatitides|Contact Dermatitis|Contact Eczema|Contact Hypersensitivities|Contact Hypersensitivity|Contact Sensitivities|Contact Sensitivity|Dermatitides, Contact|Dermatitis Venenata|Eczema, Contact|Hypersensitivities, Contact|Hypersensitivity, Contact|Sensitivities, Contact|Sensitivity, Contact	Skin disease
Dermatitis, Exfoliative	MESH:D003873		The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)	MESH:D003872|MESH:D017443	C17.800.174.318|C17.800.815.318	C17.800.174|C17.800.815	Dermatitis Exfoliativa|Dermatitis Exfoliative|Dermatitis Exfoliative Generalised|Dermatitis Exfoliative Generaliseds|Dermatitis Exfoliative Generalized|Dermatitis Exfoliatives|Erythroderma|Erythrodermas|Exfoliative Dermatitides|Exfoliative Dermatitis|Exfoliative, Dermatitis|Exfoliative Generalised, Dermatitis|Exfoliative Generalized, Dermatitis|Exfoliatives, Dermatitis|Generalised, Dermatitis Exfoliative	Skin disease
Dermatitis, Irritant	MESH:D017453	DO:DOID:2772	A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms.	MESH:D003877	C17.800.174.255.400|C17.800.815.255.400	C17.800.174.255|C17.800.815.255	Dermatitides, Irritant|Dermatitides, Primary Irritant|Dermatitis, Primary Irritant|Irritant Dermatitides|Irritant Dermatitides, Primary|Irritant Dermatitis|Irritant Dermatitis, Primary|Primary Irritant Dermatitides|Primary Irritant Dermatitis	Skin disease
Dermatitis, Occupational	MESH:D009783	DO:DOID:4404	A recurrent contact dermatitis caused by substances found in the work place.	MESH:D003877|MESH:D009784	C17.800.174.255.700|C17.800.815.255.700|C24.270	C17.800.174.255|C17.800.815.255|C24	Dermatitides, Occupational|Dermatoses, Industrial|Dermatosis, Industrial|Industrial Dermatoses|Industrial Dermatosis|Occupational Dermatitides|Occupational Dermatitis	Occupational disease|Skin disease
Dermatitis, Perioral	MESH:D019557		A papular eruption of unknown etiology that progresses to residual papular erythema and scaling usually confined to the area of the mouth, and almost exclusively occurring in young women. It may also be localized or extend to involve the eyelids and adjacent glabella area of the forehead (periocular dermatitis). (Dorland, 28th ed)	MESH:D003872|MESH:D005148	C17.800.174.550|C17.800.271.250	C17.800.174|C17.800.271	Dermatitides, Periocular|Dermatitides, Perioral|Dermatitis, Periocular|Periocular Dermatitides|Periocular Dermatitis|Perioral Dermatitides|Perioral Dermatitis	Skin disease
Dermatitis, Phototoxic	MESH:D017484	DO:DOID:4407	A nonimmunologic, chemically induced type of photosensitivity producing a sometimes vesiculating dermatitis. It results in hyperpigmentation and desquamation of the light-exposed areas of the skin.	MESH:D010787|MESH:D017453	C17.800.174.255.400.225|C17.800.600.335|C17.800.815.255.400.225	C17.800.174.255.400|C17.800.600|C17.800.815.255.400	Contact Dermatitides, Phototoxic|Contact Dermatitis, Phototoxic|Dermatitides, Phototoxic|Dermatitides, Phototoxic Contact|Dermatitis, Contact, Phototoxic|Dermatitis, Phototoxic Contact|Phototoxic Contact Dermatitides|Phototoxic Contact Dermatitis|Phototoxic Dermatitides|Phototoxic Dermatitis|Phototoxicity	Skin disease
Dermatitis, Seborrheic	MESH:D012628	DO:DOID:8741	A chronic inflammatory disease of the skin with unknown etiology. It is characterized by moderate ERYTHEMA, dry, moist, or greasy (SEBACEOUS GLAND) scaling and yellow crusted patches on various areas, especially the scalp, that exfoliate as dandruff. Seborrheic dermatitis is common in children and adolescents with HIV INFECTIONS.	MESH:D003872|MESH:D012625|MESH:D017443|MESH:D017444	C17.800.174.580|C17.800.794.230|C17.800.815.580|C17.800.859.350	C17.800.174|C17.800.794|C17.800.815|C17.800.859	Dermatitides, Seborrheic|Dermatitis Seborrheica|Seborrhea|Seborrheic Dermatitides|Seborrheic Dermatitis	Skin disease
Dermatofibrosarcoma	MESH:D018223	DO:DOID:3507|OMIM:607907	A sarcoma of the deep layers of the skin. The tumors are locally aggressive tends to recur but rarely metastatic. It can be classified into variants depending on the cell type tumors are derived from or by its characteristics: Pigmented variant from MELANIN-containing DERMAL DENDRITIC CELLS; Myxoid variant, myxoid STROMAL CELLS; Giant cell variant characterized by GIANT CELLS in the tumors; and Fibrosarcomatous variant chracterized by tumor areas histologically indistinguishable from FIBROSARCOMA.	MESH:D005354	C04.557.450.565.590.350.320|C04.557.450.795.350.320	C04.557.450.565.590.350|C04.557.450.795.350	Bednar's Tumor|Bednars Tumor|Bednar Tumor|Cell Fibroblastoma, Giant|Cell Fibroblastomas, Giant|Darier Ferrand Tumor|Darier-Ferrand Tumor|Darier Hoffmann Tumor|Darier-Hoffmann Tumor|Dermatofibrosarcoma Protuberan|Dermatofibrosarcoma Protuberan, Familial|Dermatofibrosarcoma Protuberan, Fibrosarcomatous|Dermatofibrosarcoma Protuberan, Giant|Dermatofibrosarcoma Protuberan, Metastatic|Dermatofibrosarcoma Protuberan, Myxoid|Dermatofibrosarcoma Protuberan, Pigmented|Dermatofibrosarcoma Protuberans|Dermatofibrosarcoma Protuberans, Familial|Dermatofibrosarcoma Protuberans, Fibrosarcomatous|Dermatofibrosarcoma Protuberans, Giant|Dermatofibrosarcoma Protuberans, Giant Cell|Dermatofibrosarcoma Protuberans, Metastatic|Dermatofibrosarcoma Protuberans, Myxoid|Dermatofibrosarcoma Protuberans, Pigmented|Dermatofibrosarcomas|DFSP|DFSP, Fibrosarcomatous|DFSP, Juvenile|DFSP, Myxoid|DFSP, Pigmented|DFSPs, Fibrosarcomatous|DFSPs, Juvenile|DFSPs, Myxoid|DFSPs, Pigmented|Familial Dermatofibrosarcoma Protuberan|Familial Dermatofibrosarcoma Protuberans|Fibroblastoma, Giant Cell|Fibroblastomas, Giant Cell|Fibrosarcomatous Dermatofibrosarcoma Protuberan|Fibrosarcomatous Dermatofibrosarcoma Protuberans|Fibrosarcomatous DFSP|Fibrosarcomatous DFSPs|FS-DFSP|Giant Cell Fibroblastoma|Giant Cell Fibroblastomas|Giant Dermatofibrosarcoma Protuberan|Giant Dermatofibrosarcoma Protuberans|Juvenile DFSP|Juvenile DFSPs|Metastatic Dermatofibrosarcoma Protuberan|Metastatic Dermatofibrosarcoma Protuberans|Myxoid Dermatofibrosarcoma Protuberan|Myxoid Dermatofibrosarcoma Protuberans|Myxoid DFSP|Myxoid DFSPs|Pigmented Dermatofibrosarcoma Protuberan|Pigmented Dermatofibrosarcoma Protuberans|Pigmented DFSP|Pigmented DFSPs|Protuberan, Dermatofibrosarcoma|Protuberan, Familial Dermatofibrosarcoma|Protuberan, Fibrosarcomatous Dermatofibrosarcoma|Protuberan, Giant Dermatofibrosarcoma|Protuberan, Metastatic Dermatofibrosarcoma|Protuberan, Myxoid Dermatofibrosarcoma|Protuberan, Pigmented Dermatofibrosarcoma|Protuberans, Dermatofibrosarcoma|Protuberans, Familial Dermatofibrosarcoma|Protuberans, Fibrosarcomatous Dermatofibrosarcoma|Protuberans, Giant Dermatofibrosarcoma|Protuberans, Metastatic Dermatofibrosarcoma|Protuberans, Myxoid Dermatofibrosarcoma|Protuberans, Pigmented Dermatofibrosarcoma|Tumor, Bednar|Tumor, Bednar's|Tumor, Darier-Ferrand|Tumor, Darier-Hoffmann	Cancer
Dermatoleukodystrophy	MESH:C538220			MESH:D001927|MESH:D012871	C10.228.140/C538220|C17.800/C538220	C10.228.140|C17.800		Nervous system disease|Skin disease
Dermatomyositis	MESH:D003882	DO:DOID:10223|DO:DOID:14203	A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)	MESH:D003240|MESH:D012871|MESH:D017285	C05.651.594.819.500|C10.668.491.562.575.500|C17.300.250|C17.800.185	C05.651.594.819|C10.668.491.562.575|C17.300|C17.800	Adult Type Dermatomyositis|Childhood Type Dermatomyositis|Dermatomyositis, Adult Type|Dermatomyositis, Childhood Type|Dermatomyositis, Juvenile|Dermatopolymyositis|Juvenile Dermatomyositis|Juvenile Myositis|Myositis, Juvenile|Polymyositis Dermatomyositis|Polymyositis-Dermatomyositis	Connective tissue disease|Musculoskeletal disease|Nervous system disease|Skin disease
Dermatopathia pigmentosa reticularis	MESH:C535374	DO:DOID:0111342|OMIM:125595		MESH:D000505|MESH:D009260|MESH:D012878|MESH:D017495	C04.588.805/C535374|C17.800.329.937.122/C535374|C17.800.529/C535374|C17.800.621.430/C535374|C17.800.882/C535374|C23.300.035/C535374	C04.588.805|C17.800.329.937.122|C17.800.529|C17.800.621.430|C17.800.882|C23.300.035	DPR	Cancer|Pathology (anatomical condition)|Skin disease
Dermatosis Papulosa Nigra	MESH:C562379	DO:DOID:4400		MESH:D017444	C17.800.859/C562379	C17.800.859		Skin disease
Dermoid Cyst	MESH:D003884	DO:DOID:2658	A tumor consisting of displaced ectodermal structures along the lines of embryonic fusion, the wall being formed of epithelium-lined connective tissue, including skin appendages, and containing keratin, sebum, and hair. (Stedman, 25th ed)	MESH:D003560|MESH:D013724	C04.182.201|C04.557.465.910.250	C04.182|C04.557.465.910	Cyst, Dermoid|Cysts, Dermoid|Dermoid|Dermoid Cysts|Dermoids	Cancer
Dermoid Cysts, Familial Frontonasal	MESH:C563455			MESH:D003884|MESH:D009669	C04.182.201/C563455|C04.557.465.910.250/C563455|C04.588.149.721.600/C563455|C04.588.443.665.650/C563455|C05.116.231.754.600/C563455|C08.460.669/C563455|C08.785.600/C563455|C09.603.669/C563455|C09.647.685/C563455	C04.182.201|C04.557.465.910.250|C04.588.149.721.600|C04.588.443.665.650|C05.116.231.754.600|C08.460.669|C08.785.600|C09.603.669|C09.647.685		Cancer|Ear-nose-throat disease|Musculoskeletal disease|Respiratory tract disease
Desmoplastic cerebral astrocytoma of infancy	MESH:C535945			MESH:D001254|MESH:D001932|MESH:D018288	C04.557.465.625.600.380.080/C535945|C04.557.470.200.380/C535945|C04.557.470.670.380.080/C535945|C04.557.580.625.600.380.080/C535945|C04.588.614.250.195/C535945|C10.228.140.211/C535945|C10.551.240.250/C535945	C04.557.465.625.600.380.080|C04.557.470.200.380|C04.557.470.670.380.080|C04.557.580.625.600.380.080|C04.588.614.250.195|C10.228.140.211|C10.551.240.250		Cancer|Nervous system disease
Desmoplastic Small Round Cell Tumor	MESH:D058405		A rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults. It is most commonly found in the abdomen.	MESH:D012509	C04.557.450.795.315	C04.557.450.795	Desmoplastic Small Cell Tumor|Desmoplastic Small-Cell Tumor|Desmoplastic Small-Cell Tumors|Desmoplastic Small Round-Cell Tumor|Small-Cell Tumor, Desmoplastic|Small-Cell Tumors, Desmoplastic|Tumor, Desmoplastic Small-Cell|Tumors, Desmoplastic Small-Cell	Cancer
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11	OMIM:613721	DO:DOID:0080421		MESH:D013036	C10.228.140.490.375.760/613721|C10.228.140.490.493.875/613721	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE11|EIEE11|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12	OMIM:613722	DO:DOID:0080459		MESH:D013036	C10.228.140.490.375.760/613722|C10.228.140.490.493.875/613722	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE12|EIEE12|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13	OMIM:614558	DO:DOID:0080445		MESH:D013036	C10.228.140.490.375.760/614558|C10.228.140.490.493.875/614558	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE13|EIEE13|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14	OMIM:614959	DO:DOID:0080439		MESH:D013036	C10.228.140.490.375.760/614959|C10.228.140.490.493.875/614959	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE14|EIEE14|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17	OMIM:615473	DO:DOID:0080450		MESH:D013036	C10.228.140.490.375.760/615473|C10.228.140.490.493.875/615473	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE17|EIEE17|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18	OMIM:615476	DO:DOID:0080413		MESH:D013036	C10.228.140.490.375.760/615476|C10.228.140.490.493.875/615476	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE18|EIEE1|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19	OMIM:615744	DO:DOID:0080431		MESH:D013036	C10.228.140.490.375.760/615744|C10.228.140.490.493.875/615744	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE19|EIEE19|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21	OMIM:615833	DO:DOID:0080443		MESH:D013036	C10.228.140.490.375.760/615833|C10.228.140.490.493.875/615833	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE21|EIEE21|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23	OMIM:615859	DO:DOID:0080415		MESH:D013036	C10.228.140.490.375.760/615859|C10.228.140.490.493.875/615859	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE23|EIEE23|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24	OMIM:615871	DO:DOID:0080429		MESH:D013036	C10.228.140.490.375.760/615871|C10.228.140.490.493.875/615871	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE24|EIEE24|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26	OMIM:616056	DO:DOID:0080461		MESH:D013036	C10.228.140.490.375.760/616056|C10.228.140.490.493.875/616056	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE26|EIEE26|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27	OMIM:616139	DO:DOID:0080444		MESH:D013036	C10.228.140.490.375.760/616139|C10.228.140.490.493.875/616139	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE27|EIEE27|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28	OMIM:616211	DO:DOID:0080452		MESH:D013036	C10.228.140.490.375.760/616211|C10.228.140.490.493.875/616211	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE28|EIEE28|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29	OMIM:616339	DO:DOID:0080451		MESH:D013036	C10.228.140.490.375.760/616339|C10.228.140.490.493.875/616339	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE29|EIEE29|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30	OMIM:616341	DO:DOID:0080465		MESH:D013036	C10.228.140.490.375.760/616341|C10.228.140.490.493.875/616341	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE30|EIEE30|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31	OMIM:616346	DO:DOID:0080437		MESH:D013036	C10.228.140.490.375.760/616346|C10.228.140.490.493.875/616346	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE31|EIEE31|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32	OMIM:616366	DO:DOID:0080416		MESH:D013036	C10.228.140.490.375.760/616366|C10.228.140.490.493.875/616366	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE32|EIEE32|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 33	OMIM:616409	DO:DOID:0080463		MESH:D013036	C10.228.140.490.375.760/616409|C10.228.140.490.493.875/616409	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE33|EIEE33|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34	OMIM:616645	DO:DOID:0080460		MESH:D013036	C10.228.140.490.375.760/616645|C10.228.140.490.493.875/616645	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE34|EIEE34|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35	OMIM:616647	DO:DOID:0080458		MESH:D013036	C10.228.140.490.375.760/616647|C10.228.140.490.493.875/616647	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE35|EIEE35|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36	OMIM:300884	DO:DOID:0080470		MESH:D013036	C10.228.140.490.375.760/300884|C10.228.140.490.493.875/300884	C10.228.140.490.375.760|C10.228.140.490.493.875	CDG1S, INCLUDED|CDG Is, INCLUDED|CDGIs, INCLUDED|DEE36|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36;EIEE36 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Is, INCLUDED	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37	OMIM:616981	DO:DOID:0080435		MESH:D013036	C10.228.140.490.375.760/616981|C10.228.140.490.493.875/616981	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE37|EIEE37|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38	OMIM:617020	DO:DOID:0080417		MESH:D013036	C10.228.140.490.375.760/617020|C10.228.140.490.493.875/617020	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE38|EIEE38|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38|GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 23|GPIBD23	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40	OMIM:617065	DO:DOID:0080427		MESH:D013036	C10.228.140.490.375.760/617065|C10.228.140.490.493.875/617065	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE40|EIEE40|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41	OMIM:617105	DO:DOID:0080442		MESH:D013036	C10.228.140.490.375.760/617105|C10.228.140.490.493.875/617105	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE41|EIEE41|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42	OMIM:617106	DO:DOID:0080454		MESH:D013036	C10.228.140.490.375.760/617106|C10.228.140.490.493.875/617106	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE42|EIEE42|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43	OMIM:617113	DO:DOID:0080447		MESH:D013036	C10.228.140.490.375.760/617113|C10.228.140.490.493.875/617113	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE43|EIEE43|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44	OMIM:617132	DO:DOID:0080424		MESH:D013036	C10.228.140.490.375.760/617132|C10.228.140.490.493.875/617132	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE44|EIEE44|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 45	OMIM:617153	DO:DOID:0080428		MESH:D013036	C10.228.140.490.375.760/617153|C10.228.140.490.493.875/617153	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE45|EIEE45|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46	OMIM:617162	DO:DOID:0080456		MESH:D013036	C10.228.140.490.375.760/617162|C10.228.140.490.493.875/617162	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE46|EIEE46|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47	OMIM:617166	DO:DOID:0080425		MESH:D013036	C10.228.140.490.375.760/617166|C10.228.140.490.493.875/617166	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE47|EIEE47|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 48	OMIM:617276	DO:DOID:0080448		MESH:D013036	C10.228.140.490.375.760/617276|C10.228.140.490.493.875/617276	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE48|EIEE48|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 49	OMIM:617281	DO:DOID:0080441		MESH:D013036	C10.228.140.490.375.760/617281|C10.228.140.490.493.875/617281	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE49|EIEE49|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5	OMIM:613477	DO:DOID:0080438		MESH:D013036	C10.228.140.490.375.760/613477|C10.228.140.490.493.875/613477	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE5|EIEE5|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50	OMIM:616457	DO:DOID:0080419		MESH:D013036	C10.228.140.490.375.760/616457|C10.228.140.490.493.875/616457	C10.228.140.490.375.760|C10.228.140.490.493.875	CDG1Z, FORMERLY|CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iz, FORMERLY|DEE50|EIEE50|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51	OMIM:617339	DO:DOID:0080433		MESH:D013036	C10.228.140.490.375.760/617339|C10.228.140.490.493.875/617339	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE51|EIEE51|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52	OMIM:617350	DO:DOID:0080455		MESH:D013036	C10.228.140.490.375.760/617350|C10.228.140.490.493.875/617350	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE52|EIEE52|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53	OMIM:617389	DO:DOID:0080464		MESH:D013036	C10.228.140.490.375.760/617389|C10.228.140.490.493.875/617389	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE53|EIEE53|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 54	OMIM:617391	DO:DOID:0080418		MESH:D013036	C10.228.140.490.375.760/617391|C10.228.140.490.493.875/617391	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE54|EIEE54|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54	Nervous system disease
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7	OMIM:613720	DO:DOID:0080462		MESH:D013036	C10.228.140.490.375.760/613720|C10.228.140.490.493.875/613720	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE7|EIEE7|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	Nervous system disease
Developmental Delay, Epilepsy, and Neonatal Diabetes	MESH:C565253			MESH:D003920|MESH:D004827|MESH:D007232|MESH:D011596	C10.228.140.490/C565253|C10.597.606.881/C565253|C16.614/C565253|C18.452.394.750/C565253|C19.246/C565253|C23.888.592.604.882/C565253	C10.228.140.490|C10.597.606.881|C16.614|C18.452.394.750|C19.246|C23.888.592.604.882		Endocrine system disease|Infant-newborn disease|Metabolic disease|Nervous system disease|Signs and symptoms
Dextrocardia	MESH:D003914	DO:DOID:9565	A congenital defect in which the heart is located on the right side of the THORAX instead of on the left side (levocardia, the normal position). When dextrocardia is accompanied with inverted HEART ATRIA, a right-sided STOMACH, and a left-sided LIVER, the combination is called dextrocardia with SITUS INVERSUS. Dextrocardia may adversely affect other thoracic organs.	MESH:D006330|MESH:D012857	C14.240.400.280|C14.280.400.280|C16.131.240.400.280|C16.131.810.250	C14.240.400|C14.280.400|C16.131.240.400|C16.131.810	Dextrocardias	Cardiovascular disease|Congenital abnormality
dhat syndrome	MESH:C000711649			MESH:D013001|MESH:D061686	C12.100.500.530/C000711649|C12.100.875.743/C000711649|C12.200.294.530/C000711649|F03.835.700/C000711649|F03.875/C000711649	C12.100.500.530|C12.100.875.743|C12.200.294.530|F03.835.700|F03.875	semen loss syndrome|semen-loss syndrome	Mental disorder|Urogenital disease (male)
Diabetes, Gestational	MESH:D016640	DO:DOID:11714	Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.	MESH:D003920|MESH:D011248	C12.050.703.170|C18.452.394.750.448|C19.246.200	C12.050.703|C18.452.394.750|C19.246	Diabetes Mellitus, Gestational|Diabetes, Pregnancy Induced|Diabetes, Pregnancy-Induced|Gestational Diabetes|Gestational Diabetes Mellitus|Pregnancy-Induced Diabetes	Endocrine system disease|Metabolic disease|Pregnancy complication
Diabetes Insipidus	MESH:D003919	DO:DOID:9409	A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.	MESH:D007674|MESH:D010900	C12.050.351.968.419.135|C12.200.777.419.135|C12.950.419.135|C19.700.159	C12.050.351.968.419|C12.200.777.419|C12.950.419|C19.700		Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Diabetes Insipidus, Neurogenic	MESH:D020790	DO:DOID:12388|OMIM:125700	A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).	MESH:D003919	C12.050.351.968.419.135.750|C12.200.777.419.135.750|C12.950.419.135.750|C19.700.159.750	C12.050.351.968.419.135|C12.200.777.419.135|C12.950.419.135|C19.700.159	CDI|Central Diabetes Insipidus|Diabetes Insipidus, Central|Diabetes Insipidus Cranial Type|Diabetes Insipidus, Cranial Type|Diabetes Insipidus, Neurohypophyseal|Diabetes Insipidus, Neurohypophyseal Type|Diabetes Insipidus, Pituitary|Diabetes Insipidus Primary Central|Diabetes Insipidus, Primary Central|Diabetes Insipidus Secondary To Vasopressin Deficiency|Neurogenic Diabetes Insipidus|Neurohypophyseal Diabetes Insipidus|Pituitary Diabetes Insipidus|Vasopressin Defective Diabetes Insipidus|Vasopressin Deficiency	Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Diabetes Mellitus, Congenital Autoimmune	MESH:C565730			MESH:D001327|MESH:D003920	C18.452.394.750/C565730|C19.246/C565730|C20.111/C565730	C18.452.394.750|C19.246|C20.111		Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 10	MESH:C566602	OMIM:601942		MESH:D003922	C18.452.394.750.124/C566602|C19.246.267/C566602|C20.111.327/C566602	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 10|IDDM10|Insulin-Dependent Diabetes Mellitus 10|T1D10|TYPE 1 DIABETES MELLITUS 10	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 11	MESH:C563371	OMIM:601208		MESH:D003922	C18.452.394.750.124/C563371|C19.246.267/C563371|C20.111.327/C563371	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 11|IDDM11|Insulin-Dependent Diabetes Mellitus 11|T1D11|TYPE 1 DIABETES MELLITUS 11	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 12	MESH:C563326	OMIM:601388		MESH:D003922	C18.452.394.750.124/C563326|C19.246.267/C563326|C20.111.327/C563326	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 12|IDDM12|Insulin-Dependent Diabetes Mellitus 12|T1D12|TYPE 1 DIABETES MELLITUS 12	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 13	MESH:C563352	OMIM:601318		MESH:D003922	C18.452.394.750.124/C563352|C19.246.267/C563352|C20.111.327/C563352	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 13|IDDM13|Insulin-Dependent Diabetes Mellitus 13|T1D13|TYPE 1 DIABETES MELLITUS 13	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 15	MESH:C566645	OMIM:601666		MESH:D003922	C18.452.394.750.124/C566645|C19.246.267/C566645|C20.111.327/C566645	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 15|IDDM15|Insulin-Dependent Diabetes Mellitus 15|T1D15|TYPE 1 DIABETES MELLITUS 15	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 17	MESH:C566395	OMIM:603266		MESH:D003922	C18.452.394.750.124/C566395|C19.246.267/C566395|C20.111.327/C566395	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 17|IDDM17|Insulin-Dependent Diabetes Mellitus 17|TID17|TYPE 1 DIABETES MELLITUS 17	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 18	MESH:C565315	OMIM:605598		MESH:D003922	C18.452.394.750.124/C565315|C19.246.267/C565315|C20.111.327/C565315	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 18|IDDM18|Insulin-Dependent Diabetes Mellitus 18|T1D18|TYPE 1 DIABETES MELLITUS 18	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 19	MESH:C565715	OMIM:610155		MESH:D003922	C18.452.394.750.124/C565715|C19.246.267/C565715|C20.111.327/C565715	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 19|IDDM19|T1D19|TYPE 1 DIABETES MELLITUS 19	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 2	MESH:C565100	OMIM:125852		MESH:D003922	C18.452.394.750.124/C565100|C19.246.267/C565100|C20.111.327/C565100	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 2|IDDM2|Insulin-Dependent Diabetes Mellitus 2|T1D2|TYPE 1 DIABETES MELLITUS 2	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 20	MESH:C567286	OMIM:612520		MESH:D003922	C18.452.394.750.124/C567286|C19.246.267/C567286|C20.111.327/C567286	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 20|IDDM20|T1D20|TYPE 1 DIABETES MELLITUS 20	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 21	MESH:C567285	OMIM:612521		MESH:D003922	C18.452.394.750.124/C567285|C19.246.267/C567285|C20.111.327/C567285	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 21|IDDM21|T1D21|TYPE 1 DIABETES MELLITUS 21	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 22	MESH:C567284	OMIM:612522		MESH:D003922	C18.452.394.750.124/C567284|C19.246.267/C567284|C20.111.327/C567284	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 22|IDDM22|T1D22|TYPE 1 DIABETES MELLITUS 22	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 23	MESH:C567233	OMIM:612622		MESH:D003922	C18.452.394.750.124/C567233|C19.246.267/C567233|C20.111.327/C567233	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 23|IDDM23|T1D23|TYPE 1 DIABETES MELLITUS 23	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 24	MESH:C567818	OMIM:613006		MESH:D003922	C18.452.394.750.124/C567818|C19.246.267/C567818|C20.111.327/C567818	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 24|IDDM24|T1D24|TYPE 1 DIABETES MELLITUS 24	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 3	MESH:C563960	OMIM:600318		MESH:D003922	C18.452.394.750.124/C563960|C19.246.267/C563960|C20.111.327/C563960	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 3|IDDM3|Insulin-Dependent Diabetes Mellitus 3|T1D3|TYPE 1 DIABETES MELLITUS 3	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 4	MESH:C563959	OMIM:600319		MESH:D003922	C18.452.394.750.124/C563959|C19.246.267/C563959|C20.111.327/C563959	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 4|IDDM4|Insulin-Dependent Diabetes Mellitus 4|T1D4|TYPE 1 DIABETES MELLITUS 4	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 5	MESH:C563958	OMIM:600320		MESH:D003922	C18.452.394.750.124/C563958|C19.246.267/C563958|C20.111.327/C563958	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 5|IDDM5|Insulin-Dependent Diabetes Mellitus 5|T1D5|TYPE 1 DIABETES MELLITUS 5	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 6	MESH:C566603	OMIM:601941		MESH:D003922	C18.452.394.750.124/C566603|C19.246.267/C566603|C20.111.327/C566603	C18.452.394.750.124|C19.246.267|C20.111.327	AITD5, INCLUDED|DIABETES MELLITUS, INSULIN-DEPENDENT, 6|IDDM6|Insulin-Dependent Diabetes Mellitus 6|INSULIN-DEPENDENT DIABETES MELLITUS 6 AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 5, INCLUDED|T1D6|TYPE 1 DIABETES MELLITUS 6	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 7	MESH:C563957	OMIM:600321		MESH:D003922	C18.452.394.750.124/C563957|C19.246.267/C563957|C20.111.327/C563957	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 7|IDDM7|Insulin-Dependent Diabetes Mellitus 7|T1D7|TYPE 1 DIABETES MELLITUS 7	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Dependent, 8	MESH:C563433	OMIM:600883		MESH:D003922	C18.452.394.750.124/C563433|C19.246.267/C563433|C20.111.327/C563433	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, 8|IDDM8|Insulin-Dependent Diabetes Mellitus 8|T1D8|TYPE 1 DIABETES MELLITUS 8	Endocrine system disease|Immune system disease|Metabolic disease
Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans	MESH:C562710	OMIM:610549		MESH:D000052|MESH:D003920|MESH:D007333	C17.800.621.430.530.100/C562710|C18.452.394.750/C562710|C18.452.394.968.500/C562710|C19.246/C562710	C17.800.621.430.530.100|C18.452.394.750|C18.452.394.968.500|C19.246	Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans, Type A|INSULIN RECEPTOR, DEFECT IN, WITH INSULIN-RESISTANT DIABETES MELLITUS AND ACANTHOSIS NIGRICANS|Insulin Receptor Defect with Insulin-Resistant Diabetes Mellitus and Acanthosis Nigricans|IRAN, Type A	Endocrine system disease|Metabolic disease|Skin disease
Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis	MESH:C563796	OMIM:609069		MESH:D003920|MESH:D005317|MESH:D019066	C12.050.703.277.370/C563796|C16.300.390/C563796|C18.452.394.750/C563796|C19.246/C563796|C23.550.291.812/C563796|C23.550.393.450/C563796	C12.050.703.277.370|C16.300.390|C18.452.394.750|C19.246|C23.550.291.812|C23.550.393.450	DIABETES MELLITUS, PERMANENT NEONATAL, WITH CEREBELLAR AGENESIS|PACA|Pancreatic and Cerebellar Agenesis	Endocrine system disease|Fetal disease|Metabolic disease|Pathology (process)|Pregnancy complication
Diabetes Mellitus, Permanent Neonatal, With Neurologic Features	MESH:C563424			MESH:D003920|MESH:D009461	C10.597/C563424|C18.452.394.750/C563424|C19.246/C563424|C23.888.592/C563424	C10.597|C18.452.394.750|C19.246|C23.888.592		Endocrine system disease|Metabolic disease|Nervous system disease|Signs and symptoms
Diabetes Mellitus, Transient Neonatal, 1	MESH:C563322	OMIM:601410		MESH:D003920|MESH:D007232	C16.614/C563322|C18.452.394.750/C563322|C19.246/C563322	C16.614|C18.452.394.750|C19.246	6q24-RELATED DIABETES MELLITUS|DMTN|TNDM|TNDM1	Endocrine system disease|Infant-newborn disease|Metabolic disease
Diabetes Mellitus, Transient Neonatal, 2	MESH:C563672	OMIM:610374		MESH:D003920|MESH:D007232	C16.614/C563672|C18.452.394.750/C563672|C19.246/C563672	C16.614|C18.452.394.750|C19.246	TNDM2	Endocrine system disease|Infant-newborn disease|Metabolic disease
Diabetes Mellitus, Type 1	MESH:D003922	DO:DOID:9744|OMIM:222100|OMIM:612227	A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.	MESH:D001327|MESH:D003920	C18.452.394.750.124|C19.246.267|C20.111.327	C18.452.394.750|C19.246|C20.111	Autoimmune Diabetes|Brittle Diabetes Mellitus|Diabetes, Autoimmune|Diabetes, Juvenile-Onset|Diabetes Mellitus, Brittle|Diabetes Mellitus, Insulin Dependent|Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Insulin-Dependent, 1|DIABETES MELLITUS, INSULIN-DEPENDENT, 1, INCLUDED|Diabetes Mellitus, Juvenile Onset|Diabetes Mellitus, Juvenile-Onset|Diabetes Mellitus, Ketosis Prone|Diabetes Mellitus, Ketosis-Prone|Diabetes Mellitus, Sudden Onset|Diabetes Mellitus, Sudden-Onset|Diabetes Mellitus, Type I|Diabetes, Type 1|IDDM|IDDM1, INCLUDED|Insulin-Dependent Diabetes Mellitus|Insulin Dependent Diabetes Mellitus 1|Insulin-Dependent Diabetes Mellitus 1|INSULIN-DEPENDENT DIABETES MELLITUS 1, INCLUDED|Juvenile Onset Diabetes|Juvenile-Onset Diabetes|JUVENILE-ONSET DIABETES;JOD TYPE 1 DIABETES MELLITUS 1, INCLUDED|Juvenile-Onset Diabetes Mellitus|Ketosis-Prone Diabetes Mellitus|KPD|Sudden-Onset Diabetes Mellitus|T1D|T1D1, INCLUDED|Type 1 Diabetes|Type 1 Diabetes Mellitus	Endocrine system disease|Immune system disease|Metabolic disease
Diabetic Angiopathies	MESH:D003925	DO:DOID:11713	VASCULAR DISEASES that are associated with DIABETES MELLITUS.	MESH:D014652|MESH:D048909	C14.907.320|C19.246.099.500	C14.907|C19.246.099	Angiopathies, Diabetic|Angiopathy, Diabetic|Diabetic Angiopathy|Diabetic Microangiopathies|Diabetic Microangiopathy|Diabetic Vascular Complication|Diabetic Vascular Complications|Diabetic Vascular Disease|Diabetic Vascular Diseases|Microangiopathies, Diabetic|Microangiopathy, Diabetic|Vascular Complication, Diabetic|Vascular Complications, Diabetic|Vascular Disease, Diabetic|Vascular Diseases, Diabetic	Cardiovascular disease|Endocrine system disease
Diabetic Cardiomyopathies	MESH:D058065		Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.	MESH:D009202|MESH:D048909	C14.280.238.235|C19.246.099.625	C14.280.238|C19.246.099	Cardiomyopathies, Diabetic|Cardiomyopathy, Diabetic|Diabetic Cardiomyopathy	Cardiovascular disease|Endocrine system disease
Diabetic Foot	MESH:D017719		Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.	MESH:D003925|MESH:D003929|MESH:D016523	C14.907.320.191|C17.800.893.592.450.200|C19.246.099.500.191|C19.246.099.937.250	C14.907.320|C17.800.893.592.450|C19.246.099.500|C19.246.099.937	Diabetic Feet|Feet, Diabetic|Foot, Diabetic|Foot Ulcer, Diabetic	Cardiovascular disease|Endocrine system disease|Skin disease
Diabetic Nephropathies	MESH:D003928		KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.	MESH:D007674|MESH:D048909	C12.050.351.968.419.192|C12.200.777.419.192|C12.950.419.192|C19.246.099.875	C12.050.351.968.419|C12.200.777.419|C12.950.419|C19.246.099	Diabetic Glomerulosclerosis|Diabetic Kidney Disease|Diabetic Kidney Diseases|Diabetic Nephropathy|Glomerulosclerosis, Diabetic|Glomerulosclerosis, Nodular|Intracapillary Glomerulosclerosis|Kidney Disease, Diabetic|Kidney Diseases, Diabetic|Kimmelstiel Wilson Disease|Kimmelstiel-Wilson Disease|Kimmelstiel Wilson Syndrome|Kimmelstiel-Wilson Syndrome|Nephropathies, Diabetic|Nephropathy, Diabetic|Nodular Glomerulosclerosis|Syndrome, Kimmelstiel-Wilson	Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Diabetic Neuropathies	MESH:D003929	DO:DOID:11503|DO:DOID:12785|DO:DOID:9743	Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)	MESH:D010523|MESH:D048909	C10.668.829.300|C19.246.099.937	C10.668.829|C19.246.099	Amyotrophies, Diabetic|Amyotrophy, Diabetic|Asymmetric Diabetic Proximal Motor Neuropathy|Asymmetric Polyneuropathies, Diabetic|Asymmetric Polyneuropathy, Diabetic|Autonomic Neuropathies, Diabetic|Autonomic Neuropathy, Diabetic|Diabetic Amyotrophies|Diabetic Amyotrophy|Diabetic Asymmetric Polyneuropathies|Diabetic Asymmetric Polyneuropathy|Diabetic Autonomic Neuropathies|Diabetic Autonomic Neuropathy|Diabetic Mononeuropathies|Diabetic Mononeuropathy|Diabetic Mononeuropathy Simplex|Diabetic Mononeuropathy Simplices|Diabetic Neuralgia|Diabetic Neuralgias|Diabetic Neuropathies, Painful|Diabetic Neuropathy|Diabetic Neuropathy, Painful|Diabetic Polyneuropathies|Diabetic Polyneuropathy|Mononeuropathies, Diabetic|Mononeuropathy, Diabetic|Mononeuropathy Simplex, Diabetic|Mononeuropathy Simplices, Diabetic|Neuralgia, Diabetic|Neuralgias, Diabetic|Neuropathies, Diabetic|Neuropathies, Diabetic Autonomic|Neuropathies, Painful Diabetic|Neuropathy, Diabetic|Neuropathy, Diabetic Autonomic|Neuropathy, Painful Diabetic|Painful Diabetic Neuropathies|Painful Diabetic Neuropathy|Polyneuropathies, Diabetic|Polyneuropathies, Diabetic Asymmetric|Polyneuropathy, Diabetic|Polyneuropathy, Diabetic Asymmetric|Simplex, Diabetic Mononeuropathy|Simplices, Diabetic Mononeuropathy|Symmetric Diabetic Proximal Motor Neuropathy	Endocrine system disease|Nervous system disease
Diabetic Retinopathy	MESH:D003930	DO:DOID:8947	Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.	MESH:D003925|MESH:D012164	C11.768.257|C14.907.320.382|C19.246.099.500.382	C11.768|C14.907.320|C19.246.099.500	Diabetic Retinopathies|Retinopathies, Diabetic|Retinopathy, Diabetic	Cardiovascular disease|Endocrine system disease|Eye disease
Diaper Rash	MESH:D003963		A type of irritant dermatitis localized to the area in contact with a diaper and occurring most often as a reaction to prolonged contact with urine, feces, or retained soap or detergent.	MESH:D017453	C17.800.174.255.400.250|C17.800.815.255.400.250	C17.800.174.255.400|C17.800.815.255.400	Diaper Rashes|Rash, Diaper|Rashes, Diaper	Skin disease
Diarrhea 4, Malabsorptive, Congenital	MESH:C563673	OMIM:610370		MESH:D003967|MESH:D008286	C06.405.469.637/C563673|C18.452.603/C563673|C23.888.821.214/C563673	C06.405.469.637|C18.452.603|C23.888.821.214	DIAR4|Enteric Anendocrinosis	Digestive system disease|Metabolic disease|Signs and symptoms
Diarrhea 5, With Tufting Enteropathy, Congenital	MESH:C567703	OMIM:613217		MESH:D003968|MESH:D008286	C06.405.469.637/C567703|C18.452.603/C567703|C23.888.821.214.500/C567703	C06.405.469.637|C18.452.603|C23.888.821.214.500	CTE|DIAR5|Enteropathy, Congenital Tufting|Intestinal Epithelial Cell Dysplasia	Digestive system disease|Metabolic disease|Signs and symptoms
Diarrhea prodrome + Hemolytic-Uremic Syndrome	MESH:C531700			MESH:D006463	C12.050.351.968.419.936.463/C531700|C12.200.777.419.936.463/C531700|C12.950.419.936.463/C531700|C15.378.071.141.610/C531700|C15.378.140.855.925.500/C531700	C12.050.351.968.419.936.463|C12.200.777.419.936.463|C12.950.419.936.463|C15.378.071.141.610|C15.378.140.855.925.500	Diarrhea prodrome + HUS	Blood disease|Urogenital disease (female)|Urogenital disease (male)
Diaschisis	MESH:D000087505		Loss or decreased brain function within intact region of the brain distant from the site of the lesion.	MESH:D001927	C10.228.140.390	C10.228.140	Connectional Diaschisis|Diaschisis, Connectional|Diaschisis, Focal|Focal Diaschisis	Nervous system disease
Diastasis, Bone	MESH:D000070631		Abnormal separation of bones, often from a LIGAMENT.	MESH:D004204	C05.550.518.192|C26.289.192	C05.550.518|C26.289	Bone Diastases|Bone Diastasis|Diastases, Bone	Musculoskeletal disease|Wounds and injuries
Diastasis, Muscle	MESH:D000070630		Abnormal separation of muscles.	MESH:D004204	C05.550.518.288|C26.289.288	C05.550.518|C26.289	Diastases, Muscle|Muscle Diastases|Muscle Diastasis|Myodiastases|Myodiastasis	Musculoskeletal disease|Wounds and injuries
Dientamoebiasis	MESH:D004030	DO:DOID:946	Gastrointestinal infection with organisms of the genus DIENTAMOEBA.	MESH:D007411|MESH:D011528	C01.610.432.275|C01.610.752.275|C06.405.469.452.275	C01.610.432|C01.610.752|C06.405.469.452	Dientamoeba fragilis Infection|Dientamoeba fragilis Infections|Dientamoeba Infection|Dientamoeba Infections|Dientamoebiases|Infection, Dientamoeba|Infection, Dientamoeba fragilis|Infections, Dientamoeba|Infections, Dientamoeba fragilis	Digestive system disease|Parasitic disease
Dieterich's disease	MESH:C536172			MESH:D010020	C05.116.852/C536172|C23.550.717.732/C536172	C05.116.852|C23.550.717.732	Avascular necrosis of the metacarpal head|Dieterich disease	Musculoskeletal disease|Pathology (process)
Diffuse alopecia	MESH:C531609			MESH:D000506	C17.800.329.937.122.147/C531609	C17.800.329.937.122.147	Alopecia Celsi|Cazenave's Vitiligo|Celsus' Vitiligo|Jonston's Alopecia|Marginal alopecia|Patchy alopecia	Skin disease
Diffuse Axonal Injury	MESH:D020833		A relatively common sequela of blunt head injury, characterized by a global disruption of axons throughout the brain. Associated clinical features may include NEUROBEHAVIORAL MANIFESTATIONS; PERSISTENT VEGETATIVE STATE; DEMENTIA; and other disorders.	MESH:D000070625	C10.228.140.199.388.500|C10.900.300.087.219.500|C26.915.300.200.188.500	C10.228.140.199.388|C10.900.300.087.219|C26.915.300.200.188	Axonal Injuries, Diffuse|Axonal Injury, Diffuse|DAI (Diffuse Axonal Injury)|DAIs (Diffuse Axonal Injury)|Diffuse Axonal Injuries|Injuries, Diffuse Axonal|Injury, Diffuse Axonal	Nervous system disease|Wounds and injuries
Diffuse Cerebral Sclerosis of Schilder	MESH:D002549	DO:DOID:0060215|DO:DOID:0080122	A rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers' Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. (From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13(4-5):267-73)	MESH:D001927|MESH:D020278	C10.114.375.112|C10.228.140.400|C10.228.140.695.562.112|C10.314.350.112|C20.111.258.250.175	C10.114.375|C10.228.140|C10.228.140.695.562|C10.314.350|C20.111.258.250	Alper Disease|Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis|Alper's Disease|Alpers Disease|Alpers' Disease|Alpers Huttenlocher Syndrome|Alpers-Huttenlocher Syndrome|Alpers Progressive Infantile Poliodystrophy|Alper's Syndrome|Alpers Syndrome|Alpers' Syndrome|Alper Syndrome|Balo Concentric Sclerosis|Balo's Concentric Sclerosis|Cerebral Sclerosis, Diffuse|Concentric Sclerosis, Balo|Concentric Sclerosis, Balo's|Diffuse Cerebral Scleroses|Diffuse Cerebral Sclerosis|Diffuse Scleroses, Myelinoclastic|Diffuse Sclerosis, Myelinoclastic|Disease, Alpers'|Disease, Schilder|Disease, Schilder's|Encephalitis Periaxialis|Encephalitis Periaxialis Concentrica|Encephalitis Periaxialis Diffusa|Myelinoclastic Diffuse Scleroses|Myelinoclastic Diffuse Sclerosis|Neuronal Degeneration Of Childhood With Liver Disease, Progressive|Poliodystrophia Cerebri|Progressive Neuronal Degeneration of Childhood with Liver Disease|Progressive Sclerosing Poliodystrophies|Progressive Sclerosing Poliodystrophy|Schilder Disease|Schilder's Disease|Schilders Disease|Scleroses, Balo's Concentric|Scleroses, Myelinoclastic Diffuse|Sclerosis, Diffuse Cerebral|Sclerosis, Myelinoclastic Diffuse|Sudanophilic Cerebral Sclerosis|Syndrome, Alpers|Syndrome, Alpers-Huttenlocher	Immune system disease|Nervous system disease
Diffuse Intrinsic Pontine Glioma	MESH:D000080443		A rare, aggressive brain tumor that forms in the GLIAL CELLS in the PONS.	MESH:D005910|MESH:D020295	C04.557.465.625.600.380.185|C04.557.470.670.380.185|C04.557.580.625.600.380.185|C04.588.614.250.195.411.100.500|C10.228.140.211.500.100.500|C10.551.240.250.400.200.500	C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380|C04.588.614.250.195.411.100|C10.228.140.211.500.100|C10.551.240.250.400.200	Brain Tumor, DIPG|DIPG Brain Tumor|DIPG Brain Tumors|DIPG, Diffuse Intrinsic Pontine Glioma	Cancer|Nervous system disease
Diffuse Lewy Body Disease with Gaze Palsy	MESH:C565077			MESH:D015835|MESH:D020961	C10.228.140.079.862.400/C565077|C10.228.140.380.422/C565077|C10.228.662.600.200/C565077|C10.228.758/C565077|C10.292.562/C565077|C10.574.928.500/C565077|C11.590/C565077|F03.615.400.512/C565077	C10.228.140.079.862.400|C10.228.140.380.422|C10.228.662.600.200|C10.228.758|C10.292.562|C10.574.928.500|C11.590|F03.615.400.512		Eye disease|Mental disorder|Nervous system disease
Digestive System Fistula	MESH:D016154		An abnormal passage communicating between any components of the digestive system, or between any part of the digestive system and surrounding organ(s).	MESH:D004066|MESH:D005402	C06.267|C23.300.575.185	C06|C23.300.575	Digestive System Fistulas|Fistula, Digestive System|Fistulas, Digestive System	Digestive system disease|Pathology (anatomical condition)
Digestive System Neoplasms	MESH:D004067	DO:DOID:3119	Tumors or cancer of the DIGESTIVE SYSTEM.	MESH:D004066|MESH:D009371	C04.588.274|C06.301	C04.588|C06	Cancer, Digestive System|Cancer of Digestive System|Cancer of the Digestive System|Cancers, Digestive System|Digestive System Cancer|Digestive System Cancers|Digestive System Neoplasm|Neoplasm, Digestive System|Neoplasms, Digestive System	Cancer|Digestive system disease
Digital ulcers	MESH:C000721267			MESH:D012883	C17.800.893/C000721267	C17.800.893	Acral ulceration|Acral ulcers|Finger ulcers	Skin disease
Dimauro disease	MESH:C536176	OMIM:261670		MESH:D007674|MESH:D009135	C05.651/C536176|C10.668.491/C536176|C12.050.351.968.419/C536176|C12.200.777.419/C536176|C12.950.419/C536176	C05.651|C10.668.491|C12.050.351.968.419|C12.200.777.419|C12.950.419	Deficiency Mutase Phosphoglycerate|Glycogen Storage Disease X|Gsd10|Gsd X|Human muscle phosphoglycerate mutase deficiency|Myopathy due to phosphoglycerate mutase deficiency|Pgam Deficiency|PGAMM deficiency|Phosphoglycerate Mutase Deficiency|Phosphoglycerate Mutase, Muscle, Deficiency of	Musculoskeletal disease|Nervous system disease|Urogenital disease (female)|Urogenital disease (male)
Diplopia	MESH:D004172		A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.	MESH:D014786	C10.597.751.941.339|C11.966.339|C23.888.592.763.941.339	C10.597.751.941|C11.966|C23.888.592.763.941	Cortical Diplopia|Cortical Diplopias|Diplopia, Cortical|Diplopia, Horizontal|Diplopia, Intermittent|Diplopia, Monocular|Diplopia, Refractive|Diplopias|Diplopias, Cortical|Diplopias, Horizontal|Diplopias, Intermittent|Diplopias, Monocular|Diplopias, Refractive|Diplopias, Unilateral|Diplopias, Vertical|Diplopia, Unilateral|Diplopia, Vertical|Double Vision|Horizontal Diplopia|Horizontal Diplopias|Intermittent Diplopia|Intermittent Diplopias|Monocular Diplopia|Monocular Diplopias|Polyopsia|Polyopsias|Refractive Diplopia|Refractive Diplopias|Unilateral Diplopia|Unilateral Diplopias|Vertical Diplopia|Vertical Diplopias|Vision, Double	Eye disease|Nervous system disease|Signs and symptoms
Dipsogenic Diabetes Insipidus	MESH:C548013			MESH:D003919	C12.050.351.968.419.135/C548013|C12.200.777.419.135/C548013|C12.950.419.135/C548013|C19.700.159/C548013	C12.050.351.968.419.135|C12.200.777.419.135|C12.950.419.135|C19.700.159		Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Discitis	MESH:D015299	DO:DOID:10986	Inflammation of an INTERVERTEBRAL DISC or disk space which may lead to disk erosion. Until recently, discitis has been defined as a nonbacterial inflammation and has been attributed to aseptic processes (e.g., chemical reaction to an injected substance). However, recent studies provide evidence that infection may be the initial cause, but perhaps not the promoter, of most cases of discitis. Discitis has been diagnosed in patients following discography, myelography, lumbar puncture, paravertebral injection, and obstetrical epidural anesthesia. Discitis following chemonucleolysis (especially with chymopapain) is attributed to chemical reaction by some and to introduction of microorganisms by others.	MESH:D013166	C01.160.762.301|C05.116.165.762.301|C05.116.900.853.500	C01.160.762|C05.116.165.762|C05.116.900.853	Discitides|Diskitides|Diskitis|Spondylodiscitides|Spondylodiscitis|Spondylodiskitides|Spondylodiskitis	Musculoskeletal disease
Discrete Subaortic Stenosis	MESH:D021922	DO:DOID:5804	A type of constriction that is caused by the presence of a fibrous ring (discrete type) below the AORTIC VALVE, anywhere between the aortic valve and the MITRAL VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.	MESH:D001020	C14.280.484.048.750.070.210|C14.280.955.249.070.210	C14.280.484.048.750.070|C14.280.955.249.070	Discrete Subaortic Stenoses|Stenoses, Discrete Subaortic|Stenosis, Discrete Subaortic|Subaortic Stenoses, Discrete|Subaortic Stenosis, Discrete	Cardiovascular disease
Diseases	MESH:C				C			
Disorders of Environmental Origin	MESH:D007280		Disorders caused by external forces rather than by physiologic dysfunction or by pathogens.	MESH:C	C21	C		Environmental origin disorders
Disseminated Intravascular Coagulation	MESH:D004211	DO:DOID:11247	A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.	MESH:D001778|MESH:D006474|MESH:D019851	C15.378.100.220|C15.378.463.250|C15.378.925.220	C15.378.100|C15.378.463|C15.378.925	Coagulation, Disseminated Intravascular|Coagulation, Intravascular Disseminated|Coagulations, Disseminated Intravascular|Coagulations, Intravascular Disseminated|Coagulopathies, Consumption|Coagulopathy, Consumption|Consumption Coagulopathies|Consumption Coagulopathy|Disseminated Coagulation, Intravascular|Disseminated Coagulations, Intravascular|Disseminated Intravascular Coagulations|Intravascular Coagulation, Disseminated|Intravascular Coagulations, Disseminated|Intravascular Disseminated Coagulation|Intravascular Disseminated Coagulations	Blood disease
Disseminated Sclerosis with Narcolepsy	MESH:C565621			MESH:D009103|MESH:D009290	C10.114.375.500/C565621|C10.314.350.500/C565621|C10.886.425.800.200.750/C565621|C20.111.258.250.500/C565621|F03.870.400.800.200.750/C565621	C10.114.375.500|C10.314.350.500|C10.886.425.800.200.750|C20.111.258.250.500|F03.870.400.800.200.750		Immune system disease|Mental disorder|Nervous system disease
Distal Hereditary Motor Neuropathy, Type II	MESH:C580044	DO:DOID:0111206		MESH:D009134	C10.228.854.468/C580044|C10.574.562.500/C580044|C10.668.467.500/C580044	C10.228.854.468|C10.574.562.500|C10.668.467.500		Nervous system disease
Distal Osteosclerosis	MESH:C565093			MESH:D010026	C05.116.099.708.702/C565093	C05.116.099.708.702	Osteosclerosis, Distal	Musculoskeletal disease
Distichiasis with Congenital Anomalies of the Heart and Peripheral Vasculature	MESH:C565092			MESH:D006330|MESH:D054079	C14.240.400/C565092|C14.240.850/C565092|C14.280.400/C565092|C16.131.240.400/C565092|C16.131.240.850/C565092	C14.240.400|C14.240.850|C14.280.400|C16.131.240.400|C16.131.240.850		Cardiovascular disease|Congenital abnormality
Diverticulosis of Bowel, Hernia, and Retinal Detachment	MESH:C565619			MESH:D012163|MESH:D043963|MESH:D046449	C06.405.469.158.587/C565619|C11.768.648/C565619|C23.300.707.374/C565619	C06.405.469.158.587|C11.768.648|C23.300.707.374		Digestive system disease|Eye disease|Pathology (anatomical condition)
Diverticulosis, Small Intestinal	MESH:C565620			MESH:D004240	C06.405.205.282.750/C565620|C23.300.415/C565620	C06.405.205.282.750|C23.300.415		Digestive system disease|Pathology (anatomical condition)
Diverticulum	MESH:D004240		A pouch or sac developed from a tubular or saccular organ, such as the GASTROINTESTINAL TRACT.	MESH:D000076385|MESH:D020763	C06.405.205.282.750|C23.300.415	C06.405.205.282|C23.300	Diverticula|Diverticulosis	Digestive system disease|Pathology (anatomical condition)
Diverticulum, Colon	MESH:D004241		A pouch or sac opening from the COLON.	MESH:D004240	C06.405.205.282.750.500|C23.300.415.500	C06.405.205.282.750|C23.300.415	Colon Diverticula|Colon Diverticulum|Colonic Diverticula|Colonic Diverticulum|Diverticula, Colon|Diverticula, Colonic|Diverticulum, Colonic	Digestive system disease|Pathology (anatomical condition)
Diverticulum, Esophageal	MESH:D004936		Saccular protrusion beyond the wall of the ESOPHAGUS.	MESH:D004240	C06.405.205.282.750.625|C23.300.415.625	C06.405.205.282.750|C23.300.415	Diverticula, Esophageal|Esophageal Diverticula|Esophageal Diverticulum	Digestive system disease|Pathology (anatomical condition)
Diverticulum, Stomach	MESH:D013273		Saccular, outward protrusion of all or a portion of the wall of the STOMACH.	MESH:D004240	C06.405.205.282.750.687|C23.300.415.687	C06.405.205.282.750|C23.300.415	Diverticula, Gastric|Diverticula, Stomach|Diverticulum, Gastric|Gastric Diverticula|Gastric Diverticulum|Stomach Diverticula|Stomach Diverticulum	Digestive system disease|Pathology (anatomical condition)
DK Phocomelia Syndrome	MESH:C565618			MESH:D000015|MESH:D004480|MESH:D004677|MESH:D013921|MESH:D014564	C05.660.585.350/C565618|C10.500.680.488/C565618|C12.050.351.875/C565618|C12.200.706/C565618|C12.800/C565618|C15.378.140.855/C565618|C16.131.077/C565618|C16.131.621.585.350/C565618|C16.131.666.680.488/C565618|C16.131.939/C565618|C23.300.707.186/C565618	C05.660.585.350|C10.500.680.488|C12.050.351.875|C12.200.706|C12.800|C15.378.140.855|C16.131.077|C16.131.621.585.350|C16.131.666.680.488|C16.131.939|C23.300.707.186	Phocomelia, Thrombocytopenia, Encephalocele, Urogenital Malformations|Von Voss-Cherstvoy Syndrome	Blood disease|Congenital abnormality|Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
DNA Repair-Deficiency Disorders	MESH:D049914		Disorders resulting from defective DNA REPAIR processes or the associated cellular responses to DNA DAMAGE.	MESH:D008659	C18.452.284	C18.452	Chromosome Instability Syndrome|Chromosome Instability Syndromes|Deficient DNA Repair|Deficient DNA Repairs|Disorder, DNA Repair-Deficiency|Disorders, DNA Repair-Deficiency|DNA Repair-Deficiencies|DNA Repair Deficiency|DNA Repair-Deficiency|DNA Repair-Deficiency Disorder|DNA Repair Deficiency Disorders|DNA Repair, Deficient|DNA Repairs, Deficient|Repair, Deficient DNA|Repairs, Deficient DNA|Syndrome, Chromosome Instability|Syndromes, Chromosome Instability	Metabolic disease
DNA Virus Infections	MESH:D004266		Diseases caused by DNA VIRUSES.	MESH:D014777	C01.925.256	C01.925	DNA Virus Infection|Infection, DNA Virus|Infections, DNA Virus|Virus Infection, DNA|Virus Infections, DNA	Viral disease
Dohle Bodies and Leukemia	MESH:C565617			MESH:D015470	C04.557.337.539.275/C565617	C04.557.337.539.275		Cancer
Donath-Landsteiner hemolytic anemia	MESH:C538618			MESH:D000744	C15.378.071.141.125/C538618|C20.111.175/C538618	C15.378.071.141.125|C20.111.175	Donath-Landsteiner syndrome|Dressler syndrome|Harley syndrome|Immune hemolytic anemia, paroxysmal cold	Blood disease|Immune system disease
dopamine beta hydroxylase deficiency	MESH:C535600	DO:DOID:0090145|OMIM:223360		MESH:D001342	C10.177/C535600	C10.177	Congenital dopamine beta hydroxylase deficiency|dopamine beta-hydroxylase deficiency|Dopamine beta Hydroxylase Deficiency, Congenital|DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL|dopamine b-hydroxylase|Noradrenaline deficiency|Norepinephrine deficiency|ORTHOSTATIC HYPOTENSION 1|ORTHYP1	Nervous system disease
Double Nail for Fifth Toe	MESH:C565090			MESH:D009260|MESH:D009264	C17.800.529/C565090|C23.300.820/C565090	C17.800.529|C23.300.820		Pathology (anatomical condition)|Skin disease
Double Outlet Right Ventricle	MESH:D004310	DO:DOID:6406	Incomplete transposition of the great vessels in which both the AORTA and the PULMONARY ARTERY arise from the RIGHT VENTRICLE. The only outlet of the LEFT VENTRICLE is a large ventricular septal defect (VENTRICULAR SEPTAL DEFECTS or VSD). The various subtypes are classified by the location of the septal defect, such as subaortic, subpulmonary, or noncommitted.	MESH:D006345|MESH:D014188	C14.240.400.560.540.500|C14.240.400.915.300|C14.280.400.560.540.500|C14.280.400.915.300|C16.131.240.400.560.540.500|C16.131.240.400.915.300	C14.240.400.560.540|C14.240.400.915|C14.280.400.560.540|C14.280.400.915|C16.131.240.400.560.540|C16.131.240.400.915	Anomaly, Taussig-Bing|Double-Outlet Right Ventricle|Double Outlet Right Ventricle, Noncommitted VSD|Double-Outlet Right Ventricles|Double Outlet Right Ventricle, Subaortic VSD|Double Outlet Right Ventricle, Subpulmonary VSD|Right Ventricle, Double-Outlet|Taussig Bing Anomaly|Taussig-Bing Anomaly|Ventricle, Double-Outlet Right	Cardiovascular disease|Congenital abnormality
Doughnut Lesions of Skull, Familial	MESH:C565089			MESH:D001848	C05.116.099/C565089	C05.116.099		Musculoskeletal disease
Doyne honeycomb retinal dystrophy	MESH:C535602	DO:DOID:0060745|OMIM:126600		MESH:D015594	C10.292.700.450/C535602|C11.640.513/C535602	C10.292.700.450|C11.640.513	DHRD|Doyne honeycomb degeneration of retina|DOYNE HONEYCOMB DEGENERATION OF RETINA;DHD MALATTIA LEVENTINESE, INCLUDED|DRUSEN, RADIAL, AUTOSOMAL DOMINANT, INCLUDED|Malattia Leventinese|MLVT, INCLUDED	Eye disease|Nervous system disease
Drachtman Weinblatt Sitarz syndrome	MESH:C535603			MESH:D001855|MESH:D009421	C10.500/C535603|C15.378.190/C535603|C16.131.666/C535603	C10.500|C15.378.190|C16.131.666	Marrow hypoplasia associated with congenital neurologic anomalies	Blood disease|Congenital abnormality|Nervous system disease
Drug Hypersensitivity	MESH:D004342		Immunologically mediated adverse reactions to medicinal substances used legally or illegally.	MESH:D006967|MESH:D064420	C20.543.206|C25.100.468	C20.543|C25.100	Allergies, Drug|Allergy, Drug|Drug Allergies|Drug Allergy|Drug Hypersensitivities|Hypersensitivities, Drug|Hypersensitivity, Drug	Immune system disease
Drug-Related Side Effects and Adverse Reactions	MESH:D064420		Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.	MESH:D064419	C25.100	C25	Adverse Drug Event|Adverse Drug Events|Adverse Drug Reaction|Adverse Drug Reactions|Drug Event, Adverse|Drug Events, Adverse|Drug Reaction, Adverse|Drug Reactions, Adverse|Drug Related Side Effects and Adverse Reaction|Drug-Related Side Effects and Adverse Reaction|Drug Related Side Effects and Adverse Reactions|Drug Side Effect|Drug Side Effects|Drug Toxicities|Drug Toxicity|Effects, Drug Side|Reactions, Adverse Drug|Side Effect, Drug|Side Effects, Drug|Side Effects of Drugs|Toxicities, Drug|Toxicity, Drug	
Drug Resistant Epilepsy	MESH:D000069279		Epileptic condition in which adequate trials of two tolerated and appropriately chosen and used ANTIEPILEPTIC DRUGS schedules to achieve sustained seizure freedom failed.	MESH:D004827	C10.228.140.490.125	C10.228.140.490	Drug Refractory Epilepsies|Drug Refractory Epilepsy|Drug Resistant Epilepsies|Epilepsies, Drug Refractory|Epilepsies, Drug Resistant|Epilepsies, Intractable|Epilepsies, Medication Resistant|Epilepsies, Refractory|Epilepsy, Drug Refractory|Epilepsy, Drug Resistant|Epilepsy, Intractable|Epilepsy, Medication Resistant|Epilepsy, Refractory|Intractable Epilepsies|Intractable Epilepsy|Medication Resistant Epilepsies|Medication Resistant Epilepsy|Refractory Epilepsies|Refractory Epilepsies, Drug|Refractory Epilepsy|Refractory Epilepsy, Drug|Resistant Epilepsies, Drug|Resistant Epilepsies, Medication|Resistant Epilepsy, Drug|Resistant Epilepsy, Medication	Nervous system disease
Dry Eye Syndromes	MESH:D015352	DO:DOID:10140	Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.	MESH:D007766	C11.496.260	C11.496	Dry Eye|Dry Eye Disease|Dry Eye Diseases|Dry Eye, Evaporative|Dry Eyes|Dry Eye Syndrome|Evaporative Dry Eye|Evaporative Dry Eye Disease|Evaporative Dry Eyes|Evaporative Dry Eye Syndrome	Eye disease
Ductus Arteriosus, Patent	MESH:D004374	DO:DOID:13832|OMIM:607411|OMIM:617035|OMIM:617039	A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.	MESH:D006330	C14.240.400.340|C14.280.400.340|C16.131.240.400.340	C14.240.400|C14.280.400|C16.131.240.400	Patency of the Ductus Arteriosus|Patent Ductus Arteriosus|PATENT DUCTUS ARTERIOSUS 1|PATENT DUCTUS ARTERIOSUS 2|PATENT DUCTUS ARTERIOSUS 3|Patent Ductus Arteriosus Familial|PDA|PDA1|PDA2|PDA3	Cardiovascular disease|Congenital abnormality
Dumping Syndrome	MESH:D004377	DO:DOID:14495	Gastrointestinal symptoms resulting from an absent or nonfunctioning pylorus.	MESH:D011178	C06.405.748.630.310|C23.550.767.812.500	C06.405.748.630|C23.550.767.812	Dumping Syndromes|Syndrome, Dumping|Syndromes, Dumping	Digestive system disease|Pathology (process)
Duodenal Neoplasms	MESH:D004379	DO:DOID:10021|DO:DOID:1737	Tumors or cancer of the DUODENUM.	MESH:D004378|MESH:D007414	C04.588.274.476.411.445|C06.301.371.411.445|C06.405.249.411.445|C06.405.469.275.270|C06.405.469.491.445	C04.588.274.476.411|C06.301.371.411|C06.405.249.411|C06.405.469.275|C06.405.469.491	Cancer, Duodenal|Cancer of Duodenum|Cancer of the Duodenum|Duodenal Cancer|Duodenal Neoplasm|Duodenum Cancer|Neoplasm, Duodenal|Neoplasms, Duodenal	Cancer|Digestive system disease
Dupuytren Contracture	MESH:D004387	OMIM:126900	A fibromatosis of the palmar fascia characterized by thickening and contracture of the fibrous bands on the palmar surfaces of the hand and fingers. It arises most commonly in men between the ages of 30 and 50.	MESH:D003240|MESH:D003286|MESH:D005350	C04.557.450.565.590.340.173|C05.651.197.270|C17.300.270	C04.557.450.565.590.340|C05.651.197|C17.300	Contracture, Dupuytren|Contracture, Dupuytren's|DUPC1, INCLUDED|DUPUYTREN CONTRACTURE 1, INCLUDED|Dupuytren Disease|Dupuytren's Contracture|Dupuytrens Contracture|Dupuytren's Disease|Dupuytrens Disease|Fibromatosis, Palmar|Palmar Fibromatosis|PLANTAR FIBROMAS, INCLUDED|PLANTAR FIBROMATOSIS, FAMILIAL, INCLUDED	Cancer|Connective tissue disease|Musculoskeletal disease
Dupuytren Contracture 1	MESH:C565083			MESH:D004387	C04.557.450.565.590.340.173/C565083|C05.651.197.270/C565083|C17.300.270/C565083	C04.557.450.565.590.340.173|C05.651.197.270|C17.300.270		Cancer|Connective tissue disease|Musculoskeletal disease
Dwarfism, Pituitary	MESH:D004393	DO:DOID:0060870	A form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene (GH1) in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development.	MESH:D001849|MESH:D004392|MESH:D007018	C05.116.099.343.445|C05.116.132.358|C10.228.140.617.738.300.300|C19.297.312|C19.700.482.311	C05.116.099.343|C05.116.132|C10.228.140.617.738.300|C19.297|C19.700.482	Dwarfism, Growth Hormone Deficiency|Growth Hormone Deficiency Dwarfism|Hypophysial Dwarf|Hyposomatotrophic Dwarfism|Isolated GH Deficiency|Isolated Growth Hormone Deficiency|Isolated HGH Deficiency|Isolated Human Growth Hormone Deficiency|Isolated Somatotropin Deficiency|Isolated Somatotropin Deficiency Disorder|Nanism, Pituitary|Pituitary Dwarf|Pituitary Dwarfism|Pituitary Nanism	Endocrine system disease|Musculoskeletal disease|Nervous system disease
Dysarthria	MESH:D004401		Disorders of speech articulation caused by imperfect coordination of pharynx, larynx, tongue, or face muscles. This may result from CRANIAL NERVE DISEASES; NEUROMUSCULAR DISEASES; CEREBELLAR DISEASES; BASAL GANGLIA DISEASES; BRAIN STEM diseases; or diseases of the corticobulbar tracts (see PYRAMIDAL TRACTS). The cortical language centers are intact in this condition. (From Adams et al., Principles of Neurology, 6th ed, p489)	MESH:D001184	C10.597.606.150.500.800.150.200|C23.888.592.604.150.500.800.150.200	C10.597.606.150.500.800.150|C23.888.592.604.150.500.800.150	Dysarthoses|Dysarthosis|Dysarthria, Flaccid|Dysarthria, Guttural|Dysarthria, Hyperkinetic|Dysarthria, Hypokinetic|Dysarthria, Mixed|Dysarthrias|Dysarthria, Scanning|Dysarthrias, Flaccid|Dysarthrias, Guttural|Dysarthrias, Hyperkinetic|Dysarthrias, Hypokinetic|Dysarthrias, Mixed|Dysarthria, Spastic|Dysarthrias, Scanning|Dysarthrias, Spastic|Flaccid Dysarthria|Flaccid Dysarthrias|Guttural Dysarthria|Guttural Dysarthrias|Hyperkinetic Dysarthria|Hyperkinetic Dysarthrias|Hypokinetic Dysarthria|Hypokinetic Dysarthrias|Mixed Dysarthria|Mixed Dysarthrias|Scanning Dysarthria|Scanning Dysarthrias|Scanning Speech|Scanning Speechs|Spastic Dysarthria|Spastic Dysarthrias|Speechs, Scanning	Nervous system disease|Signs and symptoms
Dysautonomia like disorder	MESH:C535728			MESH:D054969	C10.177.575/C535728	C10.177.575	Dysautonomia-Like Disorder	Nervous system disease
Dysbetalipoproteinemia due to Defect in Apolipoprotein E-d	MESH:C566261			MESH:D050171	C18.452.584.500/C566261	C18.452.584.500		Metabolic disease
Dyschromatosis symmetrica hereditaria 1	MESH:C535729	DO:DOID:0060257|OMIM:127400		MESH:D010859	C17.800.621/C535729|C23.550.755/C535729	C17.800.621|C23.550.755	DSH|DSH1|Dyschromatosis symmetrica hereditaria|DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1|Familial reticulate acropigmentation of Dohi|RAD|Reticulate acropigmentation of Dohi|Symmetric dyschromatosis of the extremities	Pathology (process)|Skin disease
Dysentery, Amebic	MESH:D004404		DYSENTERY caused by intestinal amebic infection, chiefly with ENTAMOEBA HISTOLYTICA. This condition may be associated with amebic infection of the LIVER and other distant sites.	MESH:D000562|MESH:D004403|MESH:D007411	C01.610.432.396|C01.610.752.049.328|C06.405.205.331.312|C06.405.469.300.312|C06.405.469.452.396	C01.610.432|C01.610.752.049|C06.405.205.331|C06.405.469.300|C06.405.469.452	Amebiases, Intestinal|Amebiasis, Intestinal|Amebic Colitides|Amebic Colitis|Amebic Dysenteries|Amebic Dysentery|Amoebiases, Intestinal|Amoebiasis, Intestinal|Amoebic Colitides|Amoebic Colitis|Amoebic Dysenteries|Amoebic Dysentery|Colitides, Amebic|Colitides, Amoebic|Colitis, Amebic|Colitis, Amoebic|Dysenteries, Amebic|Dysenteries, Amoebic|Dysentery, Amoebic|Entamoebiases, Intestinal|Entamoebiasis, Intestinal|Intestinal Amebiases|Intestinal Amebiasis|Intestinal Amoebiases|Intestinal Amoebiasis|Intestinal Entamoeba histolytica Infection|Intestinal Entamoebiases|Intestinal Entamoebiasis	Digestive system disease|Parasitic disease
Dyserythropoiesis, Congenital, with Internuclear Chromatin Bridges and Ultrastructurally Normal Erythroblast Heterochromatin	MESH:C566368			MESH:D000740	C15.378.071/C566368	C15.378.071		Blood disease
Dysfibrinogenemia Causing Recurrent Thrombosis	MESH:C565018			MESH:D013927|MESH:D020147	C14.907.355.830/C565018|C15.378.100.141/C565018	C14.907.355.830|C15.378.100.141		Blood disease|Cardiovascular disease
Dysgammaglobulinemia	MESH:D004406	DO:DOID:11702	An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins.	MESH:D001796|MESH:D007153	C15.378.147.333|C20.673.430	C15.378.147|C20.673	Dysgammaglobulinemias	Blood disease|Immune system disease
Dysgerminoma	MESH:D004407	DO:DOID:4441	A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16% of all germ cell tumors but are rare before the age of 10, although nearly 50% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1646)	MESH:D018237	C04.557.465.330.300	C04.557.465.330	Disgerminoma|Disgerminomas|Dysgerminomas	Cancer
Dysgeusia	MESH:D004408		A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.	MESH:D013651	C10.597.751.861.479|C23.888.592.763.861.479	C10.597.751.861|C23.888.592.763.861	Altered Taste|Distorted Taste|Dysgeusias|Parageusia|Parageusias|Taste, Altered|Taste, Distorted	Nervous system disease|Signs and symptoms
Dyskinesia, Drug-Induced	MESH:D004409		Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)	MESH:D020258|MESH:D020820|MESH:D064420	C10.228.662.262.500|C10.597.350.275|C10.720.312|C23.888.592.350.275|C25.100.750|C25.723.705.200	C10.228.662.262|C10.597.350|C10.720|C23.888.592.350|C25.100|C25.723.705	Drug-Induced Dyskinesia|Drug-Induced Dyskinesias|Dyskinesia, Drug Induced|Dyskinesia, Medication Induced|Dyskinesia, Medication-Induced|Dyskinesias, Drug-Induced|Dyskinesias, Medication-Induced|Medication Induced Dyskinesia|Medication-Induced Dyskinesia|Medication-Induced Dyskinesias	Nervous system disease|Signs and symptoms
Dyskinesia, Familial, with Facial Myokymia	MESH:C564676	OMIM:606703		MESH:D020385|MESH:D020820	C10.228.662.262/C564676|C10.597.350/C564676|C10.597.613.650/C564676|C23.888.592.350/C564676|C23.888.592.608.650/C564676	C10.228.662.262|C10.597.350|C10.597.613.650|C23.888.592.350|C23.888.592.608.650	FDFM	Nervous system disease|Signs and symptoms
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET	OMIM:616921			MESH:D006948|MESH:D009069	C10.228.662/616921|C10.597.350.350/616921|C23.888.592.350.350/616921	C10.228.662|C10.597.350.350|C23.888.592.350.350	IOLOD	Nervous system disease|Signs and symptoms
Dyskinesias	MESH:D020820	DO:DOID:9854	Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.	MESH:D009069|MESH:D009461	C10.228.662.262|C10.597.350|C23.888.592.350	C10.228.662|C10.597|C23.888.592	Abnormal Movement|Abnormal Movements|Asterixis|Ballismus|Dyskinesia|Dyskinesia, Lingual-Facial-Buccal|Dyskinesia, Linguofacial|Dyskinesia, Oral|Dyskinesia, Oral-Facial|Dyskinesia, Orofacial|Dyskinesias, Lingual-Facial-Buccal|Dyskinesias, Linguofacial|Dyskinesias, Oral|Dyskinesias, Oral-Facial|Dyskinesias, Orofacial|Hemiballism|Hemiballismus|Involuntary Movement|Involuntary Movements|Lingual Facial Buccal Dyskinesia|Lingual-Facial-Buccal Dyskinesia|Lingual-Facial-Buccal Dyskinesias|Linguofacial Dyskinesia|Linguofacial Dyskinesias|Movement, Abnormal|Movement, Involuntary|Movements, Abnormal|Movements, Involuntary|Oral Dyskinesia|Oral Dyskinesias|Oral Facial Dyskinesia|Oral-Facial Dyskinesia|Oral-Facial Dyskinesias|Orofacial Dyskinesia|Orofacial Dyskinesias|Tardive Oral Dyskinesia|Tardive Oral Dyskinesias	Nervous system disease|Signs and symptoms
Dyslipidemias	MESH:D050171		Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.	MESH:D052439	C18.452.584.500	C18.452.584	Dyslipidemia|Dyslipoproteinemia|Dyslipoproteinemias	Metabolic disease
Dysosteosclerosis	MESH:C562973			MESH:D010026	C05.116.099.708.702/C562973	C05.116.099.708.702		Musculoskeletal disease
Dysostoses	MESH:D004413	DO:DOID:1934	Defective bone formation involving individual bones, singly or in combination.	MESH:D001848	C05.116.099.370	C05.116.099	Dysostosis	Musculoskeletal disease
Dysphasia, Familial Developmental	MESH:C563997			MESH:D001037	C10.597.606.150.500.800.100/C563997|C23.888.592.604.150.500.800.100/C563997	C10.597.606.150.500.800.100|C23.888.592.604.150.500.800.100		Nervous system disease|Signs and symptoms
Dysphonia	MESH:D055154		Difficulty and/or pain in PHONATION or speaking.	MESH:D014832	C08.360.940.325|C09.400.940.325|C10.597.975.325|C23.888.592.979.325	C08.360.940|C09.400.940|C10.597.975|C23.888.592.979	Dysphonia, Hyperkinetic|Dysphonia, Organic Tremor|Dysphonia, Spastic|Hyperkinetic Dysphonia|Neurologic Adducter Spastic Dysphonia|Organic Tremor Dysphonia|Phonation Disorder|Phonation Disorders|Spastic Dysphonia|Spastic Dysphonia, Neurologic Adducter	Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Dysplasia epiphysealis hemimelica	MESH:C537997			MESH:D001848	C05.116.099/C537997	C05.116.099	Trevor disease	Musculoskeletal disease
Dyspnea	MESH:D004417		Difficult or labored breathing.	MESH:D012120|MESH:D012818	C08.618.326|C23.888.852.371	C08.618|C23.888.852	Breathlessness|Breathlessnesses|Breath Shortness|Breath Shortnesses|Dyspneas|Shortness of Breath	Respiratory tract disease|Signs and symptoms
Dyspnea, Paroxysmal	MESH:D004418		A disorder characterized by sudden attacks of respiratory distress in at rest patients with HEART FAILURE and PULMONARY EDEMA. It usually occurs at night after several hours of sleep in a reclining position. Patients awaken with a feeling of suffocation, coughing, a cold sweat, and TACHYCARDIA. When there is significant WHEEZING, it is called cardiac asthma.	MESH:D004417|MESH:D006333	C08.618.326.396|C14.280.434.313|C23.888.852.371.396	C08.618.326|C14.280.434|C23.888.852.371	Asthma, Cardiac|Dyspnea, Paroxysmal Nocturnal|Dyspneas, Paroxysmal|Paroxysmal Dyspnea|Paroxysmal Dyspneas	Cardiovascular disease|Respiratory tract disease|Signs and symptoms
Dystonia	MESH:D004421	DO:DOID:543|OMIM:612067|OMIM:614860|OMIM:615034|OMIM:615073|OMIM:616411	An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)	MESH:D020820	C10.597.350.300|C23.888.592.350.300	C10.597.350|C23.888.592.350	Diurnal Dystonia|DYSTONIA 16|DYSTONIA 23|DYSTONIA 24|DYSTONIA 25|DYSTONIA 27|Dystonia, Diurnal|Dystonia, Limb|Dystonia, Muscle|Dystonia, Paroxysmal|DYT16|DYT23|DYT24|DYT25|DYT27|Limb Dystonia|Muscle Dystonia|Paroxysmal Dystonia	Nervous system disease|Signs and symptoms
Dystonia 12	MESH:C538001	OMIM:128235		MESH:D020821	C10.228.662.300/C538001	C10.228.662.300	Dystonia-Parkinsonism, Rapid-Onset|Dyt12|Rapid-onset dystonia-parkinsonism|Rapid-Onset Dystonia Parkinsonism|RDP	Nervous system disease
Dystonia 13, Torsion	MESH:C564354	OMIM:607671		MESH:D004421|MESH:D014102	C10.597.350.300/C564354|C23.300.970/C564354|C23.888.592.350.300/C564354	C10.597.350.300|C23.300.970|C23.888.592.350.300	DYSTONIA 13, TORSION, AUTOSOMAL DOMINANT|DYT13	Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Dystonia 16	MESH:C567430			MESH:D020821	C10.228.662.300/C567430	C10.228.662.300	DYT16	Nervous system disease
Dystonia 17, Torsion, Autosomal Recessive	MESH:C567319	OMIM:612406		MESH:D020821	C10.228.662.300/C567319	C10.228.662.300	DYT17	Nervous system disease
Dystonia 18	MESH:C564288			MESH:D020821	C10.228.662.300/C564288	C10.228.662.300	Paroxysmal Exercise-Induced Dystonia|Paroxysmal Exertion-Induced Dyskinesia	Nervous system disease
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES	OMIM:617282			MESH:D001480|MESH:D009896|MESH:D020821	C10.228.140.079/617282|C10.228.662.300/617282|C10.292.700.225/617282|C11.640.451/617282	C10.228.140.079|C10.228.662.300|C10.292.700.225|C11.640.451	DYSTONIA 29, CHILDHOOD-ONSET|DYT29|DYTOABG|MEPAN SYNDROME	Eye disease|Nervous system disease
Dystonia, Dopa-responsive	MESH:C538007	OMIM:128230		MESH:D020821	C10.228.662.300/C538007	C10.228.662.300	Dopa-Responsive Dystonia|Dopa-responsive dystonia, autosomal dominant|DRD|Dystonia 5|Dystonia, Dopa-responsive, autosomal dominant|Dystonia-Parkinsonism with diurnal fluctuation|Dystonia, progressive, with diurnal variation|DYT5|Hereditary Progressive Dystonia with Marked Diurnal Fluctuation|Segawa syndrome, autosomal dominant	Nervous system disease
Dystonia, Focal, Task-Specific	MESH:C566973			MESH:D020821	C10.228.662.300/C566973	C10.228.662.300	Focal Hand Dystonia|Focal Task-Specific Dystonia|FTSD|Musician's Dystonia|Occupational Cramp|Occupational Dystonia|Task-Specific Dystonia|Task-Specific Focal Dystonia	Nervous system disease
Dystonia-Parkinsonism, Adult-Onset	MESH:C567844	DO:DOID:0060900		MESH:D020734|MESH:D020821	C10.228.140.079.862/C567844|C10.228.662.300/C567844|C10.228.662.600/C567844	C10.228.140.079.862|C10.228.662.300|C10.228.662.600	Parkinson Disease 14, Autosomal Recessive	Nervous system disease
Dystonia with Cerebellar Atrophy	MESH:C567131			MESH:D002526|MESH:D004421	C10.228.140.252/C567131|C10.597.350.300/C567131|C23.888.592.350.300/C567131	C10.228.140.252|C10.597.350.300|C23.888.592.350.300		Nervous system disease|Signs and symptoms
Dystonia with Ringbinden	MESH:C565608			MESH:D003286|MESH:D020821	C05.550.323/C565608|C05.651.197/C565608|C10.228.662.300/C565608	C05.550.323|C05.651.197|C10.228.662.300		Musculoskeletal disease|Nervous system disease
Dystonic Disorders	MESH:D020821	DO:DOID:0050835|DO:DOID:543|OMIM:617284	Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.	MESH:D009069	C10.228.662.300	C10.228.662	Adult-Onset Dystonia|Adult Onset Dystonias|Adult-Onset Dystonias|Adult Onset Idiopathic Focal Dystonias|Adult-Onset Idiopathic Focal Dystonias|Adult Onset Idiopathic Torsion Dystonias|Adult-Onset Idiopathic Torsion Dystonias|Autosomal Dominant Familial Dystonia|Autosomal Recessive Familial Dystonia|Childhood Onset Dystonia|Childhood Onset Dystonias|DYSTONIA 28, CHILDHOOD-ONSET|Dystonia, Adult-Onset|Dystonia, Childhood Onset|Dystonia Disorder|Dystonia Disorders|Dystonia, Familial|Dystonia, Focal|Dystonia, Hereditary|Dystonia, Idiopathic Familial|Dystonia, Primary|Dystonia, Psychogenic|Dystonias, Adult-Onset|Dystonias, Childhood Onset|Dystonia, Secondary|Dystonias, Familial|Dystonias, Focal|Dystonias, Hereditary|Dystonias, Idiopathic Familial|Dystonia, Sporadic|Dystonias, Primary|Dystonias, Psychogenic|Dystonias, Secondary|Dystonias, Sporadic|Dystonic Disorder|DYT28|Familial Dystonia|Familial Dystonia, Autosomal Dominant|Familial Dystonia, Autosomal Recessive|Familial Dystonia, Idiopathic|Familial Dystonias|Familial Dystonias, Idiopathic|Focal Dystonia|Focal Dystonias|Hereditary Dystonia|Hereditary Dystonias|Idiopathic Familial Dystonia|Idiopathic Familial Dystonias|Primary Dystonia|Primary Dystonias|Pseudodystonia|Pseudodystonias|Psychogenic Dystonia|Psychogenic Dystonias|Secondary Dystonia|Secondary Dystonias|Sporadic Dystonia|Sporadic Dystonias|Writer Cramp|Writer's Cramp|Writers Cramp	Nervous system disease
Eales disease	MESH:C538011			MESH:D009389|MESH:D031300	C11.768.757/C538011|C14.907.940.815/C538011|C23.550.589.500/C538011	C11.768.757|C14.907.940.815|C23.550.589.500	Idiopathic obliterative vasculopathy|Idiopathic recurrent vitreal hemorrhage	Cardiovascular disease|Eye disease|Pathology (process)
Earache	MESH:D004433		Pain in the ear.	MESH:D004427|MESH:D010146	C09.218.350|C23.888.592.612.302	C09.218|C23.888.592.612	Earaches|Otalgia|Otalgias	Ear-nose-throat disease|Signs and symptoms
Ear Deformities, Acquired	MESH:D004426		Distortion or disfigurement of the ear caused by disease or injury after birth.	MESH:D004427	C09.218.271	C09.218	Acquired Ear Deformities|Acquired Ear Deformity|Deformities, Acquired Ear|Deformity, Acquired Ear|Ear Deformity, Acquired	Ear-nose-throat disease
Ear Diseases	MESH:D004427	DO:DOID:2742	Pathological processes of the ear, the hearing, and the equilibrium system of the body.	MESH:D010038	C09.218	C09	Disease, Ear|Disease, Otologic|Disease, Otological|Ear Disease|Otological Disease|Otological Diseases|Otologic Disease|Otologic Diseases	Ear-nose-throat disease
Early-onset ataxia with oculomotor apraxia and hypoalbuminemia	MESH:C538013	OMIM:208920		MESH:D001072|MESH:D002524|MESH:D034141	C10.228.140.252.190/C538013|C10.597.350.090.500/C538013|C10.597.606.881.350/C538013|C15.378.147.607.500/C538013|C23.888.592.350.090.200/C538013|C23.888.592.604.882.350/C538013	C10.228.140.252.190|C10.597.350.090.500|C10.597.606.881.350|C15.378.147.607.500|C23.888.592.350.090.200|C23.888.592.604.882.350	AOA|AOA1|Ataxia, Adult-Onset, With Oculomotor Apraxia|Ataxia, Early-Onset, With Oculomotor Apraxia And Hypoalbuminemia|Ataxia-oculomotor apraxia 1|Ataxia-oculomotor apraxia syndrome|Ataxia-telangiectasia-like syndrome|Cerebellar Ataxia, Early-Onset, With Hypoalbuminemia|CEREBELLAR ATAXIA, EARLY-ONSET, WITH HYPOALBUMINEMIA;EOCA-HA ATAXIA, ADULT-ONSET, WITH OCULOMOTOR APRAXIA, INCLUDED|EAOH|Early-Onset Ataxia with Ocular Motor Apraxia and Hypoalbuminemia|Early-onset cerebellar ataxia with hypoalbuminemia	Blood disease|Nervous system disease|Signs and symptoms
Early-Onset Glaucoma	MESH:C580055			MESH:D005901	C11.525.381/C580055	C11.525.381	Hereditary Glaucoma	Eye disease
Ear Neoplasms	MESH:D004428	DO:DOID:5101|DO:DOID:833	Tumors or cancer of any part of the hearing and equilibrium system of the body (the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR).	MESH:D004427|MESH:D010039	C04.588.443.665.312|C09.218.334|C09.647.312	C04.588.443.665|C09.218|C09.647	Auricular Cancer|Auricular Cancers|Auricular Neoplasms|Cancer, Auricular|Cancer of Ear|Cancer of Ear Auricle|Cancer of the Ear|Cancers, Auricular|Ear Auricle Cancer|Ear Auricle Cancers|Ear Auricle Neoplasm|Ear Auricle Neoplasms|Ear Cancer|Ear Neoplasm|Neoplasm, Ear|Neoplasms, Auricular|Neoplasms, Ear|Neoplasms of Ear Auricle	Cancer|Ear-nose-throat disease
Ebstein Anomaly	MESH:D004437	DO:DOID:14289|OMIM:224700	A congenital heart defect characterized by downward or apical displacement of the TRICUSPID VALVE, usually with the septal and posterior leaflets being attached to the wall of the RIGHT VENTRICLE. It is characterized by a huge RIGHT ATRIUM and a small and less effective right ventricle.	MESH:D006330	C14.240.400.395|C14.280.400.395|C16.131.240.400.395	C14.240.400|C14.280.400|C16.131.240.400	Anomaly, Ebstein|Anomaly, Ebstein's|Ebstein Malformation|Ebstein's Anomaly|Ebsteins Anomaly|Ebstein's Anomaly, Familial|Ebstein's Malformation|Ebsteins Malformation|Familial Ebstein Anomaly|Familial Ebstein's Anomaly|Familial Ebsteins Anomaly|Malformation, Ebstein's	Cardiovascular disease|Congenital abnormality
Ecchymosis	MESH:D004438		Extravasation of blood into the skin, resulting in a nonelevated, rounded or irregular, blue or purplish patch, larger than a petechia.	MESH:D001778|MESH:D006470|MESH:D012877	C15.378.100.452|C23.550.414.625|C23.888.885.312	C15.378.100|C23.550.414|C23.888.885	Ecchymoses	Blood disease|Pathology (process)|Signs and symptoms
Eccrine Porocarcinoma	MESH:D057090	DO:DOID:7566	A rare malignant neoplasm of the sweat glands. It most often develops as a form of degenerative progression from a benign ECCRINE POROMA.	MESH:D000230	C04.557.470.200.025.500	C04.557.470.200.025	Eccrine Porocarcinomas|Eccrine Poroma, Malignant|Eccrine Poromas, Malignant|Malignant Eccrine Poroma|Malignant Eccrine Poromas|Porocarcinoma, Eccrine|Porocarcinomas, Eccrine|Poroma, Malignant Eccrine|Poromas, Malignant Eccrine	Cancer
Eccrine Syringofibroadenomatosis with Eyelid Abnormalities	MESH:C566347			MESH:D005141|MESH:D018226	C04.557.450.565.590.595.350/C566347|C04.557.470.625.350/C566347|C11.338/C566347	C04.557.450.565.590.595.350|C04.557.470.625.350|C11.338		Cancer|Eye disease
Echinococcosis, Hepatic	MESH:D004444		Liver disease caused by infections with parasitic tapeworms of the genus ECHINOCOCCUS, such as Echinococcus granulosus or Echinococcus multilocularis. Ingested Echinococcus ova burrow into the intestinal mucosa. The larval migration to the liver via the PORTAL VEIN leads to watery vesicles (HYDATID CYST).	MESH:D004443|MESH:D008109	C01.610.335.190.396.314|C01.610.518.314|C06.552.664.272	C01.610.335.190.396|C01.610.518|C06.552.664	Alveolar Echinococcosis, Hepatic|Cyst, Hepatic Hydatid|Cysts, Hepatic Hydatid|Echinococcosis, Hepatic Alveolar|Hepatic Alveolar Echinococcosis|Hepatic Echinococcosis|Hepatic Hydatid Cyst|Hepatic Hydatid Cysts|Hepatic Hydatidosis|Hydatid Cyst, Hepatic|Hydatid Cysts, Hepatic|Hydatidosis, Hepatic	Digestive system disease|Parasitic disease
Echolalia	MESH:D004454	DO:DOID:4188	Involuntary ('parrot-like'), meaningless repetition of a recently heard word, phrase, or song. This condition may be associated with transcortical APHASIA; SCHIZOPHRENIA; or other disorders. (From Adams et al., Principles of Neurology, 6th ed, p485)	MESH:D013064	C10.597.606.150.500.800.300|C23.888.592.604.150.500.800.300	C10.597.606.150.500.800|C23.888.592.604.150.500.800	Echophrasia|Echo Reaction|Echo Speech|Reaction, Echo|Reactions, Echo|Speech, Echo	Nervous system disease|Signs and symptoms
Echo Virus 11 Sensitivity	MESH:C565071	OMIM:129150		MESH:D004198|MESH:D004457	C01.925.782.687.359.347/C565071|C23.550.291.687/C565071	C01.925.782.687.359.347|C23.550.291.687	E11S	Pathology (process)|Viral disease
Echovirus Infections	MESH:D004457		Infectious disease processes, including meningitis, diarrhea, and respiratory disorders, caused by echoviruses.	MESH:D004769	C01.925.782.687.359.347	C01.925.782.687.359	Echovirus Infection|Echo Virus Infection|Echo Virus Infections|Infection, Echovirus|Infection, Echo Virus|Infections, Echovirus|Infections, Echo Virus	Viral disease
Ectopia Cordis	MESH:D054083		A rare developmental defect in which the heart is abnormally located partially or totally outside the THORAX. It is the result of defective fusion of the anterior chest wall. Depending on the location of the heart, ectopia cordis can be thoracic, thoracoabdominal, abdominal, and cervical.	MESH:D006330	C14.240.400.422|C16.131.240.400.422	C14.240.400|C16.131.240.400	Cordis, Ectopia	Cardiovascular disease|Congenital abnormality
Ectopia pupillae	MESH:C536185	OMIM:129750		MESH:D011681	C10.597.690/C536185|C11.710/C536185|C23.888.592.708/C536185	C10.597.690|C11.710|C23.888.592.708	Familial ectopic pupil	Eye disease|Nervous system disease|Signs and symptoms
Ectrodactyly cardiopathy dysmorphism	MESH:C536187			MESH:D000015|MESH:D006330|MESH:D019066|MESH:D038061	C05.660.585.512/C536187|C14.240.400/C536187|C14.280.400/C536187|C16.131.077/C536187|C16.131.240.400/C536187|C16.131.621.585.512/C536187|C23.550.291.812/C536187	C05.660.585.512|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.585.512|C23.550.291.812	Ectrodactyly of lower limbs, congenital heart defect and characteristic facies|Van Den Ende Brunner syndrome	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Pathology (process)
Ectrodactyly of Lower Limbs, Congenital Heart Defect, and Micrognathia	MESH:C563344			MESH:D006330|MESH:D008844|MESH:D038061	C05.500.460.457/C563344|C05.660.207.540.460.457/C563344|C05.660.585.512/C563344|C07.320.440.457/C563344|C07.650.500.460.457/C563344|C14.240.400/C563344|C14.280.400/C563344|C16.131.240.400/C563344|C16.131.621.207.540.460.457/C563344|C16.131.621.585.512/C563344|C16.131.850.500.460.457/C563344	C05.500.460.457|C05.660.207.540.460.457|C05.660.585.512|C07.320.440.457|C07.650.500.460.457|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.540.460.457|C16.131.621.585.512|C16.131.850.500.460.457		Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease
Ectropion	MESH:D004483	DO:DOID:1570	The turning outward (eversion) of the edge of the eyelid, resulting in the exposure of the palpebral conjunctiva. (Dorland, 27th ed)	MESH:D005141	C11.338.362	C11.338	Ectropions	Eye disease
Eczema	MESH:D004485		A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).	MESH:D003872|MESH:D017443	C17.800.174.620|C17.800.815.620	C17.800.174|C17.800.815	Dermatitides, Eczematous|Dermatitis, Eczematous|Eczemas|Eczematous Dermatitides|Eczematous Dermatitis	Skin disease
Eczema, Dyshidrotic	MESH:D011146	DO:DOID:9230	A recurrent eczematous reaction characterized by the development of vesicular eruptions on the palms and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. (Dorland, 27th ed)	MESH:D004485|MESH:D012872	C17.800.174.620.300|C17.800.815.620.300|C17.800.865.385	C17.800.174.620|C17.800.815.620|C17.800.865	Dyshidrotic Eczema|Dyshidrotic Eczemas|Dyshydrotic Eczema|Dyshydrotic Eczemas|Eczema, Dyshydrotic|Eczemas, Dyshidrotic|Eczemas, Dyshydrotic|Eczemas, Vesicular Palmoplantar|Eczema, Vesicular Palmoplantar|Palmoplantar Eczemas, Vesicular|Palmoplantar Eczema, Vesicular|Pompholyx|Vesicular Palmoplantar Eczema|Vesicular Palmoplantar Eczemas	Skin disease
Edema, Cardiac	MESH:D004489		Abnormal fluid retention by the body due to impaired cardiac function or heart failure. It is usually characterized by increase in venous and capillary pressure, and swollen legs when standing. It is different from the generalized edema caused by renal dysfunction (NEPHROTIC SYNDROME).	MESH:D004487|MESH:D006333	C14.280.434.482|C23.888.277.197	C14.280.434|C23.888.277	Cardiac Edema|Cardiac Edemas|Edemas, Cardiac	Cardiovascular disease|Signs and symptoms
Egg and banana sign	MESH:C000721407			MESH:D006976	C08.381.423/C000721407|C14.907.489.556/C000721407	C08.381.423|C14.907.489.556	Egg-and-banana sign	Cardiovascular disease|Respiratory tract disease
Egg Hypersensitivity	MESH:D021181	DO:DOID:4377	Allergic reaction to eggs that is triggered by the immune system.	MESH:D005512	C20.543.480.370.150	C20.543.480.370	Allergies, Egg|Allergy, Egg|Egg Allergies|Egg Allergy|Egg Hypersensitivities|Hypersensitivities, Egg|Hypersensitivity, Egg	Immune system disease
Eisenmenger Complex	MESH:D004541		A condition associated with VENTRICULAR SEPTAL DEFECT and other congenital heart defects that allow the mixing of pulmonary and systemic circulation, increase blood flow into the lung, and subsequent responses to low oxygen in blood. This complex is characterized by progressive PULMONARY HYPERTENSION; HYPERTROPHY of the RIGHT VENTRICLE; CYANOSIS; and ERYTHROCYTOSIS.	MESH:D006330	C14.240.400.450|C14.280.400.450|C16.131.240.400.450	C14.240.400|C14.280.400|C16.131.240.400	Complex, Eisenmenger|Complex, Eisenmenger's|Eisenmenger's Complex|Eisenmengers Complex|Eisenmenger's Syndrome|Eisenmengers Syndrome|Eisenmenger Syndrome|Syndrome, Eisenmenger|Syndrome, Eisenmenger's	Cardiovascular disease|Congenital abnormality
Elastosis perforans serpiginosa	MESH:C536202			MESH:D012871	C17.800/C536202	C17.800	Elastoma intrapapillare perforans verruciformis|Miescher elastoma	Skin disease
Elbow Tendinopathy	MESH:D000070639		Inflammation (tendinitis) or degeneration (tendinosis) of the tendons of the elbow.	MESH:D052256	C05.651.869.435|C26.874.800.500	C05.651.869|C26.874.800	Elbow Tendinopathies|Epicondylitides, Medial|Epicondylitis, Medial|Golfer's Elbow|Golfers Elbow|Medial Epicondylitides|Medial Epicondylitis|Tendinopathies, Elbow|Tendinopathy, Elbow	Musculoskeletal disease|Wounds and injuries
Elephantiasis	MESH:D004604	DO:DOID:0050138|DO:DOID:4976	Hypertrophy and thickening of tissues from causes other than filarial infection, the latter being described as ELEPHANTIASIS, FILARIAL.	MESH:D008209	C15.604.496.320	C15.604.496	Bigfoot Disease|Bigfoot Diseases|Disease, Bigfoot|Disease, Microcrystal|Diseases, Bigfoot|Diseases, Microcrystal|Elephantiases|Elephantiases, Endemic|Elephantiases, Endemic Non-Filarial|Elephantiasis, Endemic|Elephantiasis, Endemic Non-Filarial|Elephantiasis Nostras Verrucosa|Elephantiasis Nostras Verrucosas|Endemic Elephantiases|Endemic Elephantiasis|Endemic Non-Filarial Elephantiases|Endemic Non Filarial Elephantiasis|Endemic Non-Filarial Elephantiasis|foot, Mossy|foots, Mossy|Lymphostatic Verrucoses|Lymphostatic Verrucosis|Microcrystal Disease|Microcrystal Diseases|Mossy foot|Mossy foots|Non-Filarial Elephantiases, Endemic|Non-Filarial Elephantiasis, Endemic|Nostras Verrucosa, Elephantiasis|Nostras Verrucosas, Elephantiasis|Podoconioses|Podoconiosis|Verrucosa, Elephantiasis Nostras|Verrucosas, Elephantiasis Nostras|Verrucoses, Lymphostatic|Verrucosis, Lymphostatic	Lymphatic disease
Elephantiasis, Filarial	MESH:D004605	DO:DOID:12211	Parasitic infestation of the human lymphatic system by WUCHERERIA BANCROFTI or BRUGIA MALAYI. It is also called lymphatic filariasis.	MESH:D000079426|MESH:D005368|MESH:D008209	C01.610.335.508.700.750.361.350|C01.920.750|C15.604.496.490	C01.610.335.508.700.750.361|C01.920|C15.604.496	Bancroftian Elephantiases|Bancroftian Elephantiasis|Bancroftian Filariases|Bancroftian Filariasis|Elephantiases, Bancroftian|Elephantiases, Filarial|Elephantiases, Malayi|Elephantiasis, Bancroftian|Elephantiasis, Malayi|Filarial Elephantiases|Filarial Elephantiasis|Filariases, Bancroftian|Filariases, Lymphatic|Filariases, Malayi|Filariasis, Bancroftian|Filariasis, Lymphatic|Filariasis, Malayi|Lymphatic Filariases|Lymphatic Filariasis|Malayi Elephantiases|Malayi Elephantiasis|Malayi Filariases|Malayi Filariasis	Lymphatic disease|Parasitic disease
Embolic Stroke	MESH:D000083262		An ischemic stroke due to a blood clot, emboli or other types of blockage which forms somewhere other than the brain and subsequently travels near and restricts blood flow to the brain. Most often the origin of the clot is from the heart and is referred to as cardioembolic stroke.	MESH:D000083242	C10.228.140.300.775.400.375|C14.907.253.855.400.375	C10.228.140.300.775.400|C14.907.253.855.400	Cardio embolic Stroke|Cardio-embolic Stroke|Cardioembolic Stroke|Cardio-embolic Strokes|Cardioembolic Strokes|Embolic Strokes|Stroke, Cardioembolic|Stroke, Cardio-embolic|Stroke, Embolic|Strokes, Cardioembolic|Strokes, Cardio-embolic|Strokes, Embolic	Cardiovascular disease|Nervous system disease
Embolism	MESH:D004617		Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.	MESH:D016769	C14.907.355.350	C14.907.355	Embolisms|Embolus	Cardiovascular disease
Embolism, Air	MESH:D004618		Blocking of a blood vessel by air bubbles that enter the circulatory system, usually after TRAUMA; surgical procedures, or changes in atmospheric pressure.	MESH:D004617	C14.907.355.350.254	C14.907.355.350	Air Embolism|Air Embolisms|Embolism, Gas|Embolisms, Air|Embolisms, Gas|Gas Embolism|Gas Embolisms	Cardiovascular disease
Embolism, Amniotic Fluid	MESH:D004619		Blocking of maternal circulation by AMNIOTIC FLUID that is forced into uterine VEINS by strong UTERINE CONTRACTION near the end of pregnancy. It is characterized by the sudden onset of severe respiratory distress and HYPOTENSION that can lead to maternal DEATH.	MESH:D004617|MESH:D011249	C12.050.703.634.404|C14.583.404|C14.907.355.350.354	C12.050.703.634|C14.583|C14.907.355.350	Amniotic Fluid Embolism|Amniotic Fluid Embolisms|Embolisms, Amniotic Fluid	Cardiovascular disease|Pregnancy complication
Embolism and Thrombosis	MESH:D016769		A collective term for pathological conditions which are caused by the formation of a blood clot (THROMBUS) in a blood vessel, or by blocking of a blood vessel with an EMBOLUS, undissolved materials in the blood stream.	MESH:D014652	C14.907.355	C14.907	Thrombosis and Embolism	Cardiovascular disease
Embolism, Cholesterol	MESH:D017700	DO:DOID:1461	Blocking of a blood vessel by CHOLESTEROL-rich atheromatous deposits, generally occurring in the flow from a large artery to small arterial branches. It is also called arterial-arterial embolization or atheroembolism which may be spontaneous or iatrogenic. Patients with spontaneous atheroembolism often have painful, cyanotic digits of acute onset.	MESH:D004620	C14.907.355.350.454.500	C14.907.355.350.454	Atheroembolism|Atheroembolisms|Cholesterol Embolism|Cholesterol Embolisms|Embolisms, Cholesterol	Cardiovascular disease
Embolism, Fat	MESH:D004620		Blocking of a blood vessel by fat deposits in the circulation. It is often seen after fractures of large bones or after administration of CORTICOSTEROIDS.	MESH:D004617	C14.907.355.350.454	C14.907.355.350	Embolisms, Fat|Fat Embolism|Fat Embolisms|Fat Embolism Syndrome	Cardiovascular disease
Embolism, Paradoxical	MESH:D019320		Blockage of an artery due to passage of a clot (THROMBUS) from a systemic vein to a systemic artery without its passing through the lung which acts as a filter to remove blood clots from entering the arterial circulation. Paradoxical embolism occurs when there is a defect that allows a clot to cross directly from the right to the left side of the heart as in the cases of ATRIAL SEPTAL DEFECTS or open FORAMEN OVALE. Once in the arterial circulation, a clot can travel to the brain, block an artery, and cause a STROKE.	MESH:D013923	C14.907.355.590.400	C14.907.355.590	Crossed Embolism|Crossed Embolisms|Embolism, Crossed|Embolisms, Crossed|Embolisms, Paradoxical|Paradoxical Embolism|Paradoxical Embolisms	Cardiovascular disease
Emphysema, Congenital, With Deafness, Penoscrotal Web, And Mental Retardation	MESH:C566519			MESH:D003638|MESH:D004646|MESH:D008607	C09.218.458.341.186/C566519|C10.597.606.360/C566519|C10.597.751.418.341.186/C566519|C23.550.325/C566519|C23.888.592.604.646/C566519|C23.888.592.763.393.341.186/C566519|F03.625.539/C566519	C09.218.458.341.186|C10.597.606.360|C10.597.751.418.341.186|C23.550.325|C23.888.592.604.646|C23.888.592.763.393.341.186|F03.625.539		Ear-nose-throat disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Emphysema, Hereditary Pulmonary	MESH:C565057	OMIM:130700		MESH:D011656	C08.381.495.389.750/C565057|C23.550.291.500.875.875/C565057	C08.381.495.389.750|C23.550.291.500.875.875		Pathology (process)|Respiratory tract disease
Empty delta sign	MESH:C000721352			MESH:D012851	C10.228.140.300.525.425.500/C000721352|C14.907.253.566.350.500/C000721352|C14.907.355.590.213.350.500/C000721352	C10.228.140.300.525.425.500|C14.907.253.566.350.500|C14.907.355.590.213.350.500		Cardiovascular disease|Nervous system disease
Empty Sella Syndrome	MESH:D004652	DO:DOID:3642	A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: (1) primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; (2) secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.	MESH:D010900	C10.228.140.617.738.200|C19.700.320	C10.228.140.617.738|C19.700	Empty Sella Syndrome, Primary|Empty Sella Syndromes|Empty Sella Syndrome, Secondary|Empty Sella Turcica|Empty Sella Turcicas|Empty Sella Turcica Syndrome|Primary Empty Sella Syndrome|Secondary Empty Sella Syndrome|Sella Turcica, Empty|Sella Turcicas, Empty	Endocrine system disease|Nervous system disease
Empyema, Pleural	MESH:D016724	DO:DOID:3798	Suppurative inflammation of the pleural space.	MESH:D004653|MESH:D010995|MESH:D012141	C01.748.265|C01.830.305.310|C08.528.240|C08.730.265|C23.550.470.756.305.250	C01.748|C01.830.305|C08.528|C08.730|C23.550.470.756.305	Empyemas, Pleural|Empyemas, Thoracic|Empyema, Thoracic|Pleural Empyema|Pleural Empyemas|Pyothorax|Thoracic Empyema|Thoracic Empyemas	Pathology (process)|Respiratory tract disease
Empyema, Tuberculous	MESH:D004654	DO:DOID:14305	Empyema due to MYCOBACTERIUM TUBERCULOSIS.	MESH:D014396|MESH:D016724	C01.748.265.320|C01.748.912.405|C01.830.305.310.320|C08.528.240.320|C08.528.928.405|C08.730.265.320|C08.730.912.405|C23.550.470.756.305.250.320	C01.748.265|C01.748.912|C01.830.305.310|C08.528.240|C08.528.928|C08.730.265|C08.730.912|C23.550.470.756.305.250	Empyema, Pleural, Tuberculous|Empyemas, Tuberculous|Tuberculous Empyema|Tuberculous Empyemas	Pathology (process)|Respiratory tract disease
Encephalitis	MESH:D004660	DO:DOID:9588	Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.	MESH:D000090862|MESH:D001927	C10.228.140.430|C10.586.250	C10.228.140|C10.586	Brain Inflammation|Brain Inflammations|Encephalitis, Rasmussen|Inflammation, Brain|Rasmussen Encephalitis|Rasmussen's Syndrome|Rasmussen Syndrome	Nervous system disease
Encephalitis, Arbovirus	MESH:D004671	DO:DOID:646	Infections of the brain caused by arthropod-borne viruses (i.e., arboviruses) primarily from the families TOGAVIRIDAE; FLAVIVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; and RHABDOVIRIDAE. Life cycles of these viruses are characterized by ZOONOSES, with birds and lower mammals serving as intermediate hosts. The virus is transmitted to humans by the bite of mosquitoes (CULICIDAE) or TICKS. Clinical manifestations include fever, headache, alterations of mentation, focal neurologic deficits, and COMA. (From Clin Microbiol Rev 1994 Jan;7(1):89-116; Walton, Brain's Diseases of the Nervous System, 10th ed, p321)	MESH:D001102|MESH:D012327|MESH:D018792	C01.207.245.340.300|C01.207.399.750.300|C01.920.500.343|C01.925.081.343|C01.925.182.525.300|C01.925.782.310|C10.228.140.430.520.750.300|C10.228.228.245.340.300|C10.228.228.399.750.300|C10.586.250.520.750.300	C01.207.245.340|C01.207.399.750|C01.920.500|C01.925.081|C01.925.182.525|C01.925.782|C10.228.140.430.520.750|C10.228.228.245.340|C10.228.228.399.750|C10.586.250.520.750	Arboviral Encephalitides|Arboviral Encephalitis|Arbovirus Encephalitides|Arbovirus Encephalitis|Arthropod-Borne Encephalitides|Arthropod Borne Encephalitis|Arthropod-Borne Encephalitis|Arthropod-Borne Viral Encephalitides|Arthropod Borne Viral Encephalitis|Arthropod-Borne Viral Encephalitis|Encephalitides, Arboviral|Encephalitides, Arbovirus|Encephalitides, Arthropod-Borne|Encephalitides, Arthropod-Borne Viral|Encephalitides, Epidemic|Encephalitides, Mosquito-Borne|Encephalitis, Arboviral|Encephalitis, Arthropod Borne|Encephalitis, Arthropod-Borne|Encephalitis, Arthropod-Borne Viral|Encephalitis, Epidemic|Encephalitis, Mosquito Borne|Encephalitis, Mosquito-Borne|Epidemic Encephalitides|Epidemic Encephalitis|Mosquito-Borne Encephalitides|Mosquito Borne Encephalitis|Mosquito-Borne Encephalitis|Viral Encephalitides, Arthropod-Borne|Viral Encephalitis, Arthropod Borne|Viral Encephalitis, Arthropod-Borne	Nervous system disease|Viral disease
Encephalitis, California	MESH:D004670	DO:DOID:0050118	A viral infection of the brain caused by serotypes of California encephalitis virus (ENCEPHALITIS VIRUS, CALIFORNIA) transmitted to humans by the mosquito AEDES triseriatus. The majority of cases are caused by the LA CROSSE VIRUS. This condition is endemic to the midwestern United States and primarily affects children between 5-10 years of age. Clinical manifestations include FEVER; VOMITING; HEADACHE; and abdominal pain followed by SEIZURES, altered mentation, and focal neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13)	MESH:D002044|MESH:D004671	C01.207.245.340.300.200|C01.207.399.750.300.200|C01.920.500.343.340|C01.925.081.343.340|C01.925.182.525.300.200|C01.925.782.147.340|C01.925.782.310.340|C10.228.140.430.520.750.300.200|C10.228.228.245.340.300.200|C10.228.228.399.750.300.200|C10.586.250.520.750.300.200	C01.207.245.340.300|C01.207.399.750.300|C01.920.500.343|C01.925.081.343|C01.925.182.525.300|C01.925.782.147|C01.925.782.310|C10.228.140.430.520.750.300|C10.228.228.245.340.300|C10.228.228.399.750.300|C10.586.250.520.750.300	California Encephalitis|California Encephalitis Virus Infection|California Viral Encephalitis|Encephalitis, California Viral|Encephalitis, California, Viral|Encephalitis, La Crosse|La Crosse Encephalitis|La Crosse Encephalitis Virus Infection|Viral Encephalitis, California	Nervous system disease|Viral disease
Encephalitis, Herpes Simplex	MESH:D020803	OMIM:610551|OMIM:613002|OMIM:614849|OMIM:614850|OMIM:616532	An acute (or rarely chronic) inflammatory process of the brain caused by SIMPLEXVIRUS infections which may be fatal. The majority of infections are caused by human herpesvirus 1 (HERPESVIRUS 1, HUMAN) and less often by human herpesvirus 2 (HERPESVIRUS 2, HUMAN). Clinical manifestations include FEVER; HEADACHE; SEIZURES; HALLUCINATIONS; behavioral alterations; APHASIA; hemiparesis; and COMA. Pathologically, the condition is marked by a hemorrhagic necrosis involving the medial and inferior TEMPORAL LOBE and orbital regions of the FRONTAL LOBE. (From Adams et al., Principles of Neurology, 6th ed, pp751-4)	MESH:D006566|MESH:D018792	C01.207.245.340.350|C01.207.399.750.350|C01.925.182.525.350|C01.925.256.466.262|C10.228.140.430.520.750.350|C10.228.228.245.340.350|C10.228.228.399.750.350|C10.586.250.520.750.350	C01.207.245.340|C01.207.399.750|C01.925.182.525|C01.925.256.466|C10.228.140.430.520.750|C10.228.228.245.340|C10.228.228.399.750|C10.586.250.520.750	Acute Necrotizing Encephalitis, Herpetic|Encephalitides, Herpes Simplex|Encephalitides, Herpetic|Encephalitis, Herpes|Encephalitis, Herpetic|ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 1|ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 5|ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 6|ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7|Herpes Encephalitis|Herpes Simplex Encephalitides|Herpes Simplex Encephalitis|HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1|HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2, INCLUDED|HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 3|HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4|HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 5|Herpes Simplex Meningoencephalitides|Herpes Simplex Meningoencephalitis|Herpetic Acute Necrotizing Encephalitis|Herpetic Encephalitides|Herpetic Encephalitis|Herpetic Meningoencephalitides|Herpetic Meningoencephalitis|IIAE1|IIAE2, INCLUDED|IIAE5|IIAE6|IIAE7|IMMUNODEFICIENCY 83, SUSCEPTIBILITY TO VIRAL INFECTIONS;IMD83 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC),|Meningoencephalitides, Herpes Simplex|Meningoencephalitides, Herpetic|Meningoencephalitis, Herpes Simplex|Meningoencephalitis, Herpes Simplex Virus|Meningoencephalitis, Herpetic|PNEUMONITIS, INFECTION (VIRAL)-INDUCED, SUSCEPTIBILITY TO, INCLUDED|SUSCEPTIBILITY TO, 2, INCLUDED	Nervous system disease|Viral disease
Encephalitis, Japanese	MESH:D004672	DO:DOID:10844	A mosquito-borne encephalitis caused by the Japanese B encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE) occurring throughout Eastern Asia and Australia. The majority of infections occur in children and are subclinical or have features limited to transient fever and gastrointestinal symptoms. Inflammation of the brain, spinal cord, and meninges may occur and lead to transient or permanent neurologic deficits (including a POLIOMYELITIS-like presentation); SEIZURES; COMA; and death. (From Adams et al., Principles of Neurology, 6th ed, p751; Lancet 1998 Apr 11;351(9109):1094-7)	MESH:D004671|MESH:D018177	C01.207.245.340.300.400|C01.207.399.750.300.400|C01.920.500.343.345|C01.925.081.343.345|C01.925.182.525.300.250|C01.925.782.310.345|C01.925.782.350.250.300|C10.228.140.430.520.750.300.400|C10.228.228.245.340.300.400|C10.228.228.399.750.300.400|C10.586.250.520.750.300.400	C01.207.245.340.300|C01.207.399.750.300|C01.920.500.343|C01.925.081.343|C01.925.182.525.300|C01.925.782.310|C01.925.782.350.250|C10.228.140.430.520.750.300|C10.228.228.245.340.300|C10.228.228.399.750.300|C10.586.250.520.750.300	Encephalitis, Japanese B|Japanese B Encephalitis|Japanese B Viral Encephalitis|Japanese Encephalitis|Viral Encephalitis, Japanese B	Nervous system disease|Viral disease
Encephalitis, St. Louis	MESH:D004674	DO:DOID:10845	A viral encephalitis caused by the St. Louis encephalitis virus (ENCEPHALITIS VIRUS, ST. LOUIS), a FLAVIVIRUS. It is transmitted to humans and other vertebrates primarily by mosquitoes of the genus CULEX. The primary animal vectors are wild birds and the disorder is endemic to the midwestern and southeastern United States. Infections may be limited to an influenza-like illness or present as an ASEPTIC MENINGITIS or ENCEPHALITIS. Clinical manifestations of the encephalitic presentation may include SEIZURES, lethargy, MYOCLONUS, focal neurologic signs, COMA, and DEATH. (From Adams et al., Principles of Neurology, 6th ed, p750)	MESH:D004671|MESH:D018177	C01.207.245.340.300.550|C01.207.399.750.300.550|C01.920.500.343.350|C01.925.081.343.350|C01.925.182.525.300.300|C01.925.782.310.350|C01.925.782.350.250.450|C10.228.140.430.520.750.300.550|C10.228.228.245.340.300.550|C10.228.228.399.750.300.550|C10.586.250.520.750.300.550	C01.207.245.340.300|C01.207.399.750.300|C01.920.500.343|C01.925.081.343|C01.925.182.525.300|C01.925.782.310|C01.925.782.350.250|C10.228.140.430.520.750.300|C10.228.228.245.340.300|C10.228.228.399.750.300|C10.586.250.520.750.300	Encephalitis, Saint Louis|Encephalitis, Viral, St. Louis|Lethargic Encephalitis, Type C|Louis Meningoencephalitides, St.|Meningoencephalitides, St. Louis|Meningoencephalitis, St. Louis|Saint Louis Encephalitis|St. Louis Encephalitis|St. Louis Meningoencephalitides|St. Louis Meningoencephalitis|St. Louis Viral Encephalitis|Type C Lethargic Encephalitis	Nervous system disease|Viral disease
Encephalitis, Tick-Borne	MESH:D004675	DO:DOID:0050175	Encephalitis caused by neurotropic viruses that are transmitted via the bite of TICKS. In Europe, the diseases are caused by ENCEPHALITIS VIRUSES, TICK-BORNE, which give rise to Russian spring-summer encephalitis, central European encephalitis, louping ill encephalitis, and related disorders. Powassan encephalitis occurs in North America and Russia and is caused by the Powassan virus. ASEPTIC MENINGITIS and rarely encephalitis may complicate COLORADO TICK FEVER which is endemic to mountainous regions of the western United States. (From Joynt, Clinical Neurology, 1996, Ch26, pp14-5)	MESH:D004671|MESH:D017282|MESH:D018177	C01.207.245.340.300.775|C01.207.399.750.300.775|C01.920.500.343.360|C01.920.930.400|C01.925.081.343.360|C01.925.182.525.300.350|C01.925.782.310.360|C01.925.782.350.250.500|C10.228.140.430.520.750.300.775|C10.228.228.245.340.300.775|C10.228.228.399.750.300.775|C10.586.250.520.750.300.775	C01.207.245.340.300|C01.207.399.750.300|C01.920.500.343|C01.920.930|C01.925.081.343|C01.925.182.525.300|C01.925.782.310|C01.925.782.350.250|C10.228.140.430.520.750.300|C10.228.228.245.340.300|C10.228.228.399.750.300|C10.586.250.520.750.300	Central European Encephalitis|Disease, Powassan Virus|Encephalitis, Central European|Encephalitis, European Tick Borne|Encephalitis, European Tick-Borne|Encephalitis, Far Eastern Russian|Encephalitis, Louping Ill|Encephalitis, Powassan|Encephalitis, Russian Spring Summer|Encephalitis, Russian Spring-Summer|Encephalitis, Tick Borne|European Tick Borne Encephalitis|European Tick-Borne Encephalitis|Far Eastern Russian Encephalitis|Louping Ill Encephalitis|Powassan Encephalitides|Powassan Encephalitis|Powassan Virus Disease|Powassan Virus Diseases|Russian Spring Summer Encephalitis|Russian Spring-Summer Encephalitis|Spring-Summer Encephalitis, Russian|Tick Borne Encephalitis|Tick-Borne Encephalitis|Tick-Borne Encephalitis, European|Virus Disease, Powassan|Virus Diseases, Powassan	Nervous system disease|Viral disease
Encephalitis, Varicella Zoster	MESH:D020804		Inflammation of brain tissue caused by infection with the varicella-zoster virus (HERPESVIRUS 3, HUMAN). This condition is associated with immunocompromised states, including the ACQUIRED IMMUNODEFICIENCY SYNDROME. Pathologically, the virus tends to induce a vasculopathy and infect oligodendrocytes and ependymal cells, leading to CEREBRAL INFARCTION, multifocal regions of demyelination, and periventricular necrosis. Manifestations of varicella encephalitis usually occur 5-7 days after onset of HERPES ZOSTER and include HEADACHE; VOMITING; lethargy; focal neurologic deficits; FEVER; and COMA. (From Joynt, Clinical Neurology, 1996, Ch 26, pp29-32; Hum Pathol 1996 Sep;27(9):927-38)	MESH:D000073618|MESH:D018792	C01.207.245.340.400|C01.207.399.750.400|C01.925.182.525.400|C01.925.256.466.930.500|C10.228.140.430.520.750.400|C10.228.228.245.340.400|C10.228.228.399.750.400|C10.586.250.520.750.400	C01.207.245.340|C01.207.399.750|C01.925.182.525|C01.925.256.466.930|C10.228.140.430.520.750|C10.228.228.245.340|C10.228.228.399.750|C10.586.250.520.750	Encephalitis, Herpes Zoster|Encephalitis, Human Herpesvirus 3|Encephalitis, Varicella|Encephalitis, VZ Virus|Herpes Zoster Encephalitis|Herpes Zoster Meningoencephalitis|Meningoencephalitis, Herpes Zoster|Varicella Encephalitides|Varicella Encephalitis|Varicella Zoster Encephalitis|Virus Encephalitis, VZ|Zoster Encephalitis, Herpes|Zoster Encephalitis, Varicella	Nervous system disease|Viral disease
Encephalitis, Viral	MESH:D018792		Inflammation of brain parenchymal tissue as a result of viral infection. Encephalitis may occur as primary or secondary manifestation of TOGAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; BUNYAVIRIDAE INFECTIONS; PICORNAVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RETROVIRIDAE INFECTIONS; and ARENAVIRIDAE INFECTIONS.	MESH:D000069544|MESH:D020805	C01.207.245.340|C01.207.399.750|C01.925.182.525|C10.228.140.430.520.750|C10.228.228.245.340|C10.228.228.399.750|C10.586.250.520.750	C01.207.245|C01.207.399|C01.925.182|C10.228.140.430.520|C10.228.228.245|C10.228.228.399|C10.586.250.520	Encephalomyelitis, Infectious, Viral|Encephalomyelitis, Viral Infectious|Infectious Encephalomyelitis, Viral|Viral Encephalitis|Viral Infectious Encephalomyelitis	Nervous system disease|Viral disease
Encephalocardiomyopathy, Mitochondrial, Neonatal, Due To Atp Synthase Deficiency	MESH:C567528			MESH:D017237	C05.651.460.620/C567528|C10.228.140.163.540/C567528|C10.668.491.500.500/C567528|C18.452.132.540/C567528|C18.452.660.560.620/C567528	C05.651.460.620|C10.228.140.163.540|C10.668.491.500.500|C18.452.132.540|C18.452.660.560.620		Metabolic disease|Musculoskeletal disease|Nervous system disease
Encephalomalacia	MESH:D004678	DO:DOID:2034	Softening or loss of brain tissue following CEREBRAL INFARCTION; cerebral ischemia (see BRAIN ISCHEMIA), infection, CRANIOCEREBRAL TRAUMA, or other injury. The term is often used during gross pathologic inspection to describe blurred cortical margins and decreased consistency of brain tissue following infarction. Multicystic encephalomalacia refers to the formation of multiple cystic cavities of various sizes in the cerebral cortex of neonates and infants following injury, most notably perinatal hypoxia-ischemic events. (From Davis et al., Textbook of Neuropathology, 2nd ed, p665; J Neuropathol Exp Neurol, 1995 Mar;54(2):268-75)	MESH:D001927	C10.228.140.461	C10.228.140	Cerebromalacia|Cerebromalacias|Encephalomalacia, Multicystic|Encephalomalacias|Encephalomalacias, Multicystic|Multicystic Encephalomalacia|Multicystic Encephalomalacias	Nervous system disease
Encephalomalacia, Multilocular	MESH:C565597			MESH:D004678	C10.228.140.461/C565597	C10.228.140.461		Nervous system disease
Encephalomyelitis	MESH:D004679	DO:DOID:640	A general term indicating inflammation of the BRAIN and SPINAL CORD, often used to indicate an infectious process, but also applicable to a variety of autoimmune and toxic-metabolic conditions. There is significant overlap regarding the usage of this term and ENCEPHALITIS in the literature.	MESH:D000090862|MESH:D002494	C01.207.291|C10.228.228.291|C10.586.500	C01.207|C10.228.228|C10.586	Encephalomyelitis, Inflammatory|Inflammatory Encephalomyelitis|Myeloencephalitides|Myeloencephalitis	Nervous system disease
Encephalomyelitis, Acute Disseminated	MESH:D004673	DO:DOID:13664|DO:DOID:639	An acute or subacute inflammatory process of the CENTRAL NERVOUS SYSTEM characterized histologically by multiple foci of perivascular demyelination. Symptom onset usually occurs several days after an acute viral infection or immunization, but it may coincide with the onset of infection or rarely no antecedent event can be identified. Clinical manifestations include CONFUSION, somnolence, FEVER, nuchal rigidity, and involuntary movements. The illness may progress to COMA and eventually be fatal. (Adams et al., Principles of Neurology, 6th ed, p921)	MESH:D020278	C10.114.375.225|C10.228.140.695.562.225|C10.314.350.225|C20.111.258.250.350	C10.114.375|C10.228.140.695.562|C10.314.350|C20.111.258.250	Acute Disseminated Encephalomyelitides|Acute Disseminated Encephalomyelitis|Disseminated Encephalomyelitides, Acute|Disseminated Encephalomyelitis, Acute|Encephalitides, Post-Vaccinal|Encephalitis, Postvaccinal|Encephalitis, Post Vaccinal|Encephalitis, Post-Vaccinal|Encephalitis, Vaccination|Encephalomyelitides, Acute Disseminated|Encephalomyelitides, Post-Vaccinal|Encephalomyelitis, Postexanthem|Encephalomyelitis, Postinfectious|Encephalomyelitis, Post-Vaccinal|Postexanthem Encephalomyelitis|Postinfectious Encephalomyelitis|Post-Vaccinal Encephalitides|Postvaccinal Encephalitis|Post Vaccinal Encephalitis|Post-Vaccinal Encephalitis|Post-Vaccinal Encephalomyelitides|Post Vaccinal Encephalomyelitis|Post-Vaccinal Encephalomyelitis|Vaccination Encephalitis	Immune system disease|Nervous system disease
Encephalomyelitis, Autoimmune, Experimental	MESH:D004681		An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5)	MESH:D020278|MESH:D020721	C10.114.703.300|C10.228.140.695.562.250|C10.314.350.250|C20.111.258.625.300	C10.114.703|C10.228.140.695.562|C10.314.350|C20.111.258.625	Allergic Encephalomyelitis|Allergic Encephalomyelitis, Experimental|Autoimmune Encephalomyelitis, Experimental|Autoimmune Experimental Encephalomyelitis|Encephalomyelitis, Allergic|Encephalomyelitis, Autoimmune Experimental|Encephalomyelitis, Experimental Allergic|Encephalomyelitis, Experimental Autoimmune|Experimental Allergic Encephalomyelitides|Experimental Allergic Encephalomyelitis|Experimental Autoimmune Encephalomyelitis|Experimental Encephalomyelitis, Autoimmune	Immune system disease|Nervous system disease
Encephalomyelitis, Eastern Equine	MESH:D020242	DO:DOID:10841	A form of arboviral encephalitis (primarily affecting equines) endemic to eastern regions of North America. The causative organism (ENCEPHALOMYELITIS VIRUS, EASTERN EQUINE) may be transmitted to humans via the bite of AEDES mosquitoes. Clinical manifestations include the acute onset of fever, HEADACHE, altered mentation, and SEIZURES followed by coma. The condition is fatal in up to 50% of cases. Recovery may be marked by residual neurologic deficits and EPILEPSY. (From Joynt, Clinical Neurology, 1996, Ch26, pp9-10)	MESH:D004683	C01.207.245.340.450.200|C01.207.291.323.162|C01.207.399.750.450.200|C01.920.500.078.370.162|C01.920.500.343.655.177|C01.925.081.343.655.177|C01.925.782.930.100.370.162|C10.228.140.430.520.750.450.200|C10.228.228.245.340.450.200|C10.228.228.291.323.162|C10.228.228.399.750.450.200|C10.586.250.520.750.450.200|C10.586.500.406.200	C01.207.245.340.450|C01.207.291.323|C01.207.399.750.450|C01.920.500.078.370|C01.920.500.343.655|C01.925.081.343.655|C01.925.782.930.100.370|C10.228.140.430.520.750.450|C10.228.228.245.340.450|C10.228.228.291.323|C10.228.228.399.750.450|C10.586.250.520.750.450|C10.586.500.406	Eastern Equine Encephalitides|Eastern Equine Encephalitis|Eastern Equine Encephalomyelitides|Eastern Equine Encephalomyelitis|Eastern Equine Encephalomyelitis Virus Infection|Encephalitides, Eastern Equine|Encephalitis, Eastern Equine|Encephalomyelitides, Eastern Equine|Equine Encephalitides, Eastern|Equine Encephalitis, Eastern|Equine Encephalomyelitides, Eastern|Equine Encephalomyelitis, Eastern	Nervous system disease|Viral disease
Encephalomyelitis, Equine	MESH:D004683		A group of ALPHAVIRUS INFECTIONS which affect horses and man, transmitted via the bites of mosquitoes. Disorders in this category are endemic to regions of South America and North America. In humans, clinical manifestations vary with the type of infection, and range from a mild influenza-like syndrome to a fulminant encephalitis. (From Joynt, Clinical Neurology, 1996, Ch26, pp8-10)	MESH:D004671|MESH:D004679|MESH:D018354|MESH:D018792	C01.207.245.340.450|C01.207.291.323|C01.207.399.750.450|C01.920.500.078.370|C01.920.500.343.655|C01.925.081.343.655|C01.925.182.525.450|C01.925.782.930.100.370|C10.228.140.430.520.750.450|C10.228.228.245.340.450|C10.228.228.291.323|C10.228.228.399.750.450|C10.586.250.520.750.450|C10.586.500.406	C01.207.245.340|C01.207.291|C01.207.399.750|C01.920.500.078|C01.920.500.343|C01.925.081.343|C01.925.182.525|C01.925.782.930.100|C10.228.140.430.520.750|C10.228.228.245.340|C10.228.228.291|C10.228.228.399.750|C10.586.250.520.750|C10.586.500	Encephalitis, Equine|Equine Encephalitis|Equine Encephalomyelitis|Equine Encephalomyelitis Viral Infections|Equine Encephalomyelitis Virus Infections|Infections, Equine Encephalomyelitis Virus	Nervous system disease|Viral disease
Encephalomyelitis, Venezuelan Equine	MESH:D004685	DO:DOID:9584	A form of arboviral encephalitis endemic to Central America and the northern latitudes of South America. The causative organism (ENCEPHALITIS VIRUS, VENEZUELAN EQUINE) is transmitted to humans and horses via the bite of several mosquito species. Human viral infection may be asymptomatic or remain restricted to a mild influenza-like illness. Encephalitis, usually not severe, occurs in a small percentage of cases and may rarely feature SEIZURES and COMA. (From Joynt, Clinical Neurology, 1996, Ch26, pp9-10)	MESH:D004683	C01.207.245.340.450.600|C01.207.291.323.325|C01.207.399.750.450.600|C01.920.500.078.370.325|C01.920.500.343.655.355|C01.925.081.343.655.355|C01.925.182.525.450.250|C01.925.782.930.100.370.325|C10.228.140.430.520.750.450.600|C10.228.228.245.340.450.600|C10.228.228.291.323.325|C10.228.228.399.750.450.600|C10.586.250.520.750.450.600|C10.586.500.406.225	C01.207.245.340.450|C01.207.291.323|C01.207.399.750.450|C01.920.500.078.370|C01.920.500.343.655|C01.925.081.343.655|C01.925.182.525.450|C01.925.782.930.100.370|C10.228.140.430.520.750.450|C10.228.228.245.340.450|C10.228.228.291.323|C10.228.228.399.750.450|C10.586.250.520.750.450|C10.586.500.406	Encephalitis, Venezuelan Equine|Encephalomyelitides, Venezuelan Equine|Equine Encephalitis, Venezuelan|Equine Encephalomyelitides, Venezuelan|Equine Encephalomyelitis, Venezuelan|Venezuelan Equine Encephalitis|Venezuelan Equine Encephalomyelitides|Venezuelan Equine Encephalomyelitis	Nervous system disease|Viral disease
Encephalomyelitis, Western Equine	MESH:D020241	DO:DOID:10843	A form of arboviral encephalitis (which primarily affects horses) endemic to western and central regions of NORTH AMERICA. The causative organism (ENCEPHALOMYELITIS VIRUS, WESTERN EQUINE) may be transferred to humans via the bite of mosquitoes (CULEX tarsalis and others). Clinical manifestations include headache and influenza-like symptoms followed by alterations in mentation, SEIZURES, and COMA. DEATH occurs in a minority of cases. Survivors may recover fully or be left with residual neurologic dysfunction, including PARKINSONISM, POSTENCEPHALITIC. (From Joynt, Clinical Neurology, 1996, Ch26, pp8-9)	MESH:D004683	C01.207.245.340.450.800|C01.207.291.323.662|C01.207.399.750.450.800|C01.920.500.078.370.662|C01.920.500.343.655.677|C01.925.081.343.655.677|C01.925.182.525.450.300|C01.925.782.930.100.370.662|C10.228.140.430.520.750.450.800|C10.228.228.245.340.450.800|C10.228.228.291.323.662|C10.228.228.399.750.450.800|C10.586.250.520.750.450.800|C10.586.500.406.250	C01.207.245.340.450|C01.207.291.323|C01.207.399.750.450|C01.920.500.078.370|C01.920.500.343.655|C01.925.081.343.655|C01.925.182.525.450|C01.925.782.930.100.370|C10.228.140.430.520.750.450|C10.228.228.245.340.450|C10.228.228.291.323|C10.228.228.399.750.450|C10.586.250.520.750.450|C10.586.500.406	Encephalitis, Western Equine|Equine Encephalitis, Western|Western Equine Encephalitis|Western Equine Encephalomyelitis	Nervous system disease|Viral disease
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3	OMIM:608033			MESH:D004684|MESH:D007239	C01/608033|C10.114.375.225.500/608033|C10.114.375.362/608033|C10.228.140.695.562.225.500/608033|C10.228.140.695.562.375/608033|C10.314.350.225.500/608033|C10.314.350.375/608033|C20.111.258.250.350.500/608033|C20.111.258.250.425/608033	C01|C10.114.375.225.500|C10.114.375.362|C10.228.140.695.562.225.500|C10.228.140.695.562.375|C10.314.350.225.500|C10.314.350.375|C20.111.258.250.350.500|C20.111.258.250.425	ANE|ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO|IIAE3	Immune system disease|Nervous system disease
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	OMIM:614212			MESH:D001927|MESH:D007239	C01/614212|C10.228.140/614212	C01|C10.228.140	IIAE4	Nervous system disease
Encephalopathy, Axonal, with Necrotizing Myopathy, Cardiomyopathy, and Cataracts	MESH:C565596			MESH:D001928|MESH:D002386|MESH:D009135|MESH:D009202	C05.651/C565596|C10.228.140.163/C565596|C10.668.491/C565596|C11.510.245/C565596|C14.280.238/C565596|C18.452.132/C565596	C05.651|C10.228.140.163|C10.668.491|C11.510.245|C14.280.238|C18.452.132		Cardiovascular disease|Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1	OMIM:617186			MESH:D001929|MESH:D056784	C10.228.140.187/617186|C10.228.140.695/617186	C10.228.140.187|C10.228.140.695	PEBEL|PEBEL1	Nervous system disease
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY	OMIM:617207			MESH:D001927|MESH:D009134|MESH:D009896	C10.228.140/617207|C10.228.854.468/617207|C10.292.700.225/617207|C10.574.562.500/617207|C10.668.467.500/617207|C11.640.451/617207	C10.228.140|C10.228.854.468|C10.292.700.225|C10.574.562.500|C10.668.467.500|C11.640.451	PEAMO	Eye disease|Nervous system disease
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY	OMIM:615924			MESH:D001927|MESH:D008060	C10.228.140/615924|C17.800.849.391/615924|C18.452.584.625/615924|C18.452.880.391/615924	C10.228.140|C17.800.849.391|C18.452.584.625|C18.452.880.391	PELD	Metabolic disease|Nervous system disease|Skin disease
Enchondromatosis	MESH:D004687	DO:DOID:4624|OMIM:166000	Benign growths of cartilage in the metaphyses of several bones.	MESH:D010009	C05.116.099.708.338	C05.116.099.708	Chondrodysplasia with Hemangioma|Chondroplasia Angiomatosis|Disease, Ollier|Disease, Ollier's|Dyschondrodysplasia with Hemangiomas|DYSCHONDROPLASIA|Dyschondroplasia and Cavernous Hemangioma|Enchondroma, Multiple|Enchondromas, Multiple|Enchondromatoses|Enchondromatosis, Multiple|ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE|Enchondromatosis with Hemangiomata|Enchondromatosis with Multiple Cavernous Hemangiomas|Enchondroses, Multiple|Enchondrosis, Multiple|Hemangiomata with Dyschondroplasia|Hemangiomatosis Chondrodystrophica|Kast Syndrome|Maffucci Syndrome|Multiple Angiomas and Endochondromas|Multiple Enchondroma|Multiple Enchondromas|Multiple Enchondroses|Multiple Enchondrosis|Ollier Disease|Ollier's Disease|Olliers Disease|OSTEOCHONDROMATOSIS|Syndrome, Maffucci	Musculoskeletal disease
Endarteritis	MESH:D004692		Inflammation of the inner endothelial lining (TUNICA INTIMA) of an artery.	MESH:D001167	C14.907.940.090.340	C14.907.940.090	Endarteritides	Cardiovascular disease
Endocardial Cushion Defects	MESH:D004694	DO:DOID:0050651	A spectrum of septal defects involving the ATRIAL SEPTUM; VENTRICULAR SEPTUM; and the atrioventricular valves (TRICUSPID VALVE; BICUSPID VALVE). These defects are due to incomplete growth and fusion of the ENDOCARDIAL CUSHIONS which are important in the formation of two atrioventricular canals, site of future atrioventricular valves.	MESH:D006343	C14.240.400.560.350|C14.280.400.560.350|C16.131.240.400.560.350	C14.240.400.560|C14.280.400.560|C16.131.240.400.560	Cushion Defect, Endocardial|Cushion Defects, Endocardial|Defect, Endocardial Cushion|Defects, Endocardial Cushion|Endocardial Cushion Defect|Persistent Common Atrioventricular Canal	Cardiovascular disease|Congenital abnormality
Endocardial Fibroelastosis	MESH:D004695	DO:DOID:12929	A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (CARDIOMYOPATHY, RESTRICTIVE). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (HEART DEFECTS CONGENITAL;) INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.	MESH:D009202	C14.280.238.281	C14.280.238	Endocardial Fibroelastoses|Endomyocardial Fibroelastosis|Fibroelastoses, Endocardial|Fibroelastosis, Endocardial	Cardiovascular disease
Endocardial Fibroelastosis and Coarctation of Abdominal Aorta	MESH:C565592			MESH:D001017|MESH:D004695	C14.240.400.090/C565592|C14.280.238.281/C565592|C14.280.400.090/C565592|C16.131.240.400.090/C565592	C14.240.400.090|C14.280.238.281|C14.280.400.090|C16.131.240.400.090		Cardiovascular disease|Congenital abnormality
Endocarditis	MESH:D004696	DO:DOID:10314	Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.	MESH:D006331	C14.280.282	C14.280	Endocarditides|Endocarditides, Infective|Endocarditis, Infective|Infective Endocarditides|Infective Endocarditis	Cardiovascular disease
Endocarditis, Non-Infective	MESH:D059905		Formation of a non-infectious THROMBUS, referred to as vegetation, on previously undamaged ENDOCARDIUM. It usually occurs as a complication of connective-tissue diseases and cancers because of the associated hypercoagulable state (see THROMBOPHILIA).	MESH:D004696	C14.280.282.703	C14.280.282	Endocarditides, Marantic|Endocarditides, Non-Infective|Endocarditis, Marantic|Endocarditis, Non-Bacterial Thrombotic|Endocarditis, Non Infective|Marantic Endocarditides|Marantic Endocarditis|Non-Bacterial Thrombotic Endocarditis|Non-Infective Endocarditides|Non Infective Endocarditis|Non-Infective Endocarditis	Cardiovascular disease
Endocrine-Cerebroosteodysplasia	MESH:C567210	OMIM:612651		MESH:D002493|MESH:D004700	C10.228/C567210|C19/C567210	C10.228|C19	ECO	Endocrine system disease|Nervous system disease
Endocrine Gland Neoplasms	MESH:D004701	DO:DOID:170	Tumors or cancer of the ENDOCRINE GLANDS.	MESH:D004700|MESH:D009371	C04.588.322|C19.344	C04.588|C19	Cancer, Endocrine|Cancer, Endocrine Gland|Cancer of Endocrine Gland|Cancer of the Endocrine Gland|Cancers, Endocrine|Carcinoma, Endocrine Gland|Carcinoma of Endocrine Gland|Endocrine Cancer|Endocrine Cancers|Endocrine Gland Cancer|Endocrine Gland Carcinoma|Endocrine Gland Neoplasm|Neoplasm, Endocrine Gland|Neoplasms, Endocrine Gland	Cancer|Endocrine system disease
Endodermal Sinus Tumor	MESH:D018240	DO:DOID:1911	An unusual and aggressive tumor of germ-cell origin that reproduces the extraembryonic structures of the early embryo. It is the most common malignant germ cell tumor found in children. It is characterized by a labyrinthine glandular pattern of flat epithelial cells and rounded papillary processes with a central capillary (Schiller-Duval body). The tumor is rarely bilateral. Before the use of combination chemotherapy, the tumor was almost invariably fatal. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1189)	MESH:D008649	C04.557.465.510.350	C04.557.465.510	Endodermal Sinus Tumors|Tumor, Endodermal Sinus|Tumors, Endodermal Sinus|Tumors, Yolk Sac|Tumor, Yolk Sac|Yolk Sac Tumor|Yolk Sac Tumors	Cancer
Endoleak	MESH:D057867		Postoperative hemorrhage from an endovascular AORTIC ANEURYSM repaired with endoluminal placement of stent grafts (BLOOD VESSEL PROSTHESIS IMPLANTATION). It is associated with pressurization, expansion, and eventual rupture of the aneurysm.	MESH:D000783|MESH:D019106	C14.907.055.501|C23.550.414.941.500|C23.550.767.850.500	C14.907.055|C23.550.414.941|C23.550.767.850	Endoleaks|Leak, Perigraft|Leaks, Perigraft|Perigraft Leak|Perigraft Leaks	Cardiovascular disease|Pathology (process)
Endolymphatic Hydrops	MESH:D018159	DO:DOID:9848	An accumulation of ENDOLYMPH in the inner ear (LABYRINTH) leading to buildup of pressure and distortion of intralabyrinthine structures, such as COCHLEA and SEMICIRCULAR CANALS. It is characterized by SENSORINEURAL HEARING LOSS; TINNITUS; and sometimes VERTIGO.	MESH:D007759	C09.218.568.217	C09.218.568	Hydrops, Endolymphatic	Ear-nose-throat disease
Endometrial Hyperplasia	MESH:D004714	DO:DOID:0080365	Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.	MESH:D014591	C12.050.351.500.852.228|C12.100.250.852.228	C12.050.351.500.852|C12.100.250.852	Atypical Endometrial Hyperplasia|Atypical Endometrial Hyperplasias|Complex Endometrial Hyperplasia|Complex Endometrial Hyperplasias|Endometrial Hyperplasia, Atypical|Endometrial Hyperplasia, Complex|Endometrial Hyperplasias|Endometrial Hyperplasias, Atypical|Endometrial Hyperplasias, Complex|Endometrial Hyperplasia, Simple|Endometrial Hyperplasias, Simple|Hyperplasia, Atypical Endometrial|Hyperplasia, Complex Endometrial|Hyperplasia, Endometrial|Hyperplasias, Atypical Endometrial|Hyperplasias, Complex Endometrial|Hyperplasias, Endometrial|Hyperplasia, Simple Endometrial|Hyperplasias, Simple Endometrial|Simple Endometrial Hyperplasia|Simple Endometrial Hyperplasias	Urogenital disease (female)
Endometrial Neoplasms	MESH:D016889	DO:DOID:1380|DO:DOID:2871|OMIM:608089	Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.	MESH:D014594	C04.588.945.418.948.585|C12.050.351.500.852.762.200|C12.050.351.937.418.875.200|C12.100.250.852.762.200|C12.900.418.875.200	C04.588.945.418.948|C12.050.351.500.852.762|C12.050.351.937.418.875|C12.100.250.852.762|C12.900.418.875	Cancer, Endometrial|Cancer, Endometrium|Cancer of Endometrium|Cancer of the Endometrium|Cancers, Endometrial|Cancers, Endometrium|Carcinoma, Endometrial|Carcinoma of Endometrium|Carcinomas, Endometrial|Endometrial Cancer|Endometrial Cancers|Endometrial Carcinoma|Endometrial Carcinomas|Endometrial Neoplasm|Endometrium Cancer|Endometrium Cancers|Endometrium Carcinoma|Endometrium Carcinomas|Neoplasm, Endometrial|Neoplasms, Endometrial	Cancer|Urogenital disease (female)
Endometrial Stromal Tumors	MESH:D036821	DO:DOID:5166	Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).	MESH:D009372|MESH:D012509|MESH:D016889	C04.557.450.565.325|C04.557.450.795.332|C12.050.351.500.852.762.200.500|C12.050.351.937.418.875.200.374|C12.100.250.852.762.200.500|C12.900.418.875.200.374	C04.557.450.565|C04.557.450.795|C12.050.351.500.852.762.200|C12.050.351.937.418.875.200|C12.100.250.852.762.200|C12.900.418.875.200	Endolymphatic Stromal Myoses|Endolymphatic Stromal Myosis|Endometrial Stromal Tumor|Myoses, Endolymphatic Stromal|Myosis, Endolymphatic Stromal|Sarcoma, Endometrial Stromal, Low-Grade|Stromal Myoses, Endolymphatic|Stromal Myosis, Endolymphatic|Stromal Tumor, Endometrial|Stromal Tumors, Endometrial|Tumor, Endometrial Stromal|Tumors, Endometrial Stromal	Cancer|Urogenital disease (female)
Endometriosis	MESH:D004715	DO:DOID:289|OMIM:131200	A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.	MESH:D005831	C12.050.351.500.163|C12.100.250.163	C12.050.351.500|C12.100.250	ENDO1|Endometrioma|Endometriomas|Endometrioses|ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1	Urogenital disease (female)
Endometritis	MESH:D004716	DO:DOID:1002	Inflammation of the ENDOMETRIUM, usually caused by intrauterine infections. Endometritis is the most common cause of postpartum fever.	MESH:D000292|MESH:D014591	C12.050.351.500.056.750.249|C12.050.351.500.852.299|C12.100.250.056.750.249|C12.100.250.852.299	C12.050.351.500.056.750|C12.050.351.500.852|C12.100.250.056.750|C12.100.250.852	Endomyometritis	Urogenital disease (female)
Endomyocardial Fibrosis	MESH:D004719	DO:DOID:12932	A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).	MESH:D009202	C14.280.238.406	C14.280.238	Endomyocardial Fibroses|Fibroses, Endomyocardial|Fibrosis, Endomyocardial	Cardiovascular disease
Endophthalmitis	MESH:D009877	DO:DOID:4692	Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.	MESH:D015817	C01.375.265|C11.294.265	C01.375|C11.294	Endophthalmitides|Endophthalmitides, Infectious|Endophthalmitis, Infectious|Infectious Endophthalmitides|Infectious Endophthalmitis|Ophthalmia|Ophthalmias	Eye disease
Endotoxin Hyporesponsiveness	MESH:C566417			MESH:D007153	C20.673/C566417	C20.673		Immune system disease
Enophthalmos	MESH:D015841	DO:DOID:11175	Recession of the eyeball into the orbit.	MESH:D009916	C11.675.319	C11.675		Eye disease
Enteropathy-Associated T-Cell Lymphoma	MESH:D058527		A primary peripheral T-cell lymphoma in the gastrointestinal tract, most often in the jejunum, associated with a history of CELIAC DISEASE or other gastrointestinal diseases.	MESH:D016399	C04.557.386.480.750.099|C15.604.515.569.480.750.399|C20.683.515.761.480.750.199	C04.557.386.480.750|C15.604.515.569.480.750|C20.683.515.761.480.750	Enteropathy Associated T Cell Lymphoma|Enteropathy-Associated T-Cell Lymphomas|Lymphomas, Enteropathy-Associated T-Cell|Lymphoma, T-Cell, Enteropathy-Associated|T Cell Lymphoma, Enteropathy Associated|T-Cell Lymphoma, Enteropathy-Associated|T-Cell Lymphomas, Enteropathy-Associated	Cancer|Immune system disease|Lymphatic disease
Enterovirus Infections	MESH:D004769		Diseases caused by ENTEROVIRUS.	MESH:D010850	C01.925.782.687.359	C01.925.782.687	Enterovirus Infection|Infection, Enterovirus|Infections, Enterovirus	Viral disease
Enthesopathy	MESH:D000070676	DO:DOID:204	A disorder occurring at the site of insertion of TENDONS or LIGAMENTS into bones or JOINT CAPSULES.	MESH:D052256	C05.651.869.653|C26.874.800.750	C05.651.869|C26.874.800	Enthesopathies	Musculoskeletal disease|Wounds and injuries
Entropion	MESH:D004774	DO:DOID:12397	The turning inward (inversion) of the edge of the eyelid, with the tarsal cartilage turned inward toward the eyeball. (Dorland, 27th ed)	MESH:D005141	C11.338.443	C11.338	Entropions	Eye disease
Eosinophilia	MESH:D004802	DO:DOID:999	Abnormal increase of EOSINOPHILS in the blood, tissues or organs.	MESH:D007960	C15.378.553.231	C15.378.553	Eosinophilias|Eosinophilias, Tropical|Eosinophilia, Tropical|Tropical Eosinophilia|Tropical Eosinophilias	Blood disease
Eosinophilia, Familial	MESH:C562722	OMIM:131400		MESH:D004802	C15.378.553.231/C562722	C15.378.553.231	EOS|Familial eosinophilia	Blood disease
Eosinophilia-Myalgia Syndrome	MESH:D016603	DO:DOID:998	A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)	MESH:D004802|MESH:D009135	C05.651.290|C10.668.491.050|C15.378.553.231.335	C05.651|C10.668.491|C15.378.553.231	Eosinophilia Myalgia Syndrome|Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related|Eosinophilia-Myalgia Syndromes|Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related|L-Tryptophan-Related Eosinophilia-Myalgia Syndrome|L-Tryptophan-Related Eosinophilia-Myalgia Syndromes|Syndrome, Eosinophilia-Myalgia|Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related|Syndrome, L-Tryptophan-Related Eosinophilia-Myalgia|Syndromes, Eosinophilia-Myalgia|Syndromes, L-Tryptophan-Related Eosinophilia-Myalgia	Blood disease|Musculoskeletal disease|Nervous system disease
Eosinophilic enteropathy	MESH:C535952			MESH:D004751|MESH:D004802|MESH:D005756	C06.405.205.462/C535952|C06.405.205.697/C535952|C06.405.469.326/C535952|C06.405.748.398/C535952|C15.378.553.231/C535952	C06.405.205.462|C06.405.205.697|C06.405.469.326|C06.405.748.398|C15.378.553.231	Eosinophilic enteritis|Eosinophilic gastritis|Eosinophilic gastroenteritis|Eosinophilic gastroenteropathy	Blood disease|Digestive system disease
Eosinophilic Esophagitis	MESH:D057765	DO:DOID:13922|OMIM:610247|OMIM:613412	Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.	MESH:D004802|MESH:D004941|MESH:D006969	C06.405.117.620.209|C06.405.205.663.209|C15.378.553.231.341|C20.543.480.356	C06.405.117.620|C06.405.205.663|C15.378.553.231|C20.543.480	Chronic Esophagitides, Eosinophilic|Chronic Esophagitis, Eosinophilic|EE|EOE1|EOE2|Eosinophilic Chronic Esophagitides|Eosinophilic Chronic Esophagitis|Eosinophilic Esophagitides|Esophagitides, Eosinophilic|Esophagitides, Eosinophilic Chronic|Esophagitis, Eosinophilic|ESOPHAGITIS, EOSINOPHILIC, 1|ESOPHAGITIS, EOSINOPHILIC, 2|Esophagitis, Eosinophilic Chronic	Blood disease|Digestive system disease|Immune system disease
Eosinophilic Fasciitis	MESH:C562487			MESH:D004802|MESH:D005208	C05.321/C562487|C15.378.553.231/C562487	C05.321|C15.378.553.231	diffuse fasciitis with eosinophilia|Shulman syndrome	Blood disease|Musculoskeletal disease
Eosinophilic Granuloma	MESH:D004803		The most benign and common form of Langerhans-cell histiocytosis which involves localized nodular lesions predominantly of the bones but also of the gastric mucosa, small intestine, lungs, or skin, with infiltration by EOSINOPHILS.	MESH:D001847|MESH:D004802|MESH:D006099|MESH:D006646	C05.116.391|C08.381.483.375.500|C15.378.553.231.348|C15.604.250.400.360|C23.550.382.250	C05.116|C08.381.483.375|C15.378.553.231|C15.604.250.400|C23.550.382	Eosinophilic Granulomas|Granuloma, Eosinophilic|Granulomas, Eosinophilic	Blood disease|Lymphatic disease|Musculoskeletal disease|Pathology (process)|Respiratory tract disease
Eosinophilic pustular folliculitis	MESH:C535953			MESH:D004802|MESH:D005499|MESH:D012872	C15.378.553.231/C535953|C17.800.329.500/C535953|C17.800.865/C535953	C15.378.553.231|C17.800.329.500|C17.800.865	Eosinophilic folliculitis, pustular|Ofuji disease|Ofuji's disease	Blood disease|Skin disease
Eosinophilic synovitis	MESH:C535954			MESH:D004802|MESH:D013585	C05.550.870/C535954|C15.378.553.231/C535954	C05.550.870|C15.378.553.231	Idiopathic eosinophilic synovitis	Blood disease|Musculoskeletal disease
Ependymoma	MESH:D004806	DO:DOID:4844|DO:DOID:5075|DO:DOID:5500|DO:DOID:5505	Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9)	MESH:D005910	C04.557.465.625.600.380.290|C04.557.470.670.380.290|C04.557.580.625.600.380.290	C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380	Anaplastic Ependymoma|Anaplastic Ependymomas|Cellular Ependymoma|Clear Cell Ependymoma|Ependymoma, Anaplastic|Ependymoma, Myxopapillary|Ependymoma, Papillary|Ependymomas|Ependymomas, Anaplastic|Ependymomas, Myxopapillary|Ependymomas, Papillary|Myxopapillary Ependymoma|Myxopapillary Ependymomas|Papillary Ependymoma|Papillary Ependymomas	Cancer
Epiblepharon of Upper Lid	MESH:C565051			MESH:D005141	C11.338/C565051	C11.338	Epiblepharon of Lower Lid	Eye disease
Epidermal Cyst	MESH:D004814		Intradermal or subcutaneous saclike structure, the wall of which is stratified epithelium containing keratohyalin granules.	MESH:D003560	C04.182.254	C04.182	Cyst, Epidermal|Cyst, Epidermoid|Cyst, Pilar|Cyst, Sebaceous|Cysts, Epidermal|Cysts, Epidermoid|Cysts, Pilar|Cysts, Sebaceous|Epidermal Cysts|Epidermoid Cyst|Epidermoid Cysts|Pilar Cyst|Pilar Cysts|Sebaceous Cyst|Sebaceous Cysts	Cancer
Epidermal Nevus	MESH:C580062	OMIM:162900		MESH:D009506	C04.557.665.560/C580062	C04.557.665.560	Epidermal Naevus|Nevus, Epidermal|Nevus, Keratinocytic, Nonepidermolytic|NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC  NEVUS SEBACEOUS, INCLUDED|NEVUS, WOOLLY HAIR, INCLUDED	Cancer
Epidermodysplasia Verruciformis	MESH:D004819	DO:DOID:13777|OMIM:226400	An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.	MESH:D014860	C01.925.256.650.810.345|C01.925.825.810.260|C01.925.928.914.345|C17.800.838.790.810.260	C01.925.256.650.810|C01.925.825.810|C01.925.928.914|C17.800.838.790.810	Disease, Lewandowsky-Lutz|Disease, Lutz-Lewandowsky|EPIDERMODYSPLASIA VERRUCIFORMIS|EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1|EV|EV1|Lewandowsky Lutz Disease|Lewandowsky-Lutz Disease|Lutz Lewandowsky Disease|Lutz-Lewandowsky Disease	Skin disease|Viral disease
Epidural Abscess	MESH:D020802	DO:DOID:11387	Circumscribed collections of suppurative material occurring in the spinal or intracranial EPIDURAL SPACE. The majority of epidural abscesses occur in the spinal canal and are associated with OSTEOMYELITIS of a vertebral body; ANALGESIA, EPIDURAL; and other conditions. Clinical manifestations include local and radicular pain, weakness, sensory loss, URINARY INCONTINENCE, and FECAL INCONTINENCE. Cranial epidural abscesses are usually associated with OSTEOMYELITIS of a cranial bone, SINUSITIS, or OTITIS MEDIA. (From Adams et al., Principles of Neurology, 6th ed, p710 and pp1240-1; J Neurol Neurosurg Psychiatry 1998 Aug;65(2):209-12)	MESH:D000038|MESH:D002494|MESH:D013118|MESH:D020819	C01.207.300|C01.207.709.350|C01.830.025.325|C10.228.228.300|C10.228.228.709.350|C10.228.854.303	C01.207|C01.207.709|C01.830.025|C10.228.228|C10.228.228.709|C10.228.854	Abscess, Cranial Epidural|Abscess, Cranial Extradural|Abscess, Epidural|Abscesses, Intracranial Extradural|Abscess, Extradural|Abscess, Intracranial Epidural|Abscess, Intracranial Extradural|Abscess, Spinal Epidural|Abscess, Spinal Extradural|Cranial Epidural Abscess|Cranial Extradural Abscess|Epidural Abscess, Cranial|Epidural Abscess, Intracranial|Epidural Abscess, Spinal|Extradural Abscess|Extradural Abscesses, Intracranial|Extradural Abscess, Intracranial|Extradural Abscess, Spinal|Intracranial Epidural Abscess|Intracranial Extradural Abscess|Intracranial Extradural Abscesses|Spinal Epidural Abscess|Spinal Extradural Abscess	Nervous system disease
Epidural Neoplasms	MESH:D015174	DO:DOID:3618	Neoplasms located in the space between the vertebral PERIOSTEUM and DURA MATER surrounding the SPINAL CORD. Tumors in this location are most often metastatic in origin and may cause neurologic deficits by mass effect on the spinal cord or nerve roots or by interfering with blood supply to the spinal cord.	MESH:D013120	C04.588.614.250.803.342|C10.228.854.765.342|C10.551.240.750.200	C04.588.614.250.803|C10.228.854.765|C10.551.240.750	Epidural Neoplasm|Epidural Neoplasm, Malignant|Epidural Neoplasms, Malignant|Epidural Tumor|Epidural Tumors|Malignant Epidural Neoplasm|Malignant Epidural Neoplasms|Neoplasms, Epidural	Cancer|Nervous system disease
Epiglottitis	MESH:D004826	DO:DOID:9398	Inflammation of the EPIGLOTTIS.	MESH:D059525	C01.748.798.200|C08.730.798.200	C01.748.798|C08.730.798	Epiglottitides	Respiratory tract disease
Epilepsia Partialis Continua	MESH:D017036		A variant of EPILEPSY characterized by continuous focal jerking of a body part over a period of hours, days, or even years without spreading to other body regions. Contractions may be aggravated by movement and are reduced, but not abolished during sleep. ELECTROENCEPHALOGRAPHY demonstrates epileptiform (spike and wave) discharges over the hemisphere opposite to the affected limb in most instances. The repetitive movements may originate from the CEREBRAL CORTEX or from subcortical structures (e.g., BRAIN STEM; BASAL GANGLIA). This condition is associated with Russian Spring and Summer encephalitis (see ENCEPHALITIS, TICK BORNE); Rasmussen syndrome (see ENCEPHALITIS); MULTIPLE SCLEROSIS; DIABETES MELLITUS; BRAIN NEOPLASMS; and CEREBROVASCULAR DISORDERS. (From Brain, 1996 April;119(pt2):393-407; Epilepsia 1993;34;Suppl 1:S29-S36; and Adams et al., Principles of Neurology, 6th ed, p319)	MESH:D013226	C10.597.742.785.260|C23.888.592.742.785.260	C10.597.742.785|C23.888.592.742.785	Chronic Progressive Epilepsia Partialis Continua|Epilepsia Partialis Continua, Chronic Progressive|Epilepsies, Kojevnikov's|Epilepsy, Kojevnikov's|Epilepsy, Kojewnikov's|Kojevnikov Epilepsy|Kojevnikov's Epilepsies|Kojevnikov's Epilepsy|Kojewnikov Epilepsy|Kojewnikov's Epilepsy|Kojewnikow's Syndrome|Kojewnikow Syndrome|Kozhevnikov's Syndrome|Kozhevnikov Syndrome|Kozhevnikow Syndrome, Progressive Variant|Progressive Variant of Kozhevnikow Syndrome	Nervous system disease|Signs and symptoms
Epilepsies, Myoclonic	MESH:D004831	DO:DOID:308|OMIM:607208	A clinically diverse group of epilepsy syndromes characterized either by myoclonic seizures or by myoclonus in association with other seizure types. Myoclonic epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic.	MESH:D000073376|MESH:D004829	C10.228.140.490.375.130|C10.228.140.490.493.063	C10.228.140.490.375|C10.228.140.490.493	Astatic Epilepsies, Myoclonic|Astatic Epilepsy, Myoclonic|Benign Infantile Myoclonic Epilepsy|Cryptogenic Myoclonic Epilepsies|Cryptogenic Myoclonic Epilepsy|DEE6A|DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6A|Doose Syndrome|Dravet Syndrome|Dravet Syndromes|DRVT|Early Childhood Epilepsy, Myoclonic|Early Childhood, Myoclonic Epilepsy|EIEE6|Encephalopathies, Myoclonic|Encephalopathy, Myoclonic|Epilepsies, Cryptogenic Myoclonic|Epilepsies, Idiopathic Myoclonic|Epilepsies, Infantile Myoclonic|Epilepsies, Myoclonic Absence|Epilepsies, Myoclonic Astatic|Epilepsies, Symptomatic Myoclonic|Epilepsy, Cryptogenic Myoclonic|Epilepsy, Early Childhood, Myoclonic|Epilepsy, Idiopathic Myoclonic|Epilepsy, Infantile Myoclonic|Epilepsy, Myoclonic|Epilepsy, Myoclonic Absence|Epilepsy, Myoclonic Astatic|Epilepsy, Myoclonic, Early Childhood|Epilepsy, Myoclonic, Infantile|Epilepsy, Myoclonic, Infantile, Benign|Epilepsy, Myoclonic, Infantile, Severe|Epilepsy, Myoclonus|Epilepsy, Symptomatic Myoclonic|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6|Idiopathic Myoclonic Epilepsies|Idiopathic Myoclonic Epilepsy|Infantile Myoclonic Epilepsies|Infantile Myoclonic Epilepsy|Infantile Severe Myoclonic Epilepsy|Myoclonic Absence Epilepsies|Myoclonic Absence Epilepsy|Myoclonic Astatic Epilepsies|Myoclonic Astatic Epilepsy|Myoclonic Encephalopathies|Myoclonic Encephalopathy|Myoclonic Epilepsies|Myoclonic Epilepsies, Cryptogenic|Myoclonic Epilepsies, Idiopathic|Myoclonic Epilepsies, Infantile|Myoclonic Epilepsies, Symptomatic|Myoclonic Epilepsy|Myoclonic Epilepsy, Benign Infantile|Myoclonic Epilepsy, Cryptogenic|Myoclonic Epilepsy, Early Childhood|Myoclonic Epilepsy, Idiopathic|Myoclonic Epilepsy, Infantile|Myoclonic Epilepsy, Infantile, Benign|Myoclonic Epilepsy, Infantile, Severe|Myoclonic Epilepsy, Severe Infantile|Myoclonic Epilepsy, Severe, Of Infancy|Myoclonic Epilepsy, Symptomatic|Myoclonic Seizure Disorder|Myoclonic Seizure Disorders|Myoclonus Epilepsies|Myoclonus Epilepsy|Seizure Disorder, Myoclonic|Seizure Disorders, Myoclonic|Severe Infantile Myoclonic Epilepsy|Severe Myoclonic Epilepsy, Infantile|Severe Myoclonic Epilepsy Of Infancy|SMEI|Symptomatic Myoclonic Epilepsies|Symptomatic Myoclonic Epilepsy	Nervous system disease
Epilepsies, Partial	MESH:D004828	DO:DOID:2234	Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered (simple partial seizure) or disturbed (complex partial seizure). Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely. (From Adams et al., Principles of Neurology, 6th ed, pp317)	MESH:D004827	C10.228.140.490.360	C10.228.140.490	Abdominal Epilepsies|Abdominal Epilepsy|Amygdalo-Hippocampal Epilepsies|Amygdalo-Hippocampal Epilepsy|Benign Focal Epilepsy, Childhood|Benign Occipital Epilepsies|Benign Occipital Epilepsy|Benign Occipital Epilepsy, Childhood|Childhood Benign Focal Epilepsy|Childhood Benign Occipital Epilepsy|Digestive Epilepsies|Digestive Epilepsy|Disorders, Focal Seizure|Disorders, Partial Seizure|Epilepsies, Abdominal|Epilepsies, Amygdalo-Hippocampal|Epilepsies, Benign Occipital|Epilepsies, Digestive|Epilepsies, Focal|Epilepsies, Gelastic|Epilepsies, Localization-Related|Epilepsies, Occipital Lobe|Epilepsies, Rhinencephalic|Epilepsies, Simple Partial|Epilepsy, Abdominal|Epilepsy, Benign Occipital|Epilepsy, Focal|Epilepsy, Localization-Related|Epilepsy, Partial|Epilepsy, Simple Partial|Focal Epilepsies|Focal Epilepsy|Focal Seizure Disorder|Focal Seizure Disorders|Gelastic Epilepsies|Gelastic Epilepsy|Lobe Epilepsy, Occipital|Localization-Related Epilepsies|Localization-Related Epilepsy|Occipital Epilepsies, Benign|Occipital Epilepsy, Benign|Occipital Lobe Epilepsies|Occipital Lobe Epilepsy|Panayiotopoulos Syndrome|Partial Epilepsies|Partial Epilepsies, Simple|Partial Epilepsy|Partial Seizure Disorder|Partial Seizure Disorders|Partial Seizures, Simple|Partial Seizures, Simple, Consciousness Preserved|Rhinencephalic Epilepsies|Rhinencephalic Epilepsy|Seizure Disorder, Focal|Seizure Disorder, Partial|Seizure Disorders, Focal|Seizure Disorders, Partial|Seizures, Simple Partial|Seizures, Subclinical|Seizure, Subclinical|Seizures, Uncinate|Seizure, Uncinate|Simple Partial Epilepsies|Simple Partial Seizures|Subclinical Seizure|Subclinical Seizures|Uncinate Seizure|Uncinate Seizures	Nervous system disease
Epilepsy	MESH:D004827	DO:DOID:1826	A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)	MESH:D001927	C10.228.140.490	C10.228.140	Aura|Auras|Awakening Epilepsy|Cryptogenic Epilepsies|Cryptogenic Epilepsy|Epilepsies|Epilepsies, Cryptogenic|Epilepsy, Awakening|Epilepsy, Cryptogenic|Seizure Disorder|Seizure Disorders	Nervous system disease
Epilepsy, Absence	MESH:D004832	DO:DOID:0070309|DO:DOID:1825|OMIM:600131|OMIM:607631|OMIM:611942|OMIM:612269	A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736)	MESH:D000073376|MESH:D004829	C10.228.140.490.375.260|C10.228.140.490.493.125	C10.228.140.490.375|C10.228.140.490.493	Absence Epilepsy|Absence Epilepsy, Childhood|Absence Epilepsy, Juvenile|Absence Seizure Disorder|Absence Seizure Disorders|Akinetic Petit Mal|Childhood Absence Epilepsy|ECA1|ECA5|ECA6|EIG6, INCLUDED|EJA1|Epilepsy, Absence, Atypical|Epilepsy, Childhood Absence|EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1|EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5|EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 6, INCLUDED|Epilepsy Juvenile Absence|Epilepsy, Juvenile Absence|EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1|Epilepsy, Minor|Epilepsy, Petit Mal|JAE1|Juvenile Absence Epilepsy|Minor Epilepsy|Petit Mal, Akinetic|Petit Mal Epilepsy|Pykno Epilepsy|Pykno-Epilepsy|Pyknolepsies|Pyknolepsy|Seizure Disorder, Absence|Seizure Disorders, Absence	Nervous system disease
Epilepsy, Benign Neonatal, 1, And-Or Myokymia	MESH:C567743			MESH:D004827|MESH:D020385	C10.228.140.490/C567743|C10.597.613.650/C567743|C23.888.592.608.650/C567743	C10.228.140.490|C10.597.613.650|C23.888.592.608.650		Nervous system disease|Signs and symptoms
Epilepsy, Childhood Absence, Susceptibility To, 4	MESH:C567002			MESH:D004832	C10.228.140.490.375.260/C567002|C10.228.140.490.493.125/C567002	C10.228.140.490.375.260|C10.228.140.490.493.125		Nervous system disease
Epilepsy, Complex Partial	MESH:D017029	DO:DOID:12382	A disorder characterized by recurrent partial seizures marked by impairment of cognition. During the seizure the individual may experience a wide variety of psychic phenomenon including formed hallucinations, illusions, deja vu, intense emotional feelings, confusion, and spatial disorientation. Focal motor activity, sensory alterations and AUTOMATISM may also occur. Complex partial seizures often originate from foci in one or both temporal lobes. The etiology may be idiopathic (cryptogenic partial complex epilepsy) or occur as a secondary manifestation of a focal cortical lesion (symptomatic partial complex epilepsy). (From Adams et al., Principles of Neurology, 6th ed, pp317-8)	MESH:D004828	C10.228.140.490.360.260	C10.228.140.490.360	Complex Partial Epilepsy|Complex Partial Seizure Disorder|Cryptogenic Partial Complex Epilepsy|Disorder, Complex Partial Seizures|Epilepsy, Cryptogenic, Partial Complex|Epilepsy, Psychic Equivalent|Epilepsy, Psychomotor|Epilepsy, Symptomatic, Partial Complex|Partial Complex Epilepsy, Cryptogenic|Partial Complex Epilepsy, Symptomatic|Partial Epilepsy, Complex|Psychic Equivalent Epilepsy|Psychomotor Epilepsy|Seizure Disorder, Complex Partial|Symptomatic Partial Complex Epilepsy	Nervous system disease
Epilepsy, Familial Adult Myoclonic, 3	MESH:C567098	OMIM:613608		MESH:D004831	C10.228.140.490.375.130/C567098|C10.228.140.490.493.063/C567098	C10.228.140.490.375.130|C10.228.140.490.493.063	CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3|FAME3|FCMTE3	Nervous system disease
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5	OMIM:615400	DO:DOID:0111691		MESH:D004831	C10.228.140.490.375.130/615400|C10.228.140.490.493.063/615400	C10.228.140.490.375.130|C10.228.140.490.493.063	CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 5|FAME5|FCMTE5	Nervous system disease
Epilepsy, Familial Mesial Temporal Lobe	MESH:C566903			MESH:D004833	C10.228.140.490.360.290/C566903|C10.228.140.490.493.375/C566903	C10.228.140.490.360.290|C10.228.140.490.493.375		Nervous system disease
EPILEPSY, FAMILIAL TEMPORAL LOBE, 1	OMIM:600512	DO:DOID:0060748		MESH:D004833	C10.228.140.490.360.290/600512|C10.228.140.490.493.375/600512	C10.228.140.490.360.290|C10.228.140.490.493.375	ADLTE|ADPEAF|EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT|EPILEPSY, PARTIAL, WITH AUDITORY FEATURES|ETL1	Nervous system disease
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2	OMIM:608096	DO:DOID:0060755		MESH:D004833	C10.228.140.490.360.290/608096|C10.228.140.490.493.375/608096	C10.228.140.490.360.290|C10.228.140.490.493.375	ETL2|FTLE	Nervous system disease
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3	OMIM:611630	DO:DOID:0060750		MESH:D004833	C10.228.140.490.360.290/611630|C10.228.140.490.493.375/611630	C10.228.140.490.360.290|C10.228.140.490.493.375	EPILEPSY, FAMILIAL MESIAL TEMPORAL LOBE|ETL3|FMTLE	Nervous system disease
Epilepsy, Familial Temporal Lobe, 4	MESH:C566902	OMIM:611631		MESH:D004833	C10.228.140.490.360.290/C566902|C10.228.140.490.493.375/C566902	C10.228.140.490.360.290|C10.228.140.490.493.375	Epilepsy, Occipitotemporal Lobe, And Migraine With Aura|EPOLM|ETL4	Nervous system disease
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	OMIM:614417	DO:DOID:0060752		MESH:D004833	C10.228.140.490.360.290/614417|C10.228.140.490.493.375/614417	C10.228.140.490.360.290|C10.228.140.490.493.375	ETL5	Nervous system disease
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7	OMIM:616436	DO:DOID:0060751		MESH:D004833	C10.228.140.490.360.290/616436|C10.228.140.490.493.375/616436	C10.228.140.490.360.290|C10.228.140.490.493.375	ETL7	Nervous system disease
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8	OMIM:616461	DO:DOID:0060754		MESH:D004833	C10.228.140.490.360.290/616461|C10.228.140.490.493.375/616461	C10.228.140.490.360.290|C10.228.140.490.493.375	ETL8	Nervous system disease
Epilepsy, Frontal Lobe	MESH:D017034	DO:DOID:3331	A localization-related (focal) form of epilepsy characterized by seizures which arise in the FRONTAL LOBE.	MESH:D000073376|MESH:D004828	C10.228.140.490.360.270|C10.228.140.490.493.188	C10.228.140.490.360|C10.228.140.490.493	Anterior Fronto-Polar Epilepsies|Anterior Fronto-Polar Epilepsy|Benign Frontal Childhood Epilepsy|Childhood Benign Frontal Epilepsy|Cingulate Epilepsies|Cingulate Epilepsy|Epilepsies, Anterior Fronto-Polar|Epilepsies, Cingulate|Epilepsies, Orbito-Frontal|Epilepsies, Supplementary Motor|Epilepsy, Anterior Fronto Polar|Epilepsy, Anterior Fronto-Polar|Epilepsy, Benign Frontal, Childhood|Epilepsy, Cingulate|Epilepsy, Opercular|Epilepsy, Orbito Frontal|Epilepsy, Orbito-Frontal|Epilepsy, Supplementary Motor|Frontal Epilepsy, Benign, Childhood|Frontal Lobe Epilepsies|Frontal Lobe Epilepsy|Opercular Epilepsies|Opercular Epilepsy|Orbito-Frontal Epilepsies|Orbito-Frontal Epilepsy|Supplementary Motor Epilepsies|Supplementary Motor Epilepsy	Nervous system disease
Epilepsy, Generalized	MESH:D004829	DO:DOID:1827	Recurrent conditions characterized by epileptic seizures which arise diffusely and simultaneously from both hemispheres of the brain. Classification is generally based upon motor manifestations of the seizure (e.g., convulsive, nonconvulsive, akinetic, atonic, etc.) or etiology (e.g., idiopathic, cryptogenic, and symptomatic). (From Mayo Clin Proc, 1996 Apr;71(4):405-14)	MESH:D004827	C10.228.140.490.375	C10.228.140.490	Akinetic Epilepsies|Akinetic Epilepsy|Atonic Epilepsies|Atonic Epilepsy|Convulsive Epilepsies, Generalized|Convulsive Epilepsy, Generalized|Convulsive Generalized Seizure Disorder|Convulsive Seizure Disorder, Generalized|Epilepsies, Akinetic|Epilepsies, Atonic|Epilepsies, Generalized|Epilepsies, Generalized Convulsive|Epilepsies, Tonic|Epilepsy, Akinetic|Epilepsy, Atonic|Epilepsy, Generalized Convulsive|Epilepsy, Generalized Nonconvulsive|Epilepsy, Symptomatic Generalized|Epilepsy, Tonic|Generalized Convulsive Epilepsies|Generalized Convulsive Epilepsy|Generalized Epilepsies|Generalized Epilepsy|Generalized Epilepsy, Symptomatic|Generalized Nonconvulsive Epilepsy|Generalized Nonconvulsive Seizure Disorder|Generalized Onset Seizure Disorder|Generalized Seizure Disorder|Generalized Seizure Disorder, Convulsive|Generalized Seizure Disorder, Nonconvulsive|Generalized Seizure Disorders|Nonconvulsive Epilepsy, Generalized|Nonconvulsive Generalized Seizure Disorder|Nonconvulsive Seizure Disorder, Generalized|Seizure Disorder, Convulsive, Generalized|Seizure Disorder, Generalized|Seizure Disorder, Generalized, Convulsive|Seizure Disorder, Generalized Nonconvulsive|Seizure Disorder, Generalized Onset|Seizure Disorder, Nonconvulsive Generalized|Seizure Disorders, Generalized|Symptomatic Generalized Epilepsy|Tonic Epilepsies|Tonic Epilepsy	Nervous system disease
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME	OMIM:616577			MESH:D004827|MESH:D008607|MESH:D034381	C09.218.458.341/616577|C10.228.140.490/616577|C10.597.606.360/616577|C10.597.751.418.341/616577|C23.888.592.604.646/616577|C23.888.592.763.393.341/616577|F03.625.539/616577	C09.218.458.341|C10.228.140.490|C10.597.606.360|C10.597.751.418.341|C23.888.592.604.646|C23.888.592.763.393.341|F03.625.539	EHLMRS	Ear-nose-throat disease|Mental disorder|Nervous system disease|Signs and symptoms
EPILEPSY, HOT WATER, 1	OMIM:613339			MESH:D004827	C10.228.140.490/613339	C10.228.140.490	BATHING EPILEPSY|HWE1|WATER IMMERSION EPILEPSY	Nervous system disease
EPILEPSY, HOT WATER, 2	OMIM:613340			MESH:D004827	C10.228.140.490/613340	C10.228.140.490	HWE2	Nervous system disease
Epilepsy, Idiopathic Generalized	MESH:C562694	OMIM:600669|OMIM:606972|OMIM:607628|OMIM:607682|OMIM:608762|OMIM:609750|OMIM:611934|OMIM:612899|OMIM:613060|OMIM:616685		MESH:D004829	C10.228.140.490.375/C562694	C10.228.140.490.375	EIG|EIG11|EIG14|EIG1, INCLUDED|EIG2|EIG3|EIG4|EIG5|EIG8|EIG9|EJA2, INCLUDED|EJM6,|EJM6, INCLUDED|EJM7, INCLUDED|EJM8,|EJM8, INCLUDED|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10;EIG10 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5,|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 2|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 4|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 5|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 10|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 14|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 8, INCLUDED|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 9|EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 2, INCLUDED|EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED|EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED|EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8, INCLUDED|GEFS5, INCLUDED|GEFS+5, SUSCEPTIBILITY TO, INCLUDED|GEFSP5, SUSCEPTIBILITY TO, INCLUDED|GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED|Idiopathic Generalized Epilepsy|IDIOPATHIC GENERALIZED EPILEPSY;IGE EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 1, INCLUDED|SUSCEPTIBILITY TO, INCLUDED	Nervous system disease
Epilepsy, Intractable Childhood, With Generalized Tonic-Clonic Seizures	MESH:C564607			MESH:D004830	C10.228.140.490.375.290/C564607	C10.228.140.490.375.290	ICEGTC	Nervous system disease
Epilepsy, Myoclonic, Benign Adult Familial, Type 1	MESH:C563399	OMIM:601068		MESH:D004831	C10.228.140.490.375.130/C563399|C10.228.140.490.493.063/C563399	C10.228.140.490.375.130|C10.228.140.490.493.063	BAFME1|Benign Adult Familial Myoclonic Epilepsy 1|Cortical Myoclonic Tremor With Epilepsy, Familial|CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 1|Cortical Tremor, Familial|Epilepsy, Familial Adult Myoclonic, 1|FAME1|FCMTE1	Nervous system disease
Epilepsy, Myoclonic, Benign Adult Familial, Type 2	MESH:C564313	OMIM:607876		MESH:D004831	C10.228.140.490.375.130/C564313|C10.228.140.490.493.063/C564313	C10.228.140.490.375.130|C10.228.140.490.493.063	ADCME|BAFME2|Benign Adult Familial Myoclonic Epilepsy 2|CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2|Cortical Myoclonus And Epilepsy, Autosomal Dominant|Epilepsy, Familial Adult Myoclonic 2|EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2|FAME2|FCMTE2	Nervous system disease
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5	OMIM:615005	DO:DOID:0060686		MESH:D017034	C10.228.140.490.360.270/615005|C10.228.140.490.493.188/615005	C10.228.140.490.360.270|C10.228.140.490.493.188	ENFL5	Nervous system disease
Epilepsy, Nocturnal Frontal Lobe, Type 1	MESH:C563930	OMIM:600513		MESH:D017034	C10.228.140.490.360.270/C563930|C10.228.140.490.493.188/C563930	C10.228.140.490.360.270|C10.228.140.490.493.188	ENFL1|EPILEPSY, NOCTURNAL FRONTAL LOBE, 1	Nervous system disease
Epilepsy, Nocturnal Frontal Lobe, Type 2	MESH:C566400	OMIM:603204		MESH:D017034	C10.228.140.490.360.270/C566400|C10.228.140.490.493.188/C566400	C10.228.140.490.360.270|C10.228.140.490.493.188	ENFL2|EPILEPSY, NOCTURNAL FRONTAL LOBE, 2	Nervous system disease
Epilepsy, Nocturnal Frontal Lobe, Type 3	MESH:C565334	OMIM:605375		MESH:D017034	C10.228.140.490.360.270/C565334|C10.228.140.490.493.188/C565334	C10.228.140.490.360.270|C10.228.140.490.493.188	ENFL3|EPILEPSY, NOCTURNAL FRONTAL LOBE, 3	Nervous system disease
Epilepsy occipital calcifications	MESH:C535496			MESH:D002114|MESH:D004827	C10.228.140.490/C535496|C18.452.174.130/C535496	C10.228.140.490|C18.452.174.130	Bilateral occipital calcifications with epilepsy|Epilepsy with bilateral occipital calcifications|Familial unilateral and bilateral occipital calcifications and epilepsy	Metabolic disease|Nervous system disease
Epilepsy, Partial, Motor	MESH:D020938	DO:DOID:3327	A disorder characterized by recurrent localized paroxysmal discharges of cerebral neurons that give rise to seizures that have motor manifestations. The majority of partial motor seizures originate in the FRONTAL LOBE (see also EPILEPSY, FRONTAL LOBE). Motor seizures may manifest as tonic or clonic movements involving the face, one limb or one side of the body. A variety of more complex patterns of movement, including abnormal posturing of extremities, may also occur.	MESH:D004828	C10.228.140.490.360.272	C10.228.140.490.360	Clonic Seizures, Focal|Epilepsy, Focal Motor|Epilepsy, Hemimotor|Epilepsy, Motor Partial|Focal Clonic Seizure|Focal Clonic Seizures|Focal Motor Epilepsy|Focal Tonic Seizure|Focal Tonic Seizures|Hemimotor Epilepsies|Hemimotor Epilepsy|Hemimotor Seizure Disorder|Hemimotor Seizure Disorders|Motor Epilepsy, Focal|Motor Partial Seizure Disorder|Motor Seizure Disorder|Motor Seizure Disorders|Partial Epilepsy, Motor|Partial Seizure Disorder, Motor|Seizure Disorder, Hemimotor|Seizure Disorder, Motor|Seizure Disorder, Partial, Motor|Seizure Disorders, Hemimotor|Seizure Disorders, Motor|Seizure, Focal Clonic|Seizures, Versive|Seizure, Versive|Tonic Seizure, Focal|Tonic Seizures, Focal|Versive Seizure|Versive Seizures	Nervous system disease
Epilepsy, Partial, Sensory	MESH:D020937	DO:DOID:3330	A disorder characterized by recurrent focal onset seizures which have sensory (i.e., olfactory, visual, tactile, gustatory, or auditory) manifestations. Partial seizures that feature alterations of consciousness are referred to as complex partial seizures (EPILEPSY, COMPLEX PARTIAL).	MESH:D004828	C10.228.140.490.360.275	C10.228.140.490.360	Epilepsy, Sensory|Epilepsy, Sensory Partial|Focal Seizure Disorder, Sensory|Focal Sensory Seizure|Focal Sensory Seizures|Gustatory Partial Seizure|Gustatory Partial Seizures|Olfactory Partial Seizure|Olfactory Partial Seizures|Partial Epilepsy, Sensory|Partial Seizure, Gustatory|Partial Seizure, Olfactory|Partial Seizures, Gustatory|Partial Seizures, Olfactory|Partial Seizures, Vertiginous|Partial Seizures, Visual|Partial Seizure, Vertiginous|Partial Seizure, Visual|Partial Sensory Seizure|Partial Sensory Seizures|Seizure Disorder, Partial, Sensory|Seizure Disorder, Sensory|Seizure Disorder, Sensory, Focal|Seizure Disorders, Sensory|Seizure, Focal Sensory|Seizure, Gustatory Partial|Seizure, Olfactory Partial|Seizure, Partial Sensory|Seizures, Focal Sensory|Seizures, Olfactory Partial|Seizures, Partial Sensory|Seizures, Simple Partial, Special Sensory Symptoms|Seizures, Vertiginous Partial|Seizure, Vertiginous Partial|Seizure, Visual Partial|Sensory Epilepsy|Sensory Focal Seizure Disorder|Sensory Partial Epilepsy|Sensory Partial Seizure Disorder|Sensory Seizure Disorder|Sensory Seizure Disorders|Sensory Seizure, Focal|Sensory Seizure, Partial|Sensory Seizures, Focal|Sensory Seizures, Partial|Simple Partial Seizures, Special Sensory Symptoms|Vertiginous Partial Seizure|Vertiginous Partial Seizures|Visual Partial Seizure|Visual Partial Seizures	Nervous system disease
Epilepsy, Partial, with Pericentral Spikes	MESH:C564605	OMIM:607221		MESH:D004828	C10.228.140.490.360/C564605	C10.228.140.490.360	EPPS|PEPS	Nervous system disease
Epilepsy, Partial, with Variable Foci	MESH:C565785	OMIM:604364|OMIM:617116|OMIM:617118		MESH:D004828	C10.228.140.490.360/C565785	C10.228.140.490.360	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI|EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1|EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2|EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3|EPILEPSY, PARTIAL, WITH VARIABLE FOCI|FFEVF|FFEVF1|FFEVF2|FFEVF3|FPEVF	Nervous system disease
Epilepsy, Post-Traumatic	MESH:D004834		Recurrent seizures causally related to CRANIOCEREBRAL TRAUMA. Seizure onset may be immediate but is typically delayed for several days after the injury and may not occur for up to two years. The majority of seizures have a focal onset that correlates clinically with the site of brain injury. Cerebral cortex injuries caused by a penetrating foreign object (CRANIOCEREBRAL TRAUMA, PENETRATING) are more likely than closed head injuries (HEAD INJURIES, CLOSED) to be associated with epilepsy. Concussive convulsions are nonepileptic phenomena that occur immediately after head injury and are characterized by tonic and clonic movements. (From Rev Neurol 1998 Feb;26(150):256-261; Sports Med 1998 Feb;25(2):131-6)	MESH:D001930|MESH:D004827	C10.228.140.199.650|C10.228.140.490.380|C10.900.300.087.600|C26.915.300.200.475	C10.228.140.199|C10.228.140.490|C10.900.300.087|C26.915.300.200	Concussive Convulsion|Concussive Convulsions|Convulsion, Concussive|Convulsions, Concussive|Disorder, Post-Traumatic Seizure|Disorders, Post-Traumatic Seizure|Early Post-Traumatic Seizure|Early Post Traumatic Seizures|Early Post-Traumatic Seizures|Epilepsies, Post-Traumatic|Epilepsies, Traumatic|Epilepsy, Post Traumatic|Epilepsy, Traumatic|Impact Seizure|Impact Seizures|Late Post-Traumatic Seizure|Late Post Traumatic Seizures|Late Post-Traumatic Seizures|Post-Traumatic Epilepsies|Post-Traumatic Epilepsy|Post Traumatic Seizure Disorder|Post-Traumatic Seizure Disorder|Post-Traumatic Seizure Disorders|Post-Traumatic Seizure, Early|Post-Traumatic Seizure, Late|Post-Traumatic Seizures, Early|Post-Traumatic Seizures, Late|Seizure Disorder, Post Traumatic|Seizure Disorder, Post-Traumatic|Seizure Disorders, Post-Traumatic|Seizure, Early Post-Traumatic|Seizure, Late Post-Traumatic|Seizures, Early Post-Traumatic|Seizures, Late Post-Traumatic|Traumatic Epilepsies|Traumatic Epilepsy	Nervous system disease|Wounds and injuries
Epilepsy, Progressive Myoclonic 2B	MESH:C564976			MESH:D020191	C10.228.140.490.375.130.650/C564976|C10.228.140.490.493.063.650/C564976	C10.228.140.490.375.130.650|C10.228.140.490.493.063.650		Nervous system disease
Epilepsy, Progressive Myoclonic 3	MESH:C567095	DO:DOID:0111446		MESH:D020191	C10.228.140.490.375.130.650/C567095|C10.228.140.490.493.063.650/C567095	C10.228.140.490.375.130.650|C10.228.140.490.493.063.650		Nervous system disease
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	OMIM:611726	DO:DOID:0111446		MESH:D020191	C10.228.140.490.375.130.650/611726|C10.228.140.490.493.063.650/611726	C10.228.140.490.375.130.650|C10.228.140.490.493.063.650	CEROID LIPOFUSCINOSIS, NEURONAL, 14|CLN14|EPM3	Nervous system disease
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE	OMIM:254900	DO:DOID:0111444		MESH:D009207|MESH:D051437	C10.597.350.500/254900|C12.050.351.968.419.780/254900|C12.200.777.419.780/254900|C12.950.419.780/254900|C23.888.592.350.500/254900	C10.597.350.500|C12.050.351.968.419.780|C12.200.777.419.780|C12.950.419.780|C23.888.592.350.500	ACTION MYOCLONUS-RENAL FAILURE SYNDROME|AMRF|EPM4|MYOCLONUS-NEPHROPATHY SYNDROME	Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Epilepsy, Reflex	MESH:D020195	DO:DOID:2548	A subtype of epilepsy characterized by seizures that are consistently provoked by a certain specific stimulus. Auditory, visual, and somatosensory stimuli as well as the acts of writing, reading, eating, and decision making are examples of events or activities that may induce seizure activity in affected individuals. (From Neurol Clin 1994 Feb;12(1):57-8)	MESH:D004827	C10.228.140.490.450	C10.228.140.490	Audiogenic Epilepsies|Audiogenic Epilepsy|Audiogenic Reflex Epilepsies|Audiogenic Reflex Epilepsy|Cursive Epilepsy|Cursive Reflex Epilepsies (Running)|Cursive Reflex Epilepsy (Running)|Decision Making Reflex Epilepsy|Eating-Induced Epilepsies|Eating Induced Epilepsy|Eating-Induced Epilepsy|Eating-Induced Reflex Epilepsies|Eating-Induced Reflex Epilepsy|Epilepsies, Audiogenic Reflex|Epilepsies, Cursive|Epilepsies, Eating-Induced|Epilepsies, Eating-Induced Reflex|Epilepsies, Immersion Related|Epilepsies, Musicogenic|Epilepsies, Musicogenic Reflex|Epilepsies, Photosensitive|Epilepsies, Photosensitive Reflex|Epilepsies, Reading|Epilepsies, Reading Reflex|Epilepsies, Reflex|Epilepsies, Tactile Reflex|Epilepsies, Writing-Induced Reflex|Epilepsy, Audiogenic|Epilepsy, Audiogenic Reflex|Epilepsy, Cursive|Epilepsy, Cursive Reflex (Running)|Epilepsy, Eating-Induced|Epilepsy, Eating-Induced Reflex|Epilepsy, Immersion Related|Epilepsy, Musicogenic|Epilepsy, Musicogenic Reflex|Epilepsy, Photogenic|Epilepsy, Photosensitive|Epilepsy, Photosensitive Reflex|Epilepsy, Reading|Epilepsy, Reading Reflex|Epilepsy, Tactile Reflex|Epilepsy, Writing-Induced Reflex|Immersion Related Epilepsies|Immersion Related Epilepsy|Musicogenic Epilepsies|Musicogenic Epilepsy|Musicogenic Reflex Epilepsies|Musicogenic Reflex Epilepsy|Photosensitive Epilepsies|Photosensitive Epilepsy|Photosensitive Reflex Epilepsies|Photosensitive Reflex Epilepsy|Reading Epilepsies|Reading Epilepsy|Reading Reflex Epilepsies|Reading Reflex Epilepsy|Reflex Epilepsies|Reflex Epilepsies, Audiogenic|Reflex Epilepsies, Cursive (Running)|Reflex Epilepsies, Eating-Induced|Reflex Epilepsies, Musicogenic|Reflex Epilepsies, Photosensitive|Reflex Epilepsies, Reading|Reflex Epilepsies, Tactile|Reflex Epilepsies, Writing-Induced|Reflex Epilepsy|Reflex Epilepsy, Audiogenic|Reflex Epilepsy, Cursive (Running)|Reflex Epilepsy, Eating Induced|Reflex Epilepsy, Eating-Induced|Reflex Epilepsy, Musicogenic|Reflex Epilepsy, Photosensitive|Reflex Epilepsy, Reading|Reflex Epilepsy, Tactile|Reflex Epilepsy, Visual Pattern|Reflex Epilepsy, Writing-Induced|Tactile Reflex Epilepsies|Tactile Reflex Epilepsy|Visual Pattern Reflex Epilepsy|Writing-Induced Reflex Epilepsies|Writing Induced Reflex Epilepsy|Writing-Induced Reflex Epilepsy	Nervous system disease
Epilepsy, Rolandic	MESH:D019305	DO:DOID:3329|OMIM:117100	An autosomal dominant inherited partial epilepsy syndrome with onset between age 3 and 13 years. Seizures are characterized by PARESTHESIA and tonic or clonic activity of the lower face associated with drooling and DYSARTHRIA. In most cases, affected children are neurologically and developmentally normal. (From Epilepsia 1998 39;Suppl 4:S32-S41)	MESH:D000073376|MESH:D004828	C10.228.140.490.360.280|C10.228.140.490.493.250	C10.228.140.490.360|C10.228.140.490.493	BCECTS|BECTS|Benign Childhood Epilepsy With Centro Temporal Spikes|Benign Childhood Epilepsy With Centro-Temporal Spikes|Benign Epilepsy Of Childhood With Centrotemporal Spikes|Benign Epilepsy With Centrotemporal Spikes|Benign Rolandic Epilepsy|Benign Rolandic Epilepsy of Childhood|Centralopathic Epilepsies|Centralopathic Epilepsy|Centrotemporal Epilepsies|Centrotemporal Epilepsy|ECT|Epilepsies, Centralopathic|Epilepsies, Centrotemporal|Epilepsies, Rolandic|Epilepsies, Temporal-Central Focal|Epilepsy, Benign Rolandic|Epilepsy, Centralopathic|Epilepsy, Centrotemporal|Epilepsy, Rolands|Epilepsy, Sylvian|Epilepsy, Temporal-Central Focal|Focal Epilepsies, Temporal-Central|Focal Epilepsy, Temporal-Central|Rolandic Epilepsies|Rolandic Epilepsy|Rolandic Epilepsy, Benign|Rolands Epilepsy|Sylvian Epilepsy|Temporal-Central Focal Epilepsies|Temporal Central Focal Epilepsy|Temporal-Central Focal Epilepsy	Nervous system disease
Epilepsy, rolandic with paroxysmal exercise-induced dystonia and writer's cramp	MESH:C535499	OMIM:608105		MESH:D004421|MESH:D019305|MESH:D020821	C10.228.140.490.360.280/C535499|C10.228.140.490.493.250/C535499|C10.228.662.300/C535499|C10.597.350.300/C535499|C23.888.592.350.300/C535499	C10.228.140.490.360.280|C10.228.140.490.493.250|C10.228.662.300|C10.597.350.300|C23.888.592.350.300	Epilepsy, Rolandic, With Paroxysmal Exercise-Induced Dystonia And Writer's Cramp|EPRPDC|RE-PED-WC	Nervous system disease|Signs and symptoms
Epilepsy telangiectasia	MESH:C535497			MESH:D004406|MESH:D004827|MESH:D008607|MESH:D013684	C10.228.140.490/C535497|C10.597.606.360/C535497|C14.907.823/C535497|C15.378.147.333/C535497|C20.673.430/C535497|C23.888.592.604.646/C535497|F03.625.539/C535497	C10.228.140.490|C10.597.606.360|C14.907.823|C15.378.147.333|C20.673.430|C23.888.592.604.646|F03.625.539	Epilepsy-Telangiectasia	Blood disease|Cardiovascular disease|Immune system disease|Mental disorder|Nervous system disease|Signs and symptoms
Epilepsy, Temporal Lobe	MESH:D004833	DO:DOID:3328	A localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321).	MESH:D000073376|MESH:D004828	C10.228.140.490.360.290|C10.228.140.490.493.375	C10.228.140.490.360|C10.228.140.490.493	Benign Psychomotor Epilepsy, Childhood|Childhood Benign Psychomotor Epilepsy|Epilepsies, Lateral Temporal|Epilepsies, Temporal Lobe|Epilepsies, Uncinate|Epilepsy, Benign Psychomotor, Childhood|Epilepsy, Lateral Temporal|Epilepsy, Uncinate|Lateral Temporal Epilepsies|Lateral Temporal Epilepsy|Temporal Lobe Epilepsies|Temporal Lobe Epilepsy|Uncinate Epilepsies|Uncinate Epilepsy	Nervous system disease
Epilepsy, Tonic-Clonic	MESH:D004830	DO:DOID:7725	A generalized seizure disorder characterized by recurrent major motor seizures. The initial brief tonic phase is marked by trunk flexion followed by diffuse extension of the trunk and extremities. The clonic phase features rhythmic flexor contractions of the trunk and limbs, pupillary dilation, elevations of blood pressure and pulse, urinary incontinence, and tongue biting. This is followed by a profound state of depressed consciousness (post-ictal state) which gradually improves over minutes to hours. The disorder may be cryptogenic, familial, or symptomatic (caused by an identified disease process). (From Adams et al., Principles of Neurology, 6th ed, p329)	MESH:D004829	C10.228.140.490.375.290	C10.228.140.490.375	Convulsion Disorders, Tonic-Clonic|Convulsion Disorder, Tonic-Clonic|Convulsion, Grand Mal|Convulsions, Grand Mal|Convulsions, Tonic Clonic|Convulsion Syndromes, Tonic-Clonic|Convulsion Syndrome, Tonic-Clonic|Convulsion, Tonic Clonic|Cryptogenic Tonic-Clonic Epilepsies|Cryptogenic Tonic Clonic Epilepsy|Cryptogenic Tonic-Clonic Epilepsy|Disorders, Tonic-Clonic Convulsion|Disorders, Tonic-Clonic Seizure|Disorder, Tonic-Clonic Convulsion|Disorder, Tonic-Clonic Seizure|Epilepsies, Cryptogenic Tonic-Clonic|Epilepsies, Familial Tonic-Clonic|Epilepsies, Symptomatic Tonic-Clonic|Epilepsies, Tonic-Clonic|Epilepsy, Cryptogenic Tonic-Clonic|Epilepsy, Familial Tonic-Clonic|Epilepsy, Grand Mal|Epilepsy, Major|Epilepsy, Symptomatic Tonic-Clonic|Epilepsy, Tonic Clonic|Epilepsy, Tonic-Clonic, Cryptogenic|Epilepsy, Tonic-Clonic, Familial|Epilepsy, Tonic-Clonic, Symptomatic|Familial Tonic-Clonic Epilepsies|Familial Tonic Clonic Epilepsy|Familial Tonic-Clonic Epilepsy|Grand Mal Convulsion|Grand Mal Convulsions|Grand Mal Epilepsy|Grand Mal Seizure Disorder|Major Epilepsies|Major Epilepsy|Major Motor Seizure Disorder|Seizure Disorder, Grand Mal|Seizure Disorder, Major Motor|Seizure Disorders, Tonic-Clonic|Seizure Disorder, Tonic Clonic|Seizure Disorder, Tonic-Clonic|Seizure Syndromes, Tonic-Clonic|Seizure Syndrome, Tonic-Clonic|Symptomatic Tonic-Clonic Epilepsies|Symptomatic Tonic Clonic Epilepsy|Symptomatic Tonic-Clonic Epilepsy|Syndromes, Tonic-Clonic Convulsion|Syndromes, Tonic-Clonic Seizure|Syndrome, Tonic-Clonic Convulsion|Syndrome, Tonic-Clonic Seizure|Tonic Clonic Convulsion|Tonic Clonic Convulsion Disorder|Tonic-Clonic Convulsion Disorder|Tonic-Clonic Convulsion Disorders|Tonic Clonic Convulsions|Tonic Clonic Convulsion Syndrome|Tonic-Clonic Convulsion Syndrome|Tonic-Clonic Convulsion Syndromes|Tonic-Clonic Epilepsies|Tonic-Clonic Epilepsies, Cryptogenic|Tonic-Clonic Epilepsies, Familial|Tonic-Clonic Epilepsies, Symptomatic|Tonic-Clonic Epilepsy|Tonic-Clonic Epilepsy, Cryptogenic|Tonic-Clonic Epilepsy, Familial|Tonic-Clonic Epilepsy, Symptomatic|Tonic Clonic Seizure Disorder|Tonic-Clonic Seizure Disorder|Tonic-Clonic Seizure Disorders|Tonic Clonic Seizure Syndrome|Tonic-Clonic Seizure Syndrome|Tonic-Clonic Seizure Syndromes	Nervous system disease
Epileptic Encephalopathy, Early Infantile, 3	MESH:C562695	OMIM:609304		MESH:D013036	C10.228.140.490.375.760/C562695|C10.228.140.490.493.875/C562695	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE3|DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3|Early Myoclonic Encephalopathy|EIEE3|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3|Myoclonic Epilepsy, Neonatal, With Suppression-Burst Pattern	Nervous system disease
Epileptic Encephalopathy, Early Infantile, 4	MESH:C567404	OMIM:612164		MESH:D013036	C10.228.140.490.375.760/C567404|C10.228.140.490.493.875/C567404	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE4|DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4|EIEE4|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	Nervous system disease
Epileptic Syndromes	MESH:D000073376		EPILEPTIC SEIZURES that are of similar type and age of onset and have other similar features (e.g., clinical course, EEG findings, genetic association and neuropathology).	MESH:D004827	C10.228.140.490.493	C10.228.140.490	Epilepsies, Familial|Epilepsies, Syndromic|Epilepsy, Familial|Epilepsy Syndrome|Epilepsy Syndromes|Epilepsy, Syndromic|Epileptic Syndrome|Familial Epilepsies|Familial Epilepsy|Syndromic Epilepsies|Syndromic Epilepsy	Nervous system disease
Epiphyses, Slipped	MESH:D004839		A complete or partial separation of the EPIPHYSES from the DIAPHYSES.	MESH:D001847	C05.116.425	C05.116	Epiphysiolyses|Epiphysiolysis|Slipped Epiphyses	Musculoskeletal disease
Epiretinal Membrane	MESH:D019773	DO:DOID:2006	A membrane on the vitreal surface of the retina resulting from the proliferation of one or more of three retinal elements: (1) fibrous astrocytes; (2) fibrocytes; and (3) RETINAL PIGMENT EPITHELIUM. Localized epiretinal membranes may occur at the posterior pole of the eye without clinical signs or may cause marked loss of vision as a result of covering, distorting, or detaching the FOVEA CENTRALIS. Epiretinal membranes may cause vascular leakage and secondary retinal edema. In younger individuals some membranes appear to be developmental in origin and occur in otherwise normal eyes. The majority occur in association with RETINAL HOLES, ocular concussions, retinal inflammation, or after ocular surgery. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p291)	MESH:D012164	C11.768.328	C11.768	Cellophane Maculopathies|Cellophane Maculopathy|Epimacular Membrane|Epimacular Membranes|Epiretinal Membranes|Fibrosis, Premacular|Fibrosis, Preretinal Macular|Macular Fibrosis, Preretinal|Macular Pucker|Macular Puckers|Maculopathy, Cellophane|Membrane, Epimacular|Membrane, Epiretinal|Membrane, Preretinal|Premacular Fibroses|Premacular Fibrosis|Preretinal Macular Fibroses|Preretinal Macular Fibrosis|Preretinal Membrane|Preretinal Membranes|Pucker, Macular|Retinopathy, Surface-Wrinkling|Surface-Wrinkling Retinopathies|Surface Wrinkling Retinopathy|Surface-Wrinkling Retinopathy	Eye disease
Episodic Ataxia	MESH:C580065	DO:DOID:963		MESH:D001259	C10.597.350.090/C580065|C23.888.592.350.090/C580065	C10.597.350.090|C23.888.592.350.090		Nervous system disease|Signs and symptoms
Episodic Ataxia, Type 1	MESH:C563278	OMIM:160120		MESH:D001259|MESH:D020385	C10.597.350.090/C563278|C10.597.613.650/C563278|C23.888.592.350.090/C563278|C23.888.592.608.650/C563278	C10.597.350.090|C10.597.613.650|C23.888.592.350.090|C23.888.592.608.650	AEM|AEMK|Ataxia, Episodic, with Myokymia|CONTINUOUS MUSCLE FIBER ACTIVITY, HEREDITARY, INCLUDED|EA1|EAM|Episodic Ataxia with Myokymia|ISAACS-MERTENS SYNDROME, INCLUDED|Myokymia 1 With Or Without Hypomagnesemia|MYOKYMIA 1 WITH OR WITHOUT HYPOMAGNESEMIA, INCLUDED|Myokymia with Periodic Ataxia|MYOKYMIA WITH PERIODIC ATAXIA MYOKYMIA 1, INCLUDED|Paroxysmal Ataxia with Neuromyotonia, Hereditary	Nervous system disease|Signs and symptoms
Episodic Ataxia, Type 2	MESH:C535506	OMIM:108500		MESH:D001259|MESH:D009759	C10.292.562.675/C535506|C10.597.350.090/C535506|C11.590.400/C535506|C23.888.592.350.090/C535506	C10.292.562.675|C10.597.350.090|C11.590.400|C23.888.592.350.090	Acetazolamide-responsive episodic ataxia syndrome|Acetazolamide-responsive, hereditary, paroxysmal, cerebellar ataxia|Acetazolamide-Responsive Hereditary Paroxysmal Cerebellar Ataxia|APCA|Ataxia, Episodic, With Nystagmus|Ataxia, familial, paroxysmal|Ataxia, Familial Paroxysmal|CAPA|Cerebellar ataxia, paroxysmal, Acetazolamide-responsive|Cerebellopathy, hereditary paroxysmal|EA2|Episodic Ataxia, Nystagmus-Associated|Episodic ataxia type 2|Episodic ataxia with nystagmus|Nystagmus-associated episodic ataxia	Eye disease|Nervous system disease|Signs and symptoms
Episodic Ataxia, Type 3	MESH:C564697	OMIM:606554		MESH:D001259|MESH:D014012|MESH:D014717	C09.218.458.670/C564697|C09.218.568.900.883/C564697|C10.597.350.090/C564697|C10.597.751.418.670/C564697|C10.597.951/C564697|C23.888.592.350.090/C564697|C23.888.592.763.393.670/C564697|C23.888.592.958/C564697	C09.218.458.670|C09.218.568.900.883|C10.597.350.090|C10.597.751.418.670|C10.597.951|C23.888.592.350.090|C23.888.592.763.393.670|C23.888.592.958	Ataxia, Episodic, With Vertigo And Tinnitus|EA3	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Episodic Ataxia, Type 4	MESH:C564698			MESH:D001259	C10.597.350.090/C564698|C23.888.592.350.090/C564698	C10.597.350.090|C23.888.592.350.090	Ataxia, Periodic Vestibulocerebellar|Periodic Vestibulocerebellar Ataxia	Nervous system disease|Signs and symptoms
Episodic Ataxia, Type 5	MESH:C566601	OMIM:613855		MESH:D002524	C10.228.140.252.190/C566601|C10.597.350.090.500/C566601|C23.888.592.350.090.200/C566601	C10.228.140.252.190|C10.597.350.090.500|C23.888.592.350.090.200	EA5	Nervous system disease|Signs and symptoms
Episodic Ataxia, Type 6	MESH:C567207	OMIM:612656		MESH:D002524	C10.228.140.252.190/C567207|C10.597.350.090.500/C567207|C23.888.592.350.090.200/C567207	C10.228.140.252.190|C10.597.350.090.500|C23.888.592.350.090.200	EA6	Nervous system disease|Signs and symptoms
Episodic Ataxia, Type 7	MESH:C567459	OMIM:611907		MESH:D001259	C10.597.350.090/C567459|C23.888.592.350.090/C567459	C10.597.350.090|C23.888.592.350.090	EA7	Nervous system disease|Signs and symptoms
Episodic Kinesigenic Dyskinesia 2	MESH:C567026	OMIM:611031		MESH:D020820	C10.228.662.262/C567026|C10.597.350/C567026|C23.888.592.350/C567026	C10.228.662.262|C10.597.350|C23.888.592.350	Dystonia 19|DYT19|EKD2	Nervous system disease|Signs and symptoms
Epistaxis	MESH:D004844		Bleeding from the nose.	MESH:D006470|MESH:D009668|MESH:D012818	C08.460.261|C09.603.261|C23.550.414.712|C23.888.852.040	C08.460|C09.603|C23.550.414|C23.888.852	Bleeding, Nasal|Bleedings, Nasal|Nasal Bleeding|Nasal Bleedings|Nosebleed|Nose Bleed|Nosebleeds|Nose Bleeds	Ear-nose-throat disease|Pathology (process)|Respiratory tract disease|Signs and symptoms
Epstein-Barr Virus Infections	MESH:D020031		Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).	MESH:D006566|MESH:D014412	C01.925.256.466.313|C01.925.928.313	C01.925.256.466|C01.925.928	EBV Infection|EBV Infections|Epstein Barr Virus Infection|Epstein-Barr Virus Infection|Epstein Barr Virus Infections|Herpesvirus 4 Infections, Human|Human Herpesvirus 4 Infections|Human Herpes Virus 4 Infections|Infection, EBV|Infection, Epstein-Barr Virus|Infections, EBV|Infections, Epstein-Barr Virus|Virus Infection, Epstein-Barr|Virus Infections, Epstein-Barr	Viral disease
EPSTEIN-BARR VIRUS INSERTION SITE 1	OMIM:132850			MESH:D020031	C01.925.256.466.313/132850|C01.925.928.313/132850	C01.925.256.466.313|C01.925.928.313	EBVS1|EPSTEIN-BARR VIRUS INTEGRATION SITE	Viral disease
Erdheim-Chester Disease	MESH:D031249	DO:DOID:4329	A rare form of non-Langerhans-cell histiocytosis (HISTIOCYTOSIS, NON-LANGERHANS-CELL) with onset in middle age. The systemic disease is characterized by infiltration of lipid-laden macrophages, multinucleated giant cells, an inflammatory infiltrate of lymphocytes and histiocytes in the bone marrow, and a generalized sclerosis of the long bones.	MESH:D015616	C15.604.250.410.224	C15.604.250.410	Erdheim Chester Disease|Granulomatosis, Lipid|Lipid Granulomatosis	Lymphatic disease
Erectile Dysfunction	MESH:D007172		The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.	MESH:D005832|MESH:D012735|MESH:D020018	C12.100.500.214|C12.100.875.486|C12.200.294.214|F03.835.400	C12.100.500|C12.100.875|C12.200.294|F03.835	Dysfunction, Erectile|Impotence|Impotence, Male|Impotence, Male Sexual|Male Impotence|Male Sexual Impotence|Sexual Impotence, Male	Mental disorder|Urogenital disease (male)
Ergotism	MESH:D004881		Poisoning caused by ingesting ergotized grain or by the misdirected or excessive use of ergot as a medicine.	MESH:D015651	C25.723.680.262	C25.723.680	Ergotisms|Ergot Poisoning|Ergot Poisonings|Fire, St. Anthonys|Poisoning, Ergot|Poisonings, Ergot|Saint Anthony Fire|Saint Anthony's Fire|Saint Anthonys Fire|St. Anthony Fire|St. Anthony's Fire|St. Anthonys Fire	
Erosive Adenomatosis of the Nipple	MESH:C000626393			MESH:D000236|MESH:D001943|MESH:D010212	C04.557.470.035/C000626393|C04.557.470.700.600/C000626393|C04.588.180/C000626393|C17.800.090.500/C000626393	C04.557.470.035|C04.557.470.700.600|C04.588.180|C17.800.090.500	Erosive Adenomatosis|Florid Papillomatosis of the Nipple|Nipple Adenoma|Papillomatosis, Florid, of Nipple	Cancer|Skin disease
Erythema elevatum diutinum	MESH:C535509	DO:DOID:0060567		MESH:D018366	C14.907.940.910/C535509|C20.543.520.910/C535509	C14.907.940.910|C20.543.520.910	Extracellular cholesterosis|Leukocytoclastic vasculitis	Cardiovascular disease|Immune system disease
Erythema Infectiosum	MESH:D016731	DO:DOID:8743	Contagious infection with human B19 Parvovirus most commonly seen in school age children and characterized by fever, headache, and rashes of the face, trunk, and extremities. It is often confused with RUBELLA.	MESH:D004890|MESH:D010322|MESH:D017193	C01.925.256.700.300|C01.925.825.260|C17.800.229.335|C17.800.838.790.260	C01.925.256.700|C01.925.825|C17.800.229|C17.800.838.790	Fifth Disease|Infection, Parvovirus B19|Parvovirus B19 Infection|Parvovirus B19 Infections	Skin disease|Viral disease
Erythema Multiforme	MESH:D004892	DO:DOID:0050185	A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic 'bull's-eye' lesions usually occurring on the dorsal aspect of the hands and forearms.	MESH:D004890|MESH:D012872	C17.800.229.400|C17.800.865.475	C17.800.229|C17.800.865		Skin disease
Erythema Palmare Hereditarium	MESH:C565041			MESH:D006229	C17.800.338/C565041	C17.800.338		Skin disease
Erythremia, Alpha-Globin Type	MESH:C564195			MESH:D011087	C04.588.448.200.500/C564195|C15.378.190.250.500/C564195|C15.378.190.636.753/C564195|C15.378.400.200.500/C564195	C04.588.448.200.500|C15.378.190.250.500|C15.378.190.636.753|C15.378.400.200.500		Blood disease|Cancer
Erythremia, Beta-Globin Type	MESH:C564193			MESH:D011087	C04.588.448.200.500/C564193|C15.378.190.250.500/C564193|C15.378.190.636.753/C564193|C15.378.400.200.500/C564193	C04.588.448.200.500|C15.378.190.250.500|C15.378.190.636.753|C15.378.400.200.500		Blood disease|Cancer
Erythroblastosis, Fetal	MESH:D004899	DO:DOID:1098	A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN.	MESH:D005315|MESH:D006402|MESH:D007154|MESH:D007232	C12.050.703.277.060|C15.378.295|C16.300.060|C16.614.304|C20.306	C12.050.703.277|C15.378|C16.300|C16.614|C20	Erythroblastoses, Fetal|Erythroblastosis Fetali|Erythroblastosis Fetalis|Fetal Erythroblastoses|Fetal Erythroblastosis|Fetali, Erythroblastosis|Fetalis, Erythroblastosis|Hemolytic Disease of Newborn|Newborn Hemolytic Disease|Newborn Hemolytic Diseases	Blood disease|Fetal disease|Immune system disease|Infant-newborn disease|Pregnancy complication
Erythrocyte Amp Deaminase Deficiency	MESH:C567878	OMIM:612874		MESH:D009135	C05.651/C567878|C10.668.491/C567878	C05.651|C10.668.491		Musculoskeletal disease|Nervous system disease
Erythrocyte Lactate Transporter Defect	MESH:C565449	OMIM:245340		MESH:D009135	C05.651/C565449|C10.668.491/C565449	C05.651|C10.668.491	Lactate Transporter Defect, Myopathy due to	Musculoskeletal disease|Nervous system disease
Erythrocytosis, Familial, 2	MESH:C563918	OMIM:263400		MESH:D011086	C15.378.738/C563918	C15.378.738	ECYT2|Erythrocytosis, Autosomal Recessive Benign|Polycythemia, Chuvash Type|Polycythemia, VHL-Dependent|POLYCYTHEMIA, VHL-DEPENDENT POLYCYTHEMIA, CHUVASH TYPE, INCLUDED	Blood disease
Erythrocytosis, Familial, 3	MESH:C565221	OMIM:609820		MESH:D011086	C15.378.738/C565221	C15.378.738	ECYT3	Blood disease
Erythrocytosis, Familial, 4	MESH:C567086	OMIM:611783		MESH:D011086	C15.378.738/C567086	C15.378.738	ECYT4	Blood disease
Erythroderma desquamativa of Leiner	MESH:C535512			MESH:D003873	C17.800.174.318/C535512|C17.800.815.318/C535512	C17.800.174.318|C17.800.815.318	Erythroderma Desquamativum of Infancy|Generalized erythroderma, diarrhea, and failure to thrive|Leiner-Moussous Desquamative Erythroderma	Skin disease
Erythroleukemia, Familial	MESH:C565039			MESH:D015470	C04.557.337.539.275/C565039	C04.557.337.539.275	Di Guglielmo Disease, Familial|Leukemia, Acute Myelogenous, M6	Cancer
Erythromelalgia	MESH:D004916	DO:DOID:9240|OMIM:133020	A peripheral arterial disease that is characterized by the triad of ERYTHEMA, burning PAIN, and increased SKIN TEMPERATURE of the extremities (or red, painful extremities). Erythromelalgia may be classified as primary or idiopathic, familial or non-familial. Secondary erythromelalgia is associated with other diseases, the most common being MYELOPROLIFERATIVE DISORDERS.	MESH:D016491	C14.907.617.500	C14.907.617	Erythermalgia|Erythermalgia, Primary|Erythermalgias|Erythermalgias, Primary|Erythromelalgia, Familial|ERYTHROMELALGIA, FAMILIAL NEUROPATHY, SMALL FIBER, INCLUDED|Erythromelalgia, Primary|Erythromelalgias|Familial Erythromelalgia|Primary Erythermalgia|Primary Erythermalgias|Primary Erythromelalgia|SFNP, INCLUDED	Cardiovascular disease
Erythroplasia	MESH:D004919		A condition of the mucous membrane characterized by erythematous papular lesions.	MESH:D011230	C04.834.288	C04.834	Erythroplasias	Cancer
Esophageal Cyst	MESH:D004934		Any fluid-filled closed cavity or sac (CYSTS) that is lined by an EPITHELIUM and found in the ESOPHAGUS region.	MESH:D003560|MESH:D004935	C04.182.281|C06.405.117.316	C04.182|C06.405.117	Cyst, Esophageal|Cysts, Esophageal|Esophageal Cysts	Cancer|Digestive system disease
Esophageal Fistula	MESH:D004937		Abnormal passage communicating with the ESOPHAGUS. The most common type is TRACHEOESOPHAGEAL FISTULA between the esophagus and the TRACHEA.	MESH:D004935|MESH:D016154	C06.267.250|C06.405.117.367|C23.300.575.185.250	C06.267|C06.405.117|C23.300.575.185	Esophageal Fistulas|Fistula, Esophageal|Fistulas, Esophageal	Digestive system disease|Pathology (anatomical condition)
Esophageal Neoplasms	MESH:D004938	DO:DOID:5041|OMIM:133239	Tumors or cancer of the ESOPHAGUS.	MESH:D004935|MESH:D005770|MESH:D006258	C04.588.274.476.205|C04.588.443.353|C06.301.371.205|C06.405.117.430|C06.405.249.205	C04.588.274.476|C04.588.443|C06.301.371|C06.405.117|C06.405.249	AERODIGESTIVE TRACT CANCER, SUSCEPTIBILITY TO, INCLUDED|Cancer, Esophageal|Cancer, Esophagus|Cancer of Esophagus|Cancer of the Esophagus|Cancers, Esophageal|Cancers, Esophagus|ESCC, SUSCEPTIBILITY TO, INCLUDED|Esophageal Cancer|Esophageal Cancers|Esophageal Neoplasm|ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SUSCEPTIBILITY TO, INCLUDED|Esophagus Cancer|Esophagus Cancers|Esophagus Neoplasm|Esophagus Neoplasms|GASTRIC CARDIA ADENOCARCINOMA, SUSCEPTIBILITY TO, INCLUDED|Neoplasm, Esophageal|Neoplasm, Esophagus|Neoplasms, Esophageal|Neoplasms, Esophagus	Cancer|Digestive system disease
Esophageal Perforation	MESH:D004939		An opening or hole in the ESOPHAGUS that is caused by TRAUMA, injury, or pathological process.	MESH:D004935|MESH:D014947	C06.405.117.468|C26.348	C06.405.117|C26	Esophageal Perforations|Perforation, Esophageal|Perforations, Esophageal	Digestive system disease|Wounds and injuries
Esophageal Ring, Lower	MESH:C562765			MESH:D003680	C06.405.117.119/C562765|C09.775.174/C562765	C06.405.117.119|C09.775.174		Digestive system disease|Ear-nose-throat disease
Esophageal Squamous Cell Carcinoma	MESH:D000077277	DO:DOID:3748	A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.	MESH:D002294|MESH:D004938	C04.557.470.200.400.330|C04.557.470.700.400.565|C04.588.274.476.205.500|C04.588.443.353.500|C06.301.371.205.500|C06.405.117.430.500|C06.405.249.205.500	C04.557.470.200.400|C04.557.470.700.400|C04.588.274.476.205|C04.588.443.353|C06.301.371.205|C06.405.117.430|C06.405.249.205	Oesophageal Squamous Cell Carcinoma	Cancer|Digestive system disease
Esotropia	MESH:D004948	DO:DOID:10293|DO:DOID:9840	A form of ocular misalignment characterized by an excessive convergence of the visual axes, resulting in a 'cross-eye' appearance. An example of this condition occurs when paralysis of the lateral rectus muscle causes an abnormal inward deviation of one eye on attempted gaze.	MESH:D013285	C10.292.562.887.300|C11.590.810.400	C10.292.562.887|C11.590.810	Convergent Strabismus|Cross Eye|Cross-Eye|Cross-Eyes|Esodeviation|Esodeviations|Esophoria|Esophorias|Esotropia, Intermittent|Esotropia, Monocular|Esotropia, Primary|Esotropias|Esotropia, Secondary|Intermittent Esotropia|Intermittent Esotropias|Internal Strabismus|Monocular Esotropia|Monocular Esotropias|Primary Esotropia|Primary Esotropias|Secondary Esotropia|Secondary Esotropias|Strabismus, Convergent|Strabismus, Internal	Eye disease|Nervous system disease
Essential Hypertension	MESH:D000075222	DO:DOID:10825|OMIM:145500|OMIM:603918|OMIM:604329|OMIM:607329|OMIM:608742|OMIM:610261|OMIM:610262|OMIM:610948|OMIM:611014	Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500	MESH:D006973	C14.907.489.165	C14.907.489	EHT|Hypertension, Essential|HYPERTENSION, ESSENTIAL, BODY MASS-RELATED|HYPERTENSION, ESSENTIAL, KIDNEY FUNCTION-RELATED|HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 1|HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2|HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3|HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 4|HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 5|HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6|HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 7|HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 8|HYT1|HYT2|HYT3|HYT4|HYT5|HYT6|HYT7|HYT8	Cardiovascular disease
Essential Tremor	MESH:D020329	DO:DOID:4990	A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)	MESH:D009069	C10.228.662.350	C10.228.662	Benign Essential Tremor|Benign Essential Tremors|Essential Tremor, Benign|Essential Tremors|Essential Tremors, Benign|Familial Tremor|Familial Tremors|Hereditary Essential Tremor|Tremor, Benign Essential|Tremor, Essential|Tremor, Familial|Tremors, Benign Essential|Tremors, Essential|Tremors, Familial	Nervous system disease
Esthesioneuroblastoma, Olfactory	MESH:D018304	DO:DOID:369	A malignant olfactory neuroblastoma arising from the olfactory epithelium of the superior nasal cavity and cribriform plate. It is uncommon (3% of nasal tumors) and rarely is associated with the production of excess hormones (e.g., SIADH, Cushing Syndrome). It has a high propensity for multiple local recurrences and bony metastases. (From Holland et al., Cancer Medicine, 3rd ed, p1245; J Laryngol Otol 1998 Jul;112(7):628-33)	MESH:D009447|MESH:D020431	C04.557.465.625.600.590.650.550.150|C04.557.470.670.590.650.550.150|C04.557.580.625.600.590.650.550.150|C10.292.650.200	C04.557.465.625.600.590.650.550|C04.557.470.670.590.650.550|C04.557.580.625.600.590.650.550|C10.292.650	Aesthesioneuroblastoma|Aesthesioneuroblastomas|Esthesioneuroblastoma|Esthesioneuroblastoma, Paranasal Sinus Nasal Cavity|Esthesioneuroblastoma, Paranasal Sinus-Nasal Cavity|Esthesioneuroblastomas|Esthesioneuroblastomas, Olfactory|Neuroblastoma, Olfactory|Neuroblastomas, Olfactory|Olfactory Esthesioneuroblastoma|Olfactory Esthesioneuroblastomas|Olfactory Neuroblastoma|Olfactory Neuroblastomas|Paranasal Sinus Nasal Cavity Esthesioneuroblastoma|Paranasal Sinus-Nasal Cavity Esthesioneuroblastoma	Cancer|Nervous system disease
Ethmoid Sinusitis	MESH:D015521	DO:DOID:9507	Inflammation of the NASAL MUCOSA in the ETHMOID SINUS. It may present itself as an acute (infectious) or chronic (allergic) condition.	MESH:D012852	C01.748.749.267|C08.460.692.752.267|C08.730.749.267|C09.603.692.752.267	C01.748.749|C08.460.692.752|C08.730.749|C09.603.692.752	Ethmoidal Sinusitides|Ethmoidal Sinusitis|Ethmoid Sinusitides|Sinusitides, Ethmoid|Sinusitides, Ethmoidal|Sinusitis, Ethmoid|Sinusitis, Ethmoidal	Ear-nose-throat disease|Respiratory tract disease
Evans Syndrome	MESH:C536380	DO:DOID:8931		MESH:D000744|MESH:D013921	C15.378.071.141.125/C536380|C15.378.140.855/C536380|C20.111.175/C536380	C15.378.071.141.125|C15.378.140.855|C20.111.175	Autoimmune hemolytic anemia and autoimmune thrombocytopenia|Evans' Syndrome	Blood disease|Immune system disease
Exanthema	MESH:D005076	DO:DOID:0050486	Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.	MESH:D012871	C17.800.257	C17.800	Exanthem|Rash|Rash, Skin|Skin Rash	Skin disease
Exanthema Subitum	MESH:D005077	DO:DOID:0050495	An acute, short-lived, viral disease of infants and young children characterized by a high fever at onset that drops to normal after 3-4 days and the concomitant appearance of a macular or maculopapular rash that appears first on the trunk and then spreads to other areas. It is the sixth of the classical exanthematous diseases and is caused by HHV-6; (HERPESVIRUS 6, HUMAN). (From Dorland, 27th ed)	MESH:D005076|MESH:D017193|MESH:D019349	C01.925.256.466.850.290|C01.925.825.290|C17.800.257.335|C17.800.838.790.290	C01.925.256.466.850|C01.925.825|C17.800.257|C17.800.838.790	Disease, Sixth|Roseola Infantum|Sixth Disease	Skin disease|Viral disease
Exfoliation Syndrome	MESH:D017889	DO:DOID:13641|OMIM:177650	The deposition of flaky, translucent fibrillar material most conspicuous on the anterior lens capsule and pupillary margin but also in both surfaces of the iris, the zonules, trabecular meshwork, ciliary body, corneal endothelium, and orbital blood vessels. It sometimes forms a membrane on the anterior iris surface. Exfoliation refers to the shedding of pigment by the iris. (Newell, Ophthalmology, 7th ed, p380)	MESH:D007499	C11.941.375.285	C11.941.375	Exfoliation Glaucoma|Exfoliation Syndromes|Exfoliative Syndrome|Exfoliative Syndromes|Glaucoma Capsulare|PEXG|PEXS|PSEUDOEXFOLIATION GLAUCOMA|Pseudoexfoliation Of The Lens|Pseudoexfoliation Syndrome|Pseudo Exfoliation Syndrome|Pseudo-Exfoliation Syndrome|Pseudoexfoliation Syndromes|Pseudo-Exfoliation Syndromes|Syndrome, Exfoliation|Syndrome, Exfoliative|Syndrome, Pseudoexfoliation|Syndrome, Pseudo-Exfoliation|Syndromes, Exfoliation|Syndromes, Exfoliative|Syndromes, Pseudoexfoliation|Syndromes, Pseudo-Exfoliation|XFG|XFS	Eye disease
Exophthalmos	MESH:D005094	DO:DOID:9370	Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.	MESH:D009916	C11.675.349	C11.675	Proptoses|Proptosis	Eye disease
Exostoses	MESH:D005096	DO:DOID:203	Benign hypertrophy that projects outward from the surface of bone, often containing a cartilaginous component.	MESH:D015576	C05.116.540.310	C05.116.540	Exostosis	Musculoskeletal disease
Exotropia	MESH:D005099	DO:DOID:1142|DO:DOID:1143|DO:DOID:11853	A form of ocular misalignment where the visual axes diverge inappropriately. For example, medial rectus muscle weakness may produce this condition as the affected eye will deviate laterally upon attempted forward gaze. An exotropia occurs due to the relatively unopposed force exerted on the eye by the lateral rectus muscle, which pulls the eye in an outward direction.	MESH:D013285	C10.292.562.887.650|C11.590.810.440	C10.292.562.887|C11.590.810	Alternating Exotropia|Divergent Strabismus|Exodeviation|Exodeviations|Exophoria|Exotropia, Alternating|Exotropia, Monocular|Exotropia, Primary|Exotropia, Secondary|Monocular Exotropia|Primary Exotropia|Secondary Exotropia|Strabismus, Divergent	Eye disease|Nervous system disease
Expansile Bone Lesions	MESH:C566375			MESH:D001847	C05.116/C566375	C05.116		Musculoskeletal disease
External Auditory Canal, Bilateral Atresia Of, With Congenital Vertical Talus	MESH:C566245			MESH:D004660	C10.228.140.430/C566245|C10.586.250/C566245	C10.228.140.430|C10.586.250	Atresia of External Auditory Canal and Conduction Deafness	Nervous system disease
Extranodal Extension	MESH:D000079822		A penetration of LYMPH NODE metastatic cells through the nodal capsule into the perinodal fatty tissue used in a TUMOR STAGING system (the TNM staging system).	MESH:D009362	C04.697.650.280|C23.550.727.650.280	C04.697.650|C23.550.727.650	Extracapsular Extension|Extranodal Tumor Deposit|Extranodal Tumor Deposits|Tumor Deposit|Tumor Deposit, Extranodal|Tumor Deposits	Cancer|Pathology (process)
Extrasystoles, Multiform Ventricular, with Short Stature, Hyperpigmentation and Microcephaly	MESH:C565032			MESH:D005117|MESH:D006130|MESH:D008831|MESH:D017495	C05.660.207.620/C565032|C10.500.507.400.500/C565032|C14.280.067.325/C565032|C14.280.123.375/C565032|C16.131.621.207.620/C565032|C16.131.666.507.400.500/C565032|C17.800.621.430/C565032|C23.550.073.325/C565032|C23.550.393/C565032	C05.660.207.620|C10.500.507.400.500|C14.280.067.325|C14.280.123.375|C16.131.621.207.620|C16.131.666.507.400.500|C17.800.621.430|C23.550.073.325|C23.550.393		Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Nervous system disease|Pathology (process)|Skin disease
EXUDATIVE VITREORETINOPATHY 2, X-LINKED	OMIM:305390	DO:DOID:0111413		MESH:D018630	C11.768.890/305390	C11.768.890	EVR2|EVRX|EXUDATIVE VITREORETINOPATHY, FAMILIAL, 2|FEVRX|FEVR, X-LINKED	Eye disease
EXUDATIVE VITREORETINOPATHY 6	OMIM:616468	DO:DOID:0111410		MESH:D012164	C11.768/616468	C11.768	EVR6	Eye disease
Eye Burns	MESH:D005126		Injury to any part of the eye by extreme heat, chemical agents, or ultraviolet radiation.	MESH:D002056|MESH:D005131	C10.900.300.284.250.250|C26.200.503|C26.915.300.425.250.250	C10.900.300.284.250|C26.200|C26.915.300.425.250	Burn, Eye|Burns, Eye|Eye Burn	Nervous system disease|Wounds and injuries
Eye Diseases	MESH:D005128	DO:DOID:0070356|DO:DOID:5614	Diseases affecting the eye.	MESH:C	C11	C	Eye Disease|Eye Disorder|Eye Disorders	Eye disease
Eye Foreign Bodies	MESH:D005129		Inanimate objects that become enclosed in the eye.	MESH:D005131|MESH:D005547	C10.900.300.284.250.260|C26.392.421|C26.915.300.425.250.260	C10.900.300.284.250|C26.392|C26.915.300.425.250	Eye Foreign Body|Eye Foreign Object|Eye Foreign Objects|Foreign Bodies, Eye|Foreign Body, Eye|Foreign Object, Eye|Foreign Objects, Eye	Nervous system disease|Wounds and injuries
Eye Hemorrhage	MESH:D005130		Intraocular hemorrhage from the vessels of various tissues of the eye.	MESH:D005128|MESH:D005132|MESH:D006470	C11.290|C23.550.414.756|C23.888.307.500	C11|C23.550.414|C23.888.307	Eye Hemorrhages|Hemophthalmos|Hemorrhage, Eye	Eye disease|Pathology (process)|Signs and symptoms
Eye Infections	MESH:D015817		Infection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness.	MESH:D005128|MESH:D007239	C01.375|C11.294	C01|C11	Eye Infection|Infection, Eye|Infection, Ocular|Infections, Eye|Infections, Ocular|Ocular Infection|Ocular Infections	Eye disease
Eye Infections, Viral	MESH:D015828		Infections of the eye caused by minute intracellular agents. These infections may lead to severe inflammation in various parts of the eye - conjunctiva, iris, eyelids, etc. Several viruses have been identified as the causative agents. Among these are Herpesvirus, Adenovirus, Poxvirus, and Myxovirus.	MESH:D014777|MESH:D015817	C01.375.725|C01.925.325|C11.294.800	C01.375|C01.925|C11.294	Eye Infection, Viral|Infections, Viral Eye|Infections, Viral Ocular|Infection, Viral Eye|Infection, Viral Ocular|Ocular Infections, Viral|Ocular Infection, Viral|Viral Eye Infection|Viral Eye Infections|Viral Ocular Infection|Viral Ocular Infections	Eye disease|Viral disease
Eye Injuries	MESH:D005131		Damage or trauma inflicted to the eye by external means. The concept includes both surface injuries and intraocular injuries.	MESH:D005128|MESH:D005151	C10.900.300.284.250|C11.297|C26.915.300.425.250	C10.900.300.284|C11|C26.915.300.425	Eye Injury|Injuries, Eye|Injury, Eye	Eye disease|Nervous system disease|Wounds and injuries
Eye Injuries, Penetrating	MESH:D015807		Deeply perforating or puncturing type intraocular injuries.	MESH:D005131|MESH:D014950	C10.900.300.284.250.270|C26.915.300.425.250.270|C26.986.450	C10.900.300.284.250|C26.915.300.425.250|C26.986	Eye Injury, Penetrating|Injuries, Penetrating Eye|Injury, Penetrating Eye|Penetrating Eye Injuries|Penetrating Eye Injury	Nervous system disease|Wounds and injuries
Eyelid Diseases	MESH:D005141	DO:DOID:530	Diseases involving the EYELIDS.	MESH:D005128	C11.338	C11	Disease, Eyelid|Diseases, Eyelid|Eyelid Disease	Eye disease
Eyelid Neoplasms	MESH:D005142	DO:DOID:2173	Tumors of cancer of the EYELIDS.	MESH:D005134|MESH:D005141|MESH:D005153	C04.588.443.392.500|C11.319.421|C11.338.526	C04.588.443.392|C11.319|C11.338	Eyelid Neoplasm|Neoplasm, Eyelid|Neoplasms, Eyelid	Cancer|Eye disease
Eye Manifestations	MESH:D005132		Ocular disorders attendant upon non-ocular disease or injury.	MESH:D005128|MESH:D012816	C11.300|C23.888.307	C11|C23.888	Eye Manifestation|Manifestation, Eye|Manifestations, Eye	Eye disease|Signs and symptoms
Eye Neoplasms	MESH:D005134	DO:DOID:2174	Tumors or cancer of the EYE.	MESH:D005128|MESH:D009371	C04.588.364|C11.319	C04.588|C11	Cancer, Eye|Cancer of Eye|Cancer of the Eye|Cancers, Eye|Eye Cancer|Eye Cancers|Eye Neoplasm|Neoplasm, Eye|Neoplasms, Eye	Cancer|Eye disease
Eye Pain	MESH:D058447		A dull or sharp painful sensation associated with the outer or inner structures of the eyeball, having different causes.	MESH:D005132|MESH:D010146	C11.300.500|C23.888.307.625|C23.888.592.612.316	C11.300|C23.888.307|C23.888.592.612	Eye Pains|Pain, Eye|Pains, Eye	Eye disease|Signs and symptoms
Facial Dermatoses	MESH:D005148	DO:DOID:3134	Skin diseases involving the FACE.	MESH:D012871	C17.800.271	C17.800	Dermatoses, Facial|Dermatosis, Facial|Elastoidoses, Nodular|Elastoidosis, Nodular|Elastoses, Nodular|Elastosis, Nodular|Facial Dermatosis|Favre Racouchot Syndrome|Favre-Racouchot Syndrome|Nodular Elastoidoses|Nodular Elastoidosis|Nodular Elastoses|Nodular Elastosis|Syndrome, Favre-Racouchot	Skin disease
FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE	OMIM:615139			MESH:D006130|MESH:D007153|MESH:D019465|MESH:D054068	C05.660.207/615139|C14.907.617.625/615139|C16.131.621.207/615139|C17.800.862.355/615139|C20.673/615139|C23.550.393/615139|C23.888.885.437/615139	C05.660.207|C14.907.617.625|C16.131.621.207|C17.800.862.355|C20.673|C23.550.393|C23.888.885.437	FILS	Cardiovascular disease|Congenital abnormality|Immune system disease|Musculoskeletal disease|Pathology (process)|Signs and symptoms|Skin disease
Facial Hemiatrophy	MESH:D005150	DO:DOID:1757	A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.	MESH:D005155|MESH:D009059	C07.465.284|C07.465.299.375|C10.292.319.375	C07.465|C07.465.299|C10.292.319	Atrophies, Hemifacial|Atrophies, Progressive Hemifacial|Atrophy, Hemifacial|Atrophy, Progressive Hemifacial|Atrophy, Romberg Hemi-Facial|Disease, Parry-Romberg|Disease, Romberg|Disease, Romberg's|Facial Hemiatrophies|Facial Hemiatrophies, Progressive|Facial Hemiatrophy of Romberg|Facial Hemiatrophy, Progressive|Hemiatrophies, Facial|Hemiatrophies, Progressive Facial|Hemiatrophy, Facial|Hemiatrophy, Progressive Facial|Hemifacial Atrophies|Hemifacial Atrophy|Hemifacial Atrophy, Progressive|Hemi-Facial Atrophy, Romberg|Parry Romberg Disease|Parry-Romberg Disease|Parry Romberg Syndrome|Parry-Romberg Syndrome|Progressive Facial Hemiatrophies|Progressive Facial Hemiatrophy|Progressive Hemifacial Atrophies|Progressive Hemifacial Atrophy|Romberg Disease|Romberg Facial Hemiatrophy|Romberg Hemi Facial Atrophy|Romberg Hemi-Facial Atrophy|Romberg's Disease|Rombergs Disease|Syndrome, Parry-Romberg	Mouth disease|Nervous system disease
Facial Hypertrichosis	MESH:C565029			MESH:D006983	C17.800.329.875/C565029	C17.800.329.875		Skin disease
Facial Injuries	MESH:D005151		General or unspecified injuries to the soft tissue or bony portions of the face.	MESH:D006259	C10.900.300.284|C26.915.300.425	C10.900.300|C26.915.300	Facial Injury|Injuries, Facial|Injury, Facial	Nervous system disease|Wounds and injuries
Facial Neoplasms	MESH:D005153		New abnormal growth of tissue in the FACE.	MESH:D006258	C04.588.443.392	C04.588.443	Facial Neoplasm|Neoplasm, Facial|Neoplasms, Facial	Cancer
Facial Nerve Diseases	MESH:D005155	DO:DOID:14075|DO:DOID:1756	Diseases of the facial nerve or nuclei. Pontine disorders may affect the facial nuclei or nerve fascicle. The nerve may be involved intracranially, along its course through the petrous portion of the temporal bone, or along its extracranial course. Clinical manifestations include facial muscle weakness, loss of taste from the anterior tongue, hyperacusis, and decreased lacrimation.	MESH:D003389|MESH:D009059	C07.465.299|C10.292.319	C07.465|C10.292	Acquired Facial Neuropathies|Acquired Facial Neuropathy|Cranial Nerve VII Diseases|Cranial Nerve VII Disorders|Disease, Facial Nerve|Diseases, Facial Nerve|Disorder, Facial Nerve|Disorders, Facial Nerve|Facial Myokymia|Facial Myokymias|Facial Nerve Disease|Facial Nerve Disorder|Facial Nerve Disorders|Facial Nerve Motor Disorders|Facial Nerve Sensory Disorders|Facial Neuritides|Facial Neuritis|Facial Neuropathies|Facial Neuropathies, Acquired|Facial Neuropathies, Familial|Facial Neuropathy|Facial Neuropathy, Acquired|Facial Neuropathy, Familial|Familial Facial Neuropathies|Familial Facial Neuropathy|Ganglionitides, Geniculate|Ganglionitis, Geniculate|Geniculate Ganglionitides|Geniculate Ganglionitis|Motor Disorders, Facial Nerve|Myokymia, Facial|Myokymias, Facial|Neuritides, Facial|Neuritis, Facial|Neuropathies, Facial|Neuropathies, Familial Facial|Neuropathy, Facial|Neuropathy, Familial Facial|Sensory Disorders, Facial Nerve|Seventh Cranial Nerve Diseases	Mouth disease|Nervous system disease
Facial Nerve Injuries	MESH:D020220		Traumatic injuries to the facial nerve. This may result in FACIAL PARALYSIS, decreased lacrimation and salivation, and loss of taste sensation in the anterior tongue. The nerve may regenerate and reform its original pattern of innervation, or regenerate aberrantly, resulting in inappropriate lacrimation in response to gustatory stimuli (e.g., 'crocodile tears') and other syndromes.	MESH:D005155|MESH:D020209	C07.465.299.500|C10.292.200.500|C10.292.319.500|C10.900.300.218.300|C26.915.300.400.300	C07.465.299|C10.292.200|C10.292.319|C10.900.300.218|C26.915.300.400	Avulsion, Facial Nerve|Cranial Nerve VII Injuries|Facial Nerve Avulsion|Facial Nerve Avulsions|Facial Nerve Injury|Facial Nerve Trauma|Facial Nerve Traumas|Facial Neuropathy, Traumatic|Injuries, Cranial Nerve VII|Injuries, Seventh Cranial Nerve|Injury, Facial Nerve|Marginal Mandibular Nerve Injuries|Marginal Mandibular Nerve Injury|Nerve Avulsion, Facial|Nerve Injury, Facial|Nerve Trauma, Facial|Neuropathy, Traumatic Facial|Seventh Cranial Nerve Injuries|Trauma, Facial Nerve|Traumatic Facial Neuropathies|Traumatic Facial Neuropathy	Mouth disease|Nervous system disease|Wounds and injuries
Facial Neuralgia	MESH:D005156	DO:DOID:13865	Neuralgic syndromes which feature chronic or recurrent FACIAL PAIN as the primary manifestation of disease. Disorders of the trigeminal and facial nerves are frequently associated with these conditions.	MESH:D005155	C07.465.299.625|C10.292.319.625	C07.465.299|C10.292.319	Craniofacial Pain Syndrome|Craniofacial Pain Syndromes|Facial Neuralgias|Facial Pain Syndrome|Facial Pain Syndromes|Myofacial Pain Syndrome|Myofacial Pain Syndromes|Neuralgia, Facial|Neuralgias, Facial|Neuralgia, Sphenopalatine|Neuralgias, Sphenopalatine|Pain Syndrome, Craniofacial|Pain Syndrome, Facial|Pain Syndrome, Myofacial|Pain Syndromes, Craniofacial|Pain Syndromes, Facial|Pain Syndromes, Myofacial|Sphenopalatine Neuralgia|Sphenopalatine Neuralgias|Syndrome, Craniofacial Pain|Syndrome, Facial Pain|Syndrome, Myofacial Pain|Syndromes, Craniofacial Pain|Syndromes, Facial Pain|Syndromes, Myofacial Pain	Mouth disease|Nervous system disease
Facial Palsy, Congenital, Unilateral Or Bilateral	MESH:C563309			MESH:D005146|MESH:D005155|MESH:D005158	C07.465.299/C563309|C07.465.327/C563309|C10.292.319/C563309|C10.597.622.214/C563309|C23.300.505/C563309|C23.888.592.636.214/C563309	C07.465.299|C07.465.327|C10.292.319|C10.597.622.214|C23.300.505|C23.888.592.636.214		Mouth disease|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Facial Palsy, Familial Recurrent Peripheral	MESH:C565028			MESH:D005158	C07.465.327/C565028|C10.597.622.214/C565028|C23.888.592.636.214/C565028	C07.465.327|C10.597.622.214|C23.888.592.636.214		Mouth disease|Nervous system disease|Signs and symptoms
Facial Paralysis	MESH:D005158	DO:DOID:13934	Severe or complete loss of facial muscle motor function. This condition may result from central or peripheral lesions. Damage to CNS motor pathways from the cerebral cortex to the facial nuclei in the pons leads to facial weakness that generally spares the forehead muscles. FACIAL NERVE DISEASES generally results in generalized hemifacial weakness. NEUROMUSCULAR JUNCTION DISEASES and MUSCULAR DISEASES may also cause facial paralysis or paresis.	MESH:D009059|MESH:D010243	C07.465.327|C10.597.622.214|C23.888.592.636.214	C07.465|C10.597.622|C23.888.592.636	Central Facial Paralyses|Central Facial Paralysis|Facial Palsies|Facial Palsy|Facial Palsy, Lower Motor Neuron|Facial Palsy, Upper Motor Neuron|Facial Paralyses, Central|Facial Paralyses, Peripheral|Facial Paralysis, Central|Facial Paralysis, Peripheral|Facial Paresis|Hemifacial Paralysis|Lower Motor Neuron Facial Palsy|Palsies, Facial|Palsy, Facial|Paralyses, Central Facial|Paralyses, Facial|Paralyses, Hemifacial|Paralysis, Central Facial|Paralysis, Facial|Paralysis, Hemifacial|Paralysis, Peripheral Facial|Pareses, Facial|Paresis, Facial|Peripheral Facial Paralysis|Upper Motor Neuron Facial Palsy	Mouth disease|Nervous system disease|Signs and symptoms
Facial paresis, hereditary, congenital	MESH:C536386	OMIM:601471|OMIM:604185|OMIM:614744		MESH:D005158	C07.465.327/C536386|C10.597.622.214/C536386|C23.888.592.636.214/C536386	C07.465.327|C10.597.622.214|C23.888.592.636.214	FACIAL PALSY, CONGENITAL, UNILATERAL OR BILATERAL|FACIAL PARESIS, HEREDITARY CONGENITAL, 1|FACIAL PARESIS, HEREDITARY CONGENITAL, 2|FACIAL PARESIS, HEREDITARY CONGENITAL, 3|HCFP1|HCFP2|HCFP3|MBS2, FORMERLY|MBS3, FORMERLY|MOBIUS SYNDROME 2, FORMERLY|MOBIUS SYNDROME 3, FORMERLY|MOEBIUS SYNDROME 2, FORMERLY|MOEBIUS SYNDROME 3, FORMERLY	Mouth disease|Nervous system disease|Signs and symptoms
Faciocardiomelic Dysplasia, Lethal	MESH:C565578			MESH:D006330|MESH:D008865|MESH:D014071|MESH:D017880	C05.660.585/C565578|C07.465.525.520/C565578|C07.650.525.520/C565578|C07.650.800/C565578|C07.793.700/C565578|C14.240.400/C565578|C14.280.400/C565578|C16.131.240.400/C565578|C16.131.621.585/C565578|C16.131.850.525.520/C565578|C16.131.850.800/C565578	C05.660.585|C07.465.525.520|C07.650.525.520|C07.650.800|C07.793.700|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.585|C16.131.850.525.520|C16.131.850.800		Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease
Faciocardiomelic Syndrome	MESH:C567176			MESH:D006330|MESH:D008607|MESH:D019066|MESH:D019465	C05.660.207/C567176|C10.597.606.360/C567176|C14.240.400/C567176|C14.280.400/C567176|C16.131.240.400/C567176|C16.131.621.207/C567176|C23.550.291.812/C567176|C23.888.592.604.646/C567176|F03.625.539/C567176	C05.660.207|C10.597.606.360|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207|C23.550.291.812|C23.888.592.604.646|F03.625.539		Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Faciocardiorenal syndrome	MESH:C536388			MESH:D002972|MESH:D006330	C05.500.460.185/C536388|C05.660.207.540.460.185/C536388|C07.320.440.185/C536388|C07.465.525.185/C536388|C07.650.500.460.185/C536388|C07.650.525.185/C536388|C14.240.400/C536388|C14.280.400/C536388|C16.131.240.400/C536388|C16.131.621.207.540.460.185/C536388|C16.131.850.500.460.185/C536388|C16.131.850.525.185/C536388	C05.500.460.185|C05.660.207.540.460.185|C07.320.440.185|C07.465.525.185|C07.650.500.460.185|C07.650.525.185|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.540.460.185|C16.131.850.500.460.185|C16.131.850.525.185	Eastman Bixler syndrome	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease
Factor V Excess with Spontaneous Thrombosis	MESH:C565026			MESH:D019851	C15.378.925/C565026	C15.378.925	Proaccelerin Excess	Blood disease
Fahr's disease	MESH:C536275	DO:DOID:0060230|OMIM:213600		MESH:D001480|MESH:D002114|MESH:D019636	C10.228.140.079/C536275|C10.574/C536275|C18.452.174.130/C536275	C10.228.140.079|C10.574|C18.452.174.130	Adult-onset idiopathic nonarteriosclerotic cerebral calcification|Basal Ganglia Calcification, Idiopathic, 1|BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2, FORMERLY|BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3, FORMERLY|Bilateral Striopallidodentate Calcinosis|BSPDC|BSPDC Bilateral striopallidodentate calcinosis|Cerebral Calcification, Nonarteriosclerotic, Idiopathic, Adult-Onset|Cerebrovascular ferrocalcinosis|FAHR DISEASE, FAMILIAL, FORMERLY|Fahr's syndrome|Familial idiopathic basal ganglia calcification|Ferrocalcinosis, Cerebrovascular|Fibgc|IBGC1|IBGC2, FORMERLY|IBGC3, FORMERLY|Idiopathic basal ganglia calcification 1|PFBC|PRIMARY FAMILIAL BRAIN CALCIFICATION|Striopallidodentate Calcinosis|Striopallidodentate calcinosis, autosomal dominant, adult onset|Striopallidodentate Calcinosis, Autosomal Dominant, Adult-Onset|Striopallidodentate Calcinosis, Bilateral	Metabolic disease|Nervous system disease
Fallopian Tube Diseases	MESH:D005184	DO:DOID:1962	Diseases involving the FALLOPIAN TUBES including neoplasms (FALLOPIAN TUBE NEOPLASMS); SALPINGITIS; tubo-ovarian abscess; and blockage.	MESH:D000291	C12.050.351.500.056.390|C12.100.250.056.390	C12.050.351.500.056|C12.100.250.056	Disease, Fallopian Tube|Diseases, Fallopian Tube|Fallopian Tube Disease|Obstructions, Tubal|Obstruction, Tubal|Tubal Obstruction|Tubal Obstructions	Urogenital disease (female)
Fallopian Tube Neoplasms	MESH:D005185	DO:DOID:1963|DO:DOID:1964	Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.	MESH:D005184|MESH:D005833	C04.588.945.418.365|C12.050.351.500.056.390.390|C12.050.351.937.418.365|C12.100.250.056.390.390|C12.900.418.365	C04.588.945.418|C12.050.351.500.056.390|C12.050.351.937.418|C12.100.250.056.390|C12.900.418	Cancer, Fallopian Tube|Cancer of the Fallopian Tube|Cancers, Fallopian Tube|Fallopian Tube Cancer|Fallopian Tube Cancers|Fallopian Tube Neoplasm|Neoplasm, Fallopian Tube|Neoplasms, Fallopian Tube	Cancer|Urogenital disease (female)
Fallot complex with severe mental and growth retardation	MESH:C536608			MESH:D006130|MESH:D008607|MESH:D013771	C10.597.606.360/C536608|C14.240.400.849/C536608|C14.280.400.849/C536608|C16.131.240.400.849/C536608|C23.550.393/C536608|C23.888.592.604.646/C536608|F03.625.539/C536608	C10.597.606.360|C14.240.400.849|C14.280.400.849|C16.131.240.400.849|C23.550.393|C23.888.592.604.646|F03.625.539	Bindewald Ulmer Muller syndrome	Cardiovascular disease|Congenital abnormality|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Familial acanthosis nigricans	MESH:C531598			MESH:D000052	C17.800.621.430.530.100/C531598	C17.800.621.430.530.100		Skin disease
Familial Acute Myeloid Leukemia with Mutated Cebpa	MESH:C580075			MESH:D015470	C04.557.337.539.275/C580075	C04.557.337.539.275	Cebpa-Dependent Familial Acute Myeloid Leukemia|Familial Acute Myeloid Leukaemia	Cancer
Familial anomalous origin of right pulmonary artery	MESH:C535681			MESH:D006330	C14.240.400/C535681|C14.280.400/C535681|C16.131.240.400/C535681	C14.240.400|C14.280.400|C16.131.240.400	ARPA, Familial|Right pulmonary artery, anomalous origin of, familial	Cardiovascular disease|Congenital abnormality
Familial antiphospholipid syndrome	MESH:C531622	OMIM:107320		MESH:D016736	C20.111.197/C531622	C20.111.197	Antiphospholipid Syndrome, Familial|Lupus anticoagulant, familial	Immune system disease
Familial apoceruloplasmin deficiency	MESH:C536004	OMIM:604290		MESH:D019189|MESH:D019636	C10.574/C536004|C18.452.565/C536004	C10.574|C18.452.565	Aceruloplasminemia|Ceruloplasmin deficiency|CERULOPLASMIN DEFICIENCY, INCLUDED|HEMOSIDEROSIS, SYSTEMIC, DUE TO ACERULOPLASMINEMIA, INCLUDED|Hereditary hypoceruloplasminemia|Hypoceruloplasminemia|HYPOCERULOPLASMINEMIA, INCLUDED	Metabolic disease|Nervous system disease
Familial benign hypercalcemia, type 3	MESH:C537147	OMIM:600740		MESH:D006934	C18.452.174.451/C537147|C18.452.950.340/C537147	C18.452.174.451|C18.452.950.340	Familial benign hypercalcemia, Oklahoma variant|Familial Benign Hypercalcemia, Type III|FBH3|HHC3|Hypercalcemia, familial benign, Oklahoma type|Hypercalcemia, familial benign, type 3|Hypercalcemia, Familial Benign, Type III|Hypocalciuric hypercalcemia, familial, type 3|Hypocalciuric Hypercalcemia, Familial, Type III	Metabolic disease
Familial Burkitt's lymphoma	MESH:C538493			MESH:D002051	C01.925.256.466.313.165/C538493|C01.925.928.313.165/C538493|C04.557.386.480.150.165/C538493|C15.604.515.569.480.150.165/C538493|C20.683.515.761.480.150.165/C538493	C01.925.256.466.313.165|C01.925.928.313.165|C04.557.386.480.150.165|C15.604.515.569.480.150.165|C20.683.515.761.480.150.165		Cancer|Immune system disease|Lymphatic disease|Viral disease
Familial capillaro-venous leptomeningeal angiomatosis	MESH:C536609			MESH:D000798|MESH:D001932	C04.588.614.250.195/C536609|C10.228.140.211/C536609|C10.551.240.250/C536609|C14.907.077/C536609	C04.588.614.250.195|C10.228.140.211|C10.551.240.250|C14.907.077		Cancer|Cardiovascular disease|Nervous system disease
Familial cerebral cavernous malformation	MESH:C536610			MESH:D020786	C04.557.645.375.385.500/C536610|C10.500.190.200/C536610|C14.240.850.875.249/C536610|C14.907.454.385.500/C536610|C15.378.463.515.385.500/C536610|C16.131.666.190.200/C536610	C04.557.645.375.385.500|C10.500.190.200|C14.240.850.875.249|C14.907.454.385.500|C15.378.463.515.385.500|C16.131.666.190.200	Familial cavernous hemangioma|Familial cerebral cavernous angioma	Blood disease|Cancer|Cardiovascular disease|Congenital abnormality|Nervous system disease
Familial ependymoma	MESH:C531673			MESH:D004806	C04.557.465.625.600.380.290/C531673|C04.557.470.670.380.290/C531673|C04.557.580.625.600.380.290/C531673	C04.557.465.625.600.380.290|C04.557.470.670.380.290|C04.557.580.625.600.380.290	Adult intracranial ependymoma|Childhood ependymoma|Ependymoma, Familial	Cancer
Familial hypersensitivity pneumonitis	MESH:C536846			MESH:D000542	C08.381.483.125/C536846|C08.674.055/C536846|C20.543.480.680.075/C536846	C08.381.483.125|C08.674.055|C20.543.480.680.075	Hypersensitivity pneumonitis familial|Hypersensitivity Pneumonitis, Familial	Immune system disease|Respiratory tract disease
Familial Letterer-Siwe disease	MESH:C538636	DO:DOID:2571		MESH:D006646	C08.381.483.375/C538636|C15.604.250.400/C538636	C08.381.483.375|C15.604.250.400	Histiocytosis X, acute disseminated	Lymphatic disease|Respiratory tract disease
Familial multiple trichodiscomas	MESH:C536847			MESH:D005350|MESH:D012878	C04.557.450.565.590.340/C536847|C04.588.805/C536847|C17.800.882/C536847	C04.557.450.565.590.340|C04.588.805|C17.800.882	Hereditary multiple trichodiscomas|Trichodiscomas, Familial Multiple	Cancer|Skin disease
Familial myelofibrosis	MESH:C536848			MESH:D055728	C15.378.190.636.765/C536848	C15.378.190.636.765		Blood disease
Familial neurocardiogenic syncope	MESH:C536849			MESH:D019462	C10.177.575.600.800/C536849|C10.597.606.358.800.600.500/C536849|C23.888.592.604.359.800.600.500/C536849	C10.177.575.600.800|C10.597.606.358.800.600.500|C23.888.592.604.359.800.600.500	Familial vasovagal syncope|Syncope, familial neurocardiogenic|Syncope, familial vasovagal	Nervous system disease|Signs and symptoms
Familial Osteochondritis Dissecans	MESH:C580095			MESH:D010008	C05.116.791.668/C580095	C05.116.791.668	Osteochondritis Dissecans, Short Stature, and Early-Onset Osteoarthritis	Musculoskeletal disease
Familial Paget's disease of bone	MESH:C538098			MESH:D010001	C05.116.692/C538098	C05.116.692	Paget disease of bone, type 1	Musculoskeletal disease
Familial paroxysmal dystonia	MESH:C537180	OMIM:128200		MESH:D004421	C10.597.350.300/C537180|C23.888.592.350.300/C537180	C10.597.350.300|C23.888.592.350.300	Dystonia 10|Dystonia, familial paroxysmal|DYT10|EKD1|Episodic Kinesigenic Dyskinesia 1|Familial Paroxysmal Kinesigenic Dyskinesia|Paroxysmal kinesigenic choreoathetosis|Paroxysmal Kinesigenic Dyskinesia|PKC|PKD	Nervous system disease|Signs and symptoms
Familial pars planitis	MESH:C531774			MESH:D015868	C11.941.160.478.700/C531774|C11.941.879.780.900.300.659/C531774|C11.941.879.900.500/C531774	C11.941.160.478.700|C11.941.879.780.900.300.659|C11.941.879.900.500		Eye disease
Familial pityriasis rubra pilaris	MESH:C531784			MESH:D010916	C17.800.859.600.685/C531784	C17.800.859.600.685	Pityriasis rubra pilaris--familial type	Skin disease
Familial primary biliary cirrhosis	MESH:C538544			MESH:D008105	C06.130.120.135.250.250/C538544|C06.552.150.250/C538544|C06.552.630.400/C538544|C23.550.355.412.400/C538544	C06.130.120.135.250.250|C06.552.150.250|C06.552.630.400|C23.550.355.412.400		Digestive system disease|Pathology (process)
Familial primary gastric lymphoma	MESH:C535648			MESH:D008228|MESH:D013274	C04.557.386.480/C535648|C04.588.274.476.767/C535648|C06.301.371.767/C535648|C06.405.249.767/C535648|C06.405.748.789/C535648|C15.604.515.569.480/C535648|C20.683.515.761.480/C535648	C04.557.386.480|C04.588.274.476.767|C06.301.371.767|C06.405.249.767|C06.405.748.789|C15.604.515.569.480|C20.683.515.761.480	Gastric lymphoma|Gastric Lymphoma, Primary|Primary gastric lymphoma	Cancer|Digestive system disease|Immune system disease|Lymphatic disease
Familial Primary Pulmonary Hypertension	MESH:D065627	OMIM:615342|OMIM:615343|OMIM:615344	Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.	MESH:D006976	C08.381.423.300	C08.381.423	Heritable Pulmonary Arterial Hypertension|Hypertension, Idiopathic Pulmonary|Hypertension, Primary Pulmonary|Idiopathic Pulmonary Arterial Hypertension|Idiopathic Pulmonary Hypertension|Pph1 With Hht|PPH2|PPH3|PPH4|Primary Pulmonary Hypertension|Pulmonary Hypertension, Idiopathic|Pulmonary Hypertension, Primary|Pulmonary Hypertension, Primary, 1|Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia|PULMONARY HYPERTENSION, PRIMARY, 2|PULMONARY HYPERTENSION, PRIMARY, 3|PULMONARY HYPERTENSION, PRIMARY, 4|Pulmonary Hypertension, Primary, Dexfenfluramine-Associated|Pulmonary Hypertension, Primary, Fenfluramine-Associated	Respiratory tract disease
Familial progressive supranuclear palsy	MESH:C538572			MESH:D013494	C10.228.140.079.882/C538572|C10.228.662.700/C538572|C10.292.562.750.500/C538572|C10.574.945.500/C538572|C10.597.622.447.690/C538572|C11.590.472.500/C538572|C23.888.592.636.447.690/C538572	C10.228.140.079.882|C10.228.662.700|C10.292.562.750.500|C10.574.945.500|C10.597.622.447.690|C11.590.472.500|C23.888.592.636.447.690		Eye disease|Nervous system disease|Signs and symptoms
Familial renal cell carcinoma	MESH:C536851			MESH:D002292	C04.557.470.200.025.390/C536851|C04.588.945.947.535.160/C536851|C12.050.351.937.820.535.160/C536851|C12.050.351.968.419.473.160/C536851|C12.200.758.820.750.160/C536851|C12.200.777.419.473.160/C536851|C12.900.820.535.160/C536851|C12.950.419.473.160/C536851|C12.950.983.535.160/C536851	C04.557.470.200.025.390|C04.588.945.947.535.160|C12.050.351.937.820.535.160|C12.050.351.968.419.473.160|C12.200.758.820.750.160|C12.200.777.419.473.160|C12.900.820.535.160|C12.950.419.473.160|C12.950.983.535.160	Familial renal carcinoma	Cancer|Urogenital disease (female)|Urogenital disease (male)
Familial spinal arachnoiditis	MESH:C531624			MESH:D001100	C10.586.625.097/C531624	C10.586.625.097	Spinal arachnoiditis|Spinal tuberculous arachnoiditis	Nervous system disease
Familial subependymomas	MESH:C538553			MESH:D018315	C04.557.465.625.600.380.290.390/C538553|C04.557.470.670.380.290.390/C538553|C04.557.580.625.600.380.290.390/C538553	C04.557.465.625.600.380.290.390|C04.557.470.670.380.290.390|C04.557.580.625.600.380.290.390		Cancer
Fanconi like syndrome	MESH:C536855			MESH:D006968|MESH:D007153|MESH:D010198|MESH:D012878	C04.588.805/C536855|C15.378.700/C536855|C17.800.882/C536855|C20.543.418/C536855|C20.673/C536855	C04.588.805|C15.378.700|C17.800.882|C20.543.418|C20.673	Fanconi-Like Syndrome	Blood disease|Cancer|Immune system disease|Skin disease
Farmer's Lung	MESH:D005203	DO:DOID:14453|DO:DOID:2708	A form of alveolitis or pneumonitis due to an acquired hypersensitivity to inhaled antigens associated with farm environment. Antigens in the farm dust are commonly from bacteria actinomycetes (SACCHAROPOLYSPORA and THERMOACTINOMYCES), fungi, and animal proteins in the soil, straw, crops, pelts, serum, and excreta.	MESH:D000382|MESH:D000542	C08.381.483.125.365|C08.674.055.365|C20.543.480.680.075.365|C24.080.365	C08.381.483.125|C08.674.055|C20.543.480.680.075|C24.080	Farmer Lung|Farmers Lung|Farmer's Lungs|Mushroom Worker Lung|Mushroom Worker's Lung|Mushroom Workers Lung|Mushroom Worker's Lungs	Immune system disease|Occupational disease|Respiratory tract disease
Fascial Dystrophy, Congenital	MESH:C563219			MESH:D003240	C17.300/C563219	C17.300		Connective tissue disease
Fasciculation	MESH:D005207		Involuntary contraction of the muscle fibers innervated by a motor unit. Fasciculations may be visualized as a muscle twitch or dimpling under the skin, but usually do not generate sufficient force to move a limb. They may represent a benign condition or occur as a manifestation of MOTOR NEURON DISEASE or PERIPHERAL NERVOUS SYSTEM DISEASES. (Adams et al., Principles of Neurology, 6th ed, p1294)	MESH:D020879	C10.597.613.250|C23.888.592.608.250	C10.597.613|C23.888.592.608	Benign Fasciculation|Benign Fasciculations|Fasciculation, Benign|Fasciculation, Muscular|Fasciculations|Fasciculations, Benign|Fasciculation, Skeletal Muscle|Fasciculations, Muscular|Fasciculations, Skeletal Muscle|Fasciculations, Tongue|Fasciculation, Tongue|Muscle Fasciculation, Skeletal|Muscle Fasciculations, Skeletal|Muscular Fasciculation|Muscular Fasciculations|Skeletal Muscle Fasciculation|Skeletal Muscle Fasciculations|Tongue Fasciculation|Tongue Fasciculations	Nervous system disease|Signs and symptoms
Fasciitis	MESH:D005208	DO:DOID:9598	Inflammation of the fascia. There are three major types: 1, Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma and considered by some a variant of scleroderma; 2, Necrotizing fasciitis (FASCIITIS, NECROTIZING), a serious fulminating infection (usually by a beta hemolytic streptococcus) causing extensive necrosis of superficial fascia; 3, Nodular/Pseudosarcomatous /Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm; it is not malignant but is sometimes mistaken for fibrosarcoma.	MESH:D009140	C05.321	C05	Fasciitides|Fascitides|Fascitis	Musculoskeletal disease
Fasciitis, Necrotizing	MESH:D019115	DO:DOID:9602	A fulminating bacterial infection of the deep layers of the skin and FASCIA. It can be caused by many different organisms, with STREPTOCOCCUS PYOGENES being the most common.	MESH:D005208	C05.321.550	C05.321	Fasciitides, Necrotizing|Fascitides, Necrotizing|Fascitis, Necrotizing|Necrotizing Fasciitides|Necrotizing Fasciitis|Necrotizing Fascitides|Necrotizing Fascitis	Musculoskeletal disease
Fasciitis, Plantar	MESH:D036981	DO:DOID:9600	Inflammation of the plantar fascia (APONEUROSIS) on the bottom of the foot causing heel pain. The etiology of plantar fasciitis remains controversial but is likely to involve a biomechanical imbalance. Though often presenting along with HEEL SPUR, they do not appear to be causally related.	MESH:D005208|MESH:D005534	C05.321.600|C05.360.350	C05.321|C05.360	Chronic Plantar Fasciitis|Fasciitis, Chronic Plantar|Fasciitis, Plantar, Chronic|Heel, Policeman's|Heels, Policeman's|Heel Spur Syndrome|Plantar Fasciitis|Plantar Fasciitis, Chronic|Policeman Heel|Policeman's Heel|Policemans Heel|Policeman's Heels	Musculoskeletal disease
Fascioliasis	MESH:D005211	DO:DOID:885	Liver disease caused by infections with parasitic flukes of the genus FASCIOLA, such as FASCIOLA HEPATICA.	MESH:D008109|MESH:D014201	C01.610.335.865.354|C01.610.518.424|C06.552.664.424	C01.610.335.865|C01.610.518|C06.552.664	Fasciola Infection|Fasciola Infections|Fascioliases|Infection, Fasciola|Infections, Fasciola	Digestive system disease|Parasitic disease
FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1	OMIM:606035			MESH:D007333|MESH:D009765|MESH:D020022	C18.452.394.968.500/606035|C18.654.726.750.500/606035|C23.550.291.687.500/606035|C23.888.144.699.500/606035	C18.452.394.968.500|C18.654.726.750.500|C23.550.291.687.500|C23.888.144.699.500	FIQTL1	Metabolic disease|Nutrition disorder|Pathology (process)|Signs and symptoms
Fatigue Syndrome, Chronic	MESH:D015673	DO:DOID:8544	A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)	MESH:D002908|MESH:D004679|MESH:D009135|MESH:D009468|MESH:D014777	C01.925.330|C05.651.310|C10.586.500.600|C10.668.364|C23.550.291.500.407	C01.925|C05.651|C10.586.500|C10.668|C23.550.291.500	Chronic Fatigue and Immune Dysfunction Syndrome|Chronic Fatigue Disorder|Chronic Fatigue Disorders|Chronic Fatigue Fibromyalgia Syndrome|Chronic Fatigue-Fibromyalgia Syndrome|Chronic Fatigue-Fibromyalgia Syndromes|Chronic Fatigue Syndrome|Chronic Fatigue Syndromes|Encephalomyelitis, Myalgic|Fatigue Disorder, Chronic|Fatigue Disorders, Chronic|Fatigue-Fibromyalgia Syndrome, Chronic|Fatigue-Fibromyalgia Syndromes, Chronic|Fatigue Syndrome, Postviral|Fatigue Syndromes, Chronic|Fatigue Syndromes, Postviral|Infectious Mononucleosis Like Syndrome, Chronic|Infectious Mononucleosis-Like Syndrome, Chronic|Myalgic Encephalomyelitis|Postviral Fatigue Syndrome|Postviral Fatigue Syndromes|Royal Free Disease|Systemic Exertion Intolerance Disease	Musculoskeletal disease|Nervous system disease|Pathology (process)|Viral disease
Fatty Liver, Alcoholic	MESH:D005235	DO:DOID:9452	Lipid infiltration of the hepatic parenchymal cells that is due to ALCOHOL ABUSE. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of TRIGLYCERIDES accumulated.	MESH:D005234|MESH:D008108	C06.552.241.390|C06.552.645.390|C25.775.100.087.645.390	C06.552.241|C06.552.645|C25.775.100.087.645	Alcoholic Fatty Liver|Alcoholic Steatohepatitis	Digestive system disease|Substance-related disorder
Febrile Convulsions, Familial, 1	MESH:C565162	OMIM:121210		MESH:D003294	C10.597.742.571/C565162|C23.888.592.742.571/C565162	C10.597.742.571|C23.888.592.742.571	Convulsions, Familial Febrile, 1|FEB1|FEBRILE SEIZURES, FAMILIAL, 1|Seizures, Familial, 1	Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 10	MESH:C567218	OMIM:612637		MESH:D003294	C10.597.742.571/C567218|C23.888.592.742.571/C567218	C10.597.742.571|C23.888.592.742.571	CONVULSIONS, FAMILIAL FEBRILE, 10|FEB10|FEBRILE SEIZURES, FAMILIAL, 10|Seizures, Familial Febrile, 10	Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 2	MESH:C566541	OMIM:602477		MESH:D003294	C10.597.742.571/C566541|C23.888.592.742.571/C566541	C10.597.742.571|C23.888.592.742.571	Convulsions, Familial Febrile, 2|CONVULSIONS, FAMILIAL FEBRILE, 2, INCLUDED|EIG17|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 17|FEB2, INCLUDED|FEBRILE SEIZURES, FAMILIAL, 2, INCLUDED|GEFS+11, INCLUDED|GEFSP11, INCLUDED|GEFS+, TYPE 11, INCLUDED|GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 11, INCLUDED|Seizures, Familial Febrile, 2	Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 3a	MESH:C567820			MESH:D003294	C10.597.742.571/C567820|C23.888.592.742.571/C567820	C10.597.742.571|C23.888.592.742.571	Convulsions, Familial Febrile, 3a|Seizures, Familial Febrile, 3a	Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 3b	MESH:C567821			MESH:D003294	C10.597.742.571/C567821|C23.888.592.742.571/C567821	C10.597.742.571|C23.888.592.742.571		Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 4	MESH:C565788	OMIM:604352		MESH:D003294	C10.597.742.571/C565788|C23.888.592.742.571/C565788	C10.597.742.571|C23.888.592.742.571	Convulsions, Familial Febrile, 4|FEB4|FEBRILE SEIZURES, FAMILIAL, 4|Seizures, Familial Febrile, 4	Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 5	MESH:C563762	OMIM:609255		MESH:D003294	C10.597.742.571/C563762|C23.888.592.742.571/C563762	C10.597.742.571|C23.888.592.742.571	Convulsions, Familial Febrile, 5|FEB5|FEBRILE SEIZURES, FAMILIAL, 5|Seizures, Familial Febrile, 5	Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 6	MESH:C563764	OMIM:609253		MESH:D003294	C10.597.742.571/C563764|C23.888.592.742.571/C563764	C10.597.742.571|C23.888.592.742.571	Convulsions, Familial Febrile, 6|FEB6|FEBRILE SEIZURES, FAMILIAL, 6|Seizures, Familial Febrile, 6	Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 7	MESH:C566929	OMIM:611515		MESH:D003294	C10.597.742.571/C566929|C23.888.592.742.571/C566929	C10.597.742.571|C23.888.592.742.571	FEB7|FEBRILE CONVULSIONS, FAMILIAL, 7|FEBRILE SEIZURES, FAMILIAL, 7	Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 8	MESH:C566975			MESH:D003294	C10.597.742.571/C566975|C23.888.592.742.571/C566975	C10.597.742.571|C23.888.592.742.571		Nervous system disease|Signs and symptoms
Febrile Convulsions, Familial, 9	MESH:C566901	OMIM:611634		MESH:D003294	C10.597.742.571/C566901|C23.888.592.742.571/C566901	C10.597.742.571|C23.888.592.742.571	FEB9|FEBRILE CONVULSIONS, FAMILIAL, 9|FEBRILE SEIZURES, FAMILIAL, 9	Nervous system disease|Signs and symptoms
Febrile Neutropenia	MESH:D064147		Fever accompanied by a significant reduction in the number of NEUTROPHILS.	MESH:D009503	C15.378.553.546.184.564.750	C15.378.553.546.184.564	Febrile Neutropenias|Neutropenia, Febrile|Neutropenias, Febrile	Blood disease
Febrile Seizures Associated with Afebrile Seizures	MESH:C565813			MESH:D003294	C10.597.742.571/C565813|C23.888.592.742.571/C565813	C10.597.742.571|C23.888.592.742.571		Nervous system disease|Signs and symptoms
FEBRILE SEIZURES, FAMILIAL, 11	OMIM:614418	DO:DOID:0111308		MESH:D003294	C10.597.742.571/614418|C23.888.592.742.571/614418	C10.597.742.571|C23.888.592.742.571	CONVULSIONS, FAMILIAL FEBRILE, 11|FEB11	Nervous system disease|Signs and symptoms
FEBRILE SEIZURES, FAMILIAL, 8	OMIM:607681	DO:DOID:0111298		MESH:C566975|MESH:D004832	C10.228.140.490.375.260/607681|C10.228.140.490.493.125/607681|C10.597.742.571/C566975/607681|C23.888.592.742.571/C566975/607681	C10.228.140.490.375.260|C10.228.140.490.493.125|C10.597.742.571/C566975|C23.888.592.742.571/C566975	ECA2,|ECA2, INCLUDED|EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2, INCLUDED|FEB8|GEFS+3, INCLUDED|GEFSP3, INCLUDED|GEFS+, TYPE 3, INCLUDED|GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3, INCLUDED	Nervous system disease|Signs and symptoms
Febrile Ulceronecrotic Mucha-Habermann disease	MESH:C537077			MESH:D006561|MESH:D017514	C01.925.256.466.382/C537077|C01.925.825.320/C537077|C17.800.838.790.320/C537077|C17.800.859.475.650/C537077|C17.800.859.575.650/C537077|C17.800.859.600.650/C537077	C01.925.256.466.382|C01.925.825.320|C17.800.838.790.320|C17.800.859.475.650|C17.800.859.575.650|C17.800.859.600.650	FUMHD|Ulceronecrotic Mucha-Habermann disease	Skin disease|Viral disease
Feigenbaum Bergeron Richardson syndrome	MESH:C536178			MESH:D001161|MESH:D003920|MESH:D004831|MESH:D006312|MESH:D009207|MESH:D009404|MESH:D019636	C09.218.458.341.374/C536178|C10.228.140.490.375.130/C536178|C10.228.140.490.493.063/C536178|C10.574/C536178|C10.597.350.500/C536178|C10.597.751.418.341.374/C536178|C12.050.351.968.419.630.643/C536178|C12.200.777.419.630.643/C536178|C12.950.419.630.643/C536178|C14.907.137.126/C536178|C18.452.394.750/C536178|C19.246/C536178|C23.888.592.350.500/C536178|C23.888.592.763.393.341.374/C536178	C09.218.458.341.374|C10.228.140.490.375.130|C10.228.140.490.493.063|C10.574|C10.597.350.500|C10.597.751.418.341.374|C12.050.351.968.419.630.643|C12.200.777.419.630.643|C12.950.419.630.643|C14.907.137.126|C18.452.394.750|C19.246|C23.888.592.350.500|C23.888.592.763.393.341.374		Cardiovascular disease|Ear-nose-throat disease|Endocrine system disease|Metabolic disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Felty Syndrome	MESH:D005258	DO:DOID:11042	A rare complication of rheumatoid arthritis with autoimmune NEUTROPENIA; and SPLENOMEGALY.	MESH:D001172	C05.550.114.154.389|C05.799.114.389|C17.300.775.099.389|C20.111.199.389	C05.550.114.154|C05.799.114|C17.300.775.099|C20.111.199	Familial Felty's Syndrome|Familial Feltys Syndrome|Familial Felty Syndrome|Felty's Syndrome|Feltys Syndrome|Felty's Syndrome, Familial|Felty Syndrome, Familial|Rheumatoid Arthritis, Splenomegaly and Neutropenia|Syndrome, Familial Felty|Syndrome, Familial Felty's|Syndrome, Felty|Syndrome, Felty's	Connective tissue disease|Immune system disease|Musculoskeletal disease
Female Urogenital Diseases	MESH:D052776		Pathological processes of the female URINARY TRACT and the reproductive system (GENITALIA, FEMALE).	MESH:D005261	C12.050.351	C12.050	Female Genitourinary Disease|Female Genitourinary Diseases|Female Urogenital Disease|Genitourinary Disease, Female|Genitourinary Diseases, Female|Urogenital Disease, Female|Urogenital Diseases, Female	Urogenital disease (female)
Female Urogenital Diseases and Pregnancy Complications	MESH:D005261		Pathological processes of the female URINARY TRACT, the reproductive system (GENITALIA, FEMALE), and disorders related to PREGNANCY.	MESH:D000091642	C12.050	C12		
Femoracetabular Impingement	MESH:D057925		A pathological mechanical process that can lead to hip failure. It is caused by abnormalities of the ACETABULUM and/or FEMUR combined with rigorous hip motion, leading to repetitive collisions that damage the soft tissue structures.	MESH:D007592|MESH:D010335	C05.550.384|C23.550.347	C05.550|C23.550	Femoracetabular Impingements|Femoroacetabular Impingement|Femoro Acetabular Impingement|Femoro-Acetabular Impingement|Femoroacetabular Impingements|Femoro-Acetabular Impingements|Femoroacetabular Impingement Syndrome|Femoroacetabular Impingement Syndromes|Impingement, Femoracetabular|Impingement, Femoroacetabular|Impingement, Femoro-Acetabular|Impingements, Femoracetabular|Impingements, Femoroacetabular|Impingements, Femoro-Acetabular|Impingement Syndrome, Femoroacetabular|Impingement Syndromes, Femoroacetabular|Syndrome, Femoroacetabular Impingement|Syndromes, Femoroacetabular Impingement	Musculoskeletal disease|Pathology (process)
Femoral Neoplasms	MESH:D005266	DO:DOID:5546	New abnormal growth of tissue in the FEMUR.	MESH:D001859	C04.588.149.276|C05.116.231.343	C04.588.149|C05.116.231	Femoral Neoplasm|Neoplasm, Femoral|Neoplasms, Femoral	Cancer|Musculoskeletal disease
Femoral Neuropathy	MESH:D020428	DO:DOID:4196	Disease involving the femoral nerve. The femoral nerve may be injured by ISCHEMIA (e.g., in association with DIABETIC NEUROPATHIES), nerve compression, trauma, COLLAGEN DISEASES, and other disease processes. Clinical features include MUSCLE WEAKNESS or PARALYSIS of hip flexion and knee extension, ATROPHY of the QUADRICEPS MUSCLE, reduced or absent patellar reflex, and impaired sensation over the anterior and medial thigh.	MESH:D020422	C10.668.829.500.200	C10.668.829.500	Bernhardt Roth Syndrome|Bernhardt-Roth Syndrome|Femoral Mononeuropathies|Femoral Mononeuropathy|Femoral Nerve Disease|Femoral Nerve Diseases|Femoral Nerve Dysfunction|Femoral Nerve Dysfunctions|Femoral Neuritides|Femoral Neuritis|Femoral Neuropathies|Lateral Femoral Cutaneous Nerve Entrapment|Meralgia Paresthetica|Mononeuropathy, Femoral|Nerve Disease, Femoral|Nerve Diseases, Femoral|Nerve Dysfunction, Femoral|Neuritis, Femoral|Neuropathy, Femoral	Nervous system disease
Femur Head Necrosis	MESH:D005271	OMIM:608805|OMIM:617383	Aseptic or avascular necrosis of the femoral head. The major types are idiopathic (primary), as a complication of fractures or dislocations, and LEGG-CALVE-PERTHES DISEASE.	MESH:D010020	C05.116.852.175|C23.550.717.732.368	C05.116.852|C23.550.717.732	ANFH|ANFH1|ANFH2|Aseptic Necrosis of Femur Head|Avascular Necrosis Of Femoral Head, Primary|AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1|AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2|Avascular Necrosis of Femur Head|FEMORAL HEAD, ASEPTIC NECROSIS OF|Femoral Head, Avascular Necrosis Of|Femur Head Necroses|Head Necrosis, Femur|Ischemic Necrosis Of Femoral Head|Necrosis, Aseptic, of Femur Head|Necrosis, Avascular, of Femur Head|Necrosis, Femur Head|OSTEONECROSIS OF FEMORAL HEAD	Musculoskeletal disease|Pathology (process)
Fetal Macrosomia	MESH:D005320		A condition of fetal overgrowth leading to a large-for-gestational-age FETUS. It is defined as BIRTH WEIGHT greater than 4,000 grams or above the 90th percentile for population and sex-specific growth curves. It is commonly seen in GESTATIONAL DIABETES; PROLONGED PREGNANCY; and pregnancies complicated by pre-existing diabetes mellitus.	MESH:D001724|MESH:D005315|MESH:D011254|MESH:D016640|MESH:D048909	C12.050.703.170.500|C12.050.703.277.570|C12.050.703.726.570|C16.300.570|C19.246.099.968|C23.888.144.186.500	C12.050.703.170|C12.050.703.277|C12.050.703.726|C16.300|C19.246.099|C23.888.144.186	Fetal Macrosomias|Macrosomia, Fetal|Macrosomias, Fetal	Endocrine system disease|Fetal disease|Pregnancy complication|Signs and symptoms
Fetofetal Transfusion	MESH:D005330	DO:DOID:13576	Passage of blood from one fetus to another via an arteriovenous communication or other shunt, in a monozygotic twin pregnancy. It results in anemia in one twin and polycythemia in the other. (Lee et al., Wintrobe's Clinical Hematology, 9th ed, p737-8)	MESH:D000751	C15.378.071.363.344|C16.614.053.344	C15.378.071.363|C16.614.053	Cross Transfusion, Intrauterine|Cross-Transfusion, Intrauterine|Cross-Transfusions, Intrauterine|Fetal Transfusion Syndrome|Fetal Transfusion Syndromes|Fetofetal Transfusions|Fetofetal Transfusion Syndrome|Fetofetal Transfusion Syndromes|Intrauterine Cross Transfusion|Intrauterine Cross-Transfusion|Intrauterine Cross-Transfusions|Syndrome, Fetal Transfusion|Syndrome, Fetofetal Transfusion|Syndromes, Fetal Transfusion|Syndromes, Fetofetal Transfusion|Syndromes, Twin-to-Twin Transfusion|Syndromes, Twin Transfusion|Syndrome, Twin-to-Twin Transfusion|Syndrome, Twin Transfusion|Transfusion, Fetofetal|Transfusions, Fetofetal|Transfusions, Twin|Transfusion Syndrome, Fetal|Transfusion Syndrome, Fetofetal|Transfusion Syndromes, Fetal|Transfusion Syndromes, Fetofetal|Transfusion Syndromes, Twin|Transfusion Syndromes, Twin-to-Twin|Transfusion Syndrome, Twin|Transfusion Syndrome, Twin-to-Twin|Transfusion, Twin|Twin to Twin Transfusion Syndrome|Twin-to-Twin Transfusion Syndrome|Twin-to-Twin Transfusion Syndromes|Twin Transfusion|Twin Transfusions|Twin Transfusion Syndrome|Twin Transfusion Syndromes|Twin Twin Transfusion Syndrome	Blood disease|Infant-newborn disease
Fetomaternal Transfusion	MESH:D005331		Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed)	MESH:D000751	C15.378.071.363.511|C16.614.053.511	C15.378.071.363|C16.614.053	Fetomaternal Hemorrhage|Fetomaternal Hemorrhages|Fetomaternal Transfusions|Hemorrhage, Fetomaternal|Hemorrhages, Fetomaternal|Transfusion, Fetomaternal|Transfusions, Fetomaternal	Blood disease|Infant-newborn disease
Fibrinolytic Defect	MESH:C565017			MESH:D001778	C15.378.100/C565017	C15.378.100		Blood disease
Fibroadenoma	MESH:D018226	DO:DOID:1618	An adenoma containing fibrous tissue. It should be differentiated from ADENOFIBROMA which is a tumor composed of connective tissue (fibroma) containing glandular (adeno-) structures. (From Dorland, 27th ed)	MESH:D018225	C04.557.450.565.590.595.350|C04.557.470.625.350	C04.557.450.565.590.595|C04.557.470.625	Fibroadenomas	Cancer
Fibrocartilaginous embolism	MESH:C537927			MESH:D002357|MESH:D004617	C05.182/C537927|C14.907.355.350/C537927|C17.300.182/C537927	C05.182|C14.907.355.350|C17.300.182	Embolism, fibrocartilaginous|Nucleus pulposus embolism	Cardiovascular disease|Connective tissue disease|Musculoskeletal disease
Fibrocystic Breast Disease	MESH:D005348	DO:DOID:10354|DO:DOID:5998	A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.	MESH:D001941	C17.800.090.750	C17.800.090	Adenoses, Microglandular|Adenosis, Microglandular|Adenosis of Breast|Breast Adenosis|Breast Cystic Disease|Breast Cystic Diseases|Breast Disease, Cystic|Breast Disease, Fibrocystic|Breast Dysplasia|Breast Fibrocystic Change|Breast Fibrocystic Changes|Breast Fibrocystic Disease|Chronic Cystic Mastitis|Cystic Breast Disease|Cystic Disease of Breast|Cystic Mastitis, Chronic|Disease, Cystic Breast|Disease, Fibrocystic Breast|Dysplasia, Breast|Dysplasia, Mammary|Fibrocystic Changes of Breast|Fibrocystic Disease of Breast|Fibrocystic Mastopathy|Mammary Dysplasia|Mastopathy, Fibrocystic|Microglandular Adenoses|Microglandular Adenosis	Skin disease
Fibrolamellar hepatocellular carcinoma	MESH:C537258	DO:DOID:5015		MESH:D006528	C04.557.470.200.025.255/C537258|C04.588.274.623.160/C537258|C06.301.623.160/C537258|C06.552.697.160/C537258	C04.557.470.200.025.255|C04.588.274.623.160|C06.301.623.160|C06.552.697.160	Fibrolamellar variant of hepatocellular carcinoma|Hepatocellular carcinoma (fibrolamellar variant)	Cancer|Digestive system disease
Fibroma	MESH:D005350		A benign tumor of fibrous or fully developed connective tissue.	MESH:D018218	C04.557.450.565.590.340	C04.557.450.565.590	Fibromas|Fibromatoses|Fibromatosis|Fibromyxoma|Fibromyxomas|Myxofibroma|Myxofibromas	Cancer
Fibroma, Desmoplastic	MESH:D018220		An extremely rare bone tumor characterized by abundant collagen formation and a fibrous stroma, without evidence of mitosis or pleomorphism. It appears on x-rays as an osteolytic lesion with well-defined margins and must be differentiated from primary fibrosarcoma of bone. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1441)	MESH:D005350	C04.557.450.565.590.340.345	C04.557.450.565.590.340	Collagenous Fibroma|Collagenous Fibromas|Desmoplastic Fibroblastoma|Desmoplastic Fibroblastomas|Desmoplastic Fibroma|Desmoplastic Fibromas|Fibroblastoma, Desmoplastic|Fibroma, Collagenous	Cancer
Fibroma, Ossifying	MESH:D018214	DO:DOID:180	A benign central bone tumor, usually of the jaws (especially the mandible), composed of fibrous connective tissue within which bone is formed.	MESH:D005350|MESH:D018213	C04.557.450.565.575.400|C04.557.450.565.590.340.360	C04.557.450.565.575|C04.557.450.565.590.340	Fibromas, Ossifying|Ossifying Fibroma|Ossifying Fibromas	Cancer
Fibromatosis, Abdominal	MESH:D018221		A relatively large mass of unusually firm scarlike connective tissue resulting from active participation of fibroblasts, occurring most frequently in the abdominal muscles of women who have borne children. The fibroblasts infiltrate surrounding muscle and fascia. (Stedman, 25th ed)	MESH:D005350	C04.557.450.565.590.340.400	C04.557.450.565.590.340	Abdominal Fibromatoses|Abdominal Fibromatosis|Fibromatoses, Abdominal	Cancer
Fibromatosis, Aggressive	MESH:D018222		A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. (Stedman, 25th ed)	MESH:D005350	C04.557.450.565.590.340.410	C04.557.450.565.590.340	Aggressive Fibromatoses|Aggressive Fibromatosis|Desmoid|Desmoids|Fibromatoses, Aggressive	Cancer
Fibromatosis, Congenital Generalized	MESH:C562978	OMIM:228550|OMIM:615293		MESH:D018224	C04.557.450.565.590.550/C562978	C04.557.450.565.590.550	CGF|FIBROMATOSIS, CONGENITAL GENERALIZED|IMF1|IMF2|Myofibromatosis, Infantile|MYOFIBROMATOSIS, INFANTILE, 1|MYOFIBROMATOSIS, INFANTILE, 2|Myofibromatosis, Juvenile	Cancer
Fibromatosis, Plantar	MESH:D000071380	DO:DOID:8936	A fibromatosis of the plantar fascia characterized by thickening of the fibrous bands on the plantar aponeurosis in the sole of the foot and toes.	MESH:D003240|MESH:D003286|MESH:D005350|MESH:D005534	C04.557.450.565.590.340.705|C05.360.375|C05.651.197.369|C17.300.349|C17.800.321.063	C04.557.450.565.590.340|C05.360|C05.651.197|C17.300|C17.800.321	Ledderhose Disease|Ledderhose's Disease|Plantar Fibromatosis	Cancer|Connective tissue disease|Musculoskeletal disease|Skin disease
Fibromuscular Dysplasia	MESH:D005352		An idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to STENOSIS of small and medium-sized arteries. There is true proliferation of SMOOTH MUSCLE CELLS and fibrous tissue. Fibromuscular dysplasia lesions are smooth stenosis and occur most often in the renal and carotid arteries. They may also occur in other peripheral arteries of the extremity.	MESH:D001157	C14.907.137.372	C14.907.137	Arteries Fibromuscular Dysplasia|Arteries Fibromuscular Dysplasias|Dysplasia, Fibromuscular|Fibromuscular Dysplasia of Arteries|Fibromuscular Dysplasias	Cardiovascular disease
Fibromyalgia	MESH:D005356	DO:DOID:631	A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)	MESH:D009135|MESH:D012216	C05.651.324|C05.799.321|C10.668.491.425	C05.651|C05.799|C10.668.491	Diffuse Myofascial Pain Syndrome|Fibromyalgia Fibromyositis Syndrome|Fibromyalgia-Fibromyositis Syndrome|Fibromyalgia-Fibromyositis Syndromes|Fibromyalgia, Primary|Fibromyalgias|Fibromyalgia, Secondary|Fibromyalgias, Primary|Fibromyalgias, Secondary|Fibromyositis Fibromyalgia Syndrome|Fibromyositis-Fibromyalgia Syndrome|Fibromyositis-Fibromyalgia Syndromes|Fibrositides|Fibrositis|Muscular Rheumatism|Myofascial Pain Syndrome, Diffuse|Primary Fibromyalgia|Primary Fibromyalgias|Rheumatism, Muscular|Secondary Fibromyalgia|Secondary Fibromyalgias|Syndrome, Fibromyalgia-Fibromyositis|Syndrome, Fibromyositis-Fibromyalgia|Syndromes, Fibromyalgia-Fibromyositis|Syndromes, Fibromyositis-Fibromyalgia	Musculoskeletal disease|Nervous system disease
Fibrosarcoma	MESH:D005354	DO:DOID:3355	A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)	MESH:D012509|MESH:D018218	C04.557.450.565.590.350|C04.557.450.795.350	C04.557.450.565.590|C04.557.450.795	Fibrosarcomas	Cancer
Fibrosis of Extraocular Muscles, Congenital, with Synergistic Divergence	MESH:C566508			MESH:D005355|MESH:D015835	C10.228.758/C566508|C10.292.562/C566508|C11.590/C566508|C23.550.355/C566508	C10.228.758|C10.292.562|C11.590|C23.550.355	Congenital Fibrosis Syndrome with Synergistic Divergence|External Ophthalmoplegia with Synergistic Divergence	Eye disease|Nervous system disease|Pathology (process)
Fibrous Dysplasia, Monostotic	MESH:D005358		FIBROUS DYSPLASIA OF BONE involving only one bone.	MESH:D005357	C05.116.099.708.375.372	C05.116.099.708.375	Dysplasia, Monostotic Fibrous|Dysplasias, Monostotic Fibrous|Fibrous Dysplasias, Monostotic|Monostotic Fibrous Dysplasia|Monostotic Fibrous Dysplasias	Musculoskeletal disease
Fibrous Dysplasia of Bone	MESH:D005357		A disease of bone marked by thinning of the cortex by fibrous tissue containing bony spicules, producing pain, disability, and gradually increasing deformity. Only one bone may be involved (FIBROUS DYSPLASIA, MONOSTOTIC) or several (FIBROUS DYSPLASIA, POLYOSTOTIC).	MESH:D010009	C05.116.099.708.375	C05.116.099.708	Bone Fibrocartilaginous Dysplasia|Bone Fibrocartilaginous Dysplasias|Bone Fibrocystic Dysplasia|Bone Fibrocystic Dysplasias|Bone Fibrous Dysplasia|Bone Fibrous Dysplasias|Fibrocartilaginous Dysplasia of Bone|Fibrocystic Dysplasia of Bone|Jaffe Lichtenstein Disease|Jaffe-Lichtenstein Disease|Osteitis Fibrosa Disseminata	Musculoskeletal disease
Fibrous Dysplasia, Polyostotic	MESH:D005359	DO:DOID:1858|OMIM:174800	FIBROUS DYSPLASIA OF BONE affecting several bones. When melanotic pigmentation (CAFE-AU-LAIT SPOTS) and multiple endocrine hyperfunction are additionally associated it is referred to as Albright syndrome.	MESH:D005357	C05.116.099.708.375.381	C05.116.099.708.375	Albright-Mccune-Sternberg Syndrome|Albright's Disease|Albright's Disease of Bone|Albright's Syndrome|Albright's Syndrome with Precocious Puberty|Albright-Sternberg Syndrome|Albright Syndrome|ALBRIGHT SYNDROME POLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED|Dysplasia, Polyostotic Fibrous|Dysplasias, Polyostotic Fibrous|Fibrous Dysplasias, Polyostotic|Fibrous Dysplasia with Pigmentary Skin Changes and Precocious Puberty|MAS|McCune Albright Syndrome|McCune-Albright Syndrome|PFD, INCLUDED|POFD, INCLUDED|Polyostotic Fibrous Dysplasia|Polyostotic Fibrous Dysplasias|Syndrome, Albright|Syndrome, Albright's|Syndrome, McCune-Albright	Musculoskeletal disease
Fibula, Recurrent Dislocation of Head of	MESH:C565011			MESH:D004204	C05.550.518/C565011|C26.289/C565011	C05.550.518|C26.289		Musculoskeletal disease|Wounds and injuries
FICOLIN 3 DEFICIENCY	OMIM:613860			MESH:D007153	C20.673/613860	C20.673	FCN3 DEFICIENCY|LCAPD3|LECTIN COMPLEMENT ACTIVATION PATHWAY, DEFECT IN, 3	Immune system disease
Filoviridae Infections	MESH:D018702		Infections with viruses of the family FILOVIRIDAE. The infections in humans consist of a variety of clinically similar viral hemorrhagic fevers but the natural reservoir host is unknown.	MESH:D018701	C01.925.782.580.250	C01.925.782.580	Filoviridae Infection|Filovirus Infection|Filovirus Infections|Infection, Filoviridae|Infection, Filovirus|Infections, Filoviridae	Viral disease
Fingerprint Body Myopathy	MESH:C564425			MESH:D009135	C05.651/C564425|C10.668.491/C564425	C05.651|C10.668.491		Musculoskeletal disease|Nervous system disease
Fitz-Hugh-Curtis syndrome	MESH:C537936			MESH:D000292|MESH:D006505|MESH:D010538	C01.463.600/C537936|C01.635.500/C537936|C06.552.380/C537936|C06.844.640/C537936|C12.050.351.500.056.750/C537936|C12.100.250.056.750/C537936	C01.463.600|C01.635.500|C06.552.380|C06.844.640|C12.050.351.500.056.750|C12.100.250.056.750	Gonococcal Perihepatitis|Perihepatitis Syndrome	Digestive system disease|Urogenital disease (female)
Flaujeac factor deficiency	MESH:C537060	DO:DOID:0111676|OMIM:228960		MESH:D001778	C15.378.100/C537060	C15.378.100	Fitzgerald Trait|FITZGERALD TRAIT  KININOGEN DEFICIENCY, TOTAL, INCLUDED|FLAUJEAC TRAIT, INCLUDED|High molecular weight kininogen deficiency|HMWK Deficiency|Kininogen Deficiency, High Molecular Weight|KININOGEN DEFICIENCY, HIGH MOLECULAR WEIGHT AND LOW MOLECULAR WEIGHT, INCLUDED|Kininogen Deficiency, Total|WILLIAMS TRAIT, INCLUDED	Blood disease
Flaviviridae Infections	MESH:D018178		Infections with viruses of the family FLAVIVIRIDAE.	MESH:D012327	C01.925.782.350	C01.925.782	Flaviviridae Infection|Infection, Flaviviridae|Infections, Flaviviridae	Viral disease
Flavivirus Infections	MESH:D018177		Infections with viruses of the genus FLAVIVIRUS, family FLAVIVIRIDAE.	MESH:D018178	C01.925.782.350.250	C01.925.782.350	Flavivirus Infection|Infection, Flavivirus|Infections, Flavivirus	Viral disease
Fleck Retina of Kandori	MESH:C562701			MESH:D009755	C11.966.671/C562701	C11.966.671		Eye disease
Floating-Betalipoproteinemia	MESH:C566265			MESH:D050171	C18.452.584.500/C566265	C18.452.584.500		Metabolic disease
Floating-harbor syndrome	MESH:C537062	DO:DOID:0111358|OMIM:136140		MESH:D000015|MESH:D006130|MESH:D006345|MESH:D019465	C05.660.207/C537062|C14.240.400.560.540/C537062|C14.280.400.560.540/C537062|C16.131.077/C537062|C16.131.240.400.560.540/C537062|C16.131.621.207/C537062|C23.550.393/C537062	C05.660.207|C14.240.400.560.540|C14.280.400.560.540|C16.131.077|C16.131.240.400.560.540|C16.131.621.207|C23.550.393	FLHS|Leisti-Hollander-Rimoin Syndrome|Pelletier-Leisti syndrome	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Pathology (process)
Flood Factor Deficiency	MESH:C565009			MESH:D020147	C15.378.100.141/C565009	C15.378.100.141		Blood disease
Florid cemento-osseous dysplasia	MESH:C537063			MESH:D005357|MESH:D010019	C01.160.495/C537063|C05.116.099.708.375/C537063|C05.116.165.495/C537063	C01.160.495|C05.116.099.708.375|C05.116.165.495		Musculoskeletal disease
Florid cystic endosalpingiosis of the uterus	MESH:C537064			MESH:D003536|MESH:D005185	C04.557.470.200.025.480/C537064|C04.557.470.590.480/C537064|C04.588.945.418.365/C537064|C12.050.351.500.056.390.390/C537064|C12.050.351.937.418.365/C537064|C12.100.250.056.390.390/C537064|C12.900.418.365/C537064	C04.557.470.200.025.480|C04.557.470.590.480|C04.588.945.418.365|C12.050.351.500.056.390.390|C12.050.351.937.418.365|C12.100.250.056.390.390|C12.900.418.365	Cystic endosalpingiosis of the uterus	Cancer|Urogenital disease (female)
FLOTCH syndrome	MESH:C537065			MESH:D001762|MESH:D004814|MESH:D006201|MESH:D009260|MESH:D010859|MESH:D012164	C04.182.254/C537065|C11.338.133/C537065|C11.768/C537065|C17.800.329/C537065|C17.800.529/C537065|C17.800.621/C537065|C23.550.755/C537065	C04.182.254|C11.338.133|C11.768|C17.800.329|C17.800.529|C17.800.621|C23.550.755	Friedel Heid Grosshans syndrome	Cancer|Eye disease|Pathology (process)|Skin disease
Fluoride Poisoning	MESH:D005458		Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of FLUORIDE compounds.	MESH:D011041	C25.723.380	C25.723	Fluoride Poisonings|Poisoning, Fluoride|Poisonings, Fluoride	
Focal Infection	MESH:D005490		An infection at a specific location that may spread to another region of the body.	MESH:D007239	C01.392	C01	Focal Infections|Infection, Focal|Infections, Focal	
Foix Chavany Marie syndrome	MESH:C537069			MESH:D003680|MESH:D004401|MESH:D005158	C06.405.117.119/C537069|C07.465.327/C537069|C09.775.174/C537069|C10.597.606.150.500.800.150.200/C537069|C10.597.622.214/C537069|C23.888.592.604.150.500.800.150.200/C537069|C23.888.592.636.214/C537069	C06.405.117.119|C07.465.327|C09.775.174|C10.597.606.150.500.800.150.200|C10.597.622.214|C23.888.592.604.150.500.800.150.200|C23.888.592.636.214	Anterior Opercular Syndrome|Bilateral Anterior Opercular Syndrome|Congenital Foix-Chavany-Marie syndrome|Facio-Labio-Pharyngo-Glosso-Laryngo-Brachial Paralysis|Facio-Pharyngo-Glossal Diplegia with Automatic-Voluntary Movement Dissociation|Opercular Syndrome, Anterior|Pseudobulbar Paralysis, Cortical Type	Digestive system disease|Ear-nose-throat disease|Mouth disease|Nervous system disease|Signs and symptoms
Folate Malabsorption, Hereditary	MESH:C562799	DO:DOID:0111678|OMIM:229050		MESH:D005494|MESH:D008286	C06.405.469.637/C562799|C18.452.603/C562799|C18.654.521.500.133.699.308/C562799	C06.405.469.637|C18.452.603|C18.654.521.500.133.699.308	Congenital Folate Malabsorption|Folic Acid Transport Defect|Hereditary Folate Malabsorption	Digestive system disease|Metabolic disease|Nutrition disorder
Follicular Cyst	MESH:D005497		Cyst due to the occlusion of the duct of a follicle or small gland.	MESH:D003560	C04.182.300	C04.182	Cyst, Follicular|Cysts, Follicular|Follicular Cysts	Cancer
Folliculitis	MESH:D005499	DO:DOID:4409	Inflammation of follicles, primarily hair follicles.	MESH:D006201	C17.800.329.500	C17.800.329	Folliculitides|Sycoses|Sycosis	Skin disease
Foodborne Diseases	MESH:D005517		Acute illnesses, usually affecting the GASTROINTESTINAL TRACT, brought on by consuming contaminated food or beverages. Most of these diseases are infectious, caused by a variety of bacteria, viruses, or parasites that can be foodborne. Sometimes the diseases are caused by harmful toxins from the microbes or other chemicals present in the food. Especially in the latter case, the condition is often called food poisoning.	MESH:D011041	C25.723.415	C25.723	Disease, Foodborne|Disease, Food-borne|Food borne Disease|Food-borne Disease|Foodborne Disease|Food borne Diseases|Food-borne Diseases|Food borne Illness|Food-borne Illness|Foodborne Illness|Food borne Illnesses|Food-borne Illnesses|Foodborne Illnesses|Food Poisoning|Food Poisonings|Illnesses, Foodborne|Illness, Foodborne|Illness, Food-borne|Poisoning, Food	
Food Hypersensitivity	MESH:D005512	DO:DOID:3044	Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food.	MESH:D006969	C20.543.480.370	C20.543.480	Allergies, Food|Allergy, Food|Food Allergies|Food Allergy|Food Hypersensitivities|Hypersensitivities, Food|Hypersensitivity, Food	Immune system disease
Foot Deformities	MESH:D005530		Alterations or deviations from normal shape or size which result in a disfigurement of the foot.	MESH:D009140	C05.330	C05	Deformities, Foot|Deformities, Metatarsal|Deformity, Foot|Deformity, Metatarsal|Foot Deformity|Metatarsal Deformities|Metatarsal Deformity	Musculoskeletal disease
Foot Deformities, Acquired	MESH:D005531		Distortion or disfigurement of the foot, or a part of the foot, acquired through disease or injury after birth.	MESH:D005530	C05.330.488	C05.330	Acquired Foot Deformities|Acquired Foot Deformity|Deformities, Acquired Foot|Deformity, Acquired Foot|Foot Deformity, Acquired	Musculoskeletal disease
Foot Dermatoses	MESH:D005533		Skin diseases of the foot, general or unspecified.	MESH:D005534	C17.800.321.125	C17.800.321	Dermatoses, Foot|Dermatosis, Foot|Foot Dermatosis	Skin disease
Foot Diseases	MESH:D005534		Anatomical and functional disorders affecting the foot.	MESH:D009140|MESH:D012871	C05.360|C17.800.321	C05|C17.800	Foot Disease	Musculoskeletal disease|Skin disease
Foot Ulcer	MESH:D016523		Lesion on the surface of the skin of the foot, usually accompanied by inflammation. The lesion may become infected or necrotic and is frequently associated with diabetes or leprosy.	MESH:D005534|MESH:D007871	C17.800.321.250|C17.800.893.592.450	C17.800.321|C17.800.893.592	Foot Ulcers|Plantar Ulcer|Plantar Ulcers|Ulcer, Foot|Ulcer, Plantar|Ulcers, Foot|Ulcers, Plantar	Skin disease
Foramen Ovale, Patent	MESH:D054092	DO:DOID:13620	A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance.	MESH:D006344	C14.240.400.560.375.258|C14.280.400.560.375.258|C16.131.240.400.560.375.258	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	Oval Foramen, Patent|Patent Foramen Ovale|Patent Oval Foramen	Cardiovascular disease|Congenital abnormality
FOR heavy chain disease protein, human	MESH:C483996			MESH:D006362	C15.378.147.780.490/C483996|C15.604.515.435/C483996|C20.683.780.490/C483996	C15.378.147.780.490|C15.604.515.435|C20.683.780.490	gamma 1 heavy chain disease protein FOR, human	Blood disease|Immune system disease|Lymphatic disease
Formaldehyde poisoning	MESH:C537268			MESH:D012130	C08.674/C537268|C20.543.480.680/C537268	C08.674|C20.543.480.680	Formaldehyde Exposure|Formaldehyde Toxicity|Formalin Intoxication|Formalin Toxicity	Immune system disease|Respiratory tract disease
Forney Robinson Pascoe syndrome	MESH:C537269	OMIM:157800		MESH:D000015|MESH:D006312|MESH:D008944|MESH:D010026	C05.116.099.708.702/C537269|C09.218.458.341.374/C537269|C10.597.751.418.341.374/C537269|C14.280.484.461/C537269|C16.131.077/C537269|C23.888.592.763.393.341.374/C537269	C05.116.099.708.702|C09.218.458.341.374|C10.597.751.418.341.374|C14.280.484.461|C16.131.077|C23.888.592.763.393.341.374	CARDIOSPONDYLOCARPOFACIAL SYNDROME|Congenital heart disease, deafness, and skeletal malformations|CSCF|Mitral Regurgitation, Conductive Deafness, and Fusion of Cervical Vertebrae and of Carpal and Tarsal Bones	Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Fourth Cranial Nerve Palsy, Familial Congenital	MESH:C565007			MESH:D020432	C10.292.850/C565007	C10.292.850	Strabismus from Superior Oblique Palsy|Superior Oblique Oculomotor Palsy, Familial Congenital|Trochlear Nerve Palsy, Familial Congenital	Nervous system disease
Fowler Christmas Chapple syndrome	MESH:C537271			MESH:D011085|MESH:D014555	C04.182.612.765/C537271|C12.050.351.500.056.630.580.765/C537271|C12.050.351.968.934/C537271|C12.100.250.056.630.580.765/C537271|C12.200.777.934/C537271|C12.950.934/C537271|C19.391.630.580.765/C537271	C04.182.612.765|C12.050.351.500.056.630.580.765|C12.050.351.968.934|C12.100.250.056.630.580.765|C12.200.777.934|C12.950.934|C19.391.630.580.765	Voiding dysfunction, and polycystic ovaries	Cancer|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Fox-Fordyce Disease	MESH:D005588	DO:DOID:1381	Chronic pruritic disease, usually in women, characterized by small follicular papular eruptions in APOCRINE GLANDS areas. It is caused by obstruction and rupture of intraepidermal apocrine ducts.	MESH:D008883	C17.800.946.492.285	C17.800.946.492	Apocrine Miliaria|Disease, Fox-Fordyce|Fox Fordyce Disease|Fox Fordyce Syndrome|Fox-Fordyce Syndrome|Miliaria, Apocrine|Syndrome, Fox-Fordyce	Skin disease
Fracture Dislocation	MESH:D000072039		Fracture of a bone near an articulation with concomitant dislocation of that joint.	MESH:D004204|MESH:D050723	C05.550.518.336|C26.289.336|C26.404.026	C05.550.518|C26.289|C26.404	Dislocation Fracture|Dislocation, Fracture|Dislocation Fractures|Dislocations, Fracture|Fracture, Dislocation|Fracture Dislocations|Fractures, Dislocation	Musculoskeletal disease|Wounds and injuries
Fraser-Like Syndrome	MESH:C565562			MESH:D010048|MESH:D015619|MESH:D019465	C04.182.612/C565562|C05.660.207/C565562|C08.695/C565562|C12.050.351.500.056.630.580/C565562|C12.100.250.056.630.580/C565562|C16.131.621.207/C565562|C16.131.740/C565562|C19.391.630.580/C565562	C04.182.612|C05.660.207|C08.695|C12.050.351.500.056.630.580|C12.100.250.056.630.580|C16.131.621.207|C16.131.740|C19.391.630.580	Fused Eyelids, Airway Anomalies, Ovarian Cysts, and Digital Anomalies	Cancer|Congenital abnormality|Endocrine system disease|Musculoskeletal disease|Respiratory tract disease|Urogenital disease (female)
Frenkel Russe syndrome	MESH:C535638			MESH:D000361|MESH:D012166|MESH:D013684	C11.290.807/C535638|C11.768.710/C535638|C14.907.823/C535638|C15.378.147.142/C535638|C15.604.515.032/C535638|C20.673.088/C535638|C23.550.414.756.775/C535638	C11.290.807|C11.768.710|C14.907.823|C15.378.147.142|C15.604.515.032|C20.673.088|C23.550.414.756.775	Retinal Telangiectasia and Hypogammaglobulinemia|Retinal telangiectasia associated with hypogammaglobulinemia	Blood disease|Cardiovascular disease|Eye disease|Immune system disease|Lymphatic disease|Pathology (process)
Frontal Sinusitis	MESH:D015522	DO:DOID:10791	Inflammation of the NASAL MUCOSA in the FRONTAL SINUS. In many cases, it is caused by an infection of the bacteria STREPTOCOCCUS PNEUMONIAE or HAEMOPHILUS INFLUENZAE.	MESH:D012852	C01.748.749.387|C08.460.692.752.387|C08.730.749.387|C09.603.692.752.387	C01.748.749|C08.460.692.752|C08.730.749|C09.603.692.752	Frontal Sinusitides|Sinusitides, Frontal|Sinusitis, Frontal	Ear-nose-throat disease|Respiratory tract disease
Frontoocular Syndrome	MESH:C565340			MESH:D005124|MESH:D006330|MESH:D019465	C05.660.207/C565340|C11.250/C565340|C14.240.400/C565340|C14.280.400/C565340|C16.131.240.400/C565340|C16.131.384/C565340|C16.131.621.207/C565340	C05.660.207|C11.250|C14.240.400|C14.280.400|C16.131.240.400|C16.131.384|C16.131.621.207		Cardiovascular disease|Congenital abnormality|Eye disease|Musculoskeletal disease
Fundus Albipunctatus	MESH:C562733	DO:DOID:11105|OMIM:136880		MESH:D012164	C11.768/C562733	C11.768	Retinitis Punctata Albescens|RETINITIS PUNCTATA ALBESCENS, INCLUDED	Eye disease
Fundus Dystrophy, Pseudoinflammatory, Of Sorsby	MESH:C564992	OMIM:136900		MESH:D008268	C11.768.585.439/C564992	C11.768.585.439	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY|Macular Dystrophy, Hemorrhagic|SFD|SORSBY FUNDUS DYSTROPHY	Eye disease
Gait Apraxia	MESH:D020235	DO:DOID:4260	Impaired ambulation not attributed to sensory impairment or motor weakness. FRONTAL LOBE disorders; BASAL GANGLIA DISEASES (e.g., PARKINSONIAN DISORDERS); DEMENTIA, MULTI-INFARCT; ALZHEIMER DISEASE; and other conditions may be associated with gait apraxia.	MESH:D001072|MESH:D020233	C10.597.404.400|C10.597.606.881.350.600|C23.888.592.413.400|C23.888.592.604.882.350.600	C10.597.404|C10.597.606.881.350|C23.888.592.413|C23.888.592.604.882.350	Apraxia, Bruns' Gait|Apraxia, Frontal Gait|Apraxia, Gait|Apraxia of Gait|Apraxias, Bruns' Gait|Apraxias, Frontal Gait|Apraxias, Gait|Bruns Apraxia, Gait|Bruns' Apraxia, Gait|Bruns' Apraxia of Gait|Bruns Gait Apraxia|Bruns' Gait Apraxia|Bruns' Gait Apraxias|Dyspraxia of Gait|Frontal Gait Apraxia|Frontal Gait Apraxias|Gait Apraxia, Bruns'|Gait Apraxia, Frontal|Gait Apraxias|Gait Apraxias, Bruns'|Gait Apraxias, Frontal|Gait Dyspraxia|Gait Dyspraxias	Nervous system disease|Signs and symptoms
Gait Ataxia	MESH:D020234		Impairment of the ability to coordinate the movements required for normal ambulation (WALKING) which may result from impairments of motor function or sensory feedback. This condition may be associated with BRAIN DISEASES (including CEREBELLAR DISEASES and BASAL GANGLIA DISEASES); SPINAL CORD DISEASES; or PERIPHERAL NERVOUS SYSTEM DISEASES.	MESH:D001259|MESH:D020233	C10.597.350.090.750|C10.597.404.450|C23.888.592.350.090.600|C23.888.592.413.450	C10.597.350.090|C10.597.404|C23.888.592.350.090|C23.888.592.413	Ataxia, Cerebellar Gait|Ataxia, Gait|Ataxia of Gait|Ataxias, Cerebellar Gait|Ataxia, Sensory Gait|Ataxias, Gait|Ataxias, Sensory Gait|Cerebellar Gait|Cerebellar Gait Ataxia|Cerebellar Gait Ataxias|Cerebellar Gaits|Gait Ataxia, Cerebellar|Gait Ataxias|Gait Ataxias, Cerebellar|Gait Ataxia, Sensory|Gait Ataxias, Sensory|Gait, Cerebellar|Gaits, Cerebellar|Sensory Gait Ataxia|Sensory Gait Ataxias	Nervous system disease|Signs and symptoms
Gait Disorders, Neurologic	MESH:D020233		Gait abnormalities that are a manifestation of nervous system dysfunction. These conditions may be caused by a wide variety of disorders which affect motor control, sensory feedback, and muscle strength including: CENTRAL NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or MUSCULAR DISEASES.	MESH:D009461	C10.597.404|C23.888.592.413	C10.597|C23.888.592	Ambulation Disorder, Neurologic|Ambulation Disorders, Neurologic|Athetotic Gait|Broadened Gait|Charcot Gait|Charcot Gaits|Charcot's Gait|Charcots Gait|Drop Foot Gait|Duck Gait|Festinating Gait|Foot Gait, Drop|Frontal Gait|Gait, Athetotic|Gait, Broadened|Gait, Charcot|Gait, Charcot's|Gait Disorder, Neurologic|Gait Disorder, Sensorimotor|Gait Disorders, Sensorimotor|Gait, Drop Foot|Gait, Duck|Gait Dysfunction, Neurologic|Gait Dysfunctions, Neurologic|Gait, Festinating|Gait, Frontal|Gait, Hemiplegic|Gait, Hysterical|Gait, Reeling|Gait, Rigid|Gaits, Charcot|Gait, Scissors|Gait, Shuffling|Gait, Spastic|Gait, Stumbling|Gait, Unsteady|Gait, Widebased|Hemiplegic Gait|Hysterical Gait|Locomotion Disorder, Neurologic|Locomotion Disorders, Neurologic|Marche a Petit Pas|Neurologic Ambulation Disorder|Neurologic Ambulation Disorders|Neurologic Gait Disorder|Neurologic Gait Disorders|Neurologic Gait Dysfunction|Neurologic Gait Dysfunctions|Neurologic Locomotion Disorder|Neurologic Locomotion Disorders|Rapid Fatigue of Gait|Reeling Gait|Rigid Gait|Scissors Gait|Sensorimotor Gait Disorder|Sensorimotor Gait Disorders|Shuffling Gait|Shuffling Gaits|Spastic Gait|Stumbling Gait|Unsteady Gait|Widebased Gait	Nervous system disease|Signs and symptoms
Galactocele	MESH:C535998	DO:DOID:10686		MESH:D047688	C04.182.156/C535998|C17.800.090.249/C535998	C04.182.156|C17.800.090.249	Galactocoele|Galactocoele of childhood|Lacteal cyst|Lactocele	Cancer|Skin disease
Galactorrhea-Hyperprolactinemia	MESH:C535402			MESH:D005687|MESH:D006966	C10.228.140.617.738.250.450/C535402|C12.050.703.844.506.389/C535402|C17.800.090.937.439/C535402|C19.700.355.600/C535402	C10.228.140.617.738.250.450|C12.050.703.844.506.389|C17.800.090.937.439|C19.700.355.600	Galactorrhoea-Hyperprolactinaemia	Endocrine system disease|Nervous system disease|Pregnancy complication|Skin disease
GALLBLADDER DISEASE 1	OMIM:600803	DO:DOID:1949		MESH:D002764|MESH:D002769|MESH:D042882	C06.130.409/600803|C06.130.409.633/600803|C06.130.564.263/600803|C06.130.564.332.500/600803|C23.300.175.525/600803	C06.130.409|C06.130.409.633|C06.130.564.263|C06.130.564.332.500|C23.300.175.525	CHOLELITHIASIS, LOW PHOSPHOLIPID-ASSOCIATED|GBD1|LPAC	Digestive system disease|Pathology (anatomical condition)
Gallbladder Neoplasms	MESH:D005706	DO:DOID:3121	Tumors or cancer of the gallbladder.	MESH:D001661|MESH:D005705	C04.588.274.120.401|C06.130.320.401|C06.130.564.401|C06.301.120.401	C04.588.274.120|C06.130.320|C06.130.564|C06.301.120	Bladder Cancer, Gall|Bladder Cancers, Gall|Cancer, Gallbladder|Cancer, Gall Bladder|Cancer of Gallbladder|Cancer of the Gallbladder|Cancers, Gallbladder|Cancers, Gall Bladder|Gallbladder Cancer|Gall Bladder Cancer|Gallbladder Cancers|Gall Bladder Cancers|Gallbladder Neoplasm|Neoplasm, Gallbladder|Neoplasms, Gallbladder	Cancer|Digestive system disease
Gallstones	MESH:D042882		Solid crystalline precipitates in the BILIARY TRACT, usually formed in the GALLBLADDER, resulting in the condition of CHOLELITHIASIS. Gallstones, derived from the BILE, consist mainly of calcium, cholesterol, or bilirubin.	MESH:D002137|MESH:D002769|MESH:D041761	C06.130.409.633|C06.130.564.332.500|C23.300.175.525	C06.130.409|C06.130.564.332|C23.300.175	Biliary Calculi|Biliary Calculi, Common Bile Duct|Calculi, Biliary|Common Bile Duct Calculi|Common Bile Duct Gallstone|Common Bile Duct Gall Stone|Common Bile Duct Gallstones|Common Bile Duct Gall Stones|Gallstone|Gall Stone|Gall Stones|Gallstones, Common Bile Duct|Gall Stones, Common Bile Duct	Digestive system disease|Pathology (anatomical condition)
Gamma-A-Globulin, Defect in Assembly of	MESH:C564991			MESH:D017098	C15.378.147.333.500/C564991|C20.673.430.500/C564991	C15.378.147.333.500|C20.673.430.500	IgA, Defect in Assembly of|Immunoglobulin A, Defect in Assembly of	Blood disease|Immune system disease
Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to	MESH:C565557	DO:DOID:0111681|OMIM:230450		MESH:D000743	C15.378.071.141/C565557	C15.378.071.141		Blood disease
Ganglioglioma	MESH:D018303	DO:DOID:5078	Rare indolent tumors comprised of neoplastic glial and neuronal cells which occur primarily in children and young adults. Benign lesions tend to be associated with long survival unless the tumor degenerates into a histologically malignant form. They tend to occur in the optic nerve and white matter of the brain and spinal cord.	MESH:D005910	C04.557.465.625.600.380.350|C04.557.470.670.380.350|C04.557.580.625.600.380.350	C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380	Benign Ganglioglioma|Benign Gangliogliomas|Ganglioglioma, Benign|Ganglioglioma, Intracranial|Ganglioglioma, Malignant|Gangliogliomas|Gangliogliomas, Benign|Gangliogliomas, Intracranial|Gangliogliomas, Malignant|Intracranial Ganglioglioma|Intracranial Gangliogliomas|Malignant Ganglioglioma|Malignant Gangliogliomas	Cancer
Ganglion Cysts	MESH:D045888		Nodular tumor-like lesions or mucoid flesh, arising from tendon sheaths, LIGAMENTS, or JOINT CAPSULE, especially of the hands, wrists, or feet. They are not true cysts as they lack epithelial wall. They are distinguished from SYNOVIAL CYSTS by the lack of communication with a joint cavity or the SYNOVIAL MEMBRANE.	MESH:D003560|MESH:D017520	C04.182.347|C17.300.550.274	C04.182|C17.300.550	Cyst, Ganglion|Cyst, Ganglionic|Cyst, Myxoid|Cysts, Ganglion|Cysts, Ganglionic|Cysts, Myxoid|Ganglion|Ganglion Cyst|Ganglionic Cyst|Ganglionic Cysts|Ganglions|Myxoid Cyst|Myxoid Cysts	Cancer|Connective tissue disease
Ganglioneuroblastoma	MESH:D018305	DO:DOID:4163	A moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. It may undergo transformation into a neuroblastoma. It arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. Cervical ganglioneuroblastomas may be associated with HORNER SYNDROME and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.	MESH:D009447	C04.557.465.625.600.590.650.550.300|C04.557.470.670.590.650.550.300|C04.557.580.625.600.590.650.550.300	C04.557.465.625.600.590.650.550|C04.557.470.670.590.650.550|C04.557.580.625.600.590.650.550	Ganglioneuroblastomas	Cancer
Ganglioneuroma	MESH:D005729	DO:DOID:2426|DO:DOID:4817	A benign neoplasm that usually arises from the sympathetic trunk in the mediastinum. Histologic features include spindle cell proliferation (resembling a neurofibroma) and the presence of large ganglion cells. The tumor may present clinically with HORNER SYNDROME or diarrhea due to ectopic production of vasoactive intestinal peptide. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p966)	MESH:D018302	C04.557.465.625.600.355|C04.557.470.670.355|C04.557.580.625.600.355	C04.557.465.625.600|C04.557.470.670|C04.557.580.625.600	Gangliocytoma|Gangliocytomas|Ganglioneuromas	Cancer
Gardner-Diamond syndrome	MESH:C535645			MESH:D001327|MESH:D005162|MESH:D011618|MESH:D017445	C17.800.862/C535645|C20.111/C535645|F03.700.675/C535645|F03.875.375/C535645	C17.800.862|C20.111|F03.700.675|F03.875.375	Autoerythrocyte sensitization|Psychogenic purpura	Immune system disease|Mental disorder|Skin disease
Gardner Morrisson Abbot syndrome	MESH:C535643			MESH:D000015|MESH:D013921	C15.378.140.855/C535643|C16.131.077/C535643	C15.378.140.855|C16.131.077	Thrombocytopenia multiple congenital anomaly	Blood disease|Congenital abnormality
Gas Poisoning	MESH:D005739		Poisoning that results from exposure to gases such as CARBON MONOXIDE; NOBLE GASES; OXYGEN; or NATURAL GAS.	MESH:D011041	C25.723.455	C25.723	Gas Poisonings|Poisoning, Gas|Poisonings, Gas	
Gastric Antral Vascular Ectasia	MESH:D020252	DO:DOID:2493	A distinct vascular lesion in the PYLORIC ANTRUM that is characterized by tortuous dilated blood vessels (ectasia) radiating outward from the PYLORUS. The vessel pattern resembles the stripes on the surface of a watermelon. This lesion causes both acute and chronic GASTROINTESTINAL HEMORRHAGE.	MESH:D013272|MESH:D016888	C06.405.748.280|C14.907.075.280	C06.405.748|C14.907.075	Antral Vascular Ectasia|Antral Vascular Ectasias|Ectasia, Antral Vascular|Ectasias, Antral Vascular|Stomachs, Watermelon|Stomach, Watermelon|Vascular Ectasia, Antral|Vascular Ectasias, Antral|Watermelon Stomach|Watermelon Stomachs	Cardiovascular disease|Digestive system disease
Gastric Fistula	MESH:D005747		Abnormal passage communicating with the STOMACH.	MESH:D016154	C06.267.375|C23.300.575.185.375	C06.267|C23.300.575.185	Fistula, Gastric|Fistula, Stomach|Stomach Fistula	Digestive system disease|Pathology (anatomical condition)
Gastric Volvulus, Intrathoracic	MESH:C564989			MESH:D006551|MESH:D013277	C06.405.748.895/C564989|C23.300.707.960.500.467/C564989	C06.405.748.895|C23.300.707.960.500.467		Digestive system disease|Pathology (anatomical condition)
Gastrinoma	MESH:D015408	DO:DOID:5577	A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1).	MESH:D018273	C04.557.470.200.025.290.500|C04.588.274.761.500.124|C04.588.322.475.500.124|C06.301.761.500.124|C06.689.667.500.124|C19.344.421.500.124	C04.557.470.200.025.290|C04.588.274.761.500|C04.588.322.475.500|C06.301.761.500|C06.689.667.500|C19.344.421.500	Gastrinomas|Gastrin Producing Tumor|Gastrin-Producing Tumor|Gastrin-Producing Tumors|Islet Cell Tumor, Ulcerogenic|Tumor, Gastrin-Producing|Tumors, Gastrin-Producing|Ulcerogenic Islet Cell Tumor	Cancer|Digestive system disease|Endocrine system disease
Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650			MESH:D007414|MESH:D010190|MESH:D013274|MESH:D018358	C04.557.465.625.650/C535650|C04.557.580.625.650/C535650|C04.588.274.476.411/C535650|C04.588.274.476.767/C535650|C04.588.274.761/C535650|C04.588.322.475/C535650|C06.301.371.411/C535650|C06.301.371.767/C535650|C06.301.761/C535650|C06.405.249.411/C535650|C06.405.249.767/C535650|C06.405.469.491/C535650|C06.405.748.789/C535650|C06.689.667/C535650|C19.344.421/C535650	C04.557.465.625.650|C04.557.580.625.650|C04.588.274.476.411|C04.588.274.476.767|C04.588.274.761|C04.588.322.475|C06.301.371.411|C06.301.371.767|C06.301.761|C06.405.249.411|C06.405.249.767|C06.405.469.491|C06.405.748.789|C06.689.667|C19.344.421	Gastroenteropancreatic neuroendocrine tumor|GEP neuroendocrine tumor	Cancer|Digestive system disease|Endocrine system disease
Gastrointestinal Hemorrhage	MESH:D006471		Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.	MESH:D005767|MESH:D006470	C06.405.227|C23.550.414.788	C06.405|C23.550.414	Gastrointestinal Hemorrhages|Hematochezia|Hematochezias|Hemorrhage, Gastrointestinal	Digestive system disease|Pathology (process)
Gastrointestinal Neoplasms	MESH:D005770	DO:DOID:3119	Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.	MESH:D004067|MESH:D005767	C04.588.274.476|C06.301.371|C06.405.249	C04.588.274|C06.301|C06.405	Cancer, Gastrointestinal|Cancer of Gastrointestinal Tract|Cancer of the Gastrointestinal Tract|Cancers, Gastrointestinal|Gastrointestinal Cancer|Gastrointestinal Cancers|Gastrointestinal Neoplasm|Gastrointestinal Tract Cancer|Gastrointestinal Tract Cancers|Neoplasm, Gastrointestinal|Neoplasms, Gastrointestinal	Cancer|Digestive system disease
Gastrointestinal Stromal Tumors	MESH:D046152	DO:DOID:9253|OMIM:606764	All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).	MESH:D005770|MESH:D009372	C04.557.450.565.370|C06.301.371.308|C06.405.249.308	C04.557.450.565|C06.301.371|C06.405.249	Gastrointestinal Stromal Neoplasm|Gastrointestinal Stromal Neoplasms|Gastrointestinal Stromal Sarcoma|Gastrointestinal Stromal Tumor|GIST|Neoplasm, Gastrointestinal Stromal|Neoplasms, Gastrointestinal Stromal|Stromal Neoplasm, Gastrointestinal|Stromal Neoplasms, Gastrointestinal|Stromal Tumor, Gastrointestinal|Stromal Tumors, Gastrointestinal|Tumor, Gastrointestinal Stromal|Tumors, Gastrointestinal Stromal	Cancer|Digestive system disease
Gastroparesis	MESH:D018589	DO:DOID:11914	Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.	MESH:D010243|MESH:D013272	C06.405.748.543|C23.888.592.636.263	C06.405.748|C23.888.592.636	Gastric Stases|Gastric Stasis|Gastropareses|Stases, Gastric|Stasis, Gastric	Digestive system disease|Signs and symptoms
Gaze Palsy, Familial Horizontal, with Progressive Scoliosis	MESH:C564593	OMIM:607313		MESH:D012600|MESH:D017246	C05.116.900.800.875/C564593|C05.651.460.700/C564593|C10.292.562.750.250/C564593|C10.597.622.447.511/C564593|C10.668.491.500.700/C564593|C11.590.472.250/C564593|C18.452.660.560.700/C564593|C23.550.291.500.688/C564593|C23.888.592.636.447.511/C564593	C05.116.900.800.875|C05.651.460.700|C10.292.562.750.250|C10.597.622.447.511|C10.668.491.500.700|C11.590.472.250|C18.452.660.560.700|C23.550.291.500.688|C23.888.592.636.447.511	Familial Horizontal Gaze Palsy with Progressive Scoliosis|Familial Idiopathic Scoliosis Associated with Congenital Encephalopathy|Familial Infantile Scoliosis Associated with Bilateral Paralysis of Conjugate Gaze|GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1|Hgpps|HGPPS1|HGPPS OPHTHALMOPLEGIA, PROGRESSIVE EXTERNAL, AND SCOLIOSIS, INCLUDED|Horizontal Gaze Palsy with Progressive Scoliosis|Ophthalmoplegia, Progressive External, and Scoliosis	Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Generalized Epilepsy and Paroxysmal Dyskinesia	MESH:C563719	OMIM:609446		MESH:D002819|MESH:D004829	C10.228.140.490.375/C563719|C10.228.662.262.249/C563719|C10.597.350.250/C563719|C23.888.592.350.250/C563719	C10.228.140.490.375|C10.228.662.262.249|C10.597.350.250|C23.888.592.350.250	Epilepsy, Generalized, with Paroxysmal Dyskinesia|GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA|GEPD|PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY|PNKD3	Nervous system disease|Signs and symptoms
Generalized Epilepsy with Febrile Seizures Plus	MESH:C565808			MESH:D003294|MESH:D004829	C10.228.140.490.375/C565808|C10.597.742.571/C565808|C23.888.592.742.571/C565808	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571		Nervous system disease|Signs and symptoms
Generalized Epilepsy With Febrile Seizures Plus, 7	MESH:C567827			MESH:D003294|MESH:D004829	C10.228.140.490.375/C567827|C10.597.742.571/C567827|C23.888.592.742.571/C567827	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	GEFSP7|Generalized Epilepsy With Febrile Seizures Plus, Type 7	Nervous system disease|Signs and symptoms
Generalized Epilepsy With Febrile Seizures Plus, Type 1	MESH:C565809	OMIM:604233		MESH:D003294|MESH:D004829	C10.228.140.490.375/C565809|C10.597.742.571/C565809|C23.888.592.742.571/C565809	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	GEFS+1|GEFSP1|GEFS, Type 1|GEFS+, TYPE 1	Nervous system disease|Signs and symptoms
Generalized Epilepsy With Febrile Seizures Plus, Type 2	MESH:C565810	OMIM:604403		MESH:D003294|MESH:D004829	C10.228.140.490.375/C565810|C10.597.742.571/C565810|C23.888.592.742.571/C565810	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	FEB3A, INCLUDED|GEFSP2|GEFS, Type 2|GEFS+, TYPE 2;GEFS+2 FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED	Nervous system disease|Signs and symptoms
Generalized Epilepsy With Febrile Seizures Plus, Type 3	MESH:C565811			MESH:D003294|MESH:D004829	C10.228.140.490.375/C565811|C10.597.742.571/C565811|C23.888.592.742.571/C565811	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	GEFSP3|GEFS, Type 3	Nervous system disease|Signs and symptoms
Generalized Epilepsy With Febrile Seizures Plus, Type 4	MESH:C565227	OMIM:609800		MESH:D003294|MESH:D004829	C10.228.140.490.375/C565227|C10.597.742.571/C565227|C23.888.592.742.571/C565227	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	GEFS+4|GEFSP4|GEFSP, Type 4|GEFS+, TYPE 4	Nervous system disease|Signs and symptoms
Generalized Epilepsy With Febrile Seizures Plus, Type 5	MESH:C565812			MESH:D003294|MESH:D004829	C10.228.140.490.375/C565812|C10.597.742.571/C565812|C23.888.592.742.571/C565812	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	GEFSP5|GEFS, Type 5	Nervous system disease|Signs and symptoms
Generalized Epilepsy With Febrile Seizures Plus, Type 6	MESH:C567371	OMIM:612279		MESH:D003294|MESH:D004829	C10.228.140.490.375/C567371|C10.597.742.571/C567371|C23.888.592.742.571/C567371	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	GEFS+6|GEFSP6|GEFS, Type 6|GEFS+, TYPE 6	Nervous system disease|Signs and symptoms
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7	OMIM:613863	DO:DOID:0111295		MESH:D003294|MESH:D004829	C10.228.140.490.375/613863|C10.597.742.571/613863|C23.888.592.742.571/613863	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	FEB3B, INCLUDED|GEFSP7|GEFS+, TYPE 7;GEFS+7 FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED	Nervous system disease|Signs and symptoms
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 8	OMIM:613828	DO:DOID:0111299		MESH:D003294|MESH:D004829	C10.228.140.490.375/613828|C10.597.742.571/613828|C23.888.592.742.571/613828	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	GEFS+8|GEFSP8|GEFS+, TYPE 8	Nervous system disease|Signs and symptoms
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9	OMIM:616172	DO:DOID:0111301		MESH:D003294|MESH:D004829	C10.228.140.490.375/616172|C10.597.742.571/616172|C23.888.592.742.571/616172	C10.228.140.490.375|C10.597.742.571|C23.888.592.742.571	GEFS+9|GEFSP9|GEFS+, TYPE 9	Nervous system disease|Signs and symptoms
Geniospasm	MESH:C537682	OMIM:190100		MESH:D007571|MESH:D014202	C05.500/C537682|C07.320/C537682|C10.597.350.850/C537682|C23.888.592.350.850/C537682	C05.500|C07.320|C10.597.350.850|C23.888.592.350.850	Geniospasm 1|GSM1|Hereditary geniospasm|Trembling chin	Mouth disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Genital Diseases	MESH:D000091662		Pathological processes involving the reproductive tract (GENITALIA).	MESH:D000091642	C12.100	C12	Disease, Genital|Diseases, Genital|Genital Disease	
Genital Diseases, Female	MESH:D005831	DO:DOID:229	Pathological processes involving the female reproductive tract (GENITALIA, FEMALE).	MESH:D000091662|MESH:D052776	C12.050.351.500|C12.100.250	C12.050.351|C12.100	Diseases, Female Genital|Diseases, Gynecologic|Female Genital Disease|Female Genital Diseases|Genital Disease, Female|Gynecologic Disease|Gynecologic Diseases	Urogenital disease (female)
Genital Neoplasms, Female	MESH:D005833	DO:DOID:120	Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).	MESH:D014565	C04.588.945.418|C12.050.351.937.418|C12.900.418	C04.588.945|C12.050.351.937|C12.900	Female Genital Neoplasm|Female Genital Neoplasms|Genital Neoplasm, Female|Gynecologic Neoplasm|Gynecologic Neoplasms|Neoplasm, Female Genital|Neoplasm, Gynecologic|Neoplasms, Female Genital|Neoplasms, Gynecologic	Cancer|Urogenital disease (female)
Genital Neoplasms, Male	MESH:D005834	DO:DOID:3856	Tumor or cancer of the MALE GENITALIA.	MESH:D005832|MESH:D014565	C04.588.945.440|C12.100.500.260|C12.200.294.260|C12.200.758.409|C12.900.619	C04.588.945|C12.100.500|C12.200.294|C12.200.758|C12.900	Genital Neoplasm, Male|Male Genital Neoplasm|Male Genital Neoplasms|Neoplasm, Male Genital|Neoplasms, Male Genital	Cancer|Urogenital disease (male)
Genito palato cardiac syndrome	MESH:C537683			MESH:D002972|MESH:D006061|MESH:D006330|MESH:D008844	C05.500.460.185/C537683|C05.500.460.457/C537683|C05.660.207.540.460.185/C537683|C05.660.207.540.460.457/C537683|C07.320.440.185/C537683|C07.320.440.457/C537683|C07.465.525.185/C537683|C07.650.500.460.185/C537683|C07.650.500.460.457/C537683|C07.650.525.185/C537683|C12.050.351.875.253.096.687/C537683|C12.050.351.875.253.309.388/C537683|C12.200.706.316.096.687/C537683|C12.200.706.316.309.388/C537683|C12.800.316.096.687/C537683|C12.800.316.309.388/C537683|C14.240.400/C537683|C14.280.400/C537683|C16.131.240.400/C537683|C16.131.621.207.540.460.185/C537683|C16.131.621.207.540.460.457/C537683|C16.131.850.500.460.185/C537683|C16.131.850.500.460.457/C537683|C16.131.850.525.185/C537683|C16.131.939.316.096.687/C537683|C16.131.939.316.309.388/C537683|C19.391.119.096.687/C537683|C19.391.119.309.388/C537683	C05.500.460.185|C05.500.460.457|C05.660.207.540.460.185|C05.660.207.540.460.457|C07.320.440.185|C07.320.440.457|C07.465.525.185|C07.650.500.460.185|C07.650.500.460.457|C07.650.525.185|C12.050.351.875.253.096.687|C12.050.351.875.253.309.388|C12.200.706.316.096.687|C12.200.706.316.309.388|C12.800.316.096.687|C12.800.316.309.388|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.540.460.185|C16.131.621.207.540.460.457|C16.131.850.500.460.185|C16.131.850.500.460.457|C16.131.850.525.185|C16.131.939.316.096.687|C16.131.939.316.309.388|C19.391.119.096.687|C19.391.119.309.388	Gardner-Silengo-Wachtel syndrome|Genito-palato-cardiac syndrome|Genitopalatocardiac syndrome|Male pseudohermaphroditism with micrognathia, cleft palate and conotruncal cardiac defect	Cardiovascular disease|Congenital abnormality|Endocrine system disease|Mouth disease|Musculoskeletal disease|Urogenital disease (female)|Urogenital disease (male)
Genu Valgum	MESH:D056304		An inward slant of the thigh in which the knees are close together and the ankles far apart. Genu valgum can develop due to skeletal and joint dysplasias (e.g., OSTEOARTHRITIS; HURLER SYNDROME); and malnutrition (e.g., RICKETS; FLUORIDE POISONING).	MESH:D001847	C05.116.482	C05.116	Genu Valga|Genu Valgas|Genu Valgums|Knees, Knock|Knock Knee|Knock Knees|Valga, Genu|Valgas, Genu	Musculoskeletal disease
Genu valgum, st Helena familial	MESH:C537685			MESH:D056304	C05.116.482/C537685	C05.116.482	Genu valgum, hereditary pubertal|Genu Valgum, St. Helena Familial|Hereditary pubertal genu valgum|St. Helena familial genu valgum	Musculoskeletal disease
Genu Varum	MESH:D056305		An outward slant of the thigh in which the knees are wide apart and the ankles close together. Genu varum can develop due to skeletal and joint dysplasia (e.g., OSTEOARTHRITIS; Blount's disease); and malnutrition (e.g., RICKETS; FLUORIDE POISONING).	MESH:D001847	C05.116.511	C05.116	Bow Leg|Bow Legs|Genu Varus|Leg, Bow|Legs, Bow	Musculoskeletal disease
Geographic Atrophy	MESH:D057092		A form of MACULAR DEGENERATION also known as dry macular degeneration marked by occurrence of a well-defined progressive lesion or atrophy in the central part of the RETINA called the MACULA LUTEA. It is distinguishable from WET MACULAR DEGENERATION in that the latter involves neovascular exudates.	MESH:D008268	C11.768.585.439.122	C11.768.585.439	Atrophies, Geographic|Atrophy, Geographic|Degeneration, Dry Macular|Degenerations, Dry Macular|Dry Macular Degeneration|Dry Macular Degenerations|Geographic Atrophies|Macular Degeneration, Dry|Macular Degenerations, Dry	Eye disease
Germinoma	MESH:D018237	DO:DOID:3304	A malignant neoplasm of the germinal tissue of the GONADS; MEDIASTINUM; or pineal region. Germinomas are uniform in appearance, consisting of large, round cells with vesicular nuclei and clear or finely granular eosinophilic-staining cytoplasm. (Stedman, 265th ed; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1642-3)	MESH:D009373	C04.557.465.330	C04.557.465	Germinomas	Cancer
Gerstmann Syndrome	MESH:D005862	DO:DOID:4969	A disorder of cognition characterized by the tetrad of finger agnosia, dysgraphia, DYSCALCULIA, and right-left disorientation. The syndrome may be developmental or acquired. Acquired Gerstmann syndrome is associated with lesions in the dominant (usually left) PARIETAL LOBE which involve the angular gyrus or subjacent white matter. (From Adams et al., Principles of Neurology, 6th ed, p457)	MESH:D000377	C10.597.606.762.100.300|C23.888.592.604.764.100.300	C10.597.606.762.100|C23.888.592.604.764.100	Acquired Gerstmann's Syndrome|Acquired Gerstmann Syndrome|de Gerstmann, Syndrome|Developmental Gerstmann's Syndrome|Developmental Gerstmanns Syndrome|Developmental Gerstmann Syndrome|Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphia|Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphias|Gerstmann Badal Syndrome|Gerstmann-Badal Syndrome|Gerstmann's Syndrome|Gerstmann's Syndrome, Acquired|Gerstmann's Syndrome, Developmental|Gerstmann Syndrome 2|Gerstmann Syndrome, Acquired|Gerstmann, Syndrome de|Gerstmann Syndrome, Developmental|Syndrome, Acquired Gerstmann|Syndrome, Acquired Gerstmann's|Syndrome de Gerstmann|Syndrome, Developmental Gerstmann|Syndrome, Gerstmann|Syndrome, Gerstmann-Badal	Nervous system disease|Signs and symptoms
Gestational Diabetes Insipidus	MESH:C548014			MESH:D003919	C12.050.351.968.419.135/C548014|C12.200.777.419.135/C548014|C12.950.419.135/C548014|C19.700.159/C548014	C12.050.351.968.419.135|C12.200.777.419.135|C12.950.419.135|C19.700.159		Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Gestational Trophoblastic Disease	MESH:D031901	DO:DOID:3590	A group of diseases arising from pregnancy that are commonly associated with hyperplasia of trophoblasts (TROPHOBLAST) and markedly elevated human CHORIONIC GONADOTROPIN. They include HYDATIDIFORM MOLE, invasive mole (HYDATIDIFORM MOLE, INVASIVE), placental-site trophoblastic tumor (TROPHOBLASTIC TUMOR, PLACENTAL SITE), and CHORIOCARCINOMA. These neoplasms have varying propensities for invasion and spread.	MESH:D014328	C04.557.465.955.416|C04.850.908.416|C12.050.703.720.949.416	C04.557.465.955|C04.850.908|C12.050.703.720.949	Disease, Gestational Trophoblastic|Diseases, Gestational Trophoblastic|Gestational Trophoblastic Diseases|Gestational Trophoblastic Neoplasia|Gestational Trophoblastic Neoplasm|Gestational Trophoblastic Neoplasms|Neoplasia, Gestational Trophoblastic|Neoplasm, Gestational Trophoblastic|Neoplasms, Gestational Trophoblastic|Trophoblastic Disease, Gestational|Trophoblastic Diseases, Gestational|Trophoblastic Neoplasia, Gestational|Trophoblastic Neoplasm, Gestational|Trophoblastic Neoplasms, Gestational	Cancer|Pregnancy complication
Giant Cell Arteritis	MESH:D013700	DO:DOID:13375	A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)	MESH:D001167|MESH:D017445|MESH:D020293	C10.114.875.700|C10.228.140.300.850.500|C14.907.253.946.700|C14.907.940.090.530|C14.907.940.907.700|C17.800.862.252|C20.111.258.962.800	C10.114.875|C10.228.140.300.850|C14.907.253.946|C14.907.940.090|C14.907.940.907|C17.800.862|C20.111.258.962	Aortic Arteritis, Giant Cell|Aortitides, Giant Cell|Aortitis, Giant Cell|Arteritides, Cranial|Arteritides, Giant Cell|Arteritides, Juvenile Temporal|Arteritides, Temporal|Arteritis, Cranial|Arteritis, Giant Cell|Arteritis, Giant Cell, Horton|Arteritis, Giant Cell, Horton's|Arteritis, Juvenile Temporal|Arteritis, Temporal|Cranial Arteritides|Cranial Arteritis|Giant Cell Aortic Arteritis|Giant Cell Aortitides|Giant Cell Aortitis|Giant Cell Aortitis, Horton's|Giant Cell Arteritides|Giant Cell Arteritis, Horton|Horton Disease|Horton Giant Cell Arteritis|Horton's Disease|Hortons Disease|Horton's Giant Cell Arteritis|Juvenile Temporal Arteritides|Juvenile Temporal Arteritis|Temporal Arteritides|Temporal Arteritides, Juvenile|Temporal Arteritis|Temporal Arteritis, Juvenile	Cardiovascular disease|Immune system disease|Nervous system disease|Skin disease
Giant Cell Tumor of Bone	MESH:D018212	DO:DOID:4305	A bone tumor composed of cellular spindle-cell stroma containing scattered multinucleated giant cells resembling osteoclasts. The tumors range from benign to frankly malignant lesions. The tumor occurs most frequently in an end of a long tubular bone in young adults. (From Dorland, 27th ed; Stedman, 25th ed)	MESH:D005870|MESH:D018213	C04.557.450.565.380.380|C04.557.450.565.575.420	C04.557.450.565.380|C04.557.450.565.575		Cancer
Giant Cell Tumor of Tendon Sheath	MESH:D000070779	DO:DOID:2701|DO:DOID:314	A tumor arising in the SYNOVIAL MEMBRANE; SYNOVIAL BURSA; or TENDON sheath. It is characterized by OSTEOCLAST-like GIANT CELLS; FOAM CELLS; pigmented HEMOSIDERIN-laden MACROPHAGES and inflammatory infiltrate. It is classified either as diffuse or localized tenosynovitis.	MESH:D005870|MESH:D013585|MESH:D052256	C04.557.450.565.380.690|C05.550.870.445|C05.651.869.762	C04.557.450.565.380|C05.550.870|C05.651.869	Fibrous Histiocytoma of Tendon Sheath|Localized Giant Cell Tumor of the Tendon Sheath|Localized Nodular Tenosynovitides|Localized Nodular Tenosynovitis|Localized Pigmented Villonodular Synovitis|Nodular Tenosynovitides|Nodular Tenosynovitides, Localized|Nodular Tenosynovitis|Nodular Tenosynovitis, Localized|Tenosynovial Giant Cell Tumor|Tenosynovitides, Localized Nodular|Tenosynovitides, Nodular|Tenosynovitis, Localized Nodular|Tenosynovitis, Nodular	Cancer|Musculoskeletal disease
Giant Cell Tumors	MESH:D005870	DO:DOID:200	Tumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE.	MESH:D009372	C04.557.450.565.380	C04.557.450.565	Cell Tumor, Giant|Cell Tumors, Giant|Giant Cell Tumor|Tumor, Giant Cell|Tumors, Giant Cell	Cancer
Giant mammary hamartoma	MESH:C536818			MESH:D006222	C04.445/C536818	C04.445	Giant hamartoma of the breast	Cancer
Giant Platelet Syndrome with Thrombocytopenia	MESH:C564237			MESH:D013921	C15.378.140.855/C564237	C15.378.140.855		Blood disease
Giardiasis	MESH:D005873	DO:DOID:10718	An infection of the SMALL INTESTINE caused by the flagellated protozoan GIARDIA. It is spread via contaminated food and water and by direct person-to-person contact.	MESH:D007411|MESH:D011528	C01.610.432.481|C01.610.752.400|C06.405.469.452.481	C01.610.432|C01.610.752|C06.405.469.452	Giardia duodenalis Infection|Giardia duodenalis Infections|Giardia Infection|Giardia Infections|Giardia intestinalis Infection|Giardia intestinalis Infections|Giardia lamblia Infection|Giardia lamblia Infections|Giardiases|Infection, Giardia|Infection, Giardia duodenalis|Infection, Giardia intestinalis|Infection, Giardia lamblia|Infections, Giardia|Infections, Giardia duodenalis|Infections, Giardia intestinalis|Infections, Giardia lamblia|Lambliases|Lambliasis	Digestive system disease|Parasitic disease
Gigantiform Cementoma, Familial	MESH:C563017			MESH:D002485|MESH:D007573	C04.557.695.210/C563017|C04.588.149.721.450/C563017|C05.116.231.754.450/C563017|C05.500.499/C563017|C07.320.515/C563017	C04.557.695.210|C04.588.149.721.450|C05.116.231.754.450|C05.500.499|C07.320.515	Cemental Dysplasia, Periapical|Cementomas, Familial Multiple	Cancer|Mouth disease|Musculoskeletal disease
Gigantism	MESH:D005877		The condition of accelerated and excessive GROWTH in children or adolescents who are exposed to excess HUMAN GROWTH HORMONE before the closure of EPIPHYSES. It is usually caused by somatotroph hyperplasia or a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. These patients are of abnormally tall stature, more than 3 standard deviations above normal mean height for age.	MESH:D001848|MESH:D001849|MESH:D006964	C05.116.099.492|C05.116.132.479|C19.700.355.528	C05.116.099|C05.116.132|C19.700.355	Gigantism, Pituitary|Pituitary Gigantism	Endocrine system disease|Musculoskeletal disease
Gingival Hemorrhage	MESH:D005884		The flowing of blood from the marginal gingival area, particularly the sulcus, seen in such conditions as GINGIVITIS, marginal PERIODONTITIS, injury, and ASCORBIC ACID DEFICIENCY.	MESH:D005882|MESH:D006472	C07.465.625.446|C07.465.714.258.250|C23.550.414.922.500	C07.465.625|C07.465.714.258|C23.550.414.922	Gingival Hemorrhages|Hemorrhage, Gingival	Mouth disease|Pathology (process)
Gingival Neoplasms	MESH:D005887	DO:DOID:7280	New abnormal growth of tissue in the GINGIVA.	MESH:D005882|MESH:D009062	C04.588.443.591.402|C07.465.530.402|C07.465.714.258.409	C04.588.443.591|C07.465.530|C07.465.714.258	Congenital Epulides|Congenital Epulis|Epulides, Congenital|Epulis, Congenital|Gingival Neoplasm|Neoplasm, Gingival|Neoplasms, Gingival	Cancer|Mouth disease
Glassy cell carcinoma of the cervix	MESH:C536823			MESH:D002583	C04.588.945.418.948.850/C536823|C12.050.351.500.852.593.131/C536823|C12.050.351.500.852.762.850/C536823|C12.050.351.937.418.875.850/C536823|C12.100.250.852.593.131/C536823|C12.100.250.852.762.850/C536823|C12.900.418.875.850/C536823	C04.588.945.418.948.850|C12.050.351.500.852.593.131|C12.050.351.500.852.762.850|C12.050.351.937.418.875.850|C12.100.250.852.593.131|C12.100.250.852.762.850|C12.900.418.875.850	Glassy cell adenocarcinoma of the uterine cervix	Cancer|Urogenital disease (female)
Glaucoma	MESH:D005901	DO:DOID:1686	An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)	MESH:D009798	C11.525.381	C11.525	Glaucomas	Eye disease
Glaucoma 1, Open Angle, A	MESH:C564234	OMIM:137750		MESH:D005902	C11.525.381.407/C564234	C11.525.381.407	Glaucoma, Primary Open Angle, Juvenile-Onset, 1|GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET, 1;JOAG1 GLAUCOMA 1, OPEN ANGLE, L, INCLUDED|GLC1A|GLC1L, INCLUDED	Eye disease
GLAUCOMA 1, OPEN ANGLE, B	OMIM:606689	DO:DOID:1067		MESH:D005902	C11.525.381.407/606689	C11.525.381.407	GLC1B	Eye disease
Glaucoma 1, Open Angle, C	MESH:C566641			MESH:D005902	C11.525.381.407/C566641	C11.525.381.407		Eye disease
Glaucoma 1, Open Angle, D	MESH:C566551	OMIM:602429		MESH:D005902	C11.525.381.407/C566551	C11.525.381.407	GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET|GLC1D	Eye disease
Glaucoma 1, Open Angle, E	MESH:C564233			MESH:D005902	C11.525.381.407/C564233	C11.525.381.407		Eye disease
Glaucoma 1, Open Angle, F	MESH:C566383	OMIM:603383		MESH:D005902	C11.525.381.407/C566383	C11.525.381.407	GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET|GLC1F	Eye disease
Glaucoma 1, Open Angle, G	MESH:C563692	OMIM:609887		MESH:D005902	C11.525.381.407/C563692	C11.525.381.407	GLC1G	Eye disease
Glaucoma 1, Open Angle, H	MESH:C566976	OMIM:611276		MESH:D005902	C11.525.381.407/C566976	C11.525.381.407	GLC1H	Eye disease
Glaucoma 1, Open Angle, I	MESH:C565724	OMIM:609745		MESH:D005902	C11.525.381.407/C565724	C11.525.381.407	GLC1I	Eye disease
Glaucoma 1, Open Angle, J	MESH:C563874	OMIM:608695		MESH:D005902	C11.525.381.407/C563874	C11.525.381.407	Glaucoma, Primary Open Angle, Juvenile-Onset, 2|GLC1J|JOAG2	Eye disease
Glaucoma 1, Open Angle, K	MESH:C563873	OMIM:608696		MESH:D005902	C11.525.381.407/C563873	C11.525.381.407	Glaucoma, Primary Open Angle, Juvenile-Onset, 3|GLC1K|JOAG3	Eye disease
Glaucoma 1, Open Angle, M	MESH:C566436	OMIM:610535		MESH:D005902	C11.525.381.407/C566436	C11.525.381.407	GLC1M	Eye disease
Glaucoma 1, Open Angle, N	MESH:C566977	OMIM:611274		MESH:D005902	C11.525.381.407/C566977	C11.525.381.407	GLC1N	Eye disease
Glaucoma 1, Open Angle, O	MESH:C567753	OMIM:613100		MESH:D005901	C11.525.381/C567753	C11.525.381	Glc1o|Primary Open Angle Glaucoma-1O	Eye disease
GLAUCOMA 1, PRIMARY OPEN ANGLE, C	OMIM:601682			MESH:D005902	C11.525.381.407/601682	C11.525.381.407	GLC1C	Eye disease
Glaucoma 3, Primary Congenital, A	MESH:C565547	OMIM:231300		MESH:D005901	C11.525.381/C565547	C11.525.381	BUPHTHALMOS GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET, INCLUDED|GLAUCOMA, CONGENITAL|GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET, INCLUDED|GLC3|GLC3A	Eye disease
GLAUCOMA 3, PRIMARY CONGENITAL, C	OMIM:613085	DO:DOID:0050593		MESH:D005901	C11.525.381/613085	C11.525.381	GLC3C	Eye disease
Glaucoma 3, Primary Congenital, D	MESH:C567765	OMIM:613086		MESH:D005901	C11.525.381/C567765	C11.525.381	Glc3d	Eye disease
GLAUCOMA 3, PRIMARY CONGENITAL, E	OMIM:617272			MESH:D005901	C11.525.381/617272	C11.525.381	GLC3E	Eye disease
Glaucoma 3, primary infantile, B	MESH:C536824	OMIM:600975		MESH:D005901	C11.525.381/C536824	C11.525.381	Glaucoma, primary congenital, type 3B|Glaucoma, Primary Congenital, Type B|GLC3B|GLC3, TYPE B|Primary congenital glaucoma type 3B	Eye disease
Glaucoma and Sleep Apnea	MESH:C564232			MESH:D005901|MESH:D012891	C08.618.085.852/C564232|C10.886.425.800.750/C564232|C11.525.381/C564232	C08.618.085.852|C10.886.425.800.750|C11.525.381		Eye disease|Nervous system disease|Respiratory tract disease
Glaucoma, Angle-Closure	MESH:D015812	DO:DOID:13550	A form of glaucoma in which the intraocular pressure increases because the angle of the anterior chamber is blocked and the aqueous humor cannot drain from the anterior chamber.	MESH:D005901	C11.525.381.056	C11.525.381	Angle Closure Glaucoma|Angle-Closure Glaucoma|Angle Closure Glaucomas|Angle-Closure Glaucomas|Closed-Angle Glaucoma|Closed-Angle Glaucomas|Glaucoma, Angle Closure|Glaucoma, Closed Angle|Glaucoma, Closed-Angle|Glaucoma, Narrow Angle|Glaucoma, Narrow-Angle|Glaucomas, Angle Closure|Glaucomas, Angle-Closure|Glaucomas, Closed-Angle|Glaucomas, Narrow-Angle|Glaucomas, Uncompensated|Glaucomas, Uncompensative|Glaucoma, Uncompensated|Glaucoma, Uncompensative|Narrow-Angle Glaucoma|Narrow-Angle Glaucomas|Uncompensated Glaucoma|Uncompensated Glaucomas|Uncompensative Glaucoma|Uncompensative Glaucomas	Eye disease
Glaucoma Iridogoniodysplasia, Familial	MESH:C566650			MESH:D005901	C11.525.381/C566650	C11.525.381		Eye disease
Glaucoma, Neovascular	MESH:D015355	DO:DOID:1687	A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.	MESH:D005901	C11.525.381.348	C11.525.381	Glaucomas, Neovascular|Neovascular Glaucoma|Neovascular Glaucomas	Eye disease
GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	OMIM:606657			MESH:D005901	C11.525.381/606657	C11.525.381	GLAUCOMA, NORMAL PRESSURE, SUSCEPTIBILITY TO|NPG|NTG	Eye disease
Glaucoma, Open-Angle	MESH:D005902	DO:DOID:1067|DO:DOID:1070|OMIM:137760	Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris.	MESH:D005901	C11.525.381.407	C11.525.381	Chronic Primary Open Angle Glaucoma|Compensated Glaucoma|Compensative Glaucoma|GLAUCOMA 1, OPEN ANGLE, E, INCLUDED|Glaucoma, Compensated|Glaucoma, Compensative|Glaucoma, Open Angle|Glaucoma, Pigmentary|Glaucoma, Primary Open Angle|GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET, INCLUDED|Glaucoma, Secondary Open Angle|Glaucoma, Simple|Glaucoma Simplex|GLC1E, INCLUDED|Open Angle Glaucoma|Open-Angle Glaucoma|Open Angle Glaucomas|Open-Angle Glaucomas|Pigmentary Glaucoma|POAG|Primary Open Angle Glaucoma|Secondary Open Angle Glaucoma|Simple Glaucoma|Simplex, Glaucoma|Simplices, Glaucoma	Eye disease
Glaucoma-Related Pigment Dispersion Syndrome	MESH:C563184	DO:DOID:0060680|OMIM:600510		MESH:D005902	C11.525.381.407/C563184	C11.525.381.407	Glaucoma, Pigment-Dispersion Type|GPDS1|GPDS1 Glaucoma-Related Pigment Dispersion Syndrome|PDS|Pigment-Dispersion Syndrome|PIGMENT DISPERSION SYNDROME	Eye disease
Glaucoma with Elevated Episcleral Venous Pressure	MESH:C564235			MESH:D005902	C11.525.381.407/C564235	C11.525.381.407		Eye disease
Glioblastoma	MESH:D005909	DO:DOID:3068|DO:DOID:3074	A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.	MESH:D001254	C04.557.465.625.600.380.080.335|C04.557.470.670.380.080.335|C04.557.580.625.600.380.080.335	C04.557.465.625.600.380.080|C04.557.470.670.380.080|C04.557.580.625.600.380.080	Astrocytoma, Grade IV|Astrocytomas, Grade IV|Giant Cell Glioblastoma|Giant Cell Glioblastomas|Glioblastoma, Giant Cell|Glioblastoma Multiforme|Glioblastomas|Glioblastomas, Giant Cell|Grade IV Astrocytoma|Grade IV Astrocytomas	Cancer
Glioma	MESH:D005910	DO:DOID:3070|DO:DOID:5076|OMIM:137800|OMIM:607248|OMIM:613028|OMIM:613029|OMIM:613030|OMIM:613031|OMIM:613033|OMIM:616568	Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)	MESH:D018302	C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380	C04.557.465.625.600|C04.557.470.670|C04.557.580.625.600	ASTROCYTOMA, INCLUDED|EPENDYMOMA, INCLUDED|GBM, INCLUDED|Glial Cell Tumor|Glial Cell Tumors|GLIOBLASTOMA MULTIFORME, INCLUDED|Glioma, Malignant|Glioma, Mixed|GLIOMA OF BRAIN, FAMILIAL, INCLUDED|Gliomas|Gliomas, Malignant|Gliomas, Mixed|GLIOMA SUSCEPTIBILITY 1|GLIOMA SUSCEPTIBILITY 2|GLIOMA SUSCEPTIBILITY 3|GLIOMA SUSCEPTIBILITY 4|GLIOMA SUSCEPTIBILITY 5|GLIOMA SUSCEPTIBILITY 6|GLIOMA SUSCEPTIBILITY 8|GLIOMA SUSCEPTIBILITY 9|GLM1|GLM2|GLM3|GLM4|GLM5|GLM6|GLM8|GLM9|GLM, INCLUDED|Malignant Glioma|Malignant Gliomas|Mixed Glioma|Mixed Gliomas|OLIGODENDROGLIOMA, INCLUDED|SUBEPENDYMOMA, INCLUDED|Tumor, Glial Cell|Tumors, Glial Cell	Cancer
Glioma of Brain, Familial	MESH:C564230			MESH:D001932|MESH:D005910	C04.557.465.625.600.380/C564230|C04.557.470.670.380/C564230|C04.557.580.625.600.380/C564230|C04.588.614.250.195/C564230|C10.228.140.211/C564230|C10.551.240.250/C564230	C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380|C04.588.614.250.195|C10.228.140.211|C10.551.240.250		Cancer|Nervous system disease
Glioma, Subependymal	MESH:D018315	DO:DOID:4843	Rare, slow-growing, benign intraventricular tumors, often asymptomatic and discovered incidentally. The tumors are classified histologically as ependymomas and demonstrate a proliferation of subependymal fibrillary astrocytes among the ependymal tumor cells. (From Clin Neurol Neurosurg 1997 Feb;99(1):17-22)	MESH:D004806	C04.557.465.625.600.380.290.390|C04.557.470.670.380.290.390|C04.557.580.625.600.380.290.390	C04.557.465.625.600.380.290|C04.557.470.670.380.290|C04.557.580.625.600.380.290	Adult Subependymal Astrocytoma|Adult Subependymal Astrocytomas|Astrocytoma, Adult Subependymal|Astrocytomas, Adult Subependymal|Astrocytomas, Subependymal|Astrocytoma, Subependymal|Gliomas, Subependymal|Glioses, Subependymal|Gliosis, Subependymal|Subependymal Astrocytoma|Subependymal Astrocytoma, Adult|Subependymal Astrocytomas|Subependymal Astrocytomas, Adult|Subependymal Glioma|Subependymal Gliomas|Subependymal Glioses|Subependymal Gliosis|Subependymoma|Subependymomas	Cancer
Gliosarcoma	MESH:D018316	DO:DOID:3071	Rare mixed tumors of the brain and rarely the spinal cord which contain malignant neuroectodermal (glial) and mesenchymal components, including spindle-shaped fibrosarcoma cells. These tumors are highly aggressive and present primarily in adults as rapidly expanding mass lesions. They may arise in tissue that has been previously irradiated. (From Br J Neurosurg 1995 Apr;9(2):171-8)	MESH:D005910	C04.557.465.625.600.380.400|C04.557.470.670.380.400|C04.557.580.625.600.380.400	C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380	Glioblastoma with Sarcomatous Component|Glioma, Sarcomatous|Gliomas, Sarcomatous|Gliosarcomas|Sarcomatous Glioma|Sarcomatous Gliomas	Cancer
Globulin Anomaly involving Beta (2A)-Globulin	MESH:C564229			MESH:D001778	C15.378.100/C564229	C15.378.100		Blood disease
Glomerulocystic Kidney Disease with Hyperuricemia and Isosthenuria	MESH:C563693			MESH:D033461|MESH:D052177	C12.050.351.968.419.403/C563693|C12.200.777.419.403/C563693|C12.950.419.403/C563693|C23.550.449/C563693	C12.050.351.968.419.403|C12.200.777.419.403|C12.950.419.403|C23.550.449		Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Glomerulonephritis, IGA	MESH:D005922	DO:DOID:2986|OMIM:161950|OMIM:613944|OMIM:616818	A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE.	MESH:D001327|MESH:D005921	C12.050.351.968.419.570.363.608|C12.200.777.419.570.363.608|C12.950.419.570.363.608|C20.111.525	C12.050.351.968.419.570.363|C12.200.777.419.570.363|C12.950.419.570.363|C20.111	Berger Disease|Berger's Disease|Bergers Disease|Glomerulonephritides, IGA|IGA Glomerulonephritis|IGAN|IGAN1|IGAN2|IGAN3|IGA Nephropathy|Iga Nephropathy 1|IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1|IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2|IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3|IGA Type Nephritis|Immunoglobulin A Nephropathy|Nephritis, IGA Type|Nephropathy 1, Iga|Nephropathy, IGA|Nephropathy, Immunoglobulin A	Immune system disease|Urogenital disease (female)|Urogenital disease (male)
Glomerulonephritis, Membranoproliferative	MESH:D015432	DO:DOID:2920	Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN.	MESH:D005921|MESH:D007154	C12.050.351.968.419.570.363.615|C12.200.777.419.570.363.615|C12.950.419.570.363.615|C20.425	C12.050.351.968.419.570.363|C12.200.777.419.570.363|C12.950.419.570.363|C20	DDD MPGNII|Dense Deposit Disease|Glomerulonephritides, Hypocomplementemic|Glomerulonephritides, Membranoproliferative|Glomerulonephritides, Mesangiocapillary|Glomerulonephritis, Hypocomplementemic|Glomerulonephritis, Mesangiocapillary|Hypocomplementemic Glomerulonephritides|Hypocomplementemic Glomerulonephritis|Membranoproliferative Glomerulonephritides|Membranoproliferative Glomerulonephritis|Membranoproliferative Glomerulonephritis, Subendothelial|Membranoproliferative Glomerulonephritis, Type I|Membranoproliferative Glomerulonephritis Type II|Membranoproliferative Glomerulonephritis, Type II|Membranoproliferative Glomerulonephritis, Type III|Mesangiocapillary Glomerulonephritides|Mesangiocapillary Glomerulonephritis|Mesangiocapillary Glomerulonephritis, Type I|Mesangiocapillary Glomerulonephritis, Type II|MPGN|MPGNII|Subendothelial Membranoproliferative Glomerulonephritis|Type II MPGN	Immune system disease|Urogenital disease (female)|Urogenital disease (male)
Glomerulonephritis, Membranous	MESH:D015433	DO:DOID:10976|OMIM:614692	A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.	MESH:D001327|MESH:D005921	C12.050.351.968.419.570.363.625|C12.200.777.419.570.363.625|C12.950.419.570.363.625|C20.111.535	C12.050.351.968.419.570.363|C12.200.777.419.570.363|C12.950.419.570.363|C20.111	Extramembranous Glomerulopathy|Glomerulonephritides, Idiopathic Membranous|Glomerulonephritides, Membranous|Glomerulonephritis, Idiopathic Membranous|Glomerulonephropathy, Membranous|Glomerulopathy, Extramembranous|Glomerulopathy, Membranous|Heymann Nephritis|Idiopathic Membranous Glomerulonephritides|Idiopathic Membranous Glomerulonephritis|Idiopathic Membranous Nephropathy|MBNP|Membranous Glomerulonephritides|Membranous Glomerulonephritides, Idiopathic|Membranous Glomerulonephritis|Membranous Glomerulonephritis, Idiopathic|Membranous Glomerulonephropathy|Membranous Glomerulopathy|Membranous Nephropathy|Membranous Nephropathy, Idiopathic|MEMBRANOUS NEPHROPATHY, SUSCEPTIBILITY TO|Nephritis, Heymann|Nephropathy, Idiopathic Membranous|Nephropathy, Membranous	Immune system disease|Urogenital disease (female)|Urogenital disease (male)
Glomerulonephritis sparse hair telangiectases	MESH:C536825			MESH:D000505|MESH:D013684|MESH:D015432	C12.050.351.968.419.570.363.615/C536825|C12.200.777.419.570.363.615/C536825|C12.950.419.570.363.615/C536825|C14.907.823/C536825|C17.800.329.937.122/C536825|C20.425/C536825|C23.300.035/C536825	C12.050.351.968.419.570.363.615|C12.200.777.419.570.363.615|C12.950.419.570.363.615|C14.907.823|C17.800.329.937.122|C20.425|C23.300.035	Cutaneous telangiectasia, sparse hair and membranoproliferative glomerulonephritis|Glomerulonephritis With Sparse Hair And Telangiectases|Telangiectatic membranoproliferative glomerulonephritis	Cardiovascular disease|Immune system disease|Pathology (anatomical condition)|Skin disease|Urogenital disease (female)|Urogenital disease (male)
Glomerulonephritis With Isolated C3 Deposits And Factor I Deficiency	MESH:C567033			MESH:D015432	C12.050.351.968.419.570.363.615/C567033|C12.200.777.419.570.363.615/C567033|C12.950.419.570.363.615/C567033|C20.425/C567033	C12.050.351.968.419.570.363.615|C12.200.777.419.570.363.615|C12.950.419.570.363.615|C20.425		Immune system disease|Urogenital disease (female)|Urogenital disease (male)
Glomerulopathy with fibronectin deposits	MESH:C536826	OMIM:137950|OMIM:601894		MESH:D015432	C12.050.351.968.419.570.363.615/C536826|C12.200.777.419.570.363.615/C536826|C12.950.419.570.363.615/C536826|C20.425/C536826	C12.050.351.968.419.570.363.615|C12.200.777.419.570.363.615|C12.950.419.570.363.615|C20.425	Fibronectin glomerulopathy|GFND1|GFND2|Glomerular nephritis, familial, with fibronectin deposits|GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1|Glomerulopathy With Fibronectin Deposits 2|GLOMERULOPATHY WITH GIANT FIBRILLAR DEPOSITS|LOBULAR GLOMERULOPATHY, FAMILIAL	Immune system disease|Urogenital disease (female)|Urogenital disease (male)
Glomus Jugulare Tumor	MESH:D005925		A paraganglioma involving the glomus jugulare, a microscopic collection of chemoreceptor tissue in the adventitia of the bulb of the jugular vein. It may cause paralysis of the vocal cords, attacks of dizziness, blackouts, and nystagmus. It is not resectable but radiation therapy is effective. It regresses slowly, but permanent control is regularly achieved. (From Dorland, 27th ed; Stedman, 25th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1603-4)	MESH:D010236	C04.557.465.625.650.700.705.340|C04.557.580.625.650.700.705.340	C04.557.465.625.650.700.705|C04.557.580.625.650.700.705	Glomus Jugulare Tumors|Glomus Tumors, Familial, 1|Jugulare Tumor, Glomus|Jugulare Tumors, Glomus|Tumor, Glomus Jugulare|Tumors, Glomus Jugulare	Cancer
Glomus Tumor	MESH:D005918	DO:DOID:2431|DO:DOID:2436	A blue-red, extremely painful vascular neoplasm involving a glomeriform arteriovenous anastomosis (glomus body), which may be found anywhere in the skin, most often in the distal portion of the fingers and toes, especially beneath the nail. It is composed of specialized pericytes (sometimes termed glomus cells), usually in single encapsulated nodular masses which may be several millimeters in diameter (From Stedman, 27th ed). CHEMODECTOMA, a tumor of NEURAL CREST origin, is also sometimes called a glomus tumor.	MESH:D009383	C04.557.645.350	C04.557.645	Glomangioma|Glomangiomas|Glomus Tumors|Tumor, Glomus|Tumors, Glomus	Cancer
Glomus Tympanicum Tumor	MESH:D043604		A rare PARAGANGLIOMA involving the GLOMUS TYMPANICUM, a collection of chemoreceptor tissue adjacent to the TYMPANIC CAVITY. It can cause TINNITUS and conductive hearing loss (HEARING LOSS, CONDUCTIVE).	MESH:D010236	C04.557.465.625.650.700.705.360|C04.557.580.625.650.700.705.360	C04.557.465.625.650.700.705|C04.557.580.625.650.700.705	Glomus Tympanicum Tumors|Tumor, Glomus Tympanicum|Tumors, Glomus Tympanicum	Cancer
Glomus vagale tumors	MESH:C536827	OMIM:138000		MESH:D005918|MESH:D010236	C04.557.465.625.650.700.705/C536827|C04.557.580.625.650.700.705/C536827|C04.557.645.350/C536827	C04.557.465.625.650.700.705|C04.557.580.625.650.700.705|C04.557.645.350	Glomangiomas, Multiple|Glomus Tumors, Multiple|Glomuvenous malformations|GVM|Venous Malformations With Glomus Cells|VMGLOM	Cancer
Glossalgia	MESH:D005926		Painful sensations in the tongue, including a sensation of burning.	MESH:D010146|MESH:D014060	C07.465.910.280|C23.888.592.612.414	C07.465.910|C23.888.592.612	Glossalgias|Glossodynia|Glossodynias|Glossopyroses|Glossopyrosis	Mouth disease|Signs and symptoms
Glossopharyngeal Nerve Diseases	MESH:D020435	DO:DOID:14423|DO:DOID:7558	Diseases of the ninth cranial (glossopharyngeal) nerve or its nuclei in the medulla. The nerve may be injured by diseases affecting the lower brain stem, floor of the posterior fossa, jugular foramen, or the nerve's extracranial course. Clinical manifestations include loss of sensation from the pharynx, decreased salivation, and syncope. Glossopharyngeal neuralgia refers to a condition that features recurrent unilateral sharp pain in the tongue, angle of the jaw, external auditory meatus and throat that may be associated with SYNCOPE. Episodes may be triggered by cough, sneeze, swallowing, or pressure on the tragus of the ear. (Adams et al., Principles of Neurology, 6th ed, p1390)	MESH:D003389	C10.292.450	C10.292	Cranial Nerve IX Diseases|Cranial Nerve IX Disorders|Glossopharyngeal Motor Neuropathies|Glossopharyngeal Motor Neuropathy|Glossopharyngeal Nerve Disease|Glossopharyngeal Nerve Sensory Neuropathy|Glossopharyngeal Nerve Taste Disorder|Glossopharyngeal Neuralgia|Glossopharyngeal Neuralgias|Motor Neuropathies, Glossopharyngeal|Motor Neuropathy, Glossopharyngeal|Neuralgia, Glossopharyngeal|Neuralgias, Glossopharyngeal|Ninth Cranial Nerve Diseases|Sensory Neuropathy, Glossopharyngeal Nerve|Taste Disorder, Glossopharyngeal Nerve	Nervous system disease
Glossopharyngeal Nerve Injuries	MESH:D061287		Traumatic injuries to the GLOSSOPHARYNGEAL NERVE.	MESH:D020209|MESH:D020435	C10.292.200.531|C10.292.450.500|C10.900.300.218.331|C26.915.300.400.343	C10.292.200|C10.292.450|C10.900.300.218|C26.915.300.400	Avulsion, Glossopharyngeal Nerve|Avulsions, Glossopharyngeal Nerve|Contusion, Glossopharyngeal Nerve|Contusions, Glossopharyngeal Nerve|Cranial Nerve IX Injury|Glossopharyngeal Nerve Avulsion|Glossopharyngeal Nerve Avulsions|Glossopharyngeal Nerve Contusion|Glossopharyngeal Nerve Contusions|Glossopharyngeal Nerve Injury|Glossopharyngeal Nerve Transection|Glossopharyngeal Nerve Transections|Glossopharyngeal Nerve Trauma|Glossopharyngeal Nerve Traumas|Glossopharyngeal Neuropathies, Traumatic|Glossopharyngeal Neuropathy, Traumatic|Injuries, Glossopharyngeal Nerve|Injury, Cranial Nerve IX|Injury, Glossopharyngeal Nerve|Injury, Ninth Cranial Nerve|Nerve Avulsion, Glossopharyngeal|Nerve Avulsions, Glossopharyngeal|Nerve Contusion, Glossopharyngeal|Nerve Contusions, Glossopharyngeal|Nerve Injuries, Glossopharyngeal|Nerve Injury, Glossopharyngeal|Nerve Transection, Glossopharyngeal|Nerve Transections, Glossopharyngeal|Nerve Trauma, Glossopharyngeal|Nerve Traumas, Glossopharyngeal|Neuropathies, Traumatic Glossopharyngeal|Neuropathy, Traumatic Glossopharyngeal|Ninth Cranial Nerve Injuries|Ninth Cranial Nerve Injury|Ninth-Nerve Palsies, Traumatic|Ninth Nerve Palsy, Traumatic|Ninth-Nerve Palsy, Traumatic|Ninth Nerve Trauma|Ninth-Nerve Trauma|Ninth-Nerve Traumas|Palsies, Traumatic Ninth-Nerve|Palsy, Traumatic Ninth-Nerve|Transection, Glossopharyngeal Nerve|Transections, Glossopharyngeal Nerve|Trauma, Glossopharyngeal Nerve|Trauma, Ninth-Nerve|Traumas, Glossopharyngeal Nerve|Traumas, Ninth-Nerve|Traumatic Glossopharyngeal Neuropathies|Traumatic Glossopharyngeal Neuropathy|Traumatic Ninth-Nerve Palsies|Traumatic Ninth Nerve Palsy|Traumatic Ninth-Nerve Palsy	Nervous system disease|Wounds and injuries
Glucagonoma	MESH:D005935		An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.	MESH:D018273	C04.557.470.200.025.290.750|C04.588.274.761.500.249|C04.588.322.475.500.249|C06.301.761.500.249|C06.689.667.500.249|C19.344.421.500.249	C04.557.470.200.025.290|C04.588.274.761.500|C04.588.322.475.500|C06.301.761.500|C06.689.667.500|C19.344.421.500	Adenoma, alpha Cell|Adenoma, alpha-Cell|Adenomas, alpha-Cell|alpha-Cell Adenoma|alpha-Cell Adenomas|alpha Cell Tumor|alpha-Cell Tumor|alpha-Cell Tumors|Glucagonomas|Glucagonoma Syndrome|Glucagonoma Syndromes|Syndrome, Glucagonoma|Syndromes, Glucagonoma|Tumor, alpha-Cell|Tumors, alpha-Cell	Cancer|Digestive system disease|Endocrine system disease
Glucose Intolerance	MESH:D018149	DO:DOID:10603	A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.	MESH:D006943	C18.452.394.952.500	C18.452.394.952	Glucose Intolerances|Glucose Tolerance, Impaired|Glucose Tolerances, Impaired|Impaired Glucose Tolerance|Impaired Glucose Tolerances|Intolerance, Glucose|Intolerances, Glucose|Tolerance, Impaired Glucose|Tolerances, Impaired Glucose	Metabolic disease
Glucose Metabolism Disorders	MESH:D044882	DO:DOID:4194	Pathological conditions in which the BLOOD GLUCOSE cannot be maintained within the normal range, such as in HYPOGLYCEMIA and HYPERGLYCEMIA. Etiology of these disorders varies. Plasma glucose concentration is critical to survival for it is the predominant fuel for the CENTRAL NERVOUS SYSTEM.	MESH:D008659	C18.452.394	C18.452	Disorder, Glucose Metabolic|Disorder, Glucose Metabolism|Disorders, Glucose Metabolic|Disorders, Glucose Metabolism|Glucose Metabolic Disorder|Glucose Metabolic Disorders|Glucose Metabolism Disorder|Metabolic Disorder, Glucose|Metabolic Disorders, Glucose|Metabolism Disorder, Glucose|Metabolism Disorders, Glucose	Metabolic disease
GLUT1 DEFICIENCY SYNDROME 2	OMIM:612126	DO:DOID:0090045		MESH:C564288|MESH:D004421	C10.228.662.300/C564288/612126|C10.597.350.300/612126|C23.888.592.350.300/612126	C10.228.662.300/C564288|C10.597.350.300|C23.888.592.350.300	DYSTONIA 18|DYT18|GLUT1DS2|PAROXYSMAL EXERCISE-INDUCED DYSKINESIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA|PAROXYSMAL EXERTION-INDUCED DYSTONIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA|PED WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA	Nervous system disease|Signs and symptoms
Glutathione Peroxidase Deficiency, Hemolytic Anemia possibly due to	MESH:C564217	OMIM:614164		MESH:D000743	C15.378.071.141/C564217	C15.378.071.141	GLUTATHIONE PEROXIDASE DEFICIENCY|GPXD	Blood disease
Glutathione Reductase, Hemolytic Anemia due to Deficiency of, in Red Cells	MESH:C564218			MESH:D000743	C15.378.071.141/C564218	C15.378.071.141		Blood disease
Glyceraldehyde-3-phosphate dehydrogenase deficiency	MESH:C536837			MESH:D044882	C18.452.394/C536837	C18.452.394		Metabolic disease
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	OMIM:617301			MESH:D001928	C10.228.140.163/617301|C18.452.132/617301	C10.228.140.163|C18.452.132		Metabolic disease|Nervous system disease
Glycoprotein IA Deficiency	MESH:C566000			MESH:D013921	C15.378.140.855/C566000	C15.378.140.855	GP IA Deficiency	Blood disease
Glycosuria	MESH:D006029		The appearance of an abnormally large amount of GLUCOSE in the urine, such as more than 500 mg/day in adults. It can be due to HYPERGLYCEMIA or genetic defects in renal reabsorption (RENAL GLYCOSURIA).	MESH:D014555|MESH:D044882	C12.050.351.968.934.363|C12.200.777.934.363|C12.950.934.363|C18.452.394.937	C12.050.351.968.934|C12.200.777.934|C12.950.934|C18.452.394		Metabolic disease|Urogenital disease (female)|Urogenital disease (male)
Glycosylphosphatidylinositol deficiency	MESH:C537277			MESH:D012640	C10.597.742/C537277|C23.888.592.742/C537277	C10.597.742|C23.888.592.742		Nervous system disease|Signs and symptoms
GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS	OMIM:138800	DO:DOID:0050489		MESH:C562732|MESH:D018310	C04.557.475.750.847/138800|C04.588.322.455.648/138800|C04.588.322.762.500/138800|C04.588.945.440.915.500/138800|C12.050.351.500.056.630.705.648/138800|C12.050.351.937.418.685.648/138800|C12.100.250.056.630.705.648/138800|C12.100.500.260.937.500/138800|C12.200.294.260.937.500/138800|C12.200.758.409.937.500/138800|C12.900.418.685.648/138800|C12.900.619.937.500/138800|C19.344.410.648/138800|C19.344.762.500/138800|C19.391.630.705.648/138800|C19.391.829.782.500/138800|C19.874.283.501/C562732/138800	C04.557.475.750.847|C04.588.322.455.648|C04.588.322.762.500|C04.588.945.440.915.500|C12.050.351.500.056.630.705.648|C12.050.351.937.418.685.648|C12.100.250.056.630.705.648|C12.100.500.260.937.500|C12.200.294.260.937.500|C12.200.758.409.937.500|C12.900.418.685.648|C12.900.619.937.500|C19.344.410.648|C19.344.762.500|C19.391.630.705.648|C19.391.829.782.500|C19.874.283.501/C562732	EUTHYROID GOITER|GOITER, NONTOXIC, WITH INTRATHYROIDAL CALCIFICATION|MNG1|MULTINODULAR GOITER, ADOLESCENT|SIMPLE GOITER	Cancer|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Graft vs Host Disease	MESH:D006086	OMIM:614395	The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.	MESH:D007154	C20.452	C20	Disease, Graft-Versus-Host|Disease, Graft-vs-Host|Disease, Homologous Wasting|Disease, Runt|Diseases, Graft-Versus-Host|Diseases, Graft-vs-Host|Graft Versus Host Disease|Graft-Versus-Host Disease|GRAFT-VERSUS-HOST DISEASE, RESISTANCE TO, INCLUDED|Graft-Versus-Host Diseases|GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO|Graft-vs-Host Disease|Graft-vs-Host Diseases|GVHDS|Homologous Wasting Disease|Runt Disease	Immune system disease
Granular Cell Tumor	MESH:D016586	DO:DOID:2411	Unusual tumor affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; however, it is considered to be a myoblastoma of, usually, a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma.	MESH:D009379	C04.557.450.590.350	C04.557.450.590	Cell Myoblastoma, Granular|Cell Myoblastomas, Granular|Cell Tumor, Granular|Cell Tumors, Granular|Granular Cell Myoblastoma|Granular Cell Myoblastomas|Granular Cell Tumors|Myoblastoma, Granular Cell|Myoblastomas, Granular Cell|Tumor, Granular Cell|Tumors, Granular Cell	Cancer
Granulocytopenia with Immunoglobulin Abnormality	MESH:C565535	DO:DOID:0111974		MESH:D000361|MESH:D000380	C15.378.147.142/C565535|C15.378.553.546.184/C565535|C15.604.515.032/C565535|C20.673.088/C565535	C15.378.147.142|C15.378.553.546.184|C15.604.515.032|C20.673.088		Blood disease|Immune system disease|Lymphatic disease
Granuloma	MESH:D006099		A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.	MESH:D008232|MESH:D010335	C15.604.515.292|C23.550.382	C15.604.515|C23.550	Granulomas	Lymphatic disease|Pathology (process)
Granuloma Annulare	MESH:D016460	DO:DOID:3777	Benign granulomatous disease of unknown etiology characterized by a ring of localized or disseminated papules or nodules on the skin and palisading histiocytes surrounding necrobiotic tissue resulting from altered collagen structures.	MESH:D006099|MESH:D017441	C17.300.200.495.380|C17.800.550.380|C23.550.382.375	C17.300.200.495|C17.800.550|C23.550.382		Connective tissue disease|Pathology (process)|Skin disease
Granuloma, Giant Cell	MESH:D006101	DO:DOID:1866	A non-neoplastic inflammatory lesion, usually of the jaw or gingiva, containing large, multinucleated cells. It includes reparative giant cell granuloma. Peripheral giant cell granuloma refers to the gingiva (giant cell epulis); central refers to the jaw.	MESH:D005882|MESH:D006099|MESH:D007571	C05.500.368|C07.320.391|C07.465.714.258.557|C23.550.382.468	C05.500|C07.320|C07.465.714.258|C23.550.382	Epulides, Giant Cell|Epulis, Giant Cell|Giant Cell Epulides|Giant Cell Epulis|Giant Cell Granuloma|Giant Cell Granulomas|Granuloma, Giant Cell Reparative|Granulomas, Giant Cell|Peripheral Giant Cell Granuloma	Mouth disease|Musculoskeletal disease|Pathology (process)
Granuloma, Laryngeal	MESH:D006102		A tumor-like nodule or mass of inflammatory granulation tissue projecting into the lumen of the LARYNX.	MESH:D007818|MESH:D012131|MESH:D015769	C08.280.400|C08.360.232|C08.618.846.414|C09.400.232|C23.550.382.968.500	C08.280|C08.360|C08.618.846|C09.400|C23.550.382.968	Granuloma of Larynx|Granulomas, Laryngeal|Laryngeal Granuloma|Laryngeal Granulomas|Larynx Granuloma|Larynx Granulomas	Ear-nose-throat disease|Pathology (process)|Respiratory tract disease
Granuloma, Lethal Midline	MESH:D006103	DO:DOID:9072	A condition that is characterized by inflammation, ulceration, and perforation of the nose and the PALATE with progressive destruction of midline facial structures. This syndrome can be manifested in several diseases including the nasal type of EXTRANODAL NK-T-CELL LYMPHOMA and GRANULOMATOSIS WITH POLYANGIITIS.	MESH:D009668	C08.460.393|C09.603.393	C08.460|C09.603	Granuloma Gangraenescens|Granulomas, Lethal Midline|Lethal Midline Granuloma|Lethal Midline Granulomas|Midline Granuloma, Lethal|Midline Granulomas, Lethal|Polymorphic Reticuloses|Polymorphic Reticulosis|Reticuloses, Polymorphic|Reticulosis, Polymorphic	Ear-nose-throat disease|Respiratory tract disease
Granuloma, Respiratory Tract	MESH:D015769		Granulomatous disorders affecting one or more sites in the respiratory tract.	MESH:D006099|MESH:D012140	C08.280|C23.550.382.968	C08|C23.550.382	Granulomas, Respiratory Tract|Respiratory Tract Granuloma|Respiratory Tract Granulomas	Pathology (process)|Respiratory tract disease
Granulomas, congenital cerebral	MESH:C537294			MESH:D001927|MESH:D006099	C10.228.140/C537294|C15.604.515.292/C537294|C23.550.382/C537294	C10.228.140|C15.604.515.292|C23.550.382	Congenital cerebral granulomas	Lymphatic disease|Nervous system disease|Pathology (process)
Granulomatosis, Orofacial	MESH:D051261		A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.	MESH:D009059|MESH:D010335	C07.465.353|C23.550.384	C07.465|C23.550	Granulomatoses, Orofacial|Orofacial Granulomatoses|Orofacial Granulomatosis	Mouth disease|Pathology (process)
Granulomatosis with Polyangiitis	MESH:D014890	DO:DOID:12132|OMIM:608710	A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.	MESH:D017563|MESH:D056648	C08.381.483.950|C14.907.940.897.249.750|C20.111.193.875	C08.381.483|C14.907.940.897.249|C20.111.193	GPA|Granulomatosis, Wegener|Granulomatosis, Wegener's|Granulomatosis with Polyangiitides|Polyangiitides, Granulomatosis with|Polyangiitis, Granulomatosis with|Wegener Granulomatosis|WEGENER GRANULOMATOSIS, FORMERLY|Wegener's Granulomatosis|WG, FORMERLY|with Polyangiitides, Granulomatosis|with Polyangiitis, Granulomatosis	Cardiovascular disease|Immune system disease|Respiratory tract disease
Granulomatous Angiitis of the Central Nervous System	MESH:C537295			MESH:D020293	C10.114.875/C537295|C10.228.140.300.850/C537295|C14.907.253.946/C537295|C14.907.940.907/C537295|C20.111.258.962/C537295	C10.114.875|C10.228.140.300.850|C14.907.253.946|C14.907.940.907|C20.111.258.962	Granulomatous Angiitis of CNS|Granulomatous angiitis of the nervous system	Cardiovascular disease|Immune system disease|Nervous system disease
Granulosa Cell Tumor	MESH:D006106	DO:DOID:2999	A neoplasm composed entirely of GRANULOSA CELLS, occurring mostly in the OVARY. In the adult form, it may contain some THECA CELLS. This tumor often produces ESTRADIOL and INHIBIN. The excess estrogen exposure can lead to other malignancies in women and PRECOCIOUS PUBERTY in girls. In rare cases, granulosa cell tumors have been identified in the TESTES.	MESH:D010051|MESH:D018312	C04.557.475.750.656|C04.588.322.455.398|C12.050.351.500.056.630.705.398|C12.050.351.937.418.685.398|C12.100.250.056.630.705.398|C12.900.418.685.398|C19.344.410.398|C19.391.630.705.398	C04.557.475.750|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.344.410|C19.391.630.705	Cancer, Granulosa Cell|Cancer of Granulosa Cells|Cancers, Granulosa Cell|Cell Cancer, Granulosa|Cell Cancers, Granulosa|Cells Cancer, Granulosa|Cells Cancers, Granulosa|Granulosa Cell Cancer|Granulosa Cell Cancers|Granulosa Cells Cancer|Granulosa Cells Cancers|Granulosa Cell Tumors|Tumor, Granulosa Cell|Tumors, Granulosa Cell	Cancer|Endocrine system disease|Urogenital disease (female)
Granulosa cell tumor of the ovary	MESH:C537296			MESH:D006106	C04.557.475.750.656/C537296|C04.588.322.455.398/C537296|C12.050.351.500.056.630.705.398/C537296|C12.050.351.937.418.685.398/C537296|C12.100.250.056.630.705.398/C537296|C12.900.418.685.398/C537296|C19.344.410.398/C537296|C19.391.630.705.398/C537296	C04.557.475.750.656|C04.588.322.455.398|C12.050.351.500.056.630.705.398|C12.050.351.937.418.685.398|C12.100.250.056.630.705.398|C12.900.418.685.398|C19.344.410.398|C19.391.630.705.398	Adult granulosa cell tumor of the ovary|GCT of the ovary|Granulosa theca cell tumor|Granulosa theca cell tumor of the ovary	Cancer|Endocrine system disease|Urogenital disease (female)
Granulosis Rubra Nasi	MESH:C562483			MESH:D006945|MESH:D017444	C17.800.859/C562483|C17.800.946.350/C562483	C17.800.859|C17.800.946.350		Skin disease
Graves Disease	MESH:D006111	DO:DOID:12361|OMIM:275000|OMIM:603388	A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).	MESH:D001327|MESH:D005094|MESH:D006042|MESH:D006980	C11.675.349.500|C19.874.283.605|C19.874.397.370|C20.111.555	C11.675.349|C19.874.283|C19.874.397|C20.111	Basedow Disease|Basedow's Disease|Basedows Disease|Disease, Basedow|Disease, Basedow's|Disease, Graves|Disease, Graves'|Exophthalmic Goiter|Exophthalmic Goiters|Goiter, Exophthalmic|Goiters, Exophthalmic|Graves' Disease|GRAVES DISEASE, SUSCEPTIBILITY TO, 1|GRAVES DISEASE, SUSCEPTIBILITY TO, 2|GRD|GRD1|GRD2|Hyperthyroidism, Autoimmune|THYROTOXICOSIS	Endocrine system disease|Eye disease|Immune system disease
GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1	OMIM:300351			MESH:D006111	C11.675.349.500/300351|C19.874.283.605/300351|C19.874.397.370/300351|C20.111.555/300351	C11.675.349.500|C19.874.283.605|C19.874.397.370|C20.111.555	GRDX1 GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 2, INCLUDED|GRDX2, INCLUDED	Endocrine system disease|Eye disease|Immune system disease
Graying of Hair, Precocious	MESH:C564209			MESH:D010859	C17.800.621/C564209|C23.550.755/C564209	C17.800.621|C23.550.755	White Hair, Premature	Pathology (process)|Skin disease
Groll Hirschowitz syndrome	MESH:C537305			MESH:D002100|MESH:D003711|MESH:D006313	C09.218.458.341.887.432/C537305|C09.218.807.186.432/C537305|C10.228.140.068.432/C537305|C10.314/C537305|C10.597.751.418.341.887.432/C537305|C23.888.144.243.963.500.500/C537305|C23.888.592.763.393.341.887.432/C537305	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.314|C10.597.751.418.341.887.432|C23.888.144.243.963.500.500|C23.888.592.763.393.341.887.432	Deafness, Nerve Type, with Mesenteric Diverticula of Small Bowel and Progressive Sensory Neuropathy|Groll-Hirschowitz Syndrome	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Growth and Developmental Retardation, Ocular Ptosis, Cardiac Defect, and Anal Atresia	MESH:C565755			MESH:D001006|MESH:D001763|MESH:D006130|MESH:D006330|MESH:D008607	C06.198.050/C565755|C10.597.606.360/C565755|C11.338.204/C565755|C14.240.400/C565755|C14.280.400/C565755|C16.131.240.400/C565755|C16.131.314.094/C565755|C23.550.393/C565755|C23.888.592.604.646/C565755|F03.625.539/C565755	C06.198.050|C10.597.606.360|C11.338.204|C14.240.400|C14.280.400|C16.131.240.400|C16.131.314.094|C23.550.393|C23.888.592.604.646|F03.625.539	ROCA Syndrome|ROCA-Weidemann Syndrome	Cardiovascular disease|Congenital abnormality|Digestive system disease|Eye disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Growth hormone excess	MESH:C531600			MESH:D000172	C05.116.132.082/C531600|C10.228.140.617.738.250.100/C531600|C19.700.355.179/C531600	C05.116.132.082|C10.228.140.617.738.250.100|C19.700.355.179		Endocrine system disease|Musculoskeletal disease|Nervous system disease
Growth Hormone-Secreting Pituitary Adenoma	MESH:D049912	DO:DOID:6255|OMIM:102200|OMIM:300943	A pituitary tumor that secretes GROWTH HORMONE. In humans, excess HUMAN GROWTH HORMONE leads to ACROMEGALY.	MESH:D000236|MESH:D010911	C04.557.470.035.415|C04.588.322.609.292|C10.228.140.617.738.675.299|C19.344.609.292|C19.700.734.292	C04.557.470.035|C04.588.322.609|C10.228.140.617.738.675|C19.344.609|C19.700.734	Acromegaly Due To Pituitary Adenoma|ACROMEGALY DUE TO PITUITARY ADENOMA 1|ACROMEGALY DUE TO PITUITARY ADENOMA 2|ACROMEGALY, X-LINKED|Adenoma, Somatotroph|Adenomas, Somatotroph|FIPA, INCLUDED|FIS|GH Secreting Pituitary Adenoma|GH-Secreting Pituitary Adenoma|GH-Secreting Pituitary Adenomas|IFS|Isolated Familial Somatotropinoma|PAGH1 PITUITARY ADENOMA PREDISPOSITION, INCLUDED|PAP, INCLUDED|PITA1|PITA2|PITUITARY ADENOMA 1, MULTIPLE TYPES|PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING|PITUITARY ADENOMA, FAMILIAL ISOLATED, INCLUDED|Pituitary Adenoma, GH Secreting|Pituitary Adenoma, GH-Secreting|Pituitary Adenoma, Growth Hormone Secreting|Pituitary Adenoma, Growth Hormone-Secreting|Pituitary Adenomas, GH-Secreting|Pituitary Growth Hormone Secreting Adenoma|Pituitary Growth Hormone-Secreting Adenoma|Somatotroph Adenoma|Somatotroph Adenomas|Somatotrophinoma, Familial|Somatotropinoma, Familial Isolated	Cancer|Endocrine system disease|Nervous system disease
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY	OMIM:617093			MESH:D006130|MESH:D008107|MESH:D008607|MESH:D009123	C06.552/617093|C10.597.606.360/617093|C10.597.613.575/617093|C23.550.393/617093|C23.888.592.604.646/617093|C23.888.592.608.575/617093|F03.625.539/617093	C06.552|C10.597.606.360|C10.597.613.575|C23.550.393|C23.888.592.604.646|C23.888.592.608.575|F03.625.539	GRIDHH	Digestive system disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Guanidinoacetate methyltransferase deficiency	MESH:C537622	DO:DOID:0050799|OMIM:612736		MESH:D007805|MESH:D009069	C10.228.662/C537622|C10.597.606.150.500.550/C537622|C23.888.592.604.150.500.550/C537622	C10.228.662|C10.597.606.150.500.550|C23.888.592.604.150.500.550	CCDS2|CEREBRAL CREATINE DEFICIENCY SYNDROME 2|Creatine Deficiency Syndrome Due To Gamt Deficiency|GAMT Deficiency|GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	Nervous system disease|Signs and symptoms
Guillain-Barre Syndrome	MESH:D020275	DO:DOID:12842|OMIM:139393	An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)	MESH:D010523|MESH:D011129	C10.114.750.100|C10.314.750.450|C10.668.829.350|C10.668.829.800.750.300|C20.111.258.750.400	C10.114.750|C10.314.750|C10.668.829|C10.668.829.800.750|C20.111.258.750	Acute Autoimmune Neuropathies|Acute Autoimmune Neuropathy|Acute Infectious Polyneuritis|Acute Inflammatory Demyelinating Polyneuropathy|Acute Inflammatory Demyelinating Polyradiculoneuropathy|Acute Inflammatory Polyneuropathies|Acute Inflammatory Polyneuropathy|Acute Inflammatory Polyradiculoneuropathies|Acute Inflammatory Polyradiculoneuropathy|Autoimmune Neuropathies, Acute|Autoimmune Neuropathy, Acute|CIDP, INCLUDED|Demyelinating Polyradiculoneuropathy, Acute Inflammatory|Familial Guillain-Barre Syndrome|Familial Guillain-Barre Syndromes|GBS|Guillain Barre Syndrome|Guillain Barré Syndrome|Guillain-Barré Syndrome|Guillain Barre Syndrome, Familial|Guillain-Barre Syndrome, Familial|Guillain-Barré Syndromes|Guillain-Barre Syndromes, Familial|Guillaine Barre Syndrome|Guillaine-Barre Syndrome|Infectious Polyneuritis, Acute|Inflammatory Demyelinating Polyradiculoneuropathy, Acute|Inflammatory Polyneuropathies, Acute|Inflammatory Polyneuropathy Acute|Inflammatory Polyneuropathy, Acute|Inflammatory Polyradiculoneuropathies, Acute|Landry Guillain Barre Syndrome|Landry-Guillain-Barre Syndrome|Neuropathies, Acute Autoimmune|Neuropathy, Acute Autoimmune|Polyneuritis, Acute Infectious|Polyneuropathies, Acute Inflammatory|Polyneuropathy Acute, Inflammatory|Polyneuropathy, Acute Inflammatory|Polyneuropathy, Inflammatory Demyelinating, Acute|POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, ACUTE;AIDP  POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC, INCLUDED|Polyradiculoneuropathies, Acute Inflammatory|Polyradiculoneuropathy, Acute Inflammatory|Polyradiculoneuropathy, Acute Inflammatory Demyelinating|Syndrome, Familial Guillain-Barre|Syndrome, Guillain-Barre|Syndrome, Guillain-Barré|Syndrome, Guillaine-Barre|Syndrome, Landry-Guillain-Barre|Syndromes, Familial Guillain-Barre|Syndromes, Guillain-Barré	Immune system disease|Nervous system disease
Gynatresia	MESH:D006175	DO:DOID:429	Absence of a normal opening in the lumen of the female genital tract, from the FALLOPIAN TUBES to the VAGINA. This anomaly may be congenital or acquired due to injuries, diseases, or TISSUE ADHESIONS.	MESH:D005831	C12.050.351.500.320|C12.100.250.320	C12.050.351.500|C12.100.250	Asherman's Syndrome|Ashermans Syndrome|Asherman Syndrome|Gynatresias|Intrauterine Synechiae|Syndrome, Asherman|Syndrome, Asherman's|Synechiae, Intrauterine|Synechiae, Uterine|Uterine Synechiae	Urogenital disease (female)
Gynecomastia	MESH:D006177	DO:DOID:11603|DO:DOID:12698	Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.	MESH:D001941	C17.800.090.875	C17.800.090	Adolescent Gynecomastia|Breast Enlargement, Male|Enlargement, Male Breast|Gynecomastia, Adolescent|Gynecomastia, Infant|Gynecomastia, Newborn|Infant Gynecomastia|Male Breast Enlargement|Newborn Gynecomastia	Skin disease
Gynecomastia, Familial	MESH:C564416			MESH:D006177	C17.800.090.875/C564416	C17.800.090.875		Skin disease
Hair Diseases	MESH:D006201	DO:DOID:421	Diseases affecting the orderly growth and persistence of hair.	MESH:D012871	C17.800.329	C17.800	Hair Disease	Skin disease
Hairy Ears	MESH:C562484			MESH:D006983	C17.800.329.875/C562484	C17.800.329.875	Hypertrichosis Pinnae Auris	Skin disease
Hairy elbows	MESH:C535618			MESH:D006130|MESH:D006983	C17.800.329.875/C535618|C23.550.393/C535618	C17.800.329.875|C23.550.393	Hypertrichosis cubiti|Hypertrichosis cubiti short stature|MacDermot Patton Williams syndrome	Pathology (process)|Skin disease
Hairy nose tip	MESH:C535619			MESH:D006983	C17.800.329.875/C535619	C17.800.329.875		Skin disease
Hallucinations	MESH:D006212		Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.	MESH:D010468	C10.597.606.762.300|C23.888.592.604.764.300	C10.597.606.762|C23.888.592.604.764	Auditory Hallucination|Auditory Hallucinations|Auditory Hallucinations, Verbal|Auditory Hallucination, Verbal|Body Sensation Hallucination|Body Sensation Hallucinations|Dissociative Hallucination|Dissociative Hallucinations|Elementary Hallucination|Elementary Hallucinations|Gustatory Hallucination|Gustatory Hallucinations|Hallucination|Hallucination, Auditory|Hallucination, Dissociative|Hallucination, Elementary|Hallucination, Gustatory|Hallucination, Hypnagogic|Hallucination, Hypnapompic|Hallucination, Kinesthetic|Hallucination, Mood Congruent|Hallucination, Mood Incongruent|Hallucination of Body Sensation|Hallucination, Olfactory|Hallucination, Organic|Hallucination, Reflex|Hallucinations, Auditory|Hallucinations, Dissociative|Hallucinations, Elementary|Hallucination, Sensory|Hallucinations, Formed, of People|Hallucinations, Gustatory|Hallucinations, Hypnagogic|Hallucinations, Hypnapompic|Hallucinations, Internal Body Sensation|Hallucinations, Kinesthetic|Hallucinations, Mood Congruent|Hallucinations, Mood Incongruent|Hallucinations, Olfactory|Hallucination, Somatic|Hallucinations, Organic|Hallucinations, Reflex|Hallucinations, Sensory|Hallucinations, Somatic|Hallucinations, Tactile|Hallucinations, Verbal Auditory|Hallucinations, Visual|Hallucinations, Visual, Formed|Hallucinations, Visual, Unformed|Hallucination, Tactile|Hallucination, Verbal Auditory|Hallucination, Visual|Hypnagogic Hallucination|Hypnagogic Hallucinations|Hypnapompic Hallucination|Hypnapompic Hallucinations|Kinesthetic Hallucination|Kinesthetic Hallucinations|Mood Congruent Hallucination|Mood Congruent Hallucinations|Mood Incongruent Hallucination|Mood Incongruent Hallucinations|Olfactory Hallucination|Olfactory Hallucinations|Organic Hallucination|Organic Hallucinations|Reflex Hallucination|Reflex Hallucinations|Sensory Hallucination|Sensory Hallucinations|Somatic Hallucination|Somatic Hallucinations|Tactile Hallucination|Tactile Hallucinations|Verbal Auditory Hallucination|Verbal Auditory Hallucinations|Visual Hallucination|Visual Hallucinations	Nervous system disease|Signs and symptoms
Hallux Limitus	MESH:D020857		A bony proliferation and articular degeneration of the first METATARSOPHALANGEAL JOINT that is characterized by pain and a progressive decrease in the dorsiflexion range of motion.	MESH:D005531|MESH:D007592|MESH:D018409	C05.330.488.300|C05.550.445|C26.558.300.500	C05.330.488|C05.550|C26.558.300	Limitus, Hallux	Musculoskeletal disease|Wounds and injuries
Hallux Rigidus	MESH:D020859		A condition caused by degenerative arthritis (see OSTEOARTHRITIS) of the METATARSOPHALANGEAL JOINT of the great toe and characterized by pain and limited dorsiflexion, but relatively unrestricted plantar flexion.	MESH:D005531|MESH:D007592	C05.330.488.310|C05.550.450	C05.330.488|C05.550	Rigidus, Hallux	Musculoskeletal disease
Hallux Valgus	MESH:D006215		Lateral displacement of the great toe (HALLUX), producing deformity of the first METATARSOPHALANGEAL JOINT with callous, bursa, or BUNION formation over the bony prominence.	MESH:D005530	C05.330.610	C05.330	Hallux Abductovalgus	Musculoskeletal disease
Hallux Varus	MESH:D050488		Displacement of the great toe (HALLUX) towards the midline or away from the other TOES. It can be congenital or acquired.	MESH:D005530	C05.330.612	C05.330	Metatarsus Primus Varus	Musculoskeletal disease
Hamartoma	MESH:D006222		A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.	MESH:D009369	C04.445	C04	Hamartomas	Cancer
Hamartoma, Precalcaneal Congenital Fibrolipomatous	MESH:C565226			MESH:D006222	C04.445/C565226	C04.445	Precalcaneal congenital fibrolipomatous hamartoma	Cancer
Hamman-Rich Syndrome	MESH:D000080203	DO:DOID:2797	Acute idiopathic interstitial pneumonitis characterized by diffuse PULMONARY ALVEOLI damage with uniform edematous connective tissue proliferation. It is often associated with extensive fibroblastic distortion of the lung parenchyma and leads to ADULT RESPIRATORY DISTRESS SYNDROME in later stages.	MESH:D054990	C08.381.483.652.500.500	C08.381.483.652.500	Acute Interstitial Pneumonia|Acute Interstitial Pneumonias|Acute Interstitial Pneumonitides|Acute Interstitial Pneumonitis|Hamman Rich Disease|Hamman-Rich Disease|Hamman Rich Syndrome|Interstitial Pneumonia, Acute|Interstitial Pneumonitis, Acute|Pneumonia, Acute Interstitial|Pneumonitis, Acute Interstitial	Respiratory tract disease
Hammer Toe Syndrome	MESH:D037801		A condition characterized by a series of interrelated digital symptoms and joint changes of the lesser digits and METATARSOPHALANGEAL JOINTS of the FOOT. The syndrome can include some or all of the following conditions: hammer toe, claw toe, mallet toe, overlapping fifth toe, curly toe, EXOSTOSIS; HYPEROSTOSIS; interdigital heloma, or contracted toe.	MESH:D005530	C05.330.615	C05.330	Clawtoe|Claw Toe|Clawtoes|Claw Toes|Hammer Toe|Hammer Toes|Hammertoe Syndrome|Mallet Toe|Mallet Toes|Toe, Claw|Toe, Hammer|Toe, Mallet|Toes, Claw|Toes, Hammer|Toes, Mallet	Musculoskeletal disease
Hand-Arm Vibration Syndrome	MESH:D053421		An occupational disorder resulting from prolonged exposure to vibration, affecting the fingers, hands, and forearms. It occurs in workers who regularly use vibrating tools such as jackhammers, power chain saws, riveters, etc. Symptoms include episodic finger blanching, NUMBNESS, tingling, and loss of nerve sensitivity.	MESH:D009784|MESH:D010523|MESH:D014652	C10.668.829.380|C14.907.440|C24.400	C10.668.829|C14.907|C24	Hand Arm Vibration Syndrome|Hand-Arm Vibration Syndromes|Syndrome, Hand-Arm Vibration|Syndromes, Hand-Arm Vibration|Vibration Syndrome, Hand-Arm|Vibration Syndromes, Hand-Arm	Cardiovascular disease|Nervous system disease|Occupational disease
Hand Deformities	MESH:D006226		Alterations or deviations from normal shape or size which result in a disfigurement of the hand.	MESH:D009140	C05.390	C05	Deformities, Hand|Deformity, Hand|Hand Deformity	Musculoskeletal disease
Hand Deformities, Acquired	MESH:D006227		Deformities of the hand, or a part of the hand, acquired after birth as the result of injury or disease.	MESH:D006226	C05.390.110	C05.390	Acquired Hand Deformities|Acquired Hand Deformity|Deformities, Acquired Hand|Deformity, Acquired Hand|Hand Deformity, Acquired	Musculoskeletal disease
Hand Dermatoses	MESH:D006229	DO:DOID:3158	Skin diseases involving the HANDS.	MESH:D012871	C17.800.338	C17.800	Dermatoses, Hand|Dermatosis, Hand|Hand Dermatosis	Skin disease
Hand, Foot and Mouth Disease	MESH:D006232	DO:DOID:10881	A mild, highly infectious viral disease of children, characterized by vesicular lesions in the mouth and on the hands and feet. It is caused by coxsackieviruses A.	MESH:D003384	C01.925.782.687.359.213.331	C01.925.782.687.359.213	Hand Foot and Mouth Disease|Hand, Foot, and Mouth Disease|Hand, Foot, Mouth Disease	Viral disease
Hand-Foot Syndrome	MESH:D060831		Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.	MESH:D003875	C17.800.174.600.587|C25.100.468.380.587	C17.800.174.600|C25.100.468.380	Acral Erythema, Chemotherapy-Induced|Acral Erythemas, Chemotherapy-Induced|Chemotherapy Induced Acral Erythema|Chemotherapy-Induced Acral Erythema|Chemotherapy-Induced Acral Erythemas|Chemotherapy Induced Palmoplantar Erythrodysesthesia|Chemotherapy-Induced Palmoplantar Erythrodysesthesia|Chemotherapy-Induced Palmoplantar Erythrodysesthesias|Hand Foot Syndrome|Hand-Foot Syndromes|Palmoplantar Erythrodysesthesia, Chemotherapy-Induced|Palmoplantar Erythrodysesthesias, Chemotherapy-Induced|Syndrome, Hand-Foot|Syndromes, Hand-Foot	Skin disease
Hantavirosis	MESH:C535630			MESH:D006480	C01.925.782.147.420.400/C535630|C01.925.782.417.300/C535630	C01.925.782.147.420.400|C01.925.782.417.300	Hantavirus fever	Viral disease
Hantavirus Infections	MESH:D018778		Infections with viruses of the genus HANTAVIRUS. This is associated with at least four clinical syndromes: HEMORRHAGIC FEVER WITH RENAL SYNDROME caused by viruses of the Hantaan group; a milder form of HFRS caused by SEOUL VIRUS; nephropathia epidemica caused by PUUMALA VIRUS; and HANTAVIRUS PULMONARY SYNDROME caused by SIN NOMBRE VIRUS.	MESH:D002044	C01.925.782.147.420	C01.925.782.147	Hantavirus Infection|Infections, Hantavirus	Viral disease
Hantavirus Pulmonary Syndrome	MESH:D018804	DO:DOID:14472	Acute respiratory illness in humans caused by the SIN NOMBRE VIRUS whose primary rodent reservoir is the deer mouse Peromyscus maniculatus. First identified in the southwestern United States, this syndrome is characterized most commonly by fever, myalgias, headache, cough, and rapid respiratory failure.	MESH:D012131|MESH:D018778	C01.925.782.147.420.380|C08.618.846.450	C01.925.782.147.420|C08.618.846	Hantavirus Associated Respiratory Distress Syndrome|Hantavirus-Associated Respiratory Distress Syndrome|Hantavirus Pulmonary Syndromes|HARDS	Respiratory tract disease|Viral disease
Hapnes Boman Skeie syndrome	MESH:C536960			MESH:D000798|MESH:D008068|MESH:D012983	C04.588.839/C536960|C14.907.077/C536960|C17.800.463/C536960|C18.452.584.718/C536960	C04.588.839|C14.907.077|C17.800.463|C18.452.584.718	Tendons, Extensor, of Fingers, Anomalous Insertion of	Cancer|Cardiovascular disease|Metabolic disease|Skin disease
Harding ataxia	MESH:C535633			MESH:D002524	C10.228.140.252.190/C535633|C10.597.350.090.500/C535633|C23.888.592.350.090.200/C535633	C10.228.140.252.190|C10.597.350.090.500|C23.888.592.350.090.200	Ataxia, harding type|Cerebellar ataxia early onset with retained tendon reflex|Cerebellar Ataxia, Early-Onset, with Retained Tendon Reflexes	Nervous system disease|Signs and symptoms
Harlequin syndrome	MESH:C535634			MESH:D001342|MESH:D005483|MESH:D007007	C10.177/C535634|C17.800.946.370/C535634|C23.888.885.344/C535634	C10.177|C17.800.946.370|C23.888.885.344	Sudden onset of unilateral flushing and sweating|Unilateral loss of facial flushing and sweating with contralateral anhidrosis	Nervous system disease|Signs and symptoms|Skin disease
Hashimoto-Pritzker syndrome	MESH:C535843			MESH:D006646	C08.381.483.375/C535843|C15.604.250.400/C535843	C08.381.483.375|C15.604.250.400	Hashimoto-Pritzker disease|Hashimoto-Pritzker histiocytosis	Lymphatic disease|Respiratory tract disease
Hashimoto's encephalitis	MESH:C535841			MESH:D004660|MESH:D050031	C10.228.140.430/C535841|C10.586.250/C535841|C19.874.871.102.500/C535841	C10.228.140.430|C10.586.250|C19.874.871.102.500	Hashimoto's encephalopathy|Steroid-responsive encephalopathy associated with autoimmune thyroiditis	Endocrine system disease|Nervous system disease
Headache Disorders	MESH:D020773		Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)	MESH:D001927	C10.228.140.546	C10.228.140	Cephalgia Syndrome|Cephalgia Syndromes|Chronic Daily Headache|Chronic Daily Headaches|Chronic Headache|Chronic Headaches|Daily Headache, Chronic|Daily Headaches, Chronic|Headache, Chronic|Headache, Chronic Daily|Headache Disorder|Headache, Intractable|Headaches, Chronic|Headaches, Chronic Daily|Headaches, Intractable|Headache Syndrome|Headache Syndromes|Intractable Headache|Intractable Headaches|Syndrome, Headache	Nervous system disease
Headache Disorders, Primary	MESH:D051270		Conditions in which the primary symptom is HEADACHE and the headache cannot be attributed to any known causes.	MESH:D020773	C10.228.140.546.399	C10.228.140.546	Alarm Clock Headache|Alarm Clock Headaches|Benign Cough Headache|Benign Cough Headaches|Benign Exertional Headache|Benign Exertional Headaches|Clock Headache, Alarm|Clock Headaches, Alarm|Cough Headache|Cough Headache, Benign|Cough Headaches, Benign|Disorder, Primary Headache|Disorders, Primary Headache|Exertional Headache, Benign|Exertional Headaches, Benign|Headache, Alarm Clock|Headache, Benign Cough|Headache, Benign Exertional|Headache, Cough|Headache Disorder, Primary|Headache, Hypnic|Headache, Ice-Pick|Headache, Primary Cough|Headache, Primary Exertional|Headache, Primary Stabbing|Headache, Primary Thunderclap|Headaches, Alarm Clock|Headaches, Benign Cough|Headaches, Benign Exertional|Headaches, Ice-Pick|Headache, Stabbing|Headache Syndrome, Hypnic|Headache Syndromes, Hypnic|Headache, Thunderclap|Hypnic Headache|Hypnic Headache Syndrome|Hypnic Headache Syndromes|Ice Pick Headache|Ice-Pick Headache|Ice-Pick Headaches|Primary Cough Headache|Primary Exertional Headache|Primary Headache Disorder|Primary Headache Disorders|Primary Stabbing Headache|Primary Thunderclap Headache|Stabbing Headache|Thunderclap Headache	Nervous system disease
Headache Disorders, Secondary	MESH:D051271		Conditions with HEADACHE symptom that can be attributed to a variety of causes including BRAIN VASCULAR DISORDERS; WOUNDS AND INJURIES; INFECTION; drug use or its withdrawal.	MESH:D020773	C10.228.140.546.699	C10.228.140.546	Analgesic Overuse Headache|Analgesic Overuse Headaches|Analgesic Rebound Headache|Analgesic Rebound Headaches|Disorder, Secondary Headache|Disorders, Secondary Headache|Headache, Analgesic Overuse|Headache, Analgesic Rebound|Headache Disorder, Secondary|Headache, Medication Overuse|Headaches, Analgesic Overuse|Headaches, Analgesic Rebound|Headaches, Medication Overuse|Medication Overuse Headache|Medication Overuse Headaches|Overuse Headache, Medication|Overuse Headaches, Medication|Secondary Headache Disorder|Secondary Headache Disorders	Nervous system disease
Head and Neck Neoplasms	MESH:D006258	DO:DOID:11934	Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)	MESH:D009371	C04.588.443	C04.588	Cancer, Head|Cancer, Neck|Cancer of Head|Cancer of Head and Neck|Cancer of Neck|Cancer of the Head|Cancer of the Head and Neck|Cancer of the Neck|Cancers, Head|Cancers, Neck|Head and Neck Cancer|Head and Neck Neoplasm|Head Cancer|Head Cancers|Head, Neck Neoplasms|Head Neoplasm|Head Neoplasms|Neck Cancer|Neck Cancers|Neck Neoplasm|Neck Neoplasms|Neoplasm, Head|Neoplasm, Neck|Neoplasms, Head|Neoplasms, Head and Neck|Neoplasms, Neck|Neoplasms, UADT|Neoplasms, Upper Aerodigestive Tract|Neoplasm, UADT|UADT Neoplasm|UADT Neoplasms|Upper Aerodigestive Tract Neoplasm|Upper Aerodigestive Tract Neoplasms	Cancer
Head Injuries, Closed	MESH:D016489		Traumatic injuries to the cranium where the integrity of the skull is not compromised and no bone fragments or other objects penetrate the skull and DURA MATER. This frequently results in mechanical injury being transmitted to intracranial structures which may produce TRAUMATIC BRAIN INJURIES, hemorrhage, or CRANIAL NERVE INJURIES. (From Rowland, Merritt's Textbook of Neurology, 9th ed, p417)	MESH:D006259|MESH:D014949	C10.900.300.350|C26.915.300.450|C26.974.382	C10.900.300|C26.915.300|C26.974	Blunt Head Injuries|Blunt Head Injury|Closed Head Injuries|Closed Head Injury|Closed Head Trauma|Closed Head Traumas|Head Injuries, Blunt|Head Injuries, Nonpenetrating|Head Injury, Blunt|Head Injury, Closed|Head Injury, Nonpenetrating|Head Trauma, Closed|Head Traumas, Closed|Injuries, Closed Head|Nonpenetrating Head Injuries|Nonpenetrating Head Injury	Nervous system disease|Wounds and injuries
Head Injuries, Penetrating	MESH:D020197		Head injuries which feature compromise of the skull and dura mater. These may result from gunshot wounds (WOUNDS, GUNSHOT), stab wounds (WOUNDS, STAB), and other forms of trauma.	MESH:D006259|MESH:D014950	C10.900.300.675|C26.915.300.475|C26.986.500	C10.900.300|C26.915.300|C26.986	Brain Injuries, Penetrating|Brain Injury, Penetrating|Cranial Trauma, Penetrating|Cranial Traumas, Penetrating|Craniocerebral Trauma, Penetrating|Craniocerebral Traumas, Penetrating|Head Injuries, Penetrating, Missile|Head Injury, Penetrating|Head Trauma, Penetrating|Head Traumas, Penetrating|Injuries, Penetrating Head|Injury, Penetrating Head|Missile Injuries, Penetrating, Head|Penetrating Brain Injuries|Penetrating Brain Injury|Penetrating Cranial Trauma|Penetrating Cranial Traumas|Penetrating Craniocerebral Trauma|Penetrating Craniocerebral Traumas|Penetrating Head Injuries|Penetrating Head Injury|Penetrating Head Trauma|Penetrating Head Traumas|Penetrating Missile Injuries, Head|Trauma, Penetrating Cranial|Trauma, Penetrating Craniocerebral|Trauma, Penetrating Head|Traumas, Penetrating Cranial|Traumas, Penetrating Craniocerebral|Traumas, Penetrating Head	Nervous system disease|Wounds and injuries
Healthcare-Associated Pneumonia	MESH:D000077299		Infection of the lung often accompanied by inflammation that is acquired through an interaction within a healthcare institution often through a therapeutic experience (e.g., use of catheters or ventilators).	MESH:D003428|MESH:D011014	C01.248.250|C01.748.610.300|C08.381.677.300|C08.730.610.300|C23.550.291.875.500.500	C01.248|C01.748.610|C08.381.677|C08.730.610|C23.550.291.875.500	Healthcare Associated Pneumonia|Healthcare-Associated Pneumonias|Hospital Acquired Pneumonia|Hospital Acquired Pneumonias|Nosocomial Pneumonia|Nosocomial Pneumonias|Pneumonia, Healthcare-Associated|Pneumonia, Hospital Acquired|Pneumonia, Nosocomial	Pathology (process)|Respiratory tract disease
Hearing Disorders	MESH:D006311		Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices, including the sensorineural pathways.	MESH:D004427|MESH:D012678	C09.218.458|C10.597.751.418|C23.888.592.763.393	C09.218|C10.597.751|C23.888.592.763	Distorted Hearing|Dysacusis|Hearing Disorder|Hearing, Distorted|Paracousis|Paracusis	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss	MESH:D034381		A general term for the complete or partial loss of the ability to hear from one or both ears.	MESH:D006311	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	C09.218.458|C10.597.751.418|C23.888.592.763.393	Deafnesses, Transitory|Deafness, Transitory|Hearing Impairment|Hearing Loss, Transitory|Hypoacuses|Hypoacusis|Loss, Hearing|Loss, Transitory Hearing|Transitory Deafness|Transitory Deafnesses|Transitory Hearing Loss|Transitory Hearing Losses	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, Bilateral	MESH:D006312		Partial hearing loss in both ears.	MESH:D034381	C09.218.458.341.374|C10.597.751.418.341.374|C23.888.592.763.393.341.374	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	Bilateral Deafness|Bilateral, Deafness|Bilateral Hearing Loss|Bilateral Hearing Losses|Bilaterals, Deafness|Deafness Bilateral|Deafness, Bilateral|Deafness Bilaterals|Loss, Bilateral Hearing	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, Central	MESH:D006313		Hearing loss due to disease of the AUDITORY PATHWAYS (in the CENTRAL NERVOUS SYSTEM) which originate in the COCHLEAR NUCLEI of the PONS and then ascend bilaterally to the MIDBRAIN, the THALAMUS, and then the AUDITORY CORTEX in the TEMPORAL LOBE. Bilateral lesions of the auditory pathways are usually required to cause central hearing loss. Cortical deafness refers to loss of hearing due to bilateral auditory cortex lesions. Unilateral BRAIN STEM lesions involving the cochlear nuclei may result in unilateral hearing loss.	MESH:D001304|MESH:D006319	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C23.888.592.763.393.341.887.432	C09.218.458.341.887|C09.218.807.186|C10.228.140.068|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Central Hearing Loss|Cortical Deafness|Deafness, Cortical	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO	OMIM:613290			MESH:D034381	C09.218.458.341/613290|C10.597.751.418.341/613290|C23.888.592.763.393.341/613290	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	CIHL	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, Conductive	MESH:D006314		Hearing loss due to interference with the mechanical reception or amplification of sound to the COCHLEA. The interference is in the outer or middle ear involving the EAR CANAL; TYMPANIC MEMBRANE; or EAR OSSICLES.	MESH:D034381	C09.218.458.341.562|C10.597.751.418.341.562|C23.888.592.763.393.341.562	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	Conductive Hearing Loss	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, Functional	MESH:D006315		Hearing loss without a physical basis. Often observed in patients with psychological or behavioral disorders.	MESH:D034381	C09.218.458.341.750|C10.597.751.418.341.750|C23.888.592.763.393.341.750	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	Functional Hearing Loss|Hearing Loss, Nonorganic|Hearing Loss, Psychogenic|Nonorganic Hearing Loss|Psychogenic Hearing Loss	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, High-Frequency	MESH:D006316		Hearing loss in frequencies above 1000 hertz.	MESH:D034381	C09.218.458.341.812|C10.597.751.418.341.812|C23.888.592.763.393.341.812	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	Hearing Loss, High Frequency|High-Frequency Hearing Loss	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, Mixed Conductive-Sensorineural	MESH:D046089		Hearing loss due to damage or impairment of both the conductive elements (HEARING LOSS, CONDUCTIVE) and the sensorineural elements (HEARING LOSS, SENSORINEURAL) of the ear.	MESH:D034381	C09.218.458.341.849|C10.597.751.418.341.849|C23.888.592.763.393.341.849	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	Hearing Loss, Mixed|Hearing Loss, Mixed Conductive Sensorineural|Losses, Mixed Hearing|Loss, Mixed Hearing|Mixed Hearing Loss	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, Noise-Induced	MESH:D006317		Hearing loss due to exposure to explosive loud noise or chronic exposure to sound level greater than 85 dB. The hearing loss is often in the frequency range 4000-6000 hertz.	MESH:D006319	C09.218.458.341.887.460|C10.597.751.418.341.887.460|C23.888.592.763.393.341.887.460	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Acoustic Trauma|Hearing Loss, Noise Induced|Noise-Induced Hearing Loss	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, Sensorineural	MESH:D006319	DO:DOID:10003	Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.	MESH:D034381	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	Cochlear Hearing Loss|Deafnesses, Neurosensory|Deafnesses, Sensoryneural|Deafness Neurosensory|Deafness, Neurosensory|Deafness, Sensoryneural|Hearing Loss, Cochlear|Neurosensory Deafness|Neurosensory Deafnesses|Sensorineural Hearing Loss|Sensoryneural Deafness|Sensoryneural Deafnesses	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, Sudden	MESH:D003639		Sensorineural hearing loss which develops suddenly over a period of hours or a few days. It varies in severity from mild to total deafness. Sudden deafness can be due to head trauma, vascular diseases, infections, or can appear without obvious cause or warning.	MESH:D034381	C09.218.458.341.900|C10.597.751.418.341.900|C23.888.592.763.393.341.900	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	Deafness, Sudden|Sudden Deafness|Sudden Hearing Loss	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hearing Loss, Unilateral	MESH:D046088		Partial or complete hearing loss in one ear.	MESH:D034381	C09.218.458.341.950|C10.597.751.418.341.950|C23.888.592.763.393.341.950	C09.218.458.341|C10.597.751.418.341|C23.888.592.763.393.341	Deafness Unilateral|Deafness, Unilateral|Unilateral Deafness|Unilateral, Deafness|Unilateral Hearing Loss	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
HEART AND BRAIN MALFORMATION SYNDROME	OMIM:616920			MESH:D006343|MESH:D008850|MESH:D009421|MESH:D011596	C10.500/616920|C10.597.606.881/616920|C11.250.566/616920|C14.240.400.560/616920|C14.280.400.560/616920|C16.131.240.400.560/616920|C16.131.384.666/616920|C16.131.666/616920|C23.888.592.604.882/616920	C10.500|C10.597.606.881|C11.250.566|C14.240.400.560|C14.280.400.560|C16.131.240.400.560|C16.131.384.666|C16.131.666|C23.888.592.604.882	HBMS	Cardiovascular disease|Congenital abnormality|Eye disease|Nervous system disease|Signs and symptoms
Heart Aneurysm	MESH:D006322	DO:DOID:9768	A localized bulging or dilatation in the muscle wall of a heart (MYOCARDIUM), usually in the LEFT VENTRICLE. Blood-filled aneurysms are dangerous because they may burst. Fibrous aneurysms interfere with the heart function through the loss of contractility. True aneurysm is bound by the vessel wall or cardiac wall. False aneurysms are HEMATOMA caused by myocardial rupture.	MESH:D000783|MESH:D006331	C14.280.358|C14.907.055.608	C14.280|C14.907.055	Aneurysm, Cardiac|Aneurysm, Heart|Aneurysms, Cardiac|Aneurysms, Heart|Cardiac Aneurysm|Cardiac Aneurysms|Heart Aneurysms	Cardiovascular disease
Heart Arrest	MESH:D006323	DO:DOID:0060319	Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.	MESH:D006331	C14.280.383	C14.280	Arrest, Cardiac|Arrest, Cardiopulmonary|Arrest, Heart|Asystole|Asystoles|Cardiac Arrest|Cardiopulmonary Arrest	Cardiovascular disease
Heart Block	MESH:D006327		Impaired conduction of cardiac impulse that can occur anywhere along the conduction pathway, such as between the SINOATRIAL NODE and the right atrium (SA block) or between atria and ventricles (AV block). Heart blocks can be classified by the duration, frequency, or completeness of conduction block. Reversibility depends on the degree of structural or functional defects.	MESH:D000075224|MESH:D001145	C14.280.067.558|C14.280.123.500|C23.550.073.425	C14.280.067|C14.280.123|C23.550.073	Atrioventricular Dissociation|Atrioventricular Dissociations|Auriculo Ventricular Dissociation|Auriculo-Ventricular Dissociation|Auriculo-Ventricular Dissociations|A V Dissociation|A-V Dissociation|A-V Dissociations|Block, Heart|Blocks, Heart|Dissociation, Atrioventricular|Dissociation, Auriculo-Ventricular|Dissociation, A-V|Dissociations, Atrioventricular|Dissociations, Auriculo-Ventricular|Dissociations, A-V|Heart Blocks	Cardiovascular disease|Pathology (process)
Heart Block, Nonprogressive	MESH:C566185			MESH:D006327	C14.280.067.558/C566185|C14.280.123.500/C566185|C23.550.073.425/C566185	C14.280.067.558|C14.280.123.500|C23.550.073.425		Cardiovascular disease|Pathology (process)
Heart Defects, Congenital	MESH:D006330	DO:DOID:1682	Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.	MESH:D006331|MESH:D018376	C14.240.400|C14.280.400|C16.131.240.400	C14.240|C14.280|C16.131.240	Abnormality, Heart|Congenital Heart Defect|Congenital Heart Defects|Congenital Heart Disease|Congenital Heart Diseases|Defect, Congenital Heart|Defects, Congenital Heart|Disease, Congenital Heart|Heart Abnormalities|Heart Abnormality|Heart Defect, Congenital|Heart Disease, Congenital|Heart, Malformation Of|Malformation Of Heart|Malformation Of Hearts	Cardiovascular disease|Congenital abnormality
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES	OMIM:600001	DO:DOID:0111733		MESH:D000013|MESH:D006330	C14.240.400/600001|C14.280.400/600001|C16.131.240.400/600001|C16.131/600001	C14.240.400|C14.280.400|C16.131|C16.131.240.400	HDCA|PACHD|PANCREATIC AGENESIS AND CONGENITAL HEART DEFECTS|PANCREATIC HYPOPLASIA, CONGENITAL, WITH DIABETES MELLITUS AND CONGENITAL HEART DISEASE	Cardiovascular disease|Congenital abnormality
Heart defects limb shortening	MESH:C535850			MESH:D000015|MESH:D006330|MESH:D017880	C05.660.585/C535850|C14.240.400/C535850|C14.280.400/C535850|C16.131.077/C535850|C16.131.240.400/C535850|C16.131.621.585/C535850	C05.660.585|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.585	Cardioskeletal syndrome, Kuwaiti type|Congenital heart disease and skeletal malformations	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Heart Diseases	MESH:D006331	DO:DOID:114	Pathological conditions involving the HEART including its structural and functional abnormalities.	MESH:D002318	C14.280	C14	Cardiac Disease|Cardiac Diseases|Cardiac Disorder|Cardiac Disorders|Heart Disease|Heart Disorder|Heart Disorders	Cardiovascular disease
Heart Failure	MESH:D006333	DO:DOID:6000	A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.	MESH:D006331	C14.280.434	C14.280	Cardiac Failure|Congestive Heart Failure|Decompensation, Heart|Heart Decompensation|Heart Failure, Congestive|Heart Failure, Left Sided|Heart Failure, Left-Sided|Heart Failure, Right Sided|Heart Failure, Right-Sided|Left Sided Heart Failure|Left-Sided Heart Failure|Myocardial Failure|Right Sided Heart Failure|Right-Sided Heart Failure	Cardiovascular disease
Heart Failure, Diastolic	MESH:D054144	DO:DOID:9775	Heart failure caused by abnormal myocardial relaxation during DIASTOLE leading to defective cardiac filling.	MESH:D006333	C14.280.434.611	C14.280.434	Diastolic Heart Failure|Diastolic Heart Failures|Heart Failure, Normal Ejection Fraction|Heart Failure, Preserved Ejection Fraction	Cardiovascular disease
Heart Failure, Systolic	MESH:D054143	DO:DOID:9651	Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.	MESH:D006333	C14.280.434.676	C14.280.434	Heart Failure, Reduced Ejection Fraction|Heart Failures, Systolic|Systolic Heart Failure|Systolic Heart Failures	Cardiovascular disease
Heart-hand syndrome, Spanish type	MESH:C535853			MESH:D006330|MESH:D059327	C05.660.585.262/C535853|C14.240.400/C535853|C14.280.400/C535853|C16.131.240.400/C535853|C16.131.621.585.262/C535853	C05.660.585.262|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.585.262	Brachydactyly and intraventricular conduction defect|Upper limb malformations and congenital cardiac anomalies	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Heart Neoplasms	MESH:D006338	DO:DOID:117	Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.	MESH:D006331|MESH:D013899	C04.588.894.309|C14.280.459	C04.588.894|C14.280	Cancer, Cardiac|Cancer, Heart|Cancers, Cardiac|Cancers, Heart|Carcinoma, Cardiac|Carcinomas, Cardiac|Cardiac Cancer|Cardiac Cancers|Cardiac Carcinoma|Cardiac Carcinomas|Cardiac Neoplasm|Cardiac Neoplasms|Cardiac Tumor|Cardiac Tumors|Heart Cancer|Heart Cancers|Heart Neoplasm|Heart Tumor|Heart Tumors|Intracavitary Tumors of the Heart|Myocardial Tumor (Rhabdomyomas and Fibromas)|Myocardial Tumors (Rhabdomyomas and Fibromas)|Neoplasm, Cardiac|Neoplasm, Heart|Neoplasms, Cardiac|Neoplasms, Heart|Primary Cardiac Tumors, Childhood|Tumor, Cardiac|Tumor, Heart|Tumor, Myocardial (Rhabdomyomas and Fibromas)|Tumors, Cardiac|Tumors, Heart|Tumors, Myocardial (Rhabdomyomas and Fibromas)	Cancer|Cardiovascular disease
Heart Rupture	MESH:D006341		Disease-related laceration or tearing of tissues of the heart, including the free-wall MYOCARDIUM; HEART SEPTUM; PAPILLARY MUSCLES; CHORDAE TENDINEAE; and any of the HEART VALVES. Pathological rupture usually results from myocardial infarction (HEART RUPTURE, POST-INFARCTION).	MESH:D006331	C14.280.470	C14.280	Cardiac Free Wall Rupture|Cardiac Rupture|Cardiac Ruptures|Free Wall Rupture, Heart|Heart Ruptures|Ventricular Free Wall Rupture	Cardiovascular disease
Heart Rupture, Post-Infarction	MESH:D006342		Laceration or tearing of cardiac tissues appearing after MYOCARDIAL INFARCTION.	MESH:D006341	C14.280.470.475	C14.280.470	Cardiac Rupture, Post Infarction|Cardiac Rupture, Post-Infarction|Cardiac Ruptures, Post-Infarction|Heart Rupture, Post Infarction|Heart Ruptures, Post-Infarction|Post-Infarction Cardiac Rupture|Post-Infarction Cardiac Ruptures|Post Infarction Heart Rupture|Post-Infarction Heart Rupture|Post-Infarction Heart Ruptures|Rupture, Post-Infarction Cardiac|Rupture, Post-Infarction Heart|Ruptures, Post-Infarction Cardiac|Ruptures, Post-Infarction Heart	Cardiovascular disease
Heart Septal Defects	MESH:D006343	DO:DOID:1681	Abnormalities in any part of the HEART SEPTUM resulting in abnormal communication between the left and the right chambers of the heart. The abnormal blood flow inside the heart may be caused by defects in the ATRIAL SEPTUM, the VENTRICULAR SEPTUM, or both.	MESH:D006330	C14.240.400.560|C14.280.400.560|C16.131.240.400.560	C14.240.400|C14.280.400|C16.131.240.400	Cardiac Septal Defect|Cardiac Septal Defects|Defect, Cardiac Septal|Defect, Heart Septal|Defects, Cardiac Septal|Defects, Heart Septal|Heart Septal Defect|Septal Defect, Cardiac|Septal Defect, Heart|Septal Defects, Cardiac|Septal Defects, Heart	Cardiovascular disease|Congenital abnormality
Heart Septal Defects, Atrial	MESH:D006344	DO:DOID:1882	Developmental abnormalities in any portion of the ATRIAL SEPTUM resulting in abnormal communications between the two upper chambers of the heart. Classification of atrial septal defects is based on location of the communication and types of incomplete fusion of atrial septa with the ENDOCARDIAL CUSHIONS in the fetal heart. They include ostium primum, ostium secundum, sinus venosus, and coronary sinus defects.	MESH:D006343	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	C14.240.400.560|C14.280.400.560|C16.131.240.400.560	Atrial Septal Defect|Atrial Septal Defect Ostium Primum|Atrial Septal Defects|Defect, Atrial Septal|Defects, Atrial Septal|Ostium Primum, Persistent|Ostium Secundum Atrial Septal Defect|Persistent Ostium Primum|Primum, Persistent Ostium|Septal Defect, Atrial|Septal Defects, Atrial	Cardiovascular disease|Congenital abnormality
Heart Septal Defects, Ventricular	MESH:D006345	DO:DOID:1657|OMIM:614429|OMIM:614431|OMIM:614432	Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.	MESH:D006343	C14.240.400.560.540|C14.280.400.560.540|C16.131.240.400.560.540	C14.240.400.560|C14.280.400.560|C16.131.240.400.560	Defect, Intraventricular Septal|Defects, Intraventricular Septal|Defect, Ventricular Septal|Intraventricular Septal Defect|Intraventricular Septal Defects|Septal Defect, Intraventricular|Septal Defects, Intraventricular|Septal Defects, Ventricular|Septal Defect, Ventricular|Ventricular Septal Defect|VENTRICULAR SEPTAL DEFECT 1|VENTRICULAR SEPTAL DEFECT 2|VENTRICULAR SEPTAL DEFECT 3|Ventricular Septal Defects|VSD1|VSD2|VSD3	Cardiovascular disease|Congenital abnormality
Heart Valve Diseases	MESH:D006349	DO:DOID:4079	Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).	MESH:D006331	C14.280.484	C14.280	Disease, Heart Valvular|Heart Disease, Valvular|Heart Valve Disease|Heart Valvular Disease|Heart Valvular Diseases|Valve Disease, Heart|Valvular Disease, Heart|Valvular Heart Disease|Valvular Heart Diseases	Cardiovascular disease
Heart Valve Prolapse	MESH:D016127	DO:DOID:4079	Downward displacement of any one of the HEART VALVES from its normal position. This usually results in failed valve closure.	MESH:D006349	C14.280.484.400	C14.280.484	Heart Valve Prolapses|Prolapse, Heart Valve|Prolapses, Heart Valve|Valve Prolapse, Heart|Valve Prolapses, Heart	Cardiovascular disease
Heavy Chain Disease	MESH:D006362	DO:DOID:0060125	A disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. The amino acid sequences of the N-(amino-) terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross-links to the light chains. The defect arises through faulty coupling of the variable (V) and constant (C) region genes.	MESH:D008232|MESH:D010265	C15.378.147.780.490|C15.604.515.435|C20.683.780.490	C15.378.147.780|C15.604.515|C20.683.780	Franklin Disease|Franklin's Disease|Franklins Disease|gamma Chain Disease|gamma-Chain Disease|gamma-Chain Diseases|Heavy Chain Diseases|mu Chain Disease|mu-Chain Disease|mu-Chain Diseases	Blood disease|Immune system disease|Lymphatic disease
heavy chain disease proteins, human	MESH:C032598			MESH:D006362	C15.378.147.780.490/C032598|C15.604.515.435/C032598|C20.683.780.490/C032598	C15.378.147.780.490|C15.604.515.435|C20.683.780.490		Blood disease|Immune system disease|Lymphatic disease
Heavy Metal Poisoning	MESH:D000075322		Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of HEAVY METALS. Acute and chronic exposures can cause ANEMIA; KIDNEY and LIVER damage; PULMONARY EDEMA; MEMORY LOSS and behavioral changes; bone deformities in children; and MISCARRIAGE or PREMATURE LABOR in pregnant women.	MESH:D011041	C25.723.522	C25.723	Heavy Metal Poisonings|Metal Poisoning, Heavy|Metal Poisonings, Heavy|Poisoning, Heavy Metal|Poisonings, Heavy Metal	
Heavy Metal Poisoning, Nervous System	MESH:D020260		Conditions associated with damage or dysfunction of the nervous system caused by exposure to heavy metals, which may cause a variety of central, peripheral, or autonomic nervous system injuries.	MESH:D020258	C10.720.475	C10.720	Poisoning, Heavy Metals, Nervous System	Nervous system disease
Hecht Scott syndrome	MESH:C535856			MESH:D000015|MESH:D006228|MESH:D006330|MESH:D019465	C05.390.408/C535856|C05.660.207/C535856|C05.660.585.988.425/C535856|C14.240.400/C535856|C14.280.400/C535856|C16.131.077/C535856|C16.131.240.400/C535856|C16.131.621.207/C535856|C16.131.621.585.988.500/C535856	C05.390.408|C05.660.207|C05.660.585.988.425|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.207|C16.131.621.585.988.500	Limb deficiency-heart malformation syndrome	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Heel Spur	MESH:D036982	DO:DOID:210	A bony outgrowth on the lower surface of the CALCANEUS. Though often presenting along with plantar fasciitis (FASCIITIS, PLANTAR), they are not considered causally related.	MESH:D005096|MESH:D005534	C05.116.540.310.600|C05.360.400	C05.116.540.310|C05.360	Calcaneal Spur|Calcaneal Spurs|Heel Spurs|Spur, Calcaneal|Spur, Heel|Spurs, Calcaneal|Spurs, Heel	Musculoskeletal disease
Hemangioblastoma	MESH:D018325	DO:DOID:5241	A benign tumor of the nervous system that may occur sporadically or in association with VON HIPPEL-LINDAU DISEASE. It accounts for approximately 2% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Histologically, the tumors are composed of multiple capillary and sinusoidal channels lined with endothelial cells and clusters of lipid-laden pseudoxanthoma cells. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, retina, and supratentorial compartment. Cerebellar hemangioblastomas usually present in the third decade with INTRACRANIAL HYPERTENSION, and ataxia. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2071-2)	MESH:D018324	C04.557.645.375.380.370	C04.557.645.375.380	Hemangioblastoma, Multiple|Hemangioblastomas|Hemangioblastomas, Multiple|Multiple Hemangioblastoma|Multiple Hemangioblastomas	Cancer
Hemangioendothelioma	MESH:D006390		A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866)	MESH:D006391	C04.557.645.375.370	C04.557.645.375	Endotheliomas, Vascular|Endothelioma, Vascular|Hemangio Endothelioma|Hemangio-Endothelioma|Hemangioendotheliomas|Hemangio-Endotheliomas|Vascular Endothelioma|Vascular Endotheliomas	Cancer
Hemangioendothelioma, Epithelioid	MESH:D018323		A tumor of medium-to-large veins, composed of plump-to-spindled endothelial cells that bulge into vascular spaces in a tombstone-like fashion. These tumors are thought to have 'borderline' aggression, where one-third develop local recurrences, but only rarely metastasize. It is unclear whether the epithelioid hemangioendothelioma is truly neoplastic or an exuberant tissue reaction, nor is it clear if this is equivalent to Kimura's disease (see ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA). (Segen, Dictionary of Modern Medicine, 1992)	MESH:D006390	C04.557.645.375.370.380	C04.557.645.375.370	Epithelioid Hemangioendothelioma|Epithelioid Hemangioendotheliomas|Hemangioendotheliomas, Epithelioid	Cancer
Hemangioma	MESH:D006391	DO:DOID:255|DO:DOID:277|DO:DOID:468|DO:DOID:474	A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)	MESH:D009383	C04.557.645.375	C04.557.645	Angioma|Chorangioma|Chorangiomas|Chorioangioma|Chorioangiomas|Hemangioma, Histiocytoid|Hemangioma, Intramuscular|Hemangiomas|Hemangiomas, Histiocytoid|Hemangiomas, Intramuscular|Histiocytoid Hemangioma|Histiocytoid Hemangiomas|Intramuscular Hemangioma|Intramuscular Hemangiomas	Cancer
Hemangioma, Capillary	MESH:D018324	DO:DOID:2725	A dull red, firm, dome-shaped hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. (Dorland, 27th ed)	MESH:D006391	C04.557.645.375.380	C04.557.645.375	Capillary Hemangioma|Capillary Hemangiomas|Hemangiomas, Capillary	Cancer
Hemangioma, Cavernous	MESH:D006392	DO:DOID:483	A vascular anomaly that is a collection of tortuous BLOOD VESSELS and connective tissue. This tumor-like mass with the large vascular space is filled with blood and usually appears as a strawberry-like lesion in the subcutaneous areas of the face, extremities, or other regions of the body including the central nervous system.	MESH:D006391|MESH:D020141	C04.557.645.375.385|C14.907.454.385|C15.378.463.515.385	C04.557.645.375|C14.907.454|C15.378.463.515	Angioma, Cavernous|Cavernous Angioma|Cavernous Hemangioma|Cavernous Hemangiomas|Hemangiomas, Cavernous|Hemangiomas, Strawberry|Hemangioma, Strawberry|Strawberry Hemangioma|Strawberry Hemangiomas	Blood disease|Cancer|Cardiovascular disease
Hemangioma, Cavernous, Central Nervous System	MESH:D020786	OMIM:116860	A vascular anomaly composed of a collection of large, thin walled tortuous VEINS that can occur in any part of the central nervous system but lack intervening nervous tissue. Familial occurrence is common and has been associated with a number of genes mapped to 7q, 7p and 3q. Clinical features include SEIZURES; HEADACHE; STROKE; and progressive neurological deficit.	MESH:D006392|MESH:D020785	C04.557.645.375.385.500|C10.500.190.200|C14.240.850.875.249|C14.907.454.385.500|C15.378.463.515.385.500|C16.131.666.190.200	C04.557.645.375.385|C10.500.190|C14.240.850.875|C14.907.454.385|C15.378.463.515.385|C16.131.666.190	Angioma, Familial Cavernous|Angiomas, Familial Cavernous|Angiomatous Malformation, Cavernous|Angiomatous Malformations, Cavernous|Brain Cavernous Hemangioma|Brain Cavernous Hemangiomas|CAM|Capillary Malformation, Cerebral|Capillary Malformations, Cerebral|Cavernous Angioma, Central Nervous System|Cavernous Angioma, Familial|Cavernous Angiomas, Familial|Cavernous Angiomatous Malformation|Cavernous Angiomatous Malformations|Cavernous Hemangioma, Central Nervous System|Cavernous Hemangioma, Cerebral|Cavernous Hemangioma, Extracerebral|Cavernous Hemangioma, Intracerebral|Cavernous Hemangioma of Brain|Cavernous Hemangiomas, Cerebral|Cavernous Hemangiomas, Extracerebral|Cavernous Hemangiomas, Intracerebral|Cavernous Malformation, Cerebral|Cavernous Malformation, Familial|Cavernous Malformations, Cerebral|Cavernous Malformations, Familial|CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED|CCM|CCM1, INCLUDED|Central Nervous System Cavernous Hemangioma|Cerebral Capillary Malformation|Cerebral Capillary Malformations|CEREBRAL CAPILLARY MALFORMATIONS CEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED|Cerebral Cavernous Hemangioma|Cerebral Cavernous Hemangiomas|Cerebral Cavernous Malformation|Cerebral Cavernous Malformations|Extracerebral Cavernous Hemangioma|Extracerebral Cavernous Hemangiomas|Familial Cavernous Angioma|Familial Cavernous Angiomas|Familial Cavernous Malformation|Familial Cavernous Malformations|Hemangioma, Cerebral Cavernous|Hemangioma, Extracerebral Cavernous|Hemangioma, Intracerebral Cavernous|Hemangiomas, Cerebral Cavernous|Hemangiomas, Extracerebral Cavernous|Hemangiomas, Intracerebral Cavernous|HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATED WITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED|Intracerebral Cavernous Hemangioma|Intracerebral Cavernous Hemangiomas|Malformation, Cavernous Angiomatous|Malformation, Cerebral Capillary|Malformation, Cerebral Cavernous|Malformation, Familial Cavernous|Malformations, Cavernous Angiomatous|Malformations, Cerebral Capillary|Malformations, Cerebral Cavernous|Malformations, Familial Cavernous	Blood disease|Cancer|Cardiovascular disease|Congenital abnormality|Nervous system disease
Hemangiomas of Small Intestine	MESH:C564201			MESH:D006391|MESH:D007414	C04.557.645.375/C564201|C04.588.274.476.411/C564201|C06.301.371.411/C564201|C06.405.249.411/C564201|C06.405.469.491/C564201	C04.557.645.375|C04.588.274.476.411|C06.301.371.411|C06.405.249.411|C06.405.469.491		Cancer|Digestive system disease
Hemangiomatosis, Cutaneous, with Associated Features	MESH:C562438			MESH:D006391|MESH:D007593|MESH:D010688|MESH:D012868	C04.557.645.375/C562438|C05.550.521/C562438|C12.100.500.494.684/C562438|C12.200.294.494.684/C562438|C16.131.831/C562438|C17.800.804/C562438	C04.557.645.375|C05.550.521|C12.100.500.494.684|C12.200.294.494.684|C16.131.831|C17.800.804		Cancer|Congenital abnormality|Musculoskeletal disease|Skin disease|Urogenital disease (male)
Hemangiomatosis, Disseminated	MESH:C566283			MESH:D006391	C04.557.645.375/C566283	C04.557.645.375		Cancer
Hemangiomatosis, familial pulmonary capillary	MESH:C535861			MESH:D006976|MESH:D008175|MESH:D018324	C04.557.645.375.380/C535861|C04.588.894.797.520/C535861|C08.381.423/C535861|C08.381.540/C535861|C08.785.520/C535861|C14.907.489.556/C535861	C04.557.645.375.380|C04.588.894.797.520|C08.381.423|C08.381.540|C08.785.520|C14.907.489.556	Familial pulmonary capillary hemangiomatosis	Cancer|Cardiovascular disease|Respiratory tract disease
Hemangiopericytoma	MESH:D006393	DO:DOID:264	A tumor composed of spindle cells with a rich vascular network, which apparently arises from pericytes, cells of smooth muscle origin that lie around small vessels. Benign and malignant hemangiopericytomas exist, and the rarity of these lesions has led to considerable confusion in distinguishing between benign and malignant variants. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1364)	MESH:D009383	C04.557.645.380	C04.557.645	Hemangiopericytomas	Cancer
Hemangiopericytoma, Malignant	MESH:C562740			MESH:D006393	C04.557.645.380/C562740	C04.557.645.380		Cancer
Hemangiosarcoma	MESH:D006394	DO:DOID:0001816	A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)	MESH:D009383|MESH:D012509	C04.557.450.795.390|C04.557.645.390	C04.557.450.795|C04.557.645	Angiosarcoma|Angiosarcomas|Hemangiosarcomas	Cancer
Hemarthrosis	MESH:D006395	DO:DOID:801	Bleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia.	MESH:D006470|MESH:D007592	C05.550.459|C23.550.414.794	C05.550|C23.550.414	Hemarthroses	Musculoskeletal disease|Pathology (process)
Hematemesis	MESH:D006396		Vomiting of blood that is either fresh bright red, or older 'coffee-ground' in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.	MESH:D006471|MESH:D014839	C06.405.227.400|C23.550.414.788.400|C23.888.821.937.019	C06.405.227|C23.550.414.788|C23.888.821.937	Hematemeses	Digestive system disease|Pathology (process)|Signs and symptoms
Hematocele	MESH:D006398	DO:DOID:12332	Hemorrhage into a canal or cavity of the body, such as the space covered by the serous membrane (tunica vaginalis) around the TESTIS leading to testicular hematocele or scrotal hematocele.	MESH:D005832|MESH:D006470	C12.100.500.287|C12.200.294.287|C23.550.414.817	C12.100.500|C12.200.294|C23.550.414	Hematoceles|Hematocele, Scrotal|Hematoceles, Scrotal|Hematoceles, Testicular|Hematocele, Testicular|Scrotal Hematocele|Scrotal Hematoceles|Testicular Hematocele|Testicular Hematoceles	Pathology (process)|Urogenital disease (male)
Hematocolpos	MESH:D006399		A blood-filled VAGINA that is obstructed.	MESH:D014623	C12.050.351.500.894.300|C12.100.250.894.300	C12.050.351.500.894|C12.100.250.894		Urogenital disease (female)
Hematologic Diseases	MESH:D006402	DO:DOID:74	Disorders of the blood and blood forming tissues.	MESH:D006425	C15.378	C15	Blood Disease|Blood Diseases|Disease, Blood|Disease, Hematologic|Disease, Hematological|Diseases, Blood|Diseases, Hematologic|Diseases, Hematological|Hematological Disease|Hematological Diseases|Hematologic Disease	Blood disease
Hematologic Neoplasms	MESH:D019337	DO:DOID:2531	Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.	MESH:D006402|MESH:D009371	C04.588.448|C15.378.400	C04.588|C15.378	Hematological Malignancies|Hematological Malignancy|Hematological Neoplasm|Hematological Neoplasms|Hematologic Malignancies|Hematologic Malignancy|Hematologic Neoplasm|Hematopoietic Malignancies|Hematopoietic Malignancy|Hematopoietic Neoplasm|Hematopoietic Neoplasms|Malignancies, Hematologic|Malignancies, Hematological|Malignancies, Hematopoietic|Malignancy, Hematologic|Malignancy, Hematological|Malignancy, Hematopoietic|Neoplasm, Hematologic|Neoplasm, Hematological|Neoplasm, Hematopoietic|Neoplasms, Hematologic|Neoplasms, Hematological|Neoplasms, Hematopoietic	Blood disease|Cancer
Hematoma, Epidural, Cranial	MESH:D006407		Accumulation of blood in the EPIDURAL SPACE between the SKULL and the DURA MATER, often as a result of bleeding from the MENINGEAL ARTERIES associated with a temporal or parietal bone fracture. Epidural hematoma tends to expand rapidly, compressing the dura and underlying brain. Clinical features may include HEADACHE; VOMITING; HEMIPARESIS; and impaired mental function.	MESH:D006406|MESH:D020198|MESH:D020300	C10.228.140.300.535.450.300|C10.900.300.837.300|C14.907.253.573.400.400|C23.550.414.838.349|C23.550.414.913.400|C26.915.300.490.400	C10.228.140.300.535.450|C10.900.300.837|C14.907.253.573.400|C23.550.414.838|C23.550.414.913|C26.915.300.490	Cranial Epidural Hematoma|Cranial Epidural Hematomas|Cranial Epidural Hemorrhage|Cranial Epidural Hemorrhages|Cranial Extradural Hematoma|Cranial Extradural Hematomas|Cranial Extradural Hemorrhage|Cranial Extradural Hemorrhages|Epidural Hematoma, Cranial|Epidural Hematoma, Intracranial|Epidural Hematomas, Cranial|Epidural Hematomas, Intracranial|Epidural Hemorrhage, Cranial|Epidural Hemorrhages, Cranial|Extradural Hematoma, Cranial|Extradural Hematomas, Cranial|Extradural Hemorrhage, Cranial|Extradural Hemorrhages, Cranial|Hematoma, Cranial Epidural|Hematoma, Cranial Extradural|Hematoma, Epidural, Intracranial|Hematoma, Intracranial Epidural|Hematomas, Cranial Epidural|Hematomas, Cranial Extradural|Hematomas, Intracranial Epidural|Hemorrhage, Cranial Epidural|Hemorrhage, Cranial Extradural|Hemorrhages, Cranial Epidural|Hemorrhages, Cranial Extradural|Intracranial Epidural Hematoma|Intracranial Epidural Hematomas	Cardiovascular disease|Nervous system disease|Pathology (process)|Wounds and injuries
Hematoma, Subdural	MESH:D006408		Accumulation of blood in the SUBDURAL SPACE between the DURA MATER and the arachnoidal layer of the MENINGES. This condition primarily occurs over the surface of a CEREBRAL HEMISPHERE, but may develop in the spinal canal (HEMATOMA, SUBDURAL, SPINAL). Subdural hematoma can be classified as the acute or the chronic form, with immediate or delayed symptom onset, respectively. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.	MESH:D006406|MESH:D020198|MESH:D020300	C10.228.140.300.535.450.400|C10.900.300.837.600|C14.907.253.573.400.450|C23.550.414.838.700|C23.550.414.913.700|C26.915.300.490.450	C10.228.140.300.535.450|C10.900.300.837|C14.907.253.573.400|C23.550.414.838|C23.550.414.913|C26.915.300.490	Hematomas, Subdural|Hematomas, Traumatic Subdural|Hematoma, Traumatic Subdural|Hemorrhages, Subdural|Hemorrhage, Subdural|Subdural Hematoma|Subdural Hematomas|Subdural Hematomas, Traumatic|Subdural Hematoma, Traumatic|Subdural Hemorrhage|Subdural Hemorrhages|Traumatic Subdural Hematoma|Traumatic Subdural Hematomas	Cardiovascular disease|Nervous system disease|Pathology (process)|Wounds and injuries
Hematoma, Subdural, Acute	MESH:D020199		Accumulation of blood in the SUBDURAL SPACE with acute onset of neurological symptoms. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.	MESH:D006408	C10.228.140.300.535.450.400.050|C10.900.300.837.600.050|C14.907.253.573.400.450.050|C23.550.414.838.700.100|C23.550.414.913.700.100|C26.915.300.490.450.050	C10.228.140.300.535.450.400|C10.900.300.837.600|C14.907.253.573.400.450|C23.550.414.838.700|C23.550.414.913.700|C26.915.300.490.450	Acute Subdural Hematoma|Acute Subdural Hematomas|Hematoma, Acute Subdural|Hematomas, Acute Subdural|Hemorrhage, Subdural, Acute|Subdural Hematoma, Acute|Subdural Hematomas, Acute	Cardiovascular disease|Nervous system disease|Pathology (process)|Wounds and injuries
Hematoma, Subdural, Chronic	MESH:D020200		Accumulation of blood in the SUBDURAL SPACE with delayed onset of neurological symptoms. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.	MESH:D002908|MESH:D006408	C10.228.140.300.535.450.400.120|C10.900.300.837.600.120|C14.907.253.573.400.450.120|C23.550.291.500.431|C23.550.414.838.700.200|C23.550.414.913.700.200|C26.915.300.490.450.120	C10.228.140.300.535.450.400|C10.900.300.837.600|C14.907.253.573.400.450|C23.550.291.500|C23.550.414.838.700|C23.550.414.913.700|C26.915.300.490.450	Chronic Subdural Hematoma|Chronic Subdural Hematomas|Hematoma, Chronic Subdural|Hematomas, Chronic Subdural|Hemorrhage, Subdural, Chronic|Subdural Hematoma, Chronic|Subdural Hematomas, Chronic	Cardiovascular disease|Nervous system disease|Pathology (process)|Wounds and injuries
Hematoma, Subdural, Intracranial	MESH:D046648		Accumulation of blood in the SUBDURAL SPACE over the CEREBRAL HEMISPHERE.	MESH:D006408	C10.228.140.300.535.450.400.400|C10.900.300.837.600.400|C14.907.253.573.400.450.400|C23.550.414.838.700.400|C23.550.414.913.700.400|C26.915.300.490.450.400	C10.228.140.300.535.450.400|C10.900.300.837.600|C14.907.253.573.400.450|C23.550.414.838.700|C23.550.414.913.700|C26.915.300.490.450	Hematoma, Intracranial Subdural|Hematomas, Intracranial Subdural|Hematoma, Subdural, Cranial|Intracranial Subdural Hematoma|Intracranial Subdural Hematomas|Intracranial Subdural Hematoma, Traumatic|Subdural Hematoma, Intracranial|Subdural Hematomas, Intracranial|Subdural Hematoma, Traumatic, Intracranial|Traumatic Intracranial Subdural Hematoma	Cardiovascular disease|Nervous system disease|Pathology (process)|Wounds and injuries
Hematometra	MESH:D006409	DO:DOID:9958	Blood-filled UTERUS.	MESH:D014591	C12.050.351.500.852.495|C12.100.250.852.495	C12.050.351.500.852|C12.100.250.852	Hematometras	Urogenital disease (female)
Hematuria	MESH:D006417		Presence of blood in the urine.	MESH:D006470|MESH:D014555	C12.050.351.968.934.442|C12.200.777.934.442|C12.950.934.442|C23.550.414.849	C12.050.351.968.934|C12.200.777.934|C12.950.934|C23.550.414	Hematurias	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Hematuria, Benign Familial	MESH:C562476	OMIM:141200		MESH:D006417	C12.050.351.968.934.442/C562476|C12.200.777.934.442/C562476|C12.950.934.442/C562476|C23.550.414.849/C562476	C12.050.351.968.934.442|C12.200.777.934.442|C12.950.934.442|C23.550.414.849	BFH|Thin-Basement-Membrane Nephropathy|Thin Membrane Nephropathy|TMN	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Heme Oxygenase 1 Deficiency	MESH:C564200	OMIM:614034		MESH:D000743|MESH:D006130|MESH:D019189	C15.378.071.141/C564200|C18.452.565/C564200|C23.550.393/C564200	C15.378.071.141|C18.452.565|C23.550.393	HMOX1D	Blood disease|Metabolic disease|Pathology (process)
Hemianopsia	MESH:D006423		Partial or complete loss of vision in one half of the visual field(s) of one or both eyes. Subtypes include altitudinal hemianopsia, characterized by a visual defect above or below the horizontal meridian of the visual field. Homonymous hemianopsia refers to a visual defect that affects both eyes equally, and occurs either to the left or right of the midline of the visual field. Binasal hemianopsia consists of loss of vision in the nasal hemifields of both eyes. Bitemporal hemianopsia is the bilateral loss of vision in the temporal fields. Quadrantanopsia refers to loss of vision in one quarter of the visual field in one or both eyes.	MESH:D001766|MESH:D014786	C10.597.751.941.512|C11.966.075.500|C23.888.592.763.941.512	C10.597.751.941|C11.966.075|C23.888.592.763.941	Altidudinal Hemianopia|Altidudinal Hemianopias|Altitudinal Hemianopsia|Altitudinal Hemianopsias|Binasal Hemianopia|Binasal Hemianopias|Binasal Hemianopsia|Binasal Hemianopsias|Bitemporal Hemianopia|Bitemporal Hemianopias|Bitemporal Hemianopsia|Bitemporal Hemianopsias|Hemianopia|Hemianopia, Altidudinal|Hemianopia, Binasal|Hemianopia, Bitemporal|Hemianopia, Homonymous|Hemianopias|Hemianopias, Altidudinal|Hemianopias, Binasal|Hemianopias, Bitemporal|Hemianopias, Homonymous|Hemianopsia, Altitudinal|Hemianopsia, Binasal|Hemianopsia, Bitemporal|Hemianopsia, Homonymous|Hemianopsias|Hemianopsias, Altitudinal|Hemianopsias, Binasal|Hemianopsias, Bitemporal|Hemianopsias, Homonymous|Homonymous Hemianopia|Homonymous Hemianopias|Homonymous Hemianopsia|Homonymous Hemianopsias|Quadrantanopia|Quadrantanopias|Quadrantanopsia|Quadrantanopsias	Eye disease|Nervous system disease|Signs and symptoms
Hemic and Lymphatic Diseases	MESH:D006425		Hematologic diseases and diseases of the lymphatic system collectively. Hemic diseases include disorders involving the formed elements (e.g., ERYTHROCYTE AGGREGATION, INTRAVASCULAR) and chemical components (e.g., BLOOD PROTEIN DISORDERS); lymphatic diseases include disorders relating to lymph, lymph nodes, and lymphocytes.	MESH:C	C15	C	Blood and Lymphatic System Disorders	
Hemifacial Hyperplasia With Strabismus	MESH:C564199			MESH:D000550|MESH:D005146|MESH:D013285	C10.228.140.055/C564199|C10.292.562.887/C564199|C10.597.751.941.073/C564199|C11.590.810/C564199|C11.966.073/C564199|C23.300.505/C564199|C23.888.592.763.941.073/C564199	C10.228.140.055|C10.292.562.887|C10.597.751.941.073|C11.590.810|C11.966.073|C23.300.505|C23.888.592.763.941.073	Bencze Syndrome	Eye disease|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Hemifacial Spasm	MESH:D019569		Recurrent clonic contraction of facial muscles, restricted to one side. It may occur as a manifestation of compressive lesions involving the seventh cranial nerve (FACIAL NERVE DISEASES), during recovery from BELL PALSY, or in association with other disorders. (From Adams et al., Principles of Neurology, 6th ed, p1378)	MESH:D009059|MESH:D013035	C07.465.364|C10.597.613.750.400|C23.888.592.608.750.400	C07.465|C10.597.613.750|C23.888.592.608.750	Facial Spasms, Unilateral|Facial Spasm, Unilateral|Hemifacial Myokymia|Hemifacial Spasms|Myokymia, Hemifacial|Spasm, Hemifacial|Spasms, Hemifacial|Spasms, Unilateral Facial|Spasm, Unilateral Facial|Unilateral Facial Spasm|Unilateral Facial Spasms	Mouth disease|Nervous system disease|Signs and symptoms
Hemifacial Spasm, Familial	MESH:C564198			MESH:D019569	C07.465.364/C564198|C10.597.613.750.400/C564198|C23.888.592.608.750.400/C564198	C07.465.364|C10.597.613.750.400|C23.888.592.608.750.400		Mouth disease|Nervous system disease|Signs and symptoms
Hemiplegia	MESH:D006429	DO:DOID:10969	Severe or complete loss of motor function on one side of the body. This condition is usually caused by BRAIN DISEASES that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, BRAIN STEM lesions; cervical SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; and other conditions may manifest as hemiplegia. The term hemiparesis (see PARESIS) refers to mild to moderate weakness involving one side of the body.	MESH:D010243	C10.597.622.295|C23.888.592.636.312	C10.597.622|C23.888.592.636	Crossed Hemiplegia|Crossed Hemiplegias|Flaccid Hemiplegia|Flaccid Hemiplegias|Hemiplegia, Crossed|Hemiplegia, Flaccid|Hemiplegia, Infantile|Hemiplegia, Post Ictal|Hemiplegia, Post-Ictal|Hemiplegias|Hemiplegias, Crossed|Hemiplegias, Flaccid|Hemiplegias, Infantile|Hemiplegia, Spastic|Hemiplegias, Post-Ictal|Hemiplegias, Spastic|Hemiplegias, Transient|Hemiplegia, Transient|Infantile Hemiplegia|Infantile Hemiplegias|Monoplegia|Monoplegias|Post-Ictal Hemiplegia|Post-Ictal Hemiplegias|Spastic Hemiplegia|Spastic Hemiplegias|Transient Hemiplegia|Transient Hemiplegias	Nervous system disease|Signs and symptoms
Hemiplegic migraine, familial type 1	MESH:C536890	OMIM:141500		MESH:D002524|MESH:D008881	C10.228.140.252.190/C536890|C10.228.140.546.399.750/C536890|C10.597.350.090.500/C536890|C23.888.592.350.090.200/C536890	C10.228.140.252.190|C10.228.140.546.399.750|C10.597.350.090.500|C23.888.592.350.090.200	FHM|FHM1|MHP1 MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA, INCLUDED|Migraine, Familial Hemiplegic, 1|Migraine, familial hemiplegic 1, with progressive cerebellar ataxia|MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	Nervous system disease|Signs and symptoms
Hemiplegic migraine, familial type 2	MESH:C537246	OMIM:602481		MESH:D020325	C10.228.140.546.399.750.250/C537246	C10.228.140.546.399.750.250	Familial hemiplegic migraine, type 2|FHM2|MHP2 MIGRAINE, FAMILIAL BASILAR, INCLUDED|Migraine, familial hemiplegic, 2	Nervous system disease
Hemoglobin M Disease	MESH:C581942			MESH:D008708	C15.378.619/C581942	C15.378.619		Blood disease
Hemoglobinuria, Paroxysmal	MESH:D006457	DO:DOID:0060284|OMIM:300818|OMIM:615399	A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.	MESH:D000743|MESH:D009190	C15.378.071.141.560|C15.378.190.625.460	C15.378.071.141|C15.378.190.625	Cold Paroxysmal Hemoglobinuria|Hemoglobinuria, Cold Paroxysmal|Hemoglobinuria, Nocturnal Paroxysmal|Hemoglobinuria, Paroxysmal Cold|Hemoglobinuria, Paroxysmal Nocturnal|Marchiafava Micheli Syndrome|Marchiafava-Micheli Syndrome|Nocturnal Paroxysmal Hemoglobinuria|Paroxysmal Cold Hemoglobinuria|Paroxysmal Hemoglobinuria|Paroxysmal Hemoglobinuria, Cold|Paroxysmal Hemoglobinuria, Nocturnal|Paroxysmal Nocturnal Hemoglobinuria|PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1|PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2|PNH1|PNH2|Syndrome, Marchiafava-Micheli	Blood disease
Hemolytic Anemia with Thermal Sensitivity of Red Cells	MESH:C565522			MESH:D000743	C15.378.071.141/C565522	C15.378.071.141		Blood disease
Hemolytic Poikilocytic Anemia due to Reduced Ankyrin Binding Sites	MESH:C564197			MESH:D000743	C15.378.071.141/C564197	C15.378.071.141		Blood disease
Hemolytic-Uremic Syndrome	MESH:D006463	DO:DOID:12554	A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.	MESH:D000743|MESH:D014511|MESH:D057049	C12.050.351.968.419.936.463|C12.200.777.419.936.463|C12.950.419.936.463|C15.378.071.141.610|C15.378.140.855.925.500	C12.050.351.968.419.936|C12.200.777.419.936|C12.950.419.936|C15.378.071.141|C15.378.140.855.925	Gasser's Syndrome|Gassers Syndrome|Gasser Syndrome|Hemolytic Uremic Syndrome|Syndrome, Hemolytic-Uremic	Blood disease|Urogenital disease (female)|Urogenital disease (male)
Hemoperitoneum	MESH:D006465		Accumulations of blood in the PERITONEAL CAVITY due to internal HEMORRHAGE.	MESH:D006470|MESH:D010532	C06.844.400|C23.550.414.888	C06.844|C23.550.414	Hemoperitoneums	Digestive system disease|Pathology (process)
Hemophagocytic lymphohistiocytosis, familial, 2	MESH:C537250	OMIM:603553		MESH:D051359	C15.604.250.410.575/C537250	C15.604.250.410.575	FHL2|HLH2|HPLH2	Lymphatic disease
Hemophagocytic lymphohistiocytosis, familial, 3	MESH:C537251	OMIM:608898		MESH:D051359	C15.604.250.410.575/C537251	C15.604.250.410.575	FHL3|HLH3|HPLH3	Lymphatic disease
Hemophagocytic lymphohistiocytosis, familial, 4	MESH:C537252	OMIM:603552		MESH:D051359	C15.604.250.410.575/C537252	C15.604.250.410.575	FHL4|HLH4|HPLH4	Lymphatic disease
Hemophagocytic Lymphohistiocytosis, Familial, 5	MESH:C567752	OMIM:613101		MESH:D051359	C15.604.250.410.575/C567752	C15.604.250.410.575	Fhl5|HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITH OR WITHOUT MICROVILLUS INCLUSION DISEASE	Lymphatic disease
Hemopneumothorax	MESH:D006468	DO:DOID:2718	Collection of air and blood in the pleural cavity.	MESH:D006491|MESH:D010995	C08.528.338|C23.550.414.904.500	C08.528|C23.550.414.904		Pathology (process)|Respiratory tract disease
Hemoptysis	MESH:D006469		Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.	MESH:D006470|MESH:D008171|MESH:D012818	C08.381.348|C23.550.414.896|C23.888.852.430	C08.381|C23.550.414|C23.888.852	Hemoptyses	Pathology (process)|Respiratory tract disease|Signs and symptoms
HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	OMIM:613730			MESH:D002114|MESH:D002386|MESH:D006474	C11.510.245/613730|C15.378.463/613730|C18.452.174.130/613730	C11.510.245|C15.378.463|C18.452.174.130	HDBSCC	Blood disease|Eye disease|Metabolic disease
Hemorrhagic Disorders	MESH:D006474	DO:DOID:2213	Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).	MESH:D006402	C15.378.463	C15.378	Diatheses, Hemorrhagic|Diathesis, Hemorrhagic|Disorder, Hemorrhagic|Disorders, Hemorrhagic|Hemorrhagic Diatheses|Hemorrhagic Diathesis|Hemorrhagic Disorder	Blood disease
Hemorrhagic Fever, American	MESH:D006478		Diseases caused by American hemorrhagic fever viruses (ARENAVIRUSES, NEW WORLD).	MESH:D001117|MESH:D006482	C01.925.782.082.440|C01.925.782.417.400	C01.925.782.082|C01.925.782.417	American Hemorrhagic Fever|Argentinian Hemorrhagic Fever|Bolivian Hemorrhagic Fever|Fever, American Hemorrhagic|Fever, Argentinian Hemorrhagic|Fever, Bolivian Hemorrhagic|Hemorrhagic Fever, Argentinian|Hemorrhagic Fever, Bolivian	Viral disease
Hemorrhagic Fever, Crimean	MESH:D006479	DO:DOID:12287	A severe, often fatal disease in humans caused by the Crimean-Congo hemorrhagic fever virus (HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO).	MESH:D001102|MESH:D002044|MESH:D006482|MESH:D017282	C01.920.500.528|C01.920.930.430|C01.925.081.522|C01.925.782.147.444|C01.925.782.417.412	C01.920.500|C01.920.930|C01.925.081|C01.925.782.147|C01.925.782.417	Congo Crimean Hemorrhagic Fever|Congo-Crimean Hemorrhagic Fever|Congo Virus Infection|Crimean Congo Haemorrhagic Fever|Crimean-Congo Haemorrhagic Fever|Crimean Congo Hemorrhagic Fever|Crimean-Congo Hemorrhagic Fever|Crimean Hemorrhagic Fever|Fever, Congo-Crimean Hemorrhagic|Fever, Crimean-Congo Haemorrhagic|Fever, Crimean-Congo Hemorrhagic|Fever, Crimean Hemorrhagic|Haemorrhagic Fever, Crimean-Congo|Hemorrhagic Fever, Congo-Crimean|Hemorrhagic Fever, Crimean-Congo|Infection, Congo Virus	Viral disease
Hemorrhagic Fever, Ebola	MESH:D019142	DO:DOID:4325	A highly fatal, acute hemorrhagic fever caused by EBOLAVIRUS.	MESH:D006482|MESH:D018702	C01.925.782.417.415|C01.925.782.580.250.400	C01.925.782.417|C01.925.782.580.250	Ebola Hemorrhagic Fever|Ebola Infection|Ebola Virus Disease|Ebolavirus Infection|Ebola Virus Infection|Ebolavirus Infections|Infection, Ebola|Infection, Ebolavirus|Infection, Ebola Virus|Infections, Ebolavirus|Virus Infection, Ebola	Viral disease
Hemorrhagic Fever, Omsk	MESH:D006481	DO:DOID:992	Infection with the Omsk hemorrhagic fever virus, a Flavivirus.	MESH:D001102|MESH:D006482|MESH:D017282|MESH:D018177	C01.920.930.440|C01.925.081.611|C01.925.782.350.250.560|C01.925.782.417.435	C01.920.930|C01.925.081|C01.925.782.350.250|C01.925.782.417	Fever, Omsk Hemorrhagic|Omsk Hemorrhagic Fever	Viral disease
Hemorrhagic Fevers, Viral	MESH:D006482		A group of viral diseases of diverse etiology but having many similar clinical characteristics; increased capillary permeability, leukopenia, and thrombocytopenia are common to all. Hemorrhagic fevers are characterized by sudden onset, fever, headache, generalized myalgia, backache, conjunctivitis, and severe prostration, followed by various hemorrhagic symptoms. Hemorrhagic fever with kidney involvement is HEMORRHAGIC FEVER WITH RENAL SYNDROME.	MESH:D012327	C01.925.782.417	C01.925.782	Fevers, Viral Hemorrhagic|Fever, Viral Hemorrhagic|Hemorrhagic Fever, Viral|Viral Hemorrhagic Fever|Viral Hemorrhagic Fevers	Viral disease
Hemorrhagic Fever with Renal Syndrome	MESH:D006480	DO:DOID:11266	An acute febrile disease occurring predominately in Asia. It is characterized by fever, prostration, vomiting, hemorrhagic phenonema, shock, and renal failure. It is caused by any one of several closely related species of the genus Hantavirus. The most severe form is caused by HANTAAN VIRUS whose natural host is the rodent Apodemus agrarius. Milder forms are caused by SEOUL VIRUS and transmitted by the rodents Rattus rattus and R. norvegicus, and the PUUMALA VIRUS with transmission by Clethrionomys galreolus.	MESH:D006482|MESH:D018778	C01.925.782.147.420.400|C01.925.782.417.300	C01.925.782.147.420|C01.925.782.417	Epidemic Hemorrhagic Fever|Epidemic Hemorrhagic Fevers|Hemorrhagic Fever, Epidemic|Hemorrhagic Fever, Korean|Hemorrhagic Fevers, Epidemic|Hemorrhagic Nephroso-Nephritides|Hemorrhagic Nephroso Nephritis|Hemorrhagic Nephroso-Nephritis|HFRS|Korean Hemorrhagic Fever|Nephropathia Epidemica|Nephroso-Nephritides, Hemorrhagic|Nephroso-Nephritis, Hemorrhagic	Viral disease
Hemorrhagic shock and encephalopathy syndrome	MESH:C537254			MESH:D001778|MESH:D001927|MESH:D012771	C10.228.140/C537254|C15.378.100/C537254|C23.550.414.980/C537254|C23.550.835.650/C537254	C10.228.140|C15.378.100|C23.550.414.980|C23.550.835.650		Blood disease|Nervous system disease|Pathology (process)
Hemorrhagic Stroke	MESH:D000083302		Stroke due to rupture of a weakened blood vessel in the brain (e.g., CEREBRAL HEMISPHERES; CEREBELLUM; SUBARACHNOID SPACE).	MESH:D020521	C10.228.140.300.775.300|C14.907.253.855.300	C10.228.140.300.775|C14.907.253.855	Hemorrhage Stroke, Intracerebral|Hemorrhagic Stroke, Intracerebral|Hemorrhagic Strokes|Hemorrhagic Stroke, Subarachnoid|Intracerebral Hemorrhage Stroke|Intracerebral Hemorrhage Strokes|Intracerebral Hemorrhagic Stroke|Intracerebral Hemorrhagic Strokes|Stroke, Hemorrhagic|Stroke, Intracerebral Hemorrhage|Stroke, Intracerebral Hemorrhagic|Stroke, Subarachnoid Hemorrhagic|Subarachnoid Hemorrhagic Stroke|Subarachnoid Hemorrhagic Strokes	Cardiovascular disease|Nervous system disease
Hemorrhoids	MESH:D006484	DO:DOID:9746	Swollen veins in the lower part of the RECTUM or ANUS. Hemorrhoids can be inside the anus (internal), under the skin around the anus (external), or protruding from inside to outside of the anus. People with hemorrhoids may or may not exhibit symptoms which include bleeding, itching, and pain.	MESH:D012002|MESH:D014652	C06.405.469.860.401|C14.907.449	C06.405.469.860|C14.907	Hemorrhoid	Cardiovascular disease|Digestive system disease
Hemosiderosis	MESH:D006486	DO:DOID:12119	Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.	MESH:D019190	C18.452.565.500.500	C18.452.565.500	Hemosideroses	Metabolic disease
Hemosiderosis, Systemic, due to Aceruloplasminemia	MESH:C565801			MESH:D006486	C18.452.565.500.500/C565801	C18.452.565.500.500		Metabolic disease
Hemostatic Disorders	MESH:D020141	DO:DOID:484	Pathological processes involving the integrity of blood circulation. Hemostasis depends on the integrity of BLOOD VESSELS, blood fluidity, and BLOOD COAGULATION. Majority of the hemostatic disorders are caused by disruption of the normal interaction between the VASCULAR ENDOTHELIUM, the plasma proteins (including BLOOD COAGULATION FACTORS), and PLATELETS.	MESH:D006474|MESH:D014652	C14.907.454|C15.378.463.515	C14.907|C15.378.463	Disorders, Vascular Hemostatic|Disorder, Vascular Hemostatic|Hemostatic Disorder|Hemostatic Disorders, Vascular|Hemostatic Disorder, Vascular|Vascular Hemostatic Disorder|Vascular Hemostatic Disorders	Blood disease|Cardiovascular disease
Hemothorax	MESH:D006491		Hemorrhage within the pleural cavity.	MESH:D006470|MESH:D010995	C08.528.380|C23.550.414.904	C08.528|C23.550.414		Pathology (process)|Respiratory tract disease
Henipavirus Infections	MESH:D045464		Infections with viruses of the genus HENIPAVIRUS, family PARAMYXOVIRIDAE.	MESH:D018184	C01.925.782.580.600.400	C01.925.782.580.600	Encephalitis, Nipah Virus|Hendra Virus Infection|Hendra Virus Infections|Henipavirus Infection|Infection, Hendra Virus|Infection, Henipavirus|Infection, Nipah Virus|Infection, NiV|Nipah Virus Encephalitis|Nipah Virus Infection|NiV Infection|NiV Infections|Virus Encephalitis, Nipah|Virus Infection, Hendra|Virus Infection, Nipah|Virus Infections, Hendra	Viral disease
Hepadnaviridae Infections	MESH:D018347		Virus diseases caused by the HEPADNAVIRIDAE.	MESH:D004266	C01.925.256.430	C01.925.256	Hepadnaviridae Infection|Infection, Hepadnaviridae|Infections, Hepadnaviridae	Viral disease
Heparin Cofactor II Deficiency	MESH:C562865	DO:DOID:0111901|OMIM:612356		MESH:D013927	C14.907.355.830/C562865	C14.907.355.830	HCF2 DEFICIENCY|Hcf II Deficiency|THPH10|THROMBOPHILIA DUE TO HEPARIN COFACTOR II DEFICIENCY|Thrombophilia, Susceptibility to, due to Heparin Cofactor Ii Deficiency	Cardiovascular disease
Hepatic Adenomas, Familial	MESH:C564190	OMIM:142330		MESH:D000236|MESH:D008113	C04.557.470.035/C564190|C04.588.274.623/C564190|C06.301.623/C564190|C06.552.697/C564190	C04.557.470.035|C04.588.274.623|C06.301.623|C06.552.697	Liver Cell Adenomas, Familial	Cancer|Digestive system disease
Hepatic Encephalopathy	MESH:D006501	DO:DOID:12550|DO:DOID:13413	A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)	MESH:D001928|MESH:D017093	C06.552.308.500.356|C10.228.140.163.360|C18.452.132.360	C06.552.308.500|C10.228.140.163|C18.452.132	Coma, Hepatic|Comas, Hepatic|Encephalopathies, Hepatic|Encephalopathies, Hepatocerebral|Encephalopathies, Portal-Systemic|Encephalopathies, Portosystemic|Encephalopathy, Hepatic|Encephalopathy, Hepatocerebral|Encephalopathy, Portal Systemic|Encephalopathy, Portal-Systemic|Encephalopathy, Portosystemic|Fulminant Hepatic Failure with Cerebral Edema|Hepatic Coma|Hepatic Comas|Hepatic Encephalopathies|Hepatic Stupor|Hepatic Stupors|Hepatocerebral Encephalopathies|Hepatocerebral Encephalopathy|Portal-Systemic Encephalopathies|Portal Systemic Encephalopathy|Portal-Systemic Encephalopathy|Portosystemic Encephalopathies|Portosystemic Encephalopathy|Stupor, Hepatic|Stupors, Hepatic	Digestive system disease|Metabolic disease|Nervous system disease
HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI INFECTION	OMIM:604201			MESH:D008103|MESH:D008109|MESH:D012555	C01.610.335.865.859.576/604201|C01.610.518/604201|C01.920.922.576/604201|C06.552.630/604201|C06.552.664/604201|C23.550.355.412/604201	C01.610.335.865.859.576|C01.610.518|C01.920.922.576|C06.552.630|C06.552.664|C23.550.355.412	SM2  HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA JAPONICUM INFECTION, INCLUDED	Digestive system disease|Parasitic disease|Pathology (process)
Hepatic Infarction	MESH:D000081011	DO:DOID:13738	Formation of infarct resulting from obstruction of HEPATIC ARTERY and/or PORTAL VEIN most often after LIVER TRANSPLANTATION or hepatobiliary surgery.	MESH:D007238|MESH:D008107	C06.552.289|C23.550.513.355.500|C23.550.717.489.500	C06.552|C23.550.513.355|C23.550.717.489	Hepatic Infarct|Hepatic Infarctions|Hepatic Infarcts|Infarct, Hepatic|Infarction, Hepatic|Infarction, Liver|Infarct, Liver|Liver Infarct|Liver Infarction|Liver Infarctions|Liver Infarcts	Digestive system disease|Pathology (process)
Hepatic Veno-Occlusive Disease	MESH:D006504		Liver disease that is caused by injuries to the ENDOTHELIAL CELLS of the vessels and subendothelial EDEMA, but not by THROMBOSIS. Extracellular matrix, rich in FIBRONECTINS, is usually deposited around the HEPATIC VEINS leading to venous outflow occlusion and sinusoidal obstruction.	MESH:D008107|MESH:D014652	C06.552.360|C14.907.460	C06.552|C14.907	Disease, Hepatic Veno-Occlusive|Hepatic Veno Occlusive Disease|Hepatic Veno-Occlusive Diseases|Sinusoidal Obstruction Syndrome|Syndrome, Sinusoidal Obstruction|Veno Occlusive Disease, Hepatic|Veno-Occlusive Disease, Hepatic	Cardiovascular disease|Digestive system disease
Hepatic venoocclusive disease with immunodeficiency	MESH:C537257	OMIM:235550		MESH:D006504|MESH:D007153	C06.552.360/C537257|C14.907.460/C537257|C20.673/C537257	C06.552.360|C14.907.460|C20.673	Familial Veno-Occlusive Disease with Immunodeficiency|Hepatic Veno-Occlusive Disease with Immunodeficiency|Veno-Occlusive Disease and Immunodeficiency Syndrome|VODI	Cardiovascular disease|Digestive system disease|Immune system disease
Hepatitis A	MESH:D006506	DO:DOID:12549	INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.	MESH:D004769|MESH:D006525	C01.925.440.420|C01.925.782.687.359.500|C06.552.380.705.422	C01.925.440|C01.925.782.687.359|C06.552.380.705	Hepatitides, Infectious|Hepatitis, Infectious|Infectious Hepatitides|Infectious Hepatitis	Digestive system disease|Viral disease
Hepatitis, Alcoholic	MESH:D006519		INFLAMMATION of the LIVER due to ALCOHOL ABUSE. It is characterized by NECROSIS of HEPATOCYTES, infiltration by NEUTROPHILS, and deposit of MALLORY BODIES. Depending on its severity, the inflammatory lesion may be reversible or progress to LIVER CIRRHOSIS.	MESH:D006505|MESH:D008108	C06.552.380.290|C06.552.645.490|C25.775.100.087.645.490	C06.552.380|C06.552.645|C25.775.100.087.645	Alcoholic Hepatitis|Alcoholic Hepatitis, Chronic|Chronic Alcoholic Hepatitides|Chronic Alcoholic Hepatitis|Hepatitis, Alcoholic, Chronic	Digestive system disease|Substance-related disorder
Hepatitis, Autoimmune	MESH:D019693	DO:DOID:2048	A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.	MESH:D001327|MESH:D006521	C06.552.380.350.300|C20.111.567	C06.552.380.350|C20.111	Autoimmune Chronic Hepatitides|Autoimmune Chronic Hepatitis|Autoimmune Hepatitides|Autoimmune Hepatitis|Chronic Hepatitides, Autoimmune|Chronic Hepatitis, Autoimmune|Hepatitides, Autoimmune|Hepatitides, Autoimmune Chronic|Hepatitis, Autoimmune Chronic	Digestive system disease|Immune system disease
Hepatitis B	MESH:D006509	DO:DOID:2043|OMIM:610424	INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.	MESH:D000086982|MESH:D006525|MESH:D018347	C01.221.250.500|C01.925.256.430.400|C01.925.440.435|C06.552.380.705.437	C01.221.250|C01.925.256.430|C01.925.440|C06.552.380.705	HBV, RESISTANCE TO, INCLUDED|HBV, SUSCEPTIBILITY TO HEPATITIS B VIRUS, RESISTANCE TO, INCLUDED|Hepatitis B Virus Infection|HEPATITIS B VIRUS, SUSCEPTIBILITY TO	Digestive system disease|Viral disease
Hepatitis B, Chronic	MESH:D019694		INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.	MESH:D006509|MESH:D006521	C01.221.250.500.100|C01.925.256.430.400.100|C01.925.440.435.100|C06.552.380.350.100|C06.552.380.705.437.100|C23.550.291.500.477.500	C01.221.250.500|C01.925.256.430.400|C01.925.440.435|C06.552.380.350|C06.552.380.705.437|C23.550.291.500.477	Chronic Hepatitis B|Chronic Hepatitis B Virus Infection|Hepatitis B Virus Infection, Chronic	Digestive system disease|Pathology (process)|Viral disease
Hepatitis C	MESH:D006526	DO:DOID:1883|OMIM:609532	INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.	MESH:D000086982|MESH:D006525|MESH:D018178	C01.221.250.750|C01.925.440.440|C01.925.782.350.350|C06.552.380.705.440	C01.221.250|C01.925.440|C01.925.782.350|C06.552.380.705	HCV, RESISTANCE TO, INCLUDED|HCV, SUSCEPTIBILITY TO HEPATITIS C VIRUS, RESISTANCE TO, INCLUDED|HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF, INCLUDED|HEPATITIS C VIRUS, SUSCEPTIBILITY TO|Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted|Parenterally Transmitted Non A, Non B Hepatitis|Parenterally-Transmitted Non-A, Non-B Hepatitis|PT-NANBH	Digestive system disease|Viral disease
Hepatitis C, Chronic	MESH:D019698		INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.	MESH:D006521|MESH:D006526	C01.221.250.750.120|C01.925.440.440.120|C01.925.782.350.350.120|C06.552.380.350.120|C06.552.380.705.440.120|C23.550.291.500.477.750	C01.221.250.750|C01.925.440.440|C01.925.782.350.350|C06.552.380.350|C06.552.380.705.440|C23.550.291.500.477	Chronic Hepatitis C	Digestive system disease|Pathology (process)|Viral disease
Hepatitis, Chronic	MESH:D006521	DO:DOID:2237	INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.	MESH:D002908|MESH:D006505	C06.552.380.350|C23.550.291.500.477	C06.552.380|C23.550.291.500	Chronic Active Hepatitis|Chronic Hepatitis|Chronic Hepatitis, Cryptogenic|Chronic Persistent Hepatitides|Chronic Persistent Hepatitis|Cryptogenic Chronic Hepatitis|Hepatitis, Chronic Active|Hepatitis, Chronic, Cryptogenic|Hepatitis, Chronic Persistent|Hepatitis, Cryptogenic Chronic	Digestive system disease|Pathology (process)
Hepatitis D	MESH:D003699	DO:DOID:2047	INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.	MESH:D006525|MESH:D012327	C01.925.440.450|C01.925.782.450|C06.552.380.705.450	C01.925.440|C01.925.782|C06.552.380.705	Amazon Black Fever|Black Fever, Amazon|Delta Hepatitis|Delta Infection|Delta Superinfection|Delta Superinfections|Disease, Labrea|Diseases, Labrea|Fever, Amazon Black|Hepatitides, Delta|Hepatitis, Delta|Infection, Delta|Infections, Delta|Labrea Disease|Labrea Diseases|Superinfection, Delta|Superinfections, Delta	Digestive system disease|Viral disease
Hepatitis D, Chronic	MESH:D019701		INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS in conjunction with HEPATITIS B VIRUS and lasting six months or more.	MESH:D003699|MESH:D006521	C01.925.440.450.100|C01.925.782.450.100|C06.552.380.350.220|C06.552.380.705.450.100|C23.550.291.500.477.875	C01.925.440.450|C01.925.782.450|C06.552.380.350|C06.552.380.705.450|C23.550.291.500.477	Chronic Delta Hepatitides|Chronic Delta Hepatitis|Chronic Hepatitis D|Delta Hepatitides, Chronic|Delta Hepatitis, Chronic|Hepatitides, Chronic Delta|Hepatitis, Chronic Delta	Digestive system disease|Pathology (process)|Viral disease
Hepatitis E	MESH:D016751	DO:DOID:4411	Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.	MESH:D006525|MESH:D012327	C01.925.440.470|C01.925.782.455|C06.552.380.705.470	C01.925.440|C01.925.782|C06.552.380.705	Enterically Transmitted Non A, Non B Hepatitis|Enterically-Transmitted Non-A, Non-B Hepatitis|Epidemic Non A, Non B Hepatitis|Epidemic Non-A, Non-B Hepatitis|ET-NANBH|Hepatitides, Water-Borne|Hepatitis, Viral, Non-A, Non-B, Enterically-Transmitted|Hepatitis, Water Borne|Hepatitis, Water-Borne|Water-Borne Hepatitides|Water-Borne Hepatitis	Digestive system disease|Viral disease
Hepatitis, Viral, Human	MESH:D006525		INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).	MESH:D006505|MESH:D014777	C01.925.440|C06.552.380.705	C01.925|C06.552.380	Human Viral Hepatitides|Human Viral Hepatitis|Viral Hepatitides, Human|Viral Hepatitis, Human	Digestive system disease|Viral disease
Hepatoblastoma	MESH:D018197	DO:DOID:687	A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)	MESH:D018193	C04.557.435.380	C04.557.435	Hepatoblastomas	Cancer
Hepatoblastoma Caused By Somatic Mutation	MESH:C567299			MESH:D006528	C04.557.470.200.025.255/C567299|C04.588.274.623.160/C567299|C06.301.623.160/C567299|C06.552.697.160/C567299	C04.557.470.200.025.255|C04.588.274.623.160|C06.301.623.160|C06.552.697.160		Cancer|Digestive system disease
Hepatomegaly	MESH:D006529		Enlargement of the liver.	MESH:D006984|MESH:D008107	C06.552.416|C23.300.775.525	C06.552|C23.300.775	Enlarged Liver|Liver, Enlarged	Digestive system disease|Pathology (anatomical condition)
Hepatopulmonary Syndrome	MESH:D020065	DO:DOID:900	A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).	MESH:D008107|MESH:D008171	C06.552.455|C08.381.385	C06.552|C08.381	Hepato Pulmonary Syndrome|Hepato-Pulmonary Syndrome|Hepatopulmonary Syndromes|Hepato-Pulmonary Syndromes|Syndrome, Hepatopulmonary|Syndrome, Hepato-Pulmonary|Syndromes, Hepatopulmonary|Syndromes, Hepato-Pulmonary	Digestive system disease|Respiratory tract disease
Hepatorenal Syndrome	MESH:D006530	DO:DOID:11823	Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.	MESH:D007674|MESH:D008107	C06.552.465|C12.050.351.968.419.291|C12.200.777.419.291|C12.950.419.291	C06.552|C12.050.351.968.419|C12.200.777.419|C12.950.419	Syndrome, Hepatorenal	Digestive system disease|Urogenital disease (female)|Urogenital disease (male)
Hereditary alpha-tryptasemia syndrome	MESH:C000715748			MESH:D000090267	C20.762.500/C000715748	C20.762.500	Hereditary alpha-tryptasemia	Immune system disease
Hereditary Angioedema Type III	MESH:D056828	OMIM:610618	A form of hereditary angioedema that occurs in women and is precipitated or worsened by high ESTROGEN levels. It is associated with mutations in the gene for FACTOR XII that result in its increased activity.	MESH:D054179	C14.907.079.500.500|C17.800.862.945.066.500.500|C20.543.480.904.066.500.500	C14.907.079.500|C17.800.862.945.066.500|C20.543.480.904.066.500	Angioedema, Estrogen-Sensitive Hereditary|ANGIOEDEMA, HEREDITARY, 3|Angioedema, Hereditary, Type III|Angioedemas, Estrogen-Sensitive Hereditary|Angioneurotic Edema, Hereditary, with Normal C1 Inhibitor Concentration and Function|Estrogen Related HAE|Estrogen-Related HAE|Estrogen-Related HAEs|Estrogen Sensitive HAE|Estrogen-Sensitive HAE|Estrogen-Sensitive HAEs|Estrogen Sensitive Hereditary Angioedema|Estrogen-Sensitive Hereditary Angioedema|Estrogen-Sensitive Hereditary Angioedemas|HAE3|HAE, Estrogen-Related|HAE, Estrogen-Sensitive|HAEs, Estrogen-Related|HAEs, Estrogen-Sensitive|HAE with Normal C1 Inhibitor Concentration and Function|Hereditary Angioedema, Estrogen-Sensitive|Hereditary Angioedemas, Estrogen-Sensitive|Hereditary Angioedema with Normal C1 Inhibitor Activity	Cardiovascular disease|Immune system disease|Skin disease
Hereditary Angioedema Types I and II	MESH:D056829		Forms of hereditary angioedema that occur due to mutations in the gene for COMPLEMENT C1 INHIBITOR PROTEIN. Type I hereditary angioedema is associated with reduced serum levels of complement C1 inhibitor protein. Type II hereditary angioedema is associated with the production of a non-functional complement C1 inhibitor protein.	MESH:D054179	C14.907.079.500.750|C17.800.862.945.066.500.750|C20.543.480.904.066.500.750	C14.907.079.500|C17.800.862.945.066.500|C20.543.480.904.066.500	Angioedema, Hereditary, Type I|Angioedema, Hereditary, Type II|Angioedema, Hereditary, Types I and II|C1 Esterase Inhibitor, Deficiency Of|Deficiency of C1 Esterase Inhibitor|Hereditary Angioedema Type 1|Hereditary Angioedema Type I|Hereditary Angioedema Type II	Cardiovascular disease|Immune system disease|Skin disease
Hereditary bundle branch system defect	MESH:C566873			MESH:D000075224|MESH:D006327	C14.280.067.558/C566873|C14.280.123.500/C566873|C14.280.123/C566873|C23.550.073.425/C566873	C14.280.067.558|C14.280.123|C14.280.123.500|C23.550.073.425	Cardiac conduction defect, progressive|Heart block progressive, familial|Heart block, progressive familial, type 1|Heart Block, Progressive Familial, Type I|Lenegre Lev disease|Lenegre-Lev Disease|Pfhb1a|Pfhbi|PfhbIa|Progressive Familial Heart Block, Type Ia	Cardiovascular disease|Pathology (process)
Hereditary Diffuse Leukoencephalopathy with Spheroids	MESH:C580150	OMIM:221820		MESH:D056784	C10.228.140.695/C580150	C10.228.140.695	Adult-Onset Leukodystrophy with Neuroaxonal Spheroids|ALSP|Autosomal Dominant Leukoencephalopathy with Neuroaxonal Spheroids|Dementia, Familial, Neumann Type|Gliosis, Familial Progressive Subcortical|GPSC|HDLS|Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids|LEUKOENCEPHALOPATHY, ADULT-ONSET, WITH AXONAL SPHEROIDS AND PIGMENTED GLIA|Leukoencephalopathy, Diffuse Hereditary, With Spheroids|LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS|Leukoencephalopathy with Neuroaxonal Spheroids, Autosomal Dominant|Neuroaxonal Leukodystrophy|Subcortical Gliosis of Neumann	Nervous system disease
Hereditary pancreatitis	MESH:C537262	OMIM:167800		MESH:D050500	C06.689.750.830/C537262|C23.550.291.500.750/C537262	C06.689.750.830|C23.550.291.500.750	Autosomal Dominant Hereditary Pancreatitis|Familial Pancreatitis|Hereditary Chronic Pancreatitis|HP|HPC|PANCREATITIS, CALCIFIC, INCLUDED|PANCREATITIS, CHRONIC PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED|PANCREATITIS, CHRONIC, PROTECTION AGAINST, INCLUDED|Pancreatitis, Hereditary|PCTT	Digestive system disease|Pathology (process)
Hereditary Renal Cancer Associated 1	MESH:C564169			MESH:D007680	C04.588.945.947.535/C564169|C12.050.351.937.820.535/C564169|C12.050.351.968.419.473/C564169|C12.200.758.820.750/C564169|C12.200.777.419.473/C564169|C12.900.820.535/C564169|C12.950.419.473/C564169|C12.950.983.535/C564169	C04.588.945.947.535|C12.050.351.937.820.535|C12.050.351.968.419.473|C12.200.758.820.750|C12.200.777.419.473|C12.900.820.535|C12.950.419.473|C12.950.983.535	Renal Carcinoma, Familial, Associated 1	Cancer|Urogenital disease (female)|Urogenital disease (male)
Hereditary vertical nystagmus	MESH:C537857			MESH:D009759	C10.292.562.675/C537857|C11.590.400/C537857	C10.292.562.675|C11.590.400	Congenital hereditary vertical nystagmus|Nystagmus, hereditary vertical	Eye disease|Nervous system disease
Hernandez Fragoso syndrome	MESH:C536062			MESH:D005128|MESH:D010024|MESH:D012871|MESH:D017496	C05.116.198.579/C536062|C11/C536062|C17.800.621.440/C536062|C17.800/C536062|C18.452.104.579/C536062	C05.116.198.579|C11|C17.800|C17.800.621.440|C18.452.104.579	Osteoporosis and Oculocutaneous Hypopigmentation Syndrome|Osteoporosis oculocutaneous hypopigmentation syndrome	Eye disease|Metabolic disease|Musculoskeletal disease|Skin disease
Herpangina	MESH:D006557	DO:DOID:10883	Acute types of coxsackievirus infections or ECHOVIRUS INFECTIONS that usually affect children during the summer and are characterized by vesiculoulcerative lesions on the MUCOUS MEMBRANES of the THROAT; DYSPHAGIA; VOMITING, and FEVER.	MESH:D003384|MESH:D004457	C01.925.782.687.359.213.466|C01.925.782.687.359.347.500	C01.925.782.687.359.213|C01.925.782.687.359.347	Herpanginas	Viral disease
Herpes Genitalis	MESH:D006558	DO:DOID:8704	Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females.	MESH:D005831|MESH:D005832|MESH:D006561|MESH:D015229	C01.221.812.640.350|C01.778.640.350|C01.925.256.466.382.290|C01.925.813.350|C12.050.351.500.342|C12.100.250.342|C12.100.500.329|C12.100.937.640.350|C12.200.294.329	C01.221.812.640|C01.778.640|C01.925.256.466.382|C01.925.813|C12.050.351.500|C12.100.250|C12.100.500|C12.100.937.640|C12.200.294	Genital Herpes|Genital Herpes Simplex|Herpes, Genital|Herpes Simplex, Genital|Herpes Simplex Virus Genital Infection	Urogenital disease (female)|Urogenital disease (male)|Viral disease
Herpes Labialis	MESH:D006560		Herpes simplex, caused by type 1 virus, primarily spread by oral secretions and usually occurring as a concomitant of fever. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares. (Dorland, 27th ed.)	MESH:D006561|MESH:D008047	C01.925.256.466.382.316|C01.925.825.320.320|C07.465.409.466|C17.800.838.790.320.320	C01.925.256.466.382|C01.925.825.320|C07.465.409|C17.800.838.790.320	Blister, Fever|Blisters, Fever|Cold Sore|Cold Sores|Fever Blister|Fever Blisters|Herpes Simplex, Labial|Labial Herpes Simplex|Sore, Cold|Sores, Cold	Mouth disease|Skin disease|Viral disease
Herpes Simplex	MESH:D006561	DO:DOID:8566	A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.)	MESH:D006566|MESH:D017193	C01.925.256.466.382|C01.925.825.320|C17.800.838.790.320	C01.925.256.466|C01.925.825|C17.800.838.790	Herpes Simplex Virus Infection	Skin disease|Viral disease
Herpesviridae Infections	MESH:D006566		Virus diseases caused by the HERPESVIRIDAE.	MESH:D004266	C01.925.256.466	C01.925.256	B Virus Infection|B Virus Infections|Herpesviridae Infection|Herpesvirus Infection|Herpesvirus Infections|Infection, B Virus|Infection, Herpesviridae|Infection, Herpesvirus|Infections, B Virus|Infections, Herpesviridae|Infections, Herpesvirus	Viral disease
Herpes Zoster	MESH:D006562	DO:DOID:8536	An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)	MESH:D000073618	C01.925.256.466.930.750	C01.925.256.466.930	Shingles|Zona|Zoster	Viral disease
Herpes Zoster Ophthalmicus	MESH:D006563		Virus infection of the Gasserian ganglion and its nerve branches characterized by pain and vesicular eruptions with much swelling. Ocular involvement is usually heralded by a vesicle on the tip of the nose. This area is innervated by the nasociliary nerve.	MESH:D006562|MESH:D015828	C01.375.725.450|C01.925.256.466.930.750.466|C01.925.325.450|C11.294.800.450	C01.375.725|C01.925.256.466.930.750|C01.925.325|C11.294.800	Herpes Zoster, Ocular|Ocular Herpes Zoster	Eye disease|Viral disease
Herpes Zoster Oticus	MESH:D016697	DO:DOID:9210	A syndrome characterized by facial palsy in association with a herpetic eruption of the external auditory meatus. This may occasionally be associated with tinnitus, vertigo, deafness, severe otalgia, and inflammation of the pinna. The condition is caused by reactivation of a latent HERPESVIRUS 3, HUMAN infection which causes inflammation of the facial and vestibular nerves, and may occasionally involve additional cranial nerves. (From Adams et al., Principles of Neurology, 6th ed, p757)	MESH:D004427|MESH:D005155|MESH:D006562	C01.925.256.466.930.750.733|C07.465.299.750|C09.218.513|C10.292.319.750	C01.925.256.466.930.750|C07.465.299|C09.218|C10.292.319	Auricular Syndrome of Ramsay Hunt|Ganglionitis, Herpetic Geniculate|Geniculate Ganglionitides, Herpetic|Geniculate Ganglionitis, Herpetic|Geniculate Herpes Zoster|Geniculate Neuralgia|Geniculate Neuralgias|Herpes Zoster Auricularis|Herpes Zoster Cephalicus|Herpes Zoster, Geniculate|Herpetic Geniculate Ganglionitides|Herpetic Geniculate Ganglionitis|Neuralgia, Geniculate|Neuralgias, Geniculate|Ramsay Hunt Auricular Syndrome|Ramsay Hunt Syndrome|Syndrome, Ramsay Hunt	Ear-nose-throat disease|Mouth disease|Nervous system disease|Viral disease
Herrmann syndrome	MESH:C538113			MESH:D002524|MESH:D003638|MESH:D003920|MESH:D003929|MESH:D007674|MESH:D009207	C09.218.458.341.186/C538113|C10.228.140.252.190/C538113|C10.597.350.090.500/C538113|C10.597.350.500/C538113|C10.597.751.418.341.186/C538113|C10.668.829.300/C538113|C12.050.351.968.419/C538113|C12.200.777.419/C538113|C12.950.419/C538113|C18.452.394.750/C538113|C19.246.099.937/C538113|C19.246/C538113|C23.888.592.350.090.200/C538113|C23.888.592.350.500/C538113|C23.888.592.763.393.341.186/C538113	C09.218.458.341.186|C10.228.140.252.190|C10.597.350.090.500|C10.597.350.500|C10.597.751.418.341.186|C10.668.829.300|C12.050.351.968.419|C12.200.777.419|C12.950.419|C18.452.394.750|C19.246|C19.246.099.937|C23.888.592.350.090.200|C23.888.592.350.500|C23.888.592.763.393.341.186	Photomyoclonus, Diabetes Mellitus, Deafness, Nephropathy, And Cerebral Dysfunction	Ear-nose-throat disease|Endocrine system disease|Metabolic disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Heterochromia iridis	MESH:C538115			MESH:D007499|MESH:D010859	C11.941.375/C538115|C17.800.621/C538115|C23.550.755/C538115	C11.941.375|C17.800.621|C23.550.755	Asymmetry in the pigmentation of the irides|Pigmentary abnormality of the anterior segment of the eye	Eye disease|Pathology (process)|Skin disease
Heterotaxy Syndrome	MESH:D059446	OMIM:208530	Abnormal thoracoabdominal VISCERA arrangement (visceral heterotaxy) or malformation that involves additional CONGENITAL HEART DEFECTS (e.g., heart isomerism; DEXTROCARDIA) and/or abnormal SPLEEN (e.g., asplenia and polysplenia). Irregularities with the central nervous system, the skeleton and urinary tract are often associated with the syndrome.	MESH:D000015|MESH:D006330|MESH:D013158	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592	C14.240.400|C14.280.400|C15.604.744|C16.131.077|C16.131.240.400	Ambiguus, Situs|Ambiguus Viscerum, Situs|Ambiguus Viscerums, Situs|Asplenia Syndrome|Asplenia Syndromes|Asplenia with Cardiovascular Anomalies|Atrial Isomerism, Left|Atrial Isomerism, Right|Atrial Isomerisms, Left|Atrial Isomerisms, Right|Heterotaxies, Visceral|Heterotaxy Syndromes|Heterotaxy, Visceral|HETEROTAXY, VISCEROATRIAL, AUTOSOMAL RECESSIVE, INCLUDED|Isomerism, Left Atrial|Isomerism, Right Atrial|Isomerisms, Left Atrial|Isomerisms, Right Atrial|Ivemark Syndrome|IVEMARK SYNDROME POLYSPLENIA SYNDROME, INCLUDED|Left Atrial Isomerism|Left Atrial Isomerisms|Left Atrial Isomerism with Polysplenia|POLYASPLENIA, INCLUDED|Polysplenia Syndrome|Polysplenia Syndromes|RAI|Right Atrial Isomerism|Right Atrial Isomerisms|Right Atrial Isomerism with Asplenia|RIGHT ISOMERISM|Situs Ambiguus|Situs Ambiguus Viscerum|Situs Ambiguus Viscerums|Situs Ambiguus with Asplenia|Situs Ambiguus with Polysplenia|Syndrome, Asplenia|Syndrome, Heterotaxy|Syndrome, Ivemark|Syndrome, Polysplenia|Syndromes, Asplenia|Syndromes, Heterotaxy|Syndromes, Polysplenia|VAH, AUTOSOMAL RECESSIVE, INCLUDED|Visceral Heterotaxies|Visceral Heterotaxy|Viscerum, Situs Ambiguus|Viscerums, Situs Ambiguus	Cardiovascular disease|Congenital abnormality|Lymphatic disease
Heterotaxy, Visceral, 3, Autosomal	MESH:C565237	OMIM:606325		MESH:D059446	C14.240.400.592/C565237|C14.280.400.592/C565237|C15.604.744.146/C565237|C16.131.077.401/C565237|C16.131.240.400.592/C565237	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592	HTX3	Cardiovascular disease|Congenital abnormality|Lymphatic disease
HETEROTAXY, VISCERAL, 4, AUTOSOMAL	OMIM:613751	DO:DOID:0050545		MESH:D059446	C14.240.400.592/613751|C14.280.400.592/613751|C15.604.744.146/613751|C16.131.077.401/613751|C16.131.240.400.592/613751	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592	HTX4	Cardiovascular disease|Congenital abnormality|Lymphatic disease
HETEROTAXY, VISCERAL, 6, AUTOSOMAL	OMIM:614779	DO:DOID:0050545		MESH:D059446	C14.240.400.592/614779|C14.280.400.592/614779|C15.604.744.146/614779|C16.131.077.401/614779|C16.131.240.400.592/614779	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592	HTX6	Cardiovascular disease|Congenital abnormality|Lymphatic disease
HETEROTAXY, VISCERAL, 7, AUTOSOMAL	OMIM:616749			MESH:D059446	C14.240.400.592/616749|C14.280.400.592/616749|C15.604.744.146/616749|C16.131.077.401/616749|C16.131.240.400.592/616749	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592	HTX7	Cardiovascular disease|Congenital abnormality|Lymphatic disease
HETEROTAXY, VISCERAL, 8, AUTOSOMAL	OMIM:617205			MESH:D059446	C14.240.400.592/617205|C14.280.400.592/617205|C15.604.744.146/617205|C16.131.077.401/617205|C16.131.240.400.592/617205	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592	HTX8	Cardiovascular disease|Congenital abnormality|Lymphatic disease
Heterotaxy, Visceroatrial, Autosomal Recessive	MESH:C566864			MESH:D059446	C14.240.400.592/C566864|C14.280.400.592/C566864|C15.604.744.146/C566864|C16.131.077.401/C566864|C16.131.240.400.592/C566864	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592		Cardiovascular disease|Congenital abnormality|Lymphatic disease
Hexokinase Deficiency Hemolytic Anemia	MESH:C562995			MESH:D000743	C15.378.071.141/C562995	C15.378.071.141		Blood disease
Hhhh Syndrome	MESH:C564411			MESH:D001264|MESH:D010291	C10.597.350.110/C564411|C10.597.636/C564411|C23.888.592.350.110/C564411|C23.888.592.643/C564411	C10.597.350.110|C10.597.636|C23.888.592.350.110|C23.888.592.643	Hereditary Hemihypotrophy Hemiparesis Hemiathetosis Syndrome	Nervous system disease|Signs and symptoms
Hidradenitis	MESH:D016575	DO:DOID:2282	The inflammation of a sweat gland (usually of the apocrine type). The condition can be idiopathic or occur as a result of or in association with another underlying condition. Neutrophilic eccrine hidradenitis is a relatively rare variant that has been reported in patients undergoing chemotherapy, usually for non-Hodgkin lymphomas or leukemic conditions.	MESH:D013543	C17.800.946.315	C17.800.946	Eccrine Hidradenitides, Neutrophilic|Eccrine Hidradenitis, Neutrophilic|Hidradenitides|Hidradenitides, Neutrophilic Eccrine|Hidradenitis, Neutrophilic Eccrine|Hidrosadenitides|Hidrosadenitis|Hydradenitides|Hydradenitis|Neutrophilic Eccrine Hidradenitides|Neutrophilic Eccrine Hidradenitis	Skin disease
Hidrocystoma	MESH:D018251	DO:DOID:3893	A cystic form of sweat gland adenoma (ADENOMA, SWEAT GLAND). It is produced by the cystic proliferation of apocrine secretory glands. It is not uncommon, occurring in adult life in no particular age group, with males and females equally affected. The commonest site is around the eye, particularly lateral to the outer canthus. It is cured by surgical removal. (Stedman, 25th ed; Rook et al., Textbook of Dermatology, 4th ed, p2410)	MESH:D006607	C04.557.470.035.175.375|C04.557.470.550.175.375	C04.557.470.035.175|C04.557.470.550.175	Hidrocystomas	Cancer
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	OMIM:606613			MESH:D050171	C18.452.584.500/606613	C18.452.584.500	HDLC1|HDLCQ1	Metabolic disease
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12	OMIM:612797			MESH:D050171	C18.452.584.500/612797	C18.452.584.500	HDLCQ12	Metabolic disease
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2	OMIM:607053			MESH:D050171	C18.452.584.500/607053	C18.452.584.500	HDLCQ2	Metabolic disease
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3	OMIM:607687			MESH:D050171	C18.452.584.500/607687	C18.452.584.500	HDLCQ3	Metabolic disease
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4	OMIM:610239			MESH:D050171	C18.452.584.500/610239	C18.452.584.500	HDLCQ4	Metabolic disease
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5	OMIM:610761			MESH:D050171	C18.452.584.500/610761	C18.452.584.500	HDLCQ5	Metabolic disease
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6	OMIM:610762			MESH:D050171	C18.452.584.500/610762	C18.452.584.500	HDLCQ6	Metabolic disease
High Pressure Neurological Syndrome	MESH:D006610	DO:DOID:3230	A syndrome related to increased atmospheric pressure and characterized by tremors, nausea, dizziness, decreased motor and mental performance, and SEIZURES. This condition may occur in those who dive deeply (c. 1000 ft) usually while breathing a mixture of oxygen and helium. The condition is associated with a neuroexcitatory effect of helium.	MESH:D002493|MESH:D009784	C10.228.566|C24.410	C10.228|C24	Experimental High Pressure Neurological Syndrome|High Pressure Nervous Syndrome|High Pressure Neural Syndrome|High Pressure Neurological Syndrome, Experimental|HPNS|HPNSs	Nervous system disease|Occupational disease
Hip Contracture	MESH:D006616		Permanent fixation of the hip in primary positions, with limited passive or active motion at the hip joint. Locomotion is difficult and pain is sometimes present when the hip is in motion. It may be caused by trauma, infection, or poliomyelitis. (From Current Medical Information & Technology, 5th ed)	MESH:D003286	C05.550.323.468|C05.651.197.468	C05.550.323|C05.651.197	Contracture, Hip|Contractures, Hip|Hip Contractures	Musculoskeletal disease
Hip Dislocation	MESH:D006617		Displacement of the femur bone from its normal position at the HIP JOINT.	MESH:D004204|MESH:D025981	C05.550.518.384|C26.289.384|C26.531.500	C05.550.518|C26.289|C26.531	Dislocation, Hip|Dislocations, Hip|Displacement, Hip|Displacements, Hip|Dysplasia, Hip|Dysplasias, Hip|Hip Dislocations|Hip Displacement|Hip Displacements|Hip Dysplasia|Hip Dysplasias	Musculoskeletal disease|Wounds and injuries
Hip socket neuropathy	MESH:C531783			MESH:D012585|MESH:D055958	C10.668.829.500.675.399/C531783|C10.668.829.500.675.800/C531783|C10.668.829.550.500/C531783|C10.668.829.600.675/C531783|C10.668.829.600.800/C531783|C23.888.592.612.664.675/C531783|C23.888.592.612.664.800/C531783|C23.888.592.612.944.750/C531783	C10.668.829.500.675.399|C10.668.829.500.675.800|C10.668.829.550.500|C10.668.829.600.675|C10.668.829.600.800|C23.888.592.612.664.675|C23.888.592.612.664.800|C23.888.592.612.944.750	Deep gluteal syndrome|Pseudosciatica|Wallet sciatica	Nervous system disease|Signs and symptoms
Hirschsprung Disease, Cardiac Defects, and Autonomic Dysfunction	MESH:C563939	OMIM:613870		MESH:D001342|MESH:D006330|MESH:D006627	C06.198.439/C563939|C06.405.469.158.701.439/C563939|C10.177/C563939|C14.240.400/C563939|C14.280.400/C563939|C16.131.240.400/C563939|C16.131.314.439/C563939	C06.198.439|C06.405.469.158.701.439|C10.177|C14.240.400|C14.280.400|C16.131.240.400|C16.131.314.439	HCAD	Cardiovascular disease|Congenital abnormality|Digestive system disease|Nervous system disease
Hirschsprung disease ganglioneuroblastoma	MESH:C538119			MESH:D006627|MESH:D018305	C04.557.465.625.600.590.650.550.300/C538119|C04.557.470.670.590.650.550.300/C538119|C04.557.580.625.600.590.650.550.300/C538119|C06.198.439/C538119|C06.405.469.158.701.439/C538119|C16.131.314.439/C538119	C04.557.465.625.600.590.650.550.300|C04.557.470.670.590.650.550.300|C04.557.580.625.600.590.650.550.300|C06.198.439|C06.405.469.158.701.439|C16.131.314.439	Neuroblastoma with Hirschsprung disease	Cancer|Congenital abnormality|Digestive system disease
Hirschsprung Disease with Heart Defects, Laryngeal Anomalies, and Preaxial Polydactyly	MESH:C565817			MESH:D000015|MESH:D006330|MESH:D006627|MESH:D017689	C05.660.585.600/C565817|C06.198.439/C565817|C06.405.469.158.701.439/C565817|C14.240.400/C565817|C14.280.400/C565817|C16.131.077/C565817|C16.131.240.400/C565817|C16.131.314.439/C565817|C16.131.621.585.600/C565817	C05.660.585.600|C06.198.439|C06.405.469.158.701.439|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.314.439|C16.131.621.585.600		Cardiovascular disease|Congenital abnormality|Digestive system disease|Musculoskeletal disease
Hirschsprung Disease with Ulnar Polydactyly, Polysyndactyly of Big Toes, and Ventricular Septal Defect	MESH:C565517			MESH:D006345|MESH:D006627|MESH:D017689	C05.660.585.600/C565517|C06.198.439/C565517|C06.405.469.158.701.439/C565517|C14.240.400.560.540/C565517|C14.280.400.560.540/C565517|C16.131.240.400.560.540/C565517|C16.131.314.439/C565517|C16.131.621.585.600/C565517	C05.660.585.600|C06.198.439|C06.405.469.158.701.439|C14.240.400.560.540|C14.280.400.560.540|C16.131.240.400.560.540|C16.131.314.439|C16.131.621.585.600		Cardiovascular disease|Congenital abnormality|Digestive system disease|Musculoskeletal disease
Histiocytic Disorders, Malignant	MESH:D015620	DO:DOID:2570	Distinctive neoplastic disorders of histiocytes. Included are malignant neoplasms of MACROPHAGES and DENDRITIC CELLS.	MESH:D009370|MESH:D015614	C04.557.227|C15.604.250.390	C04.557|C15.604.250	Disorder, Malignant Histiocytic|Disorders, Malignant Histiocytic|Histiocytic Disorder, Malignant|Malignant Histiocytic Disorder|Malignant Histiocytic Disorders	Cancer|Lymphatic disease
Histiocytic Necrotizing Lymphadenitis	MESH:D020042		Development of lesions in the lymph node characterized by infiltration of the cortex or paracortex by large collections of proliferating histiocytes and complete or, more often, incomplete necrosis of lymphoid tissue.	MESH:D008199	C15.604.315.300	C15.604.315	Disease, Kikuchi|Disease, Kikuchi-Fujimoto|Disease, Kikuchi-Fujimoto's|Disease, Kikuchi's|Histiocytic Necrotising Lymphadenitides|Histiocytic Necrotising Lymphadenitis|Kikuchi Disease|Kikuchi Fujimoto Disease|Kikuchi-Fujimoto Disease|Kikuchi Fujimoto's Disease|Kikuchi-Fujimoto's Disease|Kikuchi-Fujimotos Disease|Kikuchi Necrotizing Lymphadenitis|Kikuchi's Disease|Kikuchis Disease|Kikuchi's Disease, Nosocomial|Lymphadenitides, Histiocytic Necrotising|Lymphadenitis, Histiocytic Necrotising|Lymphadenitis, Histiocytic Necrotizing|Lymphadenitis, Kikuchi Necrotizing|Necrotising Lymphadenitides, Histiocytic|Necrotising Lymphadenitis, Histiocytic|Necrotizing Lymphadenitis, Histiocytic|Necrotizing Lymphadenitis, Kikuchi|Nosocomial Kikuchi Disease|Nosocomial Kikuchi's Disease|Nosocomial Kikuchis Disease	Lymphatic disease
Histiocytic Sarcoma	MESH:D054747	DO:DOID:0080915	Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.	MESH:D015620	C04.557.227.380|C15.604.250.390.380	C04.557.227|C15.604.250.390	Histiocytic Lymphomas, True|Histiocytic Lymphoma, True|Histiocytic Sarcomas|Histiocytoses, Malignant|Histiocytoses, True Malignant|Histiocytosis, Malignant|Histiocytosis, True Malignant|Lymphomas, True Histiocytic|Lymphoma, True Histiocytic|Malignant Histiocytoses|Malignant Histiocytoses, True|Malignant Histiocytosis|Malignant Histiocytosis, True|Sarcoma, Histiocytic|Sarcomas, Histiocytic|True Histiocytic Lymphoma|True Histiocytic Lymphomas|True Malignant Histiocytoses|True Malignant Histiocytosis	Cancer|Lymphatic disease
Histiocytoma	MESH:D051642	DO:DOID:4231	A neoplasm containing HISTIOCYTES. Important forms include BENIGN FIBROUS HISTIOCYTOMA; and MALIGNANT FIBROUS HISTIOCYTOMA.	MESH:D018218	C04.557.450.565.590.425	C04.557.450.565.590	Histiocytomas	Cancer
Histiocytoma, Angiomatoid Fibrous	MESH:C563181	OMIM:612160		MESH:D051677	C04.557.450.565.590.425.360/C563181|C04.557.450.795.400/C563181	C04.557.450.565.590.425.360|C04.557.450.795.400		Cancer
Histiocytoma, Benign Fibrous	MESH:D018219	DO:DOID:4415|DO:DOID:4418	A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)	MESH:D051642	C04.557.450.565.590.425.350	C04.557.450.565.590.425	Angioma, Sclerosing|Angiomas, Sclerosing|Benign Fibrous Histiocytoma|Benign Fibrous Histiocytomas|Cutaneous Histiocytoma|Cutaneous Histiocytomas|Dermatofibroma|Dermatofibromas|Fibrous Histiocytoma|Fibrous Histiocytoma, Benign|Fibrous Histiocytomas|Fibrous Histiocytomas, Benign|Hemangioma, Sclerosing|Hemangiomas, Sclerosing|Histiocytoma, Cutaneous|Histiocytoma, Fibrous|Histiocytomas, Benign Fibrous|Histiocytomas, Cutaneous|Histiocytomas, Fibrous|Sclerosing Angioma|Sclerosing Angiomas|Sclerosing Hemangioma|Sclerosing Hemangiomas	Cancer
Histiocytoma, Malignant Fibrous	MESH:D051677	DO:DOID:1907	The most commonly diagnosed soft tissue sarcoma. It is a neoplasm with a fibrohistiocytic appearance found chiefly in later adult life, with peak incidence in the 7th decade.	MESH:D012509|MESH:D051642	C04.557.450.565.590.425.360|C04.557.450.795.400	C04.557.450.565.590.425|C04.557.450.795	Fibrohistiocytic Tumor, Malignant|Fibrohistiocytic Tumors, Malignant|Fibrous Histiocytoma, Malignant|Fibrous Histiocytomas, Malignant|Histiocytomas, Malignant Fibrous|Malignant Fibrohistiocytic Tumor|Malignant Fibrohistiocytic Tumors|Malignant Fibrous Histiocytoma|Malignant Fibrous Histiocytomas|Pleomorphic Malignant Fibrous Histiocytoma|Tumor, Malignant Fibrohistiocytic|Tumors, Malignant Fibrohistiocytic	Cancer
Histiocytosis	MESH:D015614	DO:DOID:3405	General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS-CELL; and HISTIOCYTIC DISORDERS, MALIGNANT.	MESH:D008206	C15.604.250	C15.604	Histiocytoses	Lymphatic disease
Histiocytosis, Langerhans-Cell	MESH:D006646	DO:DOID:2571	A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder.	MESH:D015614|MESH:D017563	C08.381.483.375|C15.604.250.400	C08.381.483|C15.604.250	Aleukemic Reticuloendothelioses, Systemic|Aleukemic Reticuloendotheliosis, Systemic|Cell Granulomatoses, Langerhans|Cell Granulomatosis, Langerhans|Cell Histiocytoses, Langerhans|Cell Histiocytosis, Langerhans|Disease, Hand-Schueller-Christian|Disease, Hand-Schüller-Christian|Disease, Letterer-Siwe|Disease, Schueller-Christian|Generalized Histiocytoses|Generalized Histiocytosis|Granulomatoses, Langerhans Cell|Granulomatosis, Langerhans Cell|Granulomatosis, Langerhans-Cell|Hand Schueller Christian Disease|Hand-Schueller-Christian Disease|Hand Schueller Christian Syndrome|Hand-Schueller-Christian Syndrome|Hand Schüller Christian Disease|Hand-Schüller-Christian Disease|Hand Schüller Christian Syndrome|Hand-Schüller-Christian Syndrome|Hashimoto-Pritzger Disease|Histiocytoses, Generalized|Histiocytoses, Langerhans Cell|Histiocytoses, Type 2|Histiocytosis, Generalized|Histiocytosis, Langerhans Cell|Histiocytosis, Type 2|Histiocytosis X|Histiocytosis-X|Histiocytosis X, Pulmonary|Langerhans Cell Granulomatoses|Langerhans Cell Granulomatosis|Langerhans-Cell Granulomatosis|Langerhans Cell Granulomatosis, Pulmonary|Langerhans Cell Histiocytoses|Langerhans Cell Histiocytosis|Langerhans-Cell Histiocytosis|Letterer Siwe Disease|Letterer-Siwe Disease|Non-Lipid Reticuloendothelioses|Non Lipid Reticuloendotheliosis|Non-Lipid Reticuloendotheliosis|Pulmonary Histiocytosis X|Pulmonary Langerhans Cell Granulomatosis|Reticuloendothelioses, Non-Lipid|Reticuloendothelioses, Systemic Aleukemic|Reticuloendotheliosis, Non-Lipid|Reticuloendotheliosis, Systemic Aleukemic|Schueller Christian Disease|Schueller-Christian Disease|Syndrome, Hand-Schueller-Christian|Syndrome, Hand-Schüller-Christian|Systemic Aleukemic Reticuloendothelioses|Systemic Aleukemic Reticuloendotheliosis|Type 2 Histiocytoses|Type 2 Histiocytosis	Lymphatic disease|Respiratory tract disease
Histiocytosis, Non-Langerhans-Cell	MESH:D015616	DO:DOID:4330|DO:DOID:4394	Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma; JUVENILE XANTHOGRANULOMA; xanthoma disseminatum; as well as the lipid storage diseases (SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES).	MESH:D015614	C15.604.250.410	C15.604.250	Disseminatum, Xanthoma|Histiocytosis, Non Langerhans Cell|Non-Langerhans-Cell Histiocytosis|Reticulohistiocytoma|Reticulohistiocytomas|Xanthoma Disseminatum	Lymphatic disease
Histiocytosis, Progressive Mucinous	MESH:C564186			MESH:D012878|MESH:D015614|MESH:D018297	C04.557.470.590/C564186|C04.588.805/C564186|C15.604.250/C564186|C17.800.882/C564186	C04.557.470.590|C04.588.805|C15.604.250|C17.800.882		Cancer|Lymphatic disease|Skin disease
Histiocytosis, Sinus	MESH:D015618		Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy.	MESH:D015616	C15.604.250.410.450	C15.604.250.410	Destombes Rosai Dorfman Syndrome|Destombes-Rosai-Dorfman Syndrome|Disease, Rosai-Dorfman|Histiocytoses, Sinus|Rosai Dorfman Disease|Rosai-Dorfman Disease|Sinus Histiocytoses|Sinus Histiocytosis|Sinus Histiocytosis with Massive Lymphadenopathy|Syndrome, Destombes-Rosai-Dorfman	Lymphatic disease
Histiocytosis with joint contractures and sensorineural deafness	MESH:C538322	OMIM:602782		MESH:D003286|MESH:D006319|MESH:D015614	C05.550.323/C538322|C05.651.197/C538322|C09.218.458.341.887/C538322|C10.597.751.418.341.887/C538322|C15.604.250/C538322|C23.888.592.763.393.341.887/C538322	C05.550.323|C05.651.197|C09.218.458.341.887|C10.597.751.418.341.887|C15.604.250|C23.888.592.763.393.341.887	Faisalabad histiocytosis|HISTIOCYTOSIS AND LYMPHADENOPATHY WITH OR WITHOUT CUTANEOUS, CARDIAC, AND/OR ENDOCRINE FEATURES, JOINT CONTRACTURES, AND/OR DEAFNESS|HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME|HISTIOCYTOSIS WITH JOINT CONTRACTURES AND SENSORINEURAL DEAFNESS|HJCD|H SYNDROME|Hyperpigmentation, Cutaneous, with Hypertrichosis, Hepatosplenomegaly, Heart Anomalies, and Hypogonadism With or Without Hearing Loss|PHID|PIGMENTED HYPERTRICHOSIS WITH INSULIN-DEPENDENT DIABETES MELLITUS|Pigmented Hypertrichosis With Insulin-Dependent Diabetes Mellitus Syndrome|ROSAI-DORFMAN DISEASE, FAMILIAL|SHML|SINUS HISTIOCYTOSIS AND MASSIVE LYMPHADENOPATHY	Ear-nose-throat disease|Lymphatic disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Hittner Hirsch Kreh syndrome	MESH:C538323			MESH:D000015|MESH:D003103|MESH:D006319|MESH:D006330|MESH:D008607|MESH:D008850	C09.218.458.341.887/C538323|C10.597.606.360/C538323|C10.597.751.418.341.887/C538323|C11.250.110/C538323|C11.250.566/C538323|C11.270.147/C538323|C14.240.400/C538323|C14.280.400/C538323|C16.131.077/C538323|C16.131.240.400/C538323|C16.131.384.282/C538323|C16.131.384.666/C538323|C23.888.592.604.646/C538323|C23.888.592.763.393.341.887/C538323|F03.625.539/C538323	C09.218.458.341.887|C10.597.606.360|C10.597.751.418.341.887|C11.250.110|C11.250.566|C11.270.147|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.384.282|C16.131.384.666|C23.888.592.604.646|C23.888.592.763.393.341.887|F03.625.539		Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
HIV-Associated Lipodystrophy Syndrome	MESH:D039682		Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.	MESH:D008060|MESH:D015658	C01.221.250.875.550|C01.221.812.640.400.530|C01.778.640.400.530|C01.925.782.815.616.400.550|C01.925.813.400.530|C12.100.937.640.400.530|C17.800.849.391.400|C18.452.584.625.400|C18.452.880.391.400|C20.673.480.400	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C12.100.937.640.400|C17.800.849.391|C18.452.584.625|C18.452.880.391|C20.673.480	HIV Associated Lipodystrophy|HIV-Associated Lipodystrophy|HIV Associated Lipodystrophy Syndrome|HIV Lipodystrophy Syndrome|Lipodystrophy, HIV-Associated|Lipodystrophy Syndrome, HIV|Lipodystrophy Syndrome, HIV-Associated	Immune system disease|Metabolic disease|Skin disease|Viral disease
HIV Enteropathy	MESH:D019053		A syndrome characterized by chronic, well-established DIARRHEA (greater than one month in duration) without an identified infectious cause after thorough evaluation, in an HIV-positive individual. It is thought to be due to direct or indirect effects of HIV on the enteric mucosa. HIV enteropathy is a diagnosis of exclusion and can be made only after other forms of diarrheal illness have been ruled out. (Harrison's Principles of Internal Medicine, 13th ed, pp1607-8; Haubrich et al., Bockus Gastroenterology, 5th ed, p1155)	MESH:D007410|MESH:D015658	C01.221.250.875.398|C01.221.812.640.400.480|C01.778.640.400.480|C01.925.782.815.616.400.398|C01.925.813.400.480|C06.405.469.400|C12.100.937.640.400.480|C20.673.480.480	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C06.405.469|C12.100.937.640.400|C20.673.480	AIDS-Associated Enteropathies|AIDS Associated Enteropathy|AIDS-Associated Enteropathy|AIDS Enteropathies|AIDS Enteropathies, Idiopathic|AIDS Enteropathy|AIDS Enteropathy, Idiopathic|Enteropathies, AIDS|Enteropathies, AIDS-Associated|Enteropathies, HIV|Enteropathies, HIV-Associated|Enteropathies, Idiopathic AIDS|Enteropathy, AIDS|Enteropathy, AIDS Associated|Enteropathy, AIDS-Associated|Enteropathy, HIV|Enteropathy, HIV Associated|Enteropathy, HIV-Associated|Enteropathy, Idiopathic AIDS|HIV-Associated Enteropathies|HIV Associated Enteropathy|HIV-Associated Enteropathy|HIV Enteropathies|Idiopathic AIDS Enteropathies|Idiopathic AIDS Enteropathy	Digestive system disease|Immune system disease|Viral disease
HIV Infections	MESH:D015658	DO:DOID:526|OMIM:609423	Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).	MESH:D000086982|MESH:D007153|MESH:D015229|MESH:D016180	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C12.100.937.640.400|C20.673.480	C01.221.250|C01.221.812.640|C01.778.640|C01.925.782.815.616|C01.925.813|C12.100.937.640|C20.673	ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED|AIDS, PROGRESSION TO, INCLUDED|Coinfection, HIV|Coinfections, HIV|HIV-1, RESISTANCE TO, INCLUDED|HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED|HIV Coinfection|HIV Coinfections|HIV Infection|HTLV-III Infection|HTLV III Infections|HTLV-III Infections|HTLV-III-LAV Infection|HTLV III LAV Infections|HTLV-III-LAV Infections|HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO|Infection, HIV|Infection, HTLV-III|Infection, HTLV-III-LAV|Infections, HIV|Infections, HTLV-III|Infections, HTLV-III-LAV|T Lymphotropic Virus Type III Infections, Human|T-Lymphotropic Virus Type III Infections, Human	Immune system disease|Viral disease
HIV Seropositivity	MESH:D006679		Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).	MESH:D015658	C01.221.250.875.500|C01.221.812.640.400.500|C01.778.640.400.500|C01.925.782.815.616.400.500|C01.925.813.400.500|C12.100.937.640.400.500|C20.673.480.500	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C12.100.937.640.400|C20.673.480	AIDS Seroconversion|AIDS Seroconversions|AIDS Seropositivities|AIDS Seropositivity|Antibody Positivities, HIV|Antibody Positivity, HIV|Anti-HIV Positivities|Anti HIV Positivity|Anti-HIV Positivity|HIV Antibody Positivities|HIV Antibody Positivity|HIV Seroconversion|HIV Seroconversions|HIV Seropositivities|HTLV III Seroconversion|HTLV-III Seroconversion|HTLV-III Seroconversions|HTLV-III Seropositivities|HTLV III Seropositivity|HTLV-III Seropositivity|Positivities, Anti-HIV|Positivities, HIV Antibody|Positivity, Anti-HIV|Positivity, HIV Antibody|Seroconversion, AIDS|Seroconversion, HIV|Seroconversion, HTLV-III|Seroconversions, AIDS|Seroconversions, HIV|Seroconversions, HTLV-III|Seropositivities, AIDS|Seropositivities, HIV|Seropositivities, HTLV-III|Seropositivity, AIDS|Seropositivity, HIV|Seropositivity, HTLV-III	Immune system disease|Viral disease
HIV Wasting Syndrome	MESH:D019247		Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. (From Harrison's Principles of Internal Medicine, 13th ed, p1611).	MESH:D015658|MESH:D019282	C01.221.250.875.520|C01.221.812.640.400.520|C01.778.640.400.520|C01.925.782.815.616.400.520|C01.925.813.400.520|C12.100.937.640.400.520|C18.452.915.520|C18.654.940.520|C20.673.480.520	C01.221.250.875|C01.221.812.640.400|C01.778.640.400|C01.925.782.815.616.400|C01.925.813.400|C12.100.937.640.400|C18.452.915|C18.654.940|C20.673.480	AIDS Wasting Syndrome|HIV Wasting Disease|Slim Disease|Wasting Disease, HIV|Wasting Syndrome, AIDS|Wasting Syndrome, HIV	Immune system disease|Metabolic disease|Nutrition disorder|Viral disease
Hoarseness	MESH:D006685		An unnaturally deep or rough quality of voice.	MESH:D012120|MESH:D012818|MESH:D014832	C08.360.940.490|C08.618.490|C09.400.940.490|C10.597.975.550|C23.888.592.979.550|C23.888.852.490	C08.360.940|C08.618|C09.400.940|C10.597.975|C23.888.592.979|C23.888.852	Hoarsenesses|Hoarseness, Neurogenic|Hoarseness of Voice|Hoarseness, Voice|Neurogenic Hoarseness|Neurogenic Hoarsenesses|Voice Hoarseness	Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Hodgkin Disease	MESH:D006689	DO:DOID:8543|DO:DOID:8567|DO:DOID:8628|DO:DOID:8654|OMIM:236000	A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.	MESH:D008223	C04.557.386.355|C15.604.515.569.355|C20.683.515.761.355	C04.557.386|C15.604.515.569|C20.683.515.761	Adult Hodgkin Lymphoma|CHL|Disease, Hodgkin|Disease, Hodgkins|Disease, Hodgkin's|Granuloma, Hodgkin|Granuloma, Hodgkins|Granuloma, Hodgkin's|Granuloma, Malignant|HODGKIN DISEASE|Hodgkin Granuloma|Hodgkin Lymphoma|Hodgkin Lymphoma, Adult|Hodgkin's Disease|Hodgkins Disease|Hodgkin's Granuloma|Hodgkins Granuloma|Hodgkin's Lymphoma|Hodgkins Lymphoma|Lymphocyte Depletion Hodgkin's Lymphoma|Lymphocyte Rich Classical Hodgkin's Lymphoma|Lymphocyte-Rich Classical Hodgkin's Lymphoma|Lymphogranuloma, Malignant|Lymphogranulomas, Malignant|Lymphoma, Hodgkin|LYMPHOMA, HODGKIN, CLASSIC|Lymphoma, Hodgkin's|Malignant Granuloma|Malignant Granulomas|Malignant Lymphogranuloma|Malignant Lymphogranulomas|Mixed Cellularity Hodgkin's Lymphoma|Nodular Lymphocyte Predominant Hodgkin's Lymphoma|Nodular Lymphocyte-Predominant Hodgkin's Lymphoma|Nodular Sclerosing Hodgkin's Lymphoma	Cancer|Immune system disease|Lymphatic disease
Ho Kaufman Mcalister syndrome	MESH:C538325			MESH:D000014|MESH:D000015|MESH:D001847|MESH:D002972|MESH:D006330|MESH:D006618|MESH:D008844	C05.116/C538325|C05.500.460.185/C538325|C05.500.460.457/C538325|C05.660.207.540.460.185/C538325|C05.660.207.540.460.457/C538325|C05.660.297.500/C538325|C07.320.440.185/C538325|C07.320.440.457/C538325|C07.465.525.185/C538325|C07.650.500.460.185/C538325|C07.650.500.460.457/C538325|C07.650.525.185/C538325|C14.240.400/C538325|C14.280.400/C538325|C16.131.042/C538325|C16.131.077/C538325|C16.131.240.400/C538325|C16.131.621.207.540.460.185/C538325|C16.131.621.207.540.460.457/C538325|C16.131.621.297.500/C538325|C16.131.621.449/C538325|C16.131.850.500.460.185/C538325|C16.131.850.500.460.457/C538325|C16.131.850.525.185/C538325	C05.116|C05.500.460.185|C05.500.460.457|C05.660.207.540.460.185|C05.660.207.540.460.457|C05.660.297.500|C07.320.440.185|C07.320.440.457|C07.465.525.185|C07.650.500.460.185|C07.650.500.460.457|C07.650.525.185|C14.240.400|C14.280.400|C16.131.042|C16.131.077|C16.131.240.400|C16.131.621.207.540.460.185|C16.131.621.207.540.460.457|C16.131.621.297.500|C16.131.621.449|C16.131.850.500.460.185|C16.131.850.500.460.457|C16.131.850.525.185		Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease
Holt-Oram syndrome	MESH:C535326	DO:DOID:0060468|OMIM:142900		MESH:D000015|MESH:D006330|MESH:D006344|MESH:D038061|MESH:D038062	C05.660.585.512/C535326|C05.660.585.988/C535326|C14.240.400.560.375/C535326|C14.240.400/C535326|C14.280.400.560.375/C535326|C14.280.400/C535326|C16.131.077/C535326|C16.131.240.400.560.375/C535326|C16.131.240.400/C535326|C16.131.621.585.512/C535326|C16.131.621.585.988/C535326	C05.660.585.512|C05.660.585.988|C14.240.400|C14.240.400.560.375|C14.280.400|C14.280.400.560.375|C16.131.077|C16.131.240.400|C16.131.240.400.560.375|C16.131.621.585.512|C16.131.621.585.988	Atriodigital dysplasia|Atrio-Digital Syndrome|Cardiac-Limb Syndrome|Cervico-Oculo-Acoustic Syndrome|Heart-hand syndrome|Heart-Hand Syndrome, Type 1|HOS|HOS1|Ventriculo-Radial Syndrome|Wildervanck syndrome	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Holzgreve Wagner Rehder syndrome	MESH:C535327	DO:DOID:0060566		MESH:D000015|MESH:D002971|MESH:D002972|MESH:D006330	C05.500.460.185/C535327|C05.660.207.540.460.185/C535327|C07.320.440.185/C535327|C07.465.409.225/C535327|C07.465.525.164/C535327|C07.465.525.185/C535327|C07.650.500.460.185/C535327|C07.650.525.164/C535327|C07.650.525.185/C535327|C14.240.400/C535327|C14.280.400/C535327|C16.131.077/C535327|C16.131.240.400/C535327|C16.131.621.207.540.460.185/C535327|C16.131.850.500.460.185/C535327|C16.131.850.525.164/C535327|C16.131.850.525.185/C535327	C05.500.460.185|C05.660.207.540.460.185|C07.320.440.185|C07.465.409.225|C07.465.525.164|C07.465.525.185|C07.650.500.460.185|C07.650.525.164|C07.650.525.185|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.207.540.460.185|C16.131.850.500.460.185|C16.131.850.525.164|C16.131.850.525.185	Complex congenital heart defect, renal agenesis, and cleft lip and palate|Holzgreve syndrome	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease
Homozygous 11p15-p14 Deletion Syndrome	MESH:C564701	OMIM:606528		MESH:D002872|MESH:D006319|MESH:D006946|MESH:D007410	C06.405.469/C564701|C09.218.458.341.887/C564701|C10.597.751.418.341.887/C564701|C18.452.394.968/C564701|C23.550.210.050.500.500/C564701|C23.888.592.763.393.341.887/C564701	C06.405.469|C09.218.458.341.887|C10.597.751.418.341.887|C18.452.394.968|C23.550.210.050.500.500|C23.888.592.763.393.341.887	Hyperinsulinism, Infantile, with Enteropathy and Deafness	Digestive system disease|Ear-nose-throat disease|Metabolic disease|Nervous system disease|Pathology (process)|Signs and symptoms
Hordnes Engebretsen Knudtson syndrome	MESH:C536067			MESH:D000015|MESH:D003398|MESH:D008607|MESH:D011666	C05.116.099.370.894.232/C536067|C05.660.207.240/C536067|C05.660.906.364/C536067|C10.597.606.360/C536067|C14.280.484.716/C536067|C14.280.955.750/C536067|C16.131.077/C536067|C16.131.621.207.240/C536067|C16.131.621.906.364/C536067|C23.888.592.604.646/C536067|F03.625.539/C536067	C05.116.099.370.894.232|C05.660.207.240|C05.660.906.364|C10.597.606.360|C14.280.484.716|C14.280.955.750|C16.131.077|C16.131.621.207.240|C16.131.621.906.364|C23.888.592.604.646|F03.625.539		Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Horner Syndrome	MESH:D006732	DO:DOID:11486	A syndrome associated with defective sympathetic innervation to one side of the face, including the eye. Clinical features include MIOSIS; mild BLEPHAROPTOSIS; and hemifacial ANHIDROSIS (decreased sweating)(see HYPOHIDROSIS). Lesions of the BRAIN STEM; cervical SPINAL CORD; first thoracic nerve root; apex of the LUNG; CAROTID ARTERY; CAVERNOUS SINUS; and apex of the ORBIT may cause this condition. (From Miller et al., Clinical Neuro-Ophthalmology, 4th ed, pp500-11)	MESH:D001342|MESH:D015877	C10.177.350|C10.597.690.362.500|C11.710.528.500|C23.888.592.708.362.500	C10.177|C10.597.690.362|C11.710.528|C23.888.592.708.362	Acquired Horner Syndrome|Bernard's Syndrome|Bernards Syndrome|Bernard Syndrome|Bernard Syndromes|Central Horner Syndrome|Claude Bernard Horner Syndrome|Claude Bernard-Horner Syndrome|Horner's Syndrome|Horners Syndrome|Horner's Syndrome, Pupil|Horners Syndrome, Pupil|Horner Syndrome, Acquired|Horner Syndrome, Central|Horner Syndrome, Pupil|Miosis, Innervational Defect|Ocular Ophthalmoplegias, Sympathetic|Ocular-Ophthalmoplegias, Sympathetic|Ocular Ophthalmoplegia, Sympathetic|Ocular-Ophthalmoplegia, Sympathetic|Oculosympathetic Syndrome|Oculosympathetic Syndromes|Ophthalmoplegias, Sympathetic Ocular|Ophthalmoplegia, Sympathetic Ocular|Ptosis Sympathetic|Pupil Horner's Syndrome|Sympathetic Ocular Ophthalmoplegia|Sympathetic Ocular-Ophthalmoplegia|Sympathetic Ocular Ophthalmoplegias|Sympathetic Ocular-Ophthalmoplegias|Syndrome, Acquired Horner|Syndrome, Bernard|Syndrome, Bernard's|Syndrome, Central Horner|Syndrome, Claude Bernard-Horner|Syndrome, Horner|Syndrome, Horner's|Syndrome, Oculosympathetic|Syndrome, Pupil Horner's|Syndromes, Bernard|Syndromes, Oculosympathetic	Eye disease|Nervous system disease|Signs and symptoms
Horner Syndrome, Congenital	MESH:C564178			MESH:D006732	C10.177.350/C564178|C10.597.690.362.500/C564178|C11.710.528.500/C564178|C23.888.592.708.362.500/C564178	C10.177.350|C10.597.690.362.500|C11.710.528.500|C23.888.592.708.362.500		Eye disease|Nervous system disease|Signs and symptoms
HTLV-II Infections	MESH:D015491		Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2.	MESH:D006800	C01.925.782.815.200.480|C20.673.483.480	C01.925.782.815.200|C20.673.483	HTLV-II Infection|Human T lymphotropic Virus 2 Infection|Human T-lymphotropic Virus 2 Infection|Human T lymphotropic Virus 2 Infections|Human T-lymphotropic Virus 2 Infections|Infection, HTLV-II|Infections, HTLV II|Infections, HTLV-II	Immune system disease|Viral disease
HTLV-I Infections	MESH:D015490		Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.	MESH:D006800	C01.925.782.815.200.470|C20.673.483.470	C01.925.782.815.200|C20.673.483	HTLV-I Infection|HTLV I Infections|Human T lymphotropic Virus 1 Infection|Human T-lymphotropic Virus 1 Infection|Human T lymphotropic Virus 1 Infections|Human T-lymphotropic Virus 1 Infections|Infection, HTLV-I|Infections, HTLV I|Infections, HTLV-I	Immune system disease|Viral disease
Human Herpesvirus 6 encephalitis	MESH:C538117			MESH:D018792|MESH:D019349	C01.207.245.340/C538117|C01.207.399.750/C538117|C01.925.182.525/C538117|C01.925.256.466.850/C538117|C10.228.140.430.520.750/C538117|C10.228.228.245.340/C538117|C10.228.228.399.750/C538117|C10.586.250.520.750/C538117	C01.207.245.340|C01.207.399.750|C01.925.182.525|C01.925.256.466.850|C10.228.140.430.520.750|C10.228.228.245.340|C10.228.228.399.750|C10.586.250.520.750		Nervous system disease|Viral disease
Human Herpesvirus Type 6, Integrated	MESH:C565771			MESH:D019349	C01.925.256.466.850/C565771	C01.925.256.466.850		Viral disease
HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1	OMIM:167959			MESH:D002583	C04.588.945.418.948.850/167959|C12.050.351.500.852.593.131/167959|C12.050.351.500.852.762.850/167959|C12.050.351.937.418.875.850/167959|C12.100.250.852.593.131/167959|C12.100.250.852.762.850/167959|C12.900.418.875.850/167959	C04.588.945.418.948.850|C12.050.351.500.852.593.131|C12.050.351.500.852.762.850|C12.050.351.937.418.875.850|C12.100.250.852.593.131|C12.100.250.852.762.850|C12.900.418.875.850	HPV18I1|PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1	Cancer|Urogenital disease (female)
HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2	OMIM:167960			MESH:D002583	C04.588.945.418.948.850/167960|C12.050.351.500.852.593.131/167960|C12.050.351.500.852.762.850/167960|C12.050.351.937.418.875.850/167960|C12.100.250.852.593.131/167960|C12.100.250.852.762.850/167960|C12.900.418.875.850/167960	C04.588.945.418.948.850|C12.050.351.500.852.593.131|C12.050.351.500.852.762.850|C12.050.351.937.418.875.850|C12.100.250.852.593.131|C12.100.250.852.762.850|C12.900.418.875.850	HPV18I2|PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2	Cancer|Urogenital disease (female)
Human spumaretrovirus infection	MESH:C536069			MESH:D012192	C01.925.782.815/C536069	C01.925.782.815	Human spumaretroviridae infection	Viral disease
Humoral Hypercalcemia Of Malignancy	MESH:C562390			MESH:D006934|MESH:D010257	C04.730/C562390|C18.452.174.451/C562390|C18.452.950.340/C562390	C04.730|C18.452.174.451|C18.452.950.340		Cancer|Metabolic disease
Hunter Carpenter Macdonald syndrome	MESH:C536071			MESH:D019150	C10.228.140.744/C536071	C10.228.140.744		Nervous system disease
Hunter-Macdonald Syndrome	MESH:C567445			MESH:D000015|MESH:D008579	C04.557.580.520/C567445|C04.557.645.520/C567445|C04.588.614.250.580.500/C567445|C10.551.240.500.500/C567445|C16.131.077/C567445	C04.557.580.520|C04.557.645.520|C04.588.614.250.580.500|C10.551.240.500.500|C16.131.077		Cancer|Congenital abnormality|Nervous system disease
Hutchinson's Melanotic Freckle	MESH:D018327		A cellular subtype of malignant melanoma. It is a pigmented lesion composed of melanocytes occurring on sun-exposed skin, usually the face and neck. The melanocytes are commonly multinucleated with a 'starburst' appearance. It is considered by many to be the in situ phase of lentigo maligna melanoma.	MESH:D008545	C04.557.465.625.650.510.385|C04.557.580.625.650.510.385|C04.557.665.510.385	C04.557.465.625.650.510|C04.557.580.625.650.510|C04.557.665.510	Freckle, Hutchinson's Melanotic|Freckle, Melanotic|Freckles, Melanotic|Hutchinson Melanotic Freckle|Hutchinsons Melanotic Freckle|Lentigo Maligna|Lentigo, Malignant|Lentigos, Malignant|Malignant Lentigo|Malignant Lentigos|Melanotic Freckle|Melanotic Freckle, Hutchinson's|Melanotic Freckles	Cancer
Hutterite cerebroosteonephrodysplasia syndrome	MESH:C536074			MESH:D006130|MESH:D009404	C12.050.351.968.419.630.643/C536074|C12.200.777.419.630.643/C536074|C12.950.419.630.643/C536074|C23.550.393/C536074	C12.050.351.968.419.630.643|C12.200.777.419.630.643|C12.950.419.630.643|C23.550.393	Cerebroosteonephrosis syndrome|Congenital shortness with mild spondylorhizomelic dwarfism	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Hyaloideoretinal degeneration of Wagner	MESH:C536075	OMIM:143200		MESH:D012162	C11.270.612/C536075|C11.768.585/C536075	C11.270.612|C11.768.585	Erosive vitreoretinopathy|ERVR|HYALOIDEORETINAL DEGENERATION OF WAGNER|Vcan-Related Vitreoretinopathy|Wagner Disease|Wagner Syndrome|Wagner Syndrome 1|Wagner syndrome type 1|Wagner vitreoretinal degeneration|WAGNER VITREORETINOPATHY|WGN1|WGVRP	Eye disease
Hydatidiform Mole	MESH:D006828	DO:DOID:3590|OMIM:231090|OMIM:614293	Trophoblastic hyperplasia associated with normal gestation, or molar pregnancy. It is characterized by the swelling of the CHORIONIC VILLI and elevated human CHORIONIC GONADOTROPIN. Hydatidiform moles or molar pregnancy may be categorized as complete or partial based on their gross morphology, histopathology, and karyotype.	MESH:D031901	C04.557.465.955.416.812|C04.850.908.416.750|C12.050.703.720.949.416.875	C04.557.465.955.416|C04.850.908.416|C12.050.703.720.949.416	CHM|Complete Hydatidiform Mole|Complete Hydatidiform Moles|GESTATIONAL TROPHOBLASTIC DISEASE|HYDATIDIFORM MOLE|Hydatidiform Mole, Complete|Hydatidiform Mole, Partial|HYDATIDIFORM MOLE, RECURRENT, 1|HYDATIDIFORM MOLE, RECURRENT, 2|Hydatidiform Moles|Hydatidiform Moles, Complete|Hydatidiform Moles, Partial|Hydatid Mole|Hydatid Moles|HYDM|HYDM1|HYDM2|Molar Pregnancies|Molar Pregnancy|Mole, Complete Hydatidiform|Mole, Hydatid|Mole, Hydatidiform|Mole, Partial Hydatidiform|Moles, Complete Hydatidiform|Moles, Hydatid|Moles, Hydatidiform|Moles, Partial Hydatidiform|Partial Hydatidiform Mole|Partial Hydatidiform Moles|Pregnancies, Molar|Pregnancy, Molar	Cancer|Pregnancy complication
Hydatidiform Mole, Invasive	MESH:D002820		A uterine tumor derived from persistent gestational TROPHOBLASTS, most likely after a molar pregnancy (HYDATIDIFORM MOLE). Invasive hyadatiform mole develops in about 15% of patients after evacuation of a complete mole and less frequently after other types of gestation. It may perforate the MYOMETRIUM and erode uterine vessels causing hemorrhage.	MESH:D006828	C04.557.465.955.416.812.500|C04.850.908.416.750.500|C12.050.703.720.949.416.875.500	C04.557.465.955.416.812|C04.850.908.416.750|C12.050.703.720.949.416.875	Chorioadenoma|Chorioadenomas|Hydatidiform Moles, Invasive|Invasive Hydatidiform Mole|Invasive Hydatidiform Moles|Invasive Mole|Invasive Moles|Mole, Invasive|Mole, Invasive Hydatidiform|Moles, Invasive|Moles, Invasive Hydatidiform	Cancer|Pregnancy complication
Hydrarthrosis	MESH:D006833		Accumulation of watery fluid in the cavity of a joint. (Dorland, 27th ed)	MESH:D007592	C05.550.509	C05.550	Hydrarthroses	Musculoskeletal disease
Hydroa Vacciniforme	MESH:D006837		A vesicular and bullous eruption having a tendency to recur in summer during childhood and commonly appearing on sun-exposed skin. The lesions are surrounded by an erythematous zone and resemble a vaccination. (From Dorland, 27th ed)	MESH:D010787|MESH:D012872	C17.800.600.425|C17.800.865.575	C17.800.600|C17.800.865		Skin disease
Hydroa vacciniforme, familial	MESH:C536077			MESH:D006837	C17.800.600.425/C536077|C17.800.865.575/C536077	C17.800.600.425|C17.800.865.575	Familial hydroa vacciniforme	Skin disease
Hydrocephalus	MESH:D006849	DO:DOID:10908|DO:DOID:14159|DO:DOID:1573|OMIM:236600	Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA.	MESH:D001927	C10.228.140.602	C10.228.140	Aqueductal Stenoses|Aqueductal Stenosis|Cerebral Ventriculomegalies|Cerebral Ventriculomegalies, Fetal|Cerebral Ventriculomegaly|Cerebral Ventriculomegaly, Fetal|Communicating Hydrocephalus|Congenital Hydrocephalus|Fetal Cerebral Ventriculomegalies|Fetal Cerebral Ventriculomegaly|HYC1|Hydrocephalus, Communicating|Hydrocephalus, Congenital|HYDROCEPHALUS, CONGENITAL, 1|Hydrocephalus Ex Vacuo|Hydrocephalus Ex-Vacuo|Hydrocephalus Ex-Vacuos|HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1, FORMERLY|Hydrocephalus, Obstructive|Hydrocephalus, Post-Traumatic|Hydrocephaly|Obstructive Hydrocephalus|Post Traumatic Hydrocephalus|Post-Traumatic Hydrocephalus|Stenoses, Aqueductal|Stenosis, Aqueductal|Ventriculomegalies, Cerebral|Ventriculomegalies, Fetal Cerebral|VENTRICULOMEGALY|Ventriculomegaly, Cerebral|Ventriculomegaly, Fetal Cerebral	Nervous system disease
Hydrocephalus, Autosomal Dominant	MESH:C563973			MESH:D006849	C10.228.140.602/C563973	C10.228.140.602		Nervous system disease
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES	OMIM:615219	DO:DOID:10908		MESH:D006849	C10.228.140.602/615219	C10.228.140.602	HYC2|HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 2, FORMERLY	Nervous system disease
Hydrocephalus, endocardial fibroelastosis, and cataracts	MESH:C535855			MESH:D002386|MESH:D004695|MESH:D006849	C10.228.140.602/C535855|C11.510.245/C535855|C14.280.238.281/C535855	C10.228.140.602|C11.510.245|C14.280.238.281	Communicating hydrocephalus, endocardial fibroelastosis (EFE) and congenital cataracts	Cardiovascular disease|Eye disease|Nervous system disease
Hydrocephalus, Normal Pressure	MESH:D006850	DO:DOID:1572|OMIM:236690	A form of compensated hydrocephalus characterized clinically by a slowly progressive gait disorder (see GAIT DISORDERS, NEUROLOGIC), progressive intellectual decline, and URINARY INCONTINENCE. Spinal fluid pressure tends to be in the high normal range. This condition may result from processes which interfere with the absorption of CSF including SUBARACHNOID HEMORRHAGE, chronic MENINGITIS, and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp631-3)	MESH:D006849	C10.228.140.602.750	C10.228.140.602	Hakim's Syndrome|Hakims Syndrome|Hakim's Syndromes|Hakim Syndrome|Hakim Syndromes|HYDNP1|Hydrocephalus, Normal-Pressure|HYDROCEPHALUS, NORMAL-PRESSURE, 1|Normal Pressure Hydrocephalus|NPH (Normal Pressure Hydrocephalus)|NPHs (Normal Pressure Hydrocephalus)|Syndrome, Hakim|Syndrome, Hakim's|Syndromes, Hakim|Syndromes, Hakim's	Nervous system disease
Hydrocolpos	MESH:D052202		A fluid-filled VAGINA that is obstructed.	MESH:D014623	C12.050.351.500.894.500|C12.100.250.894.500	C12.050.351.500.894|C12.100.250.894		Urogenital disease (female)
Hydropneumothorax	MESH:D006872		A collection of fluid and gas within the pleural cavity. (Dorland, 27th ed)	MESH:D010995	C08.528.434	C08.528		Respiratory tract disease
Hydrothorax	MESH:D006876		A collection of watery fluid in the pleural cavity. (Dorland, 27th ed)	MESH:D010995	C08.528.476	C08.528		Respiratory tract disease
Hyperacusis	MESH:D012001		An abnormally disproportionate increase in the sensation of loudness in response to auditory stimuli of normal volume. COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; FACIAL NERVE DISEASES; STAPES SURGERY; and other disorders may be associated with this condition.	MESH:D006311	C09.218.458.505|C10.597.751.418.505|C23.888.592.763.393.505	C09.218.458|C10.597.751.418|C23.888.592.763.393	Auditory Hyperesthesia|Auditory Hyperesthesias|Disturbance, Loudness Perception|Disturbances, Loudness Perception|Hyperacuses|Hyperacusia|Hyperacusias|Hyperesthesia, Auditory|Hyperesthesias, Auditory|Loudness Perception Disturbance|Loudness Perception Disturbances|Loudness Recruitment|Loudness Recruitments|Perception Disturbance, Loudness|Perception Disturbances, Loudness|Phonophobia|Phonophobias|Recruitment, Loudness	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Hyperalgesia	MESH:D006930		An increased sensation of pain or discomfort produced by minimally noxious stimuli due to damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve.	MESH:D020886	C10.597.751.791.400|C23.888.592.763.770.400	C10.597.751.791|C23.888.592.763.770	Allodynia|Allodynia, Mechanical|Allodynias|Allodynia, Tactile|Allodynia, Thermal|Hyperalgesia, Mechanical|Hyperalgesia, Primary|Hyperalgesias|Hyperalgesia, Secondary|Hyperalgesias, Thermal|Hyperalgesia, Tactile|Hyperalgesia, Thermal|Hyperalgesic Sensation|Hyperalgesic Sensations|Hyperalgia|Hyperalgia, Mechanical|Hyperalgia, Primary|Hyperalgia, Secondary|Mechanical Allodynia|Mechanical Hyperalgesia|Mechanical Hyperalgia|Mechanical Hyperalgias|Primary Hyperalgia|Primary Hyperalgias|Secondary Hyperalgia|Secondary Hyperalgias|Sensation, Hyperalgesic|Sensations, Hyperalgesic|Tactile Allodynia|Thermal Allodynia|Thermal Hyperalgesia	Nervous system disease|Signs and symptoms
HYPERALPHALIPOPROTEINEMIA 1	OMIM:143470	DO:DOID:0111369		MESH:D006951	C18.452.584.500.500.644/143470	C18.452.584.500.500.644	CETP DEFICIENCY  HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 10, INCLUDED|CHOLESTEROL ESTER TRANSFER PROTEIN DEFICIENCY|HALP1|HDLCQ10, INCLUDED	Metabolic disease
Hypercalcemia	MESH:D006934	DO:DOID:12678	Abnormally high level of calcium in the blood.	MESH:D002128|MESH:D014883	C18.452.174.451|C18.452.950.340	C18.452.174|C18.452.950	Hypercalcemias|Milk Alkali Syndrome|Milk-Alkali Syndrome|Syndrome, Milk-Alkali	Metabolic disease
Hypercalcemia, Infantile	MESH:C562999	OMIM:143880|OMIM:616963		MESH:D006934	C18.452.174.451/C562999|C18.452.950.340/C562999	C18.452.174.451|C18.452.950.340	HCINF1|HCINF2|HYPERCALCEMIA, IDIOPATHIC, OF INFANCY|Hypercalcemia, Infantile, 1|Hypercalcemia, infantile, 2	Metabolic disease
Hypercalciuric Hypercalcemia	MESH:C563373			MESH:D006934	C18.452.174.451/C563373|C18.452.950.340/C563373	C18.452.174.451|C18.452.950.340		Metabolic disease
Hypercalciuric Hypocalcemia, Familial	MESH:C562783			MESH:D006996|MESH:D007011|MESH:D053565	C18.452.174.509/C562783|C18.452.950.509/C562783|C19.642.482/C562783|C23.888.942.337/C562783	C18.452.174.509|C18.452.950.509|C19.642.482|C23.888.942.337	Hypocalcemia, Autosomal Dominant|Hypocalcemia, Familial|Hypoparathyroidism, Autosomal Dominant	Endocrine system disease|Metabolic disease|Signs and symptoms
Hypercholesterolemia	MESH:D006937		A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.	MESH:D006949	C18.452.584.500.500.396	C18.452.584.500.500	Cholesterol, Elevated|Cholesterol Level, High|Cholesterol Levels, High|Cholesterols, Elevated|Elevated Cholesterol|Elevated Cholesterols|High Cholesterol Level|High Cholesterol Levels|Hypercholesteremia|Hypercholesteremias|Hypercholesterolemias|Level, High Cholesterol|Levels, High Cholesterol	Metabolic disease
Hypercholesterolemia, Autosomal Dominant, 3	MESH:C566337	OMIM:603776		MESH:D006951	C18.452.584.500.500.644/C566337	C18.452.584.500.500.644	FH3|FH3 LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1, INCLUDED|FHCL3|HCHOLA3|HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3|HYPERCHOLESTEROLEMIA, FAMILIAL, 3|LDLCQ1, INCLUDED	Metabolic disease
Hypercholesterolemia, Autosomal Recessive	MESH:C566331	OMIM:603813		MESH:D006937	C18.452.584.500.500.396/C566331	C18.452.584.500.500.396	ARH|ARH1, FORMERLY|ARH2, FORMERLY|FHCB1, FORMERLY|FHCB2, FORMERLY|FHCL4|HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE|HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE, 1, FORMERLY|HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE, 2, FORMERLY|HYPERCHOLESTEROLEMIA, FAMILIAL, 4	Metabolic disease
Hyperekplexia	MESH:D000071017	DO:DOID:0060696	A neurological disorder characterized by an excessive startle reaction with ABNORMAL REFLEX;  MYOCLONIC JERKS; and MUSCLE HYPERTONIA.	MESH:D002493	C10.228.590	C10.228	Hyperekplexias	Nervous system disease
Hyperemia	MESH:D006940		The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).	MESH:D014652	C14.907.474	C14.907	Active Hyperemia|Arterial Hyperemia|Congestion, Venous|Engorgement, Venous|Hyperemia, Active|Hyperemia, Arterial|Hyperemia, Passive|Hyperemia, Reactive|Hyperemias|Hyperemias, Reactive|Passive Hyperemia|Reactive Hyperemia|Reactive Hyperemias|Venous Congestion|Venous Engorgement	Cardiovascular disease
Hypereosinophilic Syndrome	MESH:D017681	OMIM:607685	A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.	MESH:D004802	C15.378.553.231.549	C15.378.553.231	Endocarditis, Loeffler|Endocarditis, Loefflers|Endocarditis, Loeffler's|Eosinophilic Leukemia|Eosinophilic Leukemias|HES|Hypereosinophilic Syndrome, Idiopathic|Hypereosinophilic Syndromes|Hypereosinophilic Syndromes, Idiopathic|Idiopathic Hypereosinophilic Syndrome|Idiopathic Hypereosinophilic Syndromes|Leukemia, Eosinophilic|Leukemias, Eosinophilic|Loeffler Endocarditis|Loeffler's Endocarditis|Loefflers Endocarditis|Syndrome, Hypereosinophilic|Syndrome, Idiopathic Hypereosinophilic|Syndromes, Hypereosinophilic|Syndromes, Idiopathic Hypereosinophilic	Blood disease
Hyperesthesia	MESH:D006941		Increased sensitivity to cutaneous stimulation due to a diminished threshold or an increased response to stimuli.	MESH:D020886	C10.597.751.791.450|C23.888.592.763.770.450	C10.597.751.791|C23.888.592.763.770	Hyperesthesias|Hyperesthesias, Tactile|Hyperesthesias, Thermal|Hyperesthesia, Tactile|Hyperesthesia, Thermal|Hyperesthetic Sensation|Hyperesthetic Sensations|Oxyesthesia|Oxyesthesias|Sensation, Hyperesthetic|Sensations, Hyperesthetic|Tactile Hyperesthesia|Tactile Hyperesthesias|Thermal Hyperesthesia|Thermal Hyperesthesias	Nervous system disease|Signs and symptoms
Hyperexplexia hereditary	MESH:C538136	OMIM:149400|OMIM:614618|OMIM:614619		MESH:D009127	C05.651.504/C538136|C10.597.613.550.500/C538136|C23.888.592.608.550.500/C538136	C05.651.504|C10.597.613.550.500|C23.888.592.608.550.500	Congenital stiff person syndrome|Exagerrated startle reflex|EXAGGERATED STARTLE REACTION|Familial startle disease|HKPX1|HKPX2|HKPX3|HYPEREKPLEXIA 1|HYPEREKPLEXIA 2|HYPEREKPLEXIA 3|Kok disease|STARTLE DISEASE, FAMILIAL|STARTLE REACTION, EXAGGERATED|STHE|Stiff baby syndrome|STIFF-BABY SYNDROME|STIFF-MAN SYNDROME, CONGENITAL|STIFF-PERSON SYNDROME, CONGENITAL	Musculoskeletal disease|Nervous system disease|Signs and symptoms
Hyperferritinemia	MESH:D000085583		A finding of elevated serum level of FERRITIN. It is often associated with IRON OVERLOAD, repeated blood transfusions, malignancy, iron metabolic syndromes, virus infection, liver injury or dysfunction, and renal failure. Hyperferritinemia in iron metabolic syndromes (e.g., Still's diseases, and HEMOPHAGOCYTIC SYNDROME) is referred to as dysmetabolic hyperferritinemia.	MESH:D019189	C18.452.565.300	C18.452.565	Dysmetabolic Hyperferritinemia|Elevated Serum Ferritin|Hyperferritinemia, Dysmetabolic|Hyperferritinemias|Raised Serum Ferritin|Serum Ferritin, Elevated|Serum Ferritin, Raised|Ultrahyperferritinemia|Ultrahyperferritinemias	Metabolic disease
Hyperferritinemia, hereditary, with congenital cataracts	MESH:C538137	DO:DOID:0111256|OMIM:600886		MESH:D002386|MESH:D019189	C11.510.245/C538137|C18.452.565/C538137	C11.510.245|C18.452.565	Bonneau-Beaumont Syndrome|Dominant hyperferritinemia and cataract|Hereditary hyperferritinemia-cataract syndrome|Hereditary Hyperferritinemia with Congenital Cataracts|HHCS|HRFTC|Hyperferritinemia cataract syndrome|Hyperferritinemia-Cataract Syndrome|HYPERFERRITINEMIA, HEREDITARY, WITH CONGENITAL CATARACTS|HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	Eye disease|Metabolic disease
Hypergammaglobulinemia	MESH:D006942		An excess of GAMMA-GLOBULINS in the serum due to chronic infections or PARAPROTEINEMIAS.	MESH:D001796|MESH:D007160|MESH:D012816	C15.378.147.542|C20.683.460|C23.888.512	C15.378.147|C20.683|C23.888	Hypergammaglobulinemias|Hyperimmunoglobulinemia|Hyperimmunoglobulinemias	Blood disease|Immune system disease|Signs and symptoms
Hyperglycemia	MESH:D006943	DO:DOID:4195	Abnormally high BLOOD GLUCOSE level.	MESH:D044882	C18.452.394.952	C18.452.394	Hyperglycemia, Postprandial|Hyperglycemias|Hyperglycemias, Postprandial|Postprandial Hyperglycemia|Postprandial Hyperglycemias	Metabolic disease
Hypergonadotropic Hypogonadism And Partial Alopecia	MESH:C567109			MESH:D000505|MESH:D007006	C17.800.329.937.122/C567109|C19.391.482/C567109|C23.300.035/C567109	C17.800.329.937.122|C19.391.482|C23.300.035		Endocrine system disease|Pathology (anatomical condition)|Skin disease
Hyperheparinemia	MESH:C562723			MESH:D001778	C15.378.100/C562723	C15.378.100		Blood disease
Hyperhidrosis	MESH:D006945		Excessive sweating. In the localized type, the most frequent sites are the palms, soles, axillae, inguinal folds, and the perineal area. Its chief cause is thought to be emotional. Generalized hyperhidrosis may be induced by a hot, humid environment, by fever, or by vigorous exercise.	MESH:D013543	C17.800.946.350	C17.800.946	Hyperidrosis	Skin disease
Hyperhidrosis Palmaris Et Plantaris	MESH:C563185			MESH:D006945	C17.800.946.350/C563185	C17.800.946.350		Skin disease
Hyperimmunoglobulin G1(A1) Syndrome	MESH:C564173	OMIM:144120		MESH:D006942	C15.378.147.542/C564173|C20.683.460/C564173|C23.888.512/C564173	C15.378.147.542|C20.683.460|C23.888.512		Blood disease|Immune system disease|Signs and symptoms
Hyperinsulinemic hypoglycemia, familial, 3	MESH:C538374	OMIM:602485		MESH:D006946|MESH:D007003	C18.452.394.968/C538374|C18.452.394.984/C538374	C18.452.394.968|C18.452.394.984	HHF3	Metabolic disease
Hyperinsulinemic Hypoglycemia, Familial, 4	MESH:C566493	OMIM:609975		MESH:D006946|MESH:D007003	C18.452.394.968/C566493|C18.452.394.984/C566493	C18.452.394.968|C18.452.394.984	HHF4	Metabolic disease
Hyperinsulinemic Hypoglycemia, Familial, 5	MESH:C566494	OMIM:609968		MESH:D006946|MESH:D007003	C18.452.394.968/C566494|C18.452.394.984/C566494	C18.452.394.968|C18.452.394.984	HHF5	Metabolic disease
Hyperinsulinemic hypoglycemia, familial, 6	MESH:C538375	OMIM:606762		MESH:D006946|MESH:D007003	C18.452.394.968/C538375|C18.452.394.984/C538375	C18.452.394.968|C18.452.394.984	HHF6|Hyperinsulinism-hyperammonemia syndrome	Metabolic disease
Hyperinsulinemic hypoglycemia, familial, 7	MESH:C538376	DO:DOID:0070214|OMIM:610021		MESH:D006946|MESH:D007003	C18.452.394.968/C538376|C18.452.394.984/C538376	C18.452.394.968|C18.452.394.984	HHF7|Hyperinsulinemic hypoglycemia, exercise-induced	Metabolic disease
Hyperinsulinism	MESH:D006946	DO:DOID:2018	A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.	MESH:D044882	C18.452.394.968	C18.452.394	Compensatory Hyperinsulinemia|Endogenous Hyperinsulinism|Exogenous Hyperinsulinism|Hyperinsulinemia|Hyperinsulinemia, Compensatory|Hyperinsulinism, Endogenous|Hyperinsulinism, Exogenous	Metabolic disease
Hyperinsulinism, autosomal recessive	MESH:C538567			MESH:D046768	C06.689.150.500/C538567|C16.614.200.500/C538567|C18.452.394.968.250.500/C538567|C18.452.394.984.200.500/C538567	C06.689.150.500|C16.614.200.500|C18.452.394.968.250.500|C18.452.394.984.200.500		Digestive system disease|Infant-newborn disease|Metabolic disease
Hyperkalemia	MESH:D006947		Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)	MESH:D014883	C18.452.950.396	C18.452.950	Hyperkalemias|Hyperpotassemia|Hyperpotassemias	Metabolic disease
Hyperkeratosis lenticularis perstans	MESH:C538377	OMIM:144150		MESH:D007642	C17.800.428/C538377	C17.800.428	Flegel disease|Flegel's disease|HLP|Hyperkeratosis lenticularis perstans of Flegel	Skin disease
Hyperkeratotic Cutaneous Capillary-Venous Malformations Associated With Cerebral Capillary Malformations	MESH:C566153			MESH:D012868|MESH:D020785	C10.500.190/C566153|C14.240.850.875/C566153|C16.131.240.850.875/C566153|C16.131.666.190/C566153|C16.131.831/C566153|C17.800.804/C566153	C10.500.190|C14.240.850.875|C16.131.240.850.875|C16.131.666.190|C16.131.831|C17.800.804		Cardiovascular disease|Congenital abnormality|Nervous system disease|Skin disease
Hyperkinesis	MESH:D006948		Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders.	MESH:D020820	C10.597.350.350|C23.888.592.350.350	C10.597.350|C23.888.592.350	Generalized Hyperkinesia|Generalized Hyperkinesias|Hyperactivity, Motor|Hyperkinesia|Hyperkinesia, Generalized|Hyperkinesias, Generalized|Hyperkinetic Movement|Hyperkinetic Movements|Motor Hyperactivity|Movement, Hyperkinetic|Movements, Hyperkinetic	Nervous system disease|Signs and symptoms
Hyperlactatemia	MESH:D065906		Increase in blood LACTATE concentration often associated with SEPTIC SHOCK; LUNG INJURY; SEPSIS; and DRUG TOXICITY. When hyperlactatemia is associated with low body pH (acidosis) it is LACTIC ACIDOSIS.	MESH:D008659|MESH:D012816	C18.452.479|C23.888.516	C18.452|C23.888	Hyperlactatemias	Metabolic disease|Signs and symptoms
Hyperlexia	MESH:C565500			MESH:D007806	C10.597.606.150.500/C565500|C23.888.592.604.150.500/C565500	C10.597.606.150.500|C23.888.592.604.150.500	Compulsive Reading|Precocious Reading	Nervous system disease|Signs and symptoms
Hyperlipemia with Familial Hypercholesterolemic Xanthomatosis	MESH:C566263			MESH:D006949|MESH:D014973	C18.452.584.500.500/C566263|C18.452.584.750/C566263	C18.452.584.500.500|C18.452.584.750		Metabolic disease
Hyperlipidemias	MESH:D006949	DO:DOID:1168	Conditions with excess LIPIDS in the blood.	MESH:D050171	C18.452.584.500.500	C18.452.584.500	Hyperlipemia|Hyperlipemias|Hyperlipidemia|Lipemia|Lipemias|Lipidemia|Lipidemias	Metabolic disease
Hyperlipoproteinemias	MESH:D006951	DO:DOID:1168	Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.	MESH:D006949	C18.452.584.500.500.644	C18.452.584.500.500	Hyperlipoproteinemia	Metabolic disease
HYPERLIPOPROTEINEMIA, TYPE ID	OMIM:615947	DO:DOID:0111420		MESH:D006951	C18.452.584.500.500.644/615947	C18.452.584.500.500.644		Metabolic disease
Hyperlipoproteinemia, Type II, and Deafness	MESH:C564170			MESH:D003638|MESH:D006951	C09.218.458.341.186/C564170|C10.597.751.418.341.186/C564170|C18.452.584.500.500.644/C564170|C23.888.592.763.393.341.186/C564170	C09.218.458.341.186|C10.597.751.418.341.186|C18.452.584.500.500.644|C23.888.592.763.393.341.186		Ear-nose-throat disease|Metabolic disease|Nervous system disease|Signs and symptoms
HYPERMANGANESEMIA WITH DYSTONIA 1	OMIM:613280	DO:DOID:0080536		MESH:C548016	C18.452/C548016/613280	C18.452/C548016	HMDPC|HMNDYT1|HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS	Metabolic disease
HYPERMANGANESEMIA WITH DYSTONIA 2	OMIM:617013	DO:DOID:0080537		MESH:C548016	C18.452/C548016/617013	C18.452/C548016	HMNDYT2	Metabolic disease
Hypermanganesemia with Dystonia Polycythemia and Cirrhosis	MESH:C548016			MESH:D008659	C18.452/C548016	C18.452	Dystonia-Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease|Hepatic Cirrhosis, Dystonia, Polycythaemia, and Hypermanganesaemia|Hepatic Cirrhosis, Dystonia, Polycythemia, and Hypermanganesemia|Hmdpc|Hypermanganesemia With Dystonia, Polycythemia, And Cirrhosis|Parkinsonism and Dystonia with Hypermanganesemia, Polycythemia, and Chronic Liver Disease	Metabolic disease
Hypermetabolism due to Defect in Mitochondria	MESH:C565498			MESH:D028361	C18.452.660/C565498	C18.452.660		Metabolic disease
Hypernatremia	MESH:D006955		Excessive amount of sodium in the blood. (Dorland, 27th ed)	MESH:D014883	C18.452.950.452	C18.452.950	Hypernatremias	Metabolic disease
Hyperopia	MESH:D006956	DO:DOID:9834	A refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus behind the retina, as a result of the eyeball being too short from front to back. It is also called farsightedness because the near point is more distant than it is in emmetropia with an equal amplitude of accommodation. (Dorland, 27th ed)	MESH:D012030	C11.744.479	C11.744	Farsightedness|Hypermetropia	Eye disease
Hyperostosis	MESH:D015576	DO:DOID:205	Increase in the mass of bone per unit volume.	MESH:D001847	C05.116.540	C05.116	Bone Hypertrophies|Bone Hypertrophy|Hyperostoses|Hypertrophies, Bone|Hypertrophy, Bone	Musculoskeletal disease
Hyperostosis corticalis deformans juvenilis	MESH:C537701			MESH:D010001	C05.116.692/C537701	C05.116.692	Chronic Congenital Idiopathic Hyperphosphatasemia|Familial Idiopathic Hyperphosphatasemia|Familial Osteoectasia|Hyperphosphatasemia, chronic congenital idiopathic|Hyperphosphatasemia with Bone Disease|Hyperphosphatasia, familial idiopathic|Idiopathic Hyperphosphatasia|Juvenile Paget Disease|Juvenile Paget's Disease|Osteochalasia Desmalis Familiaris|Osteoectasia, familial|Osteoectasia with Hyperphosphatasia|Paget disease of bone 5, juvenile-onset	Musculoskeletal disease
Hyperostosis Cranialis Interna	MESH:C564168			MESH:D010026|MESH:D015576	C05.116.099.708.702/C564168|C05.116.540/C564168	C05.116.099.708.702|C05.116.540		Musculoskeletal disease
Hyperostosis, Diffuse Idiopathic Skeletal	MESH:D004057	DO:DOID:6652	A disease of elderly men characterized by large osteophytes that bridge vertebrae and ossification of ligaments and tendon insertions.	MESH:D013128|MESH:D015576	C05.116.540.410|C05.116.900.815.651	C05.116.540|C05.116.900.815	Ankylosing Hyperostoses, Vertebral|Ankylosing Hyperostosis, Vertebral|Ankylosing Vertebral Hyperostosis with Tylosis|Diffuse Idiopathic Skeletal Hyperostosis|Disease, Forestier|Disease, Forestier-Rotes|Disease, Forestier's|Forestier Disease|Forestier Rotes Disease|Forestier-Rotes Disease|Forestier's Disease|Forestiers Disease|Hyperostoses, Vertebral Ankylosing|Hyperostosis, Vertebral Ankylosing|Vertebral Ankylosing Hyperostoses|Vertebral Ankylosing Hyperostosis	Musculoskeletal disease
Hyperostosis Frontalis Interna	MESH:D006957		Thickening of the inner table of the frontal bone, which may be associated with hypertrichosis and obesity. It most commonly affects women near menopause.	MESH:D010009|MESH:D015576	C05.116.099.708.486|C05.116.540.420	C05.116.099.708|C05.116.540	Leontiasis Ossium|Morgagni Stewart Morel Syndrome|Morgagni-Stewart-Morel Syndrome|Syndrome, Morgagni-Stewart-Morel	Musculoskeletal disease
Hyperostosis frontalis interna, obesity, shortness and cognitive impairment	MESH:C538586			MESH:D006957	C05.116.099.708.486/C538586|C05.116.540.420/C538586	C05.116.099.708.486|C05.116.540.420		Musculoskeletal disease
Hyperostosis-hyperphosphatemia syndrome	MESH:C538381			MESH:D015576|MESH:D054559	C05.116.540/C538381|C18.452.750.199/C538381	C05.116.540|C18.452.750.199	Cortical hyperostosis with hyperphosphatemia|Hyperostosis with hyperphosphatemia	Metabolic disease|Musculoskeletal disease
Hyperparathyroidism 2	MESH:C563273	OMIM:145001		MESH:D000236|MESH:D005350|MESH:D006961|MESH:D007573	C04.557.450.565.590.340/C563273|C04.557.470.035/C563273|C04.588.149.721.450/C563273|C05.116.231.754.450/C563273|C05.500.499/C563273|C07.320.515/C563273|C19.642.355/C563273	C04.557.450.565.590.340|C04.557.470.035|C04.588.149.721.450|C05.116.231.754.450|C05.500.499|C07.320.515|C19.642.355	Familial Cystic Parathyroid Adenomatosis|Familial Primary Hyperparathyroidism with Multiple Ossifying Jaw Fibromas|Hereditary Hyperparathyroidism-Jaw Tumor Syndrome|Hpt-Jt|HRPT2|HYPERPARATHYROIDISM 2 WITH JAW TUMORS|Hyperparathyroidism, Familial Primary, with Multiple Ossifying Jaw Fibromas|Hyperparathyroidism-Jaw Tumor Syndrome|Hyperparathyroidism-Jaw Tumor Syndrome, Hereditary|HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY;HPT-JT PARATHYROID ADENOMATOSIS, FAMILIAL CYSTIC, INCLUDED	Cancer|Endocrine system disease|Mouth disease|Musculoskeletal disease
Hyperparathyroidism, Neonatal Severe Primary	MESH:C563375	OMIM:239200		MESH:D007232|MESH:D049950	C16.614/C563375|C19.642.355.239/C563375	C16.614|C19.642.355.239	HYPERPARATHYROIDISM, NEONATAL SEVERE|HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY|NHPT|NSHPT|NSPH	Endocrine system disease|Infant-newborn disease
Hyperphosphatemia	MESH:D054559	DO:DOID:0050459	A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.	MESH:D010760	C18.452.750.199	C18.452.750	Hyperphosphatemias	Metabolic disease
Hyperphosphatemia, Polyuria, and Seizures	MESH:C565494			MESH:D011141|MESH:D012640|MESH:D054559	C10.597.742/C565494|C12.050.351.968.934.616/C565494|C12.200.777.934.616/C565494|C12.950.934.616/C565494|C18.452.750.199/C565494|C23.888.592.742/C565494|C23.888.942.600/C565494	C10.597.742|C12.050.351.968.934.616|C12.200.777.934.616|C12.950.934.616|C18.452.750.199|C23.888.592.742|C23.888.942.600		Metabolic disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Hyperpigmentation	MESH:D017495		Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.	MESH:D010859	C17.800.621.430	C17.800.621	Hypermelanoses|Hypermelanosis	Skin disease
Hyperpigmentation, Familial Progressive	MESH:C564163			MESH:D017495	C17.800.621.430/C564163	C17.800.621.430	Melanosis Universalis Hereditaria	Skin disease
Hyperpigmentation of Eyelids	MESH:C562400	DO:DOID:10122		MESH:D005141|MESH:D017495	C11.338/C562400|C17.800.621.430/C562400	C11.338|C17.800.621.430		Eye disease|Skin disease
Hyperpigmentation of Fuldauer and Kuijpers	MESH:C564164			MESH:D017495	C17.800.621.430/C564164	C17.800.621.430		Skin disease
HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE	OMIM:145250	DO:DOID:0111373		MESH:C564163	C17.800.621.430/C564163/145250	C17.800.621.430/C564163	FPH2, FORMERLY|FPHH|HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 2, FORMERLY|MELANOSIS UNIVERSALIS HEREDITARIA|MUH	Skin disease
Hyperpituitarism	MESH:D006964	DO:DOID:2444	Disease of the glandular, anterior portion of the pituitary (PITUITARY GLAND, ANTERIOR) resulting in hypersecretion of ADENOHYPOPHYSEAL HORMONES such as GROWTH HORMONE; PROLACTIN; THYROTROPIN; LUTEINIZING HORMONE; FOLLICLE STIMULATING HORMONE ; and ADRENOCORTICOTROPIC HORMONE. Hyperpituitarism usually is caused by a functional ADENOMA.	MESH:D010900	C10.228.140.617.738.250|C19.700.355	C10.228.140.617.738|C19.700	Follicle Stimulating Hormone, Inappropriate Secretion|FSH Hypersecretion, Pituitary|Hypersecretion, Pituitary FSH|Hypersecretion, Pituitary LH|Hypersecretion, Pituitary TSH|Inappropriate Follicle Stimulating Hormone Secretion|Inappropriate FSH Secretion Syndrome|Inappropriate LH Secretion Syndrome|Inappropriate Luteinizing Hormone Secretion|Inappropriate Thyroid Stimulating Hormone Secretion|Inappropriate TSH Secretion Syndrome|LH Hypersecretion, Pituitary|Luteinizing Hormone, Inappropriate Secretion|Pituitary FSH Hypersecretion|Pituitary LH Hypersecretion|Pituitary TSH Hypersecretion|Thyroid Stimulating Hormone, Inappropriate Secretion|TSH Hypersecretion, Pituitary	Endocrine system disease|Nervous system disease
Hyperprolactinemia	MESH:D006966	DO:DOID:12700|OMIM:615555	Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)	MESH:D006964	C10.228.140.617.738.250.450|C19.700.355.600	C10.228.140.617.738.250|C19.700.355	HPRL|Hyperprolactinaemia|Hyperprolactinemias|Hypersecretion Syndrome, Prolactin|Inappropriate Prolactin Secretion|Inappropriate Prolactin Secretion Syndrome|Inappropriate Secretion Prolactin|Prolactin Hypersecretion Syndrome|Prolactin, Inappropriate Secretion|Prolactin Secretion, Inappropriate|Secretion, Inappropriate Prolactin|Secretion Prolactin, Inappropriate|Syndrome, Prolactin Hypersecretion	Endocrine system disease|Nervous system disease
Hyperprothrombinemia	MESH:C566755			MESH:D019851	C15.378.925/C566755	C15.378.925	Prothrombin G20210a Thrombophilia|Prothrombin Thrombophilia	Blood disease
Hypersensitivity	MESH:D006967	DO:DOID:1205	Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.	MESH:D007154	C20.543	C20	Allergic Reaction|Allergic Reactions|Allergies|Allergy|Hypersensitivities|Reaction, Allergic|Reactions, Allergic	Immune system disease
Hypersensitivity, Delayed	MESH:D006968		An increased reactivity to specific antigens mediated not by antibodies but by cells.	MESH:D006967	C20.543.418	C20.543	Delayed Hypersensitivities|Delayed Hypersensitivity|Hypersensitivities, Delayed|Hypersensitivities, Tuberculin-Type|Hypersensitivities, Type IV|Hypersensitivity, Tuberculin Type|Hypersensitivity, Tuberculin-Type|Hypersensitivity, Type IV|Tuberculin-Type Hypersensitivities|Tuberculin Type Hypersensitivity|Tuberculin-Type Hypersensitivity|Type IV Hypersensitivities|Type IV Hypersensitivity	Immune system disease
Hypersensitivity, Immediate	MESH:D006969		Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.	MESH:D006967	C20.543.480	C20.543	Atopic Hypersensitivities|Atopic Hypersensitivity|Hypersensitivities, Atopic|Hypersensitivities, IgE-Mediated|Hypersensitivities, Immediate|Hypersensitivities, Type I|Hypersensitivity, Atopic|Hypersensitivity, IgE-Mediated|Hypersensitivity, Type I|IgE-Mediated Hypersensitivities|IgE Mediated Hypersensitivity|IgE-Mediated Hypersensitivity|Immediate Hypersensitivities|Immediate Hypersensitivity|Type I Hypersensitivities|Type I Hypersensitivity	Immune system disease
Hypersplenism	MESH:D006971	DO:DOID:6376	Condition characterized by splenomegaly, some reduction in the number of circulating blood cells in the presence of a normal or hyperactive bone marrow, and the potential for reversal by splenectomy.	MESH:D013158	C15.604.744.293	C15.604.744	Anemia, Splenic|Anemias, Splenic|Splenic Anemia|Splenic Anemias	Lymphatic disease
Hypertelorism and tetralogy of Fallot	MESH:C538386			MESH:D006972|MESH:D013771	C05.116.099.370.231.480/C538386|C05.660.207.231.480/C538386|C14.240.400.849/C538386|C14.280.400.849/C538386|C16.131.240.400.849/C538386|C16.131.621.207.231.480/C538386	C05.116.099.370.231.480|C05.660.207.231.480|C14.240.400.849|C14.280.400.849|C16.131.240.400.849|C16.131.621.207.231.480		Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Hypertension	MESH:D006973	DO:DOID:10763	Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.	MESH:D014652	C14.907.489	C14.907	Blood Pressure, High|Blood Pressures, High|High Blood Pressure|High Blood Pressures	Cardiovascular disease
Hypertension, Diastolic, Resistance to	MESH:C563897	OMIM:608622		MESH:D006973	C14.907.489/C563897	C14.907.489		Cardiovascular disease
Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy	MESH:C565359	OMIM:605115		MESH:D006973	C14.907.489/C565359	C14.907.489		Cardiovascular disease
Hypertension, Malignant	MESH:D006974	DO:DOID:10824	A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.	MESH:D006973	C14.907.489.330	C14.907.489	Malignant Hypertension	Cardiovascular disease
Hypertension, Pregnancy-Induced	MESH:D046110		A condition in pregnant women with elevated systolic (>140 mm Hg) and diastolic (>90 mm Hg) blood pressure on at least two occasions 6 h apart. HYPERTENSION complicates 8-10% of all pregnancies, generally after 20 weeks of gestation. Gestational hypertension can be divided into several broad categories according to the complexity and associated symptoms, such as EDEMA; PROTEINURIA; SEIZURES; abnormalities in BLOOD COAGULATION and liver functions.	MESH:D006973|MESH:D011248	C12.050.703.395|C14.907.489.480	C12.050.703|C14.907.489	Gestational Hypertension|Hypertension, Gestational|Hypertension, Pregnancy Induced|Hypertension, Pregnancy Transient|Hypertensions, Pregnancy Induced|Induced Hypertension, Pregnancy|Induced Hypertensions, Pregnancy|Pregnancy Induced Hypertension|Pregnancy-Induced Hypertension|Pregnancy Transient Hypertension|Transient Hypertension, Pregnancy	Cardiovascular disease|Pregnancy complication
Hypertension, Pulmonary	MESH:D006976	DO:DOID:6432|OMIM:178600	Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.	MESH:D006973|MESH:D008171	C08.381.423|C14.907.489.556	C08.381|C14.907.489	PHT|PPH1|PPH1 WITH HHT, INCLUDED|PULMONARY ARTERIAL HYPERTENSION;PAH PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED|Pulmonary Hypertension|PULMONARY HYPERTENSION, PRIMARY, 1|PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA, INCLUDED|PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED	Cardiovascular disease|Respiratory tract disease
Hypertension, Renal	MESH:D006977	DO:DOID:1073	Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.	MESH:D006973|MESH:D007674	C12.050.351.968.419.331|C12.200.777.419.331|C12.950.419.331|C14.907.489.631	C12.050.351.968.419|C12.200.777.419|C12.950.419|C14.907.489	Hypertensions, Renal|Renal Hypertension|Renal Hypertensions	Cardiovascular disease|Urogenital disease (female)|Urogenital disease (male)
Hypertension, Renovascular	MESH:D006978	DO:DOID:1591	Hypertension due to RENAL ARTERY OBSTRUCTION or compression.	MESH:D006977	C12.050.351.968.419.331.490|C12.200.777.419.331.490|C12.950.419.331.490|C14.907.489.631.485	C12.050.351.968.419.331|C12.200.777.419.331|C12.950.419.331|C14.907.489.631	Goldblatt Hypertension|Goldblatt Syndrome|Hypertension, Goldblatt|Renovascular Hypertension|Syndrome, Goldblatt	Cardiovascular disease|Urogenital disease (female)|Urogenital disease (male)
Hypertension Resistant to Conventional Therapy	MESH:C563514			MESH:D003329|MESH:D006973	C14.280.647.250.295/C563514|C14.907.489/C563514|C14.907.585.250.295/C563514	C14.280.647.250.295|C14.907.489|C14.907.585.250.295		Cardiovascular disease
Hypertensive Encephalopathy	MESH:D020343	DO:DOID:9427	Brain dysfunction or damage resulting from sustained MALIGNANT HYPERTENSION. When BLOOD PRESSURE exceeds the limits of cerebral autoregulation, cerebral blood flow is impaired (BRAIN ISCHEMIA). Clinical manifestations include HEADACHE; NAUSEA; VOMITING; SEIZURES; altered mental status (in some cases progressing to COMA); PAPILLEDEMA; and RETINAL HEMORRHAGE.	MESH:D019586	C10.228.140.631.500	C10.228.140.631	Encephalopathy, Hypertensive	Nervous system disease
Hypertensive Nephropathy	MESH:C563161	OMIM:608026		MESH:D006977|MESH:D009393	C12.050.351.968.419.331/C563161|C12.050.351.968.419.570/C563161|C12.200.777.419.331/C563161|C12.200.777.419.570/C563161|C12.950.419.331/C563161|C12.950.419.570/C563161|C14.907.489.631/C563161	C12.050.351.968.419.331|C12.050.351.968.419.570|C12.200.777.419.331|C12.200.777.419.570|C12.950.419.331|C12.950.419.570|C14.907.489.631	HNP1	Cardiovascular disease|Urogenital disease (female)|Urogenital disease (male)
Hypertensive Retinopathy	MESH:D058437	DO:DOID:11561	Degenerative changes to the RETINA due to HYPERTENSION.	MESH:D006973|MESH:D012164	C11.768.346|C14.907.489.815	C11.768|C14.907.489	Hypertensive Retinopathies|Retinopathies, Hypertensive|Retinopathy, Hypertensive	Cardiovascular disease|Eye disease
Hyperthermia	MESH:D000084462		An abnormal elevation of body temperature, usually as a result of inability to regulate core body temperature due to non-pathologic factors.	MESH:D001832|MESH:D018882	C23.888.119.455|C26.522.750	C23.888.119|C26.522	Hyperthermias	Signs and symptoms|Wounds and injuries
Hyperthyroidism, Familial Gestational	MESH:C566384	OMIM:603373		MESH:D006980|MESH:D011248	C12.050.703/C566384|C19.874.397/C566384	C12.050.703|C19.874.397		Endocrine system disease|Pregnancy complication
Hypertrichosis	MESH:D006983	DO:DOID:420	Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.	MESH:D006201	C17.800.329.875	C17.800.329	Hypertrichoses	Skin disease
Hypertrichosis, anterior cervical	MESH:C538390			MESH:D006983	C17.800.329.875/C538390	C17.800.329.875	Anterior cervical hypertrichosis|Hairy throat|Hairy throat syndrome	Skin disease
Hypertriglyceridemia	MESH:D015228		A condition of elevated levels of TRIGLYCERIDES in the blood.	MESH:D006949	C18.452.584.500.500.851	C18.452.584.500.500	Hypertriglyceridemias	Metabolic disease
HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE	OMIM:614480			MESH:D015228	C18.452.584.500.500.851/614480	C18.452.584.500.500.851	HTGTI	Metabolic disease
Hypertriglyceridemic Waist	MESH:D064250		A screening phenotype consisting of both elevated WAIST CIRCUMFERENCE and elevated fasting TRIGLYCERIDES level.	MESH:D012816|MESH:D015228	C18.452.584.500.500.851.875|C23.888.521	C18.452.584.500.500.851|C23.888	Enlarged Waist Elevated Triglycerides|Waist, Hypertriglyceridemic	Metabolic disease|Signs and symptoms
Hypertrophia Musculorum Vera	MESH:C564152			MESH:D006984|MESH:D009135	C05.651/C564152|C10.668.491/C564152|C23.300.775/C564152	C05.651|C10.668.491|C23.300.775		Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)
Hypertrophic Neuropathy And Cataract	MESH:C565490			MESH:D002386|MESH:D010523	C10.668.829/C565490|C11.510.245/C565490	C10.668.829|C11.510.245		Eye disease|Nervous system disease
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	OMIM:613845			MESH:D000471|MESH:D006976|MESH:D033461|MESH:D051437	C08.381.423/613845|C12.050.351.968.419.780/613845|C12.200.777.419.780/613845|C12.950.419.780/613845|C14.907.489.556/613845|C18.452.076.354/613845|C23.550.449/613845	C08.381.423|C12.050.351.968.419.780|C12.200.777.419.780|C12.950.419.780|C14.907.489.556|C18.452.076.354|C23.550.449	HUPRAS|HUPRA SYNDROME	Cardiovascular disease|Metabolic disease|Pathology (process)|Respiratory tract disease|Urogenital disease (female)|Urogenital disease (male)
Hyperuricemic Nephropathy, Familial Juvenile 2	MESH:C567760	OMIM:613092		MESH:D000740|MESH:D033461|MESH:D051437	C12.050.351.968.419.780/C567760|C12.200.777.419.780/C567760|C12.950.419.780/C567760|C15.378.071/C567760|C23.550.449/C567760	C12.050.351.968.419.780|C12.200.777.419.780|C12.950.419.780|C15.378.071|C23.550.449	ADTKD4|Early-Onset Hyperuricemia, Anemia, And Progressive Kidney Failure|Familial Juvenile Hyperuricemic Nephropathy 2|Hnfj2|HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2|Ren-Related Kidney Disease|TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4	Blood disease|Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3	OMIM:614227	DO:DOID:0060062		MESH:D007674|MESH:D033461	C12.050.351.968.419/614227|C12.200.777.419/614227|C12.950.419/614227|C23.550.449/614227	C12.050.351.968.419|C12.200.777.419|C12.950.419|C23.550.449	HNFJ3	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Hyperventilation	MESH:D006985		A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.	MESH:D012120|MESH:D012818	C08.618.501|C23.888.852.591	C08.618|C23.888.852	Hyperventilations	Respiratory tract disease|Signs and symptoms
Hypesthesia	MESH:D006987		Absent or reduced sensitivity to cutaneous stimulation.	MESH:D020886	C10.597.751.791.500|C23.888.592.763.770.500	C10.597.751.791|C23.888.592.763.770	Hypesthesias|Hypesthesias, Tactile|Hypesthesias, Thermal|Hypesthesia, Tactile|Hypesthesia, Thermal|Hypoesthesia|Hypoesthesias|Impaired Sensation|Impaired Sensations|Numbness|Reduced Sensation|Reduced Sensations|Sensation, Impaired|Sensation, Reduced|Sensations, Impaired|Sensations, Reduced|Tactile Hypesthesia|Tactile Hypesthesias|Thermal Hypesthesia|Thermal Hypesthesias	Nervous system disease|Signs and symptoms
Hyphema	MESH:D006988		Bleeding in the anterior chamber of the eye.	MESH:D005130	C11.290.484|C23.550.414.756.550	C11.290|C23.550.414.756	Hyphemas	Eye disease|Pathology (process)
Hypoalbuminemia	MESH:D034141	OMIM:616000	A condition in which albumin level in blood (SERUM ALBUMIN) is below the normal range. Hypoalbuminemia may be due to decreased hepatic albumin synthesis, increased albumin catabolism, altered albumin distribution, or albumin loss through the urine (ALBUMINURIA).	MESH:D007019	C15.378.147.607.500	C15.378.147.607	ANALBA|ANALBUMINEMIA	Blood disease
Hypobetalipoproteinemia, Familial, 1	MESH:C566267	OMIM:615558		MESH:D052476	C18.452.584.500.875.440.750/C566267|C18.452.584.563.497/C566267	C18.452.584.500.875.440.750|C18.452.584.563.497	Acanthocytosis With Hypobetalipoproteinemia|FHBL|FHBL1|HYPOBETALIPOPROTEINEMIA, FAMILIAL|Hypobetalipoproteinemia, Normotriglyceridemic|HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4, INCLUDED|LDLCQ4, INCLUDED	Metabolic disease
Hypobetalipoproteinemia, Familial, Apolipoprotein B	MESH:D052476		An autosomal dominant disorder of lipid metabolism. It is caused by mutations of APOLIPOPROTEINS B, main components of CHYLOMICRONS and BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include abnormally low LDL, normal triglyceride level, and dietary fat malabsorption.	MESH:D006995|MESH:D008052	C18.452.584.500.875.440.750|C18.452.584.563.497	C18.452.584.500.875.440|C18.452.584.563	Abetalipoproteinemia, Normotriglyceridemic, Steinbert Type|Apolipoprotein B Deficiencies|Apolipoprotein B Deficiency|Apolipoprotein B Deficiency Disease|Hypobetalipoproteinemia, Familial, Apo B	Metabolic disease
Hypocalcemia	MESH:D006996		Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)	MESH:D002128|MESH:D014883	C18.452.174.509|C18.452.950.509	C18.452.174|C18.452.950	Hypocalcemias	Metabolic disease
Hypocalcemia, Autosomal Dominant, with Bartter Syndrome	MESH:C563374	OMIM:601198		MESH:D001477|MESH:D006996	C12.050.351.968.419.815.279/C563374|C12.200.777.419.815.279/C563374|C12.950.419.815.279/C563374|C18.452.174.509/C563374|C18.452.950.509/C563374|C19.053.800.604.249/C563374	C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C18.452.174.509|C18.452.950.509|C19.053.800.604.249	HYPERCALCIURIC HYPOCALCEMIA|HYPOC1|HYPOCALCEMIA, AUTOSOMAL DOMINANT 1|HYPOCALCEMIA, FAMILIAL HYPOCALCEMIA, AUTOSOMAL DOMINANT 1, WITH BARTTER SYNDROME, INCLUDED	Endocrine system disease|Metabolic disease|Urogenital disease (female)|Urogenital disease (male)
Hypocalciuric Hypercalcemia, Acquired	MESH:C564151			MESH:D006934	C18.452.174.451/C564151|C18.452.950.340/C564151	C18.452.174.451|C18.452.950.340		Metabolic disease
Hypocalciuric hypercalcemia, familial, type 1	MESH:C537145	OMIM:145980		MESH:D006934	C18.452.174.451/C537145|C18.452.950.340/C537145	C18.452.174.451|C18.452.950.340	Familial Benign Hypercalcemia 1|Familial benign hypercalcemia type 1|Familial hypocalciuric hypercalcemia|FBH1|FHH|FHH1|HHC|HHC1|Hypercalcemia, Familial Benign|HYPERCALCEMIA, FAMILIAL BENIGN HYPOCALCIURIC HYPERCALCEMIA, ACQUIRED, INCLUDED|Hypercalcemia, familial benign type 1|Hypocalciuric Hypercalcemia, Familial, Type I	Metabolic disease
Hypocalciuric hypercalcemia, familial, type 2	MESH:C537146	OMIM:145981		MESH:D006934	C18.452.174.451/C537146|C18.452.950.340/C537146	C18.452.174.451|C18.452.950.340	Familial benign hypercalcemia, type 2|Familial Benign Hypercalcemia, Type II|FBH2|HHC2|Hypercalcemia, familial benign type 2|Hypercalcemia, Familial Benign, Type II|Hypocalciuric Hypercalcemia, Familial, Type II	Metabolic disease
Hypoglobulinemia and Absent B Cells	MESH:C565765			MESH:D001796|MESH:D007153	C15.378.147/C565765|C20.673/C565765	C15.378.147|C20.673		Blood disease|Immune system disease
Hypoglossal Nerve Diseases	MESH:D020437	DO:DOID:13814	Diseases of the twelfth cranial (hypoglossal) nerve or nuclei. The nuclei and fascicles of the nerve are located in the medulla, and the nerve exits the skull via the hypoglossal foramen and innervates the muscles of the tongue. Lower brain stem diseases, including ischemia and MOTOR NEURON DISEASES may affect the nuclei or nerve fascicles. The nerve may also be injured by diseases of the posterior fossa or skull base. Clinical manifestations include unilateral weakness of tongue musculature and lingual dysarthria, with deviation of the tongue towards the side of weakness upon attempted protrusion.	MESH:D003389	C10.292.525	C10.292	Cranial Nerve XII Diseases|Cranial Nerve XII Disorders|Hypoglossal Nerve Disease|Hypoglossal Nerve Palsies|Hypoglossal Nerve Palsy|Hypoglossal Neuralgia|Hypoglossal Neuralgias|Hypoglossal Neuropathies|Hypoglossal Neuropathy|Neuralgia, Hypoglossal|Neuralgias, Hypoglossal|Neuropathies, Hypoglossal|Neuropathy, Hypoglossal|Palsies, Hypoglossal Nerve|Palsy, Hypoglossal Nerve|Twelfth Cranial Nerve Diseases|Twelfth Cranial Nerve Disorder	Nervous system disease
Hypoglossal Nerve Injuries	MESH:D061228		Traumatic injuries to the HYPOGLOSSAL NERVE.	MESH:D020209|MESH:D020437	C10.292.200.562|C10.292.525.500|C10.900.300.218.362|C26.915.300.400.387	C10.292.200|C10.292.525|C10.900.300.218|C26.915.300.400	Avulsion, Hypoglossal Nerve|Avulsions, Hypoglossal Nerve|Contusion, Hypoglossal Nerve|Contusions, Hypoglossal Nerve|Cranial Nerve XII Injury|Hypoglossal Nerve Avulsion|Hypoglossal Nerve Avulsions|Hypoglossal Nerve Contusion|Hypoglossal Nerve Contusions|Hypoglossal Nerve Injury|Hypoglossal Nerve Transection|Hypoglossal Nerve Transections|Hypoglossal Nerve Trauma|Hypoglossal Nerve Traumas|Hypoglossal Neuropathies, Traumatic|Hypoglossal Neuropathy, Traumatic|Injuries, Hypoglossal Nerve|Injury, Cranial Nerve XII|Injury, Hypoglossal Nerve|Injury, Twelfth Cranial Nerve|Nerve Avulsion, Hypoglossal|Nerve Avulsions, Hypoglossal|Nerve Contusion, Hypoglossal|Nerve Contusions, Hypoglossal|Nerve Injuries, Hypoglossal|Nerve Injury, Hypoglossal|Nerve Transection, Hypoglossal|Nerve Transections, Hypoglossal|Nerve Trauma, Hypoglossal|Nerve Traumas, Hypoglossal|Neuropathies, Traumatic Hypoglossal|Neuropathy, Traumatic Hypoglossal|Palsies, Traumatic Twelfth-Nerve|Palsy, Traumatic Twelfth-Nerve|Transection, Hypoglossal Nerve|Transections, Hypoglossal Nerve|Trauma, Hypoglossal Nerve|Traumas, Hypoglossal Nerve|Traumas, Twelfth-Nerve|Traumatic Hypoglossal Neuropathies|Traumatic Hypoglossal Neuropathy|Traumatic Twelfth-Nerve Palsies|Traumatic Twelfth Nerve Palsy|Traumatic Twelfth-Nerve Palsy|Trauma, Twelfth-Nerve|Twelfth Cranial Nerve Injuries|Twelfth Cranial Nerve Injury|Twelfth-Nerve Palsies, Traumatic|Twelfth Nerve Palsy, Traumatic|Twelfth-Nerve Palsy, Traumatic|Twelfth Nerve Trauma|Twelfth-Nerve Trauma|Twelfth-Nerve Traumas	Nervous system disease|Wounds and injuries
Hypoglycemia	MESH:D007003	DO:DOID:9993	A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.	MESH:D044882	C18.452.394.984	C18.452.394	Fasting Hypoglycemia|Hypoglycemia, Fasting|Hypoglycemia, Postabsorptive|Hypoglycemia, Postprandial|Hypoglycemia, Reactive|Postabsorptive Hypoglycemia|Postprandial Hypoglycemia|Reactive Hypoglycemia	Metabolic disease
Hypoglycemia, leucine-induced	MESH:C537150	OMIM:240800		MESH:D007003	C18.452.394.984/C537150	C18.452.394.984	Leucine-sensitive hypoglycemia of infancy|LIH	Metabolic disease
Hypogonadism, Male, With Mental Retardation And Skeletal Anomalies	MESH:C564406			MESH:D007006|MESH:D008607	C10.597.606.360/C564406|C19.391.482/C564406|C23.888.592.604.646/C564406|F03.625.539/C564406	C10.597.606.360|C19.391.482|C23.888.592.604.646|F03.625.539		Endocrine system disease|Mental disorder|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA	OMIM:614839	DO:DOID:0090089		MESH:D000857|MESH:D007006	C10.597.751.600/614839|C19.391.482/614839|C23.888.592.763.550/614839	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH10	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA	OMIM:614840	DO:DOID:0090071		MESH:D000857|MESH:D007006	C10.597.751.600/614840|C19.391.482/614840|C23.888.592.763.550/614840	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH11	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA	OMIM:614842	DO:DOID:0090073		MESH:D000857|MESH:D007006	C10.597.751.600/614842|C19.391.482/614842|C23.888.592.763.550/614842	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH13	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA	OMIM:614858	DO:DOID:0090087		MESH:D000857|MESH:D007006	C10.597.751.600/614858|C19.391.482/614858|C23.888.592.763.550/614858	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH14	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	OMIM:614880	DO:DOID:0090075		MESH:D000857|MESH:D007006	C10.597.751.600/614880|C19.391.482/614880|C23.888.592.763.550/614880	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH15	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA	OMIM:614897	DO:DOID:0090080		MESH:D000857|MESH:D007006	C10.597.751.600/614897|C19.391.482/614897|C23.888.592.763.550/614897	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH16	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA	OMIM:615266	DO:DOID:0090079		MESH:D000857|MESH:D007006	C10.597.751.600/615266|C19.391.482/615266|C23.888.592.763.550/615266	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH17	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA	OMIM:615267	DO:DOID:0090076		MESH:D000857|MESH:D007006	C10.597.751.600/615267|C19.391.482/615267|C23.888.592.763.550/615267	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH18	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA	OMIM:615269	DO:DOID:0090090		MESH:D000857|MESH:D007006	C10.597.751.600/615269|C19.391.482/615269|C23.888.592.763.550/615269	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH19	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA	OMIM:615270	DO:DOID:0090082		MESH:D000857|MESH:D007006	C10.597.751.600/615270|C19.391.482/615270|C23.888.592.763.550/615270	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH20	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA	OMIM:615271	DO:DOID:0090093		MESH:D000857|MESH:D007006	C10.597.751.600/615271|C19.391.482/615271|C23.888.592.763.550/615271	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH21	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA	OMIM:616030	DO:DOID:0090081		MESH:D000857|MESH:D007006	C10.597.751.600/616030|C19.391.482/616030|C23.888.592.763.550/616030	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH22	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA	OMIM:614837	DO:DOID:0090074		MESH:D000857|MESH:D007006	C10.597.751.600/614837|C19.391.482/614837|C23.888.592.763.550/614837	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH8	Endocrine system disease|Nervous system disease|Signs and symptoms
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA	OMIM:614838	DO:DOID:0090085		MESH:D000857|MESH:D007006	C10.597.751.600/614838|C19.391.482/614838|C23.888.592.763.550/614838	C10.597.751.600|C19.391.482|C23.888.592.763.550	HH9	Endocrine system disease|Nervous system disease|Signs and symptoms
Hypohidrosis	MESH:D007007	DO:DOID:11155|DO:DOID:11156	Abnormally diminished or absent perspiration. Both generalized and segmented (reduced or absent sweating in circumscribed locations) forms of the disease are usually associated with other underlying conditions.	MESH:D013543	C17.800.946.370	C17.800.946	Anhidrosis	Skin disease
Hypokalemia	MESH:D007008		Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)	MESH:D014883	C18.452.950.565	C18.452.950	Hypokalemias|Hypopotassemia|Hypopotassemias	Metabolic disease
Hypokinesia	MESH:D018476		Slow or diminished movement of body musculature. It may be associated with BASAL GANGLIA DISEASES; MENTAL DISORDERS; prolonged inactivity due to illness; and other conditions.	MESH:D020820	C10.597.350.400|C23.888.592.350.400	C10.597.350|C23.888.592.350	Antiorthostatic Hypokinesia|Antiorthostatic Hypokinesias|Bradykinesia|Bradykinesias|Hypodynamia|Hypokinesia, Antiorthostatic|Hypokinesias, Antiorthostatic	Nervous system disease|Signs and symptoms
Hypomagnesemia 1, Intestinal	MESH:C566593	OMIM:602014		MESH:D006996|MESH:D008275	C18.452.174.509/C566593|C18.452.950.509/C566593|C18.654.521.500.439/C566593	C18.452.174.509|C18.452.950.509|C18.654.521.500.439	HOMG|HOMG1|HSH|Hypomagnesemia, Intestinal, with Secondary Hypocalcemia|Hypomagnesemia with Secondary Hypocalcemia|HYPOMAGNESEMIC TETANY	Metabolic disease|Nutrition disorder
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	OMIM:615281			MESH:D010264|MESH:D056784	C10.228.140.695/615281|C10.597.622.669/615281|C23.888.592.636.637/615281	C10.228.140.695|C10.597.622.669|C23.888.592.636.637	ASPARTYL-tRNA SYNTHETASE DEFICIENCY|HBSL	Nervous system disease|Signs and symptoms
Hyponatremia	MESH:D007010		Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)	MESH:D014883	C18.452.950.620	C18.452.950	Hyponatremias	Metabolic disease
Hypopharyngeal Neoplasms	MESH:D007012	DO:DOID:8533	Tumors or cancer of the HYPOPHARYNX.	MESH:D010610	C04.588.443.665.710.485|C07.550.745.436|C09.647.710.485|C09.775.549.485	C04.588.443.665.710|C07.550.745|C09.647.710|C09.775.549	Cancer, Hypopharyngeal|Cancers, Hypopharyngeal|Hypopharyngeal Cancer|Hypopharyngeal Cancers|Hypopharyngeal Neoplasm|Neoplasm, Hypopharyngeal|Neoplasms, Hypopharyngeal	Cancer|Ear-nose-throat disease|Mouth disease
Hypophosphatemia	MESH:D017674	DO:DOID:0050336	A condition of an abnormally low level of PHOSPHATES in the blood.	MESH:D010760	C18.452.750.400	C18.452.750	Hypophosphatemias	Metabolic disease
Hypophosphatemic Bone Disease	MESH:C564145	OMIM:146350		MESH:D001851|MESH:D017674	C05.116.198/C564145|C18.452.104/C564145|C18.452.750.400/C564145	C05.116.198|C18.452.104|C18.452.750.400	HBD	Metabolic disease|Musculoskeletal disease
Hypophosphatemic Rickets And Hyperparathyroidism	MESH:C567423	OMIM:612089		MESH:D049950|MESH:D063730	C05.116.198.816.875/C567423|C18.452.104.816.875/C567423|C18.452.174.845.875/C567423|C18.452.750.400.750/C567423|C18.654.521.500.133.770.734.875/C567423|C19.642.355.239/C567423	C05.116.198.816.875|C18.452.104.816.875|C18.452.174.845.875|C18.452.750.400.750|C18.654.521.500.133.770.734.875|C19.642.355.239		Endocrine system disease|Metabolic disease|Musculoskeletal disease|Nutrition disorder
Hypophysitis	MESH:D000072659		Inflammation of the PITUITARY GLAND.	MESH:D010900	C10.228.140.617.738.275|C19.700.419	C10.228.140.617.738|C19.700	Hypophysitides	Endocrine system disease|Nervous system disease
Hypopigmentation	MESH:D017496		A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.	MESH:D010859	C17.800.621.440	C17.800.621	Hypomelanoses|Hypomelanosis	Skin disease
Hypopituitarism	MESH:D007018	DO:DOID:9406|DO:DOID:9476	Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.	MESH:D010900	C10.228.140.617.738.300|C19.700.482	C10.228.140.617.738|C19.700	Adenohypophyseal Hyposecretion|Anterior Pituitary Hyposecretion Syndrome|Disease, Simmonds|Hypopituitarism, Postpartum|Hyposecretion, Adenohypophyseal|Hyposecretion Syndrome, Anterior Pituitary|Insufficiency, Pituitary|Panhypopituitarism, Postpartum|Pituitary Insufficiency|Pituitary Insufficiency, Postpartum|Postpartum Hypopituitarism|Postpartum Panhypopituitarism|Postpartum Pituitary Insufficiency|Sheehan's Syndrome|Sheehans Syndrome|Sheehan Syndrome|Simmond's Disease|Simmonds Disease|Simmonds' Disease|Syndrome, Sheehan|Syndrome, Sheehan's	Endocrine system disease|Nervous system disease
Hypopituitarism, Congenital, with Central Diabetes Insipidus	MESH:C565477			MESH:D007018|MESH:D020790	C10.228.140.617.738.300/C565477|C12.050.351.968.419.135.750/C565477|C12.200.777.419.135.750/C565477|C12.950.419.135.750/C565477|C19.700.159.750/C565477|C19.700.482/C565477	C10.228.140.617.738.300|C12.050.351.968.419.135.750|C12.200.777.419.135.750|C12.950.419.135.750|C19.700.159.750|C19.700.482		Endocrine system disease|Nervous system disease|Urogenital disease (female)|Urogenital disease (male)
Hypoplastic Left Heart Syndrome	MESH:D018636	DO:DOID:9955|OMIM:241550|OMIM:614435	A condition caused by underdevelopment of the whole left half of the heart. It is characterized by hypoplasia of the left cardiac chambers (HEART ATRIUM; HEART VENTRICLE), the AORTA, the AORTIC VALVE, and the MITRAL VALVE. Severe symptoms appear in early infancy when DUCTUS ARTERIOSUS closes.	MESH:D006330	C14.240.400.625|C14.280.400.625|C16.131.240.400.625	C14.240.400|C14.280.400|C16.131.240.400	HLHS|HLHS1|HLHS2|HYPOPLASTIC LEFT HEART SYNDROME 1|HYPOPLASTIC LEFT HEART SYNDROME 2|Left Heart Hypoplasia Syndrome|Left Heart Syndrome, Hypoplastic	Cardiovascular disease|Congenital abnormality
Hypoproteinemia	MESH:D007019		A condition in which total serum protein level is below the normal range. Hypoproteinemia can be caused by protein malabsorption in the gastrointestinal tract, EDEMA, or PROTEINURIA.	MESH:D001796	C15.378.147.607	C15.378.147	Hypoproteinemias	Blood disease
Hypotension	MESH:D007022		Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.	MESH:D014652	C14.907.514	C14.907	Blood Pressure, Low|Hypotension, Vascular|Low Blood Pressure|Vascular Hypotension	Cardiovascular disease
Hypotension, Orthostatic	MESH:D007024		A significant drop in BLOOD PRESSURE after assuming a standing position. Orthostatic hypotension is a finding, and defined as a 20-mm Hg decrease in systolic pressure or a 10-mm Hg decrease in diastolic pressure 3 minutes after the person has risen from supine to standing. Symptoms generally include DIZZINESS, blurred vision, and SYNCOPE.	MESH:D007022|MESH:D054971	C10.177.575.600.450|C14.907.514.482	C10.177.575.600|C14.907.514	Hypotension, Postural|Orthostatic Hypotension|Postural Hypotension	Cardiovascular disease|Nervous system disease
Hypothalamic Diseases	MESH:D007027	DO:DOID:1931|DO:DOID:6676	Neoplastic, inflammatory, infectious, and other diseases of the hypothalamus. Clinical manifestations include appetite disorders; AUTONOMIC NERVOUS SYSTEM DISEASES; SLEEP DISORDERS; behavioral symptoms related to dysfunction of the LIMBIC SYSTEM; and neuroendocrine disorders.	MESH:D001927	C10.228.140.617	C10.228.140	Diencephalic Syndrome, Pituitary|Diencephalic Syndromes, Pituitary|Disease, Hypothalamic|Diseases, Hypothalamic|Disorder, Hypothalamic-Adenohypophyseal|Disorder, Hypothalamic-Neurohypophyseal|Disorders, Hypothalamic-Adenohypophyseal|Disorders, Hypothalamic-Neurohypophyseal|Dysfunction Syndrome, Hypothalamic|Dysfunction Syndromes, Hypothalamic|Dysinhibition Syndrome, Hypothalamic|Dysinhibition Syndromes, Hypothalamic|Froehlich's Syndrome|Froehlichs Syndrome|Froehlich Syndrome|Hypothalamic-Adenohypophyseal Disorder|Hypothalamic Adenohypophyseal Disorders|Hypothalamic-Adenohypophyseal Disorders|Hypothalamic Disease|Hypothalamic Dysfunction Syndrome|Hypothalamic Dysfunction Syndromes|Hypothalamic Dysinhibition Syndrome|Hypothalamic Dysinhibition Syndromes|Hypothalamic-Neurohypophyseal Disorder|Hypothalamic Neurohypophyseal Disorders|Hypothalamic-Neurohypophyseal Disorders|Hypothalamic Overactivity Syndrome|Hypothalamic Overactivity Syndromes|Hypothalamic Pseudopuberties|Hypothalamic Pseudopuberty|Overactivity Syndrome, Hypothalamic|Overactivity Syndromes, Hypothalamic|Pituitary Diencephalic Syndrome|Pituitary Diencephalic Syndromes|Pseudopuberties, Hypothalamic|Pseudopuberty, Hypothalamic|Syndrome, Froehlich's|Syndrome, Hypothalamic Dysfunction|Syndrome, Hypothalamic Dysinhibition|Syndrome, Hypothalamic Overactivity|Syndromes, Hypothalamic Dysfunction|Syndromes, Hypothalamic Dysinhibition|Syndromes, Hypothalamic Overactivity|Syndromes, Pituitary Diencephalic	Nervous system disease
Hypothalamic hamartomas	MESH:C537158	OMIM:241800		MESH:D006222|MESH:D007027	C04.445/C537158|C10.228.140.617/C537158	C04.445|C10.228.140.617	Congenital hypothalamic hamartoma syndrome|Hamartoma of the hypothalamus|Hypothalamic hamartoma|PALLISTER-HALL-LIKE SYNDROME|PHLS	Cancer|Nervous system disease
Hypothalamic Neoplasms	MESH:D007029	DO:DOID:3644	Benign and malignant tumors of the HYPOTHALAMUS. Pilocytic astrocytomas and hamartomas are relatively frequent histologic types. Neoplasms of the hypothalamus frequently originate from adjacent structures, including the OPTIC CHIASM, optic nerve (see OPTIC NERVE NEOPLASMS), and pituitary gland (see PITUITARY NEOPLASMS). Relatively frequent clinical manifestations include visual loss, developmental delay, macrocephaly, and precocious puberty. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2051)	MESH:D007027|MESH:D015173	C04.588.614.250.195.885.500|C10.228.140.211.885.500|C10.228.140.617.477|C10.551.240.250.700.500	C04.588.614.250.195.885|C10.228.140.211.885|C10.228.140.617|C10.551.240.250.700	Benign Hypothalamic Neoplasm|Benign Hypothalamic Neoplasms|Cancer, Hypothalamic|Cancers, Hypothalamic|Hypothalamic Cancer|Hypothalamic Cancers|Hypothalamic-Chiasmatic Neoplasm|Hypothalamic Chiasmatic Neoplasms|Hypothalamic-Chiasmatic Neoplasms|Hypothalamic Neoplasm|Hypothalamic Neoplasm, Malignant|Hypothalamic Neoplasms, Benign|Hypothalamic Neoplasms, Malignant|Hypothalamic-Pituitary Neoplasm|Hypothalamic Pituitary Neoplasms|Hypothalamic-Pituitary Neoplasms|Hypothalamic Teratoma|Hypothalamic Teratomas|Hypothalamic Tumor|Hypothalamic Tumors|Hypothalamo-Neurohypophysial Region Neoplasm|Hypothalamo Neurohypophysial Region Neoplasms|Hypothalamo-Neurohypophysial Region Neoplasms|Hypothalamus Neoplasm|Hypothalamus Neoplasms|Hypothalamus Tumor|Hypothalamus Tumors|Malignant Hypothalamic Neoplasm|Malignant Hypothalamic Neoplasms|Neoplasm, Benign Hypothalamic|Neoplasm, Hypothalamic|Neoplasm, Hypothalamic-Chiasmatic|Neoplasm, Hypothalamic-Pituitary|Neoplasm, Hypothalamo-Neurohypophysial Region|Neoplasm, Hypothalamus|Neoplasm, Malignant Hypothalamic|Neoplasms, Hypothalamic|Neoplasms, Hypothalamic, Benign|Neoplasms, Hypothalamic Chiasmatic|Neoplasms, Hypothalamic-Chiasmatic|Neoplasms, Hypothalamic, Malignant|Neoplasms, Hypothalamic Pituitary|Neoplasms, Hypothalamic-Pituitary|Neoplasms, Hypothalamo Neurohypophysial Region|Neoplasms, Hypothalamo-Neurohypophysial Region|Neoplasms, Hypothalamus|Neoplasms, Malignant Hypothalamic|Teratoma, Hypothalamic|Teratomas, Hypothalamic|Tumor, Hypothalamic|Tumor, Hypothalamus|Tumors, Hypothalamic|Tumors, Hypothalamus	Cancer|Nervous system disease
Hypothyroidism, Autoimmune	MESH:C562768			MESH:D013967|MESH:D050031	C19.874.871.102.500/C562768|C19.874.871.102/C562768|C20.111.809/C562768	C19.874.871.102|C19.874.871.102.500|C20.111.809		Endocrine system disease|Immune system disease
HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT	OMIM:300888	DO:DOID:0111140		MESH:D007037|MESH:D013733	C12.100.500.829/300888|C12.200.294.829/300888|C19.391.829/300888|C19.874.482/300888	C12.100.500.829|C12.200.294.829|C19.391.829|C19.874.482	CHTE	Endocrine system disease|Urogenital disease (male)
Hypotonia, congenital nystagmus, ataxia and abnormal auditory brainstem response	MESH:C537159			MESH:D001259|MESH:D003711|MESH:D009123|MESH:D020417	C10.292.562.675.300/C537159|C10.314/C537159|C10.597.350.090/C537159|C10.597.613.575/C537159|C11.590.400.300/C537159|C16.614.643/C537159|C23.888.592.350.090/C537159|C23.888.592.608.575/C537159	C10.292.562.675.300|C10.314|C10.597.350.090|C10.597.613.575|C11.590.400.300|C16.614.643|C23.888.592.350.090|C23.888.592.608.575	Hypotonia, Congenital Nystagmus, Ataxia, And Abnormal Auditory Brainstem Responses	Eye disease|Infant-newborn disease|Nervous system disease|Signs and symptoms
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION	OMIM:616816			MESH:D009123|MESH:D011596	C10.597.606.881/616816|C10.597.613.575/616816|C23.888.592.604.882/616816|C23.888.592.608.575/616816	C10.597.606.881|C10.597.613.575|C23.888.592.604.882|C23.888.592.608.575	IHPMR	Nervous system disease|Signs and symptoms
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1	OMIM:615419			MESH:D009123|MESH:D011596|MESH:D019066	C10.597.606.881/615419|C10.597.613.575/615419|C23.550.291.812/615419|C23.888.592.604.882/615419|C23.888.592.608.575/615419	C10.597.606.881|C10.597.613.575|C23.550.291.812|C23.888.592.604.882|C23.888.592.608.575	IHPRF|IHPRF1	Nervous system disease|Pathology (process)|Signs and symptoms
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2	OMIM:616801			MESH:D009123|MESH:D011596|MESH:D019066	C10.597.606.881/616801|C10.597.613.575/616801|C23.550.291.812/616801|C23.888.592.604.882/616801|C23.888.592.608.575/616801	C10.597.606.881|C10.597.613.575|C23.550.291.812|C23.888.592.604.882|C23.888.592.608.575	IHPRF2	Nervous system disease|Pathology (process)|Signs and symptoms
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3	OMIM:616900			MESH:D009123|MESH:D011596|MESH:D019066	C10.597.606.881/616900|C10.597.613.575/616900|C23.550.291.812/616900|C23.888.592.604.882/616900|C23.888.592.608.575/616900	C10.597.606.881|C10.597.613.575|C23.550.291.812|C23.888.592.604.882|C23.888.592.608.575	IHPRF3	Nervous system disease|Pathology (process)|Signs and symptoms
Hypotrichosis	MESH:D007039	DO:DOID:4535|OMIM:278150|OMIM:604379|OMIM:613981|OMIM:614237|OMIM:614238|OMIM:615059|OMIM:615885|OMIM:615896	Presence of less than the normal amount of hair. (Dorland, 27th ed)	MESH:D006201	C17.800.329.937	C17.800.329	AH|ARWH1, INCLUDED|ARWH2, INCLUDED|HTSS2|Hypotrichoses|HYPOTRICHOSIS 10|HYPOTRICHOSIS 11|HYPOTRICHOSIS 12|HYPOTRICHOSIS 13|HYPOTRICHOSIS 3|HYPOTRICHOSIS 7|HYPOTRICHOSIS 8|HYPOTRICHOSIS 9|HYPOTRICHOSIS, AUTOSOMAL RECESSIVE|HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 2|HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 3;LAH3 WOOLLY HAIR, AUTOSOMAL RECESSIVE 1, WITH OR WITHOUT HYPOTRICHOSIS, INCLUDED|HYPOTRICHOSIS SIMPLEX OF THE SCALP 2|HYPOTRICHOSIS, TOTAL, MARI TYPE  WOOLLY HAIR, AUTOSOMAL RECESSIVE 2, WITH OR WITHOUT HYPOTRICHOSIS, INCLUDED|HYPOTRICHOSIS WITH WOOLLY HAIR|HYPT10|HYPT11|HYPT12|HYPT13|HYPT3|HYPT7|HYPT8|HYPT9|LAH2|WH/HT, INCLUDED	Skin disease
HYPOTRICHOSIS 2	OMIM:146520	DO:DOID:0110699		MESH:C537160	C17.800.329.937/C537160/146520	C17.800.329.937/C537160	HTSS|HTSS1|HYPOTRICHOSIS SIMPLEX OF THE SCALP 1|HYPOTRICHOSIS, SPANISH TYPE|HYPT2	Skin disease
Hypotrichosis 5	MESH:C567554	OMIM:612841		MESH:D007039	C17.800.329.937/C567554	C17.800.329.937	HYPT5|Marie Unna Hereditary Hypotrichosis 2|MUHH2	Skin disease
Hypotrichosis And Recurrent Skin Vesicles	MESH:C567751	OMIM:613102		MESH:D001768|MESH:D007039	C17.800.329.937/C567751|C17.800.865.187/C567751|C23.300.122/C567751	C17.800.329.937|C17.800.865.187|C23.300.122	HYPTSV	Pathology (anatomical condition)|Skin disease
Hypotrichosis, Localized, Autosomal Recessive 1	MESH:C564312	OMIM:607903		MESH:D007039	C17.800.329.937/C564312	C17.800.329.937	HTL|HYPOTRICHOSIS 6|Hypotrichosis, Localized, Autosomal Recessive|HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 1|HYPT6|LAH|LAH1|MONILETHRIX-LIKE HYPOTRICHOSIS	Skin disease
Hypotrichosis, Localized, Autosomal Recessive, 3	MESH:C566950			MESH:D007039	C17.800.329.937/C566950	C17.800.329.937		Skin disease
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	OMIM:137940	DO:DOID:0111360		MESH:C536825|MESH:C564327|MESH:D008209	C12.050.351.968.419.570.363.615/C536825/137940|C12.200.777.419.570.363.615/C536825/137940|C12.950.419.570.363.615/C536825/137940|C14.907.823/C536825/137940|C14.907.823/C564327/137940|C15.604.496/137940|C15.604.496/C564327/137940|C17.800.329.937.122/C536825/137940|C17.800.329.937/C564327/137940|C20.425/C536825/137940|C23.300.035/C536825/137940	C12.050.351.968.419.570.363.615/C536825|C12.200.777.419.570.363.615/C536825|C12.950.419.570.363.615/C536825|C14.907.823/C536825|C14.907.823/C564327|C15.604.496|C15.604.496/C564327|C17.800.329.937.122/C536825|C17.800.329.937/C564327|C20.425/C536825|C23.300.035/C536825	GLOMERULONEPHRITIS WITH SPARSE HAIR AND TELANGIECTASES|HLTRS|TELANGIECTATIC MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	Cardiovascular disease|Immune system disease|Lymphatic disease|Pathology (anatomical condition)|Skin disease|Urogenital disease (female)|Urogenital disease (male)
Hypotrichosis-Lymphedema-Telangiectasia Syndrome	MESH:C564327	OMIM:607823		MESH:D007039|MESH:D008209|MESH:D013684	C14.907.823/C564327|C15.604.496/C564327|C17.800.329.937/C564327	C14.907.823|C15.604.496|C17.800.329.937	HLTS	Cardiovascular disease|Lymphatic disease|Skin disease
Hypotrichosis simplex	MESH:C537160	OMIM:605389		MESH:D007039	C17.800.329.937/C537160	C17.800.329.937	Hereditary hypotrichosis simplex|HHS|HTS|HYPOTRICHOSIS 1|HYPOTRICHOSIS SIMPLEX, GENERALIZED, HEREDITARY|HYPT1	Skin disease
Hypotrichosis Simplex of Scalp	MESH:C564143			MESH:D007039	C17.800.329.937/C564143	C17.800.329.937	Hypotrichosis, Spanish Type	Skin disease
Hypoventilation	MESH:D007040		A reduction in the amount of air entering the pulmonary alveoli.	MESH:D012131|MESH:D012818	C08.618.846.565|C23.888.852.638	C08.618.846|C23.888.852	Hypoventilations	Respiratory tract disease|Signs and symptoms
Hypoxia, Brain	MESH:D002534		A reduction in brain oxygen supply due to ANOXEMIA (a reduced amount of oxygen being carried in the blood by HEMOGLOBIN), or to a restriction of the blood supply to the brain, or both. Severe hypoxia is referred to as anoxia and is a relatively common cause of injury to the central nervous system. Prolonged brain anoxia may lead to BRAIN DEATH or a PERSISTENT VEGETATIVE STATE. Histologically, this condition is characterized by neuronal loss which is most prominent in the HIPPOCAMPUS; GLOBUS PALLIDUS; CEREBELLUM; and inferior olives.	MESH:D000860|MESH:D001927	C10.228.140.624|C23.888.852.079.797	C10.228.140|C23.888.852.079	Anoxia, Brain|Anoxia, Cerebral|Anoxic Brain Damage|Anoxic Encephalopathies|Anoxic Encephalopathy|Brain Anoxia|Brain Damage, Anoxic|Brain Damage, Hypoxic|Brain Hypoxia|Cerebral Anoxia|Cerebral Hypoxia|Damage, Anoxic Brain|Damage, Hypoxic Brain|Encephalopathies, Anoxic|Encephalopathies, Hypoxic|Encephalopathy, Anoxic|Encephalopathy, Hypoxic|Hypoxia, Cerebral|Hypoxic Brain Damage|Hypoxic Encephalopathies|Hypoxic Encephalopathy	Nervous system disease|Signs and symptoms
Hypoxia-Ischemia, Brain	MESH:D020925		A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.	MESH:D002534|MESH:D002545	C10.228.140.300.150.716|C10.228.140.624.500|C14.907.253.092.716|C23.888.852.079.797.500	C10.228.140.300.150|C10.228.140.624|C14.907.253.092|C23.888.852.079.797	Anoxia Ischemia, Brain|Anoxia-Ischemia, Brain|Anoxia Ischemia, Cerebral|Anoxia-Ischemia, Cerebral|Anoxia-Ischemias, Brain|Anoxia-Ischemias, Cerebral|Anoxic-Ischemic Encephalopathies|Anoxic Ischemic Encephalopathy|Anoxic-Ischemic Encephalopathy|Brain Anoxia Ischemia|Brain Anoxia-Ischemia|Brain Anoxia-Ischemias|Brain Hypoxia Ischemia|Brain Hypoxia-Ischemia|Brain Hypoxia-Ischemias|Brain Ischemia Anoxia|Brain Ischemia-Anoxia|Brain Ischemia-Anoxias|Brain Ischemia Hypoxia|Brain Ischemia-Hypoxia|Brain Ischemia-Hypoxias|Cerebral Anoxia Ischemia|Cerebral Anoxia-Ischemia|Cerebral Anoxia-Ischemias|Cerebral Hypoxia Ischemia|Cerebral Hypoxia-Ischemia|Cerebral Hypoxia-Ischemias|Cerebral Ischemia Anoxia|Cerebral Ischemia-Anoxia|Cerebral Ischemia-Anoxias|Cerebral Ischemia Hypoxia|Cerebral Ischemia-Hypoxia|Cerebral Ischemia-Hypoxias|Encephalopathies, Anoxic-Ischemic|Encephalopathies, Hypoxic-Ischemic|Encephalopathies, Ischemic-Hypoxic|Encephalopathy, Anoxic Ischemic|Encephalopathy, Anoxic-Ischemic|Encephalopathy, Hypoxic Ischemic|Encephalopathy, Hypoxic-Ischemic|Encephalopathy, Ischemic-Hypoxic|Hypoxia Ischemia, Brain|Hypoxia Ischemia, Cerebral|Hypoxia-Ischemia, Cerebral|Hypoxia-Ischemias, Brain|Hypoxia-Ischemias, Cerebral|Hypoxic-Ischemic Encephalopathies|Hypoxic Ischemic Encephalopathy|Hypoxic-Ischemic Encephalopathy|Ischemia Anoxia, Brain|Ischemia-Anoxia, Brain|Ischemia Anoxia, Cerebral|Ischemia-Anoxia, Cerebral|Ischemia-Anoxias, Brain|Ischemia-Anoxias, Cerebral|Ischemia Hypoxia, Brain|Ischemia-Hypoxia, Brain|Ischemia Hypoxia, Cerebral|Ischemia-Hypoxia, Cerebral|Ischemia-Hypoxias, Brain|Ischemia-Hypoxias, Cerebral|Ischemic-Hypoxic Encephalopathies|Ischemic Hypoxic Encephalopathy|Ischemic-Hypoxic Encephalopathy	Cardiovascular disease|Nervous system disease|Signs and symptoms
Ichthyosis hystrix gravior	MESH:C536087			MESH:D007057|MESH:D010212	C04.557.470.700.600/C536087|C16.131.831.512/C536087|C16.614.492/C536087|C17.800.428.333/C536087|C17.800.804.512/C536087	C04.557.470.700.600|C16.131.831.512|C16.614.492|C17.800.428.333|C17.800.804.512	Ichthyosis, Lambert Type|Lambert type ichthyosis|Porcupine man	Cancer|Congenital abnormality|Infant-newborn disease|Skin disease
Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis	MESH:C564365	OMIM:607626		MESH:D000505|MESH:D007057|MESH:D007960|MESH:D015209	C06.130.120.200.110/C564365|C15.378.553/C564365|C16.131.831.512/C564365|C16.614.492/C564365|C17.800.329.937.122/C564365|C17.800.428.333/C564365|C17.800.804.512/C564365|C23.300.035/C564365	C06.130.120.200.110|C15.378.553|C16.131.831.512|C16.614.492|C17.800.329.937.122|C17.800.428.333|C17.800.804.512|C23.300.035	Ichthyosis-Sclerosing Cholangitis Syndrome|ILVASC|Neonatal Ichthyosis-Sclerosing Cholangitis Syndrome|Nisch Syndrome	Blood disease|Congenital abnormality|Digestive system disease|Infant-newborn disease|Pathology (anatomical condition)|Skin disease
Idiopathic basal ganglia calcification, childhood onset	MESH:C536276			MESH:D001480|MESH:D002114	C10.228.140.079/C536276|C18.452.174.130/C536276	C10.228.140.079|C18.452.174.130	Basal Ganglia Calcification, Idiopathic, Childhood-Onset|Bilateral striopallidodentate calcinosis, childhood onset|Cerebral calcification, nonarteriosclerotic, childhood onset, idiopathic|Cerebral Calcification, Nonarteriosclerotic, Idiopathic, Childhood-Onset|IBGC, childhood onset|Striopallidodentate Calcinosis, Bilateral, Childhood-Onset	Metabolic disease|Nervous system disease
Idiopathic inflammatory myopathy, familial	MESH:C000598744			MESH:D009220	C05.651.594/C000598744|C10.668.491.562/C000598744	C05.651.594|C10.668.491.562	Idiopathic myopathy|Myopathy, familial idiopathic inflammatory	Musculoskeletal disease|Nervous system disease
Idiopathic Interstitial Pneumonias	MESH:D054988		A group of interstitial lung diseases with no known etiology. There are several entities with varying patterns of inflammation and fibrosis. They are classified by their distinct clinical-radiological-pathological features and prognosis. They include IDIOPATHIC PULMONARY FIBROSIS; CRYPTOGENIC ORGANIZING PNEUMONIA; and others.	MESH:D054990	C08.381.483.652.500.750	C08.381.483.652.500	Idiopathic Interstitial Pneumonia|Interstitial Pneumonia, Idiopathic|Interstitial Pneumonias, Idiopathic|Pneumonia, Idiopathic Interstitial|Pneumonias, Idiopathic Interstitial	Respiratory tract disease
Idiopathic intracranial hypertension with papilledema	MESH:C531795			MESH:D011559	C10.228.140.631.750/C531795	C10.228.140.631.750		Nervous system disease
Idiopathic Juxtafoveal Retinal Telangiectasia	MESH:C548027			MESH:D058456	C11.768.748/C548027|C14.907.823.502/C548027	C11.768.748|C14.907.823.502		Cardiovascular disease|Eye disease
Idiopathic orthostatic hypotension	MESH:C544351			MESH:D007024|MESH:D054970	C10.177.575.600.450/C544351|C10.177.575.650/C544351|C14.907.514.482/C544351	C10.177.575.600.450|C10.177.575.650|C14.907.514.482		Cardiovascular disease|Nervous system disease
Idiopathic Pulmonary Fibrosis	MESH:D054990	DO:DOID:0050156|OMIM:178500	A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.	MESH:D011658|MESH:D054988	C08.381.483.652.500|C08.381.483.652.500.750.624	C08.381.483.652|C08.381.483.652.500.750	Cryptogenic Fibrosing Alveolitides|Cryptogenic Fibrosing Alveolitis|Dysplasia, Fibrocystic Pulmonary|Familial Idiopathic Pulmonary Fibrosis|Fibrocystic Pulmonary Dysplasia|Fibrocystic Pulmonary Dysplasias|Fibrosing Alveolitides, Cryptogenic|Fibrosing Alveolitis, Cryptogenic|Idiopathic Fibrosing Alveolitis, Chronic Form|Idiopathic Pulmonary Fibroses|Idiopathic Pulmonary Fibrosis, Familial|Interstitial Pneumonia, Usual|Interstitial Pneumonitis, Usual|INTERSTITIAL PNEUMONITIS, USUAL;UIP HAMMAN-RICH DISEASE, INCLUDED|IPF|Pneumonitides, Usual Interstitial|Pneumonitis, Usual Interstitial|Pulmonary Dysplasia, Fibrocystic|Pulmonary Fibroses, Idiopathic|Pulmonary Fibrosis, Idiopathic|Usual Interstitial Pneumonia|Usual Interstitial Pneumonias|Usual Interstitial Pneumonitides|Usual Interstitial Pneumonitis	Respiratory tract disease
Idiopathic pulmonary hemosiderosis	MESH:C536281	DO:DOID:12118		MESH:D006486|MESH:D008171	C08.381/C536281|C18.452.565.500.500/C536281	C08.381|C18.452.565.500.500	Alveolar hypoventilation syndrome|Hemosiderosis, pulmonary, with deficiency of gamma-a globulin|Pulmonary hemosiderosis	Metabolic disease|Respiratory tract disease
Idiopathic subglottic tracheal stenosis	MESH:C536283			MESH:D014135	C08.907.663/C536283	C08.907.663		Respiratory tract disease
IgA Deficiency	MESH:D017098	DO:DOID:0060025|DO:DOID:11701	A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN A.	MESH:D004406	C15.378.147.333.500|C20.673.430.500	C15.378.147.333|C20.673.430	Deficiencies, IgA|Deficiency, IgA|IgA Deficiencies	Blood disease|Immune system disease
IgA Vasculitis	MESH:D011695	DO:DOID:11123	A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.	MESH:D007105|MESH:D011693|MESH:D014657|MESH:D020141	C14.907.940.777|C15.378.100.802.375|C15.378.463.515.580|C20.543.520.600|C23.550.414.950.375|C23.888.885.687.375	C14.907.940|C15.378.100.802|C15.378.463.515|C20.543.520|C23.550.414.950|C23.888.885.687	Allergic Purpura|Anaphylactoid Purpura|Hemorrhagica, Purpura|Hemorrhagic Vasculitis|Henoch Purpura|Henoch Schoenlein Purpura|Henoch-Schoenlein Purpura|Henoch Schonlein Purpura|Henoch-Schonlein Purpura|Henoch Schonlein Purpuras|Henoch-Schonlein Purpuras|Nonthrombocytopenic Purpura|Nonthrombopenic Purpura|Nonthrombopenic Purpuras|Purpura, Allergic|Purpura, Anaphylactoid|Purpura Hemorrhagica|Purpura, Henoch|Purpura, Henoch-Schoenlein|Purpura, Henoch Schonlein|Purpura, Henoch-Schonlein|Purpura, Nonthrombocytopenic|Purpura, Nonthrombopenic|Purpura, Rheumatoid|Purpura, Schoenlein Henoch|Purpura, Schoenlein-Henoch|Purpura, Schonlein Henoch|Purpura, Schonlein-Henoch|Purpuras, Henoch Schonlein|Purpuras, Henoch-Schonlein|Purpuras, Nonthrombopenic|Purpuras, Schonlein-Henoch|Rheumatoid Purpura|Schoenlein Henoch Purpura|Schoenlein-Henoch Purpura|Schonlein-Henoch Purpura|Schonlein-Henoch Purpuras|Schonlein Purpura, Henoch|Schonlein Purpuras, Henoch|Vasculitis, Hemorrhagic|Vasculitis, IgA	Blood disease|Cardiovascular disease|Immune system disease|Pathology (process)|Signs and symptoms
Ige Responsiveness, Atopic	MESH:C564133	OMIM:147050		MESH:D012130	C08.674/C564133|C20.543.480.680/C564133	C08.674|C20.543.480.680	ATOPIC HYPERSENSITIVITY, INCLUDED|ATOPY, SUSCEPTIBILITY TO, INCLUDED|IGEL|IgE, LEVEL OF|IGER|Ige Response Underlying Allergic Asthma and Rhinitis|IgE RESPONSE UNDERLYING ALLERGIC ASTHMA AND RHINITIS IgE, ELEVATED LEVEL OF, INCLUDED|Immunoglobulin E, Basic Level of, in Serum	Immune system disease|Respiratory tract disease
IgG Deficiency	MESH:D017099	DO:DOID:14176	A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN G.	MESH:D004406	C15.378.147.333.750|C20.673.430.750	C15.378.147.333|C20.673.430	Deficiencies, IgG|Deficiency, IgG|IgG Deficiencies	Blood disease|Immune system disease
IGHM protein, human	MESH:C041229			MESH:D006362	C15.378.147.780.490/C041229|C15.604.515.435/C041229|C20.683.780.490/C041229	C15.378.147.780.490|C15.604.515.435|C20.683.780.490	BOT heavy chain disease protein, human|immunoglobulin heavy constant mu protein, human	Blood disease|Immune system disease|Lymphatic disease
Ileal Neoplasms	MESH:D007078		Tumors or cancer in the ILEUM region of the small intestine (INTESTINE, SMALL).	MESH:D007077|MESH:D007414	C04.588.274.476.411.501|C06.301.371.411.501|C06.405.249.411.501|C06.405.469.420.501|C06.405.469.491.501	C04.588.274.476.411|C06.301.371.411|C06.405.249.411|C06.405.469.420|C06.405.469.491	Cancer, Ileal|Cancer of ILEUM|Cancer of the ILEUM|Cancers, Ileal|Ileal Cancer|Ileal Cancers|Ileal Neoplasm|ILEUM Cancer|ILEUM Cancers|Neoplasm, Ileal|Neoplasms, Ileal	Cancer|Digestive system disease
Iliac Aneurysm	MESH:D017543		Abnormal balloon- or sac-like dilatation in the wall of any one of the iliac arteries including the common, the internal, or the external ILIAC ARTERY.	MESH:D000783	C14.907.055.625	C14.907.055	Aneurysm, Iliac|Aneurysms, Iliac|Iliac Aneurysms	Cardiovascular disease
Illusions	MESH:D007088		The misinterpretation of a real external, sensory experience.	MESH:D010468	C10.597.606.762.400|C23.888.592.604.764.400	C10.597.606.762|C23.888.592.604.764	Auditory Illusion|Auditory Illusions|Autokinetic Effect|Autokinetic Effects|Autokinetic Illusion|Autokinetic Illusions|Effect, Autokinetic|Effects, Autokinetic|Illusion|Illusion, Auditory|Illusion, Autokinetic|Illusion, Kinesthetic|Illusions, Auditory|Illusions, Autokinetic|Illusions, Kinesthetic|Illusions, Tactile|Illusions, Visual|Illusion, Tactile|Illusion, Visual|Kinesthetic Illusion|Kinesthetic Illusions|Tactile Illusion|Tactile Illusions|Visual Illusion|Visual Illusions	Nervous system disease|Signs and symptoms
Imerslund-Grasbeck syndrome	MESH:C538556	OMIM:261100		MESH:D000749|MESH:D008286|MESH:D011507|MESH:D014806	C06.405.469.637/C538556|C12.050.351.968.934.734/C538556|C12.200.777.934.734/C538556|C12.950.934.734/C538556|C15.378.071.252.196/C538556|C18.452.603/C538556|C18.654.521.500.133.699.923/C538556|C23.888.942.750/C538556	C06.405.469.637|C12.050.351.968.934.734|C12.200.777.934.734|C12.950.934.734|C15.378.071.252.196|C18.452.603|C18.654.521.500.133.699.923|C23.888.942.750	Enterocyte cobalamin malabsorption|Enterocyte intrinsic factor receptor, defect of|IGS1|IMERSLUND-GRASBECK SYNDROME 1|Megaloblastic Anemia 1|MEGALOBLASTIC ANEMIA, 1|MEGALOBLASTIC ANEMIA, FINNISH TYPE|MGA1|PERNICIOUS ANEMIA, JUVENILE, DUE TO SELECTIVE INTESTINAL MALABSORPTION OF VITAMIN B12, WITH PROTEINURIA	Blood disease|Digestive system disease|Metabolic disease|Nutrition disorder|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Immersion Foot	MESH:D007102		A condition of the feet produced by prolonged exposure of the feet to water. Exposure for 48 hours or more to warm water causes tropical immersion foot or warm-water immersion foot common in Vietnam where troops were exposed to prolonged or repeated wading in paddy fields or streams. Trench foot results from prolonged exposure to cold, without actual freezing. It was common in trench warfare during World War I, when soldiers stood, sometimes for hours, in trenches with a few inches of cold water in them. (Andrews' Diseases of the Skin, 8th ed, p27)	MESH:D005534	C17.800.321.500	C17.800.321	Feet, Immersion|Feet, Trench|Foot, Immersion|Foot, Trench|Immersion Feet|Trench Feet|Trench Foot	Skin disease
Immune Complex Diseases	MESH:D007105	DO:DOID:1557	Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA.	MESH:D006967	C20.543.520	C20.543	Disease, Immune Complex|Diseases, Immune Complex|Hypersensitivities, Type III|Hypersensitivity, Type III|Immune Complex Disease|Type III Hypersensitivities|Type III Hypersensitivity	Immune system disease
Immune Deficiency Disease	MESH:C565469			MESH:D007153	C20.673/C565469	C20.673		Immune system disease
Immune Reconstitution Inflammatory Syndrome	MESH:D054019		Exuberant inflammatory response towards a previously acquired or undiagnosed opportunistic infection. It is frequently seen in AIDS patients following antiretroviral treatment.	MESH:D007154	C20.608	C20	Immune Reconstitution Disease|Immune Reconstitution Syndrome|Immune Reconstitution Syndromes|Immune Restoration Disease|Immune Restoration Diseases|Immune Restoration Syndrome|Reconstitution Disease, Immune|Reconstitution Syndrome, Immune|Restoration Syndrome, Immune	Immune system disease
IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT	OMIM:146820			MESH:D007154	C20/146820	C20	IGAT	Immune system disease
Immune System Diseases	MESH:D007154		Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.	MESH:C	C20	C	Disease, Immune|Disease, Immune System|Disease, Immunologic|Disease, Immunological|Diseases of Immune System|Disorder, Immune System|Immune Disease|Immune Diseases|Immune Disorder|Immune Disorders|Immune System Disease|Immune System Disorder|Immune System Disorders|Immunological Disease|Immunological Diseases|Immunologic Disease|Immunologic Diseases	Immune system disease
Immunoblastic Lymphadenopathy	MESH:D007119	DO:DOID:0111147	A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.	MESH:D000072281|MESH:D008232	C15.604.338.500|C15.604.515.509|C20.683.515.501	C15.604.338|C15.604.515|C20.683.515	Angioimmunoblastic Lymphadenopathies|Angioimmunoblastic Lymphadenopathy|Immunoblastic Lymphadenopathies|Lymphadenopathies, Angioimmunoblastic|Lymphadenopathies, Immunoblastic|Lymphadenopathy, Angioimmunoblastic|Lymphadenopathy, Immunoblastic	Immune system disease|Lymphatic disease
IMMUNODEFICIENCY 11	OMIM:615206	DO:DOID:0111957		MESH:D007153	C20.673/615206	C20.673	CARD11 IMMUNODEFICIENCY|IMD11|IMD11A	Immune system disease
IMMUNODEFICIENCY 12	OMIM:615468	DO:DOID:0111988		MESH:D007153	C20.673/615468	C20.673	IMD12	Immune system disease
IMMUNODEFICIENCY 14A, AUTOSOMAL DOMINANT	OMIM:615513	DO:DOID:0111936		MESH:D007153	C20.673/615513	C20.673	ACTIVATED PI3K-DELTA SYNDROME|APDS|IMD14A|p110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY, AND IMMUNODEFICIENCY|PASLI	Immune system disease
IMMUNODEFICIENCY 15B	OMIM:615592	DO:DOID:0111959		MESH:D007153	C20.673/615592	C20.673	IMD15B	Immune system disease
IMMUNODEFICIENCY 16	OMIM:615593	DO:DOID:0111935		MESH:D007153	C20.673/615593	C20.673	IMD16|OX40 DEFICIENCY	Immune system disease
IMMUNODEFICIENCY 17	OMIM:615607	DO:DOID:0111973		MESH:D007153	C20.673/615607	C20.673	CD3-GAMMA DEFICIENCY|IMD17|SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE	Immune system disease
IMMUNODEFICIENCY 18	OMIM:615615	DO:DOID:0111971		MESH:D007153	C20.673/615615	C20.673	CD3-EPSILON DEFICIENCY IMMUNODEFICIENCY 18, SEVERE COMBINED IMMUNODEFICIENCY VARIANT, INCLUDED|IMD18|IMMUNODEFICIENCY 18, SCID VARIANT, INCLUDED	Immune system disease
IMMUNODEFICIENCY 19	OMIM:615617	DO:DOID:0111972		MESH:D007153	C20.673/615617	C20.673	CD3-DELTA DEFICIENCY|IMD19|SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE|SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	Immune system disease
IMMUNODEFICIENCY 20	OMIM:615707	DO:DOID:0111941		MESH:D007153	C20.673/615707	C20.673	IMD20	Immune system disease
IMMUNODEFICIENCY 21	OMIM:614172	DO:DOID:0111947		MESH:D007153	C20.673/614172	C20.673	COMBINED IMMUNODEFICIENCY WITH SUSCEPTIBILITY TO MYCOBACTERIAL, VIRAL, AND FUNGAL INFECTIONS|DCML|DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY|GATA2 DEFICIENCY|IMD21|MONOCYTOPENIA AND MYCOBACTERIAL INFECTION SYNDROME|MONOCYTOPENIA WITH SUSCEPTIBILITY TO MYCOBACTERIAL, FUNGAL, AND PAPILLOMAVIRUS INFECTIONS AND MYELODYSPLASIA|MONOMAC	Immune system disease
IMMUNODEFICIENCY 22	OMIM:615758	DO:DOID:0111937		MESH:D007153	C20.673/615758	C20.673	IMD22	Immune system disease
IMMUNODEFICIENCY 23	OMIM:615816	DO:DOID:0111953		MESH:D007153	C20.673/615816	C20.673	IMD23|IMMUNODEFICIENCY-VASCULITIS-MYOCLONUS SYNDROME|IMMUNODEFICIENCY WITH HYPER IgE AND COGNITIVE IMPAIRMENT|IVMS	Immune system disease
IMMUNODEFICIENCY 24	OMIM:615897	DO:DOID:0111938		MESH:D007153	C20.673/615897	C20.673	IMD24	Immune system disease
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES	OMIM:615966	DO:DOID:0111961		MESH:D007153|MESH:D009461	C10.597/615966|C20.673/615966|C23.888.592/615966	C10.597|C20.673|C23.888.592	IMD26	Immune system disease|Nervous system disease|Signs and symptoms
IMMUNODEFICIENCY 27B	OMIM:615978	DO:DOID:0111956		MESH:D007153	C20.673/615978	C20.673	IFNGR1 DEFICIENCY, AUTOSOMAL DOMINANT|IMD27B|IMMUNODEFICIENCY 27B, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT	Immune system disease
IMMUNODEFICIENCY 28	OMIM:614889	DO:DOID:0111995		MESH:D007153	C20.673/614889	C20.673	IFNGR2 DEFICIENCY|IMD28|IMMUNODEFICIENCY 28, MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE	Immune system disease
IMMUNODEFICIENCY 29	OMIM:614890	DO:DOID:0111950		MESH:D007153	C20.673/614890	C20.673	IL12B DEFICIENCY|IMD29	Immune system disease
IMMUNODEFICIENCY 30	OMIM:614891	DO:DOID:0111990		MESH:D007153	C20.673/614891	C20.673	IL12RB1 DEFICIENCY|IMD30	Immune system disease
IMMUNODEFICIENCY 31A	OMIM:614892	DO:DOID:0111945		MESH:D007153	C20.673/614892	C20.673	IMD31A|IMMUNODEFICIENCY 31A, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT|STAT1 DEFICIENCY, AUTOSOMAL DOMINANT	Immune system disease
IMMUNODEFICIENCY 31B	OMIM:613796	DO:DOID:0111944		MESH:D007153	C20.673/613796	C20.673	IMD31B|IMMUNODEFICIENCY 31B, MYCOBACTERIAL AND VIRAL INFECTIONS, AUTOSOMAL RECESSIVE|STAT1 DEFICIENCY, AUTOSOMAL RECESSIVE	Immune system disease
IMMUNODEFICIENCY 31C	OMIM:614162	DO:DOID:0111946|DO:DOID:2058		MESH:D007153	C20.673/614162	C20.673	CANDF7|CANDIDIASIS, FAMILIAL, 7|CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT|IMD31C	Immune system disease
IMMUNODEFICIENCY 32A	OMIM:614893	DO:DOID:0111986		MESH:D007153	C20.673/614893	C20.673	CD11C-POSITIVE/CD1C-POSITIVE DENDRITIC CELL DEFICIENCY, AUTOSOMAL DOMINANT|IMD32A|IMMUNODEFICIENCY 32A, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT|IRF8 DEFICIENCY, AUTOSOMAL DOMINANT	Immune system disease
IMMUNODEFICIENCY 32B	OMIM:226990	DO:DOID:0111985		MESH:D007153	C20.673/226990	C20.673	EPSTEIN-BARR VIRUS, SUSCEPTIBILITY TO CHRONIC INFECTION BY|IMD32B|IMMUNODEFICIENCY 32B, MONOCYTE, DENDRITIC CELL, AND NATURAL KILLER CELL DEFICIENCY, AUTOSOMAL RECESSIVE|IRF8 DEFICIENCY, AUTOSOMAL RECESSIVE	Immune system disease
IMMUNODEFICIENCY 36	OMIM:616005	DO:DOID:0111949		MESH:D007153	C20.673/616005	C20.673	IMD36	Immune system disease
IMMUNODEFICIENCY 37	OMIM:616098	DO:DOID:0111939		MESH:D007153	C20.673/616098	C20.673	IMD37	Immune system disease
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION	OMIM:616126	DO:DOID:0111934		MESH:D001480|MESH:D002114|MESH:D007153	C10.228.140.079/616126|C18.452.174.130/616126|C20.673/616126	C10.228.140.079|C18.452.174.130|C20.673	IMD38|IMMUNODEFICIENCY 38, MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE|ISG15 DEFICIENCY, AUTOSOMAL RECESSIVE	Immune system disease|Metabolic disease|Nervous system disease
IMMUNODEFICIENCY 39	OMIM:616345	DO:DOID:0111969		MESH:D007153	C20.673/616345	C20.673	IMD39	Immune system disease
IMMUNODEFICIENCY 40	OMIM:616433	DO:DOID:0111951		MESH:D007153	C20.673/616433	C20.673	IMD40	Immune system disease
IMMUNODEFICIENCY 42	OMIM:616622	DO:DOID:0111940		MESH:D007153	C20.673/616622	C20.673	IMD42	Immune system disease
IMMUNODEFICIENCY 44	OMIM:616636	DO:DOID:0111975		MESH:D007153	C20.673/616636	C20.673	IMD44	Immune system disease
IMMUNODEFICIENCY 45	OMIM:616669	DO:DOID:0111994		MESH:D007153	C20.673/616669	C20.673	IMD45	Immune system disease
IMMUNODEFICIENCY 46	OMIM:616740	DO:DOID:0111948		MESH:D007153	C20.673/616740	C20.673	IMD46	Immune system disease
IMMUNODEFICIENCY 47	OMIM:300972	DO:DOID:0112002		MESH:D007153	C20.673/300972	C20.673	CDG2S|CDGIIs|CDG IIs|CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIs|IMD47|IMMUNODEFICIENCY AND HEPATOPATHY WITH OR WITHOUT NEUROLOGIC FEATURES	Immune system disease
IMMUNODEFICIENCY 48	OMIM:269840	DO:DOID:0111943		MESH:D007153	C20.673/269840	C20.673	IMD48|SELECTIVE T-CELL DEFECT|STCD	Immune system disease
IMMUNODEFICIENCY 49	OMIM:617237	DO:DOID:0111979		MESH:D007153	C20.673/617237	C20.673	IMD49|SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE, WITH INTELLECTUAL DISABILITY, SPASTICITY, AND CRANIOFACIAL ABNORMALITIES|SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE, WITH INTELLECTUAL DISABILITY, SPASTICITY, AND CRANIOFACIAL ABNORMALITIES	Immune system disease
IMMUNODEFICIENCY 50	OMIM:300988	DO:DOID:0112001		MESH:D007153	C20.673/300988	C20.673	IMD50|IMMUNODEFICIENCY 50, X-LINKED RECESSIVE	Immune system disease
IMMUNODEFICIENCY 51	OMIM:613953	DO:DOID:0111996		MESH:D007153	C20.673/613953	C20.673	CANDF5, FORMERLY|CANDIDIASIS, FAMILIAL, 5, FORMERLY|IMD51	Immune system disease
IMMUNODEFICIENCY 54	OMIM:609981	DO:DOID:0111967		MESH:D007153|MESH:D049914	C18.452.284/609981|C20.673/609981	C18.452.284|C20.673	IMD54|NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT|NATURAL KILLER CELL DEFICIENCY, FAMILIAL ISOLATED|NKCD|NKGCD	Immune system disease|Metabolic disease
IMMUNODEFICIENCY 56	OMIM:615207	DO:DOID:0111982		MESH:D007153	C20.673/615207	C20.673	IL21R IMMUNODEFICIENCY|IMD56	Immune system disease
IMMUNODEFICIENCY 8	OMIM:615401	DO:DOID:0060019		MESH:D007153	C20.673/615401	C20.673	IMD8	Immune system disease
IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY	OMIM:614700	DO:DOID:12177		MESH:D017074	C20.673.330/614700	C20.673.330	CVID8	Immune system disease
Immunodeficiency due to Defect in CD3-Epsilon	MESH:C566082			MESH:D007153	C20.673/C566082	C20.673		Immune system disease
Immunodeficiency due to Defect in CD3-Gamma	MESH:C566083			MESH:D007153	C20.673/C566083	C20.673		Immune system disease
Immunodeficiency due to Defect in MAPBP-Interacting Protein	MESH:C563663	OMIM:610798		MESH:D007153	C20.673/C563663	C20.673		Immune system disease
Immunodeficiency, Partial Combined, with Absence of HLA Determinants and Beta-2-Microglobulin from Lymphocytes	MESH:C565468			MESH:D007153	C20.673/C565468	C20.673		Immune system disease
Immunodeficiency with Defective Leukocyte and Lymphocyte Function and with Response to Histamine-1 Antagonist	MESH:C564135			MESH:D007153	C20.673/C564135	C20.673		Immune system disease
Immunodeficiency without anhidrotic ectodermal dysplasia	MESH:C536289			MESH:D007153	C20.673/C536289	C20.673	Immunodeficiency, isolated|Immunodeficiency, pure	Immune system disease
IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA	OMIM:300853	DO:DOID:0080319		MESH:D001327	C20.111/300853	C20.111	XMEN	Immune system disease
Immunoglobulin a deficiency 1	MESH:C536290	OMIM:137100		MESH:D017098	C15.378.147.333.500/C536290|C20.673.430.500/C536290	C15.378.147.333.500|C20.673.430.500	Gamma-a-globulin, selective deficiency of|IGAD1|Iga, selective deficiency of|Immunoglobulin a, selective deficiency of	Blood disease|Immune system disease
Immunoglobulin a deficiency 2	MESH:C536291	OMIM:609529		MESH:D017098	C15.378.147.333.500/C536291|C20.673.430.500/C536291	C15.378.147.333.500|C20.673.430.500	IGAD2|Iga, selective deficiency of, taci-related|Immunoglobulin a, selective deficiency of, taci-related	Blood disease|Immune system disease
Immunoglobulin G4-Related Disease	MESH:D000077733		A spectrum of systemic autoimmune diseases in which IMMUNOGLOBULIN G4 plays a pathophysiologic role. It can affect multiple organs in highly variable presentations, characterized by inflammatory lesions composed of IgG4-positive PLASMA CELLS, further infiltrated by T helper cells (T-LYMPHOCYTES, HELPER-INDUCER) when linked to progressive FIBROSIS and eventual organ damage.	MESH:D001327	C20.111.572	C20.111	Autoimmune Disease, IgG4-Associated|IgG4 Associated Autoimmune Disease|IgG4-Associated Autoimmune Disease|IgG4-Associated Autoimmune Diseases|IgG4-RD|IgG4 Related Disease|IgG4-Related Disease|IgG4-Related Diseases|IgG4 Related Kidney Disease|IgG4-Related Kidney Disease|IgG4-Related Kidney Diseases|IgG4 Related Sclerosing Disease|IgG4-Related Sclerosing Disease|IgG4-Related Sclerosing Diseases|IgG4 Related Systemic Disease|Immunoglobulin G4 Related Disease|Immunoglobulin G4-Related Diseases|Immunoglobulin G4 Related Kidney Disease|Immunoglobulin G4-Related Kidney Disease|Immunoglobulin G4 Related Sclerosing Disease|Immunoglobulin G4-Related Sclerosing Disease|Kidney Disease, IgG4-Related|Sclerosing Disease, IgG4-Related	Immune system disease
IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY	OMIM:614102			MESH:D007153	C20.673/614102	C20.673	IGKCD|KAPPA CHAIN DEFICIENCY	Immune system disease
Immunoglobulin Light-chain Amyloidosis	MESH:D000075363		A nonproliferative disorder of the PLASMA CELL characterized by excessive production and misfolding of IMMUNOGLOBULIN LIGHT CHAINS that form insoluble amyloid fibrils (see AMYLOID DEPOSITS) in various tissues. Clinical features include LIVER FAILURE; MULTIPLE MYELOMA; NEPHROTIC SYNDROME; RESTRICTIVE CARDIOMYOPATHY, and neuropathies.	MESH:D000686|MESH:D008232|MESH:D010265|MESH:D054219	C04.557.595.250|C18.452.845.500.550|C20.683.515.507|C20.683.780.565	C04.557.595|C18.452.845.500|C20.683.515|C20.683.780	AL Amyloidoses|AL Amyloidosis|Amyloidoses, Primary|Amyloidoses, Primary Systemic|Amyloidosis, Immunoglobulin Light chain|Amyloidosis, Immunoglobulin Light-chain|Amyloidosis, Primary|Amyloidosis, Primary Systemic|Immunoglobulin Light-chain Amyloidoses|Immunoglobulin Light chain Amyloidosis|Primary Amyloidoses|Primary Amyloidosis|Primary Systemic Amyloidoses|Primary Systemic Amyloidosis|Systemic Amyloidoses, Primary|Systemic Amyloidosis, Primary	Cancer|Immune system disease|Metabolic disease
Immuno-hemolytic anemia	MESH:C538437			MESH:D000744	C15.378.071.141.125/C538437|C20.111.175/C538437	C15.378.071.141.125|C20.111.175	Familial auto-immune hemolytic anemia	Blood disease|Immune system disease
Immunologic Deficiency Syndromes	MESH:D007153	DO:DOID:612	Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.	MESH:D007154	C20.673	C20	Antibody Deficiency Syndrome|Antibody Deficiency Syndromes|Deficiency Syndrome, Antibody|Deficiency Syndrome, Immunologic|Deficiency Syndrome, Immunological|Deficiency Syndromes, Antibody|Deficiency Syndromes, Immunologic|Deficiency Syndromes, Immunological|Immunological Deficiency Syndrome|Immunological Deficiency Syndromes|Immunologic Deficiency Syndrome|Syndrome, Antibody Deficiency|Syndrome, Immunological Deficiency|Syndrome, Immunologic Deficiency|Syndromes, Antibody Deficiency|Syndromes, Immunological Deficiency|Syndromes, Immunologic Deficiency	Immune system disease
Immunoproliferative Disorders	MESH:D007160	DO:DOID:2916	Disorders characterized by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.	MESH:D007154	C20.683	C20	Disorder, Immunoproliferative|Disorders, Immunoproliferative|Immunoproliferative Disorder	Immune system disease
Immunoproliferative Small Intestinal Disease	MESH:D007161		A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine (INTESTINE, SMALL) and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA.	MESH:D006362|MESH:D007414|MESH:D008223|MESH:D008232	C04.557.386.390|C06.301.371.411.512|C06.405.249.411.512|C06.405.469.491.505|C15.378.147.780.490.512|C15.604.515.435.512|C20.683.515.512|C20.683.780.490.512	C04.557.386|C06.301.371.411|C06.405.249.411|C06.405.469.491|C15.378.147.780.490|C15.604.515.435|C20.683.515|C20.683.780.490	alpha Chain Disease|alpha-Chain Disease|alpha-Chain Diseases|Disease, alpha-Chain|Diseases, alpha-Chain|Heavy Chain Disease, IgA Type|IPSID|Lymphoma, Mediterranean|Mediterranean Lymphoma	Blood disease|Cancer|Digestive system disease|Immune system disease|Lymphatic disease
IMPAIRED INTELLECTUAL DEVELOPMENT AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	OMIM:616789			MESH:D006330|MESH:D008607|MESH:D019465	C05.660.207/616789|C10.597.606.360/616789|C14.240.400/616789|C14.280.400/616789|C16.131.240.400/616789|C16.131.621.207/616789|C23.888.592.604.646/616789|F03.625.539/616789	C05.660.207|C10.597.606.360|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207|C23.888.592.604.646|F03.625.539	ASADOLLAHI-RAUCH SYNDROME|MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS|MRFACD	Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Inappropriate ADH Syndrome	MESH:D007177	DO:DOID:3401	A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.	MESH:D010900|MESH:D014883	C10.228.140.617.738.320|C18.452.950.626|C19.700.490	C10.228.140.617.738|C18.452.950|C19.700	ADH Syndrome, Inappropriate|Antidiuretic Hormone, Inappropriate Secretion|Inappropriate Vasopressin Secretion Syndrome|Schwartz Bartter Syndrome|Schwartz-Bartter Syndrome|SIADH|Syndrome, Inappropriate ADH|Syndrome of Inappropriate ADH (SIADH) Secretion|Syndrome, Schwartz-Bartter	Endocrine system disease|Metabolic disease|Nervous system disease
Inclusion Body Myopathy 3, Autosomal Dominant	MESH:C565311	OMIM:605637		MESH:D003286|MESH:D009886|MESH:D018979	C05.550.323/C565311|C05.651.197/C565311|C05.651.594.600/C565311|C10.292.562.750/C565311|C10.597.622.447/C565311|C10.668.491.562.500/C565311|C11.590.472/C565311|C23.888.592.636.447/C565311	C05.550.323|C05.651.197|C05.651.594.600|C10.292.562.750|C10.597.622.447|C10.668.491.562.500|C11.590.472|C23.888.592.636.447	IBM3, FORMERLY|INCLUSION BODY MYOPATHY 3, AUTOSOMAL DOMINANT, FORMERLY|MYOPATHY, PROXIMAL, WITH OPHTHALMOPLEGIA|Myopathy with Congenital Joint Contractures, Ophthalmoplegia, and Rimmed Vacuoles|MYPOP	Eye disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Inclusion body myopathy, autosomal dominant	MESH:C538330			MESH:D003286|MESH:D009886|MESH:D018979	C05.550.323/C538330|C05.651.197/C538330|C05.651.594.600/C538330|C10.292.562.750/C538330|C10.597.622.447/C538330|C10.668.491.562.500/C538330|C11.590.472/C538330|C23.888.592.636.447/C538330	C05.550.323|C05.651.197|C05.651.594.600|C10.292.562.750|C10.597.622.447|C10.668.491.562.500|C11.590.472|C23.888.592.636.447	Inclusion body myopathy 3	Eye disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Inclusion body myopathy autosomal recessive	MESH:C538329	DO:DOID:0080718		MESH:D018979	C05.651.594.600/C538329|C10.668.491.562.500/C538329	C05.651.594.600|C10.668.491.562.500	Inclusion body myopathy 2, autosomal recessive|Inclusion Body Myopathy, Autosomal Recessive|Inclusion body myopathy quadriceps sparing|Inclusion Body Myopathy, Quadriceps-Sparing	Musculoskeletal disease|Nervous system disease
INFANTILE CEREBELLAR-RETINAL DEGENERATION	OMIM:614559	DO:DOID:0050883		MESH:D001264|MESH:D009896|MESH:D011596|MESH:D012162	C10.292.700.225/614559|C10.597.350.110/614559|C10.597.606.881/614559|C11.270.612/614559|C11.640.451/614559|C11.768.585/614559|C23.888.592.350.110/614559|C23.888.592.604.882/614559	C10.292.700.225|C10.597.350.110|C10.597.606.881|C11.270.612|C11.640.451|C11.768.585|C23.888.592.350.110|C23.888.592.604.882	ICRD	Eye disease|Nervous system disease|Signs and symptoms
Infantile Epileptic-Dyskinetic Encephalopathy	MESH:C567924	OMIM:308350		MESH:D013036	C10.228.140.490.375.760/C567924|C10.228.140.490.493.875/C567924	C10.228.140.490.375.760|C10.228.140.490.493.875	DEE1|DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1|Early Infantile Epileptic Encephalopathy|EIEE1|Epileptic Encephalopathy, Early Infantile, 1|INFANTILE EPILEPTIC-DYSKINETIC ENCEPHALOPATHY|Infantile Spasm Syndrome, X-Linked 1|ISSX1|Ohtahara Syndrome|OHTAHARA SYNDROME, X-LINKED|West Syndrome, X-Linked|X-linked infantile spasms|X-linked infantile spasm syndrome|X-Linked West Syndrome|XMESID	Nervous system disease
Infantile polyarteritis	MESH:C537014			MESH:D009080	C14.907.940.560/C537014|C15.604.560/C537014|C17.800.862.560/C537014	C14.907.940.560|C15.604.560|C17.800.862.560		Cardiovascular disease|Lymphatic disease|Skin disease
Infantile polymyoclonus	MESH:C535524			MESH:D053578	C04.588.614.550.600/C535524|C04.730.856.596/C535524|C10.228.758.500/C535524|C10.292.562.831/C535524|C10.574.781.662/C535524|C10.597.350.500.500/C535524|C11.590.725/C535524	C04.588.614.550.600|C04.730.856.596|C10.228.758.500|C10.292.562.831|C10.574.781.662|C10.597.350.500.500|C11.590.725	Polymyoclonus, infantile	Cancer|Eye disease|Nervous system disease
Infarction, Anterior Cerebral Artery	MESH:D020243	DO:DOID:3528	NECROSIS occurring in the ANTERIOR CEREBRAL ARTERY system, including branches such as Heubner's artery. These arteries supply blood to the medial and superior parts of the CEREBRAL HEMISPHERE, Infarction in the anterior cerebral artery usually results in sensory and motor impairment in the lower body.	MESH:D002539|MESH:D002544	C10.228.140.300.150.477.200.400|C10.228.140.300.510.200.325|C10.228.140.300.775.200.200.400|C14.907.253.092.477.200.400|C14.907.253.560.200.325|C14.907.253.855.200.200.400|C23.550.513.355.250.200.400|C23.550.717.489.250.200.400	C10.228.140.300.150.477.200|C10.228.140.300.510.200|C10.228.140.300.775.200.200|C14.907.253.092.477.200|C14.907.253.560.200|C14.907.253.855.200.200|C23.550.513.355.250.200|C23.550.717.489.250.200	ACA Infarct|ACA Infarction|ACA Infarctions|ACA Infarcts|Anterior Cerebral Artery Infarction|Anterior Cerebral Artery Stroke|Anterior Cerebral Artery Syndrome|Artery Infarction, Heubner|Artery Infarction, Heubner's|Heubner Artery Infarction|Heubner's Artery Infarction|Heubners Artery Infarction|Infarct, ACA|Infarction, ACA|Infarction, Anterior Cerebral Artery Circulation|Infarction, Anterior Cerebral Artery Distribution|Infarction, Heubner Artery|Infarction, Heubner's Artery|Infarctions, ACA|Infarcts, ACA|Stroke, Anterior Cerebral Artery|Syndrome, Anterior Cerebral Artery	Cardiovascular disease|Nervous system disease|Pathology (process)
Infarction, Middle Cerebral Artery	MESH:D020244	DO:DOID:3525	NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.	MESH:D002539|MESH:D002544	C10.228.140.300.150.477.200.450|C10.228.140.300.510.200.387|C10.228.140.300.775.200.200.450|C14.907.253.092.477.200.450|C14.907.253.560.200.387|C14.907.253.855.200.200.450|C23.550.513.355.250.200.450|C23.550.717.489.250.200.450	C10.228.140.300.150.477.200|C10.228.140.300.510.200|C10.228.140.300.775.200.200|C14.907.253.092.477.200|C14.907.253.560.200|C14.907.253.855.200.200|C23.550.513.355.250.200|C23.550.717.489.250.200	Cerebral Infarction, Middle Cerebral Artery|Embolic Infarction, Middle Cerebral Artery|Embolus, Middle Cerebral Artery|Infarct, MCA|Infarcts, MCA|Left Middle Cerebral Artery Infarction|MCA Infarct|MCA Infarction|MCA Infarcts|Middle Cerebral Artery Circulation Infarction|Middle Cerebral Artery Embolic Infarction|Middle Cerebral Artery Embolus|Middle Cerebral Artery Infarction|Middle Cerebral Artery Occlusion|Middle Cerebral Artery Stroke|Middle Cerebral Artery Syndrome|Middle Cerebral Artery Thrombosis|Middle Cerebral Artery Thrombotic Infarction|Occlusion, Middle Cerebral Artery|Right Middle Cerebral Artery Infarction|Stroke, Middle Cerebral Artery|Thrombosis, Middle Cerebral Artery|Thrombotic Infarction, Middle Cerebral Artery	Cardiovascular disease|Nervous system disease|Pathology (process)
Infarction, Posterior Cerebral Artery	MESH:D020762	DO:DOID:3821	NECROSIS induced by ISCHEMIA in the POSTERIOR CEREBRAL ARTERY distribution system which supplies portions of the BRAIN STEM; the THALAMUS; TEMPORAL LOBE, and OCCIPITAL LOBE. Depending on the size and location of infarction, clinical features include OLFACTION DISORDERS and visual problems (AGNOSIA; ALEXIA; HEMIANOPSIA).	MESH:D002539|MESH:D002544	C10.228.140.300.150.477.200.475|C10.228.140.300.510.200.418|C10.228.140.300.775.200.200.475|C14.907.253.092.477.200.475|C14.907.253.560.200.418|C14.907.253.855.200.200.475|C23.550.513.355.250.200.475|C23.550.717.489.250.200.475	C10.228.140.300.150.477.200|C10.228.140.300.510.200|C10.228.140.300.775.200.200|C14.907.253.092.477.200|C14.907.253.560.200|C14.907.253.855.200.200|C23.550.513.355.250.200|C23.550.717.489.250.200	Embolic Infarction, Posterior Cerebral Artery|Infarction, PCA|Infarct, PCA|Infarcts, PCA|PCA Infarct|PCA Infarction|PCA Infarcts|Posterior Cerebral Artery Embolic Infarction|Posterior Cerebral Artery Infarction|Posterior Cerebral Artery Stroke|Posterior Cerebral Artery Syndrome|Posterior Cerebral Artery Thrombotic Infarction|Stroke, Posterior Cerebral Artery|Thrombotic Infarction, Posterior Cerebral Artery	Cardiovascular disease|Nervous system disease|Pathology (process)
Infections	MESH:D007239		Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.	MESH:C	C01	C	Infection|Infection and Infestation|Infections and Infestations|Infestation and Infection|Infestations and Infections	
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	OMIM:613759			MESH:D001927|MESH:D007239|MESH:D008107|MESH:D018376	C01/613759|C06.552/613759|C10.228.140/613759|C14.240/613759|C16.131.240/613759	C01|C06.552|C10.228.140|C14.240|C16.131.240	FADD DEFICIENCY	Cardiovascular disease|Congenital abnormality|Digestive system disease|Nervous system disease
Infectious Encephalitis	MESH:D000069544		Brain inflammation caused by an infectious agent.	MESH:D002494|MESH:D004660	C01.207.399|C10.228.140.430.520|C10.228.228.399|C10.586.250.520	C01.207|C10.228.140.430|C10.228.228|C10.586.250	Encephalitis Infection|Encephalitis Infections|Encephalitis, Infectious|Infection, Encephalitis|Infections, Encephalitis	Nervous system disease
Infectious Mononucleosis	MESH:D007244	DO:DOID:8568	A common, acute infection usually caused by the Epstein-Barr virus (HERPESVIRUS 4, HUMAN). There is an increase in mononuclear white blood cells and other atypical lymphocytes, generalized lymphadenopathy, splenomegaly, and occasionally hepatomegaly with hepatitis.	MESH:D007960|MESH:D008232|MESH:D020031	C01.925.256.466.313.400|C15.378.553.381|C15.604.515.516|C20.683.515.515	C01.925.256.466.313|C15.378.553|C15.604.515|C20.683.515	Fever, Glandular|Glandular Fever|Mononucleosis, Infectious	Blood disease|Immune system disease|Lymphatic disease|Viral disease
Inferior Wall Myocardial Infarction	MESH:D056989	DO:DOID:5850	MYOCARDIAL INFARCTION in which the inferior wall of the heart is involved. It is often caused by occlusion of the right coronary artery.	MESH:D009203	C14.280.647.500.187|C14.907.585.500.187|C23.550.513.355.750.187|C23.550.717.489.750.187	C14.280.647.500|C14.907.585.500|C23.550.513.355.750|C23.550.717.489.750	Acute Inferior Myocardial Infarction|Diaphragmatic Myocardial Infarction|Diaphragmatic Myocardial Infarctions|Infarction, Diaphragmatic Myocardial|Infarction, Inferior Myocardial|Infarctions, Diaphragmatic Myocardial|Infarctions, Inferior Myocardial|Inferior Myocardial Infarction|Inferior Myocardial Infarctions|Myocardial Infarction, Diaphragmatic|Myocardial Infarction, Inferior|Myocardial Infarction, Inferior Wall|Myocardial Infarctions, Diaphragmatic|Myocardial Infarctions, Inferior	Cardiovascular disease|Pathology (process)
Infertility	MESH:D007246	DO:DOID:5223	A reduced or absent capacity to reproduce.	MESH:D000091662	C12.100.750	C12.100	Reproductive Sterility|Sterility|Sterility, Reproductive|Subfertility|Sub-Fertility	
Infertility, Female	MESH:D007247		Diminished or absent ability of a female to achieve conception.	MESH:D005831|MESH:D007246	C12.050.351.500.498|C12.100.250.498|C12.100.750.350	C12.050.351.500|C12.100.250|C12.100.750	Female Infertility|Female Sterility|Female Subfertility|Female Sub-Fertility|Postpartum Sterility|Sterility, Female|Sterility, Postpartum|Subfertility, Female|Sub Fertility, Female|Sub-Fertility, Female	Urogenital disease (female)
Inflammation of the whole uveal tract	MESH:C531766			MESH:D015864	C11.941.879.780/C531766	C11.941.879.780		Eye disease
Inflammatory Breast Neoplasms	MESH:D058922	DO:DOID:6263	Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.	MESH:D001943	C04.588.180.576|C17.800.090.500.576	C04.588.180|C17.800.090.500	Breast Cancer, Inflammatory|Breast Cancers, Inflammatory|Breast Carcinoma, Inflammatory|Breast Carcinomas, Inflammatory|Breast Neoplasm, Inflammatory|Breast Neoplasms, Inflammatory|Cancer, Inflammatory Breast|Cancers, Inflammatory Breast|Carcinoma, Inflammatory Breast|Carcinomas, Inflammatory Breast|Inflammatory Breast Cancer|Inflammatory Breast Cancer (IBC)|Inflammatory Breast Cancers|Inflammatory Breast Carcinoma|Inflammatory Breast Carcinomas|Inflammatory Breast Neoplasm|Neoplasm, Inflammatory Breast|Neoplasms, Inflammatory Breast	Cancer|Skin disease
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1	OMIM:614328			MESH:D007232|MESH:D009205|MESH:D012871|MESH:D015212	C06.405.205.731/614328|C06.405.469.432/614328|C14.280.238.625/614328|C16.614/614328|C17.800/614328	C06.405.205.731|C06.405.469.432|C14.280.238.625|C16.614|C17.800	NISBD1	Cardiovascular disease|Digestive system disease|Infant-newborn disease|Skin disease
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2	OMIM:616069			MESH:D007232|MESH:D009205|MESH:D012871|MESH:D015212	C06.405.205.731/616069|C06.405.469.432/616069|C14.280.238.625/616069|C16.614/616069|C17.800/616069	C06.405.205.731|C06.405.469.432|C14.280.238.625|C16.614|C17.800	NISBD2	Cardiovascular disease|Digestive system disease|Infant-newborn disease|Skin disease
Influenza, Human	MESH:D007251	DO:DOID:8469|OMIM:614680	An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.	MESH:D009976|MESH:D012141	C01.748.310|C01.925.782.620.365|C08.730.310	C01.748|C01.925.782.620|C08.730	Flu, Human|Grippe|Human Flu|Human Influenza|Human Influenzas|Influenza|Influenza in Human|Influenza in Humans|Influenzas|INFLUENZA, SEVERE, SUSCEPTIBILITY TO|Influenzas, Human	Respiratory tract disease|Viral disease
Infratentorial Neoplasms	MESH:D015192	DO:DOID:4706	Intracranial tumors originating in the region of the brain inferior to the TENTORIUM CEREBELLI, which contains the cerebellum, FOURTH VENTRICLE; CEREBELLOPONTINE ANGLE; BRAIN STEM, and related structures. Primary tumors of this region are more frequent in children, and may present with ATAXIA; CRANIAL NERVE DISEASES; vomiting; HEADACHE; HYDROCEPHALUS; or other signs of neurologic dysfunction. Relatively frequent histologic subtypes include TERATOMA; MEDULLOBLASTOMA; GLIOBLASTOMA; ASTROCYTOMA; EPENDYMOMA; CRANIOPHARYNGIOMA; and choroid plexus papilloma (PAPILLOMA, CHOROID PLEXUS).	MESH:D001932	C04.588.614.250.195.411|C10.228.140.211.500|C10.551.240.250.400	C04.588.614.250.195|C10.228.140.211|C10.551.240.250	Benign Infratentorial Neoplasm|Benign Infratentorial Neoplasms|Cancer, Infratentorial|Infratentorial Cancer|Infratentorial Cancers|Infratentorial Neoplasm|Infratentorial Neoplasm, Benign|Infratentorial Neoplasm, Malignant|Infratentorial Neoplasms, Benign|Infratentorial Neoplasms, Malignant|Infratentorial Tumor|Infratentorial Tumors|Malignant Infratentorial Neoplasm|Malignant Infratentorial Neoplasms|Neoplasm, Benign Infratentorial|Neoplasm, Infratentorial|Neoplasm, Malignant Infratentorial|Neoplasm, Posterior Fossa|Neoplasms, Infratentorial|Neoplasms, Malignant Infratentorial|Neoplasms, Posterior Fossa|Posterior Fossa Neoplasm|Posterior Fossa Neoplasms|Posterior Fossa Tumor|Posterior Fossa Tumors|Tumor, Infratentorial|Tumor, Posterior Fossa	Cancer|Nervous system disease
Infundibulopelvic dysgenesis	MESH:C535528			MESH:D003251|MESH:D007674	C12.050.351.968.419/C535528|C12.200.777.419/C535528|C12.950.419/C535528|C23.300.287/C535528	C12.050.351.968.419|C12.200.777.419|C12.950.419|C23.300.287		Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Inherited Peripheral Neuropathy	MESH:C548028			MESH:D010523	C10.668.829/C548028	C10.668.829		Nervous system disease
Inosine Phosphorylase Deficiency, Immune Defect Due To	MESH:C565465			MESH:D007153	C20.673/C565465	C20.673		Immune system disease
Insomnia, Fatal Familial	MESH:D034062	DO:DOID:0050433|OMIM:600072	An autosomal dominant disorder characterized by degeneration of the THALAMUS and progressive insomnia. It is caused by a mutation in the prion protein (PRIONS).	MESH:D007319|MESH:D017096	C01.207.800.392|C10.228.228.800.392|C10.574.843.512|C10.886.425.800.800.400	C01.207.800|C10.228.228.800|C10.574.843|C10.886.425.800.800	Familial Fatal Insomnia|Familial Fatal, Insomnia|Familial Fatal Insomnias|Familial Fatals, Insomnia|Fatal Familial Insomnia|Fatal Familial Insomnias|Fatal Insomnia, Familial|Fatal, Insomnia Familial|Fatal Insomnias, Familial|Fatals, Insomnia Familial|FFI|Insomnia Familial Fatal|Insomnia, Familial Fatal|Insomnia Familial Fatals|INSOMNIA, FATAL FAMILIAL|Insomnias, Familial Fatal|Insomnias, Fatal Familial	Nervous system disease
Insulin Coma	MESH:D007331		Severe HYPOGLYCEMIA induced by a large dose of exogenous INSULIN resulting in a COMA or profound state of unconsciousness from which the individual cannot be aroused.	MESH:D003128|MESH:D007003	C10.597.606.358.800.200.600|C18.452.394.984.492	C10.597.606.358.800.200|C18.452.394.984	Coma, Insulin|Insulin Shock|Shock, Insulin	Metabolic disease|Nervous system disease
Insulin-Like Growth Factor I Deficiency	MESH:C563867	OMIM:608747		MESH:D006130|MESH:D006319	C09.218.458.341.887/C563867|C10.597.751.418.341.887/C563867|C23.550.393/C563867|C23.888.592.763.393.341.887/C563867	C09.218.458.341.887|C10.597.751.418.341.887|C23.550.393|C23.888.592.763.393.341.887	Growth Retardation with Sensorineural Deafness and Mental Retardation|IGF1 Deficiency	Ear-nose-throat disease|Nervous system disease|Pathology (process)|Signs and symptoms
Insulinoma	MESH:D007340	DO:DOID:3892|OMIM:606960	A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.	MESH:D007516	C04.557.470.035.100.852|C04.588.274.761.249.500|C04.588.322.475.249.500|C06.301.761.249.500|C06.689.667.249.500|C19.344.421.249.500	C04.557.470.035.100|C04.588.274.761.249|C04.588.322.475.249|C06.301.761.249|C06.689.667.249|C19.344.421.249	Adenoma, beta Cell|Adenoma, beta-Cell|Adenomas, beta-Cell|beta-Cell Adenoma|beta-Cell Adenomas|beta Cell Tumor|beta-Cell Tumor|beta-Cell Tumors|Insulinomas|INSULINOMA TUMOR SUPPRESSOR GENE LOCUS|Insuloma|Insulomas|Tumor, beta-Cell|Tumors, beta-Cell	Cancer|Digestive system disease|Endocrine system disease
Insulin Resistance	MESH:D007333		Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.	MESH:D006946	C18.452.394.968.500	C18.452.394.968	Insulin Sensitivity|Resistance, Insulin|Sensitivity, Insulin	Metabolic disease
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	OMIM:617173	DO:DOID:0081008		MESH:D001145|MESH:D008607|MESH:D011596	C10.597.606.360/617173|C10.597.606.881/617173|C14.280.067/617173|C23.550.073/617173|C23.888.592.604.646/617173|C23.888.592.604.882/617173|F03.625.539/617173	C10.597.606.360|C10.597.606.881|C14.280.067|C23.550.073|C23.888.592.604.646|C23.888.592.604.882|F03.625.539	IDDCA	Cardiovascular disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Interatrial Block	MESH:D000074021		Impaired or delayed impulse conduction between the right and left HEART ATRIA. Advanced interatrial blocks are often associated with arrhythmias (e.g., ATRIAL FLUTTER; and ATRIAL FIBRILLATION), direct conduction block via the Bachmann's bundle and concomitant left atrial enlargement. Syndrome of advanced interatrial block associated with SUPRAVENTRICULAR TACHYCARDIA is referred to as Bayes syndrome.	MESH:D006327	C14.280.067.558.430|C14.280.123.500.430|C23.550.073.425.270	C14.280.067.558|C14.280.123.500|C23.550.073.425	Bayes Syndrome|Bayes' Syndrome|Block, Interatrial|Conduction Delay, Interatrial|Interatrial Blocks|Interatrial Conduction Delay|Interatrial Conduction Delays	Cardiovascular disease|Pathology (process)
Interferon gamma, receptor 1, deficiency	MESH:C535530	DO:DOID:0111955		MESH:D014777	C01.925/C535530	C01.925		Viral disease
Interleukin 2 Receptor, Alpha, Deficiency of	MESH:C565232	DO:DOID:0111968|OMIM:606367		MESH:D007153	C20.673/C565232	C20.673	CD25 Deficiency|IL2RA Deficiency|IMD41|IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY|INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF	Immune system disease
Intermittent Claudication	MESH:D007383	DO:DOID:3669	A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.	MESH:D001161|MESH:D012816	C14.907.137.126.669|C23.888.531	C14.907.137.126|C23.888	Claudication, Intermittent	Cardiovascular disease|Signs and symptoms
Internal Carotid Artery, Spontaneous Dissection of	MESH:C564125			MESH:D020215	C10.228.140.300.200.345.300/C564125|C10.228.140.300.350.500.300/C564125|C10.900.250.300.300/C564125|C14.907.055.050.150/C564125|C14.907.253.123.345.300/C564125|C14.907.253.535.500.300/C564125|C26.915.200.200.500/C564125	C10.228.140.300.200.345.300|C10.228.140.300.350.500.300|C10.900.250.300.300|C14.907.055.050.150|C14.907.253.123.345.300|C14.907.253.535.500.300|C26.915.200.200.500		Cardiovascular disease|Nervous system disease|Wounds and injuries
INTERSTITIAL LUNG AND LIVER DISEASE	OMIM:615486			MESH:D008107|MESH:D017563	C06.552/615486|C08.381.483/615486	C06.552|C08.381.483	ILFS2, FORMERLY|ILLD|INFANTILE LIVER FAILURE SYNDROME 2, FORMERLY|PULMONARY ALVEOLAR PROTEINOSIS, REUNION ISLAND	Digestive system disease|Respiratory tract disease
Intertrigo	MESH:D007402		A superficial dermatitis occurring on skin surfaces in contact with each other, such as the axillae, neck creases, intergluteal fold, between the toes, etc. Obesity is a predisposing factor. The condition is caused by moisture and friction and is characterized by erythema, maceration, burning, and exudation.	MESH:D003872|MESH:D017443	C17.800.174.640|C17.800.815.650	C17.800.174|C17.800.815		Skin disease
Intervertebral Disc Degeneration	MESH:D055959		Degenerative changes in the INTERVERTEBRAL DISC due to aging or structural damage, especially to the vertebral end-plates.	MESH:D013122	C05.116.900.153	C05.116.900	Degeneration, Disc|Degeneration, Disk|Degeneration, Intervertebral Disc|Degeneration, Intervertebral Disk|Degenerative Disc Disease|Degenerative Disc Diseases|Degenerative Intervertebral Disc|Degenerative Intervertebral Discs|Degenerative Intervertebral Disk|Degenerative Intervertebral Disks|Degradation, Disc|Degradation, Disk|Disc Degeneration|Disc Degeneration, Intervertebral|Disc Degenerations|Disc, Degenerative Intervertebral|Disc Degradation|Disc Degradations|Disc Disease, Degenerative|Disk Degeneration|Disk Degeneration, Intervertebral|Disk Degenerations|Disk, Degenerative Intervertebral|Disk Degradation|Disk Degradations|Intervertebral Disc Degenerations|Intervertebral Disc, Degenerative|Intervertebral Disk Degeneration|Intervertebral Disk Degenerations|Intervertebral Disk, Degenerative	Musculoskeletal disease
Intestinal Diseases, Parasitic	MESH:D007411		Infections of the INTESTINES with PARASITES, commonly involving PARASITIC WORMS. Infections with roundworms (NEMATODE INFECTIONS) and tapeworms (CESTODE INFECTIONS) are also known as HELMINTHIASIS.	MESH:D007410|MESH:D010272	C01.610.432|C06.405.469.452	C01.610|C06.405.469	Disease, Parasitic Intestinal|Diseases, Parasitic Intestinal|Intestinal Disease, Parasitic|Parasitic Intestinal Disease|Parasitic Intestinal Diseases	Digestive system disease|Parasitic disease
Intestinal Fistula	MESH:D007412		An abnormal anatomical passage between the INTESTINE, and another segment of the intestine or other organs. External intestinal fistula is connected to the SKIN (enterocutaneous fistula). Internal intestinal fistula can be connected to a number of organs, such as STOMACH (gastrocolic fistula), the BILIARY TRACT (cholecystoduodenal fistula), or the URINARY BLADDER of the URINARY TRACT (colovesical fistula). Risk factors include inflammatory processes, cancer, radiation treatment, and surgical misadventures (MEDICAL ERRORS).	MESH:D007410|MESH:D016154	C06.267.550|C06.405.469.471|C23.300.575.185.550	C06.267|C06.405.469|C23.300.575.185	Cholecystoduodenal Fistula|Colovesical Fistula|Enterocutaneous Fistula|Fistula, Cholecystoduodenal|Fistula, Colovesical|Fistula, Enterocutaneous|Fistula, Intestinal	Digestive system disease|Pathology (anatomical condition)
Intestinal helminthiasis	MESH:C531698			MESH:D006373|MESH:D007411	C01.610.335/C531698|C01.610.432/C531698|C06.405.469.452/C531698	C01.610.335|C01.610.432|C06.405.469.452		Digestive system disease|Parasitic disease
Intestinal Neoplasms	MESH:D007414	DO:DOID:10155|DO:DOID:4610	Tumors or cancer of the INTESTINES.	MESH:D005770|MESH:D007410	C04.588.274.476.411|C06.301.371.411|C06.405.249.411|C06.405.469.491	C04.588.274.476|C06.301.371|C06.405.249|C06.405.469	Cancer, Intestinal|Cancer, Intestines|Cancer of Intestines|Cancer of the Intestines|Cancers, Intestinal|Cancers, Intestines|Intestinal Cancer|Intestinal Cancers|Intestinal Neoplasm|Intestines Cancer|Intestines Cancers|Intestines Neoplasm|Intestines Neoplasms|Neoplasm, Intestinal|Neoplasm, Intestines|Neoplasms, Intestinal|Neoplasms, Intestines	Cancer|Digestive system disease
Intestinal Pseudoobstruction with Patent Ductus Arteriosus and Natal Teeth	MESH:C538341			MESH:D004374|MESH:D007418	C06.405.469.531.492.500/C538341|C14.240.400.340/C538341|C14.280.400.340/C538341|C16.131.240.400.340/C538341	C06.405.469.531.492.500|C14.240.400.340|C14.280.400.340|C16.131.240.400.340	Natal teeth, intestinal pseudoobstruction and patent ductus	Cardiovascular disease|Congenital abnormality|Digestive system disease
Intestinal Volvulus	MESH:D045822	DO:DOID:8445	A twisting in the intestine (INTESTINES) that can cause INTESTINAL OBSTRUCTION.	MESH:D007415|MESH:D014102	C06.405.469.531.568|C23.300.970.500	C06.405.469.531|C23.300.970	Volvulus|Volvulus, Intestinal|Volvulus, Intestine	Digestive system disease|Pathology (anatomical condition)
Intra-Abdominal Hypertension	MESH:D059325		Pathological elevation of intra-abdominal pressure (>12 mm Hg). It may develop as a result of SEPSIS; PANCREATITIS; capillary leaks, burns, or surgery. When the pressure is higher than 20 mm Hg, often with end-organ dysfunction, it is referred to as abdominal compartment syndrome.	MESH:D003161	C05.651.180.297|C14.907.303.297	C05.651.180|C14.907.303	Abdominal Compartment Syndrome|Abdominal Compartment Syndromes|Compartment Syndrome, Abdominal|Compartment Syndromes, Abdominal|Hypertension, Intraabdominal|Hypertension, Intra-Abdominal|Hypertensions, Intraabdominal|Hypertensions, Intra-Abdominal|Intraabdominal Hypertension|Intra Abdominal Hypertension|Intraabdominal Hypertensions|Intra-Abdominal Hypertensions|Syndrome, Abdominal Compartment|Syndromes, Abdominal Compartment	Cardiovascular disease|Musculoskeletal disease
Intraabdominal Infections	MESH:D059413		Infection within the PERITONEAL CAVITY. A frequent cause is an ANASTOMOTIC LEAK following surgery.	MESH:D007239	C01.463	C01	Infection, Intraabdominal|Infection, Intra-Abdominal|Infections, Intraabdominal|Infections, Intra-Abdominal|Intraabdominal Infection|Intra-Abdominal Infection|Intra Abdominal Infections|Intra-Abdominal Infections	
Intracranial Aneurysm	MESH:D002532	DO:DOID:10941	Abnormal outpouching in the wall of intracranial blood vessels. Most common are the saccular (berry) aneurysms located at branch points in CIRCLE OF WILLIS at the base of the brain. Vessel rupture results in SUBARACHNOID HEMORRHAGE or INTRACRANIAL HEMORRHAGES. Giant aneurysms (>2.5 cm in diameter) may compress adjacent structures, including the OCULOMOTOR NERVE. (From Adams et al., Principles of Neurology, 6th ed, p841)	MESH:D000783|MESH:D020765	C10.228.140.300.510.600|C14.907.055.635|C14.907.253.560.300	C10.228.140.300.510|C14.907.055|C14.907.253.560	Aneurysm, Anterior Cerebral Artery|Aneurysm, Anterior Communicating Artery|Aneurysm, Basilar Artery|Aneurysm, Berry|Aneurysm, Brain|Aneurysm, Cerebral|Aneurysm, Giant Intracranial|Aneurysm, Intracranial|Aneurysm, Intracranial Mycotic|Aneurysm, Middle Cerebral Artery|Aneurysm, Posterior Cerebral Artery|Aneurysm, Posterior Communicating Artery|Aneurysms, Basilar Artery|Aneurysms, Berry|Aneurysms, Brain|Aneurysms, Cerebral|Aneurysms, Giant Intracranial|Aneurysms, Intracranial|Aneurysms, Intracranial Mycotic|Anterior Cerebral Artery Aneurysm|Anterior Communicating Artery Aneurysm|Artery Aneurysm, Basilar|Artery Aneurysms, Basilar|Basilar Artery Aneurysm|Basilar Artery Aneurysms|Berry Aneurysm|Berry Aneurysms|Brain Aneurysm|Brain Aneurysms|Cerebral Aneurysm|Cerebral Aneurysms|Giant Intracranial Aneurysm|Giant Intracranial Aneurysms|Intracranial Aneurysm, Giant|Intracranial Aneurysms|Intracranial Aneurysms, Giant|Intracranial Mycotic Aneurysm|Intracranial Mycotic Aneurysms|Middle Cerebral Artery Aneurysm|Mycotic Aneurysm, Intracranial|Mycotic Aneurysms, Intracranial|Posterior Cerebral Artery Aneurysm|Posterior Communicating Artery Aneurysm	Cardiovascular disease|Nervous system disease
Intracranial Arterial Diseases	MESH:D020765	DO:DOID:13089	Pathological conditions involving ARTERIES in the skull, such as arteries supplying the CEREBRUM, the CEREBELLUM, the BRAIN STEM, and associated structures. They include atherosclerotic, congenital, traumatic, infectious, inflammatory, and other pathological processes.	MESH:D002561	C10.228.140.300.510|C14.907.253.560	C10.228.140.300|C14.907.253	Arterial Brain Disease|Arterial Brain Diseases|Arterial Brain Disorder|Arterial Brain Disorders|Arterial Disease, Brain|Arterial Disease, Intracranial|Arterial Diseases, Brain|Arterial Diseases, Intracranial|Arterial Disorder, Intracranial|Arterial Disorders, Intracranial|Brain Arterial Disease|Brain Arterial Diseases|Brain Diseases, Arterial|Brain Disorder, Arterial|Brain Disorders, Arterial|Intracranial Arterial Disease|Intracranial Arterial Disorder|Intracranial Arterial Disorders	Cardiovascular disease|Nervous system disease
Intracranial Arteriosclerosis	MESH:D002537	DO:DOID:12720|DO:DOID:13097	Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.	MESH:D001161|MESH:D020765	C10.228.140.300.510.800|C14.907.137.126.372|C14.907.253.560.350	C10.228.140.300.510|C14.907.137.126|C14.907.253.560	Arterioscleroses, Cerebral|Arterioscleroses, Intracranial|Arteriosclerosis, Cerebral|Arteriosclerosis, Intracranial|Atheroscleroses, Cerebral|Atheroscleroses, Intracranial|Atherosclerosis, Cerebral|Atherosclerosis, Intracranial|Cerebral Arterioscleroses|Cerebral Arteriosclerosis|Cerebral Atheroscleroses|Cerebral Atherosclerosis|Intracranial Arterioscleroses|Intracranial Atheroscleroses|Intracranial Atherosclerosis	Cardiovascular disease|Nervous system disease
Intracranial Arteriovenous Malformations	MESH:D002538	DO:DOID:0060688|OMIM:108010	Congenital vascular anomalies in the brain characterized by direct communication between an artery and a vein without passing through the CAPILLARIES. The locations and size of the shunts determine the symptoms including HEADACHES; SEIZURES; STROKE; INTRACRANIAL HEMORRHAGES; mass effect; and vascular steal effect.	MESH:D001165|MESH:D002561|MESH:D020765|MESH:D020785	C10.228.140.300.520|C10.500.190.500|C14.240.850.750.295|C14.240.850.875.500|C14.907.150.295|C14.907.253.560.400|C16.131.240.850.750.295|C16.131.240.850.875.500|C16.131.666.190.500	C10.228.140.300|C10.500.190|C14.240.850.750|C14.240.850.875|C14.907.150|C14.907.253.560|C16.131.240.850.750|C16.131.240.850.875|C16.131.666.190	Arteriovenous Malformation, Cerebral|Arteriovenous Malformation, Intracranial|Arteriovenous Malformations, Cerebral|Arteriovenous Malformations, Intracranial|ARTERIOVENOUS MALFORMATIONS OF THE BRAIN|AVM (Arteriovenous Malformation) Intracranial|BAVM|Cerebral Arteriovenous Malformation|Cerebral Arteriovenous Malformations|CEREBRAL ARTERIOVENOUS MALFORMATIONS INTRACRANIAL HEMORRHAGE IN BRAIN ARTERIOVENOUS MALFORMATIONS, SUSCEPTIBILITY TO, INCLUDED|Congenital Intracranial Arteriovenous Malformations|Intracranial Arteriovenous Malformation|Intracranial Arteriovenous Malformation, Ruptured|Intracranial Arteriovenous Malformations, Congenital|Malformation, Cerebral Arteriovenous|Malformation, Intracranial Arteriovenous|Malformations, Cerebral Arteriovenous|Malformations, Intracranial Arteriovenous|Ruptured Intracranial Arteriovenous Malformation	Cardiovascular disease|Congenital abnormality|Nervous system disease
Intracranial Embolism	MESH:D020766	DO:DOID:4372	Blocking of a blood vessel in the SKULL by an EMBOLUS which can be a blood clot (THROMBUS) or other undissolved material in the blood stream. Most emboli are of cardiac origin and are associated with HEART DISEASES. Other non-cardiac sources of emboli are usually associated with VASCULAR DISEASES.	MESH:D002542	C10.228.140.300.525.400|C14.907.253.566.300|C14.907.355.590.213.300	C10.228.140.300.525|C14.907.253.566|C14.907.355.590.213	Brain Emboli|Brain Embolism|Brain Embolus|Cerebral Emboli|Cerebral Embolism|Cerebral Embolus|Emboli, Brain|Emboli, Cerebral|Embolism, Brain|Embolism, Cerebral|Embolism, Intracranial|Embolus, Brain|Embolus, Cerebral	Cardiovascular disease|Nervous system disease
Intracranial Embolism and Thrombosis	MESH:D002542		Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures.	MESH:D002561|MESH:D013923	C10.228.140.300.525|C14.907.253.566|C14.907.355.590.213	C10.228.140.300|C14.907.253|C14.907.355.590	Brain Embolism and Thrombosis|Cerebral Embolism and Thrombosis|Embolism and Thrombosis, Brain	Cardiovascular disease|Nervous system disease
Intracranial Hemorrhage, Hypertensive	MESH:D020299		Bleeding within the SKULL that is caused by systemic HYPERTENSION, usually in association with INTRACRANIAL ARTERIOSCLEROSIS. Hypertensive hemorrhages are most frequent in the BASAL GANGLIA; CEREBELLUM; PONS; and THALAMUS; but may also involve the CEREBRAL CORTEX, subcortical white matter, and other brain structures.	MESH:D020300	C10.228.140.300.535.325|C14.907.253.573.350	C10.228.140.300.535|C14.907.253.573	Cerebral Hemorrhage, Hypertensive|Cerebral Hemorrhages, Hypertensive|Cerebral Hypertensive Hemorrhage|Cerebral Hypertensive Hemorrhages|Hemorrhage, Cerebral Hypertensive|Hemorrhage, Hypertensive Cerebral|Hemorrhage, Hypertensive Intracerebral|Hemorrhage, Hypertensive Intracranial|Hemorrhage, Intracranial Hypertensive|Hemorrhages, Cerebral Hypertensive|Hemorrhages, Hypertensive Cerebral|Hemorrhages, Hypertensive Intracerebral|Hemorrhages, Hypertensive Intracranial|Hemorrhages, Intracranial Hypertensive|Hypertensive Cerebral Hemorrhage|Hypertensive Cerebral Hemorrhages|Hypertensive Hemorrhage, Cerebral|Hypertensive Hemorrhage, Intracranial|Hypertensive Hemorrhages, Cerebral|Hypertensive Hemorrhages, Intracranial|Hypertensive Intracerebral Hemorrhage|Hypertensive Intracerebral Hemorrhages|Hypertensive Intracranial Hemorrhage|Hypertensive Intracranial Hemorrhages|Intracerebral Hemorrhage, Hypertensive|Intracerebral Hemorrhages, Hypertensive|Intracranial Hemorrhages, Hypertensive|Intracranial Hypertensive Hemorrhage|Intracranial Hypertensive Hemorrhages	Cardiovascular disease|Nervous system disease
Intracranial Hemorrhages	MESH:D020300		Bleeding within the SKULL, including hemorrhages in the brain and the three membranes of MENINGES. The escape of blood often leads to the formation of HEMATOMA in the cranial epidural, subdural, and subarachnoid spaces.	MESH:D002561|MESH:D006470	C10.228.140.300.535|C14.907.253.573|C23.550.414.913	C10.228.140.300|C14.907.253|C23.550.414	Brain Hemorrhage|Brain Hemorrhages|Hemorrhage, Brain|Hemorrhage, Intracranial|Hemorrhage, Posterior Fossa|Hemorrhages, Brain|Hemorrhages, Intracranial|Hemorrhages, Posterior Fossa|Intracranial Hemorrhage|Posterior Fossa Hemorrhage|Posterior Fossa Hemorrhages	Cardiovascular disease|Nervous system disease|Pathology (process)
Intracranial Hemorrhage, Traumatic	MESH:D020198		Bleeding within the SKULL induced by penetrating and nonpenetrating traumatic injuries, including hemorrhages into the tissues of CEREBRUM; BRAIN STEM; and CEREBELLUM; as well as into the epidural, subdural and subarachnoid spaces of the MENINGES.	MESH:D006259|MESH:D020300	C10.228.140.300.535.450|C10.900.300.837|C14.907.253.573.400|C26.915.300.490	C10.228.140.300.535|C10.900.300|C14.907.253.573|C26.915.300	Hematomas, Traumatic Intracranial|Hematoma, Traumatic Intracranial|Hemorrhage, Intracranial, Traumatic|Hemorrhages, Traumatic Intracranial|Hemorrhage, Traumatic Intracranial|Intracranial Hematomas, Traumatic|Intracranial Hematoma, Traumatic|Intracranial Hemorrhages, Traumatic|Traumatic Intracranial Hematoma|Traumatic Intracranial Hematomas|Traumatic Intracranial Hemorrhage|Traumatic Intracranial Hemorrhages	Cardiovascular disease|Nervous system disease|Wounds and injuries
Intracranial Hypertension	MESH:D019586	DO:DOID:9428	Increased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.	MESH:D001927	C10.228.140.631	C10.228.140	Elevated ICP (Intracranial Pressure)|Elevated Intracranial Pressure|Hypertension, Intracranial|ICP, Elevated (Intracranial Pressure)|ICP (Intracranial Pressure) Elevation|ICP (Intracranial Pressure) Increase|Intracranial Pressure, Elevated|Intracranial Pressure Increase|Pressure, Elevated Intracranial|Pressure Increase, Intracranial	Nervous system disease
Intracranial Hypotension	MESH:D019585	DO:DOID:4723	Reduction of CEREBROSPINAL FLUID pressure characterized clinically by ORTHOSTATIC HEADACHE and occasionally by an ABDUCENS NERVE PALSY; HEARING LOSS; NAUSEA; neck stiffness, and other symptoms. This condition may be spontaneous or secondary to CEREBROSPINAL FLUID LEAK; SPINAL PUNCTURE; NEUROSURGICAL PROCEDURES; DEHYDRATION; UREMIA; trauma (see also CRANIOCEREBRAL TRAUMA); and other processes. Chronic hypotension may be associated with subdural hematomas (see HEMATOMA, SUBDURAL) or hygromas. (From Semin Neurol 1996 Mar;16(1):5-10; Adams et al., Principles of Neurology, 6th ed, pp637-8)	MESH:D001927	C10.228.140.638	C10.228.140	Cerebrospinal Fluid Hypovolemia|Cerebrospinal Fluid Hypovolemias|CSF Hypovolemia|CSF Hypovolemias|Essential Intracranial Hypotension|Fluid Hypovolemia, Cerebrospinal|Fluid Hypovolemias, Cerebrospinal|Hypotension, Essential Intracranial|Hypotension, Intracranial|Hypotension, Secondary Intracranial|Hypotension, Spontaneous Intracranial|Hypovolemia, Cerebrospinal Fluid|Hypovolemia, CSF|Hypovolemias, Cerebrospinal Fluid|Hypovolemias, CSF|Intracranial Hypotension, Essential|Intracranial Hypotension, Secondary|Intracranial Hypotension, Spontaneous|Secondary Intracranial Hypotension|Spontaneous Intracranial Hypotension	Nervous system disease
Intracranial Thrombosis	MESH:D020767	DO:DOID:4193	Formation or presence of a blood clot (THROMBUS) in a blood vessel within the SKULL. Intracranial thrombosis can lead to thrombotic occlusions and BRAIN INFARCTION. The majority of the thrombotic occlusions are associated with ATHEROSCLEROSIS.	MESH:D002542	C10.228.140.300.525.425|C14.907.253.566.350|C14.907.355.590.213.350	C10.228.140.300.525|C14.907.253.566|C14.907.355.590.213	Brain Thromboses|Brain Thrombosis|Brain Thrombus|Cerebral Thromboses|Cerebral Thrombosis|Cerebral Thrombus|Intracranial Thromboses|Intracranial Thrombus|Thromboses, Brain|Thromboses, Cerebral|Thromboses, Intracranial|Thrombosis, Brain|Thrombosis, Cerebral|Thrombosis, Intracranial|Thrombus, Brain|Thrombus, Cerebral|Thrombus, Intracranial	Cardiovascular disease|Nervous system disease
Intranuclear Rod Myopathy	MESH:C580202			MESH:D017696	C05.651.575.290/C580202|C10.668.491.550.290/C580202	C05.651.575.290|C10.668.491.550.290	Intranuclear Nemaline Rod Myopathy|Nemaline Myopathy with Exclusively Intranuclear Rods	Musculoskeletal disease|Nervous system disease
Intraocular Lymphoma	MESH:D064090	DO:DOID:775	A form of malignant cancer which occurs within the eyeball.	MESH:D005134|MESH:D008223	C04.557.386.435|C04.588.364.447|C15.604.515.569.417|C20.683.515.761.417	C04.557.386|C04.588.364|C15.604.515.569|C20.683.515.761	Intraocular Lymphomas|Lymphoma, Intraocular|Lymphomas, Intraocular	Cancer|Immune system disease|Lymphatic disease
Intrinsic Factor Deficiency	MESH:C563242	OMIM:261000		MESH:D000752	C15.378.071.252.196.500/C563242|C18.654.521.500.133.699.923.280/C563242	C15.378.071.252.196.500|C18.654.521.500.133.699.923.280	IFD|Pernicious Anemia, Congenital, due to Defect of Intrinsic Factor	Blood disease|Nutrition disorder
Iridocorneal Endothelial Syndrome	MESH:D057129	DO:DOID:11554	A grouping of three closely linked conditions: iris nevus (or Cogan-Reese) syndrome, Chandler Syndrome, and essential (progressive) iris atrophy. The most common features of this syndrome are the movement of endothelial cells off the cornea onto the iris leading to corneal swelling, distortion of the iris, and variable degrees of distortion of the pupil. The abnormal cell movement plugs fluid outflow channels of the eye causing GLAUCOMA.	MESH:D003316|MESH:D007499	C11.204.497|C11.941.375.322	C11.204|C11.941.375	Chandler's Syndrome|Chandlers Syndrome|Chandler Syndrome|Endothelial Syndrome, Iridocorneal|ICE Syndrome|Iridocorneal Endothelial Syndromes|Iris Atrophy with Corneal Edema and Glaucoma	Eye disease
Iridocyclitis	MESH:D015863		Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision.	MESH:D007499|MESH:D014606	C11.941.375.360|C11.941.879.780.880.400	C11.941.375|C11.941.879.780.880	Cyclitides, Heterochromic|Cyclitis, Heterochromic|Heterochromic Cyclitides|Heterochromic Cyclitis|Iridocyclitides	Eye disease
Iris Diseases	MESH:D007499	DO:DOID:240	Diseases, dysfunctions, or disorders of or located in the iris.	MESH:D014603	C11.941.375	C11.941	Disease, Iris|Diseases, Iris|Iris Disease	Eye disease
Iris flocculi	MESH:C000721429			MESH:D007499	C11.941.375/C000721429	C11.941.375		Eye disease
Iris hypoplasia and glaucoma	MESH:C535538	OMIM:308500		MESH:D005901|MESH:D012164	C11.525.381/C535538|C11.768/C535538	C11.525.381|C11.768	IHG|Iris Hypoplasia with Glaucoma	Eye disease
Iris Neoplasms	MESH:D015811	DO:DOID:3478	Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi.	MESH:D007499|MESH:D014604	C04.588.364.978.400|C11.319.494.400|C11.941.375.375|C11.941.855.400	C04.588.364.978|C11.319.494|C11.941.375|C11.941.855	Iris Neoplasm|Neoplasm, Iris|Neoplasms, Iris	Cancer|Eye disease
Iritis	MESH:D007500	DO:DOID:1406	Inflammation of the iris characterized by circumcorneal injection, aqueous flare, keratotic precipitates, and constricted and sluggish pupil along with discoloration of the iris.	MESH:D007499|MESH:D014606	C11.941.375.385|C11.941.879.780.880.448	C11.941.375|C11.941.879.780.880	Iritides	Eye disease
Iron Deficiencies	MESH:D000090463		Deficient amounts of iron in the body as a result of blood loss, diets deficient in iron, or an iron uptake or storage disorder.	MESH:D019189	C18.452.565.400	C18.452.565	Deficiencies, Iron|Deficiencies, Latent Iron|Deficiency, Iron|Deficiency, Latent Iron|Hypoferritinemia|Hypoferritinemias|Iron Deficiencies, Latent|Iron Deficiency|Iron Deficiency, Latent|Latent Iron Deficiencies|Latent Iron Deficiency|Sideropenia|Sideropenias	Metabolic disease
Iron Metabolism Disorders	MESH:D019189	DO:DOID:2351	Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. (From Mosby's Medical, Nursing, & Allied Health Dictionary, 4th ed)	MESH:D008659	C18.452.565	C18.452	Disorder, Iron Metabolism|Disorders, Iron Metabolism|Iron Metabolism Disorder|Metabolism Disorder, Iron|Metabolism Disorders, Iron	Metabolic disease
Iron Overload	MESH:D019190		An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989)	MESH:D019189	C18.452.565.500	C18.452.565	Overload, Iron	Metabolic disease
Iron Overload, Autosomal Dominant	MESH:C565020			MESH:D019190	C18.452.565.500/C565020	C18.452.565.500		Metabolic disease
Iron-Refractory Iron Deficiency Anemia	MESH:C562385	DO:DOID:11252|OMIM:206200		MESH:D018798	C15.378.071.196.300/C562385|C18.452.565.400.500/C562385	C15.378.071.196.300|C18.452.565.400.500	Anemia, Hypochromic Microcytic, with Defect in Iron Metabolism|IRIDA|IRIDA Iron-refractory iron deficiency anemia|Iron-Handling Disorder, Hereditary|Pseudo-Iron-Deficiency Anemia	Blood disease|Metabolic disease
Irons Bhan syndrome	MESH:C535539			MESH:D006344|MESH:D008209|MESH:D019066	C14.240.400.560.375/C535539|C14.280.400.560.375/C535539|C15.604.496/C535539|C16.131.240.400.560.375/C535539|C23.550.291.812/C535539	C14.240.400.560.375|C14.280.400.560.375|C15.604.496|C16.131.240.400.560.375|C23.550.291.812	Autosomal recessive syndrome of lymphedema, hydroceles, atrial septal defect, and characteristic facial changes|Lymphedema, atrial septal defect, and characteristic facial changes	Cardiovascular disease|Congenital abnormality|Lymphatic disease|Pathology (process)
Irritable heart	MESH:C531763			MESH:D054971	C10.177.575.600/C531763|C23.888.592.610/C531763	C10.177.575.600|C23.888.592.610	Soldiers heart	Nervous system disease|Signs and symptoms
Isaacs Syndrome	MESH:D020386	OMIM:137200	A rare neuromuscular disorder with onset usually in late childhood or early adulthood, characterized by intermittent or continuous widespread involuntary muscle contractions; FASCICULATION; hyporeflexia; MUSCLE CRAMP; MUSCLE WEAKNESS; HYPERHIDROSIS; TACHYCARDIA; and MYOKYMIA. Involvement of pharyngeal or laryngeal muscles may interfere with speech and breathing. The continuous motor activity persists during sleep and general anesthesia (distinguishing this condition from STIFF-PERSON SYNDROME). Familial and acquired (primarily autoimmune) forms have been reported. (From Ann NY Acad Sci 1998 May 13;841:482-496; Adams et al., Principles of Neurology, 6th ed, p1491)	MESH:D009135|MESH:D010523	C05.651.392|C10.668.829.425	C05.651|C10.668.829	Acquired Neuromyotonia|Continuous Muscle Activity Syndrome|Continuous Myokymia|Continuous Myokymias|Gamstorp Wohlfart Syndrome|Gamstorp-Wohlfart Syndrome|Isaacs Mertens Syndrome|Isaacs-Mertens Syndrome|Isaacs Pseudomyotonia Syndrome|Isaacs' Syndrome|Isaac Syndrome|Myokymia, Continuous|MYOKYMIA, MYOTONIA, AND MUSCLE WASTING|Myokymia, Myotonia, Muscle Wasting, And Hyperhidrosis|Myokymias, Continuous|Neuromyotonia|Neuromyotonia, Acquired|NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE|NMAN|Pseudomyotonia|Pseudomyotonia Syndrome of Isaacs|Quantal Squander|Syndrome of Continuous Muscle Activity	Musculoskeletal disease|Nervous system disease
Ischemic Attack, Transient	MESH:D002546	DO:DOID:224	Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)	MESH:D002545	C10.228.140.300.150.836|C14.907.253.092.836	C10.228.140.300.150|C14.907.253.092	Anterior Circulation Transient Ischemic Attack|Attacks, Transient Ischemic|Attack, Transient Ischemic|Brainstem Ischemias, Transient|Brainstem Ischemia, Transient|Brain Stem Ischemia, Transient|Brainstem Transient Ischemic Attack|Brain Stem Transient Ischemic Attack|Brain TIA|Carotid Circulation Transient Ischemic Attack|Cerebral Ischemias, Transient|Cerebral Ischemia, Transient|Crescendo Transient Ischemic Attacks|Ischemias, Transient Brainstem|Ischemias, Transient Cerebral|Ischemia, Transient Brainstem|Ischemia, Transient Cerebral|Ischemic Attacks, Transient|Posterior Circulation Transient Ischemic Attack|TIA, Brain|TIAs (Transient Ischemic Attack)|TIA (Transient Ischemic Attack)|Transient Brainstem Ischemia|Transient Cerebral Ischemia|Transient Cerebral Ischemias|Transient Ischemic Attack|Transient Ischemic Attack, Anterior Circulation|Transient Ischemic Attack, Brainstem|Transient Ischemic Attack, Brain Stem|Transient Ischemic Attack, Carotid Circulation|Transient Ischemic Attack, Posterior Circulation|Transient Ischemic Attacks|Transient Ischemic Attacks, Crescendo|Transient Ischemic Attack, Vertebrobasilar Circulation|Vertebrobasilar Circulation Transient Ischemic Attack	Cardiovascular disease|Nervous system disease
Ischemic Contracture	MESH:D054061	DO:DOID:5587	A type of permanent damage to muscles and nerves that results from prolonged lack blood flow to those tissues. It is characterized by shortening and stiffening of the muscles.	MESH:D003161|MESH:D003286	C05.550.323.734|C05.651.180.531|C05.651.197.734|C14.907.303.531	C05.550.323|C05.651.180|C05.651.197|C14.907.303	Contracture, Ischemic|Contractures, Ischemic|Contractures, Volkmann|Contracture, Volkmann|Contracture, Volkmann's Ischemic|Ischemic Contractures|Ischemic Contracture, Volkmann's|Volkmann Contracture|Volkmann Contractures|Volkmann Ischemic Contracture|Volkmann's Ischemic Contracture|Volkmanns Ischemic Contracture	Cardiovascular disease|Musculoskeletal disease
Ischemic Stroke	MESH:D000083242	OMIM:601367	Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.	MESH:D020521	C10.228.140.300.775.400|C14.907.253.855.400	C10.228.140.300.775|C14.907.253.855	Acute Ischemic Stroke|Acute Ischemic Strokes|CEREBRAL INFARCTION|CEREBROVASCULAR ACCIDENT|Cryptogenic Embolism Stroke|Cryptogenic Embolism Strokes|Cryptogenic Ischemic Stroke|Cryptogenic Ischemic Strokes|Cryptogenic Stroke|Cryptogenic Strokes|Embolism Stroke, Cryptogenic|Ischaemic Stroke|Ischaemic Strokes|Ischemic Stroke, Acute|Ischemic Stroke, Cryptogenic|Ischemic Strokes|Stroke, Acute Ischemic|Stroke, Cryptogenic|Stroke, Cryptogenic Embolism|Stroke, Cryptogenic Ischemic|Stroke, Ischaemic|Stroke, Ischemic|Stroke, Wake-up|Wake up Stroke|Wake-up Stroke|Wake-up Strokes	Cardiovascular disease|Nervous system disease
Ischiopatellar dysplasia	MESH:C535540	DO:DOID:0111382|OMIM:147891		MESH:D001848	C05.116.099/C535540	C05.116.099	Coxopodopatellar Syndrome|ICPPS|ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION|ISCHIOPATELLAR DYSPLASIA|PATELLA APLASIA, COXA VARA, AND TARSAL SYNOSTOSIS|Scott-Taor syndrome|Small patella syndrome|SPS	Musculoskeletal disease
Islet Cell Adenomatosis	MESH:C563258			MESH:D007516	C04.557.470.035.100/C563258|C04.588.274.761.249/C563258|C04.588.322.475.249/C563258|C06.301.761.249/C563258|C06.689.667.249/C563258|C19.344.421.249/C563258	C04.557.470.035.100|C04.588.274.761.249|C04.588.322.475.249|C06.301.761.249|C06.689.667.249|C19.344.421.249		Cancer|Digestive system disease|Endocrine system disease
Islet cell tumor syndrome	MESH:C531777			MESH:D010190|MESH:D010673	C04.557.465.625.650.700.725/C531777|C04.557.580.625.650.700.725/C531777|C04.588.274.761/C531777|C04.588.322.475/C531777|C06.301.761/C531777|C06.689.667/C531777|C19.344.421/C531777	C04.557.465.625.650.700.725|C04.557.580.625.650.700.725|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421	Bilateral pheochromocytoma and islet cell adenoma of the pancreas|Chromaffinoma|Familial islet cell tumors|Familial pheochromocytoma	Cancer|Digestive system disease|Endocrine system disease
Isolated Growth Hormone Deficiency, Type II	MESH:C562704	OMIM:173100		MESH:D004393	C05.116.099.343.445/C562704|C05.116.132.358/C562704|C10.228.140.617.738.300.300/C562704|C19.297.312/C562704|C19.700.482.311/C562704	C05.116.099.343.445|C05.116.132.358|C10.228.140.617.738.300.300|C19.297.312|C19.700.482.311	Growth Hormone Deficiency, Isolated, Autosomal Dominant|IGHD2|IGHD II|Pituitary Dwarfism Due To Isolated Growth Hormone Deficiency, Autosomal Dominant	Endocrine system disease|Musculoskeletal disease|Nervous system disease
Isolated left subclavian artery	MESH:C000721268			MESH:D054079	C14.240.850/C000721268|C16.131.240.850/C000721268	C14.240.850|C16.131.240.850	Isolation of the left subclavian artery	Cardiovascular disease|Congenital abnormality
Jamaican vomiting sickness	MESH:C537562			MESH:D010939	C25.723.756/C537562	C25.723.756	Ackee poisoning	
JANSEN-DE VRIES SYNDROME	OMIM:617450			MESH:D005767|MESH:D008607|MESH:D010146|MESH:D011596	C06.405/617450|C10.597.606.360/617450|C10.597.606.881/617450|C23.888.592.604.646/617450|C23.888.592.604.882/617450|C23.888.592.612/617450|F03.625.539/617450	C06.405|C10.597.606.360|C10.597.606.881|C23.888.592.604.646|C23.888.592.604.882|C23.888.592.612|F03.625.539	IDDGIP, FORMERLY|INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD, FORMERLY|JDVS	Digestive system disease|Mental disorder|Nervous system disease|Signs and symptoms
Jaw Cysts	MESH:D007570		Saccular lesions lined with epithelium and contained within pathologically formed cavities in the jaw; also nonepithelial cysts (pseudocysts) as they apply to the jaw, e.g., traumatic or solitary cyst, static bone cavity, and aneurysmal bone cyst. True jaw cysts are classified as odontogenic or nonodontogenic.	MESH:D001845|MESH:D007571	C04.182.089.530|C05.500.470|C07.320.450	C04.182.089|C05.500|C07.320	Cyst, Jaw|Cysts, Jaw|Jaw Cyst	Cancer|Mouth disease|Musculoskeletal disease
Jaw Diseases	MESH:D007571		Diseases involving the JAW.	MESH:D009057|MESH:D009140	C05.500|C07.320	C05|C07	Disease, Jaw|Diseases, Jaw|Jaw Disease	Mouth disease|Musculoskeletal disease
Jaw, Edentulous	MESH:D007575		The total absence of teeth from either the mandible or the maxilla, but not both. Total absence of teeth from both is MOUTH, EDENTULOUS. Partial absence of teeth in either is JAW, EDENTULOUS, PARTIALLY.	MESH:D007571|MESH:D009066	C05.500.480|C07.320.550|C07.465.550.425|C07.793.597.425	C05.500|C07.320|C07.465.550|C07.793.597	Edentulous Jaw|Edentulous Jaws|Jaws, Edentulous	Mouth disease|Musculoskeletal disease
Jaw, Edentulous, Partially	MESH:D007576		Absence of teeth from a portion of the mandible and/or maxilla.	MESH:D007575	C05.500.480.450|C07.320.550.450|C07.465.550.425.450|C07.793.597.425.450	C05.500.480|C07.320.550|C07.465.550.425|C07.793.597.425		Mouth disease|Musculoskeletal disease
Jaw Fractures	MESH:D007572		Fractures of the upper or lower jaw.	MESH:D008446|MESH:D012887	C10.900.300.284.500.400|C26.404.750.467|C26.915.300.425.500.400	C10.900.300.284.500|C26.404.750|C26.915.300.425.500	Fracture, Jaw|Fractures, Jaw|Jaw Fracture	Nervous system disease|Wounds and injuries
Jaw Neoplasms	MESH:D007573	DO:DOID:1862	Cancers or tumors of the MAXILLA or MANDIBLE unspecified. For neoplasms of the maxilla, MAXILLARY NEOPLASMS is available and of the mandible, MANDIBULAR NEOPLASMS is available.	MESH:D007571|MESH:D012888	C04.588.149.721.450|C05.116.231.754.450|C05.500.499|C07.320.515	C04.588.149.721|C05.116.231.754|C05.500|C07.320	Cancer, Jaw|Cancer of Jaw|Cancer of the Jaw|Cancers, Jaw|Jaw Cancer|Jaw Cancers|Jaw Neoplasm|Neoplasm, Jaw|Neoplasms, Jaw	Cancer|Mouth disease|Musculoskeletal disease
Jejunal Neoplasms	MESH:D007580	DO:DOID:13499|DO:DOID:3218	Tumors or cancer in the JEJUNUM region of the small intestine (INTESTINE, SMALL).	MESH:D007414|MESH:D007579	C04.588.274.476.411.523|C06.301.371.411.523|C06.405.249.411.523|C06.405.469.491.523|C06.405.469.600.523	C04.588.274.476.411|C06.301.371.411|C06.405.249.411|C06.405.469.491|C06.405.469.600	Cancer, Jejunal|Cancer of Jejunum|Cancer of the Jejunum|Cancers, Jejunal|Jejunal Cancer|Jejunal Cancers|Jejunal Neoplasm|Jejunum Cancer|Jejunum Cancers|Neoplasm, Jejunal|Neoplasms, Jejunal	Cancer|Digestive system disease
Jensen syndrome	MESH:C537568			MESH:D003704|MESH:D006313|MESH:D009896	C09.218.458.341.887.432/C537568|C09.218.807.186.432/C537568|C10.228.140.068.432/C537568|C10.228.140.380/C537568|C10.292.700.225/C537568|C10.597.751.418.341.887.432/C537568|C11.640.451/C537568|C23.888.592.763.393.341.887.432/C537568|F03.615.400/C537568	C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.228.140.380|C10.292.700.225|C10.597.751.418.341.887.432|C11.640.451|C23.888.592.763.393.341.887.432|F03.615.400	Nerve deafness optic nerve atrophy, and dementia|Opticoacoustic Nerve Atrophy With Dementia|Opticoacustic nerve atrophy with dementia|Syndrome of opticoacoustic nerve atrophy with dementia	Ear-nose-throat disease|Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Jervell And Lange-Nielsen Syndrome 2	MESH:C567343	OMIM:612347		MESH:D029593	C14.280.067.565.440/C567343|C14.280.123.625.440/C567343|C16.131.240.400.715.440/C567343	C14.280.067.565.440|C14.280.123.625.440|C16.131.240.400.715.440	Jlns2	Cardiovascular disease|Congenital abnormality
Jervell-Lange Nielsen Syndrome	MESH:D029593	DO:DOID:2842|OMIM:220400	A form of long QT syndrome that is associated with congenital deafness. It is characterized by abnormal cardioelectrophysiology involving the VOLTAGE-GATED POTASSIUM CHANNEL. It results from mutation of KCNQ1 gene (Subtype 1 or JLN1) or the KCNE1 gene (Subtype 2 or JLN2).	MESH:D008133	C14.280.067.565.440|C14.280.123.625.440|C16.131.240.400.715.440	C14.280.067.565|C14.280.123.625|C16.131.240.400.715	Cardio Auditory Syncope Syndrome|Cardio-Auditory-Syncope Syndrome|Cardio-Auditory-Syncope Syndromes|Cardioauditory Syndrome of Jervell and Lange Nielsen|Cardioauditory Syndrome of Jervell and Lange-Nielsen|Deafness, Congenital, and Functional Heart Disease|Jervell and Lange Nielsen Syndrome|Jervell and Lange-Nielsen Syndrome|Jervell And Lange Nielsen Syndrome 1|Jervell And Lange-Nielsen Syndrome 1|Jervell Lange Nielsen Syndrome|JLNS1|Prolonged QT Interval in EKG and Sudden Death|Surdo Cardiac Syndrome|Surdo-Cardiac Syndrome|Surdo-Cardiac Syndromes|Syndrome, Cardio-Auditory-Syncope|Syndrome, Jervell-Lange Nielsen|Syndromes, Cardio-Auditory-Syncope|Syndrome, Surdo-Cardiac	Cardiovascular disease|Congenital abnormality
Joint Deformities, Acquired	MESH:D016916		Deformities acquired after birth as the result of injury or disease. The joint deformity is often associated with rheumatoid arthritis and leprosy.	MESH:D007592	C05.550.515	C05.550	Acquired Joint Deformities|Acquired Joint Deformity|Deformities, Acquired Joint|Deformity, Acquired Joint|Joint Deformity, Acquired	Musculoskeletal disease
Joint Diseases	MESH:D007592	DO:DOID:381	Diseases involving the JOINTS.	MESH:D009140	C05.550	C05	Arthropathies|Arthropathy|Joint Disease	Musculoskeletal disease
Joint Dislocations	MESH:D004204		Displacement of bones from their normal positions at a joint.	MESH:D007592|MESH:D014947	C05.550.518|C26.289	C05.550|C26	Dislocation, Joint|Dislocations, Joint|Inferior Dislocation|Inferior Dislocations|Joint Dislocation|Joint Subluxation|Joint Subluxations|Luxatio Erecta|Subluxation, Joint|Subluxations, Joint	Musculoskeletal disease|Wounds and injuries
Joint Instability	MESH:D007593		Lack of stability of a joint or joint prosthesis.	MESH:D007592	C05.550.521	C05.550	Hypermobilities, Joint|Hypermobility, Joint|Instabilities, Joint|Instability, Joint|Joint Hypermobilities|Joint Hypermobility|Joint Instabilities|Joint Laxities|Joint Laxity|Laxities, Joint|Laxity, Joint	Musculoskeletal disease
Joint laxity, familial	MESH:C535884			MESH:D007593	C05.550.521/C535884	C05.550.521	Articular hypermobility syndrome|Familial joint instability syndrome|Joint instability syndrome	Musculoskeletal disease
Joint Loose Bodies	MESH:D007594		Fibrous, bony, cartilaginous and osteocartilaginous fragments in a synovial joint. Major causes are osteochondritis dissecans, synovial chondromatosis, osteophytes, fractured articular surfaces and damaged menisci.	MESH:D007592	C05.550.535	C05.550	Joint Loose Body|Loose Bodies, Joint|Loose Body, Joint	Musculoskeletal disease
Joubert syndrome 3	MESH:C536295	DO:DOID:0110998|OMIM:608629		MESH:D002526|MESH:D009123|MESH:D015835	C10.228.140.252/C536295|C10.228.758/C536295|C10.292.562/C536295|C10.597.613.575/C536295|C11.590/C536295|C23.888.592.608.575/C536295	C10.228.140.252|C10.228.758|C10.292.562|C10.597.613.575|C11.590|C23.888.592.608.575	JBTS3	Eye disease|Nervous system disease|Signs and symptoms
Joubert syndrome 4	MESH:C536296	DO:DOID:0110999|OMIM:609583		MESH:D002526|MESH:D012162|MESH:D052177	C10.228.140.252/C536296|C11.270.612/C536296|C11.768.585/C536296|C12.050.351.968.419.403/C536296|C12.200.777.419.403/C536296|C12.950.419.403/C536296	C10.228.140.252|C11.270.612|C11.768.585|C12.050.351.968.419.403|C12.200.777.419.403|C12.950.419.403	JBTS4	Eye disease|Nervous system disease|Urogenital disease (female)|Urogenital disease (male)
Joubert syndrome 5	MESH:C537688	DO:DOID:0111000|OMIM:610188		MESH:D002526|MESH:D007674|MESH:D009123|MESH:D015835	C10.228.140.252/C537688|C10.228.758/C537688|C10.292.562/C537688|C10.597.613.575/C537688|C11.590/C537688|C12.050.351.968.419/C537688|C12.200.777.419/C537688|C12.950.419/C537688|C23.888.592.608.575/C537688	C10.228.140.252|C10.228.758|C10.292.562|C10.597.613.575|C11.590|C12.050.351.968.419|C12.200.777.419|C12.950.419|C23.888.592.608.575	JBTS5	Eye disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Joubert syndrome 6	MESH:C537689	DO:DOID:0111001|OMIM:610688		MESH:D002526|MESH:D007674|MESH:D015835	C10.228.140.252/C537689|C10.228.758/C537689|C10.292.562/C537689|C11.590/C537689|C12.050.351.968.419/C537689|C12.200.777.419/C537689|C12.950.419/C537689	C10.228.140.252|C10.228.758|C10.292.562|C11.590|C12.050.351.968.419|C12.200.777.419|C12.950.419	JBTS6	Eye disease|Nervous system disease|Urogenital disease (female)|Urogenital disease (male)
Joubert Syndrome 7	MESH:C566916	DO:DOID:0111002|OMIM:611560		MESH:D001259|MESH:D002526|MESH:D008607|MESH:D015835|MESH:D052177	C10.228.140.252/C566916|C10.228.758/C566916|C10.292.562/C566916|C10.597.350.090/C566916|C10.597.606.360/C566916|C11.590/C566916|C12.050.351.968.419.403/C566916|C12.200.777.419.403/C566916|C12.950.419.403/C566916|C23.888.592.350.090/C566916|C23.888.592.604.646/C566916|F03.625.539/C566916	C10.228.140.252|C10.228.758|C10.292.562|C10.597.350.090|C10.597.606.360|C11.590|C12.050.351.968.419.403|C12.200.777.419.403|C12.950.419.403|C23.888.592.350.090|C23.888.592.604.646|F03.625.539	JBTS7	Eye disease|Mental disorder|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Jugular foramen syndrome	MESH:C000630779			MESH:D003389	C10.292/C000630779	C10.292		Nervous system disease
Juvenile giant cell arteritis	MESH:C538533			MESH:D013700	C10.114.875.700/C538533|C10.228.140.300.850.500/C538533|C14.907.253.946.700/C538533|C14.907.940.090.530/C538533|C14.907.940.907.700/C538533|C17.800.862.252/C538533|C20.111.258.962.800/C538533	C10.114.875.700|C10.228.140.300.850.500|C14.907.253.946.700|C14.907.940.090.530|C14.907.940.907.700|C17.800.862.252|C20.111.258.962.800	Juvenile cranial arteritis|Juvenile polymyalgia rheumatica	Cardiovascular disease|Immune system disease|Nervous system disease|Skin disease
Juvenile linear scleroderma	MESH:C543758			MESH:D012594	C17.300.787/C543758|C17.800.767/C543758	C17.300.787|C17.800.767		Connective tissue disease|Skin disease
Juvenile macular degeneration and hypotrichosis	MESH:C537698	OMIM:601553		MESH:D007039|MESH:D008268	C11.768.585.439/C537698|C17.800.329.937/C537698	C11.768.585.439|C17.800.329.937	HJMD|Hypotrichosis, congenital, with juvenile macular dystrophy|Hypotrichosis With Cone-Rod Dystrophy|Juvenile macular dystrophy and congenital hypotrichosis	Eye disease|Skin disease
Juvenile-onset dystonia	MESH:C537704	OMIM:607371		MESH:D020821	C10.228.662.300/C537704	C10.228.662.300	DJO|Dystonia, juvenile-onset	Nervous system disease
Juvenile-onset scleroderma	MESH:C543759			MESH:D012594|MESH:D012595	C17.300.787/C543759|C17.300.799/C543759|C17.800.767/C543759|C17.800.784/C543759	C17.300.787|C17.300.799|C17.800.767|C17.800.784	Juvenile Scleroderma	Connective tissue disease|Skin disease
Juvenile osteoporosis	MESH:C537700			MESH:D010024	C05.116.198.579/C537700|C18.452.104.579/C537700	C05.116.198.579|C18.452.104.579	Childhood-Onset Primary Osteoporosis|Idiopathic juvenile osteoporosis|Juvenile Primary Osteoporosis|Osteoporosis, juvenile	Metabolic disease|Musculoskeletal disease
Juvenile pauciarticular chronic arthritis	MESH:C536312			MESH:D001171	C05.550.114.122/C536312|C05.799.056/C536312|C17.300.775.049/C536312|C20.111.198/C536312	C05.550.114.122|C05.799.056|C17.300.775.049|C20.111.198	Pauciarticular chronic arthritis	Connective tissue disease|Immune system disease|Musculoskeletal disease
Juvenile Polyposis with Hereditary Hemorrhagic Telangiectasia	MESH:C563412	OMIM:175050		MESH:D013683|MESH:D044483	C06.405.469.578/C563412|C14.907.454.900/C563412|C14.907.823.780/C563412|C15.378.463.515.900/C563412|C16.131.240.850.968/C563412	C06.405.469.578|C14.907.454.900|C14.907.823.780|C15.378.463.515.900|C16.131.240.850.968	JPHHT Syndrome|JP/HHT SYNDROME|JPHT|JPSHHT|JPS/HHT|Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome|JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME|JUVENILE POLYPOSIS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA|Polyposis, Generalized Juvenile, with Pulmonary Arteriovenous Malformation|Telangiectasia, Hereditary Hemorrhagic, with Juvenile Polyposis Coli	Blood disease|Cardiovascular disease|Congenital abnormality|Digestive system disease
Juvenile systemic scleroderma	MESH:C537703			MESH:D012595	C17.300.799/C537703|C17.800.784/C537703	C17.300.799|C17.800.784		Connective tissue disease|Skin disease
Kallikrein hypertension	MESH:C537707			MESH:D006973	C14.907.489/C537707	C14.907.489	Kallikrein attenuated hypertension	Cardiovascular disease
Kantaputra Gorlin syndrome	MESH:C535547	OMIM:156232		MESH:D001848|MESH:D005530	C05.116.099/C535547|C05.330/C535547	C05.116.099|C05.330	MDK|Mesomelic dysplasia, Kantaputra type|Mesomelic dysplasia, Thai type|Mesomelic dysplasia with ankle, carpal, and tarsal synostosis|MMDK	Musculoskeletal disease
Kaposiform Hemangioendothelioma	MESH:C537007			MESH:D006390|MESH:D012514|MESH:D059885	C01.925.256.466.860/C537007|C04.557.450.795.850/C537007|C04.557.645.375.370/C537007|C04.557.645.375.617/C537007|C04.557.645.750/C537007|C15.378.140.855.645/C537007	C01.925.256.466.860|C04.557.450.795.850|C04.557.645.375.370|C04.557.645.375.617|C04.557.645.750|C15.378.140.855.645	Congenital cutaneous multifocal kaposiform hemangioendothelioma|Kaposiform hemangio-endothelioma	Blood disease|Cancer|Viral disease
Kaposi Varicelliform Eruption	MESH:D007617	DO:DOID:9123	A disseminated vesicular-pustular eruption caused by the herpes simplex virus (HERPESVIRUS HOMINIS), the VACCINIA VIRUS, or Varicella zoster (HERPESVIRUS 3, HUMAN). It is usually superimposed on a preexisting, inactive or active, atopic dermatitis (DERMATITIS, ATOPIC).	MESH:D006561	C01.925.256.466.382.410|C01.925.825.320.410|C17.800.838.790.320.410	C01.925.256.466.382|C01.925.825.320|C17.800.838.790.320	Eczema Herpeticum|Eczema Vaccinatum|Eruption, Kaposi's Varicelliform|Eruption, Kaposi Varicelliform|Kaposi's Varicelliform Eruption|Kaposis Varicelliform Eruption|Varicelliform Eruption, Kaposi|Varicelliform Eruption, Kaposi's	Skin disease|Viral disease
Kappa-Chain Deficiency	MESH:C564131			MESH:D007153	C20.673/C564131	C20.673		Immune system disease
Karak Syndrome	MESH:C548029			MESH:D019150	C10.228.140.744/C548029	C10.228.140.744		Nervous system disease
Karoshi Death	MESH:D065907		Sudden death from overwork, most often as a result of acute CARDIOVASCULAR STROKE.	MESH:D016757	C14.280.383.220.500|C23.550.260.322.250.500	C14.280.383.220|C23.550.260.322.250	Death, Karoshi|Deaths, Karoshi|Karoshi-Death|Karoshi Deaths|Karoshi-Deaths	Cardiovascular disease|Pathology (process)
Kasabach-Merritt Syndrome	MESH:D059885		Rapidly growing vascular lesion along the midline axis of the neck, upper trunk, and extremities that is characterized by CONSUMPTION COAGULOPATHY; THROMBOCYTOPENIA; and HEMOLYTIC ANEMIA. It is often associated with infantile Kaposiform HEMANGIOENDOTHELIOMA and other vascular tumors such as tufted ANGIOMA.	MESH:D006391|MESH:D013921	C04.557.645.375.617|C15.378.140.855.645	C04.557.645.375|C15.378.140.855	Hemangioma Thrombocytopenia Syndrome|Hemangioma-Thrombocytopenia Syndrome|Hemangioma Thrombocytopenia Syndromes|Kasabach Merritt Phenomenon|Kasabach-Merritt Phenomenon|Kasabach Merritt Syndrome|Phenomenon, Kasabach-Merritt|Syndrome, Hemangioma Thrombocytopenia|Syndrome, Kasabach-Merritt|Syndromes, Hemangioma Thrombocytopenia|Syndromes, Thrombocytopenia-Hemangioma|Syndrome, Thrombocytopenia-Hemangioma|Thrombocytopenia Hemangioma Syndrome|Thrombocytopenia-Hemangioma Syndrome|Thrombocytopenia-Hemangioma Syndromes	Blood disease|Cancer
Kashin-Beck Disease	MESH:D057767		Disabling osteochondrodysplasia with OSTEOSCLEROSIS, cone-shaped METAPHYSIS, and shortening of the DIAPHYSIS. It is endemic in parts of Siberia and northern China. Mineral deficiencies (e.g., selenium, iodine), fungal cereal contamination, and water contamination may be contributing factors in its etiology.	MESH:D010009	C05.116.099.708.534	C05.116.099.708	Disease, Kashin-Beck|Kashin Beck Disease	Musculoskeletal disease
Kasznica Carlson Coppedge syndrome	MESH:C537011			MESH:D000015|MESH:D006330|MESH:D016137|MESH:D063173	C05.500.460.827/C537011|C05.660.207.540.460.827/C537011|C07.320.440.827/C537011|C07.320.610.827/C537011|C07.650.500.460.827/C537011|C10.500.680.800.730/C537011|C14.240.400/C537011|C14.280.400/C537011|C16.131.077/C537011|C16.131.240.400/C537011|C16.131.621.207.540.460.827/C537011|C16.131.666.680.800.730/C537011|C16.131.850.500.460.827/C537011	C05.500.460.827|C05.660.207.540.460.827|C07.320.440.827|C07.320.610.827|C07.650.500.460.827|C10.500.680.800.730|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.207.540.460.827|C16.131.666.680.800.730|C16.131.850.500.460.827	Ectrodactyly spina bifida cardiopathy	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease|Nervous system disease
Kearns-Sayre Syndrome	MESH:D007625	DO:DOID:12934|OMIM:530000	A mitochondrial disorder featuring the triad of chronic progressive EXTERNAL OPHTHALMOPLEGIA, cardiomyopathy (CARDIOMYOPATHIES) with conduction block (HEART BLOCK), and RETINITIS PIGMENTOSA. Disease onset is in the first or second decade. Elevated CSF protein, sensorineural deafness, seizures, and pyramidal signs may also be present. Ragged-red fibers are found on muscle biopsy. (Adams et al., Principles of Neurology, 6th ed, p984)	MESH:D009202|MESH:D012174|MESH:D017246	C05.651.460.700.500|C10.292.562.750.250.500|C10.597.622.447.511.500|C10.668.491.500.700.500|C11.590.472.250.500|C11.768.585.658.500.627|C14.280.238.510|C18.452.660.560.700.500|C23.550.291.500.688.500|C23.888.592.636.447.511.500	C05.651.460.700|C10.292.562.750.250|C10.597.622.447.511|C10.668.491.500.700|C11.590.472.250|C11.768.585.658.500|C14.280.238|C18.452.660.560.700|C23.550.291.500.688|C23.888.592.636.447.511	Chronic Progressive External Ophthalmoplegia with Myopathy|CPEO with Myopathies|CPEO with Myopathy|Cpeo With Ragged-Red Fibers|CPEO with Ragged Red Fibers|Cytopathies, Kearns-Sayre Mitochondrial|Cytopathy, Kearn-Sayre Mitochondrial|Cytopathy, Kearns-Sayre Mitochondrial|Kearn Sayre Mitochondrial Cytopathy|Kearn-Sayre Mitochondrial Cytopathy|Kearns-Sayre Mitochondrial Cytopathies|Kearns Sayre Mitochondrial Cytopathy|Kearns-Sayre Mitochondrial Cytopathy|Kearns Sayre Shy Daroff Syndrome|Kearns-Sayre-Shy-Daroff Syndrome|Kearns Sayre Syndrome|Kearns Syndrome|Kearns' Syndrome|Kearn Syndrome|KSS|Mitochondrial Cytopathies, Kearns-Sayre|MITOCHONDRIAL CYTOPATHY|Mitochondrial Cytopathy, Kearn-Sayre|Mitochondrial Cytopathy, Kearns-Sayre|Myopathies, CPEO with|Myopathy, CPEO with|Oculocraniosomatic Syndrome|Oculocraniosomatic Syndromes|Ophthalmoplegia, Pigmentary Degeneration of Retina, and Cardiomyopathy|Ophthalmoplegia Plus Syndrome|Ophthalmoplegia-Plus Syndrome|Ophthalmoplegia Plus Syndromes|Ophthalmoplegia-Plus Syndromes|Ophthalmoplegia, Progressive External, With Ragged-Red Fibers|Sayre Syndrome, Kearns|Syndrome, Kearns|Syndrome, Kearns'|Syndrome, Kearns Sayre|Syndrome, Kearns-Sayre|Syndrome, Kearns-Sayre-Shy-Daroff|Syndrome, Oculocraniosomatic|Syndrome, Ophthalmoplegia Plus|Syndrome, Ophthalmoplegia-Plus|Syndromes, Ophthalmoplegia-Plus	Cardiovascular disease|Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Keratitis	MESH:D007634	DO:DOID:4677	Inflammation of the cornea.	MESH:D003316	C11.204.564	C11.204	Keratitides	Eye disease
Keratitis, Dendritic	MESH:D007635	DO:DOID:0080158	A form of herpetic keratitis characterized by the formation of small vesicles which break down and coalesce to form recurring dendritic ulcers, characteristically irregular, linear, branching, and ending in knoblike extremities. (Dictionary of Visual Science, 3d ed)	MESH:D016849	C01.375.725.465.450|C01.925.256.466.382.465.450|C01.925.325.465.450|C11.204.564.425.450|C11.294.800.475.450	C01.375.725.465|C01.925.256.466.382.465|C01.925.325.465|C11.204.564.425|C11.294.800.475	Dendritic Keratitides|Dendritic Keratitis|Furrow Keratitides|Furrow Keratitis|Keratitides, Dendritic|Keratitides, Furrow|Keratitis, Furrow	Eye disease|Viral disease
Keratitis Fugax Hereditaria	MESH:C563650			MESH:D007634	C11.204.564/C563650	C11.204.564	Keratoendotheliitis Fugax Hereditaria	Eye disease
Keratitis, hereditary	MESH:C537022	DO:DOID:0111383|OMIM:148190		MESH:D007634	C11.204.564/C537022	C11.204.564	Dominantly inherited keratitis	Eye disease
Keratitis, Herpetic	MESH:D016849	DO:DOID:0080158	A superficial, epithelial Herpesvirus hominis infection of the cornea, characterized by the presence of small vesicles which may break down and coalesce to form dendritic ulcers (KERATITIS, DENDRITIC). (Dictionary of Visual Science, 3d ed)	MESH:D006561|MESH:D007634|MESH:D015828	C01.375.725.465|C01.925.256.466.382.465|C01.925.325.465|C11.204.564.425|C11.294.800.475	C01.375.725|C01.925.256.466.382|C01.925.325|C11.204.564|C11.294.800	Herpes Simplex Keratitides|Herpes Simplex Keratitis|Herpes Simplex, Ocular|Herpetic Keratitides|Herpetic Keratitis|Keratitides, Herpes Simplex|Keratitides, Herpetic|Keratitis, Herpes Simplex|Ocular Herpes Simplex	Eye disease|Viral disease
Keratitis-Ichthyosis-Deafness Syndrome	MESH:C580224			MESH:D007634	C11.204.564/C580224	C11.204.564	Keratitis, Ichthyosis, and Deafness	Eye disease
Keratitis sicca	MESH:C531719			MESH:D007638	C11.187.183.394.500/C531719|C11.204.564.585.630/C531719|C11.496.260.394/C531719	C11.187.183.394.500|C11.204.564.585.630|C11.496.260.394		Eye disease
Keratoacanthoma	MESH:D007636	DO:DOID:3149	A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.	MESH:D012871	C17.800.417	C17.800	Keratoacanthomas	Skin disease
Keratoacanthoma familial	MESH:C536150	OMIM:132800		MESH:D002277|MESH:D007636	C04.557.470.200/C536150|C17.800.417/C536150	C04.557.470.200|C17.800.417	Epithelioma, self-healing squamous, 1|ESS1, FORMERLY|Ferguson-Smith Type epithelioma|FERGUSON-SMITH-TYPE EPITHELIOMA|MSSE|Multiple self-healing squamous epithelioma|MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO	Cancer|Skin disease
Keratoactinomycosis	MESH:C000598941			MESH:D003320|MESH:D003607	C01.375.177/C000598941|C11.204.564.225/C000598941|C11.294.177/C000598941|C11.496.221/C000598941	C01.375.177|C11.204.564.225|C11.294.177|C11.496.221		Eye disease
Keratoconjunctivitis	MESH:D007637	DO:DOID:9368	Simultaneous inflammation of the cornea and conjunctiva.	MESH:D003231|MESH:D007634	C11.187.183.394|C11.204.564.585	C11.187.183|C11.204.564	Keratoconjunctivitides	Eye disease
Keratoconjunctivitis Sicca	MESH:D007638	DO:DOID:12895	Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME.	MESH:D007637|MESH:D015352	C11.187.183.394.500|C11.204.564.585.630|C11.496.260.394	C11.187.183.394|C11.204.564.585|C11.496.260	Sicca, Keratoconjunctivitis	Eye disease
Keratoconus	MESH:D007640	DO:DOID:10126	A noninflammatory, usually bilateral protrusion of the cornea, the apex being displaced downward and nasally. It occurs most commonly in females at about puberty. The cause is unknown but hereditary factors may play a role. The -conus refers to the cone shape of the corneal protrusion. (From Dorland, 27th ed)	MESH:D003316	C11.204.627	C11.204		Eye disease
Keratoconus 1	MESH:C563649	OMIM:148300		MESH:D007640	C11.204.627/C563649	C11.204.627	KTCN1	Eye disease
Keratoconus 2	MESH:C563827	OMIM:608932		MESH:D007640	C11.204.627/C563827	C11.204.627	KTCN2	Eye disease
Keratoconus 3	MESH:C563900	OMIM:608586		MESH:D007640	C11.204.627/C563900	C11.204.627	KTCN3	Eye disease
Keratoconus 4	MESH:C563752	OMIM:609271		MESH:D007640	C11.204.627/C563752	C11.204.627	KTCN4	Eye disease
Keratoconus posticus circumscriptus	MESH:C536151			MESH:D007640	C11.204.627/C536151	C11.204.627		Eye disease
Keratosis	MESH:D007642	DO:DOID:161	Any horny growth such as a wart or callus.	MESH:D012871	C17.800.428	C17.800	Blennorrhagica, Keratosis|Blennorrhagicas, Keratosis|Blennorrhagicum, Keratoderma|Blennorrhagicums, Keratoderma|Keratoderma Blennorrhagicum|Keratoderma Blennorrhagicums|Keratoma|Keratomas|Keratoses|Keratosis Blennorrhagica|Keratosis Blennorrhagicas	Skin disease
Keratosis, Actinic	MESH:D055623	DO:DOID:8866	White or pink lesions on the arms, hands, face, or scalp that arise from sun-induced DNA DAMAGE to KERATINOCYTES in exposed areas. They are considered precursor lesions to superficial SQUAMOUS CELL CARCINOMA.	MESH:D007642|MESH:D011230	C04.834.450|C17.800.428.570	C04.834|C17.800.428	Actinic Keratoses|Actinic Keratosis|Keratoses, Actinic	Cancer|Skin disease
Keratosis, Familial Actinic	MESH:C567190			MESH:D055623	C04.834.450/C567190|C17.800.428.570/C567190	C04.834.450|C17.800.428.570		Cancer|Skin disease
Keratosis, Seborrheic	MESH:D017492	DO:DOID:6498|OMIM:182000	Benign eccrine poromas that present as multiple oval, brown-to-black plaques, located mostly on the chest and back. The age of onset is usually in the fourth or fifth decade.	MESH:D007642	C17.800.428.580	C17.800.428	Keratoses, Seborrheic|Keratosis Seborrheica|Seborrheic Keratoses|Seborrheic Keratosis	Skin disease
Kernicterus	MESH:D007647	DO:DOID:2382	A term used pathologically to describe BILIRUBIN staining of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER (e.g., SEPSIS). This condition occurs primarily in neonates (INFANT, NEWBORN), but may rarely occur in adults. (Menkes, Textbook of Child Neurology, 5th ed, p613)	MESH:D001928|MESH:D004899|MESH:D006932	C10.228.140.163.480|C15.378.295.502|C16.614.304.502|C18.452.132.480|C20.306.502|C23.550.429.750	C10.228.140.163|C15.378.295|C16.614.304|C18.452.132|C20.306|C23.550.429	Bilirubin Encephalopathies|Bilirubin Encephalopathy|Encephalopathies, Bilirubin|Encephalopathies, Hyperbilirubinemic|Encephalopathy, Bilirubin|Encephalopathy, Hyperbilirubinemic|Hyperbilirubinemic Encephalopathies|Hyperbilirubinemic Encephalopathy	Blood disease|Immune system disease|Infant-newborn disease|Metabolic disease|Nervous system disease|Pathology (process)
Keshan disease	MESH:C536166			MESH:D004769|MESH:D009202	C01.925.782.687.359/C536166|C14.280.238/C536166	C01.925.782.687.359|C14.280.238		Cardiovascular disease|Viral disease
Ketosis	MESH:D007662		A condition characterized by an abnormally elevated concentration of KETONE BODIES in the blood (acetonemia) or urine (acetonuria). It is a sign of DIABETES COMPLICATION, starvation, alcoholism or a mitochondrial metabolic disturbance (e.g., MAPLE SYRUP URINE DISEASE).	MESH:D000138	C18.452.076.176.652	C18.452.076.176	Acetonemia|Acetonemias|Acetonuria|Acetonurias|Ketoacidemia|Ketoacidemias|Ketoacidoses|Ketoacidoses, Metabolic|Ketoacidosis|Ketoacidosis, Metabolic|Ketoaciduria|Ketoacidurias|Ketonemia|Ketonemias|Ketonuria|Ketonurias|Ketoses, Metabolic|Ketosis, Metabolic|Metabolic Ketoacidoses|Metabolic Ketoacidosis|Metabolic Ketoses|Metabolic Ketosis	Metabolic disease
Keutel syndrome	MESH:C536167	OMIM:245150		MESH:D000015|MESH:D002114|MESH:D002357|MESH:D006228|MESH:D011666	C05.182/C536167|C05.390.408/C536167|C05.660.585.988.425/C536167|C14.280.484.716/C536167|C14.280.955.750/C536167|C16.131.077/C536167|C16.131.621.585.988.500/C536167|C17.300.182/C536167|C18.452.174.130/C536167	C05.182|C05.390.408|C05.660.585.988.425|C14.280.484.716|C14.280.955.750|C16.131.077|C16.131.621.585.988.500|C17.300.182|C18.452.174.130	KTLS|Pulmonic stenosis, brachytelephalangism, and calcification of cartilages	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Metabolic disease|Musculoskeletal disease
Kidney Calculi	MESH:D007669		Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE.	MESH:D014545|MESH:D053040	C12.050.351.968.419.600.500|C12.050.351.968.967.249.500|C12.050.351.968.967.500.503|C12.200.777.419.600.500|C12.200.777.967.249.500|C12.200.777.967.500.503|C12.950.419.600.500|C12.950.967.249.500|C12.950.967.500.503|C23.300.175.850.550	C12.050.351.968.419.600|C12.050.351.968.967.249|C12.050.351.968.967.500|C12.200.777.419.600|C12.200.777.967.249|C12.200.777.967.500|C12.950.419.600|C12.950.967.249|C12.950.967.500|C23.300.175.850	Calculi, Kidney|Calculi, Renal|Calculus, Kidney|Calculus, Renal|Kidney Calculus|Kidney Stone|Kidney Stones|Nephrolith|Renal Calculi|Renal Calculus|Stone, Kidney|Stones, Kidney	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules	MESH:C531755			MESH:D009397	C12.050.351.968.419.590/C531755|C12.200.777.419.590/C531755|C12.950.419.590/C531755|C18.452.174.130.560/C531755	C12.050.351.968.419.590|C12.200.777.419.590|C12.950.419.590|C18.452.174.130.560		Metabolic disease|Urogenital disease (female)|Urogenital disease (male)
Kidney Failure, Chronic	MESH:D007676	DO:DOID:784	The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.	MESH:D051436	C12.050.351.968.419.780.750.500|C12.200.777.419.780.750.500|C12.950.419.780.750.500|C23.550.291.500.906.500	C12.050.351.968.419.780.750|C12.200.777.419.780.750|C12.950.419.780.750|C23.550.291.500.906	Chronic Kidney Failure|Chronic Renal Failure|Disease, End-Stage Kidney|Disease, End-Stage Renal|End Stage Kidney Disease|End-Stage Kidney Disease|End Stage Renal Disease|End-Stage Renal Disease|End-Stage Renal Failure|ESRD|Kidney Disease, End-Stage|Renal Disease, End Stage|Renal Disease, End-Stage|Renal Failure, Chronic|Renal Failure, End Stage|Renal Failure, End-Stage	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Kidney Neoplasms	MESH:D007680	DO:DOID:263	Tumors or cancers of the KIDNEY.	MESH:D007674|MESH:D014571	C04.588.945.947.535|C12.050.351.937.820.535|C12.050.351.968.419.473|C12.200.758.820.750|C12.200.777.419.473|C12.900.820.535|C12.950.419.473|C12.950.983.535	C04.588.945.947|C12.050.351.937.820|C12.050.351.968.419|C12.200.758.820|C12.200.777.419|C12.900.820|C12.950.419|C12.950.983	Cancer, Kidney|Cancer of Kidney|Cancer of the Kidney|Cancer, Renal|Cancers, Kidney|Cancers, Renal|Kidney Cancer|Kidney Cancers|Kidney Neoplasm|Neoplasm, Kidney|Neoplasm, Renal|Neoplasms, Kidney|Neoplasms, Renal|Renal Cancer|Renal Cancers|Renal Neoplasm|Renal Neoplasms	Cancer|Urogenital disease (female)|Urogenital disease (male)
Kifafa seizure disorder	MESH:C537708			MESH:D004827	C10.228.140.490/C537708	C10.228.140.490	Complex familial seizure disorder|Vitsala	Nervous system disease
Kimura Disease	MESH:D000082242	DO:DOID:7365	A chronic inflammatory disease characterized by benign enlargement of cervical LYMPH NODE and SALIVARY GLANDS with increased levels of IMMUNOGLOBULIN E. Unlike ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA it involves eosinophil infiltrates in lymph node and salivary glands and mostly found in Asian males.	MESH:D004802|MESH:D008199|MESH:D012466	C07.465.815.178|C15.378.553.231.774|C15.604.315.459	C07.465.815|C15.378.553.231|C15.604.315	Disease, Kimura|Disease, Kimura's|Eosinophilic Granuloma of Soft Tissue|Eosinophilic Hyperplastic Lymphogranuloma|Eosinophilic Hyperplastic Lymphogranulomas|Eosinophilic Lymphofollicular Granuloma|Eosinophilic Lymphofollicular Granulomas|Eosinophilic Lymphofolliculoses|Eosinophilic Lymphofolliculosis|Granuloma, Eosinophilic Lymphofollicular|Hyperplastic Lymphogranuloma, Eosinophilic|Kimura's Disease|Kimuras Disease|Kimura's Diseases|Lymphofollicular Granuloma, Eosinophilic|Lymphofolliculosis, Eosinophilic|Lymphogranuloma, Eosinophilic Hyperplastic	Blood disease|Lymphatic disease|Mouth disease
Kininogen Deficiency, High Molecular Weight and Low Molecular Weight	MESH:C567116			MESH:D001796	C15.378.147/C567116	C15.378.147		Blood disease
Klatskin Tumor	MESH:D018285	DO:DOID:4927	Cholangiocarcinoma arising near or at the confluence of the right and left hepatic ducts (COMMON HEPATIC DUCT). These tumors are generally small, sharply localized, and seldom metastasizing.	MESH:D018281	C04.557.470.200.025.450.500	C04.557.470.200.025.450	Cholangiocarcinoma, Hilar|Cholangiocarcinoma, Perihilar|Cholangiocarcinomas, Hilar|Cholangiocarcinomas, Perihilar|Hilar Cholangiocarcinoma|Hilar Cholangiocarcinomas|Klatskin's Tumor|Klatskins Tumor|Perihilar Cholangiocarcinoma|Perihilar Cholangiocarcinomas|Tumor, Klatskin|Tumor, Klatskin's	Cancer
Kleefstra Syndrome	MESH:C563043	DO:DOID:0060352|OMIM:610253		MESH:D002872|MESH:D006330|MESH:D008607|MESH:D019465	C05.660.207/C563043|C10.597.606.360/C563043|C14.240.400/C563043|C14.280.400/C563043|C16.131.240.400/C563043|C16.131.621.207/C563043|C23.550.210.050.500.500/C563043|C23.888.592.604.646/C563043|F03.625.539/C563043	C05.660.207|C10.597.606.360|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207|C23.550.210.050.500.500|C23.888.592.604.646|F03.625.539	9q34.3 Deletion Syndrome|9q34.3 Microdeletion Syndrome|9q Subtelomeric Deletion Syndrome|9q- Syndrome|Chromosome 9q34.3 Deletion Syndrome|KLEEFSTRA SYNDROME 1|KLEFS1	Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Klippel-Trenaunay-Weber Syndrome	MESH:D007715	DO:DOID:2926|OMIM:149000	A congenital disorder that is characterized by a triad of capillary malformations (HEMANGIOMA), venous malformations (ARTERIOVENOUS FISTULA), and soft tissue or bony hypertrophy of the limb. This syndrome is caused by mutations in the VG5Q gene which encodes a strong angiogenesis stimulator.	MESH:D000798	C14.907.077.410	C14.907.077	Angioosteohypertrophy Syndrome|Angio Osteohypertrophy Syndrome|Angio-Osteohypertrophy Syndrome|Angioosteohypertrophy Syndromes|Angio-Osteohypertrophy Syndromes|Angiopathies, Congenital Dysplastic|Angiopathy, Congenital Dysplastic|Congenital Dysplastic Angiopathies|Congenital Dysplastic Angiopathy|Disease, Klippel-Trenaunay|Dysplastic Angiopathies, Congenital|Dysplastic Angiopathy, Congenital|Klippel Trenaunay Disease|Klippel-Trenaunay Disease|Klippel Trenaunay Syndrome|Klippel-Trenaunay Syndrome|Klippel-Trenaunay Syndromes|Klippel Trenaunay Weber Syndrome|Klippel Trénaunay Weber Syndrome|Klippel-Trénaunay-Weber Syndrome|KTS|KTW Syndrome|KTW Syndromes|Syndrome, Angioosteohypertrophy|Syndrome, Angio-Osteohypertrophy|Syndrome, Klippel Trenaunay|Syndrome, Klippel-Trenaunay|Syndrome, Klippel-Trenaunay-Weber|Syndrome, Klippel-Trénaunay-Weber|Syndrome, KTW|Syndromes, Angioosteohypertrophy|Syndromes, Angio-Osteohypertrophy|Syndromes, Klippel-Trenaunay|Syndromes, KTW	Cardiovascular disease
Knee Dislocation	MESH:D031221		Slippage of the FEMUR off the TIBIA.	MESH:D004204|MESH:D007718	C05.550.518.500|C26.289.500|C26.558.554.500	C05.550.518|C26.289|C26.558.554	Dislocation, Knee|Dislocations, Knee|Knee Dislocations	Musculoskeletal disease|Wounds and injuries
Korsakoff Syndrome	MESH:D020915	DO:DOID:10915|OMIM:277730	An acquired cognitive disorder characterized by inattentiveness and the inability to form short term memories. This disorder is frequently associated with chronic ALCOHOLISM; but it may also result from dietary deficiencies; CRANIOCEREBRAL TRAUMA; NEOPLASMS; CEREBROVASCULAR DISORDERS; ENCEPHALITIS; EPILEPSY; and other conditions. (Adams et al., Principles of Neurology, 6th ed, p1139)	MESH:D008569	C10.597.606.525.400|C23.888.592.604.529.400	C10.597.606.525|C23.888.592.604.529	ALCOHOL-INDUCED ENCEPHALOPATHY|Korsakoff Psychoses|Korsakoff Psychosis|Psychoses, Korsakoff|Psychosis, Korsakoff|TRANSKETOLASE DEFECT|Wernicke Korsakoff Syndrome|Wernicke-Korsakoff Syndrome|Wernicke-Korsakoff Syndromes	Nervous system disease|Signs and symptoms
Kounis Syndrome	MESH:D000074962		A disorder of cardiac function secondary to hypersensitivity reactions. It is characterized by coexistence of acute coronary syndromes and cardiac MAST CELL and PLATELET ACTIVATION. It may be induced by exposure to drugs (e.g., antibiotics, anesthetics, contrast media), food, and environmental triggers (e.g., insect bites and stings, poison ivy).	MESH:D006967|MESH:D017202	C14.280.647.375|C14.907.585.375|C20.543.560	C14.280.647|C14.907.585|C20.543	Allergic Acute Coronary Syndrome|Allergic Angina Syndrome|Allergic Angina Syndromes|Allergic Myocardial Infarction|Allergic Myocardial Infarctions|Myocardial Infarction, Allergic	Cardiovascular disease|Immune system disease
Kousseff Nichols syndrome	MESH:C537504			MESH:D009634	C05.660.207.690/C537504|C14.240.400.787/C537504|C14.280.400.787/C537504|C16.131.240.400.784/C537504|C16.131.621.207.690/C537504|C17.300.690/C537504	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	Noonan like contracture myopathy hyperpyrexia	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
Kowarski syndrome	MESH:C537505	OMIM:262650		MESH:D004393	C05.116.099.343.445/C537505|C05.116.132.358/C537505|C10.228.140.617.738.300.300/C537505|C19.297.312/C537505|C19.700.482.311/C537505	C05.116.099.343.445|C05.116.132.358|C10.228.140.617.738.300.300|C19.297.312|C19.700.482.311	BIODEFECTIVE GROWTH HORMONE|Nanism due to growth hormone qualitative anomaly|Pituitary dwarfism 4|Pituitary dwarfism with normal immunoreactive growth hormone|Pituitary Dwarfism With Normal Immunoreactive Growth Hormone And Low Somatomedin	Endocrine system disease|Musculoskeletal disease|Nervous system disease
Kozlowski Rafinski Klicharska syndrome	MESH:C537509			MESH:D001848|MESH:D002386|MESH:D006130|MESH:D008607|MESH:D011596|MESH:D019066	C05.116.099/C537509|C10.597.606.360/C537509|C10.597.606.881/C537509|C11.510.245/C537509|C23.550.291.812/C537509|C23.550.393/C537509|C23.888.592.604.646/C537509|C23.888.592.604.882/C537509|F03.625.539/C537509	C05.116.099|C10.597.606.360|C10.597.606.881|C11.510.245|C23.550.291.812|C23.550.393|C23.888.592.604.646|C23.888.592.604.882|F03.625.539	Metaphyseal and epiphyseal dysplasia with unusual facies and cataract	Eye disease|Mental disorder|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Krukenberg Tumor	MESH:D007725	DO:DOID:9597	Mucocellular carcinoma of the ovary, usually metastatic from the gastrointestinal tract, characterized by areas of mucoid degeneration and the presence of signet-ring-like cells. It accounts for 30%-40% of metastatic cancers to the ovaries and possibly 1%-2% of all malignant ovarian tumors. The lesions may not be discovered until the primary disease is advanced, and most patients die of their disease within a year. In some cases, a primary tumor is not found. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1685)	MESH:D018279	C04.557.470.200.025.415.410|C04.557.470.590.415.410	C04.557.470.200.025.415|C04.557.470.590.415	Carcinoma, Krukenberg|Krukenberg Carcinoma|Krukenberg's Tumor|Krukenbergs Tumor|Tumor, Krukenberg|Tumor, Krukenberg's	Cancer
Kufor-Rakeb syndrome	MESH:C537177	DO:DOID:0060556|OMIM:606693		MESH:D020734	C10.228.140.079.862/C537177|C10.228.662.600/C537177	C10.228.140.079.862|C10.228.662.600	KRPPD|KRPPD Kufor Rakeb pallidopyramidal degeneration with supranuclear upgaze paresis and dementia|KRS|Pallidopyramidal Degeneration with Supranuclear Upgaze Paresis and Dementia|PARK9|Parkinson disease 9|PARKINSON DISEASE 9, AUTOSOMAL RECESSIVE, JUVENILE-ONSET	Nervous system disease
Kuru	MESH:D007729	DO:DOID:648|OMIM:245300	A prion disease found exclusively among the Fore linguistic group natives of the highlands of NEW GUINEA. The illness is primarily restricted to adult females and children of both sexes. It is marked by the subacute onset of tremor and ataxia followed by motor weakness and incontinence. Death occurs within 3-6 months of disease onset. The condition is associated with ritual cannibalism, and has become rare since this practice has been discontinued. Pathologic features include a noninflammatory loss of neurons that is most prominent in the cerebellum, glial proliferation, and amyloid plaques. (From Adams et al., Principles of Neurology, 6th ed, p773)	MESH:D017096	C01.207.800.435|C10.228.228.800.435|C10.574.843.625	C01.207.800|C10.228.228.800|C10.574.843	Encephalopathy, Kuru|Kuru Encephalopathy|KURU, SUSCEPTIBILITY TO	Nervous system disease
Kyasanur Forest Disease	MESH:D007733	DO:DOID:11320	Tick-borne flavivirus infection occurring in the Kyasanur Forest in India.	MESH:D001102|MESH:D006482|MESH:D017282|MESH:D018177	C01.920.930.475|C01.925.081.656|C01.925.782.350.250.635|C01.925.782.417.475	C01.920.930|C01.925.081|C01.925.782.350.250|C01.925.782.417	Kyasanur Forest Disease Virus Infection	Viral disease
Kyphoscoliosis 1	MESH:C565711	OMIM:610170		MESH:D007738|MESH:D012600	C05.116.900.800.500/C565711|C05.116.900.800.875/C565711	C05.116.900.800.500|C05.116.900.800.875	KYPSC1	Musculoskeletal disease
Kyphosis	MESH:D007738		Deformities of the SPINE characterized by an exaggerated convexity of the vertebral column. The forward bending of the thoracic region usually is more than 40 degrees. This deformity sometimes is called round back or hunchback.	MESH:D013121	C05.116.900.800.500	C05.116.900.800	Hyperkyphoses|Hyperkyphosis|Kyphoses	Musculoskeletal disease
Labyrinth Diseases	MESH:D007759	DO:DOID:2952	Pathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS).	MESH:D004427	C09.218.568	C09.218	Ear Disease, Inner|Ear Diseases, Inner|Inner Ear Disease|Inner Ear Diseases|Labyrinth Disease	Ear-nose-throat disease
Labyrinthitis	MESH:D007762	DO:DOID:1468	Inflammation of the inner ear (LABYRINTH).	MESH:D007759|MESH:D010031	C09.218.568.558|C09.218.705.371	C09.218.568|C09.218.705	Labyrinthitides|Otitis Interna	Ear-nose-throat disease
Lachiewicz Sibley syndrome	MESH:C538131			MESH:D004427|MESH:D005402|MESH:D007674	C09.218/C538131|C12.050.351.968.419/C538131|C12.200.777.419/C538131|C12.950.419/C538131|C23.300.575/C538131	C09.218|C12.050.351.968.419|C12.200.777.419|C12.950.419|C23.300.575	Hereditary renal disease and preauricular pits	Ear-nose-throat disease|Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Lacrimal Apparatus Diseases	MESH:D007766	DO:DOID:13757|DO:DOID:1400	Diseases of the LACRIMAL APPARATUS.	MESH:D005128	C11.496	C11	Apparatus Disease, Lacrimal|Apparatus Diseases, Lacrimal|Disease, Lacrimal Apparatus|Diseases, Lacrimal Apparatus|Epiphora|Epiphoras|Lacrimal Apparatus Disease	Eye disease
Lacrimal Duct Obstruction	MESH:D007767	DO:DOID:13929|OMIM:149700	Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)	MESH:D007766	C11.496.456	C11.496	Duct Obstruction, Lacrimal|Duct Obstruction, Nasolacrimal|Duct Obstruction, Tear|LACRIMAL DUCT DEFECT|Lacrimal Duct Obstructions|LACRIMAL PUNCTA, ABSENCE OF|LCDD|Nasolacrimal Duct Obstruction|Nasolacrimal Duct Obstructions|Obstruction, Lacrimal Duct|Obstruction, Nasolacrimal Duct|Obstruction, Tear Duct|Tear Duct Obstruction|Tear Duct Obstructions	Eye disease
Lacrimal Puncta, Absence of	MESH:C566703			MESH:D007766	C11.496/C566703	C11.496		Eye disease
Lactic Acidosis, Chronic Adult Form	MESH:C563640			MESH:D000140	C18.452.076.176.180/C563640	C18.452.076.176.180		Metabolic disease
Lactic acidosis congenital infantile	MESH:C538134			MESH:D000140	C18.452.076.176.180/C538134	C18.452.076.176.180		Metabolic disease
Lactic Acidosis, Fatal Infantile	MESH:C566885			MESH:D000140	C18.452.076.176.180/C566885	C18.452.076.176.180		Metabolic disease
Lambert-Eaton Myasthenic Syndrome	MESH:D015624	DO:DOID:0050214	An autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle, lower extremities, trunk, and shoulder girdle. There is relative sparing of extraocular and bulbar muscles. CARCINOMA, SMALL CELL of the lung is a frequently associated condition, although other malignancies and autoimmune diseases may be associated. Muscular weakness results from impaired impulse transmission at the NEUROMUSCULAR JUNCTION. Presynaptic calcium channel dysfunction leads to a reduced amount of acetylcholine being released in response to stimulation of the nerve. (From Adams et al., Principles of Neurology, 6th ed, pp 1471)	MESH:D009157	C04.588.614.550.500.225|C04.730.856.490.225|C10.114.656.150|C10.574.781.588.225|C10.668.758.725.150|C20.111.258.500.150	C04.588.614.550.500|C04.730.856.490|C10.114.656|C10.574.781.588|C10.668.758.725|C20.111.258.500	Eaton-Lambert Myasthenic-Myopathic Syndrome|Eaton Lambert Myasthenic Syndrome|Eaton-Lambert Myasthenic Syndrome|Eaton-Lambert Myopathic-Myasthenic Syndrome|Eaton-Lambert Myopathic-Myasthenic Syndromes|Eaton Lambert Syndrome|Eaton-Lambert Syndrome|Lambert-Eaton Myasthenic-Myopathic Syndrome|Lambert-Eaton Myasthenic-Myopathic Syndromes|Lambert Eaton Myasthenic Syndrome|Lambert-Eaton Myopathic-Myasthenic Syndrome|Lambert-Eaton Myopathic-Myasthenic Syndromes|Lambert Eaton Syndrome|Lambert-Eaton Syndrome|Myasthenic Myopathic Syndrome of Eaton Lambert|Myasthenic-Myopathic Syndrome of Eaton-Lambert|Myasthenic Myopathic Syndrome of Lambert Eaton|Myasthenic-Myopathic Syndrome of Lambert-Eaton|Myasthenic Syndrome, Eaton-Lambert|Myasthenic Syndrome, Lambert Eaton|Myasthenic Syndrome, Lambert-Eaton|Myopathic Myasthenic Syndrome of Eaton Lambert|Myopathic-Myasthenic Syndrome of Eaton-Lambert|Myopathic-Myasthenic Syndrome of Lambert-Eaton|Syndrome, Eaton-Lambert|Syndrome, Eaton-Lambert Myasthenic|Syndrome, Lambert-Eaton|Syndrome, Lambert-Eaton Myasthenic	Cancer|Immune system disease|Nervous system disease
Landau-Kleffner Syndrome	MESH:D018887	DO:DOID:2538	A syndrome characterized by the onset of isolated language dysfunction in otherwise normal children (age of onset 4-7 years) and epileptiform discharges on ELECTROENCEPHALOGRAPHY. Seizures, including atypical absence (EPILEPSY, ABSENCE), complex partial (EPILEPSY, COMPLEX PARTIAL), and other types may occur. The electroencephalographic abnormalities and seizures tend to resolve by puberty. The language disorder may also resolve although some individuals are left with severe language dysfunction, including APHASIA and auditory AGNOSIA. (From Menkes, Textbook of Child Neurology, 5th ed, pp749-50; J Child Neurol 1997 Nov;12(8):489-495).	MESH:D000073376	C10.228.140.490.493.500	C10.228.140.490.493	Acquired Aphasia with Convulsive Disorder|Acquired Childhoood Aphasia with Convulsive Disorder|Acquired Epileptic Aphasia|Acquired Epileptic Aphasias|Acquired Epileptiform Aphasia|Acquired Epileptiform Aphasias|Aphasia, Acquired Epileptic|Aphasia, Acquired, With Convulsive Disorder|Aphasia, Epileptic, Acquired|Epileptic Aphasia, Acquired|Epileptic Aphasias, Acquired|Epileptiform Aphasia, Acquired|Epileptiform Aphasias, Acquired|Landau Kleffner Acquired Epileptiform Aphasia|Landau-Kleffner Acquired Epileptiform Aphasia|Landau Kleffner Syndrome|Syndrome, Landau-Kleffner	Nervous system disease
Langer-Giedion Syndrome	MESH:D015826	DO:DOID:4998|OMIM:150230	Autosomal dominant disorder characterized by cone-shaped epiphyses in the hands and multiple cartilaginous exostoses. INTELLECTUAL DISABILITY and abnormalities of chromosome 8 are often present. The exostoses in this syndrome appear identical to those of hereditary multiple exostoses (EXOSTOSES, HEREDITARY MULTIPLE).	MESH:D010009	C05.116.099.708.582	C05.116.099.708	Acrodysplasia V|Acrodysplasia Vs|CHROMOSOME 8q24.1 DELETION SYNDROME|Giedion Langer Syndrome|Giedion-Langer Syndrome|Langer Giedion Syndrome|LANGER-GIEDION SYNDROME|LGS|Syndrome, Giedion-Langer|Syndrome, Langer-Giedion|Trichorhinophalangeal Syndrome Type 2|Trichorhinophalangeal Syndrome Type II|Trichorhinophalangeal Syndrome, Type II|Tricho Rhino Phalangeal Syndrome Type II|Tricho-Rhino-Phalangeal Syndrome Type II|Trichorhinophalangeal Syndrome with Exostoses|TRPS2|TRPSII	Musculoskeletal disease
Langerhans Cell Sarcoma	MESH:D054752	DO:DOID:7146	Rare malignant neoplasm of dendritic LANGERHANS CELLS exhibiting atypical cytology, frequent mitoses, and aggressive clinical behavior. They can be distinguished from other histiocytic and dendritic proliferations by immunohistochemical and ultrastructure studies. Cytologically benign proliferations of Langerhans cells are called LANGERHANS CELL HISTIOCYTOSIS.	MESH:D015620	C04.557.227.500|C15.604.250.390.500	C04.557.227|C15.604.250.390	Langerhans Cell Sarcomas|Sarcoma, Langerhans Cell|Sarcomas, Langerhans Cell	Cancer|Lymphatic disease
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA	OMIM:617182			MESH:D001145|MESH:D001289|MESH:D003072|MESH:D007805	C10.597.606.150.500.550/617182|C14.280.067/617182|C23.550.073/617182|C23.888.592.604.150.500.550/617182|F03.615.250/617182|F03.625.094.150/617182	C10.597.606.150.500.550|C14.280.067|C23.550.073|C23.888.592.604.150.500.550|F03.615.250|F03.625.094.150	LADCI	Cardiovascular disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Language Development Disorders	MESH:D007805		Conditions characterized by language abilities (comprehension and expression of speech and writing) that are below the expected level for a given age, generally in the absence of an intellectual impairment. These conditions may be associated with DEAFNESS; BRAIN DISEASES; MENTAL DISORDERS; or environmental factors.	MESH:D007806	C10.597.606.150.500.550|C23.888.592.604.150.500.550	C10.597.606.150.500|C23.888.592.604.150.500	Auditory Processing Disorder, Central|Central Auditory Processing Disorder|Delay, Speech|Delays, Speech|Developmental Disorder, Speech or Language|Developmental Language Disorder|Developmental Language Disorders|Development Disorder, Language|Disorder, Language Development|Disorders, Language Development|Language Delay|Language Delays|Language Development Disorder|Language Disorder, Developmental|Language Disorders, Developmental|Semantic Pragmatic Disorder|Semantic-Pragmatic Disorder|Semantic-Pragmatic Disorders|Speech Delay|Speech Delays|Speech or Language, Developmental Disorder	Nervous system disease|Signs and symptoms
Language Disorders	MESH:D007806	DO:DOID:93	Conditions characterized by deficiencies of comprehension or expression of written and spoken forms of language. These include acquired and developmental disorders.	MESH:D003147	C10.597.606.150.500|C23.888.592.604.150.500	C10.597.606.150|C23.888.592.604.150	Acquired Language Disorder|Acquired Language Disorders|Language Disorder|Language Disorder, Acquired|Language Disorders, Acquired	Nervous system disease|Signs and symptoms
Laryngeal Abductor Paralysis with Cerebellar Ataxia and Motor Neuropathy	MESH:C565252			MESH:D002524|MESH:D011115|MESH:D014826|MESH:D055154	C08.360.931/C565252|C08.360.940.325/C565252|C09.400.931/C565252|C09.400.940.325/C565252|C10.228.140.252.190/C565252|C10.292.887.800/C565252|C10.597.350.090.500/C565252|C10.597.622.943/C565252|C10.597.975.325/C565252|C10.668.829.800/C565252|C23.888.592.350.090.200/C565252|C23.888.592.636.943/C565252|C23.888.592.979.325/C565252	C08.360.931|C08.360.940.325|C09.400.931|C09.400.940.325|C10.228.140.252.190|C10.292.887.800|C10.597.350.090.500|C10.597.622.943|C10.597.975.325|C10.668.829.800|C23.888.592.350.090.200|C23.888.592.636.943|C23.888.592.979.325		Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Laryngeal Adductor Paralysis	MESH:C562861	OMIM:150270		MESH:D014826	C08.360.931/C562861|C09.400.931/C562861|C10.292.887.800/C562861|C10.597.622.943/C562861|C23.888.592.636.943/C562861	C08.360.931|C09.400.931|C10.292.887.800|C10.597.622.943|C23.888.592.636.943	LAP|Vocal Cord Dysfunction, Adductor Type	Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Laryngeal Diseases	MESH:D007818	DO:DOID:786	Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.	MESH:D010038|MESH:D012140	C08.360|C09.400	C08|C09	Disease, Laryngeal|Disease, Larynx|Diseases, Laryngeal|Diseases, Larynx|Laryngeal Disease|Laryngeal Perichondritides|Laryngeal Perichondritis|Larynx Disease|Larynx Diseases|Perichondritides, Laryngeal|Perichondritis, Laryngeal	Ear-nose-throat disease|Respiratory tract disease
Laryngeal Edema	MESH:D007819		Abnormal accumulation of fluid in tissues of any part of the LARYNX, commonly associated with laryngeal injuries and allergic reactions.	MESH:D007818	C08.360.313|C09.400.313	C08.360|C09.400	Edema, Laryngeal|Edemas, Laryngeal|Laryngeal Edemas	Ear-nose-throat disease|Respiratory tract disease
Laryngeal Neoplasms	MESH:D007822	DO:DOID:2596|DO:DOID:2598	Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.	MESH:D007818|MESH:D010039|MESH:D012142	C04.588.443.665.481|C08.360.369|C08.785.481|C09.400.369|C09.647.481	C04.588.443.665|C08.360|C08.785|C09.400|C09.647	Cancer, Laryngeal|Cancer, Larynx|Cancer of Larynx|Cancer of the Larynx|Cancers, Laryngeal|Cancers, Larynx|Laryngeal Cancer|Laryngeal Cancers|Laryngeal Neoplasm|Larynx Cancer|Larynx Cancers|Larynx Neoplasm|Larynx Neoplasms|Neoplasm, Laryngeal|Neoplasm, Larynx|Neoplasms, Laryngeal|Neoplasms, Larynx	Cancer|Ear-nose-throat disease|Respiratory tract disease
Laryngeal Nerve Injuries	MESH:D061224		Traumatic injuries to the LARYNGEAL NERVE.	MESH:D007818|MESH:D061223	C08.360.424|C09.400.424|C10.292.200.937.750|C10.900.300.218.887.750|C26.915.300.400.912.750	C08.360|C09.400|C10.292.200.937|C10.900.300.218.887|C26.915.300.400.912	Avulsion, Laryngeal Nerve|Avulsions, Laryngeal Nerve|Contusion, Laryngeal Nerve|Contusions, Laryngeal Nerve|Injuries, Laryngeal Nerve|Injury, Laryngeal Nerve|Laryngeal Nerve Avulsion|Laryngeal Nerve Avulsions|Laryngeal Nerve Contusion|Laryngeal Nerve Contusions|Laryngeal Nerve Injury|Laryngeal Nerve Transection|Laryngeal Nerve Transections|Laryngeal Nerve Trauma|Laryngeal Nerve Traumas|Laryngeal Neuropathies, Traumatic|Laryngeal Neuropathy, Traumatic|Nerve Avulsion, Laryngeal|Nerve Avulsions, Laryngeal|Nerve Contusion, Laryngeal|Nerve Contusions, Laryngeal|Nerve Injuries, Laryngeal|Nerve Injury, Laryngeal|Nerve Transection, Laryngeal|Nerve Transections, Laryngeal|Nerve Trauma, Laryngeal|Nerve Traumas, Laryngeal|Neuropathies, Traumatic Laryngeal|Neuropathy, Traumatic Laryngeal|Transection, Laryngeal Nerve|Transections, Laryngeal Nerve|Trauma, Laryngeal Nerve|Traumas, Laryngeal Nerve|Traumatic Laryngeal Neuropathies|Traumatic Laryngeal Neuropathy	Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Wounds and injuries
Laryngeal papillomatosis	MESH:C537876			MESH:D007822|MESH:D010212	C04.557.470.700.600/C537876|C04.588.443.665.481/C537876|C08.360.369/C537876|C08.785.481/C537876|C09.400.369/C537876|C09.647.481/C537876	C04.557.470.700.600|C04.588.443.665.481|C08.360.369|C08.785.481|C09.400.369|C09.647.481	Juvenile laryngeal papillomatosis|Recurrent laryngeal papillomatosis|Warts in the throat	Cancer|Ear-nose-throat disease|Respiratory tract disease
Laryngismus	MESH:D007826		A disorder in which the adductor muscles of the VOCAL CORDS exhibit increased activity leading to laryngeal spasm. Laryngismus causes closure of the VOCAL FOLDS and airflow obstruction during inspiration.	MESH:D064706	C08.360.895.500|C08.618.980.500|C09.400.895.500	C08.360.895|C08.618.980|C09.400.895	Laryngeal Spasm|Laryngeal Spasms|Laryngospasm|Laryngospasms|Spasm, Laryngeal|Spasms, Laryngeal	Ear-nose-throat disease|Respiratory tract disease
Laryngitis	MESH:D007827	DO:DOID:3437	Inflammation of the LARYNGEAL MUCOSA, including the VOCAL CORDS. Laryngitis is characterized by irritation, edema, and reduced pliability of the mucosa leading to VOICE DISORDERS such as APHONIA and HOARSENESS.	MESH:D007818|MESH:D012141	C01.748.368|C08.360.535|C08.730.368|C09.400.535	C01.748|C08.360|C08.730|C09.400	Laryngitides	Ear-nose-throat disease|Respiratory tract disease
Laryngo onycho cutaneous syndrome	MESH:C537032	OMIM:245660		MESH:D003229|MESH:D007818	C08.360/C537032|C09.400/C537032|C11.187/C537032	C08.360|C09.400|C11.187	Laryngeal and ocular granulation in indian children|Laryngoonychocutaneous Syndrome|LOCS|Logic syndrome	Ear-nose-throat disease|Eye disease|Respiratory tract disease
Laryngopharyngeal Reflux	MESH:D057045		Back flow of gastric contents to the LARYNGOPHARYNX where it comes in contact with tissues of the upper aerodigestive tract. Laryngopharyngeal reflux is an extraesophageal manifestation of GASTROESOPHAGEAL REFLUX.	MESH:D005764|MESH:D007818	C06.405.117.119.500.484.500|C08.360.577	C06.405.117.119.500.484|C08.360	Gastric Reflux, Supraesophageal|Gastric Reflux, Supraesophageal (SEGR)|Gastric Regurgitation|Reflux, Laryngopharyngeal|Reflux, Supraesophageal Gastric|Reflux, Supraesophageal Gastric (SEGR)|Regurgitation, Gastric|Supraesophageal Gastric Reflux|Supraesophageal Gastric Reflux (SEGR)	Digestive system disease|Respiratory tract disease
Larynx, Congenital Partial Atresia of	MESH:C563637			MESH:D007818	C08.360/C563637|C09.400/C563637	C08.360|C09.400		Ear-nose-throat disease|Respiratory tract disease
Lassa Fever	MESH:D007835	DO:DOID:9537	An acute febrile human disease caused by the LASSA VIRUS.	MESH:D001117|MESH:D006482	C01.925.782.082.545|C01.925.782.417.505	C01.925.782.082|C01.925.782.417	Fever, Lassa|Infection, Lassa Virus|Lassa Fevers|Lassa Virus Infection|Lassa Virus Infections|Virus Infection, Lassa	Viral disease
Latent Autoimmune Diabetes in Adults	MESH:D000071698	DO:DOID:0080846	Autoimmune diabetes in adults with slowly progressive PANCREATIC BETA CELL failure and the presence of circulating autoantibodies to PANCREATIC ISLETS cell antigens.	MESH:D001327|MESH:D003920	C18.452.394.750.714|C19.246.656|C20.111.576	C18.452.394.750|C19.246|C20.111	Diabetes Mellitus Type 1.5|Diabetes, Type 1.5|LADA, Latent Autoimmune Diabetes in Adults|Latent Autoimmune Diabetes of Adults|Type 1.5 Diabetes|Type 1.5 Diabetes Mellitus	Endocrine system disease|Immune system disease|Metabolic disease
Latent Infection	MESH:D000085343		Delayed infection of the host by a dormant or inactive pathogen.	MESH:D007239	C01.550	C01	Infection, Latent|Infection, Reactivated|Infection Reactivation|Infection, Reactivation|Infection Reactivations|Latent Infections|Reactivated Infection|Reactivation Infection|Reactivation, Infection|Reactivation Infections	
Late-Onset Retinal Degeneration	MESH:C565309	OMIM:605670		MESH:D012162	C11.270.612/C565309|C11.768.585/C565309	C11.270.612|C11.768.585	LORD|Retinal Degeneration, Late-Onset, Autosomal Dominant	Eye disease
Laterality Defects, Autosomal Dominant	MESH:C563391	OMIM:601086		MESH:D059446	C14.240.400.592/C563391|C14.280.400.592/C563391|C15.604.744.146/C563391|C16.131.077.401/C563391|C16.131.240.400.592/C563391	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592		Cardiovascular disease|Congenital abnormality|Lymphatic disease
Lateral Medullary Syndrome	MESH:D014854	DO:DOID:3522	INFARCTION of the dorsolateral aspect of MEDULLA OBLONGATA in the BRAIN STEM. It is caused by occlusion of the VERTEBRAL ARTERY and/or the posterior inferior cerebellar artery. Clinical manifestations vary with the size of infarction, but may include loss of pain and temperature sensation in the ipsilateral face and contralateral body below the chin; ipsilateral HORNER SYNDROME; ipsilateral ATAXIA; DYSARTHRIA; VERTIGO; nausea, hiccup; dysphagia; and VOCAL CORD PARALYSIS. (From Adams et al., Principles of Neurology, 6th ed, p801)	MESH:D020526	C10.228.140.300.150.477.100.500|C10.228.140.300.775.200.100.500|C14.907.253.092.477.100.500|C14.907.253.855.200.100.500|C23.550.513.355.250.100.500|C23.550.717.489.250.100.500	C10.228.140.300.150.477.100|C10.228.140.300.775.200.100|C14.907.253.092.477.100|C14.907.253.855.200.100|C23.550.513.355.250.100|C23.550.717.489.250.100	Dorsolateral Medullary Syndrome|Lateral Bulbar Syndrome|Lateral Medullary Syndromes|Medullary Syndrome, Dorsolateral|Posterior Inferior Cerebellar Artery Syndrome|Syndromes, Lateral Medullary|Syndrome, Vieseaux-Wallenberg|Syndrome, Wallenberg|Vieseaux Wallenberg Syndrome|Vieseaux-Wallenberg Syndrome|Wallenberg's Syndrome|Wallenbergs Syndrome|Wallenberg Syndrome	Cardiovascular disease|Nervous system disease|Pathology (process)
Lateral Sinus Thrombosis	MESH:D020227	DO:DOID:3574	Formation or presence of a blood clot (THROMBUS) in the LATERAL SINUSES. This condition is often associated with ear infections (OTITIS MEDIA or MASTOIDITIS) without antibiotic treatment. In developed nations, lateral sinus thrombosis can result from CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; NEUROSURGICAL PROCEDURES; THROMBOPHILIA; and other conditions. Clinical features include HEADACHE; VERTIGO; and increased intracranial pressure.	MESH:D012851	C10.228.140.300.525.425.500.562|C14.907.253.566.350.500.562|C14.907.355.590.213.350.500.562	C10.228.140.300.525.425.500|C14.907.253.566.350.500|C14.907.355.590.213.350.500	Lateral Sinus Thrombophlebitis|Lateral Sinus Thromboses|Phlebitis, Lateral Sinus, Septic|Septic Phlebitis, Lateral Sinus|Sinus Thromboses, Transverse|Thrombophlebitis, Lateral Sinus|Thromboses, Lateral Sinus|Thromboses, Transverse Sinus|Thrombosis, Lateral Sinus|Thrombosis, Transverse Sinus|Transverse Sinus Thromboses|Transverse Sinus Thrombosis	Cardiovascular disease|Nervous system disease
Latex Hypersensitivity	MESH:D020315		Allergic reaction to products containing processed natural rubber latex such as rubber gloves, condoms, catheters, dental dams, balloons, and sporting equipment. Both T-cell mediated (HYPERSENSITIVITY, DELAYED) and IgE antibody-mediated (HYPERSENSITIVITY, IMMEDIATE) allergic responses are possible. Delayed hypersensitivity results from exposure to antioxidants present in the rubber; immediate hypersensitivity results from exposure to a latex protein.	MESH:D006967	C20.543.600	C20.543	Allergies, Latex|Allergies, Rubber|Allergies, Rubber Latex|Allergy, Latex|Allergy, Rubber|Allergy, Rubber Latex|Hypersensitivities, Latex|Hypersensitivity, Latex|Latex Allergies|Latex Allergy|Latex Hypersensitivities|Natural Rubber Latex Allergy|Rubber Allergies|Rubber Allergy|Rubber Latex Allergies|Rubber Latex Allergy	Immune system disease
Lathyrism	MESH:D007842		A paralytic condition of the legs caused by ingestion of lathyrogens, especially BETA-AMINOPROPIONITRILE or beta-N-oxalyl amino-L-alanine, which are found in the seeds of plants of the genus LATHYRUS.	MESH:D010939	C25.723.756.558	C25.723.756	Neurolathyrism	
Lattice Degeneration of Retina Leading to Retinal Detachment	MESH:C563633			MESH:D012162|MESH:D012163	C11.270.612/C563633|C11.768.585/C563633|C11.768.648/C563633	C11.270.612|C11.768.585|C11.768.648		Eye disease
Laurence Prosser Rocker syndrome	MESH:C537882			MESH:D006345|MESH:D006627|MESH:D017689	C05.660.585.600/C537882|C06.198.439/C537882|C06.405.469.158.701.439/C537882|C14.240.400.560.540/C537882|C14.280.400.560.540/C537882|C16.131.240.400.560.540/C537882|C16.131.314.439/C537882|C16.131.621.585.600/C537882	C05.660.585.600|C06.198.439|C06.405.469.158.701.439|C14.240.400.560.540|C14.280.400.560.540|C16.131.240.400.560.540|C16.131.314.439|C16.131.621.585.600		Cardiovascular disease|Congenital abnormality|Digestive system disease|Musculoskeletal disease
Lazy Leukocyte Syndrome	MESH:C562721			MESH:D007960|MESH:D009503	C15.378.553.546.184.564/C562721|C15.378.553/C562721	C15.378.553|C15.378.553.546.184.564		Blood disease
Lead Poisoning	MESH:D007855		Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of LEAD or lead compounds.	MESH:D000075322	C25.723.522.750	C25.723.522	Lead Poisonings|Poisoning, Lead|Poisonings, Lead	
Lead Poisoning, Nervous System	MESH:D020263		Injury to the nervous system secondary to exposure to lead compounds. Two distinct clinical patterns occur in children (LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD) and adults (LEAD POISONING, NERVOUS SYSTEM, ADULT). In children, lead poisoning typically produces an encephalopathy. In adults, exposure to toxic levels of lead is associated with a peripheral neuropathy.	MESH:D007855|MESH:D020260	C10.720.475.400|C25.723.522.750.500	C10.720.475|C25.723.522.750	Lead-Induced Nervous System Diseases|Lead Neurotoxicity Syndrome|Lead Neurotoxicity Syndromes|Lead Poisoning, Neurologic|Nervous System Diseases, Lead-Induced|Nervous System Plumbism|Nervous System Poisoning, Lead|Neurologic Lead Poisoning|Neurologic Plumbism|Neurotoxicity Syndrome, Lead|Neurotoxicity Syndromes, Lead|Plumbism, Nervous System|Plumbism, Neurologic|Poisoning, Lead, Nervous System|Poisoning, Lead, Neurologic|Syndrome, Lead Neurotoxicity|Syndromes, Lead Neurotoxicity	Nervous system disease
Lead Poisoning, Nervous System, Adult	MESH:D020265		Neurologic conditions in adults associated with acute or chronic exposure to lead or any of its salts. The most common lead related neurologic syndrome in adults consists of a polyneuropathy involving motor fibers. This tends to affect distal nerves and may present as wrist drop due to RADIAL NEUROPATHY. Additional features of chronic lead exposure include ANEMIA; CONSTIPATION; colicky abdominal pain; a bluish lead line of the gums; interstitial nephritis (NEPHRITIS, INTERSTITIAL); and saturnine gout. An encephalopathy may rarely occur. (From Adams et al., Principles of Neurology, 6th ed, p1212)	MESH:D020263	C10.720.475.400.350|C25.723.522.750.500.400	C10.720.475.400|C25.723.522.750.500	Adult Neurologic Saturnism|Lead Induced Nervous System Diseases, Adult|Lead-Induced Polyneuropathies|Lead Induced Polyneuropathy|Lead-Induced Polyneuropathy|Lead Poisoning, Neurologic, Adult|Lead Polyneuropathy|Nervous System Diseases, Lead Induced, Adult|Nervous System Poisoning, Lead, Adult|Nervous System Toxicity, Lead, Adult|Neurologic Saturnism, Adult|Neurotoxicity Syndrome, Lead, Adult|Plumbism, Neurologic, Adult|Poisoning, Lead, Nervous System, Adult|Poisoning, Lead, Neurologic, Adult|Polyneuropathies, Lead-Induced|Polyneuropathy, Lead|Polyneuropathy, Lead Induced|Polyneuropathy, Lead-Induced|Saturnism, Adult Neurologic	Nervous system disease
Lead Poisoning, Nervous System, Childhood	MESH:D020264		Neurologic disorders occurring in children following lead exposure. The most frequent manifestation of childhood lead toxicity is an encephalopathy associated with chronic ingestion of lead that usually presents between the ages of 1 and 3 years. Clinical manifestations include behavioral changes followed by lethargy; CONVULSIONS; HALLUCINATIONS; DELIRIUM; ATAXIA; and vomiting. Elevated intracranial pressure (HYPERTENSION, INTRACRANIAL) and CEREBRAL EDEMA may occur. (From Adams et al., Principles of Neurology, 6th ed, p1210-2)	MESH:D020263	C10.720.475.400.700|C25.723.522.750.500.700	C10.720.475.400|C25.723.522.750.500	Childhood Lead Encephalopathy|Childhood Neurologic Saturnism|Childhood Saturine Encephalopathy|Encephalopathy, Childhood Lead|Encephalopathy, Childhood Saturine|Lead Encephalopathy, Childhood|Lead Induced Nervous System Disease, Childhood|Lead-Induced Nervous System Disease, Childhood|Lead Poisoning, Neurologic, Childhood|Nervous System Disease, Lead-Induced, Childhood|Nervous System Poisoning, Lead, Childhood|Neurologic Saturnism, Childhood|Neurotoxicity Syndrome, Lead, Childhood|Plumbism, Neurologic, Childhood|Poisoning, Lead, Nervous System, Childhood|Poisoning, Lead, Neurologic, Childhood|Saturine Encephalopathy, Childhood|Saturnism, Childhood Neurologic	Nervous system disease
Leber Congenital Amaurosis	MESH:D057130	DO:DOID:14791	A rare degenerative inherited eye disease that appears at birth or in the first few months of life that results in a loss of vision. Not to be confused with LEBER HEREDITARY OPTIC NEUROPATHY, the disease is thought to be caused by abnormal development of PHOTORECEPTOR CELLS in the RETINA, or by the extremely premature degeneration of retinal cells.	MESH:D012164|MESH:D015785	C11.270.516|C11.768.364	C11.270|C11.768	Abiotrophies, Leber|Abiotrophy, Leber|Amauroses, Leber Congenital|Amauroses, Leber's|Amaurosis, Leber Congenital|Amaurosis, Leber's|Blindness, Congenital Retinal|Blindnesses, Congenital Retinal|Congenital Amauroses, Leber|Congenital Amaurosis, Leber|Congenital Amaurosis of Retinal Origin|Congenital Retinal Blindness|Congenital Retinal Blindnesses|Dysgenesis Neuroepithelialis Retinae|Hereditary Epithelial Dysplasia of Retina|Hereditary Retinal Aplasia|Heredoretinopathia Congenitalis|Leber Abiotrophies|Leber Abiotrophy|Leber Amaurosis|Leber Congenital Amauroses|Leber Congenital Tapetoretinal Degeneration|Leber's Amauroses|Leber's Amaurosis|Lebers Amaurosis|Retinal Blindnesses, Congenital	Eye disease
Leber Congenital Amaurosis 10	MESH:C565720	OMIM:611755		MESH:D057130	C11.270.516/C565720|C11.768.364/C565720	C11.270.516|C11.768.364	LCA10	Eye disease
Leber Congenital Amaurosis 11	MESH:C564140	OMIM:613837		MESH:D057130	C11.270.516/C564140|C11.768.364/C564140	C11.270.516|C11.768.364	LCA11	Eye disease
Leber Congenital Amaurosis 12	MESH:C565697	OMIM:610612		MESH:D057130	C11.270.516/C565697|C11.768.364/C565697	C11.270.516|C11.768.364	LCA12	Eye disease
Leber Congenital Amaurosis 13	MESH:C567197	OMIM:612712		MESH:D057130	C11.270.516/C567197|C11.768.364/C567197	C11.270.516|C11.768.364	LCA13|RETINITIS PIGMENTOSA 53, INCLUDED|RP53, INCLUDED	Eye disease
LEBER CONGENITAL AMAUROSIS 15	OMIM:613843	DO:DOID:0110189		MESH:D057130	C11.270.516/613843|C11.768.364/613843	C11.270.516|C11.768.364	LCA15|RETINITIS PIGMENTOSA, JUVENILE, TULP1-RELATED, INCLUDED	Eye disease
LEBER CONGENITAL AMAUROSIS 16	OMIM:614186	DO:DOID:0110118		MESH:D057130	C11.270.516/614186|C11.768.364/614186	C11.270.516|C11.768.364	LCA16	Eye disease
LEBER CONGENITAL AMAUROSIS 17	OMIM:615360	DO:DOID:0110217		MESH:D057130	C11.270.516/615360|C11.768.364/615360	C11.270.516|C11.768.364	LCA17	Eye disease
Leber Congenital Amaurosis 4	MESH:C565778	OMIM:604393		MESH:D057130	C11.270.516/C565778|C11.768.364/C565778	C11.270.516|C11.768.364	Cone-Rod Dystrophy, Aipl1-Related|CONE-ROD DYSTROPHY, AIPL1-RELATED, INCLUDED|LCA4|Retinitis Pigmentosa, Juvenile, Aipl1-Related|RETINITIS PIGMENTOSA, JUVENILE, AIPL1-RELATED, INCLUDED	Eye disease
Leber Congenital Amaurosis 6	MESH:C565327	OMIM:613826		MESH:D057130	C11.270.516/C565327|C11.768.364/C565327	C11.270.516|C11.768.364	LCA6	Eye disease
LEBER CONGENITAL AMAUROSIS 7	OMIM:613829	DO:DOID:0110333		MESH:D057130	C11.270.516/613829|C11.768.364/613829	C11.270.516|C11.768.364	LCA7	Eye disease
LEBER CONGENITAL AMAUROSIS 8	OMIM:613835	DO:DOID:0110079		MESH:D057130	C11.270.516/613835|C11.768.364/613835	C11.270.516|C11.768.364	LCA8	Eye disease
Leber congenital amaurosis type 3	MESH:C536998			MESH:D057130	C11.270.516/C536998|C11.768.364/C536998	C11.270.516|C11.768.364	Amaurosis congenita of Leber, 3	Eye disease
Leber congenital amaurosis, type 4	MESH:C536999			MESH:D057130	C11.270.516/C536999|C11.768.364/C536999	C11.270.516|C11.768.364	Amaurosis congenita of Leber, 4	Eye disease
Left-Right Axis Malformations	MESH:C566610			MESH:D059446	C14.240.400.592/C566610|C14.280.400.592/C566610|C15.604.744.146/C566610|C16.131.077.401/C566610|C16.131.240.400.592/C566610	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592		Cardiovascular disease|Congenital abnormality|Lymphatic disease
Leg, Absence Deformity of, with Congenital Cataract	MESH:C565442	OMIM:246000		MESH:D002386	C11.510.245/C565442	C11.510.245		Eye disease
Leg Dermatoses	MESH:D007868	DO:DOID:3142	A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. (From Stedman, 25th ed)	MESH:D012871	C17.800.446	C17.800	Dermatoses, Leg|Dermatosis, Leg|Leg Dermatosis	Skin disease
Legg-Calve-Perthes Disease	MESH:D007873	DO:DOID:14415|OMIM:150600	A particular type of FEMUR HEAD NECROSIS occurring in children, mainly male, with a course of four years or so.	MESH:D005271	C05.116.852.175.570	C05.116.852.175	Coxa Plana|Disease, Legg-Calve-Perthes|Disease, Legg-Calvé-Perthes|Disease, Legg-Perthes|Disease, Perthes|LCP|LCPD|Legg Calve Perthes Disease|Legg Calvé Perthes Disease|Legg-Calvé-Perthes Disease|Legg Calve Perthes Syndrome|Legg-Calve-Perthes Syndrome|Legg Calvé Perthes Syndrome|Legg-Calvé-Perthes Syndrome|Legg Perthes Disease|Legg-Perthes Disease|Osteochondritis Deforman|Osteochondritis Deformans|Perthes Disease|Syndrome, Legg-Calve-Perthes|Syndrome, Legg-Calvé-Perthes	Musculoskeletal disease
Leg Ulcer	MESH:D007871		Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes.	MESH:D012883	C17.800.893.592	C17.800.893	Leg Ulcers|Ulcer, Leg|Ulcers, Leg	Skin disease
Leg Ulcers, Familial, of Juvenile Onset	MESH:C563632			MESH:D007871	C17.800.893.592/C563632	C17.800.893.592		Skin disease
Leiomyoma	MESH:D007889	DO:DOID:127|DO:DOID:13223	A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.	MESH:D009379	C04.557.450.590.450	C04.557.450.590	Fibroid|Fibroids|Fibroids, Uterine|Fibroid Tumor|Fibroid Tumors|Fibroid, Uterine|Fibroid Uterus|Fibromas, Uterine|Fibroma, Uterine|Fibromyoma|Fibromyomas|Leiomyomas|Leiomyoma, Uterine|Tumor, Fibroid|Tumors, Fibroid|Uterine Fibroid|Uterine Fibroids|Uterine Fibroma|Uterine Fibromas|Uterus, Fibroid	Cancer
Leiomyoma, Epithelioid	MESH:D018230		A relatively rare smooth muscle tumor found most frequently in the wall of the gastrointestinal tract, especially in the stomach. It is similar to other smooth muscle tumors but may become very large and hemorrhage and exhibit small cystic areas. Simple excision is almost always curative. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1354)	MESH:D007889	C04.557.450.590.450.455	C04.557.450.590.450	Epithelioid Leiomyoma|Epithelioid Leiomyomas|Leiomyoblastoma|Leiomyoblastomas|Leiomyomas, Epithelioid	Cancer
Leiomyoma of vulva and esophagus	MESH:C537006			MESH:D004938|MESH:D014594|MESH:D018231	C04.557.450.590.450.465/C537006|C04.588.274.476.205/C537006|C04.588.443.353/C537006|C04.588.945.418.948/C537006|C06.301.371.205/C537006|C06.405.117.430/C537006|C06.405.249.205/C537006|C12.050.351.500.852.762/C537006|C12.050.351.937.418.875/C537006|C12.100.250.852.762/C537006|C12.900.418.875/C537006	C04.557.450.590.450.465|C04.588.274.476.205|C04.588.443.353|C04.588.945.418.948|C06.301.371.205|C06.405.117.430|C06.405.249.205|C12.050.351.500.852.762|C12.050.351.937.418.875|C12.100.250.852.762|C12.900.418.875	Esophagogastric and vulvar leiomyomatosis|Leiomyomatosis, esophagogastric and vulvar	Cancer|Digestive system disease|Urogenital disease (female)
Leiomyomatosis	MESH:D018231	DO:DOID:5138	The state of having multiple leiomyomas throughout the body. (Stedman, 25th ed)	MESH:D007889	C04.557.450.590.450.465	C04.557.450.590.450	Leiomyomatoses	Cancer
Leiomyomatosis, esophageal and vulval, with nephropathy	MESH:C537113	OMIM:308940		MESH:D009394|MESH:D018231	C04.557.450.590.450.465/C537113|C12.050.351.875.742/C537113|C12.050.351.968.419.570.620/C537113|C12.200.706.742/C537113|C12.200.777.419.570.620/C537113|C12.800.742/C537113|C12.950.419.570.620/C537113|C16.131.939.742/C537113|C17.300.200.517/C537113	C04.557.450.590.450.465|C12.050.351.875.742|C12.050.351.968.419.570.620|C12.200.706.742|C12.200.777.419.570.620|C12.800.742|C12.950.419.570.620|C16.131.939.742|C17.300.200.517	Alport Syndrome And Diffuse Leiomyomatosis|Alport syndrome with diffuse leiomyomatosis|ATS-DL|CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME|Diffuse leiomyomatosis in Alport syndrome|Diffuse Leiomyomatosis With Alport Syndrome|DL-ATS|LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME|LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY	Cancer|Congenital abnormality|Connective tissue disease|Urogenital disease (female)|Urogenital disease (male)
LEIOMYOMA, UTERINE	OMIM:150699	DO:DOID:13223		MESH:D007889|MESH:D014594	C04.557.450.590.450/150699|C04.588.945.418.948/150699|C12.050.351.500.852.762/150699|C12.050.351.937.418.875/150699|C12.100.250.852.762/150699|C12.900.418.875/150699	C04.557.450.590.450|C04.588.945.418.948|C12.050.351.500.852.762|C12.050.351.937.418.875|C12.100.250.852.762|C12.900.418.875	UL	Cancer|Urogenital disease (female)
Leiomyosarcoma	MESH:D007890	DO:DOID:1967|DO:DOID:5264|DO:DOID:5268	A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865)	MESH:D009379|MESH:D012509	C04.557.450.590.455|C04.557.450.795.455	C04.557.450.590|C04.557.450.795	Epithelioid Leiomyosarcoma|Epithelioid Leiomyosarcomas|Leiomyosarcoma, Epithelioid|Leiomyosarcoma, Myxoid|Leiomyosarcomas|Leiomyosarcomas, Epithelioid|Leiomyosarcomas, Myxoid|Myxoid Leiomyosarcoma|Myxoid Leiomyosarcomas	Cancer
Lens Diseases	MESH:D007905	DO:DOID:110	Diseases involving the CRYSTALLINE LENS.	MESH:D005128	C11.510	C11	Disease, Lens|Diseases, Lens|Lens Disease	Eye disease
Lens Subluxation	MESH:D007906	DO:DOID:11364	Incomplete rupture of the zonule with the displaced lens remaining behind the pupil. In dislocation, or complete rupture, the lens is displaced forward into the anterior chamber or backward into the vitreous body. When congenital, this condition is known as ECTOPIA LENTIS.	MESH:D007905	C11.510.598	C11.510	Dislocation, Lens|Dislocations, Lens|Lens Dislocation|Lens Dislocation and Subluxation|Lens Dislocations|Lens Subluxations|Subluxation, Lens|Subluxations, Lens	Eye disease
Lentiginosis, Centrofacial Neurodysraphic	MESH:C563630			MESH:D007911	C17.800.621.430.530.550/C563630	C17.800.621.430.530.550	Lentiginosis, Touraine Type	Skin disease
Lentiginosis Profusa	MESH:C573023	OMIM:151001		MESH:D007911	C17.800.621.430.530.550/C573023	C17.800.621.430.530.550	Lentiginosis, Diffuse|Lentiginosis, Generalized|Lentiginosis, Inherited Patterned|LENTIGINOSIS PROFUSA	Skin disease
Lentigo	MESH:D007911		Small circumscribed melanoses resembling, but differing histologically from, freckles. The concept includes senile lentigo ('liver spots') and nevoid lentigo (nevus spilus, lentigo simplex) and may also occur in association with multiple congenital defects or congenital syndromes (e.g., Peutz-Jeghers syndrome).	MESH:D008548	C17.800.621.430.530.550	C17.800.621.430.530	Lentigines|Lentiginoses|Lentiginosis|Lentigos	Skin disease
Lentivirus Infections	MESH:D016180		Virus diseases caused by the Lentivirus genus. They are multi-organ diseases characterized by long incubation periods and persistent infection.	MESH:D012192	C01.925.782.815.616	C01.925.782.815	Infection, Lentivirus|Infections, Lentivirus|Lentivirus Infection	Viral disease
LEOPARD Syndrome	MESH:D044542	DO:DOID:14291|OMIM:151100	An autosomal dominant disorder with an acronym of its seven features (LENTIGO; ELECTROCARDIOGRAM abnormalities; ocular HYPERTELORISM; PULMONARY STENOSIS; abnormal genitalia; retardation of growth; and DEAFNESS or SENSORINEURAL HEARING LOSS). This syndrome is caused by mutations of PTPN11 gene encoding the non-receptor PROTEIN TYROSINE PHOSPHATASE, type 11, and is an allelic to NOONAN SYNDROME. Features of LEOPARD syndrome overlap with those of NEUROFIBROMATOSIS 1 which is caused by mutations in the NEUROFIBROMATOSIS 1 GENES.	MESH:D000015|MESH:D006330|MESH:D007911|MESH:D011666|MESH:D019465	C05.660.207.525|C14.240.400.695|C14.280.400.695|C14.280.484.716.525|C16.131.077.525|C16.131.240.400.685|C16.131.621.207.525|C17.800.621.430.530.550.525	C05.660.207|C14.240.400|C14.280.400|C14.280.484.716|C16.131.077|C16.131.240.400|C16.131.621.207|C17.800.621.430.530.550	Cardio Cutaneous Syndrome|Cardio-Cutaneous Syndrome|Cardio-Cutaneous Syndromes|Cardiomyopathic Lentiginoses|Cardiomyopathic Lentiginoses, Progressive|Cardiomyopathic Lentiginosis|Cardiomyopathic, Lentiginosis|Cardiomyopathic Lentiginosis, Progressive|Cardiomyopathics, Lentiginosis|Lentigines Syndrome, Multiple|Lentigines Syndromes, Multiple|Lentiginoses, Cardiomyopathic|Lentiginoses, Progressive Cardiomyopathic|Lentiginosis Cardiomyopathic|Lentiginosis, Cardiomyopathic|Lentiginosis Cardiomyopathics|Lentiginosis, Progressive Cardiomyopathic|Leopard Syndrome 1|LEOPARD Syndrome, 1|LEOPARD Syndromes|LPRD1|Multiple Lentigines Syndrome|Multiple Lentigines Syndromes|Noonan Syndrome with Multiple Lentigines|Progressive Cardiomyopathic Lentiginoses|Progressive Cardiomyopathic Lentiginosis|Syndrome, Cardio-Cutaneous|Syndrome, LEOPARD|Syndrome, Multiple Lentigines|Syndromes, Cardio-Cutaneous|Syndromes, LEOPARD|Syndromes, Multiple Lentigines	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Skin disease
LEOPARD syndrome, 2	MESH:C537117	OMIM:611554		MESH:D044542	C05.660.207.525/C537117|C14.240.400.695/C537117|C14.280.400.695/C537117|C14.280.484.716.525/C537117|C16.131.077.525/C537117|C16.131.240.400.685/C537117|C16.131.621.207.525/C537117|C17.800.621.430.530.550.525/C537117	C05.660.207.525|C14.240.400.695|C14.280.400.695|C14.280.484.716.525|C16.131.077.525|C16.131.240.400.685|C16.131.621.207.525|C17.800.621.430.530.550.525	Leopard Syndrome 2|LPRD2	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Skin disease
LEOPARD SYNDROME 3	OMIM:613707	DO:DOID:0080550		MESH:D044542	C05.660.207.525/613707|C14.240.400.695/613707|C14.280.400.695/613707|C14.280.484.716.525/613707|C16.131.077.525/613707|C16.131.240.400.685/613707|C16.131.621.207.525/613707|C17.800.621.430.530.550.525/613707	C05.660.207.525|C14.240.400.695|C14.280.400.695|C14.280.484.716.525|C16.131.077.525|C16.131.240.400.685|C16.131.621.207.525|C17.800.621.430.530.550.525	LPRD3	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Skin disease
Leriche Syndrome	MESH:D007925		A condition caused by occlusion of terminal aorta, the primary branches of the ABDOMINAL AORTA, as in aortoiliac obstruction. Leriche syndrome usually occurs in males and is characterized by IMPOTENCE, absence of a pulse in the femoral arteries, weakness and numbness in the lower back, buttocks, hips, and lower limbs.	MESH:D001018|MESH:D001157	C14.907.109.661|C14.907.137.427	C14.907.109|C14.907.137	Leriche's Syndrome|Leriches Syndrome|Syndrome, Leriche|Syndrome, Leriche's	Cardiovascular disease
Lethal Congenital Contractural Syndrome 3	MESH:C566961	OMIM:611369		MESH:D003286|MESH:D009133	C05.550.323/C566961|C05.651.197/C566961|C10.597.613.612/C566961|C23.300.070.500/C566961|C23.888.592.608.612/C566961	C05.550.323|C05.651.197|C10.597.613.612|C23.300.070.500|C23.888.592.608.612	LCCS3|LETHAL CONGENITAL CONTRACTURE SYNDROME 3|Multiple Contractural Syndrome, Israeli Bedouin Type B|MULTIPLE CONTRACTURE SYNDROME, ISRAELI BEDOUIN TYPE B	Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Lethal congenital erythroderma	MESH:C535513			MESH:D003873	C17.800.174.318/C535513|C17.800.815.318/C535513	C17.800.174.318|C17.800.815.318	Erythroderma lethal congenital|Erythroderma, Lethal Congenital	Skin disease
Lethargy	MESH:D053609		A general state of sluggishness, listless, or uninterested, with being tired, and having difficulty concentrating and doing simple tasks. It may be related to DEPRESSION or DRUG ADDICTION.	MESH:D019954	C10.597.606.441|C23.888.592.604.444	C10.597.606|C23.888.592.604		Nervous system disease|Signs and symptoms
Leukemia	MESH:D007938	DO:DOID:1240	A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)	MESH:D009370	C04.557.337	C04.557	Leucocythaemia|Leucocythaemias|Leucocythemia|Leucocythemias|Leukemias	Cancer
Leukemia, Acute, X-Linked	MESH:C564112			MESH:D007938	C04.557.337/C564112	C04.557.337		Cancer
Leukemia, Basophilic, Acute	MESH:D015471		A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.	MESH:D015470	C04.557.337.539.275.125	C04.557.337.539.275	Acute Basophilic Leukemia|Acute Basophilic Leukemias|Basophilic Leukemia, Acute|Basophilic Leukemias, Acute|Leukemia, Acute Basophilic|Leukemias, Acute Basophilic	Cancer
Leukemia, B-Cell	MESH:D015448		A malignant disease of the B-LYMPHOCYTES in the bone marrow and/or blood.	MESH:D007945	C04.557.337.428.080|C15.604.515.560.080|C20.683.515.528.080	C04.557.337.428|C15.604.515.560|C20.683.515.528	B Cell Leukemia|B-Cell Leukemia|B-Cell Leukemias|B-Cell Lymphocytic Leukemia|B-Cell Lymphocytic Leukemias|B Lymphocytic Leukemia|B-Lymphocytic Leukemia|B-Lymphocytic Leukemias|Leukemia, B Cell|Leukemia, B-Cell Lymphocytic|Leukemia, B-Lymphocytic|Leukemia, Lymphocytic, B Cell|Leukemia, Lymphocytic, B-Cell|Leukemias, B-Cell|Leukemias, B-Cell Lymphocytic|Leukemias, B-Lymphocytic|Lymphocytic Leukemia, B Cell|Lymphocytic Leukemia, B-Cell|Lymphocytic Leukemias, B-Cell	Cancer|Immune system disease|Lymphatic disease
Leukemia, Biphenotypic, Acute	MESH:D015456	DO:DOID:9953	An acute leukemia exhibiting cell features characteristic of both the myeloid and lymphoid lineages and probably arising from MULTIPOTENT STEM CELLS.	MESH:D007945	C04.557.337.428.100|C15.604.515.560.100|C20.683.515.528.100	C04.557.337.428|C15.604.515.560|C20.683.515.528	Acute Biphenotypic Leukemia|Acute Biphenotypic Leukemias|Acute Leukemia, Biphenotypic|Acute Leukemia, Hybrid|Acute Leukemia, Mixed-Lineage|Acute Leukemias, Biphenotypic|Acute Leukemias, Hybrid|Acute Leukemias, Mixed-Lineage|B and T Cell Acute Lymphoblastic Leukemia|B- and T-Cell Acute Lymphoblastic Leukemia|B and T Cell Leukemia, Acute|B- and T-Cell Leukemia, Acute|Biphenotypic Acute Leukemia|Biphenotypic Acute Leukemias|Biphenotypic Leukemia, Acute|Biphenotypic Leukemias, Acute|Hybrid Acute Leukemia|Hybrid Acute Leukemias|Leukemia, Acute Biphenotypic|Leukemia, Biphenotypic Acute|Leukemia, Hybrid Acute|Leukemia, Lymphocytic, Acute, Mixed Cell|Leukemia, Lymphocytic, Acute, Mixed-Cell|Leukemia, Mixed, B and T Cell|Leukemia, Mixed, B- and T-Cell|Leukemia, Mixed Cell|Leukemia, Mixed-Cell|Leukemia, Mixed-Lineage Acute|Leukemias, Acute Biphenotypic|Leukemias, Biphenotypic Acute|Leukemias, Hybrid Acute|Leukemias, Mixed-Cell|Leukemias, Mixed-Lineage Acute|Lymphocytic Leukemia, Acute, B and T Cell|Lymphocytic Leukemia, Acute, B- and T-Cell|Mixed-Cell Leukemia|Mixed-Cell Leukemias|Mixed-Lineage Acute Leukemia|Mixed Lineage Acute Leukemias|Mixed-Lineage Acute Leukemias	Cancer|Immune system disease|Lymphatic disease
Leukemia, Eosinophilic, Acute	MESH:D015472		A rare acute myeloid leukemia characterized by abnormal EOSINOPHILS in the bone marrow.	MESH:D015470	C04.557.337.539.275.300	C04.557.337.539.275	Acute Eosinophilic Leukemia|Acute Eosinophilic Leukemias|Eosinophilic Leukemia, Acute|Eosinophilic Leukemias, Acute|Leukemia, Acute Eosinophilic|Leukemias, Acute Eosinophilic	Cancer
Leukemia, Erythroblastic, Acute	MESH:D004915		A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.	MESH:D009196|MESH:D015470	C04.557.337.539.275.325|C15.378.190.636.276	C04.557.337.539.275|C15.378.190.636	Acute Erythroblastic Leukemia|Acute Erythroblastic Leukemias|Di Guglielmo Disease|Di Guglielmo's Disease|Di Guglielmos Disease|Disease, Di Guglielmo|Disease, Di Guglielmo's|Erythremic Myeloses|Erythremic Myelosis|Erythroblastic Leukemia, Acute|Erythroblastic Leukemias, Acute|Erythroleukemia|Erythroleukemias|Leukemia, Acute Erythroblastic|Leukemia, Myeloid, Acute, M6|Leukemias, Acute Erythroblastic|Myeloid Leukemia, Acute, M6|Myeloses, Erythremic|Myelosis, Erythremic	Blood disease|Cancer
Leukemia, Experimental	MESH:D007942		Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.	MESH:D007938|MESH:D009374	C04.557.337.372|C04.619.531	C04.557.337|C04.619	Animal Leukemia Model|Animal Leukemia Models|Experimental Leukemia|Experimental Leukemias|Leukemia Model, Animal|Leukemia Models, Animal|Leukemias, Experimental	Cancer
Leukemia, Hairy Cell	MESH:D007943	DO:DOID:285	A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of 'hairy' or 'flagellated' cells in the blood and bone marrow.	MESH:D007938|MESH:D008232	C04.557.337.415|C15.604.515.553|C20.683.515.517	C04.557.337|C15.604.515|C20.683.515	Hairy Cell Leukemia|Hairy Cell Leukemias|Leukemias, Hairy Cell|Leukemic Reticuloendothelioses|Leukemic Reticuloendotheliosis|Reticuloendothelioses, Leukemic|Reticuloendotheliosis, Leukemic	Cancer|Immune system disease|Lymphatic disease
Leukemia L1210	MESH:D007939		An experimental LYMPHOCYTIC LEUKEMIA of mice.	MESH:D007942	C04.557.337.372.594|C04.619.531.594	C04.557.337.372|C04.619.531	L 1210, Leukemia|L1210, Leukemia|Leukemia L 1210	Cancer
Leukemia L5178	MESH:D007940		An experimental lymphocytic leukemia of mice.	MESH:D007942	C04.557.337.372.602|C04.619.531.602	C04.557.337.372|C04.619.531	L5178, Leukemia|L5178, Lymphoma|Lymphoma L5178	Cancer
Leukemia, Large Granular Lymphocytic	MESH:D054066		A spectrum of disorders characterized by clonal expansions of the peripheral blood LYMPHOCYTE populations known as large granular lymphocytes which contain abundant cytoplasm and azurophilic granules. Subtypes develop from either CD3-negative NATURAL KILLER CELLS or CD3-positive T-CELLS. The clinical course of both subtypes can vary from spontaneous regression to progressive, malignant disease.	MESH:D015458	C04.557.337.428.580.049|C15.604.515.560.575.049|C20.683.515.528.582.049	C04.557.337.428.580|C15.604.515.560.575|C20.683.515.528.582	Aggressive Natural Killer Cell Leukemia|Aggressive NK Cell Leukemia|Granular Lymphocytoses, Large|Granular Lymphocytosis, Large|Large Granular Lymphocyte Leukemia|Large Granular Lymphocytoses|Large Granular Lymphocytosis|Leukemia, LGL|Leukemia, Lymphocytic, Large Granular|Leukemia, Natural Killer Cell Large Granular Lymphocytic|Leukemia, NK LGL|Leukemia, NK-LGL|Leukemias, LGL|Leukemias, NK-LGL|Leukemias, T-LGL|Leukemia, T Cell Large Granular Lymphocytic|Leukemia, T-Cell Large Granular Lymphocytic|Leukemia, T LGL|Leukemia, T-LGL|LGL Leukemia|LGL Leukemias|Lymphocytoses, Large Granular|Lymphocytosis, Large Granular|Lymphoproliferative Disease of Granular Lymphocytes|Lymphoproliferative Disease of Large Granular Lymphocytes|Natural Killer Cell Large Granular Lymphocytic Leukemia|NK Cell Large Granular Lymphocytic Leukemia|NK-Cell Large Granular Lymphocytic Leukemia|NK LGL Leukemia|NK-LGL Leukemia|NK-LGL Leukemias|T Cell Large Granular Lymphocyte Leukemia|T-Cell Large Granular Lymphocyte Leukemia|T Cell Large Granular Lymphocytic Leukemia|T-Cell Large Granular Lymphocytic Leukemia|T LGL Leukemia|T-LGL Leukemia|T-LGL Leukemias	Cancer|Immune system disease|Lymphatic disease
Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	DO:DOID:1040|OMIM:109543|OMIM:151400|OMIM:609630|OMIM:612557|OMIM:612558|OMIM:612559	A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.	MESH:D002908|MESH:D015448	C04.557.337.428.080.125|C15.604.515.560.080.125|C20.683.515.528.080.125|C23.550.291.500.483	C04.557.337.428.080|C15.604.515.560.080|C20.683.515.528.080|C23.550.291.500	B Cell Chronic Lymphocytic Leukemia|B-Cell Chronic Lymphocytic Leukemia|B Cell Leukemia, Chronic|B-Cell Leukemia, Chronic|B-Cell Leukemias, Chronic|B-Cell Malignancies, Low-Grade|B Cell Malignancy, Low Grade|B-Cell Malignancy, Low-Grade|BCLL|B Lymphocytic Leukemia, Chronic|B-Lymphocytic Leukemia, Chronic|B-Lymphocytic Leukemias, Chronic|Chronic B-Cell Leukemia|Chronic B-Cell Leukemias|Chronic B-Lymphocytic Leukemia|Chronic B-Lymphocytic Leukemias|Chronic Lymphatic Leukemia|Chronic Lymphatic Leukemias|Chronic Lymphoblastic Leukemia|Chronic Lymphoblastic Leukemias|Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemias|CLL|CLL Lymphoplasmacytoid Lymphoma|CLL Lymphoplasmacytoid Lymphomas|CLLS1|CLLS2|CLLS3|CLLS4|CLLS5|DBM|Diffuse Well Differentiated Lymphocytic Lymphoma|Diffuse Well-Differentiated Lymphocytic Lymphoma|Disrupted In B Cell Malignancy|Disrupted In B-Cell Malignancy|Leukemia, B Cell, Chronic|Leukemia, B-Cell, Chronic|Leukemia, Chronic B-Cell|Leukemia, Chronic B-Lymphocytic|Leukemia, Chronic Lymphatic|Leukemia, Chronic Lymphocytic|Leukemia, Chronic Lymphocytic, B-Cell|LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 1|LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2|LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3|LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 4|LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 5|Leukemia, Lymphoblastic, Chronic|Leukemia, Lymphocytic, Chronic|Leukemia, Lymphocytic, Chronic, B Cell|Leukemias, Chronic B-Cell|Leukemias, Chronic B-Lymphocytic|Leukemias, Chronic Lymphatic|Leukemias, Chronic Lymphoblastic|Low-Grade B-Cell Malignancies|Low-Grade B-Cell Malignancy|Lymphatic Leukemia, Chronic|Lymphatic Leukemias, Chronic|Lymphoblastic Leukemia, Chronic|Lymphoblastic Leukemias, Chronic|Lymphocytic Leukemia, Chronic|Lymphocytic Leukemia, Chronic, B Cell|Lymphocytic Leukemia, Chronic, B-Cell|Lymphocytic Leukemias, Chronic|Lymphocytic Lymphoma|Lymphocytic Lymphoma, Diffuse, Well Differentiated|Lymphocytic Lymphoma, Diffuse, Well-Differentiated|Lymphocytic Lymphomas|Lymphocytic Lymphoma, Small|Lymphocytic Lymphomas, Small|Lymphocytic Lymphomas, Well-Differentiated|Lymphocytic Lymphoma, Well Differentiated|Lymphocytic Lymphoma, Well-Differentiated|Lymphoma, CLL Lymphoplasmacytoid|Lymphoma, Lymphocytic|Lymphoma, Lymphocytic, Diffuse, Well Differentiated|Lymphoma, Lymphocytic, Diffuse, Well-Differentiated|Lymphoma, Lymphocytic, Well Differentiated|Lymphoma, Lymphocytic, Well-Differentiated|Lymphoma, Lymphoplasmacytoid, CLL|Lymphomas, CLL Lymphoplasmacytoid|Lymphomas, Lymphocytic|Lymphoma, Small Cell|Lymphoma, Small-Cell|Lymphoma, Small Lymphocytic|Lymphoma, Small Lymphocytic, Plasmacytoid|Lymphomas, Small-Cell|Lymphomas, Small Lymphocytic|Lymphomas, Well-Differentiated Lymphocytic|Lymphoma, Well-Differentiated Lymphocytic|Lymphoplasmacytoid Lymphoma, CLL|Lymphoplasmacytoid Lymphomas, CLL|Malignancies, Low-Grade B-Cell|Malignancy, Low-Grade B-Cell|Small Cell Lymphoma|Small-Cell Lymphoma|Small-Cell Lymphomas|Small Lymphocytic Lymphoma|Small Lymphocytic Lymphomas|Well-Differentiated Lymphocytic Lymphoma|Well-Differentiated Lymphocytic Lymphomas	Cancer|Immune system disease|Lymphatic disease|Pathology (process)
Leukemia, Lymphoid	MESH:D007945	DO:DOID:1037	Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.	MESH:D007938|MESH:D008232	C04.557.337.428|C15.604.515.560|C20.683.515.528	C04.557.337|C15.604.515|C20.683.515	Leukemia, Lymphocytic|Leukemias, Lymphocytic|Leukemias, Lymphoid|Lymphocytic Leukemia|Lymphocytic Leukemias|Lymphoid Leukemia|Lymphoid Leukemias	Cancer|Immune system disease|Lymphatic disease
Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	DO:DOID:0050523|DO:DOID:5603	Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa.	MESH:D015458	C04.557.337.428.580.100|C15.604.515.560.575.100|C20.683.515.528.582.100	C04.557.337.428.580|C15.604.515.560.575|C20.683.515.528.582	Adult T-Cell Leukemia|Adult T-Cell Leukemia-Lymphoma|Adult T-Cell Leukemia-Lymphomas|Adult T-Cell Leukemias|ATLL|HTLV Associated Leukemia Lymphoma|HTLV-Associated Leukemia-Lymphoma|HTLV-Associated Leukemia-Lymphomas|HTLV I Associated T Cell Leukemia Lymphoma|HTLV-I-Associated T-Cell Leukemia-Lymphoma|HTLV-I-Associated T-Cell Leukemia-Lymphomas|Human T Cell Leukemia Lymphoma|Human T-Cell Leukemia-Lymphoma|Human T-Cell Leukemia-Lymphomas|Human T Lymphotropic Virus Associated Leukemia Lymphoma|Human T Lymphotropic Virus-Associated Leukemia-Lymphoma|Leukemia, Adult T Cell|Leukemia, Adult T-Cell|Leukemia Lymphoma, Adult T Cell|Leukemia-Lymphoma, HTLV-Associated|Leukemia-Lymphoma, HTLV-I-Associated T-Cell|Leukemia-Lymphoma, Human T-Cell|Leukemia-Lymphomas, Adult T-Cell|Leukemia-Lymphomas, HTLV-Associated|Leukemia-Lymphomas, HTLV-I-Associated T-Cell|Leukemia-Lymphomas, Human T-Cell|Leukemia Lymphoma, T Cell, Acute, HTLV I Associated|Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated|Leukemias, Adult T-Cell|T Cell Leukemia, Adult|T-Cell Leukemia, Adult|T Cell Leukemia Lymphoma, Adult|T-Cell Leukemia-Lymphoma, Adult|T Cell Leukemia Lymphoma, HTLV I Associated|T-Cell Leukemia-Lymphoma, HTLV-I-Associated|T-Cell Leukemia-Lymphoma, Human|T-Cell Leukemia-Lymphomas, Adult|T-Cell Leukemia-Lymphomas, HTLV-I-Associated|T-Cell Leukemia-Lymphomas, Human|T-Cell Leukemias, Adult	Cancer|Immune system disease|Lymphatic disease
Leukemia, Mast-Cell	MESH:D007946	DO:DOID:9254	A form of systemic mastocytosis (MASTOCYTOSIS, SYSTEMIC) characterized by the presence of large numbers of tissue MAST CELLS in the peripheral blood without skin lesions. It is a high-grade LEUKEMIA disease with bone marrow smear of >20% MAST CELLS, multi-organ failure and a short survival.	MESH:D007938|MESH:D015470|MESH:D034721	C04.557.337.440|C04.557.337.539.275.440|C20.762.750.750.500	C04.557.337|C04.557.337.539.275|C20.762.750.750	Leukemia, Mast Cell|Leukemias, Mast-Cell|Mast Cell Leukemia|Mast-Cell Leukemia|Mast-Cell Leukemias	Cancer|Immune system disease
Leukemia, Megakaryoblastic, Acute	MESH:D007947	DO:DOID:8761	An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. MYELOFIBROSIS or increased bone marrow RETICULIN is common.	MESH:D015470	C04.557.337.539.275.450	C04.557.337.539.275	Acute Megakaryoblastic Leukemia|Acute Megakaryoblastic Leukemias|Acute Megakaryocytic Leukemia|Acute Megakaryocytic Leukemias|Leukemia, Acute Megakaryoblastic|Leukemia, Acute Megakaryocytic|Leukemia, Megakaryocytic|Leukemia, Megakaryocytic, Acute|Leukemia, Myeloid, Acute, M7|Leukemias, Acute Megakaryoblastic|Leukemias, Acute Megakaryocytic|Leukemias, Megakaryocytic|Megakaryoblastic Leukemia, Acute|Megakaryoblastic Leukemias, Acute|Megakaryocytic Leukemia|Megakaryocytic Leukemia, Acute|Megakaryocytic Leukemias|Megakaryocytic Leukemias, Acute|Myeloid Leukemia, Acute, M7	Cancer
Leukemia, Monocytic, Acute	MESH:D007948	DO:DOID:8864	An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES.	MESH:D015470	C04.557.337.539.275.484	C04.557.337.539.275	Acute Monoblastic Leukemia|Acute Monoblastic Leukemias|Acute Monocytic Leukemia|Acute Monocytic Leukemias|Leukemia, Acute Monocytic|Leukemia, Monoblastic, Acute|Leukemia, Myeloid, Acute, M5|Leukemia, Myeloid, Schilling Type|Leukemia, Myeloid, Schilling-Type|Leukemias, Acute Monoblastic|Leukemias, Acute Monocytic|Leukemia, Schilling-Type Myeloid|Monoblastic Leukemia, Acute|Monoblastic Leukemias, Acute|Monocytic Leukemia, Acute|Monocytic Leukemias, Acute|Myeloid Leukemia, Acute, M5|Myeloid Leukemia, Schilling Type|Myeloid Leukemia, Schilling-Type|Schilling-Type Myeloid Leukemia	Cancer
Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	OMIM:608232	Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.	MESH:D002908|MESH:D007951|MESH:D009196	C04.557.337.539.250|C15.378.190.636.370|C23.550.291.500.485	C04.557.337.539|C15.378.190.636|C23.550.291.500	ACML, INCLUDED|Chronic Granulocytic Leukemia|Chronic Granulocytic Leukemias|Chronic Myelocytic Leukemia|Chronic Myelocytic Leukemias|Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemias|Chronic Myeloid Leukemia|Chronic Myeloid Leukemias|CML|Granulocytic Leukemia, Chronic|Granulocytic Leukemias, Chronic|Leukemia, Chronic Granulocytic|Leukemia, Chronic Myelocytic|Leukemia, Chronic Myelogenous|LEUKEMIA, CHRONIC MYELOGENOUS LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATANIB, INCLUDED|Leukemia, Chronic Myeloid|LEUKEMIA, CHRONIC MYELOID, ATYPICAL, INCLUDED|Leukemia, Granulocytic, Chronic|Leukemia, Myelocytic, Chronic|Leukemia, Myelogenous, Chronic|Leukemia, Myelogenous, Ph1 Positive|Leukemia, Myelogenous, Ph1-Positive|Leukemia, Myeloid, Chronic|Leukemia, Myeloid, Ph1 Positive|Leukemia, Myeloid, Ph1-Positive|Leukemia, Myeloid, Philadelphia Positive|Leukemia, Myeloid, Philadelphia-Positive|Leukemia, Ph1-Positive Myelogenous|Leukemia, Ph1-Positive Myeloid|Leukemia, Philadelphia-Positive Myeloid|Leukemias, Chronic Granulocytic|Leukemias, Chronic Myelocytic|Leukemias, Chronic Myelogenous|Leukemias, Chronic Myeloid|Leukemias, Ph1-Positive Myelogenous|Leukemias, Ph1-Positive Myeloid|Leukemias, Philadelphia-Positive Myeloid|Myelocytic Leukemia, Chronic|Myelocytic Leukemias, Chronic|Myelogenous Leukemia, Chronic|Myelogenous Leukemia, Ph1 Positive|Myelogenous Leukemia, Ph1-Positive|Myelogenous Leukemias, Chronic|Myelogenous Leukemias, Ph1-Positive|Myeloid Leukemia, Chronic|Myeloid Leukemia, Ph1 Positive|Myeloid Leukemia, Ph1-Positive|Myeloid Leukemia, Philadelphia Positive|Myeloid Leukemia, Philadelphia-Positive|Myeloid Leukemias, Chronic|Myeloid Leukemias, Ph1-Positive|Myeloid Leukemias, Philadelphia-Positive|Ph1-Positive Myelogenous Leukemia|Ph1-Positive Myelogenous Leukemias|Ph1-Positive Myeloid Leukemia|Ph1-Positive Myeloid Leukemias|Philadelphia-Positive Myeloid Leukemia|Philadelphia-Positive Myeloid Leukemias	Blood disease|Cancer|Pathology (process)
Leukemia, Myeloid	MESH:D007951	DO:DOID:8593|DO:DOID:8692	Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.	MESH:D007938	C04.557.337.539	C04.557.337	Chronic Monocytic Leukemia|Chronic Monocytic Leukemias|Granulocytic Leukemia|Granulocytic Leukemias|Leukemia, Chronic Monocytic|Leukemia, Granulocytic|Leukemia, Monocytic, Chronic|Leukemia, Myelocytic|Leukemia, Myelogenous|Leukemias, Chronic Monocytic|Leukemias, Granulocytic|Leukemias, Myelocytic|Leukemias, Myelogenous|Leukemias, Myeloid|Monocytic Leukemia, Chronic|Monocytic Leukemias, Chronic|Myelocytic Leukemia|Myelocytic Leukemias|Myelogenous Leukemia|Myelogenous Leukemias|Myeloid Leukemia|Myeloid Leukemias	Cancer
Leukemia, Myeloid, Accelerated Phase	MESH:D015465		The phase of chronic myeloid leukemia following the chronic phase (LEUKEMIA, MYELOID, CHRONIC-PHASE), where there are increased systemic symptoms, worsening cytopenias, and refractory LEUKOCYTOSIS.	MESH:D015464	C04.557.337.539.250.300|C15.378.190.636.370.300|C23.550.291.500.485.300	C04.557.337.539.250|C15.378.190.636.370|C23.550.291.500.485	Leukemia, Myelogenous, Aggressive Phase|Leukemia, Myelogenous, Aggressive-Phase|Leukemia, Myeloid, Accelerated-Phase|Leukemia, Myeloid, Aggressive-Phase|Myelogenous Leukemia, Chronic, Aggressive Phase|Myelogenous Leukemia, Chronic, Aggressive-Phase|Myeloid Leukemia, Chronic, Accelerated Phase|Myeloid Leukemia, Chronic, Accelerated-Phase|Myeloid Leukemia, Chronic, Aggressive Phase|Myeloid Leukemia, Chronic, Aggressive-Phase	Blood disease|Cancer|Pathology (process)
Leukemia, Myeloid, Acute	MESH:D015470	DO:DOID:9119|OMIM:601626	Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.	MESH:D007951	C04.557.337.539.275	C04.557.337.539	Acute Myeloblastic Leukemia|Acute Myeloblastic Leukemias|Acute Myelocytic Leukemia|Acute Myelocytic Leukemias|Acute Myelogenous Leukemia|Acute Myelogenous Leukemias|Acute Myeloid Leukemia|Acute Myeloid Leukemias|Acute Myeloid Leukemia with Maturation|Acute Myeloid Leukemia without Maturation|Acute Nonlymphoblastic Leukemia|Acute Nonlymphoblastic Leukemias|Acute Nonlymphocytic Leukemia|Acute Nonlymphocytic Leukemias|AML|ANLL|Leukemia, Acute Myeloblastic|Leukemia, Acute Myelocytic|Leukemia, Acute Myelogenous|LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED|Leukemia, Acute Myeloid|Leukemia, Acute Nonlymphoblastic|Leukemia, Acute Nonlymphocytic|Leukemia, Myeloblastic, Acute|Leukemia, Myelocytic, Acute|Leukemia, Myelogenous, Acute|Leukemia, Myeloid, Acute, M1|Leukemia, Myeloid, Acute, M2|Leukemia, Nonlymphoblastic, Acute|Leukemia, Nonlymphocytic, Acute|Leukemias, Acute Myeloblastic|Leukemias, Acute Myelocytic|Leukemias, Acute Myelogenous|Leukemias, Acute Myeloid|Leukemias, Acute Nonlymphoblastic|Leukemias, Acute Nonlymphocytic|Myeloblastic Leukemia, Acute|Myeloblastic Leukemias, Acute|Myelocytic Leukemia, Acute|Myelocytic Leukemias, Acute|Myelogenous Leukemia, Acute|Myelogenous Leukemias, Acute|Myeloid Leukemia, Acute|Myeloid Leukemia, Acute, M1|Myeloid Leukemia, Acute, M2|Myeloid Leukemias, Acute|Nonlymphoblastic Leukemia, Acute|Nonlymphoblastic Leukemias, Acute|Nonlymphocytic Leukemia, Acute|Nonlymphocytic Leukemias, Acute	Cancer
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	MESH:D054438	DO:DOID:0060597	A myelodysplastic/myeloproliferative disorder characterized by myelodysplasia associated with bone marrow and peripheral blood patterns similar to CHRONIC MYELOID LEUKEMIA, but cytogenetically lacking a PHILADELPHIA CHROMOSOME or bcr/abl fusion gene (GENES, ABL).	MESH:D002908|MESH:D007951|MESH:D054437	C04.557.337.539.300|C15.378.190.615.500|C23.550.291.500.493	C04.557.337.539|C15.378.190.615|C23.550.291.500	Atypical Chronic Myeloid Leukemia|Chronic Myeloid Leukemia, Atypical|Leukemia, Myelogenous, Ph1 Negative|Leukemia, Myelogenous, Ph1-Negative|Leukemia, Myeloid, Chronic, Atypical|Leukemia, Myeloid, Ph1 Negative|Leukemia, Myeloid, Ph1-Negative|Leukemia, Myeloid, Philadelphia Negative|Leukemia, Myeloid, Philadelphia-Negative|Leukemia, Ph1-Negative Myelogenous|Leukemia, Ph1-Negative Myeloid|Leukemia, Philadelphia-Negative Myeloid|Leukemias, Ph1-Negative Myelogenous|Leukemias, Ph1-Negative Myeloid|Leukemias, Philadelphia-Negative Myeloid|Myelogenous Leukemia, Ph1 Negative|Myelogenous Leukemia, Ph1-Negative|Myelogenous Leukemias, Ph1-Negative|Myeloid Leukemia, Ph1 Negative|Myeloid Leukemia, Ph1-Negative|Myeloid Leukemia, Philadelphia Negative|Myeloid Leukemia, Philadelphia-Negative|Myeloid Leukemias, Ph1-Negative|Myeloid Leukemias, Philadelphia-Negative|Ph1-Negative Myelogenous Leukemia|Ph1-Negative Myelogenous Leukemias|Ph1-Negative Myeloid Leukemia|Ph1-Negative Myeloid Leukemias|Philadelphia-Negative Myeloid Leukemia|Philadelphia-Negative Myeloid Leukemias	Blood disease|Cancer|Pathology (process)
Leukemia, Myeloid, Chronic-Phase	MESH:D015466		The initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. Patients range from asymptomatic to those exhibiting ANEMIA; SPLENOMEGALY; and increased cell turnover. There are 5% or fewer blast cells in the blood and bone marrow in this phase.	MESH:D015464	C04.557.337.539.250.400|C15.378.190.636.370.400|C23.550.291.500.485.400	C04.557.337.539.250|C15.378.190.636.370|C23.550.291.500.485	Granulocytic Leukemia, Chronic, Stable Phase|Granulocytic Leukemia, Chronic, Stable-Phase|Leukemia, Granulocytic, Chronic Phase|Leukemia, Granulocytic, Chronic-Phase|Leukemia, Myelogenous, Chronic Phase|Leukemia, Myelogenous, Chronic-Phase|Leukemia, Myeloid, Chronic Phase|Leukemia, Myeloid, Stable Phase|Leukemia, Myeloid, Stable-Phase|Myelogenous Leukemia, Chronic, Chronic Phase|Myelogenous Leukemia, Chronic, Chronic-Phase|Myeloid Leukemia, Chronic, Chronic Phase|Myeloid Leukemia, Chronic, Chronic-Phase|Myeloid Leukemia, Chronic, Stable-Phase	Blood disease|Cancer|Pathology (process)
Leukemia, Myelomonocytic, Acute	MESH:D015479		A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.	MESH:D007951	C04.557.337.539.520	C04.557.337.539	Acute Myelomonocytic Leukemia|Acute Myelomonocytic Leukemias|Leukemia, Acute Myelomonocytic|Leukemia, Myeloid, Acute, M4|Leukemia, Myeloid, Naegeli-Type|Leukemia, Naegeli-Type Myeloid|Leukemias, Acute Myelomonocytic|Myeloid Leukemia, Acute, M4|Myeloid Leukemia, Naegeli Type|Myeloid Leukemia, Naegeli-Type|Myelomonocytic Leukemia, Acute|Myelomonocytic Leukemias, Acute|Naegeli-Type Myeloid Leukemia	Cancer
Leukemia, Myelomonocytic, Chronic	MESH:D015477		A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.	MESH:D002908|MESH:D007951|MESH:D054437	C04.557.337.539.522|C15.378.190.615.510|C23.550.291.500.495	C04.557.337.539|C15.378.190.615|C23.550.291.500	Chronic Myelomonocytic Leukemia|Chronic Myelomonocytic Leukemias|Leukemia, Chronic Myelomonocytic|Leukemias, Chronic Myelomonocytic|Myelomonocytic Leukemia, Chronic|Myelomonocytic Leukemias, Chronic	Blood disease|Cancer|Pathology (process)
Leukemia, Myelomonocytic, Juvenile	MESH:D054429	DO:DOID:0050458|OMIM:607785	A leukemia affecting young children characterized by SPLENOMEGALY, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.	MESH:D007951|MESH:D054437	C04.557.337.539.525|C15.378.190.615.520	C04.557.337.539|C15.378.190.615	CMML, INCLUDED|JMML|Juvenile Chronic Myelogenous Leukemia|Juvenile Myelomonocytic Leukemia|Juvenile Myelomonocytic Leukemias|Leukemia, Juvenile Myelomonocytic|LEUKEMIA, JUVENILE MYELOMONOCYTIC LEUKEMIA, CHRONIC MYELOMONOCYTIC, INCLUDED|Myelomonocytic Leukemia, Juvenile|Myelomonocytic Leukemias, Juvenile	Blood disease|Cancer
Leukemia, Neutrophilic, Chronic	MESH:D015467		A rare myeloproliferative disorder that is characterized by a sustained, mature neutrophilic leukocytosis. No monocytosis, EOSINOPHILIA, or basophilia is present, nor is there a PHILADELPHIA CHROMOSOME or bcr-abl fusion gene (GENES, ABL).	MESH:D002908|MESH:D009196	C15.378.190.636.380|C23.550.291.500.497	C15.378.190.636|C23.550.291.500	Chronic Neutrophilic Leukemia|Chronic Neutrophilic Leukemias|Leukemia, Chronic Neutrophilic|Leukemias, Chronic Neutrophilic|Neutrophilic Leukemia, Chronic|Neutrophilic Leukemias, Chronic	Blood disease|Pathology (process)
Leukemia P388	MESH:D007941		An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.	MESH:D007942	C04.557.337.372.782|C04.619.531.782	C04.557.337.372|C04.619.531	P388D(1) Leukemia|P388, Leukemia	Cancer
Leukemia, Plasma Cell	MESH:D007952	DO:DOID:9513	A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.	MESH:D007938|MESH:D009101	C04.557.337.595|C04.557.595.500.500|C20.683.515.845.500	C04.557.337|C04.557.595.500|C20.683.515.845	Leukemia, Plasmacytic|Leukemias, Plasma Cell|Leukemias, Plasmacytic|Plasma Cell Leukemia|Plasma Cell Leukemias|Plasmacytic Leukemia|Plasmacytic Leukemias	Cancer|Immune system disease
Leukemia, Prolymphocytic	MESH:D015463	DO:DOID:1039	A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA.	MESH:D007945	C04.557.337.428.565|C15.604.515.560.550|C20.683.515.528.565	C04.557.337.428|C15.604.515.560|C20.683.515.528	Leukemias, Prolymphocytic|Prolymphocytic Leukemia|Prolymphocytic Leukemias	Cancer|Immune system disease|Lymphatic disease
Leukemia, Prolymphocytic, B-Cell	MESH:D054403		A neoplasm of prolymphocytes affecting the blood, bone marrow, and spleen. It is characterized by prolymphocytes exceeding 55% of the lymphoid cells in the blood and profound splenomegaly.	MESH:D015448|MESH:D015463	C04.557.337.428.080.562|C04.557.337.428.565.745|C15.604.515.560.080.562|C15.604.515.560.550.745|C20.683.515.528.080.562|C20.683.515.528.565.745	C04.557.337.428.080|C04.557.337.428.565|C15.604.515.560.080|C15.604.515.560.550|C20.683.515.528.080|C20.683.515.528.565	B Cell Prolymphocytic Leukemia|B-Cell Prolymphocytic Leukemia|B-Cell Prolymphocytic Leukemias|Leukemia, B-Cell Prolymphocytic|Leukemias, B-Cell Prolymphocytic|Prolymphocytic Leukemia, B-Cell|Prolymphocytic Leukemias, B-Cell	Cancer|Immune system disease|Lymphatic disease
Leukemia, Prolymphocytic, T-Cell	MESH:D015461		A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia.	MESH:D015458|MESH:D015463	C04.557.337.428.565.750|C04.557.337.428.580.075|C15.604.515.560.550.750|C15.604.515.560.575.125|C20.683.515.528.565.750|C20.683.515.528.582.125	C04.557.337.428.565|C04.557.337.428.580|C15.604.515.560.550|C15.604.515.560.575|C20.683.515.528.565|C20.683.515.528.582	Leukemia, Lymphocytic, Chronic, T Cell|Leukemia, Lymphocytic, Chronic, T-Cell|Leukemias, T-Cell Prolymphocytic|Leukemia, T Cell, Chronic|Leukemia, T-Cell, Chronic|Leukemia, T-Cell Prolymphocytic|Lymphocytic Leukemia, T Cell, Chronic|Lymphocytic Leukemia, T-Cell, Chronic|Prolymphocytic Leukemias, T-Cell|Prolymphocytic Leukemia, T-Cell|T-Cell Leukemia, Chronic|T Cell Prolymphocytic Leukemia|T-Cell Prolymphocytic Leukemia|T-Cell Prolymphocytic Leukemias|T-Lymphocytic Leukemia, Chronic	Cancer|Immune system disease|Lymphatic disease
Leukemia, Promyelocytic, Acute	MESH:D015473	DO:DOID:0060318|OMIM:612376	An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.	MESH:D015470	C04.557.337.539.275.700	C04.557.337.539.275	Acute Promyelocytic Leukemia|Acute Promyelocytic Leukemias|AML M3|ANLL, M3|APL|Leukemia, Acute Promyelocytic|Leukemia, Myeloid, Acute, M3|Leukemia, Progranulocytic|M3 ANLL|Myeloid Leukemia, Acute, M3|Progranulocytic Leukemia|Promyelocytic Leukemia, Acute	Cancer
Leukemia, Radiation-Induced	MESH:D007953		Leukemia produced by exposure to IONIZING RADIATION or NON-IONIZING RADIATION.	MESH:D007938|MESH:D009381|MESH:D011832	C04.557.337.650|C04.682.512|C26.733.345	C04.557.337|C04.682|C26.733	Leukemia, Radiation Induced|Leukemias, Radiation-Induced|Radiation Induced Leukemia|Radiation-Induced Leukemia|Radiation-Induced Leukemias	Cancer|Wounds and injuries
Leukemia, T-Cell	MESH:D015458	DO:DOID:715	A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.	MESH:D007945	C04.557.337.428.580|C15.604.515.560.575|C20.683.515.528.582	C04.557.337.428|C15.604.515.560|C20.683.515.528	Leukemia, Lymphocytic, T Cell|Leukemia, Lymphocytic, T-Cell|Leukemias, T-Cell|Leukemias, T-Cell Lymphocytic|Leukemias, T Lymphocytic|Leukemias, T-Lymphocytic|Leukemia, T Cell|Leukemia, T-Cell Lymphocytic|Leukemia, T Lymphocytic|Leukemia, T-Lymphocytic|Lymphocytic Leukemias, T|Lymphocytic Leukemias, T-Cell|Lymphocytic Leukemia, T|Lymphocytic Leukemia, T Cell|Lymphocytic Leukemia, T-Cell|T Cell Leukemia|T-Cell Leukemia|T-Cell Leukemias|T-Cell Lymphocytic Leukemia|T-Cell Lymphocytic Leukemias|T Lymphocytic Leukemia|T-Lymphocytic Leukemia|T Lymphocytic Leukemias|T-Lymphocytic Leukemias	Cancer|Immune system disease|Lymphatic disease
Leukemic Infiltration	MESH:D017254		A pathologic change in leukemia in which leukemic cells permeate various organs at any stage of the disease. All types of leukemia show various degrees of infiltration, depending upon the type of leukemia. The degree of infiltration may vary from site to site. The liver and spleen are common sites of infiltration, the greatest appearing in myelocytic leukemia, but infiltration is seen also in the granulocytic and lymphocytic types. The kidney is also a common site and of the gastrointestinal system, the stomach and ileum are commonly involved. In lymphocytic leukemia the skin is often infiltrated. The central nervous system too is a common site.	MESH:D009361	C04.697.645.500|C23.550.727.645.500	C04.697.645|C23.550.727.645	Infiltration, Leukemic|Infiltrations, Leukemic|Leukemic Infiltrations	Cancer|Pathology (process)
Leukemoid Reaction	MESH:D007955		A peripheral blood picture resembling that of leukemia or indistinguishable from it on the basis of morphologic appearance alone. (Dorland, 27th ed)	MESH:D007964|MESH:D009196	C15.378.190.636.484|C15.378.553.475.428	C15.378.190.636|C15.378.553.475	Leukemoid Reactions|Reaction, Leukemoid|Reactions, Leukemoid	Blood disease
Leukocyte Disorders	MESH:D007960	DO:DOID:9500	Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.	MESH:D006402	C15.378.553	C15.378	Disorder, Leukocyte|Disorders, Leukocyte|Leukocyte Disorder	Blood disease
Leukocyte Nuclear Appendages, Hereditary Prevalence of	MESH:C563626			MESH:D007960	C15.378.553/C563626	C15.378.553		Blood disease
Leukocytosis	MESH:D007964		A transient increase in the number of leukocytes in a body fluid.	MESH:D007960|MESH:D010335	C15.378.553.475|C23.550.526	C15.378.553|C23.550	Leukocytoses|Pleocytoses|Pleocytosis	Blood disease|Pathology (process)
Leukoencephalitis, Acute Hemorrhagic	MESH:D004684	DO:DOID:10992|DO:DOID:5222	A fulminant and often fatal demyelinating disease of the brain which primarily affects young adults and children. Clinical features include the rapid onset of weakness, SEIZURES, and COMA. It may follow a viral illness or MYCOPLASMA PNEUMONIAE infections but in most instances there is no precipitating event. Pathologic examination reveals marked perivascular demyelination and necrosis of white matter with microhemorrhages. (Adams et al., Principles of Neurology, 6th ed, pp924-5)	MESH:D004673|MESH:D020278	C10.114.375.225.500|C10.114.375.362|C10.228.140.695.562.225.500|C10.228.140.695.562.375|C10.314.350.225.500|C10.314.350.375|C20.111.258.250.350.500|C20.111.258.250.425	C10.114.375|C10.114.375.225|C10.228.140.695.562|C10.228.140.695.562.225|C10.314.350|C10.314.350.225|C20.111.258.250|C20.111.258.250.350	Acute Hemorrhagic Encephalomyelitides|Acute Hemorrhagic Encephalomyelitis|Acute Hemorrhagic Leukoencephalitides|Acute Hemorrhagic Leukoencephalitis|Acute Necrotizing Encephalitides|Acute Necrotizing Encephalitis|Disease, Hurst|Disease, Hurst's|Encephalitides, Acute Necrotizing|Encephalitis, Acute Necrotizing|Encephalomyelitides, Acute Hemorrhagic|Encephalomyelitides, Hemorrhagic Necrotizing|Encephalomyelitis, Acute Hemorrhagic|Encephalomyelitis, Acute Necrotizing Hemorrhagic|Encephalomyelitis, Hemorrhagic Necrotizing|Encephalomyelitis, Necrotizing Hemorrhagic|Hemorrhagic Encephalomyelitides, Acute|Hemorrhagic Encephalomyelitides, Necrotizing|Hemorrhagic Encephalomyelitis, Acute|Hemorrhagic Encephalomyelitis, Necrotizing|Hemorrhagic Leukoencephalitides, Acute|Hemorrhagic Leukoencephalitides, Subacute|Hemorrhagic Leukoencephalitis, Acute|Hemorrhagic Leukoencephalitis, Subacute|Hemorrhagic Necrotizing Encephalomyelitis|Hurst Disease|Hurst's Disease|Hursts Disease|Hurst Syndrome|Leukoencephalitides, Acute Hemorrhagic|Leukoencephalitides, Subacute Hemorrhagic|Leukoencephalitis Acuta Hemorrhagica|Leukoencephalitis, Subacute Hemorrhagic|Necrotizing Encephalitides, Acute|Necrotizing Encephalitis, Acute|Necrotizing Encephalomyelitides, Hemorrhagic|Necrotizing Encephalomyelitis, Hemorrhagic|Necrotizing Hemorrhagic Encephalomyelitides|Necrotizing Hemorrhagic Encephalomyelitis|Subacute Hemorrhagic Leukoencephalitides|Subacute Hemorrhagic Leukoencephalitis|Syndrome, Hurst	Immune system disease|Nervous system disease
Leukoencephalopathies	MESH:D056784		Any of various diseases affecting the white matter of the central nervous system.	MESH:D001927	C10.228.140.695	C10.228.140	CACH Syndrome|CACH Syndromes|CACH VWM Syndrome|CACH VWM Syndromes|Centralis Diffusa, Myelinosis|Childhood Ataxia with Central Nervous System Hypomyelination|Childhood Ataxia with Central Nervous System Hypomyelinization|Childhood Ataxia with Diffuse Central Nervous System Hypomyelination|Cree Leukoencephalopathies|Cree Leukoencephalopathy|Diffusa, Myelinosis Centralis|Diffusas, Myelinosis Centralis|Leukoencephalopathy|Leukoencephalopathy, Cree|Leukoencephalopathy with Vanishing White Matter|Myelinosis Centralis Diffusa|Myelinosis Centralis Diffusas|Syndrome, CACH VWM|Vanishing White Matter Disease|Vanishing White Matter Leukodystrophy|VWM Syndrome, CACH|White Matter Disease|White Matter Diseases	Nervous system disease
Leukoencephalopathy, Arthritis, Colitis, and Hypogammaglobulinema	MESH:C563852			MESH:D000361|MESH:D001168|MESH:D003092|MESH:D056784	C05.550.114/C563852|C06.405.205.265/C563852|C06.405.469.158.188/C563852|C10.228.140.695/C563852|C15.378.147.142/C563852|C15.604.515.032/C563852|C20.673.088/C563852	C05.550.114|C06.405.205.265|C06.405.469.158.188|C10.228.140.695|C15.378.147.142|C15.604.515.032|C20.673.088		Blood disease|Digestive system disease|Immune system disease|Lymphatic disease|Musculoskeletal disease|Nervous system disease
Leukoencephalopathy, arthritis, colitis, and hypogammaglobulinemia	MESH:C535888			MESH:D000015|MESH:D000361|MESH:D001168|MESH:D003092|MESH:D056784	C05.550.114/C535888|C06.405.205.265/C535888|C06.405.469.158.188/C535888|C10.228.140.695/C535888|C15.378.147.142/C535888|C15.604.515.032/C535888|C16.131.077/C535888|C20.673.088/C535888	C05.550.114|C06.405.205.265|C06.405.469.158.188|C10.228.140.695|C15.378.147.142|C15.604.515.032|C16.131.077|C20.673.088		Blood disease|Congenital abnormality|Digestive system disease|Immune system disease|Lymphatic disease|Musculoskeletal disease|Nervous system disease
Leukoencephalopathy Brain Calcifications and Cysts	MESH:C000598644	OMIM:614561		MESH:D002114|MESH:D020863|MESH:D056784	C04.588.614.250.387/C000598644|C10.228.140.695/C000598644|C10.500.142/C000598644|C10.551.240.375/C000598644|C16.131.666.142/C000598644|C18.452.174.130/C000598644	C04.588.614.250.387|C10.228.140.695|C10.500.142|C10.551.240.375|C16.131.666.142|C18.452.174.130	Labrune Syndrome|LCC|LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	Cancer|Congenital abnormality|Metabolic disease|Nervous system disease
Leukoencephalopathy, Cystic, Without Megalencephaly	MESH:C567845	OMIM:612951		MESH:D003560|MESH:D056784	C04.182/C567845|C10.228.140.695/C567845|C23.300.306/C567845	C04.182|C10.228.140.695|C23.300.306		Cancer|Nervous system disease|Pathology (anatomical condition)
Leukoencephalopathy, Progressive Multifocal	MESH:D007968	DO:DOID:643	An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)	MESH:D003711|MESH:D012897|MESH:D018792|MESH:D027601|MESH:D056784	C01.207.245.340.500|C01.207.399.750.500|C01.925.182.525.500|C01.925.256.721.500|C01.925.839.550|C10.228.140.430.520.750.500|C10.228.140.695.750|C10.228.228.245.340.500|C10.228.228.399.750.500|C10.314.450|C10.586.250.520.750.500	C01.207.245.340|C01.207.399.750|C01.925.182.525|C01.925.256.721|C01.925.839|C10.228.140.430.520.750|C10.228.140.695|C10.228.228.245.340|C10.228.228.399.750|C10.314|C10.586.250.520.750	Encephalitis, JC Polyomavirus|Encephalopathies, JC Polyomavirus|Encephalopathy, JC Polyomavirus|JC Polyomavirus Encephalitis|JC Polyomavirus Encephalopathy|Leukoencephalopathies, Progressive Multifocal|Multifocal Leukoencephalopathies, Progressive|Multifocal Leukoencephalopathy, Progressive|Progressive Multifocal Leukoencephalopathies|Progressive Multifocal Leukoencephalopathy	Nervous system disease|Viral disease
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE	OMIM:615889			MESH:D010049|MESH:D056784	C10.228.140.695/615889|C12.050.351.500.056.630/615889|C12.100.250.056.630/615889|C19.391.630/615889	C10.228.140.695|C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	LKENP	Endocrine system disease|Nervous system disease|Urogenital disease (female)
LEUKOENCEPHALOPATHY WITH ATAXIA	OMIM:615651			MESH:D001259|MESH:D056784	C10.228.140.695/615651|C10.597.350.090/615651|C23.888.592.350.090/615651	C10.228.140.695|C10.597.350.090|C23.888.592.350.090	LKPAT	Nervous system disease|Signs and symptoms
Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation	MESH:C567009	OMIM:611105		MESH:D028361|MESH:D056784	C10.228.140.695/C567009|C18.452.660/C567009	C10.228.140.695|C18.452.660	LBSL|Mitochondrial Aspartyl-tRNA Synthetase Deficiency	Metabolic disease|Nervous system disease
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	OMIM:613724			MESH:D004421|MESH:D011115|MESH:D056784	C10.228.140.695/613724|C10.597.350.300/613724|C10.668.829.800/613724|C23.888.592.350.300/613724	C10.228.140.695|C10.597.350.300|C10.668.829.800|C23.888.592.350.300	LKDMN|STEROL CARRIER PROTEIN 2 DEFICIENCY	Nervous system disease|Signs and symptoms
Leukoencephalopathy with Dystonia and Motor Neuropathy, SCPx-Deficient	MESH:C566654			MESH:D004421|MESH:D011115|MESH:D056784	C10.228.140.695/C566654|C10.597.350.300/C566654|C10.668.829.800/C566654|C23.888.592.350.300/C566654	C10.228.140.695|C10.597.350.300|C10.668.829.800|C23.888.592.350.300		Nervous system disease|Signs and symptoms
Leukomalacia, Periventricular	MESH:D007969	DO:DOID:13088	Degeneration of white matter adjacent to the CEREBRAL VENTRICLES following cerebral hypoxia or BRAIN ISCHEMIA in neonates. The condition primarily affects white matter in the perfusion zone between superficial and deep branches of the MIDDLE CEREBRAL ARTERY. Clinical manifestations include VISION DISORDERS; CEREBRAL PALSY; PARAPLEGIA; SEIZURES; and cognitive disorders. (From Adams et al., Principles of Neurology, 6th ed, p1021; Joynt, Clinical Neurology, 1997, Ch4, pp30-1)	MESH:D002561|MESH:D004678|MESH:D007235	C10.228.140.300.700|C10.228.140.461.550|C14.907.253.612|C16.614.521.450	C10.228.140.300|C10.228.140.461|C14.907.253|C16.614.521	Cerebral Leukomalacia, Neonatal|Cerebral Leukomalacias, Neonatal|Cystic Periventricular Leukomalacia|Cystic Periventricular Leukomalacias|Encephalomalacia, Periventricular|Encephalomalacias, Periventricular|Leucomalacia, Periventricular|Leucomalacias, Periventricular|Leukomalacia, Cystic Periventricular|Leukomalacia, Neonatal Cerebral|Leukomalacias, Cystic Periventricular|Leukomalacias, Neonatal Cerebral|Leukomalacias, Periventricular|Neonatal Cerebral Leukomalacia|Neonatal Cerebral Leukomalacias|Periventricular Encephalomalacia|Periventricular Encephalomalacias|Periventricular Leucomalacia|Periventricular Leucomalacias|Periventricular Leukomalacia|Periventricular Leukomalacia, Cystic|Periventricular Leukomalacias|Periventricular Leukomalacias, Cystic	Cardiovascular disease|Infant-newborn disease|Nervous system disease
Leukonychia totalis	MESH:C535889			MESH:D009260|MESH:D017496	C17.800.529/C535889|C17.800.621.440/C535889	C17.800.529|C17.800.621.440	Hereditary white nails|Porcelain nails	Skin disease
Leukopenia	MESH:D007970	DO:DOID:615	A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).	MESH:D007960	C15.378.553.546	C15.378.553	Leukocytopenia|Leukocytopenias|Leukopenias	Blood disease
Leukoplakia	MESH:D007971		A white patch lesion found on a MUCOUS MEMBRANE that cannot be scraped off. Leukoplakia is generally considered a precancerous condition, however its appearance may also result from a variety of HEREDITARY DISEASES.	MESH:D011230|MESH:D020763	C04.834.512|C23.300.816	C04.834|C23.300	Lesion, Leukoplakic|Lesions, Leukoplakic|Leukokeratoses|Leukokeratosis|Leukoplakias|Leukoplakic Lesion|Leukoplakic Lesions	Cancer|Pathology (anatomical condition)
Leukoplakia, Hairy	MESH:D017733	DO:DOID:0060315	Epithelial hyperplasia of the oral mucosa associated with Epstein-Barr virus (HERPESVIRUS 4, HUMAN) and found almost exclusively in persons with HIV infection. The lesion consists of a white patch that is often corrugated or hairy.	MESH:D007972|MESH:D020031	C01.925.256.466.313.500|C04.588.443.591.545.500|C04.834.512.513.500|C07.465.530.545.500|C23.300.816.513.500	C01.925.256.466.313|C04.588.443.591.545|C04.834.512.513|C07.465.530.545|C23.300.816.513	Hairy Leukoplakia|Hairy Leukoplakia, Oral|Hairy Leukoplakias|Hairy Leukoplakias, Oral|Leukoplakia, Hairy, Oral|Leukoplakia, Oral Hairy|Leukoplakias, Hairy|Leukoplakias, Oral Hairy|Oral Hairy Leukoplakia|Oral Hairy Leukoplakias	Cancer|Mouth disease|Pathology (anatomical condition)|Viral disease
Leukoplakia, Oral	MESH:D007972		A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY).	MESH:D007971|MESH:D009062	C04.588.443.591.545|C04.834.512.513|C07.465.530.545|C23.300.816.513	C04.588.443.591|C04.834.512|C07.465.530|C23.300.816	Keratoses, Oral|Keratosis, Oral|Leukokeratoses, Oral|Leukokeratosis, Oral|Leukoplakias, Oral|Oral Keratoses|Oral Keratosis|Oral Leukokeratoses|Oral Leukokeratosis|Oral Leukoplakia|Oral Leukoplakias	Cancer|Mouth disease|Pathology (anatomical condition)
Leukorrhea	MESH:D007973	DO:DOID:3766	A clear or white discharge from the VAGINA, consisting mainly of MUCUS.	MESH:D019522	C12.050.351.500.894.700.500|C12.100.250.894.700.500	C12.050.351.500.894.700|C12.100.250.894.700	Leukorrheas	Urogenital disease (female)
Leukostasis	MESH:D018921	DO:DOID:12986	Abnormal intravascular leukocyte aggregation and clumping often seen in leukemia patients. The brain and lungs are the two most commonly affected organs. This acute syndrome requires aggressive cytoreductive modalities including chemotherapy and/or leukophoresis. It is differentiated from LEUKEMIC INFILTRATION which is a neoplastic process where leukemic cells invade organs.	MESH:D007960	C15.378.553.560	C15.378.553	Leukostases|Leukostasis Syndrome|Leukostasis Syndromes|Syndrome, Leukostasis|Syndromes, Leukostasis	Blood disease
Levator-Medial Rectus Synkinesis	MESH:C563625			MESH:D015835|MESH:D046608	C10.228.758/C563625|C10.292.562/C563625|C10.597.350.675/C563625|C11.590/C563625|C23.888.592.350.675/C563625	C10.228.758|C10.292.562|C10.597.350.675|C11.590|C23.888.592.350.675	Oculomotor-Levator Synkinesis	Eye disease|Nervous system disease|Signs and symptoms
Levator syndrome	MESH:C535890			MESH:D001004|MESH:D010146	C06.405.469.860.101/C535890|C23.888.592.612/C535890	C06.405.469.860.101|C23.888.592.612	Levator ani spasm syndrome|Levator ani syndrome	Digestive system disease|Signs and symptoms
Levocardia	MESH:D007979		Congenital abnormalities in which the HEART is in the normal position (levocardia) in the left side of the chest but some or all of the THORAX or ABDOMEN viscera are transposed laterally (SITUS INVERSUS). It is also known as situs inversus with levocardia, or isolated levocardia. This condition is often associated with severe heart defects and splenic abnormalities such as asplenia or polysplenia.	MESH:D006330|MESH:D012857	C14.240.400.701|C14.280.400.701|C16.131.240.400.701|C16.131.810.700	C14.240.400|C14.280.400|C16.131.240.400|C16.131.810	Isolated Levocardia|Levocardia, Isolated|Situs Inversus with Levocardia	Cardiovascular disease|Congenital abnormality
Leydig Cell Adenoma, Somatic, with Male-Limited Precocious Puberty	MESH:C567168			MESH:D000236|MESH:D007984|MESH:D011629	C04.557.470.035/C567168|C04.557.475.750.847.249/C567168|C04.588.322.762.500.249/C567168|C04.588.945.440.915.500.249/C567168|C12.100.500.260.937.500.249/C567168|C12.200.294.260.937.500.249/C567168|C12.200.758.409.937.500.249/C567168|C12.900.619.937.500.249/C567168|C19.344.762.500.249/C567168|C19.391.693/C567168|C19.391.829.782.500.249/C567168	C04.557.470.035|C04.557.475.750.847.249|C04.588.322.762.500.249|C04.588.945.440.915.500.249|C12.100.500.260.937.500.249|C12.200.294.260.937.500.249|C12.200.758.409.937.500.249|C12.900.619.937.500.249|C19.344.762.500.249|C19.391.693|C19.391.829.782.500.249		Cancer|Endocrine system disease|Urogenital disease (male)
Leydig Cell Tumor	MESH:D007984	DO:DOID:2696	Gonadal interstitial or stromal cell neoplasm composed of only LEYDIG CELLS. These tumors may produce one or more of the steroid hormones such as ANDROGENS; ESTROGENS; and CORTICOSTEROIDS. Clinical symptoms include testicular swelling, GYNECOMASTIA, sexual precocity in children, or virilization (VIRILISM) in females.	MESH:D018310	C04.557.475.750.847.249|C04.588.322.762.500.249|C04.588.945.440.915.500.249|C12.100.500.260.937.500.249|C12.200.294.260.937.500.249|C12.200.758.409.937.500.249|C12.900.619.937.500.249|C19.344.762.500.249|C19.391.829.782.500.249	C04.557.475.750.847|C04.588.322.762.500|C04.588.945.440.915.500|C12.100.500.260.937.500|C12.200.294.260.937.500|C12.200.758.409.937.500|C12.900.619.937.500|C19.344.762.500|C19.391.829.782.500	Interstitial Cell Tumor|Interstitial Cell Tumors|Tumor, Interstitial Cell|Tumor, Leydig Cell|Tumors, Interstitial Cell	Cancer|Endocrine system disease|Urogenital disease (male)
Lichen Nitidus	MESH:D017513	DO:DOID:8573	A chronic inflammatory disease characterized by shiny, flat-topped, usually flesh-colored micropapules no larger than the head of a pin. Lesions are localized in the early stages, found chiefly on the lower abdomen, penis, and inner surface of the thighs. Distribution may become generalized as the disease progresses.	MESH:D017512	C17.800.859.475.545	C17.800.859.475		Skin disease
Lichenoid Eruptions	MESH:D017512		Conditions in which there is histological damage to the lower epidermis along with a grouped chronic inflammatory infiltrate in the papillary dermis disturbing the interface between the epidermis and dermis. LICHEN PLANUS is the prototype of all lichenoid eruptions. (From Rook et al., Textbook of Dermatology, 4th ed, p398)	MESH:D017444	C17.800.859.475	C17.800.859	Eruption, Licheniform|Eruption, Lichenoid|Eruptions, Licheniform|Eruptions, Lichenoid|Licheniform Eruption|Licheniform Eruptions|Lichenoid Eruption	Skin disease
Lichen Planus	MESH:D008010	DO:DOID:9201	An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a 'saw-tooth' pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.	MESH:D017512	C17.800.859.475.560	C17.800.859.475	Cutaneous Lichen Planus|Lichen Planopilaris|Lichen Planus, Cutaneous|Lichen Planus, Mucosal|Lichen Ruber Planus|Lichen Rubra Planus|Mucosal Lichen Planus|Planopilaris, Lichen	Skin disease
Lichen Planus, Familial	MESH:C563624			MESH:D008010	C17.800.859.475.560/C563624	C17.800.859.475.560		Skin disease
Lichen planus follicularis	MESH:C535892			MESH:D008010	C17.800.859.475.560/C535892	C17.800.859.475.560	Follicular lichen planus tumidus|Lichen planus follicularis tumidus|Lichen planus tumidus follicularis	Skin disease
Lichen Planus, Oral	MESH:D017676		Oral lesions accompanying cutaneous lichen planus or often occurring alone. The buccal mucosa, lips, gingivae, floor of the mouth, and palate are usually affected (in a descending order of frequency). Typically, oral lesions consist of radiating white or gray, velvety, threadlike lines, arranged in a reticular pattern, at the intersection of which there may be minute, white, elevated dots or streaks (Wickham's striae). (Jablonski, Illustrated Dictionary of Dentistry)	MESH:D008010|MESH:D009059	C07.465.397|C17.800.859.475.560.397	C07.465|C17.800.859.475.560	Oral Lichen Planus	Mouth disease|Skin disease
Lichen Sclerosus et Atrophicus	MESH:D018459		A chronic inflammatory mucocutaneous disease usually affecting the female genitalia (VULVAR LICHEN SCLEROSUS) and BALANITIS XEROTICA OBLITERANS in males. It is also called white spot disease and Csillag's disease.	MESH:D017512	C17.800.859.475.605	C17.800.859.475	Lichen Scleroses|Lichen Sclerosis|Lichen Sclerosis et Atrophicus|Lichen Sclerosus|Scleroses, Lichen|Sclerosis, Lichen|Sclerosus, Lichen	Skin disease
Lichtenstein syndrome	MESH:C535894			MESH:D005357|MESH:D007153|MESH:D009503|MESH:D019066	C05.116.099.708.375/C535894|C15.378.553.546.184.564/C535894|C20.673/C535894|C23.550.291.812/C535894	C05.116.099.708.375|C15.378.553.546.184.564|C20.673|C23.550.291.812		Blood disease|Immune system disease|Musculoskeletal disease|Pathology (process)
Limbic Encephalitis	MESH:D020363		A paraneoplastic syndrome marked by degeneration of neurons in the LIMBIC SYSTEM. Clinical features include HALLUCINATIONS, loss of EPISODIC MEMORY; ANOSMIA; AGEUSIA; TEMPORAL LOBE EPILEPSY; DEMENTIA; and affective disturbance (depression). Circulating anti-neuronal antibodies (e.g., anti-Hu; anti-Yo; anti-Ri; and anti-Ma2) and small cell lung carcinomas or testicular carcinoma are frequently associated with this syndrome.	MESH:D004660|MESH:D020361|MESH:D020805	C01.207.245.700|C04.588.614.550.450|C04.730.856.437|C10.228.140.430.525|C10.228.228.245.700|C10.574.781.550|C10.586.250.525	C01.207.245|C04.588.614.550|C04.730.856|C10.228.140.430|C10.228.228.245|C10.574.781|C10.586.250	Encephalitides, Paraneoplastic Limbic|Encephalitis, Limbic|Encephalitis, Paraneoplastic Limbic|Limbic Encephalitis, Paraneoplastic|Paraneoplastic Limbic Encephalitis	Cancer|Nervous system disease
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3	OMIM:300952	DO:DOID:0111876		MESH:D000015|MESH:D009202|MESH:D012868	C14.280.238/300952|C16.131.077/300952|C16.131.831/300952|C17.800.804/300952	C14.280.238|C16.131.077|C16.131.831|C17.800.804	LINEAR SKIN DEFECTS WITH CARDIOMYOPATHY AND OTHER CONGENITAL ANOMALIES|LSDMCA3	Cardiovascular disease|Congenital abnormality|Skin disease
Lingual Nerve Injuries	MESH:D061222		Traumatic injuries to the LINGUAL NERVE. It may be a complication following dental treatments.	MESH:D061221	C07.465.299.625.500.349.500|C10.292.200.875.500|C10.292.319.625.700.349.500|C10.900.300.218.775.500|C26.915.300.400.825.500	C07.465.299.625.500.349|C10.292.200.875|C10.292.319.625.700.349|C10.900.300.218.775|C26.915.300.400.825	Contusion, Lingual Nerve|Contusions, Lingual Nerve|Injuries, Lingual Nerve|Injury, Lingual Nerve|Lingual Nerve Contusion|Lingual Nerve Contusions|Lingual Nerve Injury|Lingual Nerve Transection|Lingual Nerve Transections|Lingual Neuropathy, Traumatic|Nerve Contusion, Lingual|Nerve Contusions, Lingual|Nerve Injuries, Lingual|Nerve Injury, Lingual|Nerve Transection, Lingual|Nerve Transections, Lingual|Transection, Lingual Nerve|Transections, Lingual Nerve	Mouth disease|Nervous system disease|Wounds and injuries
Linitis Plastica	MESH:D008039	DO:DOID:4023	A condition where the stomach wall becomes thickened, rubbery and loses its ability to distend. The stomach assumes a 'leather bottle' shape. It is most often seen in adenocarcinoma of the stomach. The term is often used synonymously with diffuse adenocarcinoma of the stomach.	MESH:D002293	C04.557.470.200.025.095.410	C04.557.470.200.025.095		Cancer
Lipedema	MESH:D065134		Disorder of adipose tissue characterized by symmetric and bilateral enlargement of the lower extremities due to abnormal deposition of SUBCUTANEOUS FAT often in obese women. It is associated with HEMATOMA, pain and may progress to secondary LYMPHEDEMA which is known as lipolymphedema.	MESH:D003240	C17.300.451	C17.300	Lipedemas|Lipoedema|Lipoedemas|Lipolymphedema|Lipolymphedemas	Connective tissue disease
Lip, Hamartomatous	MESH:C563621			MESH:D006222|MESH:D008047	C04.445/C563621|C07.465.409/C563621	C04.445|C07.465.409	Enlargement of Lower Lip	Cancer|Mouth disease
Lipid Metabolism Disorders	MESH:D052439		Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body.	MESH:D008659	C18.452.584	C18.452	Lipid Metabolism Disorder|Metabolism Disorder, Lipid|Metabolism Disorders, Lipid	Metabolic disease
Lip Neoplasms	MESH:D008048	DO:DOID:8564	Tumors or cancer of the LIP.	MESH:D008047|MESH:D009062	C04.588.443.591.550|C07.465.409.640|C07.465.530.550	C04.588.443.591|C07.465.409|C07.465.530	Cancer, Lip|Cancer of Lip|Cancer of the Lip|Cancers, Lip|Lip Cancer|Lip Cancers|Lip Neoplasm|Neoplasm, Lip|Neoplasms, Lip	Cancer|Mouth disease
Lipoatrophy with diabetes, hepatic steatosis, cardiomyopathy, and leukomelanodermic papules	MESH:C535905			MESH:D002312|MESH:D003920|MESH:D005234|MESH:D008060	C06.552.241/C535905|C14.280.238.100/C535905|C14.280.484.048.750.070.160/C535905|C17.800.849.391/C535905|C18.452.394.750/C535905|C18.452.584.625/C535905|C18.452.880.391/C535905|C19.246/C535905	C06.552.241|C14.280.238.100|C14.280.484.048.750.070.160|C17.800.849.391|C18.452.394.750|C18.452.584.625|C18.452.880.391|C19.246		Cardiovascular disease|Digestive system disease|Endocrine system disease|Metabolic disease|Skin disease
Lipoblastoma	MESH:D062689		Benign tumors of fatty tissues found in infancy and childhood. It is associated chromosomal aberrations that result in activation of an oncogene on chromosome band 8q12.	MESH:D008067	C04.557.450.550.400.500	C04.557.450.550.400	Lipoblastomas|Lipoblastomatoses|Lipoblastomatosis	Cancer
Lipodermatosclerosis	MESH:C537026			MESH:D003872|MESH:D012594	C17.300.787/C537026|C17.800.174/C537026|C17.800.767/C537026	C17.300.787|C17.800.174|C17.800.767	Acute lipodermatosclerosis	Connective tissue disease|Skin disease
Lipodystrophy	MESH:D008060	DO:DOID:811	A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.	MESH:D012875|MESH:D052439	C17.800.849.391|C18.452.584.625|C18.452.880.391	C17.800.849|C18.452.584|C18.452.880	Lipodystrophies	Metabolic disease|Skin disease
Lipodystrophy, Partial, Acquired	MESH:C562448	OMIM:608709		MESH:D008060	C17.800.849.391/C562448|C18.452.584.625/C562448|C18.452.880.391/C562448	C17.800.849.391|C18.452.584.625|C18.452.880.391	APLD|APLD, SUSCEPTIBILITY TO|Barraquer-Simons Syndrome|Lipodystrophy, Cephalothoracic Type|LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO|Lipodystrophy, Partial, Progressive	Metabolic disease|Skin disease
Lipoma	MESH:D008067	DO:DOID:10192|DO:DOID:3315	A benign tumor composed of fat cells (ADIPOCYTES). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule.	MESH:D018205	C04.557.450.550.400	C04.557.450.550	Atypical Lipoma|Atypical Lipomas|Fatty Tumor|Fatty Tumors|Hibernoma|Hibernomas|Lipoma, Atypical|Lipoma, Pleomorphic|Lipomas|Lipomas, Atypical|Lipomas, Pleomorphic|Lipomata|Lipomatas|Lipomatoses, Multiple|Lipomatosis, Multiple|Multiple Lipomatoses|Multiple Lipomatosis|Pleomorphic Lipoma|Pleomorphic Lipomas|Tumor, Fatty|Tumors, Fatty	Cancer
Lipoma of the Conjunctiva	MESH:C563620			MESH:D003230|MESH:D008067	C04.557.450.550.400/C563620|C04.588.364.235/C563620|C11.187.169/C563620|C11.319.217/C563620	C04.557.450.550.400|C04.588.364.235|C11.187.169|C11.319.217		Cancer|Eye disease
Lipomatosis	MESH:D008068	DO:DOID:3153	A disorder characterized by the accumulation of encapsulated or unencapsulated tumor-like fatty tissue resembling LIPOMA.	MESH:D012871|MESH:D052439	C17.800.463|C18.452.584.718	C17.800|C18.452.584	Lipomatoses	Metabolic disease|Skin disease
LIPOMATOSIS, MULTIPLE	OMIM:151900	DO:DOID:14116|DO:DOID:3315		MESH:D008067|MESH:D008068	C04.557.450.550.400/151900|C17.800.463/151900|C18.452.584.718/151900	C04.557.450.550.400|C17.800.463|C18.452.584.718	FML|LIPO|LIPOMA|LIPOMATOSIS, FAMILIAL MULTIPLE	Cancer|Metabolic disease|Skin disease
Lipomatosis, Multiple Symmetrical	MESH:D008069	DO:DOID:14116	A condition characterized by the growth of unencapsulated masses of ADIPOSE TISSUE symmetrically deposited around the neck, shoulders, or other sites around the body.	MESH:D008068	C17.800.463.500|C18.452.584.718.750	C17.800.463|C18.452.584.718	Benign Symmetrical Lipomatoses|Benign Symmetrical Lipomatosis|Cephalothoracic Lipodystrophies|Cephalothoracic Lipodystrophy|Circumscribed Lipomatoses, Nodular|Circumscribed Lipomatosis, Nodular|Disease, Madelung|Disease, Madelung's|Launois Bensaude Syndrome|Launois-Bensaude Syndrome|Lipodystrophies, Cephalothoracic|Lipodystrophy, Cephalothoracic|Lipomatoses, Multiple Symmetric|Lipomatoses, Nodular Circumscribed|Lipomatosis, Benign Symmetrical|Lipomatosis Familial Benign Cervical|Lipomatosis, Familial Benign Cervical|Lipomatosis, Multiple Symmetric|Lipomatosis, Nodular Circumscribed|Madelung Disease|Madelung Neck|Madelung's Disease|Madelungs Disease|Madelung's Neck|Madelungs Neck|Multiple Symmetrical Lipomatoses|Multiple Symmetrical Lipomatosis|Multiple Symmetric Lipomatoses|Multiple Symmetric Lipomatosis|Nodular Circumscribed Lipomatoses|Nodular Circumscribed Lipomatosis|Symmetrical Lipomatoses, Multiple|Symmetrical Lipomatosis, Benign|Symmetrical Lipomatosis, Multiple|Symmetric Lipomatoses, Multiple|Symmetric Lipomatosis, Multiple	Metabolic disease|Skin disease
Lipomatous hemangiopericytoma	MESH:C537029			MESH:D006393|MESH:D008067|MESH:D012004	C04.557.450.550.400/C537029|C04.557.645.380/C537029|C04.588.274.476.411.307.790/C537029|C06.301.371.411.307.790/C537029|C06.405.249.411.307.790/C537029|C06.405.469.491.307.790/C537029|C06.405.469.860.180.500/C537029	C04.557.450.550.400|C04.557.645.380|C04.588.274.476.411.307.790|C06.301.371.411.307.790|C06.405.249.411.307.790|C06.405.469.491.307.790|C06.405.469.860.180.500		Cancer|Digestive system disease
Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia	MESH:C563617			MESH:D006951	C18.452.584.500.500.644/C563617	C18.452.584.500.500.644		Metabolic disease
Liposarcoma	MESH:D008080	DO:DOID:3382|DO:DOID:5690|DO:DOID:5702	A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed)	MESH:D012509|MESH:D018205	C04.557.450.550.420|C04.557.450.795.465	C04.557.450.550|C04.557.450.795	Atypical Lipomatous Tumor|Atypical Lipomatous Tumors|Dedifferentiated Liposarcoma|Dedifferentiated Liposarcomas|Lipomatous Tumor, Atypical|Liposarcoma, Dedifferentiated|Liposarcoma, Pleomorphic|Liposarcomas|Liposarcoma, Well Differentiated|Pleomorphic Liposarcoma|Pleomorphic Liposarcomas|Well Differentiated Liposarcoma|Well Differentiated Liposarcomas	Cancer
Liposarcoma, Myxoid	MESH:D018208	DO:DOID:5363|OMIM:613488	A liposarcoma containing round mesenchymal cells and a myxoid extracellular matrix in stroma.	MESH:D008080	C04.557.450.550.420.425|C04.557.450.795.465.425	C04.557.450.550.420|C04.557.450.795.465	Liposarcoma, Round Cell|Liposarcomas, Myxoid|Myxoid Liposarcoma|Myxoid Liposarcomas|Round Cell Liposarcoma|Round Cell Liposarcomas	Cancer
Littoral cell angioma of the spleen	MESH:C537031			MESH:D006391|MESH:D013160	C04.557.645.375/C537031|C04.588.842/C537031|C15.604.744.680/C537031	C04.557.645.375|C04.588.842|C15.604.744.680	Littoral cell angioma	Cancer|Lymphatic disease
Livedoid Vasculopathy	MESH:D000090122		A rare cutaneous thrombotic disease due to occlusion of dermal vessels. It is characterized by purpuric maculae and ulcerations especially during summer which form scars called atrophie blanche. It is more associated with other syndromes (e.g., PROTEIN C DEFICIENCY; HYPERHOMOCYSTEINEMIA).	MESH:D013927|MESH:D017445	C14.907.355.830.573|C17.800.862.406	C14.907.355.830|C17.800.862	Livedoid Vasculitis|Livedoid Vasculopathies|Livedo Reticularis with Summer Ulceration|Vasculitis, Livedoid|Vasculopathy, Livedoid	Cardiovascular disease|Skin disease
Livedo Reticularis	MESH:D054068		A condition characterized by a reticular or fishnet pattern on the skin of lower extremities and other parts of the body. This red and blue pattern is due to deoxygenated blood in unstable dermal blood vessels. The condition is intensified by cold exposure and relieved by rewarming.	MESH:D012877|MESH:D016491|MESH:D017445	C14.907.617.625|C17.800.862.355|C23.888.885.437	C14.907.617|C17.800.862|C23.888.885	Cutis Marmorata|Livedo Racemosa|Marmorata, Cutis|Racemosa, Livedo	Cardiovascular disease|Signs and symptoms|Skin disease
Liver Abscess, Amebic	MESH:D008101		Single or multiple areas of PUS due to infection by any ameboid protozoa (AMEBIASIS). A common form is caused by the ingestion of ENTAMOEBA HISTOLYTICA.	MESH:D000562|MESH:D008100|MESH:D008109	C01.610.518.600|C01.610.752.049.703|C01.830.025.020.455.460|C06.552.597.517|C06.552.664.642	C01.610.518|C01.610.752.049|C01.830.025.020.455|C06.552.597|C06.552.664	Abscess, Amebic, Hepatic|Abscess, Amebic Liver|Abscess, Amoebic Hepatic|Abscess, Amoebic Liver|Abscesses, Amebic Liver|Abscesses, Amoebic Hepatic|Abscesses, Amoebic Liver|Abscess, Hepatic, Amebic|Abscess, Liver, Amebic|Amebiasis, Hepatic|Amebic Liver Abscess|Amebic Liver Abscesses|Amoebiasis, Hepatic|Amoebic Hepatic Abscess|Amoebic Hepatic Abscesses|Amoebic Liver Abscess|Amoebic Liver Abscesses|Entamoebiases, Hepatic|Entamoebiasis, Hepatic|Hepatic Abscess, Amoebic|Hepatic Abscesses, Amoebic|Hepatic Amebiasis|Hepatic Amoebiasis|Hepatic Entamoebiases|Hepatic Entamoebiasis|Liver Abscess, Amoebic|Liver Abscesses, Amebic|Liver Abscesses, Amoebic	Digestive system disease|Parasitic disease
Liver Cirrhosis	MESH:D008103	DO:DOID:5082	Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.	MESH:D005355|MESH:D008107	C06.552.630|C23.550.355.412	C06.552|C23.550.355	Cirrhosis, Hepatic|Cirrhosis, Liver|Fibrosis, Liver|Hepatic Cirrhosis|Liver Fibrosis	Digestive system disease|Pathology (process)
Liver Cirrhosis, Alcoholic	MESH:D008104	DO:DOID:14018	FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING.	MESH:D008103|MESH:D008108	C06.552.630.380|C06.552.645.590|C23.550.355.412.380|C25.775.100.087.645.550	C06.552.630|C06.552.645|C23.550.355.412|C25.775.100.087.645	Alcoholic Cirrhosis|Alcoholic Hepatic Cirrhosis|Alcoholic Liver Cirrhosis|Hepatic Cirrhosis, Alcoholic	Digestive system disease|Pathology (process)|Substance-related disorder
Liver Cirrhosis, Biliary	MESH:D008105	DO:DOID:12236|OMIM:109720|OMIM:614220|OMIM:614221	FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.	MESH:D002780|MESH:D008103	C06.130.120.135.250.250|C06.552.150.250|C06.552.630.400|C23.550.355.412.400	C06.130.120.135.250|C06.552.150|C06.552.630|C23.550.355.412	Biliary Cholangitides, Primary|Biliary Cholangitis, Primary|Biliary Cholangitis, Secondary|Biliary Cirrhosis|Biliary Cirrhosis, Primary|Biliary Cirrhosis, Primary, 1|BILIARY CIRRHOSIS, PRIMARY, 4|BILIARY CIRRHOSIS, PRIMARY, 5|Biliary Cirrhosis, Secondary|Cholangitides, Primary Biliary|Cholangitis, Chronic Nonsuppurative Destructive|Cholangitis, Primary Biliary|Cholangitis, Secondary Biliary|Cirrhosis, Biliary|Cirrhosis, Secondary Biliary|Liver Cirrhoses, Biliary|Liver Cirrhosis, Obstructive|Obstructive Liver Cirrhosis|PBC|PBC1|PBC4|PBC5|Primary Biliary Cholangitides|Primary Biliary Cholangitis|Primary Biliary Cirrhosis|Secondary Biliary Cholangitides|Secondary Biliary Cholangitis|Secondary Biliary Cirrhosis	Digestive system disease|Pathology (process)
Liver Cirrhosis, Experimental	MESH:D008106		Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.	MESH:D008103	C06.552.630.467|C23.550.355.412.467	C06.552.630|C23.550.355.412	Cirrhoses, Experimental Liver|Cirrhosis, Experimental Liver|Experimental Hepatic Cirrhosis|Experimental Liver Cirrhoses|Experimental Liver Cirrhosis|Hepatic Cirrhosis, Experimental|Liver Cirrhoses, Experimental	Digestive system disease|Pathology (process)
Liver Diseases, Alcoholic	MESH:D008108		Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.	MESH:D008107|MESH:D020751	C06.552.645|C25.775.100.087.645	C06.552|C25.775.100.087	Alcoholic Liver Disease|Alcoholic Liver Diseases|Liver Disease, Alcoholic	Digestive system disease|Substance-related disorder
Liver Diseases, Parasitic	MESH:D008109		Liver diseases caused by infections with PARASITES, such as tapeworms (CESTODA) and flukes (TREMATODA).	MESH:D008107|MESH:D010272	C01.610.518|C06.552.664	C01.610|C06.552	Disease, Parasitic Liver|Diseases, Parasitic Liver|Liver Disease, Parasitic|Parasitic Liver Disease|Parasitic Liver Diseases	Digestive system disease|Parasitic disease
Liver Neoplasms	MESH:D008113	DO:DOID:3571	Tumors or cancer of the LIVER.	MESH:D004067|MESH:D008107	C04.588.274.623|C06.301.623|C06.552.697	C04.588.274|C06.301|C06.552	Cancer, Hepatic|Cancer, Hepatocellular|Cancer, Liver|Cancer of Liver|Cancer of the Liver|Cancers, Hepatic|Cancers, Hepatocellular|Cancers, Liver|Hepatic Cancer|Hepatic Cancers|Hepatic Neoplasm|Hepatic Neoplasms|Hepatocellular Cancer|Hepatocellular Cancers|Liver Cancer|Liver Cancers|Liver Neoplasm|Neoplasm, Hepatic|Neoplasm, Liver|Neoplasms, Hepatic|Neoplasms, Liver	Cancer|Digestive system disease
Liver Neoplasms, Experimental	MESH:D008114		Experimentally induced tumors of the LIVER.	MESH:D008113|MESH:D009374	C04.588.274.623.460|C04.619.540|C06.301.623.460|C06.552.697.580	C04.588.274.623|C04.619|C06.301.623|C06.552.697	Experimental Hepatoma|Experimental Hepatomas|Experimental Liver Neoplasm|Experimental Liver Neoplasms|Hepatoma, Experimental|Hepatoma, Morris|Hepatoma, Novikoff|Hepatomas, Experimental|Liver Neoplasm, Experimental|Morris Hepatoma|Neoplasms, Experimental Liver|Novikoff Hepatoma	Cancer|Digestive system disease
Locked-In Syndrome	MESH:D000080422	DO:DOID:12697	Acquired neuromuscular disorder characterized by complete paralysis of voluntary muscles and lower CRANIAL NERVES except for limited voluntary eye movements. It is due to various cerebrospinal disconnections at or near the PONS and the POSTERIOR CRANIAL FOSSA, typically secondary to pontine hemorrhage or infarct. Because cognitive function is intact it is sometimes referred to as a pseudocoma state.	MESH:D009468|MESH:D011782	C10.597.622.760.500|C10.668.416|C23.888.592.636.786.500	C10.597.622.760|C10.668|C23.888.592.636.786	Cerebromedullospinal Disconnection|Cerebromedullospinal Disconnections|Locked In Syndrome|Locked-In Syndromes|Ventral Pontine Syndrome|Ventral Pontine Syndromes	Nervous system disease|Signs and symptoms
Loose Anagen Hair Syndrome	MESH:D058247	DO:DOID:0111702|OMIM:600628	Benign childhood alopecia that improves spontaneously with aging. It is characterized by anagen hairs (misshapen hair bulbs and absent inner and outer root sheaths), thin, and sparse hairs that pulls out easily.	MESH:D000505	C17.800.329.937.122.348|C23.300.035.500	C17.800.329.937.122|C23.300.035	Anagen Syndrome, Loose|Anagen Syndromes, Loose|Loose Anagen Syndrome|Loose Anagen Syndromes|Syndrome, Loose Anagen|Syndromes, Loose Anagen	Pathology (anatomical condition)|Skin disease
Lordosis	MESH:D008141		The anterior concavity in the curvature of the lumbar and cervical spine as viewed from the side. The term usually refers to abnormally increased curvature (hollow back, saddle back, swayback). It does not include lordosis as normal mating posture in certain animals ( = POSTURE + SEX BEHAVIOR, ANIMAL).	MESH:D013121	C05.116.900.800.750	C05.116.900.800		Musculoskeletal disease
Loss of reflex tearing	MESH:C000721448			MESH:D012021|MESH:D015352	C10.597.704/C000721448|C11.496.260/C000721448|C23.888.592.717/C000721448	C10.597.704|C11.496.260|C23.888.592.717	Reflex tearing loss	Eye disease|Nervous system disease|Signs and symptoms
Lown-Ganong-Levine Syndrome	MESH:D008151	DO:DOID:13087	A form of ventricular pre-excitation characterized by a short PR interval and a normal QRS complex. In this syndrome, the atrial impulse conducts via the JAMES FIBERS which connect the atrium to BUNDLE OF HIS bypassing the upper ATRIOVENTRICULAR NODE. HEART VENTRICLES are depolarized normally through the His-Purkinje system.	MESH:D011226	C14.280.067.780.560|C14.280.123.750.560	C14.280.067.780|C14.280.123.750	Lown Ganong Levine Syndrome|Short PR Normal QRS Complex Syndrome|Short PR-Normal QRS Complex Syndrome|Syndrome, Lown-Ganong-Levine	Cardiovascular disease
Low Tension Glaucoma	MESH:D057066	DO:DOID:13544	A form of glaucoma in which chronic optic nerve damage and loss of vision normally attributable to buildup of intraocular pressure occurs despite prevailing conditions of normal intraocular pressure.	MESH:D005901|MESH:D009901	C11.525.381.703|C11.640.225	C11.525.381|C11.640	Glaucoma, Low Tension|Glaucoma, Normal Tension|Low Tension Glaucomas|Normal Tension Glaucoma|Normal Tension Glaucomas	Eye disease
Lubinsky syndrome	MESH:C543092			MESH:D002386|MESH:D007006	C11.510.245/C543092|C19.391.482/C543092	C11.510.245|C19.391.482	Cataracts and testicular failure|Hypogonadism-Cataract Syndrome	Endocrine system disease|Eye disease
Lung Abscess	MESH:D008169	DO:DOID:0060317	Solitary or multiple collections of PUS within the lung parenchyma as a result of infection by bacteria, protozoa, or other agents.	MESH:D000038|MESH:D008171|MESH:D012141	C01.748.407|C01.830.025.490|C08.381.450|C08.730.407	C01.748|C01.830.025|C08.381|C08.730	Abscesses, Lung|Abscesses, Pulmonary|Abscess, Lung|Abscess, Pulmonary|Lung Abscesses|Pulmonary Abscess|Pulmonary Abscesses	Respiratory tract disease
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME	OMIM:617241			MESH:D007153|MESH:D008171|MESH:D019457	C08.381/617241|C20.673/617241|C23.550.210.170/617241	C08.381|C20.673|C23.550.210.170	LICS	Immune system disease|Pathology (process)|Respiratory tract disease
Lung Diseases	MESH:D008171	DO:DOID:850	Pathological processes involving any part of the LUNG.	MESH:D012140	C08.381	C08	Disease, Lung|Disease, Pulmonary|Diseases, Lung|Diseases, Pulmonary|Lung Disease|Pulmonary Disease|Pulmonary Diseases	Respiratory tract disease
Lung Diseases, Interstitial	MESH:D017563	DO:DOID:3082	A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.	MESH:D008171	C08.381.483	C08.381	Diffuse Parenchymal Lung Disease|Diffuse Parenchymal Lung Diseases|Interstitial Lung Disease|Interstitial Lung Diseases|Interstitial Pneumonia|Interstitial Pneumonias|Interstitial Pneumonitides|Interstitial Pneumonitis|Lung Disease, Interstitial|Pneumonia, Interstitial|Pneumonias, Interstitial|Pneumonitides, Interstitial|Pneumonitis, Interstitial	Respiratory tract disease
Lung Diseases, Obstructive	MESH:D008173	DO:DOID:2320	Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.	MESH:D008171	C08.381.495	C08.381	Lung Disease, Obstructive|Obstructive Lung Disease|Obstructive Lung Diseases|Obstructive Pulmonary Disease|Obstructive Pulmonary Diseases|Pulmonary Disease, Obstructive|Pulmonary Diseases, Obstructive	Respiratory tract disease
Lung, Hyperlucent	MESH:D019568	DO:DOID:10032	A lung with reduced markings on its chest radiograph and increased areas of transradiancy (hyperlucency). A hyperlucent lung is usually associated with pulmonary emphysema or PNEUMOTHORAX.	MESH:D008171	C08.381.570	C08.381	Hyperlucent Lung|Hyperlucent Lungs|Hyperlucent Lungs, Unilateral|Hyperlucent Lung, Unilateral|Hyperlucent Thorax|Lungs, Hyperlucent|Lungs, Unilateral Hyperlucent|Lung, Unilateral Hyperlucent|MacLeod Syndrome|Swyer James Syndrome|Swyer-James Syndrome|Syndrome, MacLeod|Syndrome, Swyer-James|Thorax, Hyperlucent|Unilateral Hyperlucent Lung|Unilateral Hyperlucent Lungs	Respiratory tract disease
Lung Injury	MESH:D055370		Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES.	MESH:D008171|MESH:D013898	C08.381.520|C26.891.554	C08.381|C26.891	Chronic Lung Injuries|Chronic Lung Injury|Injuries, Lung|Injuries, Pulmonary|Injury, Lung|Injury, Pulmonary|Lung Injuries|Lung Injuries, Chronic|Lung Injury, Chronic|Pulmonary Injuries|Pulmonary Injury	Respiratory tract disease|Wounds and injuries
Lung Neoplasms	MESH:D008175	DO:DOID:3683|OMIM:211980|OMIM:608935|OMIM:612052|OMIM:612571|OMIM:612593|OMIM:614210	Tumors or cancer of the LUNG.	MESH:D008171|MESH:D012142	C04.588.894.797.520|C08.381.540|C08.785.520	C04.588.894.797|C08.381|C08.785	ADENOCARCINOMA OF LUNG, INCLUDED|ADENOCARCINOMA OF LUNG, SUSCEPTIBILITY TO|ALVEOLAR CELL CARCINOMA, INCLUDED|Cancer, Lung|Cancer of Lung|Cancer of the Lung|Cancer, Pulmonary|Cancers, Lung|Cancers, Pulmonary|LNCR1|LNCR2, INCLUDED|LNCR3|LNCR4|LNCR5|Lung Cancer|LUNG CANCER, PROTECTION AGAINST, INCLUDED|Lung Cancers|LUNG CANCER SUSCEPTIBILITY 1|LUNG CANCER SUSCEPTIBILITY 3|LUNG CANCER SUSCEPTIBILITY 4|LUNG CANCER SUSCEPTIBILITY 5|Lung Neoplasm|Neoplasm, Lung|Neoplasm, Pulmonary|Neoplasms, Lung|Neoplasms, Pulmonary|NICOTINE DEPENDENCE, SUSCEPTIBILITY TO  LUNG CANCER SUSCEPTIBILITY 2, INCLUDED|NONSMALL CELL LUNG CANCER, INCLUDED|Pulmonary Cancer|Pulmonary Cancers|Pulmonary Neoplasm|Pulmonary Neoplasms|SMOKING AS A QUANTITATIVE TRAIT LOCUS 3|SQTL3	Cancer|Respiratory tract disease
Lupus Erythematosus, Cutaneous	MESH:D008178		A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).	MESH:D003240|MESH:D012871	C17.300.475|C17.800.480	C17.300|C17.800	Cutaneous Lupus Erythematosus|Lupus Erythematosus, Cutaneous, Subacute|Lupus Erythematosus, Subacute Cutaneous	Connective tissue disease|Skin disease
Lupus Erythematosus, Discoid	MESH:D008179		A chronic form of cutaneous lupus erythematosus (LUPUS ERYTHEMATOSUS, CUTANEOUS) in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur.	MESH:D008178	C17.300.475.479|C17.800.480.479	C17.300.475|C17.800.480	Discoid Lupus Erythematosus|Lupus Erythematosus, Chronic Cutaneous|Lupus Erythematosus, Cutaneous, Chronic	Connective tissue disease|Skin disease
Lupus Erythematosus, Systemic	MESH:D008180	DO:DOID:9074|OMIM:152700|OMIM:300809|OMIM:601744|OMIM:605218|OMIM:605480|OMIM:608437|OMIM:609903|OMIM:609939|OMIM:610065|OMIM:610066|OMIM:610927|OMIM:612251|OMIM:612253|OMIM:612254|OMIM:612378|OMIM:613145|OMIM:614420	A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.	MESH:D001327|MESH:D003240	C17.300.480|C20.111.590	C17.300|C20.111	Disease, Libman-Sacks|EXCESS LMW-DNA, INCLUDED|EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA, INCLUDED|Libman Sacks Disease|Libman-Sacks Disease|Lupus Erythematosus Disseminatus|SLE|SLEB1|SLEB10|SLEB11|SLEB12|SLEB13|SLEB14|SLEB15|SLEB16|SLEB2|SLEB3|SLEB4|SLEB5|SLEB6|SLEB7|SLEB8|SLEB9|Systemic Lupus Erythematosus|SYSTEMIC LUPUS ERYTHEMATOSUS 16|SYSTEMIC LUPUS ERYTHEMATOSUS, RESISTANCE TO, 1, INCLUDED|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 12|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 4|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 5|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 7|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 8|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9	Connective tissue disease|Immune system disease
Lupus Nephritis	MESH:D008181	DO:DOID:0080162	Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).	MESH:D005921|MESH:D008180	C12.050.351.968.419.570.363.680|C12.200.777.419.570.363.680|C12.950.419.570.363.680|C17.300.480.680|C20.111.590.560	C12.050.351.968.419.570.363|C12.200.777.419.570.363|C12.950.419.570.363|C17.300.480|C20.111.590	Glomerulonephritides, Lupus|Glomerulonephritis, Lupus|Lupus Glomerulonephritides|Lupus Glomerulonephritis|Lupus Nephritides|Nephritides, Lupus|Nephritis, Lupus	Connective tissue disease|Immune system disease|Urogenital disease (female)|Urogenital disease (male)
Lupus Vasculitis, Central Nervous System	MESH:D020945		Central nervous system vasculitis that is associated with SYSTEMIC LUPUS ERYTHEMATOSUS. Clinical manifestations may include DEMENTIA; SEIZURES; CRANIAL NERVE DISEASES; HEMIPARESIS; BLINDNESS; DYSPHASIA; and other neurological disorders.	MESH:D008180|MESH:D008590|MESH:D020293	C01.207.245.550.500|C01.207.570.450|C10.114.875.850|C10.228.140.300.850.750|C10.228.140.430.550.500|C10.228.228.245.550.500|C10.228.228.570.450|C10.586.250.550.500|C10.586.625.500.500|C14.907.253.946.850|C14.907.940.907.850|C17.300.480.750|C20.111.258.962.900|C20.111.590.750	C01.207.245.550|C01.207.570|C10.114.875|C10.228.140.300.850|C10.228.140.430.550|C10.228.228.245.550|C10.228.228.570|C10.586.250.550|C10.586.625.500|C14.907.253.946|C14.907.940.907|C17.300.480|C20.111.258.962|C20.111.590	Central Nervous System Lupus|Central Nervous System Lupus Vasculitis|Central Nervous System Systemic Lupus Erythematosis|Lupus Meningoencephalitides|Lupus Meningoencephalitis|Meningoencephalitides, Lupus|Meningoencephalitis, Lupus|Neuropsychiatric Systemic Lupus Erythematosus|Systemic Lupus Erythematosis, Central Nervous System	Cardiovascular disease|Connective tissue disease|Immune system disease|Nervous system disease
Lutembacher Syndrome	MESH:D008185	DO:DOID:1998	A condition characterized by a combination of OSTIUM SECUNDUM ATRIAL SEPTAL DEFECT and an acquired MITRAL VALVE STENOSIS.	MESH:D006344	C14.240.400.560.375.518|C14.280.400.560.375.518|C16.131.240.400.560.375.518	C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375	Lutembacher's Syndrome|Lutembachers Syndrome|Syndrome, Lutembacher|Syndrome, Lutembacher's	Cardiovascular disease|Congenital abnormality
Luteoma	MESH:D018311		An ovarian neoplasm composed of LUTEAL CELLS derived from luteinized GRANULOSA CELLS and THECA CELLS. Luteomas respond to GONADOTROPINS, and vary in their hormone production (PROGESTERONE; ESTROGENS; or ANDROGENS). During PREGNANCY, a transient type of luteoma may develop due to an exaggerated LUTEINIZATION of the OVARY.	MESH:D010051|MESH:D018312	C04.557.475.750.751|C04.588.322.455.464|C12.050.351.500.056.630.705.464|C12.050.351.937.418.685.464|C12.100.250.056.630.705.464|C12.900.418.685.464|C19.344.410.464|C19.391.630.705.464	C04.557.475.750|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.344.410|C19.391.630.705	Gestational Luteoma|Gestational Luteomas|Luteinoma|Luteoma, Gestational|Luteoma of Pregnancy|Luteoma, Pregnancy|Luteomas|Luteomas, Gestational|Luteomas, Pregnancy|Pregnancy Luteoma|Pregnancy Luteomas	Cancer|Endocrine system disease|Urogenital disease (female)
Lymphadenitis	MESH:D008199	DO:DOID:1602	Inflammation of the lymph nodes.	MESH:D008206	C15.604.315	C15.604	Adenitides|Adenitis|Lymphadenitides	Lymphatic disease
Lymphadenopathy	MESH:D000072281		Disease of LYMPH NODES which are abnormal in size, number or consistency.	MESH:D008206	C15.604.338	C15.604	Adenopathies|Adenopathy|Lymphadenopathies	Lymphatic disease
Lymphangiectasia, pulmonary, congenital	MESH:C537727	OMIM:265300		MESH:D008171|MESH:D008200	C08.381/C537727|C15.604.360/C537727	C08.381|C15.604.360	CPL|Lymphangiectasia pulmonary congenital|Lymphangiomatosis, pulmonary|Pulmonary cystic lymphangiectasis	Lymphatic disease|Respiratory tract disease
Lymphangiectasis	MESH:D008200		A transient dilatation of the lymphatic vessels.	MESH:D008206	C15.604.360	C15.604	Lymphangiectases	Lymphatic disease
Lymphangioleiomyomatosis	MESH:D018192	OMIM:606690	A disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath (DYSPNEA).	MESH:D008203|MESH:D054973	C04.557.375.460.465|C04.557.450.692.500|C15.604.515.562.465|C20.683.515.710.465	C04.557.375.460|C04.557.450.692|C15.604.515.562|C20.683.515.710	LAM|Lymphangioleiomyomatoses|Lymphangiomyomatoses|Lymphangiomyomatosis	Cancer|Immune system disease|Lymphatic disease
Lymphangioma	MESH:D008202	DO:DOID:1475	A benign tumor resulting from a congenital malformation of the lymphatic system. Lymphangioendothelioma is a type of lymphangioma in which endothelial cells are the dominant component.	MESH:D018190	C04.557.375.450	C04.557.375	Cavernous Lymphangioma|Cavernous Lymphangiomas|Endothelioma, Lymphatic|Endotheliomas, Lymphatic|Lymphangioendothelioma|Lymphangioendotheliomas|Lymphangioma, Cavernous|Lymphangiomas|Lymphangiomas, Cavernous|Lymphatic Endothelioma|Lymphatic Endotheliomas	Cancer
Lymphangioma, Cystic	MESH:D018191	DO:DOID:3081	A cystic growth originating from lymphatic tissue. It is usually found in the neck, axilla, or groin.	MESH:D008202	C04.557.375.450.450	C04.557.375.450	Colli, Cystic Hygroma|Cystic Hygroma|Cystic Hygroma Colli|Cystic Hygromas|Cystic Lymphangioma|Cystic Lymphangiomas|Hygroma|Hygroma Colli, Cystic|Hygroma, Cystic|Hygromas|Hygromas, Cystic|Lymphangiomas, Cystic	Cancer
Lymphangiomyoma	MESH:D008203		A tumorlike condition characterized by SMOOTH MUSCLE and ENDOTHELIUM proliferation of LYMPHATIC VESSELS and LYMPH NODES in the MEDIASTINUM and retroperitoneum, also in the lung. It may be manifested by chylous PLEURAL EFFUSION and ASCITES.	MESH:D008232|MESH:D018190	C04.557.375.460|C15.604.515.562|C20.683.515.710	C04.557.375|C15.604.515|C20.683.515	Lymphangioleiomyoma|Lymphangioleiomyomas|Lymphangiomyomas	Cancer|Immune system disease|Lymphatic disease
Lymphangiosarcoma	MESH:D008204	DO:DOID:2689	A malignant tumor originating from the endothelial cells of lymphatic vessels. Most lymphangiosarcomas arise in an arm secondary to radical mastectomy but they sometimes complicate idiopathic lymphedema. The lymphedema has usually been present for 6 to 10 years before malignant changes develop. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)	MESH:D012509|MESH:D018190	C04.557.375.480|C04.557.450.795.480	C04.557.375|C04.557.450.795	Lymphangioendothelioma, Malignant|Lymphangioendotheliomas, Malignant|Lymphangiosarcomas|Malignant Lymphangioendothelioma|Malignant Lymphangioendotheliomas	Cancer
Lymphangitis	MESH:D008205	DO:DOID:9317	A lymphatic disease characterized by INFLAMMATION of LYMPHATIC VESSELS.	MESH:D008206	C15.604.406	C15.604	Lymphangitides	Lymphatic disease
Lymphatic Diseases	MESH:D008206	DO:DOID:75	Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.	MESH:D006425	C15.604	C15	Disease, Lymphatic|Diseases, Lymphatic|Lymphatic Disease|Lymphatism|Status Lymphaticus	Lymphatic disease
LYMPHATIC MALFORMATION 3	OMIM:613480	DO:DOID:0070208		MESH:D008209	C15.604.496/613480	C15.604.496	LMPH1C, FORMERLY|LMPHM3|LYMPHEDEMA, HEREDITARY, IC, FORMERLY	Lymphatic disease
LYMPHATIC MALFORMATION 4	OMIM:615907	DO:DOID:0070209		MESH:D008209	C15.604.496/615907	C15.604.496	LMPH1D, FORMERLY|LMPHM4|LYMPHEDEMA, HEREDITARY, ID, FORMERLY	Lymphatic disease
LYMPHATIC MALFORMATION 6	OMIM:616843			MESH:D008209	C15.604.496/616843	C15.604.496	GENERALIZED LYMPHATIC DYSPLASIA OF FOTIOU|LMPH3, FORMERLY|LMPHM6|LYMPHEDEMA, HEREDITARY, III, FORMERLY	Lymphatic disease
Lymphatic Metastasis	MESH:D008207		Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.	MESH:D009362	C04.697.650.560|C23.550.727.650.560	C04.697.650|C23.550.727.650	Lymphatic Metastases|Lymph Node Metastases|Lymph Node Metastasis|Metastasis, Lymph Node	Cancer|Pathology (process)
Lymphatic Vessel Tumors	MESH:D018190		Neoplasms composed of lymphoid tissue, a lattice work of reticular tissue the interspaces of which contain lymphocytes. The concept does not refer to neoplasms located in lymphatic vessels.	MESH:D009370	C04.557.375	C04.557	Lymphatic Vessel Tumor|Tumor, Lymphatic Vessel|Tumors, Lymphatic Vessel	Cancer
Lymphedema	MESH:D008209	DO:DOID:0070212|DO:DOID:4977|OMIM:153100	Edema due to obstruction of lymph vessels or disorders of the lymph nodes.	MESH:D008206	C15.604.496	C15.604	Congenital Familial Lymphedema|Congenital Hereditary Lymphedema|Congenital Hereditary Lymphedemas|Congenital Lymphedema, Primary|Congenital Lymphedemas, Primary|Early Onset Lymphedema|Early-Onset Lymphedema|Early Onset Lymphedemas|Early-Onset Lymphedemas|Hereditary Lymphedema|Hereditary Lymphedema 1|Hereditary Lymphedema 1s|Hereditary Lymphedema, Congenital|Hereditary Lymphedemas|Hereditary Lymphedemas, Congenital|Hereditary Lymphedema Type I|LMPH1A, FORMERLY|LMPHM1|LYMPHATIC MALFORMATION 1|Lymphedema, Congenital Hereditary|Lymphedema, Early Onset|Lymphedema, Early-Onset|Lymphedema, Hereditary|Lymphedema, Hereditary, Ia|LYMPHEDEMA, HEREDITARY, IA, FORMERLY|LYMPHEDEMA, HEREDITARY, TYPE I, FORMERLY|Lymphedema, Nonne-Milroy|Lymphedema, Primary Congenital|Lymphedemas|Lymphedemas, Congenital Hereditary|Lymphedemas, Early Onset|Lymphedemas, Early-Onset|Lymphedemas, Hereditary|Lymphedemas, Primary Congenital|Milroy Disease|Milroy's Disease|Milroys Disease|Nonne Milroy Disease|Nonne-Milroy Disease|Nonne Milroy Lymphedema|Nonne-Milroy Lymphedema|Nonne Milroy Meige Disease|Nonne-Milroy-Meige Disease|PCL|Primary Congenital Lymphedema|Primary Congenital Lymphedemas	Lymphatic disease
Lymphedema and Cerebral Arteriovenous Anomaly	MESH:C563612			MESH:D002538|MESH:D008209	C10.228.140.300.520/C563612|C10.500.190.500/C563612|C14.240.850.750.295/C563612|C14.240.850.875.500/C563612|C14.907.150.295/C563612|C14.907.253.560.400/C563612|C15.604.496/C563612|C16.131.240.850.750.295/C563612|C16.131.240.850.875.500/C563612|C16.131.666.190.500/C563612	C10.228.140.300.520|C10.500.190.500|C14.240.850.750.295|C14.240.850.875.500|C14.907.150.295|C14.907.253.560.400|C15.604.496|C16.131.240.850.750.295|C16.131.240.850.875.500|C16.131.666.190.500		Cardiovascular disease|Congenital abnormality|Lymphatic disease|Nervous system disease
Lymphedema, Cardiac Septal Defects, And Characteristic Facies	MESH:C567398			MESH:D000015|MESH:D006344|MESH:D008209|MESH:D019066	C14.240.400.560.375/C567398|C14.280.400.560.375/C567398|C15.604.496/C567398|C16.131.077/C567398|C16.131.240.400.560.375/C567398|C23.550.291.812/C567398	C14.240.400.560.375|C14.280.400.560.375|C15.604.496|C16.131.077|C16.131.240.400.560.375|C23.550.291.812	Irons-Bianchi Syndrome|Lymphedema, Atrial Septal Defect, And Characteristic Facies	Cardiovascular disease|Congenital abnormality|Lymphatic disease|Pathology (process)
Lymphedema, Congenital Recessive	MESH:C565432			MESH:D008209	C15.604.496/C565432	C15.604.496		Lymphatic disease
Lymphedema distichiasis syndrome	MESH:C537710	DO:DOID:0111509|OMIM:153400		MESH:D008209	C15.604.496/C537710	C15.604.496	Hereditary lymphedema-distichiasis syndrome|LPHDST|Lymphedema-Distichiasis Syndrome|Lymphedema with distichiasis|LYMPHEDEMA WITH DISTICHIASIS LYMPHEDEMA-DISTICHIASIS SYNDROME WITH RENAL DISEASE AND DIABETES MELLITUS, INCLUDED	Lymphatic disease
Lymphedema-Distichiasis Syndrome with Renal Disease and Diabetes Mellitus	MESH:C567188			MESH:D003920|MESH:D007674|MESH:D008209	C12.050.351.968.419/C567188|C12.200.777.419/C567188|C12.950.419/C567188|C15.604.496/C567188|C18.452.394.750/C567188|C19.246/C567188	C12.050.351.968.419|C12.200.777.419|C12.950.419|C15.604.496|C18.452.394.750|C19.246		Endocrine system disease|Lymphatic disease|Metabolic disease|Urogenital disease (female)|Urogenital disease (male)
Lymphedema, Hereditary, IB	MESH:C567452	OMIM:611944		MESH:D008209	C15.604.496/C567452	C15.604.496	LMPH1B|LMPH1B, FORMERLY|LMPHM2|LYMPHATIC MALFORMATION 2|LYMPHEDEMA, HEREDITARY, IB, FORMERLY	Lymphatic disease
Lymphedema, Hereditary, II	MESH:C562467	DO:DOID:0070213|OMIM:153200		MESH:D008209	C15.604.496/C562467	C15.604.496	LMPH2, FORMERLY|LMPHM5|LYMPHATIC MALFORMATION 5|LYMPHEDEMA, HEREDITARY, II, FORMERLY|Lymphedema, Late-Onset|Lymphedema Praecox|Meige Disease|Meige Lymphedema	Lymphatic disease
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	OMIM:614038			MESH:D008209|MESH:D009190	C15.378.190.625/614038|C15.604.496/614038	C15.378.190.625|C15.604.496	EMBERGER SYNDROME	Blood disease|Lymphatic disease
Lymphoblastic Leukemia, Acute, with Lymphomatous Features	MESH:C565429	OMIM:247640		MESH:D054198	C04.557.337.428.600/C565429|C15.604.515.560.600/C565429|C20.683.515.528.600/C565429	C04.557.337.428.600|C15.604.515.560.600|C20.683.515.528.600	LALL|Lymphomatous ALL	Cancer|Immune system disease|Lymphatic disease
Lymphoblastic Transformation, Inhibition of	MESH:C565433			MESH:D007154	C20/C565433	C20		Immune system disease
Lymphoblastic Transformation, Intrinsic Defect in	MESH:C565431			MESH:D007153	C20.673/C565431	C20.673		Immune system disease
Lymphocele	MESH:D008210	DO:DOID:4347	Cystic mass containing lymph from diseased lymphatic channels or following surgical trauma or other injury.	MESH:D003560|MESH:D008206	C04.182.430|C15.604.510	C04.182|C15.604	Cyst, Lymphatic|Cysts, Lymphatic|Lymphatic Cyst|Lymphatic Cysts|Lymphoceles|Lymphocoele|Lymphocoeles	Cancer|Lymphatic disease
Lymphocytic Choriomeningitis	MESH:D008216	DO:DOID:12155	A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)	MESH:D001117|MESH:D008587	C01.207.245.500.500|C01.925.182.550.500|C01.925.782.082.580|C10.228.228.245.500.500|C10.586.625.400.500	C01.207.245.500|C01.925.182.550|C01.925.782.082|C10.228.228.245.500|C10.586.625.400	Armstrong's Syndrome|Armstrong Syndrome|Choriomeningitis, Lymphocytic|Encephalomyelitis, Lymphocytic Choriomeningitis Virus|Lymphocytic Choriomeningitis Virus Encephalomyelitis|Syndrome, Armstrong|Syndrome, Armstrong's	Nervous system disease|Viral disease
Lymphocytosis	MESH:D008218		Excess of normal lymphocytes in the blood or in any effusion.	MESH:D007964	C15.378.553.475.604	C15.378.553.475	Lymphocytoses	Blood disease
Lymphohistiocytosis, Hemophagocytic	MESH:D051359	DO:DOID:0050120|OMIM:267700	A group of related disorders characterized by LYMPHOCYTOSIS; HISTIOCYTOSIS; and hemophagocytosis. The two major forms are familial and reactive.	MESH:D015616	C15.604.250.410.575	C15.604.250.410	Erythrophagocytic Lymphohistiocytoses, Familial|Erythrophagocytic Lymphohistiocytosis, Familial|Familial Erythrophagocytic Lymphohistiocytoses|Familial Erythrophagocytic Lymphohistiocytosis|Familial Hemophagocytic Histiocytoses|Familial Hemophagocytic Histiocytosis|Familial Hemophagocytic Lymphocytoses|Familial Hemophagocytic Lymphocytosis|Familial Hemophagocytic Lymphohistiocytoses|Familial Hemophagocytic Lymphohistiocytosis|Familial Hemophagocytic Reticuloses|Familial Hemophagocytic Reticulosis|Familial Histiocytic Reticuloses|Familial Histiocytic Reticulosis|FEL|FHL|FHL1|FHLH|Hemophagocytic Histiocytoses, Familial|Hemophagocytic Histiocytosis, Familial|Hemophagocytic Hymphohistiocytoses, Primary|Hemophagocytic Hymphohistiocytosis, Primary|Hemophagocytic Lymphocytoses, Familial|Hemophagocytic Lymphocytosis, Familial|Hemophagocytic Lymphohistiocytoses|Hemophagocytic Lymphohistiocytoses, Familial|Hemophagocytic Lymphohistiocytoses, Primary|Hemophagocytic Lymphohistiocytosis|Hemophagocytic Lymphohistiocytosis, Familial|Hemophagocytic Lymphohistiocytosis Familial 1|Hemophagocytic Lymphohistiocytosis Familial -1|Hemophagocytic Lymphohistiocytosis, Familial, 1|Hemophagocytic Lymphohistiocytosis, Primary|Hemophagocytic Reticuloses, Familial|Hemophagocytic Reticulosis, Familial|Hemophagocytic Syndrome|Hemophagocytic Syndrome, Infection Associated|Hemophagocytic Syndrome, Infection-Associated|Hemophagocytic Syndrome, Reactive|Hemophagocytic Syndromes|Histiocytic Reticuloses, Familial|Histiocytic Reticulosis, Familial|Histiocytoses, Familial Hemophagocytic|Histiocytosis, Familial Hemophagocytic|HLH1|HPLH|HPLH1|Hymphohistiocytoses, Primary Hemophagocytic|Hymphohistiocytosis, Primary Hemophagocytic|Infection-Associated Hemophagocytic Syndrome|Lymphocytoses, Familial Hemophagocytic|Lymphocytosis, Familial Hemophagocytic|Lymphohistiocytoses, Familial Erythrophagocytic|Lymphohistiocytoses, Familial Hemophagocytic|Lymphohistiocytoses, Hemophagocytic|Lymphohistiocytoses, Primary Hemophagocytic|Lymphohistiocytosis, Familial Erythrophagocytic|Lymphohistiocytosis, Familial Hemophagocytic|Lymphohistiocytosis, Primary Hemophagocytic|Primary Hemophagocytic Hymphohistiocytoses|Primary Hemophagocytic Hymphohistiocytosis|Primary Hemophagocytic Lymphohistiocytoses|Primary Hemophagocytic Lymphohistiocytosis|Reactive Hemophagocytic Syndrome|Reticuloses, Familial Hemophagocytic|Reticuloses, Familial Histiocytic|Reticulosis, Familial Hemophagocytic|Reticulosis, Familial Histiocytic	Lymphatic disease
Lymphoid Interstitial Pneumonia	MESH:C562489			MESH:D017563	C08.381.483/C562489	C08.381.483		Respiratory tract disease
Lymphoid System Deterioration, Progressive	MESH:C565430			MESH:D007153	C20.673/C565430	C20.673		Immune system disease
Lymphokine Deficiency	MESH:C565428			MESH:D007153	C20.673/C565428	C20.673		Immune system disease
Lymphoma	MESH:D008223	DO:DOID:0060058	A general term for various neoplastic diseases of the lymphoid tissue.	MESH:D008232|MESH:D009370	C04.557.386|C15.604.515.569|C20.683.515.761	C04.557|C15.604.515|C20.683.515	Germinoblastic Sarcoma|Germinoblastic Sarcomas|Germinoblastoma|Germinoblastomas|Lymphoma, Malignant|Lymphomas|Lymphomas, Malignant|Malignant Lymphoma|Malignant Lymphomas|Reticulolymphosarcoma|Reticulolymphosarcomas|Sarcoma, Germinoblastic|Sarcomas, Germinoblastic	Cancer|Immune system disease|Lymphatic disease
Lymphoma, AIDS-Related	MESH:D016483		B-cell lymphoid tumors that occur in association with AIDS. Patients often present with an advanced stage of disease and highly malignant subtypes including BURKITT LYMPHOMA; IMMUNOBLASTIC LARGE-CELL LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; and DIFFUSE, LARGE B-CELL, LYMPHOMA. The tumors are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in AIDS is a complex result of EBV infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.	MESH:D016393	C04.557.386.480.150.450|C15.604.515.569.480.150.450|C20.683.515.761.480.150.450	C04.557.386.480.150|C15.604.515.569.480.150|C20.683.515.761.480.150	AIDS Associated Lymphoma|AIDS-Associated Lymphoma|AIDS-Associated Lymphomas|AIDS Related Lymphoma|AIDS-Related Lymphoma|AIDS-Related Lymphomas|HIV Related Lymphoma|HIV-Related Lymphoma|HIV-Related Lymphomas|Lymphoma, AIDS Associated|Lymphoma, AIDS-Associated|Lymphoma, AIDS Related|Lymphoma, HIV Related|Lymphoma, HIV-Related|Lymphomas, AIDS-Associated|Lymphomas, AIDS-Related|Lymphomas, HIV-Related	Cancer|Immune system disease|Lymphatic disease
Lymphoma, B-Cell	MESH:D016393	DO:DOID:707	A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.	MESH:D008228	C04.557.386.480.150|C15.604.515.569.480.150|C20.683.515.761.480.150	C04.557.386.480|C15.604.515.569.480|C20.683.515.761.480	B Cell Lymphoma|B-Cell Lymphoma|B-Cell Lymphomas|Lymphoma, B Cell|Lymphomas, B-Cell	Cancer|Immune system disease|Lymphatic disease
Lymphoma, B-Cell, Marginal Zone	MESH:D018442	OMIM:137245	Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.	MESH:D016393	C04.557.386.480.150.570|C15.604.515.569.480.150.570|C20.683.515.761.480.150.570	C04.557.386.480.150|C15.604.515.569.480.150|C20.683.515.761.480.150	GASTRIC LYMPHOMA, PRIMARY|Lymphoma, MALT|Lymphoma, Mucosa Associated Lymphoid Tissue|Lymphoma, Mucosa-Associated Lymphoid Tissue|LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TYPE|Lymphoma of Mucosa Associated Lymphoid Tissue|Lymphoma of Mucosa-Associated Lymphoid Tissue|Lymphomas, MALT|MALT Lymphoma|MALT Lymphomas|Marginal Zone B Cell Lymphoma|Marginal Zone B-Cell Lymphoma|Mucosa Associated Lymphoid Tissue Lymphoma|Mucosa-Associated Lymphoid Tissue Lymphoma	Cancer|Immune system disease|Lymphatic disease
Lymphoma, Extranodal NK-T-Cell	MESH:D054391		An extranodal neoplasm, usually possessing an NK-cell phenotype and associated with EPSTEIN-BARR VIRUS. These lymphomas exhibit a broad morphologic spectrum, frequent necrosis, angioinvasion, and most commonly present in the midfacial region, but also in other extranodal sites.	MESH:D016399	C04.557.386.480.750.199	C04.557.386.480.750	Extranodal NK T Cell Lymphoma|Extranodal NK-T-Cell Lymphoma|Extranodal NK T Cell Lymphoma, Nasal|Extranodal NK-T-Cell Lymphoma, Nasal|Extranodal NK T Cell Lymphoma, Nasal and Nasal Type|Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type|Extranodal NK T Cell Lymphoma, Nasal Type|Extranodal NK-T-Cell Lymphoma, Nasal Type|Extranodal NK-T-Cell Lymphomas|Lymphoma, Extranodal NK T Cell|Lymphomas, Extranodal NK-T-Cell|NK-T-Cell Lymphoma, Extranodal|NK-T-Cell Lymphomas, Extranodal	Cancer
Lymphoma, Follicular	MESH:D008224	DO:DOID:0050873|OMIM:613024	Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES.	MESH:D008228	C04.557.386.480.350|C15.604.515.569.480.350|C20.683.515.761.480.350	C04.557.386.480|C15.604.515.569.480|C20.683.515.761.480	Brill Symmers Disease|Brill-Symmers Disease|Disease, Brill-Symmers|FL1|Follicular Large Cell Lymphoma|Follicular Large-Cell Lymphoma|Follicular Large-Cell Lymphomas|Follicular Lymphoma|Follicular Lymphoma, Giant|Follicular Lymphoma, Grade 1|Follicular Lymphoma, Grade 2|Follicular Lymphoma, Grade 3|Follicular Lymphomas|Follicular Lymphomas, Giant|FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1|Follicular Mixed Cell Lymphoma|Follicular Mixed-Cell Lymphoma|Follicular Mixed-Cell Lymphomas|Giant Follicular Lymphoma|Giant Follicular Lymphomas|Histiocytic Lymphoma, Nodular|Histiocytic Lymphomas, Nodular|Large Cell Lymphoma, Follicular|Large-Cell Lymphoma, Follicular|Large-Cell Lymphomas, Follicular|Large Lymphoid Lymphoma, Nodular|Lymphocytic Lymphoma, Nodular, Poorly Differentiated|Lymphocytic Lymphoma, Nodular, Poorly-Differentiated|Lymphoma, Follicular, Grade 1|Lymphoma, Follicular, Grade 2|Lymphoma, Follicular, Grade 3|Lymphoma, Follicular Large Cell|Lymphoma, Follicular Large-Cell|Lymphoma, Follicular Mixed-Cell|Lymphoma, Follicular, Mixed Cell|Lymphoma, Follicular, Mixed Lymphocytic-Histiocytic|Lymphoma, Follicular, Mixed Small and Large Lymphoid|Lymphoma, Follicular, Small and Large Cleaved Cell|Lymphoma, Follicular, Small and Large Cleaved-Cell|Lymphoma, Giant Follicular|Lymphoma, Histiocytic, Nodular|Lymphoma, Large Cell, Follicular|Lymphoma, Large-Cell, Follicular|Lymphoma, Large Lymphoid, Nodular|Lymphoma, Lymphocytic, Nodular, Poorly Differentiated|Lymphoma, Lymphocytic, Nodular, Poorly-Differentiated|Lymphoma, Mixed-Cell, Follicular|Lymphoma, Nodular|Lymphoma, Nodular Histiocytic|Lymphoma, Nodular, Large Follicular Center Cell|Lymphoma, Nodular, Large Follicular Center-Cell|Lymphoma, Nodular, Mixed Lymphocytic Histiocytic|Lymphoma, Nodular, Mixed Lymphocytic-Histiocytic|Lymphoma, Nodular, Mixed Small and Large Cell|Lymphomas, Follicular|Lymphomas, Follicular Large-Cell|Lymphomas, Follicular Mixed-Cell|Lymphomas, Giant Follicular|Lymphoma, Small Cleaved Cell, Follicular|Lymphoma, Small Cleaved-Cell, Follicular|Lymphoma, Small Follicular Center Cell|Lymphoma, Small Follicular Center-Cell|Lymphoma, Small Lymphoid, Follicular|Lymphomas, Nodular|Lymphomas, Nodular Histiocytic|Mixed Cell Lymphoma, Follicular|Mixed-Cell Lymphoma, Follicular|Mixed-Cell Lymphomas, Follicular|Nodular Histiocytic Lymphoma|Nodular Histiocytic Lymphomas|Nodular Large Follicular Center Cell Lymphoma|Nodular Large Follicular Center-Cell Lymphoma|Nodular Lymphoma|Nodular Lymphomas|Small Cleaved Cell Lymphoma, Follicular|Small Cleaved-Cell Lymphoma, Follicular|Small Follicular Center Cell Lymphoma|Small Follicular Center-Cell Lymphoma	Cancer|Immune system disease|Lymphatic disease
Lymphoma, Large B-Cell, Diffuse	MESH:D016403	DO:DOID:0050745	Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.	MESH:D016393	C04.557.386.480.150.585|C15.604.515.569.480.150.585|C20.683.515.761.480.150.585	C04.557.386.480.150|C15.604.515.569.480.150|C20.683.515.761.480.150	Diffuse Histiocytic Lymphoma|Diffuse Histiocytic Lymphomas|Diffuse Large B Cell Lymphoma|Diffuse Large B-Cell Lymphoma|Diffuse, Large B-Cell, Lymphoma|Diffuse Large Cell Lymphoma|Diffuse Large-Cell Lymphoma|Diffuse Large-Cell Lymphomas|Histiocytic Lymphoma|Histiocytic Lymphoma, Diffuse|Histiocytic Lymphomas|Large Cell Lymphoma, Diffuse|Large-Cell Lymphoma, Diffuse|Large Lymphoid Lymphoma, Diffuse|Lymphoma, Diffuse Histiocytic|Lymphoma, Diffuse Large Cell|Lymphoma, Diffuse Large-Cell|Lymphoma, Histiocytic|Lymphoma, Histiocytic, Diffuse|Lymphoma, Large Cell, Diffuse|Lymphoma, Large-Cell, Diffuse|Lymphoma, Large Lymphoid, Diffuse	Cancer|Immune system disease|Lymphatic disease
Lymphoma, Large-Cell, Anaplastic	MESH:D017728		A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called 'hallmark' cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.	MESH:D016399	C04.557.386.480.750.399|C15.604.515.569.480.750.600|C20.683.515.761.480.750.399	C04.557.386.480.750|C15.604.515.569.480.750|C20.683.515.761.480.750	Anaplastic Large Cell Lymphoma|Anaplastic Large-Cell Lymphoma|Anaplastic Large-Cell Lymphomas|CD30+ Anaplastic Large Cell Lymphoma|CD30+ Anaplastic Large-Cell Lymphoma|CD30 Positive Anaplastic Large Cell Lymphoma|CD30-Positive Anaplastic Large-Cell Lymphoma|Ki 1 Lymphoma|Ki-1 Lymphoma|Ki-1 Lymphomas|Large-Cell Lymphoma, Anaplastic|Large-Cell Lymphomas, Anaplastic|Lymphoma, Anaplastic Large-Cell|Lymphoma, Ki-1|Lymphoma, Large-Cell, Ki-1|Lymphomas, Anaplastic Large-Cell|Lymphomas, Ki-1|Systemic Anaplastic Large Cell Lymphoma|Systemic Anaplastic Large-Cell Lymphoma	Cancer|Immune system disease|Lymphatic disease
Lymphoma, Large-Cell, Immunoblastic	MESH:D016400		Malignant lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas (LYMPHOMA, T-CELL, PERIPHERAL) recorded in both the United States and Japan.	MESH:D008228	C04.557.386.480.493|C15.604.515.569.480.493|C20.683.515.761.480.487	C04.557.386.480|C15.604.515.569.480|C20.683.515.761.480	Diffuse Immunoblastic Lymphosarcoma|Diffuse Immunoblastic Lymphosarcomas|Immunoblastic Large Cell Lymphoma|Immunoblastic Large-Cell Lymphoma|Immunoblastic Large-Cell Lymphomas|Immunoblastic Lymphoma, Large-Cell|Immunoblastic Lymphomas, Large-Cell|Immunoblastic Lymphosarcoma, Diffuse|Immunoblastic Lymphosarcomas, Diffuse|Immunoblastic Sarcoma|Immunoblastic Sarcomas|Immunoblastoma|Immunoblastomas|Large Cell Immunoblastic Lymphoma|Large-Cell Immunoblastic Lymphoma|Large-Cell Immunoblastic Lymphomas|Large-Cell Lymphoma, Immunoblastic|Large-Cell Lymphomas, Immunoblastic|Lymphoma, Immunoblastic Large-Cell|Lymphoma, Immunoblastic, Large Cell|Lymphoma, Immunoblastic, Large-Cell|Lymphoma, Large Cell, Immunoblastic|Lymphoma, Large-Cell Immunoblastic|Lymphomas, Immunoblastic Large-Cell|Lymphomas, Large-Cell Immunoblastic|Lymphosarcoma, Diffuse Immunoblastic|Lymphosarcomas, Diffuse Immunoblastic|Sarcoma, Immunoblastic|Sarcomas, Immunoblastic	Cancer|Immune system disease|Lymphatic disease
Lymphoma, Mantle-Cell	MESH:D020522	DO:DOID:0050746	A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).	MESH:D008228	C04.557.386.480.525|C15.604.515.569.480.525|C20.683.515.761.480.525	C04.557.386.480|C15.604.515.569.480|C20.683.515.761.480	Centrocytic Small-Cell Lymphoma|Centrocytic Small-Cell Lymphomas|Diffuse Lymphocytic Lymphoma, Poorly Differentiated|Diffuse Lymphocytic Lymphoma, Poorly-Differentiated|Lymphocytic Lymphoma, Diffuse, Poorly Differentiated|Lymphocytic Lymphoma, Diffuse, Poorly-Differentiated|Lymphoma, Centrocytic Small Cell|Lymphoma, Centrocytic Small-Cell|Lymphoma, Lymphocytic, Diffuse, Intermediate Differentiated|Lymphoma, Lymphocytic, Diffuse, Poorly-Differentiated|Lymphoma, Lymphocytic, Intermediate|Lymphoma, Mantle Cell|Lymphoma, Mantle-Zone|Lymphomas, Centrocytic Small-Cell|Lymphoma, Small-Cell, Centrocytic|Lymphomas, Mantle-Cell|Lymphomas, Mantle-Zone|Mantle Cell Lymphoma|Mantle-Cell Lymphoma|Mantle-Cell Lymphomas|Mantle Zone Lymphoma|Mantle-Zone Lymphoma|Mantle-Zone Lymphomas|Small-Cell Lymphoma, Centrocytic|Small-Cell Lymphomas, Centrocytic	Cancer|Immune system disease|Lymphatic disease
Lymphoma, Non-Hodgkin	MESH:D008228	DO:DOID:0060060|DO:DOID:8538|OMIM:605027	Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.	MESH:D008223	C04.557.386.480|C15.604.515.569.480|C20.683.515.761.480	C04.557.386|C15.604.515.569|C20.683.515.761	Diffuse Lymphoma|Diffuse Lymphomas|Diffuse Mixed Cell Lymphoma|Diffuse Mixed-Cell Lymphoma|Diffuse Mixed-Cell Lymphomas|Diffuse Mixed Small and Large Cell Lymphoma|Diffuse Small Cleaved Cell Lymphoma|Diffuse Small Cleaved-Cell Lymphoma|Diffuse Undifferentiated Lymphoma|Diffuse Undifferentiated Lymphomas|High-Grade Lymphoma|High-Grade Lymphomas|Intermediate-Grade Lymphoma|Intermediate-Grade Lymphomas|Low-Grade Lymphoma|Low-Grade Lymphomas|Lymphatic Sarcoma|Lymphatic Sarcomas|Lymphocytic-Histiocytic Lymphoma, Mixed|Lymphocytic-Histiocytic Lymphomas, Mixed|Lymphoma, Atypical Diffuse Small Lymphoid|Lymphoma, Diffuse|Lymphoma, Diffuse Mixed-Cell|Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic|Lymphoma, Diffuse Undifferentiated|Lymphoma, High Grade|Lymphoma, High-Grade|Lymphoma, Intermediate Grade|Lymphoma, Intermediate-Grade|Lymphoma, Low Grade|Lymphoma, Low-Grade|Lymphoma, Mixed|Lymphoma, Mixed Cell|Lymphoma, Mixed-Cell|Lymphoma, Mixed Cell, Diffuse|Lymphoma, Mixed-Cell, Diffuse|Lymphoma, Mixed Lymphocytic Histiocytic|Lymphoma, Mixed Lymphocytic-Histiocytic|Lymphoma, Mixed Small and Large Cell, Diffuse|Lymphoma, Nonhodgkin|Lymphoma, Non Hodgkin|Lymphoma, Non-Hodgkin, Familial|Lymphoma, Nonhodgkins|Lymphoma, Nonhodgkin's|Lymphoma, Non Hodgkins|Lymphoma, Non Hodgkin's|Lymphoma, Non-Hodgkins|Lymphoma, Non-Hodgkin's|Lymphoma, Pleomorphic|Lymphoma, Small and Large Cleaved-Cell, Diffuse|Lymphoma, Small Cleaved Cell, Diffuse|Lymphoma, Small Cleaved-Cell, Diffuse|Lymphoma, Small Noncleaved Cell|Lymphoma, Small Noncleaved-Cell|Lymphoma, Small Non Cleaved Cell|Lymphoma, Small Non-Cleaved-Cell|Lymphoma, Undifferentiated|Lymphoma, Undifferentiated, Diffuse|Lymphosarcoma|Lymphosarcomas|Mixed Cell Lymphoma|Mixed-Cell Lymphoma|Mixed Cell Lymphoma, Diffuse|Mixed-Cell Lymphoma, Diffuse|Mixed-Cell Lymphomas|Mixed Lymphocytic-Histiocytic Lymphoma|Mixed Lymphocytic-Histiocytic Lymphomas|Mixed Lymphoma|Mixed Lymphomas|Mixed Small and Large Cell Lymphoma, Diffuse|NHL|Noncleaved-Cell Lymphoma, Small|Non-Cleaved-Cell Lymphoma, Small|Non Hodgkin Lymphoma|Non-Hodgkin Lymphoma|Nonhodgkin's Lymphoma|Nonhodgkins Lymphoma|Non Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma|Non-Hodgkins Lymphoma|Pleomorphic Lymphoma|Pleomorphic Lymphomas|Reticulosarcoma|Reticulosarcomas|Reticulum Cell Sarcoma|Reticulum-Cell Sarcoma|Reticulum Cell Sarcomas|Reticulum-Cell Sarcomas|Sarcoma, Lymphatic|Sarcoma, Reticulum Cell|Sarcoma, Reticulum-Cell|Small Cleaved Cell Lymphoma, Diffuse|Small Cleaved-Cell Lymphoma, Diffuse|Small Noncleaved Cell Lymphoma|Small Noncleaved-Cell Lymphoma|Small Non Cleaved Cell Lymphoma|Small Non-Cleaved-Cell Lymphoma|Small Noncleaved-Cell Lymphomas|Small Non-Cleaved-Cell Lymphomas|Undifferentiated Lymphoma|Undifferentiated Lymphoma, Diffuse|Undifferentiated Lymphomas	Cancer|Immune system disease|Lymphatic disease
Lymphoma, Primary Cutaneous Anaplastic Large Cell	MESH:D054446		Anaplastic lymphoma of the skin which develops as a primary neoplasm expressing the CD30 ANTIGEN. It is characterized by solitary nodules or ulcerated tumors.	MESH:D016410	C04.557.386.480.750.800.507|C15.604.515.569.480.750.800.507|C20.683.515.761.480.750.800.507	C04.557.386.480.750.800|C15.604.515.569.480.750.800|C20.683.515.761.480.750.800	Primary Cutaneous Anaplastic Large Cell Lymphoma|Primary Cutaneous CD30 positive Large T Cell Lymphoma|Primary Cutaneous CD30-positive Large T-Cell Lymphoma	Cancer|Immune system disease|Lymphatic disease
Lymphoma, Primary Effusion	MESH:D054685		A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency.	MESH:D016393	C04.557.386.480.150.592|C15.604.515.569.480.150.592|C20.683.515.761.480.150.592	C04.557.386.480.150|C15.604.515.569.480.150|C20.683.515.761.480.150	Effusion Lymphoma, Primary|Effusion Lymphomas, Primary|Lymphomas, Primary Effusion|Primary Effusion Lymphoma|Primary Effusion Lymphomas	Cancer|Immune system disease|Lymphatic disease
Lymphoma, T-Cell	MESH:D016399		A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.	MESH:D008228	C04.557.386.480.750|C15.604.515.569.480.750|C20.683.515.761.480.750	C04.557.386.480|C15.604.515.569.480|C20.683.515.761.480	Lymphomas, T-Cell|Lymphoma, T Cell|T Cell Lymphoma|T-Cell Lymphoma|T-Cell Lymphomas	Cancer|Immune system disease|Lymphatic disease
Lymphoma, T-Cell, Cutaneous	MESH:D016410	DO:DOID:0060061	A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders.	MESH:D016399	C04.557.386.480.750.800|C15.604.515.569.480.750.800|C20.683.515.761.480.750.800	C04.557.386.480.750|C15.604.515.569.480.750|C20.683.515.761.480.750	Cutaneous T Cell Lymphoma|Cutaneous T-Cell Lymphoma|Cutaneous T-Cell Lymphomas|Granulomatous Slack Skin|Lymphoma, Cutaneous T-Cell|Lymphomas, Cutaneous T-Cell|Lymphoma, T Cell, Cutaneous|Slack Skin, Granulomatous|T Cell Lymphoma, Cutaneous|T-Cell Lymphoma, Cutaneous|T-Cell Lymphomas, Cutaneous	Cancer|Immune system disease|Lymphatic disease
Lymphoma, T-Cell, Peripheral	MESH:D016411		A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC), this group's unique features warrant separate treatment.	MESH:D016399	C04.557.386.480.750.825|C15.604.515.569.480.750.825|C20.683.515.761.480.750.825	C04.557.386.480.750|C15.604.515.569.480.750|C20.683.515.761.480.750	Lymphoma, Peripheral T-Cell|Lymphomas, Peripheral T-Cell|Lymphoma, T Cell, Peripheral|Peripheral T Cell Lymphoma|Peripheral T-Cell Lymphoma|Peripheral T-Cell Lymphomas|T Cell Lymphoma, Peripheral|T-Cell Lymphoma, Peripheral|T-Cell Lymphomas, Peripheral	Cancer|Immune system disease|Lymphatic disease
Lymphomatoid Granulomatosis	MESH:D008230		An angiocentric and angiodestructive lymphoproliferative disorder primarily involving the lungs. It is caused by an Epstein-Barr virus-induced transformation of the B-cells, in a T-cell rich environment. Clinically and pathologically it resembles EXTRANODAL NK-T-CELL LYMPHOMA.	MESH:D011230|MESH:D016393	C04.557.386.480.150.600|C04.834.567|C15.604.515.569.480.150.600|C20.683.515.761.480.150.600	C04.557.386.480.150|C04.834|C15.604.515.569.480.150|C20.683.515.761.480.150	Granulomatoses, Lymphomatoid|Granulomatosis, Lymphomatoid|Lymphomatoid Granulomatoses	Cancer|Immune system disease|Lymphatic disease
Lymphomatoid Papulosis	MESH:D017731		Clinically benign, histologically malignant, recurrent cutaneous T-cell lymphoproliferative disorder characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble REED-STERNBERG CELLS of HODGKIN DISEASE or the malignant cells of CUTANEOUS T-CELL LYMPHOMA. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including MYCOSIS FUNGOIDES; HODGKIN DISEASE; CUTANEOUS T-CELL LYMPHOMA; or ANAPLASTIC LARGE-CELL LYMPHOMA.	MESH:D016410	C04.557.386.480.750.800.528|C15.604.515.569.480.750.800.528|C20.683.515.761.480.750.800.528	C04.557.386.480.750.800|C15.604.515.569.480.750.800|C20.683.515.761.480.750.800	Lymphomatoid Papuloses|Papuloses, Lymphomatoid|Papulosis, Lymphomatoid	Cancer|Immune system disease|Lymphatic disease
Lymphopenia	MESH:D008231	DO:DOID:614	Reduction in the number of lymphocytes.	MESH:D007153|MESH:D007970	C15.378.553.546.605|C20.673.627	C15.378.553.546|C20.673	Lymphocytopenia|Lymphocytopenias|Lymphopenias	Blood disease|Immune system disease
Lymphopenic Hypergammaglobulinemia, Antibody Deficiency, Autoimmune Hemolytic Anemia, and Glomerulonephritis	MESH:C565427			MESH:D000744|MESH:D005921|MESH:D006942|MESH:D007153	C12.050.351.968.419.570.363/C565427|C12.200.777.419.570.363/C565427|C12.950.419.570.363/C565427|C15.378.071.141.125/C565427|C15.378.147.542/C565427|C20.111.175/C565427|C20.673/C565427|C20.683.460/C565427|C23.888.512/C565427	C12.050.351.968.419.570.363|C12.200.777.419.570.363|C12.950.419.570.363|C15.378.071.141.125|C15.378.147.542|C20.111.175|C20.673|C20.683.460|C23.888.512		Blood disease|Immune system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Lymphoproliferative Disorders	MESH:D008232	DO:DOID:0070324|OMIM:308240	Disorders characterized by proliferation of lymphoid tissue, general or unspecified.	MESH:D007160|MESH:D008206	C15.604.515|C20.683.515	C15.604|C20.683	Disease, Duncan|Diseases, X-Linked Lymphoproliferative|Disease, X-Linked Lymphoproliferative|Disorder, Lymphoproliferative|Disorders, Lymphoproliferative|Disorders, X-Linked Lymphoproliferative|Disorder, X-Linked Lymphoproliferative|Duncan Disease|Duncan's Syndrome|EBV INFECTION, SEVERE, SUSCEPTIBILITY TO|EBVS|Epstein Barr Virus Induced Lymphoproliferative Disease In Males|Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males|Epstein Barr Virus Infection, Familial Fatal|Epstein-Barr Virus Infection, Familial Fatal|Familial Fatal Epstein Barr Infection|Familial Fatal Epstein-Barr Infection|IMD5|Immunodeficiency 5|Immunodeficiency 5s|Immunodeficiency, X Linked Progressive Combined Variable|Immunodeficiency, X-Linked Progressive Combined Variable|INFECTIOUS MONONUCLEOSIS, SEVERE, SUSCEPTIBILITY TO|Lymphoproliferative Diseases, X-Linked|Lymphoproliferative Disease, X Linked|Lymphoproliferative Disease, X-Linked|Lymphoproliferative Disorder|Lymphoproliferative Disorders, X-Linked|Lymphoproliferative Disorder, X-Linked|Lymphoproliferative Syndromes, X-Linked|Lymphoproliferative Syndrome, X-Linked|Lymphoproliferative Syndrome, X-Linked, 1|LYP|Purtilo Syndrome|Purtilo Syndromes|Syndrome, Purtilo|Syndromes, Purtilo|Syndromes, X-Linked Lymphoproliferative|Syndrome, X-Linked Lymphoproliferative|X Linked Lymphoproliferative Disease|X-Linked Lymphoproliferative Disease|X-Linked Lymphoproliferative Diseases|X Linked Lymphoproliferative Disorder|X-Linked Lymphoproliferative Disorder|X-Linked Lymphoproliferative Disorders|X Linked Lymphoproliferative Syndrome|X-Linked Lymphoproliferative Syndrome|X-Linked Lymphoproliferative Syndromes|XLP|XLP1|XLPD	Immune system disease|Lymphatic disease
LYMPHOPROLIFERATIVE SYNDROME 2	OMIM:615122	DO:DOID:0060708		MESH:D008232	C15.604.515/615122|C20.683.515/615122	C15.604.515|C20.683.515	CD27 DEFICIENCY|LPFS2	Immune system disease|Lymphatic disease
Lymphoproliferative Syndrome, Ebv-Associated, Autosomal, 1	MESH:C567815	OMIM:613011		MESH:D008232	C15.604.515/C567815|C20.683.515/C567815	C15.604.515|C20.683.515	LPFS1|LYMPHOPROLIFERATIVE SYNDROME 1	Immune system disease|Lymphatic disease
MacKay Shek Carr syndrome	MESH:C538364			MESH:D005901|MESH:D012162	C11.270.612/C538364|C11.525.381/C538364|C11.768.585/C538364	C11.270.612|C11.525.381|C11.768.585	Retinal degeneration, nanophthalmos, glaucoma|Retinal Degeneration with Nanophthalmos, Cystic Macular Degeneration, and Angle Closure Glaucoma	Eye disease
Macleod Fraser syndrome	MESH:C537715			MESH:D003286	C05.550.323/C537715|C05.651.197/C537715	C05.550.323|C05.651.197		Musculoskeletal disease
Macrocephaly mesodermal hamartoma spectrum	MESH:C537716			MESH:D016715	C04.445.435.500/C537716|C04.651.435.500/C537716|C05.116.099.750/C537716|C05.660.585.620/C537716|C16.131.077.740/C537716|C16.131.621.585.620/C537716	C04.445.435.500|C04.651.435.500|C05.116.099.750|C05.660.585.620|C16.131.077.740|C16.131.621.585.620	Elattoproteus syndrome|Gigantism, partial, of hands and feet, nevi, hemihypertrophy, and macrocephaly|Hemihypertrophy and macrocephaly|Partial gigantism of hands and feet, nevi, hemihypertrophy, macrocephaly	Cancer|Congenital abnormality|Musculoskeletal disease
Macrocytosis, Familial	MESH:C564004	OMIM:600084		MESH:D006402	C15.378/C564004	C15.378		Blood disease
Macroepiphyseal dysplasia, McAlister Coe type	MESH:C537721			MESH:D001848|MESH:D010024|MESH:D012871	C05.116.099/C537721|C05.116.198.579/C537721|C17.800/C537721|C18.452.104.579/C537721	C05.116.099|C05.116.198.579|C17.800|C18.452.104.579	Macroepiphyseal Dysplasia with Osteoporosis, Wrinkled Skin, and Aged Appearance|McAlister Coe Whyte syndrome	Metabolic disease|Musculoskeletal disease|Skin disease
Macrophage Activation Syndrome	MESH:D055501		A serious complication of childhood systemic inflammatory disorders that is thought to be caused by excessive activation and proliferation of T-LYMPHOCYTES and MACROPHAGES. It is seen predominantly in children with systemic onset JUVENILE IDIOPATHIC ARTHRITIS.	MESH:D008232	C20.683.515.800	C20.683.515	Syndrome, Macrophage Activation	Immune system disease
Macrophagic myofasciitis	MESH:C537829			MESH:D005208|MESH:D009220	C05.321/C537829|C05.651.594/C537829|C10.668.491.562/C537829	C05.321|C05.651.594|C10.668.491.562	Macrophagic myofasciitis, childhood	Musculoskeletal disease|Nervous system disease
Macrosomia Adiposa Congenita	MESH:C565425			MESH:D004700|MESH:D006130	C19/C565425|C23.550.393/C565425	C19|C23.550.393		Endocrine system disease|Pathology (process)
Macrothrombocytopenia, Autosomal Dominant, Tubb1-Related	MESH:C567747	OMIM:613112		MESH:D013921	C15.378.140.855/C567747	C15.378.140.855		Blood disease
Macrothrombocytopenia progressive deafness	MESH:C537831			MESH:D006319|MESH:D013921	C09.218.458.341.887/C537831|C10.597.751.418.341.887/C537831|C15.378.140.855/C537831|C23.888.592.763.393.341.887/C537831	C09.218.458.341.887|C10.597.751.418.341.887|C15.378.140.855|C23.888.592.763.393.341.887	Brodie Chole Griffin syndrome|Macrothrombocytopenia and Progressive Sensorineural Deafness	Blood disease|Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Macular Degeneration	MESH:D008268	DO:DOID:10871|DO:DOID:4448	Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.	MESH:D012162	C11.768.585.439	C11.768.585	Age Related Macular Degeneration|Age-Related Macular Degeneration|Age-Related Macular Degenerations|Age Related Maculopathies|Age-Related Maculopathies|Age Related Maculopathy|Age-Related Maculopathy|Degeneration, Macular|Dystrophy, Macular|Macular Degeneration, Age Related|Macular Degeneration, Age-Related|Macular Degenerations|Macular Dystrophies|Macular Dystrophy|Maculopathies|Maculopathies, Age-Related|Maculopathy|Maculopathy, Age Related|Maculopathy, Age-Related	Eye disease
Macular Degeneration, Age-Related, 1	MESH:C566411	OMIM:603075		MESH:D008268	C11.768.585.439/C566411	C11.768.585.439	ARMD1|Maculopathy, Age-Related, 1	Eye disease
Macular Degeneration, Age-Related, 10	MESH:C566935	OMIM:611488		MESH:D008268	C11.768.585.439/C566935	C11.768.585.439	ARMD10	Eye disease
Macular Degeneration, Age-Related, 11	MESH:C567450	OMIM:611953		MESH:D008268	C11.768.585.439/C567450	C11.768.585.439	ARMD11	Eye disease
MACULAR DEGENERATION, AGE-RELATED, 12	OMIM:613784	DO:DOID:0110024		MESH:D008268	C11.768.585.439/613784	C11.768.585.439	ARMD12	Eye disease
MACULAR DEGENERATION, AGE-RELATED, 13	OMIM:615439	DO:DOID:0110025		MESH:D008268	C11.768.585.439/615439	C11.768.585.439	ARMD13	Eye disease
MACULAR DEGENERATION, AGE-RELATED, 14	OMIM:615489	DO:DOID:0110026		MESH:D008268	C11.768.585.439/615489	C11.768.585.439	ARMD14|MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED	Eye disease
MACULAR DEGENERATION, AGE-RELATED, 15	OMIM:615591	DO:DOID:0110027		MESH:D008268	C11.768.585.439/615591	C11.768.585.439	ARMD15	Eye disease
Macular Degeneration, Age-Related, 2	MESH:C562479	OMIM:153800		MESH:D008268	C11.768.585.439/C562479	C11.768.585.439	Armd2|Macular Degeneration, Senile|Maculopathy, Age-Related, 2	Eye disease
Macular Degeneration, Age-Related, 3	MESH:C563838	OMIM:608895		MESH:D008268	C11.768.585.439/C563838	C11.768.585.439	ARMD3, INCLUDED|HNARMD|MACULAR DEGENERATION, AGE-RELATED, 3, INCLUDED|NEUROPATHY, HEREDITARY, WITH OR WITHOUT AGE-RELATED MACULAR DEGENERATION	Eye disease
Macular Degeneration, Age-Related, 4	MESH:C565196	OMIM:610698		MESH:D008268	C11.768.585.439/C565196	C11.768.585.439	ARMD4	Eye disease
MACULAR DEGENERATION, AGE-RELATED, 5	OMIM:613761	DO:DOID:0110028		MESH:D008268	C11.768.585.439/613761	C11.768.585.439	ARMD5	Eye disease
Macular Degeneration, Age-Related, 6	MESH:C563674	OMIM:613757		MESH:D008268	C11.768.585.439/C563674	C11.768.585.439	ARMD6	Eye disease
Macular Degeneration, Age-Related, 7	MESH:C565718	OMIM:610149		MESH:D008268	C11.768.585.439/C565718	C11.768.585.439	MACULAR DEGENERATION, AGE-RELATED, 7;ARMD7 MACULAR DEGENERATION, AGE-RELATED, NEOVASCULAR TYPE, SUSCEPTIBILITY|MACULAR DEGENERATION, AGE-RELATED, WET TYPE, SUSCEPTIBILITY TO, INCLUDED|TO, INCLUDED	Eye disease
MACULAR DEGENERATION, AGE-RELATED, 8	OMIM:613778	DO:DOID:0110020		MESH:D008268	C11.768.585.439/613778	C11.768.585.439	ARMD8	Eye disease
Macular Degeneration, Age-Related, 9	MESH:C566958	OMIM:611378		MESH:D008268	C11.768.585.439/C566958	C11.768.585.439	ARMD9	Eye disease
MACULAR DEGENERATION, EARLY-ONSET	OMIM:616118			MESH:D008268	C11.768.585.439/616118	C11.768.585.439	EOMD	Eye disease
Macular dystrophy, concentric annular	MESH:C537833	OMIM:153870		MESH:D008268	C11.768.585.439/C537833	C11.768.585.439	BCAMD, FORMERLY|MACULAR DYSTROPHY, BENIGN CONCENTRIC ANNULAR, FORMERLY|MACULAR DYSTROPHY, CONCENTRIC ANNULAR, FORMERLY|Maculopathy, bull's eye|MCDCA, FORMERLY|RETINITIS PIGMENTOSA 91|RP91	Eye disease
MACULAR DYSTROPHY, RETINAL, 3	OMIM:608850			MESH:D008268	C11.768.585.439/608850	C11.768.585.439	MCDR3	Eye disease
Macular Edema	MESH:D008269	DO:DOID:4447|DO:DOID:4449|OMIM:153880	Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)	MESH:D008268	C11.768.585.439.245	C11.768.585.439	Central Retinal Edema, Cystoid|CYMD|Cystoid Macular Dystrophy|Cystoid Macular Edema|Cystoid Macular Edema, Postoperative|DCMD|Edema, Cystoid Macular|Edema, Macular|Irvine Gass Syndrome|Irvine-Gass Syndrome|Macular Dystrophy, Dominant Cystoid|Macular Edema, Cystoid|MDDC|Syndrome, Irvine-Gass	Eye disease
Macules hereditary congenital hypopigmented and hyperpigmented	MESH:C537836			MESH:D010859	C17.800.621/C537836|C23.550.755/C537836	C17.800.621|C23.550.755	Congenital hypomelanotic and hypermelanotic macules|Hereditary congenital hypopigmented and hyperpigmented macules|Macules, Hereditary Congenital Hypopigmented and Hyperpigmented|Westerhof Beemer Cormane syndrome	Pathology (process)|Skin disease
Malabsorption Syndromes	MESH:D008286		General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.	MESH:D007410|MESH:D008659	C06.405.469.637|C18.452.603	C06.405.469|C18.452	Malabsorption Syndrome|Syndrome, Malabsorption|Syndromes, Malabsorption	Digestive system disease|Metabolic disease
Malaria, Cerebral	MESH:D016779	DO:DOID:14069	A condition characterized by somnolence or coma in the presence of an acute infection with PLASMODIUM FALCIPARUM (and rarely other Plasmodium species). Initial clinical manifestations include HEADACHES; SEIZURES; and alterations of mentation followed by a rapid progression to COMA. Pathologic features include cerebral capillaries filled with parasitized erythrocytes and multiple small foci of cortical and subcortical necrosis. (From Adams et al., Principles of Neurology, 6th ed, p136)	MESH:D008288|MESH:D020808	C01.207.205.300.500|C01.610.105.300.500|C01.610.752.530.620|C01.920.875.620|C10.228.228.205.300.500	C01.207.205.300|C01.610.105.300|C01.610.752.530|C01.920.875|C10.228.228.205.300	Cerebral Malaria|Malaria Meningitis|Meningitis, Malaria	Nervous system disease|Parasitic disease
Male Germ Cell Tumor	MESH:C564777			MESH:D009373|MESH:D013736	C04.557.465/C564777|C04.588.322.762/C564777|C04.588.945.440.915/C564777|C12.100.500.260.937/C564777|C12.200.294.260.937/C564777|C12.200.758.409.937/C564777|C12.900.619.937/C564777|C19.344.762/C564777|C19.391.829.782/C564777	C04.557.465|C04.588.322.762|C04.588.945.440.915|C12.100.500.260.937|C12.200.294.260.937|C12.200.758.409.937|C12.900.619.937|C19.344.762|C19.391.829.782		Cancer|Endocrine system disease|Urogenital disease (male)
Malignant Atrophic Papulosis	MESH:D054853		Variously described as a vasculopathy, endovasculitis, or occlusive arteriopathy, this condition occurs in a benign cutaneous form and a lethal multiorgan systemic variant. It is characterized by a narrowing and occlusion of the lumen of small to medium-sized blood vessels, leading to ischemia and infarction in the involved organ systems. The etiology and pathophysiology are unknown.	MESH:D001157|MESH:D014657|MESH:D017445	C14.907.137.520|C14.907.940.530|C17.800.862.457	C14.907.137|C14.907.940|C17.800.862	Atrophic Papuloses, Malignant|Atrophic Papulosis, Malignant|Degos Disease|Degos's Malignant Atrophic Papulosis|Degos Syndrome|Disease, Degos|Disease, Kohlmeier-Degos|Erythrokeratoderma en cocardes|Kohlmeier-Degos Disease|Malignant Atrophic Papuloses|Papuloses, Malignant Atrophic|Papulosis, Malignant Atrophic|Syndrome, Degos	Cardiovascular disease|Skin disease
Malignant Carcinoid Syndrome	MESH:D008303		A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)	MESH:D002276	C04.557.465.625.650.200.500|C04.557.470.200.025.200.500|C04.557.580.625.650.200.500	C04.557.465.625.650.200|C04.557.470.200.025.200|C04.557.580.625.650.200	Carcinoid Syndrome, Malignant|Carcinoid Syndromes, Malignant|Malignant Carcinoid Syndromes|Syndrome, Malignant Carcinoid|Syndromes, Malignant Carcinoid	Cancer
Malignant mesenchymal tumor	MESH:C535700	DO:DOID:5758		MESH:D008637	C04.557.435.500/C535700	C04.557.435.500	Malignant mesenchymoma	Cancer
Malignant Teratocarcinosarcoma	MESH:C535701			MESH:D002296|MESH:D009669|MESH:D013724	C04.557.435.290/C535701|C04.557.450.795.290/C535701|C04.557.465.910/C535701|C04.588.149.721.600/C535701|C04.588.443.665.650/C535701|C05.116.231.754.600/C535701|C08.460.669/C535701|C08.785.600/C535701|C09.603.669/C535701|C09.647.685/C535701	C04.557.435.290|C04.557.450.795.290|C04.557.465.910|C04.588.149.721.600|C04.588.443.665.650|C05.116.231.754.600|C08.460.669|C08.785.600|C09.603.669|C09.647.685	Paranasal sinus teratocarcinosarcoma|Paranasal sinus teratocarcinosarcoma (type)|Sinonasal teratocarcinosarcoma|Sinonasal teratocarcinosarcoma (type)	Cancer|Ear-nose-throat disease|Musculoskeletal disease|Respiratory tract disease
Malocclusion and Short Stature	MESH:C565421			MESH:D006130|MESH:D008310|MESH:D019066	C07.793.494/C565421|C23.550.291.812/C565421|C23.550.393/C565421	C07.793.494|C23.550.291.812|C23.550.393		Mouth disease|Pathology (process)
Malpuech facial clefting syndrome	MESH:C535704	OMIM:248340		MESH:D000015|MESH:D002658|MESH:D006330|MESH:D019465	C05.660.207/C535704|C14.240.400/C535704|C14.280.400/C535704|C16.131.077/C535704|C16.131.240.400/C535704|C16.131.621.207/C535704|F03.625.421/C535704	C05.660.207|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.207|F03.625.421	3MC3|3MC SYNDROME 3|Facial clefting syndrome, Gypsy type|MALPUECH FACIAL CLEFTING SYNDROME, FORMERLY|Malpuech syndrome	Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease
Mammary Analogue Secretory Carcinoma	MESH:D000069295		A malignant neoplasm of epithelial cells of the SALIVARY GLANDS, with microcystic architecture, low-grade nuclei, and granular vacuolated cytoplasm.	MESH:D002277	C04.557.470.200.588	C04.557.470.200		Cancer
Mammary Neoplasms, Experimental	MESH:D008325		Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.	MESH:D009374|MESH:D015674	C04.588.531.500|C04.619.590	C04.588.531|C04.619	Experimental Mammary Neoplasm|Experimental Mammary Neoplasms|Mammary Neoplasm, Experimental|Neoplasm, Experimental Mammary|Neoplasms, Experimental Mammary	Cancer
Mandibular Diseases	MESH:D008336		Diseases involving the MANDIBLE.	MESH:D007571	C05.500.607|C07.320.610	C05.500|C07.320	Disease, Mandibular|Diseases, Mandibular|Mandibular Disease	Mouth disease|Musculoskeletal disease
Mandibular Fractures	MESH:D008337		Fractures of the lower jaw.	MESH:D007572	C10.900.300.284.500.400.255|C26.404.750.467.441|C26.915.300.425.500.400.255	C10.900.300.284.500.400|C26.404.750.467|C26.915.300.425.500.400	Fracture, Mandibular|Fractures, Mandibular|Mandibular Fracture	Nervous system disease|Wounds and injuries
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME	OMIM:615381			MESH:D001848|MESH:D003638|MESH:D008060|MESH:D008336	C05.116.099/615381|C05.500.607/615381|C07.320.610/615381|C09.218.458.341.186/615381|C10.597.751.418.341.186/615381|C17.800.849.391/615381|C18.452.584.625/615381|C18.452.880.391/615381|C23.888.592.763.393.341.186/615381	C05.116.099|C05.500.607|C07.320.610|C09.218.458.341.186|C10.597.751.418.341.186|C17.800.849.391|C18.452.584.625|C18.452.880.391|C23.888.592.763.393.341.186	MDPL	Ear-nose-throat disease|Metabolic disease|Mouth disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms|Skin disease
Mandibular Injuries	MESH:D008338		Injuries to the lower jaw bone.	MESH:D008446	C10.900.300.284.500.500|C26.915.300.425.500.500	C10.900.300.284.500|C26.915.300.425.500	Injuries, Mandibular|Injury, Mandibular|Mandibular Injury	Nervous system disease|Wounds and injuries
Mandibular Neoplasms	MESH:D008339	DO:DOID:2338	Tumors or cancer of the MANDIBLE.	MESH:D007573|MESH:D008336	C04.588.149.721.450.583|C05.116.231.754.450.583|C05.500.499.583|C05.500.607.442|C07.320.515.583|C07.320.610.583	C04.588.149.721.450|C05.116.231.754.450|C05.500.499|C05.500.607|C07.320.515|C07.320.610	Mandibular Neoplasm|Neoplasm, Mandibular|Neoplasms, Mandibular	Cancer|Mouth disease|Musculoskeletal disease
Mandibular Nerve Injuries	MESH:D000080902		Traumatic injuries to the MANDIBULAR NERVE and its branches. Note that marginal mandibular nerve injury is a type of FACIAL NERVE INJURIES. Injuries to LINGUAL NERVE branch of mandibular nerve is LINGUAL NERVE INJURIES.	MESH:D061221	C07.465.299.625.500.349.750|C10.292.200.875.750|C10.292.319.625.700.349.750|C10.900.300.218.775.750|C26.915.300.400.825.750	C07.465.299.625.500.349|C10.292.200.875|C10.292.319.625.700.349|C10.900.300.218.775|C26.915.300.400.825	Auriculotemporal Nerve Injuries|Auriculotemporal Nerve Injury|Buccal Nerve Injuries|Buccal Nerve Injury|Deep Temporal Nerve Injuries|Inferior Alveolar Nerve Injuries|Injury, Auriculotemporal Nerve|Injury, Buccal Nerve|Injury, Mandibular Nerve|Injury, Masseteric Nerve|Injury, Mental Nerve|Lateral Pterygoid Nerve Injuries|Mandibular Nerve Injury|Masseteric Nerve Injuries|Masseteric Nerve Injury|Mental Nerve Injuries|Mental Nerve Injury|Nerve Injuries, Auriculotemporal|Nerve Injury, Auriculotemporal|Nerve Injury, Buccal|Nerve Injury, Mandibular|Nerve Injury, Masseteric	Mouth disease|Nervous system disease|Wounds and injuries
Mandibuloacral dysplasia with type A lipodystrophy	MESH:C535705	OMIM:248370		MESH:D008060|MESH:D030981	C05.116.099.052/C535705|C05.116.264.579.052/C535705|C17.800.849.391/C535705|C18.452.584.625/C535705|C18.452.880.391/C535705	C05.116.099.052|C05.116.264.579.052|C17.800.849.391|C18.452.584.625|C18.452.880.391	Craniomandibular Dermatodysostosis|CRANIOMANDIBULAR DERMATODYSOSTOSIS MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, ATYPICAL, INCLUDED|Lipodystrophy, type A, associated with mandibuloacral dysplasia|MADA|Mandibuloacral Dysplasia with Type A Lipodystrophy, Atypical	Metabolic disease|Musculoskeletal disease|Skin disease
Manganese Poisoning	MESH:D020149		Manganese poisoning is associated with chronic inhalation of manganese particles by individuals who work with manganese ore. Clinical features include CONFUSION; HALLUCINATIONS; and an extrapyramidal syndrome (PARKINSON DISEASE, SECONDARY) that includes rigidity; DYSTONIA; retropulsion; and TREMOR. (Adams, Principles of Neurology, 6th ed, p1213)	MESH:D000075322|MESH:D020260	C10.720.475.500|C25.723.522.813	C10.720.475|C25.723.522	Manganese Neurotoxicity Syndrome|Manganese Neurotoxicity Syndromes|Nervous System Diseases, Manganese Induced|Nervous System Diseases, Manganese-Induced|Nervous System Poisoning, Manganese|Neurotoxicity Syndrome, Manganese|Neurotoxicity Syndromes, Manganese|Poisoning, Manganese|Syndrome, Manganese Neurotoxicity|Syndromes, Manganese Neurotoxicity	Nervous system disease
Mania	MESH:D000087122		A state of elevated excitement with over-activity sometimes accompanied with psychotic symptoms (e.g., PSYCHOMOTOR AGITATION, inflated SELF ESTEEM and flight of ideas). It is often associated with mental disorders (e.g., CYCLOTHYMIC DISORDER; and BIPOLAR DISEASES).	MESH:D019954	C10.597.606.483|C23.888.592.604.487	C10.597.606|C23.888.592.604	Episode, Manic|Hypomania|Hypomanias|Hypomanic Episode|Hypomanic Episodes|Manias|Manic Episode|Manic Episodes|Manic State	Nervous system disease|Signs and symptoms
Manz syndrome	MESH:C535709			MESH:D008275|MESH:D009397	C12.050.351.968.419.590/C535709|C12.200.777.419.590/C535709|C12.950.419.590/C535709|C18.452.174.130.560/C535709|C18.654.521.500.439/C535709	C12.050.351.968.419.590|C12.200.777.419.590|C12.950.419.590|C18.452.174.130.560|C18.654.521.500.439	Familial hypomagnesemia - hypercalciuria	Metabolic disease|Nutrition disorder|Urogenital disease (female)|Urogenital disease (male)
Marchiafava-Bignami Disease	MESH:D054319		A neurodegenerative condition that is characterized by demyelination or necrosis of the CORPUS CALLOSUM. Symptoms include DEPRESSION; PARANOIA; DEMENTIA; SEIZURES; and ATAXIA which can progress to COMA and death in a few months. Marchiafava-Bignami syndrome is seen often in alcoholics but has been found in non-alcoholics as well.	MESH:D001928|MESH:D003711	C10.228.140.163.510|C10.314.475	C10.228.140.163|C10.314	Marchiafava Bignami Disease|Marchiafava Bignami Syndrome|Marchiafava-Bignami Syndrome	Nervous system disease
Marcus Gunn phenomenon	MESH:C535908	DO:DOID:560		MESH:D001763|MESH:D006330|MESH:D007569|MESH:D009422|MESH:D012021	C05.500.460/C535908|C05.660.207.540.460/C535908|C07.320.440/C535908|C07.650.500.460/C535908|C10.597.704/C535908|C10/C535908|C11.338.204/C535908|C14.240.400/C535908|C14.280.400/C535908|C16.131.240.400/C535908|C16.131.621.207.540.460/C535908|C16.131.850.500.460/C535908|C23.888.592.717/C535908	C05.500.460|C05.660.207.540.460|C07.320.440|C07.650.500.460|C10|C10.597.704|C11.338.204|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.540.460|C16.131.850.500.460|C23.888.592.717	Familial Marcus Gunn phenomenon|Jaw-winking|Maxillopalpebral synkinesis	Cardiovascular disease|Congenital abnormality|Eye disease|Mouth disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Margins of Excision	MESH:D000072662		The edges of tissue removed in a surgery for assessment of the effectiveness of a surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. When the margin is negative or not involved by tumor (e.g., CANCER) it suggests all of the tumor has been removed by the surgery.	MESH:D065308	C23.149.625	C23.149	Excision Margin|Excision Margins|Margin, Resection|Margins, Resection|Margins, Surgical|Margins, Tumor-Free|Margin, Surgical|Margin, Tumor-Free|Negative Surgical Margin|Negative Surgical Margins|Positive Surgical Margin|Positive Surgical Margins|Resection Margin|Resection Margins|Surgical Margin|Surgical Margin, Negative|Surgical Margin, Positive|Surgical Margins|Surgical Margins, Negative|Surgical Margins, Positive|Tumor-Free Margin|Tumor Free Margins|Tumor-Free Margins	
Marie Unna congenital hypotrichosis	MESH:C535912	OMIM:146550		MESH:D007039	C17.800.329.937/C535912	C17.800.329.937	HYPOTRICHOSIS 4|Hypotrichosis, Marie Unna type|HYPOTRICHOSIS, MARIE UNNA TYPE, 1|HYPT4|Marie Unna hereditary hypotrichosis|MARIE UNNA HEREDITARY HYPOTRICHOSIS 1|MUHH1	Skin disease
Marie Unna Hereditary Hypotrichosis 1	MESH:C567718			MESH:D007039	C17.800.329.937/C567718	C17.800.329.937	Hypotrichosis 4|Hypotrichosis, Marie Unna Type, 1	Skin disease
Marinesco-Sjogren-like syndrome (MSLS)	MESH:C535913			MESH:D002386|MESH:D002524|MESH:D008607|MESH:D009135	C05.651/C535913|C10.228.140.252.190/C535913|C10.597.350.090.500/C535913|C10.597.606.360/C535913|C10.668.491/C535913|C11.510.245/C535913|C23.888.592.350.090.200/C535913|C23.888.592.604.646/C535913|F03.625.539/C535913	C05.651|C10.228.140.252.190|C10.597.350.090.500|C10.597.606.360|C10.668.491|C11.510.245|C23.888.592.350.090.200|C23.888.592.604.646|F03.625.539		Eye disease|Mental disorder|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Martsolf syndrome	MESH:C536028	DO:DOID:0111586|OMIM:212720		MESH:D002386|MESH:D007006|MESH:D008607	C10.597.606.360/C536028|C11.510.245/C536028|C19.391.482/C536028|C23.888.592.604.646/C536028|F03.625.539/C536028	C10.597.606.360|C11.510.245|C19.391.482|C23.888.592.604.646|F03.625.539	Cataract, mental retardation, hypogonadism|Cataract-Mental Retardation-Hypogonadism|MARTS|MARTS1|MARTSOLF SYNDROME|MARTSOLF SYNDROME 1	Endocrine system disease|Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Masked Hypertension	MESH:D059468		Phenomenon where increased BLOOD PRESSURE readings taken in non-clinical settings (e.g., HOME BLOOD PRESSURE MONITORING) do not replicate in clinical settings.	MESH:D006973	C14.907.489.861	C14.907.489	Hypertension, Masked|Hypertensions, Masked|Masked Hypertensions	Cardiovascular disease
MASS syndrome	MESH:C536030	OMIM:604308		MESH:D008945|MESH:D009216|MESH:D012871	C11.744.636/C536030|C14.280.484.400.500/C536030|C17.800/C536030	C11.744.636|C14.280.484.400.500|C17.800	Mass phenotype|OCTD|Overlap connective tissue disease	Cardiovascular disease|Eye disease|Skin disease
Mast Cell Activation Disorders	MESH:D000090362		A spectrum of primary, secondary, and idiopathic disorders involving MAST CELLS and characterized by an aberrant release of mast cell mediators which result in multiple and variable inflammatory and allergic symptoms. These disorders are associated with various mutations in tyrosine kinase KIT (PROTO-ONCOGENE PROTEINS C-KIT) and other genes, underlying conditions, and responses to allergic or non-allergic triggers of mast cell stimulation and degranulation such as local anesthetics, lactam antibiotics, muscle relaxants, specific foods, environmental toxins, physical conditions such as vibration, cold, pressure, and stress.	MESH:D007154	C20.762	C20	Clonal Mast Cell Proliferation Disorders|Mast Cell Activation Disease|Mast Cell Disease|Mast-Cell Disease|Mast Cell Diseases|Mast-Cell Diseases|Monoclonal Mast Cell Activation Syndrome|Primary Mast Cell Activation Disorders	Immune system disease
Mast Cell Activation Syndrome	MESH:D000090267		A clinically and genetically heterogeneous group of mast cell disorders in which there is aberrant release of mast cell mediators with little to no accompanying proliferation of MAST CELLS.	MESH:D000090362	C20.762.500	C20.762	Idiopathic Mast Cell Activation Disorder|Mast Cell Activation Syndromes|nc MCAS|nc-MCAS|Non Clonal Mast Cell Activation Disorder|Non-Clonal Mast Cell Activation Disorder|Nonclonal Mast Cell Activation Syndrome|Non Clonal Mast Cell Activation Syndrome|Non-Clonal Mast Cell Activation Syndrome	Immune system disease
Mast-Cell Sarcoma	MESH:D012515	DO:DOID:355	A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.	MESH:D008415	C04.557.450.565.465.124|C20.762.750.375	C04.557.450.565.465|C20.762.750	Malignant Mastocytoma|Malignant Mastocytomas|Mast Cell Sarcoma|Mast-Cell Sarcomas|Mastocytoma, Malignant|Mastocytomas, Malignant|Sarcoma, Mast Cell|Sarcoma, Mast-Cell|Sarcomas, Mast-Cell	Cancer|Immune system disease
Mastocytic enterocolitis	MESH:C536032			MESH:D008415	C04.557.450.565.465/C536032|C20.762.750/C536032	C04.557.450.565.465|C20.762.750		Cancer|Immune system disease
Mastocytoma	MESH:D034801	DO:DOID:4659	A solid tumor consisting of a dense infiltration of MAST CELLS. It is generally benign.	MESH:D008415	C04.557.450.565.465.249|C20.762.750.469	C04.557.450.565.465|C20.762.750	Benign Mastocytoma|Extracutaneous Mastocytoma|Extracutaneous Mastocytomas|Mastocytoma, Benign|Mastocytoma, Extracutaneous|Mastocytomas, Extracutaneous	Cancer|Immune system disease
Mastocytoma, Skin	MESH:D054705	DO:DOID:3666	A variant of cutaneous mastocytosis which occurs as a single lesion usually in infants. It is found mostly in the wrist and trunk and there is no atypical cytomorphology.	MESH:D034701|MESH:D034801	C04.557.450.565.465.249.500|C04.557.450.565.465.500.500|C04.588.805.309.500|C17.800.882.356.500|C20.762.750.469.500|C20.762.750.563.500	C04.557.450.565.465.249|C04.557.450.565.465.500|C04.588.805.309|C17.800.882.356|C20.762.750.469|C20.762.750.563	Skin Mastocytoma|Solitary Mastocytoma of Skin	Cancer|Immune system disease|Skin disease
Mastocytosis	MESH:D008415	DO:DOID:350|OMIM:154800	A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).	MESH:D000090362|MESH:D009372	C04.557.450.565.465|C20.762.750	C04.557.450.565|C20.762	MASTC|MAST CELL LEUKEMIA, INCLUDED|MASTOCYTOSIS, CUTANEOUS|MASTOCYTOSIS, DIFFUSE CUTANEOUS MASTOCYTOSIS, SYSTEMIC, INCLUDED|MASTOCYTOSIS, INDOLENT, INCLUDED|MASTOCYTOSIS, MACULOPAPULAR CUTANEOUS|MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC DISORDER, INCLUDED|MASTSYS, INCLUDED|URTICARIA PIGMENTOSA	Cancer|Immune system disease
Mastocytosis, Cutaneous	MESH:D034701	DO:DOID:3663|DO:DOID:3665	Skin lesions due to abnormal infiltration of MAST CELLS. Cutaneous mastocytosis is confined to the skin without the involvement of other tissues or organs, and is mostly found in children. The three major variants are: URTICARIA PIGMENTOSA; diffuse cutaneous mastocytosis; and SOLITARY MASTOCYTOMA OF SKIN.	MESH:D008415|MESH:D012878	C04.557.450.565.465.500|C04.588.805.309|C17.800.882.356|C20.762.750.563	C04.557.450.565.465|C04.588.805|C17.800.882|C20.762.750	Bullous Mastocytoses|Bullous Mastocytosis|Cutaneous Mastocytoses|Cutaneous Mastocytoses, Diffuse|Cutaneous Mastocytosis|Cutaneous Mastocytosis, Diffuse|Mastocytoses, Bullous|Mastocytoses, Cutaneous|Mastocytoses, Skin|Mastocytosis, Bullous|Mastocytosis, Diffuse Cutaneous|Mastocytosis, Skin|Skin Mastocytoses|Skin Mastocytosis	Cancer|Immune system disease|Skin disease
Mastocytosis, cutaneous, with short stature, conductive hearing loss and microtia	MESH:C536033			MESH:D006314|MESH:D034701|MESH:D065817	C04.557.450.565.465.500/C536033|C04.588.805.309/C536033|C09.218.235/C536033|C09.218.458.341.562/C536033|C10.597.751.418.341.562/C536033|C16.131.287/C536033|C17.800.882.356/C536033|C20.762.750.563/C536033|C23.888.592.763.393.341.562/C536033	C04.557.450.565.465.500|C04.588.805.309|C09.218.235|C09.218.458.341.562|C10.597.751.418.341.562|C16.131.287|C17.800.882.356|C20.762.750.563|C23.888.592.763.393.341.562		Cancer|Congenital abnormality|Ear-nose-throat disease|Immune system disease|Nervous system disease|Signs and symptoms|Skin disease
Mastocytosis, Systemic	MESH:D034721	DO:DOID:349|DO:DOID:4660|DO:DOID:4798	A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.	MESH:D008415	C04.557.450.565.465.750|C20.762.750.750	C04.557.450.565.465|C20.762.750	Aggressive Systemic Mastocytoses|Aggressive Systemic Mastocytosis|Indolent Systemic Mastocytoses|Indolent Systemic Mastocytosis|Mast-Cell Diseases, Systemic|Mast-Cell Disease, Systemic|Mastocytoses, Aggressive Systemic|Mastocytoses, Indolent Systemic|Mastocytoses, Systemic|Mastocytosis, Aggressive Systemic|Mastocytosis, Indolent Systemic|Systemic Mast Cell Disease|Systemic Mast-Cell Disease|Systemic Mast-Cell Diseases|Systemic Mastocytoses|Systemic Mastocytoses, Aggressive|Systemic Mastocytoses, Indolent|Systemic Mastocytosis|Systemic Mastocytosis, Aggressive|Systemic Mastocytosis, Indolent	Cancer|Immune system disease
Mastoiditis	MESH:D008417	DO:DOID:0060322	Inflammation of the honeycomb-like MASTOID BONE in the skull just behind the ear. It is usually a complication of OTITIS MEDIA.	MESH:D010019|MESH:D010033	C01.160.495.500|C05.116.165.495.249|C09.218.705.663.652	C01.160.495|C05.116.165.495|C09.218.705.663	Mastoiditides	Ear-nose-throat disease|Musculoskeletal disease
Maxillary Diseases	MESH:D008439		Diseases involving the MAXILLA.	MESH:D007571	C05.500.693|C07.320.660	C05.500|C07.320	Disease, Maxillary|Diseases, Maxillary|Maxillary Disease	Mouth disease|Musculoskeletal disease
Maxillary Fractures	MESH:D008440		Fractures of the upper jaw.	MESH:D007572	C10.900.300.284.500.400.510|C26.404.750.467.611|C26.915.300.425.500.400.510	C10.900.300.284.500.400|C26.404.750.467|C26.915.300.425.500.400	Fracture, Maxillary|Fractures, Maxillary|Maxillary Fracture	Nervous system disease|Wounds and injuries
Maxillary Neoplasms	MESH:D008441	DO:DOID:4618	Cancer or tumors of the MAXILLA or upper jaw.	MESH:D007573|MESH:D008439	C04.588.149.721.450.601|C05.116.231.754.450.601|C05.500.499.601|C05.500.693.528|C07.320.515.601|C07.320.660.601	C04.588.149.721.450|C05.116.231.754.450|C05.500.499|C05.500.693|C07.320.515|C07.320.660	Maxillary Neoplasm|Neoplasm, Maxillary|Neoplasms, Maxillary	Cancer|Mouth disease|Musculoskeletal disease
Maxillary Sinusitis	MESH:D015523	DO:DOID:2051	Inflammation of the NASAL MUCOSA in the MAXILLARY SINUS. In many cases, it is caused by an infection of the bacteria HAEMOPHILUS INFLUENZAE; STREPTOCOCCUS PNEUMONIAE; or STAPHYLOCOCCUS AUREUS.	MESH:D012852	C01.748.749.578|C08.460.692.752.578|C08.730.749.578|C09.603.692.752.578	C01.748.749|C08.460.692.752|C08.730.749|C09.603.692.752	Maxillary Sinusitides|Sinusitides, Maxillary|Sinusitis, Maxillary	Ear-nose-throat disease|Respiratory tract disease
Maxillary Sinus Neoplasms	MESH:D008444	DO:DOID:1358	Tumors or cancer of the MAXILLARY SINUS. They represent the majority of paranasal neoplasms.	MESH:D010255	C04.588.443.665.650.693.575|C08.460.669.693.575|C08.460.692.503.503|C08.785.600.693.575|C09.603.669.693.575|C09.603.692.503.503|C09.647.685.693.575	C04.588.443.665.650.693|C08.460.669.693|C08.460.692.503|C08.785.600.693|C09.603.669.693|C09.603.692.503|C09.647.685.693	Cancer, Maxillary Sinus|Cancer of Maxillary Sinus|Cancers, Maxillary Sinus|Maxillary Sinus Cancer|Maxillary Sinus Cancers|Maxillary Sinus Neoplasm|Neoplasm, Maxillary Sinus|Neoplasms, Maxillary Sinus	Cancer|Ear-nose-throat disease|Respiratory tract disease
Maxillofacial Injuries	MESH:D008446		General or unspecified injuries involving the face and jaw (either upper, lower, or both).	MESH:D005151	C10.900.300.284.500|C26.915.300.425.500	C10.900.300.284|C26.915.300.425	Injuries, Maxillofacial|Injury, Maxillofacial|Maxillofacial Injury	Nervous system disease|Wounds and injuries
May-Thurner Syndrome	MESH:D062108		A compression of ILIAC VEIN that results in a decreased flow in the vein and in the left LOWER EXTREMITY due to a vascular malformation. It may result in left leg EDEMA, pain, iliofemoral DEEP VENOUS THROMBOSIS and POSTTHROMBOTIC SYNDROME. Compression of the left common ILIAC VEIN by the right common ILIAC ARTERY against the underlying fifth LUMBAR VERTEBRA is the typical underlying malformation.	MESH:D016491|MESH:D054079	C14.240.850.906|C14.907.617.648|C16.131.240.850.890	C14.240.850|C14.907.617|C16.131.240.850	Cockett Syndrome|Compression Syndrome, Iliocaval|Compression Syndromes, Iliocaval|Iliac Vein Compression Syndrome|Iliocaval Compression Syndrome|Iliocaval Compression Syndromes|May Thurner Syndrome|Syndrome, Cockett|Syndrome, Iliocaval Compression|Syndrome, May-Thurner|Syndromes, Iliocaval Compression	Cardiovascular disease|Congenital abnormality
McDonough syndrome	MESH:C538158			MESH:D000015|MESH:D003456|MESH:D006330|MESH:D007738|MESH:D008607|MESH:D019066	C05.116.900.800.500/C538158|C10.597.606.360/C538158|C12.100.500.829.258/C538158|C12.200.294.829.258/C538158|C12.200.706.258/C538158|C12.800.258/C538158|C14.240.400/C538158|C14.280.400/C538158|C16.131.077/C538158|C16.131.240.400/C538158|C16.131.939.258/C538158|C19.391.829.258/C538158|C23.550.291.812/C538158|C23.888.592.604.646/C538158|F03.625.539/C538158	C05.116.900.800.500|C10.597.606.360|C12.100.500.829.258|C12.200.294.829.258|C12.200.706.258|C12.800.258|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.939.258|C19.391.829.258|C23.550.291.812|C23.888.592.604.646|F03.625.539	Mental retardation, peculiar facies, kyphoscoliosis, diastasis recti, cryptorchidism, and congenital heart defect	Cardiovascular disease|Congenital abnormality|Endocrine system disease|Mental disorder|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms|Urogenital disease (male)
McKusick Kaufman syndrome	MESH:C538159	DO:DOID:0111255|OMIM:236700		MESH:D000015|MESH:D006330|MESH:D014591|MESH:D017689|MESH:D052202	C05.660.585.600/C538159|C12.050.351.500.852/C538159|C12.050.351.500.894.500/C538159|C12.100.250.852/C538159|C12.100.250.894.500/C538159|C14.240.400/C538159|C14.280.400/C538159|C16.131.077/C538159|C16.131.240.400/C538159|C16.131.621.585.600/C538159	C05.660.585.600|C12.050.351.500.852|C12.050.351.500.894.500|C12.100.250.852|C12.100.250.894.500|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.585.600	HMCS|Hydrometrocolpos, postaxial polydactyly, and congenital heart malformation|Hydrometrocolpos syndrome|Kaufman-Mckusick Syndrome|Kaufman McKusick syndrome|Mckusick-Kaufman Syndrome|MKKS	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Urogenital disease (female)
McPherson Clemens syndrome	MESH:C538160			MESH:D000015|MESH:D002971|MESH:D002972|MESH:D006330|MESH:D019066|MESH:D045822	C05.500.460.185/C538160|C05.660.207.540.460.185/C538160|C06.405.469.531.568/C538160|C07.320.440.185/C538160|C07.465.409.225/C538160|C07.465.525.164/C538160|C07.465.525.185/C538160|C07.650.500.460.185/C538160|C07.650.525.164/C538160|C07.650.525.185/C538160|C14.240.400/C538160|C14.280.400/C538160|C16.131.077/C538160|C16.131.240.400/C538160|C16.131.621.207.540.460.185/C538160|C16.131.850.500.460.185/C538160|C16.131.850.525.164/C538160|C16.131.850.525.185/C538160|C23.300.970.500/C538160|C23.550.291.812/C538160	C05.500.460.185|C05.660.207.540.460.185|C06.405.469.531.568|C07.320.440.185|C07.465.409.225|C07.465.525.164|C07.465.525.185|C07.650.500.460.185|C07.650.525.164|C07.650.525.185|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.207.540.460.185|C16.131.850.500.460.185|C16.131.850.525.164|C16.131.850.525.185|C23.300.970.500|C23.550.291.812	Cleft lip, cleft palate, characteristic facies, intestinal malrotation, and lethal congenital heart disease|Cleft Lip-Palate with Characteristic Facies, Intestinal Malrotation, and Lethal Congenital Heart Disease	Cardiovascular disease|Congenital abnormality|Digestive system disease|Mouth disease|Musculoskeletal disease|Pathology (anatomical condition)|Pathology (process)
McPherson Robertson Cammarano syndrome	MESH:C538161			MESH:D001763|MESH:D011681|MESH:D013285	C10.292.562.887/C538161|C10.597.690/C538161|C11.338.204/C538161|C11.590.810/C538161|C11.710/C538161|C23.888.592.708/C538161	C10.292.562.887|C10.597.690|C11.338.204|C11.590.810|C11.710|C23.888.592.708	Dominantly inherited ptosis, strabismus and ectopic pupils	Eye disease|Nervous system disease|Signs and symptoms
Measles	MESH:D008457	DO:DOID:8622	A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM.	MESH:D018185	C01.925.782.580.600.500.500	C01.925.782.580.600.500	Rubeola	Viral disease
Medial Medullary Syndrome	MESH:C536134			MESH:D020526	C10.228.140.300.150.477.100/C536134|C10.228.140.300.775.200.100/C536134|C14.907.253.092.477.100/C536134|C14.907.253.855.200.100/C536134|C23.550.513.355.250.100/C536134|C23.550.717.489.250.100/C536134	C10.228.140.300.150.477.100|C10.228.140.300.775.200.100|C14.907.253.092.477.100|C14.907.253.855.200.100|C23.550.513.355.250.100|C23.550.717.489.250.100		Cardiovascular disease|Nervous system disease|Pathology (process)
Medial Tibial Stress Syndrome	MESH:D058923		SKELETAL MUSCLE pain and tenderness along the posteromedial TIBIA resulting from exercise such as running and other physical activity.	MESH:D007869|MESH:D009135	C05.651.426|C10.668.491.087|C26.558.705	C05.651|C10.668.491|C26.558	Medial Tibial Stress Syndrome (MTSS)|Medial Tibial Stress Syndromes|Shin Splint|Shin Splints	Musculoskeletal disease|Nervous system disease|Wounds and injuries
Median Arcuate Ligament Syndrome	MESH:D000074742	DO:DOID:9892	Compression of the CELIAC ARTERY by the median arcuate ligament, a fibrous band of the DIAPHRAGM, causing abdominal pain after eating and weight loss. OMIM: 116870	MESH:D001157|MESH:D004065|MESH:D054079	C06.198.929|C14.240.850.922|C14.907.137.527|C16.131.240.850.898	C06.198|C14.240.850|C14.907.137|C16.131.240.850	Celiac Artery Compression Syndrome|Celiac Artery Stenosis from Compression by Median Arcuate Ligament of Diaphragm|Celiac Trunk Compression Syndrome|Dunbar Syndrome|Syndrome, Dunbar	Cardiovascular disease|Congenital abnormality|Digestive system disease
Median cleft lip, corpus callosum, lipoma, and skin polyps	MESH:C536135			MESH:D002971|MESH:D003103|MESH:D008067|MESH:D009298|MESH:D012871|MESH:D061085	C04.557.450.550.400/C536135|C07.465.409.225/C536135|C07.465.525.164/C536135|C07.650.525.164/C536135|C08.460.572/C536135|C09.603.557/C536135|C10.500.034/C536135|C11.250.110/C536135|C11.270.147/C536135|C16.131.384.282/C536135|C16.131.666.034/C536135|C16.131.850.525.164/C536135|C17.800/C536135|C23.300.008/C536135|C23.300.825.557/C536135	C04.557.450.550.400|C07.465.409.225|C07.465.525.164|C07.650.525.164|C08.460.572|C09.603.557|C10.500.034|C11.250.110|C11.270.147|C16.131.384.282|C16.131.666.034|C16.131.850.525.164|C17.800|C23.300.008|C23.300.825.557	Cleft, median, of upper lip with polyps of facial skin and nasal mucosa|Pai Levkoff syndrome|Pai syndrome	Cancer|Congenital abnormality|Ear-nose-throat disease|Eye disease|Mouth disease|Nervous system disease|Pathology (anatomical condition)|Respiratory tract disease|Skin disease
Median Neuropathy	MESH:D020423		Disease involving the median nerve, from its origin at the BRACHIAL PLEXUS to its termination in the hand. Clinical features include weakness of wrist and finger flexion, forearm pronation, thenar abduction, and loss of sensation over the lateral palm, first three fingers, and radial half of the ring finger. Common sites of injury include the elbow, where the nerve passes through the two heads of the pronator teres muscle (pronator syndrome) and in the carpal tunnel (CARPAL TUNNEL SYNDROME).	MESH:D020422	C10.668.829.500.500	C10.668.829.500	Distal Medial Neuropathies|Distal Medial Neuropathy|Entrapment, Median Nerve|Medial Neuropathy, Distal|Median Mononeuropathies|Median Mononeuropathy|Median Nerve Disease|Median Nerve Diseases|Median Nerve Entrapment|Median Nerve Entrapment Neuropathy|Median Nerve Entrapments|Median Nerve Neuralgia|Median Nerve Neuralgias|Median Nerve Neuropathies|Median Nerve Neuropathy|Median Neuropathies|Median Neuropathy, Proximal|Mononeuropathy, Median|Nerve Disease, Median|Nerve Entrapment, Median|Nerve Neuropathy, Median|Neuralgia, Median Nerve|Neuropathy, Distal Medial|Neuropathy, Median|Neuropathy, Median Nerve|Neuropathy, Proximal Median|Proximal Median Neuropathies|Proximal Median Neuropathy	Nervous system disease
Mediastinal Cyst	MESH:D008476		Cysts of one of the parts of the mediastinum: the superior part, containing the trachea, esophagus, thoracic duct and thymus organs; the inferior middle part, containing the pericardium; the inferior anterior part containing some lymph nodes; and the inferior posterior part, containing the thoracic duct and esophagus.	MESH:D003560|MESH:D008477	C04.182.444|C08.846.187.145	C04.182|C08.846.187	Cyst, Mediastinal|Cyst, Pericardial|Cysts, Mediastinal|Cysts, Pericardial|Cysts, Thoracic|Cysts, Thymic|Cysts, Tracheal|Cyst, Thoracic|Cyst, Thymic|Cyst, Tracheal|Mediastinal Cysts|Pericardial Cyst|Pericardial Cysts|Thoracic Cyst|Thoracic Cysts|Thymic Cyst|Thymic Cysts|Tracheal Cyst|Tracheal Cysts	Cancer|Respiratory tract disease
Mediastinal Diseases	MESH:D008477		Disorders of the mediastinum, general or unspecified.	MESH:D013896	C08.846.187	C08.846	Disease, Mediastinal|Diseases, Mediastinal|Mediastinal Disease	Respiratory tract disease
Mediastinal Emphysema	MESH:D008478		Presence of air in the mediastinal tissues due to leakage of air from the tracheobronchial tree, usually as a result of trauma.	MESH:D004646|MESH:D008477	C08.846.187.290|C23.550.325.250	C08.846.187|C23.550.325	Emphysema, Mediastinal|Emphysemas, Mediastinal|Mediastinal Emphysemas|Pneumomediastinum	Pathology (process)|Respiratory tract disease
Mediastinal Fibrosis	MESH:C536136			MESH:D008480|MESH:D012598	C08.846.187.790/C536136|C23.550.823/C536136	C08.846.187.790|C23.550.823	Fibrosing mediastinitis|Idiopathic mediastinal fibrosis|Sclerosing mediastinitis	Pathology (process)|Respiratory tract disease
Mediastinal Neoplasms	MESH:D008479	DO:DOID:5559	Tumors or cancer of the MEDIASTINUM.	MESH:D008477|MESH:D013899	C04.588.894.479|C08.846.187.580	C04.588.894|C08.846.187	Cancer, Mediastinal|Cancer, Mediastinum|Cancer of Mediastinum|Cancer of the Mediastinum|Cancers, Mediastinal|Cancers, Mediastinum|Mediastinal Cancer|Mediastinal Cancers|Mediastinal Neoplasm|Mediastinum Cancer|Mediastinum Cancers|Mediastinum Neoplasm|Mediastinum Neoplasms|Neoplasm, Mediastinal|Neoplasm, Mediastinum|Neoplasms, Mediastinal|Neoplasms, Mediastinum	Cancer|Respiratory tract disease
Mediastinitis	MESH:D008480	DO:DOID:819	Inflammation of the mediastinum, the area between the pleural sacs.	MESH:D008477	C08.846.187.790	C08.846.187	Inflammation, Mediastinum|Inflammations, Mediastinum|Mediastinitides|Mediastinum Inflammation|Mediastinum Inflammations	Respiratory tract disease
Medulloblastoma	MESH:D008527	DO:DOID:0050902|DO:DOID:3861|DO:DOID:3864|DO:DOID:3868|DO:DOID:3869|OMIM:155255	A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)	MESH:D005910|MESH:D018242	C04.557.465.625.600.380.515|C04.557.465.625.600.590.500|C04.557.470.670.380.515|C04.557.470.670.590.500|C04.557.580.625.600.380.515|C04.557.580.625.600.590.500	C04.557.465.625.600.380|C04.557.465.625.600.590|C04.557.470.670.380|C04.557.470.670.590|C04.557.580.625.600.380|C04.557.580.625.600.590	Adult Medulloblastoma|Adult Medulloblastomas|Arachnoidal Cerebellar Sarcoma, Circumscribed|Childhood Medulloblastoma|Childhood Medulloblastomas|Desmoplastic Medulloblastoma|Desmoplastic Medulloblastomas|MBEN, INCLUDED|MDB|Medulloblastoma, Adult|Medulloblastoma, Childhood|Medulloblastoma, Desmoplastic|MEDULLOBLASTOMA, DESMOPLASTIC, INCLUDED|Medulloblastoma, Melanocytic|Medulloblastomas|Medulloblastomas, Adult|Medulloblastomas, Childhood|Medulloblastomas, Desmoplastic|Medulloblastomas, Melanocytic|MEDULLOBLASTOMA WITH EXTENSIVE NODULARITY, INCLUDED|Medullomyoblastoma|Medullomyoblastomas|Melanocytic Medulloblastoma|Melanocytic Medulloblastomas|Sarcoma, Cerebellar, Circumscribed Arachnoidal	Cancer
MEESTER-LOEYS SYNDROME	OMIM:300989	DO:DOID:0111861		MESH:D000784|MESH:D017545	C14.907.055.050/300989|C14.907.055.239.125/300989|C14.907.109.139.125/300989	C14.907.055.050|C14.907.055.239.125|C14.907.109.139.125	MRLS	Cardiovascular disease
Megalencephaly cutis marmorata telangiectatica congenita	MESH:C536142			MESH:D000015|MESH:D013684|MESH:D017445|MESH:D058627	C05.660.207.536/C536142|C10.500.507.400.249/C536142|C14.907.823/C536142|C16.131.077/C536142|C16.131.621.207.532/C536142|C16.131.666.507.400.249/C536142|C17.800.862/C536142	C05.660.207.536|C10.500.507.400.249|C14.907.823|C16.131.077|C16.131.621.207.532|C16.131.666.507.400.249|C17.800.862	Macrocephaly-Capillary Malformation|Macrocephaly cutis marmorata telangiectatica congenita|Macrocephaly-Cutis Marmorata Telangiectatica Congenita|Megalencephaly-Cutis Marmorata Telangiectatica Congenita|Megalocephaly cutis marmorata telangiectatica congenita	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Nervous system disease|Skin disease
Megaloblastic Anemia due to Dihydrofolate Reductase Deficiency	MESH:C565095	OMIM:613839		MESH:D000749	C15.378.071.252.196/C565095	C15.378.071.252.196	DHFR Deficiency	Blood disease
Mehta Lewis Patton syndrome	MESH:C536147			MESH:D000848|MESH:D001763|MESH:D003398|MESH:D006330	C05.116.099.370.894.232/C536147|C05.660.207.240/C536147|C05.660.906.364/C536147|C07.650.800.100/C536147|C07.793.700.100/C536147|C11.338.204/C536147|C14.240.400/C536147|C14.280.400/C536147|C16.131.240.400/C536147|C16.131.621.207.240/C536147|C16.131.621.906.364/C536147|C16.131.850.800.100/C536147	C05.116.099.370.894.232|C05.660.207.240|C05.660.906.364|C07.650.800.100|C07.793.700.100|C11.338.204|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.240|C16.131.621.906.364|C16.131.850.800.100	Congenital heart disease, ptosis, hypodontia, and craniosynostosis	Cardiovascular disease|Congenital abnormality|Eye disease|Mouth disease|Musculoskeletal disease
Meibomian Gland Dysfunction	MESH:D000080343		A chronic dysfunction of MEIBOMIAN GLANDS characterized by altered tear film stability and function due to a decrease or alteration in lipid quality/content in meibum. It is often associated with evaporative-type DRY EYE SYNDROME.	MESH:D005141	C11.338.780	C11.338	Dysfunction, Meibomian Gland|Meibomian Gland Dysfunctions|MG Dysfunction|MG Dysfunctions	Eye disease
Meige Syndrome	MESH:D008538	DO:DOID:3982	A syndrome characterized by orofacial DYSTONIA; including BLEPHAROSPASM; forceful jaw opening; lip retraction; platysma muscle spasm; and tongue protrusion. It primarily affects older adults, with an incidence peak in the seventh decade of life. (From Adams et al., Principles of Neurology, 6th ed, p108)	MESH:D001480|MESH:D020821	C10.228.140.079.590|C10.228.662.300.500	C10.228.140.079|C10.228.662.300	Blepharospasm Oromandibular Dyskinesia|Blepharospasm-Oromandibular Dyskinesia|Blepharospasm-Oromandibular Dyskinesias|Blepharospasm Oromandibular Dystonia|Blepharospasm-Oromandibular Dystonia|Blepharospasm-Oromandibular Dystonias|Blepharospasm Oromandibular Dystonia Syndrome|Blepharospasm-Oromandibular Dystonia Syndrome|Blepharospasm Oromandibular Dystonia Syndrome, Idiopathic|Blepharospasm-Oromandibular Dystonia Syndrome, Idiopathic|Blepharospasm-Oromandibular Dystonia Syndromes|Brueghel Syndrome|Dyskinesia, Blepharospasm-Oromandibular|Dyskinesia, Idiopathic Orofacial|Dyskinesias, Blepharospasm-Oromandibular|Dyskinesias, Idiopathic Orofacial|Dystonia, Blepharospasm-Oromandibular|Dystonias, Blepharospasm-Oromandibular|Dystonia Syndrome, Blepharospasm-Oromandibular|Dystonia Syndromes, Blepharospasm-Oromandibular|Idiopathic Blepharospasm Oromandibular Dystonia Syndrome|Idiopathic Blepharospasm-Oromandibular Dystonia Syndrome|Idiopathic Orofacial Dyskinesia|Idiopathic Orofacial Dyskinesias|Orofacial Dyskinesia, Idiopathic|Orofacial Dyskinesias, Idiopathic|Syndrome, Blepharospasm-Oromandibular Dystonia	Nervous system disease
Meigs Syndrome	MESH:D008539		The triad of benign FIBROMA or other ovarian tumors with ASCITES, and HYDROTHORAX due to large PLEURAL EFFUSIONS.	MESH:D010051	C04.588.322.455.531|C12.050.351.500.056.630.705.531|C12.050.351.937.418.685.531|C12.100.250.056.630.705.531|C12.900.418.685.531|C19.344.410.531|C19.391.630.705.531	C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.344.410|C19.391.630.705	Meig's Syndrome|Meigs' Syndrome|Meig Syndrome	Cancer|Endocrine system disease|Urogenital disease (female)
Melanocytic nevus syndrome, congenital	MESH:C536819	DO:DOID:0111359|OMIM:137550		MESH:D009508|MESH:D012878	C04.557.665.560.615/C536819|C04.588.805/C536819|C17.800.882/C536819	C04.557.665.560.615|C04.588.805|C17.800.882	CMNS|Giant congenital pigmented nevus|Giant pigmented hairy nevus|GPHN|PIGMENTED MOLES NEVUS SPILUS, INCLUDED|SPITZ NEVUS, INCLUDED	Cancer|Skin disease
Melanoma	MESH:D008545	DO:DOID:1909	A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)	MESH:D018326|MESH:D018358	C04.557.465.625.650.510|C04.557.580.625.650.510|C04.557.665.510	C04.557.465.625.650|C04.557.580.625.650|C04.557.665	Malignant Melanoma|Malignant Melanomas|Melanoma, Malignant|Melanomas|Melanomas, Malignant	Cancer
Melanoma, Amelanotic	MESH:D018328	DO:DOID:4359	An unpigmented malignant melanoma. It is an anaplastic melanoma consisting of cells derived from melanoblasts but not forming melanin. (Dorland, 27th ed; Stedman, 25th ed)	MESH:D008545	C04.557.465.625.650.510.515|C04.557.580.625.650.510.515|C04.557.665.510.515	C04.557.465.625.650.510|C04.557.580.625.650.510|C04.557.665.510	Amelanotic Melanoma|Amelanotic Melanomas|Melanomas, Amelanotic	Cancer
Melanoma astrocytoma syndrome	MESH:C536149	DO:DOID:0111511|OMIM:155755		MESH:D001254|MESH:D008545|MESH:D009423	C04.557.465.625.600.380.080/C536149|C04.557.465.625.650.510/C536149|C04.557.470.670.380.080/C536149|C04.557.580.625.600.380.080/C536149|C04.557.580.625.650.510/C536149|C04.557.665.510/C536149|C04.588.614/C536149|C10.551/C536149	C04.557.465.625.600.380.080|C04.557.465.625.650.510|C04.557.470.670.380.080|C04.557.580.625.600.380.080|C04.557.580.625.650.510|C04.557.665.510|C04.588.614|C10.551	Cutaneous malignant melanoma and cerebral astrocytoma|Melanoma and neural system tumor syndrome|Melanoma-Astrocytoma Syndrome	Cancer|Nervous system disease
Melanoma, Cutaneous Malignant	MESH:C562393	DO:DOID:8923		MESH:D008545|MESH:D012878	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805/C562393|C17.800.882/C562393	C04.557.465.625.650.510|C04.557.580.625.650.510|C04.557.665.510|C04.588.805|C17.800.882	Dysplastic Nevus Syndrome, Hereditary|Familial Atypical Mole-Malignant Melanoma Syndrome|Famm|Melanoma, Familial	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1	OMIM:155600			MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/155600|C04.557.580.625.650.510/C562393/155600|C04.557.665.510/C562393/155600|C04.588.805/155600|C04.588.805/C562393/155600|C17.800.882/155600|C17.800.882/C562393/155600	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	B-K MOLE SYNDROME|CMM|CMM1|DNS|DYSPLASTIC NEVUS SYNDROME, HEREDITARY|FAMILIAL ATYPICAL MOLE-MALIGNANT MELANOMA SYNDROME|FAMMM|MELANOMA, CUTANEOUS MALIGNANT|MELANOMA, FAMILIAL|MELANOMA, MALIGNANT|MLM	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10	OMIM:615848			MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/615848|C04.557.580.625.650.510/C562393/615848|C04.557.665.510/C562393/615848|C04.588.805/615848|C04.588.805/C562393/615848|C17.800.882/615848|C17.800.882/C562393/615848	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	CMM10	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	OMIM:155601			MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/155601|C04.557.580.625.650.510/C562393/155601|C04.557.665.510/C562393/155601|C04.588.805/155601|C04.588.805/C562393/155601|C17.800.882/155601|C17.800.882/C562393/155601	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	CMM2	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3	OMIM:609048			MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/609048|C04.557.580.625.650.510/C562393/609048|C04.557.665.510/C562393/609048|C04.588.805/609048|C04.588.805/C562393/609048|C17.800.882/609048|C17.800.882/C562393/609048	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	CMM3	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4	OMIM:608035	DO:DOID:8923		MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/608035|C04.557.580.625.650.510/C562393/608035|C04.557.665.510/C562393/608035|C04.588.805/608035|C04.588.805/C562393/608035|C17.800.882/608035|C17.800.882/C562393/608035	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	CMM4	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5	OMIM:613099			MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/613099|C04.557.580.625.650.510/C562393/613099|C04.557.665.510/C562393/613099|C04.588.805/613099|C04.588.805/C562393/613099|C17.800.882/613099|C17.800.882/C562393/613099	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	CMM5	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6	OMIM:613972			MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/613972|C04.557.580.625.650.510/C562393/613972|C04.557.665.510/C562393/613972|C04.588.805/613972|C04.588.805/C562393/613972|C17.800.882/613972|C17.800.882/C562393/613972	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	CMM6	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7	OMIM:612263	DO:DOID:8923		MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/612263|C04.557.580.625.650.510/C562393/612263|C04.557.665.510/C562393/612263|C04.588.805/612263|C04.588.805/C562393/612263|C17.800.882/612263|C17.800.882/C562393/612263	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	CMM7	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8	OMIM:614456			MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/614456|C04.557.580.625.650.510/C562393/614456|C04.557.665.510/C562393/614456|C04.588.805/614456|C04.588.805/C562393/614456|C17.800.882/614456|C17.800.882/C562393/614456	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	CMM8|MELANOMA AND RENAL CELL CARCINOMA, SUSCEPTIBILITY TO	Cancer|Skin disease
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9	OMIM:615134			MESH:C562393|MESH:D012878	C04.557.465.625.650.510/C562393/615134|C04.557.580.625.650.510/C562393/615134|C04.557.665.510/C562393/615134|C04.588.805/615134|C04.588.805/C562393/615134|C17.800.882/615134|C17.800.882/C562393/615134	C04.557.465.625.650.510/C562393|C04.557.580.625.650.510/C562393|C04.557.665.510/C562393|C04.588.805|C04.588.805/C562393|C17.800.882|C17.800.882/C562393	CMM9	Cancer|Skin disease
Melanoma, Experimental	MESH:D008546		Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.	MESH:D008545|MESH:D009374	C04.557.465.625.650.510.525|C04.557.580.625.650.510.525|C04.557.665.510.525|C04.619.600	C04.557.465.625.650.510|C04.557.580.625.650.510|C04.557.665.510|C04.619	B16 Melanoma|B16 Melanomas|Cloudman S91 Melanoma|Experimental Melanoma|Experimental Melanomas|Harding Passey Melanoma|Harding-Passey Melanoma|Melanoma, B16|Melanoma, Cloudman S91|Melanoma, Harding Passey|Melanoma, Harding-Passey|Melanomas, B16|Melanomas, Experimental|S91 Melanoma, Cloudman	Cancer
Melanoma, Malignant Familial Intraocular	MESH:C563596			MESH:D005134|MESH:D008545	C04.557.465.625.650.510/C563596|C04.557.580.625.650.510/C563596|C04.557.665.510/C563596|C04.588.364/C563596|C11.319/C563596	C04.557.465.625.650.510|C04.557.580.625.650.510|C04.557.665.510|C04.588.364|C11.319		Cancer|Eye disease
Melanosis	MESH:D008548		Disorders of increased melanin pigmentation that develop without preceding inflammatory disease.	MESH:D017495	C17.800.621.430.530	C17.800.621.430	Chloasma|Chloasmas|Freckle|Freckles|Melanism|Melanoses|Melasma|Melasmas	Skin disease
Melanosis, Universal	MESH:C563594			MESH:D017495	C17.800.621.430/C563594	C17.800.621.430		Skin disease
Melena	MESH:D008551		The black, tarry, foul-smelling FECES that contain degraded blood.	MESH:D006471	C06.405.227.600|C23.550.414.788.600	C06.405.227|C23.550.414.788	Melenas	Digestive system disease|Pathology (process)
Melkersson-Rosenthal Syndrome	MESH:D008556	DO:DOID:1761|OMIM:155900	An idiopathic syndrome characterized by one or more of the following; recurrent orofacial swelling, relapsing facial paralysis, and fissured tongue (lingua plicata). The onset is usually in childhood and relapses are common. Cheilitis granulomatosa is a monosymptomatic variant of this condition. (Dermatol Clin 1996 Apr;14(2):371-9; Magalini & Magalini, Dictionary of Medical Syndromes, 4th ed, p531)	MESH:D005155|MESH:D009059	C07.465.299.800|C07.465.466|C10.292.319.800	C07.465|C07.465.299|C10.292.319	Cheilitis Granulomatosa|Cheilitis Granulomatosa, Facial Neuropathy, Orofacial Edema|Cheilitis Granulomatosa, Orofacial Edema, Facial Neuropathy|Cheilitis, Miescher-Melkersson-Rosenthal Granulomatous|Facial Neuropathy, Cheilitis Granulomatosa, Orofacial Edema|Facial Neuropathy, Orofacial Edema, Cheilitis Granulomatosa|Granulomatous Cheilitis|Granulomatous Cheilitis, Miescher-Melkersson-Rosenthal|Macrocheilia, Facial Palsy, Edema|Melkerson Rosenthal Syndrome|Melkerson-Rosenthal Syndrome|Melkersson Rosenthal Miescher Syndrome|Melkersson-Rosenthal-Miescher Syndrome|Melkersson Rosenthal Syndrome|Melkersson Syndrome|Miescher Melkersson Rosenthal Granulomatous Cheilitis|Miescher-Melkersson-Rosenthal Granulomatous Cheilitis|MROS|MRS|Orofacial Edema, Cheilitis Granulomatosa, Facial Neuropathy|Orofacial Edema, Facial Neuropathy, Cheilitis Granulomatosa|Rosenthal Melkerson Syndrome|Rosenthal-Melkerson Syndrome|Rosenthal Melkersson Syndrome|Rosenthal-Melkersson Syndrome|Syndrome, Melkerson Rosenthal	Mouth disease|Nervous system disease
Melorheostosis	MESH:D008557	DO:DOID:4253|OMIM:155950	A form of osteosclerosis extending in a linear track mainly through one of the long bones of the upper and lower limbs.	MESH:D010026	C05.116.099.708.702.593	C05.116.099.708.702	MEL|Melorheostoses|MELORHEOSTOSIS, ISOLATED|Melorheostosis of Leri	Musculoskeletal disease
Membranous Cranial Ossification, Delayed	MESH:C563592			MESH:D001848	C05.116.099/C563592	C05.116.099		Musculoskeletal disease
Membranous Obstruction of Inferior Vena Cava	MESH:C563013			MESH:D006502	C06.552.347/C563013|C14.907.355.830.925.275/C563013	C06.552.347|C14.907.355.830.925.275		Cardiovascular disease|Digestive system disease
Memory Disorders	MESH:D008569		Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.	MESH:D019954	C10.597.606.525|C23.888.592.604.529	C10.597.606|C23.888.592.604	Age-Related Memory Disorder|Age Related Memory Disorders|Age-Related Memory Disorders|Cognitive Retention Disorder|Cognitive Retention Disorders|Deficit, Memory|Deficits, Memory|Memory Deficit|Memory Deficits|Memory Disorder|Memory Disorder, Age-Related|Memory Disorders, Age Related|Memory Disorders, Age-Related|Memory Disorder, Semantic|Memory Disorder, Spatial|Memory Disorders, Semantic|Memory Disorders, Spatial|Memory Loss|Memory Losses|Retention Disorder, Cognitive|Retention Disorders, Cognitive|Semantic Memory Disorder|Semantic Memory Disorders|Spatial Memory Disorder|Spatial Memory Disorders	Nervous system disease|Signs and symptoms
Mengel Konigsmark syndrome	MESH:C537239			MESH:D006314	C09.218.458.341.562/C537239|C10.597.751.418.341.562/C537239|C23.888.592.763.393.341.562/C537239	C09.218.458.341.562|C10.597.751.418.341.562|C23.888.592.763.393.341.562	Conductive hearing loss and malformed low-set ears|Ear deformity and conductive hearing loss|Familial congenital moderate neural hearing loss	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Meniere Disease	MESH:D008575	DO:DOID:9849	A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops.	MESH:D018159	C09.218.568.217.500	C09.218.568.217	Auditory Vertigo|Auditory Vertigos|Aural Vertigo|Disease, Meniere|Disease, Ménière|Disease, Meniere's|Disease, Ménière's|Diseases, Ménière|Diseases, Ménière's|Ménière Disease|Ménière Diseases|Meniere's Disease|Menieres Disease|Ménière's Disease|Ménières Disease|Ménière's Diseases|Meniere's Syndrome|Menieres Syndrome|Ménière's Vertigo|Ménières Vertigo|Ménière's Vertigos|Meniere Syndrome|Ménière Vertigo|Otogenic Vertigo|Otogenic Vertigos|Syndrome, Meniere's|Vertigo, Auditory|Vertigo, Aural|Vertigo, Ménière's|Vertigo, Otogenic|Vertigos, Auditory|Vertigos, Ménière's|Vertigos, Otogenic	Ear-nose-throat disease
Meningeal Carcinomatosis	MESH:D055756		Primary or secondary neoplasm in the ARACHNOID or SUBARACHNOID SPACE. It appears as a diffuse fibrotic thickening of the MENINGES associated with variable degrees of inflammation.	MESH:D008577	C04.588.614.250.580.150|C10.551.240.500.150	C04.588.614.250.580|C10.551.240.500	Carcinomatoses, Leptomeningeal|Carcinomatoses, Meningeal|Carcinomatosis, Leptomeningeal|Carcinomatosis, Meningeal|Carcinomatous Meningitides|Carcinomatous Meningitis|Leptomeningeal Carcinomatoses|Leptomeningeal Carcinomatosis|Meningeal Carcinomatoses|Meningitides, Carcinomatous|Meningitis, Carcinomatous	Cancer|Nervous system disease
Meningeal Neoplasms	MESH:D008577		Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.	MESH:D016543	C04.588.614.250.580|C10.551.240.500	C04.588.614.250|C10.551.240	Benign Meningeal Neoplasm|Benign Meningeal Neoplasms|Cancer, Meningeal|Cancers, Meningeal|Intracranial Meningeal Neoplasm|Intracranial Meningeal Neoplasms|Leptomeningeal Neoplasm|Leptomeningeal Neoplasms|Malignant Meningeal Neoplasm|Malignant Meningeal Neoplasms|Meningeal Cancer|Meningeal Cancers|Meningeal Neoplasm|Meningeal Neoplasm, Benign|Meningeal Neoplasm, Intracranial|Meningeal Neoplasm, Malignant|Meningeal Neoplasms, Benign|Meningeal Neoplasms, Intracranial|Meningeal Neoplasms, Malignant|Meningeal Neoplasm, Spinal|Meningeal Neoplasms, Spinal|Meningeal Tumor|Meningeal Tumors|Neoplasm, Benign Meningeal|Neoplasm, Intracranial Meningeal|Neoplasm, Leptomeningeal|Neoplasm, Malignant Meningeal|Neoplasm, Meningeal|Neoplasms, Benign Meningeal|Neoplasms, Intracranial Meningeal|Neoplasms, Leptomeningeal|Neoplasms, Malignant Meningeal|Neoplasms, Meningeal|Neoplasm, Spinal Meningeal|Neoplasms, Spinal Meningeal|Spinal Meningeal Neoplasm|Spinal Meningeal Neoplasms|Tumor, Meningeal|Tumors, Meningeal	Cancer|Nervous system disease
Meningioma	MESH:D008579	DO:DOID:0080842|DO:DOID:1138|DO:DOID:3565|DO:DOID:3772|DO:DOID:4141|DO:DOID:4210|DO:DOID:4587|DO:DOID:4588|DO:DOID:4594|DO:DOID:6114|DO:DOID:6548|DO:DOID:6869|DO:DOID:7210|DO:DOID:7211|DO:DOID:7212|DO:DOID:7213|DO:DOID:8057	A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7)	MESH:D008577|MESH:D009380|MESH:D009383	C04.557.580.520|C04.557.645.520|C04.588.614.250.580.500|C10.551.240.500.500	C04.557.580|C04.557.645|C04.588.614.250.580|C10.551.240.500	Angioblastic Meningioma|Angioblastic Meningiomas|Angiomatous Meningioma|Angiomatous Meningiomas|Benign Meningioma|Benign Meningiomas|Cerebral Convexity Meningioma|Cerebral Convexity Meningiomas|Clear Cell Meningioma|Clear Cell Meningiomas|Convexity Meningioma, Cerebral|Convexity Meningiomas, Cerebral|Fibrous Meningioma|Fibrous Meningiomas|Groove Meningiomas, Olfactory|Hemangioblastic Meningioma|Hemangioblastic Meningiomas|Hemangiopericytic Meningioma|Hemangiopericytic Meningiomas|Intracranial Meningioma|Intracranial Meningiomas|Intraorbital Meningioma|Intraorbital Meningiomas|Intraventricular Meningioma|Intraventricular Meningiomas|Malignant Meningioma|Malignant Meningiomas|Meningioma, Angioblastic|Meningioma, Angiomatous|Meningioma, Benign|Meningioma, Cerebral Convexity|Meningioma, Clear Cell|Meningioma, Fibrous|Meningioma, Hemangioblastic|Meningioma, Hemangiopericytic|Meningioma, Intracranial|Meningioma, Intraorbital|Meningioma, Intraventricular|Meningioma, Malignant|Meningioma, Meningotheliomatous|Meningioma, Microcystic|Meningioma, Multiple|Meningioma, Olfactory Groove|Meningioma, Papillary|Meningioma, Parasagittal|Meningioma, Posterior Fossa|Meningioma, Psammomatous|Meningiomas|Meningiomas, Angioblastic|Meningiomas, Angiomatous|Meningiomas, Benign|Meningiomas, Cerebral Convexity|Meningiomas, Clear Cell|Meningioma, Secretory|Meningiomas, Fibrous|Meningiomas, Hemangioblastic|Meningiomas, Hemangiopericytic|Meningiomas, Intracranial|Meningiomas, Intraorbital|Meningiomas, Intraventricular|Meningiomas, Malignant|Meningiomas, Meningotheliomatous|Meningiomas, Microcystic|Meningiomas, Multiple|Meningiomas, Olfactory Groove|Meningiomas, Papillary|Meningiomas, Parasagittal|Meningioma, Sphenoid Wing|Meningioma, Spinal|Meningiomas, Posterior Fossa|Meningiomas, Psammomatous|Meningiomas, Secretory|Meningiomas, Sphenoid Wing|Meningiomas, Spinal|Meningiomas, Transitional|Meningiomas, Xanthomatous|Meningiomatoses|Meningiomatosis|Meningioma, Transitional|Meningioma, Xanthomatous|Meningotheliomatous Meningioma|Meningotheliomatous Meningiomas|Microcystic Meningioma|Microcystic Meningiomas|Multiple Meningioma|Multiple Meningiomas|Olfactory Groove Meningioma|Olfactory Groove Meningiomas|Papillary Meningioma|Papillary Meningiomas|Parasagittal Meningioma|Parasagittal Meningiomas|Posterior Fossa Meningioma|Posterior Fossa Meningiomas|Psammomatous Meningioma|Psammomatous Meningiomas|Secretory Meningioma|Secretory Meningiomas|Sphenoid Wing Meningioma|Sphenoid Wing Meningiomas|Spinal Meningioma|Spinal Meningiomas|Transitional Meningioma|Transitional Meningiomas|Wing Meningioma, Sphenoid|Wing Meningiomas, Sphenoid|Xanthomatous Meningioma|Xanthomatous Meningiomas	Cancer|Nervous system disease
Meningism	MESH:D008580		A condition characterized by neck stiffness, headache, and other symptoms suggestive of meningeal irritation, but without actual inflammation of the meninges (MENINGITIS). Spinal fluid pressure may be elevated but spinal fluid is normal. (DeJong, The Neurologic Examination, 4th ed, p673)	MESH:D009461	C10.597.544|C23.888.592.544	C10.597|C23.888.592	Dupre's Syndrome|Dupres Syndrome|Dupre Syndrome|Meningisms|Meningismus|Meningitis Like Reaction|Meningitis-Like Reaction|Meningitis-Like Reactions|Pseudomeningitides|Pseudomeningitis|Reaction, Meningitis-Like|Reactions, Meningitis-Like|Syndrome, Dupre|Syndrome, Dupre's	Nervous system disease|Signs and symptoms
Meningitis	MESH:D008581	DO:DOID:9471	Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6)	MESH:D000090862	C10.586.625	C10.586	Meningitides|Pachymeningitides|Pachymeningitis	Nervous system disease
Meningitis, Aseptic	MESH:D008582	DO:DOID:12157	A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. (From Adams et al., Principles of Neurology, 6th ed, p745)	MESH:D008581	C10.586.625.220	C10.586.625	Aseptic Meningitis	Nervous system disease
Meningitis, Viral	MESH:D008587	DO:DOID:10310	Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)	MESH:D008581|MESH:D020805	C01.207.245.500|C01.925.182.550|C10.228.228.245.500|C10.586.625.400	C01.207.245|C01.925.182|C10.228.228.245|C10.586.625	Meningitides, Viral|Viral Meningitides|Viral Meningitis	Nervous system disease|Viral disease
Meningoencephalitis	MESH:D008590	DO:DOID:10554	An inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.	MESH:D002494|MESH:D004660|MESH:D008581|MESH:D020805	C01.207.245.550|C01.207.570|C10.228.140.430.550|C10.228.228.245.550|C10.228.228.570|C10.586.250.550|C10.586.625.500	C01.207|C01.207.245|C10.228.140.430|C10.228.228|C10.228.228.245|C10.586.250|C10.586.625	Cerebromeningitides|Cerebromeningitis|Encephalomeningitides|Encephalomeningitis|Meningoencephalitides	Nervous system disease
Menopause, Premature	MESH:D008594	DO:DOID:10787	The premature cessation of menses (MENSTRUATION) when the last menstrual period occurs in a woman under the age of 40. It is due to the depletion of OVARIAN FOLLICLES. Premature MENOPAUSE can be caused by diseases; OVARIECTOMY; RADIATION; chemicals; and chromosomal abnormalities.	MESH:D010049	C12.050.351.500.056.630.250|C12.100.250.056.630.250	C12.050.351.500.056.630|C12.100.250.056.630	Premature Menopause	Urogenital disease (female)
Menorrhagia	MESH:D008595		Excessive uterine bleeding during MENSTRUATION.	MESH:D008599|MESH:D014592	C12.050.351.500.852.691.449|C12.100.250.852.691.449|C23.550.414.993.350|C23.550.568.875	C12.050.351.500.852.691|C12.100.250.852.691|C23.550.414.993|C23.550.568	Heavy Menstrual Bleeding|Heavy Period|Heavy Periods|Hypermenorrhea|Menstrual Bleeding, Heavy	Pathology (process)|Urogenital disease (female)
Mental and Growth Retardation with Amblyopia	MESH:C563591			MESH:D000550|MESH:D006130|MESH:D008607	C10.228.140.055/C563591|C10.597.606.360/C563591|C10.597.751.941.073/C563591|C11.966.073/C563591|C23.550.393/C563591|C23.888.592.604.646/C563591|C23.888.592.763.941.073/C563591|F03.625.539/C563591	C10.228.140.055|C10.597.606.360|C10.597.751.941.073|C11.966.073|C23.550.393|C23.888.592.604.646|C23.888.592.763.941.073|F03.625.539		Eye disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Mental retardation, keratoconus, febrile seizures, and sinoatrial block	MESH:C537452			MESH:D007640|MESH:D008607|MESH:D012640|MESH:D012848	C10.597.606.360/C537452|C10.597.742/C537452|C11.204.627/C537452|C14.280.067.558.750/C537452|C14.280.123.500.750/C537452|C23.550.073.425.780/C537452|C23.888.592.604.646/C537452|C23.888.592.742/C537452|F03.625.539/C537452	C10.597.606.360|C10.597.742|C11.204.627|C14.280.067.558.750|C14.280.123.500.750|C23.550.073.425.780|C23.888.592.604.646|C23.888.592.742|F03.625.539		Cardiovascular disease|Eye disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Mental retardation Mietens Weber type	MESH:C537444			MESH:D003286|MESH:D003318|MESH:D006130|MESH:D008607|MESH:D020417	C05.550.323/C537444|C05.651.197/C537444|C10.292.562.675.300/C537444|C10.597.606.360/C537444|C11.204.299/C537444|C11.590.400.300/C537444|C16.614.643/C537444|C23.550.393/C537444|C23.888.592.604.646/C537444|F03.625.539/C537444	C05.550.323|C05.651.197|C10.292.562.675.300|C10.597.606.360|C11.204.299|C11.590.400.300|C16.614.643|C23.550.393|C23.888.592.604.646|F03.625.539	Mental retardation syndrome, Mietens Weber type|Mental Retardation Syndrome, Mietens-Weber Type|Mietens-Weber syndrome	Eye disease|Infant-newborn disease|Mental disorder|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Meralgia Paraesthetica, Familial	MESH:C563590			MESH:D009408	C10.668.829.550/C563590	C10.668.829.550		Nervous system disease
Mercury Poisoning	MESH:D008630		Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of MERCURY or MERCURY COMPOUNDS.	MESH:D000075322	C25.723.522.875	C25.723.522	Mercury Poisonings|Poisoning, Mercury|Poisonings, Mercury	
Mercury Poisoning, Nervous System	MESH:D020262		Neurologic disorders associated with exposure to inorganic and organic forms of MERCURY. Acute intoxication may be associated with gastrointestinal disturbances, mental status changes, and PARAPARESIS. Chronic exposure to inorganic mercury usually occurs in industrial workers, and manifests as mental confusion, prominent behavioral changes (including psychosis), DYSKINESIAS, and NEURITIS. Alkyl mercury poisoning may occur through ingestion of contaminated seafood or grain, and its characteristic features include POLYNEUROPATHY; ATAXIA; vision loss; NYSTAGMUS, PATHOLOGIC; and DEAFNESS. (From Joynt, Clinical Neurology, 1997, Ch20, pp10-15)	MESH:D008630|MESH:D020260	C10.720.475.600|C25.723.522.875.500	C10.720.475|C25.723.522.875	Encephalopathy, Mercury|Inorganic Mercury Poisoning|Mad Hatter Disease|Mad Hatter Diseases|Mad Hatter's Disease|Mad Hatters Disease|Mercurialism, Nervous System|Mercurialism, Neurologic|Mercurial Neuroanesthenia|Mercurial Psychosis|Mercury Encephalopathy|Mercury Induced Nervous System Diseases|Mercury-Induced Nervous System Diseases|Mercury Neurotoxicity Syndrome|Mercury Neurotoxicity Syndromes|Mercury Poisoning, Inorganic|Mercury Poisoning, Neurologic|Mercury Poisoning, Organic|Mercury Psychosis|Minamata Disease|Nervous System Diseases, Mercury Induced|Nervous System Diseases, Mercury-Induced|Nervous System Mercurialism|Nervous System Poisoning, Mercury|Neuroanesthenia, Mercurial|Neurologic Mercurialism|Neurologic Mercury Poisoning|Neurotoxicity Syndrome, Mercury|Neurotoxicity Syndromes, Mercury|Organic Mercury Poisoning|Poisoning, Inorganic Mercury|Poisoning, Mercury, Nervous System|Poisoning, Mercury, Neurologic|Poisoning, Neurologic Mercury|Poisoning, Organic Mercury|Psychosis, Mercurial|Psychosis, Mercury|Syndrome, Mercury Neurotoxicity|Syndromes, Mercury Neurotoxicity|System Mercurialism, Nervous	Nervous system disease
Mesangial sclerosis, diffuse	MESH:C537346			MESH:D009404|MESH:D012598	C12.050.351.968.419.630.643/C537346|C12.200.777.419.630.643/C537346|C12.950.419.630.643/C537346|C23.550.823/C537346	C12.050.351.968.419.630.643|C12.200.777.419.630.643|C12.950.419.630.643|C23.550.823	Diffuse isolated mesangial sclerosis|Diffuse mesangial sclerosis|Familial mesangial sclerosis|Isolated diffuse mesangial sclerosis|Mesangial Sclerosis, Familial|Mesangial Sclerosis, Isolated Diffuse|Nephrotic syndrome, early onset with diffuse mesangial sclerosis|Nephrotic Syndrome, Early-Onset, With Diffuse Mesangial Sclerosis	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Mesenchymoma	MESH:D008637	DO:DOID:2668	A mixed mesenchymal tumor composed of two or more mesodermal cellular elements not commonly associated, not counting fibrous tissue as one of the elements. Mesenchymomas are widely distributed in the body and about 75% are malignant. (Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)	MESH:D018193	C04.557.435.500	C04.557.435	Mesenchymomas	Cancer
Mesenteric Cyst	MESH:D008639		A rare intra-abdominal tumor in the MESENTERY. Mesenteric cysts are usually benign and can be very large fluid-filled (2000 mL) lesions.	MESH:D003560|MESH:D010534	C04.182.473|C06.844.620.500	C04.182|C06.844.620	Cyst, Mesenteric|Cysts, Mesenteric|Mesenteric Cysts	Cancer|Digestive system disease
Mesenteric Ischemia	MESH:D065666		Ischemic tissue injury produced by insufficient perfusion of intestinal tissue by the MESENTERIC CIRCULATION (i.e., CELIAC ARTERY; SUPERIOR MESENTERIC ARTERY; INFERERIOR MESENTERIC ARTERY; and MESENTERIC VEINS). It can progress from ISCHEMIA; EDEMA; and GANGRENE of the bowel wall to PERITONITIS and cardiovascular collapse.	MESH:D007410|MESH:D010532|MESH:D014652	C06.405.469.656|C06.844.460|C14.907.549	C06.405.469|C06.844|C14.907	Acute Mesenteric Arterial Embolus|Acute Mesenteric Arterial Thrombosis|Insufficiencies, Mesenteric Vascular|Insufficiency, Mesenteric Vascular|Ischemia, Mesenteric|Ischemia, Nonocclusive Mesenteric|Ischemias, Mesenteric|Ischemias, Nonocclusive Mesenteric|Mesenteric Ischemia, Nonocclusive|Mesenteric Ischemias|Mesenteric Ischemias, Nonocclusive|Mesenteric Vascular Insufficiencies|Mesenteric Vascular Insufficiency|Mesenteric Venous Thromboses|Mesenteric Venous Thrombosis|Nonocclusive Mesenteric Ischemia|Nonocclusive Mesenteric Ischemias|Occlusive Mesenteric Arterial Ischemia|Thromboses, Mesenteric Venous|Thrombosis, Mesenteric Venous|Vascular Insufficiencies, Mesenteric|Vascular Insufficiency, Mesenteric|Venous Thromboses, Mesenteric|Venous Thrombosis, Mesenteric	Cardiovascular disease|Digestive system disease
Mesenteric Lymphadenitis	MESH:D008640	DO:DOID:10782	INFLAMMATION of LYMPH NODES in the MESENTERY.	MESH:D008199|MESH:D010532	C06.844.520|C15.604.315.618	C06.844|C15.604.315	Lymphadenitides, Mesenteric|Lymphadenitis, Mesenteric|Mesenteric Lymphadenitides	Digestive system disease|Lymphatic disease
Mesenteric Vascular Occlusion	MESH:D008641	DO:DOID:13252	Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6)	MESH:D001157|MESH:D007410|MESH:D010532	C06.405.469.675|C06.844.550|C14.907.137.534	C06.405.469|C06.844|C14.907.137	Mesenteric Vascular Occlusions|Occlusion, Mesenteric Vascular|Occlusions, Mesenteric Vascular|Vascular Occlusion, Mesenteric|Vascular Occlusions, Mesenteric	Cardiovascular disease|Digestive system disease
Mesomelic Dysplasia, Camera Type	MESH:C567503			MESH:D001848	C05.116.099/C567503	C05.116.099		Musculoskeletal disease
Mesonephroma	MESH:D008649	DO:DOID:4468	A rare tumor of the female genital tract, most often the ovary, formerly considered to be derived from mesonephric rests. Two varieties are recognized: (1) clear cell carcinoma, so called because of its histologic resemblance to renal cell carcinoma, and now considered to be of muellerian duct derivation and (2) an embryonal tumor (called also ENDODERMAL SINUS TUMOR and yolk sac tumor), occurring chiefly in children. The latter variety may also arise in the testis. (Dorland, 27th ed)	MESH:D009373	C04.557.465.510	C04.557.465	Mesonephromas	Cancer
Mesothelioma	MESH:D008654	DO:DOID:2645	A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)	MESH:D000236|MESH:D018301	C04.557.470.035.510|C04.557.470.660.510	C04.557.470.035|C04.557.470.660	Mesotheliomas	Cancer
Mesothelioma, Cystic	MESH:D018261		A peritoneal mesothelioma affecting mainly young females and producing cysts of variable size and number lined by a single layer of benign mesothelial cells. The disease follows a benign course and is compatible with a normal life expectancy, requiring occasionally partial excision or decompression for relief of pain or other symptoms. Malignant potential is exceptional. (From Holland et al., Cancer Medicine, 3d ed, p1345)	MESH:D008654	C04.557.470.035.510.515|C04.557.470.660.510.515	C04.557.470.035.510|C04.557.470.660.510	Cystic Mesothelioma|Cystic Mesotheliomas|Mesotheliomas, Cystic	Cancer
Mesothelioma, Malignant	MESH:D000086002	DO:DOID:1790|DO:DOID:7474|OMIM:156240	A type of mesothelioma with a tendency to metastasize.  Most tumors originate from either the PLEURA or PERITONEUM, tumors may also originate in the PERICARDIUM or testicular tissue. It is associated with ASBESTOS exposure. Somatic mutations identified in WT1, BCL10, CDKN2A, NF2, and BAP1 genes are associated with the malignancy. OMIM: 156240.	MESH:D008175|MESH:D008654|MESH:D010997	C04.557.470.035.510.757|C04.557.470.660.510.757|C04.588.894.797.520.173|C04.588.894.797.640.350|C08.381.540.144|C08.785.520.124|C08.785.640.350	C04.557.470.035.510|C04.557.470.660.510|C04.588.894.797.520|C04.588.894.797.640|C08.381.540|C08.785.520|C08.785.640	Malignant Mesothelioma|Malignant Mesotheliomas|Malignant Pleural Mesothelioma|Malignant Pleural Mesotheliomas|MESOM|Mesothelioma, Malignant Pleural|Mesotheliomas, Malignant|Mesotheliomas, Malignant Pleural|Pleural Mesothelioma, Malignant|Pleural Mesotheliomas, Malignant	Cancer|Respiratory tract disease
Metabolic Diseases	MESH:D008659	DO:DOID:0014667	Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)	MESH:D009750	C18.452	C18	Disease, Metabolic|Diseases, Metabolic|Metabolic Disease|Thesaurismoses|Thesaurismosis	Metabolic disease
Metabolic Side Effects of Drugs and Substances	MESH:D065606		Specific effects of drugs and substances on metabolic pathways such as those occurring through the CYTOCHROME P-450 ENZYME SYSTEM. These include effects that often result in DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; and HERB-DRUG INTERACTIONS.	MESH:D064420	C25.100.812	C25.100	Drug Effects on Metabolism|Metabolic Side Effects of Drugs|Metabolic Side Effects of Substances|Substance Effects on Metabolism	
Metabolic Syndrome	MESH:D024821	DO:DOID:14221	A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.	MESH:D007333|MESH:D008659	C18.452.394.968.500.570|C18.452.625	C18.452|C18.452.394.968.500	Cardiometabolic Syndrome|Cardiometabolic Syndromes|Cardiovascular Syndrome, Metabolic|Cardiovascular Syndromes, Metabolic|Dysmetabolic Syndrome X|Insulin Resistance Syndrome X|Metabolic Cardiovascular Syndrome|Metabolic Syndromes|Metabolic Syndrome X|Metabolic X Syndrome|Reaven Syndrome X|Syndrome, Cardiometabolic|Syndrome, Metabolic|Syndrome, Metabolic Cardiovascular|Syndrome, Metabolic X|Syndromes, Cardiometabolic|Syndromes, Metabolic|Syndrome X, Dysmetabolic|Syndrome X, Insulin Resistance|Syndrome X, Metabolic|Syndrome X, Reaven|X Syndrome, Metabolic	Metabolic disease
Metaphyseal Dysostosis, Mental Retardation, and Conductive Deafness	MESH:C565396			MESH:D004413|MESH:D006314|MESH:D008607	C05.116.099.370/C565396|C09.218.458.341.562/C565396|C10.597.606.360/C565396|C10.597.751.418.341.562/C565396|C23.888.592.604.646/C565396|C23.888.592.763.393.341.562/C565396|F03.625.539/C565396	C05.116.099.370|C09.218.458.341.562|C10.597.606.360|C10.597.751.418.341.562|C23.888.592.604.646|C23.888.592.763.393.341.562|F03.625.539		Ear-nose-throat disease|Mental disorder|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Metatarsalgia	MESH:D037061		Pain in the region of the METATARSUS. It can include pain in the METATARSAL BONES; METATARSOPHALANGEAL JOINT; and/or intermetatarsal joints (TARSAL JOINTS).	MESH:D005534|MESH:D007592|MESH:D010146	C05.360.500|C05.550.610|C23.888.592.612.540	C05.360|C05.550|C23.888.592.612		Musculoskeletal disease|Signs and symptoms
Metatarsal Valgus	MESH:D000070591		A foot anomaly in which the forefoot is angled outward relative to the hindfoot.	MESH:D005530	C05.330.663	C05.330	Metatarsus Valgus|Out Toeing|Out-Toeing|Out-Toeings|Toeing Out|Toeing Outs	Musculoskeletal disease
Metatarsus Varus	MESH:D000070592		A foot anomaly in which the forefoot (METATARSUS) is angled inward relative to the heel.	MESH:D005530	C05.330.711	C05.330	Adductovarus, Metatarsus|Adductus, Metatarsus|In Toeing|In-Toeing|Metatarsal Varus|Metatarsus Adductovarus|Metatarsus Adductus|Pigeon Toed|Pigeon-Toed|Toed, Pigeon|Toeing In|Varus, Metatarsal|Varus, Metatarsus	Musculoskeletal disease
Methemoglobinemia	MESH:D008708	DO:DOID:10783	The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)	MESH:D006402	C15.378.619	C15.378	Methemoglobinemias	Blood disease
Methemoglobinemia, Alpha-Globin Type	MESH:C564194			MESH:D008708	C15.378.619/C564194	C15.378.619		Blood disease
Methemoglobinemia, Beta-Globin Type	MESH:C564192			MESH:D008708	C15.378.619/C564192	C15.378.619		Blood disease
Methemoglobinemia Type IV	MESH:C567102	OMIM:250790		MESH:D008708	C15.378.619/C567102	C15.378.619	ISOLATED 17,20-LYASE DEFICIENCY, PURE|METAG|METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA|Methemoglobinemia due to Deficiency of Cytochrome B5|METHEMOGLOBINEMIA DUE TO DEFICIENCY OF CYTOCHROME b5, FORMERLY|METHEMOGLOBINEMIA TYPE IV, FORMERLY	Blood disease
Metrorrhagia	MESH:D008796		Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.	MESH:D014592	C12.050.351.500.852.691.622|C12.100.250.852.691.622|C23.550.414.993.700	C12.050.351.500.852.691|C12.100.250.852.691|C23.550.414.993	Bleeding Between Periods|Bleeding, Breakthrough|Breakthrough Bleeding|Dysfunctional Uterine Bleeding|Dysfunctional Uterine Bleedings|Intermenstrual Bleeding|Spotting|Uterine Bleeding, Dysfunctional	Pathology (process)|Urogenital disease (female)
Mexican Cardiomelic Dysplasia	MESH:C563087			MESH:D006330|MESH:D017689	C05.660.585.600/C563087|C14.240.400/C563087|C14.280.400/C563087|C16.131.240.400/C563087|C16.131.621.585.600/C563087	C05.660.585.600|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.585.600	Mesoaxial Hexadactyly and Cardiac Malformation	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Meyenburg-Altherr-Uehlinger syndrome	MESH:C537574			MESH:D001168|MESH:D003638|MESH:D011081	C05.182.531/C537574|C05.550.114/C537574|C09.218.458.341.186/C537574|C10.597.751.418.341.186/C537574|C17.300.182.531/C537574|C23.888.592.763.393.341.186/C537574	C05.182.531|C05.550.114|C09.218.458.341.186|C10.597.751.418.341.186|C17.300.182.531|C23.888.592.763.393.341.186	Ashkenazi syndrome|Atrophic polychondritis, cartilagenous arthritic deafness syndrome|Jaksch' syndrome|Jaksch Wartenhorst's syndrome|Von Jaksch Wartenhorst's syndrome	Connective tissue disease|Ear-nose-throat disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Microaneurysm	MESH:D000071071	DO:DOID:11295	Aneurysm of the MICROVASCULATURE. Charcot__ouchard aneurysms are aneurysms of the brain vasculature which is a common cause of CEREBRAL HEMORRHAGE. Retinal microaneurysm is an early diagnostic sign of DIABETIC RETINOPATHY.	MESH:D000783	C14.907.055.817	C14.907.055	Aneurysm, Charcot-Bouchard|Aneurysm, Miliary|Aneurysms, Charcot-Bouchard|Aneurysms, Miliary|Charcot Bouchard Aneurysm|Charcot-Bouchard Aneurysm|Charcot Bouchard Aneurysms|Charcot-Bouchard Aneurysms|Microaneurysm, Retinal|Microaneurysms|Microaneurysms, Retinal|Miliary Aneurysm|Miliary Aneurysms|Retinal Microaneurysm|Retinal Microaneurysms	Cardiovascular disease
Microcephaly seizures mental retardation heart disorders	MESH:C537544			MESH:D000015|MESH:D006330|MESH:D008607|MESH:D008831|MESH:D012640	C05.660.207.620/C537544|C10.500.507.400.500/C537544|C10.597.606.360/C537544|C10.597.742/C537544|C14.240.400/C537544|C14.280.400/C537544|C16.131.077/C537544|C16.131.240.400/C537544|C16.131.621.207.620/C537544|C16.131.666.507.400.500/C537544|C23.888.592.604.646/C537544|C23.888.592.742/C537544|F03.625.539/C537544	C05.660.207.620|C10.500.507.400.500|C10.597.606.360|C10.597.742|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.207.620|C16.131.666.507.400.500|C23.888.592.604.646|C23.888.592.742|F03.625.539	Microcephaly, seizures, mental retardation, congenital heart disease, and skeletal abnormalities	Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Microcephaly with Chemotactic Defect and Transient Hypogammaglobulinemia	MESH:C565381			MESH:D000361|MESH:D008831|MESH:D019066	C05.660.207.620/C565381|C10.500.507.400.500/C565381|C15.378.147.142/C565381|C15.604.515.032/C565381|C16.131.621.207.620/C565381|C16.131.666.507.400.500/C565381|C20.673.088/C565381|C23.550.291.812/C565381	C05.660.207.620|C10.500.507.400.500|C15.378.147.142|C15.604.515.032|C16.131.621.207.620|C16.131.666.507.400.500|C20.673.088|C23.550.291.812		Blood disease|Congenital abnormality|Immune system disease|Lymphatic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)
Microcoria, congenital	MESH:C537550	OMIM:156600		MESH:D011681	C10.597.690/C537550|C11.710/C537550|C23.888.592.708/C537550	C10.597.690|C11.710|C23.888.592.708	CHROMOSOME 13q32 DELETION SYNDROME|Congenital microcoria|Congenital miosis|MCOR|Miosis, congenital|Pinhole pupils	Eye disease|Nervous system disease|Signs and symptoms
Microcystic adnexal carcinoma	MESH:C000632664			MESH:D012878|MESH:D018294	C04.557.470.550/C000632664|C04.588.805/C000632664|C17.800.882/C000632664	C04.557.470.550|C04.588.805|C17.800.882		Cancer|Skin disease
Microphthalmia associated with colobomatous cyst	MESH:C537463			MESH:D003103|MESH:D003560|MESH:D008850	C04.182/C537463|C11.250.110/C537463|C11.250.566/C537463|C11.270.147/C537463|C16.131.384.282/C537463|C16.131.384.666/C537463|C23.300.306/C537463	C04.182|C11.250.110|C11.250.566|C11.270.147|C16.131.384.282|C16.131.384.666|C23.300.306	Microphthalmos bilateral, colobomatous orbital cyst	Cancer|Congenital abnormality|Eye disease|Pathology (anatomical condition)
Microphthalmia, syndromic 2	MESH:C537465	DO:DOID:0111809|OMIM:300166		MESH:D002386|MESH:D006343|MESH:D008850	C11.250.566/C537465|C11.510.245/C537465|C14.240.400.560/C537465|C14.280.400.560/C537465|C16.131.240.400.560/C537465|C16.131.384.666/C537465	C11.250.566|C11.510.245|C14.240.400.560|C14.280.400.560|C16.131.240.400.560|C16.131.384.666	ANOP2, FORMERLY|Cataracts, microphthalmia, radiculomegaly and septal heart defects|MAA2, FORMERLY|Marashi Gorlin syndrome|MCOPS2|Microphthalmia, cataracts, radiculomegaly, and septal heart defects|Oculo facio cardio dental syndrome|Oculofaciocardiodental syndrome|OFCD Syndrome	Cardiovascular disease|Congenital abnormality|Eye disease
Microscopic Polyangiitis	MESH:D055953		A primary systemic vasculitis of small- and some medium-sized vessels. It is characterized by a tropism for kidneys and lungs, positive association with anti-neutrophil cytoplasmic antibodies (ANCA), and a paucity of immunoglobulin deposits in vessel walls.	MESH:D056648|MESH:D059345	C10.228.140.300.275.600|C14.907.253.329.600|C14.907.940.897.249.500|C20.111.193.750	C10.228.140.300.275|C14.907.253.329|C14.907.940.897.249|C20.111.193	Microscopic Polyangiitides|Polyangiitides, Microscopic|Polyangiitis, Microscopic	Cardiovascular disease|Immune system disease|Nervous system disease
Microvascular Angina	MESH:D017566		ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.	MESH:D000787	C14.280.647.187.575|C14.907.585.187.575	C14.280.647.187|C14.907.585.187	Angina, Microvascular|Angina Pectoris with Normal Coronary Arteriogram|Angina Syndrome X|Angina Syndrome Xs|Angina X Syndrome|Angina X Syndromes|Cardiac Syndrome X|Syndrome, Angina X|Syndrome X, Angina|Syndrome X, Cardiac|Syndrome Xs, Angina|X Syndrome, Angina	Cardiovascular disease
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1	OMIM:603933			MESH:D003925|MESH:D003928|MESH:D003930	C11.768.257/603933|C12.050.351.968.419.192/603933|C12.200.777.419.192/603933|C12.950.419.192/603933|C14.907.320.382/603933|C14.907.320/603933|C19.246.099.500.382/603933|C19.246.099.500/603933|C19.246.099.875/603933	C11.768.257|C12.050.351.968.419.192|C12.200.777.419.192|C12.950.419.192|C14.907.320|C14.907.320.382|C19.246.099.500|C19.246.099.500.382|C19.246.099.875	END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO, INCLUDED|MICROVASCULAR COMPLICATIONS OF DIABETES, PROTECTION AGAINST, INCLUDED|MVCD1|NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED|NEUROPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED|NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED|NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO  MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, INCLUDED|PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO|PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED	Cardiovascular disease|Endocrine system disease|Eye disease|Urogenital disease (female)|Urogenital disease (male)
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2	OMIM:612623			MESH:D003925	C14.907.320/612623|C19.246.099.500/612623	C14.907.320|C19.246.099.500	END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO|MVCD2|PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO	Cardiovascular disease|Endocrine system disease
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3	OMIM:612624			MESH:D003925	C14.907.320/612624|C19.246.099.500/612624	C14.907.320|C19.246.099.500	END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO|MVCD3|NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO	Cardiovascular disease|Endocrine system disease
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4	OMIM:612628			MESH:D003925|MESH:D003928	C12.050.351.968.419.192/612628|C12.200.777.419.192/612628|C12.950.419.192/612628|C14.907.320/612628|C19.246.099.500/612628|C19.246.099.875/612628	C12.050.351.968.419.192|C12.200.777.419.192|C12.950.419.192|C14.907.320|C19.246.099.500|C19.246.099.875	MVCD4|NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO	Cardiovascular disease|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5	OMIM:612633			MESH:D003925|MESH:D003928	C12.050.351.968.419.192/612633|C12.200.777.419.192/612633|C12.950.419.192/612633|C14.907.320/612633|C19.246.099.500/612633|C19.246.099.875/612633	C12.050.351.968.419.192|C12.200.777.419.192|C12.950.419.192|C14.907.320|C19.246.099.500|C19.246.099.875	MVCD5|RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO	Cardiovascular disease|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6	OMIM:612634			MESH:D003925|MESH:D003928	C12.050.351.968.419.192/612634|C12.200.777.419.192/612634|C12.950.419.192/612634|C14.907.320/612634|C19.246.099.500/612634|C19.246.099.875/612634	C12.050.351.968.419.192|C12.200.777.419.192|C12.950.419.192|C14.907.320|C19.246.099.500|C19.246.099.875	MVCD6|NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO	Cardiovascular disease|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7	OMIM:612635			MESH:D003925	C14.907.320/612635|C19.246.099.500/612635	C14.907.320|C19.246.099.500	MVCD7|NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO|NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO|PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO	Cardiovascular disease|Endocrine system disease
Middle East respiratory syndrome vaccine	MESH:C000705427			MESH:D018352	C01.925.782.600.550.200/C000705427	C01.925.782.600.550.200	ChAdOx1 MERS|ChAdOx1 MERS vaccine|Middle East respiratory syndrome vaccine ChAdOx1 MERS	Viral disease
Middle Lobe Syndrome	MESH:D008878	DO:DOID:2810	Atelectasis of the right middle pulmonary lobe, with chronic pneumonitis. (Dorland, 27th ed)	MESH:D001261	C08.381.730.542	C08.381.730	Brock's Syndrome|Brocks Syndrome|Brock Syndrome|Syndrome, Brock's|Syndromes, Middle Lobe	Respiratory tract disease
Midline granulomatosis	MESH:C538667			MESH:D014890	C08.381.483.950/C538667|C14.907.940.897.249.750/C538667|C20.111.193.875/C538667	C08.381.483.950|C14.907.940.897.249.750|C20.111.193.875		Cardiovascular disease|Immune system disease|Respiratory tract disease
Midphalangeal hair	MESH:C537471			MESH:D006983	C17.800.329.875/C537471	C17.800.329.875	Middigital hair	Skin disease
Migraine Disorders	MESH:D008881	DO:DOID:6364	A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)	MESH:D051270	C10.228.140.546.399.750	C10.228.140.546.399	Abdominal Migraine|Abdominal Migraines|Acute Confusional Migraine|Acute Confusional Migraines|Cervical Migraine Syndrome|Cervical Migraine Syndromes|Disorder, Migraine|Disorders, Migraine|Headache, Migraine|Headache, Sick|Headaches, Migraine|Headaches, Sick|Hemicrania Migraine|Hemicrania Migraines|Migraine|Migraine, Abdominal|Migraine, Acute Confusional|Migraine Disorder|Migraine Headache|Migraine Headaches|Migraine, Hemicrania|Migraines|Migraines, Abdominal|Migraines, Acute Confusional|Migraines, Hemicrania|Migraine Syndrome, Cervical|Migraine Syndromes, Cervical|Migraine Variant|Migraine Variants|Sick Headache|Sick Headaches|Status Migrainosus|Variant, Migraine|Variants, Migraine	Nervous system disease
Migraine, Familial Basilar	MESH:C566540			MESH:D008881	C10.228.140.546.399.750/C566540	C10.228.140.546.399.750		Nervous system disease
Migraine, Familial Hemiplegic, 3	MESH:C566500	OMIM:609634		MESH:D008881	C10.228.140.546.399.750/C566500	C10.228.140.546.399.750	FHM3	Nervous system disease
Migraine, Familial Hemiplegic, 4	MESH:C564385			MESH:D008881	C10.228.140.546.399.750/C564385	C10.228.140.546.399.750		Nervous system disease
Migraine, Sporadic Hemiplegic	MESH:C563405			MESH:D020325	C10.228.140.546.399.750.250/C563405	C10.228.140.546.399.750.250		Nervous system disease
Migraine with Aura	MESH:D020325	DO:DOID:10024|OMIM:609179|OMIM:609670	A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)	MESH:D008881	C10.228.140.546.399.750.250	C10.228.140.546.399.750	Acute Onset Aura Migraine|Basilar Artery Migraine|Basilar Migraine|Basilar Migraines|Basilar Type Migraine|Basilar-Type Migraine|Classical Migraine|Classic Migraine|Complicated Migraine|Familial Hemiplegic Migraine|Familial Hemiplegic Migraines|Hemiplegic Migraine, Familial|Hemiplegic-Ophthalmoplegic Migraine|MGR7|MGR9|Migraine Aura without Headache|Migraine, Basilar|Migraine, Basilar Artery|Migraine, Basilar-Type|Migraine, Classic|Migraine, Classical|Migraine, Complicated|Migraine, Prolonged Aura|Migraine with Acute Onset Aura|Migraine with Auras|MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 7|MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 9|Migraine with Prolonged Aura|Migraine with Typical Aura|Prolonged Aura Migraine|Typical Aura without Headache	Nervous system disease
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	OMIM:157300	DO:DOID:6364		MESH:D020325|MESH:D020326	C10.228.140.546.399.750.250/157300|C10.228.140.546.399.750.450/157300	C10.228.140.546.399.750.250|C10.228.140.546.399.750.450	MA|MGAU|MGR1|MIGRAINE	Nervous system disease
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12	OMIM:611706			MESH:D020325|MESH:D020326	C10.228.140.546.399.750.250/611706|C10.228.140.546.399.750.450/611706	C10.228.140.546.399.750.250|C10.228.140.546.399.750.450	MGR12	Nervous system disease
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13	OMIM:613656			MESH:D020325|MESH:D020326	C10.228.140.546.399.750.250/613656|C10.228.140.546.399.750.450/613656	C10.228.140.546.399.750.250|C10.228.140.546.399.750.450	MGR13	Nervous system disease
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 2	OMIM:300125			MESH:D020325|MESH:D020326	C10.228.140.546.399.750.250/300125|C10.228.140.546.399.750.450/300125	C10.228.140.546.399.750.250|C10.228.140.546.399.750.450	MFTS|MGR2	Nervous system disease
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	OMIM:607498			MESH:D020325|MESH:D020326	C10.228.140.546.399.750.250/607498|C10.228.140.546.399.750.450/607498	C10.228.140.546.399.750.250|C10.228.140.546.399.750.450	MGR3	Nervous system disease
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	OMIM:607508			MESH:D020325|MESH:D020326	C10.228.140.546.399.750.250/607508|C10.228.140.546.399.750.450/607508	C10.228.140.546.399.750.250|C10.228.140.546.399.750.450	MGR5	Nervous system disease
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	OMIM:607516			MESH:D020325|MESH:D020326	C10.228.140.546.399.750.250/607516|C10.228.140.546.399.750.450/607516	C10.228.140.546.399.750.250|C10.228.140.546.399.750.450	FHM4, INCLUDED|MGR6 MIGRAINE, FAMILIAL HEMIPLEGIC, 4, INCLUDED	Nervous system disease
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 8	OMIM:609570			MESH:D020325|MESH:D020326	C10.228.140.546.399.750.250/609570|C10.228.140.546.399.750.450/609570	C10.228.140.546.399.750.250|C10.228.140.546.399.750.450	MGR8	Nervous system disease
Migraine without Aura	MESH:D020326	DO:DOID:12783|OMIM:607501	Recurrent unilateral pulsatile headaches, not preceded or accompanied by an aura, in attacks lasting 4-72 hours. It is characterized by PAIN of moderate to severe intensity; aggravated by physical activity; and associated with NAUSEA and / or PHOTOPHOBIA and PHONOPHOBIA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)	MESH:D008881	C10.228.140.546.399.750.450	C10.228.140.546.399.750	Common Migraine|Common Migraines|MGOA|MGR4|Migraine, Common|Migraines, Common|MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	Nervous system disease
Milia, Multiple Eruptive	MESH:C562823			MESH:D007642	C17.800.428/C562823	C17.800.428	Multiple eruptive milia	Skin disease
Miliaria	MESH:D008883	DO:DOID:11153|DO:DOID:1382	A syndrome of cutaneous changes associated with sweat retention and extravasation of sweat at different levels in the skin. Miliaria rubra, or prickly heat, results from apocrine duct obstruction. The sweat then seeps into the epidermis, producing pruritic erythematous papulovesicles. (From Dorland, 27th ed)	MESH:D013543	C17.800.946.492	C17.800.946	Heat, Prickly|Miliaria Rubra|Prickly Heat	Skin disease
Milk Hypersensitivity	MESH:D016269	DO:DOID:4376	Allergic reaction to milk (usually cow's milk) or milk products. MILK HYPERSENSITIVITY should be differentiated from LACTOSE INTOLERANCE, an intolerance to milk as a result of congenital deficiency of lactase.	MESH:D005512	C20.543.480.370.500	C20.543.480.370	Allergy, Cow's Milk|Allergy, Milk|Cow Milk Allergy|Cow's Milk Allergies|Cow's Milk Allergy|Cows Milk Allergy|Cow's Milk Protein Allergy|Hypersensitivity, Milk|Milk Allergies|Milk Allergy|Milk Allergy, Cow's|Milk Hypersensitivities	Immune system disease
Milk Sickness	MESH:D018602		An acute, often fatal disease caused by the ingestion of milk, milk products, or the flesh of cattle or sheep which have a disease known as trembles. It is marked by weakness, anorexia, vomiting, constipation, and sometimes muscular tremors. It is caused by poisoning by white snakeroot (Eupatorium rugosum) and the rayless goldenrod (Haplopappus heterophyllus). (From Dorland, 27th ed)	MESH:D010939	C25.723.756.600	C25.723.756	Sickness, Milk	
Miller Fisher Syndrome	MESH:D019846	DO:DOID:12889	A variant of the GUILLAIN-BARRE SYNDROME characterized by the acute onset of oculomotor dysfunction, ataxia, and loss of deep tendon reflexes with relative sparing of strength in the extremities and trunk. The ataxia is produced by peripheral sensory nerve dysfunction and not by cerebellar injury. Facial weakness and sensory loss may also occur. The process is mediated by autoantibodies directed against a component of myelin found in peripheral nerves. (Adams et al., Principles of Neurology, 6th ed, p1313; Neurology 1987 Sep;37(9):1493-8)	MESH:D002526|MESH:D015835|MESH:D020275	C10.114.750.100.500|C10.228.140.252.500|C10.292.562.350|C10.314.750.450.500|C10.668.829.350.500|C10.668.829.800.750.300.500|C11.590.312|C20.111.258.750.400.500	C10.114.750.100|C10.228.140.252|C10.292.562|C10.314.750.450|C10.668.829.350|C10.668.829.800.750.300|C11.590|C20.111.258.750.400	Fisher Syndrome|Guillain Barre Syndrome, Miller Fisher Variant|Guillain-Barre Syndrome, Miller Fisher Variant|Miller-Fisher Syndrome|Miller Fisher Variant of Guillain Barre Syndrome|Ophthalmoplegia, Ataxia and Areflexia Syndrome|Syndrome, Fisher|Syndrome, Miller Fisher|Syndrome, Miller-Fisher	Eye disease|Immune system disease|Nervous system disease
Minicore Myopathy, Moderate, with Hand Involvement	MESH:C566147			MESH:D020512	C05.651.575.300/C566147|C10.668.491.550.300/C566147	C05.651.575.300|C10.668.491.550.300	Multicore Myopathy, Moderate, with Hand Involvement|Multiminicore Disease, Moderate, with Hand Involvement	Musculoskeletal disease|Nervous system disease
Minicore Myopathy with External Ophthalmoplegia	MESH:C564969	OMIM:255320		MESH:D009886|MESH:D020914	C05.651.575/C564969|C10.292.562.750/C564969|C10.597.622.447/C564969|C10.668.491.550/C564969|C11.590.472/C564969|C23.888.592.636.447/C564969	C05.651.575|C10.292.562.750|C10.597.622.447|C10.668.491.550|C11.590.472|C23.888.592.636.447	Minicore Disease|Minicore Myopathy|Multicore Disease|Multicore Myopathy|Multicore Myopathy With External Ophthalmoplegia|Multiminicore Disease|Multi-Minicore Disease|Multiminicore Disease With External Ophthalmoplegia|Multiminicore Myopathy|MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	Eye disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
MINOCA	MESH:D000088442		Myocardial infarction in the absence of obstructive coronary artery disease. CORONARY CIRCULATION disruption is due to various other factors such as ATHEROSCLEROTIC PLAQUE and CORONARY VASOSPASM.	MESH:D009203	C14.280.647.500.328|C14.907.585.500.422|C23.550.513.355.750.328|C23.550.717.489.750.328	C14.280.647.500|C14.907.585.500|C23.550.513.355.750|C23.550.717.489.750	Myocardial Infarction and Non obstructed Coronary Arteries|Myocardial Infarction and Non-obstructed Coronary Arteries|Myocardial Infarction and Nonobstructed Coronary Arteries|Myocardial Infarction with Non obstructive Coronary Arteries|Myocardial Infarction with Non-obstructive Coronary Arteries|Myocardial Infarction with Nonobstructive Coronary Arteries	Cardiovascular disease|Pathology (process)
Miosis	MESH:D015877		Pupillary constriction. This may result from congenital absence of the dilatator pupillary muscle, defective sympathetic innervation, or irritation of the CONJUNCTIVA or CORNEA.	MESH:D011681	C10.597.690.362|C11.710.528|C23.888.592.708.362	C10.597.690|C11.710|C23.888.592.708	Constricted Pupil|Constricted Pupils|Mioses|Mioses, Persistent|Mioses, Pupillary|Miosis, Persistent|Miosis, Pupillary|Persistent Mioses|Persistent Miosis|Pupil, Constricted|Pupillary Mioses|Pupillary Miosis|Pupils, Constricted|Pupil, Small|Pupils, Small|Small Pupil|Small Pupils	Eye disease|Nervous system disease|Signs and symptoms
MIRAGE SYNDROME	OMIM:617053			MESH:D000309|MESH:D006130|MESH:D007239|MESH:D007410|MESH:D009190|MESH:D014564	C01/617053|C06.405.469/617053|C12.050.351.875/617053|C12.200.706/617053|C12.800/617053|C15.378.190.625/617053|C16.131.939/617053|C19.053.500/617053|C23.550.393/617053	C01|C06.405.469|C12.050.351.875|C12.200.706|C12.800|C15.378.190.625|C16.131.939|C19.053.500|C23.550.393	MIRAGE|MYELODYSPLASIA, INFECTION, RESTRICTION OF GROWTH, ADRENAL HYPOPLASIA, GENITAL PHENOTYPES, AND ENTEROPATHY	Blood disease|Congenital abnormality|Digestive system disease|Endocrine system disease|Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
MIRROR MOVEMENTS 1	OMIM:157600			MESH:D020820	C10.228.662.262/157600|C10.597.350/157600|C23.888.592.350/157600	C10.228.662.262|C10.597.350|C23.888.592.350	BIMANUAL SYNERGIA|MIRROR MOVEMENTS 1 AND/OR AGENESIS OF THE CORPUS CALLOSUM|MIRROR MOVEMENTS, CONGENITAL|MRMV1	Nervous system disease|Signs and symptoms
MIRROR MOVEMENTS 2	OMIM:614508			MESH:D020820	C10.228.662.262/614508|C10.597.350/614508|C23.888.592.350/614508	C10.228.662.262|C10.597.350|C23.888.592.350	MRMV2	Nervous system disease|Signs and symptoms
MIRROR MOVEMENTS 3	OMIM:616059			MESH:D020820	C10.228.662.262/616059|C10.597.350/616059|C23.888.592.350/616059	C10.228.662.262|C10.597.350|C23.888.592.350	MRMV3	Nervous system disease|Signs and symptoms
Mitochondrial complex I deficiency	MESH:C537475	DO:DOID:0060536|OMIM:252010		MESH:D028361	C18.452.660/C537475	C18.452.660	MC1DN1|MITOCHONDRIAL COMPLEX I DEFICIENCY|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1|Mitochondrial NADH dehydrogenase component of complex I, deficiency of|Nadh-Coenzyme Q Reductase Deficiency|NADH coenzyme q reductase deficiency|NADH:Q(1) Oxidoreductase deficiency	Metabolic disease
Mitochondrial Complex III Deficiency	MESH:C565128	OMIM:615157|OMIM:615158|OMIM:615159|OMIM:615160|OMIM:615453|OMIM:615824|OMIM:615838|OMIM:616111		MESH:D028361	C18.452.660/C565128	C18.452.660	MC3DN2|MC3DN3|MC3DN4|MC3DN5|MC3DN6|MC3DN7|MC3DN8|MC3DN9|MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2|MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3|MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4|MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5|MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6|MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7|MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8|MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	Metabolic disease
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	OMIM:124000	DO:DOID:0080111		MESH:C565128	C18.452.660/C565128/124000	C18.452.660/C565128	MC3DN1	Metabolic disease
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1	OMIM:604273	DO:DOID:0050768		MESH:D028361	C18.452.660/604273	C18.452.660	MC5DN1|MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATPAF2 TYPE	Metabolic disease
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2	OMIM:614052	DO:DOID:0060331		MESH:D028361	C18.452.660/614052	C18.452.660	ENCEPHALOCARDIOMYOPATHY, MITOCHONDRIAL, NEONATAL, DUE TO ATP SYNTHASE DEFICIENCY|MC5DN2|MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, TMEM70 TYPE	Metabolic disease
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3	OMIM:614053	DO:DOID:0060332		MESH:D028361	C18.452.660/614053	C18.452.660	MC5DN3|MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	Metabolic disease
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4	OMIM:615228	DO:DOID:0060333		MESH:D028361	C18.452.660/615228	C18.452.660	MC5DN4|MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5A1 TYPE	Metabolic disease
Mitochondrial cytopathy	MESH:C540770			MESH:D007625|MESH:D017240	C05.651.460.700.500/C540770|C05.651.460/C540770|C10.292.562.750.250.500/C540770|C10.597.622.447.511.500/C540770|C10.668.491.500.700.500/C540770|C10.668.491.500/C540770|C11.590.472.250.500/C540770|C11.768.585.658.500.627/C540770|C14.280.238.510/C540770|C18.452.660.560.700.500/C540770|C18.452.660.560/C540770|C23.550.291.500.688.500/C540770|C23.888.592.636.447.511.500/C540770	C05.651.460|C05.651.460.700.500|C10.292.562.750.250.500|C10.597.622.447.511.500|C10.668.491.500|C10.668.491.500.700.500|C11.590.472.250.500|C11.768.585.658.500.627|C14.280.238.510|C18.452.660.560|C18.452.660.560.700.500|C23.550.291.500.688.500|C23.888.592.636.447.511.500		Cardiovascular disease|Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Mitochondrial Diseases	MESH:D028361	DO:DOID:700	Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.	MESH:D008659	C18.452.660	C18.452	Deficiencies, Oxidative Phosphorylation|Deficiencies, Respiratory Chain|Deficiency, Oxidative Phosphorylation|Deficiency, Respiratory Chain|Disease, Mitochondrial|Disorder, Mitochondrial|Disorders, Mitochondrial|Electron Transport Chain Deficiencies, Mitochondrial|Mitochondrial Disease|Mitochondrial Disorder|Mitochondrial Disorders|Mitochondrial Electron Transport Chain Deficiencies|Mitochondrial Respiratory Chain Deficiencies|Oxidative Phosphorylation Deficiencies|Oxidative Phosphorylation Deficiency|Phosphorylation Deficiencies, Oxidative|Phosphorylation Deficiency, Oxidative|Respiratory Chain Deficiencies, Mitochondrial|Respiratory Chain Deficiency	Metabolic disease
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	OMIM:615084	DO:DOID:0080129		MESH:D017240	C05.651.460/615084|C10.668.491.500/615084|C18.452.660.560/615084	C05.651.460|C10.668.491.500|C18.452.660.560	MTDPS11	Metabolic disease|Musculoskeletal disease|Nervous system disease
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT	OMIM:617184	DO:DOID:0080130		MESH:D017240	C05.651.460/617184|C10.668.491.500/617184|C18.452.660.560/617184	C05.651.460|C10.668.491.500|C18.452.660.560	MTDPS12A	Metabolic disease|Musculoskeletal disease|Nervous system disease
MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE	OMIM:615418	DO:DOID:0080335		MESH:D017240	C05.651.460/615418|C10.668.491.500/615418|C18.452.660.560/615418	C05.651.460|C10.668.491.500|C18.452.660.560	MTDPS12B	Metabolic disease|Musculoskeletal disease|Nervous system disease
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE)	OMIM:615471	DO:DOID:0080131		MESH:D017240	C05.651.460/615471|C10.668.491.500/615471|C18.452.660.560/615471	C05.651.460|C10.668.491.500|C18.452.660.560	MTDPS13	Metabolic disease|Musculoskeletal disease|Nervous system disease
MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE)	OMIM:616896	DO:DOID:0080336		MESH:D017240	C05.651.460/616896|C10.668.491.500/616896|C18.452.660.560/616896	C05.651.460|C10.668.491.500|C18.452.660.560	MTDPS14	Metabolic disease|Musculoskeletal disease|Nervous system disease
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE)	OMIM:617156	DO:DOID:0080337		MESH:D017240	C05.651.460/617156|C10.668.491.500/617156|C18.452.660.560/617156	C05.651.460|C10.668.491.500|C18.452.660.560	MTDPS15	Metabolic disease|Musculoskeletal disease|Nervous system disease
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	OMIM:609560	DO:DOID:0080120		MESH:C563698	C05.651/C563698/609560|C10.668.491/C563698/609560|C18.452.660/C563698/609560	C05.651/C563698|C10.668.491/C563698|C18.452.660/C563698	MITOCHONDRIAL DNA DEPLETION MYOPATHY, TK2-RELATED|MTDPS2	Metabolic disease|Musculoskeletal disease|Nervous system disease
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	OMIM:251880	DO:DOID:0080121		MESH:D006501|MESH:D028361	C06.552.308.500.356/251880|C10.228.140.163.360/251880|C18.452.132.360/251880|C18.452.660/251880	C06.552.308.500.356|C10.228.140.163.360|C18.452.132.360|C18.452.660	MTDPS3	Digestive system disease|Metabolic disease|Nervous system disease
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	OMIM:203700	DO:DOID:0080122		MESH:D002549|MESH:D008103|MESH:D028361	C06.552.630/203700|C10.114.375.112/203700|C10.228.140.400/203700|C10.228.140.695.562.112/203700|C10.314.350.112/203700|C18.452.660/203700|C20.111.258.250.175/203700|C23.550.355.412/203700	C06.552.630|C10.114.375.112|C10.228.140.400|C10.228.140.695.562.112|C10.314.350.112|C18.452.660|C20.111.258.250.175|C23.550.355.412	ALPERS DIFFUSE DEGENERATION OF CEREBRAL GRAY MATTER WITH HEPATIC CIRRHOSIS|ALPERS-HUTTENLOCHER SYNDROME|ALPERS PROGRESSIVE INFANTILE POLIODYSTROPHY|ALPERS SYNDROME|MTDPS4A|NEURONAL DEGENERATION OF CHILDHOOD WITH LIVER DISEASE, PROGRESSIVE|PNDC	Digestive system disease|Immune system disease|Metabolic disease|Nervous system disease|Pathology (process)
Mitochondrial DNA Depletion Syndrome, Hepatocerebral Form, Autosomal Recessive	MESH:C567608			MESH:D017240	C05.651.460/C567608|C10.668.491.500/C567608|C18.452.660.560/C567608	C05.651.460|C10.668.491.500|C18.452.660.560		Metabolic disease|Musculoskeletal disease|Nervous system disease
Mitochondrial DNA Depletion Syndrome, Myopathic Form	MESH:C563698	DO:DOID:0080120		MESH:D009135|MESH:D028361	C05.651/C563698|C10.668.491/C563698|C18.452.660/C563698	C05.651|C10.668.491|C18.452.660	Mitochondrial DNA Depletion Myopathy, Autosomal Recessive	Metabolic disease|Musculoskeletal disease|Nervous system disease
Mitochondrial Encephalomyopathies	MESH:D017237	DO:DOID:890	A heterogenous group of disorders characterized by alterations of mitochondrial metabolism that result in muscle and nervous system dysfunction. These are often multisystemic and vary considerably in age at onset (usually in the first or second decade of life), distribution of affected muscles, severity, and course. (From Adams et al., Principles of Neurology, 6th ed, pp984-5)	MESH:D001928|MESH:D017240	C05.651.460.620|C10.228.140.163.540|C10.668.491.500.500|C18.452.132.540|C18.452.660.560.620	C05.651.460|C10.228.140.163|C10.668.491.500|C18.452.132|C18.452.660.560	Encephalomyopathies, Mitochondrial|Encephalomyopathy, Mitochondrial|Mitochondrial Encephalomyopathy	Metabolic disease|Musculoskeletal disease|Nervous system disease
Mitochondrial encephalopathy	MESH:C538525			MESH:D017237	C05.651.460.620/C538525|C10.228.140.163.540/C538525|C10.668.491.500.500/C538525|C18.452.132.540/C538525|C18.452.660.560.620/C538525	C05.651.460.620|C10.228.140.163.540|C10.668.491.500.500|C18.452.132.540|C18.452.660.560.620		Metabolic disease|Musculoskeletal disease|Nervous system disease
Mitochondrial Myopathies	MESH:D017240	DO:DOID:699|OMIM:251900	A group of muscle diseases associated with abnormal mitochondria function.	MESH:D009135|MESH:D028361	C05.651.460|C10.668.491.500|C18.452.660.560	C05.651|C10.668.491|C18.452.660	Disease, Luft|Disease, Luft's|Luft Disease|Luft's Disease|Lufts Disease|Megaconial Myopathies|Megaconial Myopathy|MEOAL|Mitochondrial Myopathy|MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY|Myopathies, Mitochondrial|Myopathies, Pleoconial|Myopathy, Megaconial|Myopathy, Pleoconial|Pleoconial Myopathies|Pleoconial Myopathy	Metabolic disease|Musculoskeletal disease|Nervous system disease
Mitochondrial Myopathy with a Defect in Mitochondrial Protein Transport	MESH:C565376			MESH:D017240	C05.651.460/C565376|C10.668.491.500/C565376|C18.452.660.560/C565376	C05.651.460|C10.668.491.500|C18.452.660.560		Metabolic disease|Musculoskeletal disease|Nervous system disease
Mitochondrial Myopathy with Diabetes	MESH:C564026			MESH:D003920|MESH:D017240	C05.651.460/C564026|C10.668.491.500/C564026|C18.452.394.750/C564026|C18.452.660.560/C564026|C19.246/C564026	C05.651.460|C10.668.491.500|C18.452.394.750|C18.452.660.560|C19.246	Mitochondrial Myopathy, Lipid Type	Endocrine system disease|Metabolic disease|Musculoskeletal disease|Nervous system disease
Mitochondrial myopathy with lactic acidosis	MESH:C537476	OMIM:251950		MESH:D000140|MESH:D006130|MESH:D006313|MESH:D017240	C05.651.460/C537476|C09.218.458.341.887.432/C537476|C09.218.807.186.432/C537476|C10.228.140.068.432/C537476|C10.597.751.418.341.887.432/C537476|C10.668.491.500/C537476|C18.452.076.176.180/C537476|C18.452.660.560/C537476|C23.550.393/C537476|C23.888.592.763.393.341.887.432/C537476	C05.651.460|C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.751.418.341.887.432|C10.668.491.500|C18.452.076.176.180|C18.452.660.560|C23.550.393|C23.888.592.763.393.341.887.432	MMLA	Ear-nose-throat disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Mitochondrial Phosphate Carrier Deficiency	MESH:C563665	OMIM:610773		MESH:D028361	C18.452.660/C563665	C18.452.660	MPCD|NEONATAL HYPERTROPHIC CARDIOMYOPATHY, RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND LACTIC ACIDOSIS	Metabolic disease
Mitral Valve Insufficiency	MESH:D008944	DO:DOID:11502	Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.	MESH:D006349	C14.280.484.461	C14.280.484	Incompetence, Mitral|Incompetence, Mitral Valve|Insufficiency, Mitral|Insufficiency, Mitral Valve|Mitral Incompetence|Mitral Insufficiency|Mitral Regurgitation|Mitral Valve Incompetence|Mitral Valve Regurgitation|Regurgitation, Mitral|Regurgitation, Mitral Valve|Valve Incompetence, Mitral|Valve Insufficiency, Mitral|Valve Regurgitation, Mitral	Cardiovascular disease
Mitral Valve Prolapse	MESH:D008945	DO:DOID:988	Abnormal protrusion or billowing of one or both of the leaflets of MITRAL VALVE into the LEFT ATRIUM during SYSTOLE. This allows the backflow of blood into left atrium leading to MITRAL VALVE INSUFFICIENCY; SYSTOLIC MURMURS; or CARDIAC ARRHYTHMIA.	MESH:D016127	C14.280.484.400.500	C14.280.484.400	Click Murmur Syndrome|Click-Murmur Syndrome|Click-Murmur Syndrome, Mitral|Click-Murmur Syndromes|Click-Murmur Syndrome, Systolic|Floppy Mitral Valve|Floppy Mitral Valves|Mitral Click Murmur Syndrome|Mitral Click-Murmur Syndrome|Mitral Valve, Floppy|Mitral Valve, Prolapsed|Mitral Valve Prolapses|Mitral Valve Prolapse Syndrome|Mitral Valves, Floppy|Mitral Valves, Prolapsed|Prolapsed Mitral Valve|Prolapsed Mitral Valves|Prolapse, Mitral Valve|Prolapses, Mitral Valve|Syndrome, Click-Murmur|Syndrome, Mitral Click-Murmur|Syndromes, Click-Murmur|Syndrome, Systolic Click-Murmur|Systolic Click Murmur Syndrome|Systolic Click-Murmur Syndrome|Valve, Prolapsed Mitral|Valve Prolapse, Mitral|Valve Prolapses, Mitral|Valves, Prolapsed Mitral	Cardiovascular disease
MITRAL VALVE PROLAPSE 1	OMIM:157700	DO:DOID:988		MESH:D008945	C14.280.484.400.500/157700	C14.280.484.400.500	BARLOW SYNDROME|CLICK-MURMUR SYNDROME|FLOPPY MITRAL VALVE|MITRAL REGURGITATION, FAMILIAL|MITRAL VALVE PROLAPSE, FAMILIAL;MVP PROLAPSED MITRAL VALVE|MITRAL VALVE PROLAPSE, MYXOMATOUS 1|MMVP1|MVP1|MYXOMATOUS MITRAL VALVE PROLAPSE 1|MYXOMATOUS VALVULAR DISEASE, FAMILIAL|PMV	Cardiovascular disease
Mitral Valve Prolapse, Myxomatous 1	MESH:C563573			MESH:D008945	C14.280.484.400.500/C563573	C14.280.484.400.500	Myxomatous Mitral Valve Prolapse 1	Cardiovascular disease
Mitral Valve Prolapse, Myxomatous 2	MESH:C564326	OMIM:607829		MESH:D008945	C14.280.484.400.500/C564326	C14.280.484.400.500	MITRAL VALVE PROLAPSE 2|MITRAL VALVE PROLAPSE, MYXOMATOUS 2|MMVP2|MVP2|Myxomatous Mitral Valve Prolapse 2	Cardiovascular disease
Mitral Valve Prolapse, Myxomatous 3	MESH:C563655	OMIM:610840		MESH:D008945	C14.280.484.400.500/C563655	C14.280.484.400.500	MITRAL VALVE PROLAPSE 3|MITRAL VALVE PROLAPSE, MYXOMATOUS 3|MMVP3|MVP3|Myxomatous Mitral Valve Prolapse 3	Cardiovascular disease
Mitral Valve Stenosis	MESH:D008946	DO:DOID:1754	Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.	MESH:D006349	C14.280.484.517	C14.280.484	Mitral Stenoses|Mitral Stenosis|Mitral Valve Stenoses|Stenoses, Mitral|Stenoses, Mitral Valve|Stenosis, Mitral|Stenosis, Mitral Valve|Valve Stenoses, Mitral|Valve Stenosis, Mitral	Cardiovascular disease
Mixed Connective Tissue Disease	MESH:D008947	DO:DOID:3492	A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a 'speckled' epidermal nuclear staining pattern on direct immunofluorescence.	MESH:D003240	C17.300.540	C17.300	Connective Tissue Disease, Mixed|MCTD|Sharp Syndrome|Syndrome, Sharp	Connective tissue disease
Mixed sclerosing bone dystrophy	MESH:C537479			MESH:D010026	C05.116.099.708.702/C537479	C05.116.099.708.702		Musculoskeletal disease
Mixed Tumor, Malignant	MESH:D018198	DO:DOID:154	A malignant tumor composed of more than one type of neoplastic tissue. (Dorland, 27th ed)	MESH:D018193	C04.557.435.525	C04.557.435	Malignant Mixed Tumor|Malignant Mixed Tumors|Mixed Tumors, Malignant|Tumor, Malignant Mixed|Tumors, Malignant Mixed	Cancer
Mixed Tumor, Mesodermal	MESH:D018199	DO:DOID:4236	A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20% of patients. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1702)	MESH:D012509|MESH:D018193	C04.557.435.530|C04.557.450.795.530	C04.557.435|C04.557.450.795	Mesodermal Mixed Tumor|Mesodermal Mixed Tumors|Mixed Tumors, Mesodermal|Tumor, Mesodermal Mixed|Tumors, Mesodermal Mixed	Cancer
Mixed Tumor, Mullerian	MESH:D018200	DO:DOID:4236	A tumor, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of estrogen has been postulated as a possible etiological factor in this tumor. (Holland et al., Cancer Medicine, 3d ed, p1703)	MESH:D018193	C04.557.435.540	C04.557.435	Mullerian Mixed Tumor|Tumor, Mullerian Mixed	Cancer
Molluscum Contagiosum	MESH:D008976	DO:DOID:8867	A common, benign, usually self-limited viral infection of the skin and occasionally the conjunctivae by a poxvirus (MOLLUSCUM CONTAGIOSUM VIRUS). (Dorland, 27th ed)	MESH:D011213|MESH:D017193	C01.925.256.743.611|C01.925.825.550|C17.800.838.790.550	C01.925.256.743|C01.925.825|C17.800.838.790		Skin disease|Viral disease
Monckeberg Medial Calcific Sclerosis	MESH:D050380		Thickening and loss of elasticity of the walls of muscular ARTERIES due to calcification of the TUNICA MEDIA, the concentric layers of helically arranged SMOOTH MUSCLE CELLS.	MESH:D061205	C18.452.174.130.780.500	C18.452.174.130.780	Calcific Scleroses, Medial|Calcific Sclerosis, Medial|Medial Calcific Scleroses|Medial Calcific Sclerosis|Mönckeberg Medial Calcific Sclerosis|Monckeberg Sclerosis|Mönckeberg Sclerosis|Monckeberg's Medial Calcific Sclerosis|Mönckeberg's Medial Calcific Sclerosis|Monckeberg's Sclerosis|Monckebergs Sclerosis|Mönckeberg's Sclerosis|Mönckebergs Sclerosis|Scleroses, Medial Calcific|Sclerosis, Medial Calcific|Sclerosis, Monckeberg Medial Calcific|Sclerosis, Mönckeberg Medial Calcific|Sclerosis, Monckeberg's|Sclerosis, Mönckeberg's	Metabolic disease
Monday morning fever	MESH:C531641			MESH:D002095	C08.381.483.581.275/C531641|C08.381.520.702.275/C531641|C24.800.323/C531641	C08.381.483.581.275|C08.381.520.702.275|C24.800.323		Occupational disease|Respiratory tract disease
Mongolian Spot	MESH:D049328	DO:DOID:4702	A bluish-gray to gray-brown benign, melanocytic nevus found usually in the LUMBOSACRAL REGION of dark-skinned people, especially those of East Asian ancestry. It is usually congenital or appears shortly after birth, and disappears in childhood.	MESH:D009508	C04.557.665.560.615.530	C04.557.665.560.615	Blue Spot, Mongolian|Mongolian Blue Spot|Spot, Mongolian	Cancer
Monoclonal Gammopathy of Undetermined Significance	MESH:D008998		Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia.	MESH:D006942|MESH:D010265	C15.378.147.542.640|C15.378.147.780.570|C20.683.460.640|C20.683.780.640	C15.378.147.542|C15.378.147.780|C20.683.460|C20.683.780	Benign Monoclonal Gammapathies|Benign Monoclonal Gammapathy|Benign Monoclonal Gammopathies|Benign Monoclonal Gammopathy|Monoclonal Gammapathies, Benign|Monoclonal Gammapathy, Benign|Monoclonal Gammapathy of Undetermined Significance|Monoclonal Gammopathies, Benign|Monoclonal Gammopathy, Benign	Blood disease|Immune system disease
Monocyte Chemotactic Disorder	MESH:C565371			MESH:D007154	C20/C565371	C20		Immune system disease
Monocyte Esterase Deficiency	MESH:C566173			MESH:D007960	C15.378.553/C566173	C15.378.553	Monocyte Carboxylesterase Deficiency	Blood disease
Mononegavirales Infections	MESH:D018701		Infections with viruses of the order MONONEGAVIRALES. The concept includes FILOVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; and RHABDOVIRIDAE INFECTIONS.	MESH:D012327	C01.925.782.580	C01.925.782	Infection, Mononegavirales|Infections, Mononegavirales|Mononegavirales Infection	Viral disease
Mononeuropathies	MESH:D020422	DO:DOID:1188|DO:DOID:1802|DO:DOID:1835	Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ISCHEMIA; traumatic injury; compression; CONNECTIVE TISSUE DISEASES; CUMULATIVE TRAUMA DISORDERS; and other conditions.	MESH:D010523	C10.668.829.500	C10.668.829	Mononeuritides|Mononeuritis|Mononeuritis Multiplex|Mononeuropathy|Mononeuropathy Multiplex|Mononeuropathy Multiplex Syndrome|Mononeuropathy Multiplex Syndromes|Syndrome, Mononeuropathy Multiplex|Syndromes, Mononeuropathy Multiplex	Nervous system disease
MONONEUROPATHY OF THE MEDIAN NERVE, MILD	OMIM:613353			MESH:D020422	C10.668.829.500/613353	C10.668.829.500	CARPAL TUNNEL SYNDROME, SUSCEPTIBILITY TO|MNMN	Nervous system disease
Monteggia's Fracture	MESH:D009011		Fracture in the proximal half of the shaft of the ulna, with dislocation of the head of the radius.	MESH:D000072039|MESH:D014458	C05.550.518.336.750|C26.289.336.750|C26.404.937.547	C05.550.518.336|C26.289.336|C26.404.937	Fracture, Monteggia's|Monteggia Fracture|Monteggias Fracture	Musculoskeletal disease|Wounds and injuries
Morbillivirus Infections	MESH:D018185		Infections with viruses of the genus MORBILLIVIRUS, family PARAMYXOVIRIDAE. Infections mainly cause acute disease in their hosts, although in some cases infection is persistent and leads to degenerative conditions.	MESH:D018184	C01.925.782.580.600.500	C01.925.782.580.600	Infection, Morbillivirus|Infections, Morbillivirus|Morbillivirus Infection	Viral disease
Morphological and Microscopic Findings	MESH:D065308		Morphological findings useful in differentiation and classification of results in CYTODIAGNOSIS and related techniques.	MESH:D013568	C23.149	C23		
Morton Neuroma	MESH:D000070607		A nerve inflammation in the foot caused by chronic compression of the plantar nerve between the METATARSAL BONES.	MESH:D009437|MESH:D037061	C05.360.500.500|C05.550.610.500|C10.668.829.600.375|C23.888.592.612.540.500|C23.888.592.612.664.275	C05.360.500|C05.550.610|C10.668.829.600|C23.888.592.612.540|C23.888.592.612.664	Disease, Morton's|Intermetatarsal Neuroma|Intermetatarsal Neuromas|Metatarsalgia, Morton's|Morton Disease|Morton Metatarsalgia|Morton Neuralgia|Morton's Disease|Mortons Disease|Morton's Metatarsalgia|Mortons Metatarsalgia|Morton's Neuralgia|Mortons Neuralgia|Morton's Neuroma|Mortons Neuroma|Neuralgia, Morton's|Neuroma, Intermetatarsal|Neuroma, Morton|Neuroma, Morton's|Neuromas, Intermetatarsal	Musculoskeletal disease|Nervous system disease|Signs and symptoms
Motor Neuron Disease	MESH:D016472	DO:DOID:230|DO:DOID:231|DO:DOID:4873	Diseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes (see MUSCULAR ATROPHY, SPINAL) the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy (BULBAR PALSY, PROGRESSIVE), the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation. (Adams et al., Principles of Neurology, 6th ed, p1089)	MESH:D009468|MESH:D019636	C10.574.562|C10.668.467	C10.574|C10.668	Anterior Horn Cell Disease|Familial Motor Neuron Disease|Lateral Scleroses|Lateral Scleroses, Primary|Lateral Sclerosis|Lateral Sclerosis, Primary|Lower Motor Neuron Disease|Motor Neuron Disease, Familial|Motor Neuron Disease, Lower|Motor Neuron Diseases|Motor Neuron Disease, Secondary|Motor Neuron Disease, Upper|Motor System Disease|Motor System Diseases|Neuron Disease, Motor|Neuron Diseases, Motor|Primary Lateral Scleroses|Primary Lateral Sclerosis|Scleroses, Lateral|Scleroses, Primary Lateral|Sclerosis, Lateral|Sclerosis, Primary Lateral|Secondary Motor Neuron Disease|Upper Motor Neuron Disease	Nervous system disease
Motor Neuron Disease with Dementia and Ophthalmoplegia	MESH:C563954			MESH:D003704|MESH:D009886|MESH:D016472	C10.228.140.380/C563954|C10.292.562.750/C563954|C10.574.562/C563954|C10.597.622.447/C563954|C10.668.467/C563954|C11.590.472/C563954|C23.888.592.636.447/C563954|F03.615.400/C563954	C10.228.140.380|C10.292.562.750|C10.574.562|C10.597.622.447|C10.668.467|C11.590.472|C23.888.592.636.447|F03.615.400		Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Motor neuropathy peripheral with dysautonomia	MESH:C536988			MESH:D001342	C10.177/C536988	C10.177	Lisker Garcia Ramos syndrome|Motor Neuropathy, Peripheral, with Dysautonomia|Peripheral motor neuropathy associated with autonomic dysfunction	Nervous system disease
Mouth Breathing	MESH:D009058		Abnormal breathing through the mouth, usually associated with obstructive disorders of the nasal passages.	MESH:D012120|MESH:D012818	C08.618.659|C23.888.852.761	C08.618|C23.888.852	Breathing, Mouth|Breathings, Mouth|Mouth Breathings	Respiratory tract disease|Signs and symptoms
Mouth Neoplasms	MESH:D009062		Tumors or cancer of the MOUTH.	MESH:D006258|MESH:D009059	C04.588.443.591|C07.465.530	C04.588.443|C07.465	Cancer, Mouth|Cancer of Mouth|Cancer of the Mouth|Cancer, Oral|Cancers, Mouth|Cancers, Oral|Mouth Cancer|Mouth Cancers|Mouth Neoplasm|Neoplasm, Mouth|Neoplasm, Oral|Neoplasms, Mouth|Neoplasms, Oral|Oral Cancer|Oral Cancers|Oral Neoplasm|Oral Neoplasms	Cancer|Mouth disease
Movement Disorders	MESH:D009069	DO:DOID:480	Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.	MESH:D002493	C10.228.662	C10.228	Dyskinesia Syndrome|Dyskinesia Syndromes|Etat Marbre|Movement Disorder|Movement Disorder Syndrome|Movement Disorder Syndromes|Status Marmoratus	Nervous system disease
Moyamoya Disease	MESH:D009072	DO:DOID:13099	A noninflammatory, progressive occlusion of the intracranial CAROTID ARTERIES and the formation of netlike collateral arteries arising from the CIRCLE OF WILLIS. Cerebral angiogram shows the puff-of-smoke (moyamoya) collaterals at the base of the brain. It is characterized by endothelial HYPERPLASIA and FIBROSIS with thickening of arterial walls. This disease primarily affects children but can also occur in adults.	MESH:D001157|MESH:D002340|MESH:D002539	C10.228.140.300.200.600|C10.228.140.300.510.200.737|C14.907.137.615|C14.907.253.123.620|C14.907.253.560.200.737	C10.228.140.300.200|C10.228.140.300.510.200|C14.907.137|C14.907.253.123|C14.907.253.560.200	Cerebrovascular Moyamoya Disease|Classic Moyamoya Disease|Disease, Classic Moyamoya|Disease, Moya-Moya|Disease, Primary Moyamoya|Moya Moya Disease|Moya-Moya Disease|Moyamoya Disease, Classic|Moyamoya Disease, Primary|Moyamoya Disease, Secondary|Moyamoya Diseases, Primary|Moyamoya Syndrome|Primary Moyamoya Disease|Primary Moyamoya Diseases|Progressive Intracranial Occlusive Arteropathy (Moyamoya)|Secondary Moyamoya Disease	Cardiovascular disease|Nervous system disease
Moyamoya disease 1	MESH:C536991	OMIM:252350		MESH:D009072	C10.228.140.300.200.600/C536991|C10.228.140.300.510.200.737/C536991|C14.907.137.615/C536991|C14.907.253.123.620/C536991|C14.907.253.560.200.737/C536991	C10.228.140.300.200.600|C10.228.140.300.510.200.737|C14.907.137.615|C14.907.253.123.620|C14.907.253.560.200.737	MOYAMOYA DISEASE|MYMY|MYMY1|Spontaneous occlusion of the circle of Willis	Cardiovascular disease|Nervous system disease
Moyamoya disease 2	MESH:C536992	OMIM:607151		MESH:D009072	C10.228.140.300.200.600/C536992|C10.228.140.300.510.200.737/C536992|C14.907.137.615/C536992|C14.907.253.123.620/C536992|C14.907.253.560.200.737/C536992	C10.228.140.300.200.600|C10.228.140.300.510.200.737|C14.907.137.615|C14.907.253.123.620|C14.907.253.560.200.737	MYMY2	Cardiovascular disease|Nervous system disease
Moyamoya disease 3	MESH:C536993	OMIM:608796		MESH:D009072	C10.228.140.300.200.600/C536993|C10.228.140.300.510.200.737/C536993|C14.907.137.615/C536993|C14.907.253.123.620/C536993|C14.907.253.560.200.737/C536993	C10.228.140.300.200.600|C10.228.140.300.510.200.737|C14.907.137.615|C14.907.253.123.620|C14.907.253.560.200.737	MYMY3	Cardiovascular disease|Nervous system disease
MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM	OMIM:300845	DO:DOID:13099		MESH:D007006|MESH:D009072|MESH:D019465	C05.660.207/300845|C10.228.140.300.200.600/300845|C10.228.140.300.510.200.737/300845|C14.907.137.615/300845|C14.907.253.123.620/300845|C14.907.253.560.200.737/300845|C16.131.621.207/300845|C19.391.482/300845	C05.660.207|C10.228.140.300.200.600|C10.228.140.300.510.200.737|C14.907.137.615|C14.907.253.123.620|C14.907.253.560.200.737|C16.131.621.207|C19.391.482	CHROMOSOME Xq28 DELETION SYNDROME, 3.4-KB|MYMY4|SYNDROMIC MOYAMOYA DISEASE	Cardiovascular disease|Congenital abnormality|Endocrine system disease|Musculoskeletal disease|Nervous system disease
MOYAMOYA DISEASE 5	OMIM:614042	DO:DOID:13099		MESH:D009072	C10.228.140.300.200.600/614042|C10.228.140.300.510.200.737/614042|C14.907.137.615/614042|C14.907.253.123.620/614042|C14.907.253.560.200.737/614042	C10.228.140.300.200.600|C10.228.140.300.510.200.737|C14.907.137.615|C14.907.253.123.620|C14.907.253.560.200.737	MYMY5	Cardiovascular disease|Nervous system disease
MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA	OMIM:615750	DO:DOID:13099		MESH:D004931|MESH:D009072	C06.405.117.119.500.432/615750|C10.228.140.300.200.600/615750|C10.228.140.300.510.200.737/615750|C14.907.137.615/615750|C14.907.253.123.620/615750|C14.907.253.560.200.737/615750	C06.405.117.119.500.432|C10.228.140.300.200.600|C10.228.140.300.510.200.737|C14.907.137.615|C14.907.253.123.620|C14.907.253.560.200.737	MYMY6	Cardiovascular disease|Digestive system disease|Nervous system disease
MPTP Poisoning	MESH:D020267		A condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia (PARKINSON DISEASE, SECONDARY). MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. (Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36(2):250-8)	MESH:D010302|MESH:D020258	C10.228.140.079.862.800.300|C10.228.662.600.700.250|C10.720.606|C25.723.705.400	C10.228.140.079.862.800|C10.228.662.600.700|C10.720|C25.723.705	MPTP Induced Degeneration of the Striatum|MPTP-Induced Degeneration of the Striatum|MPTP Induced Parkinsonism|MPTP-Induced Parkinsonism|MPTP Neurotoxicity Syndrome|MPTP Neurotoxicity Syndromes|Neurotoxicity Syndrome, MPTP|Neurotoxicity Syndromes, MPTP|Parkinsonism, MPTP-Induced|Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|Poisoning, MPTP	Nervous system disease
Mucinoses	MESH:D017520	DO:DOID:3141	Mucoid states characterized by the elevated deposition and accumulation of mucin (mucopolysaccharides) in dermal tissue. The fibroblasts are responsible for the production of acid mucopolysaccharides (GLYCOSAMINOGLYCANS) in the ground substance of the connective tissue system. When fibroblasts produce abnormally large quantities of mucopolysaccharides as hyaluronic acid, chondroitin sulfate, or heparin, they accumulate in large amounts in the dermis.	MESH:D003240	C17.300.550	C17.300	Mucinosis	Connective tissue disease
Mucinosis, Follicular	MESH:D000507	DO:DOID:9905	A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary (idiopathic) or secondary to mycosis fungoides or reticulosis.	MESH:D000505|MESH:D012625|MESH:D017520	C17.300.550.550|C17.800.329.937.122.550|C17.800.794.550	C17.300.550|C17.800.329.937.122|C17.800.794	Alopecia Mucinosa|Follicular Mucinoses|Follicular Mucinosis|Mucinoses, Follicular	Connective tissue disease|Skin disease
Mucocele	MESH:D009078		A retention cyst of the salivary gland, lacrimal sac, paranasal sinuses, appendix, or gallbladder. (Stedman, 26th ed)	MESH:D003560	C04.182.511	C04.182	Mucoceles	Cancer
Mucocutaneous Lymph Node Syndrome	MESH:D009080	DO:DOID:13378|OMIM:611775	An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.	MESH:D008206|MESH:D014657|MESH:D017445	C14.907.940.560|C15.604.560|C17.800.862.560	C14.907.940|C15.604|C17.800.862	INFANTILE POLYARTERITIS|Kawasaki Disease|Kawasaki Syndrome|KD|Lymph Node Syndrome, Mucocutaneous|MUCOCUTANEOUS LYMPH NODE SYNDROME	Cardiovascular disease|Lymphatic disease|Skin disease
Mucoepidermoid Tumor	MESH:D018298		A malignant epithelial tumor of glandular tissue, especially the salivary glands, characterized by acini with mucus-producing cells and by the presence of malignant squamous elements. Most mucoepidermoid tumors are low-grade lesions readily cured by adequate excision. They may appear in any age group. They grow slowly. If high-grade, they behave aggressively, widely infiltrating the salivary gland and producing lymph node and distant metastases. (Dorland, 27th ed; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575)	MESH:D018297	C04.557.470.590.580	C04.557.470.590	Mucoepidermoid Tumors|Tumor, Mucoepidermoid|Tumors, Mucoepidermoid	Cancer
Mucositis	MESH:D052016	DO:DOID:0080178	An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).	MESH:D005759|MESH:D009059	C06.405.205.798|C07.465.584	C06.405.205|C07.465	Mucositides	Digestive system disease|Mouth disease
Mucus Inspissation of Respiratory Tract	MESH:C565366			MESH:D029424	C08.381.495.389/C565366|C23.550.291.500.875/C565366	C08.381.495.389|C23.550.291.500.875		Pathology (process)|Respiratory tract disease
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME	OMIM:166300	DO:DOID:0111534		MESH:C536051	C05.116.264.579/C536051/166300	C05.116.264.579/C536051	MCTO|MULTICENTRIC OSTEOLYSIS, AUTOSOMAL DOMINANT|OSTEOLYSIS, HEREDITARY, OF CARPAL BONES WITH OR WITHOUT NEPHROPATHY	Musculoskeletal disease
Multi-centric Castleman's Disease	MESH:C537372	DO:DOID:0111152		MESH:D005871	C15.604.515.245/C537372|C20.683.515.250/C537372	C15.604.515.245|C20.683.515.250	HHV-8-Associated Multicentric Castleman Disease|HHV8 Multicentric Castleman Disease|HHV-8-negative idiopathic multicentric Castleman disease|HHV-8-negative MCD|Idiopathic multicentric Castleman's disease|KSHV-Associated Multicentric Castleman Disease|KSHV Muticentric Castleman Disease|Multicentric Castleman's disease|Multicentric plasma cell variant of Castleman's disease|Plasmablastic multicentric Castleman disease|TAFRO HHV-8-negative multicentric Castleman disease.|TAFRO syndrome|thrombocytopenia anasarca fever renal dysfunction and organomegaly syndrome	Immune system disease|Lymphatic disease
Multifocal Choroiditis	MESH:D000080364		A multifocal uveitis syndrome involving the RETINAL PIGMENT EPITHELIUM and capillary layer of the CHOROID. It is characterized by chronic UVEITIS and multiple CHOROID lesions referred to as white dots, blurry vision, floaters, sensitivity to light, blind spots, and eye discomfort.	MESH:D000080363|MESH:D002833	C11.941.160.478.550|C11.941.879.780.900.300.489|C11.941.879.780.900.650.500	C11.941.160.478|C11.941.879.780.900.300|C11.941.879.780.900.650	Choroiditis, Multifocal	Eye disease
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1	OMIM:614080	DO:DOID:0080138		MESH:D009123|MESH:D012640	C10.597.613.575/614080|C10.597.742/614080|C23.888.592.608.575/614080|C23.888.592.742/614080	C10.597.613.575|C10.597.742|C23.888.592.608.575|C23.888.592.742	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 3|GPIBD3|MCAHS1	Nervous system disease|Signs and symptoms
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2	OMIM:300868	DO:DOID:0080139		MESH:D009123|MESH:D012640	C10.597.613.575/300868|C10.597.742/300868|C23.888.592.608.575/300868|C23.888.592.742/300868	C10.597.613.575|C10.597.742|C23.888.592.608.575|C23.888.592.742	DEE20|DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 20|EIEE20|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 20|GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 4|GPIBD4|MCAHS2	Nervous system disease|Signs and symptoms
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3	OMIM:615398	DO:DOID:0080140		MESH:D009123|MESH:D012640	C10.597.613.575/615398|C10.597.742/615398|C23.888.592.608.575/615398|C23.888.592.742/615398	C10.597.613.575|C10.597.742|C23.888.592.608.575|C23.888.592.742	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 7|GPIBD7|MCAHS3	Nervous system disease|Signs and symptoms
MULTIPLE FIBROADENOMAS OF THE BREAST	OMIM:615554			MESH:D001943|MESH:D018226	C04.557.450.565.590.595.350/615554|C04.557.470.625.350/615554|C04.588.180/615554|C17.800.090.500/615554	C04.557.450.565.590.595.350|C04.557.470.625.350|C04.588.180|C17.800.090.500	MFAB	Cancer|Skin disease
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	OMIM:245600	DO:DOID:0080575		MESH:C537874|MESH:D006130|MESH:D006330|MESH:D019465	C05.116.099/C537874/245600|C05.550.518/C537874/245600|C05.660.207/245600|C05.660/C537874/245600|C14.240.400/245600|C14.280.400/245600|C16.131.077/C537874/245600|C16.131.240.400/245600|C16.131.621.207/245600|C16.131.621/C537874/245600|C23.550.393/245600|C26.289/C537874/245600	C05.116.099/C537874|C05.550.518/C537874|C05.660.207|C05.660/C537874|C14.240.400|C14.280.400|C16.131.077/C537874|C16.131.240.400|C16.131.621.207|C16.131.621/C537874|C23.550.393|C26.289/C537874	JDSCD|LARSEN SYNDROME, AUTOSOMAL RECESSIVE, FORMERLY	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Pathology (process)|Wounds and injuries
Multiple Mitochondrial Dysfunctions Syndrome	MESH:C565304	DO:DOID:0070330|OMIM:605711|OMIM:615330|OMIM:616370		MESH:D028361	C18.452.660/C565304	C18.452.660	MMDS|MMDS1|MMDS3|MMDS4|MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1|MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3|MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4	Metabolic disease
Multiple Myeloma	MESH:D009101	DO:DOID:9538|OMIM:254500	A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.	MESH:D008232|MESH:D010265|MESH:D020141|MESH:D054219	C04.557.595.500|C14.907.454.460|C15.378.147.780.650|C15.378.463.515.460|C20.683.515.845|C20.683.780.650	C04.557.595|C14.907.454|C15.378.147.780|C15.378.463.515|C20.683.515|C20.683.780	AL AMYLOIDOSIS, INCLUDED|AL, INCLUDED|AMYLOIDOSIS, SYSTEMIC, INCLUDED|Cell Myeloma, Plasma|Cell Myelomas, Plasma|Disease, Kahler|Kahler Disease|Multiple Myelomas|Myeloma Multiple|Myeloma-Multiple|Myeloma, Multiple|Myeloma-Multiples|Myeloma, Plasma Cell|Myeloma, Plasma-Cell|Myelomas, Multiple|Myelomas, Plasma Cell|Myelomas, Plasma-Cell|Myelomatoses|Myelomatosis|Plasma Cell Myeloma|Plasma-Cell Myeloma|Plasma Cell Myelomas|Plasma-Cell Myelomas	Blood disease|Cancer|Cardiovascular disease|Immune system disease
Multiple Pulmonary Nodules	MESH:D055613		A number of small lung lesions characterized by small round masses of 2- to 3-mm in diameter. They are usually detected by chest CT scans (COMPUTED TOMOGRAPHY, X-RAY). Such nodules can be associated with metastases of malignancies inside or outside the lung, benign granulomas, or other lesions.	MESH:D008175	C04.588.894.797.520.237|C08.381.540.148|C08.785.520.148	C04.588.894.797.520|C08.381.540|C08.785.520	Multiple Pulmonary Nodule|Pulmonary Nodule, Multiple|Pulmonary Nodules, Multiple	Cancer|Respiratory tract disease
Multiple Sclerosis	MESH:D009103	DO:DOID:2377|OMIM:126200|OMIM:612594|OMIM:612595|OMIM:612596|OMIM:614810	An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)	MESH:D020278	C10.114.375.500|C10.314.350.500|C20.111.258.250.500	C10.114.375|C10.314.350|C20.111.258.250	Disseminated Sclerosis|DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED|MS|MS1, INCLUDED|MS2|MS3|MS4|MS5|MS (Multiple Sclerosis)|Multiple Sclerosis, Acute Fulminating|MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO|MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2|MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3|MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4|MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5|Sclerosis, Disseminated|Sclerosis, Multiple	Immune system disease|Nervous system disease
Multiple Sclerosis, Chronic Progressive	MESH:D020528	DO:DOID:0050783|DO:DOID:0050784|DO:DOID:0050785	A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)	MESH:D002908|MESH:D009103	C10.114.375.500.200|C10.314.350.500.200|C20.111.258.250.500.200|C23.550.291.500.625	C10.114.375.500|C10.314.350.500|C20.111.258.250.500|C23.550.291.500	Chronic Progressive Multiple Sclerosis|Multiple Sclerosis, Primary Progressive|Multiple Sclerosis, Progressive Relapsing|Multiple Sclerosis, Remittent Progressive|Multiple Sclerosis, Secondary Progressive|Primary Progressive Multiple Sclerosis|Progressive Relapsing Multiple Sclerosis|Remittent Progressive Multiple Sclerosis|Secondary Progressive Multiple Sclerosis	Immune system disease|Nervous system disease|Pathology (process)
Multiple Sclerosis, Relapsing-Remitting	MESH:D020529	DO:DOID:2378	The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)	MESH:D009103	C10.114.375.500.600|C10.314.350.500.600|C20.111.258.250.500.600	C10.114.375.500|C10.314.350.500|C20.111.258.250.500	Acute Relapsing Multiple Sclerosis|Multiple Sclerosis, Acute Relapsing|Multiple Sclerosis, Relapsing Remitting|Multiple Sclerosis, Remitting-Relapsing|Relapsing Remitting Multiple Sclerosis|Relapsing-Remitting Multiple Sclerosis|Remitting Relapsing Multiple Sclerosis|Remitting-Relapsing Multiple Sclerosis	Immune system disease|Nervous system disease
Multiple System Atrophy	MESH:D019578	DO:DOID:4752|OMIM:146500	A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)	MESH:D000080874|MESH:D001480|MESH:D009069|MESH:D054969	C10.177.575.550|C10.228.140.079.612|C10.228.662.550|C10.574.928.625	C10.177.575|C10.228.140.079|C10.228.662|C10.574.928	Atrophies, Multisystem|Atrophies, Multisystemic|Atrophy, Multiple System|Atrophy, Multisystem|Atrophy, Multisystemic|HYPOTENSION, ORTHOSTATIC, INCLUDED|MSA1|MSA1, SUSCEPTIBILITY TO AUTONOMIC FAILURE, PURE, INCLUDED|Multiple System Atrophies|MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO|Multiple System Atrophy Syndrome|Multisystem Atrophies|Multisystem Atrophy|Multisystemic Atrophies|Multisystemic Atrophy	Nervous system disease
Multiple system atrophy (MSA) with orthostatic hypotension	MESH:C537381			MESH:D019578	C10.177.575.550/C537381|C10.228.140.079.612/C537381|C10.228.662.550/C537381|C10.574.928.625/C537381	C10.177.575.550|C10.228.140.079.612|C10.228.662.550|C10.574.928.625		Nervous system disease
Mumps	MESH:D009107	DO:DOID:10264	An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed)	MESH:D010309|MESH:D019351	C01.925.782.580.600.680.500|C07.465.815.470.800.630	C01.925.782.580.600.680|C07.465.815.470.800	Epidemic Parotitides|Epidemic Parotitis|Parotitides, Epidemic|Parotitis, Epidemic	Mouth disease|Viral disease
Mungan Syndrome	MESH:C548078	OMIM:611376		MESH:D001471|MESH:D007418	C04.834.154/C548078|C06.405.117.102/C548078|C06.405.469.531.492.500/C548078	C04.834.154|C06.405.117.102|C06.405.469.531.492.500	MGS|Pseudoobstruction, Chronic Idiopathic Intestinal, With Barrett Esophagus And Cardiac Abnormalities|Visceral Neuromyopathy, Familial, With Pseudoobstruction, Megaduodenum, Barrett Esophagus, And Cardiac Abnormalities	Cancer|Digestive system disease
Muscle Cramp	MESH:D009120		A sustained and usually painful contraction of muscle fibers. This may occur as an isolated phenomenon or as a manifestation of an underlying disease process (e.g., UREMIA; HYPOTHYROIDISM; MOTOR NEURON DISEASE; etc.). (From Adams et al., Principles of Neurology, 6th ed, p1398)	MESH:D009135|MESH:D020879	C05.651.475|C10.597.613.500|C23.888.592.608.500	C05.651|C10.597.613|C23.888.592.608	Cramp|Cramp, Limb|Cramp, Muscle|Cramp, Muscular|Cramps|Cramps, Limb|Cramps, Muscle|Cramps, Muscular|Limb Cramp|Limb Cramps|Muscle Cramps|Muscular Cramp|Muscular Cramps	Musculoskeletal disease|Nervous system disease|Signs and symptoms
Muscle Cramps, Familial	MESH:C563563			MESH:D009120	C05.651.475/C563563|C10.597.613.500/C563563|C23.888.592.608.500/C563563	C05.651.475|C10.597.613.500|C23.888.592.608.500		Musculoskeletal disease|Nervous system disease|Signs and symptoms
Muscle Hypertonia	MESH:D009122		Abnormal increase in skeletal or smooth muscle tone. Skeletal muscle hypertonicity may be associated with PYRAMIDAL TRACT lesions or BASAL GANGLIA DISEASES.	MESH:D020879	C10.597.613.550|C23.888.592.608.550	C10.597.613|C23.888.592.608	Detrusor Muscle Hypertonia|Detrusor Muscle Hypertonias|Hypermyotonia|Hypermyotonias|Hypertonia, Detrusor Muscle|Hypertonia, Infantile|Hypertonia, Muscle|Hypertonia, Neonatal|Hypertonias, Detrusor Muscle|Hypertonias, Infantile|Hypertonias, Muscle|Hypertonias, Neonatal|Hypertonia, Sphincter|Hypertonias, Sphincter|Hypertonias, Transient|Hypertonia, Transient|Hypertonicities, Muscular|Hypertonicity, Muscular|Increased, Muscle Tone|Infantile Hypertonia|Infantile Hypertonias|Muscle Hypertonia, Detrusor|Muscle Hypertonias|Muscle Hypertonias, Detrusor|Muscle Tone Increased|Muscular Hypertonicities|Muscular Hypertonicity|Neonatal Hypertonia|Neonatal Hypertonias|Sphincter Hypertonia|Sphincter Hypertonias|Tone Increased, Muscle|Transient Hypertonia|Transient Hypertonias	Nervous system disease|Signs and symptoms
MUSCLE HYPERTROPHY	OMIM:614160	DO:DOID:0111072		MESH:D006984|MESH:D009135	C05.651/614160|C10.668.491/614160|C23.300.775/614160	C05.651|C10.668.491|C23.300.775	MSLHP	Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)
Muscle Hypotonia	MESH:D009123		A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.	MESH:D020879	C10.597.613.575|C23.888.592.608.575	C10.597.613|C23.888.592.608	Decreased Muscle Tone|Flaccidity, Muscle|Flaccidity, Muscular|Flaccid Muscle Tone|Floppy Muscle|Floppy Muscles|Hypomyotonia|Hypotonia|Hypotonia, Muscle|Hypotonia, Muscular|Hypotonia, Neonatal|Hypotonias, Neonatal|Hypotonias, Unilateral|Hypotonia, Unilateral|Hypotony, Muscle|Muscle Flaccidity|Muscle, Floppy|Muscle Hypotony|Muscles, Floppy|Muscle Tone Atonic|Muscle Tone Atonics|Muscle Tone, Decreased|Muscle Tone, Flaccid|Muscle Tone Poor|Muscular Flaccidities|Muscular Flaccidity|Muscular Hypotonia|Neonatal Hypotonia|Neonatal Hypotonias|Tone Atonic, Muscle|Tone Poor, Muscle|Unilateral Hypotonia	Nervous system disease|Signs and symptoms
Muscle Neoplasms	MESH:D019042	DO:DOID:4045|DO:DOID:461	Tumors or cancer located in muscle tissue or specific muscles. They are differentiated from NEOPLASMS, MUSCLE TISSUE which are neoplasms composed of skeletal, cardiac, or smooth muscle tissue, such as MYOSARCOMA or LEIOMYOMA.	MESH:D009135|MESH:D012983	C04.588.839.500|C05.651.494	C04.588.839|C05.651	Cancer, Muscle|Cancer of Muscle|Cancer of the Muscle|Cancers, Muscle|Muscle Cancer|Muscle Cancers|Muscle Neoplasm|Neoplasm, Muscle|Neoplasms, Muscle	Cancer|Musculoskeletal disease
Muscle Rigidity	MESH:D009127		Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. (From Adams et al., Principles of Neurology, 6th ed, p73)	MESH:D009122|MESH:D009135	C05.651.504|C10.597.613.550.500|C23.888.592.608.550.500	C05.651|C10.597.613.550|C23.888.592.608.550	Catatonic Rigidity|Cogwheel Rigidities|Cogwheel Rigidity|Extensor Rigidity|Extrapyramidal Rigidity|Gegenhalten|Gegenhaltens|Muscular Rigidity|Nuchal Rigidity|Rigidities, Cogwheel|Rigidity, Catatonic|Rigidity, Cogwheel|Rigidity, Extensor|Rigidity, Extrapyramidal|Rigidity, Muscle|Rigidity, Muscular|Rigidity, Nuchal	Musculoskeletal disease|Nervous system disease|Signs and symptoms
Muscle Spasticity	MESH:D009128		A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a 'free interval') followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)	MESH:D009122|MESH:D009135	C05.651.512|C10.597.613.550.550|C23.888.592.608.550.550	C05.651|C10.597.613.550|C23.888.592.608.550	Clasp Knife Spasticity|Clasp-Knife Spasticity|Spastic|Spasticity, Clasp-Knife|Spasticity, Muscle	Musculoskeletal disease|Nervous system disease|Signs and symptoms
Muscle Weakness	MESH:D018908		A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)	MESH:D009135|MESH:D010335|MESH:D020879	C05.651.515|C10.597.613.593|C23.550.695|C23.888.592.608.593	C05.651|C10.597.613|C23.550|C23.888.592.608	Muscle Weaknesses|Muscular Weakness|Muscular Weaknesses|Weaknesses, Muscle|Weaknesses, Muscular|Weakness, Muscle|Weakness, Muscular	Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Muscular Atrophy	MESH:D009133	DO:DOID:767	Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.	MESH:D001284|MESH:D020879	C10.597.613.612|C23.300.070.500|C23.888.592.608.612	C10.597.613|C23.300.070|C23.888.592.608	Atrophies, Muscle|Atrophies, Muscular|Atrophies, Neurogenic Muscular|Atrophies, Neurotrophic Muscular|Atrophy, Muscle|Atrophy, Muscular|Atrophy, Neurogenic Muscular|Atrophy, Neurotrophic Muscular|Muscle Atrophies|Muscle Atrophy|Muscular Atrophies|Muscular Atrophies, Neurogenic|Muscular Atrophies, Neurotrophic|Muscular Atrophy, Neurogenic|Muscular Atrophy, Neurotrophic|Neurogenic Muscular Atrophies|Neurogenic Muscular Atrophy|Neurotrophic Muscular Atrophies|Neurotrophic Muscular Atrophy	Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Muscular Atrophy, Malignant Neurogenic	MESH:C563559			MESH:D009133	C10.597.613.612/C563559|C23.300.070.500/C563559|C23.888.592.608.612/C563559	C10.597.613.612|C23.300.070.500|C23.888.592.608.612		Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Muscular Atrophy, Spinal	MESH:D009134	DO:DOID:0111552|DO:DOID:12377|DO:DOID:318	A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)	MESH:D013118|MESH:D016472	C10.228.854.468|C10.574.562.500|C10.668.467.500	C10.228.854|C10.574.562|C10.668.467	Adult Onset Spinal Muscular Atrophy|Adult-Onset Spinal Muscular Atrophy|Adult Spinal Muscular Atrophy|Amyotrophies, Spinal|Amyotrophy, Neurogenic Scapuloperoneal, New England Type|Amyotrophy, Spinal|Atrophies, Progressive Muscular|Atrophy, Myelopathic Muscular|Atrophy, Progressive Muscular|Atrophy, Spinal Muscular|Bulbospinal Neuronopathies|Bulbospinal Neuronopathy|Distal Spinal Muscular Atrophy|Hereditary Motor Neuronopathies|Hereditary Motor Neuronopathy|Motor Neuronopathies, Hereditary|Motor Neuronopathy, Hereditary|Muscular Atrophies, Progressive|Muscular Atrophy, Adult Spinal|Muscular Atrophy, Myelopathic|Muscular Atrophy, Progressive|Myelopathic Muscular Atrophy|Myelopathic Muscular Atrophy, Progressive|Neuronopathies, Bulbospinal|Neuronopathies, Hereditary Motor|Neuronopathy, Bulbospinal|Neuronopathy, Hereditary Motor|Oculopharyngeal Spinal Muscular Atrophy|Progressive Muscular Atrophies|Progressive Muscular Atrophy|Progressive Myelopathic Muscular Atrophy|Progressive Proximal Myelopathic Muscular Atrophy|Proximal Myelopathic Muscular Atrophy, Progressive|Scapuloperoneal Form of Spinal Muscular Atrophy|Scapuloperoneal Spinal Muscular Atrophy|Spinal Amyotrophies|Spinal Amyotrophy|Spinal Muscular Atrophy|Spinal Muscular Atrophy, Distal|Spinal Muscular Atrophy, Oculopharyngeal|Spinal Muscular Atrophy, Scapuloperoneal|Spinal Muscular Atrophy, Scapuloperoneal Form	Nervous system disease
Muscular Diseases	MESH:D009135	DO:DOID:423	Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.	MESH:D009140|MESH:D009468	C05.651|C10.668.491	C05|C10.668	Muscle Disorder|Muscle Disorders|Muscular Disease|Myopathic Condition|Myopathic Conditions|Myopathies|Myopathy	Musculoskeletal disease|Nervous system disease
Muscular Disorders, Atrophic	MESH:D020966	DO:DOID:913	Disorders characterized by an abnormal reduction in muscle volume due to a decrease in the size or number of muscle fibers. Atrophy may result from diseases intrinsic to muscle tissue (e.g., MUSCULAR DYSTROPHY) or secondary to PERIPHERAL NERVOUS SYSTEM DISEASES that impair innervation to muscle tissue (e.g., MUSCULAR ATROPHY, SPINAL).	MESH:D009135	C05.651.534|C10.668.491.175	C05.651|C10.668.491	Atrophic Muscular Disorder|Atrophic Muscular Disorders|Atrophies, Disuse|Atrophies, Spinopontine|Atrophy, Disuse|Atrophy, Spinopontine|Disorder, Atrophic Muscular|Disorders, Atrophic Muscular|Disuse Atrophies|Disuse Atrophy|Muscular Disorder, Atrophic|Spinopontine Atrophies|Spinopontine Atrophy	Musculoskeletal disease|Nervous system disease
Muscular Hypertonia, Lethal	MESH:C564982			MESH:D009122	C10.597.613.550/C564982|C23.888.592.608.550/C564982	C10.597.613.550|C23.888.592.608.550		Nervous system disease|Signs and symptoms
Muscular Hypoplasia, Congenital Universal, of Krabbe	MESH:C563553			MESH:D009135	C05.651/C563553|C10.668.491/C563553	C05.651|C10.668.491		Musculoskeletal disease|Nervous system disease
Musculoskeletal Diseases	MESH:D009140	DO:DOID:17	Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively.	MESH:C	C05	C	Musculoskeletal Disease|Orthopedic Disorder|Orthopedic Disorders	Musculoskeletal disease
Musculoskeletal Pain	MESH:D059352		Discomfort stemming from muscles, LIGAMENTS, tendons, and bones.	MESH:D009135|MESH:D010146	C05.651.538|C23.888.592.612.547	C05.651|C23.888.592.612	Musculoskeletal Pains|Pain, Musculoskeletal|Pains, Musculoskeletal	Musculoskeletal disease|Signs and symptoms
Mushroom Poisoning	MESH:D009145		Poisoning from ingestion of mushrooms, primarily from, but not restricted to, toxic varieties.	MESH:D005517|MESH:D015651	C25.723.415.551|C25.723.680.551	C25.723.415|C25.723.680	Mushroom Poisonings|Poisoning, Mushroom|Poisonings, Mushroom	
Musk, Inability to Smell	MESH:C564980			MESH:D000857	C10.597.751.600/C564980|C23.888.592.763.550/C564980	C10.597.751.600|C23.888.592.763.550		Nervous system disease|Signs and symptoms
Myalgia	MESH:D063806		Painful sensation in the muscles.	MESH:D009135|MESH:D059352	C05.651.542|C10.668.491.525|C23.888.592.612.547.249	C05.651|C10.668.491|C23.888.592.612.547	Muscle Pain|Muscle Soreness|Muscle Sorenesses|Muscle Tenderness|Pain, Muscle|Pains, Muscle|Soreness, Muscle|Tenderness, Muscle	Musculoskeletal disease|Nervous system disease|Signs and symptoms
Myasthenia Gravis	MESH:D009157	DO:DOID:437	A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.	MESH:D020274|MESH:D020361|MESH:D020511	C04.588.614.550.500|C04.730.856.490|C10.114.656|C10.574.781.588|C10.668.758.725|C20.111.258.500	C04.588.614.550|C04.730.856|C10.114|C10.574.781|C10.668.758|C20.111.258	Anti MuSK Myasthenia Gravis|Anti-MuSK Myasthenia Gravis|Generalized Myasthenia Gravis|Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis|Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis|Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis|Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis|MuSK MG|MuSK Myasthenia Gravis|Myasthenia Gravis, Anti-MuSK|Myasthenia Gravis, Generalized|Myasthenia Gravis, MuSK|Myasthenia Gravis, Ocular|Ocular Myasthenia Gravis	Cancer|Immune system disease|Nervous system disease
Myasthenia Gravis, Autoimmune, Experimental	MESH:D020720		Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor (AChR) (see RECEPTORS, CHOLINERGIC) components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (From Joynt, Clinical Neurology, 1997, Ch 54, p3)	MESH:D009157|MESH:D020721	C10.114.656.300|C10.114.703.350|C10.668.758.725.300|C20.111.258.500.300|C20.111.258.625.350	C10.114.656|C10.114.703|C10.668.758.725|C20.111.258.500|C20.111.258.625	Autoimmune Experimental Myasthenia Gravis|Experimental Autoimmune Myasthenia Gravis, Passive Transfer|Experimental Myasthenia|Experimental Myasthenia Gravis|Experimental Myasthenias|Myasthenia, Experimental|Myasthenia Gravis, Autoimmune Experimental|Myasthenia Gravis, Experimental|Myasthenia Gravis, Experimental Autoimmune|Myasthenias, Experimental|Passive Transfer Experimental Autoimmune Myasthenia Gravis	Immune system disease|Nervous system disease
Myasthenia Gravis, Neonatal	MESH:D020941	DO:DOID:14043	A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves (i.e., transient neonatal myasthenia gravis) although this disorder may rarely continue beyond the neonatal period (i.e., persistent neonatal myasthenia gravis). (From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48(1):50-4)	MESH:D009157	C10.114.656.650|C10.668.758.725.650|C20.111.258.500.650	C10.114.656|C10.668.758.725|C20.111.258.500	Antenatal Myasthenia Gravis|Myasthenia Gravis, Antenatal|Myasthenia Gravis, Neonatal, Persistent|Myasthenia Gravis, Neonatal, Transient|Myasthenia Gravis, Persistent, Neonatal|Myasthenia Gravis, Transient, Neonatal|Neonatal Myasthenia Gravis|Neonatal Myasthenia Gravis, Persistent|Neonatal Myasthenia Gravis, Transient|Persistent Neonatal Myasthenia Gravis|Transient Neonatal Myasthenia Gravis	Immune system disease|Nervous system disease
Myasthenia Gravis with Thymus Hyperplasia	MESH:C564628	OMIM:607085		MESH:D009157	C04.588.614.550.500/C564628|C04.730.856.490/C564628|C10.114.656/C564628|C10.574.781.588/C564628|C10.668.758.725/C564628|C20.111.258.500/C564628	C04.588.614.550.500|C04.730.856.490|C10.114.656|C10.574.781.588|C10.668.758.725|C20.111.258.500	MYAS1	Cancer|Immune system disease|Nervous system disease
Mycosis Fungoides	MESH:D009182	DO:DOID:8691	A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.	MESH:D016410	C04.557.386.480.750.800.550|C15.604.515.569.480.750.800.550|C20.683.515.761.480.750.800.550	C04.557.386.480.750.800|C15.604.515.569.480.750.800|C20.683.515.761.480.750.800		Cancer|Immune system disease|Lymphatic disease
Mycotoxicosis	MESH:D015651		Poisoning caused by the ingestion of mycotoxins (toxins of fungal origin).	MESH:D011041	C25.723.680	C25.723	Fungus Poisoning|Fungus Poisonings|Mycotoxicoses|Poisoning, Fungus|Poisonings, Fungus	
Mydriasis	MESH:D015878		Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in ADIE SYNDROME.	MESH:D011681	C11.710.570	C11.710		Eye disease
Myelinolysis, Central Pontine	MESH:D017590	DO:DOID:636	A demyelinating condition affecting the PONS and characterized clinically by an acute progressive QUADRIPLEGIA; DYSARTHRIA; DYSPHAGIA; and alterations of consciousness. Pathologic features include prominent demyelination in the central PONS with sparing of axons and neurons. This condition is usually associated with systemic disorders such as HYPONATREMIA; chronic ALCOHOLISM; LIVER FAILURE; severe BURNS; malignant NEOPLASMS; hemorrhagic PANCREATITIS; HEMODIALYSIS; and SEPSIS. The rapid medical correction of hyponatremia has been cited as a cause of this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1125-6)	MESH:D001928|MESH:D003711	C10.228.140.163.560|C10.314.500|C18.452.132.560	C10.228.140.163|C10.314|C18.452.132	Central Pontine Myelinoclasis|Central Pontine Myelinolysis|Extrapontine Myelinoclases|Extrapontine Myelinoclasis|Extrapontine Myelinolyses|Extrapontine Myelinolysis|Myelinoclases, Extrapontine|Myelinoclasis, Central Pontine|Myelinoclasis, Extrapontine|Myelinolyses, Extrapontine|Myelinolysis, Extrapontine|Pontine Myelinolysis, Central	Metabolic disease|Nervous system disease
Myelitis	MESH:D009187	DO:DOID:322	Inflammation of the spinal cord. Relatively common etiologies include infections; AUTOIMMUNE DISEASES; SPINAL CORD; and ischemia (see also SPINAL CORD VASCULAR DISEASES). Clinical features generally include weakness, sensory loss, localized pain, incontinence, and other signs of autonomic dysfunction.	MESH:D000090862|MESH:D002494|MESH:D013118	C01.207.618|C10.228.228.618|C10.228.854.525|C10.586.750	C01.207|C10.228.228|C10.228.854|C10.586	Infectious Myelitis|Inflammation, Spinal Cord|Inflammations, Spinal Cord|Inflammatory Myelopathies|Inflammatory Myelopathy|Myelitides|Myelitides, Subacute Necrotizing|Myelitis, Infectious|Myelitis, Subacute Necrotizing|Myelopathies, Inflammatory|Myelopathy, Inflammatory|Necrotizing Myelitides, Subacute|Necrotizing Myelitis, Subacute|Spinal Cord Inflammation|Spinal Cord Inflammations|Subacute Necrotizing Myelitides|Subacute Necrotizing Myelitis	Nervous system disease
Myelitis, Transverse	MESH:D009188		Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence. (Adams et al., Principles of Neurology, 6th ed, pp1242-6)	MESH:D009187|MESH:D020278|MESH:D020361	C01.207.618.250|C04.588.614.550.550|C04.730.856.543|C10.114.375.600|C10.228.228.618.250|C10.228.854.525.553|C10.314.350.600|C10.574.781.625|C10.586.750.553|C20.111.258.250.550	C01.207.618|C04.588.614.550|C04.730.856|C10.114.375|C10.228.228.618|C10.228.854.525|C10.314.350|C10.574.781|C10.586.750|C20.111.258.250	Acute Transverse Myelitis|Demyelinative Myelitis|Myelitides, Subacute Transverse|Myelitis, Acute Transverse|Myelitis, Demyelinative|Myelitis, Necrotizing|Myelitis, Paraneoplastic|Myelitis, Postinfectious|Myelitis, Postvaccinal|Myelitis, Subacute Transverse|Necrotizing Myelitis|Paraneoplastic Myelitis|Postinfectious Myelitis|Postvaccinal Myelitis|Subacute Transverse Myelitis|Transverse Myelitis|Transverse Myelitis, Acute|Transverse Myelitis, Subacute|Transverse Myelopathy Syndrome|Transverse Myelopathy Syndromes	Cancer|Immune system disease|Nervous system disease
Myelocerebellar Disorder	MESH:C563233	OMIM:159550		MESH:D002524|MESH:D010198	C10.228.140.252.190/C563233|C10.597.350.090.500/C563233|C15.378.700/C563233|C23.888.592.350.090.200/C563233	C10.228.140.252.190|C10.597.350.090.500|C15.378.700|C23.888.592.350.090.200	Ataxia-Pancytopenia Syndrome|ATXPC|MYELOCEREBELLAR DISORDER	Blood disease|Nervous system disease|Signs and symptoms
Myelodysplasia, Immunodeficiency, Facial Dysmorphism, Short Stature, and Psychomotor Delay	MESH:C563345			MESH:D006130|MESH:D007153|MESH:D009190|MESH:D011596|MESH:D019465	C05.660.207/C563345|C10.597.606.881/C563345|C15.378.190.625/C563345|C16.131.621.207/C563345|C20.673/C563345|C23.550.393/C563345|C23.888.592.604.882/C563345	C05.660.207|C10.597.606.881|C15.378.190.625|C16.131.621.207|C20.673|C23.550.393|C23.888.592.604.882		Blood disease|Congenital abnormality|Immune system disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Myelodysplastic-Myeloproliferative Diseases	MESH:D054437	DO:DOID:4972	Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE DISORDERS.	MESH:D001855	C15.378.190.615	C15.378.190	Disease, Myelodysplastic-Myeloproliferative|Disease, Myeloproliferative-Myelodisplastic|Diseases, Myelodysplastic-Myeloproliferative|Diseases, Myeloproliferative-Myelodisplastic|Myelodysplastic-Myeloproliferative Disease|Myelodysplastic Myeloproliferative Diseases|Myeloproliferative-Myelodisplastic Disease|Myeloproliferative Myelodisplastic Diseases|Myeloproliferative-Myelodisplastic Diseases	Blood disease
Myelodysplastic Syndromes	MESH:D009190	DO:DOID:0050908|OMIM:614286	Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.	MESH:D001855	C15.378.190.625	C15.378.190	Dysmyelopoietic Syndrome|Dysmyelopoietic Syndromes|Hematopoetic Myelodysplasia|Hematopoetic Myelodysplasias|MDS|Myelodysplasia, Hematopoetic|Myelodysplasias, Hematopoetic|Myelodysplastic Syndrome|MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED|Syndrome, Dysmyelopoietic|Syndrome, Myelodysplastic|Syndromes, Dysmyelopoietic|Syndromes, Myelodysplastic	Blood disease
MYELOID TUMOR SUPPRESSOR	OMIM:601308			MESH:D007951	C04.557.337.539/601308	C04.557.337.539	MLRL|MYELOID LEUKEMIA-RELATED LOCUS	Cancer
Myelolipoma	MESH:D018209		A rare benign tumor of the adrenal gland, several centimeters in diameter, composed in varying proportions of adipose tissue, lymphocytes, and primitive myeloid cells, probably a developmental abnormality. (Dorland, 27th ed)	MESH:D018205	C04.557.450.550.710	C04.557.450.550	Myelolipomas	Cancer
Myeloproliferative Disease, Autosomal Recessive	MESH:C564977			MESH:D009196	C15.378.190.636/C564977	C15.378.190.636		Blood disease
Myeloproliferative Disorder, Chronic, with Eosinophilia	MESH:C565054	OMIM:131440		MESH:D004802|MESH:D009196	C15.378.190.636/C565054|C15.378.553.231/C565054	C15.378.190.636|C15.378.553.231	EMP|Eosinophils, Malignant Proliferation of|MPE	Blood disease
Myeloproliferative Disorders	MESH:D009196	DO:DOID:4960	Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.	MESH:D001855	C15.378.190.636	C15.378.190	Disorder, Myeloproliferative|Disorders, Myeloproliferative|Myeloproliferative Disorder	Blood disease
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO	OMIM:616871			MESH:D019337|MESH:D054437	C04.588.448/616871|C15.378.190.615/616871|C15.378.400/616871	C04.588.448|C15.378.190.615|C15.378.400	MPLPF	Blood disease|Cancer
MYH9-Related Disorders	MESH:C535507	OMIM:155100		MESH:D006319|MESH:D013921	C09.218.458.341.887/C535507|C10.597.751.418.341.887/C535507|C15.378.140.855/C535507|C23.888.592.763.393.341.887/C535507	C09.218.458.341.887|C10.597.751.418.341.887|C15.378.140.855|C23.888.592.763.393.341.887	Alport Syndrome with Leukocyte Inclusions and Macrothrombocytopenia|Alport syndrome with macrothrombocytopenia|ALPORT SYNDROME WITH MACROTHROMBOCYTOPENIA, FORMERLY|APSM, FORMERLY|Autosomal Dominant Myh9 Spectrum Disorders|BDPLT6|BLEEDING DISORDER, PLATELET-TYPE, 6|Deafness, Autosomal Dominant 17|DFNA17|Dohle leukocyte inclusions with giant platelets|Epstein syndrome|EPSTNS|Fechtner's syndrome|Fechtner syndrome|FTNS|GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA|Macrothrombocytopathy, Nephritis, and Deafness|Macrothrombocytopathy, nephritis, deafness, and leukocyte inclusions|MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS|MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS|MACROTHROMBOCYTOPENIA, NEPHRITIS, AND DEAFNESS|MACROTHROMBOCYTOPENIA, NEPHRITIS, DEAFNESS, AND LEUKOCYTE INCLUSIONS|MACROTHROMBOCYTOPENIA WITH DISPERSED LEUKOCYTIC INCLUSIONS|Macrothrombocytopenia with leukocyte inclusions|MATINS|May-Hegglin anomaly|MHA|MYH9 Gene-Related Autosomal Macrothrombocytopenias|MYH9RD|MYH9-Related Disease|Myh9-Related Disorder|Myh9-Related Macrothrombocytopenias|SBS|Sebastian platelet syndrome|Sebastian syndrome	Blood disease|Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Myocardial Bridging	MESH:D054084		A malformation that is characterized by a muscle bridge over a segment of the CORONARY ARTERIES. Systolic contractions of the muscle bridge can lead to narrowing of coronary artery; coronary compression; MYOCARDIAL ISCHEMIA; MYOCARDIAL INFARCTION; and SUDDEN CARDIAC DEATH.	MESH:D003330	C14.240.400.210.500|C14.280.400.210.500|C16.131.240.400.210.500	C14.240.400.210|C14.280.400.210|C16.131.240.400.210	Bridging, Myocardial|Bridgings, Myocardial|Myocardial Bridgings	Cardiovascular disease|Congenital abnormality
Myocardial Infarction	MESH:D009203	DO:DOID:5844|OMIM:608446|OMIM:608557	NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).	MESH:D007238|MESH:D017202	C14.280.647.500|C14.907.585.500|C23.550.513.355.750|C23.550.717.489.750	C14.280.647|C14.907.585|C23.550.513.355|C23.550.717.489	Cardiovascular Stroke|Cardiovascular Strokes|Heart Attack|Heart Attacks|Infarction, Myocardial|Infarctions, Myocardial|Infarct, Myocardial|Infarcts, Myocardial|MCI1, INCLUDED|MCI2|Myocardial Infarct|MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED|Myocardial Infarctions|MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO|MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED|MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2|Myocardial Infarcts|Stroke, Cardiovascular|Strokes, Cardiovascular	Cardiovascular disease|Pathology (process)
Myocardial Ischemia	MESH:D017202	DO:DOID:3393	A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).	MESH:D006331|MESH:D014652	C14.280.647|C14.907.585	C14.280|C14.907	Disease, Ischemic Heart|Diseases, Ischemic Heart|Heart Disease, Ischemic|Heart Diseases, Ischemic|Ischemia, Myocardial|Ischemias, Myocardial|Ischemic Heart Disease|Ischemic Heart Diseases|Myocardial Ischemias	Cardiovascular disease
Myocardial Reperfusion Injury	MESH:D015428		Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm.	MESH:D009202|MESH:D015427|MESH:D017202	C14.280.238.615|C14.280.647.625|C14.907.585.625|C14.907.725.600|C23.550.767.877.500	C14.280.238|C14.280.647|C14.907.585|C14.907.725|C23.550.767.877	Injuries, Myocardial Reperfusion|Injury, Myocardial Reperfusion|Myocardial Ischemic Reperfusion Injury|Myocardial Reperfusion Injuries|Reperfusion Injuries, Myocardial|Reperfusion Injury, Myocardial	Cardiovascular disease|Pathology (process)
Myocardial Stunning	MESH:D017682	DO:DOID:9767	Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity.	MESH:D006331|MESH:D012816	C14.280.671|C23.888.582	C14.280|C23.888	Hibernation, Myocardial|Myocardial Hibernation|Myocardium, Stunned|Stunned Myocardium|Stunning, Myocardial	Cardiovascular disease|Signs and symptoms
Myocarditis	MESH:D009205	DO:DOID:820	Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.	MESH:D009202	C14.280.238.625	C14.280.238	Carditis|Myocarditides	Cardiovascular disease
MYOCLONIC-ATONIC EPILEPSY	OMIM:616421			MESH:D004829|MESH:D004831	C10.228.140.490.375.130/616421|C10.228.140.490.375/616421|C10.228.140.490.493.063/616421	C10.228.140.490.375|C10.228.140.490.375.130|C10.228.140.490.493.063	MAE	Nervous system disease
Myoclonic dystonia	MESH:C536096	OMIM:159900|OMIM:616398		MESH:D020821	C10.228.662.300/C536096	C10.228.662.300	Alcohol-Responsive Dystonia|Dystonia 11|DYSTONIA 11, MYOCLONIC|DYSTONIA 26, MYOCLONIC|Dystonia, Alcohol-Responsive|DYT11|DYT26|Hereditary essential myoclonus|MYOCLONIC DYSTONIA|Myoclonus-Dystonia|Myoclonus-dystonia syndrome|Myoclonus, hereditary essential	Nervous system disease
Myoclonic Epilepsies, Progressive	MESH:D020191	DO:DOID:0060162|DO:DOID:0111444|DO:DOID:891|OMIM:125370|OMIM:614018|OMIM:615369|OMIM:616187|OMIM:616230|OMIM:616540|OMIM:616640	A heterogeneous group of primarily familial EPILEPSY disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis (see MUCOLIPIDOSES), and UNVERRICHT-LUNDBORG SYNDROME.	MESH:D004831	C10.228.140.490.375.130.650|C10.228.140.490.493.063.650	C10.228.140.490.375.130|C10.228.140.490.493.063	Action Myoclonus Renal Failure Syndrome|Action Myoclonus-Renal Failure Syndrome|Ataxia, Chorea, Seizures, And Dementia|Atrophies, Dentatorubral-Pallidoluysian|Atrophy, Dentatorubral-Pallidoluysian|Atypical Inclusion Body Disease|Atypical Inclusion-Body Disease|Atypical Inclusion-Body Diseases|Biotin-Responsive Encephalopathies|Biotin Responsive Encephalopathy|Biotin-Responsive Encephalopathy|DEE94|Dentatorubral-Pallidoluysian Atrophies|Dentatorubral Pallidoluysian Atrophy|Dentatorubral-Pallidoluysian Atrophy|DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94|DRPLA|EEOC|Encephalopathies, Biotin-Responsive|Encephalopathy, Biotin-Responsive|Epilepsies, Progressive Myoclonic|Epilepsies, Progressive Myoclonus|Epilepsy, Progressive Myoclonic|EPILEPSY, PROGRESSIVE MYOCLONIC, 10|EPILEPSY, PROGRESSIVE MYOCLONIC, 6|EPILEPSY, PROGRESSIVE MYOCLONIC 7|EPILEPSY, PROGRESSIVE MYOCLONIC, 8|EPILEPSY, PROGRESSIVE MYOCLONIC, 9|Epilepsy, Progressive Myoclonus|EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET|EPM10|EPM6|EPM7|EPM8|EPM9|Familial Progressive Myoclonic Epilepsy|Haw River Syndrome|Haw River Syndromes|HRS|Inclusion-Body Disease, Atypical|Inclusion-Body Diseases, Atypical|May White Syndrome|May-White Syndrome|Myoclonic Epilepsy, Progressive|MYOCLONIC EPILEPSY WITH CHOREOATHETOSIS|Myoclonus Epilepsies, Progressive|Myoclonus Nephropathy Syndrome|Myoclonus-Nephropathy Syndrome|Myoclonus-Nephropathy Syndromes|Naito Oyanagi Disease|Naito-Oyanagi Disease|Naito-Oyanagi Diseases|NOD|Progressive Myoclonic Epilepsies|Progressive Myoclonic Epilepsy|Progressive Myoclonus Epilepsies|Progressive Myoclonus Epilepsy|River Syndromes, Haw|Syndromes, Myoclonus-Nephropathy	Nervous system disease
Myoclonic Epilepsy, Congenital Deafness, Macular Dystrophy, and Psychiatric Disorders	MESH:C565786			MESH:D001523|MESH:D003638|MESH:D004831|MESH:D008268	C09.218.458.341.186/C565786|C10.228.140.490.375.130/C565786|C10.228.140.490.493.063/C565786|C10.597.751.418.341.186/C565786|C11.768.585.439/C565786|C23.888.592.763.393.341.186/C565786|F03/C565786	C09.218.458.341.186|C10.228.140.490.375.130|C10.228.140.490.493.063|C10.597.751.418.341.186|C11.768.585.439|C23.888.592.763.393.341.186|F03		Ear-nose-throat disease|Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	OMIM:605021			MESH:D004831	C10.228.140.490.375.130/605021|C10.228.140.490.493.063/605021	C10.228.140.490.375.130|C10.228.140.490.493.063	EIM|FIME	Nervous system disease
Myoclonic Epilepsy, Hartung Type	MESH:C563550			MESH:D004831	C10.228.140.490.375.130/C563550|C10.228.140.490.493.063/C563550	C10.228.140.490.375.130|C10.228.140.490.493.063		Nervous system disease
Myoclonic Epilepsy, Juvenile	MESH:D020190	DO:DOID:4890|OMIM:254770|OMIM:604827|OMIM:608816|OMIM:611136|OMIM:611364	A disorder characterized by the onset of myoclonus in adolescence, a marked increase in the incidence of absence seizures (see EPILEPSY, ABSENCE), and generalized major motor seizures (see EPILEPSY, TONIC-CLONIC). The myoclonic episodes tend to occur shortly after awakening. Seizures tend to be aggravated by sleep deprivation and alcohol consumption. Hereditary and sporadic forms have been identified. (From Adams et al., Principles of Neurology, 6th ed, p323)	MESH:D004831	C10.228.140.490.375.130.670|C10.228.140.490.493.063.670	C10.228.140.490.375.130|C10.228.140.490.493.063	Adolescent Myoclonic Epilepsy|ECA4, INCLUDED|EIG13|EIG7|EJM|EJM1, INCLUDED|EJM2, INCLUDED|EJM3|EJM4|EJM5,|EJM5, INCLUDED|Epilepsy, Adolescent Myoclonic|EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 4, INCLUDED|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13|EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7|Epilepsy, Juvenile Myoclonic|EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5, INCLUDED|Epilepsy, Myoclonic Juvenile|Epilepsy, Myoclonic, Juvenile|Impulsive Petit Mal Epilepsy|Impulsive Petit Mal, Janz|Janz Impulsive Petit Mal|Janz Juvenile Myoclonic Epilepsy|Janz Syndrome|JANZ SYNDROME MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED|JME|JME (Juvenile Myoclonic Epilepsy)|JMEs (Juvenile Myoclonic Epilepsy)|Juvenile Epilepsy, Myoclonic|Juvenile Myoclonic Epilepsy|Juvenile Myoclonic Epilepsy of Janz|Myoclonic Epilepsy, Adolescent|MYOCLONIC EPILEPSY, JUVENILE|Myoclonic Epilepsy, Juvenile, 1|MYOCLONIC EPILEPSY, JUVENILE, 2, INCLUDED|MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 3|MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4|Myoclonic Juvenile Epilepsy|Petit Mal, Impulsive|Petit Mal, Impulsive, Janz	Nervous system disease
Myoclonic epilepsy with choreoathetosis	MESH:C538427			MESH:D020191	C10.228.140.490.375.130.650/C538427|C10.228.140.490.493.063.650/C538427	C10.228.140.490.375.130.650|C10.228.140.490.493.063.650		Nervous system disease
Myoclonus	MESH:D009207		Involuntary shock-like contractions, irregular in rhythm and amplitude, followed by relaxation, of a muscle or a group of muscles. This condition may be a feature of some CENTRAL NERVOUS SYSTEM DISEASES; (e.g., EPILEPSY, MYOCLONIC). Nocturnal myoclonus is the principal feature of the NOCTURNAL MYOCLONUS SYNDROME. (From Adams et al., Principles of Neurology, 6th ed, pp102-3).	MESH:D020820	C10.597.350.500|C23.888.592.350.500	C10.597.350|C23.888.592.350	Action Myoclonus|Extremity Myoclonus, Lower|Extremity Myoclonus, Upper|Eyelid Myoclonus|Intention Myoclonus|Jerking, Myoclonic|Jerk, Myoclonic|Jerks, Myoclonic|Lower Extremity Myoclonus|Myoclonic Jerk|Myoclonic Jerking|Myoclonic Jerks|Myoclonus, Action|Myoclonus, Eyelid|Myoclonus, Intention|Myoclonus, Lower Extremity|Myoclonus, Nocturnal|Myoclonus, Oculopalatal|Myoclonus, Palatal|Myoclonus, Segmental|Myoclonus Simplex|Myoclonus, Sleep|Myoclonus, Upper Extremity|Nocturnal Myoclonus|Oculopalatal Myoclonus|Palatal Myoclonus|Polymyoclonus|Segmental Myoclonus|Simplex, Myoclonus|Sleep Myoclonus|Upper Extremity Myoclonus	Nervous system disease|Signs and symptoms
Myoclonus, Cerebellar Ataxia, and Deafness	MESH:C563549			MESH:D002524|MESH:D003638|MESH:D009207	C09.218.458.341.186/C563549|C10.228.140.252.190/C563549|C10.597.350.090.500/C563549|C10.597.350.500/C563549|C10.597.751.418.341.186/C563549|C23.888.592.350.090.200/C563549|C23.888.592.350.500/C563549|C23.888.592.763.393.341.186/C563549	C09.218.458.341.186|C10.228.140.252.190|C10.597.350.090.500|C10.597.350.500|C10.597.751.418.341.186|C23.888.592.350.090.200|C23.888.592.350.500|C23.888.592.763.393.341.186		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
MYOCLONUS, FAMILIAL, 1	OMIM:614937			MESH:D009207	C10.597.350.500/614937|C23.888.592.350.500/614937	C10.597.350.500|C23.888.592.350.500	FCM|MYOCL1|MYOCLONUS, FAMILIAL CORTICAL	Nervous system disease|Signs and symptoms
MYOCLONUS, INTRACTABLE, NEONATAL	OMIM:617235			MESH:D009207	C10.597.350.500/617235|C23.888.592.350.500/617235	C10.597.350.500|C23.888.592.350.500	NEIMY	Nervous system disease|Signs and symptoms
Myoepithelioma	MESH:D009208	DO:DOID:2661	A usually benign tumor made up predominantly of myoepithelial cells.	MESH:D018193	C04.557.435.585	C04.557.435	Myoepithelial Tumor|Myoepithelial Tumors|Myoepitheliomas|Tumor, Myoepithelial|Tumors, Myoepithelial	Cancer
Myofascial Pain Syndromes	MESH:D009209	DO:DOID:431	Muscular pain in numerous body regions that can be reproduced by pressure on TRIGGER POINTS, localized hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.	MESH:D009135	C05.651.550	C05.651	Myofascial Pain Syndrome|Myofascial Trigger Point Pain|Pain Syndrome, Myofascial|Pain Syndromes, Myofascial|Syndrome, Myofascial Pain|Syndromes, Myofascial Pain|Trigger Point Pain, Myofascial	Musculoskeletal disease
Myofibrillar Myopathy	MESH:C580316	DO:DOID:0080307|OMIM:601419|OMIM:609452|OMIM:612954|OMIM:617114|OMIM:617258		MESH:D020914	C05.651.575/C580316|C10.668.491.550/C580316	C05.651.575|C10.668.491.550	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 7, FORMERLY|ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 7, FORMERLY|ARVC7, FORMERLY|ARVD7, FORMERLY|CARDIOMYOPATHY, DILATED, 1F AND LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1D, FORMERLY|CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT AND MUSCULAR DYSTROPHY|CDCD3, FORMERLY|CMD1F AND LGMD1D, FORMERLY|DESMINOPATHY, PRIMARY|DESMIN-RELATED MYOPATHY|DESMIN-RELATED MYOPATHY WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY|DRM|IBM1, FORMERLY|INCLUSION BODY MYOPATHY 1, AUTOSOMAL DOMINANT, FORMERLY|LGMD2R, FORMERLY|MFM1|MFM4|MFM6|MFM7|MFM8|MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R, FORMERLY|Myofibrillar Myopathies|MYOFIBRILLAR MYOPATHY WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY|MYOPATHY, MYOFIBRILLAR, 1|MYOPATHY, MYOFIBRILLAR, 4|MYOPATHY, MYOFIBRILLAR, 6|MYOPATHY, MYOFIBRILLAR, 7|MYOPATHY, MYOFIBRILLAR, 8|MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED	Musculoskeletal disease|Nervous system disease
Myofibroma	MESH:D047708	DO:DOID:4386	A benign tumor that consists chiefly of fibrous CONNECTIVE TISSUE, with variable numbers of MUSCLE CELLS forming portions of the neoplasm (From Stedman's, 27th ed).	MESH:D009372	C04.557.450.565.540|C17.300.680.540	C04.557.450.565|C17.300.680	Myofibromas	Cancer|Connective tissue disease
Myofibromatosis	MESH:D018224		A condition characterized by multiple formations of myofibromas (LEIOMYOMA).	MESH:D018218	C04.557.450.565.590.550	C04.557.450.565.590	Myofibromatoses	Cancer
Myoglobinuria	MESH:D009212	DO:DOID:0080108	The presence of MYOGLOBIN in URINE usually as a result of rhabdomyolysis.	MESH:D012206	C05.651.807.628	C05.651.807	Myoglobinurias	Musculoskeletal disease
Myoglobinuria, Acute Recurrent, Autosomal Recessive	MESH:C564832	OMIM:268200		MESH:D009212	C05.651.807.628/C564832	C05.651.807.628	Myoglobinuria, Familial Paroxysmal Paralytic|Rhabdomyolysis, Acute Recurrent	Musculoskeletal disease
Myoglobinuria, Autosomal Dominant	MESH:C563546			MESH:D009212	C05.651.807.628/C563546	C05.651.807.628		Musculoskeletal disease
Myoglobinuria, Recurrent	MESH:C564018			MESH:D009212	C05.651.807.628/C564018	C05.651.807.628		Musculoskeletal disease
Myokymia	MESH:D020385		Successive and rapid contractions of motor units associated with chronic nerve injury. The discharges arise from the peripheral aspects of regenerating nerves, and clinically impart a nearly continuous undulation of the body surface overlying the muscle. (Adams et al., Principles of Neurology, 6th ed, p1491)	MESH:D020879	C10.597.613.650|C23.888.592.608.650	C10.597.613|C23.888.592.608	Chorea, Fibrillary|Chorea, Morvan|Chorea, Morvan's|Chorea, Morvan's Fibrillary|Choreas, Fibrillary|Choreas, Morvan|Choreas, Morvan's|Fibrillary Chorea|Fibrillary Chorea, Morvan's|Fibrillary Choreas|Generalized Myokymia|Generalized Myokymias|Kymatism|Kymatisms|Morvan Chorea|Morvan Choreas|Morvan Fibrillary Chorea|Morvan's Chorea|Morvans Chorea|Morvan's Choreas|Morvan's Fibrillary Chorea|Morvans Fibrillary Chorea|Myokymia, Generalized|Myokymias|Myokymias, Generalized	Nervous system disease|Signs and symptoms
Myokymia 1	MESH:C567174			MESH:D001259	C10.597.350.090/C567174|C23.888.592.350.090/C567174	C10.597.350.090|C23.888.592.350.090		Nervous system disease|Signs and symptoms
Myoma	MESH:D009214	DO:DOID:2691	A benign neoplasm of muscular tissue. (Stedman, 25th ed)	MESH:D009379	C04.557.450.590.540	C04.557.450.590	Myomas	Cancer
Myopathic carnitine deficiency	MESH:C536100			MESH:D009135	C05.651/C536100|C10.668.491/C536100	C05.651|C10.668.491	Carnitine Deficiency, Myopathic	Musculoskeletal disease|Nervous system disease
Myopathies, Nemaline	MESH:D017696	DO:DOID:3191	A group of inherited congenital myopathic conditions characterized clinically by weakness, hypotonia, and prominent hypoplasia of proximal muscles including the face. Muscle biopsy reveals large numbers of rod-shaped structures beneath the muscle fiber plasma membrane. This disorder is genetically heterogeneous and may occasionally present in adults. (Adams et al., Principles of Neurology, 6th ed, p1453)	MESH:D020914	C05.651.575.290|C10.668.491.550.290	C05.651.575|C10.668.491.550	Adult Onset Nemaline Myopathy|Autosomal Dominant Nemaline Myopathy|Autosomal Recessive Nemaline Myopathy|Childhood Onset Nemaline Myopathy|Late Onset Nemaline Myopathy|Myopathies, Rod|Myopathies, Rod-Body|Myopathy, Nemaline|Myopathy, Rod|Myopathy, Rod Body|Myopathy, Rod-Body|Nemaline Body Disease|Nemaline Myopathies|Nemaline Myopathy|Nemaline Myopathy, Adult Onset|Nemaline Myopathy, Autosomal Dominant|Nemaline Myopathy, Autosomal Recessive|Nemaline Myopathy, Childhood Onset|Nemaline Myopathy, Late Onset|Nemaline Rod Disease|Rod Body Disease|Rod-Body Myopathies|Rod Body Myopathy|Rod-Body Myopathy|Rod Myopathies|Rod Myopathy	Musculoskeletal disease|Nervous system disease
Myopathies, Structural, Congenital	MESH:D020914	DO:DOID:0111217|DO:DOID:0111225|DO:DOID:14717|DO:DOID:422|OMIM:160150|OMIM:160565|OMIM:255310|OMIM:310400|OMIM:614807|OMIM:615883	A heterogeneous group of diseases characterized by the early onset of hypotonia, developmental delay of motor skills, non-progressive weakness. Each of these disorders is associated with a specific histologic muscle fiber abnormality.	MESH:D009135	C05.651.575|C10.668.491.550	C05.651|C10.668.491	Aggregate Myopathies, Tubular|Aggregate Myopathy, Tubular|Autosomal Dominant Myotubular Myopathy|Autosomal Recessive Centronuclear Myopathy|Centronuclear Myopathies|Centronuclear Myopathies, X-Linked|Centronuclear Myopathy|Centronuclear Myopathy, X-Linked|CFTD|CFTDM|CNM1|CNM4|CNMX|Congenital Fiber Type Disproportion|Congenital Fiber-Type Disproportion|Congenital Fiber-Type Disproportions|Congenital Myopathy with Fiber Type Disproportion|Congenital Non Progressive Myopathies|Congenital Non-Progressive Myopathies|Congenital Non-Progressive Myopathy|Congenital Structural Myopathies|Congenital Structural Myopathy|Disproportion, Congenital Fiber-Type|Disproportions, Congenital Fiber-Type|Fiber-Type Disproportion, Congenital|Fiber Type Disproportion Myopathy, Congenital|Fiber-Type Disproportion Myopathy, Congenital|Fiber-Type Disproportions, Congenital|MTM1|MTMX|Myopathies, Centronuclear|Myopathies, Congenital Non-Progressive|Myopathies, Congenital Structural|Myopathies, Myotubular|Myopathies, Tubular Aggregate|Myopathies, X-Linked Centronuclear|Myopathies, X-Linked Myotubular|Myopathy, Centronuclear|Myopathy, Centronuclear, 1|MYOPATHY, CENTRONUCLEAR, 4|Myopathy, Centronuclear, Autosomal Dominant|MYOPATHY, CENTRONUCLEAR, X-LINKED|Myopathy, Congenital Non-Progressive|Myopathy, Congenital Structural|Myopathy, Congenital, With Fiber-Type Disproportion|Myopathy, Myotubular|Myopathy, Tubular Aggregate|MYOPATHY, TUBULAR AGGREGATE, 1|MYOPATHY, TUBULAR AGGREGATE, 2|Myopathy, X-Linked Centronuclear|Myopathy, X-Linked Myotubular|Myotubular Myopathies|Myotubular Myopathies, X-Linked|Myotubular Myopathy|Myotubular Myopathy 1|Myotubular Myopathy, Autosomal Dominant|Myotubular Myopathy, X Linked|Myotubular Myopathy, X-Linked|Non Progressive Myopathies, Congenital|Non-Progressive Myopathies, Congenital|Non-Progressive Myopathy, Congenital|Structural Myopathies, Congenital|Structural Myopathy, Congenital|TAM|TAM1|TAM2|Tubular Aggregate Myopathies|Tubular Aggregate Myopathy|X-Linked Centronuclear Myopathies|X Linked Centronuclear Myopathy|X-Linked Centronuclear Myopathy|X-Linked Myotubular Myopathies|X Linked Myotubular Myopathy|X-Linked Myotubular Myopathy|XLMTM	Musculoskeletal disease|Nervous system disease
Myopathy, Actin, Congenital, with Excess of Thin Myofilaments	MESH:C563529	DO:DOID:0060239		MESH:D017696	C05.651.575.290/C563529|C10.668.491.550.290/C563529	C05.651.575.290|C10.668.491.550.290		Musculoskeletal disease|Nervous system disease
Myopathy, Cataract, Hypogonadism Syndrome	MESH:C563578			MESH:D002386|MESH:D007006|MESH:D009135|MESH:D028361	C05.651/C563578|C10.668.491/C563578|C11.510.245/C563578|C18.452.660/C563578|C19.391.482/C563578	C05.651|C10.668.491|C11.510.245|C18.452.660|C19.391.482	Ocular Myopathy with Hypogonadism	Endocrine system disease|Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease
Myopathy, Central Core	MESH:D020512	DO:DOID:3529|OMIM:117000	An inherited congenital myopathic condition characterized by weakness and hypotonia in infancy and delayed motor development. Muscle biopsy reveals a condensation of myofibrils and myofibrillar material in the central portion of each muscle fiber. (Adams et al., Principles of Neurology, 6th ed, p1452)	MESH:D020914	C05.651.575.300|C10.668.491.550.300	C05.651.575|C10.668.491.550	CCD|CCO MINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED|Central Core Disease|Central Core Disease of Muscle|Central Core Diseases|Central Core Myopathies|Central Core Myopathy|CNMDU1, INCLUDED|MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED|MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED|Myopathies, Central Core|NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED|Shy Magee Syndrome|Shy-Magee Syndrome|Syndrome, Shy-Magee	Musculoskeletal disease|Nervous system disease
Myopathy, Centronuclear, Autosomal Recessive	MESH:C562934	DO:DOID:0111220|OMIM:255200|OMIM:615959		MESH:D020914	C05.651.575/C562934|C10.668.491.550/C562934	C05.651.575|C10.668.491.550	CNM2|CNM5|MYOPATHY, CENTRONUCLEAR, 2|MYOPATHY, CENTRONUCLEAR, 5|MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE|Myotubular Myopathy, Autosomal Recessive	Musculoskeletal disease|Nervous system disease
Myopathy, Congenital, With Excess Of Muscle Spindles	MESH:C566896			MESH:D009135	C05.651/C566896|C10.668.491/C566896	C05.651|C10.668.491		Musculoskeletal disease|Nervous system disease
Myopathy, Congenital, With Fiber-Type Disproportion, X-Linked	MESH:C567594	OMIM:300580		MESH:D020914	C05.651.575/C567594|C10.668.491.550/C567594	C05.651.575|C10.668.491.550	CFTDX	Musculoskeletal disease|Nervous system disease
Myopathy, desmin storage	MESH:C536103			MESH:D018979	C05.651.594.600/C536103|C10.668.491.562.500/C536103	C05.651.594.600|C10.668.491.562.500	Cardiomyopathy due to desmin defect|Desmin storage myopathy|Myopathy with sarcoplasmic bodies and intermediate filaments	Musculoskeletal disease|Nervous system disease
Myopathy, Early-Onset, with Fatal Cardiomyopathy	MESH:C567129	OMIM:611705		MESH:D009135|MESH:D009202	C05.651/C567129|C10.668.491/C567129|C14.280.238/C567129	C05.651|C10.668.491|C14.280.238	Early-Onset Myopathy with Fatal Cardiomyopathy|EOMFC|MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY|Salih Cmd|Salih Congenital Muscular Dystrophy|Salih Myopathy|SALMY	Cardiovascular disease|Musculoskeletal disease|Nervous system disease
Myopathy, Granulovacuolar Lobular, with Electrical Myotonia	MESH:C564974			MESH:D009135|MESH:D009222	C05.651/C564974|C10.597.613.700/C564974|C10.668.491/C564974|C23.888.592.608.700/C564974	C05.651|C10.597.613.700|C10.668.491|C23.888.592.608.700		Musculoskeletal disease|Nervous system disease|Signs and symptoms
Myopathy, Hyaline Body, Autosomal Recessive	MESH:C564970	OMIM:255160		MESH:D009135	C05.651/C564970|C10.668.491/C564970	C05.651|C10.668.491	MSMB|MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE|MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE	Musculoskeletal disease|Nervous system disease
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT	OMIM:616209			MESH:D017240	C05.651.460/616209|C10.668.491.500/616209|C18.452.660.560/616209	C05.651.460|C10.668.491.500|C18.452.660.560	IMMD	Metabolic disease|Musculoskeletal disease|Nervous system disease
Myopathy, Mitochondrial, Lethal Infantile	MESH:C564017	OMIM:551000		MESH:D017240	C05.651.460/C564017|C10.668.491.500/C564017|C18.452.660.560/C564017	C05.651.460|C10.668.491.500|C18.452.660.560	LIMM|MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE	Metabolic disease|Musculoskeletal disease|Nervous system disease
Myopathy, Mitochondrial Progressive, With Congenital Cataract, Hearing Loss, And Developmental Delay	MESH:C567769	OMIM:613076		MESH:D002386|MESH:D002658|MESH:D017240|MESH:D034381	C05.651.460/C567769|C09.218.458.341/C567769|C10.597.751.418.341/C567769|C10.668.491.500/C567769|C11.510.245/C567769|C18.452.660.560/C567769|C23.888.592.763.393.341/C567769|F03.625.421/C567769	C05.651.460|C09.218.458.341|C10.597.751.418.341|C10.668.491.500|C11.510.245|C18.452.660.560|C23.888.592.763.393.341|F03.625.421	Mitochondrial Complex Deficiency, Combined|MPMCD|MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT AND DEVELOPMENTAL DELAY|Myopathy With Cataract And Combined Respiratory Chain Deficiency	Ear-nose-throat disease|Eye disease|Mental disorder|Metabolic disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Myopathy, Myofibrillar, Bag3-Related	MESH:C567843			MESH:D020914	C05.651.575/C567843|C10.668.491.550/C567843	C05.651.575|C10.668.491.550		Musculoskeletal disease|Nervous system disease
MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	OMIM:613869	DO:DOID:0080309		MESH:C563848|MESH:C580316|MESH:D009122	C05.651.575/C580316/613869|C05.651/C563848/613869|C10.597.613.550/613869|C10.668.491.550/C580316/613869|C10.668.491/C563848/613869|C11.510.245/C563848/613869|C14.280.238/C563848/613869|C23.888.592.608.550/613869	C05.651.575/C580316|C05.651/C563848|C10.597.613.550|C10.668.491.550/C580316|C10.668.491/C563848|C11.510.245/C563848|C14.280.238/C563848|C23.888.592.608.550	MFM, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	Cardiovascular disease|Eye disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Myopathy, Myosin Storage	MESH:C564253	OMIM:608358		MESH:D009135	C05.651/C564253|C10.668.491/C564253	C05.651|C10.668.491	MSMA|Myopathy, Hyaline Body, Autosomal Dominant|MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT|MYOPATHY WITH LYSIS OF TYPE I MYOFIBRILS	Musculoskeletal disease|Nervous system disease
MYOPATHY, SPHEROID BODY	OMIM:182920	DO:DOID:0080091		MESH:C580316	C05.651.575/C580316/182920|C10.668.491.550/C580316/182920	C05.651.575/C580316|C10.668.491.550/C580316		Musculoskeletal disease|Nervous system disease
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	OMIM:615673	DO:DOID:0111335		MESH:D018908	C05.651.515/615673|C10.597.613.593/615673|C23.550.695/615673|C23.888.592.608.593/615673	C05.651.515|C10.597.613.593|C23.550.695|C23.888.592.608.593	MPXPS	Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Myopathy with Giant Abnormal Mitochondria	MESH:C564971			MESH:D009135|MESH:D028361	C05.651/C564971|C10.668.491/C564971|C18.452.660/C564971	C05.651|C10.668.491|C18.452.660		Metabolic disease|Musculoskeletal disease|Nervous system disease
Myopathy with Lactic Acidosis, Hereditary	MESH:C564972	OMIM:255125		MESH:D000140|MESH:D009135	C05.651/C564972|C10.668.491/C564972|C18.452.076.176.180/C564972	C05.651|C10.668.491|C18.452.076.176.180	Hereditary Myopathy with Lactic Acidosis|HML|Iron-Sulfur Cluster Deficiency Myopathy|Myoglobinuria due to Abnormal Glycolysis|Myopathy with Deficiency of Iron-Sulfur Cluster Assembly Enzyme|Myopathy with Deficiency of ISCU|Myopathy with Deficiency of Succinate Dehydrogenase and Aconitase|Myopathy with Exercise Intolerance, Swedish Type	Metabolic disease|Musculoskeletal disease|Nervous system disease
Myopericytoma	MESH:D000077777		Rare myofibroma-like perivascular soft tissue tumor, usually benign, characterized by concentric perivascular proliferation.	MESH:D006393|MESH:D009372	C04.557.450.565.545|C04.557.645.380.500|C17.300.680.770	C04.557.450.565|C04.557.645.380|C17.300.680	Myopericytomas	Cancer|Connective tissue disease
Myopia	MESH:D009216	DO:DOID:11830|OMIM:608367	A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation (ACCOMMODATION, OCULAR) is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.	MESH:D012030	C11.744.636	C11.744	MYOPIA 17, AUTOSOMAL DOMINANT|MYOPIA 4, FORMERLY|Myopias|MYP17|MYP4, FORMERLY|Nearsightedness|Nearsightednesses	Eye disease
Myopia 10	MESH:C563758	OMIM:609259		MESH:D009216	C11.744.636/C563758	C11.744.636	MYP10	Eye disease
Myopia 11	MESH:C566490	OMIM:609994		MESH:D009216	C11.744.636/C566490	C11.744.636	MYOPIA 11, AUTOSOMAL DOMINANT|MYP11	Eye disease
Myopia 12	MESH:C566489	OMIM:609995		MESH:D009216	C11.744.636/C566489	C11.744.636	MYOPIA 12, AUTOSOMAL DOMINANT|MYP12	Eye disease
Myopia 14	MESH:C565202	OMIM:610320		MESH:D009216	C11.744.636/C565202	C11.744.636	MYP14	Eye disease
Myopia 15	MESH:C567193	OMIM:612717		MESH:D009216	C11.744.636/C567193	C11.744.636	MYOPIA 15, AUTOSOMAL DOMINANT|MYP15	Eye disease
Myopia 16	MESH:C567259	OMIM:612554		MESH:D009216	C11.744.636/C567259	C11.744.636	MYOPIA 16, AUTOSOMAL DOMINANT|MYP16	Eye disease
Myopia 18, Autosomal Recessive	MESH:C567606	OMIM:255500		MESH:D009216	C11.744.636/C567606	C11.744.636	Myopia 18|MYP18	Eye disease
MYOPIA 19, AUTOSOMAL DOMINANT	OMIM:613969	DO:DOID:11830		MESH:D009216	C11.744.636/613969	C11.744.636	MYP19	Eye disease
Myopia 2	MESH:C563541	OMIM:160700		MESH:D009216	C11.744.636/C563541	C11.744.636	MYOPIA 2, AUTOSOMAL DOMINANT|MYP2	Eye disease
MYOPIA 20, AUTOSOMAL DOMINANT	OMIM:614166	DO:DOID:11830		MESH:D009216	C11.744.636/614166	C11.744.636	MYP20	Eye disease
MYOPIA 21, AUTOSOMAL DOMINANT	OMIM:614167	DO:DOID:11830		MESH:D009216	C11.744.636/614167	C11.744.636	MYP21	Eye disease
MYOPIA 22, AUTOSOMAL DOMINANT	OMIM:615420	DO:DOID:11830		MESH:D009216	C11.744.636/615420	C11.744.636	MYP22	Eye disease
MYOPIA 23, AUTOSOMAL RECESSIVE	OMIM:615431	DO:DOID:11830		MESH:D009216	C11.744.636/615431	C11.744.636	MYP23	Eye disease
MYOPIA 24, AUTOSOMAL DOMINANT	OMIM:615946	DO:DOID:11830		MESH:D009216	C11.744.636/615946	C11.744.636	MYP24	Eye disease
MYOPIA 25, AUTOSOMAL DOMINANT	OMIM:617238			MESH:D009216	C11.744.636/617238	C11.744.636	MYP25	Eye disease
Myopia 3	MESH:C566397	OMIM:603221		MESH:D009216	C11.744.636/C566397	C11.744.636	MYOPIA 3, AUTOSOMAL DOMINANT|MYP3	Eye disease
Myopia 5	MESH:C563922	OMIM:608474		MESH:D009216	C11.744.636/C563922	C11.744.636	MYOPIA 5, AUTOSOMAL DOMINANT|MYP5	Eye disease
Myopia 6	MESH:C536105	OMIM:608908		MESH:D009216	C11.744.636/C536105	C11.744.636	Myopia, susceptibility to|MYP6	Eye disease
Myopia 7	MESH:C563761	OMIM:609256		MESH:D009216	C11.744.636/C563761	C11.744.636	MYP7	Eye disease
Myopia 8	MESH:C563760	OMIM:609257		MESH:D009216	C11.744.636/C563760	C11.744.636	MYP8	Eye disease
Myopia 9	MESH:C563759	OMIM:609258		MESH:D009216	C11.744.636/C563759	C11.744.636	MYP9	Eye disease
Myopia, Degenerative	MESH:D047728	DO:DOID:11829	Excessive axial myopia associated with complications (especially posterior staphyloma and CHOROIDAL NEOVASCULARIZATION) that can lead to BLINDNESS.	MESH:D009216	C11.744.636.500	C11.744.636	Degenerative Myopia|Degenerative Myopias|Myopia, Pathological|Myopia, Progressive|Myopias, Degenerative|Myopias, Pathological|Myopias, Progressive|Pathological Myopia|Pathological Myopias|Progressive Myopia|Progressive Myopias	Eye disease
MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION	OMIM:614292			MESH:D002386|MESH:D009216|MESH:D012162	C11.270.612/614292|C11.510.245/614292|C11.744.636/614292|C11.768.585/614292	C11.270.612|C11.510.245|C11.744.636|C11.768.585	MCVD	Eye disease
Myosarcoma	MESH:D009217	DO:DOID:4045	A general term for a malignant neoplasm derived from muscular tissue. (Stedman, 25th ed)	MESH:D009379|MESH:D012509	C04.557.450.590.550|C04.557.450.795.550	C04.557.450.590|C04.557.450.795	Myosarcomas	Cancer
Myosclerosis, Autosomal Recessive	MESH:C564968	OMIM:255600		MESH:D020914	C05.651.575/C564968|C10.668.491.550/C564968	C05.651.575|C10.668.491.550	Myopathy, Myosclerotic|Myosclerosis, Congenital, of Lowenthal	Musculoskeletal disease|Nervous system disease
Myositis	MESH:D009220	DO:DOID:633	Inflammation of a muscle or muscle tissue.	MESH:D009135	C05.651.594|C10.668.491.562	C05.651|C10.668.491	Focal Myositides|Focal Myositis|Idiopathic Inflammatory Myopathies|Idiopathic Inflammatory Myopathy|Idiopathic Inflammatory Myositis|Infectious Myositides|Infectious Myositis|Inflammatory Muscle Disease|Inflammatory Muscle Diseases|Inflammatory Myopathies|Inflammatory Myopathies, Idiopathic|Inflammatory Myopathy|Inflammatory Myopathy, Idiopathic|Muscle Disease, Inflammatory|Muscle Diseases, Inflammatory|Myopathies, Idiopathic Inflammatory|Myopathies, Inflammatory|Myopathy, Idiopathic Inflammatory|Myopathy, Inflammatory|Myositides|Myositides, Focal|Myositides, Infectious|Myositides, Proliferative|Myositis, Focal|Myositis, Infectious|Myositis, Proliferative|Proliferative Myositides|Proliferative Myositis	Musculoskeletal disease|Nervous system disease
Myositis, Inclusion Body	MESH:D018979	DO:DOID:3429|OMIM:147421	Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10)	MESH:D009220	C05.651.594.600|C10.668.491.562.500	C05.651.594|C10.668.491.562	IBM|Inclusion Body Myopathy, Sporadic|Inclusion Body Myositides|Inclusion Body Myositis|Inclusion Body Myositis, Sporadic|Myopathy, Inclusion Body, Sporadic|Myositides, Inclusion Body|Myositis, Inclusion Body, Sporadic|Sporadic Inclusion Body Myositis	Musculoskeletal disease|Nervous system disease
Myositis Ossificans	MESH:D009221	DO:DOID:13374|DO:DOID:668|OMIM:135100	A disease characterized by bony deposits or the ossification of muscle tissue.	MESH:D009220	C05.651.594.638	C05.651.594	Fibrodysplasia Ossificans Progressiva|FOP|Myositis Ossificans Progressiva|Progressive Myositis Ossificans|Progressive Ossifying Myositis	Musculoskeletal disease
Myostatin-related muscle hypertrophy	MESH:C536106	DO:DOID:0111072		MESH:D006984|MESH:D009135	C05.651/C536106|C10.668.491/C536106|C23.300.775/C536106	C05.651|C10.668.491|C23.300.775	Muscle Hypertrophy Syndrome	Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)
Myotilinopathy	MESH:C563775	OMIM:609200		MESH:D020914	C05.651.575/C563775|C10.668.491.550/C563775	C05.651.575|C10.668.491.550	LGMD1A, FORMERLY|LGMD1, FORMERLY|MFM3|MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A, FORMERLY|MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1, FORMERLY|MYOPATHY, MYOFIBRILLAR, 3|Myopathy, Myofibrillar, Myotilin-Related|MYOTILINOPATHY	Musculoskeletal disease|Nervous system disease
Myotonia	MESH:D009222		Prolonged failure of muscle relaxation after contraction. This may occur after voluntary contractions, muscle percussion, or electrical stimulation of the muscle. Myotonia is a characteristic feature of MYOTONIC DISORDERS.	MESH:D020879	C10.597.613.700|C23.888.592.608.700	C10.597.613|C23.888.592.608	Myotonia, Percussion|Myotonias|Myotonias, Percussion|Myotonic Phenomenon|Myotonic Phenomenons|Percussion Myotonia|Percussion Myotonias|Phenomenon, Myotonic|Phenomenons, Myotonic	Nervous system disease|Signs and symptoms
Myotonic Disorders	MESH:D020967	DO:DOID:0050759|DO:DOID:0111538|DO:DOID:450|OMIM:168300	Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles (e.g., intrinsic hand muscles) or occur as a generalized condition.	MESH:D009135	C05.651.662|C10.668.491.606	C05.651|C10.668.491	Disorder, Myotonic|Disorders, Myotonic|Eulenburg Disease|Eulenburg's Disease|Myopathies, Myotonic|Myopathy, Myotonic|Myotonia Fluctuans|Myotonic Disorder|Myotonic Myopathies|Myotonic Myopathy|Paralysis Periodica Paramyotonia|PARALYSIS PERIODICA PARAMYOTONICA  PARAMYOTONIA CONGENITA WITHOUT COLD PARALYSIS, INCLUDED|Paramyotonia Congenita|Paramyotonia Congenita of von Eulenberg|PARAMYOTONIA CONGENITA OF VON EULENBURG|Paramyotonia Congenita Without Cold Paralysis|PMC|Von Eulenberg Disease|Von Eulenberg's Disease	Musculoskeletal disease|Nervous system disease
Myotonic Myopathy with Cylindrical Spirals	MESH:C563535			MESH:D020967	C05.651.662/C563535|C10.668.491.606/C563535	C05.651.662|C10.668.491.606		Musculoskeletal disease|Nervous system disease
Myotoxicity	MESH:D000081030		Damage to the muscle or its function secondary to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.	MESH:D009135|MESH:D010335|MESH:D011832|MESH:D064420	C05.651.682|C10.668.491.628|C23.550.706|C25.100.828|C26.733.411	C05.651|C10.668.491|C23.550|C25.100|C26.733	Drug Associated Myopathies|Drug Associated Myopathy|Drug Induced Myopathies|Drug Induced Myopathy|Drug Related Myopathies|Drug Related Myopathy|Induced Myopathy, Drug|Myalgia Arthralgia Syndrome|Myalgia-Arthralgia Syndrome|Myalgia-Arthralgia Syndromes|Myopathies, Drug Related|Myopathy, Drug Associated|Myopathy, Drug Induced|Myopathy, Drug Related|Myopathy, Toxic|Myotoxicities|Related Myopathies, Drug|Related Myopathy, Drug|Toxic Myopathies|Toxic Myopathy	Musculoskeletal disease|Nervous system disease|Pathology (process)|Wounds and injuries
Myringosclerosis	MESH:D063371		The formation of dense connective tissue in the TYMPANIC MEMBRANE that does not necessarily cause or lead to loss of hearing.	MESH:D004427	C09.218.636	C09.218	Myringoscleroses|Tympanoscleroses|Tympanosclerosis	Ear-nose-throat disease
Myxedema	MESH:D009230	DO:DOID:11634	A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.	MESH:D007037|MESH:D017520	C17.300.550.590|C19.874.482.638	C17.300.550|C19.874.482	Myxedemas	Connective tissue disease|Endocrine system disease
Myxoma	MESH:D009232		A benign neoplasm derived from connective tissue, consisting chiefly of polyhedral and stellate cells that are loosely embedded in a soft mucoid matrix, thereby resembling primitive mesenchymal tissue. It occurs frequently intramuscularly where it may be mistaken for a sarcoma. It appears also in the jaws and the skin. (From Stedman, 25th ed)	MESH:D009372	C04.557.450.565.550	C04.557.450.565	Angiomyxoma|Angiomyxomas|Myxomas	Cancer
Myxosarcoma	MESH:D009236	DO:DOID:4136	A sarcoma, usually a liposarcoma or malignant fibrous histiocytoma, with an abundant component of myxoid tissue resembling primitive mesenchyme containing connective tissue mucin. (Stedman, 25th ed)	MESH:D009372|MESH:D012509	C04.557.450.565.560|C04.557.450.795.560	C04.557.450.565|C04.557.450.795	Myxosarcomas	Cancer
NADH cytochrome B5 reductase deficiency	MESH:C537841	OMIM:250800		MESH:D008708	C15.378.619/C537841	C15.378.619	Diaphorase deficiency|Methemoglobinemia, Congenital, Autosomal Recessive|METHEMOGLOBINEMIA, CONGENITAL, AUTOSOMAL RECESSIVE METHEMOGLOBINEMIA, TYPE I, INCLUDED|Methemoglobinemia due to deficiency of methemoglobin reductase|Methemoglobinemia, Type I|Methemoglobinemia, Type Ii|METHEMOGLOBINEMIA, TYPE II, INCLUDED|Nadh-Cytochrome B5 Reductase Deficiency|Nadh-Cytochrome B5 Reductase Deficiency, Type I|Nadh-Cytochrome B5 Reductase Deficiency, Type Ii|NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY, TYPE II, INCLUDED|NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY, TYPE I, INCLUDED|NADH-dependent methemoglobin reductase deficiency|NADH diaphorase deficiency|NADH methemoglobin reductase deficiency	Blood disease
Nail Diseases	MESH:D009260	DO:DOID:4123	Diseases of the nail plate and tissues surrounding it. The concept is limited to primates.	MESH:D012871	C17.800.529	C17.800	Disease, Nail|Diseases, Nail|Nail Disease	Skin disease
NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1	OMIM:161050	DO:DOID:0080079		MESH:C562907	C17.800.529/C562907/161050|C23.300.820/C562907/161050	C17.800.529/C562907|C23.300.820/C562907	CLAW-SHAPED NAILS|NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10, FORMERLY;NDNC10, FORMERLY NAIL GROWTH, INCLUDED|NDNC1|ONYCHAUXIS, HYPONYCHIA, AND ONYCHOLYSIS|ONYCHODYSTROPHY TOTALIS, ISOLATED|TWENTY-NAIL DYSTROPHY	Pathology (anatomical condition)|Skin disease
NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3	OMIM:151600	DO:DOID:0080081		MESH:C535889	C17.800.529/C535889/151600|C17.800.621.440/C535889/151600	C17.800.529/C535889|C17.800.621.440/C535889	LEUKONYCHIA PUNCTATA, INCLUDED|LEUKONYCHIA TOTALIS AND/OR PARTIALIS|NDNC3|PORCELAIN NAILS LEUKONYCHIA STRIATUS, INCLUDED	Skin disease
NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9	OMIM:614149	DO:DOID:0080087		MESH:D009264|MESH:D054039	C17.800.529.478/614149|C23.300.820/614149	C17.800.529.478|C23.300.820	ANONYCHIA-ONYCHOLYSIS, ISOLATED|NAIL DYSPLASIA|NDNC9|ONYCHODYSTROPHY	Pathology (anatomical condition)|Skin disease
Nail dysplasia, isolated congenital	MESH:C538333	OMIM:605779		MESH:D009260	C17.800.529/C538333	C17.800.529	Congenital Isolated nail dysplasia|Isolated congenital nail dysplasia|NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7|NDNC7|Onychodysplasia, Isolated Congenital	Skin disease
Nails, Ingrown	MESH:D009263		Excessive lateral nail growth into the nail fold. Because the lateral margin of the nail acts as a foreign body, inflammation and granulation may result. It is caused by improperly fitting shoes and by improper trimming of the nail.	MESH:D009260	C17.800.529.406	C17.800.529	Ingrown Nail|Ingrown Nails|Nail, Ingrown|Onychocryptoses|Onychocryptosis	Skin disease
Najjar syndrome	MESH:C535580	DO:DOID:0111584		MESH:D009202	C14.280.238/C535580	C14.280.238	Cardiogenital syndrome|Genital Anomaly With Cardiomyopathy	Cardiovascular disease
Nasal Alar Collapse, Bilateral	MESH:C563533			MESH:D009668	C08.460/C563533|C09.603/C563533	C08.460|C09.603		Ear-nose-throat disease|Respiratory tract disease
Nasal Obstruction	MESH:D015508		Any hindrance to the passage of air into and out of the nose. The obstruction may be unilateral or bilateral, and may involve any part of the NASAL CAVITY.	MESH:D000402|MESH:D009668	C08.460.525|C08.618.846.185.525|C09.603.525	C08.460|C08.618.846.185|C09.603	Airway Obstruction, Nasal|Bilateral Nasal Obstruction|Blockage, Nasal|Blockages, Nasal|Nasal Airway Obstruction|Nasal Blockage|Nasal Blockages|Nasal Obstruction, Bilateral|Nasal Obstruction, Unilateral|Obstruction, Bilateral Nasal|Obstruction, Nasal|Obstruction, Nasal Airway|Obstructions, Nasal|Unilateral Nasal Obstruction	Ear-nose-throat disease|Respiratory tract disease
Nasal Polyps	MESH:D009298		Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.	MESH:D009668|MESH:D011127	C08.460.572|C09.603.557|C23.300.825.557	C08.460|C09.603|C23.300.825	Nasal Polyp|Polyp, Nasal|Polyps, Nasal	Ear-nose-throat disease|Pathology (anatomical condition)|Respiratory tract disease
Nasal Septal Perforation	MESH:D061270		An opening or hole in the NASAL SEPTUM that is caused by TRAUMA, injury, drug use, or pathological process.	MESH:D009668|MESH:D014947	C08.460.595|C09.603.588|C26.670	C08.460|C09.603|C26	Nasal Septal Perforations|Nasal Septum Perforation|Nasal Septum Perforations|Perforation, Nasal Septal|Perforation, Nasal Septum|Perforations, Nasal Septal|Perforations, Nasal Septum|Septal Perforation, Nasal|Septal Perforations, Nasal|Septum Perforation, Nasal|Septum Perforations, Nasal	Ear-nose-throat disease|Respiratory tract disease|Wounds and injuries
Nasopalpebral lipoma coloboma syndrome	MESH:C538338			MESH:D000015|MESH:D003103|MESH:D005142|MESH:D008067	C04.557.450.550.400/C538338|C04.588.443.392.500/C538338|C11.250.110/C538338|C11.270.147/C538338|C11.319.421/C538338|C11.338.526/C538338|C16.131.077/C538338|C16.131.384.282/C538338	C04.557.450.550.400|C04.588.443.392.500|C11.250.110|C11.270.147|C11.319.421|C11.338.526|C16.131.077|C16.131.384.282	Nasopalpebral Lipoma-Coloboma Syndrome|Palpebral coloboma lipoma Syndrome|Palpebral Coloboma-Lipoma Syndrome	Cancer|Congenital abnormality|Eye disease
Nasopharyngeal Carcinoma	MESH:D000077274	OMIM:161550|OMIM:607107|OMIM:617075	A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.	MESH:D002277|MESH:D009303	C04.557.470.200.623|C04.588.443.665.710.650.500|C07.550.350.650.500|C07.550.745.650.500|C09.647.710.650.500|C09.775.350.650.500|C09.775.549.650.500	C04.557.470.200|C04.588.443.665.710.650|C07.550.350.650|C07.550.745.650|C09.647.710.650|C09.775.350.650|C09.775.549.650	Carcinoma, Nasopharyngeal|Carcinomas, Nasopharyngeal|NASOPHARYNGEAL CANCER NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 1, INCLUDED|Nasopharyngeal Carcinomas|NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2|NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3|NPC|NPCA|NPCA1, INCLUDED|NPCA2|NPCA3	Cancer|Ear-nose-throat disease|Mouth disease
Nasopharyngeal Diseases	MESH:D009302	DO:DOID:9561	Pathological processes involving the NASOPHARYNX.	MESH:D010608	C07.550.350|C09.775.350	C07.550|C09.775	Disease, Nasopharyngeal|Diseases, Nasopharyngeal|Diseases of Nasopharynx|Nasopharyngeal Disease|Nasopharynx Disease|Nasopharynx Diseases	Ear-nose-throat disease|Mouth disease
Nasopharyngeal Neoplasms	MESH:D009303	DO:DOID:9261	Tumors or cancer of the NASOPHARYNX.	MESH:D009302|MESH:D010610	C04.588.443.665.710.650|C07.550.350.650|C07.550.745.650|C09.647.710.650|C09.775.350.650|C09.775.549.650	C04.588.443.665.710|C07.550.350|C07.550.745|C09.647.710|C09.775.350|C09.775.549	Cancer, Nasopharyngeal|Cancer, Nasopharynx|Cancer of Nasopharynx|Cancer of the Nasopharynx|Cancers, Nasopharyngeal|Cancers, Nasopharynx|Nasopharyngeal Cancer|Nasopharyngeal Cancers|Nasopharyngeal Neoplasm|Nasopharynx Cancer|Nasopharynx Cancers|Nasopharynx Neoplasm|Nasopharynx Neoplasms|Neoplasm, Nasopharyngeal|Neoplasm, Nasopharynx|Neoplasms, Nasopharyngeal|Neoplasms, Nasopharynx	Cancer|Ear-nose-throat disease|Mouth disease
Nasopharyngeal teratoma with Dandy Walker diaphragmatic hernia	MESH:C538340			MESH:D000015|MESH:D003616|MESH:D009303|MESH:D013724|MESH:D065630	C04.557.465.910/C538340|C04.588.443.665.710.650/C538340|C07.550.350.650/C538340|C07.550.745.650/C538340|C09.647.710.650/C538340|C09.775.350.650/C538340|C09.775.549.650/C538340|C10.228.140.252.300/C538340|C10.228.140.602.500/C538340|C10.500.205/C538340|C16.131.077/C538340|C16.131.433/C538340|C16.131.666.205/C538340|C23.300.707.960.500.116/C538340	C04.557.465.910|C04.588.443.665.710.650|C07.550.350.650|C07.550.745.650|C09.647.710.650|C09.775.350.650|C09.775.549.650|C10.228.140.252.300|C10.228.140.602.500|C10.500.205|C16.131.077|C16.131.433|C16.131.666.205|C23.300.707.960.500.116	Aughton Sloan Milad syndrome	Cancer|Congenital abnormality|Ear-nose-throat disease|Mouth disease|Nervous system disease|Pathology (anatomical condition)
Nasopharyngitis	MESH:D009304	DO:DOID:10460	Inflammation of the NASOPHARYNX, usually including its mucosa, related lymphoid structure, and glands.	MESH:D009302|MESH:D010612	C01.748.561.500|C07.550.350.700|C07.550.781.500|C08.730.561.500|C09.775.350.700|C09.775.649.500	C01.748.561|C07.550.350|C07.550.781|C08.730.561|C09.775.350|C09.775.649	Nasopharyngitides	Ear-nose-throat disease|Mouth disease|Respiratory tract disease
Nathalie syndrome	MESH:C538342			MESH:D002386|MESH:D003638|MESH:D006130|MESH:D009133|MESH:D010007	C05.116.791/C538342|C05.182.520/C538342|C09.218.458.341.186/C538342|C10.597.613.612/C538342|C10.597.751.418.341.186/C538342|C11.510.245/C538342|C17.300.182.520/C538342|C23.300.070.500/C538342|C23.550.393/C538342|C23.888.592.608.612/C538342|C23.888.592.763.393.341.186/C538342	C05.116.791|C05.182.520|C09.218.458.341.186|C10.597.613.612|C10.597.751.418.341.186|C11.510.245|C17.300.182.520|C23.300.070.500|C23.550.393|C23.888.592.608.612|C23.888.592.763.393.341.186		Connective tissue disease|Ear-nose-throat disease|Eye disease|Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)|Pathology (process)|Signs and symptoms
Natural Killer Cell Deficiency, Familial Isolated	MESH:C566492	DO:DOID:0111967		MESH:D007153	C20.673/C566492	C20.673		Immune system disease
NBIA2B	MESH:C565699	OMIM:610217		MESH:D019150|MESH:D019189	C10.228.140.744/C565699|C18.452.565/C565699	C10.228.140.744|C18.452.565	Neuroaxonal Dystrophy, Atypical|NEUROAXONAL DYSTROPHY, ATYPICAL  KARAK SYNDROME, INCLUDED|Neurodegeneration With Brain Iron Accumulation 2B|Neurodegeneration With Brain Iron Accumulation, PLA2G6-Related	Metabolic disease|Nervous system disease
Necrobiosis Lipoidica	MESH:D009335	DO:DOID:3486	A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.	MESH:D012875|MESH:D017441	C17.300.200.495.545|C17.800.550.545|C17.800.849.495|C18.452.880.495	C17.300.200.495|C17.800.550|C17.800.849|C18.452.880	Diabeticorum, Necrobiosis Lipoidica|Necrobiosis Lipoidica Diabeticorum	Connective tissue disease|Metabolic disease|Skin disease
Necrobiotic Disorders	MESH:D017441		A group of disorders characterized by swelling, basophilia, and distortion of collagen bundles in the dermis.	MESH:D003095|MESH:D012871	C17.300.200.495|C17.800.550	C17.300.200|C17.800	Disorder, Necrobiotic|Disorders, Necrobiotic|Necrobioses|Necrobiosis|Necrobiotic Disorder	Connective tissue disease|Skin disease
Necrobiotic Xanthogranuloma	MESH:D058252		A cutaneous necrobiotic disorder characterized by firm, yellow plaques or nodules, often in a periorbital distribution. It is often accompanied by an elevated ERYTHROCYTE SEDIMENTATION RATE; LEUKOPENIA; and MONOCLONAL GAMMOPATHY (IgG-kappa type) and systemic involvement.	MESH:D006099|MESH:D014973|MESH:D017441	C15.604.515.292.507|C17.300.200.495.772|C17.800.550.772|C18.452.584.750.487|C23.550.382.984	C15.604.515.292|C17.300.200.495|C17.800.550|C18.452.584.750|C23.550.382	Necrobiotic Xanthogranulomas|Xanthogranuloma, Necrobiotic|Xanthogranulomas, Necrobiotic	Connective tissue disease|Lymphatic disease|Metabolic disease|Pathology (process)|Skin disease
Negative rheumatoid factor polyarthritis	MESH:C538347			MESH:D001168	C05.550.114/C538347	C05.550.114	RF-ve CP|Rheumatoid factor negative erosive chronic polyarthritis|Rheumatoid factor-negative polyarthritis	Musculoskeletal disease
Nelson Syndrome	MESH:D009347	DO:DOID:4968	A syndrome characterized by HYPERPIGMENTATION, enlarging pituitary mass, visual defects secondary to compression of the OPTIC CHIASM, and elevated serum ACTH. It is caused by the expansion of an underlying ACTH-SECRETING PITUITARY ADENOMA that grows in the absence of feedback inhibition by adrenal CORTICOSTEROIDS, usually after ADRENALECTOMY.	MESH:D049913	C04.588.322.609.145.500|C10.228.140.617.738.675.149.500|C19.344.609.145.500|C19.700.734.145.500	C04.588.322.609.145|C10.228.140.617.738.675.149|C19.344.609.145|C19.700.734.145		Cancer|Endocrine system disease|Nervous system disease
Nemaline myopathy 1	MESH:C538348	OMIM:609284		MESH:D017696	C05.651.575.290/C538348|C10.668.491.550.290/C538348	C05.651.575.290|C10.668.491.550.290	CAPM1, INCLUDED|CAP MYOPATHY 1, INCLUDED|Cap Myopathy, Tpm3-Related|NEM1|Nemaline myopathy caused by mutation in the tropomyosin 3 gene	Musculoskeletal disease|Nervous system disease
NEMALINE MYOPATHY 10	OMIM:616165	DO:DOID:0110931		MESH:D017696	C05.651.575.290/616165|C10.668.491.550.290/616165	C05.651.575.290|C10.668.491.550.290	NEM10	Musculoskeletal disease|Nervous system disease
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE	OMIM:617336	DO:DOID:0110933		MESH:D017696	C05.651.575.290/617336|C10.668.491.550.290/617336	C05.651.575.290|C10.668.491.550.290	NEM11	Musculoskeletal disease|Nervous system disease
Nemaline Myopathy 2	MESH:C538349	OMIM:256030		MESH:D017696	C05.651.575.290/C538349|C10.668.491.550.290/C538349	C05.651.575.290|C10.668.491.550.290	NEM2|Nemaline myopathy caused by mutation in the nebulin gene	Musculoskeletal disease|Nervous system disease
NEMALINE MYOPATHY 3;NEM3 MYOPATHY, ACTIN, CONGENITAL, WITH EXCESS OF THIN MYOFILAMENTS,	OMIM:161800	DO:DOID:0110927		MESH:C579880|MESH:D017696	C05.651.575.290/161800|C05.651.575/C579880/161800|C10.668.491.550.290/161800|C10.668.491.550/C579880/161800	C05.651.575.290|C05.651.575/C579880|C10.668.491.550.290|C10.668.491.550/C579880	INCLUDED|MYOPATHY, ACTIN, CONGENITAL, WITH CORES, INCLUDED|NEMALINE MYOPATHY 3, WITH INTRANUCLEAR RODS, INCLUDED	Musculoskeletal disease|Nervous system disease
Nemaline myopathy 4	MESH:C538351	OMIM:609285		MESH:D017696	C05.651.575.290/C538351|C10.668.491.550.290/C538351	C05.651.575.290|C10.668.491.550.290	CAPM2, INCLUDED|CAP MYOPATHY 2, INCLUDED|Cap Myopathy, Tpm2-Related|NEM4|Nemaline myopathy caused by mutation in the tropomyosin 2 gene	Musculoskeletal disease|Nervous system disease
Nemaline myopathy 5	MESH:C538397	OMIM:605355		MESH:D017696	C05.651.575.290/C538397|C10.668.491.550.290/C538397	C05.651.575.290|C10.668.491.550.290	Amish Nemaline Myopathy|ANM|NEM5|Nemaline Myopathy, Amish Type|Nemaline myopathy, caused by mutation in the troponin t1 gene	Musculoskeletal disease|Nervous system disease
Nemaline myopathy 6	MESH:C538398	OMIM:609273		MESH:D017696	C05.651.575.290/C538398|C10.668.491.550.290/C538398	C05.651.575.290|C10.668.491.550.290	NEM6	Musculoskeletal disease|Nervous system disease
Nemaline Myopathy 7	MESH:C565198	OMIM:610687		MESH:D017696	C05.651.575.290/C565198|C10.668.491.550.290/C565198	C05.651.575.290|C10.668.491.550.290	NEM7	Musculoskeletal disease|Nervous system disease
NEMALINE MYOPATHY 8	OMIM:615348	DO:DOID:0110930		MESH:D017696	C05.651.575.290/615348|C10.668.491.550.290/615348	C05.651.575.290|C10.668.491.550.290	NEM8	Musculoskeletal disease|Nervous system disease
NEMALINE MYOPATHY 9	OMIM:615731	DO:DOID:0110929		MESH:D017696	C05.651.575.290/615731|C10.668.491.550.290/615731	C05.651.575.290|C10.668.491.550.290	NEM9	Musculoskeletal disease|Nervous system disease
Neonatal ovarian cyst	MESH:C536396			MESH:D010048	C04.182.612/C536396|C12.050.351.500.056.630.580/C536396|C12.100.250.056.630.580/C536396|C19.391.630.580/C536396	C04.182.612|C12.050.351.500.056.630.580|C12.100.250.056.630.580|C19.391.630.580	Fetal ovarian cyst	Cancer|Endocrine system disease|Urogenital disease (female)
Neonatal Systemic lupus erythematosus	MESH:C536397			MESH:D008180	C17.300.480/C536397|C20.111.590/C536397	C17.300.480|C20.111.590	Neonatal lupus|Neonatal lupus syndrome	Connective tissue disease|Immune system disease
Neoplasm Invasiveness	MESH:D009361		Ability of neoplasms to infiltrate and actively destroy surrounding tissue.	MESH:D009385	C04.697.645|C23.550.727.645	C04.697|C23.550.727	Invasion, Neoplasm|Invasiveness, Neoplasm|Neoplasm Invasion	Cancer|Pathology (process)
Neoplasm Metastasis	MESH:D009362		The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.	MESH:D009385	C04.697.650|C23.550.727.650	C04.697|C23.550.727	Metastase|Metastases|Metastases, Neoplasm|Metastasis|Metastasis, Neoplasm|Neoplasm Metastases	Cancer|Pathology (process)
Neoplasm Micrometastasis	MESH:D061206		Newly arising secondary tumors so small they are difficult to detect by physical examination or routine imaging techniques.	MESH:D009362	C04.697.650.695|C23.550.727.650.695	C04.697.650|C23.550.727.650	Micrometastase, Neoplasm|Micrometastases|Micrometastases, Neoplasm|Micrometastasis|Micrometastasis, Neoplasm|Neoplasm Micrometastase|Neoplasm Micrometastases	Cancer|Pathology (process)
Neoplasm Recurrence, Local	MESH:D009364		The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.	MESH:D009385	C04.697.655|C23.550.727.655	C04.697|C23.550.727	Local Neoplasm Recurrence|Local Neoplasm Recurrences|Locoregional Neoplasm Recurrence|Locoregional Neoplasm Recurrences|Neoplasm Recurrence, Locoregional|Neoplasm Recurrences, Local|Neoplasm Recurrences, Locoregional|Recurrence, Local Neoplasm|Recurrence, Locoregional Neoplasm|Recurrences, Local Neoplasm|Recurrences, Locoregional Neoplasm	Cancer|Pathology (process)
Neoplasm Regression, Spontaneous	MESH:D009365		Disappearance of a neoplasm or neoplastic state without the intervention of therapy.	MESH:D009385	C04.697.670|C23.550.727.670	C04.697|C23.550.727	Neoplasm Remission, Spontaneous|Regression, Spontaneous Neoplasm|Remission, Spontaneous Neoplasm|Spontaneous Neoplasm Regression|Spontaneous Neoplasm Remission	Cancer|Pathology (process)
Neoplasm, Residual	MESH:D018365		Remnant of a tumor or cancer after primary, potentially curative therapy.	MESH:D009385	C04.697.700|C23.550.727.700	C04.697|C23.550.727	Cancer, Residual|Minimal Disease, Residual|Minimal Residual Disease|Minimal Residual Diseases|Residual Cancer|Residual Cancers|Residual Disease, Minimal|Residual Minimal Disease|Residual Minimal Diseases|Residual Neoplasm|Residual Neoplasms|Residual Tumor|Residual Tumors|Residual Tumour|Residual Tumours|Tumour, Residual	Cancer|Pathology (process)
Neoplasms	MESH:D009369	DO:DOID:162	New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	MESH:C	C04	C	Benign Neoplasm|Benign Neoplasms|Cancer|Cancers|Malignancies|Malignancy|Malignant Neoplasm|Malignant Neoplasms|Neoplasia|Neoplasias|Neoplasm|Neoplasm, Benign|Neoplasm, Malignant|Neoplasms, Benign|Neoplasms, Malignant|Tumor|Tumors	Cancer
Neoplasms, Adipose Tissue	MESH:D018205	DO:DOID:3315	Neoplasms composed of fatty tissue or connective tissue made up of fat cells in a meshwork of areolar tissue. The concept does not refer to neoplasms located in adipose tissue.	MESH:D018204	C04.557.450.550	C04.557.450	Adipose Tissue Neoplasm|Adipose Tissue Neoplasms|Neoplasm, Adipose Tissue	Cancer
Neoplasms, Adnexal and Skin Appendage	MESH:D018294		Neoplasms composed of sebaceous or sweat gland tissue or tissue of other skin appendages. The concept does not refer to neoplasms located in the sebaceous or sweat glands or in the other skin appendages.	MESH:D009375	C04.557.470.550	C04.557.470	Adnexal and Skin Appendage Neoplasms	Cancer
Neoplasms, Basal Cell	MESH:D018295	DO:DOID:2513	Neoplasms composed of cells from the deepest layer of the epidermis. The concept does not refer to neoplasms located in the stratum basale.	MESH:D009375	C04.557.470.565	C04.557.470	Basal Cell Cancer|Basal Cell Cancers|Basal Cell Neoplasm|Basal Cell Neoplasms|Cancer, Basal Cell|Cancers, Basal Cell|Cell Cancer, Basal|Cell Cancers, Basal|Cell Neoplasm, Basal|Cell Neoplasms, Basal|Neoplasm, Basal Cell	Cancer
Neoplasms, Bone Tissue	MESH:D018213	DO:DOID:3347	Neoplasms composed of bony tissue, whether normal or of a soft tissue which has become ossified. The concept does not refer to neoplasms located in bones.	MESH:D009372	C04.557.450.565.575	C04.557.450.565	Bone Tissue Neoplasm|Bone Tissue Neoplasms|Bony Tissue Neoplasm|Bony Tissue Neoplasms|Neoplasm, Bone Tissue|Neoplasm, Bony Tissue|Neoplasms, Bony Tissue|Tissue Neoplasm, Bone|Tissue Neoplasm, Bony|Tissue Neoplasms, Bone|Tissue Neoplasms, Bony	Cancer
Neoplasms by Histologic Type	MESH:D009370		A collective term for the various histological types of NEOPLASMS. It is more likely to be used by searchers than by indexers and catalogers.	MESH:D009369	C04.557	C04	Histological Type of Neoplasm|Histological Types of Neoplasms|Neoplasm Histological Type|Neoplasm Histological Types|Neoplasms by Histological Type|Neoplasms Histological Type|Neoplasms Histological Types	Cancer
Neoplasms by Site	MESH:D009371	DO:DOID:0050686	A collective term for precoordinated organ/neoplasm headings locating neoplasms by organ, as BRAIN NEOPLASMS; DUODENAL NEOPLASMS; LIVER NEOPLASMS; etc.	MESH:D009369	C04.588	C04	Neoplasms by Sites|Neoplasm Site|Neoplasm Sites|Site, Neoplasm|Sites, Neoplasm	Cancer
Neoplasms, Complex and Mixed	MESH:D018193		Neoplasms composed of more than one type of neoplastic tissue.	MESH:D009370	C04.557.435	C04.557	Complex and Mixed Neoplasms	Cancer
Neoplasms, Connective and Soft Tissue	MESH:D018204		Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.	MESH:D009370	C04.557.450	C04.557	Connective and Soft Tissue Neoplasms	Cancer
Neoplasms, Connective Tissue	MESH:D009372	DO:DOID:201	Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue.	MESH:D003240|MESH:D018204	C04.557.450.565|C17.300.680	C04.557.450|C17.300	Connective Tissue Neoplasm|Connective Tissue Neoplasms|Neoplasm, Connective Tissue	Cancer|Connective tissue disease
Neoplasms, Cystic, Mucinous, and Serous	MESH:D018297		Neoplasms containing cyst-like formations or producing mucin or serum.	MESH:D009375	C04.557.470.590	C04.557.470		Cancer
Neoplasms, Ductal, Lobular, and Medullary	MESH:D018299		Neoplasms, usually carcinoma, located within the center of an organ or within small lobes, and in the case of the breast, intraductally. The emphasis of the name is on the location of the neoplastic tissue rather than on its histological type. Most cancers of this type are located in the breast.	MESH:D009375	C04.557.470.615	C04.557.470	Ductal, Lobular, and Medullary Neoplasms	Cancer
Neoplasm Seeding	MESH:D009366		The local implantation of tumor cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumor formation.	MESH:D009362	C04.697.650.830|C23.550.727.650.830	C04.697.650|C23.550.727.650	Seeding, Neoplasm	Cancer|Pathology (process)
Neoplasms, Experimental	MESH:D009374		Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.	MESH:D009369	C04.619	C04	Experimental Neoplasm|Experimental Neoplasms|Neoplasm, Experimental	Cancer
Neoplasms, Fibroepithelial	MESH:D018225		Neoplasms composed of fibrous and epithelial tissue. The concept does not refer to neoplasms located in fibrous tissue or epithelium.	MESH:D009375|MESH:D018218	C04.557.450.565.590.595|C04.557.470.625	C04.557.450.565.590|C04.557.470	Fibroepithelial Neoplasm|Fibroepithelial Neoplasms|Neoplasm, Fibroepithelial	Cancer
Neoplasms, Fibrous Tissue	MESH:D018218	DO:DOID:3355	Neoplasms composed of fibrous tissue, the ordinary connective tissue of the body, made up largely of yellow or white fibers. The concept does not refer to neoplasms located in fibrous tissue.	MESH:D009372	C04.557.450.565.590	C04.557.450.565	Fibrous Tissue Neoplasm|Fibrous Tissue Neoplasms|Neoplasm, Fibrous Tissue	Cancer
Neoplasms, Germ Cell and Embryonal	MESH:D009373	DO:DOID:2994|DO:DOID:3095|DO:DOID:688	Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.	MESH:D009370	C04.557.465	C04.557	Cancer, Embryonal|Cancer, Embryonal and Mixed|Cancer, Germ Cell|Cancers, Embryonal|Cancers, Germ Cell|Embryonal Cancer|Embryonal Cancers|Embryonal Neoplasm|Embryonal Neoplasms|Germ Cell and Embryonal Neoplasms|Germ Cell and Embryonic Neoplasms|Germ Cell Cancer|Germ Cell Cancers|Germ Cell Neoplasms|Germ Cell Tumor|Germ Cell Tumors|Neoplasm, Embryonal|Neoplasms, Embryonal|Neoplasms, Embryonal and Mixed|Neoplasms, Germ Cell|Neoplasms, Germ Cell and Embryonic|Tumor, Germ Cell|Tumors, Germ Cell	Cancer
Neoplasms, Glandular and Epithelial	MESH:D009375	DO:DOID:305	Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.	MESH:D009370	C04.557.470	C04.557	Epithelial Neoplasm|Epithelial Neoplasm, Glandular|Epithelial Neoplasms|Epithelial Neoplasms, Glandular|Glandular and Epithelial Neoplasms|Glandular Epithelial Neoplasm|Glandular Epithelial Neoplasms|Glandular Neoplasm|Glandular Neoplasms|Neoplasm, Epithelial|Neoplasm, Glandular|Neoplasm, Glandular Epithelial|Neoplasms, Epithelial|Neoplasms, Glandular|Neoplasms, Glandular Epithelial	Cancer
Neoplasms, Gonadal Tissue	MESH:D018309		Neoplasms composed of tissues of the OVARY or the TESTIS, not neoplasms located in the ovaries or testes. Gonadal tissues include GERM CELLS, cells from the sex cord, and gonadal stromal cells.	MESH:D009370	C04.557.475	C04.557	Gonadal Tissue Neoplasm|Gonadal Tissue Neoplasms|Neoplasm, Gonadal Tissue|Tissue Neoplasm, Gonadal|Tissue Neoplasms, Gonadal	Cancer
Neoplasms, Hormone-Dependent	MESH:D009376		Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.	MESH:D009369	C04.626	C04	Hormone-Dependent Neoplasm|Hormone Dependent Neoplasms|Hormone-Dependent Neoplasms|Neoplasm, Hormone-Dependent|Neoplasms, Hormone Dependent	Cancer
Neoplasms, Mesothelial	MESH:D018301		Neoplasms composed of tissue of the mesothelium, the layer of flat cells, derived from the mesoderm, which lines the body cavity of the embryo. In the adult it forms the simple squamous epithelium which covers all true serous membranes (peritoneum, pericardium, pleura). The concept does not refer to neoplasms located in these organs. (From Dorland, 27th ed)	MESH:D009375	C04.557.470.660	C04.557.470	Mesothelial Neoplasm|Mesothelial Neoplasms|Neoplasm, Mesothelial	Cancer
Neoplasms, Multiple Primary	MESH:D009378		Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.	MESH:D009369	C04.651	C04	Multiple Primary Neoplasm|Multiple Primary Neoplasms|Multiple Primary Neoplasms, Synchronous|Neoplasm, Multiple Primary|Neoplasms, Synchronous|Neoplasms, Synchronous Multiple Primary|Neoplasm, Synchronous|Primary Neoplasm, Multiple|Primary Neoplasms, Multiple|Synchronous Multiple Primary Neoplasms|Synchronous Neoplasm|Synchronous Neoplasms	Cancer
Neoplasms, Muscle Tissue	MESH:D009379	DO:DOID:461|DO:DOID:5039	Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles.	MESH:D018204	C04.557.450.590	C04.557.450	Muscle Tissue Neoplasm|Muscle Tissue Neoplasms|Myoblastoma|Myoblastomas|Myofibroblastoma|Myofibroblastomas|Neoplasm, Muscle Tissue	Cancer
Neoplasms, Nerve Tissue	MESH:D009380	DO:DOID:3093	Neoplasms composed of nerve tissue. This concept does not refer to neoplasms located in the nervous system or its component nerves.	MESH:D009370	C04.557.580	C04.557	Neoplasm, Nerve Tissue|Neoplasm, Nervous Tissue|Neoplasms, Nervous Tissue|Nerve Tissue Neoplasm|Nerve Tissue Neoplasms|Nervous Tissue Neoplasm|Nervous Tissue Neoplasms	Cancer
Neoplasms, Neuroepithelial	MESH:D018302	DO:DOID:6128|DO:DOID:7305	Neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into NEURONS, oligodendrocytes, and ASTROCYTES. The majority of craniospinal tumors are of neuroepithelial origin. (From Dev Biol 1998 Aug 1;200(1):1-5)	MESH:D009375|MESH:D017599	C04.557.465.625.600|C04.557.470.670|C04.557.580.625.600	C04.557.465.625|C04.557.470|C04.557.580.625	Astroblastoma|Astroblastomas|Ependymoastrocytoma|Ependymoastrocytomas|Gliomatosis Cerebri|Neoplasm, Neuroepithelial|Neuroepithelial Neoplasm|Neuroepithelial Neoplasms|Neuroepithelial Tumor|Neuroepithelial Tumors|Polar Spongioblastoma|Polar Spongioblastomas|Spongioblastoma, Polar|Spongioblastomas, Polar|Tumor, Neuroepithelial|Tumors, Neuroepithelial	Cancer
Neoplasms, Plasma Cell	MESH:D054219		Neoplasms associated with a proliferation of a single clone of PLASMA CELLS and characterized by the secretion of PARAPROTEINS.	MESH:D009370	C04.557.595	C04.557	Neoplasm, Plasma Cell|Plasma Cell Neoplasm|Plasma Cell Neoplasms	Cancer
Neoplasms, Post-Traumatic	MESH:D017169		Tumors, cancer or other neoplasms caused by or resulting from trauma or other non-radiation injuries.	MESH:D009369	C04.666	C04	Cancer, Post-Traumatic|Cancers, Post-Traumatic|Malignancies, Post Traumatic|Malignancies, Post-Traumatic|Malignancy, Post-Traumatic|Neoplasm, Post-Traumatic|Neoplasms, Post Traumatic|Post Traumatic Cancer|Post-Traumatic Cancer|Post-Traumatic Cancers|Post-Traumatic Malignancies|Post-Traumatic Malignancy|Post-Traumatic Neoplasm|Post Traumatic Neoplasms|Post-Traumatic Neoplasms	Cancer
Neoplasms, Radiation-Induced	MESH:D009381		Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.	MESH:D009369|MESH:D011832	C04.682|C26.733.476	C04|C26.733	Cancer, Radiation Induced|Cancer, Radiation-Induced|Cancers, Radiation-Induced|Neoplasm, Radiation-Induced|Neoplasms, Radiation Induced|Radiation Induced Cancer|Radiation-Induced Cancer|Radiation-Induced Cancers|Radiation-Induced Neoplasm|Radiation Induced Neoplasms|Radiation-Induced Neoplasms	Cancer|Wounds and injuries
Neoplasms, Second Primary	MESH:D016609		Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.	MESH:D009369	C04.692	C04	Cancer, Second|Cancer, Second Primary|Cancers, Second|Cancers, Second Primary|Cancers, Therapy-Associated|Cancers, Therapy-Related|Cancers, Treatment-Associated|Cancers, Treatment-Related|Cancer, Therapy-Associated|Cancer, Therapy-Related|Cancer, Treatment-Associated|Cancer, Treatment-Related|Malignancies, Second|Malignancy, Second|Metachronous Neoplasm|Metachronous Neoplasms|Metachronous Second Primary Neoplasms|Neoplasm, Metachronous|Neoplasm, Second|Neoplasm, Second Primary|Neoplasms, Metachronous|Neoplasms, Metachronous Second Primary|Neoplasms, Second|Neoplasms, Therapy Associated|Neoplasms, Therapy-Associated|Neoplasms, Therapy Related|Neoplasms, Therapy-Related|Neoplasms, Treatment Associated|Neoplasms, Treatment-Associated|Neoplasms, Treatment Related|Neoplasms, Treatment-Related|Neoplasm, Therapy-Associated|Neoplasm, Therapy-Related|Neoplasm, Treatment-Associated|Neoplasm, Treatment-Related|Second Cancer|Second Cancers|Second Malignancies|Second Malignancy|Second Neoplasm|Second Neoplasms|Second Primary Cancer|Second Primary Cancers|Second Primary Neoplasm|Second Primary Neoplasms|Second Primary Neoplasms, Metachronous|Therapy Associated Cancer|Therapy-Associated Cancer|Therapy-Associated Cancers|Therapy-Associated Neoplasm|Therapy Associated Neoplasms|Therapy-Associated Neoplasms|Therapy Related Cancer|Therapy-Related Cancer|Therapy-Related Cancers|Therapy-Related Neoplasm|Therapy Related Neoplasms|Therapy-Related Neoplasms|Treatment Associated Cancer|Treatment-Associated Cancer|Treatment-Associated Cancers|Treatment-Associated Neoplasm|Treatment Associated Neoplasms|Treatment-Associated Neoplasms|Treatment Related Cancer|Treatment-Related Cancer|Treatment-Related Cancers|Treatment-Related Neoplasm|Treatment Related Neoplasms|Treatment-Related Neoplasms	Cancer
Neoplasms, Squamous Cell	MESH:D018307	DO:DOID:1749|DO:DOID:3168	Neoplasms of the SQUAMOUS EPITHELIAL CELLS. The concept does not refer to neoplasms located in tissue composed of squamous elements.	MESH:D009375	C04.557.470.700	C04.557.470	Cancer, Squamous Cell|Cancers, Squamous Cell|Cell Cancer, Squamous|Cell Cancers, Squamous|Cell Neoplasm, Squamous|Cell Neoplasms, Squamous|Neoplasm, Squamous Cell|Squamous Cell Cancer|Squamous Cell Cancers|Squamous Cell Neoplasm|Squamous Cell Neoplasms	Cancer
Neoplasms, Unknown Primary	MESH:D009382		Metastases in which the tissue of origin is unknown.	MESH:D009362	C04.697.650.895|C23.550.727.650.895	C04.697.650|C23.550.727.650	Neoplasm Metastasis, Unknown Primary|Neoplasm, Occult Primary|Neoplasms, Occult Primary|Neoplasm, Unknown Primary|Occult Primary Neoplasm|Occult Primary Neoplasms|Primary Neoplasm, Occult|Primary Neoplasms, Occult|Primary Neoplasms, Unknown|Primary Neoplasm, Unknown|Primary Tumors, Unknown|Primary Tumor, Unknown|Tumors, Unknown Primary|Tumor, Unknown Primary|Unknown Primary Neoplasm|Unknown Primary Neoplasm Metastasis|Unknown Primary Neoplasms|Unknown Primary Tumor|Unknown Primary Tumors	Cancer|Pathology (process)
Neoplasms, Vascular Tissue	MESH:D009383		Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels.	MESH:D009370	C04.557.645	C04.557	Blood Vessel Tumor|Blood Vessel Tumors|Neoplasm, Vascular Tissue|Tumor, Blood Vessel|Tumors, Blood Vessel|Vascular Tissue Neoplasm|Vascular Tissue Neoplasms	Cancer
Neoplastic Cells, Circulating	MESH:D009360		Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.	MESH:D009362	C04.697.650.900|C23.550.727.650.900	C04.697.650|C23.550.727.650	Cell, Circulating Neoplastic|Cell, Circulating Tumor|Cell, Embolic Tumor|Cell, Neoplasm Circulating|Cells, Circulating Neoplastic|Cells, Circulating Tumor|Cells, Embolic Tumor|Cells, Neoplasm Circulating|Circulating Cells, Neoplasm|Circulating Neoplastic Cell|Circulating Neoplastic Cells|Circulating Tumor Cell|Circulating Tumor Cells|Embolic Tumor Cell|Embolic Tumor Cells|Embolisms, Tumor|Embolism, Tumor|Neoplasm Circulating Cell|Neoplasm Circulating Cells|Neoplastic Cell, Circulating|Tumor Cell, Circulating|Tumor Cell, Embolic|Tumor Cells, Circulating|Tumor Cells, Embolic|Tumor Embolism|Tumor Embolisms	Cancer|Pathology (process)
Neoplastic Processes	MESH:D009385		The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.	MESH:D009369|MESH:D010335	C04.697|C23.550.727	C04|C23.550	Processes, Neoplastic	Cancer|Pathology (process)
Nephrocalcinosis	MESH:D009397	DO:DOID:12679	A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.	MESH:D002114|MESH:D007674	C12.050.351.968.419.590|C12.200.777.419.590|C12.950.419.590|C18.452.174.130.560	C12.050.351.968.419|C12.200.777.419|C12.950.419|C18.452.174.130	Nephrocalcinoses	Metabolic disease|Urogenital disease (female)|Urogenital disease (male)
Nephrogenic Fibrosing Dermopathy	MESH:D054989		A chronic, acquired, idiopathic, progressive eruption of the skin that occurs in the context of RENAL FAILURE. It is sometimes accompanied by systemic fibrosis. The pathogenesis seems to be multifactorial, with postulated involvement of circulating fibrocytes. There is a strong association between this disorder and the use of gadolinium-based contrast agents.	MESH:D005355|MESH:D012871	C17.800.553|C23.550.355.550	C17.800|C23.550.355	Dermopathies, Nephrogenic Fibrosing|Dermopathy, Nephrogenic Fibrosing|Fibroses, Nephrogenic Systemic|Fibrosing Dermopathies, Nephrogenic|Fibrosing Dermopathy, Nephrogenic|Fibrosis, Nephrogenic Systemic|Nephrogenic Fibrosing Dermopathies|Nephrogenic Systemic Fibroses|Nephrogenic Systemic Fibrosis|Systemic Fibroses, Nephrogenic|Systemic Fibrosis, Nephrogenic	Pathology (process)|Skin disease
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	OMIM:612286	DO:DOID:0080077		MESH:D010024|MESH:D053040	C05.116.198.579/612286|C12.050.351.968.419.600/612286|C12.050.351.968.967.249/612286|C12.200.777.419.600/612286|C12.200.777.967.249/612286|C12.950.419.600/612286|C12.950.967.249/612286|C18.452.104.579/612286	C05.116.198.579|C12.050.351.968.419.600|C12.050.351.968.967.249|C12.200.777.419.600|C12.200.777.967.249|C12.950.419.600|C12.950.967.249|C18.452.104.579	NPHLOP1	Metabolic disease|Musculoskeletal disease|Urogenital disease (female)|Urogenital disease (male)
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	OMIM:612287	DO:DOID:0080078		MESH:D010024|MESH:D053040	C05.116.198.579/612287|C12.050.351.968.419.600/612287|C12.050.351.968.967.249/612287|C12.200.777.419.600/612287|C12.200.777.967.249/612287|C12.950.419.600/612287|C12.950.967.249/612287|C18.452.104.579/612287	C05.116.198.579|C12.050.351.968.419.600|C12.050.351.968.967.249|C12.200.777.419.600|C12.200.777.967.249|C12.950.419.600|C12.950.967.249|C18.452.104.579	NPHLOP2	Metabolic disease|Musculoskeletal disease|Urogenital disease (female)|Urogenital disease (male)
NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO	OMIM:605990	DO:DOID:580		MESH:D007669	C12.050.351.968.419.600.500/605990|C12.050.351.968.967.249.500/605990|C12.050.351.968.967.500.503/605990|C12.200.777.419.600.500/605990|C12.200.777.967.249.500/605990|C12.200.777.967.500.503/605990|C12.950.419.600.500/605990|C12.950.967.249.500/605990|C12.950.967.500.503/605990|C23.300.175.850.550/605990	C12.050.351.968.419.600.500|C12.050.351.968.967.249.500|C12.050.351.968.967.500.503|C12.200.777.419.600.500|C12.200.777.967.249.500|C12.200.777.967.500.503|C12.950.419.600.500|C12.950.967.249.500|C12.950.967.500.503|C23.300.175.850.550	UAN|UROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Nephroma, Mesoblastic	MESH:D018201	DO:DOID:4773	A solid, unencapsulated tumor of the KIDNEY composed of spindle mesenchymal cells that resemble FIBROBLASTS or muscle cells. The homogeneous mass typically extends into the renal parenchyma and replaces most of the kidney. In most cases, mesoblastic nephroma is benign and occurs in the fetus or newborn, and rarely in the older child or the adult.	MESH:D007680|MESH:D018193	C04.557.435.600|C04.588.945.947.535.790|C12.050.351.937.820.535.790|C12.050.351.968.419.473.372|C12.200.758.820.750.372|C12.200.777.419.473.372|C12.900.820.535.790|C12.950.419.473.372|C12.950.983.535.790	C04.557.435|C04.588.945.947.535|C12.050.351.937.820.535|C12.050.351.968.419.473|C12.200.758.820.750|C12.200.777.419.473|C12.900.820.535|C12.950.419.473|C12.950.983.535	Congenital Mesoblastic Nephroma|Congenital Mesoblastic Nephromas|Mesoblastic Nephroma|Mesoblastic Nephroma, Congenital|Mesoblastic Nephromas, Congenital|Nephroma, Congenital Mesoblastic|Nephromas, Congenital Mesoblastic|Nephromas, Mesoblastic	Cancer|Urogenital disease (female)|Urogenital disease (male)
Nephropathy deafness hyperparathyroidism	MESH:C536401			MESH:D006319|MESH:D006961|MESH:D007676	C09.218.458.341.887/C536401|C10.597.751.418.341.887/C536401|C12.050.351.968.419.780.750.500/C536401|C12.200.777.419.780.750.500/C536401|C12.950.419.780.750.500/C536401|C19.642.355/C536401|C23.550.291.500.906.500/C536401|C23.888.592.763.393.341.887/C536401	C09.218.458.341.887|C10.597.751.418.341.887|C12.050.351.968.419.780.750.500|C12.200.777.419.780.750.500|C12.950.419.780.750.500|C19.642.355|C23.550.291.500.906.500|C23.888.592.763.393.341.887	Nephropathy, Deafness, And Hyperparathyroidism	Ear-nose-throat disease|Endocrine system disease|Nervous system disease|Pathology (process)|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Nephropathy, Progressive Tubulointerstitial, with Cholestatic Liver Disease	MESH:C566573			MESH:D002780|MESH:D009395	C06.130.120.135.250/C566573|C06.552.150/C566573|C12.050.351.968.419.570.643/C566573|C12.200.777.419.570.643/C566573|C12.950.419.570.643/C566573	C06.130.120.135.250|C06.552.150|C12.050.351.968.419.570.643|C12.200.777.419.570.643|C12.950.419.570.643		Digestive system disease|Urogenital disease (female)|Urogenital disease (male)
Nerve Compression Syndromes	MESH:D009408	DO:DOID:573	Mechanical compression of nerves or nerve roots from internal or external causes. These may result in a conduction block to nerve impulses (due to MYELIN SHEATH dysfunction) or axonal loss. The nerve and nerve sheath injuries may be caused by ISCHEMIA; INFLAMMATION; or a direct mechanical effect.	MESH:D010523	C10.668.829.550	C10.668.829	Compression Syndrome, Nerve|Compression Syndromes, Nerve|Entrapment, Nerve|Entrapment Neuropathies|Entrapments, Nerve|External Nerve Compression Syndromes|Internal Nerve Compression Syndromes|Nerve Compression Syndrome|Nerve Compression Syndromes, External|Nerve Compression Syndromes, Internal|Nerve Entrapment|Nerve Entrapments|Neuropathies, Entrapment|Neuropathy, Entrapment|Syndrome, Nerve Compression|Syndromes, Nerve Compression	Nervous system disease
Nerve Sheath Neoplasms	MESH:D018317	DO:DOID:1192|DO:DOID:3193|DO:DOID:4697	Neoplasms which arise from nerve sheaths formed by SCHWANN CELLS in the PERIPHERAL NERVOUS SYSTEM or by OLIGODENDROCYTES in the CENTRAL NERVOUS SYSTEM. Malignant peripheral nerve sheath tumors, NEUROFIBROMA, and NEURILEMMOMA are relatively common tumors in this category.	MESH:D009380|MESH:D010524	C04.557.580.600|C10.551.775.500|C10.668.829.725.500	C04.557.580|C10.551.775|C10.668.829.725	Neoplasm, Nerve Sheath|Neoplasms, Nerve Sheath|Nerve Sheath Neoplasm|Nerve Sheath Tumor|Nerve Sheath Tumors|Nerve Sheath Tumors, Peripheral|Perineurioma|Perineuriomas|Peripheral Nerve Sheath Tumor|Peripheral Nerve Sheath Tumors|Sheath Tumor, Nerve|Sheath Tumors, Nerve|Tumor, Nerve Sheath|Tumors, Nerve Sheath|Tumors of the Nerve Sheath	Cancer|Nervous system disease
Nervous System Autoimmune Disease, Experimental	MESH:D020721		Experimental animal models for human AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM. They include GUILLAIN-BARRE SYNDROME (see NEURITIS, AUTOIMMUNE, EXPERIMENTAL); MYASTHENIA GRAVIS (see MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL); and MULTIPLE SCLEROSIS (see ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL).	MESH:D020274	C10.114.703|C20.111.258.625	C10.114|C20.111.258	Autoimmune Disease Models, Nervous System|Autoimmune Experimental Myositis|Autoimmune Myositis, Experimental|Disease Models, Autoimmune, Nervous System|Experimental Autoimmune Myositis|Experimental Myositis, Autoimmune|Myositis, Autoimmune Experimental|Myositis, Experimental Autoimmune|Nervous System Autoimmune Disease Models	Immune system disease|Nervous system disease
Nervous System Diseases	MESH:D009422	DO:DOID:863	Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.	MESH:C	C10	C	Disease, Nervous System|Diseases, Nervous System|Disorder, Nervous System|Disorder, Neurologic|Disorder, Neurological|Disorders, Nervous System|Disorders, Neurologic|Disorders, Neurological|Nervous System Disease|Nervous System Disorder|Nervous System Disorders|Neurological Disorder|Neurological Disorders|Neurologic Disorder|Neurologic Disorders	Nervous system disease
Nervous System Neoplasms	MESH:D009423		Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms.	MESH:D009371|MESH:D009422	C04.588.614|C10.551	C04.588|C10	Neoplasm, Nervous System|Neoplasms, Nervous System|Nervous System Neoplasm|Nervous System Tumor|Nervous System Tumors|Tumor, Nervous System|Tumors, Nervous System|Tumors of the Nervous System	Cancer|Nervous system disease
Nesidioblastosis	MESH:D046768	DO:DOID:13317	An inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the PANCREAS and CONGENITAL HYPERINSULINISM. It is due to focal hyperplasia of pancreatic ISLET CELLS budding off from the ductal structures and forming new islets of Langerhans. Mutations in the islet cells involve the potassium channel gene KCNJ11 or the ATP-binding cassette transporter gene ABCC8, both on CHROMOSOME 11.	MESH:D044903	C06.689.150.500|C16.614.200.500|C18.452.394.968.250.500|C18.452.394.984.200.500	C06.689.150|C16.614.200|C18.452.394.968.250|C18.452.394.984.200	Hyperinsulinism, Familial, with Pancreatic Nesidioblastosis|Nesidioblastoses|Nesidioblastoses, Pancreatic|Nesidioblastosis of Pancreas|Nesidioblastosis, Pancreatic|Pancreas Nesidioblastoses|Pancreas Nesidioblastosis|Pancreatic Nesidioblastoses|Pancreatic Nesidioblastosis	Digestive system disease|Infant-newborn disease|Metabolic disease
Neuhauser Daly Magnelli syndrome	MESH:C536406			MESH:D004381|MESH:D009759	C06.405.469.275.800.348/C536406|C06.405.748.586.349/C536406|C10.292.562.675/C536406|C11.590.400/C536406	C06.405.469.275.800.348|C06.405.748.586.349|C10.292.562.675|C11.590.400	Essential tremors, nystagmus and duodenal ulceration|Tremor, Nystagmus, and Duodenal Ulcer|Tremor nystagmus duodenal ulcer|Tremors, nystagmus and duodenal ulcers	Digestive system disease|Eye disease|Nervous system disease
Neuhauser Eichner Opitz syndrome	MESH:C536407			MESH:D001480|MESH:D002524	C10.228.140.079/C536407|C10.228.140.252.190/C536407|C10.597.350.090.500/C536407|C23.888.592.350.090.200/C536407	C10.228.140.079|C10.228.140.252.190|C10.597.350.090.500|C23.888.592.350.090.200	Encephalopathy, recurrent, of childhood	Nervous system disease|Signs and symptoms
Neural crest tumor	MESH:C536408			MESH:D000310	C04.588.322.078/C536408|C19.053.347/C536408|C19.344.078/C536408	C04.588.322.078|C19.053.347|C19.344.078	Neural crest-derived tumors	Cancer|Endocrine system disease
Neuralgia	MESH:D009437		Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.	MESH:D010146|MESH:D010523	C10.668.829.600|C23.888.592.612.664	C10.668.829|C23.888.592.612	Atypical Neuralgia|Atypical Neuralgias|Iliohypogastric Nerve Neuralgia|Iliohypogastric Nerve Neuralgias|Ilioinguinal Neuralgia|Ilioinguinal Neuralgias|Nerve Neuralgia, Iliohypogastric|Nerve Neuralgias, Iliohypogastric|Nerve Pain|Nerve Pain, Paroxysmal|Nerve Pains|Nerve Pains, Paroxysmal|Neuralgia, Atypical|Neuralgia, Iliohypogastric Nerve|Neuralgia, Ilioinguinal|Neuralgia, Perineal|Neuralgias|Neuralgias, Atypical|Neuralgias, Iliohypogastric Nerve|Neuralgias, Ilioinguinal|Neuralgias, Perineal|Neuralgias, Stump|Neuralgias, Supraorbital|Neuralgia, Stump|Neuralgia, Supraorbital|Neuralgias, Vidian|Neuralgia, Vidian|Neurodynia|Neurodynias|Neuropathic Pain|Neuropathic Pains|Pain, Nerve|Pain, Neuropathic|Pain, Paroxysmal Nerve|Pains, Nerve|Pains, Neuropathic|Pains, Paroxysmal Nerve|Paroxysmal Nerve Pain|Paroxysmal Nerve Pains|Perineal Neuralgia|Perineal Neuralgias|Stump Neuralgia|Stump Neuralgias|Supraorbital Neuralgia|Supraorbital Neuralgias|Vidian Neuralgia|Vidian Neuralgias	Nervous system disease|Signs and symptoms
Neuralgia, Postherpetic	MESH:D051474		Pain in nerves, frequently involving facial SKIN, resulting from the activation the latent varicella-zoster virus (HERPESVIRUS 3, HUMAN). The two forms of the condition preceding the pain are HERPES ZOSTER OTICUS; and HERPES ZOSTER OPHTHALMICUS. Following the healing of the rashes and blisters, the pain sometimes persists.	MESH:D009437	C10.668.829.600.550|C23.888.592.612.664.550	C10.668.829.600|C23.888.592.612.664	Postherpetic Neuralgia	Nervous system disease|Signs and symptoms
Neurilemmoma	MESH:D009442	DO:DOID:3192	A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)	MESH:D009463|MESH:D018358	C04.557.465.625.650.595|C04.557.580.600.610.595|C04.557.580.625.650.595	C04.557.465.625.650|C04.557.580.600.610|C04.557.580.625.650	Neurilemmomas|Neurilemoma|Neurilemomas|Neurinoma|Neurinomas|Plexiform Schwannomatoses|Plexiform Schwannomatosis|Schwannoma|Schwannomas|Schwannomatosis, Plexiform	Cancer
Neuritis	MESH:D009443	DO:DOID:1803|DO:DOID:683	A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA.	MESH:D010523	C10.668.829.650	C10.668.829	Motor Neuritides|Motor Neuritis|Neuritides|Neuritides, Motor|Neuritides, Peripheral|Neuritides, Sensory|Neuritis, Motor|Neuritis, Peripheral|Neuritis, Sensory|Peripheral Neuritides|Peripheral Neuritis|Polyneuritides|Polyneuritis|Sensory Neuritides|Sensory Neuritis	Nervous system disease
Neuritis, Autoimmune, Experimental	MESH:D009444		An experimental animal model for the demyelinating disease of GUILLAINE-BARRE SYNDROME. In the most frequently used protocol, animals are injected with a peripheral nerve tissue protein homogenate. After approximately 2 weeks the animals develop a neuropathy secondary to a T cell-mediated autoimmune response directed towards the MYELIN P2 PROTEIN in peripheral nerves. Pathologic findings include a perivascular accumulation of macrophages and T lymphocytes in the peripheral nervous system, similar to that seen in the Guillaine-Barre syndrome. (From Adams et al., Principles of Neurology, 6th ed, p1314; J Neuroimmunol 1998 Apr 1;84(1):40-52)	MESH:D009443|MESH:D020721	C10.114.703.700|C10.668.829.650.500|C20.111.258.625.700	C10.114.703|C10.668.829.650|C20.111.258.625	Allergic Neuritis, Experimental|Autoimmune Neuritis, Experimental|Autoimmune Neuropathies, Experimental|Autoimmune Neuropathy, Experimental|EAN (Experimental Allergic Neuritis)|EAN (Experimental Autoimmune Neuritis)|Experimental Allergic Neuritis|Experimental Autoimmune Neuritis|Experimental Autoimmune Neuropathies|Experimental Autoimmune Neuropathy|Neuritis, Experimental Allergic|Neuritis, Experimental Autoimmune|Neuropathies, Experimental Autoimmune|Neuropathy, Experimental Autoimmune	Immune system disease|Nervous system disease
Neuroaxonal Dystrophies	MESH:D019150	DO:DOID:2367	A nonspecific term referring both to the pathologic finding of swelling of distal portions of axons in the brain and to disorders which feature this finding. Neuroaxonal dystrophy is seen in various genetic diseases, vitamin deficiencies, and aging. Infantile neuroaxonal dystrophy is an autosomal recessive disease characterized by arrested psychomotor development at 6 months to 2 years of age, ataxia, brain stem dysfunction, and quadriparesis. Juvenile and adult forms also occur. Pathologic findings include brain atrophy and widespread accumulation of axonal spheroids throughout the neuroaxis, peripheral nerves, and dental pulp. (From Davis & Robertson, Textbook of Neuropathology, 2nd ed, p927)	MESH:D001927	C10.228.140.744	C10.228.140	Adult Neuroaxonal Dystrophy|Disease, Seitelberger|Disease, Seitelberger's|Dystrophy, Adult Neuroaxonal|Dystrophy, Infantile Neuroaxonal|Dystrophy, Juvenile Neuroaxonal|Dystrophy, Neuroaxonal|Infantile Neuroaxonal Dystrophy|Juvenile Neuroaxonal Dystrophy|Late Infantile Neuroaxonal Dystrophy|NBIA2A|NBIA, PLA2G6 Related|NBIA, PLA2G6-Related|Neuroaxonal Dystrophy|Neuroaxonal Dystrophy, Adult|Neuroaxonal Dystrophy, Infantile|Neuroaxonal Dystrophy, Juvenile|Neuroaxonal Dystrophy, Late Infantile|Neurodegeneration, PLA2G6 Associated|Neurodegeneration, PLA2G6-Associated|Neurodegeneration With Brain Iron Accumulation 2A|PLA2G6-Associated Neurodegeneration|PLA2G6-Related NBIA|Seitelberger Disease|Seitelberger's Disease|Seitelbergers Disease	Nervous system disease
Neurobehavioral Manifestations	MESH:D019954		Signs and symptoms of higher cortical dysfunction caused by organic conditions. These include certain behavioral alterations and impairments of skills involved in the acquisition, processing, and utilization of knowledge or information.	MESH:D009461	C10.597.606|C23.888.592.604	C10.597|C23.888.592	Cognitive Manifestation|Cognitive Manifestations|Cognitive Symptom|Cognitive Symptoms|Manifestation, Cognitive|Manifestation, Neurobehavioral|Manifestations, Cognitive|Manifestations, Neurobehavioral|Neurobehavioral Manifestation|Neurobehavioral Signs and Symptoms|Signs and Symptoms, Neurobehavioral|Symptom, Cognitive|Symptoms, Cognitive	Nervous system disease|Signs and symptoms
Neuroblastoma	MESH:D009447	DO:DOID:769|OMIM:256700|OMIM:613013|OMIM:613014|OMIM:613015|OMIM:613016|OMIM:613017	A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)	MESH:D018241	C04.557.465.625.600.590.650.550|C04.557.470.670.590.650.550|C04.557.580.625.600.590.650.550	C04.557.465.625.600.590.650|C04.557.470.670.590.650|C04.557.580.625.600.590.650	NBLST1|NBLST2|NBLST3|NBLST4|NBLST5|NBLST6|Neuroblastomas|NEUROBLASTOMA, SUSCEPTIBILITY TO, 1|NEUROBLASTOMA, SUSCEPTIBILITY TO, 2|NEUROBLASTOMA, SUSCEPTIBILITY TO, 3|NEUROBLASTOMA, SUSCEPTIBILITY TO, 4|NEUROBLASTOMA, SUSCEPTIBILITY TO, 5|NEUROBLASTOMA, SUSCEPTIBILITY TO, 6|NEUROBLASTOMA, SUSCEPTIBILITY TO, INCLUDED|NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE, INCLUDED	Cancer
Neurocysticercosis	MESH:D020019		Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50)	MESH:D003551|MESH:D020809	C01.207.205.250.550|C01.610.105.250.550|C01.610.335.190.902.185.550|C10.228.228.205.250.550	C01.207.205.250|C01.610.105.250|C01.610.335.190.902.185|C10.228.228.205.250	Brain Cysticercosis|Central Nervous System Cysticercosis|Cerebral Coenuroses|Cerebral Coenurosis|Cerebral Cysticercoses|Cerebral Cysticercosis|CNS Cysticercoses|CNS Cysticercosis|Coenurosis, Cerebral|Cysticercosis, Brain|Cysticercosis, Central Nervous System|Cysticercosis, Cerebral|Cysticercosis, CNS|Neurocoenuroses|Neurocoenurosis|Neurocysticercoses	Nervous system disease|Parasitic disease
Neurocytoma	MESH:D018306	DO:DOID:14174	A benign brain tumor composed of neural elements which most often arise from the SEPTUM PELLUCIDUM and the walls of the lateral ventricles. Immunohistochemistry and electron microscopy evaluations may reveal expression of neuron specific enolase and synaptophysin and cells containing microtubuli, neurosecretory granules, and presynaptic vesicles. (From Acta Med Port 1994 Feb;7(2):113-9)	MESH:D001932|MESH:D018302	C04.557.465.625.600.580|C04.557.470.670.580|C04.557.580.625.600.580|C04.588.614.250.195.648|C10.228.140.211.692|C10.551.240.250.550	C04.557.465.625.600|C04.557.470.670|C04.557.580.625.600|C04.588.614.250.195|C10.228.140.211|C10.551.240.250	Central Neurocytoma|Central Neurocytomas|Neurocytoma, Central|Neurocytomas|Neurocytomas, Central	Cancer|Nervous system disease
Neurodegeneration Due To Cerebral Folate Transport Deficiency	MESH:C567791	OMIM:613068		MESH:D019150	C10.228.140.744/C567791	C10.228.140.744	NCFTD	Nervous system disease
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	OMIM:617145			MESH:D001259|MESH:D001264|MESH:D003072|MESH:D004401|MESH:D004421|MESH:D015835|MESH:D019636	C10.228.758/617145|C10.292.562/617145|C10.574/617145|C10.597.350.090/617145|C10.597.350.110/617145|C10.597.350.300/617145|C10.597.606.150.500.800.150.200/617145|C11.590/617145|C23.888.592.350.090/617145|C23.888.592.350.110/617145|C23.888.592.350.300/617145|C23.888.592.604.150.500.800.150.200/617145|F03.615.250/617145	C10.228.758|C10.292.562|C10.574|C10.597.350.090|C10.597.350.110|C10.597.350.300|C10.597.606.150.500.800.150.200|C11.590|C23.888.592.350.090|C23.888.592.350.110|C23.888.592.350.300|C23.888.592.604.150.500.800.150.200|F03.615.250	NADGP	Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	OMIM:256600	DO:DOID:0110735		MESH:C538421|MESH:D019636	C10.228.140.744/C538421/256600|C10.574/256600|C18.452.565/C538421/256600	C10.228.140.744/C538421|C10.574|C18.452.565/C538421	INAD|INAD1|NBIA2A|NEUROAXONAL DYSTROPHY, INFANTILE|NEURODEGENERATION, PLA2G6-ASSOCIATED|PLAN|SEITELBERGER DISEASE	Metabolic disease|Nervous system disease
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4	OMIM:614298	DO:DOID:0110738		MESH:C538421|MESH:D019636	C10.228.140.744/C538421/614298|C10.574/614298|C18.452.565/C538421/614298	C10.228.140.744/C538421|C10.574|C18.452.565/C538421	MITOCHONDRIAL PROTEIN-ASSOCIATED NEURODEGENERATION|MPAN|NBIA4	Metabolic disease|Nervous system disease
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5	OMIM:300894	DO:DOID:0110739		MESH:C538421|MESH:D019636	C10.228.140.744/C538421/300894|C10.574/300894|C18.452.565/C538421/300894	C10.228.140.744/C538421|C10.574|C18.452.565/C538421	BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION|BPAN|NBIA5|SENDA|STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD	Metabolic disease|Nervous system disease
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6	OMIM:615643	DO:DOID:0110740		MESH:C538421|MESH:D019636	C10.228.140.744/C538421/615643|C10.574/615643|C18.452.565/C538421/615643	C10.228.140.744/C538421|C10.574|C18.452.565/C538421	NBIA6	Metabolic disease|Nervous system disease
Neurodegeneration with brain iron accumulation (NBIA)	MESH:C538421	DO:DOID:0110734		MESH:D019150|MESH:D019189	C10.228.140.744/C538421|C18.452.565/C538421	C10.228.140.744|C18.452.565		Metabolic disease|Nervous system disease
Neurodegenerative Diseases	MESH:D019636	DO:DOID:1289	Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.	MESH:D009422	C10.574	C10	Degenerative Condition, Neurologic|Degenerative Conditions, Neurologic|Degenerative Diseases, Central Nervous System|Degenerative Diseases, Nervous System|Degenerative Diseases, Neurologic|Degenerative Diseases, Spinal Cord|Degenerative Neurologic Disease|Degenerative Neurologic Diseases|Degenerative Neurologic Disorder|Degenerative Neurologic Disorders|Nervous System Degenerative Diseases|Neurodegenerative Disease|Neurodegenerative Disorder|Neurodegenerative Disorders|Neurologic Degenerative Condition|Neurologic Degenerative Conditions|Neurologic Degenerative Disease|Neurologic Degenerative Diseases|Neurologic Disease, Degenerative|Neurologic Diseases, Degenerative|Neurologic Disorder, Degenerative|Neurologic Disorders, Degenerative	Nervous system disease
Neurodermatitis	MESH:D009450	DO:DOID:3309	An extremely variable eczematous skin disease that is presumed to be a response to prolonged vigorous scratching, rubbing, or pinching to relieve intense pruritus. It varies in intensity, severity, course, and morphologic expression in different individuals. Neurodermatitis is believed by some to be psychogenic. The circumscribed or localized form is often referred to as lichen simplex chronicus.	MESH:D003872|MESH:D017443	C17.800.174.660|C17.800.815.660	C17.800.174|C17.800.815	Circumscribed Neurodermatitides|Circumscribed Neurodermatitis|Lichen Simplex Chronicus|Localized Neurodermatitides|Localized Neurodermatitis|Neurodermatitides|Neurodermatitides, Circumscribed|Neurodermatitides, Localized|Neurodermatitis, Circumscribed|Neurodermatitis, Localized	Skin disease
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART	OMIM:616975			MESH:D001927|MESH:D005124|MESH:D006330|MESH:D065886	C10.228.140/616975|C11.250/616975|C14.240.400/616975|C14.280.400/616975|C16.131.240.400/616975|C16.131.384/616975|F03.625/616975	C10.228.140|C11.250|C14.240.400|C14.280.400|C16.131.240.400|C16.131.384|F03.625	NEDBEH	Cardiovascular disease|Congenital abnormality|Eye disease|Mental disorder|Nervous system disease
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS	OMIM:615075	DO:DOID:0070049		MESH:D008607|MESH:D014786	C10.597.606.360/615075|C10.597.751.941/615075|C11.966/615075|C23.888.592.604.646/615075|C23.888.592.763.941/615075|F03.625.539/615075	C10.597.606.360|C10.597.751.941|C11.966|C23.888.592.604.646|C23.888.592.763.941|F03.625.539	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19, FORMERLY|MRD19, FORMERLY|NEDSDV	Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Neuroectodermal Tumor, Melanotic	MESH:D017600	DO:DOID:166	A benign, rapidly growing, deeply pigmented tumor of the jaw and occasionally of other sites, consisting of an infiltrating mass of cells arranged in an alveolar pattern, and occurring almost exclusively in infants. Its source of origin is in dispute, the various theories giving rise to its several names. (Dorland, 27th ed)	MESH:D017599	C04.557.465.625.630|C04.557.580.625.630	C04.557.465.625|C04.557.580.625	Anlage Tumor, Retinal|Anlage Tumors, Retinal|Melanoameloblastoma|Melanoameloblastomas|Melanotic Neuroectodermal Tumor|Melanotic Neuroectodermal Tumors|Melanotic Progonoma|Melanotic Progonomas|Neuroectodermal Tumors, Melanotic|Progonoma, Melanotic|Progonomas, Melanotic|Retinal Anlage Tumor|Retinal Anlage Tumors|Tumor, Melanotic Neuroectodermal|Tumor, Retinal Anlage|Tumors, Melanotic Neuroectodermal|Tumors, Retinal Anlage	Cancer
Neuroectodermal Tumors	MESH:D017599	DO:DOID:171	Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells.	MESH:D009373|MESH:D009380	C04.557.465.625|C04.557.580.625	C04.557.465|C04.557.580	Neuroectodermal Tumor|Tumor, Neuroectodermal|Tumors, Neuroectodermal	Cancer
Neuroectodermal Tumors, Primitive	MESH:D018242	DO:DOID:0050902|DO:DOID:0080903|DO:DOID:4790|DO:DOID:7398	A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL). This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059)	MESH:D018302	C04.557.465.625.600.590|C04.557.470.670.590|C04.557.580.625.600.590	C04.557.465.625.600|C04.557.470.670|C04.557.580.625.600	Cerebral Primitive Neuroectodermal Tumor|Ependymoblastoma|Ependymoblastomas|Medulloepithelioma|Medulloepitheliomas|Neoplasm, Primitive Neuroepithelial|Neoplasms, Primitive Neuroepithelial|Neuroectodermal Tumor, Primitive|Neuroepithelial Neoplasm, Primitive|Neuroepithelial Neoplasms, Primitive|Neuroepithelial Tumor, Primitive|Neuroepithelial Tumors, Primitive|PNET|PNETs|Primitive Neuroectodermal Tumor|Primitive Neuroectodermal Tumors|Primitive Neuroepithelial Neoplasm|Primitive Neuroepithelial Neoplasms|Primitive Neuroepithelial Tumor|Primitive Neuroepithelial Tumors|Spongioblastoma|Spongioblastomas|Tumor, Primitive Neuroectodermal|Tumor, Primitive Neuroepithelial|Tumors, Primitive Neuroectodermal|Tumors, Primitive Neuroepithelial	Cancer
Neuroectodermal Tumors, Primitive, Peripheral	MESH:D018241	DO:DOID:3369	A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.	MESH:D018242	C04.557.465.625.600.590.650|C04.557.470.670.590.650|C04.557.580.625.600.590.650	C04.557.465.625.600.590|C04.557.470.670.590|C04.557.580.625.600.590	Extracranial Primitive Neuroectodermal Tumor|Neuroectodermal Neoplasm, Peripheral Primitive|Neuroectodermal Tumor, Peripheral|Neuroectodermal Tumor, Peripheral Primitive|Neuroectodermal Tumors, Peripheral|Neuroepithelioma, Peripheral|Neuroepitheliomas, Peripheral|Peripheral Neuroectodermal Tumor|Peripheral Neuroectodermal Tumors|Peripheral Neuroepithelioma|Peripheral Neuroepitheliomas|Peripheral Primitive Neuroectodermal Neoplasm|Peripheral Primitive Neuroectodermal Tumor|Peripheral Primitive Neuroectodermal Tumors|(pPNET) Peripheral Primitive Neuroectodermal Tumors|Primitive Neuroectodermal Tumor, Extracranial|Tumor, Peripheral Neuroectodermal|Tumors, Peripheral Neuroectodermal	Cancer
Neuroendocrine Carcinoma of Salivary Glands, Sensorineural Hearing Loss, and Enamel Hypoplasia	MESH:C566352			MESH:D003744|MESH:D006319|MESH:D012468|MESH:D018278	C04.557.465.625.650.240/C566352|C04.557.470.200.025.370/C566352|C04.557.580.625.650.240/C566352|C04.588.443.591.824/C566352|C07.465.530.824/C566352|C07.465.815.718/C566352|C07.650.800.255/C566352|C07.793.700.255/C566352|C09.218.458.341.887/C566352|C10.597.751.418.341.887/C566352|C16.131.850.800.255/C566352|C23.888.592.763.393.341.887/C566352	C04.557.465.625.650.240|C04.557.470.200.025.370|C04.557.580.625.650.240|C04.588.443.591.824|C07.465.530.824|C07.465.815.718|C07.650.800.255|C07.793.700.255|C09.218.458.341.887|C10.597.751.418.341.887|C16.131.850.800.255|C23.888.592.763.393.341.887		Cancer|Congenital abnormality|Ear-nose-throat disease|Mouth disease|Nervous system disease|Signs and symptoms
Neuroendocrine Tumors	MESH:D018358	DO:DOID:169	Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.	MESH:D017599	C04.557.465.625.650|C04.557.580.625.650	C04.557.465.625|C04.557.580.625	Neuroendocrine Tumor|Tumor, Neuroendocrine|Tumors, Neuroendocrine	Cancer
Neuroferritinopathy	MESH:C548080	DO:DOID:0110737|OMIM:606159		MESH:D019150|MESH:D019189	C10.228.140.744/C548080|C18.452.565/C548080	C10.228.140.744|C18.452.565	Basal Ganglia Disease, Adult-Onset|Ferritin-Related Neurodegeneration|Hereditary Ferritinopathy|NBIA3|Neurodegeneration With Brain Iron Accumulation 3|NEUROFERRITINOPATHY	Metabolic disease|Nervous system disease
Neurofibroma	MESH:D009455	DO:DOID:962	A moderately firm, benign, encapsulated tumor resulting from proliferation of SCHWANN CELLS and FIBROBLASTS that includes portions of nerve fibers. The tumors usually develop along peripheral or cranial nerves and are a central feature of NEUROFIBROMATOSIS 1, where they may occur intracranially or involve spinal roots. Pathologic features include fusiform enlargement of the involved nerve. Microscopic examination reveals a disorganized and loose cellular pattern with elongated nuclei intermixed with fibrous strands. (From Adams et al., Principles of Neurology, 6th ed, p1016)	MESH:D018317	C04.557.580.600.580|C10.551.775.500.750|C10.668.829.725.500.600	C04.557.580.600|C10.551.775.500|C10.668.829.725.500	Neurofibromas	Cancer|Nervous system disease
Neurofibroma, Plexiform	MESH:D018318	DO:DOID:5151	A type of neurofibroma manifesting as a diffuse overgrowth of subcutaneous tissue, usually involving the face, scalp, neck, and chest but occasionally occurring in the abdomen or pelvis. The tumors tend to progress, and may extend along nerve roots to eventually involve the spinal roots and spinal cord. This process is almost always a manifestation of NEUROFIBROMATOSIS 1. (From Adams et al., Principles of Neurology, 6th ed, p1016; J Pediatr 1997 Nov;131(5):678-82)	MESH:D009455	C04.557.580.600.580.585|C10.551.775.500.750.500|C10.668.829.725.500.600.500	C04.557.580.600.580|C10.551.775.500.750|C10.668.829.725.500.600	Elephantiasis Neuromatoses|Elephantiasis Neuromatosis|Neurofibromas, Plexiform|Neuroma, Plexiform|Neuromas, Plexiform|Pachydermatocele|Pachydermatoceles|Plexiform Neurofibroma|Plexiform Neurofibromas|Plexiform Neuroma|Plexiform Neuromas|Tumor Royale	Cancer|Nervous system disease
Neurofibrosarcoma	MESH:D018319	DO:DOID:3512|DO:DOID:5940	A malignant tumor that arises from small cutaneous nerves, is locally aggressive, and has a potential for metastasis. Characteristic histopathologic features include proliferating atypical spindle cells with slender wavy and pointed nuclei, hypocellular areas, and areas featuring organized whorls of fibroblastic proliferation. The most common primary sites are the extremities, retroperitoneum, and trunk. These tumors tend to present in childhood, often in association with NEUROFIBROMATOSIS 1. (From DeVita et al., Cancer: Principles & Practice of Oncology, 5th ed, p1662; Mayo Clin Proc 1990 Feb;65(2):164-72)	MESH:D005354|MESH:D009455	C04.557.450.565.590.350.590|C04.557.450.795.350.590|C04.557.580.600.580.795|C10.551.775.500.750.750|C10.668.829.725.500.600.600	C04.557.450.565.590.350|C04.557.450.795.350|C04.557.580.600.580|C10.551.775.500.750|C10.668.829.725.500.600	Malignant Neurilemmoma|Malignant Neurilemmomas|Malignant Neurilemoma|Malignant Neurilemomas|Malignant Peripheral Nerve Sheath Tumor|Malignant Peripheral Nerve Sheath Tumors|Malignant Schwannoma|Malignant Schwannomas|MPNST|Neurilemmoma, Malignant|Neurilemmosarcoma|Neurilemmosarcomas|Neurilemoma, Malignant|Neurofibrosarcomas|Neurogenic Sarcoma|Neurogenic Sarcomas|Peripheral Nerve Sheath Tumors, Malignant|Sarcoma, Neurogenic|Sarcomas, Neurogenic|Schwannoma, Malignant	Cancer|Nervous system disease
Neuroleptic Malignant Syndrome	MESH:D009459	DO:DOID:14464	A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)	MESH:D001480|MESH:D020258	C10.228.140.079.737|C10.720.737|C25.723.705.600	C10.228.140.079|C10.720|C25.723.705	Neuroleptic Induced Neuroleptic Malignant Syndrome|Neuroleptic-Induced Neuroleptic Malignant Syndrome|Neuroleptic Malignant Syndrome, Neuroleptic Induced|Neuroleptic-Malignant Syndrome, Neuroleptic Induced|Neuroleptic Malignant Syndromes|NMS (Neuroleptic Malignant Syndrome)|NMSs (Neuroleptic Malignant Syndrome)|Syndrome, Neuroleptic Malignant|Syndromes, Neuroleptic Malignant	Nervous system disease
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 1	OMIM:616263			MESH:D004700|MESH:D009422|MESH:D010182	C06.689/616263|C10/616263|C19/616263	C06.689|C10|C19	IMNEPD|IMNEPD1	Digestive system disease|Endocrine system disease|Nervous system disease
Neurologic Manifestations	MESH:D009461		Clinical signs and symptoms caused by nervous system injury or dysfunction.	MESH:D009422|MESH:D012816	C10.597|C23.888.592	C10|C23.888	Deficit, Focal Neurologic|Deficit, Neurologic|Deficits, Focal Neurologic|Deficits, Neurologic|Dysfunction, Neurologic|Dysfunctions, Neurologic|Finding, Neurologic|Findings, Neurologic|Focal Neurologic Deficit|Focal Neurologic Deficits|Manifestation, Neurologic|Manifestation, Neurological|Manifestations, Neurologic|Manifestations, Neurological|Neurological Manifestation|Neurological Manifestations|Neurologic Deficit|Neurologic Deficit, Focal|Neurologic Deficits|Neurologic Deficits, Focal|Neurologic Dysfunction|Neurologic Dysfunctions|Neurologic Finding|Neurologic Findings|Neurologic Manifestation|Neurologic Sign|Neurologic Signs|Neurologic Signs and Symptoms|Neurologic Symptom|Neurologic Symptoms|Sign, Neurologic|Signs, Neurologic|Symptom, Neurologic|Symptoms, Neurologic	Nervous system disease|Signs and symptoms
Neurolymphomatosis	MESH:D000077162		Infiltration of the nervous system by malignant lymphoma cells.	MESH:D009423	C10.551.568	C10.551	Neurolymphomatoses|Neurolymphomatoses, Primary|Neurolymphomatosis, Primary|Primary Neurolymphomatoses|Primary Neurolymphomatosis	Nervous system disease
Neuroma	MESH:D009463	DO:DOID:2001	A tumor made up of nerve cells and nerve fibers. (Dorland, 27th ed)	MESH:D018317	C04.557.580.600.610	C04.557.580.600	Neuromas	Cancer
Neuroma, Acoustic	MESH:D009464	DO:DOID:12689	A benign SCHWANNOMA of the eighth cranial nerve (VESTIBULOCOCHLEAR NERVE), mostly arising from the vestibular branch (VESTIBULAR NERVE) during the fifth or sixth decade of life. Clinical manifestations include HEARING LOSS; HEADACHE; VERTIGO; TINNITUS; and FACIAL PAIN. Bilateral acoustic neuromas are associated with NEUROFIBROMATOSIS 2. (From Adams et al., Principles of Neurology, 6th ed, p673)	MESH:D000160|MESH:D003390|MESH:D009442|MESH:D010039	C04.557.465.625.650.595.610|C04.557.580.600.610.595.610|C04.557.580.625.650.595.610|C04.588.614.300.015|C04.588.614.596.240.015|C09.218.807.800.675|C09.647.675|C10.292.225.750|C10.292.910.600	C04.557.465.625.650.595|C04.557.580.600.610.595|C04.557.580.625.650.595|C04.588.614.300|C04.588.614.596.240|C09.218.807.800|C09.647|C10.292.225|C10.292.910	Acoustic Neurilemmoma|Acoustic Neurilemmomas|Acoustic Neurilemoma|Acoustic Neurilemomas|Acoustic Neurinoma|Acoustic Neurinomas|Acoustic Neuroma|Acoustic Neuroma, Cerebellopontine Angle|Acoustic Neuromas|Acoustic Schwannoma|Acoustic Schwannomas|Acoustic Tumor|Acoustic Tumors|Angle Tumor|Angle Tumor, Cerebellopontine|Angle Tumors|Angle Tumors, Cerebellopontine|Cerebellopontine Angle Acoustic Neuroma|Cerebellopontine Angle Tumor|Cerebellopontine Angle Tumors|Melanocytic Vestibular Schwannoma|Melanocytic Vestibular Schwannomas|Neurilemmoma, Acoustic|Neurilemmomas, Acoustic|Neurilemoma, Acoustic|Neurilemomas, Acoustic|Neurinoma, Acoustic|Neurinoma of the Acoustic Nerve|Neurinomas, Acoustic|Neuroma, Acoustic, Unilateral|Neuromas, Acoustic|Schwannoma, Acoustic|Schwannoma, Melanocytic Vestibular|Schwannomas, Acoustic|Schwannomas, Melanocytic Vestibular|Schwannomas, Vestibular|Schwannoma, Vestibular|Tumor, Acoustic|Tumor, Angle|Tumor, Cerebellopontine Angle|Tumors, Acoustic|Tumors, Angle|Tumors, Cerebellopontine Angle|Vestibular Schwannoma|Vestibular Schwannoma, Melanocytic|Vestibular Schwannomas|Vestibular Schwannomas, Melanocytic	Cancer|Ear-nose-throat disease|Nervous system disease
Neuromuscular Disease, Congenital, With Uniform Type 1 Fiber	MESH:C567162			MESH:D020512	C05.651.575.300/C567162|C10.668.491.550.300/C567162	C05.651.575.300|C10.668.491.550.300	CNMDU1	Musculoskeletal disease|Nervous system disease
Neuromuscular Diseases	MESH:D009468	DO:DOID:440	A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.	MESH:D009422	C10.668	C10	Amyotonia Congenita|Benign Fasciculation-Cramp Syndrome|Benign Fasciculation-Cramp Syndromes|Cramp Fasciculation Syndrome|Cramp-Fasciculation Syndrome|Cramp-Fasciculation Syndromes|Fasciculation Cramp Syndrome, Benign|Fasciculation-Cramp Syndrome, Benign|Fasciculation-Cramp Syndromes, Benign|Foley Denny Brown Syndrome|Foley-Denny-Brown Syndrome|Neuromuscular Disease|Oppenheim Disease|Oppenheim's Disease|Oppenheims Disease|Syndrome, Cramp-Fasciculation|Syndrome, Foley-Denny-Brown|Syndromes, Cramp-Fasciculation	Nervous system disease
Neuromuscular Junction Diseases	MESH:D020511	DO:DOID:439	Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.	MESH:D009468	C10.668.758	C10.668	Neuromuscular Junction Disease|Neuromuscular Junction Disorder|Neuromuscular Junction Disorders|Neuromuscular Junction Toxic Disorders|Neuromuscular Transmission Disorder|Neuromuscular Transmission Disorders|Toxic Disorders, Neuromuscular Junction	Nervous system disease
Neuromuscular Manifestations	MESH:D020879		Signs and symptoms associated with diseases of the muscle, neuromuscular junction, or peripheral nerves.	MESH:D009461	C10.597.613|C23.888.592.608	C10.597|C23.888.592	Disease Manifestation, Muscle|Disease Manifestations, Muscle|Manifestation, Muscle Disease|Manifestation, Neuromuscular|Manifestations, Muscle Disease|Manifestations, Neuromuscular|Muscle Disease Manifestation|Muscle Disease Manifestations|Neuromuscular Manifestation|Neuromuscular Signs and Symptoms|Signs and Symptoms, Neuromuscular	Nervous system disease|Signs and symptoms
Neuromyelitis Optica	MESH:D009471	DO:DOID:8869	A syndrome characterized by acute OPTIC NEURITIS; MYELITIS, TRANSVERSE; demyelinating and/or necrotizing lesions in the OPTIC NERVES and SPINAL CORD; and presence of specific autoantibodies to AQUAPORIN 4.	MESH:D009188|MESH:D009902|MESH:D020278	C10.114.375.600.500|C10.114.375.800|C10.292.700.550.500|C10.314.350.600.500|C10.314.350.800|C11.640.576.695|C20.111.258.250.550.500|C20.111.258.250.775	C10.114.375|C10.114.375.600|C10.292.700.550|C10.314.350|C10.314.350.600|C11.640.576|C20.111.258.250|C20.111.258.250.550	Devic Disease|Devic Neuromyelitis Optica|Devic Neuromyelitis Opticas|Devic's Disease|Devics Disease|Devic's Neuromyelitis Optica|Devics Neuromyelitis Optica|Devic's Syndrome|Devics Syndrome|Devic Syndrome|Disease, Devic|Disease, Devic's|Neuromyelitis Optica, Devic|Neuromyelitis Optica, Devic's|Neuromyelitis Optica (NMO) Spectrum Disorder|Neuromyelitis Optica (NMO) Spectrum Disorders|Neuromyelitis Opticas, Devic|Neuromyelitis Optica Spectrum Disorder|Neuromyelitis Optica Spectrum Disorders|NMO Spectrum Disorder|NMO Spectrum Disorders|Syndrome, Devic|Syndrome, Devic's	Eye disease|Immune system disease|Nervous system disease
Neuronal intestinal pseudoobstruction	MESH:C537394	OMIM:243180|OMIM:601223		MESH:D007410|MESH:D009422	C06.405.469/C537394|C10/C537394	C06.405.469|C10	Argyrophil myenteric plexus, deficiency of|Intestinal pseudoobstruction due to neuronal disease|Neuronal intestinal dysplasia, type A|Neuronal Intestinal Dysplasia, Type B|NID A, INCLUDED|NID B|Pseudoobstruction, chronic idiopathic intestinal, neuronal type|PSEUDOOBSTRUCTION, CHRONIC IDIOPATHIC INTESTINAL, NEURONAL TYPE NEURONAL INTESTINAL DYSPLASIA, TYPE A, INCLUDED|VISCERAL NEUROPATHY, FAMILIAL, 1, AUTOSOMAL RECESSIVE|Visceral Neuropathy, Familial, Autosomal Recessive|VSCN1	Digestive system disease|Nervous system disease
Neuronal intranuclear inclusion disease	MESH:C537395			MESH:D019636	C10.574/C537395	C10.574		Nervous system disease
Neuronopathy, Distal Hereditary Motor, Type I	MESH:C566675	DO:DOID:0111200		MESH:D009134	C10.228.854.468/C566675|C10.574.562.500/C566675|C10.668.467.500/C566675	C10.228.854.468|C10.574.562.500|C10.668.467.500	Charcot-Marie-Tooth Disease, Spinal, I|Neuropathy, Distal Hereditary Motor, Type I|Spinal Muscular Atrophy, Distal, Juvenile, Autosomal Dominant, I	Nervous system disease
Neuronopathy, Distal Hereditary Motor, Type IIB	MESH:C567084	OMIM:608634		MESH:D009134	C10.228.854.468/C567084|C10.574.562.500/C567084|C10.668.467.500/C567084	C10.228.854.468|C10.574.562.500|C10.668.467.500	DHMN2B|HMN2B|HMN IIB|Neuropathy, Distal Hereditary Motor, Type IIB	Nervous system disease
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC	OMIM:613376	DO:DOID:0111209		MESH:D010523	C10.668.829/613376	C10.668.829	DHMN2C|HMN2C|HMN IIC|NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC	Nervous system disease
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID	OMIM:615575	DO:DOID:0111210		MESH:D009134	C10.228.854.468/615575|C10.574.562.500/615575|C10.668.467.500/615575	C10.228.854.468|C10.574.562.500|C10.668.467.500	DHMN2D|HMN2D|HMN IID|NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IID|SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL DOMINANT, CALF-PREDOMINANT	Nervous system disease
Neuronopathy, Distal Hereditary Motor, Type V	MESH:C563443	DO:DOID:0111204|OMIM:600794|OMIM:614751		MESH:D009134	C10.228.854.468/C563443|C10.574.562.500/C563443|C10.668.467.500/C563443	C10.228.854.468|C10.574.562.500|C10.668.467.500	DHMN5|DHMN5A|DHMN5B|Dhmn-V|DHMN V|DHMN VA|DHMN VB|Distal Hereditary Motor Neuronopathy, Type V|Distal Hereditary Motor Neuropathy, Type V|Distal Spinal Muscular Atrophy, Type V|DSMAV|DSMAVA|DSMAVB|HMN5|HMN5A|HMN 5A|HMN5B|HMN V|HMN VB|NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V|NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA|NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB|Neuropathy, Distal Hereditary Motor, Type V|NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VA|NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VB|Spinal Muscular Atrophy, Distal Type V|Spinal Muscular Atrophy, Distal, Type V|SPINAL MUSCULAR ATROPHY, DISTAL, TYPE VA|SPINAL MUSCULAR ATROPHY, DISTAL, TYPE VB|Spinal Muscular Atrophy, Distal, With Upper Limb Predominance	Nervous system disease
Neuronopathy, Distal Hereditary Motor, Type Viib	MESH:C564362	OMIM:607641		MESH:D009134	C10.228.854.468/C564362|C10.574.562.500/C564362|C10.668.467.500/C564362	C10.228.854.468|C10.574.562.500|C10.668.467.500	DHMN7B|HMN7B|HMN VIIB|Lower Motor Neuron Disease, Dynactin Type|Neuropathy, Distal Hereditary Motor, Type VIIB|Neuropathy, Distal Hereditary Motor, With Vocal Cord Paralysis, Type VIIB	Nervous system disease
Neuropathy, Painful	MESH:C564945			MESH:D010146|MESH:D010523	C10.668.829/C564945|C23.888.592.612/C564945	C10.668.829|C23.888.592.612		Nervous system disease|Signs and symptoms
Neuropathy, with Paraprotein in Serum, Cerebrospinal Fluid and Urine	MESH:C563516			MESH:D010523	C10.668.829/C563516	C10.668.829		Nervous system disease
Neurosarcoidosis	MESH:C535814			MESH:D002493|MESH:D012507	C10.228/C535814|C15.604.515.827/C535814	C10.228|C15.604.515.827	Nervous system sarcoidosis	Lymphatic disease|Nervous system disease
Neuroschistosomiasis	MESH:D020818	DO:DOID:13722	SCHISTOSOMIASIS of the brain, spinal cord, or meninges caused by infections with trematodes of the genus SCHISTOSOMA (primarily SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; and SCHISTOSOMA HAEMATOBIUM in humans). S. japonicum infections of the nervous system may cause an acute meningoencephalitis or a chronic encephalopathy. S. mansoni and S. haematobium nervous system infections are associated with acute transverse myelitis involving the lower portions of the spinal cord. (From Joynt, Clinical Neurology, 1998, Ch27, pp61-2)	MESH:D012552|MESH:D020809	C01.207.205.250.600|C01.610.105.250.600|C01.610.335.865.859.213|C01.920.922.213|C10.228.228.205.250.600	C01.207.205.250|C01.610.105.250|C01.610.335.865.859|C01.920.922|C10.228.228.205.250	Central Nervous System Schistosomiasis|Myelitis, Schistosomal|Myelopathies, Schistosomal|Myelopathy, Schistosomal|Myeloradiculopathies, Schistosomal|Myeloradiculopathy, Schistosomal|Neuroschistosomiases|Schistosomal Myelitis|Schistosomal Myelopathies|Schistosomal Myelopathy|Schistosomal Myeloradiculopathies|Schistosomal Myeloradiculopathy|Schistosomiasis, Central Nervous System	Nervous system disease|Parasitic disease
Neurothekeoma	MESH:D018321		A benign myxoma of cutaneous nerve sheath origin. Theke is from the Greek theke, sheath. (From Stedman, 25th ed)	MESH:D009232|MESH:D018317	C04.557.450.565.550.625|C04.557.580.600.625	C04.557.450.565.550|C04.557.580.600	Myxoma, Nerve Sheath|Myxomas, Nerve Sheath|Nerve Sheath Myxoma|Nerve Sheath Myxomas|Neurotheceoma|Neurotheceomas|Neurothecoma|Neurothecomas|Neurothekeomas	Cancer
Neurotoxicity Syndromes	MESH:D020258	DO:DOID:3602	Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.	MESH:D009422|MESH:D011041	C10.720|C25.723.705	C10|C25.723	Encephalitides, Toxic|Encephalitis, Toxic|Encephalopathies, Toxic|Encephalopathy, Toxic|Nervous System Poisoning|Nervous System Poisonings|Neurotoxic Disorder|Neurotoxic Disorders|Neurotoxicity Syndrome|Neurotoxin Disease|Neurotoxin Diseases|Neurotoxin Disorder|Neurotoxin Disorders|Poisoning, Nervous System|Poisonings, Nervous System|Syndrome, Neurotoxicity|Syndromes, Neurotoxicity|Toxic Encephalitides|Toxic Encephalitis|Toxic Encephalopathies|Toxic Encephalopathy	Nervous system disease
Neutropenia	MESH:D009503	DO:DOID:1227	A decrease in the number of NEUTROPHILS found in the blood.	MESH:D000380	C15.378.553.546.184.564	C15.378.553.546.184	Neutropenias	Blood disease
Neutropenia, Lethal Congenital, with Eosinophilia	MESH:C564943			MESH:D004802|MESH:D009503	C15.378.553.231/C564943|C15.378.553.546.184.564/C564943	C15.378.553.231|C15.378.553.546.184.564		Blood disease
Neutropenia, severe chronic	MESH:C535815			MESH:D009503	C15.378.553.546.184.564/C535815	C15.378.553.546.184.564	Leukopenia, benign familial|Neutropenia, chronic familial	Blood disease
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE	OMIM:615285	DO:DOID:0112132		MESH:D009503	C15.378.553.546.184.564/615285	C15.378.553.546.184.564	SCN5	Blood disease
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE	OMIM:616022	DO:DOID:0112134		MESH:D009503	C15.378.553.546.184.564/616022	C15.378.553.546.184.564	SCN6	Blood disease
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	OMIM:617014	DO:DOID:0112129		MESH:D009503	C15.378.553.546.184.564/617014	C15.378.553.546.184.564	SCN7	Blood disease
Neutropenia, Severe Congenital, Autosomal Dominant 1	MESH:C565969	OMIM:202700		MESH:D009503	C15.378.553.546.184.564/C565969	C15.378.553.546.184.564	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT|SCN1	Blood disease
Neutropenia, Severe Congenital, Autosomal Dominant 2	MESH:C567748	OMIM:613107		MESH:D009503	C15.378.553.546.184.564/C567748	C15.378.553.546.184.564	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT|SCN2|Severe Congenital Neutropenia-2	Blood disease
Neutropenia, Severe Congenital, Autosomal Recessive 3	MESH:C537592	OMIM:610738		MESH:D000080984|MESH:D009503	C15.378.190.223.500/C537592|C15.378.553.546.184.564/C537592|C16.614.183/C537592	C15.378.190.223.500|C15.378.553.546.184.564|C16.614.183	Agranulocytosis, Infantile|Agranulocytosis, infantile genetic|Autosomal dominant or sporadic congenital neutropenia|Congenital Agranulocytosis|Congenital Neutropenia|Infantile genetic agranulocytosis|Kostmann disease|Kostmann's Agranulocytosis|Kostmann's Syndrome|Kostmann syndrome|NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE|SCN3|Severe congenital neutropenia|Severe Infantile Genetic Neutropenia	Blood disease|Infant-newborn disease
Neutropenia, Severe Congenital, Autosomal Recessive 4	MESH:C567260	OMIM:612541		MESH:D009503	C15.378.553.546.184.564/C567260	C15.378.553.546.184.564	Dursun Syndrome|DURSUN SYNDROME, INCLUDED|NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE|Pulmonary Arterial Hypertension, Leukopenia, And Atrial Septal Defect|PULMONARY ARTERIAL HYPERTENSION, LEUKOPENIA, AND ATRIAL SEPTAL DEFECT, INCLUDED|Scn4	Blood disease
Neutrophil Actin Dysfunction	MESH:C564942			MESH:D007960	C15.378.553/C564942	C15.378.553		Blood disease
Neutrophil Chemotactic Response, Abnormal	MESH:C563515			MESH:D007154|MESH:D007960	C15.378.553/C563515|C20/C563515	C15.378.553|C20	Leukocyte Motility, Abnormal|Neutrophil Migration, Abnormal|Neutrophil Motility, Abnormal	Blood disease|Immune system disease
Neutrophilia, Hereditary	MESH:C563010	DO:DOID:0090120|OMIM:162830		MESH:D007960	C15.378.553/C563010	C15.378.553		Blood disease
Nevi and Melanomas	MESH:D018326		A collective term for the various types of nevi and melanomas.	MESH:D009370	C04.557.665	C04.557	Melanomas and Nevi	Cancer
Nevus	MESH:D009506		A circumscribed stable malformation of the skin and occasionally of the oral mucosa, which is not due to external causes and therefore presumed to be of hereditary origin.	MESH:D018326	C04.557.665.560	C04.557.665	Mole, Skin|Moles, Skin|Nevi|Skin Mole|Skin Moles	Cancer
Nevus, Blue	MESH:D018329		Usually a benign tumor, that commonly presents as a solitary blue nodule with spindled MELANOCYTES covered by smooth SKIN. Several variants have been identified, one variant being malignant. The blue color is caused by large, densely packed melanocytes deep in the DERMIS of the nevus. In CHILDREN, they usually occur on the BUTTOCKS and LUMBOSACRAL REGION and are referred to as cellular blue nevi. Malignant blue nevi are more commonly found on the SCALP.	MESH:D009508	C04.557.665.560.615.550	C04.557.665.560.615	Blue Nevi|Blue Nevi, Cellular|Blue Nevus|Blue Nevus, Cellular|Cellular Blue Nevi|Cellular Blue Nevus|Nevi, Blue|Nevi, Cellular Blue|Nevus, Cellular Blue	Cancer
NEVUS COMEDONICUS	OMIM:617025			MESH:D009506	C04.557.665.560/617025	C04.557.665.560	NC	Cancer
Nevus, Epithelioid and Spindle Cell	MESH:D018332		A benign compound nevus occurring most often in children before puberty, composed of spindle and epithelioid cells located mainly in the dermis, sometimes in association with large atypical cells and multinucleate cells, and having a close histopathological resemblance to malignant melanoma. The tumor presents as a smooth to slightly scaly, round to oval, raised, firm papule or nodule, ranging in color from pink-tan to purplish red, often with surface telangiectasia. (Dorland, 27th ed)	MESH:D018331	C04.557.665.560.615.625.585	C04.557.665.560.615.625	Nevus, Spindle Cell and Epithelioid|Nevus, Spitz|Spitz Nevus	Cancer
Nevus, Halo	MESH:D055882		A benign skin lesion characterized by a zone of depigmentation surrounding the nevus.	MESH:D009506	C04.557.665.560.580	C04.557.665.560	Halo Nevi|Halo Nevus|Leukoderma Acquisitum Centrifugum of Sutton|Nevi, Halo	Cancer
Nevus, Intradermal	MESH:D018330		A nevus in which nests of melanocytes are found in the dermis, but not at the epidermal-dermal junction. Benign pigmented nevi in adults are most commonly intradermal. (Stedman, 25th ed)	MESH:D009506	C04.557.665.560.590	C04.557.665.560	Intradermal Nevi|Intradermal Nevus|Nevi, Intradermal	Cancer
Nevus of Ota	MESH:D009507		A macular lesion on the side of the FACE, involving the CONJUNCTIVA and EYELIDS, as well as the adjacent facial skin, SCLERA; OCULOMOTOR MUSCLES; and PERIOSTEUM. Histological features vary from those of a MONGOLIAN SPOT to those of a BLUE NEVUS.	MESH:D009508	C04.557.665.560.615.585	C04.557.665.560.615	Nevus, Ota's|Ota Nevus|Ota's Nevus|Otas Nevus	Cancer
Nevus, Pigmented	MESH:D009508		A nevus containing melanin. The term is usually restricted to nevocytic nevi (round or oval collections of melanin-containing nevus cells occurring at the dermoepidermal junction of the skin or in the dermis proper) or moles, but may be applied to other pigmented nevi.	MESH:D009506	C04.557.665.560.615	C04.557.665.560	Melanocytic Nevi|Melanocytic Nevus|Nevi, Melanocytic|Nevi, Pigmented|Nevus, Melanocytic|Pigmented Moles|Pigmented Nevi|Pigmented Nevus	Cancer
Nevus, Sebaceous of Jadassohn	MESH:D054000	OMIM:163200	A syndrome characterized by lesions occurring on the face, scalp, or neck which consist of congenital hypoplastic malformations of cutaneous structures and which over time undergo verrucous hyperplasia. Additionally it is associated with neurological symptoms and skeletal, ophthalmological, urogenital, and cardiovascular abnormalities.	MESH:D000015|MESH:D009506|MESH:D020752	C04.557.665.560.700|C10.562.700|C16.131.077.633	C04.557.665.560|C10.562|C16.131.077	EPIDERMAL NEVUS SYNDROME, FORMERLY|Epidermal Nevus, Verrucous|Feuerstein Mims Syndrome|Feuerstein-Mims Syndrome|Inflammatory Linear Verrucose Epidermal Nevus|Inflammatory Linear Verrucous Epidermal Naevus|Jadassohn Nevus Phakomatosis|Jadassohn Nevus Sebaceus|Jadassohn Sebaceous Nevus|JNP|Linear Sebaceous Nevus|Linear Sebaceous Nevus Syndrome|Linear Verrucous Epidermal Nevus|Nevus, Linear Sebaceous|Nevus Phakomatoses, Organoid|Nevus Phakomatosis, Jadassohn|Nevus Phakomatosis, Organoid|Nevus Sebaceus of Jadassohn|Nevus, Verrucous|Nevus, Verrucous Epidermal|Organoid Nevus Phakomatoses|Organoid Nevus Phakomatosis|Phakomatoses, Organoid Nevus|Phakomatosis, Jadassohn Nevus|Phakomatosis, Organoid Nevus|Schimmelpenning Feuerstein Mims Syndrome|Schimmelpenning-Feuerstein-Mims Syndrome|Schimmelpenning Syndrome|Sebaceous Nevus, Linear|Sebaceous Nevus of Jadassohn|Sebaceous Nevus Syndrome, Linear|SFM|SFM SYNDROME|Syndrome, Feuerstein-Mims|Syndrome, Schimmelpenning|Syndrome, Schimmelpenning-Feuerstein-Mims|Verrucous Epidermal Nevus|Verrucous Nevus	Cancer|Congenital abnormality|Nervous system disease
Nevus, Spindle Cell	MESH:D018331		A form of pigmented nevus showing intense melanocytic activity around the dermo-epidermal junction. Large numbers of spindle-shaped melanocytes proliferate downward toward the dermis and usually a large amount of pigment is present. It was first described in 1976 and the bulk of patients reported have been young females with the lesions presenting on the thighs. (From Rook et al., Textbook of Dermatology, 4th ed, 1992, p185)	MESH:D009508	C04.557.665.560.615.625	C04.557.665.560.615	Nevi, Spindle Cell|Spindle Cell Nevi|Spindle Cell Nevus	Cancer
Nidovirales Infections	MESH:D030341		Infections with viruses of the order NIDOVIRALES. The concept includes ARTERIVIRUS INFECTIONS and CORONAVIRIDAE INFECTIONS.	MESH:D012327	C01.925.782.600	C01.925.782		Viral disease
Night Blindness	MESH:D009755	DO:DOID:8499	Failure or imperfection of vision at night or in dim light, with good vision only on bright days. (Dorland, 27th ed)	MESH:D014786	C11.966.671	C11.966	Blindness, Night|Nyctalopia	Eye disease
Night blindness skeletal anomalies unusual facies	MESH:C536121			MESH:D009216|MESH:D009755|MESH:D019066	C11.744.636/C536121|C11.966.671/C536121|C23.550.291.812/C536121	C11.744.636|C11.966.671|C23.550.291.812	Hunter Thomson Reed syndrome	Eye disease|Pathology (process)
Nijmegen Breakage Syndrome	MESH:D049932	DO:DOID:7400|OMIM:251260	A chromosome instability syndrome resulting from a defective response to DNA double-strand breaks. In addition to characteristic FACIES and MICROCEPHALY, patients have a range of findings including RADIOSENSITIVITY, immunodeficiency, increased cancer risk, and growth retardation. Causative mutations occur in the NBS1 gene, located on human chromosome 8q21. NBS1 codes for nibrin, the key regulator protein of the R/M/N (RAD50/MRE11/NBS1) protein complex which senses and mediates cellular response to DNA DAMAGE caused by IONIZING RADIATION.	MESH:D049914	C18.452.284.600	C18.452.284	Ataxia Telangiectasia Variant 1|Ataxia-Telangiectasia Variant 1|Ataxia-Telangiectasia Variant 1s|Ataxia Telangiectasia Variant V1|Ataxia-Telangiectasia Variant V1|Ataxia-Telangiectasia Variant V1s|ATAXIA-TELANGIECTASIA VARIANT V2, INCLUDED|At-V1|AT-V2, INCLUDED|BBS, INCLUDED|Berlin Breakage Syndrome|Breakage Syndrome, Berlin|Breakage Syndrome, Nijmegen|Immunodeficiency, Microcephaly, And Chromosomal Instability|IMMUNODEFICIENCY, MICROCEPHALY, AND CHROMOSOMAL INSTABILITY  BERLIN BREAKAGE SYNDROME, INCLUDED|Microcephaly with Normal Intelligence, Immunodeficiency, and Lymphoreticular Malignancies|NBS|Nonsyndromal Microcephaly, Autosomal Recessive, with Normal Intelligence|Seemanova Syndrome 2|Seemanova Syndrome II|Syndrome, Berlin Breakage|Syndrome, Nijmegen Breakage|Variant 1s, Ataxia-Telangiectasia|Variant V1, Ataxia-Telangiectasia|Variant V1s, Ataxia-Telangiectasia	Metabolic disease
Nocturnal Myoclonus Syndrome	MESH:D020189	DO:DOID:9207	Excessive periodic leg movements during sleep that cause micro-arousals and interfere with the maintenance of sleep. This condition induces a state of relative sleep deprivation which manifests as excessive daytime hypersomnolence. The movements are characterized by repetitive contractions of the tibialis anterior muscle, extension of the toe, and intermittent flexion of the hip, knee and ankle. (Adams et al., Principles of Neurology, 6th ed, p387)	MESH:D020447|MESH:D020919	C10.886.425.800.600|C10.886.659.618	C10.886.425.800|C10.886.659	Excessive Periodic Sleep Related Leg Movements|Excessive Periodic Sleep-Related Leg Movements|Myoclonus Syndrome, Nocturnal|Myoclonus Syndrome, Sleep|Myoclonus Syndromes, Sleep|Nocturnal Myoclonus Syndromes|Periodic Leg Movements, Excessive, Sleep-Related|Periodic Limb Movement Disorder|Periodic Movement Disorder, Sleep|Sleep Disorder, Periodic Movements|Sleep Myoclonus Syndrome|Sleep Myoclonus Syndromes|Sleep Related Periodic Leg Movements, Excessive|Sleep-Related Periodic Leg Movements, Excessive|Syndrome, Nocturnal Myoclonus|Syndrome, Sleep Myoclonus|Syndromes, Sleep Myoclonus	Nervous system disease
Nodding Syndrome	MESH:D064128		Unexplained neurologic condition characterized by episodes of atonic seizures, convulsions or staring spells with further cognitive decline.	MESH:D004829	C10.228.140.490.375.525	C10.228.140.490.375	Nodding Syndromes|Syndrome, Nodding|Syndromes, Nodding	Nervous system disease
Non-AIDS-related Kaposi sarcoma	MESH:C554497			MESH:D012514	C01.925.256.466.860/C554497|C04.557.450.795.850/C554497|C04.557.645.750/C554497	C01.925.256.466.860|C04.557.450.795.850|C04.557.645.750		Cancer|Viral disease
NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO	OMIM:258660			MESH:D018917	C10.292.700.600/258660|C11.640.643/258660|C14.907.601/258660	C10.292.700.600|C11.640.643|C14.907.601	NAION, SUSCEPTIBILITY TO|OPTIC NEUROPATHY, ANTERIOR ISCHEMIC, SUSCEPTIBILITY TO	Cardiovascular disease|Eye disease|Nervous system disease
Noncompaction of Left Ventricular Myocardium with Congenital Heart Defects	MESH:C564690			MESH:D006330	C14.240.400/C564690|C14.280.400/C564690|C16.131.240.400/C564690	C14.240.400|C14.280.400|C16.131.240.400	Left Ventricular Noncompaction, Nonisolated|Left Ventricular Noncompaction with Congenital Heart Defects	Cardiovascular disease|Congenital abnormality
Nondystrophic myotonia	MESH:C536245			MESH:D009222	C10.597.613.700/C536245|C23.888.592.608.700/C536245	C10.597.613.700|C23.888.592.608.700		Nervous system disease|Signs and symptoms
Non-Filarial Lymphedema	MESH:D062846		A form of elephantiasis caused by soil particles which penetrate the skin of the foot. It is limited to tropical regions with soils of high volcanic content.	MESH:D008209	C15.604.496.660	C15.604.496	Lymphedema, Non-Filarial|Lymphedemas, Non-Filarial|Non Filarial Lymphedema|Non-Filarial Lymphedemas	Lymphatic disease
Non functioning pancreatic endocrine tumor	MESH:C536126	DO:DOID:7698		MESH:D010190	C04.588.274.761/C536126|C04.588.322.475/C536126|C06.301.761/C536126|C06.689.667/C536126|C19.344.421/C536126	C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421	Non-functioning endocrine pancreatic tumors	Cancer|Digestive system disease|Endocrine system disease
Noninflammatory corneal thinning	MESH:C531720			MESH:D007640	C11.204.627/C531720	C11.204.627		Eye disease
Noninsulin-dependent diabetes mellitus with deafness	MESH:C536246			MESH:D003638|MESH:D003924|MESH:D028361	C09.218.458.341.186/C536246|C10.597.751.418.341.186/C536246|C18.452.394.750.149/C536246|C18.452.660/C536246|C19.246.300/C536246|C23.888.592.763.393.341.186/C536246	C09.218.458.341.186|C10.597.751.418.341.186|C18.452.394.750.149|C18.452.660|C19.246.300|C23.888.592.763.393.341.186	Ballinger-Wallace Syndrome|Diabetes and deafness, maternally inherited|Diabetes-deafness syndrome, maternally transmitted|Diabetes mellitus, type 2, with deafness|Diabetes Mellitus, Type II, With Deafness|Maternally inherited diabetes and deafness|Maternally Transmitted Diabetes-Deafness Syndrome|Mitochondrial Inherited Diabetes and Deafness|NIDDM with deafness	Ear-nose-throat disease|Endocrine system disease|Metabolic disease|Nervous system disease|Signs and symptoms
Nonmedullary thyroid carcinoma, with or without cell oxyphilia	MESH:C537842	OMIM:603386		MESH:D013964	C04.588.322.894/C537842|C04.588.443.915/C537842|C19.344.894/C537842|C19.874.788/C537842	C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788	TCO|TCO1|Thyroid Carcinoma, Nonmedullary, With Or Without Cell Oxyphilia	Cancer|Endocrine system disease
Nonodontogenic Cysts	MESH:D009631		Cysts formed from epithelial inclusions in the lines of fusion of the embryonic processes which form the jaws. They include nasopalatine or incisive canal cyst, incisive papilla cyst, globulomaxillary cyst, median palatal cyst, median alveolar cyst, median mandibular cyst, and nasoalveolar cyst.	MESH:D007570	C04.182.089.530.660|C05.500.470.660|C07.320.450.640	C04.182.089.530|C05.500.470|C07.320.450	Cyst, Nonodontogenic|Cysts, Nonodontogenic|Nonodontogenic Cyst	Cancer|Mouth disease|Musculoskeletal disease
Non-Radiographic Axial Spondyloarthritis	MESH:D000089202		Chronic inflammatory conditions affecting the axial joints which cannot be detectable on x-rays. It is characterized by pain, stiffness of joints and inflammation. Non-radiographic axial spondyloarthritis can have symptoms onset before the age of 45 and progress to more severe ANKYLOSING SPONDYLITIS over time.	MESH:D000089183	C05.116.900.853.625.800.744.250|C05.550.069.340.250|C05.550.114.865.800.744.250	C05.116.900.853.625.800.744|C05.550.069.340|C05.550.114.865.800.744	Axial Spondyloarthritis, Non-Radiographic|Non-Radiographic Axial Spondyloarthritides|Non Radiographic Axial Spondyloarthritis|Nr-axSpA|Spondyloarthritis, Non-Radiographic Axial	Musculoskeletal disease
Nonseminomatous germ cell tumor	MESH:C537844			MESH:D009373|MESH:D013736	C04.557.465/C537844|C04.588.322.762/C537844|C04.588.945.440.915/C537844|C12.100.500.260.937/C537844|C12.200.294.260.937/C537844|C12.200.758.409.937/C537844|C12.900.619.937/C537844|C19.344.762/C537844|C19.391.829.782/C537844	C04.557.465|C04.588.322.762|C04.588.945.440.915|C12.100.500.260.937|C12.200.294.260.937|C12.200.758.409.937|C12.900.619.937|C19.344.762|C19.391.829.782	Non-seminomatous germ-cell tumors|NSGCT Nonseminomatous germ cell tumor	Cancer|Endocrine system disease|Urogenital disease (male)
Non-ST Elevated Myocardial Infarction	MESH:D000072658		A myocardial infarction that does not produce elevations in the ST segments of the ELECTROCARDIOGRAM. ST segment elevation of the ECG is often used in determining the treatment protocol (see also ST Elevation Myocardial Infarction).	MESH:D009203	C14.280.647.500.469|C14.907.585.500.656|C23.550.513.355.750.469|C23.550.717.489.750.469	C14.280.647.500|C14.907.585.500|C23.550.513.355.750|C23.550.717.489.750	Infarction, Non-ST-Elevation Myocardial|Infarctions, Non-ST-Elevation Myocardial|Myocardial Infarction, Non-ST-Elevation|Myocardial Infarctions, Non-ST-Elevation|Non ST Elevated Myocardial Infarction|Non ST Elevation Myocardial Infarction|Non-ST-Elevation Myocardial Infarction|Non-ST-Elevation Myocardial Infarctions|NSTEMI	Cardiovascular disease|Pathology (process)
Nonsyndromic Deafness	MESH:C580334			MESH:D003638	C09.218.458.341.186/C580334|C10.597.751.418.341.186/C580334|C23.888.592.763.393.341.186/C580334	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	Isolated Deafness|Nonsyndromic Hearing Impairment|Nonsyndromic Hearing Loss|Undifferentiated Deafness	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Nonsyndromic sensorineural hearing loss	MESH:C537845			MESH:D006319	C09.218.458.341.887/C537845|C10.597.751.418.341.887/C537845|C23.888.592.763.393.341.887/C537845	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Autosomal dominant nonsyndromic hereditary hearing impairment|Deafness, nonsyndromic sensorineural, mitochondrial|Nonsyndromic hereditary hearing impairment	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Noonan like syndrome	MESH:C537846			MESH:D006101|MESH:D009634	C05.500.368/C537846|C05.660.207.690/C537846|C07.320.391/C537846|C07.465.714.258.557/C537846|C14.240.400.787/C537846|C14.280.400.787/C537846|C16.131.240.400.784/C537846|C16.131.621.207.690/C537846|C17.300.690/C537846|C23.550.382.468/C537846	C05.500.368|C05.660.207.690|C07.320.391|C07.465.714.258.557|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690|C23.550.382.468	Noonan-like-multiple giant cell lesion syndrome|Noonan Syndrome With Pigmented Villonodular Synovitis	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Mouth disease|Musculoskeletal disease|Pathology (process)
Noonan-Like Syndrome With Loose Anagen Hair	MESH:C564342			MESH:D009634|MESH:D058247	C05.660.207.690/C564342|C14.240.400.787/C564342|C14.280.400.787/C564342|C16.131.240.400.784/C564342|C16.131.621.207.690/C564342|C17.300.690/C564342|C17.800.329.937.122.348/C564342|C23.300.035.500/C564342	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690|C17.800.329.937.122.348|C23.300.035.500		Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease|Pathology (anatomical condition)|Skin disease
Noonan Syndrome	MESH:D009634	DO:DOID:3490|OMIM:163950	A genetically heterogeneous, multifaceted disorder characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, CRYPTORCHIDISM, multiple cardiac abnormalities (most commonly including PULMONARY VALVE STENOSIS), and some degree of INTELLECTUAL DISABILITY. The phenotype bears similarities to that of TURNER SYNDROME that occurs only in females and has its basis in a 45, X karyotype abnormality. Noonan syndrome occurs in both males and females with a normal karyotype (46,XX and 46,XY). Mutations in a several genes (PTPN11, KRAS, SOS1, NF1 and RAF1) have been associated the NS phenotype. Mutations in PTPN11 are the most common. LEOPARD SYNDROME, a disorder that has clinical features overlapping those of Noonan Syndrome, is also due to mutations in PTPN11. In addition, there is overlap with the syndrome called neurofibromatosis-Noonan syndrome due to mutations in NF1.	MESH:D003240|MESH:D006330|MESH:D019465	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	C05.660.207|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207|C17.300	Familial Turner Syndrome|Female Pseudo Turner Syndrome|Female Pseudo-Turner Syndrome|Male Turner's Syndrome|Male Turner Syndrome|Noonan Ehmke Syndrome|Noonan-Ehmke Syndrome|NOONAN SYNDROME|Noonan Syndrome 1|NS1|Pseudo-Turner Syndrome, Female|Pseudo Ullrich Turner Syndrome|Pseudo-Ullrich-Turner Syndrome|Turner Like Syndrome|Turner-Like Syndrome|Turner Phenotype with Normal Karyotype|TURNER PHENOTYPE WITH NORMAL KARYOTYPE PTERYGIUM COLLI SYNDROME, INCLUDED|Turner's Phenotype, Karyotype Normal|Turner's Syndrome, Male|Turner Syndrome, Familial|Turner Syndrome, Male|Ullrich Noonan Syndrome|Ullrich-Noonan Syndrome	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
NOONAN SYNDROME 10	OMIM:616564	DO:DOID:0060588		MESH:D009634	C05.660.207.690/616564|C14.240.400.787/616564|C14.280.400.787/616564|C16.131.240.400.784/616564|C16.131.621.207.690/616564|C17.300.690/616564	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	NS10	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
Noonan Syndrome 2	MESH:C548081	OMIM:605275		MESH:D009634	C05.660.207.690/C548081|C14.240.400.787/C548081|C14.280.400.787/C548081|C16.131.240.400.784/C548081|C16.131.621.207.690/C548081|C17.300.690/C548081	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	Noonan Syndrome, Autosomal Recessive|NS2	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
Noonan syndrome 3	MESH:C537847	OMIM:609942		MESH:D009634	C05.660.207.690/C537847|C14.240.400.787/C537847|C14.280.400.787/C537847|C16.131.240.400.784/C537847|C16.131.621.207.690/C537847|C17.300.690/C537847	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	NS3	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
Noonan Syndrome 4	MESH:C548082	OMIM:610733		MESH:D009634	C05.660.207.690/C548082|C14.240.400.787/C548082|C14.280.400.787/C548082|C16.131.240.400.784/C548082|C16.131.621.207.690/C548082|C17.300.690/C548082	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	NS4	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
Noonan Syndrome 5	MESH:C548083	OMIM:611553		MESH:D009634	C05.660.207.690/C548083|C14.240.400.787/C548083|C14.280.400.787/C548083|C16.131.240.400.784/C548083|C16.131.621.207.690/C548083|C17.300.690/C548083	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	NS5	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
Noonan Syndrome 6	MESH:C548084	OMIM:613224		MESH:D009634	C05.660.207.690/C548084|C14.240.400.787/C548084|C14.280.400.787/C548084|C16.131.240.400.784/C548084|C16.131.621.207.690/C548084|C17.300.690/C548084	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	NS6	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
NOONAN SYNDROME 7	OMIM:613706	DO:DOID:0060585		MESH:D009634	C05.660.207.690/613706|C14.240.400.787/613706|C14.280.400.787/613706|C16.131.240.400.784/613706|C16.131.621.207.690/613706|C17.300.690/613706	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	NS7	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
NOONAN SYNDROME 8	OMIM:615355	DO:DOID:0060586		MESH:D009634	C05.660.207.690/615355|C14.240.400.787/615355|C14.280.400.787/615355|C16.131.240.400.784/615355|C16.131.621.207.690/615355|C17.300.690/615355	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	NS8	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
NOONAN SYNDROME 9	OMIM:616559	DO:DOID:0060587		MESH:D009634	C05.660.207.690/616559|C14.240.400.787/616559|C14.280.400.787/616559|C16.131.240.400.784/616559|C16.131.621.207.690/616559|C17.300.690/616559	C05.660.207.690|C14.240.400.787|C14.280.400.787|C16.131.240.400.784|C16.131.621.207.690|C17.300.690	NS9	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Musculoskeletal disease
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	OMIM:607721	DO:DOID:0080692		MESH:C537846|MESH:D058247	C05.500.368/C537846/607721|C05.660.207.690/C537846/607721|C07.320.391/C537846/607721|C07.465.714.258.557/C537846/607721|C14.240.400.787/C537846/607721|C14.280.400.787/C537846/607721|C16.131.240.400.784/C537846/607721|C16.131.621.207.690/C537846/607721|C17.300.690/C537846/607721|C17.800.329.937.122.348/607721|C23.300.035.500/607721|C23.550.382.468/C537846/607721	C05.500.368/C537846|C05.660.207.690/C537846|C07.320.391/C537846|C07.465.714.258.557/C537846|C14.240.400.787/C537846|C14.280.400.787/C537846|C16.131.240.400.784/C537846|C16.131.621.207.690/C537846|C17.300.690/C537846|C17.800.329.937.122.348|C23.300.035.500|C23.550.382.468/C537846	MAZZANTI SYNDROME|NSLH|NSLH1|TOSTI SYNDROME	Cardiovascular disease|Congenital abnormality|Connective tissue disease|Mouth disease|Musculoskeletal disease|Pathology (anatomical condition)|Pathology (process)|Skin disease
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	OMIM:613563			MESH:C537846|MESH:D054429	C04.557.337.539.525/613563|C05.500.368/C537846/613563|C05.660.207.690/C537846/613563|C07.320.391/C537846/613563|C07.465.714.258.557/C537846/613563|C14.240.400.787/C537846/613563|C14.280.400.787/C537846/613563|C15.378.190.615.520/613563|C16.131.240.400.784/C537846/613563|C16.131.621.207.690/C537846/613563|C17.300.690/C537846/613563|C23.550.382.468/C537846/613563	C04.557.337.539.525|C05.500.368/C537846|C05.660.207.690/C537846|C07.320.391/C537846|C07.465.714.258.557/C537846|C14.240.400.787/C537846|C14.280.400.787/C537846|C15.378.190.615.520|C16.131.240.400.784/C537846|C16.131.621.207.690/C537846|C17.300.690/C537846|C23.550.382.468/C537846	CBL MUTATION-ASSOCIATED SYNDROME|CBL SYNDROME|NSLL	Blood disease|Cancer|Cardiovascular disease|Congenital abnormality|Connective tissue disease|Mouth disease|Musculoskeletal disease|Pathology (process)
North American Indian Childhood Cirrhosis	MESH:C565737	OMIM:604901		MESH:D008105	C06.130.120.135.250.250/C565737|C06.552.150.250/C565737|C06.552.630.400/C565737|C23.550.355.412.400/C565737	C06.130.120.135.250.250|C06.552.150.250|C06.552.630.400|C23.550.355.412.400	NAIC	Digestive system disease|Pathology (process)
Nose Deformities, Acquired	MESH:D009667		Abnormalities of the nose acquired after birth from injury or disease.	MESH:D009668	C08.460.619|C09.603.619	C08.460|C09.603	Acquired Nasal Deformities|Acquired Nasal Deformity|Acquired Nose Deformities|Acquired Nose Deformity|Nasal Deformities, Acquired|Nasal Deformity, Acquired|Nose Deformity, Acquired	Ear-nose-throat disease|Respiratory tract disease
Nose Diseases	MESH:D009668	DO:DOID:2825	Disorders of the nose, general or unspecified.	MESH:D010038|MESH:D012140	C08.460|C09.603	C08|C09	Disease, Nasal|Disease, Nose|Diseases, Nasal|Diseases, Nose|Disorder, Nasal|Disorders, Nasal|Nasal Disease|Nasal Diseases|Nasal Disorder|Nasal Disorders|Nose Disease	Ear-nose-throat disease|Respiratory tract disease
Nose Neoplasms	MESH:D009669		Tumors or cancer of the NOSE.	MESH:D009668|MESH:D010039|MESH:D012142|MESH:D012888	C04.588.149.721.600|C04.588.443.665.650|C05.116.231.754.600|C08.460.669|C08.785.600|C09.603.669|C09.647.685	C04.588.149.721|C04.588.443.665|C05.116.231.754|C08.460|C08.785|C09.603|C09.647	Cancer, Nasal|Cancer, Nose|Cancer of Nose|Cancer of the Nose|Cancers, Nasal|Cancers, Nose|Nasal Cancer|Nasal Cancers|Nasal Neoplasm|Nasal Neoplasms|Neoplasm, Nasal|Neoplasm, Nose|Neoplasms, Nasal|Neoplasms, Nose|Nose Cancer|Nose Cancers|Nose Neoplasm	Cancer|Ear-nose-throat disease|Musculoskeletal disease|Respiratory tract disease
N syndrome	MESH:C536108	OMIM:310465		MESH:D008607|MESH:D015458|MESH:D049914	C04.557.337.428.580/C536108|C10.597.606.360/C536108|C15.604.515.560.575/C536108|C18.452.284/C536108|C20.683.515.528.582/C536108|C23.888.592.604.646/C536108|F03.625.539/C536108	C04.557.337.428.580|C10.597.606.360|C15.604.515.560.575|C18.452.284|C20.683.515.528.582|C23.888.592.604.646|F03.625.539	NSX	Cancer|Immune system disease|Lymphatic disease|Mental disorder|Metabolic disease|Nervous system disease|Signs and symptoms
Nut and Peanut Hypersensitivity	MESH:D000074924		Allergic reaction to tree nuts and peanuts, including other LEGUMES, that is triggered by the immune system. It includes co-sensitization to other food (e.g., sesame seed).	MESH:D005512	C20.543.480.370.572	C20.543.480.370	Nut and Peanut Allergies|Nut and Peanut Allergy|Peanut and Nut Allergies|Peanut and Nut Allergy|Peanut and Tree Nut Allergies|Peanut and Tree Nut Allergy|Peanut and Tree Nut Hypersensitivity|Tree Nut and Peanut Allergy	Immune system disease
Nut Hypersensitivity	MESH:D021184	DO:DOID:4379	Allergic reaction to tree nuts that is triggered by the immune system.	MESH:D000074924	C20.543.480.370.572.500	C20.543.480.370.572	Allergies, Nut|Allergies, Tree Nut|Allergy, Nut|Allergy, Tree Nut|Hypersensitivities, Nut|Hypersensitivities, Tree Nut|Hypersensitivity, Nut|Hypersensitivity, Tree Nut|Nut Allergies|Nut Allergy|Nut Hypersensitivities|Nut Hypersensitivities, Tree|Nut Hypersensitivity, Tree|Tree Nut Allergies|Tree Nut Allergy|Tree Nut Hypersensitivities|Tree Nut Hypersensitivity	Immune system disease
Nutritional and Metabolic Diseases	MESH:D009750		A collective term for nutritional disorders resulting from poor absorption or nutritional imbalance, and metabolic disorders resulting from defects in biosynthesis (ANABOLISM) or breakdown (CATABOLISM) of endogenous substances.	MESH:C	C18	C		
Nystagmus, Myoclonic	MESH:C564088			MESH:D009207|MESH:D009759	C10.292.562.675/C564088|C10.597.350.500/C564088|C11.590.400/C564088|C23.888.592.350.500/C564088	C10.292.562.675|C10.597.350.500|C11.590.400|C23.888.592.350.500		Eye disease|Nervous system disease|Signs and symptoms
Nystagmus, Pathologic	MESH:D009759	DO:DOID:11771|DO:DOID:13174|DO:DOID:9650	Involuntary movements of the eye that are divided into two types, jerk and pendular. Jerk nystagmus has a slow phase in one direction followed by a corrective fast phase in the opposite direction, and is usually caused by central or peripheral vestibular dysfunction. Pendular nystagmus features oscillations that are of equal velocity in both directions and this condition is often associated with visual loss early in life. (Adams et al., Principles of Neurology, 6th ed, p272)	MESH:D015835	C10.292.562.675|C11.590.400	C10.292.562|C11.590	Conjugate Nystagmus|Convergence Nystagmus|Dissociated Nystagmus|Fatigable Positional Nystagmus|Horizontal Nystagmus|Jerk Nystagmus|Multidirectional Nystagmus|Non Fatigable Positional Nystagmus|Non-Fatigable Positional Nystagmus|Nystagmus, Conjugate|Nystagmus, Convergence|Nystagmus, Dissociated|Nystagmus, Fatigable Positional|Nystagmus, Horizontal|Nystagmus, Jerk|Nystagmus, Multidirectional|Nystagmus, Non-Fatigable Positional|Nystagmus, Pendular|Nystagmus, Periodic Alternating|Nystagmus, Permanent|Nystagmus, Rebound|Nystagmus, Retraction|Nystagmus, Rotary|Nystagmus, Rotational|Nystagmus, See-Saw|Nystagmus, Spontaneous Ocular|Nystagmus, Symptomatic|Nystagmus, Temporary|Nystagmus, Unidirectional|Nystagmus, Vertical|Ocular Nystagmus, Spontaneous|Pathologic Nystagmus|Pendular Nystagmus|Periodic Alternating Nystagmus|Permanent Nystagmus|Positional Nystagmus, Non-Fatigable|Rebound Nystagmus|Retraction Nystagmus|Rotary Nystagmus|Rotational Nystagmus|See Saw Nystagmus|See-Saw Nystagmus|Spontaneous Ocular Nystagmus|Symptomatic Nystagmus|Temporary Nystagmus|Unidirectional Nystagmus|Vertical Nystagmus	Eye disease|Nervous system disease
Obesity Hypoventilation Syndrome	MESH:D010845		HYPOVENTILATION syndrome in very obese persons with excessive ADIPOSE TISSUE around the ABDOMEN and DIAPHRAGM. It is characterized by diminished to absent ventilatory chemoresponsiveness; chronic HYPOXIA; HYPERCAPNIA; POLYCYTHEMIA; and long periods of sleep during day and night (HYPERSOMNOLENCE). It is a condition often related to OBSTRUCTIVE SLEEP APNEA but can occur separately.	MESH:D007040|MESH:D009765|MESH:D020181	C08.618.085.852.850.500|C08.618.846.565.500|C10.886.425.800.750.850.500|C18.654.726.750.500.600	C08.618.085.852.850|C08.618.846.565|C10.886.425.800.750.850|C18.654.726.750.500	Hypoventilation Syndrome, Obesity|Obesity-Hypoventilation Syndrome|Obesity-Hypoventilation Syndromes|Pickwickian Syndrome	Nervous system disease|Nutrition disorder|Respiratory tract disease
OCCULT MACULAR DYSTROPHY	OMIM:613587	DO:DOID:0050578		MESH:D008268	C11.768.585.439/613587	C11.768.585.439	OCMD|OMD	Eye disease
Ocular Hypertension	MESH:D009798	DO:DOID:9282	A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.	MESH:D005128	C11.525	C11	Glaucomas, Suspect|Glaucoma, Suspect|Hypertension, Ocular|Hypertensions, Ocular|Ocular Hypertensions|Suspect Glaucoma|Suspect Glaucomas	Eye disease
Ocular Hypotension	MESH:D015814	DO:DOID:790	Abnormally low intraocular pressure often related to chronic inflammation (uveitis).	MESH:D005128	C11.540	C11	Hypotension, Ocular|Hypotony, Ocular|Ocular Hypotony	Eye disease
Ocular Motility Disorders	MESH:D015835	DO:DOID:10235|DO:DOID:1279|DO:DOID:538	Disorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves (III, IV, and VI) are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition (e.g., OPSOCLONUS-MYOCLONUS SYNDROME). (Adams et al., Principles of Neurology, 6th ed, p240)	MESH:D002493|MESH:D003389|MESH:D005128	C10.228.758|C10.292.562|C11.590	C10.228|C10.292|C11	Brown's Tendon Sheath Syndrome|Brown Tendon Sheath Syndrome|Conjugate Gaze Spasm|Conjugate Gaze Spasms|Convergence Excess|Convergence Excesses|Convergence Insufficiencies|Convergence Insufficiency|Cyclophoria|Cyclophorias|Deficiencies, Smooth Pursuit|Deficiency, Smooth Pursuit|Deviation, Skew|Deviations, Skew|Dyskinesia, Paroxysmal Ocular|Dyskinesias, Paroxysmal Ocular|Excess, Convergence|Eye Motility Disorder|Eye Motility Disorders|Eye Movement Disorder|Eye Movement Disorders|Gaze Spasms, Conjugate|Insufficiencies, Convergence|Insufficiency, Convergence|Internuclear Ophthalmoplegia|Internuclear Ophthalmoplegias|Ocular Dyskinesia, Paroxysmal|Ocular Dyskinesias, Paroxysmal|Ocular Motility Disorder|Ocular Torticollis|Ophthalmoplegia, Internuclear|Ophthalmoplegias, Internuclear|Opsoclonus|Parinaud's Syndrome|Parinauds Syndrome|Parinaud Syndrome|Paroxysmal Ocular Dyskinesia|Paroxysmal Ocular Dyskinesias|Pseudoophthalmoplegia|Pseudoophthalmoplegias|Pursuit Deficiencies, Smooth|Pursuit Deficiency, Smooth|Skew Deviation|Skew Deviations|Smooth Pursuit Deficiencies|Smooth Pursuit Deficiency|Spasm of Conjugate Gaze|Syndrome, Brown's Tendon Sheath|Syndrome, Parinaud|Syndrome, Parinaud's|Tendon Sheath Syndrome of Brown	Eye disease|Nervous system disease
Ocular Myopathy with Curare Sensitivity	MESH:C564937			MESH:D009886	C10.292.562.750/C564937|C10.597.622.447/C564937|C11.590.472/C564937|C23.888.592.636.447/C564937	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447		Eye disease|Nervous system disease|Signs and symptoms
Oculocerebrocutaneous syndrome	MESH:C538088			MESH:D005124|MESH:D012868|MESH:D020863	C04.588.614.250.387/C538088|C10.500.142/C538088|C10.551.240.375/C538088|C11.250/C538088|C16.131.384/C538088|C16.131.666.142/C538088|C16.131.831/C538088|C17.800.804/C538088	C04.588.614.250.387|C10.500.142|C10.551.240.375|C11.250|C16.131.384|C16.131.666.142|C16.131.831|C17.800.804	Delleman syndrome|Oculo-cerebro-cutaneous syndrome|Orbital cyst with cerebral and focal dermal malformations	Cancer|Congenital abnormality|Eye disease|Nervous system disease|Skin disease
Oculomotor Nerve Diseases	MESH:D015840	DO:DOID:10864|DO:DOID:10866|DO:DOID:11550	Diseases of the oculomotor nerve or nucleus that result in weakness or paralysis of the superior rectus, inferior rectus, medial rectus, inferior oblique, or levator palpebrae muscles, or impaired parasympathetic innervation to the pupil. With a complete oculomotor palsy, the eyelid will be paralyzed, the eye will be in an abducted and inferior position, and the pupil will be markedly dilated. Commonly associated conditions include neoplasms, CRANIOCEREBRAL TRAUMA, ischemia (especially in association with DIABETES MELLITUS), and aneurysmal compression. (From Adams et al., Principles of Neurology, 6th ed, p270)	MESH:D015835	C10.292.562.700|C11.590.436	C10.292.562|C11.590	Cranial Nerve III Diseases|Nerve Disease, Oculomotor|Nerve Diseases, Oculomotor|Nerve Disorder, Oculomotor|Nerve Disorders, Oculomotor|Nerve Palsies, Oculomotor|Nerve Palsy, Oculomotor|Nerve Paralyses, Oculomotor|Nerve Paralysis, Oculomotor|Neuropathies, Oculomotor|Neuropathy, Oculomotor|Oculomotor Nerve Disease|Oculomotor Nerve Disorder|Oculomotor Nerve Disorders|Oculomotor Nerve Palsies|Oculomotor Nerve Palsy|Oculomotor Nerve Paralyses|Oculomotor Nerve Paralysis|Oculomotor Neuropathies|Oculomotor Neuropathy|Palsies, Oculomotor Nerve|Palsies, Partial Third-Nerve|Palsies, Third-Nerve|Palsies, Total Third-Nerve|Palsy, Oculomotor Nerve|Palsy, Partial Third-Nerve|Palsy, Third-Nerve|Palsy, Total Third-Nerve|Paralyses, Oculomotor Nerve|Paralyses, Third-Nerve|Paralysis, Oculomotor Nerve|Paralysis, Third-Nerve|Partial Third-Nerve Palsies|Partial Third Nerve Palsy|Partial Third-Nerve Palsy|Third Cranial Nerve Diseases|Third-Nerve Palsies|Third-Nerve Palsies, Partial|Third-Nerve Palsies, Total|Third Nerve Palsy|Third-Nerve Palsy|Third-Nerve Palsy, Partial|Third-Nerve Palsy, Total|Third-Nerve Paralyses|Third Nerve Paralysis|Third-Nerve Paralysis|Total Third-Nerve Palsies|Total Third Nerve Palsy|Total Third-Nerve Palsy	Eye disease|Nervous system disease
Oculomotor Nerve Injuries	MESH:D061220		Traumatic injuries to the OCULOMOTOR NERVE. This may result in various eye movement dysfunction.	MESH:D015840|MESH:D020209	C10.292.200.656|C10.292.562.700.500|C10.900.300.218.456|C11.590.436.600|C26.915.300.400.518	C10.292.200|C10.292.562.700|C10.900.300.218|C11.590.436|C26.915.300.400	Avulsion, Oculomotor Nerve|Avulsions, Oculomotor Nerve|Contusion, Oculomotor Nerve|Contusions, Oculomotor Nerve|Cranial Nerve III Injury|Injuries, Oculomotor Nerve|Injury, Cranial Nerve III|Injury, Oculomotor Nerve|Injury, Third Cranial Nerve|Nerve Avulsion, Oculomotor|Nerve Avulsions, Oculomotor|Nerve Contusion, Oculomotor|Nerve Contusions, Oculomotor|Nerve Injuries, Oculomotor|Nerve Injury, Oculomotor|Nerve Transection, Oculomotor|Nerve Transections, Oculomotor|Nerve Trauma, Oculomotor|Nerve Traumas, Oculomotor|Neuropathies, Traumatic Oculomotor|Neuropathy, Traumatic Oculomotor|Oculomotor Nerve Avulsion|Oculomotor Nerve Avulsions|Oculomotor Nerve Contusion|Oculomotor Nerve Contusions|Oculomotor Nerve Injury|Oculomotor Nerve Transection|Oculomotor Nerve Transections|Oculomotor Nerve Trauma|Oculomotor Nerve Traumas|Oculomotor Neuropathies, Traumatic|Oculomotor Neuropathy, Traumatic|Palsies, Traumatic Third-Nerve|Palsy, Traumatic Third-Nerve|Third Cranial Nerve Injuries|Third Cranial Nerve Injury|Third-Nerve Palsies, Traumatic|Third Nerve Palsy, Traumatic|Third-Nerve Palsy, Traumatic|Third Nerve Trauma|Third-Nerve Trauma|Third-Nerve Traumas|Transection, Oculomotor Nerve|Transections, Oculomotor Nerve|Trauma, Oculomotor Nerve|Traumas, Oculomotor Nerve|Traumas, Third-Nerve|Trauma, Third-Nerve|Traumatic Oculomotor Neuropathies|Traumatic Oculomotor Neuropathy|Traumatic Third-Nerve Palsies|Traumatic Third Nerve Palsy|Traumatic Third-Nerve Palsy	Eye disease|Nervous system disease|Wounds and injuries
Oculootofacial Dysplasia	MESH:C563682			MESH:D001006|MESH:D006344|MESH:D019465	C05.660.207/C563682|C06.198.050/C563682|C14.240.400.560.375/C563682|C14.280.400.560.375/C563682|C16.131.240.400.560.375/C563682|C16.131.314.094/C563682|C16.131.621.207/C563682	C05.660.207|C06.198.050|C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375|C16.131.314.094|C16.131.621.207		Cardiovascular disease|Congenital abnormality|Digestive system disease|Musculoskeletal disease
Oculootoradial syndrome	MESH:C535544	DO:DOID:0111381|OMIM:147750		MESH:D000015|MESH:D001006|MESH:D006228|MESH:D006312|MESH:D009886|MESH:D013921	C05.390.408/C535544|C05.660.585.988.425/C535544|C06.198.050/C535544|C09.218.458.341.374/C535544|C10.292.562.750/C535544|C10.597.622.447/C535544|C10.597.751.418.341.374/C535544|C11.590.472/C535544|C15.378.140.855/C535544|C16.131.077/C535544|C16.131.314.094/C535544|C16.131.621.585.988.500/C535544|C23.888.592.636.447/C535544|C23.888.592.763.393.341.374/C535544	C05.390.408|C05.660.585.988.425|C06.198.050|C09.218.458.341.374|C10.292.562.750|C10.597.622.447|C10.597.751.418.341.374|C11.590.472|C15.378.140.855|C16.131.077|C16.131.314.094|C16.131.621.585.988.500|C23.888.592.636.447|C23.888.592.763.393.341.374	Instituto Venezolano de Investigaciones Cientificas syndrome|IVIC|IVIC SYNDROME|OCULOOTORADIAL SYNDROME|Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia	Blood disease|Congenital abnormality|Digestive system disease|Ear-nose-throat disease|Eye disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Odontogenic Cyst, Calcifying	MESH:D018333		A mixed radiolucent-radiopaque lesion of the jaws with features of both a cyst and a solid neoplasm. It is characterized microscopically by an epithelial lining showing a palisaded layer of columnar basal cells, presence of ghost cell keratinization, dentinoid, and calcification. (Stedman, 25th ed)	MESH:D009807|MESH:D009808	C04.182.089.530.690.605|C04.557.695.605|C05.500.470.690.605|C07.320.450.670.495	C04.182.089.530.690|C04.557.695|C05.500.470.690|C07.320.450.670	Calcifying Odontogenic Cyst|Calcifying Odontogenic Cysts|Cyst, Calcifying Odontogenic|Cysts, Calcifying Odontogenic|Odontogenic Cysts, Calcifying	Cancer|Mouth disease|Musculoskeletal disease
Odontogenic Cysts	MESH:D009807		Cysts found in the jaws and arising from epithelium involved in tooth formation. They include follicular cysts (e.g., primordial cyst, dentigerous cyst, multilocular cyst), lateral periodontal cysts, and radicular cysts. They may become keratinized (odontogenic keratocysts). Follicular cysts may give rise to ameloblastomas and, in rare cases, undergo malignant transformation.	MESH:D007570	C04.182.089.530.690|C05.500.470.690|C07.320.450.670	C04.182.089.530|C05.500.470|C07.320.450	Cyst, Odontogenic|Cysts, Odontogenic|Keratocyst|Keratocysts|Odontogenic Cyst	Cancer|Mouth disease|Musculoskeletal disease
Odontogenic Tumors	MESH:D009808		Neoplasms produced from tooth-forming tissues.	MESH:D009370	C04.557.695	C04.557	Dental Tissue Neoplasm|Dental Tissue Neoplasms|Neoplasm, Dental Tissue|Neoplasms, Dental Tissue|Odontogenic Tumor|Tissue Neoplasm, Dental|Tissue Neoplasms, Dental|Tumor, Odontogenic|Tumors, Odontogenic	Cancer
Odontogenic Tumor, Squamous	MESH:D051527		A well-differentiated, benign, hamartomatous proliferation of odontogenic epithelium, probably arising from the rests of Malassez.	MESH:D009808	C04.557.695.607	C04.557.695	Odontogenic Tumors, Squamous|Squamous Odontogenic Tumor|Squamous Odontogenic Tumors|Tumor, Squamous Odontogenic|Tumors, Squamous Odontogenic	Cancer
Odontoma	MESH:D009810		A mixed tumor of odontogenic origin, in which both the epithelial and mesenchymal cells exhibit complete differentiation, resulting in the formation of tooth structures. (Jablonski, Illustrated Dictionary of Dentistry, 1982)	MESH:D009808	C04.557.695.610	C04.557.695	Ameloblastic Fibro-odontoma|Ameloblastic Fibro-odontomas|Compound Odontoma|Compound Odontomas|Fibroodontoma|Fibro Odontoma|Fibro-Odontoma|Fibro odontoma, Ameloblastic|Fibro-odontoma, Ameloblastic|Fibroodontomas|Fibro-Odontomas|Fibro-odontomas, Ameloblastic|Odontoma, Compound|Odontomas|Odontomas, Compound	Cancer
Odontoma dysphagia syndrome	MESH:C537740			MESH:D003680|MESH:D009810	C04.557.695.610/C537740|C06.405.117.119/C537740|C09.775.174/C537740	C04.557.695.610|C06.405.117.119|C09.775.174	Boder syndrome|Odontoma-Dysphagia Syndrome|Odontomatosis (multiple odontomas) with dysphagia	Cancer|Digestive system disease|Ear-nose-throat disease
Olfaction Disorders	MESH:D000857		Impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions.	MESH:D012678	C10.597.751.600|C23.888.592.763.550	C10.597.751|C23.888.592.763	Cacosmia|Cacosmias|Dysfunction, Smell|Dysosmia|Dysosmias|Impaired Olfaction|Impaired Olfactions|Impairment, Olfactory|Olfaction Disorder|Olfaction, Impaired|Olfactions, Impaired|Olfactory Impairment|Paraosmia|Paraosmias|Parosmia|Parosmias|Phantosmia|Phantosmias|Smell Disorder|Smell Disorders|Smell Dysfunction	Nervous system disease|Signs and symptoms
Olfactory Nerve Diseases	MESH:D020431	DO:DOID:367	Diseases of the first cranial (olfactory) nerve, which usually feature anosmia or other alterations in the sense of smell and taste. Anosmia may be associated with NEOPLASMS; CENTRAL NERVOUS SYSTEM INFECTIONS; CRANIOCEREBRAL TRAUMA; inherited conditions; toxins; METABOLIC DISEASES; tobacco abuse; and other conditions. (Adams et al., Principles of Neurology, 6th ed, pp229-31)	MESH:D003389	C10.292.650	C10.292	Cranial Nerve I Diseases|Cranial Nerve I Disorders|First Cranial Nerve Diseases|Olfactory Nerve Disease	Nervous system disease
Olfactory Nerve Injuries	MESH:D061219		Traumatic injuries to the OLFACTORY NERVE. It may result in various olfactory dysfunction including a complete loss of smell.	MESH:D020209|MESH:D020431	C10.292.200.687|C10.292.650.600|C10.900.300.218.487|C26.915.300.400.562	C10.292.200|C10.292.650|C10.900.300.218|C26.915.300.400	Avulsion, Olfactory Nerve|Avulsions, Olfactory Nerve|Contusion, Olfactory Nerve|Contusions, Olfactory Nerve|Cranial Nerve I Injury|First Cranial Nerve Injuries|First Cranial Nerve Injury|First-Nerve Palsies, Traumatic|First Nerve Palsy, Traumatic|First-Nerve Palsy, Traumatic|First Nerve Trauma|First-Nerve Trauma|First-Nerve Traumas|Injuries, Olfactory Nerve|Injury, Cranial Nerve I|Injury, First Cranial Nerve|Injury, Olfactory Nerve|Nerve Avulsion, Olfactory|Nerve Avulsions, Olfactory|Nerve Contusion, Olfactory|Nerve Contusions, Olfactory|Nerve Injuries, Olfactory|Nerve Injury, Olfactory|Nerve Transection, Olfactory|Nerve Transections, Olfactory|Nerve Trauma, Olfactory|Nerve Traumas, Olfactory|Neuropathies, Traumatic Olfactory|Neuropathy, Traumatic Olfactory|Olfactory Nerve Avulsion|Olfactory Nerve Avulsions|Olfactory Nerve Contusion|Olfactory Nerve Contusions|Olfactory Nerve Injury|Olfactory Nerve Transection|Olfactory Nerve Transections|Olfactory Nerve Trauma|Olfactory Nerve Traumas|Olfactory Neuropathies, Traumatic|Olfactory Neuropathy, Traumatic|Palsies, Traumatic First-Nerve|Palsy, Traumatic First-Nerve|Transection, Olfactory Nerve|Transections, Olfactory Nerve|Trauma, First-Nerve|Trauma, Olfactory Nerve|Traumas, First-Nerve|Traumas, Olfactory Nerve|Traumatic First-Nerve Palsies|Traumatic First Nerve Palsy|Traumatic First-Nerve Palsy|Traumatic Olfactory Neuropathies|Traumatic Olfactory Neuropathy	Nervous system disease|Wounds and injuries
Oligodendroglioma	MESH:D009837	DO:DOID:3181|DO:DOID:3183|DO:DOID:3186|DO:DOID:7912	A relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. They may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. Histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. Neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. The tumors may vary from well-differentiated to highly anaplastic forms. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2052; Adams et al., Principles of Neurology, 6th ed, p655)	MESH:D005910	C04.557.465.625.600.380.590|C04.557.470.670.380.590|C04.557.580.625.600.380.590	C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380	Adult Oligodendroglioma|Adult Oligodendrogliomas|Anaplastic Oligodendroglioma|Anaplastic Oligodendrogliomas|Childhood Oligodendroglioma|Childhood Oligodendrogliomas|Mixed Oligodendroglioma Astrocytoma|Mixed Oligodendroglioma-Astrocytoma|Mixed Oligodendroglioma-Astrocytomas|Mixed Oligodendroglioma Ependymoma|Mixed Oligodendroglioma-Ependymoma|Mixed Oligodendroglioma-Ependymomas|Oligodendroblastoma|Oligodendroblastomas|Oligodendroglioma, Adult|Oligodendroglioma, Anaplastic|Oligodendroglioma-Astrocytoma, Mixed|Oligodendroglioma-Astrocytomas, Mixed|Oligodendroglioma, Childhood|Oligodendroglioma-Ependymoma, Mixed|Oligodendroglioma-Ependymomas, Mixed|Oligodendrogliomas|Oligodendrogliomas, Adult|Oligodendrogliomas, Anaplastic|Oligodendrogliomas, Childhood|Oligodendrogliomas, Well-Differentiated|Oligodendroglioma, Well Differentiated|Oligodendroglioma, Well-Differentiated|Well Differentiated Oligodendroglioma|Well-Differentiated Oligodendroglioma|Well-Differentiated Oligodendrogliomas	Cancer
Oligodontia-Colorectal Cancer Syndrome	MESH:C563898	OMIM:608615		MESH:D000848|MESH:D015179	C04.588.274.476.411.307/C563898|C06.301.371.411.307/C563898|C06.405.249.411.307/C563898|C06.405.469.158.356/C563898|C06.405.469.491.307/C563898|C06.405.469.860.180/C563898|C07.650.800.100/C563898|C07.793.700.100/C563898|C16.131.850.800.100/C563898	C04.588.274.476.411.307|C06.301.371.411.307|C06.405.249.411.307|C06.405.469.158.356|C06.405.469.491.307|C06.405.469.860.180|C07.650.800.100|C07.793.700.100|C16.131.850.800.100	ODCRCS|Tooth Agenesis-Colorectal Cancer Syndrome	Cancer|Congenital abnormality|Digestive system disease|Mouth disease
Onat syndrome	MESH:C537749			MESH:D001024|MESH:D006130	C14.280.484.048.750/C537749|C14.280.955.249/C537749|C23.550.393/C537749	C14.280.484.048.750|C14.280.955.249|C23.550.393	Subaortic stenosis short stature syndrome|Subaortic Stenosis--Short Stature Syndrome	Cardiovascular disease|Pathology (process)
Oncocytoma, renal	MESH:C537750	DO:DOID:6245		MESH:D007680|MESH:D018249	C04.557.470.035.140/C537750|C04.588.945.947.535/C537750|C12.050.351.937.820.535/C537750|C12.050.351.968.419.473/C537750|C12.200.758.820.750/C537750|C12.200.777.419.473/C537750|C12.900.820.535/C537750|C12.950.419.473/C537750|C12.950.983.535/C537750	C04.557.470.035.140|C04.588.945.947.535|C12.050.351.937.820.535|C12.050.351.968.419.473|C12.200.758.820.750|C12.200.777.419.473|C12.900.820.535|C12.950.419.473|C12.950.983.535	Renal oncocytoma	Cancer|Urogenital disease (female)|Urogenital disease (male)
Oncogene Addiction	MESH:D000074723		The dependence of tumor cells on a single oncogenic pathway or protein for their continued proliferation and survival.	MESH:D009385	C04.697.850|C23.550.727.850	C04.697|C23.550.727	Addiction, Oncogene|Addiction, Oncogenic|Oncogenic Addiction	Cancer|Pathology (process)
Oncogenic osteomalacia	MESH:C537751			MESH:D010018|MESH:D010257	C04.730/C537751|C05.116.198.816.640/C537751|C18.452.104.816.640/C537751|C18.452.174.845.640/C537751|C18.654.521.500.133.770.734.640/C537751	C04.730|C05.116.198.816.640|C18.452.104.816.640|C18.452.174.845.640|C18.654.521.500.133.770.734.640	Tumor-induced osteomalacia	Cancer|Metabolic disease|Musculoskeletal disease|Nutrition disorder
Onycholysis	MESH:D054039		Separation of nail plate from the underlying nail bed. It can be a sign of skin disease, infection (such as ONYCHOMYCOSIS) or tissue injury.	MESH:D009260	C17.800.529.478	C17.800.529	Onycholyses|Photo-onycholyses|Photo onycholysis|Photo-onycholysis	Skin disease
Onycholysis, Partial, with Scleronychia	MESH:C563503			MESH:D009264|MESH:D054039	C17.800.529.478/C563503|C23.300.820/C563503	C17.800.529.478|C23.300.820		Pathology (anatomical condition)|Skin disease
Onychotrichodysplasia and neutropenia	MESH:C537752			MESH:D008607|MESH:D009264|MESH:D009503	C10.597.606.360/C537752|C15.378.553.546.184.564/C537752|C23.300.820/C537752|C23.888.592.604.646/C537752|F03.625.539/C537752	C10.597.606.360|C15.378.553.546.184.564|C23.300.820|C23.888.592.604.646|F03.625.539	Onychotrichodysplasia, chronic neutropenia and mental retardation syndrome	Blood disease|Mental disorder|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
OOCYTE MATURATION DEFECT 1	OMIM:615774			MESH:D007247	C12.050.351.500.498/615774|C12.100.250.498/615774|C12.100.750.350/615774	C12.050.351.500.498|C12.100.250.498|C12.100.750.350	OOMD|OOMD1	Urogenital disease (female)
OOCYTE MATURATION DEFECT 2	OMIM:616780			MESH:D007247	C12.050.351.500.498/616780|C12.100.250.498/616780|C12.100.750.350/616780	C12.050.351.500.498|C12.100.250.498|C12.100.750.350	OOMD2	Urogenital disease (female)
Oophoritis	MESH:D009869	DO:DOID:10974	Inflammation of the OVARY, generally caused by an ascending infection of organisms from the endocervix.	MESH:D000292|MESH:D010049	C12.050.351.500.056.630.450|C12.050.351.500.056.750.500|C12.100.250.056.630.450|C12.100.250.056.750.500|C19.391.630.450	C12.050.351.500.056.630|C12.050.351.500.056.750|C12.100.250.056.630|C12.100.250.056.750|C19.391.630	Oophoritides	Endocrine system disease|Urogenital disease (female)
Ophthalmia, Sympathetic	MESH:D009879	DO:DOID:12029	Granulomatous uveitis which follows in one eye after a penetrating injury to the other eye; the secondarily affected eye is called the sympathizing eye, and the injured eye is called the exciting or activating eye.	MESH:D001327|MESH:D015864	C11.941.879.780.500|C20.111.709	C11.941.879.780|C20.111	Ophthalmias, Sympathetic|Sympathetic Ophthalmia|Sympathetic Ophthalmias|Sympathetic Uveitides|Sympathetic Uveitis|Uveitides, Sympathetic|Uveitis, Sympathetic	Eye disease|Immune system disease
Ophthalmoplegia	MESH:D009886	DO:DOID:539	Paralysis of one or more of the ocular muscles due to disorders of the eye muscles, neuromuscular junction, supporting soft tissue, tendons, or innervation to the muscles.	MESH:D010243|MESH:D015835	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447	C10.292.562|C10.597.622|C11.590|C23.888.592.636	External Ophthalmoplegia|External Ophthalmoplegias|Internal Ophthalmoplegia|Internal Ophthalmoplegias|Oculomotor Paralysis|Ophthalmopareses|Ophthalmoparesis|Ophthalmoplegia, External|Ophthalmoplegia, Internal|Ophthalmoplegias|Ophthalmoplegias, External|Ophthalmoplegias, Internal|Paralysis, Oculomotor	Eye disease|Nervous system disease|Signs and symptoms
Ophthalmoplegia, Chronic Progressive External	MESH:D017246	DO:DOID:12558	A mitochondrial myopathy characterized by slowly progressive paralysis of the levator palpebrae, orbicularis oculi, and extraocular muscles. Ragged-red fibers and atrophy are found on muscle biopsy. Familial and sporadic forms may occur. Disease onset is usually in the first or second decade of life, and the illness slowly progresses until usually all ocular motility is lost. (From Adams et al., Principles of Neurology, 6th ed, p1422)	MESH:D002908|MESH:D009886|MESH:D017240	C05.651.460.700|C10.292.562.750.250|C10.597.622.447.511|C10.668.491.500.700|C11.590.472.250|C18.452.660.560.700|C23.550.291.500.688|C23.888.592.636.447.511	C05.651.460|C10.292.562.750|C10.597.622.447|C10.668.491.500|C11.590.472|C18.452.660.560|C23.550.291.500|C23.888.592.636.447	Chronic Progressive External Ophthalmoplegia|CPEO|Disease, Graefe|Dystrophy, Ocular Muscular|External Ophthalmoplegia, Progressive|Graefe Disease|Graefe's Disease|Mitochondrial Ocular Myopathy|Muscular Dystrophies, Ocular|Muscular Dystrophy, Ocular|Myopathy, Mitochondrial Ocular|Ocular Muscular Dystrophies|Ocular Muscular Dystrophy|Ocular Myopathy, Mitochondrial|Ocular Myopathy of Von Graefe Fuchs|Ocular Myopathy of Von Graefe-Fuchs|Ophthalmoplegia, Progressive External|Progressive External Ophthalmoplegia	Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Ophthalmoplegia, Familial Static	MESH:C563500			MESH:D009886	C10.292.562.750/C563500|C10.597.622.447/C563500|C11.590.472/C563500|C23.888.592.636.447/C563500	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447	External Ophthalmoplegia, Congenital Hereditary Nonprogressive	Eye disease|Nervous system disease|Signs and symptoms
Ophthalmoplegia, Familial Total, with Iris Transillumination	MESH:C563499			MESH:D009886	C10.292.562.750/C563499|C10.597.622.447/C563499|C11.590.472/C563499|C23.888.592.636.447/C563499	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447		Eye disease|Nervous system disease|Signs and symptoms
Ophthalmoplegia, painful	MESH:C531833			MESH:D020333	C10.292.562.900/C531833|C11.590.905/C531833	C10.292.562.900|C11.590.905	Nonspecific inflammation of the cavernous sinus or superior orbital fissure	Eye disease|Nervous system disease
Ophthalmoplegia, Progressive, with Scrotal Tongue and Mental Deficiency	MESH:C563498			MESH:D008607|MESH:D009886|MESH:D014063	C07.465.910.708/C563498|C10.292.562.750/C563498|C10.597.606.360/C563498|C10.597.622.447/C563498|C11.590.472/C563498|C23.888.592.604.646/C563498|C23.888.592.636.447/C563498|F03.625.539/C563498	C07.465.910.708|C10.292.562.750|C10.597.606.360|C10.597.622.447|C11.590.472|C23.888.592.604.646|C23.888.592.636.447|F03.625.539		Eye disease|Mental disorder|Mouth disease|Nervous system disease|Signs and symptoms
Ophthalmoplegia Totalis with Ptosis and Miosis	MESH:C564927			MESH:D001763|MESH:D009886|MESH:D015877	C10.292.562.750/C564927|C10.597.622.447/C564927|C10.597.690.362/C564927|C11.338.204/C564927|C11.590.472/C564927|C11.710.528/C564927|C23.888.592.636.447/C564927|C23.888.592.708.362/C564927	C10.292.562.750|C10.597.622.447|C10.597.690.362|C11.338.204|C11.590.472|C11.710.528|C23.888.592.636.447|C23.888.592.708.362		Eye disease|Nervous system disease|Signs and symptoms
Ophthalmoplegic Migraine	MESH:D060486		Childhood-onset of recurrent headaches with an oculomotor cranial nerve palsy. Typically, ABDUCENS NERVE; OCULOMOTOR NERVE; and TROCHLEAR NERVE are involved with DIPLOPIA and BLEPHAROPTOSIS.	MESH:D003389|MESH:D003711|MESH:D008881|MESH:D009886	C10.228.140.546.399.750.725|C10.292.562.750.375|C10.292.675|C10.314.687|C10.597.622.447.600|C11.590.472.375|C23.888.592.636.447.600	C10.228.140.546.399.750|C10.292|C10.292.562.750|C10.314|C10.597.622.447|C11.590.472|C23.888.592.636.447	Migraine, Ophthalmoplegic|Migraines, Ophthalmoplegic|Migraine Syndrome, Ophthalmoplegic|Migraine Syndromes, Ophthalmoplegic|Ophthalmoplegic Migraines|Ophthalmoplegic Migraine Syndrome|Ophthalmoplegic Migraine Syndromes|Syndrome, Ophthalmoplegic Migraine|Syndromes, Ophthalmoplegic Migraine	Eye disease|Nervous system disease|Signs and symptoms
Ophthalmoplegic Neuromuscular Disorder with Abnormal Mitochondria	MESH:C564925			MESH:D009135|MESH:D009886|MESH:D028361	C05.651/C564925|C10.292.562.750/C564925|C10.597.622.447/C564925|C10.668.491/C564925|C11.590.472/C564925|C18.452.660/C564925|C23.888.592.636.447/C564925	C05.651|C10.292.562.750|C10.597.622.447|C10.668.491|C11.590.472|C18.452.660|C23.888.592.636.447		Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Opportunistic Infections	MESH:D009894		An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.	MESH:D007239|MESH:D010272|MESH:D014777	C01.597|C01.610.684|C01.925.597	C01|C01.610|C01.925	Infection, Opportunistic|Infections, Opportunistic|Opportunistic Infection	Parasitic disease|Viral disease
Opsoclonus-Myoclonus Syndrome	MESH:D053578		A neurological condition that is characterized by uncontrolled rapid irregular movements of the eye (OPSOCLONUS) and the muscle (MYOCLONUS) causing unsteady, trembling gait. It is also known as dancing eyes-dancing feet syndrome and is often associated with neoplasms, viral infections, or autoimmune disorders involving the nervous system.	MESH:D009207|MESH:D015835|MESH:D020361	C04.588.614.550.600|C04.730.856.596|C10.228.758.500|C10.292.562.831|C10.574.781.662|C10.597.350.500.500|C11.590.725	C04.588.614.550|C04.730.856|C10.228.758|C10.292.562|C10.574.781|C10.597.350.500|C11.590	Dancing Eyes Dancing Feet Syndrome|Dancing Eyes-Dancing Feet Syndrome|Dancing Eyes, Dancing Feet Syndrome|Infants Myoclonic Encephalopathies|Infants Myoclonic Encephalopathy|Kinsbourne Syndrome|Myoclonic Encephalopathy of Infants|Myoclonus, Opsoclonus|Opsoclonus Myoclonus|Opsoclonus Myoclonus Ataxia|Opsoclonus Myoclonus Syndrome|Paraneoplastic Opsoclonus Myoclonus Ataxia|Paraneoplastic Opsoclonus-Myoclonus Ataxia	Cancer|Eye disease|Nervous system disease
Optic Atrophy	MESH:D009896	DO:DOID:5723	Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.	MESH:D009901	C10.292.700.225|C11.640.451	C10.292.700|C11.640	Atrophy, Optic	Eye disease|Nervous system disease
Optic Atrophy, Hearing Loss, and Peripheral Neuropathy, Autosomal Dominant	MESH:C563497			MESH:D009896|MESH:D010523|MESH:D034381	C09.218.458.341/C563497|C10.292.700.225/C563497|C10.597.751.418.341/C563497|C10.668.829/C563497|C11.640.451/C563497|C23.888.592.763.393.341/C563497	C09.218.458.341|C10.292.700.225|C10.597.751.418.341|C10.668.829|C11.640.451|C23.888.592.763.393.341		Ear-nose-throat disease|Eye disease|Nervous system disease|Signs and symptoms
Optic Atrophy, Hereditary, Leber	MESH:D029242	DO:DOID:705|OMIM:308905|OMIM:535000	A maternally linked genetic disorder that presents in mid-life as acute or subacute central vision loss leading to central scotoma and blindness. The disease has been associated with missense mutations in the mtDNA, in genes for Complex I, III, and IV polypeptides, that can act autonomously or in association with each other to cause the disease. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim/, MIM					
Optic Disk Drusen	MESH:D015594	DO:DOID:13561	Optic disk bodies composed primarily of acid mucopolysaccharides that may produce pseudopapilledema (elevation of the optic disk without associated INTRACRANIAL HYPERTENSION) and visual field deficits. Drusen may also occur in the retina (see RETINAL DRUSEN). (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p355)	MESH:D009901	C10.292.700.450|C11.640.513	C10.292.700|C11.640	Drusen, Optic Disc|Drusen, Optic Disk|Drusen, Optic Nerve|Optic Disc Drusen|Optic Disc Drusens|Optic Disk Drusens|Optic Nerve Drusen	Eye disease|Nervous system disease
Optic Nerve Aplasia, Bilateral	MESH:C563493			MESH:D009901	C10.292.700/C563493|C11.640/C563493	C10.292.700|C11.640		Eye disease|Nervous system disease
Optic Nerve Diseases	MESH:D009901	DO:DOID:14555|DO:DOID:1891	Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.	MESH:D003389|MESH:D005128	C10.292.700|C11.640	C10.292|C11	Cranial Nerve II Diseases|Cranial Nerve II Disorder|Disc Disorder, Optic|Disk Disorder, Optic|Disorder, Optic Disc|Foster Kennedy Syndrome|Foster-Kennedy Syndrome|Lesion, Neural-Optical|Neural Optical Lesion|Neural-Optical Lesion|Neural-Optical Lesions|Neuropathy, Optic|Optic Disc Disorder|Optic Disc Disorders|Optic Disk Disorder|Optic Disk Disorders|Optic Nerve Disease|Optic Neuropathies|Optic Neuropathy|Second Cranial Nerve Diseases|Syndrome, Foster-Kennedy	Eye disease|Nervous system disease
Optic Nerve Glioma	MESH:D020339	DO:DOID:4992|DO:DOID:6576	Glial cell derived tumors arising from the optic nerve, usually presenting in childhood.	MESH:D005910|MESH:D019574	C04.557.465.625.600.380.795|C04.557.470.670.380.795|C04.557.580.625.600.380.795|C04.588.614.300.600.600|C04.588.614.596.240.240.500|C10.292.225.800.500|C10.292.700.500.500|C10.551.360.500.500|C10.551.775.250.500.500|C11.640.544.500	C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380|C04.588.614.300.600|C04.588.614.596.240.240|C10.292.225.800|C10.292.700.500|C10.551.360.500|C10.551.775.250.500|C11.640.544	Adult Optic Nerve Glioma|Astrocytoma, Malignant, Optic Nerve|Childhood Optic Nerve Glioma|Glioma, Optic|Glioma, Optic Nerve|Glioma, Optic Nerve, Adult|Glioma, Optic Nerve, Childhood|Gliomas, Optic|Gliomas, Optic Nerve|Malignant Astrocytoma, Optic Nerve|Malignant Optic Nerve Astrocytoma|Optic Glioma|Optic Gliomas|Optic Nerve Glioma, Adult|Optic Nerve Glioma, Childhood|Optic Nerve Gliomas|Optic Nerve, Malignant Astrocytoma	Cancer|Eye disease|Nervous system disease
Optic Nerve Hypoplasia and Abnormalities of the Central Nervous System	MESH:C565949			MESH:D009901	C10.292.700/C565949|C11.640/C565949	C10.292.700|C11.640		Eye disease|Nervous system disease
Optic Nerve Hypoplasia, Bilateral	MESH:C563492	OMIM:165550		MESH:D009901	C10.292.700/C563492|C11.640/C563492	C10.292.700|C11.640	OPTIC NERVE APLASIA, BILATERAL, INCLUDED	Eye disease|Nervous system disease
Optic Nerve Injuries	MESH:D020221		Injuries to the optic nerve induced by a trauma to the face or head. These may occur with closed or penetrating injuries. Relatively minor compression of the superior aspect of orbit may also result in trauma to the optic nerve. Clinical manifestations may include visual loss, PAPILLEDEMA, and an afferent pupillary defect.	MESH:D009901|MESH:D020209	C10.292.200.750|C10.292.700.475|C10.900.300.218.550|C11.640.530|C26.915.300.400.650	C10.292.200|C10.292.700|C10.900.300.218|C11.640|C26.915.300.400	Avulsion, Optic Nerve|Avulsions, Optic Nerve|Contusion, Optic Nerve|Contusions, Optic Nerve|Cranial Nerve II Injuries|Injuries, Optic Nerve|Injury, Optic Nerve|Nerve Avulsion, Optic|Nerve Avulsions, Optic|Nerve Contusion, Optic|Nerve Contusions, Optic|Nerve Injuries, Optic|Nerve Injury, Optic|Nerve Transection, Optic|Nerve Transections, Optic|Nerve Trauma, Optic|Nerve Traumas, Optic|Neuropathies, Traumatic Optic|Neuropathy, Traumatic Optic|Optic Nerve Avulsion|Optic Nerve Avulsions|Optic Nerve Contusion|Optic Nerve Contusions|Optic Nerve Injury|Optic Nerve Transection|Optic Nerve Transections|Optic Nerve Trauma|Optic Nerve Traumas|Optic Neuropathies, Traumatic|Optic Neuropathy, Traumatic|Second Cranial Nerve Injuries|Second Cranial Nerve Trauma|Transection, Optic Nerve|Transections, Optic Nerve|Trauma, Optic Nerve|Trauma, Second Cranial Nerve|Traumas, Optic Nerve|Traumatic Optic Neuropathies|Traumatic Optic Neuropathy	Eye disease|Nervous system disease|Wounds and injuries
Optic Nerve Neoplasms	MESH:D019574	DO:DOID:3419	Benign and malignant neoplasms that arise from the optic nerve or its sheath. OPTIC NERVE GLIOMA is the most common histologic type. Optic nerve neoplasms tend to cause unilateral visual loss and an afferent pupillary defect and may spread via neural pathways to the brain.	MESH:D003390|MESH:D009901	C04.588.614.300.600|C04.588.614.596.240.240|C10.292.225.800|C10.292.700.500|C10.551.360.500|C10.551.775.250.500|C11.640.544	C04.588.614.300|C04.588.614.596.240|C10.292.225|C10.292.700|C10.551.360|C10.551.775.250|C11.640	Benign Optic Nerve Neoplasm|Benign Optic Nerve Sheath Neoplasms|Benign Optic Nerve Sheath Tumors|Benign Optic Nerve Tumor|Malignant Optic Nerve Neoplasm|Malignant Optic Nerve Sheath Neoplasms|Malignant Optic Nerve Sheath Tumors|Malignant Optic Nerve Tumor|Neoplasm, Benign, Optic Nerve|Neoplasm, Optic Nerve|Neoplasm, Optic Nerve, Benign|Neoplasms, Optic Nerve|Optic Nerve Neoplasm|Optic Nerve Neoplasm, Benign|Optic Nerve Sheath Neoplasm|Optic Nerve Sheath Neoplasms, Malignant|Optic Nerve Sheath Tumors|Optic Nerve Sheath Tumors, Benign|Optic Nerve Sheath Tumors, Malignant|Optic Nerve Tumor, Malignant|Tumor, Benign, Optic Nerve|Tumor, Malignant, Optic Nerve|Tumor, Optic Nerve, Benign|Tumor, Optic Nerve, Malignant	Cancer|Eye disease|Nervous system disease
Optic Neuritis	MESH:D009902	DO:DOID:1210	Inflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect (Marcus-Gunn pupil), and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe (neuropapillitis or anterior optic neuritis) or the portion behind the globe (retrobulbar neuritis or posterior optic neuritis).	MESH:D009901	C10.292.700.550|C11.640.576	C10.292.700|C11.640	Anterior Optic Neuritides|Anterior Optic Neuritis|Neuritides, Anterior Optic|Neuritides, Optic|Neuritides, Posterior Optic|Neuritides, Retrobulbar|Neuritis, Anterior Optic|Neuritis, Optic|Neuritis, Posterior Optic|Neuritis, Retrobulbar|Neuropapillitides|Neuropapillitis|Optic Neuritides|Optic Neuritides, Anterior|Optic Neuritides, Posterior|Optic Neuritis, Anterior|Optic Neuritis, Posterior|Posterior Optic Neuritides|Posterior Optic Neuritis|Retrobulbar Neuritides|Retrobulbar Neuritis	Eye disease|Nervous system disease
Optic Neuropathy, Ischemic	MESH:D018917	DO:DOID:12010	Ischemic injury to the OPTIC NERVE which usually affects the OPTIC DISK (optic neuropathy, anterior ischemic) and less frequently the retrobulbar portion of the nerve (optic neuropathy, posterior ischemic). The injury results from occlusion of arterial blood supply which may result from TEMPORAL ARTERITIS; ATHEROSCLEROSIS; COLLAGEN DISEASES; EMBOLISM; DIABETES MELLITUS; and other conditions. The disease primarily occurs in the sixth decade or later and presents with the sudden onset of painless and usually severe monocular visual loss. Anterior ischemic optic neuropathy also features optic disk edema with microhemorrhages. The optic disk appears normal in posterior ischemic optic neuropathy. (Glaser, Neuro-Ophthalmology, 2nd ed, p135)	MESH:D009901|MESH:D014652	C10.292.700.600|C11.640.643|C14.907.601	C10.292.700|C11.640|C14.907	Anterior Ischemic Optic Neuropathy|Ischaemic Neuropathy, Optic|Ischemia, Optic Nerve|Ischemic Neuropathy, Optic|Ischemic Optic Neuropathies|Ischemic Optic Neuropathy|NAION|Nerve Ischemia, Optic|Neuropathy, Ischemic Optic|Neuropathy, Optic Ischaemic|Neuropathy, Optic Ischemic|Nonarteritic Anterior Ischemic Optic Neuropathy|Optic Ischaemic Neuropathies|Optic Ischaemic Neuropathy|Optic Ischemic Neuropathies|Optic Ischemic Neuropathy|Optic Nerve Ischemia|Optic Nerve Ischemias|Optic Neuropathy, Anterior Ischemic|Optic Neuropathy, Posterior Ischemic|Posterior Ischemic Optic Neuropathy	Cardiovascular disease|Eye disease|Nervous system disease
Opticospinal Multiple Sclerosis	MESH:C580329			MESH:D009103	C10.114.375.500/C580329|C10.314.350.500/C580329|C20.111.258.250.500/C580329	C10.114.375.500|C10.314.350.500|C20.111.258.250.500	Opticospinal MS|Optic-Spinal MS|Optic-Spinal Multiple Sclerosis	Immune system disease|Nervous system disease
Oral Hemorrhage	MESH:D006472		Bleeding from the blood vessels of the mouth, which may occur as a result of injuries to the mouth, accidents in oral surgery, or diseases of the gums.	MESH:D006470|MESH:D009059|MESH:D009912	C07.465.625|C23.550.414.922|C23.888.619.500	C07.465|C23.550.414|C23.888.619	Hemorrhage, Oral|Oral Hemorrhages	Mouth disease|Pathology (process)|Signs and symptoms
Oral Manifestations	MESH:D009912		Disorders of the mouth attendant upon non-oral disease or injury.	MESH:D009059|MESH:D012816	C07.465.634|C23.888.619	C07.465|C23.888	Manifestation, Oral|Manifestations, Oral|Oral Manifestation	Mouth disease|Signs and symptoms
Orbital Cellulitis	MESH:D054517	DO:DOID:11234	Inflammation of the loose connective tissues around the ORBIT, bony structure around the eyeball. It is characterized by PAIN; EDEMA of the CONJUNCTIVA; swelling of the EYELIDS; EXOPHTHALMOS; limited eye movement; and loss of vision.	MESH:D002481|MESH:D009916	C11.675.387|C17.300.185.500	C11.675|C17.300.185	Cellulitides, Orbital|Cellulitis, Orbital|Orbital Cellulitides	Connective tissue disease|Eye disease
Orbital Diseases	MESH:D009916	DO:DOID:930	Diseases of the bony orbit and contents except the eyeball.	MESH:D005128	C11.675	C11	Disease, Orbital|Diseases, Orbital|Orbital Disease	Eye disease
Orbital Fractures	MESH:D009917		Fractures of the bones in the orbit, which include parts of the frontal, ethmoidal, lacrimal, and sphenoid bones and the maxilla and zygoma.	MESH:D008446|MESH:D012887	C10.900.300.284.500.550|C26.404.750.684|C26.915.300.425.500.550	C10.900.300.284.500|C26.404.750|C26.915.300.425.500	Blow Out Fracture|Blow-Out Fracture|Blow Out Fractures|Blow-Out Fractures|Fracture, Blow Out|Fracture, Blow-Out|Fracture, Orbital|Fractures, Blow Out|Fractures, Blow-Out|Fractures, Orbital|Orbital Fracture|Out Fracture, Blow|Out Fractures, Blow	Nervous system disease|Wounds and injuries
Orbital lymphoma	MESH:C537131	DO:DOID:9986		MESH:D008223|MESH:D009918	C04.557.386/C537131|C04.588.149.721.656/C537131|C04.588.364.659/C537131|C05.116.231.754.659/C537131|C11.319.457/C537131|C11.675.659/C537131|C15.604.515.569/C537131|C20.683.515.761/C537131	C04.557.386|C04.588.149.721.656|C04.588.364.659|C05.116.231.754.659|C11.319.457|C11.675.659|C15.604.515.569|C20.683.515.761	Lymphoma of the orbit|Primary orbital lymphoma	Cancer|Eye disease|Immune system disease|Lymphatic disease|Musculoskeletal disease
Orbital Myositis	MESH:D055622		Inflammation of the extraocular muscle of the eye. It is characterized by swelling which can lead to ischemia, fibrosis, or ORBITAL PSEUDOTUMOR.	MESH:D009220|MESH:D009916	C05.651.594.728|C10.668.491.562.537|C11.675.426	C05.651.594|C10.668.491.562|C11.675	Myositides, Orbital|Myositis, Orbital|Orbital Myositides	Eye disease|Musculoskeletal disease|Nervous system disease
Orbital Neoplasms	MESH:D009918	DO:DOID:4143	Neoplasms of the bony orbit and contents except the eyeball.	MESH:D005134|MESH:D009916|MESH:D012888	C04.588.149.721.656|C04.588.364.659|C05.116.231.754.659|C11.319.457|C11.675.659	C04.588.149.721|C04.588.364|C05.116.231.754|C11.319|C11.675	Neoplasm, Orbital|Neoplasms, Orbital|Orbital Neoplasm	Cancer|Eye disease|Musculoskeletal disease
Orbital Pseudotumor	MESH:D016727	DO:DOID:9369	A nonspecific tumor-like inflammatory lesion in the ORBIT of the eye. It is usually composed of mature LYMPHOCYTES; PLASMA CELLS; MACROPHAGES; LEUKOCYTES with varying degrees of FIBROSIS. Orbital pseudotumors are often associated with inflammation of the extraocular muscles (ORBITAL MYOSITIS) or inflammation of the lacrimal glands (DACRYOADENITIS).	MESH:D009916	C11.675.679	C11.675	Granuloma, Plasma Cell, Orbital|Inflammatory Pseudotumor of Orbit|Inflammatory Pseudotumor, Orbital|Inflammatory Pseudotumors, Orbital|Orbital Granuloma, Plasma Cell|Orbital Inflammatory Pseudotumor|Orbital Inflammatory Pseudotumors|Orbital Pseudotumors|Plasma Cell Granuloma, Orbital|Pseudotumor, Inflammatory, Orbital|Pseudotumor, Orbital|Pseudotumor, Orbital Inflammatory|Pseudotumors, Orbital	Eye disease
Orchitis	MESH:D009920	DO:DOID:2518	Inflammation of a TESTIS. It has many features of EPIDIDYMITIS, such as swollen SCROTUM; PAIN; PYURIA; and FEVER. It is usually related to infections in the URINARY TRACT, which likely spread to the EPIDIDYMIS and then the TESTIS through either the VAS DEFERENS or the lymphatics of the SPERMATIC CORD.	MESH:D013733	C12.100.500.829.493|C12.200.294.829.493|C19.391.829.493	C12.100.500.829|C12.200.294.829|C19.391.829	Orchitides	Endocrine system disease|Urogenital disease (male)
Organophosphate Poisoning	MESH:D062025		Poisoning due to exposure to ORGANOPHOSPHORUS COMPOUNDS, such as ORGANOPHOSPHATES; ORGANOTHIOPHOSPHATES; and ORGANOTHIOPHOSPHONATES.	MESH:D011041	C25.723.717	C25.723	Organophosphate Poisonings|Organophosphorus Poisoning|Organothiophosphate Poisoning|Organothiophosphate Poisonings|Organothiophosphonate Poisoning|Organothiophosphonate Poisonings|Poisoning, Organophosphate|Poisoning, Organothiophosphate|Poisoning, Organothiophosphonate|Poisonings, Organophosphate|Poisonings, Organothiophosphate|Poisonings, Organothiophosphonate	
Oropharyngeal Neoplasms	MESH:D009959		Tumors or cancer of the OROPHARYNX.	MESH:D010610	C04.588.443.665.710.684|C07.550.745.671|C09.647.710.685|C09.775.549.685	C04.588.443.665.710|C07.550.745|C09.647.710|C09.775.549	Cancer of Oropharnyx|Cancer of the Oropharynx|Cancer, Oropharyngeal|Cancer, Oropharynx|Cancers, Oropharyngeal|Cancers, Oropharynx|Neoplasm, Oropharyngeal|Neoplasm, Oropharynx|Neoplasms, Oropharyngeal|Neoplasms, Oropharynx|Oropharnyx Cancer|Oropharnyx Cancers|Oropharyngeal Cancer|Oropharyngeal Cancers|Oropharyngeal Neoplasm|Oropharynx Cancer|Oropharynx Cancers|Oropharynx Neoplasm|Oropharynx Neoplasms	Cancer|Ear-nose-throat disease|Mouth disease
Orstavik Lindemann Solberg syndrome	MESH:C537137	OMIM:217085		MESH:D006222|MESH:D006330|MESH:D013576|MESH:D014062	C04.445/C537137|C04.588.443.591.925/C537137|C05.116.099.370.894.819/C537137|C05.660.585.800/C537137|C05.660.906.819/C537137|C07.465.530.925/C537137|C07.465.910.470/C537137|C14.240.400/C537137|C14.280.400/C537137|C16.131.240.400/C537137|C16.131.621.585.800/C537137|C16.131.621.906.819/C537137	C04.445|C04.588.443.591.925|C05.116.099.370.894.819|C05.660.585.800|C05.660.906.819|C07.465.530.925|C07.465.910.470|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.585.800|C16.131.621.906.819	CHDTHP|Congenital heart defects, hamartomas of tongue, and polysyndactyly	Cancer|Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease
Orthomyxoviridae Infections	MESH:D009976		Virus diseases caused by the ORTHOMYXOVIRIDAE.	MESH:D012327	C01.925.782.620	C01.925.782	Infection, Orthomyxoviridae|Infection, Orthomyxovirus|Infections, Orthomyxoviridae|Infections, Orthomyxovirus|Influenza, Swine|Orthomyxoviridae Infection|Orthomyxovirus Infection|Orthomyxovirus Infections|Swine Influenza	Viral disease
Orthostatic Hypotensive Disorder, Streeten Type	MESH:C564174	OMIM:143850		MESH:D007024	C10.177.575.600.450/C564174|C14.907.514.482/C564174	C10.177.575.600.450|C14.907.514.482	Hyperbradykininism|OHDS|Orthostatic Hypotensive Disorder	Cardiovascular disease|Nervous system disease
Orthostatic Intolerance	MESH:D054971	OMIM:604715	Symptoms of cerebral hypoperfusion or autonomic overaction which develop while the subject is standing, but are relieved on recumbency. Types of this include NEUROCARDIOGENIC SYNCOPE; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; and neurogenic ORTHOSTATIC HYPOTENSION. (From Noseworthy, JH., Neurological Therapeutics Principles and Practice, 2007, p2575-2576)	MESH:D009461|MESH:D054969	C10.177.575.600|C23.888.592.610	C10.177.575|C23.888.592	Intolerance, Orthostatic|IRRITABLE HEART|MITRAL VALVE PROLAPSE SYNDROME|NEUROCIRCULATORY ASTHENIA|SOLDIERS HEART	Nervous system disease|Signs and symptoms
Oslam syndrome	MESH:C537138			MESH:D000015|MESH:D001859|MESH:D005532|MESH:D006228|MESH:D012516	C04.557.450.565.575.650/C537138|C04.557.450.795.620/C537138|C04.588.149/C537138|C05.116.231/C537138|C05.330.495/C537138|C05.390.408/C537138|C05.660.585.512.380/C537138|C05.660.585.988.425/C537138|C16.131.077/C537138|C16.131.621.585.512.500/C537138|C16.131.621.585.988.500/C537138	C04.557.450.565.575.650|C04.557.450.795.620|C04.588.149|C05.116.231|C05.330.495|C05.390.408|C05.660.585.512.380|C05.660.585.988.425|C16.131.077|C16.131.621.585.512.500|C16.131.621.585.988.500		Cancer|Congenital abnormality|Musculoskeletal disease
Osler-rendu-weber syndrome 2	MESH:C537139	OMIM:600376		MESH:D013683	C14.907.454.900/C537139|C14.907.823.780/C537139|C15.378.463.515.900/C537139|C16.131.240.850.968/C537139	C14.907.454.900|C14.907.823.780|C15.378.463.515.900|C16.131.240.850.968	Telangiectasia, hereditary hemorrhagic, type 2|TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2;HHT2 PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC|TELANGIECTASIA-RELATED, INCLUDED	Blood disease|Cardiovascular disease|Congenital abnormality
Osler-rendu-weber syndrome 3	MESH:C537140	OMIM:601101		MESH:D013683	C14.907.454.900/C537140|C14.907.823.780/C537140|C15.378.463.515.900/C537140|C16.131.240.850.968/C537140	C14.907.454.900|C14.907.823.780|C15.378.463.515.900|C16.131.240.850.968	HHT3|Telangiectasia, hereditary hemorrhagic, type 3	Blood disease|Cardiovascular disease|Congenital abnormality
Ossicular Malformations, familial	MESH:C537142			MESH:D006311	C09.218.458/C537142|C10.597.751.418/C537142|C23.888.592.763.393/C537142	C09.218.458|C10.597.751.418|C23.888.592.763.393	Familial middle ear ossicular anomalies|Familial ossicular malformations	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Ossification of Posterior Longitudinal Ligament	MESH:D017887		A calcification of the posterior longitudinal ligament of the spinal column, usually at the level of the cervical spine. It is often associated with anterior ankylosing hyperostosis.	MESH:D009999|MESH:D013122	C05.116.900.480|C23.550.751.500	C05.116.900|C23.550.751	Calcification of Posterior Longitudinal Ligament|Posterior Longitudinal Ligament Calcification|Posterior Longitudinal Ligament Ossification	Musculoskeletal disease|Pathology (process)
Ossification of the posterior longitudinal ligament of the spine	MESH:C537143	OMIM:602475		MESH:D017887	C05.116.900.480/C537143|C23.550.751.500/C537143	C05.116.900.480|C23.550.751.500	OPLL|Ossification of the Posterior Longitudinal Ligament of Spine	Musculoskeletal disease|Pathology (process)
Ossified Ear Cartilages	MESH:C563488			MESH:D002114	C18.452.174.130/C563488	C18.452.174.130		Metabolic disease
Osteitis	MESH:D010000	DO:DOID:3342	Inflammation of the bone.	MESH:D001847	C05.116.680	C05.116	Bone Inflammation|Inflammation, Bone	Musculoskeletal disease
Osteitis Deformans	MESH:D010001	DO:DOID:5408|OMIM:167250|OMIM:602080|OMIM:616833	A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry.	MESH:D001847	C05.116.692	C05.116	Osseous Paget's Disease|Paget Disease, Bone|Paget Disease of Bone|PAGET DISEASE OF BONE 2, EARLY-ONSET|PAGET DISEASE OF BONE 3|PAGET DISEASE OF BONE 6|Pagets Disease, Bone|Paget's Disease of Bone|PDB2|PDB3|PDB6	Musculoskeletal disease
Osteitis Fibrosa Cystica	MESH:D010002	DO:DOID:3341	A fibrous degeneration, cyst formation, and the presence of fibrous nodules in bone, usually due to HYPERPARATHYROIDISM.	MESH:D001849	C05.116.132.684	C05.116.132	Recklinghausen Disease, Bone|Recklinghausen Disease of Bone|Recklinghausens Disease, Bone|Recklinghausen's Disease of Bone	Musculoskeletal disease
Osteoarthritis	MESH:D010003	OMIM:140600|OMIM:165720|OMIM:607850|OMIM:610839|OMIM:612400|OMIM:612401	A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.	MESH:D001168|MESH:D012216	C05.550.114.606|C05.799.613	C05.550.114|C05.799	Arthritides, Degenerative|Arthritis, Degenerative|Arthroses|Arthrosis|Degenerative Arthritides|Degenerative Arthritis|DIPOA|GOA1|HAND OSTEOARTHRITIS;HOA  HEBERDEN NODES, INCLUDED|OA|OADIP|OS1|OS2|OS3|OS4|OS5|OS6|Osteoarthritides|OSTEOARTHRITIS, GENERALIZED, WITHOUT DYSPLASIA|OSTEOARTHRITIS OF DISTAL INTERPHALANGEAL JOINTS|OSTEOARTHRITIS OF HIP|OSTEOARTHRITIS OF HIP, FEMALE-SPECIFIC, SUSCEPTIBILITY TO|OSTEOARTHRITIS OF KNEE|OSTEOARTHRITIS OF KNEE/HIP|OSTEOARTHRITIS SUSCEPTIBILITY 1|OSTEOARTHRITIS SUSCEPTIBILITY 2|OSTEOARTHRITIS SUSCEPTIBILITY 3|OSTEOARTHRITIS SUSCEPTIBILITY 4|OSTEOARTHRITIS SUSCEPTIBILITY 5|OSTEOARTHRITIS SUSCEPTIBILITY 6|Osteoarthroses|Osteoarthrosis|Osteoarthrosis Deformans	Musculoskeletal disease
Osteoarthritis, Hip	MESH:D015207		Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.	MESH:D010003	C05.550.114.606.400|C05.799.613.400	C05.550.114.606|C05.799.613	Coxarthroses|Coxarthrosis|Hip Osteoarthritis|Osteoarthritis Of Hip|Osteoarthritis Of Hips|Osteoarthritis of the Hip	Musculoskeletal disease
Osteoarthritis, Knee	MESH:D020370		Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)	MESH:D010003	C05.550.114.606.500|C05.799.613.500	C05.550.114.606|C05.799.613	Knee Osteoarthritides|Knee Osteoarthritis|Osteoarthritis of Knee|Osteoarthritis of the Knee	Musculoskeletal disease
Osteoarthritis, Spine	MESH:D055013		A degenerative joint disease involving the SPINE. It is characterized by progressive deterioration of the spinal articular cartilage (CARTILAGE, ARTICULAR), usually with hardening of the subchondral bone and outgrowth of bone spurs (OSTEOPHYTE).	MESH:D010003|MESH:D025241	C05.116.900.853.625.399|C05.550.114.606.750|C05.550.114.865.399|C05.799.613.750	C05.116.900.853.625|C05.550.114.606|C05.550.114.865|C05.799.613	Lumbar Osteoarthritis|Osteoarthritis, Lumbar|Osteoarthritis of Spine|Osteoarthritis of the Spine|Osteoarthritis, Spinal|Spinal Osteoarthritis|Spine Osteoarthritis	Musculoskeletal disease
Osteoarthropathy of fingers familial	MESH:C537144			MESH:D055034	C05.116.821/C537144	C05.116.821	Osteoarthropathy Of Fingers, Familial|Thiemann epiphyseal disease|Thiemann's disease	Musculoskeletal disease
Osteoarthropathy, Secondary Hypertrophic	MESH:D010005	DO:DOID:10393	Symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart. (Dorland, 27th ed)	MESH:D001847|MESH:D007592	C05.116.758|C05.550.684	C05.116|C05.550	Clubbed Finger|Clubbed Fingers|Disease, Marie-Bamberger|Finger, Clubbed|Fingers, Clubbed|Hypertrophic Osteoarthropathies, Secondary|Hypertrophic Osteoarthropathy, Secondary|Marie Bamberger Disease|Marie-Bamberger Disease|Osteoarthropathies, Secondary Hypertrophic|Secondary Hypertrophic Osteoarthropathies|Secondary Hypertrophic Osteoarthropathy	Musculoskeletal disease
Osteoblastoma	MESH:D018215	DO:DOID:0060098	A benign, painful, tumor of bone characterized by the formation of osteoid tissue, primitive bone and calcified tissue. It occurs frequently in the spine of young persons. (From Dorland, 27th ed; Stedman, 25th ed)	MESH:D018213	C04.557.450.565.575.600	C04.557.450.565.575	Giant Osteoid Osteoma|Giant Osteoid Osteomas|Osteoblastomas|Osteoid Osteoma, Giant|Osteoid Osteomas, Giant|Osteoma, Giant Osteoid|Osteomas, Giant Osteoid	Cancer
Osteochondritis Dissecans	MESH:D010008	DO:DOID:84	A type of osteochondritis in which articular cartilage and associated bone becomes partially or totally detached to form joint loose bodies. Affects mainly the knee, ankle, and elbow joints.	MESH:D010007	C05.116.791.668	C05.116.791	Dissecans, Osteochondritis	Musculoskeletal disease
Osteochondroma	MESH:D015831		A cartilage-capped benign tumor that often appears as a stalk on the surface of bone. It is probably a developmental malformation rather than a true neoplasm and is usually found in the metaphysis of the distal femur, proximal tibia, or proximal humerus. Osteochondroma is the most common of benign bone tumors.	MESH:D010009|MESH:D018213	C04.557.450.565.575.610|C05.116.099.708.670	C04.557.450.565.575|C05.116.099.708	Cartilaginous Exostoses|Cartilaginous Exostosis|Chondrosteoma|Chondrosteomas|Exostoses, Cartilaginous|Exostoses, Osteocartilaginous|Exostosis, Cartilaginous|Exostosis, Osteocartilaginous|Osteocartilaginous Exostoses|Osteocartilaginous Exostosis|Osteochondromas	Cancer|Musculoskeletal disease
Osteochondromatosis	MESH:D018216		A condition marked by the presence of multiple osteochondromas. (Dorland, 27th ed)	MESH:D015831	C04.557.450.565.575.610.615|C05.116.099.708.670.615	C04.557.450.565.575.610|C05.116.099.708.670	Osteochondromatoses	Cancer|Musculoskeletal disease
Osteochondrosis	MESH:D055034	DO:DOID:7489|DO:DOID:8125	Any of a group of bone disorders involving one or more ossification centers (EPIPHYSES). It is characterized by degeneration or NECROSIS followed by revascularization and reossification. Osteochondrosis often occurs in children causing varying degrees of discomfort or pain. There are many eponymic types for specific affected areas, such as tarsal navicular (Kohler disease) and tibial tuberosity (Osgood-Schlatter disease).	MESH:D001847	C05.116.821	C05.116	Koehler Disease|Koehler's Disease|Koehlers Disease|Navicular Osteochondroses|Navicular Osteochondrosis|Osgood Schlatter Disease|Osgood-Schlatter Disease|Osteochondroses|Osteochondroses, Navicular|Osteochondrosis, Navicular	Musculoskeletal disease
Osteofibrous Dysplasia	MESH:C563276	OMIM:607278		MESH:D001848	C05.116.099/C563276	C05.116.099	OFD|OSFD|OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO|TIBIA, BOWING OF, WITH PSEUDARTHROSIS AND PECTUS EXCAVATUM	Musculoskeletal disease
Osteolysis	MESH:D010014		Dissolution of bone that particularly involves the removal or loss of calcium.	MESH:D001862	C05.116.264.579	C05.116.264	Osteolyses	Musculoskeletal disease
Osteolysis, Essential	MESH:D010015	DO:DOID:4837	Syndromes of bone destruction where the cause is not obvious such as neoplasia, infection, or trauma. The destruction follows various patterns: massive (Gorham disease), multicentric (HAJDU-CHENEY SYNDROME), or carpal/tarsal.	MESH:D001848|MESH:D010014	C05.116.099.736|C05.116.264.579.704	C05.116.099|C05.116.264.579	Cystic Angiomatosis Of Bone, Diffuse|Disappearing Bone Disease|Essential Osteolyses|Essential Osteolysis|Gorham Disease|Gorham's Disease|Gorhams Disease|Gorham Stout Disease|Gorham-Stout Disease|Idiopathic Multicentric Osteolyses|Idiopathic Multicentric Osteolysis|Massive Osteolyses|Massive Osteolysis|Multicentric Osteolyses, Idiopathic|Multicentric Osteolysis, Idiopathic|Osteolyses, Essential|Osteolysis, Idiopathic Multicentric|Osteolysis, Massive	Musculoskeletal disease
Osteolysis hereditary multicentric	MESH:C536051	OMIM:259600		MESH:D010014	C05.116.264.579/C536051	C05.116.264.579	Al-Aqeel Sewairi Syndrome|Hereditary multicentric osteolysis|MONA|Multicentric Osteolysis, Nodulosis, and Arthropathy|NAO SYNDROME|Nodulosis-Arthropathy-Osteolysis Syndrome|Osteolysis, Hereditary Multicentric|Torg osteolysis syndrome|Torg Syndrome|Torg-Winchester Syndrome|TORG-WINCHESTER SYNDROME, FORMERLY	Musculoskeletal disease
Osteolysis, Hereditary, Of Carpal Bones With Or Without Nephropathy	MESH:C567171	DO:DOID:0111534		MESH:D010014	C05.116.264.579/C567171	C05.116.264.579	Multicentric Osteolysis, Autosomal Dominant	Musculoskeletal disease
Osteoma	MESH:D010016		A benign tumor composed of bone tissue or a hard tumor of bonelike structure developing on a bone (homoplastic osteoma) or on other structures (heteroplastic osteoma). (From Dorland, 27th ed)	MESH:D018213	C04.557.450.565.575.625	C04.557.450.565.575	Osteomas	Cancer
Osteomalacia	MESH:D010018		Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.	MESH:D012279	C05.116.198.816.640|C18.452.104.816.640|C18.452.174.845.640|C18.654.521.500.133.770.734.640	C05.116.198.816|C18.452.104.816|C18.452.174.845|C18.654.521.500.133.770.734	Adult Rickets|Rickets, Adult	Metabolic disease|Musculoskeletal disease|Nutrition disorder
Osteomalacia, Sclerosing, with Cerebral Calcification	MESH:C564916			MESH:D002114|MESH:D010018	C05.116.198.816.640/C564916|C18.452.104.816.640/C564916|C18.452.174.130/C564916|C18.452.174.845.640/C564916|C18.654.521.500.133.770.734.640/C564916	C05.116.198.816.640|C18.452.104.816.640|C18.452.174.130|C18.452.174.845.640|C18.654.521.500.133.770.734.640		Metabolic disease|Musculoskeletal disease|Nutrition disorder
Osteoma of Cranial Vault, Familial	MESH:C566356			MESH:D010016|MESH:D012888	C04.557.450.565.575.625/C566356|C04.588.149.721/C566356|C05.116.231.754/C566356	C04.557.450.565.575.625|C04.588.149.721|C05.116.231.754		Cancer|Musculoskeletal disease
Osteoma of Middle Ear	MESH:C564917			MESH:D010016	C04.557.450.565.575.625/C564917	C04.557.450.565.575.625		Cancer
Osteoma, Osteoid	MESH:D010017		A benign osteoblastic tumor with central vascularized nidus surrounded by normal reactive bone. It occurs especially in second decade of life most commonly in the femoral neck but can occur in any bone and any site within a bone.	MESH:D010016	C04.557.450.565.575.625.625	C04.557.450.565.575.625	Osteoid Osteoma|Osteoid Osteomas|Osteomas, Osteoid	Cancer
Osteomas Of Mandible	MESH:C563485			MESH:D008339|MESH:D010016	C04.557.450.565.575.625/C563485|C04.588.149.721.450.583/C563485|C05.116.231.754.450.583/C563485|C05.500.499.583/C563485|C05.500.607.442/C563485|C07.320.515.583/C563485|C07.320.610.583/C563485	C04.557.450.565.575.625|C04.588.149.721.450.583|C05.116.231.754.450.583|C05.500.499.583|C05.500.607.442|C07.320.515.583|C07.320.610.583		Cancer|Mouth disease|Musculoskeletal disease
Osteomyelitis	MESH:D010019		INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.	MESH:D001850	C01.160.495|C05.116.165.495	C01.160|C05.116.165	Osteomyelitides	Musculoskeletal disease
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS	OMIM:612852			MESH:D010019|MESH:D010522|MESH:D012871	C01.160.495/612852|C01.160.595/612852|C05.116.165.495/612852|C05.116.165.595/612852|C17.800/612852	C01.160.495|C01.160.595|C05.116.165.495|C05.116.165.595|C17.800	DIRA|INTERLEUKIN 1 RECEPTOR ANTAGONIST DEFICIENCY|OMPP	Musculoskeletal disease|Skin disease
Osteonecrosis	MESH:D010020	DO:DOID:10159	Death of a bone or part of a bone, either atraumatic or posttraumatic.	MESH:D001847|MESH:D009336	C05.116.852|C23.550.717.732	C05.116|C23.550.717	Aseptic Necrosis of Bone|Avascular Necrosis of Bone|Bone Aseptic Necrosis|Bone Avascular Necrosis|Bone Necroses|Bone Necrosis|Kienbock Disease|Kienbock's Disease|Kienboeck Disease|Kienboeck's Disease|Kienboecks Disease|Necroses, Bone|Necrosis, Aseptic, of Bone|Necrosis, Avascular, of Bone|Necrosis, Bone|Osteonecroses	Musculoskeletal disease|Pathology (process)
Osteopathia striata cranial sclerosis	MESH:C536053	DO:DOID:0060886|OMIM:300373		MESH:D010026	C05.116.099.708.702/C536053	C05.116.099.708.702	Hyperostosis Generalisata with Striations|OSCS|Osteopathia Striata with Cranial Sclerosis	Musculoskeletal disease
Osteopetrosis	MESH:D010022	DO:DOID:0110938|DO:DOID:13533|OMIM:166600	Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).	MESH:D010026	C05.116.099.708.702.678	C05.116.099.708.702	Albers Schoenberg Disease|Albers-Schoenberg Disease|Albers Schonberg Disease|Albers-Schonberg Disease|Albers Schönberg Disease|Albers-Schönberg Disease|Albers Schonberg Disease, Autosomal Dominant|Albers-Schonberg Disease, Autosomal Dominant|Autosomal Dominant Osteopetrosis Type 2|Congenital Osteopetrosis|Disease, Albers-Schoenberg|Disease, Albers-Schonberg|Disease, Albers-Schönberg|Disease, Marble Bone|Marble Bone Disease|Marble Bones, Autosomal Dominant|OPTA2|Osteopetroses|Osteopetrosis, Autosomal Dominant 2|Osteopetrosis Autosomal Dominant Type 2|Osteopetrosis, Autosomal Dominant, Type II|Osteosclerosis Fragilis|Osteosclerosis Fragilis Generalisata|Osteosclerosis Fragilis Generalisatas	Musculoskeletal disease
Osteopetrosis and infantile neuroaxonal dystrophy	MESH:C536055			MESH:D010022|MESH:D019150	C05.116.099.708.702.678/C536055|C10.228.140.744/C536055	C05.116.099.708.702.678|C10.228.140.744	Infantile osteopetrosis and neuronal storage disease|Prenatal axonal dystrophy and osteopetrosis	Musculoskeletal disease|Nervous system disease
Osteopetrosis autosomal dominant type 1	MESH:C536056	DO:DOID:0110937|OMIM:607634		MESH:D010022	C05.116.099.708.702.678/C536056	C05.116.099.708.702.678	OPTA1|Osteopetrosis, Autosomal Dominant 1|Osteopetrosis, Autosomal Dominant, Type I	Musculoskeletal disease
Osteopetrosis, Autosomal Recessive 1	MESH:C564915	OMIM:259700		MESH:D010022	C05.116.099.708.702.678/C564915	C05.116.099.708.702.678	Albers-Schonberg Disease, Autosomal Recessive|Marble Bones, Autosomal Recessive|OPTB1|Osteopetrosis, Infantile Malignant 1	Musculoskeletal disease
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2	OMIM:259710	DO:DOID:0110943		MESH:D010022	C05.116.099.708.702.678/259710	C05.116.099.708.702.678	OPTB2|OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM|OSTEOPETROSIS, OSTEOCLAST-POOR	Musculoskeletal disease
Osteopetrosis, Autosomal Recessive 4	MESH:C566933	OMIM:611490		MESH:D010022	C05.116.099.708.702.678/C566933	C05.116.099.708.702.678	OPTB4|OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4|Osteopetrosis, Infantile Malignant 2	Musculoskeletal disease
Osteopetrosis, Autosomal Recessive 5	MESH:C566883	OMIM:259720		MESH:D010022	C05.116.099.708.702.678/C566883	C05.116.099.708.702.678	OPTB5|Osteopetrosis, Infantile Malignant 3	Musculoskeletal disease
Osteopetrosis, Autosomal Recessive 6	MESH:C566931	OMIM:611497		MESH:D010022	C05.116.099.708.702.678/C566931	C05.116.099.708.702.678	OPTB6|Osteopetrosis, Autosomal Recessive, Intermediate Form	Musculoskeletal disease
Osteopetrosis, Autosomal Recessive 7	MESH:C567354	OMIM:612301		MESH:D000361|MESH:D010022	C05.116.099.708.702.678/C567354|C15.378.147.142/C567354|C15.604.515.032/C567354|C20.673.088/C567354	C05.116.099.708.702.678|C15.378.147.142|C15.604.515.032|C20.673.088	OPTB7|Osteopetrosis, Osteoclast-Poor, With Hypogammaglobulinemia	Blood disease|Immune system disease|Lymphatic disease|Musculoskeletal disease
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8	OMIM:615085	DO:DOID:0110940		MESH:D010022	C05.116.099.708.702.678/615085	C05.116.099.708.702.678	OPTB8	Musculoskeletal disease
Osteopetrosis lethal	MESH:C536057			MESH:D010022	C05.116.099.708.702.678/C536057	C05.116.099.708.702.678	Autosomal malignant osteopetrosis|Lethal osteopetrosis	Musculoskeletal disease
Osteopetrosis, mild autosomal recessive form	MESH:C536059			MESH:D010022	C05.116.099.708.702.678/C536059	C05.116.099.708.702.678	Mild autosomal recessive form of osteopetrosis|Osteopetrosis, Autosomal Recessive 2|Osteopetrosis, Osteoclast-Poor	Musculoskeletal disease
Osteophyte	MESH:D054850		Bony outgrowth usually found around joints and often seen in conditions such as ARTHRITIS.	MESH:D005096	C05.116.540.310.800	C05.116.540.310	Bone Spur|Bone Spurs|Osteophytes|Spur, Bone|Spurs, Bone	Musculoskeletal disease
Osteopoikilosis and dacryocystitis	MESH:C536061			MESH:D003607|MESH:D010023	C05.116.099.708.702.685/C536061|C11.496.221/C536061|C17.300.705/C536061	C05.116.099.708.702.685|C11.496.221|C17.300.705	Dacryocystitis osteopoikilosis|Gunal Seber Basaran syndrome	Connective tissue disease|Eye disease|Musculoskeletal disease
Osteoporosis	MESH:D010024	DO:DOID:11476|OMIM:166710|OMIM:601884|OMIM:615221	Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.	MESH:D001851	C05.116.198.579|C18.452.104.579	C05.116.198|C18.452.104	Age-Related Bone Loss|Age-Related Bone Losses|Age-Related Osteoporoses|Age Related Osteoporosis|Age-Related Osteoporosis|BMND|BMND1|BMND16|Bone Loss, Age Related|Bone Loss, Age-Related|Bone Losses, Age-Related|BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS|BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1|BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16|HBM, INCLUDED|HIGH BONE MASS, INCLUDED|Osteoporoses|Osteoporoses, Age-Related|Osteoporoses, Senile|Osteoporosis, Age Related|Osteoporosis, Age-Related|OSTEOPOROSIS, EARLY-ONSET, SUSCEPTIBILITY TO|Osteoporosis, Involutional|OSTEOPOROSIS, INVOLUTIONAL  FRACTURE, HIP, SUSCEPTIBILITY TO, INCLUDED|OSTEOPOROSIS, POSTMENOPAUSAL|Osteoporosis, Post Traumatic|Osteoporosis, Post-Traumatic|Osteoporosis, Senile|OSTEOPOROSIS, SUSCEPTIBILITY TO, INCLUDED|Post-Traumatic Osteoporoses|Post-Traumatic Osteoporosis|Senile Osteoporoses|Senile Osteoporosis	Metabolic disease|Musculoskeletal disease
Osteoporosis, Postmenopausal	MESH:D015663		Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.	MESH:D010024	C05.116.198.579.610|C18.452.104.579.610	C05.116.198.579|C18.452.104.579	Bone Losses, Perimenopausal|Bone Losses, Postmenopausal|Bone Loss, Perimenopausal|Bone Loss, Postmenopausal|Osteoporoses, Postmenopausal|Osteoporoses, Post-Menopausal|Osteoporosis, Post Menopausal|Osteoporosis, Post-Menopausal|Perimenopausal Bone Loss|Perimenopausal Bone Losses|Postmenopausal Bone Loss|Postmenopausal Bone Losses|Postmenopausal Osteoporoses|Post-Menopausal Osteoporoses|Postmenopausal Osteoporosis|Post-Menopausal Osteoporosis	Metabolic disease|Musculoskeletal disease
Osteosarcoma	MESH:D012516	DO:DOID:3347|OMIM:259500	A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)	MESH:D012509|MESH:D018213	C04.557.450.565.575.650|C04.557.450.795.620	C04.557.450.565.575|C04.557.450.795	OSRC|Osteogenic Sarcoma|Osteogenic Sarcomas|OSTEOSARCOMA|Osteosarcomas|Osteosarcoma Tumor|Osteosarcoma Tumors|Sarcoma, Osteogenic|Sarcomas, Osteogenic|Tumor, Osteosarcoma|Tumors, Osteosarcoma	Cancer
Osteosarcoma, Juxtacortical	MESH:D018217	DO:DOID:3373	A form of osteogenic sarcoma of relatively low malignancy, probably arising from the periosteum and initially involving cortical bone and adjacent connective tissue. It occurs in middle-aged as well as young adults and most commonly affects the lower part of the femoral shaft. (Stedman, 25th ed)	MESH:D012516	C04.557.450.565.575.650.655|C04.557.450.795.620.655	C04.557.450.565.575.650|C04.557.450.795.620	Juxtacortical Osteosarcoma|Juxtacortical Osteosarcomas|Osteosarcomas, Juxtacortical	Cancer
Osteosarcoma, Retinoblastoma-Related	MESH:C566714			MESH:D012175|MESH:D012516	C04.557.450.565.575.650/C566714|C04.557.450.795.620/C566714|C04.557.465.625.600.725/C566714|C04.557.470.670.725/C566714|C04.557.580.625.600.725/C566714|C04.588.364.818.760/C566714|C11.270.862/C566714|C11.319.475.760/C566714|C11.768.717.760/C566714	C04.557.450.565.575.650|C04.557.450.795.620|C04.557.465.625.600.725|C04.557.470.670.725|C04.557.580.625.600.725|C04.588.364.818.760|C11.270.862|C11.319.475.760|C11.768.717.760		Cancer|Eye disease
Osteosclerosis	MESH:D010026	DO:DOID:4254	An abnormal hardening or increased density of bone tissue.	MESH:D010009	C05.116.099.708.702	C05.116.099.708	Osteoscleroses	Musculoskeletal disease
Osteosclerotic Chondrodysplasia, Lethal, With Intracellular Inclusions	MESH:C566378			MESH:D010026	C05.116.099.708.702/C566378	C05.116.099.708.702		Musculoskeletal disease
Otitis	MESH:D010031		Inflammation of the ear, which may be marked by pain (EARACHE), fever, HEARING DISORDERS, and VERTIGO. Inflammation of the external ear is OTITIS EXTERNA; of the middle ear, OTITIS MEDIA; of the inner ear, LABYRINTHITIS.	MESH:D004427	C09.218.705	C09.218	Ear Infection|Ear Infections|Ear Inflammation|Ear Inflammations|Infection, Ear|Infections, Ear|Inflammation, Ear|Inflammations, Ear|Otitides	Ear-nose-throat disease
Otitis Externa	MESH:D010032		Inflammation of the OUTER EAR including the external EAR CANAL, cartilages of the auricle (EAR CARTILAGE), and the TYMPANIC MEMBRANE.	MESH:D010031	C09.218.705.496	C09.218.705	Ear Inflammation, External|External Ear Inflammation|External Ear Inflammations|External Otitides|External Otitis|Externa, Otitis|Inflammation, External Ear|Otitides, External|Otitis, External	Ear-nose-throat disease
Otitis Media	MESH:D010033	DO:DOID:10754|OMIM:166760	Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE.	MESH:D010031	C09.218.705.663	C09.218.705	COME/ROM|Inflammation, Middle Ear|Middle Ear Inflammation|OMS|OTITIS MEDIA, CHRONIC/RECURRENT|OTITIS MEDIA, SUSCEPTIBILITY TO	Ear-nose-throat disease
Otitis Media, Suppurative	MESH:D010035	DO:DOID:11506	Inflammation of the middle ear with purulent discharge.	MESH:D010033|MESH:D013492	C01.830.694|C09.218.705.663.680	C01.830|C09.218.705.663	Otitis Media, Purulent|Purulent Otitis Media|Suppurative Otitis Media	Ear-nose-throat disease
Otitis Media with Effusion	MESH:D010034		Inflammation of the middle ear with a clear pale yellow-colored transudate.	MESH:D010033	C09.218.705.663.670	C09.218.705.663	Ear Effusion, Middle|Ear Effusions, Middle|Effusion, Middle Ear|Effusions, Middle Ear|Middle Ear Effusion|Middle Ear Effusions|Otitis Media, Secretory|Otitis Media, Serous|Secretory Otitis Media|Serous Otitis Media	Ear-nose-throat disease
Otorhinolaryngologic Diseases	MESH:D010038		Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.	MESH:C	C09	C	Disease, ENT|Disease, Otolaryngologic|Disease, Otolaryngological|Disease, Otorhinolaryngologic|Disease, Otorhinolaryngological|Diseases, ENT|Diseases, Otolaryngologic|Diseases, Otolaryngological|Diseases, Otorhinolaryngologic|Diseases, Otorhinolaryngological|ENT Disease|ENT Diseases|Otolaryngological Disease|Otolaryngological Diseases|Otolaryngologic Disease|Otolaryngologic Diseases|Otorhinolaryngological Disease|Otorhinolaryngological Diseases|Otorhinolaryngologic Disease	Ear-nose-throat disease
Otorhinolaryngologic Neoplasms	MESH:D010039		A general concept for tumors or cancer of any part of the EAR; the NOSE; the THROAT; and the PHARYNX. It is used when there is no specific heading.	MESH:D006258|MESH:D010038	C04.588.443.665|C09.647	C04.588.443|C09	Cancer, Otorhinolaryngeal|Cancers, Otorhinolaryngeal|Neoplasm, Ootorhinolaryngeal|Neoplasm, Otorhinolaryngologic|Neoplasm, Otorhinolaryngological|Neoplasms, Ootorhinolaryngeal|Neoplasms, Otorhinolaryngologic|Neoplasms, Otorhinolaryngological|Ootorhinolaryngeal Neoplasm|Ootorhinolaryngeal Neoplasms|Otorhinolaryngeal Cancer|Otorhinolaryngeal Cancers|Otorhinolaryngological Neoplasm|Otorhinolaryngological Neoplasms|Otorhinolaryngologic Neoplasm	Cancer|Ear-nose-throat disease
Otosclerosis	MESH:D010040	OMIM:166800	Formation of spongy bone in the labyrinth capsule which can progress toward the STAPES (stapedial fixation) or anteriorly toward the COCHLEA leading to conductive, sensorineural, or mixed HEARING LOSS. Several genes are associated with familial otosclerosis with varied clinical signs.	MESH:D004427	C09.218.768	C09.218	Otoscleroses|OTOSCLEROSIS 1|Otospongioses|Otospongiosis|OTS|OTSC1	Ear-nose-throat disease
Otosclerosis 2	MESH:C565302	OMIM:605727		MESH:D010040	C09.218.768/C565302	C09.218.768	OTSC2	Ear-nose-throat disease
Otosclerosis 3	MESH:C564268	OMIM:608244		MESH:D010040	C09.218.768/C564268	C09.218.768	OTSC3	Ear-nose-throat disease
Otosclerosis 4	MESH:C566914	OMIM:611571		MESH:D010040	C09.218.768/C566914	C09.218.768	OTSC4	Ear-nose-throat disease
Otosclerosis 5	MESH:C563858	OMIM:608787		MESH:D010040	C09.218.768/C563858	C09.218.768	OTSC5	Ear-nose-throat disease
Otosclerosis 7	MESH:C566913	OMIM:611572		MESH:D010040	C09.218.768/C566913	C09.218.768	OTSC7	Ear-nose-throat disease
Otosclerosis 8	MESH:C567421	OMIM:612096		MESH:D010040	C09.218.768/C567421	C09.218.768	OTSC8	Ear-nose-throat disease
Out-of-Hospital Cardiac Arrest	MESH:D058687		Occurrence of heart arrest in an individual when there is no immediate access to medical personnel or equipment.	MESH:D006323	C14.280.383.610	C14.280.383	Cardiac Arrest, Out-of-Hospital|Cardiac Arrests, Out-of-Hospital|Heart Arrest, Out-of-Hospital|Heart Arrests, Out-of-Hospital|Out of Hospital Cardiac Arrest|Out-of-Hospital Cardiac Arrests|Out of Hospital Heart Arrest|Out-of-Hospital Heart Arrest|Out-of-Hospital Heart Arrests	Cardiovascular disease
Ovarian Cysts	MESH:D010048		General term for CYSTS and cystic diseases of the OVARY.	MESH:D003560|MESH:D010049	C04.182.612|C12.050.351.500.056.630.580|C12.100.250.056.630.580|C19.391.630.580	C04.182|C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	Corpus Luteum Cyst|Corpus Luteum Cysts|Cyst, Corpus Luteum|Cyst, Ovarian|Cysts, Corpus Luteum|Cysts, Ovarian|Ovarian Cyst	Cancer|Endocrine system disease|Urogenital disease (female)
Ovarian Diseases	MESH:D010049	DO:DOID:1100	Pathological processes of the OVARY.	MESH:D000291|MESH:D006058	C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	C12.050.351.500.056|C12.100.250.056|C19.391	Disease, Ovarian|Diseases, Ovarian|Ovarian Disease	Endocrine system disease|Urogenital disease (female)
OVARIAN DYSGENESIS 1	OMIM:233300	DO:DOID:0080493		MESH:D010049	C12.050.351.500.056.630/233300|C12.100.250.056.630/233300|C19.391.630/233300	C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	GONADAL DYSGENESIS, XX TYPE|ODG1|OVARIAN DYSGENESIS, HYPERGONADOTROPIC, AUTOSOMAL RECESSIVE|OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH NORMAL KARYOTYPE|OVARIAN FAILURE, HYPERGONADOTROPIC|XXGD|XX GONADAL DYSGENESIS	Endocrine system disease|Urogenital disease (female)
OVARIAN DYSGENESIS 3	OMIM:614324	DO:DOID:0080495		MESH:D010049	C12.050.351.500.056.630/614324|C12.100.250.056.630/614324|C19.391.630/614324	C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	ODG3	Endocrine system disease|Urogenital disease (female)
OVARIAN DYSGENESIS 4	OMIM:616185	DO:DOID:0080496		MESH:D010049	C12.050.351.500.056.630/616185|C12.100.250.056.630/616185|C19.391.630/616185	C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	ODG4	Endocrine system disease|Urogenital disease (female)
Ovarian Fibromata	MESH:C562391			MESH:D005350|MESH:D010051	C04.557.450.565.590.340/C562391|C04.588.322.455/C562391|C12.050.351.500.056.630.705/C562391|C12.050.351.937.418.685/C562391|C12.100.250.056.630.705/C562391|C12.900.418.685/C562391|C19.344.410/C562391|C19.391.630.705/C562391	C04.557.450.565.590.340|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.344.410|C19.391.630.705		Cancer|Endocrine system disease|Urogenital disease (female)
Ovarian Germ Cell Cancer	MESH:C562841	DO:DOID:2155		MESH:D009373|MESH:D010051	C04.557.465/C562841|C04.588.322.455/C562841|C12.050.351.500.056.630.705/C562841|C12.050.351.937.418.685/C562841|C12.100.250.056.630.705/C562841|C12.900.418.685/C562841|C19.344.410/C562841|C19.391.630.705/C562841	C04.557.465|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.344.410|C19.391.630.705		Cancer|Endocrine system disease|Urogenital disease (female)
Ovarian gynandroblastoma	MESH:C538459			MESH:D018312	C04.557.475.750/C538459	C04.557.475.750		Cancer
Ovarian Hyperstimulation Syndrome	MESH:D016471	DO:DOID:5425|OMIM:608115	A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.	MESH:D010049	C12.050.351.500.056.630.642|C12.100.250.056.630.642|C19.391.630.642	C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	Hyperstimulation Syndrome, Ovarian|Hyperstimulation Syndromes, Ovarian|OHSS|Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous|Ovarian Hyperstimulation Syndromes	Endocrine system disease|Urogenital disease (female)
Ovarian Neoplasms	MESH:D010051	DO:DOID:2394|OMIM:167000|OMIM:607893	Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.	MESH:D004701|MESH:D005833|MESH:D010049	C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.344.410|C19.391.630.705	C04.588.322|C12.050.351.500.056.630|C12.050.351.937.418|C12.100.250.056.630|C12.900.418|C19.344|C19.391.630	Cancer of Ovary|Cancer of the Ovary|Cancer, Ovarian|Cancer, Ovary|Cancers, Ovarian|Cancers, Ovary|Neoplasm, Ovarian|Neoplasm, Ovary|Neoplasms, Ovarian|Neoplasms, Ovary|Ovarian Cancer|OVARIAN CANCER, EPITHELIAL, INCLUDED|Ovarian Cancers|OVARIAN CANCER, SUSCEPTIBILITY TO, 1|Ovarian Neoplasm|Ovary Cancer|Ovary Cancers|Ovary Neoplasm|Ovary Neoplasms|OVCAS1	Cancer|Endocrine system disease|Urogenital disease (female)
Ovarian Torsion	MESH:D000082843		A condition that occurs when an ovary twists around the ligaments that hold it in place. This twisting can cut off blood flow. It usually affects only one ovary.	MESH:D010049|MESH:D014102	C12.050.351.500.056.630.728|C12.100.250.056.630.728|C19.391.630.728|C23.300.970.625	C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630|C23.300.970	Adnexal Torsion|Adnexal Torsions|Ovarian Torsions|Torsion, Adnexal|Torsion, Ovarian|Torsions, Adnexal|Torsions, Ovarian	Endocrine system disease|Pathology (anatomical condition)|Urogenital disease (female)
Pachydermodactyly, Familial	MESH:C563947			MESH:D005350	C04.557.450.565.590.340/C563947	C04.557.450.565.590.340		Cancer
PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS	OMIM:600176			MESH:D008607|MESH:D012640|MESH:D016080|MESH:D054082	C04.182.044/600176|C04.588.614.250.387.100/600176|C10.500.142.100/600176|C10.500.507.450.499/600176|C10.551.240.375.100/600176|C10.597.606.360/600176|C10.597.742/600176|C16.131.666.142.100/600176|C16.131.666.507.450.499/600176|C23.888.592.604.646/600176|C23.888.592.742/600176|F03.625.539/600176	C04.182.044|C04.588.614.250.387.100|C10.500.142.100|C10.500.507.450.499|C10.551.240.375.100|C10.597.606.360|C10.597.742|C16.131.666.142.100|C16.131.666.507.450.499|C23.888.592.604.646|C23.888.592.742|F03.625.539	PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	Cancer|Congenital abnormality|Mental disorder|Nervous system disease|Signs and symptoms
Pacman dysplasia	MESH:C538095			MESH:D002806	C05.116.099.708.195/C538095	C05.116.099.708.195	Epiphyseal stippling with osteoclastic hyperplasia|Pacman syndrome	Musculoskeletal disease
Paget Disease, Extramammary	MESH:D010145	DO:DOID:3450	A rare cutaneous neoplasm that occurs in the elderly. It develops more frequently in women and predominantly involves apocrine gland-bearing areas, especially the vulva, scrotum, and perianal areas. The lesions develop as erythematous scaly patches that progress to crusted, pruritic, erythematous plaques. The clinical differential diagnosis includes squamous cell carcinoma in situ and superficial fungal infection. It is generally thought to be an adenocarcinoma of the epidermis, from which it extends into the contiguous epithelium of hair follicles and eccrine sweat ducts. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1478)	MESH:D000230|MESH:D018299	C04.557.470.200.025.660|C04.557.470.615.660	C04.557.470.200.025|C04.557.470.615	Extramammary Paget Disease|Extramammary, Paget Disease|Extra Mammary Paget Disease|Extra-Mammary Paget Disease|Extramammary Paget's Disease|Extramammary Pagets Disease|Extra Mammary Paget's Disease|Extra-Mammary Paget's Disease|Extra-Mammary Pagets Disease|Paget Disease Extramammary|Paget Disease, Extra Mammary|Paget Disease, Extra-Mammary|Paget's Disease, Extramammary|Pagets Disease, Extramammary|Paget's Disease, Extra Mammary|Paget's Disease, Extra-Mammary|Pagets Disease, Extra-Mammary	Cancer
Paget Disease Of Bone 4	MESH:C565240	OMIM:606263		MESH:D010001	C05.116.692/C565240	C05.116.692	PDB4	Musculoskeletal disease
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	OMIM:239000			MESH:D010001	C05.116.692/239000	C05.116.692	HYPEROSTOSIS CORTICALIS DEFORMANS JUVENILIS|HYPERPHOSPHATASEMIA, CHRONIC CONGENITAL IDIOPATHIC|HYPERPHOSPHATASIA, FAMILIAL IDIOPATHIC|JPD|JUVENILE PAGET DISEASE|OSTEOECTASIA, FAMILIAL|PDB5	Musculoskeletal disease
Pagetoid Reticulosis	MESH:D056267		A distinct variant of mycosis fungoides characterized by the presence of localized patches or plaques with an intraepidermal proliferation of neoplastic cells.	MESH:D009182	C04.557.386.480.750.800.550.600|C15.604.515.569.480.750.800.550.600|C20.683.515.761.480.750.800.550.600	C04.557.386.480.750.800.550|C15.604.515.569.480.750.800.550|C20.683.515.761.480.750.800.550	Disease, Ketron-Goodman|Disease, Woringer Kolopp|Disease, Woringer-Kolopp|Ketron Goodman Disease|Ketron-Goodman Disease|Kolopp Disease, Woringer|Pagetoid Reticuloses|Reticuloses, Pagetoid|Reticulosis, Pagetoid|Woringer Kolopp Disease|Woringer-Kolopp Disease	Cancer|Immune system disease|Lymphatic disease
Paget's Disease, Mammary	MESH:D010144		An intraductal in situ carcinoma of the breast, characterized clinically by eczema-like inflammatory skin changes and histologically by infiltration of the dermis by malignant cells (Paget's cells).	MESH:D000071960|MESH:D002285	C04.557.470.200.240.187.500|C04.557.470.615.275.625	C04.557.470.200.240.187|C04.557.470.615.275	Disease, Mammary Paget|Disease, Mammary Paget's|Mammary Paget Disease|Mammary Paget's Disease|Mammary Pagets Disease|Paget Disease, Breast|Paget Disease, Mammary|Paget Disease of Breast|Pagets Disease, Breast|Pagets Disease, Mammary|Paget's Disease of Breast|Paget's Disease of the Breast|Paget's Disease of the Nipple|Paget's Disease of the Nipple and Areola|Pigmented Mammary Paget Disease	Cancer
Palatal Neoplasms	MESH:D010157		Tumors or cancer of the PALATE, including those of the hard palate, soft palate and UVULA.	MESH:D007573|MESH:D009062	C04.588.149.721.450.692|C04.588.443.591.692|C05.116.231.754.450.692|C05.500.499.692|C07.320.515.692|C07.465.530.692	C04.588.149.721.450|C04.588.443.591|C05.116.231.754.450|C05.500.499|C07.320.515|C07.465.530	Neoplasm, Palatal|Neoplasms, Palatal|Palatal Neoplasm	Cancer|Mouth disease|Musculoskeletal disease
Palindromic rheumatism	MESH:C538103	DO:DOID:1166		MESH:D001172	C05.550.114.154/C538103|C05.799.114/C538103|C17.300.775.099/C538103|C20.111.199/C538103	C05.550.114.154|C05.799.114|C17.300.775.099|C20.111.199	Palindromic rheumatism syndrome	Connective tissue disease|Immune system disease|Musculoskeletal disease
Pallidopyramidal syndrome	MESH:C538104	OMIM:260300		MESH:D001764|MESH:D010302	C10.228.140.079.862.800/C538104|C10.228.662.600.700/C538104|C11.338.250/C538104	C10.228.140.079.862.800|C10.228.662.600.700|C11.338.250	Pallido-pyramidal disease|Pallido-Pyramidal Syndrome|PALLIDOPYRAMIDAL SYNDROME|PARK15|Parkinson Disease 15, Autosomal Recessive|PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET|Parkinsonian-Pyramidal Syndrome|PKPS	Eye disease|Nervous system disease
Pallister-Hall Syndrome	MESH:D054975	DO:DOID:9248|OMIM:146510	A pleiotropic disorder of human development that comprises hypothalamic HAMARTOMA; central and postaxial POLYDACTYLY; bifid EPIGLOTTIS; ANAL ATRESIA; and renal and other abnormalities. This disorder is associated with FRAMESHIFT MUTATIONS in the GLI3 gene which encodes the GLI3 protein, a KRUPPEL-LIKE TRANSCRIPTION FACTORS family member.	MESH:D000015|MESH:D006222|MESH:D007029|MESH:D017689	C04.445.622|C04.588.614.250.195.885.500.299|C05.660.585.600.374|C10.228.140.211.885.500.299|C10.228.140.617.477.299|C10.551.240.250.700.500.249|C16.131.077.690|C16.131.621.585.600.374	C04.445|C04.588.614.250.195.885.500|C05.660.585.600|C10.228.140.211.885.500|C10.228.140.617.477|C10.551.240.250.700.500|C16.131.077|C16.131.621.585.600	CAVE Complex|CAVE Complices|Cerebroacrovisceral Early Lethality Complex|Complex, CAVE|Complices, CAVE|Hall Pallister Syndrome|Hall-Pallister Syndrome|Hamartoblastoma Syndrome, Hypothalamic|Hamartoblastoma Syndromes, Hypothalamic|Hypothalamic Hamartoblastoma, Hypopituitarism, Imperforate Anus, and Postaxial Polydactyly|Hypothalamic Hamartoblastoma Syndrome|Hypothalamic Hamartoblastoma Syndromes|Pallister Hall Syndrome|PHS|Syndrome, Hall-Pallister|Syndrome, Hypothalamic Hamartoblastoma|Syndrome, Pallister-Hall|Syndromes, Hypothalamic Hamartoblastoma	Cancer|Congenital abnormality|Musculoskeletal disease|Nervous system disease
Palmer Pagon syndrome	MESH:C538107			MESH:D006849	C10.228.140.602/C538107	C10.228.140.602		Nervous system disease
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING	OMIM:615225			MESH:D002294|MESH:D003230|MESH:D007636|MESH:D012878	C04.557.470.200.400/615225|C04.557.470.700.400/615225|C04.588.364.235/615225|C04.588.805/615225|C11.187.169/615225|C11.319.217/615225|C17.800.417/615225|C17.800.882/615225	C04.557.470.200.400|C04.557.470.700.400|C04.588.364.235|C04.588.805|C11.187.169|C11.319.217|C17.800.417|C17.800.882	CIDED, FORMERLY|CORNEAL INTRAEPITHELIAL DYSKERATOSIS AND ECTODERMAL DYSPLASIA, FORMERLY|MSPC	Cancer|Eye disease|Skin disease
Pancoast Syndrome	MESH:D010178	DO:DOID:8007	A condition caused by an apical lung tumor (Pancoast tumor) with involvement of the nearby vertebral column and the BRACHIAL PLEXUS. Symptoms include pain in the shoulder and the arm, and atrophy of the hand.	MESH:D008175	C04.588.894.797.520.734|C08.381.540.734|C08.785.520.734	C04.588.894.797.520|C08.381.540|C08.785.520	Pancoast's Syndrome|Pancoasts Syndrome|Pancoast Tumor|Syndrome, Pancoast|Syndrome, Pancoast's|Tumor, Pancoast	Cancer|Respiratory tract disease
Pancreatic adenoma	MESH:C538110			MESH:D000236|MESH:D010190	C04.557.470.035/C538110|C04.588.274.761/C538110|C04.588.322.475/C538110|C06.301.761/C538110|C06.689.667/C538110|C19.344.421/C538110	C04.557.470.035|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421		Cancer|Digestive system disease|Endocrine system disease
Pancreatic cancer, adult	MESH:C535836			MESH:D002277|MESH:D010190	C04.557.470.200/C535836|C04.588.274.761/C535836|C04.588.322.475/C535836|C06.301.761/C535836|C06.689.667/C535836|C19.344.421/C535836	C04.557.470.200|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421		Cancer|Digestive system disease|Endocrine system disease
Pancreatic Carcinoma	MESH:C562463	DO:DOID:4905		MESH:D010190	C04.588.274.761/C562463|C04.588.322.475/C562463|C06.301.761/C562463|C06.689.667/C562463|C19.344.421/C562463	C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421	Pancreatic Acinar Carcinoma	Cancer|Digestive system disease|Endocrine system disease
Pancreatic carcinoma, familial	MESH:C535837			MESH:D002277|MESH:D010190	C04.557.470.200/C535837|C04.588.274.761/C535837|C04.588.322.475/C535837|C06.301.761/C535837|C06.689.667/C535837|C19.344.421/C535837	C04.557.470.200|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421	Familial Pancreatic carcinoma	Cancer|Digestive system disease|Endocrine system disease
Pancreatic Cyst	MESH:D010181		A true cyst of the PANCREAS, distinguished from the much more common PANCREATIC PSEUDOCYST by possessing a lining of mucous EPITHELIUM. Pancreatic cysts are categorized as congenital, retention, neoplastic, parasitic, enterogenous, or dermoid. Congenital cysts occur more frequently as solitary cysts but may be multiple. Retention cysts are gross enlargements of PANCREATIC DUCTS secondary to ductal obstruction. (From Bockus Gastroenterology, 4th ed, p4145)	MESH:D003560|MESH:D010182	C04.182.640|C06.689.500	C04.182|C06.689	Cyst, Pancreatic|Cysts, Pancreatic|Pancreatic Cysts	Cancer|Digestive system disease
Pancreatic Fistula	MESH:D010185		Abnormal passage communicating with the PANCREAS.	MESH:D010182|MESH:D016154	C06.267.775|C06.689.583|C23.300.575.185.775	C06.267|C06.689|C23.300.575.185	Fistula, Pancreatic|Fistulas, Pancreatic|Pancreatic Fistulas	Digestive system disease|Pathology (anatomical condition)
Pancreatic Hypoplasia, Congenital, with Diabetes Mellitus and Congenital Heart Disease	MESH:C564011			MESH:D003920|MESH:D006330	C14.240.400/C564011|C14.280.400/C564011|C16.131.240.400/C564011|C18.452.394.750/C564011|C19.246/C564011	C14.240.400|C14.280.400|C16.131.240.400|C18.452.394.750|C19.246		Cardiovascular disease|Congenital abnormality|Endocrine system disease|Metabolic disease
Pancreatic Intraductal Neoplasms	MESH:D000077779		EPITHELIAL NEOPLASMS with pancreatic ductal differentiation that arise from the EXOCRINE PANCREAS and grow mostly within the PANCREATIC DUCTS. They are characterized by the presence of intraductal masses with mostly papillary growth pattern. Overt production of MUCIN within the pancreatic duct is associated with pancreatic intraductal papillary-mucinous neoplasm but not intraductal tubulopapillary neoplasm.	MESH:D010190|MESH:D018299	C04.557.470.615.665|C04.588.274.761.875|C04.588.322.475.875|C06.301.761.875|C06.689.667.812|C19.344.421.875	C04.557.470.615|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421	Intraductal Neoplasm, Pancreatic|Intraductal Neoplasms, Pancreatic|Intraductal Papillary Mucinous Neoplasm, Pancreatic|Intraductal Papillary-Mucinous Neoplasm, Pancreatic|Intraductal Papillary Mucinous Neoplasms of the Pancreas|Intraductal Tubulopapillary Neoplasm, Pancreatic|IPMN, Pancreatic|Neoplasm, Pancreatic Intraductal|Pancreatic Intraductal Neoplasm|Pancreatic Intraductal Papillary Mucinous Neoplasm|Pancreatic Intraductal Tubulopapillary Neoplasm|Pancreatic IPMN|Pancreatic IPMNs	Cancer|Digestive system disease|Endocrine system disease
Pancreatic lipomatosis duodenal stenosis	MESH:C535839			MESH:D004380|MESH:D008068|MESH:D010182	C06.405.469.275.395/C535839|C06.405.469.531.311/C535839|C06.689/C535839|C17.800.463/C535839|C18.452.584.718/C535839	C06.405.469.275.395|C06.405.469.531.311|C06.689|C17.800.463|C18.452.584.718	Pancreatic lipomatosis and duodenal atresia	Digestive system disease|Metabolic disease|Skin disease
Pancreatic Lymphoma, Familial	MESH:C566516			MESH:D008223|MESH:D010190	C04.557.386/C566516|C04.588.274.761/C566516|C04.588.322.475/C566516|C06.301.761/C566516|C06.689.667/C566516|C15.604.515.569/C566516|C19.344.421/C566516|C20.683.515.761/C566516	C04.557.386|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C15.604.515.569|C19.344.421|C20.683.515.761		Cancer|Digestive system disease|Endocrine system disease|Immune system disease|Lymphatic disease
Pancreatic Neoplasms	MESH:D010190	DO:DOID:1793|OMIM:260350|OMIM:606856|OMIM:613347|OMIM:613348|OMIM:614320	Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).	MESH:D004067|MESH:D004701|MESH:D010182	C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421	C04.588.274|C04.588.322|C06.301|C06.689|C19.344	Cancer of Pancreas|Cancer of the Pancreas|Cancer, Pancreas|Cancer, Pancreatic|Cancers, Pancreas|Cancers, Pancreatic|Neoplasm, Pancreas|Neoplasm, Pancreatic|Neoplasms, Pancreas|Neoplasms, Pancreatic|Pancreas Cancer|Pancreas Cancers|Pancreas Neoplasm|Pancreas Neoplasms|PANCREATIC ACINAR CARCINOMA|Pancreatic Cancer|Pancreatic Cancers|PANCREATIC CANCER, SUSCEPTIBILITY TO, 1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2|PANCREATIC CANCER, SUSCEPTIBILITY TO, 3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4|PANCREATIC CARCINOMA|Pancreatic Neoplasm|PNCA1|PNCA2|PNCA3|PNCA4	Cancer|Digestive system disease|Endocrine system disease
Pancreatic Pseudocyst	MESH:D010192		Cyst-like space not lined by EPITHELIUM and contained within the PANCREAS. Pancreatic pseudocysts account for most of the cystic collections in the pancreas and are often associated with chronic PANCREATITIS.	MESH:D010181	C04.182.640.692|C06.689.500.692	C04.182.640|C06.689.500	Pancreatic Pseudocysts|Pseudocyst, Pancreatic|Pseudocysts, Pancreatic	Cancer|Digestive system disease
Pancreatitis, Alcoholic	MESH:D019512	DO:DOID:4988	Acute or chronic INFLAMMATION of the PANCREAS due to excessive ALCOHOL DRINKING. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.	MESH:D010195|MESH:D020751	C06.689.750.660|C25.775.100.087.730	C06.689.750|C25.775.100.087	Alcoholic Pancreatitis	Digestive system disease|Substance-related disorder
Pancreatitis, Calcific	MESH:C566837			MESH:D050500	C06.689.750.830/C566837|C23.550.291.500.750/C566837	C06.689.750.830|C23.550.291.500.750		Digestive system disease|Pathology (process)
Pancreatitis, Chronic	MESH:D050500		INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.	MESH:D002908|MESH:D010195	C06.689.750.830|C23.550.291.500.750	C06.689.750|C23.550.291.500	Chronic Pancreatitis	Digestive system disease|Pathology (process)
Pancreatitis, Sclerosing Cholangitis, and Sicca Complex	MESH:C564906			MESH:D012859|MESH:D015209|MESH:D050500	C05.550.114.154.774/C564906|C05.799.114.774/C564906|C06.130.120.200.110/C564906|C06.689.750.830/C564906|C07.465.815.929.669/C564906|C11.496.260.719/C564906|C17.300.775.099.774/C564906|C20.111.199.774/C564906|C23.550.291.500.750/C564906	C05.550.114.154.774|C05.799.114.774|C06.130.120.200.110|C06.689.750.830|C07.465.815.929.669|C11.496.260.719|C17.300.775.099.774|C20.111.199.774|C23.550.291.500.750		Connective tissue disease|Digestive system disease|Eye disease|Immune system disease|Mouth disease|Musculoskeletal disease|Pathology (process)
Pancreatoblastoma	MESH:C537162	DO:DOID:6823		MESH:D010190	C04.588.274.761/C537162|C04.588.322.475/C537162|C06.301.761/C537162|C06.689.667/C537162|C19.344.421/C537162	C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421		Cancer|Digestive system disease|Endocrine system disease
Pancytopenia	MESH:D010198	DO:DOID:12450	Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.	MESH:D006402	C15.378.700	C15.378	Pancytopenias	Blood disease
Pancytopenia and Occlusive Vascular Disease	MESH:C566836			MESH:D010198|MESH:D014652	C14.907/C566836|C15.378.700/C566836	C14.907|C15.378.700		Blood disease|Cardiovascular disease
Panniculitis	MESH:D015434	DO:DOID:1526	General term for inflammation of adipose tissue, usually of the skin, characterized by reddened subcutaneous nodules.	MESH:D003240|MESH:D012871	C17.300.710|C17.800.566	C17.300|C17.800	Cold Panniculitides|Cold Panniculitis|Panniculitides|Panniculitides, Cold|Panniculitis, Cold|Panniculitis, Subacute Nodular Migratory	Connective tissue disease|Skin disease
Panniculitis, Lupus Erythematosus	MESH:D015435		A type of lupus erythematosus characterized by deep dermal or subcutaneous nodules, most often on the head, face, or upper arms. It is generally chronic and occurs most often in women between the ages of 20 and 45.	MESH:D008179|MESH:D015434	C17.300.475.479.400|C17.300.710.400|C17.800.480.479.400|C17.800.566.400	C17.300.475.479|C17.300.710|C17.800.480.479|C17.800.566	Lupus Erythematosus Panniculitides|Lupus Erythematosus Panniculitis|Lupus Erythematosus Profundus|Lupus Panniculitides|Lupus Panniculitis|Lupus Profundus|Panniculitides, Lupus|Panniculitides, Lupus Erythematosus|Panniculitis, Lupus	Connective tissue disease|Skin disease
Panniculitis, Nodular Nonsuppurative	MESH:D010201	DO:DOID:1525	A form of panniculitis characterized by recurrent episodes of fever accompanied by the eruption of single or multiple erythematous subcutaneous nodules on the lower extremities. They normally resolve, but tend to leave depressions in the skin. The condition is most often seen in women, alone or in association with other disorders.	MESH:D015434	C17.300.710.500|C17.800.566.500	C17.300.710|C17.800.566	Disease, Weber-Christian|Nodular Nonsuppurative Panniculitides|Nodular Nonsuppurative Panniculitis|Nonsuppurative Panniculitides, Nodular|Nonsuppurative Panniculitis, Nodular|Panniculitides, Nodular Nonsuppurative|Weber Christian Disease|Weber-Christian Disease	Connective tissue disease|Skin disease
Panniculitis, Peritoneal	MESH:D015436		INFLAMMATION of the underlying layer of ADIPOSE TISSUE (panniculus) of the PERITONEUM, usually of the MESENTERY or the OMENTUM. There are several forms with various names and are usually characterized by infiltration of LYMPHOCYTES and NEUTROPHILS, fat NECROSIS, and FIBROSIS.	MESH:D010532|MESH:D015434	C06.844.600|C17.300.710.600	C06.844|C17.300.710	Lipodystrophy, Mesenteric|Liposclerotic Mesenteritis|Mesenteric Lipodystrophy|Mesenteric Panniculitis|Mesenteric Weber Christian Disease|Mesenteric Weber-Christian Disease|Mesenteritis, Liposclerotic|Mesenteritis, Retractile|Mesenteritis, Sclerosing|Omental Panniculitis|Panniculitis, Mesenteric|Panniculitis, Omental|Peritoneal Panniculitis|Retractile Mesenteritis|Sclerosing Mesenteritis	Connective tissue disease|Digestive system disease
Panostotic fibrous dysplasia	MESH:C537164			MESH:D001851|MESH:D005357|MESH:D055728	C05.116.099.708.375/C537164|C05.116.198/C537164|C15.378.190.636.765/C537164|C18.452.104/C537164	C05.116.099.708.375|C05.116.198|C15.378.190.636.765|C18.452.104		Blood disease|Metabolic disease|Musculoskeletal disease
Panuveitis	MESH:D015864	DO:DOID:12030	Inflammation in which both the anterior and posterior segments of the uvea are involved and a specific focus is not apparent. It is often severe and extensive and a serious threat to vision. Causes include systemic diseases such as tuberculosis, sarcoidosis, and syphilis, as well as malignancies. The intermediate segment of the eye is not involved.	MESH:D014605	C11.941.879.780	C11.941.879		Eye disease
Papillary renal cell carcinoma, sporadic	MESH:C538614	DO:DOID:4465		MESH:D002292	C04.557.470.200.025.390/C538614|C04.588.945.947.535.160/C538614|C12.050.351.937.820.535.160/C538614|C12.050.351.968.419.473.160/C538614|C12.200.758.820.750.160/C538614|C12.200.777.419.473.160/C538614|C12.900.820.535.160/C538614|C12.950.419.473.160/C538614|C12.950.983.535.160/C538614	C04.557.470.200.025.390|C04.588.945.947.535.160|C12.050.351.937.820.535.160|C12.050.351.968.419.473.160|C12.200.758.820.750.160|C12.200.777.419.473.160|C12.900.820.535.160|C12.950.419.473.160|C12.950.983.535.160	Papillary renal carcinoma, malignant|Papillary renal cell carcinoma, bilateral|Papillary renal cell carcinoma, familial|Papillary renal cell carcinoma, multiple	Cancer|Urogenital disease (female)|Urogenital disease (male)
Papillary Thyroid Microcarcinoma	MESH:C563277			MESH:D002291|MESH:D013964	C04.557.470.200.360/C563277|C04.557.470.700.360/C563277|C04.588.322.894/C563277|C04.588.443.915/C563277|C19.344.894/C563277|C19.874.788/C563277	C04.557.470.200.360|C04.557.470.700.360|C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788		Cancer|Endocrine system disease
Papilledema	MESH:D010211	DO:DOID:10175|DO:DOID:146|DO:DOID:6929	Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175)	MESH:D009901	C10.292.700.900|C11.640.710	C10.292.700|C11.640	Choked Disk|Choked Disks|Decreased Intraocular Pressure Associated Papilledema|Decreased Intraocular Pressure-Associated Papilledema|Disk, Choked|Edema of the Optic Disc|Edema of the Optic Disk|Edema, Optic Disc|Edema, Optic Disk|Edema, Optic Papilla|Edema, Retinal|Edemas, Optic Disc|Edemas, Optic Disk|Edemas, Retinal|Increased Intracranial Pressure Associated Papilledema|Increased Intracranial Pressure-Associated Papilledema|Optic Disc Edema|Optic Disk Edema|Optic Nerve Papillitis|Optic Papilla Edema|Optic Papillitis|Papilledema Associated with Decreased Intraocular Pressure|Papilledema Associated with Increased Intracranial Pressure|Papillitis|Papillitis, Optic|Papillitis, Optic Nerve|Retinal Edema|Retinal Edemas	Eye disease|Nervous system disease
Papilloma	MESH:D010212	DO:DOID:139|DO:DOID:2615	A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)	MESH:D018307	C04.557.470.700.600	C04.557.470.700	Papillomas|Papilloma, Squamous Cell|Papillomas, Squamous Cell|Papillomatoses|Papillomatosis|Squamous Cell Papilloma|Squamous Cell Papillomas	Cancer
Papilloma, Choroid Plexus	MESH:D020288	DO:DOID:2626|OMIM:260500	A usually benign neoplasm that arises from the cuboidal epithelium of the choroid plexus and takes the form of an enlarged CHOROID PLEXUS, which may be associated with oversecretion of CSF. The tumor usually presents in the first decade of life with signs of increased intracranial pressure including HEADACHES; ATAXIA; DIPLOPIA; and alterations of mental status. In children it is most common in the lateral ventricles and in adults it tends to arise in the fourth ventricle. Malignant transformation to choroid plexus carcinomas may rarely occur. (Adams et al., Principles of Neurology, 6th ed, p667; DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2072)	MESH:D016545	C04.588.614.250.195.205.200.500|C10.228.140.211.280.300.500|C10.551.240.250.200.200.500	C04.588.614.250.195.205.200|C10.228.140.211.280.300|C10.551.240.250.200.200	Choroid Plexus Papilloma|CHOROID PLEXUS PAPILLOMA CHOROID PLEXUS CARCINOMA, INCLUDED|Choroid Plexus Papillomas|CPC, INCLUDED|CPP|Papilloma of Choroid Plexus|Papillomas, Choroid Plexus	Cancer|Nervous system disease
Papilloma, Intraductal	MESH:D018300	DO:DOID:1627	A small, often impalpable benign papilloma arising in a lactiferous duct and frequently causing bleeding from the nipple. (Stedman, 25th ed)	MESH:D018299	C04.557.470.615.670	C04.557.470.615	Intraductal Papilloma|Intraductal Papillomas|Papillomas, Intraductal	Cancer
Papilloma, Inverted	MESH:D018308	DO:DOID:3179	A mucosal tumor of the urinary bladder or nasal cavity in which proliferating epithelium is invaginated beneath the surface and is more smoothly rounded than in other papillomas. (Stedman, 25th ed)	MESH:D010212	C04.557.470.700.600.610	C04.557.470.700.600	Inverted Papilloma|Inverted Papillomas|Papillomas, Inverted	Cancer
Papillomatosis, Familial Cutaneous	MESH:C566832			MESH:D010212|MESH:D012878	C04.557.470.700.600/C566832|C04.588.805/C566832|C17.800.882/C566832	C04.557.470.700.600|C04.588.805|C17.800.882		Cancer|Skin disease
Papillomavirus Infections	MESH:D030361	DO:DOID:11166	Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.	MESH:D004266|MESH:D014412	C01.925.256.650|C01.925.928.725	C01.925.256|C01.925.928	HPV Infection|HPV Infections|Human Papillomavirus Infection|Human Papillomavirus Infections|Papillomavirus Infection|Papillomavirus Infection, Human|Papillomavirus Infections, Human	Viral disease
Paraganglioma	MESH:D010235	DO:DOID:0050773|OMIM:168000	A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)	MESH:D018358	C04.557.465.625.650.700|C04.557.580.625.650.700	C04.557.465.625.650|C04.557.580.625.650	CAROTID BODY TUMORS|CBT1|CHEMODECTOMAS|Gangliocytic Paraganglioma|Gangliocytic Paragangliomas|GLOMUS JUGULARE TUMORS|GLOMUS TUMORS, FAMILIAL, 1|PARAGANGLIOMA, CAROTID BODY|Paraganglioma, Gangliocytic|Paragangliomas|Paragangliomas 1|Paragangliomas, Familial, 1|PARAGANGLIOMAS, FAMILIAL NONCHROMAFFIN, 1 PARAGANGLIOMAS WITH SENSORINEURAL HEARING LOSS, INCLUDED|Paragangliomas, Gangliocytic|Paragangliomata|PGL|PGL1	Cancer
Paraganglioma, Extra-Adrenal	MESH:D010236		A relatively rare, usually benign neoplasm originating in the chemoreceptor tissue of the CAROTID BODY; GLOMUS JUGULARE; GLOMUS TYMPANICUM; AORTIC BODIES; and the female genital tract. It consists histologically of rounded or ovoid hyperchromatic cells that tend to be grouped in an alveolus-like pattern within a scant to moderate amount of fibrous stroma and a few large thin-walled vascular channels. (From Stedman, 27th ed)	MESH:D010235	C04.557.465.625.650.700.705|C04.557.580.625.650.700.705	C04.557.465.625.650.700|C04.557.580.625.650.700	Chemodectoma|Chemodectomas|Extra-Adrenal Paraganglioma|Extra-Adrenal Paragangliomas|Nonchromaffin Paraganglioma|Non-Chromaffin Paraganglioma|Nonchromaffin Paragangliomas|Non-Chromaffin Paragangliomas|Paraganglioma, Extra Adrenal|Paraganglioma, Nonchromaffin|Paraganglioma, Non Chromaffin|Paraganglioma, Non-Chromaffin|Paragangliomas, Extra-Adrenal|Paragangliomas, Familial Nonchromaffin, 1|Paragangliomas, Nonchromaffin|Paragangliomas, Non-Chromaffin	Cancer
PARAGANGLIOMAS 4	OMIM:115310	DO:DOID:0050773		MESH:D010235	C04.557.465.625.650.700/115310|C04.557.580.625.650.700/115310	C04.557.465.625.650.700|C04.557.580.625.650.700	CAROTID BODY TUMORS AND MULTIPLE EXTRAADRENAL PHEOCHROMOCYTOMAS|PARAGANGLIOMA, FAMILIAL MALIGNANT|PARAGANGLIOMAS, HEREDITARY EXTRAADRENAL|PGL4|PHEOCHROMOCYTOMA, EXTRAADRENAL, AND CERVICAL PARAGANGLIOMA|PHEOCHROMOCYTOMA, FAMILIAL EXTRAADRENAL	Cancer
PARAGANGLIOMAS 5	OMIM:614165	DO:DOID:0050773		MESH:D010235	C04.557.465.625.650.700/614165|C04.557.580.625.650.700/614165	C04.557.465.625.650.700|C04.557.580.625.650.700	PGL5	Cancer
Paragangliomas with Sensorineural Hearing Loss	MESH:C566831			MESH:D006319|MESH:D010235	C04.557.465.625.650.700/C566831|C04.557.580.625.650.700/C566831|C09.218.458.341.887/C566831|C10.597.751.418.341.887/C566831|C23.888.592.763.393.341.887/C566831	C04.557.465.625.650.700|C04.557.580.625.650.700|C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887		Cancer|Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Parakeratosis	MESH:D010241		Persistence of the nuclei of the keratinocytes into the stratum corneum of the skin. This is a normal state only in the epithelium of true mucous membranes in the mouth and vagina. (Dorland, 27th ed)	MESH:D007642	C17.800.428.736	C17.800.428	Parakeratoses	Skin disease
Paralysis	MESH:D010243		A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)	MESH:D009461	C10.597.622|C23.888.592.636	C10.597|C23.888.592	Palsies|Palsy|Paralyses|Paralysis, Todd|Paralysis, Todd's|Plegia|Plegias|Todd Paralysis|Todd's Paralysis|Todds Paralysis	Nervous system disease|Signs and symptoms
Paralysis Agitans, Juvenile, Of Hunt	MESH:C562469			MESH:D010300	C10.228.140.079.862.500/C562469|C10.228.662.600.400/C562469|C10.574.928.750/C562469	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	Parkinson Disease, Juvenile, Of Hunt	Nervous system disease
Parametritis	MESH:D010249	DO:DOID:1260	Inflammation of the parametrium, the connective tissue of the pelvic floor, extending from the subserous coat of the uterus laterally between the layers of the BROAD LIGAMENT.	MESH:D000292	C12.050.351.500.056.750.750|C12.100.250.056.750.750	C12.050.351.500.056.750|C12.100.250.056.750	Cellulitides, Pelvic|Cellulitis, Pelvic|Parametritides|Pelvic Cellulitides|Pelvic Cellulitis	Urogenital disease (female)
Paramyxoviridae Infections	MESH:D018184		Infections with viruses of the family PARAMYXOVIRIDAE. This includes MORBILLIVIRUS INFECTIONS; RESPIROVIRUS INFECTIONS; PNEUMOVIRUS INFECTIONS; HENIPAVIRUS INFECTIONS; AVULAVIRUS INFECTIONS; and RUBULAVIRUS INFECTIONS.	MESH:D018701	C01.925.782.580.600	C01.925.782.580	Infection, Parainfluenza Virus|Infection, Paramyxoviridae|Infections, Parainfluenza Virus|Infections, Paramyxoviridae|Parainfluenza|Parainfluenza Virus Infection|Parainfluenza Virus Infections|Paramyxoviridae Infection|Virus Infection, Parainfluenza|Virus Infections, Parainfluenza	Viral disease
Paranasal Sinus Diseases	MESH:D010254	DO:DOID:1352	Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.	MESH:D009668	C08.460.692|C09.603.692	C08.460|C09.603	Disease, Paranasal Sinus|Diseases, Paranasal Sinus|Paranasal Sinus Disease|Sinus Disease, Paranasal|Sinus Diseases, Paranasal	Ear-nose-throat disease|Respiratory tract disease
Paranasal Sinus Neoplasms	MESH:D010255	DO:DOID:0050619|DO:DOID:1350	Tumors or cancer of the PARANASAL SINUSES.	MESH:D009669|MESH:D010254	C04.588.443.665.650.693|C08.460.669.693|C08.460.692.503|C08.785.600.693|C09.603.669.693|C09.603.692.503|C09.647.685.693	C04.588.443.665.650|C08.460.669|C08.460.692|C08.785.600|C09.603.669|C09.603.692|C09.647.685	Cancer of Paranasal Sinus|Cancer, Paranasal Sinus|Cancers, Paranasal Sinus|Neoplasm, Paranasal Sinus|Neoplasms, Paranasal Sinus|Paranasal Sinus Cancer|Paranasal Sinus Cancers|Paranasal Sinus Neoplasm	Cancer|Ear-nose-throat disease|Respiratory tract disease
Paraneoplastic Cerebellar Degeneration	MESH:D020362		Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies (anti-Yo) are found in the serum of approximately 50% of affected individuals. (Adams et al., Principles of Neurology, 6th ed, p686)	MESH:D002526|MESH:D020361	C04.588.614.550.650|C04.730.856.650|C10.228.140.252.620|C10.574.781.700	C04.588.614.550|C04.730.856|C10.228.140.252|C10.574.781	Anti Yo Associated Paraneoplastic Cerebellar Degeneration|Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration|Cerebellar Degeneration, Paraneoplastic|Cerebellar Syndrome, Paraneoplastic|Cerebellar Syndromes, Paraneoplastic|Degeneration, Paraneoplastic Cerebellar|Paraneoplastic Cerebellar Degeneration, Anti Yo Associated|Paraneoplastic Cerebellar Degeneration, Anti-Yo-Associated|Paraneoplastic Cerebellar Syndrome|Paraneoplastic Cerebellar Syndromes	Cancer|Nervous system disease
Paraneoplastic Endocrine Syndromes	MESH:D009384		Syndromes resulting from inappropriate production of HORMONES or hormone-like materials by NEOPLASMS in non-endocrine tissues or not by the usual ENDOCRINE GLANDS. Such hormone outputs are called ectopic hormone (HORMONES, ECTOPIC) secretion.	MESH:D004701|MESH:D010257	C04.588.322.490|C04.730.713|C19.344.473	C04.588.322|C04.730|C19.344	Ectopic Hormone Syndrome|Ectopic Hormone Syndromes|Endocrine Syndrome, Paraneoplastic|Paraneoplastic Endocrine Syndrome|Syndrome, Ectopic Hormone|Syndrome, Paraneoplastic Endocrine|Syndromes, Ectopic Hormone|Syndromes, Paraneoplastic Endocrine	Cancer|Endocrine system disease
Paraneoplastic Polyneuropathy	MESH:D020364	DO:DOID:8681	A diffuse or multifocal peripheral neuropathy related to the remote effects of a neoplasm, most often carcinoma or lymphoma. Pathologically, there are inflammatory changes in peripheral nerves. The most common clinical presentation is a symmetric distal mixed sensorimotor polyneuropathy. (Adams et al., Principles of Neurology, 6th ed, p1334)	MESH:D011115|MESH:D020361	C04.588.614.550.700|C04.730.856.700|C10.574.781.850|C10.668.829.800.662	C04.588.614.550|C04.730.856|C10.574.781|C10.668.829.800	Neuropathies, Paraneoplastic|Neuropathies, Paraneoplastic Peripheral|Neuropathy, Paraneoplastic|Neuropathy, Paraneoplastic Peripheral|Paraneoplastic Neuropathies|Paraneoplastic Neuropathy|Paraneoplastic Peripheral Neuropathies|Paraneoplastic Peripheral Neuropathy|Paraneoplastic Polyneuropathies|Peripheral Neuropathies, Paraneoplastic|Peripheral Neuropathy, Paraneoplastic|Polyneuropathies, Paraneoplastic|Polyneuropathy, Paraneoplastic	Cancer|Nervous system disease
Paraneoplastic Syndromes	MESH:D010257		In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.	MESH:D009369	C04.730	C04	Paraneoplastic Syndrome|Syndrome, Paraneoplastic|Syndromes, Paraneoplastic	Cancer
Paraneoplastic Syndromes, Nervous System	MESH:D020361		Degenerative or inflammatory conditions affecting the central or peripheral nervous system that develop in association with a systemic neoplasm without direct invasion by tumor. They may be associated with circulating antibodies that react with the affected neural tissue. (Intern Med 1996 Dec;35(12):925-9)	MESH:D009423|MESH:D010257|MESH:D019636	C04.588.614.550|C04.730.856|C10.574.781	C04.588.614|C04.730|C10.574	Autonomic Dysfunction, Paraneoplastic|Autonomic Dysfunctions, Paraneoplastic|Encephalomyelitis, Paraneoplastic|Nervous System Paraneoplastic Syndromes|Neurologic Syndrome, Paraneoplastic|Neurologic Syndromes, Paraneoplastic|Paraneoplastic Autonomic Dysfunction|Paraneoplastic Autonomic Dysfunctions|Paraneoplastic Encephalomyelitides|Paraneoplastic Encephalomyelitis|Paraneoplastic Neurologic Syndrome|Paraneoplastic Neurologic Syndromes|Syndrome, Paraneoplastic Neurologic|Syndromes, Paraneoplastic Neurologic	Cancer|Nervous system disease
Paraneoplastic Syndromes, Ocular	MESH:D059545		Ocular manifestations secondary to various NEOPLASMS in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.	MESH:D005134|MESH:D010257	C04.588.364.738|C04.730.900|C11.319.466	C04.588.364|C04.730|C11.319	Bilateral Diffuse Uveal Melanocytic Proliferation, Paraneoplastic|Cancer-Associated Retinopathies|Cancer Associated Retinopathy|Cancer-Associated Retinopathy|Disease, Ocular Paraneoplastic|Diseases, Ocular Paraneoplastic|Melanocytic Proliferation, Paraneoplastic|Melanocytic Proliferations, Paraneoplastic|Melanoma-Associated Retinopathies|Melanoma Associated Retinopathy|Melanoma-Associated Retinopathy|Ocular Paraneoplastic Disease|Ocular Paraneoplastic Diseases|Ocular Paraneoplastic Syndrome|Ocular Paraneoplastic Syndromes|Paraneoplastic Disease, Ocular|Paraneoplastic Diseases, Ocular|Paraneoplastic Melanocytic Proliferation|Paraneoplastic Melanocytic Proliferations|Paraneoplastic Syndrome, Ocular|Retinopathies, Cancer-Associated|Retinopathies, Melanoma-Associated|Retinopathy, Cancer-Associated|Retinopathy, Melanoma-Associated|Syndrome, Ocular Paraneoplastic|Syndromes, Ocular Paraneoplastic	Cancer|Eye disease
Paraparesis	MESH:D020335		Mild to moderate loss of bilateral lower extremity motor function, which may be a manifestation of SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; MUSCULAR DISEASES; INTRACRANIAL HYPERTENSION; parasagittal brain lesions; and other conditions.	MESH:D010291	C10.597.636.500|C23.888.592.643.500	C10.597.636|C23.888.592.643	Cerebral Paraparesis|Chronic Progressive Paraparesis|Hypotonic Paraparesis|Parapareses|Paraparesis, Cerebral|Paraparesis, Chronic Progressive|Paraparesis, Hypotonic|Paraparesis, Spinal|Progressive Paraparesis, Chronic|Spinal Paraparesis	Nervous system disease|Signs and symptoms
Paraparesis, Spastic	MESH:D020336		Mild or moderate loss of motor function accompanied by spasticity in the lower extremities. This condition is a manifestation of CENTRAL NERVOUS SYSTEM DISEASES that cause injury to the motor cortex or descending motor pathways.	MESH:D020335	C10.597.636.500.500|C23.888.592.643.500.500	C10.597.636.500|C23.888.592.643.500	Lower Extremity Weakness, Spastic|Parapareses, Spastic|Spastic Lower Extremity Weakness|Spastic Parapareses|Spastic Paraparesis	Nervous system disease|Signs and symptoms
Paraparesis, Tropical Spastic	MESH:D015493	DO:DOID:321|OMIM:159580	A subacute paralytic myeloneuropathy occurring endemically in tropical areas such as the Caribbean, Colombia, India, and Africa, as well as in the southwestern region of Japan; associated with infection by HUMAN T-CELL LEUKEMIA VIRUS I. Clinical manifestations include a slowly progressive spastic weakness of the legs, increased reflexes, Babinski signs, incontinence, and loss of vibratory and position sensation. On pathologic examination inflammatory, demyelination, and necrotic lesions may be found in the spinal cord. (Adams et al., Principles of Neurology, 6th ed, p1239)	MESH:D009187|MESH:D015490	C01.207.618.500|C01.925.782.815.200.470.710|C10.228.228.618.500|C10.228.854.525.700|C10.586.750.700	C01.207.618|C01.925.782.815.200.470|C10.228.228.618|C10.228.854.525|C10.586.750	Familial Spastic Paraparesis, Htlv 1 Associated|Familial Spastic Paraparesis, Htlv-1-Associated|HAM|Htlv-1-Associated Myelopathies|Htlv-1-Associated Myelopathy|HTLV I Associated Myelopathies|HTLV-I-Associated Myelopathies|HTLV I Associated Myelopathy|HTLV-I-Associated Myelopathy|HTLV I Associated Myelopathy Tropical Spastic Paraparesis|HTLV-I-Associated Myelopathy-Tropical Spastic Paraparesis|Human T Lymphotropic Virus Type 1 Associated Myelopathy|Human T-Lymphotropic Virus Type 1 Associated Myelopathy|Myelopathies, Htlv-1-Associated|Myelopathies, HTLV I Associated|Myelopathies, HTLV-I-Associated|Myelopathy, Htlv 1 Associated|Myelopathy, Htlv-1-Associated|Myelopathy, HTLV-I-Associated|Myelopathy, Human T Lymphotropic Virus Type 1 Associated|Myelopathy, Human T-Lymphotropic Virus Type 1 Associated|Parapareses, Tropical Spastic|Paraplegias, Tropical Spastic|Paraplegia, Tropical Spastic|Spastic Parapareses, Tropical|Spastic Paraparesis, Tropical|Spastic Paraplegias, Tropical|Spastic Paraplegia, Tropical|Tropical Spastic Parapareses|Tropical Spastic Paraparesis|Tropical Spastic Paraplegia|Tropical Spastic Paraplegias	Nervous system disease|Viral disease
Paraplegia	MESH:D010264	DO:DOID:607	Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.	MESH:D010243	C10.597.622.669|C23.888.592.636.637	C10.597.622|C23.888.592.636	Ataxic Paraplegia|Ataxic Paraplegias|Cerebral Paraplegia|Cerebral Paraplegias|Flaccid Paraplegia|Flaccid Paraplegias|Paralysis, Legs|Paralysis, Lower Extremities|Paralysis, Lower Limbs|Paraplegia, Ataxic|Paraplegia, Cerebral|Paraplegia, Flaccid|Paraplegias|Paraplegias, Ataxic|Paraplegias, Cerebral|Paraplegias, Flaccid|Paraplegia, Spastic|Paraplegia, Spinal|Paraplegias, Spastic|Paraplegias, Spinal|Spastic Paraplegia|Spastic Paraplegias|Spinal Paraplegia|Spinal Paraplegias	Nervous system disease|Signs and symptoms
Paraproteinemias	MESH:D010265	DO:DOID:6536	A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.	MESH:D001796|MESH:D007160	C15.378.147.780|C20.683.780	C15.378.147|C20.683	Cell Dyscrasia, Plasma|Cell Dyscrasias, Plasma|Dyscrasia, Plasma Cell|Dyscrasias, Plasma Cell|Gammapathies, Monoclonal|Gammapathy, Monoclonal|Gammopathies, Monoclonal|Gammopathy, Monoclonal|Monoclonal Gammapathies|Monoclonal Gammapathy|Monoclonal Gammopathies|Monoclonal Gammopathy|Paraimmunoglobulinemia|Paraimmunoglobulinemias|Paraproteinemia|Plasma Cell Dyscrasia|Plasma Cell Dyscrasias	Blood disease|Immune system disease
Parapsoriasis	MESH:D010267	DO:DOID:9088	The term applied to a group of relatively uncommon inflammatory, maculopapular, scaly eruptions of unknown etiology and resistant to conventional treatment. Eruptions are both psoriatic and lichenoid in appearance, but the diseases are distinct from psoriasis, lichen planus, or other recognized dermatoses. Proposed nomenclature divides parapsoriasis into two distinct subgroups, PITYRIASIS LICHENOIDES and parapsoriasis en plaques (small- and large-plaque parapsoriasis).	MESH:D017444	C17.800.859.575	C17.800.859	Dermatoses, Digitate|Dermatosis, Digitate|Digitate Dermatoses|Digitate Dermatosis|Erythroderma, Maculopapular|Erythrodermas, Maculopapular|Maculopapular Erythroderma|Maculopapular Erythrodermas|Parakeratosis Variegata|Parapsoriases|Parapsoriasis en Plaque|Parapsoriasis en Plaques	Skin disease
Paraquat lung	MESH:C537171			MESH:D055371	C08.381.520.500/C537171	C08.381.520.500	Paraquat induced lung disease	Respiratory tract disease
Parasystole	MESH:D017574		A cardiac arrhythmia that is caused by interaction of two independently initiated cardiac impulses of different rates from two separate foci. Generally one focus is the SINOATRIAL NODE, the normal pacemaker. The ectopic focus is usually in the HEART VENTRICLE but can be in the HEART ATRIUM or the ATRIOVENTRICULAR NODE. Modulation of the parasystolic rhythm by the sinus rhythm depends on the completeness of entrance block surrounding the parasystolic focus.	MESH:D001145	C14.280.067.672|C23.550.073.670	C14.280.067|C23.550.073	Parasystoles	Cardiovascular disease|Pathology (process)
Parathyroid Adenomatosis, Familial Cystic	MESH:C564165			MESH:D000236|MESH:D007573|MESH:D049950	C04.557.470.035/C564165|C04.588.149.721.450/C564165|C05.116.231.754.450/C564165|C05.500.499/C564165|C07.320.515/C564165|C19.642.355.239/C564165	C04.557.470.035|C04.588.149.721.450|C05.116.231.754.450|C05.500.499|C07.320.515|C19.642.355.239		Cancer|Endocrine system disease|Mouth disease|Musculoskeletal disease
Parathyroid cancer, adult	MESH:C537173			MESH:D010282	C04.588.322.525/C537173|C04.588.443.680/C537173|C19.344.525/C537173|C19.642.713/C537173	C04.588.322.525|C04.588.443.680|C19.344.525|C19.642.713	Parathyroid carcinoma, adult|Parathyroid neoplasm, adult	Cancer|Endocrine system disease
Parathyroid Neoplasms	MESH:D010282	DO:DOID:1540|DO:DOID:7608|OMIM:608266	Tumors or cancer of the PARATHYROID GLANDS.	MESH:D004701|MESH:D006258|MESH:D010279	C04.588.322.525|C04.588.443.680|C19.344.525|C19.642.713	C04.588.322|C04.588.443|C19.344|C19.642	Adenoma, Parathyroid|Adenomas, Parathyroid|Cancer of Parathyroid|Cancer of the Parathyroid|Cancer, Parathyroid|Cancers, Parathyroid|Carcinoma, Parathyroid|Carcinomas, Parathyroid|Neoplasm, Parathyroid|Neoplasms, Parathyroid|Parathyroid Adenoma|Parathyroid Adenomas|Parathyroid Cancer|Parathyroid Cancers|Parathyroid Carcinoma|Parathyroid Carcinomas|Parathyroid Neoplasm|PRTC	Cancer|Endocrine system disease
Paresis	MESH:D010291		A general term referring to a mild to moderate degree of muscular weakness, occasionally used as a synonym for PARALYSIS (severe or complete loss of motor function). In the older literature, paresis often referred specifically to paretic neurosyphilis (see NEUROSYPHILIS). 'General paresis' and 'general paralysis' may still carry that connotation. Bilateral lower extremity paresis is referred to as PARAPARESIS.	MESH:D009461	C10.597.636|C23.888.592.643	C10.597|C23.888.592	Brachial Pareses|Brachial Paresis|Crural Pareses|Crural Paresis|Extremity Pareses, Lower|Extremity Pareses, Upper|Extremity Paresis, Lower|Extremity Paresis, Upper|Hemipareses|Hemiparesis|Lower Extremity Pareses|Lower Extremity Paresis|Monopareses|Monoparesis|Muscle Pareses|Muscle Paresis|Muscular Pareses|Muscular Paresis|Pareses|Pareses, Brachial|Pareses, Crural|Pareses, Lower Extremity|Pareses, Muscle|Pareses, Muscular|Pareses, Upper Extremity|Paresis, Brachial|Paresis, Crural|Paresis, Lower Extremity|Paresis, Muscle|Paresis, Muscular|Paresis, Upper Extremity|Upper Extremity Pareses|Upper Extremity Paresis	Nervous system disease|Signs and symptoms
Paresthesia	MESH:D010292		Subjective cutaneous sensations (e.g., cold, warmth, tingling, pressure, etc.) that are experienced spontaneously in the absence of stimulation.	MESH:D020886	C10.597.751.791.875|C23.888.592.763.770.875	C10.597.751.791|C23.888.592.763.770	Distal Paresthesia|Distal Paresthesias|Dysesthesia|Dysesthesias|Formication|Formications|Painful Paresthesia|Painful Paresthesias|Paresthesia, Distal|Paresthesia, Painful|Paresthesias|Paresthesias, Distal|Paresthesias, Painful	Nervous system disease|Signs and symptoms
Parkinson Disease	MESH:D010300	DO:DOID:14330	A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)	MESH:D000080874|MESH:D020734	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	C10.228.140.079.862|C10.228.662.600|C10.574.928	Idiopathic Parkinson Disease|Idiopathic Parkinson's Disease|Lewy Body Parkinson Disease|Lewy Body Parkinson's Disease|Paralysis Agitans|Parkinson Disease, Idiopathic|Parkinsonism, Primary|Parkinson's Disease|Parkinson's Disease, Idiopathic|Parkinson's Disease, Lewy Body|Primary Parkinsonism	Nervous system disease
Parkinson Disease 10	MESH:C564653	OMIM:606852		MESH:D010300	C10.228.140.079.862.500/C564653|C10.228.662.600.400/C564653|C10.574.928.750/C564653	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	AAOPD|PARK10|Parkinson Disease, Age At Onset Of	Nervous system disease
Parkinson Disease 11	MESH:C564345			MESH:D010300	C10.228.140.079.862.500/C564345|C10.228.662.600.400/C564345|C10.574.928.750/C564345	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK11	Nervous system disease
PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	OMIM:607688			MESH:D010300	C10.228.140.079.862.500/607688|C10.228.662.600.400/607688|C10.574.928.750/607688	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK11	Nervous system disease
Parkinson Disease 13	MESH:C565204			MESH:D010300	C10.228.140.079.862.500/C565204|C10.228.662.600.400/C565204|C10.574.928.750/C565204	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK13	Nervous system disease
PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	OMIM:610297			MESH:D010300	C10.228.140.079.862.500/610297|C10.228.662.600.400/610297|C10.574.928.750/610297	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK13	Nervous system disease
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE	OMIM:612953	DO:DOID:0060900		MESH:D010300	C10.228.140.079.862.500/612953|C10.228.662.600.400/612953|C10.574.928.750/612953	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	DYSTONIA-PARKINSONISM, ADULT-ONSET|PARK14	Nervous system disease
Parkinson Disease 16	MESH:C567726	OMIM:613164		MESH:D010300	C10.228.140.079.862.500/C567726|C10.228.662.600.400/C567726|C10.574.928.750/C567726	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK16	Nervous system disease
PARKINSON DISEASE 17	OMIM:614203	DO:DOID:0060897		MESH:D010300	C10.228.140.079.862.500/614203|C10.228.662.600.400/614203|C10.574.928.750/614203	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK17	Nervous system disease
PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	OMIM:614251			MESH:D010300	C10.228.140.079.862.500/614251|C10.228.662.600.400/614251|C10.574.928.750/614251	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK18	Nervous system disease
PARKINSON DISEASE 19A, JUVENILE-ONSET	OMIM:615528	DO:DOID:0060891		MESH:D010300	C10.228.140.079.862.500/615528|C10.228.662.600.400/615528|C10.574.928.750/615528	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK19A|PARK19B, INCLUDED|PARK19, FORMERLY PARKINSON DISEASE 19B, EARLY-ONSET, INCLUDED	Nervous system disease
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT	OMIM:168601	DO:DOID:0060367		MESH:D010300	C10.228.140.079.862.500/168601|C10.228.662.600.400/168601|C10.574.928.750/168601	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK1|PARKINSON DISEASE 1, AUTOSOMAL DOMINANT LEWY BODY ATYPICAL PARKINSON DISEASE, INCLUDED	Nervous system disease
PARKINSON DISEASE 20, EARLY-ONSET	OMIM:615530	DO:DOID:0060898		MESH:D010300	C10.228.140.079.862.500/615530|C10.228.662.600.400/615530|C10.574.928.750/615530	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK20	Nervous system disease
PARKINSON DISEASE 21	OMIM:616361	DO:DOID:0111251		MESH:D010300	C10.228.140.079.862.500/616361|C10.228.662.600.400/616361|C10.574.928.750/616361	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK21	Nervous system disease
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT	OMIM:616710	DO:DOID:0080504		MESH:D010300	C10.228.140.079.862.500/616710|C10.228.662.600.400/616710|C10.574.928.750/616710	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK22	Nervous system disease
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	OMIM:616840	DO:DOID:0060896		MESH:D010300	C10.228.140.079.862.500/616840|C10.228.662.600.400/616840|C10.574.928.750/616840	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK23	Nervous system disease
Parkinson disease 3	MESH:C537176			MESH:D010300	C10.228.140.079.862.500/C537176|C10.228.662.600.400/C537176|C10.574.928.750/C537176	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750		Nervous system disease
Parkinson Disease 3, Autosomal Dominant Lewy Body	MESH:C566552	OMIM:602404		MESH:D010300	C10.228.140.079.862.500/C566552|C10.228.662.600.400/C566552|C10.574.928.750/C566552	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK3|Parkinson Disease 3, Autosomal Dominant|PARKINSON DISEASE 3, AUTOSOMAL DOMINANT LEWY BODY	Nervous system disease
Parkinson Disease 5	MESH:C566017			MESH:D020734	C10.228.140.079.862/C566017|C10.228.662.600/C566017	C10.228.140.079.862|C10.228.662.600		Nervous system disease
PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	OMIM:613643			MESH:D010300	C10.228.140.079.862.500/613643|C10.228.662.600.400/613643|C10.574.928.750/613643	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK5	Nervous system disease
Parkinson Disease 6, Autosomal Recessive Early-Onset	MESH:C565276	OMIM:605909		MESH:D010300	C10.228.140.079.862.500/C565276|C10.228.662.600.400/C565276|C10.574.928.750/C565276	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK6|Parkinson Disease 6, Early-Onset|PARKINSON DISEASE 6, EARLY-ONSET;PARK6  PARKINSON DISEASE 6, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED|Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1-Dj1|PARKINSON DISEASE, AUTOSOMAL RECESSIVE EARLY-ONSET, DIGENIC, PINK1/DJ1, INCLUDED	Nervous system disease
Parkinson Disease 7, Autosomal Recessive Early-Onset	MESH:C565238	OMIM:606324		MESH:D010300	C10.228.140.079.862.500/C565238|C10.228.662.600.400/C565238|C10.574.928.750/C565238	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK7	Nervous system disease
Parkinson Disease 8	MESH:C564631			MESH:D020734	C10.228.140.079.862/C564631|C10.228.662.600/C564631	C10.228.140.079.862|C10.228.662.600		Nervous system disease
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT	OMIM:607060	DO:DOID:0060371		MESH:D010300	C10.228.140.079.862.500/607060|C10.228.662.600.400/607060|C10.574.928.750/607060	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK8	Nervous system disease
Parkinson Disease, Familial, Type 1	MESH:C566823			MESH:D010300	C10.228.140.079.862.500/C566823|C10.228.662.600.400/C566823|C10.574.928.750/C566823	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	Atypical Parkinson Disease|Lewy Body Parkinsonism|Parkinson Disease, Autosomal Dominant	Nervous system disease
PARKINSON DISEASE, LATE-ONSET	OMIM:168600	DO:DOID:0060892		MESH:D010300	C10.228.140.079.862.500/168600|C10.228.662.600.400/168600|C10.574.928.750/168600	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750	PARK|PD	Nervous system disease
Parkinson Disease, Mitochondrial	MESH:C564015	OMIM:556500		MESH:D010300|MESH:D028361	C10.228.140.079.862.500/C564015|C10.228.662.600.400/C564015|C10.574.928.750/C564015|C18.452.660/C564015	C10.228.140.079.862.500|C10.228.662.600.400|C10.574.928.750|C18.452.660		Metabolic disease|Nervous system disease
Parkinson Disease, Postencephalitic	MESH:D010301	DO:DOID:14332	Parkinsonism following encephalitis, historically seen as a sequella of encephalitis lethargica (Von Economo Encephalitis). The early age of onset, the rapid progression of symptoms followed by stabilization, and the presence of a variety of other neurological disorders (e.g., sociopathic behavior; TICS; MUSCLE SPASMS; oculogyric crises; hyperphagia; and bizarre movements) distinguish this condition from primary PARKINSON DISEASE. Pathologic features include neuronal loss and gliosis concentrated in the MESENCEPHALON; SUBTHALAMUS; and HYPOTHALAMUS. (From Adams et al., Principles of Neurology, 6th ed, p754)	MESH:D010302	C10.228.140.079.862.800.600|C10.228.662.600.700.500	C10.228.140.079.862.800|C10.228.662.600.700	Economo-Type Parkinsonism, Postencephalitic|Encephalitis Lethargica Type Parkinsonism|Meningoencephalitic Parkinsonism, Viral|Parkinson Disease, Post Encephalitic|Parkinson Disease, Post-Encephalitic|Parkinsonian Syndrome, Postencephalitis|Parkinsonism, Postencephalitic|Parkinsonism, Postencephalitic Economo-Type|Parkinsonisms, Viral Meningoencephalitic|Parkinsonism, Viral Meningoencephalitic|Postencephalitic Economo Type Parkinsonism|Postencephalitic Economo-Type Parkinsonism|Postencephalitic Parkinson Disease|Post Encephalitic Parkinson Disease|Post-Encephalitic Parkinson Disease|Postencephalitic Parkinsonism|Postencephalitis Parkinsonian Syndrome|Viral Meningoencephalitic Parkinsonism|von Economo Encephalitis Type Parkinsonism	Nervous system disease
Parkinson Disease, Secondary	MESH:D010302	DO:DOID:13548	Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)	MESH:D020734	C10.228.140.079.862.800|C10.228.662.600.700	C10.228.140.079.862|C10.228.662.600	Atherosclerotic Parkinsonism|Parkinson Disease, Secondary Vascular|Parkinson Disease, Symptomatic|Parkinsonism, Atherosclerotic|Parkinsonism, Secondary|Parkinsonism, Symptomatic|Secondary Parkinson Disease|Secondary Parkinsonism|Secondary Vascular Parkinson Disease|Symptomatic Parkinson Disease|Symptomatic Parkinsonism	Nervous system disease
Parkinsonian Disorders	MESH:D020734	OMIM:600116	A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.	MESH:D001480|MESH:D009069	C10.228.140.079.862|C10.228.662.600	C10.228.140.079|C10.228.662	Autosomal Dominant Juvenile Parkinson Disease|Autosomal Dominant Juvenile Parkinsonism|Autosomal Dominant Parkinsonism|Autosomal Recessive Juvenile Parkinson Disease|Autosomal Recessive Juvenile Parkinsonism|Autosomal Recessive Parkinsonism|Chromosome 6 Linked Autosomal Recessive Parkinsonism|Chromosome 6-Linked Autosomal Recessive Parkinsonism|Diseases, Experimental Parkinson|Dominant Parkinsonism, Autosomal|EPDF|Experimental Parkinson Disease|Experimental Parkinson Diseases|Experimental Parkinsonism|Experimental Parkinsonism, MPTP Induced|Experimental Parkinsonism, MPTP-Induced|Experimental Parkinsonisms|Familial Juvenile Parkinsonism|Familial Parkinson Disease, Autosomal Recessive|Juvenile Parkinson Disease|Juvenile Parkinson Disease, Autosomal Dominant|Juvenile Parkinson Disease, Autosomal Recessive|Juvenile Parkinsonism|Juvenile Parkinsonism, Autosomal Dominant|Juvenile Parkinsonism, Autosomal Recessive|Juvenile Parkinsonism, Familial|Juvenile Parkinsonisms|MPTP Induced Experimental Parkinsonism|MPTP-Induced Experimental Parkinsonism|PARK2|Parkinson Disease 2|Parkinson Disease 2, Autosomal Recessive Juvenile|Parkinson Disease, Autosomal Dominant. Juvenile|Parkinson Disease Autosomal Recessive, Early Onset|Parkinson Disease, Experimental|Parkinson Disease, Familial, Autosomal Recessive|Parkinson Disease, Juvenile|Parkinson Disease, Juvenile, Autosomal Dominant|Parkinson Disease, Juvenile, Autosomal Recessive|Parkinson Diseases, Experimental|Parkinsonian Diseases|Parkinsonian Syndrome|Parkinsonian Syndromes|Parkinsonism|Parkinsonism, Autosomal Dominant|Parkinsonism, Autosomal Recessive|Parkinsonism, Early Onset, with Diurnal Fluctuation|Parkinsonism, Early-Onset, With Diurnal Fluctuation|Parkinsonism, Experimental|Parkinsonism, Familial Juvenile|Parkinsonism, Juvenile|Parkinsonism, Juvenile, Autosomal Dominant|Parkinsonism, Juvenile, Autosomal Recessive|Parkinsonism, MPTP-Induced Experimental|Parkinsonisms, Experimental|Parkinsonisms, Juvenile|PDJ|Ramsay Hunt Paralysis Syndrome|Recessive Parkinsonism, Autosomal	Nervous system disease
Parkinsonism-Dystonia, Infantile	MESH:C567730	OMIM:613135		MESH:D010300|MESH:D020821	C10.228.140.079.862.500/C567730|C10.228.662.300/C567730|C10.228.662.600.400/C567730|C10.574.928.750/C567730	C10.228.140.079.862.500|C10.228.662.300|C10.228.662.600.400|C10.574.928.750	DOPAMINE TRANSPORTER DEFICIENCY SYNDROME|DTDS|PARKINSONISM-DYSTONIA, INFANTILE, 1|PKDYS|PKDYS1	Nervous system disease
PARKINSONISM WITH SPASTICITY, X-LINKED	OMIM:300911	DO:DOID:0112105		MESH:D020734	C10.228.140.079.862/300911|C10.228.662.600/300911	C10.228.140.079.862|C10.228.662.600	XPDS	Nervous system disease
Paronychia	MESH:D010304	DO:DOID:13117	An inflammatory reaction involving the folds of the skin surrounding the fingernail. It is characterized by acute or chronic purulent, tender, and painful swellings of the tissues around the nail, caused by an abscess of the nail fold. The pathogenic yeast causing paronychia is most frequently Candida albicans. Saprophytic fungi may also be involved. The causative bacteria are usually Staphylococcus, Pseudomonas aeruginosa, or Streptococcus. (Andrews' Diseases of the Skin, 8th ed, p271)	MESH:D009260|MESH:D012874	C01.800.460|C17.800.529.639|C17.800.838.486	C01.800|C17.800.529|C17.800.838	Paronychias	Skin disease
Parotid Neoplasms	MESH:D010307	DO:DOID:9036	Tumors or cancer of the PAROTID GLAND.	MESH:D010305|MESH:D012468	C04.588.443.591.824.695|C07.465.530.824.695|C07.465.815.470.770|C07.465.815.718.589	C04.588.443.591.824|C07.465.530.824|C07.465.815.470|C07.465.815.718	Cancer of Parotid|Cancer of the Parotid|Cancer, Parotid|Cancers, Parotid|Neoplasm, Parotid|Neoplasms, Parotid|Parotid Cancer|Parotid Cancers|Parotid Neoplasm	Cancer|Mouth disease
Parovarian Cyst	MESH:D010310	DO:DOID:4333	A cyst (CYSTS) near the OVARY, derived from anomalies of the FALLOPIAN TUBES or the BROAD LIGAMENT. The paramesonephric type consists of ciliated cells similar to the oviduct epithelium. The mesonephric type consisted of an epithelium with minimally surface structures. They can be found on the thin oviduct (paratubal cysts) or near its fimbriated end (hydatid of Morgagni).	MESH:D003560	C04.182.668|C23.300.306.500	C04.182|C23.300.306	Cyst, Paratubal|Cyst, Parovarian|Cysts, Paratubal|Cysts, Parovarian|Hydatid Cyst of Morgagni|Hydatid of Morgagni|Morgagni Hydatid|Morgagni Hydatid Cyst|Morgagni Hydatid Cysts|Morgagni Hydatids|Paratubal Cyst|Paratubal Cysts|Parovarian Cysts	Cancer|Pathology (anatomical condition)
Paroxysmal Exertion-Induced Dyskinesia And Hemolytic Anemia	MESH:C567412			MESH:D000743|MESH:D020820	C10.228.662.262/C567412|C10.597.350/C567412|C15.378.071.141/C567412|C23.888.592.350/C567412	C10.228.662.262|C10.597.350|C15.378.071.141|C23.888.592.350		Blood disease|Nervous system disease|Signs and symptoms
Paroxysmal Hemicrania	MESH:D051302		A primary headache disorder that is similar to the CLUSTER HEADACHE with unilateral head pain, but differs by its multiple short severe attacks. It is usually seen in females, and may be responsive to non-steroidal-anti-inflammatory drugs (NSAIDS).	MESH:D051303	C10.228.140.546.399.937.750	C10.228.140.546.399.937	Chronic Paroxysmal Hemicrania|Chronic Paroxysmal Hemicranias|Episodic Paroxysmal Hemicrania|Episodic Paroxysmal Hemicranias|Hemicrania, Chronic Paroxysmal|Hemicrania, Episodic Paroxysmal|Hemicrania, Paroxysmal|Hemicranias, Chronic Paroxysmal|Hemicranias, Episodic Paroxysmal|Hemicranias, Paroxysmal|Paroxysmal Hemicrania, Chronic|Paroxysmal Hemicrania, Episodic|Paroxysmal Hemicranias|Paroxysmal Hemicranias, Chronic|Paroxysmal Hemicranias, Episodic	Nervous system disease
Paroxysmal nonkinesigenic dyskinesia	MESH:C537181	OMIM:118800		MESH:D002819	C10.228.662.262.249/C537181|C10.597.350.250/C537181|C23.888.592.350.250/C537181	C10.228.662.262.249|C10.597.350.250|C23.888.592.350.250	Choreoathetosis familial paroxysmal|Choreoathetosis, Familial Paroxysmal|Choreoathetosis, Nonkinesigenic|Dystonia 8|DYT8|Familial paroxysmal choreoathetosis|Familial Paroxysmal Nonkinesigenic Dyskinesia|FPD1|Mount-Reback syndrome|Nonkinesigenic choreoathetosis|Paroxysmal dystonic choreoathetosis|Paroxysmal Nonkinesigenic Dyskinesia 1|PDC|PNKD1	Nervous system disease|Signs and symptoms
Paroxysmal Nonkinesigenic Dyskinesia 2	MESH:C567001	OMIM:611147		MESH:D002819	C10.228.662.262.249/C567001|C10.597.350.250/C567001|C23.888.592.350.250/C567001	C10.228.662.262.249|C10.597.350.250|C23.888.592.350.250	Dystonia 20|DYT20|PNKD2	Nervous system disease|Signs and symptoms
Paroxysmal Tonic Upgaze, Benign Childhood, With Ataxia	MESH:C566817			MESH:D001259|MESH:D009069|MESH:D015835	C10.228.662/C566817|C10.228.758/C566817|C10.292.562/C566817|C10.597.350.090/C566817|C11.590/C566817|C23.888.592.350.090/C566817	C10.228.662|C10.228.758|C10.292.562|C10.597.350.090|C11.590|C23.888.592.350.090		Eye disease|Nervous system disease|Signs and symptoms
Paroxysmal ventricular fibrillation	MESH:C537182	OMIM:603829|OMIM:612956		MESH:D014693	C14.280.067.922/C537182|C23.550.073.922/C537182	C14.280.067.922|C23.550.073.922	Idiopathic ventricular fibrillation|IVF VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, INCLUDED|Paroxysmal familial ventricular fibrillation|Ventricular fibrillation, paroxysmal familial|VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1|VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2|VF|VF1|VF2	Cardiovascular disease|Pathology (process)
Pars Planitis	MESH:D015868	DO:DOID:12731	Form of granulomatous uveitis occurring in the region of the pars plana. This disorder is a common condition with no detectable focal pathology. It causes fibrovascular proliferation at the inferior ora serrata.	MESH:D002833|MESH:D015867	C11.941.160.478.700|C11.941.879.780.900.300.659|C11.941.879.900.500	C11.941.160.478|C11.941.879.780.900.300|C11.941.879.900	Planitis, Pars	Eye disease
Partial atrioventricular canal	MESH:C536112			MESH:D006345	C14.240.400.560.540/C536112|C14.280.400.560.540/C536112|C16.131.240.400.560.540/C536112	C14.240.400.560.540|C14.280.400.560.540|C16.131.240.400.560.540	Atrial Septal Defect, Primum Type|Partial atrioventricular septal defects|Partial AVSD|Partial common atrioventricular canal	Cardiovascular disease|Congenital abnormality
Parvoviridae Infections	MESH:D010322		Virus infections caused by the PARVOVIRIDAE.	MESH:D004266	C01.925.256.700	C01.925.256	Infection, Parvoviridae|Infection, Parvovirus|Infections, Parvoviridae|Infections, Parvovirus|Parvoviridae Infection|Parvovirus Infection|Parvovirus Infections	Viral disease
Parvovirus antenatal infection	MESH:C536301			MESH:D016731	C01.925.256.700.300/C536301|C01.925.825.260/C536301|C17.800.229.335/C536301|C17.800.838.790.260/C536301	C01.925.256.700.300|C01.925.825.260|C17.800.229.335|C17.800.838.790.260	Maternofetal infection by parvovirus|Parvovirus B19 antenatal infection	Skin disease|Viral disease
Pascual Castroviejo syndrome	MESH:C536302			MESH:D001932|MESH:D006391|MESH:D008113	C04.557.645.375/C536302|C04.588.274.623/C536302|C04.588.614.250.195/C536302|C06.301.623/C536302|C06.552.697/C536302|C10.228.140.211/C536302|C10.551.240.250/C536302	C04.557.645.375|C04.588.274.623|C04.588.614.250.195|C06.301.623|C06.552.697|C10.228.140.211|C10.551.240.250	Hemangiomas, and cutaneous and intracranial vascular deformations	Cancer|Digestive system disease|Nervous system disease
Patella, Familial Recurrent Dislocation Of	MESH:C566816			MESH:D004204|MESH:D007593	C05.550.518/C566816|C05.550.521/C566816|C26.289/C566816	C05.550.518|C05.550.521|C26.289		Musculoskeletal disease|Wounds and injuries
Patellar Dislocation	MESH:D031222		Displacement of the PATELLA from the femoral groove.	MESH:D004204|MESH:D007718	C05.550.518.625|C26.289.625|C26.558.554.750	C05.550.518|C26.289|C26.558.554	Dislocation, Patellar|Dislocations, Patellar|Patellar Dislocations	Musculoskeletal disease|Wounds and injuries
Patellofemoral Pain Syndrome	MESH:D046788	DO:DOID:14284	A syndrome characterized by retropatellar or peripatellar PAIN resulting from physical and biochemical changes in the patellofemoral joint. The pain is most prominent when ascending or descending stairs, squatting, or sitting with flexed knees. There is a lack of consensus on the etiology and treatment. The syndrome is often confused with (or accompanied by) CHONDROMALACIA PATELLAE, the latter describing a pathological condition of the CARTILAGE and not a syndrome.	MESH:D007592	C05.550.700	C05.550	Anterior Knee Pain Syndrome|Pain, Patellofemoral|Pain Syndrome, Patellofemoral|Patellofemoral Pain|Patellofemoral Pains|Patellofemoral Syndrome	Musculoskeletal disease
Patent Ductus Arteriosus and Bicuspid Aortic Valve with Hand Anomalies	MESH:C565782			MESH:D000082882|MESH:D001022|MESH:D004374|MESH:D006228	C05.390.408/C565782|C05.660.585.988.425/C565782|C14.240.400.186/C565782|C14.240.400.340/C565782|C14.280.400.186/C565782|C14.280.400.340/C565782|C14.280.484.048.500/C565782|C14.280.484.048.875/C565782|C16.131.240.400.186/C565782|C16.131.240.400.340/C565782|C16.131.621.585.988.500/C565782	C05.390.408|C05.660.585.988.425|C14.240.400.186|C14.240.400.340|C14.280.400.186|C14.280.400.340|C14.280.484.048.500|C14.280.484.048.875|C16.131.240.400.186|C16.131.240.400.340|C16.131.621.585.988.500		Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Patent Ductus Venosus	MESH:C562830			MESH:D054079	C14.240.850/C562830|C16.131.240.850/C562830	C14.240.850|C16.131.240.850	Portosystemic Venous Shunt, Congenital	Cardiovascular disease|Congenital abnormality
Pathological Conditions, Signs and Symptoms	MESH:D013568		Abnormal anatomical or physiological conditions and objective or subjective manifestations of disease, not classified as disease or syndrome.	MESH:C	C23	C	Symptoms and General Pathology	
Patterned dystrophy of retinal pigment epithelium	MESH:C536309	OMIM:169150|OMIM:608970|OMIM:617111		MESH:D058499	C11.768.585.658/C536309	C11.768.585.658	Butterfly dystrophy of retinal pigment epithelium|Butterfly-shaped pigment dystrophy of the fovea|Macular dystrophy, butterfly-shaped pigmentary|Macular Dystrophy, Butterfly-Shaped Pigmentary, 2|MACULAR DYSTROPHY, PATTERNED, 1|MACULAR DYSTROPHY, PATTERNED, 2|MACULAR DYSTROPHY, PATTERNED, 3|MARTINIQUE CRINKLED RETINAL PIGMENT EPITHELIOPATHY|MDPT1|MDPT2|MDPT3|PATTERNED DYSTROPHY OF RETINAL PIGMENT EPITHELIUM	Eye disease
Pdgfra-Associated Chronic Eosinophilic Leukemia	MESH:C580364			MESH:D007938|MESH:D017681	C04.557.337/C580364|C15.378.553.231.549/C580364	C04.557.337|C15.378.553.231.549	Chronic Eosinophilic Leukemia|Pdgfra-Associated Myeloproliferative Neoplasm	Blood disease|Cancer
Pdgfrb-Associated Chronic Eosinophilic Leukemia	MESH:C580365			MESH:D015477|MESH:D017681	C04.557.337.539.522/C580365|C15.378.190.615.510/C580365|C15.378.553.231.549/C580365|C23.550.291.500.495/C580365	C04.557.337.539.522|C15.378.190.615.510|C15.378.553.231.549|C23.550.291.500.495	Atypical Philadelphia-Negative Chronic Myeloid Leukemia|Chronic Myeloproliferative Disorder with Eosinophilia|Clonal Eosinophilia with Chronic Myeloproliferative Disorder|Primary Eosinophilia with Chronic Myeloproliferative Disorder	Blood disease|Cancer|Pathology (process)
Peanut Hypersensitivity	MESH:D021183	DO:DOID:4378	Allergic reaction to peanuts that is triggered by the immune system.	MESH:D000074924	C20.543.480.370.572.750	C20.543.480.370.572	Allergies, Peanut|Allergy, Peanut|Groundnut Hypersensitivity|Hypersensitivity, Groundnut|Hypersensitivity, Peanut|Peanut Allergies|Peanut Allergy	Immune system disease
Pectoralis Muscle, Absence of	MESH:C566793			MESH:D009135	C05.651/C566793|C10.668.491/C566793	C05.651|C10.668.491		Musculoskeletal disease|Nervous system disease
Pediatric acute-onset neuropsychiatric syndrome	MESH:C000631768			MESH:D001327|MESH:D009771	C20.111/C000631768|F03.080.600/C000631768	C20.111|F03.080.600	PANS pediatric acute-onset neuropsychiatric syndrome	Immune system disease|Mental disorder
pediatric multisystem inflammatory disease, COVID-19 related	MESH:C000705967			MESH:D000086382|MESH:D018746	C01.748.610.763.500/C000705967|C01.925.705.500/C000705967|C01.925.782.600.550.200.163/C000705967|C08.381.677.807.500/C000705967|C08.730.610.763.500/C000705967|C23.550.470.790/C000705967|C23.550.835.900/C000705967	C01.748.610.763.500|C01.925.705.500|C01.925.782.600.550.200.163|C08.381.677.807.500|C08.730.610.763.500|C23.550.470.790|C23.550.835.900	MIS-C associated with COVID-19|MISC associated with COVID-19|MIS-C multisystem inflammatory syndrome in children|multi-system inflammatory disease, pediatric, COVID-19 related|multisystem inflammatory disease, pediatric, COVID-19 related|multisystem inflammatory syndrome in children|multisystem inflammatory syndrome in children MIS-C associated with COVID-19|multi-system inflammatory syndrome, pediatric, COVID-19 related|multisystem inflammatory syndrome, pediatric, COVID-19 related|pediatric inflammatory multisystem syndrome|pediatric multi-system inflammatory disease, COVID-19 related|pediatric multi-system inflammatory syndrome, COVID-19 related|pediatric multisystem inflammatory syndrome, COVID-19 related|pediatric multi-system inflammatory syndrome, SARS-CoV-2 related|pediatric multisystem inflammatory syndrome, SARS-CoV-2 related|PIMS-TS	Pathology (process)|Respiratory tract disease|Viral disease
Peeling skin syndrome, acral type	MESH:C536316	OMIM:609796		MESH:D012871	C17.800/C536316	C17.800	Acral peeling skin syndrome|APSS|Peeling skin syndrome 2|PEELING SKIN SYNDROME, ACRAL TYPE|PSS2	Skin disease
PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS	OMIM:616295			MESH:D002613|MESH:D007642	C07.465.409.215/616295|C17.800.428/616295	C07.465.409.215|C17.800.428	PLACK	Mouth disease|Skin disease
PEHO syndrome	MESH:C536317	OMIM:260565		MESH:D001929|MESH:D009896|MESH:D013036|MESH:D019636	C10.228.140.187/C536317|C10.228.140.490.375.760/C536317|C10.228.140.490.493.875/C536317|C10.292.700.225/C536317|C10.574/C536317|C11.640.451/C536317	C10.228.140.187|C10.228.140.490.375.760|C10.228.140.490.493.875|C10.292.700.225|C10.574|C11.640.451	Infantile cerebellooptic atrophy|PEHO|PEHO-Like Syndrome|Progressive Encephalopathy with edema, Hypsarrhythmia, and Optic atrophy	Eye disease|Nervous system disease
Pelger-Huet-Like Anomaly and Episodic Fever with Abdominal Pain	MESH:C564899			MESH:D005334|MESH:D007960|MESH:D015746	C15.378.553/C564899|C23.888.119.344/C564899|C23.888.592.612.054/C564899|C23.888.821.030/C564899	C15.378.553|C23.888.119.344|C23.888.592.612.054|C23.888.821.030		Blood disease|Signs and symptoms
Peliosis Hepatis	MESH:D010382	DO:DOID:914	A vascular disease of the LIVER characterized by the occurrence of multiple blood-filled CYSTS or cavities. The cysts are lined with ENDOTHELIAL CELLS; the cavities lined with hepatic parenchymal cells (HEPATOCYTES). Peliosis hepatis has been associated with use of anabolic steroids (ANABOLIC AGENTS) and certain drugs.	MESH:D008107|MESH:D014652	C06.552.802|C14.907.609	C06.552|C14.907	Hepatis, Peliosis	Cardiovascular disease|Digestive system disease
Pelizaeus-Merzbacher like brain sclerosis	MESH:C536318			MESH:D002549	C10.114.375.112/C536318|C10.228.140.400/C536318|C10.228.140.695.562.112/C536318|C10.314.350.112/C536318|C20.111.258.250.175/C536318	C10.114.375.112|C10.228.140.400|C10.228.140.695.562.112|C10.314.350.112|C20.111.258.250.175	Cerebral sclerosis similar to Pelizaeus-Merzbacher disease	Immune system disease|Nervous system disease
Pelizaeus-Merzbacher-like disease, autosomal recessive, 2	MESH:C536319			MESH:D002549	C10.114.375.112/C536319|C10.228.140.400/C536319|C10.228.140.695.562.112/C536319|C10.314.350.112/C536319|C20.111.258.250.175/C536319	C10.114.375.112|C10.228.140.400|C10.228.140.695.562.112|C10.314.350.112|C20.111.258.250.175	Leukodystrophy, Hypomyelinating, 3|Perinatal Sudanophilic leukodystrophy	Immune system disease|Nervous system disease
Pelvic Infection	MESH:D034161		Infection involving the tissues or organs in the PELVIS.	MESH:D007239	C01.635	C01	Infection, Pelvic|Infections, Pelvic|Pelvic Infections	
Pelvic Inflammatory Disease	MESH:D000292	DO:DOID:1003	A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.	MESH:D000291|MESH:D034161	C01.635.500|C12.050.351.500.056.750|C12.100.250.056.750	C01.635|C12.050.351.500.056|C12.100.250.056	Adnexitis|Disease, Inflammatory Pelvic|Disease, Pelvic Inflammatory|Diseases, Inflammatory Pelvic|Diseases, Pelvic Inflammatory|Inflammatory Disease, Pelvic|Inflammatory Diseases, Pelvic|Inflammatory Pelvic Disease|Inflammatory Pelvic Diseases|Pelvic Disease, Inflammatory|Pelvic Diseases, Inflammatory|Pelvic Inflammatory Diseases	Urogenital disease (female)
Pelvic lipomatosis	MESH:C535549	DO:DOID:3927		MESH:D001745|MESH:D008068	C12.050.351.968.829/C535549|C12.200.777.829/C535549|C12.950.829/C535549|C17.800.463/C535549|C18.452.584.718/C535549	C12.050.351.968.829|C12.200.777.829|C12.950.829|C17.800.463|C18.452.584.718		Metabolic disease|Skin disease|Urogenital disease (female)|Urogenital disease (male)
Pelvic Lipomatosis with Crossed Renal Ectopia	MESH:C566812			MESH:D008068	C17.800.463/C566812|C18.452.584.718/C566812	C17.800.463|C18.452.584.718		Metabolic disease|Skin disease
Pelvic Neoplasms	MESH:D010386		Tumors or cancer of the pelvic region.	MESH:D009371	C04.588.699	C04.588	Cancer of Pelvis|Cancer of the Pelvis|Cancer, Pelvic|Cancer, Pelvis|Cancers, Pelvic|Cancers, Pelvis|Neoplasm, Pelvic|Neoplasm, Pelvis|Neoplasms of Pelvis|Neoplasms, Pelvic|Neoplasms, Pelvis|Pelvic Cancer|Pelvic Cancers|Pelvic Neoplasm|Pelvis Cancer|Pelvis Cancers|Pelvis Neoplasm|Pelvis Neoplasms	Cancer
Pelviscapular dysplasia	MESH:C535550			MESH:D004413	C05.116.099.370/C535550	C05.116.099.370	Cousin Syndrome|Craniofacial Dysmorphism, Hypoplasia of Scapula and Pelvis, and Short Stature|Pelvic shoulder dysplasia	Musculoskeletal disease
Pemphigoid, Benign Mucous Membrane	MESH:D010390	DO:DOID:11656	A chronic blistering disease with predilection for mucous membranes and less frequently the skin, and with a tendency to scarring. It is sometimes called ocular pemphigoid because of conjunctival mucous membrane involvement.	MESH:D003229|MESH:D012872	C11.187.482|C17.800.865.670	C11.187|C17.800.865	Benign Mucosal Pemphigoid|Benign Mucosal Pemphigoids|Benign Mucous Membrane Pemphigoid|Cicatricial Pemphigoid|Cicatricial Pemphigoid, Ocular|Cicatricial Pemphigoids, Ocular|Mucosal Pemphigoid, Benign|Mucosal Pemphigoids, Benign|Mucous Membrane Pemphigoid, Benign|Ocular Cicatricial Pemphigoid|Ocular Cicatricial Pemphigoids|Pemphigoid, Benign Mucosal|Pemphigoid, Cicatricial|Pemphigoid, Ocular Cicatricial|Pemphigoids, Benign Mucosal|Pemphigoids, Ocular Cicatricial	Eye disease|Skin disease
Pendred syndrome	MESH:C536648	DO:DOID:0060744|OMIM:274600		MESH:D006044|MESH:D006319	C09.218.458.341.887/C536648|C10.597.751.418.341.887/C536648|C19.874.283.501/C536648|C23.888.592.763.393.341.887/C536648	C09.218.458.341.887|C10.597.751.418.341.887|C19.874.283.501|C23.888.592.763.393.341.887	Autosomal Recessive Sensorineural Hearing Impairment and Goiter|Deafness with goiter|Goiter-deafness syndrome|Hypothyroidism, Congenital, Due To Dyshormonogenesis, 2B|PDS|Pendred's Syndrome|TDH2B|Thyroid Dyshormonogenesis 2B|Thyroid Hormonogenesis, Genetic Defect In, 2B	Ear-nose-throat disease|Endocrine system disease|Nervous system disease|Signs and symptoms
Penile Induration	MESH:D010411	DO:DOID:8616	A condition characterized by hardening of the PENIS due to the formation of fibrous plaques on the dorsolateral aspect of the PENIS, usually involving the membrane (tunica albuginea) surrounding the erectile tissue (corpus cavernosum penis). This may eventually cause a painful deformity of the shaft or constriction of the urethra, or both.	MESH:D003240|MESH:D010409	C12.100.500.494.508|C12.200.294.494.508|C17.300.715	C12.100.500.494|C12.200.294.494|C17.300	Cavernitides, Fibrous|Cavernitis, Fibrous|Fibromatosis, Penile|Fibrous Cavernitides|Fibrous Cavernitis|Penile Fibromatosis|Peyronie Disease|Peyronie's Disease|Peyronies Disease|Plastic Induration of the Penis	Connective tissue disease|Urogenital disease (male)
Penile Neoplasms	MESH:D010412	DO:DOID:11615|DO:DOID:11624	Cancers or tumors of the PENIS or of its component tissues.	MESH:D005834|MESH:D010409	C04.588.945.440.715|C12.100.500.260.500|C12.100.500.494.591|C12.200.294.260.500|C12.200.294.494.591|C12.200.758.409.500|C12.900.619.500	C04.588.945.440|C12.100.500.260|C12.100.500.494|C12.200.294.260|C12.200.294.494|C12.200.758.409|C12.900.619	Cancer of Penis|Cancer of the Penis|Cancer, Penile|Cancer, Penis|Cancers, Penile|Cancers, Penis|Neoplasm, Penile|Neoplasm, Penis|Neoplasms, Penile|Neoplasms, Penis|Penile Cancer|Penile Cancers|Penile Neoplasm|Penis Cancer|Penis Cancers|Penis Neoplasm|Penis Neoplasms	Cancer|Urogenital disease (male)
Peptic Ulcer Hemorrhage	MESH:D010438		Bleeding from a PEPTIC ULCER that can be located in any segment of the GASTROINTESTINAL TRACT.	MESH:D006471	C06.405.227.700|C23.550.414.788.700	C06.405.227|C23.550.414.788	Hemorrhage, Peptic Ulcer|Peptic Ulcer Hemorrhages|Ulcer Hemorrhage, Peptic	Digestive system disease|Pathology (process)
Perceptual Disorders	MESH:D010468		Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.	MESH:D019954	C10.597.606.762|C23.888.592.604.764	C10.597.606|C23.888.592.604	Discrimination Disorder, Somatosensory|Discrimination Disorders, Somatosensory|Hemisensory Neglect|Hemisensory Neglects|Hemispatial Neglect|Hemispatial Neglects|Neglect, Hemisensory|Neglect, Hemispatial|Neglect, Sensory|Neglects, Hemisensory|Perceptual Disorder|Sensory Neglect|Sensory Neglects|Somatosensory Discrimination Disorder|Somatosensory Discrimination Disorders	Nervous system disease|Signs and symptoms
Periarthritis	MESH:D010489	DO:DOID:2964	Inflammation of the tissues around a joint. (Dorland, 27th ed)	MESH:D001168|MESH:D002062	C05.550.114.678|C05.550.251.595	C05.550.114|C05.550.251	Periarthritides	Musculoskeletal disease
Pericardial Effusion	MESH:D010490	DO:DOID:11482|DO:DOID:118	Fluid accumulation within the PERICARDIUM. Serous effusions are associated with pericardial diseases. Hemopericardium is associated with trauma. Lipid-containing effusion (chylopericardium) results from leakage of THORACIC DUCT. Severe cases can lead to CARDIAC TAMPONADE.	MESH:D006331	C14.280.695	C14.280	Chylopericardium|Chylopericardiums|Effusion, Pericardial|Effusions, Pericardial|Hemopericardium|Pericardial Effusions	Cardiovascular disease
Pericardial Effusion, Chronic	MESH:C564895			MESH:D010490|MESH:D010493	C14.280.695/C564895|C14.280.720/C564895	C14.280.695|C14.280.720	Cholesterol Pericarditis	Cardiovascular disease
Pericarditis	MESH:D010493	DO:DOID:1787	Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS.	MESH:D006331	C14.280.720	C14.280	Pleuropericarditis	Cardiovascular disease
Pericarditis, Constrictive	MESH:D010494	DO:DOID:11481	Inflammation of the PERICARDIUM that is characterized by the fibrous scarring and adhesion of both serous layers, the VISCERAL PERICARDIUM and the PARIETAL PERICARDIUM leading to the loss of pericardial cavity. The thickened pericardium severely restricts cardiac filling. Clinical signs include FATIGUE, muscle wasting, and WEIGHT LOSS.	MESH:D010493	C14.280.720.595	C14.280.720	Constrictive Pericarditides|Constrictive Pericarditis|Heart Pick's Disease|Pericarditides, Constrictive|Pick Disease, Heart|Pick Disease of Heart|Picks Disease, Heart|Pick's Disease of Heart	Cardiovascular disease
Perimeningeal Infections	MESH:D020819		Infectious processes, including abscesses, effusions, and empyemas which occur in the epidural or subdural spaces surrounding the brain and spinal cord.	MESH:D002494	C01.207.709|C10.228.228.709	C01.207|C10.228.228	Infection, Parameningeal|Infection, Perimeningeal|Infections, Parameningeal|Infections, Perimeningeal|Parameningeal Infection|Parameningeal Infections|Perimeningeal Infection	Nervous system disease
Periodontal Cyst	MESH:D010509		An epithelium-lined sac containing fluid; usually found at the apex of a pulp-involved tooth. The lateral type occurs less frequently along the side of the root.	MESH:D009807|MESH:D010510	C04.182.089.530.690.790|C05.500.470.690.790|C07.320.450.670.513|C07.465.714.470	C04.182.089.530.690|C05.500.470.690|C07.320.450.670|C07.465.714	Cyst, Dental Root|Cyst, Dentoalveolar|Cyst, Lateral|Cyst, Periodontal|Cysts, Dental Root|Cysts, Dentoalveolar|Cysts, Lateral|Cysts, Periodontal|Dental Root Cyst|Dental Root Cysts|Dentoalveolar Cyst|Dentoalveolar Cysts|Lateral Cyst|Lateral Cysts|Periodontal Cysts|Root Cyst, Dental|Root Cysts, Dental	Cancer|Mouth disease|Musculoskeletal disease
Periostitis	MESH:D010522	DO:DOID:9957	Inflammation of the periosteum. The condition is generally chronic, and is marked by tenderness and swelling of the bone and an aching pain. Acute periostitis is due to infection, is characterized by diffuse suppuration, severe pain, and constitutional symptoms, and usually results in necrosis. (Dorland, 27th ed)	MESH:D001850	C01.160.595|C05.116.165.595	C01.160|C05.116.165	Periostitides	Musculoskeletal disease
Peripheral Arterial Disease	MESH:D058729	DO:DOID:0050830	Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.	MESH:D016491|MESH:D050197	C14.907.137.126.307.500|C14.907.617.671	C14.907.137.126.307|C14.907.617	Arterial Disease, Peripheral|Arterial Diseases, Peripheral|Artery Disease, Peripheral|Artery Diseases, Peripheral|Disease, Peripheral Arterial|Disease, Peripheral Artery|Diseases, Peripheral Arterial|Diseases, Peripheral Artery|Peripheral Arterial Diseases|Peripheral Artery Disease|Peripheral Artery Diseases	Cardiovascular disease
Peripheral Arterial Occlusive Disease 1	MESH:C564658	OMIM:606787		MESH:D001157|MESH:D058729	C14.907.137.126.307.500/C564658|C14.907.137/C564658|C14.907.617.671/C564658	C14.907.137|C14.907.137.126.307.500|C14.907.617.671	PAOD1|Paod1 Peripheral Arterial Occlusive Disease 1	Cardiovascular disease
Peripheral Nerve Injuries	MESH:D059348		Injuries to the PERIPHERAL NERVES.	MESH:D010523|MESH:D020196	C10.668.829.712|C10.900.575|C26.915.650	C10.668.829|C10.900|C26.915	Nerve Injuries, Peripheral|Nerve Injury, Peripheral|Peripheral Nerve Injury	Nervous system disease|Wounds and injuries
Peripheral Nervous System Diseases	MESH:D010523		Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.	MESH:D009468	C10.668.829	C10.668	Nerve Disease, Peripheral|Nerve Diseases, Peripheral|Neuropathy, Peripheral|Peripheral Nerve Disease|Peripheral Nerve Diseases|Peripheral Nervous System Disease|Peripheral Nervous System Disorders|Peripheral Neuropathies|Peripheral Neuropathy|PNS Disease|PNS Diseases|PNS (Peripheral Nervous System) Diseases	Nervous system disease
Peripheral Nervous System Neoplasms	MESH:D010524	DO:DOID:1192	Neoplasms which arise from peripheral nerve tissue. This includes NEUROFIBROMAS; SCHWANNOMAS; GRANULAR CELL TUMORS; and malignant peripheral NERVE SHEATH NEOPLASMS. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp1750-1)	MESH:D009423|MESH:D010523	C04.588.614.596|C10.551.775|C10.668.829.725	C04.588.614|C10.551|C10.668.829	Neoplasm, Peripheral Nerve|Neoplasms, Peripheral Nerve|Nerve Neoplasm, Peripheral|Nerve Neoplasms, Peripheral|Nerve Tumor, Peripheral|Nerve Tumors, Peripheral|Peripheral Nerve Neoplasm|Peripheral Nerve Neoplasms|Peripheral Nerve Neoplasms, Benign|Peripheral Nerve Neoplasms, Malignant|Peripheral Nerve Neoplastic Infiltration|Peripheral Nerve Tumor|Peripheral Nerve Tumors|Peripheral Nervous System Benign Neoplasms|Peripheral Nervous System Malignant Neoplasms|Tumor, Peripheral Nerve|Tumors, Peripheral Nerve	Cancer|Nervous system disease
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS	OMIM:614369			MESH:D006685|MESH:D009135|MESH:D010523|MESH:D034381	C05.651/614369|C08.360.940.490/614369|C08.618.490/614369|C09.218.458.341/614369|C09.400.940.490/614369|C10.597.751.418.341/614369|C10.597.975.550/614369|C10.668.491/614369|C10.668.829/614369|C23.888.592.763.393.341/614369|C23.888.592.979.550/614369|C23.888.852.490/614369	C05.651|C08.360.940.490|C08.618.490|C09.218.458.341|C09.400.940.490|C10.597.751.418.341|C10.597.975.550|C10.668.491|C10.668.829|C23.888.592.763.393.341|C23.888.592.979.550|C23.888.852.490	PNMHH	Ear-nose-throat disease|Musculoskeletal disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Peripheral Vascular Diseases	MESH:D016491		Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.	MESH:D014652	C14.907.617	C14.907	Angiopathies, Peripheral|Angiopathy, Peripheral|Disease, Peripheral Vascular|Diseases, Peripheral Vascular|Peripheral Angiopathies|Peripheral Angiopathy|Peripheral Vascular Disease|Vascular Disease, Peripheral|Vascular Diseases, Peripheral	Cardiovascular disease
Peritoneal Fibrosis	MESH:D056627		Disorder characterized by a wide range of structural changes in PERITONEUM, resulting from fibrogenic or inflammatory processes. Peritoneal fibrosis is a common complication in patients receiving PERITONEAL DIALYSIS and contributes to its gradual decrease in efficiency.	MESH:D005355|MESH:D010532	C06.844.610|C23.550.355.625	C06.844|C23.550.355	Encapsulating Peritoneal Scleroses|Encapsulating Peritoneal Sclerosis|Fibroses, Peritoneal|Fibrosing Syndrome, Peritoneal|Fibrosing Syndromes, Peritoneal|Fibrosis, Peritoneal|Peritoneal Fibroses|Peritoneal Fibrosing Syndrome|Peritoneal Fibrosing Syndromes|Peritoneal Scleroses|Peritoneal Scleroses, Encapsulating|Peritoneal Sclerosis|Peritoneal Sclerosis, Encapsulating|Scleroses, Encapsulating Peritoneal|Scleroses, Peritoneal|Sclerosis, Encapsulating Peritoneal|Sclerosis, Peritoneal|Syndrome, Peritoneal Fibrosing|Syndromes, Peritoneal Fibrosing	Digestive system disease|Pathology (process)
Peritoneal Neoplasms	MESH:D010534		Tumors or cancer of the PERITONEUM.	MESH:D000008|MESH:D004067|MESH:D010532	C04.588.033.513|C04.588.274.780|C06.301.780|C06.844.620	C04.588.033|C04.588.274|C06.301|C06.844	Carcinomatosis, Peritoneal|Malignancy, Peritoneal Surface|Neoplasm, Peritoneal|Peritoneal Carcinomatoses|Peritoneal Carcinomatosis|Peritoneal Neoplasm|Peritoneal Surface Malignancies|Peritoneal Surface Malignancy|Surface Malignancy, Peritoneal	Cancer|Digestive system disease
Peritoneal retractile mesenteritis	MESH:C538596			MESH:D015436	C06.844.600/C538596|C17.300.710.600/C538596	C06.844.600|C17.300.710.600		Connective tissue disease|Digestive system disease
Peritonsillar Abscess	MESH:D000039		An accumulation of purulent material in the area between the PALATINE TONSIL and its capsule.	MESH:D000038|MESH:D014069	C01.748.561.750.500|C01.830.025.675|C07.550.781.750.500|C08.730.561.750.500|C09.775.649.750.500	C01.748.561.750|C01.830.025|C07.550.781.750|C08.730.561.750|C09.775.649.750	Abscesses, Peritonsillar|Abscess, Peritonsillar|Peritonsillar Abscesses	Ear-nose-throat disease|Mouth disease|Respiratory tract disease
Perivascular Epithelioid Cell Neoplasms	MESH:D054973	DO:DOID:2643	A family of mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. These cells do not have a normal anatomic homolog. (From Fletcher CDM, et. al., World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, 2002).	MESH:D018204	C04.557.450.692	C04.557.450	CCMMT|Clear Cell Myomelanocytic Tumor|Clear-Cell Myomelanocytic Tumor|Clear Cell Myomelanocytic Tumors|Clear-Cell Myomelanocytic Tumors|Clear Cell Sugar Tumor|Clear-Cell Sugar Tumor|Clear Cell Sugar Tumors|Clear-Cell Sugar Tumors|Myomelanocytic Tumor, Clear-Cell|Myomelanocytic Tumors, Clear-Cell|Neoplasms, Perivascular Epithelioid Cell|PEComa|PEComas|Perivascular Epithelioid Cell Neoplasm|Perivascular Epithelioid Cell Tumor|Perivascular Epithelioid Cell Tumors|Sugar Tumor, Clear-Cell|Sugar Tumors, Clear-Cell|Tumor, Clear-Cell Myomelanocytic|Tumor, Clear-Cell Sugar|Tumors, Clear-Cell Myomelanocytic|Tumors, Clear-Cell Sugar	Cancer
Peroneal Neuropathies	MESH:D020427	DO:DOID:4201|DO:DOID:6925	Disease involving the common PERONEAL NERVE or its branches, the deep and superficial peroneal nerves. Lesions of the deep peroneal nerve are associated with PARALYSIS of dorsiflexion of the ankle and toes and loss of sensation from the web space between the first and second toe. Lesions of the superficial peroneal nerve result in weakness or paralysis of the peroneal muscles (which evert the foot) and loss of sensation over the dorsal and lateral surface of the leg. Traumatic injury to the common peroneal nerve near the head of the FIBULA is a relatively common cause of this condition. (From Joynt, Clinical Neurology, 1995, Ch51, p31)	MESH:D020422	C10.668.829.500.600	C10.668.829.500	Common Peroneal Nerve Entrapment|Common Peroneal Neuropathies|Common Peroneal Neuropathy|Deep Peroneal Neuropathies|Deep Peroneal Neuropathy|Entrapment, Peroneal Nerve|External Popliteal Neuropathies|External Popliteal Neuropathy|Fibular Nerve Disease|Fibular Nerve Diseases|Fibular Neuropathies|Fibular Neuropathy|Foot Drop|Foot Drops|Lateral Popliteal Neuropathies|Lateral Popliteal Neuropathy|Mononeuropathy, Peroneal|Nerve Disease, Fibular|Nerve Entrapment, Peroneal|Nerve Paralysis, Peroneal|Neuropathies, Fibular|Neuropathy, Common Peroneal|Neuropathy, Deep Peroneal|Neuropathy, External Popliteal|Neuropathy, Fibular|Neuropathy, Lateral Popliteal|Neuropathy, Peroneal|Neuropathy, Superficial Peroneal|Palsy, Peroneal|Paralysis, Peroneal Nerve|Peroneal Mononeuropathies|Peroneal Mononeuropathy|Peroneal Nerve Disease|Peroneal Nerve Diseases|Peroneal Nerve Entrapment|Peroneal Nerve Entrapments|Peroneal Nerve Paralyses|Peroneal Nerve Paralysis|Peroneal Neuropathy|Peroneal Neuropathy, Deep|Peroneal Neuropathy, Superficial|Peroneal Palsies|Peroneal Palsy|Popliteal Neuropathy, External|Popliteal Neuropathy, Lateral|Superficial Peroneal Neuropathies|Superficial Peroneal Neuropathy	Nervous system disease
PERRAULT SYNDROME 3	OMIM:614129	DO:DOID:0050857		MESH:D003638	C09.218.458.341.186/614129|C10.597.751.418.341.186/614129|C23.888.592.763.393.341.186/614129	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186	DEAFNESS, AUTOSOMAL RECESSIVE 81, FORMERLY|DFNB81, FORMERLY|PRLTS3	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Perry Syndrome	MESH:C566822	DO:DOID:0060486|OMIM:168605		MESH:D007040|MESH:D020734	C08.618.846.565/C566822|C10.228.140.079.862/C566822|C10.228.662.600/C566822|C23.888.852.638/C566822	C08.618.846.565|C10.228.140.079.862|C10.228.662.600|C23.888.852.638	Parkinsonism with Alveolar Hypoventilation and Mental Depression	Nervous system disease|Respiratory tract disease|Signs and symptoms
Persistent Left Superior Vena Cava	MESH:D000083402		Finding of the SUPERIOR VENA CAVA on the left instead of the usual right side of the ASCENDING AORTA. In bilateral superior vena cava it is found on both sides.	MESH:D054079	C14.240.850.930|C16.131.240.850.902	C14.240.850|C16.131.240.850	Bilateral Superior Caval Veins|Bilateral Superior Vena Cava|Bilateral SVC|Left Sided Superior Vena Cava|Left-Sided Superior Vena Cava|LSVC, Persistent|Persistent LSVC|PLSVC|Superior Vena Caval Duplication|SVC, Bilateral|SVC Duplication|SVC Duplications	Cardiovascular disease|Congenital abnormality
Persistent Polyclonal B-Cell Lymphocytosis	MESH:C564707	OMIM:606445		MESH:D008218	C15.378.553.475.604/C564707	C15.378.553.475.604	PPBL	Blood disease
Persistent Vegetative State	MESH:D018458		Vegetative state refers to the neurocognitive status of individuals with severe brain damage, in whom physiologic functions (sleep-wake cycles, autonomic control, and breathing) persist, but awareness (including all cognitive function and emotion) is abolished.	MESH:D001925|MESH:D014474	C10.228.140.140.627|C10.597.606.358.800.400|C23.888.592.604.359.800.400	C10.228.140.140|C10.597.606.358.800|C23.888.592.604.359.800	Minimally Conscious State|Minimally Conscious States|Permanent Vegetative State|Permanent Vegetative States|Persistent Unawareness State|Persistent Unawareness States|Persistent Vegetative States|Postcomatose Unawareness State|Post Comatose Unawareness State|Post-Comatose Unawareness State|Postcomatose Unawareness States|Post-Comatose Unawareness States|Post-Traumatic Unawarenesses, Prolonged|Post-Traumatic Unawareness, Prolonged|Posttraumatic Unawareness State|Post Traumatic Unawareness State|Post-Traumatic Unawareness State|Posttraumatic Unawareness States|Post-Traumatic Unawareness States|Post Traumatic Vegetative State|Post-Traumatic Vegetative State|Post-Traumatic Vegetative States|Prolonged Post Traumatic Unawareness|Prolonged Post-Traumatic Unawareness|Prolonged Post-Traumatic Unawarenesses|PVS (Persistent Vegetative State)|PVSs (Persistent Vegetative State)|State, Minimally Conscious|State, Permanent Vegetative|State, Persistent Unawareness|State, Persistent Vegetative|State, Postcomatose Unawareness|State, Post-Comatose Unawareness|State, Posttraumatic Unawareness|State, Post-Traumatic Unawareness|State, Post-Traumatic Vegetative|States, Minimally Conscious|States, Permanent Vegetative|States, Persistent Unawareness|States, Persistent Vegetative|States, Postcomatose Unawareness|States, Post-Comatose Unawareness|States, Posttraumatic Unawareness|States, Post-Traumatic Unawareness|States, Post-Traumatic Vegetative|States, Transient Vegetative|States, Vegetative|State, Transient Vegetative|State, Vegetative|Transient Vegetative State|Transient Vegetative States|Unawarenesses, Prolonged Post-Traumatic|Unawareness, Prolonged Post-Traumatic|Unawareness State, Persistent|Unawareness State, Postcomatose|Unawareness State, Post-Comatose|Unawareness State, Posttraumatic|Unawareness State, Post-Traumatic|Unawareness States, Persistent|Unawareness States, Postcomatose|Unawareness States, Post-Comatose|Unawareness States, Posttraumatic|Unawareness States, Post-Traumatic|Vegetative State|Vegetative State, Permanent|Vegetative State, Persistent|Vegetative State, Post-Traumatic|Vegetative States|Vegetative States, Permanent|Vegetative States, Persistent|Vegetative States, Post-Traumatic|Vegetative States, Transient|Vegetative State, Transient	Nervous system disease|Signs and symptoms
Pestivirus Infections	MESH:D018182		Infections with viruses of the genus PESTIVIRUS, family FLAVIVIRIDAE.	MESH:D018178	C01.925.782.350.675	C01.925.782.350	Infection, Pestivirus|Infections, Pestivirus|Pestivirus Infection	Viral disease
Peters anomaly with cataract	MESH:C537885			MESH:D002386|MESH:D005901	C11.510.245/C537885|C11.525.381/C537885	C11.510.245|C11.525.381		Eye disease
Petrositis	MESH:D059270	DO:DOID:10755	Inflammation of PETROUS BONE.	MESH:D010019|MESH:D010033	C01.160.495.750|C05.116.165.495.500|C09.218.705.663.841	C01.160.495|C05.116.165.495|C09.218.705.663	Apicitides, Petrous|Apicitis, Petrous|Gradenigo Lannois Syndrome|Gradenigo-Lannois Syndrome|Gradenigo's Syndrome|Gradenigos Syndrome|Gradenigo Syndrome|Petrositides|Petrous Apicitides|Petrous Apicitis|Syndrome, Gradenigo|Syndrome, Gradenigo-Lannois|Syndrome, Gradenigo's	Ear-nose-throat disease|Musculoskeletal disease
Phacomatosis pigmentokeratotica	MESH:C537893			MESH:D009508|MESH:D012878	C04.557.665.560.615/C537893|C04.588.805/C537893|C17.800.882/C537893	C04.557.665.560.615|C04.588.805|C17.800.882		Cancer|Skin disease
Phagocyte Bactericidal Dysfunction	MESH:D010585	DO:DOID:3262	Disorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas.	MESH:D007153|MESH:D007960	C15.378.553.774|C20.673.774	C15.378.553|C20.673	Bactericidal Dysfunction, Phagocyte|Bactericidal Dysfunctions, Phagocyte|Dysfunction, Phagocyte Bactericidal|Dysfunctions, Phagocyte Bactericidal|Phagocyte Bactericidal Dysfunctions	Blood disease|Immune system disease
Phagocytosis, Plasma-Related Defect in	MESH:C566808			MESH:D007960	C15.378.553/C566808	C15.378.553		Blood disease
Phantom Limb	MESH:D010591		Perception of painful and nonpainful phantom sensations that occur following the complete or partial loss of a limb. The majority of individuals with an amputated extremity will experience the impression that the limb is still present, and in many cases, painful. (From Neurol Clin 1998 Nov;16(4):919-36; Brain 1998 Sep;121(Pt 9):1603-30)	MESH:D010149|MESH:D010468	C10.597.606.762.700|C23.550.767.700.500|C23.888.592.604.764.700|C23.888.592.612.832.500	C10.597.606.762|C23.550.767.700|C23.888.592.604.764|C23.888.592.612.832	Limb Pain, Phantom|Limb Pains, Phantom|Limb, Phantom|Limbs, Phantom|Pain, Phantom|Pain, Phantom Limb|Pains, Phantom|Pains, Phantom Limb|Phantom Limb Pain|Phantom Limb Pains|Phantom Limbs|Phantom Pain|Phantom Pains|Phantom Sensation|Phantom Sensations|Pseudomelia|Pseudomelias|Sensation, Phantom|Sensations, Phantom	Nervous system disease|Pathology (process)|Signs and symptoms
Pharyngeal Diseases	MESH:D010608	DO:DOID:2275	Pathological processes involving the PHARYNX.	MESH:D009057|MESH:D010038	C07.550|C09.775	C07|C09	Disease, Pharyngeal|Disease, Pharynx|Diseases of Pharynx|Diseases, Pharyngeal|Diseases, Pharynx|Pharyngeal Disease|Pharynx Disease|Pharynx Diseases	Ear-nose-throat disease|Mouth disease
Pharyngeal Neoplasms	MESH:D010610	DO:DOID:0060119	Tumors or cancer of the PHARYNX.	MESH:D010039|MESH:D010608	C04.588.443.665.710|C07.550.745|C09.647.710|C09.775.549	C04.588.443.665|C07.550|C09.647|C09.775	Cancer of Pharynx|Cancer of the Pharynx|Cancer, Pharnyx|Cancer, Pharyngeal|Cancers, Pharnyx|Cancers, Pharyngeal|Neoplasm, Pharyngeal|Neoplasm, Pharynx|Neoplasms, Pharyngeal|Neoplasms, Pharynx|Pharnyx Cancer|Pharnyx Cancers|Pharyngeal Cancer|Pharyngeal Cancers|Pharyngeal Neoplasm|Pharynx Cancer|Pharynx Cancers|Pharynx Neoplasm|Pharynx Neoplasms	Cancer|Ear-nose-throat disease|Mouth disease
Pharyngitis	MESH:D010612	DO:DOID:2275	Inflammation of the throat (PHARYNX).	MESH:D010608|MESH:D012141	C01.748.561|C07.550.781|C08.730.561|C09.775.649	C01.748|C07.550|C08.730|C09.775	Pharyngitides|Sore Throat|Sore Throats|Throat, Sore	Ear-nose-throat disease|Mouth disease|Respiratory tract disease
Pheochromocytoma	MESH:D010673	DO:DOID:0050771|OMIM:171300	A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)	MESH:D010235	C04.557.465.625.650.700.725|C04.557.580.625.650.700.725	C04.557.465.625.650.700|C04.557.580.625.650.700	Extra-Adrenal Pheochromocytoma|Extra-Adrenal Pheochromocytomas|Pheochromocytoma, Extra Adrenal|Pheochromocytoma, Extra-Adrenal|Pheochromocytomas|Pheochromocytomas, Extra-Adrenal|PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	Cancer
Pheochromocytoma Islet Cell Tumor Syndrome	MESH:C566807			MESH:D010190|MESH:D010673	C04.557.465.625.650.700.725/C566807|C04.557.580.625.650.700.725/C566807|C04.588.274.761/C566807|C04.588.322.475/C566807|C06.301.761/C566807|C06.689.667/C566807|C19.344.421/C566807	C04.557.465.625.650.700.725|C04.557.580.625.650.700.725|C04.588.274.761|C04.588.322.475|C06.301.761|C06.689.667|C19.344.421		Cancer|Digestive system disease|Endocrine system disease
Phlebitis	MESH:D010689	DO:DOID:864	Inflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS).	MESH:D014657|MESH:D016491	C14.907.617.718|C14.907.940.740	C14.907.617|C14.907.940	Periphlebitides|Periphlebitis|Phlebitides	Cardiovascular disease
Phlebotomus Fever	MESH:D010217	DO:DOID:11360	Influenza-like febrile viral disease caused by several members of the BUNYAVIRIDAE family and transmitted mostly by the bloodsucking sandfly Phlebotomus papatasii.	MESH:D001102|MESH:D002044	C01.920.500.700|C01.925.081.700|C01.925.782.147.700	C01.920.500|C01.925.081|C01.925.782.147	Pappataci Fever|Pappataci Fevers|Phlebotomus Fevers|Sandfly Fever|Sandfly Fevers	Viral disease
Phosphorus Metabolism Disorders	MESH:D010760	DO:DOID:2485	Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.	MESH:D008659	C18.452.750	C18.452	Disorder, Phosphorus Metabolism|Disorders, Phosphorus Metabolism|Metabolism Disorder, Phosphorus|Metabolism Disorders, Phosphorus|Phosphorus Metabolism Disorder	Metabolic disease
PHOTOPAROXYSMAL RESPONSE 1	OMIM:132100	DO:DOID:0060281		MESH:D010787	C17.800.600/132100	C17.800.600	EPILEPSY, PHOTOGENIC|PHOTOCONVULSIVE REACTION|PHOTOSENSITIVITY|PPR|PPR1	Skin disease
PHOTOPAROXYSMAL RESPONSE 2	OMIM:609572	DO:DOID:0060281		MESH:D004829|MESH:D010787	C10.228.140.490.375/609572|C17.800.600/609572	C10.228.140.490.375|C17.800.600	PHOTOPAROXYSMAL RESPONSE WITH OR WITHOUT IDIOPATHIC GENERALIZED EPILEPSY|PPR2	Nervous system disease|Skin disease
Photoparoxysmal Response 3	MESH:C563695	OMIM:609573		MESH:D004831|MESH:D010787	C10.228.140.490.375.130/C563695|C10.228.140.490.493.063/C563695|C17.800.600/C563695	C10.228.140.490.375.130|C10.228.140.490.493.063|C17.800.600	Photoparoxysmal Response With Or Without Myoclonic Epilepsy|PPR3	Nervous system disease|Skin disease
Photophobia	MESH:D020795		Abnormal sensitivity to light. This may occur as a manifestation of EYE DISEASES; MIGRAINE; SUBARACHNOID HEMORRHAGE; MENINGITIS; and other disorders. Photophobia may also occur in association with DEPRESSION and other MENTAL DISORDERS.	MESH:D014786	C10.597.751.941.661|C11.966.741|C23.888.592.763.941.661	C10.597.751.941|C11.966|C23.888.592.763.941	Light Sensitivities|Light Sensitivity|Photophobias|Sensitivities, Light|Sensitivity, Light	Eye disease|Nervous system disease|Signs and symptoms
Photosensitivity Disorders	MESH:D010787	DO:DOID:3159	Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.	MESH:D012871	C17.800.600	C17.800	Actinic Dermatitides|Actinic Dermatitides, Chronic|Actinic Dermatitis|Actinic Dermatitis, Chronic|Actinic Reticuloid Syndrome|Actinic Reticuloid Syndromes|Chronic Actinic Dermatitides|Chronic Actinic Dermatitis|Dermatitides, Actinic|Dermatitides, Chronic Actinic|Dermatitis, Actinic|Dermatitis, Chronic Actinic|Disorder, Photosensitivity|Disorders, Photosensitivity|Photodermatitides|Photodermatitis|Photosensitivity Disorder|Photosensitization|Reticuloid Syndrome, Actinic|Reticuloid Syndromes, Actinic|Syndrome, Actinic Reticuloid|Syndromes, Actinic Reticuloid	Skin disease
Phyllodes Tumor	MESH:D003557	DO:DOID:1631|DO:DOID:3016	A type of connective tissue neoplasm typically arising from intralobular stroma of the breast. It is characterized by the rapid enlargement of an asymmetric firm mobile mass. Histologically, its leaf-like stromal clefts are lined by EPITHELIAL CELLS. Rare phyllodes tumor of the prostate is also known.	MESH:D012509	C04.557.450.795.650	C04.557.450.795	Cystosarcoma Phyllodes|Cystosarcoma Phyllodes, Malignant|Cystosarcoma Phylloides|Malignant Cystosarcoma Phyllodes|Phyllodes Tumors|Tumor, Phyllodes|Tumors, Phyllodes	Cancer
Phyllodes Tumor of the Prostate	MESH:C549759	DO:DOID:10289		MESH:D003557|MESH:D011471	C04.557.450.795.650/C549759|C04.588.945.440.770/C549759|C12.100.500.260.750/C549759|C12.100.500.565.625/C549759|C12.200.294.260.750/C549759|C12.200.294.565.625/C549759|C12.200.758.409.750/C549759|C12.900.619.750/C549759	C04.557.450.795.650|C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	Malignant Phyllodes Tumor of Prostate	Cancer|Urogenital disease (male)
PICA syndrome	MESH:C538664			MESH:D014854	C10.228.140.300.150.477.100.500/C538664|C10.228.140.300.775.200.100.500/C538664|C14.907.253.092.477.100.500/C538664|C14.907.253.855.200.100.500/C538664|C23.550.513.355.250.100.500/C538664|C23.550.717.489.250.100.500/C538664	C10.228.140.300.150.477.100.500|C10.228.140.300.775.200.100.500|C14.907.253.092.477.100.500|C14.907.253.855.200.100.500|C23.550.513.355.250.100.500|C23.550.717.489.250.100.500	Vertebral artery syndrome	Cardiovascular disease|Nervous system disease|Pathology (process)
Picornaviridae Infections	MESH:D010850		Virus diseases caused by the PICORNAVIRIDAE.	MESH:D012327	C01.925.782.687	C01.925.782	Infection, Picornaviridae|Infection, Picornavirus|Infections, Picornaviridae|Infections, Picornavirus|Picornaviridae Infection|Picornavirus Infection|Picornavirus Infections	Viral disease
Piepkorn Karp Hickok syndrome	MESH:C535774			MESH:D000015|MESH:D002114|MESH:D002972|MESH:D003398|MESH:D013576|MESH:D014564|MESH:D018376	C05.116.099.370.894.232/C535774|C05.116.099.370.894.819/C535774|C05.500.460.185/C535774|C05.660.207.240/C535774|C05.660.207.540.460.185/C535774|C05.660.585.800/C535774|C05.660.906.364/C535774|C05.660.906.819/C535774|C07.320.440.185/C535774|C07.465.525.185/C535774|C07.650.500.460.185/C535774|C07.650.525.185/C535774|C12.050.351.875/C535774|C12.200.706/C535774|C12.800/C535774|C14.240/C535774|C16.131.077/C535774|C16.131.240/C535774|C16.131.621.207.240/C535774|C16.131.621.207.540.460.185/C535774|C16.131.621.585.800/C535774|C16.131.621.906.364/C535774|C16.131.621.906.819/C535774|C16.131.850.500.460.185/C535774|C16.131.850.525.185/C535774|C16.131.939/C535774|C18.452.174.130/C535774	C05.116.099.370.894.232|C05.116.099.370.894.819|C05.500.460.185|C05.660.207.240|C05.660.207.540.460.185|C05.660.585.800|C05.660.906.364|C05.660.906.819|C07.320.440.185|C07.465.525.185|C07.650.500.460.185|C07.650.525.185|C12.050.351.875|C12.200.706|C12.800|C14.240|C16.131.077|C16.131.240|C16.131.621.207.240|C16.131.621.207.540.460.185|C16.131.621.585.800|C16.131.621.906.364|C16.131.621.906.819|C16.131.850.500.460.185|C16.131.850.525.185|C16.131.939|C18.452.174.130		Cardiovascular disease|Congenital abnormality|Metabolic disease|Mouth disease|Musculoskeletal disease|Urogenital disease (female)|Urogenital disease (male)
Pigmentation Disorders	MESH:D010859	DO:DOID:3156	Diseases affecting PIGMENTATION, including SKIN PIGMENTATION.	MESH:D010335|MESH:D012871	C17.800.621|C23.550.755	C17.800|C23.550	Disease, Schamberg|Disease, Schamberg's|Disorder, Pigmentation|Disorders, Pigmentation|Incontinentia Pigmenti Achromians|Ito Syndrome|Pigmentation Disorder|Schamberg Disease|Schamberg's Disease|Schambergs Disease|Syndrome, Ito	Pathology (process)|Skin disease
Pigmented purpuric eruption	MESH:C537186			MESH:D010859|MESH:D011693	C15.378.100.802/C537186|C17.800.621/C537186|C23.550.414.950/C537186|C23.550.755/C537186|C23.888.885.687/C537186	C15.378.100.802|C17.800.621|C23.550.414.950|C23.550.755|C23.888.885.687	Familial pigmented purpuric eruption|Familial Schamberg's disease|Schamberg purpura	Blood disease|Pathology (process)|Signs and symptoms|Skin disease
Pili annulati	MESH:C537187			MESH:D006201	C17.800.329/C537187	C17.800.329	Ringed hair	Skin disease
Pili multigemini	MESH:C537188			MESH:D006201	C17.800.329/C537188	C17.800.329	Compound hairs	Skin disease
Pili Torti	MESH:C562485			MESH:D006201	C17.800.329/C562485	C17.800.329	Twisted Hair	Skin disease
Pili torti developmental delay neurological abnormalities	MESH:C537398			MESH:D006130|MESH:D006201	C17.800.329/C537398|C23.550.393/C537398	C17.800.329|C23.550.393	Pili torti and developmental delay	Pathology (process)|Skin disease
Pili torti onychodysplasia	MESH:C537399			MESH:D006201|MESH:D009264	C17.800.329/C537399|C23.300.820/C537399	C17.800.329|C23.300.820	Twisted hair with nail dysplasias	Pathology (anatomical condition)|Skin disease
Pilomatrixoma	MESH:D018296	DO:DOID:5374|OMIM:132600	A tumor composed of cells resembling those of the hair matrix, which undergo 'mummification' and may calcify. It is a relatively uncommon tumor, which may occur at any age from infancy. The majority of patients are under 20, and females are affected more than males. The lesion is usually a solitary deep dermal or subcutaneous tumor 3-30 mm in diameter, situated in the head, neck, or upper extremity. (From Rook et al., Textbook of Dermatology, 4th ed, p2401)	MESH:D018295	C04.557.470.565.625	C04.557.470.565	Benign Pilomatricoma|Benign Pilomatrixoma|Calcifying Epithelioma of Malherbe|Epithelioma Calcificans Of Malherbe|Malherbe Calcifying Epithelioma|Pilomatricoma|Pilomatricoma, Benign|Pilomatrixoma, Benign|PTR	Cancer
Pilonidal Sinus	MESH:D010864		A hair-containing cyst or sinus, occurring chiefly in the coccygeal region.	MESH:D003560	C04.182.710	C04.182	Cyst, Pilonidal|Cysts, Pilonidal|Pilonidal Cyst|Pilonidal Cysts|Sinus, Pilonidal	Cancer
Pilotto syndrome	MESH:C537400			MESH:D000015|MESH:D002971|MESH:D002972|MESH:D006130|MESH:D006330|MESH:D008607|MESH:D012600	C05.116.900.800.875/C537400|C05.500.460.185/C537400|C05.660.207.540.460.185/C537400|C07.320.440.185/C537400|C07.465.409.225/C537400|C07.465.525.164/C537400|C07.465.525.185/C537400|C07.650.500.460.185/C537400|C07.650.525.164/C537400|C07.650.525.185/C537400|C10.597.606.360/C537400|C14.240.400/C537400|C14.280.400/C537400|C16.131.077/C537400|C16.131.240.400/C537400|C16.131.621.207.540.460.185/C537400|C16.131.850.500.460.185/C537400|C16.131.850.525.164/C537400|C16.131.850.525.185/C537400|C23.550.393/C537400|C23.888.592.604.646/C537400|F03.625.539/C537400	C05.116.900.800.875|C05.500.460.185|C05.660.207.540.460.185|C07.320.440.185|C07.465.409.225|C07.465.525.164|C07.465.525.185|C07.650.500.460.185|C07.650.525.164|C07.650.525.185|C10.597.606.360|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.207.540.460.185|C16.131.850.500.460.185|C16.131.850.525.164|C16.131.850.525.185|C23.550.393|C23.888.592.604.646|F03.625.539	Cleft lip and palate, congenital heart disease, scoliosis, short stature, and mental retardation	Cardiovascular disease|Congenital abnormality|Mental disorder|Mouth disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Pinealoma	MESH:D010871	DO:DOID:1664|DO:DOID:5032	Neoplasms which originate from pineal parenchymal cells that tend to enlarge the gland and be locally invasive. The two major forms are pineocytoma and the more malignant pineoblastoma. Pineocytomas have moderate cellularity and tend to form rosette patterns. Pineoblastomas are highly cellular tumors containing small, poorly differentiated cells. These tumors occasionally seed the neuroaxis or cause obstructive HYDROCEPHALUS or Parinaud's syndrome. GERMINOMA; CARCINOMA, EMBRYONAL; GLIOMA; and other neoplasms may arise in the pineal region with germinoma being the most common pineal region tumor. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2064; Adams et al., Principles of Neurology, 6th ed, p670)	MESH:D001932|MESH:D018302	C04.557.465.625.600.657|C04.557.470.670.657|C04.557.580.625.600.657|C04.588.614.250.195.766|C10.228.140.211.788|C10.551.240.250.625	C04.557.465.625.600|C04.557.470.670|C04.557.580.625.600|C04.588.614.250.195|C10.228.140.211|C10.551.240.250	Mixed Pineocytoma Pineoblastoma|Mixed Pineocytoma-Pineoblastoma|Mixed Pineocytoma-Pineoblastomas|Neoplasm, Pineal|Neoplasms, Pineal|Pineal Gland Tumor|Pineal Gland Tumors|Pineal Neoplasm|Pineal Neoplasms|Pinealocytoma|Pinealocytomas|Pinealomas|Pineal Parenchymal Tumor|Pineal Parenchymal Tumors|Pineal Tumor|Pineal Tumors|Pineoblastoma|Pineoblastomas|Pineocytoma|Pineocytoma-Pineoblastoma, Mixed|Pineocytoma-Pineoblastomas, Mixed|Pineocytomas|Tumor, Pineal|Tumor, Pineal Gland|Tumor, Pineal Parenchymal|Tumors, Pineal|Tumors, Pineal Gland|Tumors, Pineal Parenchymal	Cancer|Nervous system disease
Pineal Teratoma	MESH:C537401			MESH:D010871|MESH:D013724	C04.557.465.625.600.657/C537401|C04.557.465.910/C537401|C04.557.470.670.657/C537401|C04.557.580.625.600.657/C537401|C04.588.614.250.195.766/C537401|C10.228.140.211.788/C537401|C10.551.240.250.625/C537401	C04.557.465.625.600.657|C04.557.465.910|C04.557.470.670.657|C04.557.580.625.600.657|C04.588.614.250.195.766|C10.228.140.211.788|C10.551.240.250.625	Teratoma, Pineal	Cancer|Nervous system disease
Pinguecula	MESH:D059407	DO:DOID:11029	A yellowish thickened lesion on the conjunctiva near the CORNEA representing a benign degenerative change in the CONJUNCTIVA caused by the leakage and deposition of certain blood proteins through the permeable capillaries near the LIMBUS.	MESH:D003229	C11.187.631	C11.187	Pingueculas	Eye disease
Piriformis Muscle Syndrome	MESH:D055958		A chronic PELVIC PAIN characterized by pain deep in the buttock that may radiate to posterior aspects of the leg. It is caused by the piriformis muscle compressing or irritating the SCIATIC NERVE due to trauma, hypertrophy, inflammation or anatomic variations.	MESH:D009408|MESH:D009437|MESH:D017699|MESH:D020426	C10.668.829.500.675.399|C10.668.829.550.500|C10.668.829.600.675|C23.888.592.612.664.675|C23.888.592.612.944.750	C10.668.829.500.675|C10.668.829.550|C10.668.829.600|C23.888.592.612.664|C23.888.592.612.944	Muscle Syndrome, Piriformis|Muscle Syndromes, Piriformis|Piriformis Muscle Syndromes|Piriformis syndrome|Piriformis syndromes|syndrome, Piriformis|Syndrome, Piriformis Muscle|syndromes, Piriformis|Syndromes, Piriformis Muscle	Nervous system disease|Signs and symptoms
Pituitary ACTH Hypersecretion	MESH:D047748	DO:DOID:3946	A disease of the PITUITARY GLAND characterized by the excess amount of ADRENOCORTICOTROPIC HORMONE secreted. This leads to hypersecretion of cortisol (HYDROCORTISONE) by the ADRENAL GLANDS resulting in CUSHING SYNDROME.	MESH:D006964	C10.228.140.617.738.250.725|C19.700.355.800	C10.228.140.617.738.250|C19.700.355	ACTH Hypersecretion, Pituitary|Adrenocorticotropic Hormone, Inappropriate Secretion|Cushing Disease|Cushing Disease, Pituitary|Cushing Diseases, Pituitary|Cushing's Disease|Cushing Syndrome, Pituitary|Cushing Syndrome, Pituitary-Dependant|Disease, Cushing|Hypercortisolism Disorder, Pituitary-Dependant|Hypercortisolism, Pituitary-Dependant|Hypersecretion, Pituitary ACTH|Inappropriate ACTH Secretion Syndrome|Inappropriate Adrenocorticotropic Hormone Secretion|Pituitary Cushing Disease|Pituitary Cushing Diseases|Pituitary Cushing Syndrome|Pituitary Dependant Cushing Syndrome|Pituitary-Dependant Cushing Syndrome|Pituitary Dependant Hypercortisolism|Pituitary-Dependant Hypercortisolism|Pituitary Dependant Hypercortisolism Disorder|Pituitary-Dependant Hypercortisolism Disorder|Pituitary-Dependant Hypercortisolism Disorders|Pituitary-Dependant Hypercortisolisms	Endocrine system disease|Nervous system disease
Pituitary Adenoma, Familial Isolated	MESH:C566321			MESH:D049912	C04.557.470.035.415/C566321|C04.588.322.609.292/C566321|C10.228.140.617.738.675.299/C566321|C19.344.609.292/C566321|C19.700.734.292/C566321	C04.557.470.035.415|C04.588.322.609.292|C10.228.140.617.738.675.299|C19.344.609.292|C19.700.734.292		Cancer|Endocrine system disease|Nervous system disease
Pituitary Apoplexy	MESH:D010899	DO:DOID:1129	The sudden loss of blood supply to the PITUITARY GLAND, leading to tissue NECROSIS and loss of function (PANHYPOPITUITARISM). The most common cause is hemorrhage or INFARCTION of a PITUITARY ADENOMA. It can also result from acute hemorrhage into SELLA TURCICA due to HEAD TRAUMA; INTRACRANIAL HYPERTENSION; or other acute effects of central nervous system hemorrhage. Clinical signs include severe HEADACHE; HYPOTENSION; bilateral visual disturbances; UNCONSCIOUSNESS; and COMA.	MESH:D010900|MESH:D020300	C10.228.140.300.535.625|C10.228.140.617.738.350|C14.907.253.573.600|C19.700.725	C10.228.140.300.535|C10.228.140.617.738|C14.907.253.573|C19.700	Apoplexy, Pituitary	Cardiovascular disease|Endocrine system disease|Nervous system disease
Pituitary Diseases	MESH:D010900		Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.	MESH:D004700|MESH:D007027	C10.228.140.617.738|C19.700	C10.228.140.617|C19	Adenohypophyseal Disease|Adenohypophyseal Diseases|Anterior Pituitary Disease|Anterior Pituitary Diseases|Disease, Adenohypophyseal|Disease, Anterior Pituitary|Disease, Neurohypophyseal|Disease, Pituitary|Disease, Pituitary Gland|Disease, Posterior Pituitary|Diseases, Adenohypophyseal|Diseases, Anterior Pituitary|Diseases, Neurohypophyseal|Diseases, Pituitary|Diseases, Pituitary Gland|Diseases, Posterior Pituitary|Disorder, Hypophyseal|Disorder, Pituitary|Disorders, Hypophyseal|Disorders, Pituitary|Hypophyseal Disorder|Hypophyseal Disorders|Neurohypophyseal Disease|Neurohypophyseal Diseases|Pituitary Disease|Pituitary Disease, Anterior|Pituitary Disease, Posterior|Pituitary Diseases, Anterior|Pituitary Diseases, Posterior|Pituitary Disorder|Pituitary Disorders|Pituitary Gland Disease|Pituitary Gland Diseases|Posterior Pituitary Disease|Posterior Pituitary Diseases	Endocrine system disease|Nervous system disease
Pituitary dwarfism 1	MESH:C537404	OMIM:262400		MESH:D004393	C05.116.099.343.445/C537404|C05.116.132.358/C537404|C10.228.140.617.738.300.300/C537404|C19.297.312/C537404|C19.700.482.311/C537404	C05.116.099.343.445|C05.116.132.358|C10.228.140.617.738.300.300|C19.297.312|C19.700.482.311	Growth hormone deficiency, isolated, autosomal recessive|IGHD1A|IGHD IA|ILLIG-TYPE GROWTH HORMONE DEFICIENCY|Isolated growth hormone deficiency, type 1b|Isolated Growth Hormone Deficiency, Type IA|Nanism due to growth hormone isolated deficiency|Pituitary Dwarfism I|PRIMORDIAL DWARFISM|Sexual ateleiotic dwarfism	Endocrine system disease|Musculoskeletal disease|Nervous system disease
Pituitary Dwarfism with Large Sella Turcica	MESH:C562705			MESH:D004393	C05.116.099.343.445/C562705|C05.116.132.358/C562705|C10.228.140.617.738.300.300/C562705|C19.297.312/C562705|C19.700.482.311/C562705	C05.116.099.343.445|C05.116.132.358|C10.228.140.617.738.300.300|C19.297.312|C19.700.482.311		Endocrine system disease|Musculoskeletal disease|Nervous system disease
Pituitary Hormone Deficiency, Combined, 2	MESH:C563172	OMIM:262600		MESH:D004393	C05.116.099.343.445/C563172|C05.116.132.358/C563172|C10.228.140.617.738.300.300/C563172|C19.297.312/C563172|C19.700.482.311/C563172	C05.116.099.343.445|C05.116.132.358|C10.228.140.617.738.300.300|C19.297.312|C19.700.482.311	Ateliotic Dwarfism With Hypogonadism|CPHD2|Hanhart Dwarfism|PANHYPOPITUITARISM|Pituitary Dwarfism III	Endocrine system disease|Musculoskeletal disease|Nervous system disease
Pituitary Neoplasms	MESH:D010911	DO:DOID:1785|DO:DOID:3829|DO:DOID:4916	Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.	MESH:D004701|MESH:D007029|MESH:D010900	C04.588.322.609|C04.588.614.250.195.885.500.600|C10.228.140.211.885.500.600|C10.228.140.617.477.600|C10.228.140.617.738.675|C10.551.240.250.700.500.500|C19.344.609|C19.700.734	C04.588.322|C04.588.614.250.195.885.500|C10.228.140.211.885.500|C10.228.140.617.477|C10.228.140.617.738|C10.551.240.250.700.500|C19.344|C19.700	Adenoma, Pituitary|Adenomas, Pituitary|Cancer of Pituitary|Cancer of the Pituitary|Cancer, Pituitary|Cancers, Pituitary|Carcinoma, Pituitary|Carcinomas, Pituitary|Neoplasm, Pituitary|Neoplasms, Pituitary|Pituitary Adenoma|Pituitary Adenomas|Pituitary Cancer|Pituitary Cancers|Pituitary Carcinoma|Pituitary Carcinomas|Pituitary Neoplasm|Pituitary Tumor|Pituitary Tumors|Tumor, Pituitary|Tumors, Pituitary	Cancer|Endocrine system disease|Nervous system disease
Pityriasis	MESH:D010915		A name originally applied to a group of skin diseases characterized by the formation of fine, branny scales, but now used only with a modifier. (Dorland, 27th ed)	MESH:D017444	C17.800.859.600	C17.800.859	Pityriases	Skin disease
Pityriasis Lichenoides	MESH:D017514		A subgroup of PARAPSORIASIS itself divided into acute and chronic forms. The acute form is characterized by the abrupt onset of a generalized, reddish-brown, maculopapular eruption. Lesions may be vesicular, hemorrhagic, crusted, or necrotic. Histologically the disease is characterized by epidermal necrolysis. The chronic form shows milder skin changes with necrosis.	MESH:D010267|MESH:D010915|MESH:D017512	C17.800.859.475.650|C17.800.859.575.650|C17.800.859.600.650	C17.800.859.475|C17.800.859.575|C17.800.859.600	Acute Pityriasis Lichenoides|Chronic Pityriasis Lichenoides|Disease, Habermann|Disease, Habermann's|Disease, Mucha-Habermann|Habermann Disease|Habermann's Disease|Habermanns Disease|Mucha Habermann Disease|Mucha-Habermann Disease|Pityriasis Lichenoides, Acute|Pityriasis Lichenoides, Chronic|Pityriasis Lichenoides Chronica|Pityriasis Lichenoides et Varioliformis Acuta	Skin disease
Pityriasis Rosea	MESH:D017515	DO:DOID:8892	A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.	MESH:D010915	C17.800.859.600.675	C17.800.859.600		Skin disease
Pityriasis Rubra Pilaris	MESH:D010916	DO:DOID:9212|OMIM:173200	A chronic skin disease characterized by small follicular papules, disseminated reddish-brown scaly patches, and often, palmoplantar hyperkeratosis. The papules are about the size of a pin and topped by a horny plug.	MESH:D010915	C17.800.859.600.685	C17.800.859.600	PRP	Skin disease
Plantar Fibromatosis, Familial	MESH:C565084			MESH:D005350|MESH:D005534	C04.557.450.565.590.340/C565084|C05.360/C565084|C17.800.321/C565084	C04.557.450.565.590.340|C05.360|C17.800.321	Plantar Fibromas	Cancer|Musculoskeletal disease|Skin disease
Plant Poisoning	MESH:D010939		Poisoning by the ingestion of plants or its leaves, berries, roots or stalks. The manifestations in both humans and animals vary in severity from mild to life threatening. In animals, especially domestic animals, it is usually the result of ingesting moldy or fermented forage.	MESH:D011041	C25.723.756	C25.723	Plant Poisonings|Poisoning, Plant|Poisonings, Plant	
Plasmablastic Lymphoma	MESH:D000069293		Malignant lymphoma composed of large B lymphoid cells which have the immunophenotype of plasma cells and a predilection for the ORAL CAVITY.	MESH:D016403	C04.557.386.480.150.585.500|C15.604.515.569.480.150.585.500|C20.683.515.761.480.150.585.500	C04.557.386.480.150.585|C15.604.515.569.480.150.585|C20.683.515.761.480.150.585	Lymphoma, Plasmablastic|Lymphomas, Plasmablastic|Plasmablastic Diffuse Large B cell Lymphoma|Plasmablastic Diffuse Large B-cell Lymphoma|Plasmablastic Lymphomas|Plasmablasts Diffuse Large B cell Lymphoma|Plasmablasts Diffuse Large B-cell Lymphoma	Cancer|Immune system disease|Lymphatic disease
Plasma Cell Granuloma, Pulmonary	MESH:D016726	DO:DOID:3677	A tumor-like inflammatory lesion of the lung that is composed of PLASMA CELLS and fibrous tissue. It is also known as an inflammatory pseudotumor, often with calcification and measuring between 2 and 5 cm in diameter.	MESH:D008171	C08.381.600	C08.381	Granuloma, Plasma Cell, Pulmonary|Inflammatory Pseudotumor of Lung|Inflammatory Pseudotumor, Pulmonary|Inflammatory Pseudotumors, Pulmonary|Inflammatory Pulmonary Pseudotumor|Inflammatory Pulmonary Pseudotumors|Plasma Cell Granuloma of Lung|Pseudotumor, Inflammatory, Pulmonary|Pseudotumor, Pulmonary Inflammatory|Pulmonary Granuloma, Plasma Cell|Pulmonary Inflammatory Pseudotumor|Pulmonary Inflammatory Pseudotumors|Pulmonary Plasma Cell Granuloma|Pulmonary Pseudotumor, Inflammatory|Pulmonary Pseudotumors, Inflammatory	Respiratory tract disease
Plasma Clot Retraction Factor, Deficiency of	MESH:C564885			MESH:D001778|MESH:D001796	C15.378.100/C564885|C15.378.147/C564885	C15.378.100|C15.378.147		Blood disease
Plasmacytoma	MESH:D010954	DO:DOID:3721	Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites.	MESH:D008232|MESH:D054219	C04.557.595.600|C20.683.515.880	C04.557.595|C20.683.515	Plasma Cell Tumor|Plasma Cell Tumors|Plasmacytomas|Plasmocytoma|Plasmocytomas|Tumor, Plasma Cell|Tumors, Plasma Cell	Cancer|Immune system disease
Plasmacytoma anaplastic	MESH:C537514			MESH:D010954	C04.557.595.600/C537514|C20.683.515.880/C537514	C04.557.595.600|C20.683.515.880	Anaplastic skeletal plasmacytoma (type)|Anaplastic solitary extramedullary plasmacytoma of the cecum (type)|Extramedullary anaplastic plasmacytoma (type)	Cancer|Immune system disease
Plasminogen Activator Inhibitor-1 Deficiency	MESH:C567640	OMIM:613329		MESH:D006474	C15.378.463/C567640	C15.378.463	Hyperfibrinolysis Due To Pai1 Deficiency	Blood disease
Platelet-Activating Factor Acetylhydrolase Deficiency	MESH:C566640	OMIM:614278		MESH:D001249	C08.127.108/C566640|C08.381.495.108/C566640|C08.674.095/C566640|C20.543.480.680.095/C566640	C08.127.108|C08.381.495.108|C08.674.095|C20.543.480.680.095	PAFAD	Immune system disease|Respiratory tract disease
Platelet Aggregation, Spontaneous	MESH:C566800			MESH:D001791	C15.378.140/C566800	C15.378.140		Blood disease
Platelet Alpha-Delta Storage Pool Deficiency	MESH:C566794			MESH:D010981	C15.378.100.685/C566794|C15.378.140.735/C566794|C15.378.463.735/C566794	C15.378.100.685|C15.378.140.735|C15.378.463.735		Blood disease
Platelet Disorder, Undefined	MESH:C566799			MESH:D001791	C15.378.140/C566799	C15.378.140		Blood disease
Platelet Factor 3 Deficiency	MESH:C566798			MESH:D001791	C15.378.140/C566798	C15.378.140		Blood disease
Platelet Prostacyclin Receptor Defect	MESH:C564884			MESH:D001791	C15.378.140/C564884	C15.378.140	Vienna-Hietzing Defect	Blood disease
Platelet Receptor for Collagen, Deficiency of	MESH:C565999			MESH:D001791	C15.378.140/C565999	C15.378.140		Blood disease
Platelet Signal Processing Defect	MESH:C566796			MESH:D001791	C15.378.140/C566796	C15.378.140		Blood disease
Platelet Storage Pool Deficiency	MESH:D010981	DO:DOID:2223|OMIM:185050	Disorder characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored.	MESH:D001778|MESH:D001791|MESH:D006474	C15.378.100.685|C15.378.140.735|C15.378.463.735	C15.378.100|C15.378.140|C15.378.463	Acquired Storage Pool Disease|Deficiencies, Storage Pool|Deficiency, Platelet Storage Pool|Deficiency, Storage Pool|Familial Platelet Storage Pool Disease|Platelet Storage Pool Deficiencies|Platelet Storage Pool Disease|Storage Pool Deficiencies|Storage Pool Deficiency|Storage Pool Deficiency, Platelet|Storage Pool Platelet Disease	Blood disease
Pleoconial Myopathy with Salt Craving	MESH:C564883			MESH:D020914	C05.651.575/C564883|C10.668.491.550/C564883	C05.651.575|C10.668.491.550		Musculoskeletal disease|Nervous system disease
Pleural Diseases	MESH:D010995	DO:DOID:1532	Diseases involving the PLEURA.	MESH:D012140	C08.528	C08	Disease, Pleural|Diseases, Pleural|Pleural Disease	Respiratory tract disease
Pleural Effusion	MESH:D010996		Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.	MESH:D010995	C08.528.652	C08.528	Effusion, Pleural|Effusions, Pleural|Pleural Effusions	Respiratory tract disease
Pleural Effusion, Malignant	MESH:D016066		Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.	MESH:D010996|MESH:D010997	C04.588.894.797.640.700|C08.528.652.700|C08.528.694.700|C08.785.640.700	C04.588.894.797.640|C08.528.652|C08.528.694|C08.785.640	Effusion, Malignant Pleural|Effusions, Malignant Pleural|Malignant Pleural Effusion|Malignant Pleural Effusions|Pleural Effusions, Malignant	Cancer|Respiratory tract disease
Pleural Neoplasms	MESH:D010997	DO:DOID:5158	Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.	MESH:D010995|MESH:D012142	C04.588.894.797.640|C08.528.694|C08.785.640	C04.588.894.797|C08.528|C08.785	Neoplasm, Pleural|Neoplasms, Pleural|Pleural Neoplasm	Cancer|Respiratory tract disease
Pleurisy	MESH:D010998		INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.	MESH:D010995|MESH:D012141	C01.748.582|C08.528.735|C08.730.582	C01.748|C08.528|C08.730	Pleurisies|Pleuritides|Pleuritis	Respiratory tract disease
Pleurodynia, Epidemic	MESH:D011000	DO:DOID:10882	An acute, febrile, infectious disease generally occurring in epidemics. It is usually caused by coxsackieviruses B and sometimes by coxsackieviruses A; echoviruses; or other enteroviruses.	MESH:D003384	C01.925.782.687.359.213.737	C01.925.782.687.359.213	Bornholm Disease|Epidemic Myalgia|Epidemic Myalgias|Epidemic Pleurodynia|Epidemic Pleurodynias|Myalgia, Epidemic|Myalgias, Epidemic|Pleurodynias, Epidemic	Viral disease
Pleuropneumonia	MESH:D011001	DO:DOID:14319	Inflammation of the lung parenchyma that is associated with PLEURISY, inflammation of the PLEURA.	MESH:D010998|MESH:D011014	C01.748.582.473|C01.748.610.473|C08.381.677.473|C08.528.735.473|C08.730.582.473|C08.730.610.473	C01.748.582|C01.748.610|C08.381.677|C08.528.735|C08.730.582|C08.730.610	Pleuropneumonias	Respiratory tract disease
Pleuropulmonary blastoma	MESH:C537516	DO:DOID:4769|OMIM:601200		MESH:D018202	C04.557.435.675/C537516|C04.588.894.797.520.867/C537516	C04.557.435.675|C04.588.894.797.520.867	PPB|PPB FAMILIAL TUMOR AND DYSPLASIA SYNDROME|PPBFTDS	Cancer
Plexosarcoma	MESH:C537517			MESH:D001342|MESH:D012509|MESH:D046152	C04.557.450.565.370/C537517|C04.557.450.795/C537517|C06.301.371.308/C537517|C06.405.249.308/C537517|C10.177/C537517	C04.557.450.565.370|C04.557.450.795|C06.301.371.308|C06.405.249.308|C10.177	Gastrointestinal autonomic nerve tumor	Cancer|Digestive system disease|Nervous system disease
Pneumocephalus	MESH:D011007		Presence of air or gas within the intracranial cavity (e.g., epidural space, subdural space, intracerebral, etc.) which may result from traumatic injuries, fistulous tract formation, erosions of the skull from NEOPLASMS or infection, NEUROSURGICAL PROCEDURES, and other conditions.	MESH:D001930|MESH:D002493	C10.228.140.199.700|C10.228.806|C10.900.300.087.700|C26.915.300.200.650	C10.228|C10.228.140.199|C10.900.300.087|C26.915.300.200	Airocele, Cranial|Airoceles, Cranial|Cranial Airocele|Cranial Airoceles|Cranial Pneumocyst|Cranial Pneumocysts|Epidural Pneumocephalus|Gas, Intracranial|Intracranial Gas|Pneumocephalus, Epidural|Pneumocephalus, Pressure|Pneumocephalus, Tension|Pneumocephalus, Traumatic|Pneumocyst, Cranial|Pneumocysts, Cranial|Pressure Pneumocephalus|Tension Pneumocephalus|Traumatic Pneumocephalus	Nervous system disease|Wounds and injuries
Pneumoconiosis	MESH:D011009	DO:DOID:10316|DO:DOID:12522	A diffuse parenchymal lung disease caused by inhalation of dust and by tissue reaction to their presence. These inorganic, organic, particulate, or vaporized matters usually are inhaled by workers in their occupational environment, leading to the various forms (ASBESTOSIS; BYSSINOSIS; and others). Similar air pollution can also have deleterious effects on the general population.	MESH:D009784|MESH:D017563|MESH:D055370	C08.381.483.581|C08.381.520.702|C24.800	C08.381.483|C08.381.520|C24	Bagassosis|Pneumoconioses	Occupational disease|Respiratory tract disease
Pneumonia	MESH:D011014	DO:DOID:552	Infection of the lung often accompanied by inflammation.	MESH:D008171|MESH:D012141	C01.748.610|C08.381.677|C08.730.610	C01.748|C08.381|C08.730	Experimental Lung Inflammation|Experimental Lung Inflammations|Inflammation, Experimental Lung|Inflammation, Lung|Inflammation, Pulmonary|Inflammations, Lung|Inflammations, Pulmonary|Lobar Pneumonia|Lobar Pneumonias|Lung Inflammation|Lung Inflammation, Experimental|Lung Inflammations|Lung Inflammations, Experimental|Pneumonia, Lobar|Pneumonias|Pneumonias, Lobar|Pneumonitides|Pneumonitis|Pulmonary Inflammation|Pulmonary Inflammations	Respiratory tract disease
Pneumonia, Aspiration	MESH:D011015	DO:DOID:0050152|DO:DOID:3240	A type of lung inflammation resulting from the aspiration of food, liquid, or gastric contents into the upper RESPIRATORY TRACT.	MESH:D011014	C01.748.610.529|C08.381.677.529|C08.730.610.529	C01.748.610|C08.381.677|C08.730.610	Acid Aspiration Syndrome|Acid Aspiration Syndromes|Aspiration Pneumonia|Aspiration Pneumonias|Gastric Acid Aspiration Syndrome|Mendelson's Syndrome|Mendelsons Syndrome|Mendelson Syndrome|Pneumonias, Aspiration|Syndrome, Acid Aspiration|Syndrome, Mendelson|Syndrome, Mendelson's|Syndromes, Acid Aspiration	Respiratory tract disease
Pneumonia, Lipid	MESH:D011017	DO:DOID:3241	Pneumonia due to aspiration or inhalation of various oily or fatty substances.	MESH:D011015	C01.748.610.529.612|C08.381.677.529.612|C08.730.610.529.612	C01.748.610.529|C08.381.677.529|C08.730.610.529	Lipid Pneumonia|Lipid Pneumonias|Pneumonias, Lipid	Respiratory tract disease
Pneumonia, Necrotizing	MESH:D000071067		Severe complication of pneumonia characterized by liquefaction of lung tissue.	MESH:D011014	C01.748.610.608|C08.381.677.608|C08.730.610.608	C01.748.610|C08.381.677|C08.730.610	Necrotizing Pneumonia|Necrotizing Pneumonias|Pneumonias, Necrotizing	Respiratory tract disease
Pneumonia, Ventilator-Associated	MESH:D053717		Serious INFLAMMATION of the LUNG in patients who required the use of PULMONARY VENTILATOR. It is usually caused by bacterial CROSS INFECTION in hospitals.	MESH:D000077299	C01.248.250.500|C01.748.610.300.500|C08.381.677.300.500|C08.730.610.300.500|C23.550.291.875.500.500.500	C01.248.250|C01.748.610.300|C08.381.677.300|C08.730.610.300|C23.550.291.875.500.500	Ventilator-Associated Pneumonia	Pathology (process)|Respiratory tract disease
Pneumonia, Viral	MESH:D011024	DO:DOID:10533	Inflammation of the lung parenchyma that is caused by a viral infection.	MESH:D011014|MESH:D014777	C01.748.610.763|C01.925.705|C08.381.677.807|C08.730.610.763	C01.748.610|C01.925|C08.381.677|C08.730.610	Pneumonias, Viral|Viral Pneumonia|Viral Pneumonias	Respiratory tract disease|Viral disease
Pneumopericardium	MESH:D011026		Presence of air or gas in the space between the heart and the PERICARDIUM. The degree of respiratory distress depends on the amount of trapped air and circulation blocked in the systemic and pulmonary veins.	MESH:D006331	C14.280.763	C14.280	Pneumopericardiums	Cardiovascular disease
Pneumorrhachis	MESH:D063205		Presence of air or gas within the spinal canal cavity (EPIDURAL SPACE; or SUBARACHNOID SPACE). It may result from traumatic injuries, emphysema, infection and other conditions. It can also develop as a complication of various SURGICAL PROCEDURES (e.g., MYELOGRAPHY).	MESH:D013118	C10.228.854.583	C10.228.854	Epidural Pneumorrhachi|Epidural Pneumorrhachis|Pneumorrhachi|Pneumorrhachi, Epidural|Pneumorrhachis, Epidural|Pneumorrhachis, Subarachnoid|Pneumorrhachi, Subarachnoid|Subarachnoid Pneumorrhachi|Subarachnoid Pneumorrhachis	Nervous system disease
Pneumothorax	MESH:D011030	OMIM:173600	An accumulation of air or gas in the PLEURAL CAVITY, which may occur spontaneously or as a result of trauma or a pathological process. The gas may also be introduced deliberately during PNEUMOTHORAX, ARTIFICIAL.	MESH:D010995	C08.528.778	C08.528	Pneumothorax, Pressure|Pneumothorax, Primary Spontaneous|Pneumothorax, Spontaneous|Pneumothorax, Tension|Pressure Pneumothorax|Primary Spontaneous Pneumothorax|PSP|Spontaneous Pneumothorax|Spontaneous Pneumothorax, Primary|Tension Pneumothorax	Respiratory tract disease
Pneumovirus Infections	MESH:D018186		Infections with viruses of the genus PNEUMOVIRUS, family PARAMYXOVIRIDAE. This includes RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, an important cause of respiratory disease in humans.	MESH:D018184	C01.925.782.580.600.550	C01.925.782.580.600	Infection, Pneumovirus|Infections, Pneumovirus|Pneumovirus Infection	Viral disease
POEMS Syndrome	MESH:D016878	DO:DOID:14039	A multisystemic disorder characterized by a sensorimotor polyneuropathy (POLYNEUROPATHIES), organomegaly, endocrinopathy, monoclonal gammopathy, and pigmentary skin changes. Other clinical features which may be present include EDEMA; CACHEXIA; microangiopathic glomerulopathy; pulmonary hypertension (HYPERTENSION, PULMONARY); cutaneous necrosis; THROMBOCYTOSIS; and POLYCYTHEMIA. This disorder is frequently associated with osteosclerotic myeloma. (From Adams et al., Principles of Neurology, 6th ed, p1335; Rev Med Interne 1997;18(7):553-62)	MESH:D000015|MESH:D010265|MESH:D011115	C10.668.829.800.700|C15.378.147.780.750|C16.131.077.703|C20.683.780.750	C10.668.829.800|C15.378.147.780|C16.131.077|C20.683.780	Crow Fukase Syndrome|Crow-Fukase Syndrome|Organomegalies, Polyneuropathy|Organomegaly, Polyneuropathy|Polyneuropathy Organomegalies|Polyneuropathy Organomegaly|Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome|Syndrome, Crow-Fukase|Syndrome, POEMS|Syndrome, Takatsuki's|Takatsuki's Syndrome|Takatsuki Syndrome	Blood disease|Congenital abnormality|Immune system disease|Nervous system disease
Poikiloderma with Neutropenia	MESH:C565820	DO:DOID:0060551|OMIM:604173		MESH:D009503|MESH:D012868	C15.378.553.546.184.564/C565820|C16.131.831/C565820|C17.800.804/C565820	C15.378.553.546.184.564|C16.131.831|C17.800.804	PN|Poikiloderma with Neutropenia, Clericuzio-Type	Blood disease|Congenital abnormality|Skin disease
Poisoning	MESH:D011041		A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.	MESH:D064419	C25.723	C25	Poisonings	
Poliomyelitis	MESH:D011051	DO:DOID:4953	An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)	MESH:D004769|MESH:D009187|MESH:D009468	C01.207.618.750|C01.925.782.687.359.764|C10.228.228.618.750|C10.228.854.525.850|C10.586.750.850|C10.668.864	C01.207.618|C01.925.782.687.359|C10.228.228.618|C10.228.854.525|C10.586.750|C10.668	Acute Poliomyelitis|Acute Poliomyelitis, Epidemic|Encephalitis, Polio|Epidemic Acute Poliomyelitis|Infantile Paralysis|Infection, Poliomyelitis|Infections, Poliomyelitis|Nonpoliovirus Poliomyelitis|Paralysis, Infantile|Polio|Polio Encephalitis|Poliomyelitides, Preparalytic|Poliomyelitis, Acute|Poliomyelitis, Epidemic Acute|Poliomyelitis Infection|Poliomyelitis Infections|Poliomyelitis, Nonpoliovirus|Poliomyelitis, Preparalytic|Polios|Preparalytic Poliomyelitis	Nervous system disease|Viral disease
Poliomyelitis, Bulbar	MESH:D011052	DO:DOID:9786	A form of paralytic poliomyelitis affecting neurons of the MEDULLA OBLONGATA of the brain stem. Clinical features include impaired respiration, HYPERTENSION, alterations of vasomotor control, and dysphagia. Weakness and atrophy of the limbs and trunk due to spinal cord involvement is usually associated. (From Adams et al., Principles of Neurology, 6th ed, p765)	MESH:D011051	C01.207.618.750.500|C01.925.782.687.359.764.614|C10.228.228.618.750.500|C10.228.854.525.850.500|C10.586.750.850.500|C10.668.864.250	C01.207.618.750|C01.925.782.687.359.764|C10.228.228.618.750|C10.228.854.525.850|C10.586.750.850|C10.668.864	Bulbar Polio|Bulbar Poliomyelitis|Medullary Involvement Poliomyelitis|Polio, Bulbar|Poliomyelitis, Medullary Involvement	Nervous system disease|Viral disease
Polyarteritis Nodosa	MESH:D010488	DO:DOID:9810	A form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized ARTERIES, often with microaneurysms. It is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. Polyarteritis nodosa with lung involvement is called CHURG-STRAUSS SYNDROME.	MESH:D001167|MESH:D017445|MESH:D056647	C14.907.940.090.720|C14.907.940.897.500|C17.800.862.625	C14.907.940.090|C14.907.940.897|C17.800.862	Arteritides, Necrotizing|Arteritis, Necrotizing|Essential Polyarteritides|Essential Polyarteritis|Necrotizing Arteritides|Necrotizing Arteritis|Periarteritis Nodosa|Polyarteritides, Essential|Polyarteritis, Essential	Cardiovascular disease|Skin disease
Polyasplenia	MESH:C566862			MESH:D059446	C14.240.400.592/C566862|C14.280.400.592/C566862|C15.604.744.146/C566862|C16.131.077.401/C566862|C16.131.240.400.592/C566862	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592	Asplenia with Cardiovascular Abnormalities	Cardiovascular disease|Congenital abnormality|Lymphatic disease
Polycystic bone disease	MESH:C536324			MESH:D001845	C04.182.089/C536324|C05.116.070/C536324	C04.182.089|C05.116.070		Cancer|Musculoskeletal disease
Polycystic liver disease	MESH:C536330	OMIM:174050|OMIM:617004		MESH:D003560|MESH:D008107	C04.182/C536330|C06.552/C536330|C23.300.306/C536330	C04.182|C06.552|C23.300.306	Isolated autosomal dominant polycystic liver disease|Isolated polycystic liver disease|PCLD1|PCLD2|POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS|POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS	Cancer|Digestive system disease|Pathology (anatomical condition)
Polycystic Ovarian Disease due to 17-Ketosteroid Reductase Deficiency	MESH:C564868			MESH:D011085	C04.182.612.765/C564868|C12.050.351.500.056.630.580.765/C564868|C12.100.250.056.630.580.765/C564868|C19.391.630.580.765/C564868	C04.182.612.765|C12.050.351.500.056.630.580.765|C12.100.250.056.630.580.765|C19.391.630.580.765		Cancer|Endocrine system disease|Urogenital disease (female)
Polycystic Ovary Syndrome	MESH:D011085	DO:DOID:11612|OMIM:184700	A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.	MESH:D010048	C04.182.612.765|C12.050.351.500.056.630.580.765|C12.100.250.056.630.580.765|C19.391.630.580.765	C04.182.612|C12.050.351.500.056.630.580|C12.100.250.056.630.580|C19.391.630.580	HYPERANDROGENEMIA|Ovarian Degeneration, Sclerocystic|Ovarian Syndrome, Polycystic|Ovary, Sclerocystic|Ovary Syndrome, Polycystic|PCO|PCO1|PCOS|PCOS1|Polycystic Ovarian Syndrome|Polycystic Ovary Syndrome 1|Sclerocystic Ovarian Degeneration|Sclerocystic Ovaries|Sclerocystic Ovary|Sclerocystic Ovary Syndrome|Stein Leventhal Syndrome|Stein-Leventhal Syndrome|Syndrome, Polycystic Ovary|Syndrome, Stein-Leventhal	Cancer|Endocrine system disease|Urogenital disease (female)
Polycythemia	MESH:D011086	DO:DOID:8432	An increase in the total red cell mass of the blood. (Dorland, 27th ed)	MESH:D006402	C15.378.738	C15.378	Erythrocytoses|Erythrocytosis|Polycythemias	Blood disease
Polycythemia, primary familial and congenital	MESH:C536842	OMIM:133100		MESH:D011086	C15.378.738/C536842	C15.378.738	Benign Familial Polycythemia|Congenital Erythrocytosis|ECYT1|ECYT1 familial erythrocytosis-1|Erythrocytosis autosomal dominant benign|Erythrocytosis, Autosomal Dominant Benign|Erythrocytosis familial, 1|Erythrocytosis, Familial, 1|Familial Erythrocytosis|Familial erythrocytosis, 1|Familial Polycythemia|Hereditary Erythrocytosis|PFCP|POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL|Primary Familial Polycythemia	Blood disease
Polycythemia Vera	MESH:D011087	DO:DOID:8997|OMIM:263300	A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.	MESH:D009196|MESH:D019046	C04.588.448.200.500|C15.378.190.250.500|C15.378.190.636.753|C15.378.400.200.500	C04.588.448.200|C15.378.190.250|C15.378.190.636|C15.378.400.200	Disease, Osler-Vaquez|Erythremia|Erythremias|Osler Vaquez Disease|Osler-Vaquez Disease|Polycythemia, Primary|Polycythemia Ruba Vera|Polycythemia Ruba Veras|Polycythemia Rubra Vera|Polycythemia Rubra Veras|Polycythemias, Primary|Primary Polycythemia|Primary Polycythemias|PRV|PV|Ruba Vera, Polycythemia|Ruba Veras, Polycythemia|Vera, Polycythemia Ruba|Vera, Polycythemia Rubra|Veras, Polycythemia Ruba|Veras, Polycythemia Rubra	Blood disease|Cancer
Polyendocrinopathies, Autoimmune	MESH:D016884	DO:DOID:14040	Autoimmune diseases affecting multiple endocrine organs. Type I is characterized by childhood onset and chronic mucocutaneous candidiasis (CANDIDIASIS, CHRONIC MUCOCUTANEOUS), while type II exhibits any combination of adrenal insufficiency (ADDISON'S DISEASE), lymphocytic thyroiditis (THYROIDITIS, AUTOIMMUNE;), HYPOPARATHYROIDISM; and gonadal failure. In both types organ-specific ANTIBODIES against a variety of ENDOCRINE GLANDS have been detected. The type II syndrome differs from type I in that it is associated with HLA-A1 and B8 haplotypes, onset is usually in adulthood, and candidiasis is not present.	MESH:D001327|MESH:D004700	C19.787|C20.111.750	C19|C20.111	AIRE Deficiencies|AIRE Deficiency|APECED|APS Type 1|Autoimmune Polyendocrine Syndrome, Type 2|Autoimmune Polyendocrine Syndrome, Type II|Autoimmune Polyendocrinopathy|Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy|Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy|Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy|Autoimmune Polyendocrinopathy Syndrome Type 1|Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy|Autoimmune Polyglandular Syndrome, Type 1|Autoimmune Polyglandular Syndrome, Type 3|Autoimmune Polyglandular Syndrome Type I|Autoimmune Polyglandular Syndrome, Type I|Autoimmune Polyglandular Syndrome Type II|Autoimmune Polyglandular Syndrome Type III|Autoimmune Syndrome Type III, Polyglandular|Autoimmune Syndrome Type II, Polyglandular|Autoimmune Syndrome Type I, Polyglandular|Deficiency, AIRE|Diabetes Mellitus, Addison Disease, Myxedema|Diabetes Mellitus, Addison's Disease, Myxedema|Multiple Endocrine Deficiency Syndrome, Type 2|Polyendocrine Autoimmune Syndrome, Type II|Polyendocrinopathy, Autoimmune|Polyendocrinopathy Candidiasis Ectodermal Dystrophy, Autoimmune|Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy, Autoimmune|Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy, Autoimmune|Polyglandular Autoimmune Syndrome, Type 1|Polyglandular Autoimmune Syndrome, Type 2|Polyglandular Autoimmune Syndrome, Type 3|Polyglandular Autoimmune Syndrome, Type I|Polyglandular Deficiency Syndrome, Type 2|Polyglandular Type I Autoimmune Syndrome|Polyglandular Type II Autoimmune Syndrome|Polyglandular Type III Autoimmune Syndrome|Schmidt's Syndrome|Schmidt Syndrome|Syndrome, Schmidt|Syndrome, Schmidt's	Endocrine system disease|Immune system disease
Polymorphic catecholergic ventricular tachycardia	MESH:C536334	OMIM:611938|OMIM:614021|OMIM:614916		MESH:D017180	C14.280.067.845.940/C536334|C14.280.123.875.940/C536334|C23.550.073.845.940/C536334	C14.280.067.845.940|C14.280.123.875.940|C23.550.073.845.940	Bidirectional Tachycardia Induced By Catecholamines|Catecholamine-induced polymorphic ventricular tachycardia|Catecholaminergic polymorphic ventricular tachycardia|Cpvt2|CPVT3|CPVT4|Familial polymorphic ventricular tachycardia|Stress-induced polymorphic ventricular tachycardia|Ventricular Tachycardia, Catecholaminergic Polymorphic, 1|Ventricular Tachycardia, Catecholaminergic Polymorphic, 2|VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3|VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4|Ventricular Tachycardia, Familial|Ventricular Tachycardia, Familial Polymorphic|VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC|VTSIP	Cardiovascular disease|Pathology (process)
Polymyositis	MESH:D017285		Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)	MESH:D009220	C05.651.594.819|C10.668.491.562.575	C05.651.594|C10.668.491.562	Idiopathic Polymyositides|Idiopathic Polymyositis|Multiple Myositis|Myositides, Multiple|Myositis, Multiple|Ossificans, Polymyositis|Polymyositides|Polymyositides, Idiopathic|Polymyositis, Idiopathic|Polymyositis Ossificans	Musculoskeletal disease|Nervous system disease
Polyneuropathies	MESH:D011115	DO:DOID:1389|DO:DOID:14402	Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.	MESH:D010523	C10.668.829.800	C10.668.829	Acquired Polyneuropathies|Acquired Polyneuropathy|Critical Illness Polyneuropathies|Critical Illness Polyneuropathy|Familial Polyneuropathies|Familial Polyneuropathy|Inherited Polyneuropathies|Inherited Polyneuropathy|Motor Polyneuropathies|Motor Polyneuropathy|Polyneuropathies, Acquired|Polyneuropathies, Critical Illness|Polyneuropathies, Familial|Polyneuropathies, Inherited|Polyneuropathies, Motor|Polyneuropathy|Polyneuropathy, Acquired|Polyneuropathy, Critical Illness|Polyneuropathy, Familial|Polyneuropathy, Inherited|Polyneuropathy, Motor	Nervous system disease
Polyomavirus Infections	MESH:D027601		Infections with POLYOMAVIRUS, which are often cultured from the urine of kidney transplant patients. Excretion of BK VIRUS is associated with ureteral strictures and CYSTITIS, and that of JC VIRUS with progressive multifocal leukoencephalopathy (LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL).	MESH:D004266	C01.925.256.721	C01.925.256	Polyomavirus Infection	Viral disease
Polyosteolysis-Hyperostosis Syndrome	MESH:C563658			MESH:D010014|MESH:D015576	C05.116.264.579/C563658|C05.116.540/C563658	C05.116.264.579|C05.116.540		Musculoskeletal disease
Polyostotic osteolytic dysplasia, hereditary expansile	MESH:C536335	DO:DOID:0111542|OMIM:174810		MESH:D010014	C05.116.264.579/C536335	C05.116.264.579	EOF|Expansile osteolysis, familial|Familial expansile osteolysis|FEO|HEPOD|McCabe disease|Osteolysis, familial expansile|POLYOSTOTIC OSTEOLYTIC DYSPLASIA, HEREDITARY EXPANSILE	Musculoskeletal disease
Polyposis, Gastric	MESH:C562464			MESH:D013274|MESH:D018256	C04.557.470.035.215/C562464|C04.588.274.476.767/C562464|C06.301.371.767/C562464|C06.405.249.767/C562464|C06.405.748.789/C562464	C04.557.470.035.215|C04.588.274.476.767|C06.301.371.767|C06.405.249.767|C06.405.748.789		Cancer|Digestive system disease
Polyposis Of Gastric Fundus Without Polyposis Coli	MESH:C566775			MESH:D011127|MESH:D013274	C04.588.274.476.767/C566775|C06.301.371.767/C566775|C06.405.249.767/C566775|C06.405.748.789/C566775|C23.300.825/C566775	C04.588.274.476.767|C06.301.371.767|C06.405.249.767|C06.405.748.789|C23.300.825	Fundic Gland Polyposis	Cancer|Digestive system disease|Pathology (anatomical condition)
Polyps, Multiple And Recurrent Inflammatory Fibroid, Gastrointestinal	MESH:C566774			MESH:D005350|MESH:D005770	C04.557.450.565.590.340/C566774|C04.588.274.476/C566774|C06.301.371/C566774|C06.405.249/C566774	C04.557.450.565.590.340|C04.588.274.476|C06.301.371|C06.405.249		Cancer|Digestive system disease
Polyradiculoneuropathy	MESH:D011129	DO:DOID:4308	Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots.	MESH:D003711|MESH:D011115|MESH:D020274	C10.114.750|C10.314.750|C10.668.829.800.750|C20.111.258.750	C10.114|C10.314|C10.668.829.800|C20.111.258	Autoimmune Demyelinating Disease, Peripheral|Demyelinating Autoimmune Disease, Peripheral|Demyelinating Disease, Peripheral Autoimmune|Peripheral Autoimmune Demyelinating Disease|Polyradiculoneuritides|Polyradiculoneuritis|Polyradiculoneuropathies	Immune system disease|Nervous system disease
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	MESH:D020277	DO:DOID:2536|DO:DOID:5213	A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337)	MESH:D002908|MESH:D011129	C10.114.750.175|C10.314.750.700|C10.668.829.800.750.600|C20.111.258.750.800|C23.550.291.500.813	C10.114.750|C10.314.750|C10.668.829.800.750|C20.111.258.750|C23.550.291.500	Chronic Inflammatory Demyelinating Polyradiculoneuropathy|Chronic Inflammatory Polyradiculoneuropathies|Chronic Inflammatory Polyradiculoneuropathy|Chronic Inflammatory Polyradiculopathies|Chronic Inflammatory Polyradiculopathy|CIDP|Inflammatory Polyradiculoneuropathies, Chronic|Inflammatory Polyradiculoneuropathy, Chronic|Inflammatory Polyradiculopathies, Chronic|Inflammatory Polyradiculopathy, Chronic|Polyneuropathy, Inflammatory Demyelinating, Chronic|Polyradiculoneuropathies, Chronic Inflammatory|Polyradiculoneuropathy, Chronic Inflammatory|Polyradiculopathies, Chronic Inflammatory|Polyradiculopathy, Chronic Inflammatory	Immune system disease|Nervous system disease|Pathology (process)
Polyradiculopathy	MESH:D011128	DO:DOID:4307	Disease or injury involving multiple SPINAL NERVE ROOTS. Polyradiculitis refers to inflammation of multiple spinal nerve roots.	MESH:D011129	C10.668.829.800.750.700	C10.668.829.800.750	Abdominal Polyradiculopathies|Abdominal Polyradiculopathy|Polyradiculitides|Polyradiculitis|Polyradiculopathies|Polyradiculopathies, Abdominal|Polyradiculopathy, Abdominal	Nervous system disease
Polythelia, Familial	MESH:C562557			MESH:D001941	C17.800.090/C562557	C17.800.090	Accessory Nipples|Nipples, Supernumerary|Polymastia	Skin disease
Pontocerebellar Hypoplasia	MESH:C580383	DO:DOID:0060264		MESH:D002526	C10.228.140.252/C580383	C10.228.140.252	Congenital Pontocerebellar Hypoplasia	Nervous system disease
PONTOCEREBELLAR HYPOPLASIA, TYPE 10	OMIM:615803	DO:DOID:0060279		MESH:C580383	C10.228.140.252/C580383/615803	C10.228.140.252/C580383	PCH10	Nervous system disease
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	OMIM:614678	DO:DOID:0060266		MESH:C580383	C10.228.140.252/C580383/614678	C10.228.140.252/C580383	PCH1B	Nervous system disease
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C	OMIM:616081	DO:DOID:0112334		MESH:C580383	C10.228.140.252/C580383/616081	C10.228.140.252/C580383	HYPOMYELINATION WITH SPINAL MUSCULAR ATROPHY AND CEREBELLAR HYPOPLASIA|PCH1C	Nervous system disease
Pontocerebellar Hypoplasia Type 2B	MESH:C567325	DO:DOID:0060268|OMIM:612389		MESH:D002526	C10.228.140.252/C567325	C10.228.140.252	PCH2B|PONTOCEREBELLAR HYPOPLASIA, TYPE 2B	Nervous system disease
Pontocerebellar Hypoplasia Type 2C	MESH:C567324	DO:DOID:0060269|OMIM:612390		MESH:D002526	C10.228.140.252/C567324	C10.228.140.252	PCH2C|PONTOCEREBELLAR HYPOPLASIA, TYPE 2C	Nervous system disease
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	OMIM:613811	DO:DOID:0060270		MESH:C580383	C10.228.140.252/C580383/613811	C10.228.140.252/C580383	CEREBELLOCEREBRAL ATROPHY, PROGRESSIVE|PCCA|PCH2D	Nervous system disease
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E	OMIM:615851	DO:DOID:0060271		MESH:C580383	C10.228.140.252/C580383/615851	C10.228.140.252/C580383	PCH2E	Nervous system disease
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	OMIM:617026	DO:DOID:0112329		MESH:C580383	C10.228.140.252/C580383/617026	C10.228.140.252/C580383	PCH2F	Nervous system disease
PONTOCEREBELLAR HYPOPLASIA, TYPE 7	OMIM:614969	DO:DOID:0060276		MESH:C580383	C10.228.140.252/C580383/614969	C10.228.140.252/C580383	PCH7	Nervous system disease
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	OMIM:614961	DO:DOID:0060277		MESH:C580383	C10.228.140.252/C580383/614961	C10.228.140.252/C580383	PCH8	Nervous system disease
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	OMIM:615809	DO:DOID:0060278		MESH:C580383	C10.228.140.252/C580383/615809	C10.228.140.252/C580383	PCH9	Nervous system disease
Popliteal Artery Entrapment Syndrome	MESH:D000083082		Entrapment of the POPLITEAL ARTERY in the LEG due to an abnormal course of the artery often associated with onset of development and/or overuse of the gastrocnemius or popliteus muscles on the back of the leg. It is most often associated with runners and other athletes with enlarged calf muscle that compresses the popliteal artery.	MESH:D001157	C14.907.137.671	C14.907.137	Artery Entrapment, Popliteal|Entrapment, Popliteal Artery|Popliteal Artery Entrapment|Popliteal Artery Entrapments	Cardiovascular disease
Popliteal Cyst	MESH:D011151		A SYNOVIAL CYST located in the back of the knee, in the popliteal space arising from the semimembranous bursa or the knee joint.	MESH:D013581	C04.182.867.500	C04.182.867	Baker Cyst|Baker Cysts|Baker's Cyst|Cyst, Baker|Cyst, Popliteal|Cysts, Baker|Cysts, Popliteal|Popliteal Cysts	Cancer
Poroid hidradenoma	MESH:C000613206			MESH:D018250|MESH:D057091	C04.557.470.035.175.125/C000613206|C04.557.470.035.175.588/C000613206|C04.557.470.550.175.125/C000613206|C04.557.470.550.175.588/C000613206	C04.557.470.035.175.125|C04.557.470.035.175.588|C04.557.470.550.175.125|C04.557.470.550.175.588		Cancer
Poroma	MESH:D057091		A benign adnexal neoplasm derived from cells of the terminal duct of eccrine or apocrine SWEAT GLAND lineage. They typically manifest as solitary papules and occur only in the skin but unlike in ACROSPIROMA involves the epidermis.	MESH:D006607	C04.557.470.035.175.588|C04.557.470.550.175.588	C04.557.470.035.175|C04.557.470.550.175	Apocrine Poroma|Apocrine Poromas|Dermal Duct Tumor|Dermal Duct Tumors|Duct Tumor, Dermal|Eccrine Poroma|Eccrine Poromas|Hidracanthoma Simplex|Intraepidermal Poroma|Intraepidermal Poromas|Poroma, Apocrine|Poroma, Eccrine|Poroma, Intraepidermal|Poromas|Poromatoses|Poromatosis|Syringoacanthoma|Syringoacanthomas|Syringofibroadenoma|Syringofibroadenomas|Tumor, Dermal Duct	Cancer
Porphyria, Chester type	MESH:C536341			MESH:D011164	C18.452.811/C536341	C18.452.811		Metabolic disease
Porphyrias	MESH:D011164	DO:DOID:13268	A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.	MESH:D008659	C18.452.811	C18.452	Disorder, Porphyrin|Disorders, Porphyrin|Porphyria|Porphyrin Disorder|Porphyrin Disorders	Metabolic disease
Positive-Pressure Respiration, Intrinsic	MESH:D018467		Non-therapeutic positive end-expiratory pressure occurring frequently in patients with severe airway obstruction. It can appear with or without the administration of external positive end-expiratory pressure (POSITIVE-PRESSURE RESPIRATION). It presents an important load on the inspiratory muscles which are operating at a mechanical disadvantage due to hyperinflation. Auto-PEEP may cause profound hypotension that should be treated by intravascular volume expansion, increasing the time for expiration, and/or changing from assist mode to intermittent mandatory ventilation mode. (From Harrison's Principles of Internal Medicine, 12th ed, p1127)	MESH:D012131	C08.618.846.688	C08.618.846	AutoPEEP|Auto PEEP|Auto-PEEP|Intrinsic PEEP|Intrinsic Positive-Pressure Respiration|Nontherapeutic Positive Pressure Respiration|Nontherapeutic Positive-Pressure Respiration|Non Therapeutic Positive Pressure Respiration|Non-Therapeutic Positive-Pressure Respiration|Occult PEEP|Occult Positive-Pressure Respiration|PEEP, Intrinsic|PEEP, Occult|Positive Pressure Respiration, Intrinsic|Positive Pressure Respiration, Nontherapeutic|Positive-Pressure Respiration, Nontherapeutic|Positive Pressure Respiration, Non Therapeutic|Positive-Pressure Respiration, Non-Therapeutic|Positive Pressure Respiration, Occult|Positive-Pressure Respiration, Occult|Respiration, Intrinsic Positive-Pressure|Respiration, Nontherapeutic Positive Pressure|Respiration, Nontherapeutic Positive-Pressure|Respiration, Non Therapeutic Positive Pressure|Respiration, Non-Therapeutic Positive-Pressure|Respiration, Occult Positive-Pressure	Respiratory tract disease
post-acute COVID-19 syndrome	MESH:C000711409			MESH:D000086382	C01.748.610.763.500/C000711409|C01.925.705.500/C000711409|C01.925.782.600.550.200.163/C000711409|C08.381.677.807.500/C000711409|C08.730.610.763.500/C000711409	C01.748.610.763.500|C01.925.705.500|C01.925.782.600.550.200.163|C08.381.677.807.500|C08.730.610.763.500	chronic COVID syndrome|long COVID|long-COVID|long haul COVID|long-haul COVID|long hauler COVID|persistent COVID-19|post-acute COVID19 syndrome|post-acute COVID syndrome|post-acute sequelae of SARS-CoV-2 infection	Respiratory tract disease|Viral disease
Post-Cardiac Arrest Syndrome	MESH:D000080942		A reperfusion syndrome characterized by various pathophysiological processes after CARDIAC ARREST.  It may include post-cardiac arrest brain injury (HYPOXIA-ISCHEMIA, BRAIN), cardiocirculatory dysfunction, (e.g., systemic ISCHEMIA), HYPERGLYCEMIA; MULTIPLE ORGAN FAILURE and delayed death.	MESH:D001930|MESH:D006331|MESH:D015427	C10.228.140.199.850|C14.280.778|C14.907.725.638|C23.550.767.877.625	C10.228.140.199|C14.280|C14.907.725|C23.550.767.877	Postcardiac Arrest Syndrome|Post Cardiac Arrest Syndrome|Postcardiac Arrest Syndromes|Post-Cardiac Arrest Syndromes|Postresuscitation Disease|Postresuscitation Diseases	Cardiovascular disease|Nervous system disease|Pathology (process)
Postcholecystectomy Syndrome	MESH:D017562	DO:DOID:9740	Abdominal symptoms after removal of the GALLBLADDER. The common postoperative symptoms are often the same as those present before the operation, such as COLIC, bloating, NAUSEA, and VOMITING. There is pain on palpation of the right upper quadrant and sometimes JAUNDICE. The term is often used, inaccurately, to describe such postoperative symptoms not due to gallbladder removal.	MESH:D001660|MESH:D011183	C06.130.825|C23.550.767.775	C06.130|C23.550.767	Post Cholecystectomy Syndrome|Post-Cholecystectomy Syndrome|Postcholecystectomy Syndromes|Post-Cholecystectomy Syndromes|Postcholedochoduodenostomy Syndrome|Post Choledochoduodenostomy Syndrome|Post-Choledochoduodenostomy Syndrome|Postcholedochoduodenostomy Syndromes|Post-Choledochoduodenostomy Syndromes|Postcholedochojejunostomy Syndrome|Post Choledochojejunostomy Syndrome|Post-Choledochojejunostomy Syndrome|Postcholedochojejunostomy Syndromes|Post-Choledochojejunostomy Syndromes|Postcholedochostomy Syndrome|Post Choledochostomy Syndrome|Post-Choledochostomy Syndrome|Postcholedochostomy Syndromes|Post-Choledochostomy Syndromes|Sump Syndrome|Sump Syndromes|Syndrome, Postcholecystectomy|Syndrome, Post-Cholecystectomy|Syndrome, Postcholedochoduodenostomy|Syndrome, Post-Choledochoduodenostomy|Syndrome, Postcholedochojejunostomy|Syndrome, Post-Choledochojejunostomy|Syndrome, Postcholedochostomy|Syndrome, Post-Choledochostomy|Syndromes, Postcholecystectomy|Syndromes, Post-Cholecystectomy|Syndromes, Postcholedochoduodenostomy|Syndromes, Post-Choledochoduodenostomy|Syndromes, Postcholedochojejunostomy|Syndromes, Post-Choledochojejunostomy|Syndromes, Postcholedochostomy|Syndromes, Post-Choledochostomy|Syndromes, Sump|Syndrome, Sump	Digestive system disease|Pathology (process)
Post-Concussion Syndrome	MESH:D038223		The organic and psychogenic disturbances observed after closed head injuries (HEAD INJURIES, CLOSED). Post-concussion syndrome includes subjective physical complaints (i.e. headache, dizziness), cognitive, emotional, and behavioral changes. These disturbances can be chronic, permanent, or late emerging.	MESH:D001924	C10.900.300.350.300.500|C26.915.300.450.500.500|C26.974.382.200.500	C10.900.300.350.300|C26.915.300.450.500|C26.974.382.200	Chronic Post-Concussive Syndrome|Chronic Post-Concussive Syndromes|Post-Concussion Symptom|Post Concussion Symptoms|Post-Concussion Symptoms|Post Concussion Syndrome|Post-Concussive Symptom|Post Concussive Symptoms|Post-Concussive Symptoms|Post Concussive Syndrome|Post-Concussive Syndrome|Post Concussive Syndrome, Chronic|Post-Concussive Syndrome, Chronic|Post-Concussive Syndromes|Post-Concussive Syndromes, Chronic	Nervous system disease|Wounds and injuries
Post-Dural Puncture Headache	MESH:D051299		A secondary headache disorder attributed to low CEREBROSPINAL FLUID pressure caused by SPINAL PUNCTURE, usually after dural or lumbar puncture.	MESH:D051271	C10.228.140.546.699.124	C10.228.140.546.699	Headache, Postdural Puncture|Headache, Post-Dural Puncture|Headaches, Postdural Puncture|Headaches, Post-Dural Puncture|Postdural Puncture Headache|Post Dural Puncture Headache|Postdural Puncture Headaches|Post-Dural Puncture Headaches|Post-Lumbar Puncture Headache	Nervous system disease
Posterior Capsular Rupture, Ocular	MESH:D057851		A breach in the continuity of the posterior chamber of the eyeball.	MESH:D005131	C11.297.500	C11.297		Eye disease
Posterior Cervical Sympathetic Syndrome	MESH:D055010	DO:DOID:6692	A pathological condition that is characterized by a host of cranial symptoms, such as headaches, abnormal functions of the eyes and the ears, and psychological and mental disorders. This syndrome usually appears after neck injuries, inflammation, or neoplasm.	MESH:D013122	C05.116.900.596	C05.116.900	Barre Lieou Syndrome|Barre-Lieou Syndrome|Syndrome, Barre-Lieou|Syndrome of Barre Lieou|Syndrome of Barre-Lieou	Musculoskeletal disease
Posterior Leukoencephalopathy Syndrome	MESH:D054038		A condition that is characterized by HEADACHE; SEIZURES; and visual loss with edema in the posterior aspects of the CEREBRAL HEMISPHERES, such as the BRAIN STEM. Generally, lesions involve the white matter (nerve fibers) but occasionally the grey matter (nerve cell bodies).	MESH:D020343|MESH:D056784	C10.228.140.631.500.500|C10.228.140.695.875	C10.228.140.631.500|C10.228.140.695	Leukoencephalopathy Syndrome, Posterior|Leukoencephalopathy Syndromes, Posterior|Posterior Reversible Encephalopathy Syndrome|Reversible Posterior Leukoencephalopathy Syndrome|Syndrome, Posterior Leukoencephalopathy|Syndromes, Posterior Leukoencephalopathy	Nervous system disease
Posterior Tibial Tendon Dysfunction	MESH:D037081		A condition characterized by a broad range of progressive disorders ranging from TENOSYNOVITIS to tendon rupture with or without hindfoot collapse to a fixed, rigid, FLATFOOT deformity. Pathologic changes can involve associated tendons, ligaments, joint structures of the ANKLE, hindfoot, and midfoot. Posterior tibial tendon dysfunction is the most common cause of acquired flatfoot deformity in adults.	MESH:D005534	C05.360.750	C05.360	Dysfunction, Tibialis Posterior|Posterior Tibial Tendon Insufficiency|Tibialis Posterior Dysfunction|Tibial Tendon Dysfunction, Posterior	Musculoskeletal disease
Post-Exercise Hypotension	MESH:D057774		Transient reduction in blood pressure levels immediately after exercises that lasts 2-12 hours. The reduction varies but is typically 5-20 mm Hg when compared to pre-exercise levels. It exists both in normotensive and hypertensive individuals and may play a role in excercise related PHYSIOLOGIC ADAPTATION.	MESH:D007022|MESH:D054971	C10.177.575.600.537|C14.907.514.611	C10.177.575.600|C14.907.514	Hypotension, Postexercise|Hypotension, Post Exercise|Hypotension, Post-Exercise|Hypotensions, Postexercise|Hypotensions, Post Exercise|Hypotensions, Post-Exercise|Postexercise Hypotension|Post Exercise Hypotension|Postexercise Hypotensions|Post Exercise Hypotensions|Post-Exercise Hypotensions	Cardiovascular disease|Nervous system disease
Postgastrectomy Syndromes	MESH:D011178	DO:DOID:8439	Sequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (DUMPING SYNDROME and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies.	MESH:D011183|MESH:D013272	C06.405.748.630|C23.550.767.812	C06.405.748|C23.550.767	Postgastrectomy Syndrome|Syndrome, Postgastrectomy|Syndromes, Postgastrectomy	Digestive system disease|Pathology (process)
Postmastectomy Angiosarcoma	MESH:C000608733			MESH:D000072656|MESH:D006394	C04.557.450.795.390/C000608733|C04.557.645.390/C000608733|C15.604.496.160/C000608733|C23.550.767.082/C000608733	C04.557.450.795.390|C04.557.645.390|C15.604.496.160|C23.550.767.082	Post-Mastectomy Angiosarcoma|Postmastectomy Stewart-Treves Syndrome	Cancer|Lymphatic disease|Pathology (process)
Postpartum Thyroiditis	MESH:D050032		Transient autoimmune thyroiditis occurring in the POSTPARTUM PERIOD. It is characterized by the presence of high titers of AUTOANTIBODIES against THYROID PEROXIDASE and THYROGLOBULIN. Clinical signs include the triphasic thyroid hormone pattern: beginning with THYROTOXICOSIS, followed with HYPOTHYROIDISM, then return to euthyroid state by 1 year postpartum.	MESH:D011644|MESH:D013967	C12.050.703.844.714|C19.874.871.102.750	C12.050.703.844|C19.874.871.102	Post-partum Thyroiditides|Postpartum Thyroiditides|Post partum Thyroiditis|Post-partum Thyroiditis|Thyroiditides, Postpartum|Thyroiditides, Post-partum|Thyroiditis, Postpartum|Thyroiditis, Post-partum	Endocrine system disease|Pregnancy complication
Postpericardiotomy Syndrome	MESH:D011185		A nonspecific hypersensitivity reaction caused by TRAUMA to the PERICARDIUM, often following PERICARDIOTOMY. It is characterized by PERICARDIAL EFFUSION; high titers of anti-heart antibodies; low-grade FEVER; LETHARGY; loss of APPETITE; or ABDOMINAL PAIN.	MESH:D006331|MESH:D011183	C14.280.793|C23.550.767.863	C14.280|C23.550.767	Postcommissurotomy Syndrome|Postcommissurotomy Syndromes|Postpericardiotomy Syndromes|Syndrome, Postcommissurotomy|Syndrome, Postpericardiotomy|Syndromes, Postcommissurotomy|Syndromes, Postpericardiotomy	Cardiovascular disease|Pathology (process)
Postphlebitic Syndrome	MESH:D011186	DO:DOID:2364	A condition characterized by a chronically swollen limb, often a leg with stasis dermatitis and ulcerations. This syndrome can appear soon after phlebitis or years later. Postphlebitic syndrome is the result of damaged or incompetent venous valves in the limbs. Distended, tortuous VARICOSE VEINS are usually present. Leg pain may occur after long period of standing.	MESH:D010689|MESH:D014689	C14.907.617.718.760|C14.907.952.760	C14.907.617.718|C14.907.952	Disease, Postphlebitic|Diseases, Postphlebitic|Postphlebitic Disease|Postphlebitic Diseases|Postphlebitic Syndromes|Postphlebitic Ulcer|Postphlebitic Ulcers|Syndrome, Postphlebitic|Syndromes, Postphlebitic|Ulcer, Postphlebitic|Ulcers, Postphlebitic	Cardiovascular disease
Postpoliomyelitis Syndrome	MESH:D016262	DO:DOID:4952	A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. (From Ann NY Acad Sci 1995 May 25;753:68-80)	MESH:D011051|MESH:D019636|MESH:D020966	C01.207.618.750.750|C01.925.782.687.359.764.650|C05.651.534.750|C10.228.228.618.750.750|C10.228.854.525.850.750|C10.574.827|C10.586.750.850.750|C10.668.491.175.750|C10.668.864.500	C01.207.618.750|C01.925.782.687.359.764|C05.651.534|C10.228.228.618.750|C10.228.854.525.850|C10.574|C10.586.750.850|C10.668.491.175|C10.668.864	Muscular Atrophies, Postpoliomyelitis|Muscular Atrophies, Post-Poliomyelitis|Muscular Atrophy, Postpoliomyelitis|Muscular Atrophy, Post-Poliomyelitis|Postpoliomyelitis Muscular Atrophies|Post-Poliomyelitis Muscular Atrophies|Postpoliomyelitis Muscular Atrophy|Post Poliomyelitis Muscular Atrophy|Post-Poliomyelitis Muscular Atrophy|Post Poliomyelitis Syndrome|Post-Poliomyelitis Syndrome|Post-Polio Syndrome|Post-Polio Syndromes	Musculoskeletal disease|Nervous system disease|Viral disease
Postthrombotic Syndrome	MESH:D054070		A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA; PAIN; aching; heaviness; and MUSCLE CRAMP in the leg. When severe leg swelling leads to skin breakdown, it is called venous STASIS ULCER.	MESH:D014689|MESH:D020246	C14.907.355.830.925.462|C14.907.952.880	C14.907.355.830.925|C14.907.952	Syndrome, Postthrombotic|Syndrome, Venous Stasis|Venous Stasis Syndrome	Cardiovascular disease
Post-Traumatic Headache	MESH:D051298		Secondary headache attributed to TRAUMA of the HEAD and/or the NECK.	MESH:D051271	C10.228.140.546.699.249	C10.228.140.546.699	Cervicogenic Headache|Cervicogenic Headaches|Headache, Cervicogenic|Headache, Post-Traumatic|Headaches, Cervicogenic|Headaches, Post-Traumatic|Post Traumatic Headache|Post-Traumatic Headaches	Nervous system disease
Postural Orthostatic Tachycardia Syndrome	MESH:D054972	DO:DOID:0111154	A syndrome of ORTHOSTATIC INTOLERANCE combined with excessive upright TACHYCARDIA, and usually without associated ORTHOSTATIC HYPOTENSION. All variants have in common an excessively reduced venous return to the heart (central HYPOVOLEMIA) while upright.	MESH:D054971	C10.177.575.600.625	C10.177.575.600	Postural Tachycardia Syndrome|Syndrome, Postural Tachycardia|Tachycardia Syndrome, Postural	Nervous system disease
Pott Puffy Tumor	MESH:D059369		Infection of the FRONTAL BONE often as a complication of FRONTAL SINUSITIS or trauma to the frontal bone and skull. It is characterized by subperiosteal abscess with OSTEOMYELITIS.	MESH:D009916|MESH:D010019	C01.160.495.875|C05.116.165.495.750|C11.675.689	C01.160.495|C05.116.165.495|C11.675	Pott's Puffy Tumor|Potts Puffy Tumor|Puffy Tumor, Pott|Puffy Tumor, Pott's|Tumor, Pott Puffy|Tumor, Pott's Puffy	Eye disease|Musculoskeletal disease
Powell Chandra Saal syndrome	MESH:C538357			MESH:D000015|MESH:D006330|MESH:D011625|MESH:D017880	C05.660.585/C538357|C11.187.781/C538357|C14.240.400/C538357|C14.280.400/C538357|C16.131.077/C538357|C16.131.240.400/C538357|C16.131.621.585/C538357	C05.660.585|C11.187.781|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.585	PHAVER syndrome|Vertebral, radial, congenital heart, and ear defects	Cardiovascular disease|Congenital abnormality|Eye disease|Musculoskeletal disease
Poxviridae Infections	MESH:D011213	DO:DOID:8729	Virus diseases caused by the POXVIRIDAE.	MESH:D004266	C01.925.256.743	C01.925.256	Infection, Poxviridae|Infection, Poxvirus|Infections, Poxviridae|Infections, Poxvirus|Milker Nodes|Milker's Node|Milker's Nodes|Milkers Nodes|Node, Milker's|Nodes, Milker's|Poxviridae Infection|Poxvirus Infection|Poxvirus Infections	Viral disease
Preauricular Tag, Isolated, Autosomal Dominant, 1	MESH:C566904			MESH:D004427	C09.218/C566904	C09.218		Ear-nose-throat disease
Precancerous Conditions	MESH:D011230		Pathological conditions that tend eventually to become malignant.	MESH:D009369	C04.834	C04	Condition, Precancerous|Condition, Preneoplastic|Conditions, Precancerous|Conditions, Preneoplastic|Precancerous Condition|Preneoplastic Condition|Preneoplastic Conditions	Cancer
Preconception Injuries	MESH:D047489		Damages to reproductive health prior to conception (FERTILIZATION), a legal term for torts liability concerning environmental safety issues. Preconception injuries may involve either the male or the female, such as chromosomal mutations in the OVA or the SPERMATOZOA.	MESH:D007280	C21.676	C21	Injuries, Preconception|Injury, Preconception|Preconception Injury	Environmental origin disorders
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452		A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.	MESH:D054198	C04.557.337.428.600.600|C15.604.515.560.600.600|C20.683.515.528.600.600	C04.557.337.428.600|C15.604.515.560.600|C20.683.515.528.600	Leukemia, Pre B Cell|Leukemia, Pre-B-Cell|Leukemias, Pre-B-Cell|Pre B ALL|Pre B-ALL|Pre-B ALL|Pre B Cell Leukemia|Pre-B-Cell Leukemia|Pre-B-Cell Leukemias|Precursor B Cell Lymphoblastic Leukemia|Precursor B-Cell Lymphoblastic Leukemia|Precursor B Cell Lymphoblastic Leukemia Lymphoma|Precursor B Cell Lymphoblastic Lymphoma|Precursor B-Cell Lymphoblastic Lymphoma	Cancer|Immune system disease|Lymphatic disease
Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	OMIM:613065|OMIM:613067|OMIM:615545	A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.	MESH:D007945	C04.557.337.428.600|C15.604.515.560.600|C20.683.515.528.600	C04.557.337.428|C15.604.515.560|C20.683.515.528	Acute Lymphoblastic Leukemia|Acute Lymphocytic Leukemia|Acute Lymphoid Leukemia|ALL|ALL1, INCLUDED|ALL2|ALL3|ALL, Childhood|Childhood ALL|L1 Lymphocytic Leukemia|L2 Lymphocytic Leukemia|Leukemia, Acute Lymphoblastic|LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO, INCLUDED|LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED|LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2|LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3|Leukemia, Acute Lymphocytic|LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED|LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 2|Leukemia, Acute Lymphoid|LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED|Leukemia, L1 Lymphocytic|Leukemia, L2 Lymphocytic|Leukemia, Lymphoblastic|Leukemia, Lymphoblastic, Acute|Leukemia, Lymphoblastic, Acute, L1|Leukemia, Lymphoblastic, Acute, L2|Leukemia, Lymphoblastic, Acute, Philadelphia-Positive|Leukemia, Lymphocytic, Acute|Leukemia, Lymphocytic, Acute, L1|Leukemia, Lymphocytic, Acute, L2|Leukemia, Lymphoid, Acute|LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED|Lymphoblastic Leukemia|Lymphoblastic Leukemia, Acute|Lymphoblastic Leukemia, Acute, Adult|Lymphoblastic Leukemia, Acute, Childhood|Lymphoblastic Leukemia, Acute, L1|Lymphoblastic Leukemia, Acute, L2|Lymphoblastic Lymphoma|Lymphocytic Leukemia, Acute|Lymphocytic Leukemia, L1|Lymphocytic Leukemia, L2|Lymphoid Leukemia, Acute|Lymphoma, Lymphoblastic|Precursor Cell Lymphoblastic Leukemia Lymphoma	Cancer|Immune system disease|Lymphatic disease
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218		A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.	MESH:D054198	C04.557.337.428.600.620|C15.604.515.560.600.620|C20.683.515.528.600.620	C04.557.337.428.600|C15.604.515.560.600|C20.683.515.528.600	Acute T-Cell Leukemia|Acute T-Cell Leukemias|Acute T-Lymphocytic Leukemia|Acute T-Lymphocytic Leukemias|Leukemia, Acute T-Cell|Leukemia, Acute T-Lymphocytic|Leukemia, Lymphoblastic, Acute, T Cell|Leukemia, Lymphoblastic, Acute, T-Cell|Leukemia, Lymphocytic, Acute T Cell|Leukemia, Lymphocytic, Acute, T-Cell|Leukemias, Acute T-Cell|Leukemias, Acute T-Lymphocytic|Leukemia, T-Cell, Acute|Lymphoblastic Leukemia, Acute, T Cell|Lymphoblastic Leukemia, Acute, T-Cell|Lymphocytic Leukemia, T Cell, Acute|Lymphocytic Leukemia, T-Cell, Acute|Precursor T Cell Lymphoblastic Leukemia|Precursor T-Cell Lymphoblastic Leukemia|Precursor T Cell Lymphoblastic Leukemia Lymphoma|Precursor T Cell Lymphoblastic Lymphoma|Precursor T-Cell Lymphoblastic Lymphoma|T-ALL|T-Cell Acute Lymphocytic Leukemia|T Cell Leukemia, Acute|T-Cell Leukemia, Acute|T-Cell Leukemias, Acute|T Lymphocytic Leukemia, Acute|T-Lymphocytic Leukemia, Acute|T-Lymphocytic Leukemias, Acute	Cancer|Immune system disease|Lymphatic disease
Pre-Excitation, Mahaim-Type	MESH:D011227		A form of ventricular pre-excitation characterized by a normal PR interval and a long QRS interval with an initial slow deflection (delta wave). In this syndrome, the atrial impulse travel to the ventricle via the MAHAIM FIBERS which connect ATRIOVENTRICULAR NODE directly to the right ventricle wall (NODOVENTRICULAR ACCESSORY PATHWAY) or to the RIGHT BUNDLE BRANCH OF HIS (nodofascicular accessory pathway).	MESH:D011226	C14.280.067.780.770|C14.280.123.750.770	C14.280.067.780|C14.280.123.750	Mahaim Type Preexcitation|Mahaim-Type Preexcitation|Mahaim Type Pre Excitation|Mahaim-Type Pre-Excitation|Mahaim Type Pre Excitation, Nodofascicular|Mahaim-Type Pre-Excitation, Nodofascicular|Mahaim Type Pre Excitation, Nodoventricular|Mahaim-Type Pre-Excitation, Nodoventricular|Nodofascicular Mahaim Type Pre Excitation|Nodofascicular Mahaim-Type Pre-Excitation|Nodoventricular Mahaim Type Pre Excitation|Nodoventricular Mahaim-Type Pre-Excitation|Preexcitation, Mahaim-Type|Pre Excitation, Mahaim Type|Pre-Excitation, Nodofascicular Mahaim-Type|Pre-Excitation, Nodoventricular Mahaim-Type	Cardiovascular disease
Pre-Excitation Syndromes	MESH:D011226		A group of conditions in which HEART VENTRICLE activation by the atrial impulse is faster than the normal impulse conduction from the SINOATRIAL NODE. In these pre-excitation syndromes, atrial impulses often bypass the ATRIOVENTRICULAR NODE delay and travel via ACCESSORY CONDUCTING PATHWAYS connecting the atrium directly to the BUNDLE OF HIS.	MESH:D000075224|MESH:D001145	C14.280.067.780|C14.280.123.750	C14.280.067|C14.280.123	Preexcitation Syndrome|Pre-Excitation Syndrome|Preexcitation Syndromes|Pre Excitation Syndromes	Cardiovascular disease
Pregnancy Complications, Cardiovascular	MESH:D011249		The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.	MESH:D002318|MESH:D011248	C12.050.703.634|C14.583	C12.050.703|C14	Cardiovascular Pregnancy Complication|Cardiovascular Pregnancy Complications|Complication, Cardiovascular Pregnancy|Complications, Cardiovascular Pregnancy|Pregnancies, Cardiovascular Complications|Pregnancy, Cardiovascular Complications|Pregnancy Complication, Cardiovascular	Cardiovascular disease|Pregnancy complication
Pregnancy Complications, Hematologic	MESH:D011250		The co-occurrence of pregnancy and a blood disease (HEMATOLOGIC DISEASES) which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.	MESH:D006402|MESH:D011248	C12.050.703.667|C15.378.785	C12.050.703|C15.378	Complication, Hematological Pregnancy|Complication, Hematologic Pregnancy|Complications, Hematological Pregnancy|Complications, Hematologic Pregnancy|Hematological Pregnancy Complication|Hematological Pregnancy Complications|Hematologic Pregnancy Complication|Hematologic Pregnancy Complications|Pregnancies, Hematologic Complications|Pregnancy Complication, Hematologic|Pregnancy Complication, Hematological|Pregnancy Complications, Hematological|Pregnancy, Hematologic Complications	Blood disease|Pregnancy complication
Pregnancy Complications, Neoplastic	MESH:D011252		The co-occurrence of pregnancy and NEOPLASMS. The neoplastic disease may precede or follow FERTILIZATION.	MESH:D009369|MESH:D011248	C04.850|C12.050.703.720	C04|C12.050.703	Complication, Neoplastic Pregnancy|Complications, Neoplastic Pregnancy|Neoplastic Pregnancy Complication|Neoplastic Pregnancy Complications|Pregnancies, Neoplastic Complications|Pregnancy Complication, Neoplastic|Pregnancy, Neoplastic Complications	Cancer|Pregnancy complication
Prehypertension	MESH:D058246		Blood pressure levels that are between normotension and hypertension. Individuals with prehypertension are at a higher risk for developing cardiovascular diseases. Generally, prehypertension is defined as SYSTOLIC PRESSURE of 131-139 mm Hg and/or DIASTOLIC PRESSURE of 81-89 when the optimal is 120/80 mm Hg. For diabetics and other metabolism diseases the prehypertension is around 110-129/70-79 mm Hg.	MESH:D014652	C14.907.653	C14.907	Pre Hypertension|Pre-Hypertension|Prehypertensions|Pre-Hypertensions	Cardiovascular disease
PREIMPLANTATION EMBRYONIC LETHALITY 1	OMIM:616814			MESH:D007247|MESH:D020964	C12.050.351.500.498/616814|C12.050.703.039.711/616814|C12.100.250.498/616814|C12.100.750.350/616814|C23.550.260.440/616814	C12.050.351.500.498|C12.050.703.039.711|C12.100.250.498|C12.100.750.350|C23.550.260.440	PREMBL|PREMBL1	Pathology (process)|Pregnancy complication|Urogenital disease (female)
PREIMPLANTATION EMBRYONIC LETHALITY 2	OMIM:617234			MESH:D007247|MESH:D020964	C12.050.351.500.498/617234|C12.050.703.039.711/617234|C12.100.250.498/617234|C12.100.750.350/617234|C23.550.260.440/617234	C12.050.351.500.498|C12.050.703.039.711|C12.100.250.498|C12.100.750.350|C23.550.260.440	PREMBL2	Pathology (process)|Pregnancy complication|Urogenital disease (female)
Prekallikrein Deficiency	MESH:C562725	OMIM:612423		MESH:D001778	C15.378.100/C562725	C15.378.100	Fletcher Factor Deficiency|PKK Deficiency	Blood disease
Preleukemia	MESH:D011289		Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.	MESH:D006402|MESH:D011230	C04.834.770|C15.378.800	C04.834|C15.378	Preleukemias	Blood disease|Cancer
Premature aging, Okamoto type	MESH:C535270			MESH:D000015|MESH:D002386|MESH:D003920|MESH:D006130|MESH:D010024|MESH:D012516	C04.557.450.565.575.650/C535270|C04.557.450.795.620/C535270|C05.116.198.579/C535270|C11.510.245/C535270|C16.131.077/C535270|C18.452.104.579/C535270|C18.452.394.750/C535270|C19.246/C535270|C23.550.393/C535270	C04.557.450.565.575.650|C04.557.450.795.620|C05.116.198.579|C11.510.245|C16.131.077|C18.452.104.579|C18.452.394.750|C19.246|C23.550.393		Cancer|Congenital abnormality|Endocrine system disease|Eye disease|Metabolic disease|Musculoskeletal disease|Pathology (process)
Premature Ejaculation	MESH:D061686	DO:DOID:13709	The emission of SEMEN and seminal fluid during the act of preparation for sexual intercourse, i.e. before there is penetration, or shortly after penetration.	MESH:D005832|MESH:D012735|MESH:D020018	C12.100.500.530|C12.100.875.743|C12.200.294.530|F03.835.700	C12.100.500|C12.100.875|C12.200.294|F03.835	Ejaculation, Premature|Ejaculations, Premature|Ejaculatio Praecox|Ejaculatio Praecoxs|Praecox, Ejaculatio|Praecoxs, Ejaculatio|Premature Ejaculations	Mental disorder|Urogenital disease (male)
PREMATURE OVARIAN FAILURE 10	OMIM:612885	DO:DOID:0080867		MESH:D016649	C12.050.351.500.056.630.750/612885|C12.100.250.056.630.750/612885|C19.391.630.750/612885	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3, INCLUDED|MENOQ3, INCLUDED|POF10	Endocrine system disease|Urogenital disease (female)
PREMATURE OVARIAN FAILURE 11	OMIM:616946	DO:DOID:0080868|DO:DOID:0080869		MESH:D016649	C12.050.351.500.056.630.750/616946|C12.100.250.056.630.750/616946|C19.391.630.750/616946	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	POF11	Endocrine system disease|Urogenital disease (female)
PREMATURE OVARIAN FAILURE 12	OMIM:616947			MESH:D016649	C12.050.351.500.056.630.750/616947|C12.100.250.056.630.750/616947|C19.391.630.750/616947	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	POF12	Endocrine system disease|Urogenital disease (female)
PREMATURE OVARIAN FAILURE 13	OMIM:617442	DO:DOID:0080870		MESH:D016649	C12.050.351.500.056.630.750/617442|C12.100.250.056.630.750/617442|C19.391.630.750/617442	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	POF13	Endocrine system disease|Urogenital disease (female)
Premature Ovarian Failure 2b	MESH:C564476	OMIM:300604		MESH:D016649	C12.050.351.500.056.630.750/C564476|C12.100.250.056.630.750/C564476|C19.391.630.750/C564476	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	POF2B	Endocrine system disease|Urogenital disease (female)
Premature Ovarian Failure 3	MESH:C563816	OMIM:608996		MESH:D016649	C12.050.351.500.056.630.750/C563816|C12.100.250.056.630.750/C563816|C19.391.630.750/C563816	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	POF3	Endocrine system disease|Urogenital disease (female)
Premature Ovarian Failure 5	MESH:C566921	OMIM:611548		MESH:D016649	C12.050.351.500.056.630.750/C566921|C12.100.250.056.630.750/C566921|C19.391.630.750/C566921	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	Pof5	Endocrine system disease|Urogenital disease (female)
Premature Ovarian Failure 6	MESH:C567351	OMIM:612310		MESH:D016649	C12.050.351.500.056.630.750/C567351|C12.100.250.056.630.750/C567351|C19.391.630.750/C567351	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	POF6	Endocrine system disease|Urogenital disease (female)
Premature Ovarian Failure 7	MESH:C567838	OMIM:612964		MESH:D016649	C12.050.351.500.056.630.750/C567838|C12.100.250.056.630.750/C567838|C19.391.630.750/C567838	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	ADRENAL INSUFFICIENCY, NR5A1-RELATED, INCLUDED|Pof7	Endocrine system disease|Urogenital disease (female)
PREMATURE OVARIAN FAILURE 8	OMIM:615723	DO:DOID:0080865		MESH:D016649	C12.050.351.500.056.630.750/615723|C12.100.250.056.630.750/615723|C19.391.630.750/615723	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	POF8	Endocrine system disease|Urogenital disease (female)
PREMATURE OVARIAN FAILURE 9	OMIM:615724	DO:DOID:0080866		MESH:D016649	C12.050.351.500.056.630.750/615724|C12.100.250.056.630.750/615724|C19.391.630.750/615724	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	POF9	Endocrine system disease|Urogenital disease (female)
Premature ovarian failure, familial	MESH:C535272			MESH:D016649	C12.050.351.500.056.630.750/C535272|C12.100.250.056.630.750/C535272|C19.391.630.750/C535272	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	Familial premature ovarian failure|Idiopathic familial premature ovarian failure	Endocrine system disease|Urogenital disease (female)
Prenatal Bowing	MESH:C564873			MESH:D001848	C05.116.099/C564873	C05.116.099		Musculoskeletal disease
Prepapillary Vascular Loops	MESH:C563287			MESH:D005124|MESH:D054079	C11.250/C563287|C14.240.850/C563287|C16.131.240.850/C563287|C16.131.384/C563287	C11.250|C14.240.850|C16.131.240.850|C16.131.384	Preretinal Vascular Loops	Cardiovascular disease|Congenital abnormality|Eye disease
Presbycusis	MESH:D011304		Gradual bilateral hearing loss associated with aging that is due to progressive degeneration of cochlear structures and central auditory pathways. Hearing loss usually begins with the high frequencies then progresses to sounds of middle and low frequencies.	MESH:D006319	C09.218.458.341.887.772|C10.597.751.418.341.887.772|C23.888.592.763.393.341.887.772	C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887	Presbycuses	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Presbycusis 2	MESH:C567834	OMIM:612976		MESH:D011304	C09.218.458.341.887.772/C567834|C10.597.751.418.341.887.772/C567834|C23.888.592.763.393.341.887.772/C567834	C09.218.458.341.887.772|C10.597.751.418.341.887.772|C23.888.592.763.393.341.887.772	Age-Related Hearing Impairment 2|ARHI2|PRESBYCUSIS 2	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Presbyopia	MESH:D011305	DO:DOID:11638	The normal decreasing elasticity of the crystalline lens that leads to loss of accommodation.	MESH:D012030	C11.744.786	C11.744	Presbyopias	Eye disease
Presentey Anomaly	MESH:C564893	OMIM:261500		MESH:D007960	C15.378.553/C564893	C15.378.553	EOSINOPHIL PEROXIDASE DEFICIENCY|Eosinophil Peroxidase Deficiency, Partial|EPXD|Peroxidase and Phospholipid Deficiency in Eosinophils|PRESENTEY ANOMALY	Blood disease
Pressure Ulcer	MESH:D003668	DO:DOID:8717	An ulceration caused by prolonged pressure on the SKIN and TISSUES when one stays in one position for a long period of time, such as lying in bed. The bony areas of the body are the most frequently affected sites which become ischemic (ISCHEMIA) under sustained and constant pressure.	MESH:D012883	C17.800.893.665	C17.800.893	Bedsore|Bed Sore|Bedsores|Bed Sores|Decubitus Ulcer|Decubitus Ulcers|Pressure Sore|Pressure Sores|Pressure Ulcers|Sore, Bed|Sore, Pressure|Sores, Bed|Sores, Pressure|Ulcer, Decubitus|Ulcer, Pressure|Ulcers, Decubitus|Ulcers, Pressure	Skin disease
Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia	MESH:C580388	OMIM:612437		MESH:D020191	C10.228.140.490.375.130.650/C580388|C10.228.140.490.493.063.650/C580388	C10.228.140.490.375.130.650|C10.228.140.490.493.063.650	Epilepsy, Progressive Myoclonic, 1b|Epm1b|Pme with Ataxia|Prickle1-Related Progressive Myoclonus Epilepsy with Ataxia|Progressive Myoclonic Epilepsy 1b|Progressive Myoclonus Epilepsy with Ataxia	Nervous system disease
Primary angiitis of the central nervous system	MESH:C535276			MESH:D020293	C10.114.875/C535276|C10.228.140.300.850/C535276|C14.907.253.946/C535276|C14.907.940.907/C535276|C20.111.258.962/C535276	C10.114.875|C10.228.140.300.850|C14.907.253.946|C14.907.940.907|C20.111.258.962	PACNS	Cardiovascular disease|Immune system disease|Nervous system disease
Primary cortisol resistance	MESH:C535280			MESH:D047748	C10.228.140.617.738.250.725/C535280|C19.700.355.800/C535280	C10.228.140.617.738.250.725|C19.700.355.800		Endocrine system disease|Nervous system disease
Primary Dysautonomias	MESH:D054969		Disorders of the AUTONOMIC NERVOUS SYSTEM occurring as a primary condition. Manifestations can involve any or all body systems but commonly affect the BLOOD PRESSURE and HEART RATE.	MESH:D001342	C10.177.575	C10.177	Dysautonomia|Dysautonomia, Primary|Dysautonomias|Dysautonomias, Primary|Primary Dysautonomia	Nervous system disease
Primary Graft Dysfunction	MESH:D055031		A form of ischemia-reperfusion injury occurring in the early period following transplantation. Significant pathophysiological changes in MITOCHONDRIA are the main cause of the dysfunction. It is most often seen in the transplanted lung, liver, or kidney and can lead to GRAFT REJECTION.	MESH:D015427	C14.907.725.675|C23.550.767.877.750	C14.907.725|C23.550.767.877	Dysfunction, Primary Graft|Graft Dysfunction, Primary	Cardiovascular disease|Pathology (process)
Primary granulocytic sarcoma	MESH:C536413			MESH:D023981	C04.557.337.539.775/C536413|C04.557.450.795.853/C536413	C04.557.337.539.775|C04.557.450.795.853		Cancer
Primary Lateral Sclerosis, Adult, 1	MESH:C566900	OMIM:611637		MESH:D016472	C10.574.562/C566900|C10.668.467/C566900	C10.574.562|C10.668.467	PLSA|PLSA1|PLS, Adult	Nervous system disease
Primary lateral sclerosis juvenile	MESH:C536416	OMIM:606353		MESH:D016472	C10.574.562/C536416|C10.668.467/C536416	C10.574.562|C10.668.467	Juvenile Primary Lateral Sclerosis|PLSJ|PLS, JUVENILE|Primary Lateral Sclerosis, Juvenile	Nervous system disease
Primary malignant melanoma of the cervix	MESH:C536417			MESH:D002583|MESH:D008545	C04.557.465.625.650.510/C536417|C04.557.580.625.650.510/C536417|C04.557.665.510/C536417|C04.588.945.418.948.850/C536417|C12.050.351.500.852.593.131/C536417|C12.050.351.500.852.762.850/C536417|C12.050.351.937.418.875.850/C536417|C12.100.250.852.593.131/C536417|C12.100.250.852.762.850/C536417|C12.900.418.875.850/C536417	C04.557.465.625.650.510|C04.557.580.625.650.510|C04.557.665.510|C04.588.945.418.948.850|C12.050.351.500.852.593.131|C12.050.351.500.852.762.850|C12.050.351.937.418.875.850|C12.100.250.852.593.131|C12.100.250.852.762.850|C12.900.418.875.850	Primary malignant melanoma of the cervix uteri|Primary malignant melanoma of the uterine cervix|Radiation induced malignant melanoma of the cervix	Cancer|Urogenital disease (female)
Primary Myelofibrosis	MESH:D055728	DO:DOID:4971|OMIM:254450	A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.	MESH:D009196	C15.378.190.636.765	C15.378.190.636	Agnogenic Myeloid Metaplasia|Agnogenic Myeloid Metaplasias|Bone Marrow Fibroses|Bone Marrow Fibrosis|Chronic Idiopathic Myelofibrosis|Fibroses, Bone Marrow|Fibrosis, Bone Marrow|Idiopathic Myelofibrosis|Metaplasia, Agnogenic Myeloid|Metaplasia, Myeloid|Metaplasias, Agnogenic Myeloid|Metaplasias, Myeloid|MMM, INCLUDED|Myelofibroses|Myelofibroses, Primary|Myelofibrosis|Myelofibrosis, Primary|Myelofibrosis With Myeloid Metaplasia|MYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED|Myeloid Metaplasia|Myeloid Metaplasia, Agnogenic|Myeloid Metaplasias|Myeloid Metaplasias, Agnogenic|Myeloscleroses|Myelosclerosis|Myeloses, Nonleukemic|Myelosis, Nonleukemic|Nonleukemic Myeloses|Nonleukemic Myelosis|Primary Myelofibroses	Blood disease
Primary orthostatic tremor	MESH:C536418			MESH:D004244|MESH:D014202	C10.597.350.850/C536418|C23.888.592.350.850/C536418|C23.888.592.763.237/C536418	C10.597.350.850|C23.888.592.350.850|C23.888.592.763.237	Orthostatic tremor, primary|Shaky leg syndrome	Nervous system disease|Signs and symptoms
Primary Ovarian Insufficiency	MESH:D016649	DO:DOID:5426|OMIM:311360	Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene.	MESH:D010049	C12.050.351.500.056.630.750|C12.100.250.056.630.750|C19.391.630.750	C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	FMR1 Related Primary Ovarian Insufficiency|FMR1-Related Primary Ovarian Insufficiency|Fragile X Associated Primary Ovarian Insufficiency|Fragile X-Associated Primary Ovarian Insufficiency|Fragile X Premature Ovarian Failure|Gonadotropin Resistant Ovary Syndrome|Gonadotropin-Resistant Ovary Syndrome|Hypergonadotropic Ovarian Failure, X Linked|Hypergonadotropic Ovarian Failure, X-Linked|Ovarian Failure, Premature|Ovarian Insufficiency, Primary|POF|POF1|POFX|Premature Ovarian Failure|Premature Ovarian Failure 1|Premature Ovarian Failure, X Linked|Premature Ovarian Failure, X-Linked|Primary Ovarian Insufficiency, Fragile X Associated|Primary Ovarian Insufficiency, Fragile X-Associated|Resistant Ovary Syndrome|X Linked Hypergonadotropic Ovarian Failure|X-Linked Hypergonadotropic Ovarian Failure	Endocrine system disease|Urogenital disease (female)
Primary Release Disorder Of Platelets	MESH:C566759			MESH:D001791	C15.378.140/C566759	C15.378.140		Blood disease
Primary visual agnosia	MESH:C531604	DO:DOID:0060155		MESH:D000377	C10.597.606.762.100/C531604|C23.888.592.604.764.100/C531604	C10.597.606.762.100|C23.888.592.604.764.100	Monomodal visual amnesia|Visual amnesia	Nervous system disease|Signs and symptoms
Prinzmetal's variant angina	MESH:C536421			MESH:D000788	C14.280.647.187.150.150/C536421|C14.907.585.187.150.500/C536421|C23.888.592.612.233.500.150.150/C536421	C14.280.647.187.150.150|C14.907.585.187.150.500|C23.888.592.612.233.500.150.150		Cardiovascular disease|Signs and symptoms
Prion Diseases	MESH:D017096	DO:DOID:649	A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. (From Proc Natl Acad Sci USA 1998 Nov 10;95(23):13363-83)	MESH:D002494|MESH:D019636	C01.207.800|C10.228.228.800|C10.574.843	C01.207|C10.228.228|C10.574	Dementias, Transmissible|Dementia, Transmissible|Disorder, Prion-Induced|Disorders, Prion-Induced|Encephalopathies, Spongiform, Transmissible|Encephalopathies, Transmissible Spongiform|Encephalopathy, Transmissible Spongiform|Human Transmissible Spongiform Encephalopathies, Inherited|Inherited Human Transmissible Spongiform Encephalopathies|Prion-Associated Disorders|Prion Disease|Prion Induced Disorder|Prion-Induced Disorder|Prion-Induced Disorders|Prion Protein Disease|Prion Protein Diseases|Spongiform Encephalopathies, Transmissible|Spongiform Encephalopathy, Transmissible|Transmissible Dementia|Transmissible Dementias|Transmissible Spongiform Encephalopathies|Transmissible Spongiform Encephalopathy	Nervous system disease
Progesterone Resistance	MESH:C564871	OMIM:264080		MESH:D014591	C12.050.351.500.852/C564871|C12.100.250.852/C564871	C12.050.351.500.852|C12.100.250.852	Pseudocorpus Luteum Insufficiency	Urogenital disease (female)
Progressive Encephalomyelitis with Rigidity	MESH:C566113			MESH:D004679|MESH:D009127	C01.207.291/C566113|C05.651.504/C566113|C10.228.228.291/C566113|C10.586.500/C566113|C10.597.613.550.500/C566113|C23.888.592.608.550.500/C566113	C01.207.291|C05.651.504|C10.228.228.291|C10.586.500|C10.597.613.550.500|C23.888.592.608.550.500		Musculoskeletal disease|Nervous system disease|Signs and symptoms
Progressive External Ophthalmoplegia With Hypogonadism	MESH:C563576			MESH:D007006|MESH:D009886|MESH:D028361	C10.292.562.750/C563576|C10.597.622.447/C563576|C11.590.472/C563576|C18.452.660/C563576|C19.391.482/C563576|C23.888.592.636.447/C563576	C10.292.562.750|C10.597.622.447|C11.590.472|C18.452.660|C19.391.482|C23.888.592.636.447		Endocrine system disease|Eye disease|Metabolic disease|Nervous system disease|Signs and symptoms
Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1	MESH:C563575	OMIM:157640		MESH:D009886|MESH:D028361	C10.292.562.750/C563575|C10.597.622.447/C563575|C11.590.472/C563575|C18.452.660/C563575|C23.888.592.636.447/C563575	C10.292.562.750|C10.597.622.447|C11.590.472|C18.452.660|C23.888.592.636.447	PEOA1|Progressive External Ophthalmoplegia, Autosomal Dominant, 1|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 1|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1	Eye disease|Metabolic disease|Nervous system disease|Signs and symptoms
Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 2	MESH:C563750	OMIM:609283		MESH:D017246	C05.651.460.700/C563750|C10.292.562.750.250/C563750|C10.597.622.447.511/C563750|C10.668.491.500.700/C563750|C11.590.472.250/C563750|C18.452.660.560.700/C563750|C23.550.291.500.688/C563750|C23.888.592.636.447.511/C563750	C05.651.460.700|C10.292.562.750.250|C10.597.622.447.511|C10.668.491.500.700|C11.590.472.250|C18.452.660.560.700|C23.550.291.500.688|C23.888.592.636.447.511	PEOA2|Progressive External Ophthalmoplegia, Autosomal Dominant, 2|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 2|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2	Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 3	MESH:C563747	OMIM:609286		MESH:D017246	C05.651.460.700/C563747|C10.292.562.750.250/C563747|C10.597.622.447.511/C563747|C10.668.491.500.700/C563747|C11.590.472.250/C563747|C18.452.660.560.700/C563747|C23.550.291.500.688/C563747|C23.888.592.636.447.511/C563747	C05.651.460.700|C10.292.562.750.250|C10.597.622.447.511|C10.668.491.500.700|C11.590.472.250|C18.452.660.560.700|C23.550.291.500.688|C23.888.592.636.447.511	PEOA3|Progressive External Ophthalmoplegia, Autosomal Dominant, 3|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 3|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3	Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 4	MESH:C566437	OMIM:610131		MESH:D017246	C05.651.460.700/C566437|C10.292.562.750.250/C566437|C10.597.622.447.511/C566437|C10.668.491.500.700/C566437|C11.590.472.250/C566437|C18.452.660.560.700/C566437|C23.550.291.500.688/C566437|C23.888.592.636.447.511/C566437	C05.651.460.700|C10.292.562.750.250|C10.597.622.447.511|C10.668.491.500.700|C11.590.472.250|C18.452.660.560.700|C23.550.291.500.688|C23.888.592.636.447.511	PEOA4|Progressive External Ophthalmoplegia, Autosomal Dominant, 4|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 4|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4	Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5	MESH:C567768	OMIM:613077		MESH:D017246|MESH:D028361	C05.651.460.700/C567768|C10.292.562.750.250/C567768|C10.597.622.447.511/C567768|C10.668.491.500.700/C567768|C11.590.472.250/C567768|C18.452.660.560.700/C567768|C18.452.660/C567768|C23.550.291.500.688/C567768|C23.888.592.636.447.511/C567768	C05.651.460.700|C10.292.562.750.250|C10.597.622.447.511|C10.668.491.500.700|C11.590.472.250|C18.452.660|C18.452.660.560.700|C23.550.291.500.688|C23.888.592.636.447.511	Peoa5|Progressive External Ophthalmoplegia, Autosomal Dominant, 5|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 5|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5	Eye disease|Metabolic disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6	OMIM:615156	DO:DOID:0111519		MESH:D009886	C10.292.562.750/615156|C10.597.622.447/615156|C11.590.472/615156|C23.888.592.636.447/615156	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447	PEOA6|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 6	Eye disease|Nervous system disease|Signs and symptoms
Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Recessive	MESH:C564926	OMIM:258450		MESH:D009886	C10.292.562.750/C564926|C10.597.622.447/C564926|C11.590.472/C564926|C23.888.592.636.447/C564926	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447	PEOB1|Progressive External Ophthalmoplegia, Autosomal Recessive|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 1|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1	Eye disease|Nervous system disease|Signs and symptoms
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2	OMIM:616479	DO:DOID:0111515		MESH:D009886	C10.292.562.750/616479|C10.597.622.447/616479|C11.590.472/616479|C23.888.592.636.447/616479	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447	PEOB2|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 2	Eye disease|Nervous system disease|Signs and symptoms
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	OMIM:617069	DO:DOID:0111523		MESH:D009886	C10.292.562.750/617069|C10.597.622.447/617069|C11.590.472/617069|C23.888.592.636.447/617069	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447	PEOB3|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 3	Eye disease|Nervous system disease|Signs and symptoms
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	OMIM:617070	DO:DOID:0111516		MESH:D009886	C10.292.562.750/617070|C10.597.622.447/617070|C11.590.472/617070|C23.888.592.636.447/617070	C10.292.562.750|C10.597.622.447|C11.590.472|C23.888.592.636.447	PEOB4|PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 4	Eye disease|Nervous system disease|Signs and symptoms
PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	OMIM:113900	DO:DOID:0111074		MESH:C535758	C14.280.067.558/C535758/113900|C14.280.123.500/C535758/113900|C23.550.073.425/C535758/113900	C14.280.067.558/C535758|C14.280.123.500/C535758|C23.550.073.425/C535758	BUNDLE BRANCH BLOCK|CARDIAC CONDUCTION DEFECT, NONPROGRESSIVE, INCLUDED|CARDIAC CONDUCTION DEFECT, PROGRESSIVE|HEART BLOCK, PROGRESSIVE FAMILIAL, TYPE I|HEREDITARY BUNDLE BRANCH SYSTEM DEFECT;HBBD HEART BLOCK, NONPROGRESSIVE, INCLUDED|LENEGRE-LEV DISEASE|PCCD|PFHB1A|PFHBI|PFHBIA	Cardiovascular disease|Pathology (process)
Progressive Familial Heart Block, Type Ib	MESH:C567037	OMIM:604559		MESH:D006327	C14.280.067.558/C567037|C14.280.123.500/C567037|C23.550.073.425/C567037	C14.280.067.558|C14.280.123.500|C23.550.073.425	PFHB1B|PFHBIB	Cardiovascular disease|Pathology (process)
Progressive Familial Heart Block, Type II	MESH:C564202			MESH:D006327	C14.280.067.558/C564202|C14.280.123.500/C564202|C23.550.073.425/C564202	C14.280.067.558|C14.280.123.500|C23.550.073.425	PFHB2|PFHBII	Cardiovascular disease|Pathology (process)
Progressive supranuclear palsy atypical	MESH:C537240	OMIM:260540		MESH:D010300|MESH:D013494	C10.228.140.079.862.500/C537240|C10.228.140.079.882/C537240|C10.228.662.600.400/C537240|C10.228.662.700/C537240|C10.292.562.750.500/C537240|C10.574.928.750/C537240|C10.574.945.500/C537240|C10.597.622.447.690/C537240|C11.590.472.500/C537240|C23.888.592.636.447.690/C537240	C10.228.140.079.862.500|C10.228.140.079.882|C10.228.662.600.400|C10.228.662.700|C10.292.562.750.500|C10.574.928.750|C10.574.945.500|C10.597.622.447.690|C11.590.472.500|C23.888.592.636.447.690	Atypical PSP|Parkinson-Dementia Syndrome|Steele-Richardson-Olszewski Syndrome, Atypical|STEELE-RICHARDSON-OLSZEWSKI SYNDROME, ATYPICAL, INCLUDED|Supranuclear Palsy, Progressive, 1, Atypical|SUPRANUCLEAR PALSY, PROGRESSIVE, 1, ATYPICAL, INCLUDED|Supranuclear Palsy, Progressive Atypical	Eye disease|Nervous system disease|Signs and symptoms
Progressive Transformation of Germinal Centers	MESH:C548085			MESH:D002471|MESH:D008223	C04.557.386/C548085|C04.697.098.500/C548085|C15.604.515.569/C548085|C20.683.515.761/C548085|C23.550.727.098.500/C548085	C04.557.386|C04.697.098.500|C15.604.515.569|C20.683.515.761|C23.550.727.098.500		Cancer|Immune system disease|Lymphatic disease|Pathology (process)
Prolactin Deficiency with Obesity and Enlarged Testes	MESH:C564870			MESH:D007018|MESH:D009765	C10.228.140.617.738.300/C564870|C18.654.726.750.500/C564870|C19.700.482/C564870|C23.888.144.699.500/C564870	C10.228.140.617.738.300|C18.654.726.750.500|C19.700.482|C23.888.144.699.500		Endocrine system disease|Nervous system disease|Nutrition disorder|Signs and symptoms
Prolactinoma	MESH:D015175	DO:DOID:5394|OMIM:600634	A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.	MESH:D000236|MESH:D010911	C04.557.470.035.625|C04.588.322.609.792|C10.228.140.617.738.675.800|C19.344.609.792|C19.700.734.792	C04.557.470.035|C04.588.322.609|C10.228.140.617.738.675|C19.344.609|C19.700.734	Adenoma, Lactotroph|Adenoma, Prolactin-Secreting, Pituitary|Adenomas, Lactotroph|Lactotroph Adenoma|Lactotroph Adenomas|Macroprolactinoma|Macroprolactinomas|Microprolactinoma|Microprolactinomas|Pituitary Adenoma, PRL-Secreting|Pituitary Adenoma, Prolactin-Producing|Pituitary Adenoma, Prolactin Secreting|Pituitary Adenoma, Prolactin-Secreting|Pituitary Adenomas, PRL-Secreting|Pituitary Adenomas, Prolactin-Producing|Pituitary Adenomas, Prolactin-Secreting|PRL Secreting Pituitary Adenoma|PRL-Secreting Pituitary Adenoma|PRL-Secreting Pituitary Adenomas|Prolactinoma, Familial|Prolactinomas|Prolactin Producing Pituitary Adenoma|Prolactin-Producing Pituitary Adenoma|Prolactin-Producing Pituitary Adenomas|Prolactin Secreting Pituitary Adenoma|Prolactin-Secreting Pituitary Adenoma|Prolactin-Secreting Pituitary Adenomas	Cancer|Endocrine system disease|Nervous system disease
Pronation-Supination Of The Forearm, Impairment Of	MESH:C566757			MESH:D009069	C10.228.662/C566757	C10.228.662		Nervous system disease
Proopiomelanocortin Deficiency	MESH:C565726	OMIM:609734		MESH:D000309|MESH:D009765	C18.654.726.750.500/C565726|C19.053.500/C565726|C23.888.144.699.500/C565726	C18.654.726.750.500|C19.053.500|C23.888.144.699.500	OBAIRH|Obesity, Early-Onset, Adrenal Insufficiency, and Red Hair|OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR|PROOPIOMELANOCORTIN DEFICIENCY	Endocrine system disease|Nutrition disorder|Signs and symptoms
Propofol Infusion Syndrome	MESH:D000072736		Rare and often fatal drug complication which affects patients undergoing long-term treatment with high doses of PROPOFOL. It is characterized by METABOLIC ACIDOSIS; HYPERLIPIDEMIA; RHABDOMYOLYSIS; cardiovascular CIRCULATORY COLLAPSE; CARDIAC FAILURE; and KIDNEY FAILURE.	MESH:D064420	C25.100.844	C25.100	Propofol Infusion Syndromes|Propofol Related Infusion Syndrome|Propofol-Related Infusion Syndrome|Propofol-Related Infusion Syndromes|Propofol Syndrome|Propofol Syndromes	
Proprotein Convertase 1 3 Deficiency	MESH:C563423	DO:DOID:0111698|OMIM:600955		MESH:D004700|MESH:D009765	C18.654.726.750.500/C563423|C19/C563423|C23.888.144.699.500/C563423	C18.654.726.750.500|C19|C23.888.144.699.500	Obesity and Endocrinopathy due to Impaired Processing of Prohormones|PROPROTEIN CONVERTASE 1/3 DEFICIENCY	Endocrine system disease|Nutrition disorder|Signs and symptoms
Prosopagnosia	MESH:D020238	DO:DOID:4970	The inability to recognize a familiar face or to learn to recognize new faces. This visual agnosia is most often associated with lesions involving the junctional regions between the temporal and occipital lobes. The majority of cases are associated with bilateral lesions, however unilateral damage to the right occipito-temporal cortex has also been associated with this condition. (From Cortex 1995 Jun;31(2):317-29).	MESH:D000377	C10.597.606.762.100.650|C23.888.592.604.764.100.650	C10.597.606.762.100|C23.888.592.604.764.100	Acquired Prosopagnosia|Acquired Prosopagnosias|Agnosia, Facial Recognition|Agnosia for Face|Agnosia for Faces|Agnosias, Facial Recognition|Developmental Prosopagnosia|Developmental Prosopagnosias|Facial Recognition Agnosia|Facial Recognition Agnosias|Prosopagnosia, Acquired|Prosopagnosia, Developmental|Prosopagnosias|Prosopagnosias, Acquired|Prosopagnosias, Developmental|Recognition Agnosia, Facial|Recognition Agnosias, Facial	Nervous system disease|Signs and symptoms
Prosopagnosia, hereditary	MESH:C537242			MESH:D020238	C10.597.606.762.100.650/C537242|C23.888.592.604.764.100.650/C537242	C10.597.606.762.100.650|C23.888.592.604.764.100.650	Face blindness|Prosopagnosia, congenital	Nervous system disease|Signs and symptoms
Prostaglandin-Endoperoxide Synthase 1 Deficiency, Platelet	MESH:C567786			MESH:D001778|MESH:D001791	C15.378.100/C567786|C15.378.140/C567786	C15.378.100|C15.378.140	PGHS1 Deficiency|Platelet Cox1 Deficiency|Platelet Cyclooxygenase 1 Deficiency	Blood disease
PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY	OMIM:603688			MESH:D001932|MESH:D011471	C04.588.614.250.195/603688|C04.588.945.440.770/603688|C10.228.140.211/603688|C10.551.240.250/603688|C12.100.500.260.750/603688|C12.100.500.565.625/603688|C12.200.294.260.750/603688|C12.200.294.565.625/603688|C12.200.758.409.750/603688|C12.900.619.750/603688	C04.588.614.250.195|C04.588.945.440.770|C10.228.140.211|C10.551.240.250|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	CAPB|PCBC	Cancer|Nervous system disease|Urogenital disease (male)
Prostate cancer, familial	MESH:C537243	OMIM:601518		MESH:D011471	C04.588.945.440.770/C537243|C12.100.500.260.750/C537243|C12.100.500.565.625/C537243|C12.200.294.260.750/C537243|C12.200.294.565.625/C537243|C12.200.758.409.750/C537243|C12.900.619.750/C537243	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	Hereditary prostate cancer|HPC1|PRCA1|Prostate Cancer, Hereditary, 1	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 10	MESH:C567011	OMIM:611100		MESH:D011471	C04.588.945.440.770/C567011|C12.100.500.260.750/C567011|C12.100.500.565.625/C567011|C12.200.294.260.750/C567011|C12.200.294.565.625/C567011|C12.200.758.409.750/C567011|C12.900.619.750/C567011	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC10	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 11	MESH:C567449	OMIM:611955		MESH:D011471	C04.588.945.440.770/C567449|C12.100.500.260.750/C567449|C12.100.500.565.625/C567449|C12.200.294.260.750/C567449|C12.200.294.565.625/C567449|C12.200.758.409.750/C567449|C12.900.619.750/C567449	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC11	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 13	MESH:C567456	OMIM:611928		MESH:D011471	C04.588.945.440.770/C567456|C12.100.500.260.750/C567456|C12.100.500.565.625/C567456|C12.200.294.260.750/C567456|C12.200.294.565.625/C567456|C12.200.758.409.750/C567456|C12.900.619.750/C567456	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC13	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 14	MESH:C567448	OMIM:611958		MESH:D011471	C04.588.945.440.770/C567448|C12.100.500.260.750/C567448|C12.100.500.565.625/C567448|C12.200.294.260.750/C567448|C12.200.294.565.625/C567448|C12.200.758.409.750/C567448|C12.900.619.750/C567448	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC14	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 15	MESH:C567447	OMIM:611959		MESH:D011471	C04.588.945.440.770/C567447|C12.100.500.260.750/C567447|C12.100.500.565.625/C567447|C12.200.294.260.750/C567447|C12.200.294.565.625/C567447|C12.200.758.409.750/C567447|C12.900.619.750/C567447	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC15	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 3	MESH:C563883	OMIM:608656		MESH:D011471	C04.588.945.440.770/C563883|C12.100.500.260.750/C563883|C12.100.500.565.625/C563883|C12.200.294.260.750/C563883|C12.200.294.565.625/C563883|C12.200.758.409.750/C563883|C12.900.619.750/C563883	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC3	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 4	MESH:C563882	OMIM:608658		MESH:D011471	C04.588.945.440.770/C563882|C12.100.500.260.750/C563882|C12.100.500.565.625/C563882|C12.200.294.260.750/C563882|C12.200.294.565.625/C563882|C12.200.758.409.750/C563882|C12.900.619.750/C563882	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC4|Prostate Cancer, Hereditary, on Chromosome 7	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 5	MESH:C563744	OMIM:609299		MESH:D011471	C04.588.945.440.770/C563744|C12.100.500.260.750/C563744|C12.100.500.565.625/C563744|C12.200.294.260.750/C563744|C12.200.294.565.625/C563744|C12.200.758.409.750/C563744|C12.900.619.750/C563744	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC5	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 6	MESH:C563699	OMIM:609558		MESH:D011471	C04.588.945.440.770/C563699|C12.100.500.260.750/C563699|C12.100.500.565.625/C563699|C12.200.294.260.750/C563699|C12.200.294.565.625/C563699|C12.200.758.409.750/C563699|C12.900.619.750/C563699	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC6	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 7	MESH:C565201	OMIM:610321		MESH:D011471	C04.588.945.440.770/C565201|C12.100.500.260.750/C565201|C12.100.500.565.625/C565201|C12.200.294.260.750/C565201|C12.200.294.565.625/C565201|C12.200.758.409.750/C565201|C12.900.619.750/C565201	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC7|Prostate Cancer Aggressiveness	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 8	MESH:C566426	OMIM:602759		MESH:D011471	C04.588.945.440.770/C566426|C12.100.500.260.750/C566426|C12.100.500.565.625/C566426|C12.200.294.260.750/C566426|C12.200.294.565.625/C566426|C12.200.758.409.750/C566426|C12.900.619.750/C566426	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC8|PCAP|Predisposing For Prostate Cancer	Cancer|Urogenital disease (male)
Prostate Cancer, Hereditary, 9	MESH:C567031	OMIM:610997		MESH:D011471	C04.588.945.440.770/C567031|C12.100.500.260.750/C567031|C12.100.500.565.625/C567031|C12.200.294.260.750/C567031|C12.200.294.565.625/C567031|C12.200.758.409.750/C567031|C12.900.619.750/C567031	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	HPC9	Cancer|Urogenital disease (male)
Prostatic Intraepithelial Neoplasia	MESH:D019048		A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.	MESH:D002278	C04.557.470.200.240.500	C04.557.470.200.240	Intraepithelial Neoplasia, Prostatic|Intraepithelial Neoplasm, Prostatic|Intraepithelial Neoplasms, Prostatic|Intraepithelial Prostatic Neoplasia|Intraepithelial Prostatic Neoplasias|Neoplasia, Intraepithelial Prostatic|Neoplasia, Prostatic Intraepithelial|Neoplasm, Prostatic Intraepithelial|Neoplasms, Prostatic Intraepithelial|Prostatic Intraepithelial Neoplasias|Prostatic Intraepithelial Neoplasm|Prostatic Intraepithelial Neoplasms|Prostatic Neoplasia, Intraepithelial	Cancer
Prostatic Neoplasms	MESH:D011471	DO:DOID:10283|OMIM:176807|OMIM:607592	Tumors or cancer of the PROSTATE.	MESH:D005834|MESH:D011469	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	C04.588.945.440|C12.100.500.260|C12.100.500.565|C12.200.294.260|C12.200.294.565|C12.200.758.409|C12.900.619	Cancer of Prostate|Cancer of the Prostate|Cancer, Prostate|Cancer, Prostatic|Cancers, Prostate|Cancers, Prostatic|HPCQTL19|Neoplasm, Prostate|Neoplasm, Prostatic|Neoplasms, Prostate|Neoplasms, Prostatic|Prostate Cancer|PROSTATE CANCER AGGRESSIVENESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19|Prostate Cancers|Prostate Neoplasm|Prostate Neoplasms|Prostatic Cancer|Prostatic Cancers|Prostatic Neoplasm	Cancer|Urogenital disease (male)
Prostatic Neoplasms, Castration-Resistant	MESH:D064129	DO:DOID:0080909	Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.	MESH:D011471	C04.588.945.440.770.500|C12.100.500.260.750.500|C12.100.500.565.625.500|C12.200.294.260.750.500|C12.200.294.565.625.500|C12.200.758.409.750.500|C12.900.619.750.500	C04.588.945.440.770|C12.100.500.260.750|C12.100.500.565.625|C12.200.294.260.750|C12.200.294.565.625|C12.200.758.409.750|C12.900.619.750	Androgen Independent Prostatic Cancer|Androgen-Independent Prostatic Cancer|Androgen-Independent Prostatic Cancers|Androgen-Independent Prostatic Neoplasm|Androgen Independent Prostatic Neoplasms|Androgen-Independent Prostatic Neoplasms|Androgen Insensitive Prostatic Cancer|Androgen-Insensitive Prostatic Cancer|Androgen-Insensitive Prostatic Cancers|Androgen-Insensitive Prostatic Neoplasm|Androgen Insensitive Prostatic Neoplasms|Androgen-Insensitive Prostatic Neoplasms|Androgen Resistant Prostatic Cancer|Androgen-Resistant Prostatic Cancer|Androgen-Resistant Prostatic Cancers|Androgen-Resistant Prostatic Neoplasm|Androgen Resistant Prostatic Neoplasms|Androgen-Resistant Prostatic Neoplasms|Cancer, Androgen-Independent Prostatic|Cancer, Androgen-Insensitive Prostatic|Cancer, Androgen-Resistant Prostatic|Cancer, Castration-Resistant Prostatic|Cancers, Androgen-Independent Prostatic|Cancers, Androgen-Insensitive Prostatic|Cancers, Androgen-Resistant Prostatic|Cancers, Castration-Resistant Prostatic|Castration Resistant Prostatic Cancer|Castration-Resistant Prostatic Cancer|Castration-Resistant Prostatic Cancers|Castration-Resistant Prostatic Neoplasm|Castration Resistant Prostatic Neoplasms|Castration-Resistant Prostatic Neoplasms|Hormone Refractory Prostatic Cancer|Hormone Refractory Prostatic Neoplasms|Neoplasm, Androgen-Independent Prostatic|Neoplasm, Androgen-Insensitive Prostatic|Neoplasm, Androgen-Resistant Prostatic|Neoplasm, Castration-Resistant Prostatic|Neoplasms, Androgen-Independent Prostatic|Neoplasms, Androgen-Insensitive Prostatic|Neoplasms, Androgen-Resistant Prostatic|Neoplasms, Castration-Resistant Prostatic|Prostatic Cancer, Androgen Independent|Prostatic Cancer, Androgen-Independent|Prostatic Cancer, Androgen Insensitive|Prostatic Cancer, Androgen-Insensitive|Prostatic Cancer, Androgen Resistant|Prostatic Cancer, Androgen-Resistant|Prostatic Cancer, Castration Resistant|Prostatic Cancer, Castration-Resistant|Prostatic Cancer, Hormone Refractory|Prostatic Cancers, Androgen-Independent|Prostatic Cancers, Androgen-Insensitive|Prostatic Cancers, Androgen-Resistant|Prostatic Cancers, Castration-Resistant|Prostatic Neoplasm, Androgen-Independent|Prostatic Neoplasm, Androgen-Insensitive|Prostatic Neoplasm, Androgen-Resistant|Prostatic Neoplasm, Castration-Resistant|Prostatic Neoplasms, Androgen Independent|Prostatic Neoplasms, Androgen-Independent|Prostatic Neoplasms, Androgen Insensitive|Prostatic Neoplasms, Androgen-Insensitive|Prostatic Neoplasms, Androgen Resistant|Prostatic Neoplasms, Androgen-Resistant|Prostatic Neoplasms, Castration Resistant|Prostatic Neoplasms, Hormone Refractory	Cancer|Urogenital disease (male)
Protein S Deficiency	MESH:D018455	DO:DOID:2451	An autosomal dominant disorder showing decreased levels of plasma protein S antigen or activity, associated with venous thrombosis and pulmonary embolism. PROTEIN S is a vitamin K-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated PROTEIN C (also a vitamin K-dependent protein), and the clinical manifestations of its deficiency are virtually identical to those of protein C deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis. (From Harrison's Principles of Internal Medicine, 12th ed, p1511; Wintrobe's Clinical Hematology, 9th ed, p1523)	MESH:D001778|MESH:D001796|MESH:D019851	C15.378.100.800|C15.378.147.890|C15.378.925.800	C15.378.100|C15.378.147|C15.378.925	Deficiencies, Protein S|Deficiency, Protein S|Hereditary Thrombophilia Due To Protein S Deficiency|Protein S Deficiencies	Blood disease
Proteostasis Deficiencies	MESH:D057165		Disorders caused by imbalances in the PROTEIN HOMEOSTASIS network - synthesis, folding, and transport of proteins; post-translational modifications; and degradation or clearance of misfolded proteins.	MESH:D008659	C18.452.845	C18.452	Deficiencies, Proteostasis|Deficiency, Proteostasis|Disease, Protein Folding|Disease, Protein Misfolding|Diseases, Protein Folding|Diseases, Protein Misfolding|Disorder, Protein Folding|Disorder, Protein Misfolding|Disorders, Protein Folding|Disorders, Protein Misfolding|Dysfunction, Proteostasis|Dysfunctions, Proteostasis|Folding Disease, Protein|Folding Diseases, Protein|Folding Disorder, Protein|Folding Disorders, Protein|Misfolding Disease, Protein|Misfolding Diseases, Protein|Misfolding Disorder, Protein|Misfolding Disorders, Protein|Protein Folding Disease|Protein Folding Diseases|Protein Folding Disorder|Protein Folding Disorders|Protein Misfolding Disease|Protein Misfolding Diseases|Protein Misfolding Disorder|Protein Misfolding Disorders|Proteostasis Deficiency|Proteostasis Dysfunction|Proteostasis Dysfunctions	Metabolic disease
Proteus Syndrome	MESH:D016715	DO:DOID:13482|OMIM:176920	Hamartoneoplastic malformation syndrome of uncertain etiology characterized by partial GIGANTISM of the hands and/or feet, asymmetry of the limbs, plantar hyperplasia, hemangiomas (HEMANGIOMA), lipomas (LIPOMA), lymphangiomas (LYMPHANGIOMA), epidermal NEVI; MACROCEPHALY; cranial HYPEROSTOSIS, and long-bone overgrowth. Joseph Merrick, the so-called 'elephant man', apparently suffered from Proteus syndrome and not NEUROFIBROMATOSIS, a disorder with similar characteristics.	MESH:D000015|MESH:D001848|MESH:D006223|MESH:D017880	C04.445.435.500|C04.651.435.500|C05.116.099.750|C05.660.585.620|C16.131.077.740|C16.131.621.585.620	C04.445.435|C04.651.435|C05.116.099|C05.660.585|C16.131.077|C16.131.621.585	Elephant Man Disease|GIGANTISM, PARTIAL, OF HANDS AND FEET, NEVI, HEMIHYPERTROPHY, AND MACROCEPHALY ELATTOPROTEUS SYNDROME, INCLUDED|Proteus Like Syndrome|Proteus-Like Syndrome|Syndrome, Proteus-Like	Cancer|Congenital abnormality|Musculoskeletal disease
protothecosis	MESH:C000656805			MESH:D012874	C01.800/C000656805|C17.800.838/C000656805	C01.800|C17.800.838	Prototheca skin infection	Skin disease
Proximal Myopathy with Focal Depletion of Mitochondria	MESH:C563453			MESH:D009135|MESH:D028361	C05.651/C563453|C10.668.491/C563453|C18.452.660/C563453	C05.651|C10.668.491|C18.452.660		Metabolic disease|Musculoskeletal disease|Nervous system disease
Prune Belly Syndrome with Pulmonic Stenosis, Mental Retardation, and Deafness	MESH:C562894			MESH:D006319|MESH:D008607|MESH:D011535|MESH:D011666	C09.218.458.341.887/C562894|C10.597.606.360/C562894|C10.597.751.418.341.887/C562894|C14.280.484.716/C562894|C14.280.955.750/C562894|C16.131.077.745/C562894|C23.888.592.604.646/C562894|C23.888.592.763.393.341.887/C562894|F03.625.539/C562894	C09.218.458.341.887|C10.597.606.360|C10.597.751.418.341.887|C14.280.484.716|C14.280.955.750|C16.131.077.745|C23.888.592.604.646|C23.888.592.763.393.341.887|F03.625.539		Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Mental disorder|Nervous system disease|Signs and symptoms
Prurigo	MESH:D011536		A name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. (From Dorland, 27th ed)	MESH:D012871	C17.800.674	C17.800		Skin disease
Pruritus Ani	MESH:D011538		Intense chronic itching in the anal area.	MESH:D001004|MESH:D011537	C06.405.469.860.101.752|C17.800.685.544	C06.405.469.860.101|C17.800.685		Digestive system disease|Skin disease
Pruritus Vulvae	MESH:D011539		Intense itching of the external female genitals.	MESH:D011537|MESH:D014845	C12.050.351.500.944.626|C12.100.250.944.626|C17.800.685.710	C12.050.351.500.944|C12.100.250.944|C17.800.685		Skin disease|Urogenital disease (female)
Pseudoacromegaly with Severe Insulin Resistance	MESH:C566531			MESH:D000172|MESH:D007333	C05.116.132.082/C566531|C10.228.140.617.738.250.100/C566531|C18.452.394.968.500/C566531|C19.700.355.179/C566531	C05.116.132.082|C10.228.140.617.738.250.100|C18.452.394.968.500|C19.700.355.179		Endocrine system disease|Metabolic disease|Musculoskeletal disease|Nervous system disease
Pseudoangiomatous stromal hyperplasia	MESH:C535824			MESH:D000798|MESH:D001941|MESH:D006965	C14.907.077/C535824|C17.800.090/C535824|C23.550.444/C535824	C14.907.077|C17.800.090|C23.550.444	Mammary pseudoangiomatous stromal hyperplasia|Pseudoangiomatous stromal hyperplasia of the breast	Cardiovascular disease|Pathology (process)|Skin disease
Pseudoatrophoderma Colli	MESH:C562909			MESH:D012871	C17.800/C562909	C17.800		Skin disease
Pseudobulbar Palsy	MESH:D020828	DO:DOID:12680	A syndrome characterized by DYSARTHRIA, dysphagia, dysphonia, impairment of voluntary movements of tongue and facial muscles, and emotional lability. This condition is caused by diseases that affect the motor fibers that travel from the cerebral cortex to the lower BRAIN STEM (i.e., corticobulbar tracts); including MULTIPLE SCLEROSIS; MOTOR NEURON DISEASE; and CEREBROVASCULAR DISORDERS. (From Adams et al., Principles of Neurology, 6th ed, p489)	MESH:D010243	C10.597.622.714|C23.888.592.636.711	C10.597.622|C23.888.592.636	Bulbar Palsies, Spastic|Bulbar Palsy, Spastic|Dysarthria, Pseudobulbar|Dysarthrias, Pseudobulbar|Mutism, Pseudobulbar|Mutisms, Pseudobulbar|Palsies, Pseudobulbar|Palsies, Spastic Bulbar|Palsy, Pseudobulbar|Palsy, Spastic Bulbar|Paralyses, Pseudobulbar|Paralysis, Pseudobulbar|Pareses, Pseudobulbar|Paresis, Pseudobulbar|Pseudobulbar Dysarthria|Pseudobulbar Dysarthrias|Pseudobulbar Mutism|Pseudobulbar Mutisms|Pseudobulbar Palsies|Pseudobulbar Paralyses|Pseudobulbar Paralysis|Pseudobulbar Pareses|Pseudobulbar Paresis|Pseudobulbar Syndrome|Pseudobulbar Syndromes|Spastic Bulbar Palsies|Spastic Bulbar Palsy|Syndrome, Pseudobulbar|Syndromes, Pseudobulbar	Nervous system disease|Signs and symptoms
Pseudofolliculitis Barbae	MESH:C563016	OMIM:612318		MESH:D006201	C17.800.329/C563016	C17.800.329	Ingrown Hairs|PFB|Pili Incarnati	Skin disease
Pseudohyperkalemia Cardiff	MESH:C535827	OMIM:185020		MESH:D006947	C18.452.950.396/C535827	C18.452.950.396	CHC|Cryohydrocytosis|Stomatocytosis, cold-sensitive	Metabolic disease
Pseudohyperkalemia, Familial, 2, due to Red Cell Leak	MESH:C563785	OMIM:609153		MESH:D006947	C18.452.950.396/C563785	C18.452.950.396	CRYOHYDROCYTOSIS, MILD|PSEUDOHYPERKALEMIA CARDIFF|PSEUDOHYPERKALEMIA CHISWICK|PSEUDOHYPERKALEMIA EAST LONDON|PSEUDOHYPERKALEMIA FALKIRK|Pseudohyperkalemia Lille|PSHK2	Metabolic disease
Pseudolymphoma	MESH:D019310		A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. (From Dorland, 28th ed & Stedman, 26th ed)	MESH:D008206	C15.604.613	C15.604	Hyperplasia, Reactive Lymphoid|Hyperplasias, Reactive Lymphoid|Lymphocytoma|Lymphocytomas|Lymphoid Hyperplasia, Reactive|Lymphoid Hyperplasias, Reactive|Pseudolymphomas|Reactive Lymphoid Hyperplasia|Reactive Lymphoid Hyperplasias	Lymphatic disease
Pseudomonilethrix	MESH:C562988			MESH:D006201	C17.800.329/C562988	C17.800.329		Skin disease
Pseudomyxoma Peritonei	MESH:D011553	DO:DOID:3559	A peritoneal adenocarcinoma characterized by build-up of MUCUS in the PERITONEAL CAVITY. Mucus secreting cells may attach to the peritoneal lining and continue to secrete mucus. The majority of cases represent tumor spread from a primary low-grade mucinous neoplasm of the APPENDIX (NCI Thesaurus).	MESH:D002288	C04.557.470.200.025.075.500|C04.557.470.590.075.500	C04.557.470.200.025.075|C04.557.470.590.075	Ascites, Gelatinous|Gelatinous Ascites|Pseudomyxoma Peritonei Syndrome|Pseudomyxoma Peritonei Syndromes|Syndrome of Pseudomyxoma Peritonei	Cancer
Pseudotumor Cerebri	MESH:D011559	DO:DOID:11459	A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).	MESH:D019586	C10.228.140.631.750	C10.228.140.631	Benign Intracranial Hypertension|Hypertension, Benign Intracranial|Hypertension, Idiopathic Intracranial|Idiopathic Intracranial Hypertension|Intracranial Hypertension, Benign|Intracranial Hypertension, Idiopathic	Nervous system disease
Psoas Abscess	MESH:D016659		Abscess of the PSOAS MUSCLES resulting usually from disease of the lumbar vertebrae, with the pus descending into the muscle sheath. The infection is most commonly tuberculous or staphylococcal.	MESH:D000038	C01.830.025.700	C01.830.025	Abscesses, Iliopsoas|Abscesses, Psoas|Abscesses, Pyogenic Iliopsoas|Abscess, Iliopsoas|Abscess, Psoas|Abscess, Pyogenic Iliopsoas|Iliopsoas Abscess|Iliopsoas Abscesses|Iliopsoas Abscesses, Pyogenic|Iliopsoas Abscess, Pyogenic|Psoas Abscesses|Pyogenic Iliopsoas Abscess|Pyogenic Iliopsoas Abscesses	
Psoriasis	MESH:D011565	DO:DOID:4398|DO:DOID:8893|OMIM:177900|OMIM:601454|OMIM:602723|OMIM:603935|OMIM:604316|OMIM:605364|OMIM:605606|OMIM:607857|OMIM:610707|OMIM:612410|OMIM:612599|OMIM:612950|OMIM:614070|OMIM:614204|OMIM:616106	A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.	MESH:D017444	C17.800.859.675	C17.800.859	ACRODERMATITIS CONTINUA OF HALLOPEAU|DITRA|GENERALIZED PUSTULAR PSORIASIS|GPP|INTERLEUKIN 36 RECEPTOR ANTAGONIST DEFICIENCY|Palmoplantaris Pustulosis|PALMOPLANTAR PUSTULOSIS|Psoriases|PSORIASIS 10, SUSCEPTIBILITY TO|PSORIASIS 11, SUSCEPTIBILITY TO|PSORIASIS 12, SUSCEPTIBILITY TO|PSORIASIS 13, SUSCEPTIBILITY TO|PSORIASIS 14, PUSTULAR|PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO|PSORIASIS 1, SUSCEPTIBILITY TO|PSORIASIS 2|PSORIASIS 3, SUSCEPTIBILITY TO|PSORIASIS 4, SUSCEPTIBILITY TO|PSORIASIS 5, SUSCEPTIBILITY TO|PSORIASIS 6, SUSCEPTIBILITY TO|PSORIASIS 7, SUSCEPTIBILITY TO|PSORIASIS 8, SUSCEPTIBILITY TO|PSORIASIS 9, SUSCEPTIBILITY TO|PSORP|PSORS1|PSORS10|PSORS11|PSORS12|PSORS13|PSORS14|PSORS15|PSORS2|PSORS3|PSORS4|PSORS5|PSORS6|PSORS7|PSORS8|PSORS9|Pustular Psoriasis of Palms and Soles|Pustulosis of Palms and Soles|Pustulosis Palmaris et Plantaris	Skin disease
Psychogenic Nonepileptic Seizures	MESH:D000091323		Seizures caused by psychological factors without electrophysiological epileptic changes.	MESH:D012640	C10.597.742.357|C23.888.592.742.357	C10.597.742|C23.888.592.742	Nonepileptic Seizure, Psychogenic|Pseudoseizure, Psychogenic|Psychogenic Nonepileptic Seizure|Psychogenic Pseudoseizure|Psychogenic Pseudoseizures|Seizure, Psychogenic Nonepileptic	Nervous system disease|Signs and symptoms
Psychomotor Agitation	MESH:D011595		A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.	MESH:D011596|MESH:D020820	C10.597.350.600|C10.597.606.881.700|C23.888.592.350.600|C23.888.592.604.882.700	C10.597.350|C10.597.606.881|C23.888.592.350|C23.888.592.604.882	Agitation, Psychomotor|Akathisia|Excitement, Psychomotor|Hyperactivity, Psychomotor|Psychomotor Excitement|Psychomotor Hyperactivity|Psychomotor Restlessness|Restlessness|Restlessness, Psychomotor	Nervous system disease|Signs and symptoms
Psychomotor Disorders	MESH:D011596		Abnormalities of motor function that are associated with organic and non-organic cognitive disorders.	MESH:D019954	C10.597.606.881|C23.888.592.604.882	C10.597.606|C23.888.592.604	Developmental Psychomotor Disorder|Developmental Psychomotor Disorders|Impairment, Psychomotor|Impairments, Psychomotor|Psychomotor Disorder, Developmental|Psychomotor Disorders, Developmental|Psychomotor Impairment|Psychomotor Impairments	Nervous system disease|Signs and symptoms
Pterygium	MESH:D011625		An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. (Dorland, 27th ed)	MESH:D003229	C11.187.781	C11.187	Pterygiums	Eye disease
Pterygium Of Conjunctiva And Cornea	MESH:C566740	OMIM:178000		MESH:D011625	C11.187.781/C566740	C11.187.781		Eye disease
Ptosis, Hereditary Congenital 1	MESH:C566737	OMIM:178300		MESH:D001763	C11.338.204/C566737	C11.338.204	PTOS1	Eye disease
Ptosis, Strabismus, And Ectopic Pupils	MESH:C566736			MESH:D001763|MESH:D011681|MESH:D013285	C10.292.562.887/C566736|C10.597.690/C566736|C11.338.204/C566736|C11.590.810/C566736|C11.710/C566736|C23.888.592.708/C566736	C10.292.562.887|C10.597.690|C11.338.204|C11.590.810|C11.710|C23.888.592.708		Eye disease|Nervous system disease|Signs and symptoms
Pubic Symphysis Diastasis	MESH:D046548		Separation of the PUBIC SYMPHYSIS. It is an uncommon complication of CHILDBIRTH causing postpartum PAIN, but it can also arise from other causes.	MESH:D000070631|MESH:D011644	C05.550.518.192.500|C12.050.703.844.728|C26.289.192.500	C05.550.518.192|C12.050.703.844|C26.289.192	Diastases, Pubic Symphysis|Diastases, Symphysis Pubis|Diastasis, Pubic Symphysis|Diastasis Symphysis Pubis|Diastasis, Symphysis Pubis|Pubic Symphysis Diastases|Symphysis Pubis Diastases|Symphysis Pubis Diastasis|Symphysis Pubis, Diastasis	Musculoskeletal disease|Pregnancy complication|Wounds and injuries
Pudendal Neuralgia	MESH:D060545		Pain associated with a damaged PUDENDAL NERVE. Clinical features may include positional pain with sitting in the perineal and genital areas, sexual dysfunction and FECAL INCONTINENCE and URINARY INCONTINENCE.	MESH:D009408|MESH:D009437	C10.668.829.550.650|C10.668.829.600.737|C23.888.592.612.664.737	C10.668.829.550|C10.668.829.600|C23.888.592.612.664	Entrapment, Pudendal Nerve|Entrapments, Pudendal Nerve|Nerve Entrapment, Pudendal|Nerve Entrapments, Pudendal|Neuralgia, Pudendal|Neuralgias, Pudendal|Neuropathies, Pudendal|Neuropathy, Pudendal|Pudendal Canal Entrapment Syndrome|Pudendal Nerve Entrapment|Pudendal Nerve Entrapments|Pudendal Nerve Entrapment Syndrome|Pudendal Neuralgias|Pudendal Neuropathies|Pudendal Neuropathy	Nervous system disease|Signs and symptoms
Pulmonary Alveolar Proteinosis	MESH:D011649	DO:DOID:12120	A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.	MESH:D008171	C08.381.719	C08.381	Alveolar Proteinoses, Pulmonary|Alveolar Proteinosis, Pulmonary|Proteinoses, Pulmonary Alveolar|Proteinosis, Pulmonary Alveolar|Pulmonary Alveolar Proteinoses	Respiratory tract disease
Pulmonary Alveolar Proteinosis, Acquired	MESH:C567049			MESH:D001327|MESH:D011649	C08.381.719/C567049|C20.111/C567049	C08.381.719|C20.111	Pulmonary Alveolar Lipoproteinosis, Acquired|Pulmonary Alveolar Proteinosis, Autoimmune	Immune system disease|Respiratory tract disease
Pulmonary alveolar proteinosis, congenital	MESH:C535832			MESH:D011649	C08.381.719/C535832	C08.381.719	Congenital pulmonary alveolar proteinosis	Respiratory tract disease
Pulmonary Arterial Hypertension	MESH:D000081029		A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.	MESH:D006976	C08.381.423.847	C08.381.423	Arterial Hypertension, Pulmonary|Hypertension, Pulmonary Arterial	Respiratory tract disease
Pulmonary Arterial Hypertension, Hereditary Hemorrhagic Telangiectasia-Related	MESH:C563358			MESH:D000081029|MESH:D013684	C08.381.423.847/C563358|C14.907.823/C563358	C08.381.423.847|C14.907.823	Hereditary Hemorrhagic Telangiectasia-Related Pulmonary Arterial Hypertension	Cardiovascular disease|Respiratory tract disease
Pulmonary Atelectasis	MESH:D001261		Absence of air in the entire or part of a lung, such as an incompletely inflated neonate lung or a collapsed adult lung. Pulmonary atelectasis can be caused by airway obstruction, lung compression, fibrotic contraction, or other factors.	MESH:D008171	C08.381.730	C08.381	Atelectases|Atelectases, Compression|Atelectases, Compression Pulmonary|Atelectases, Congestive|Atelectases, Congestive Pulmonary|Atelectases, Contraction Pulmonary|Atelectases, Postoperative Pulmonary|Atelectases, Pulmonary|Atelectases, Resorption|Atelectases, Resorption Pulmonary|Atelectasis|Atelectasis, Compression|Atelectasis, Compression Pulmonary|Atelectasis, Congestive|Atelectasis, Congestive Pulmonary|Atelectasis, Contraction Pulmonary|Atelectasis, Postoperative Pulmonary|Atelectasis, Pulmonary|Atelectasis, Resorption|Atelectasis, Resorption Pulmonary|Collapse, Lung|Compression Atelectases|Compression Atelectasis|Compression Pulmonary Atelectases|Compression Pulmonary Atelectasis|Congestive Atelectases|Congestive Atelectasis|Congestive Pulmonary Atelectases|Congestive Pulmonary Atelectasis|Contraction Pulmonary Atelectases|Contraction Pulmonary Atelectasis|Lung Collapse|Postoperative Pulmonary Atelectases|Postoperative Pulmonary Atelectasis|Pulmonary Atelectases|Pulmonary Atelectases, Compression|Pulmonary Atelectases, Congestive|Pulmonary Atelectases, Contraction|Pulmonary Atelectases, Postoperative|Pulmonary Atelectases, Resorption|Pulmonary Atelectasis, Compression|Pulmonary Atelectasis, Congestive|Pulmonary Atelectasis, Contraction|Pulmonary Atelectasis, Postoperative|Pulmonary Atelectasis, Resorption|Resorption Atelectases|Resorption Atelectasis|Resorption Pulmonary Atelectases|Resorption Pulmonary Atelectasis	Respiratory tract disease
Pulmonary Atresia	MESH:D018633		A congenital heart defect characterized by the narrowing or complete absence of the opening between the RIGHT VENTRICLE and the PULMONARY ARTERY. Lacking a normal PULMONARY VALVE, unoxygenated blood in the right ventricle can not be effectively pumped into the lung for oxygenation. Clinical features include rapid breathing, CYANOSIS, right ventricle atrophy, and abnormal heart sounds (HEART MURMURS).	MESH:D006349|MESH:D054079	C14.240.850.937|C14.280.484.640|C16.131.240.850.906	C14.240.850|C14.280.484|C16.131.240.850	Atresia, Pulmonary|Atresia, Pulmonary Valve|Atresias, Pulmonary|Atresias, Pulmonary Valve|Pulmonary Atresias|Pulmonary Valve Atresia|Pulmonary Valve Atresias|Valve Atresia, Pulmonary|Valve Atresias, Pulmonary	Cardiovascular disease|Congenital abnormality
Pulmonary Atresia with Intact Ventricular Septum	MESH:C562832			MESH:D006330|MESH:D018633	C14.240.400/C562832|C14.240.850.937/C562832|C14.280.400/C562832|C14.280.484.640/C562832|C16.131.240.400/C562832|C16.131.240.850.906/C562832	C14.240.400|C14.240.850.937|C14.280.400|C14.280.484.640|C16.131.240.400|C16.131.240.850.906		Cardiovascular disease|Congenital abnormality
Pulmonary Atresia With Ventricular Septal Defect	MESH:C562833			MESH:D006343|MESH:D018633	C14.240.400.560/C562833|C14.240.850.937/C562833|C14.280.400.560/C562833|C14.280.484.640/C562833|C16.131.240.400.560/C562833|C16.131.240.850.906/C562833	C14.240.400.560|C14.240.850.937|C14.280.400.560|C14.280.484.640|C16.131.240.400.560|C16.131.240.850.906		Cardiovascular disease|Congenital abnormality
Pulmonary Blastoma	MESH:D018202	DO:DOID:4765	A malignant neoplasm of the lung composed chiefly or entirely of immature undifferentiated cells (i.e., blast forms) with little or virtually no stroma. (From Stedman, 25th ed)	MESH:D008175|MESH:D018193	C04.557.435.675|C04.588.894.797.520.867	C04.557.435|C04.588.894.797.520	Blastoma, Pulmonary|Blastomas, Pulmonary|Pulmonary Blastomas	Cancer
Pulmonary Bullae Causing Pneumothorax	MESH:C564863			MESH:D001768|MESH:D011030	C08.528.778/C564863|C17.800.865.187/C564863|C23.300.122/C564863	C08.528.778|C17.800.865.187|C23.300.122		Pathology (anatomical condition)|Respiratory tract disease|Skin disease
Pulmonary Disease, Chronic Obstructive	MESH:D029424	DO:DOID:3083|OMIM:606963	A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.	MESH:D002908|MESH:D008173	C08.381.495.389|C23.550.291.500.875	C08.381.495|C23.550.291.500	Airflow Obstruction, Chronic|Airflow Obstructions, Chronic|Chronic Airflow Obstruction|Chronic Airflow Obstructions|Chronic Obstructive Airway Disease|Chronic Obstructive Lung Disease|Chronic Obstructive Pulmonary Disease|Chronic Obstructive Pulmonary Diseases|COAD|COPD|COPD, SEVERE EARLY-ONSET, INCLUDED|PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, RATE OF DECLINE OF LUNG FUNCTION IN, INCLUDED|PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, SEVERE EARLY-ONSET, INCLUDED	Pathology (process)|Respiratory tract disease
Pulmonary Disease, Chronic Obstructive, Severe Early-Onset	MESH:C564641			MESH:D029424	C08.381.495.389/C564641|C23.550.291.500.875/C564641	C08.381.495.389|C23.550.291.500.875	COPD, Severe Early-Onset	Pathology (process)|Respiratory tract disease
Pulmonary Edema	MESH:D011654	DO:DOID:11396	Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.	MESH:D008171	C08.381.742	C08.381	Edema, Pulmonary|Edemas, Pulmonary|Lungs, Wet|Lung, Wet|Pulmonary Edemas|Wet Lung|Wet Lungs	Respiratory tract disease
Pulmonary edema of mountaineers	MESH:C535833			MESH:D000532|MESH:D006976	C08.381.423/C535833|C08.618.020/C535833|C14.907.489.556/C535833	C08.381.423|C08.618.020|C14.907.489.556	High altitude pulmonary hypertension	Cardiovascular disease|Respiratory tract disease
Pulmonary Embolism	MESH:D011655	DO:DOID:9477	Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.	MESH:D004617|MESH:D008171	C08.381.746|C14.907.355.350.700	C08.381|C14.907.355.350	Embolism, Pulmonary|Embolisms, Pulmonary|Pulmonary Embolisms|Pulmonary Thromboembolism|Pulmonary Thromboembolisms|Thromboembolism, Pulmonary|Thromboembolisms, Pulmonary	Cardiovascular disease|Respiratory tract disease
Pulmonary Emphysema	MESH:D011656		Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions.	MESH:D029424	C08.381.495.389.750|C23.550.291.500.875.875	C08.381.495.389|C23.550.291.500.875	Centriacinar Emphysema|Centriacinar Emphysemas|Centrilobular Emphysema|Centrilobular Emphysemas|Emphysema, Centriacinar|Emphysema, Centrilobular|Emphysema, Focal|Emphysema, Panacinar|Emphysema, Panlobular|Emphysema, Pulmonary|Emphysemas, Centriacinar|Emphysemas, Centrilobular|Emphysemas, Focal|Emphysemas, Panacinar|Emphysemas, Panlobular|Emphysemas, Pulmonary|Focal Emphysema|Focal Emphysemas|Panacinar Emphysema|Panacinar Emphysemas|Panlobular Emphysema|Panlobular Emphysemas|Pulmonary Emphysemas	Pathology (process)|Respiratory tract disease
Pulmonary Eosinophilia	MESH:D011657	DO:DOID:5870|DO:DOID:9498|DO:DOID:9503	A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.	MESH:D008171|MESH:D017681	C08.381.750|C15.378.553.231.549.750	C08.381|C15.378.553.231.549	Eosinophilia, Pulmonary|Eosinophilias, Pulmonary|Eosinophilic Pneumonia|Eosinophilic Pneumonias|Eosinophilic Pneumonias, Tropical|Eosinophilic Pneumonia, Tropical|Loeffler Syndrome|Pneumonia, Eosinophilic|Pneumonias, Eosinophilic|Pulmonary Eosinophilias|Pulmonary Eosinophilia, Simple|Simple Pulmonary Eosinophilia|Simple Pulmonary Eosinophilias|Syndrome, Loeffler|Tropical Eosinophilic Pneumonia|Tropical Eosinophilic Pneumonias	Blood disease|Respiratory tract disease
Pulmonary Fibrosis	MESH:D011658	DO:DOID:3770	A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.	MESH:D005355|MESH:D017563	C08.381.483.652|C23.550.355.644	C08.381.483|C23.550.355	Alveolitides, Fibrosing|Alveolitis, Fibrosing|Fibroses, Pulmonary|Fibrosing Alveolitides|Fibrosing Alveolitis|Fibrosis, Pulmonary|Idiopathic Diffuse Interstitial Pulmonary Fibrosis|Pulmonary Fibroses	Pathology (process)|Respiratory tract disease
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1	OMIM:614742			MESH:D001855|MESH:D011658	C08.381.483.652/614742|C15.378.190/614742|C23.550.355.644/614742	C08.381.483.652|C15.378.190|C23.550.355.644	PFBMFT1	Blood disease|Pathology (process)|Respiratory tract disease
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2	OMIM:614743			MESH:D001855|MESH:D011658	C08.381.483.652/614743|C15.378.190/614743|C23.550.355.644/614743	C08.381.483.652|C15.378.190|C23.550.355.644	PFBMFT2	Blood disease|Pathology (process)|Respiratory tract disease
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3	OMIM:616373			MESH:D001855|MESH:D011658	C08.381.483.652/616373|C15.378.190/616373|C23.550.355.644/616373	C08.381.483.652|C15.378.190|C23.550.355.644	PFBMFT3	Blood disease|Pathology (process)|Respiratory tract disease
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4	OMIM:616371			MESH:D001855|MESH:D011658	C08.381.483.652/616371|C15.378.190/616371|C23.550.355.644/616371	C08.381.483.652|C15.378.190|C23.550.355.644	PFBMFT4	Blood disease|Pathology (process)|Respiratory tract disease
PULMONARY FUNCTION	OMIM:608852			MESH:D008171	C08.381/608852	C08.381	PLF LUNG FUNCTION, SMOKING-RELATED ACCELERATED RATE OF DECLINE IN, INCLUDED	Respiratory tract disease
Pulmonary Heart Disease	MESH:D011660	DO:DOID:8515	Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.	MESH:D006331	C14.280.832	C14.280	Cor Pulmonale|Disease, Pulmonary Heart|Diseases, Pulmonary Heart|Heart Disease, Pulmonary|Heart Diseases, Pulmonary|Pulmonary Heart Diseases	Cardiovascular disease
PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN THROMBOSIS, SUSCEPTIBILITY TO	OMIM:612862			MESH:D006976|MESH:D011655	C08.381.423/612862|C08.381.746/612862|C14.907.355.350.700/612862|C14.907.489.556/612862	C08.381.423|C08.381.746|C14.907.355.350.700|C14.907.489.556	CTEPH, DVT-NEGATIVE, SUSCEPTIBILITY TO	Cardiovascular disease|Respiratory tract disease
PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO	OMIM:615371			MESH:D065627	C08.381.423.300/615371	C08.381.423.300	PHN	Respiratory tract disease
Pulmonary Hypertension, Primary, Autosomal Recessive	MESH:C564862			MESH:D006976	C08.381.423/C564862|C14.907.489.556/C564862	C08.381.423|C14.907.489.556		Cardiovascular disease|Respiratory tract disease
Pulmonary Infarction	MESH:D054060		NECROSIS of lung tissue that is cause by the lack of OXYGEN or blood supply. The most common cause of pulmonary infarction is a blood clot in the lung.	MESH:D007238|MESH:D011655	C08.381.746.500|C14.907.355.350.700.500|C23.550.513.355.875|C23.550.717.489.875	C08.381.746|C14.907.355.350.700|C23.550.513.355|C23.550.717.489	Infarction, Pulmonary|Infarctions, Pulmonary|Infarct, Pulmonary|Infarcts, Pulmonary|Pulmonary Infarct|Pulmonary Infarctions|Pulmonary Infarcts	Cardiovascular disease|Pathology (process)|Respiratory tract disease
Pulmonary Sclerosing Hemangioma	MESH:D047868	DO:DOID:5766	A benign neoplasm of pneumocytes, cells of the PULMONARY ALVEOLI. Originally considered to be vascular in origin, it is now classified as an epithelial tumor with several elements, including solid cellular areas, papillary structure, sclerotic regions, and dilated blood-filled spaces resembling HEMANGIOMA.	MESH:D008175	C04.588.894.797.520.933|C08.381.540.867|C08.785.520.867	C04.588.894.797.520|C08.381.540|C08.785.520	Hemangioma, Sclerosing, Pulmonary|Lung Sclerosing Hemangioma|Lung Sclerosing Hemangiomas|Pulmonary Sclerosing Hemangiomas|Sclerosing Hemangioma, Lung|Sclerosing Hemangioma of the Lung|Sclerosing Hemangioma, Pulmonary|Sclerosing Hemangiomas, Lung|Sclerosing Hemangiomas, Pulmonary	Cancer|Respiratory tract disease
Pulmonary Subvalvular Stenosis	MESH:D011662	DO:DOID:8861	Narrowing below the PULMONARY VALVE or well below it in the infundibuluar chamber where the pulmonary artery originates, usually caused by a defective VENTRICULAR SEPTUM or presence of fibrous tissues. It is characterized by restricted blood outflow from the RIGHT VENTRICLE into the PULMONARY ARTERY, exertional fatigue, DYSPNEA, and chest discomfort.	MESH:D011666	C14.280.484.716.762|C14.280.955.750.762	C14.280.484.716|C14.280.955.750	Conus, Obstructive Subaortic|Infundibular Stenoses, Pulmonary|Infundibular Stenosis, Pulmonary|Obstructive Subaortic Conus|Pulmonary Infundibular Stenoses|Pulmonary Infundibular Stenosis|Pulmonary Stenoses, Subvalvular|Pulmonary Stenosis, Subvalvular|Pulmonary Subvalvular Stenoses|Stenoses, Pulmonary Infundibular|Stenoses, Pulmonary Subvalvular|Stenoses, Subvalvular Pulmonary|Stenosis, Pulmonary Infundibular|Stenosis, Pulmonary Subvalvular|Stenosis, Subvalvular Pulmonary|Subaortic Conus, Obstructive|Subvalvular Pulmonary Stenoses|Subvalvular Pulmonary Stenosis|Subvalvular Stenoses, Pulmonary|Subvalvular Stenosis, Pulmonary	Cardiovascular disease
Pulmonary Valve Insufficiency	MESH:D011665	DO:DOID:14265	Backflow of blood from the PULMONARY ARTERY into the RIGHT VENTRICLE due to imperfect closure of the PULMONARY VALVE.	MESH:D006349	C14.280.484.660	C14.280.484	Incompetence, Pulmonary Valve|Insufficiency, Pulmonary Valve|Pulmonary Regurgitation|Pulmonary Valve Incompetence|Pulmonary Valve Regurgitation|Regurgitation, Pulmonary|Regurgitation, Pulmonary Valve|Valve Incompetence, Pulmonary|Valve Insufficiency, Pulmonary|Valve Regurgitation, Pulmonary	Cardiovascular disease
Pulmonary Valve Stenosis	MESH:D011666	DO:DOID:6420	The pathologic narrowing of the orifice of the PULMONARY VALVE. This lesion restricts blood outflow from the RIGHT VENTRICLE to the PULMONARY ARTERY. When the trileaflet valve is fused into an imperforate membrane, the blockage is complete.	MESH:D006349|MESH:D014694	C14.280.484.716|C14.280.955.750	C14.280.484|C14.280.955	Pulmonary Stenose|Pulmonary Stenoses|Pulmonary Stenosis|Pulmonary Valve Stenoses|Pulmonic Stenoses|Pulmonic Stenoses, Valvular|Pulmonic Stenosis|Pulmonic Stenosis, Valvular|Stenose, Pulmonary|Stenoses, Pulmonary|Stenoses, Pulmonary Valve|Stenoses, Pulmonic|Stenosis, Pulmonary|Stenosis, Pulmonary Valve|Stenosis, Pulmonic|Valvular Pulmonic Stenoses|Valvular Pulmonic Stenosis	Cardiovascular disease
Pulmonary Veno-Occlusive Disease	MESH:D011668	DO:DOID:5453|OMIM:234810|OMIM:265450	Pathological process resulting in the fibrous obstruction of the small- and medium-sized PULMONARY VEINS and PULMONARY HYPERTENSION. Veno-occlusion can arise from fibrous proliferation of the VASCULAR INTIMA and VASCULAR MEDIA; THROMBOSIS; or a combination of both.	MESH:D008171|MESH:D014652	C08.381.780|C14.907.690	C08.381|C14.907	Diseases, Pulmonary Veno-Occlusive|HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY|Pulmonary Venoocclusive Disease|Pulmonary Veno Occlusive Disease|PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT|PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE|Pulmonary Venoocclusive Diseases|Pulmonary Veno-Occlusive Diseases|PVOD|PVOD1|PVOD2|Venoocclusive Disease, Pulmonary|Veno Occlusive Disease, Pulmonary|Veno-Occlusive Disease, Pulmonary|Venoocclusive Diseases, Pulmonary|Veno-Occlusive Diseases, Pulmonary	Cardiovascular disease|Respiratory tract disease
Pulmonic Stenosis and Congenital Nephrosis	MESH:C562895			MESH:D009401|MESH:D011666	C12.050.351.968.419.630/C562895|C12.200.777.419.630/C562895|C12.950.419.630/C562895|C14.280.484.716/C562895|C14.280.955.750/C562895	C12.050.351.968.419.630|C12.200.777.419.630|C12.950.419.630|C14.280.484.716|C14.280.955.750		Cardiovascular disease|Urogenital disease (female)|Urogenital disease (male)
Pupil Disorders	MESH:D011681	DO:DOID:238	Conditions which affect the structure or function of the pupil of the eye, including disorders of innervation to the pupillary constrictor or dilator muscles, and disorders of pupillary reflexes.	MESH:D005128|MESH:D009461	C10.597.690|C11.710|C23.888.592.708	C10.597|C11|C23.888.592	Abnormal Pupillary Function|Abnormal Pupillary Functions|Afferent Pupillary Defect|Afferent Pupillary Defects|Anomalies, Pupillary|Anomaly, Pupillary|Argyll-Robertson Pupil, Non-Syphilitic|Deformed Pupil|Deformed Pupils|Ectopic Pupil|Ectopic Pupils|Efferent Pupillary Defect|Efferent Pupillary Defects|Fixed Pupil|Fixed Pupils|Hemianopic Pupil, Wernicke|Hemianopic Pupil, Wernicke's|Keyhole Pupil|Keyhole Pupils|Malformation, Pupil|Malformations, Pupil|Marcus Gunn Pupil|Marcus-Gunn Pupil|Non Syphilitic Argyll Robertson Pupil|Non-Syphilitic Argyll-Robertson Pupil|Occluded Pupil|Occluded Pupils|Occlusion, Pupillary|Occlusions, Pupillary|Paralyses, Pupillary|Paralyses, Pupillary Sector|Paralysis, Pupillary|Paralysis, Pupillary Sector|Pupil, Deformed|Pupil Disorder|Pupil, Ectopic|Pupil, Fixed|Pupil, Keyhole|Pupillary Anomalies|Pupillary Anomaly|Pupillary Defect, Afferent|Pupillary Defect, Efferent|Pupillary Defects, Afferent|Pupillary Defects, Efferent|Pupillary Disorder|Pupillary Disorders|Pupillary Function, Abnormal|Pupillary Functions, Abnormal|Pupillary Occlusion|Pupillary Occlusions|Pupillary Paralyses|Pupillary Paralysis|Pupillary Sector Paralyses|Pupillary Sector Paralysis|Pupillary Sphincter Rupture|Pupillary Sphincter Ruptures|Pupil Malformation|Pupil Malformations|Pupil, Marcus-Gunn|Pupil, Non-Syphilitic Argyll-Robertson|Pupil, Occluded|Pupil Reaction Absent|Pupils, Deformed|Pupils, Ectopic|Pupils, Fixed|Pupils, Keyhole|Pupils, Occluded|Pupil, Wernicke Hemianopic|Pupil, Wernicke's Hemianopic|Reaction Absent, Pupil|Reaction Absents, Pupil|Rupture, Pupillary Sphincter|Ruptures, Pupillary Sphincter|Sector Paralyses, Pupillary|Sector Paralysis, Pupillary|Sector Pupil Palsy|Sphincter Rupture, Pupillary|Sphincter Ruptures, Pupillary|Wernicke Hemianopic Pupil|Wernicke's Hemianopic Pupil|Wernickes Hemianopic Pupil	Eye disease|Nervous system disease|Signs and symptoms
Pure Autonomic Failure	MESH:D054970		A degenerative disease of the AUTONOMIC NERVOUS SYSTEM that is characterized by idiopathic ORTHOSTATIC HYPOTENSION and a greatly reduced level of CATECHOLAMINES. No other neurological deficits are present.	MESH:D054969	C10.177.575.650	C10.177.575	Autonomic Failure, Pure|Bradbury Eggleston Syndrome|Bradbury-Eggleston Syndrome|Syndrome, Bradbury-Eggleston	Nervous system disease
Purpura	MESH:D011693	DO:DOID:3326	Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS).	MESH:D001778|MESH:D006470|MESH:D012877	C15.378.100.802|C23.550.414.950|C23.888.885.687	C15.378.100|C23.550.414|C23.888.885	Petechiae|Purpuras	Blood disease|Pathology (process)|Signs and symptoms
Purpura Fulminans	MESH:D055665	DO:DOID:0060538	A severe, rapidly fatal reaction occurring most commonly in children following an infectious illness. It is characterized by large, rapidly spreading skin hemorrhages, fever, or shock. Purpura fulminans often accompanies or is triggered by DISSEMINATED INTRAVASCULAR COAGULATION.	MESH:D011693	C15.378.100.802.230|C23.550.414.950.230|C23.888.885.687.230	C15.378.100.802|C23.550.414.950|C23.888.885.687	Fulminans, Purpura	Blood disease|Pathology (process)|Signs and symptoms
Purpura, Hyperglobulinemic	MESH:D011694	DO:DOID:3325	Purplish or brownish red discoloration of the skin associated with increase in circulating polyclonal globulins, usually GAMMA-GLOBULINS. This syndrome often occurs on the legs of women aged 20 to 40 years.	MESH:D011693|MESH:D020141	C14.907.454.550|C15.378.100.802.250|C15.378.463.515.550|C23.550.414.950.250|C23.888.885.687.250	C14.907.454|C15.378.100.802|C15.378.463.515|C23.550.414.950|C23.888.885.687	Benign Hyperglobulinemic Purpura of Waldenström|Hypergammaglobulinemic Purpura of Waldenstrom|Hyperglobulinemic Purpura|Hyperglobulinemic Purpura of Waldenström|Hyperglobulinemic Purpuras|Hyperglobulinemic Purpura, Waldenstrom|Purpuras, Hyperglobulinemic|Purpura, Waldenstrom Hyperglobulinemic|Waldenstrom Hypergammaglobulinemic Purpura|Waldenstrom Hyperglobulinemic Purpura|Waldenström Hyperglobulinemic Purpura	Blood disease|Cardiovascular disease|Pathology (process)|Signs and symptoms
Purpura simplex	MESH:C536249			MESH:D011693	C15.378.100.802/C536249|C23.550.414.950/C536249|C23.888.885.687/C536249	C15.378.100.802|C23.550.414.950|C23.888.885.687	Hereditary familial purpura simplex	Blood disease|Pathology (process)|Signs and symptoms
Purpura, Thrombocytopenic	MESH:D011696		Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.	MESH:D007154|MESH:D011693|MESH:D057049	C15.378.100.802.687|C15.378.140.855.925.750|C20.841|C23.550.414.950.687|C23.888.885.687.687	C15.378.100.802|C15.378.140.855.925|C20|C23.550.414.950|C23.888.885.687	Purpuras, Thrombocytopenic|Purpuras, Thrombopenic|Purpura, Thrombopenic|Thrombocytopenic Purpura|Thrombocytopenic Purpuras|Thrombopenic Purpura|Thrombopenic Purpuras	Blood disease|Immune system disease|Pathology (process)|Signs and symptoms
Purpura, Thrombocytopenic, Idiopathic	MESH:D016553	DO:DOID:8924|OMIM:188030	Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.	MESH:D001327|MESH:D006474|MESH:D011696	C15.378.100.802.687.600|C15.378.140.855.925.750.600|C15.378.463.740|C20.111.759|C20.841.600|C23.550.414.950.687.600|C23.888.885.687.687.600	C15.378.100.802.687|C15.378.140.855.925.750|C15.378.463|C20.111|C20.841|C23.550.414.950.687|C23.888.885.687.687	AITP|Autoimmune Thrombocytopenia|Autoimmune Thrombocytopenias|Autoimmune Thrombocytopenic Purpura|Autoimmune Thrombocytopenic Purpuras|Disease, Werlhof|Disease, Werlhof's|Idiopathic Thrombocytopenic Purpura|Idiopathic Thrombocytopenic Purpuras|Immune Thrombocytopenia|Immune Thrombocytopenias|Immune Thrombocytopenic Purpura|Immune Thrombocytopenic Purpuras|ITP|Purpura, Autoimmune Thrombocytopenic|Purpura, Idiopathic Thrombocytopenic|Purpura, Immune Thrombocytopenic|Purpuras, Autoimmune Thrombocytopenic|Purpuras, Idiopathic Thrombocytopenic|Purpuras, Immune Thrombocytopenic|Purpura, Thrombocytopenic, Autoimmune|Thrombocytopenia, Autoimmune|Thrombocytopenia, Immune|Thrombocytopenias, Autoimmune|Thrombocytopenias, Immune|Thrombocytopenic Purpura, Autoimmune|Thrombocytopenic Purpura, Idiopathic|Thrombocytopenic Purpura, Immune|Thrombocytopenic Purpuras, Idiopathic|Thrombocytopenic Purpuras, Immune|Werlhof Disease|Werlhof's Disease|Werlhofs Disease	Blood disease|Immune system disease|Pathology (process)|Signs and symptoms
Purpura, Thrombotic Thrombocytopenic	MESH:D011697	DO:DOID:10772|OMIM:274150	An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.	MESH:D011696|MESH:D019851	C15.378.100.802.687.680|C15.378.140.855.925.750.680|C15.378.925.850|C23.550.414.950.687.680|C23.888.885.687.687.680	C15.378.100.802.687|C15.378.140.855.925.750|C15.378.925|C23.550.414.950.687|C23.888.885.687.687	Congenital Thrombotic Thrombocytopenic Purpura|Familial Thrombotic Microangiopathy|Familial Thrombotic Thrombocytopenia Purpura|Familial Thrombotic Thrombocytopenic Purpura|MICROANGIOPATHIC HEMOLYTIC ANEMIA|Microangiopathic Hemolytic Anemia, Congenital|Microangiopathy, Familial Thrombotic|Moschcowitz Disease|Moschkowitz Disease|Purpura, Thrombotic Thrombopenic|Schulman Upshaw Syndrome|Schulman-Upshaw Syndrome|Thrombocytopenic Purpura, Thrombotic|Thrombopenic Purpura, Thrombotic|Thrombotic Microangiopathy, Familial|Thrombotic Thrombocytopenic Purpura|Thrombotic Thrombocytopenic Purpura, Congenital|Thrombotic Thrombocytopenic Purpura, Familial|THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY|THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY, INFANTILE- OR ADULT-ONSET|Thrombotic Thrombopenic Purpura|TTP|Upshaw Factor, Deficiency of|Upshaw Schulman Syndrome|Upshaw-Schulman Syndrome|USS	Blood disease|Pathology (process)|Signs and symptoms
Putaminal Hemorrhage	MESH:D020146		Intracranial bleeding into the PUTAMEN, a BASAL GANGLIA nucleus. This is associated with HYPERTENSION and lipohyalinosis of small blood vessels in the putamen. Clinical manifestations vary with the size of hemorrhage, but include HEMIPARESIS; HEADACHE; and alterations of consciousness.	MESH:D020145	C10.228.140.079.127.500.500|C10.228.140.300.100.200.500|C10.228.140.300.535.200.150.500|C14.907.253.061.200.500|C14.907.253.573.200.150.500|C23.550.414.913.100.200.500	C10.228.140.079.127.500|C10.228.140.300.100.200|C10.228.140.300.535.200.150|C14.907.253.061.200|C14.907.253.573.200.150|C23.550.414.913.100.200	Brain Hemorrhage, Putaminal|Brain Hemorrhages, Putaminal|Hemorrhage, Putamen|Hemorrhage, Putaminal|Putamen Hemorrhage|Putaminal Hematoma	Cardiovascular disease|Nervous system disease|Pathology (process)
Pyknoachondrogenesis	MESH:C536251			MESH:D010026	C05.116.099.708.702/C536251	C05.116.099.708.702		Musculoskeletal disease
Pyoderma	MESH:D011711	DO:DOID:4223	Any purulent skin disease (Dorland, 27th ed).	MESH:D012871	C17.800.695	C17.800	Pyodermas	Skin disease
Pyoderma Gangrenosum	MESH:D017511	DO:DOID:8553	An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.	MESH:D011711|MESH:D012883|MESH:D017445	C17.800.695.675|C17.800.862.675|C17.800.893.675	C17.800.695|C17.800.862|C17.800.893		Skin disease
Pyogenic arthritis, pyoderma gangrenosum, and acne	MESH:C536253	OMIM:604416		MESH:D000152|MESH:D001170|MESH:D017511	C01.100/C536253|C05.550.114.099/C536253|C17.800.030.150/C536253|C17.800.695.675/C536253|C17.800.794.111/C536253|C17.800.862.675/C536253|C17.800.893.675/C536253	C01.100|C05.550.114.099|C17.800.030.150|C17.800.695.675|C17.800.794.111|C17.800.862.675|C17.800.893.675	Familial recurrent arthritis|FRA|PAPAS|PAPA syndrome|Pyogenic arthritis, pyoderma gangrenosum, and severe cystic acne|Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, and Acne	Musculoskeletal disease|Skin disease
Pyometra	MESH:D055112		An accumulation of PUS in the uterine cavity (UTERUS). Pyometra generally indicates the presence of infections.	MESH:D014591	C12.050.351.500.852.544|C12.100.250.852.544	C12.050.351.500.852|C12.100.250.852	Pyometras	Urogenital disease (female)
Pyomyositis	MESH:D052880	DO:DOID:876	An intramuscular suppuration of the large skeletal muscle groups. It is associated with INFECTION such as STAPHYLOCOCCUS AUREUS and PYODERMA. It was known as a tropical disease but is increasing among the immunocompromised (IMMUNOCOMPROMISED HOST). Symptoms include muscle pain, FEVER, and leucocytosis. It has been diagnosed by MRI SCANS.	MESH:D009220|MESH:D013492	C01.830.767|C05.651.594.909|C10.668.491.562.787	C01.830|C05.651.594|C10.668.491.562	Myositis, Tropical|Tropical Myositis	Musculoskeletal disease|Nervous system disease
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency	MESH:C566449	DO:DOID:0111329|OMIM:610090		MESH:D001928|MESH:D012640|MESH:D020925	C10.228.140.163/C566449|C10.228.140.300.150.716/C566449|C10.228.140.624.500/C566449|C10.597.742/C566449|C14.907.253.092.716/C566449|C18.452.132/C566449|C23.888.592.742/C566449|C23.888.852.079.797.500/C566449	C10.228.140.163|C10.228.140.300.150.716|C10.228.140.624.500|C10.597.742|C14.907.253.092.716|C18.452.132|C23.888.592.742|C23.888.852.079.797.500	Epileptic Encephalopathy, Neonatal, PNPO-Related|PNPOD|PNPO Deficiency|PNPO-Related Neonatal Epileptic Encephalopathy|Pyridoxal 5'-Phosphate-Dependent Epilepsy|Pyridoxine-5'-Phosphate Oxidase Deficiency|Seizures, Pyridoxine-Resistant, PLP-Sensitive	Cardiovascular disease|Metabolic disease|Nervous system disease|Signs and symptoms
Pyridoxine-dependent epilepsy	MESH:C536254	OMIM:266100|OMIM:617290		MESH:D004827	C10.228.140.490/C536254	C10.228.140.490	Aasa Dehydrogenase Deficiency|EPD|EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT|Epilepsy, Pyridoxine-Dependent|EPVB6D|PDE|Pyridoxine dependency|Pyridoxine dependency with seizures|PYRIDOXINE-DEPENDENT EPILEPSY|Pyridoxine-Dependent Seizures|Vitamin B6-Dependent Seizures	Nervous system disease
Pyruvate Dehydrogenase E1 Alpha Deficiency	MESH:C564071			MESH:D000140	C18.452.076.176.180/C564071	C18.452.076.176.180	Lactic Acidemia, Thiamine Responsive	Metabolic disease
Pyruvate dehydrogenase phosphatase deficiency	MESH:C536258	OMIM:608782		MESH:D000140	C18.452.076.176.180/C536258	C18.452.076.176.180	Lactic acidemia with pyruvate dehydrogenase phosphatase deficiency|PDHPD	Metabolic disease
QT INTERVAL, VARIATION IN	OMIM:610141			MESH:D001145	C14.280.067/610141|C23.550.073/610141	C14.280.067|C23.550.073		Cardiovascular disease|Pathology (process)
Quadricuspid Aortic Valve	MESH:D000082902		Congenital malformation where the AORTIC VALVE has four instead of three cusps. It is often associated with AORTIC REGURGITATION and AORTIC VALVE STENOSIS.	MESH:D000082862|MESH:D006330	C14.240.400.818|C14.280.400.818|C14.280.484.048.937|C16.131.240.400.817	C14.240.400|C14.280.400|C14.280.484.048|C16.131.240.400	Aortic Valve, Quadricuspid|Congenital Quadricuspid Aortic Valve|Quadricuspid Aortic Valve Condition|Quadricuspid Aortic Valve Disease|Quadricuspid Aortic Valve Disorder|Quadricuspid Aortic Valves|Quadricuspid Aortic Valvular Disease	Cardiovascular disease|Congenital abnormality
Quadriplegia	MESH:D011782	DO:DOID:12835	Severe or complete loss of motor function in all four limbs which may result from BRAIN DISEASES; SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or rarely MUSCULAR DISEASES. The locked-in syndrome is characterized by quadriplegia in combination with cranial muscle paralysis. Consciousness is spared and the only retained voluntary motor activity may be limited eye movements. This condition is usually caused by a lesion in the upper BRAIN STEM which injures the descending cortico-spinal and cortico-bulbar tracts.	MESH:D010243	C10.597.622.760|C23.888.592.636.786	C10.597.622|C23.888.592.636	Flaccid Quadriplegia|Flaccid Quadriplegias|Flaccid Tetraplegia|Flaccid Tetraplegias|Paralysis, Spinal, Quadriplegic|Quadripareses|Quadriparesis|Quadriplegia, Flaccid|Quadriplegias|Quadriplegias, Flaccid|Quadriplegia, Spastic|Quadriplegias, Spastic|Spastic Quadriplegia|Spastic Quadriplegias|Spastic Tetraplegia|Spastic Tetraplegias|Tetraplegia|Tetraplegia, Flaccid|Tetraplegias|Tetraplegias, Flaccid|Tetraplegia, Spastic|Tetraplegias, Spastic	Nervous system disease|Signs and symptoms
Rabies	MESH:D011818	DO:DOID:11260	Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf.	MESH:D018353	C01.925.782.580.830.750	C01.925.782.580.830	Hydrophobia|Lyssa|Lyssas	Viral disease
Radial Heads, Posterior Dislocation Of	MESH:C566728			MESH:D017760	C05.116.214/C566728	C05.116.214	Congenital Posterior Dislocation of the Radial Head	Musculoskeletal disease
Radial Neuropathy	MESH:D020425	DO:DOID:12171	Disease involving the RADIAL NERVE. Clinical features include weakness of elbow extension, elbow flexion, supination of the forearm, wrist and finger extension, and thumb abduction. Sensation may be impaired over regions of the dorsal forearm. Common sites of compression or traumatic injury include the AXILLA and radial groove of the HUMERUS.	MESH:D020422	C10.668.829.500.650	C10.668.829.500	Cheiralgia Paresthetica|Cheiralgia Parestheticas|Compression, Radial Nerve|Crutch Palsies|Crutch Palsy|Crutch Paralyses|Crutch Paralysis|Entrapment, Radial Nerve|Lesion, Superficial Radial Nerve|Mononeuropathy, Radial|Nerve Compression, Radial|Nerve Entrapment, Radial|Neuropathy, Radial|Night Palsies, Saturday|Night Palsy, Saturday|Palsies, Saturday Night|Palsy, Crutch|Palsy, Radial|Palsy, Radial Nerve|Palsy, Saturday Night|Paralysis, Crutch|Paresthetica, Cheiralgia|Posterior Interosseous Nerve Syndrome|Radial Mononeuropathies|Radial Mononeuropathy|Radial Nerve Compression|Radial Nerve Compressions|Radial Nerve Disease|Radial Nerve Diseases|Radial Nerve Entrapment|Radial Nerve Entrapments|Radial Nerve Palsies|Radial Nerve Palsy|Radial Neuropathies|Radial Palsies|Radial Palsy|Radial Tunnel Syndrome|Radial Tunnel Syndromes|Saturday Night Palsies|Saturday Night Palsy|Superficial Radial Nerve Lesion|Supinator Syndrome|Supinator Syndromes|Syndrome, Supinator|Tunnel Syndrome, Radial|Wartenberg Syndrome|Wrist Drop|Wrist-Drop	Nervous system disease
Radiation induced angiosarcoma of the breast	MESH:C536264			MESH:D001943|MESH:D006394|MESH:D009381	C04.557.450.795.390/C536264|C04.557.645.390/C536264|C04.588.180/C536264|C04.682/C536264|C17.800.090.500/C536264|C26.733.476/C536264	C04.557.450.795.390|C04.557.645.390|C04.588.180|C04.682|C17.800.090.500|C26.733.476	Post-irradiation angiosarcoma of the breast	Cancer|Skin disease|Wounds and injuries
Radiation induced brachial plexopathy	MESH:C536265			MESH:D011832|MESH:D020516	C10.668.829.100/C536265|C26.733/C536265	C10.668.829.100|C26.733	Radiation induced brachial neuritis|Radiation injury to the brachial plexus	Nervous system disease|Wounds and injuries
Radiation induced meningioma	MESH:C536266	OMIM:606190		MESH:D008579|MESH:D009381	C04.557.580.520/C536266|C04.557.645.520/C536266|C04.588.614.250.580.500/C536266|C04.682/C536266|C10.551.240.500.500/C536266|C26.733.476/C536266	C04.557.580.520|C04.557.645.520|C04.588.614.250.580.500|C04.682|C10.551.240.500.500|C26.733.476	Meningioma, Radiation Induced|MENINGIOMA, RADIATION-INDUCED|MNRI	Cancer|Nervous system disease|Wounds and injuries
Radiation Pneumonitis	MESH:D017564		Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.	MESH:D011832|MESH:D017563|MESH:D055370	C08.381.483.675|C08.381.520.734|C26.733.762	C08.381.483|C08.381.520|C26.733	Pneumonia, Radiation|Pneumonitis, Radiation|Radiation Pneumonia	Respiratory tract disease|Wounds and injuries
Radicular Cyst	MESH:D011842		Slow-growing fluid-filled epithelial sac at the apex of a tooth with a nonvital pulp or defective root canal filling.	MESH:D010483|MESH:D010509	C04.182.089.530.690.790.820|C05.500.470.690.790.820|C07.320.450.670.513.811|C07.320.830.820|C07.465.714.306.820	C04.182.089.530.690.790|C05.500.470.690.790|C07.320.450.670.513|C07.320.830|C07.465.714.306	Apical Periodontal Cyst|Apical Periodontal Cysts|Cyst, Apical Periodontal|Cyst, Periapical|Cyst, Radicular|Cysts, Apical Periodontal|Cysts, Periapical|Cysts, Radicular|Periapical Cyst|Periapical Cysts|Periodontal Cyst, Apical|Periodontal Cysts, Apical|Radicular Cysts	Cancer|Mouth disease|Musculoskeletal disease
Radiculoneuropathy, Fatal Neonatal	MESH:C564857			MESH:D011129	C10.114.750/C564857|C10.314.750/C564857|C10.668.829.800.750/C564857|C20.111.258.750/C564857	C10.114.750|C10.314.750|C10.668.829.800.750|C20.111.258.750		Immune system disease|Nervous system disease
Radiculopathy	MESH:D011843	DO:DOID:4306	Disease involving a spinal nerve root (see SPINAL NERVE ROOTS) which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.	MESH:D010523	C10.668.829.820	C10.668.829	Avulsion, Nerve Root|Avulsions, Nerve Root|Cervical Radiculopathies|Cervical Radiculopathy|Compression, Nerve Root|Compressions, Nerve Root|Inflammation, Nerve Root|Nerve Root Avulsion|Nerve Root Avulsions|Nerve Root Compression|Nerve Root Compressions|Nerve Root Disorder|Nerve Root Disorders|Nerve Root Inflammation|Nerve Root Inflammations|Radiculitides|Radiculitis|Radiculopathies|Radiculopathies, Cervical|Radiculopathy, Cervical	Nervous system disease
Radiodermatitis	MESH:D011855		A cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation.	MESH:D003872|MESH:D011832	C17.800.174.826|C26.733.804	C17.800.174|C26.733	Dermatitides, Radiation-Induced|Dermatitides, Radiation Recall|Dermatitis, Radiation Induced|Dermatitis, Radiation-Induced|Dermatitis, Radiation Recall|Radiation-Induced Dermatitides|Radiation Induced Dermatitis|Radiation-Induced Dermatitis|Radiation Recall Dermatitides|Radiation Recall Dermatitis|Radiation Recall Reaction|Radiation Recall Reactions|Radiodermatitides|Reaction, Radiation Recall|Reactions, Radiation Recall|Recall Reaction, Radiation|Recall Reactions, Radiation	Skin disease|Wounds and injuries
Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia	MESH:C565328	OMIM:605432		MESH:D013580|MESH:D013921	C05.116.099.370.894/C565328|C05.660.906/C565328|C15.378.140.855/C565328|C16.131.621.906/C565328	C05.116.099.370.894|C05.660.906|C15.378.140.855|C16.131.621.906	CTRUS|RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1|RUSAT|RUSAT1|THROMBOCYTOPENIA, CONGENITAL, WITH RADIOULNAR SYNOSTOSIS	Blood disease|Congenital abnormality|Musculoskeletal disease
Ragweed Sensitivity	MESH:C566725	OMIM:179450		MESH:D006969	C20.543.480/C566725	C20.543.480		Immune system disease
Raindrop Hypopigmentation	MESH:C566724			MESH:D017496	C17.800.621.440/C566724	C17.800.621.440		Skin disease
Rambaud Galian syndrome	MESH:C535283			MESH:D001927|MESH:D002114|MESH:D006819|MESH:D007511|MESH:D012164	C08.381.840.500.475/C535283|C08.618.840.500.475/C535283|C10.228.140/C535283|C11.768/C535283|C16.614.521.563.475/C535283|C18.452.174.130/C535283|C23.550.513/C535283	C08.381.840.500.475|C08.618.840.500.475|C10.228.140|C11.768|C16.614.521.563.475|C18.452.174.130|C23.550.513		Eye disease|Infant-newborn disease|Metabolic disease|Nervous system disease|Pathology (process)|Respiratory tract disease
Ramos Arroyo Clark syndrome	MESH:C535286			MESH:D000015|MESH:D003316|MESH:D003638|MESH:D004374|MESH:D008607|MESH:D012164|MESH:D019066	C09.218.458.341.186/C535286|C10.597.606.360/C535286|C10.597.751.418.341.186/C535286|C11.204/C535286|C11.768/C535286|C14.240.400.340/C535286|C14.280.400.340/C535286|C16.131.077/C535286|C16.131.240.400.340/C535286|C23.550.291.812/C535286|C23.888.592.604.646/C535286|C23.888.592.763.393.341.186/C535286|F03.625.539/C535286	C09.218.458.341.186|C10.597.606.360|C10.597.751.418.341.186|C11.204|C11.768|C14.240.400.340|C14.280.400.340|C16.131.077|C16.131.240.400.340|C23.550.291.812|C23.888.592.604.646|C23.888.592.763.393.341.186|F03.625.539	Ramos Arroyo Syndrome	Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Eye disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Ranula	MESH:D011900		A form of retention cyst of the floor of the mouth, usually due to obstruction of the ducts of the submaxillary or sublingual glands, presenting a slowly enlarging painless deep burrowing mucocele of one side of the mouth. It is also called sublingual cyst and sublingual ptyalocele.	MESH:D003560|MESH:D009059	C04.182.766|C07.465.780	C04.182|C07.465	Ranulas	Cancer|Mouth disease
Rapidly progressive glomerulonephritis with pulmonary hemorrhage	MESH:C538458			MESH:D005921|MESH:D006470|MESH:D008171	C08.381/C538458|C12.050.351.968.419.570.363/C538458|C12.200.777.419.570.363/C538458|C12.950.419.570.363/C538458|C23.550.414/C538458	C08.381|C12.050.351.968.419.570.363|C12.200.777.419.570.363|C12.950.419.570.363|C23.550.414	Anti-glomerular basement membrane antibody disease|Glomerulonephritis - pulmonary hemorrhage|Pulmonary renal syndrome	Pathology (process)|Respiratory tract disease|Urogenital disease (female)|Urogenital disease (male)
Rasmussen Johnsen Thomsen syndrome	MESH:C535290			MESH:D004660	C10.228.140.430/C535290|C10.586.250/C535290	C10.228.140.430|C10.586.250	Inherited congenital bilateral atresia of the external auditory canal, congenital bilateral vertical talus and increased interocular distance	Nervous system disease
Raynaud Disease	MESH:D011928	DO:DOID:10300	An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.	MESH:D016491	C14.907.617.812	C14.907.617	Cold Fingers, Hereditary|Raynaud Phenomenon|Raynaud's Disease|Raynauds Disease	Cardiovascular disease
Reactive angioendotheliomatosis	MESH:C535293			MESH:D006390|MESH:D012878	C04.557.645.375.370/C535293|C04.588.805/C535293|C17.800.882/C535293	C04.557.645.375.370|C04.588.805|C17.800.882		Cancer|Skin disease
Reardon Wilson Cavanagh syndrome	MESH:C535295			MESH:D001259|MESH:D006130|MESH:D008607|MESH:D034381	C09.218.458.341/C535295|C10.597.350.090/C535295|C10.597.606.360/C535295|C10.597.751.418.341/C535295|C23.550.393/C535295|C23.888.592.350.090/C535295|C23.888.592.604.646/C535295|C23.888.592.763.393.341/C535295|F03.625.539/C535295	C09.218.458.341|C10.597.350.090|C10.597.606.360|C10.597.751.418.341|C23.550.393|C23.888.592.350.090|C23.888.592.604.646|C23.888.592.763.393.341|F03.625.539	Ataxia-deafness-retardation syndrome|Ataxia, hearing loss, and mental retardation|Familial ataxia, deafness, and developmental delay	Ear-nose-throat disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Rectal Fistula	MESH:D012003	DO:DOID:0060328	An abnormal anatomical passage connecting the RECTUM to the outside, with an orifice at the site of drainage.	MESH:D007412|MESH:D012002	C06.267.550.600|C06.405.469.471.600|C06.405.469.860.752|C23.300.575.185.550.600	C06.267.550|C06.405.469.471|C06.405.469.860|C23.300.575.185.550	Anal Fistula|Fistula, Rectal	Digestive system disease|Pathology (anatomical condition)
Rectal Neoplasms	MESH:D012004	DO:DOID:1984|DO:DOID:1993	Tumors or cancer of the RECTUM.	MESH:D015179	C04.588.274.476.411.307.790|C06.301.371.411.307.790|C06.405.249.411.307.790|C06.405.469.491.307.790|C06.405.469.860.180.500	C04.588.274.476.411.307|C06.301.371.411.307|C06.405.249.411.307|C06.405.469.491.307|C06.405.469.860.180	Cancer of Rectum|Cancer of the Rectum|Cancer, Rectal|Cancer, Rectum|Neoplasm, Rectal|Neoplasm, Rectum|Neoplasms, Rectal|Rectal Cancer|Rectal Cancers|Rectal Neoplasm|Rectal Tumor|Rectal Tumors|Rectum Cancer|Rectum Cancers|Rectum Neoplasm|Rectum Neoplasms|Tumor, Rectal	Cancer|Digestive system disease
Rectal Prolapse	MESH:D012005	DO:DOID:9307	Protrusion of the rectal mucous membrane through the anus. There are various degrees: incomplete with no displacement of the anal sphincter muscle; complete with displacement of the anal sphincter muscle; complete with no displacement of the anal sphincter muscle but with herniation of the bowel; and internal complete with rectosigmoid or upper rectum intussusception into the lower rectum.	MESH:D012002|MESH:D056887	C06.405.469.860.800|C23.300.842.624.500	C06.405.469.860|C23.300.842.624	Anus Prolapse|Anus Prolapses|Prolapse, Anus|Prolapse, Rectal|Prolapses, Anus|Prolapses, Rectal|Rectal Prolapses	Digestive system disease|Pathology (anatomical condition)
Rectocele	MESH:D020047		Herniation of the RECTUM into the VAGINA.	MESH:D006547|MESH:D012002	C06.405.469.860.810|C23.300.707.984	C06.405.469.860|C23.300.707	Proctocele|Proctoceles|Rectoceles	Digestive system disease|Pathology (anatomical condition)
Rectovaginal Fistula	MESH:D012006		An abnormal anatomical passage between the RECTUM and the VAGINA.	MESH:D012003|MESH:D014624	C06.267.550.600.650|C06.405.469.471.600.650|C06.405.469.860.752.650|C12.050.351.500.894.767.249|C12.100.250.894.767.249|C23.300.575.185.550.600.650|C23.300.575.925.558	C06.267.550.600|C06.405.469.471.600|C06.405.469.860.752|C12.050.351.500.894.767|C12.100.250.894.767|C23.300.575.185.550.600|C23.300.575.925	Fistula, Rectovaginal|Fistulas, Rectovaginal|Rectovaginal Fistulas	Digestive system disease|Pathology (anatomical condition)|Urogenital disease (female)
Recurrent Laryngeal Nerve Injuries	MESH:D061226		Traumatic injuries to the RECURRENT LARYNGEAL NERVE that may result in vocal cord dysfunction.	MESH:D061224	C08.360.424.500|C09.400.424.500|C10.292.200.937.750.500|C10.900.300.218.887.750.500|C26.915.300.400.912.750.500	C08.360.424|C09.400.424|C10.292.200.937.750|C10.900.300.218.887.750|C26.915.300.400.912.750	Recurrent Laryngeal Nerve Contusion|Recurrent Laryngeal Nerve Injury|Recurrent Laryngeal Nerve Transection|Recurrent Laryngeal Nerve Trauma|Recurrent Laryngeal Neuropathy, Traumatic	Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Wounds and injuries
Recurrent respiratory papillomatosis	MESH:C535297			MESH:D012141|MESH:D030361	C01.748/C535297|C01.925.256.650/C535297|C01.925.928.725/C535297|C08.730/C535297	C01.748|C01.925.256.650|C01.925.928.725|C08.730	Juvenile laryngeal papilloma|Juvenile-onset recurrent respiratory papillomatosis|Laryngeal papilloma, recurrent|Respiratory papillomatosis	Respiratory tract disease|Viral disease
Recurrent trigger thumb	MESH:C538662			MESH:D052582	C05.651.869.816.800/C538662	C05.651.869.816.800	Bilateral trigger thumb|Congenital trigger thumb	Musculoskeletal disease
Red-Cell Aplasia, Pure	MESH:D012010	DO:DOID:1340	Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.	MESH:D000740	C15.378.071.750	C15.378.071	Aplasia, Erythrocyte|Aplasia Pure Red Cell|Aplasia, Pure Red-Cell|Aplasias, Erythrocyte|Erythrocyte Aplasia|Erythrocyte Aplasias|Pure Red Cell Aplasia|Pure Red-Cell Aplasia|Pure Red-Cell Aplasias|Red Cell Aplasia, Pure|Red-Cell Aplasias, Pure	Blood disease
red meat allergy	MESH:C000655084			MESH:D005512	C20.543.480.370/C000655084	C20.543.480.370	alpha-gal allergy|alpha-gal sensitization|alpha-gal syndrome|galactose-alpha-1,3-galactose allergy|galactose-alpha-1,3-galactose sensitization|galactose-α-1,3-galactose allergy|galactose-α-1,3-galactose sensitization|mammalian meat allergy|red meat sensitization|α-gal allergy|α-gal sensitization|α-gal syndrome	Immune system disease
Red skin pigment anomaly of New Guinea	MESH:C535515			MESH:D010859	C17.800.621/C535515|C23.550.755/C535515	C17.800.621|C23.550.755	Red skin pigment, New Guinea type	Pathology (process)|Skin disease
Reflex, Abnormal	MESH:D012021	OMIM:145290	An abnormal response to a stimulus applied to the sensory components of the nervous system. This may take the form of increased, decreased, or absent reflexes.	MESH:D009461	C10.597.704|C23.888.592.717	C10.597|C23.888.592	Abnormal Deep Tendon Reflex|Abnormal Reflex|Abnormal Reflexes|Absent Reflex|Bulbocavernosus Reflex, Decreased|Bulbocavernousus Reflex Absent|Decreased Bulbocavernosus Reflex|Decreased Reflex|Hoffman's Reflex|HRX|Hyperreflexia|Hyporeflexia|Palmo Mental Reflex|Palmo-Mental Reflex|Pendular Reflex|Reflex, Absent|Reflex Absent, Bulbocavernousus|Reflex, Acoustic, Abnormal|Reflex, Anal, Absent|Reflex, Anal, Decreased|Reflex, Ankle, Abnormal|Reflex, Ankle, Absent|Reflex, Ankle, Decreased|Reflex, Biceps, Abnormal|Reflex, Biceps, Absent|Reflex, Biceps, Decreased|Reflex, Corneal, Absent|Reflex, Corneal, Decreased|Reflex, Decreased|Reflex, Decreased Bulbocavernosus|Reflex, Deep Tendon, Abnormal|Reflex, Deep Tendon, Absent|Reflexes, Abnormal|Reflex, Gag, Absent|Reflex, Gag, Decreased|Reflex, Hoffman's|Reflex, Knee, Abnormal|Reflex, Knee, Decreased|Reflex, Moro, Asymmetric|Reflex, Palmo-Mental|Reflex, Pendular|Reflex, Triceps, Abnormal|Reflex, Triceps, Absent|Reflex, Triceps, Decreased	Nervous system disease|Signs and symptoms
Reflex Sympathetic Dystrophy	MESH:D012019	DO:DOID:1811	A syndrome characterized by severe burning pain in an extremity accompanied by sudomotor, vasomotor, and trophic changes in bone without an associated specific nerve injury. This condition is most often precipitated by trauma to soft tissue or nerve complexes. The skin over the affected region is usually erythematous and demonstrates hypersensitivity to tactile stimuli and erythema. (Adams et al., Principles of Neurology, 6th ed, p1360; Pain 1995 Oct;63(1):127-33)	MESH:D020918	C10.177.195.800|C10.668.829.250.800	C10.177.195|C10.668.829.250	Algodystrophic Syndrome|Algodystrophies|Algodystrophy|Atrophies, Sudek's|Atrophy, Sudek|Atrophy, Sudek's|Cervical Sympathetic Dystrophies|Cervical Sympathetic Dystrophy|Complex Regional Pain Syndrome, Type I|CRPS Type I|CRPS Type Is|Dystrophies, Cervical Sympathetic|Dystrophies, Reflex Sympathetic|Dystrophy, Cervical Sympathetic|Dystrophy, Reflex Sympathetic|Pain Syndrome Type I, Complex Regional|Pain Syndrome Type I, Regional, Complex|Reflex Dystrophia, Sympathetic|Reflex Sympathetic Dystrophies|Reflex Sympathetic Dystrophy Syndrome|RSD (Reflex Sympathetic Dystrophy)|RSDs (Reflex Sympathetic Dystrophy)|Shoulder Hand Syndrome|Shoulder-Hand Syndrome|Shoulder-Hand Syndromes|Sudek Atrophy|Sudek's Atrophies|Sudek's Atrophy|Sudeks Atrophy|Sympathetic Dystrophies, Cervical|Sympathetic Dystrophies, Reflex|Sympathetic Dystrophy, Cervical|Sympathetic Dystrophy, Reflex|Sympathetic Reflex Dystrophia|Sympathetic Reflex Dystrophias|Syndrome, Algodystrophic|Syndrome, Reflex Sympathetic Dystrophy|Syndrome, Shoulder-Hand|Syndromes, Shoulder-Hand|Type I Complex Regional Pain Syndrome|Type I, CRPS	Nervous system disease
Refractive Errors	MESH:D012030	DO:DOID:9835	Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.	MESH:D005128	C11.744	C11	Ametropia|Ametropias|Disorder, Refractive|Disorders, Refractive|Error, Refractive|Errors, Refractive|Refractive Disorder|Refractive Disorders|Refractive Error	Eye disease
Renal Artery Obstruction	MESH:D012078	DO:DOID:2972	Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR).	MESH:D001157|MESH:D007674	C12.050.351.968.419.775|C12.200.777.419.775|C12.950.419.775|C14.907.137.727	C12.050.351.968.419|C12.200.777.419|C12.950.419|C14.907.137	Obstruction, Renal Artery|Obstructions, Renal Artery|Renal Artery Obstructions|Renal Artery Stenoses|Renal Artery Stenosis|Stenoses, Renal Artery|Stenosis, Renal Artery	Cardiovascular disease|Urogenital disease (female)|Urogenital disease (male)
Renal cell carcinoma 1	MESH:C538557			MESH:D002292	C04.557.470.200.025.390/C538557|C04.588.945.947.535.160/C538557|C12.050.351.937.820.535.160/C538557|C12.050.351.968.419.473.160/C538557|C12.200.758.820.750.160/C538557|C12.200.777.419.473.160/C538557|C12.900.820.535.160/C538557|C12.950.419.473.160/C538557|C12.950.983.535.160/C538557	C04.557.470.200.025.390|C04.588.945.947.535.160|C12.050.351.937.820.535.160|C12.050.351.968.419.473.160|C12.200.758.820.750.160|C12.200.777.419.473.160|C12.900.820.535.160|C12.950.419.473.160|C12.950.983.535.160		Cancer|Urogenital disease (female)|Urogenital disease (male)
Renal cysts and diabetes syndrome	MESH:C535520	OMIM:137920		MESH:D002493|MESH:D003924|MESH:D052177	C10.228/C535520|C12.050.351.968.419.403/C535520|C12.200.777.419.403/C535520|C12.950.419.403/C535520|C18.452.394.750.149/C535520|C19.246.300/C535520	C10.228|C12.050.351.968.419.403|C12.200.777.419.403|C12.950.419.403|C18.452.394.750.149|C19.246.300	ADTKD3|CAKUT WITH DIABETES|CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH DIABETES|FJHN, ATYPICAL|Glomerulocystic kidney disease, hypoplastic type|Glomerulocystic kidney, familial hypoplastic|Hyperuricemic nephropathy, familial juvenile, atypical|Maturity-onset diabetes of the young, type 5|MODY5|RCAD|TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 3	Endocrine system disease|Metabolic disease|Nervous system disease|Urogenital disease (female)|Urogenital disease (male)
Renal hepatic pancreatic dysplasia Dandy Walker cyst	MESH:C537756	DO:DOID:0070121|OMIM:267010		MESH:D000015|MESH:D003616|MESH:D010181	C04.182.640/C537756|C06.689.500/C537756|C10.228.140.252.300/C537756|C10.228.140.602.500/C537756|C10.500.205/C537756|C16.131.077/C537756|C16.131.666.205/C537756	C04.182.640|C06.689.500|C10.228.140.252.300|C10.228.140.602.500|C10.500.205|C16.131.077|C16.131.666.205	Goldston syndrome|Meckel like syndrome|Meckel-Like Syndrome|MECKEL SYNDROME, TYPE 7|MKS7|Renal-Hepatic-Pancreatic Dysplasia with Dandy-Walker Cyst	Cancer|Congenital abnormality|Digestive system disease|Nervous system disease
Renal Insufficiency, Chronic	MESH:D051436		Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)	MESH:D002908|MESH:D051437	C12.050.351.968.419.780.750|C12.200.777.419.780.750|C12.950.419.780.750|C23.550.291.500.906	C12.050.351.968.419.780|C12.200.777.419.780|C12.950.419.780|C23.550.291.500	Chronic Kidney Disease|Chronic Kidney Diseases|Chronic Kidney Insufficiencies|Chronic Kidney Insufficiency|Chronic Renal Disease|Chronic Renal Diseases|Chronic Renal Insufficiencies|Chronic Renal Insufficiency|Disease, Chronic Kidney|Disease, Chronic Renal|Diseases, Chronic Kidney|Diseases, Chronic Renal|Kidney Disease, Chronic|Kidney Diseases, Chronic|Kidney Insufficiencies, Chronic|Kidney Insufficiency, Chronic|Renal Disease, Chronic|Renal Diseases, Chronic|Renal Insufficiencies, Chronic	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Renal Tubulopathy, Diabetes Mellitus, and Cerebellar Ataxia due to Duplication of Mitochondrial DNA	MESH:C564014			MESH:D002524|MESH:D003922|MESH:D007674	C10.228.140.252.190/C564014|C10.597.350.090.500/C564014|C12.050.351.968.419/C564014|C12.200.777.419/C564014|C12.950.419/C564014|C18.452.394.750.124/C564014|C19.246.267/C564014|C20.111.327/C564014|C23.888.592.350.090.200/C564014	C10.228.140.252.190|C10.597.350.090.500|C12.050.351.968.419|C12.200.777.419|C12.950.419|C18.452.394.750.124|C19.246.267|C20.111.327|C23.888.592.350.090.200		Endocrine system disease|Immune system disease|Metabolic disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Renoprival hypertension	MESH:C537760			MESH:D006977	C12.050.351.968.419.331/C537760|C12.200.777.419.331/C537760|C12.950.419.331/C537760|C14.907.489.631/C537760	C12.050.351.968.419.331|C12.200.777.419.331|C12.950.419.331|C14.907.489.631		Cardiovascular disease|Urogenital disease (female)|Urogenital disease (male)
Reoviridae Infections	MESH:D012088		Infections produced by reoviruses, general or unspecified.	MESH:D012327	C01.925.782.791	C01.925.782	Infection, Reoviridae|Infection, Reovirus|Infections, Reoviridae|Infections, Reovirus|Reoviridae Infection|Reovirus Infection|Reovirus Infections	Viral disease
Reperfusion Injury	MESH:D015427		Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.	MESH:D011183|MESH:D014652	C14.907.725|C23.550.767.877	C14.907|C23.550.767	Damage, Reperfusion|Injury, Ischemia Reperfusion|Injury, Ischemia-Reperfusion|Injury, Reperfusion|Ischemia-Reperfusion Injuries|Ischemia Reperfusion Injury|Ischemia-Reperfusion Injury|Reperfusion Damage|Reperfusion Damages|Reperfusion Injuries	Cardiovascular disease|Pathology (process)
Respiration Disorders	MESH:D012120		Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.	MESH:D012140	C08.618	C08	Disorder, Respiration|Disorders, Respiration|Respiration Disorder	Respiratory tract disease
Respiratory Aspiration	MESH:D053120		Inhaling liquid or solids, such as stomach contents, into the RESPIRATORY TRACT. When this causes severe lung damage, it is called ASPIRATION PNEUMONIA.	MESH:D010335|MESH:D012120	C08.618.749|C23.550.773	C08.618|C23.550	Aspiration, Respiratory	Pathology (process)|Respiratory tract disease
Respiratory Aspiration of Gastric Contents	MESH:D063466		Inhaling refluxed gastric or duodenal contents.	MESH:D053120|MESH:D057045	C06.405.117.119.500.484.500.500|C08.618.749.500|C23.550.773.500	C06.405.117.119.500.484.500|C08.618.749|C23.550.773		Digestive system disease|Pathology (process)|Respiratory tract disease
Respiratory Distress Syndrome	MESH:D012128	DO:DOID:11394	A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.	MESH:D008171|MESH:D012120	C08.381.840|C08.618.840	C08.381|C08.618	Acute Respiratory Distress Syndrome|Adult Respiratory Distress Syndrome|ARDS, Human|Distress Syndrome, Respiratory|Distress Syndromes, Respiratory|Human ARDS|Lung, Shock|Pediatric Respiratory Distress Syndrome|Respiratory Distress Syndrome, Acute|Respiratory Distress Syndrome, Adult|Respiratory Distress Syndrome, Pediatric|Respiratory Distress Syndromes|Shock Lung|Syndrome, Respiratory Distress	Respiratory tract disease
Respiratory Hypersensitivity	MESH:D012130		A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL.	MESH:D006969|MESH:D012140	C08.674|C20.543.480.680	C08|C20.543.480	Airway Hyper Responsiveness|Airway Hyper-Responsiveness|Hyper-Responsiveness, Airway|Hypersensitivities, Respiratory|Hypersensitivity, Respiratory|Respiratory Hypersensitivities	Immune system disease|Respiratory tract disease
Respiratory Insufficiency	MESH:D012131		Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)	MESH:D012120	C08.618.846	C08.618	Acute Hypercapnic Respiratory Failure|Acute Hypoxemic Respiratory Failure|Depressions, Ventilatory|Failure, Hypercapnic Respiratory|Failure, Hypoxemic Respiratory|Failure, Respiratory|Hypercapnic Acute Respiratory Failure|Hypercapnic Respiratory Failure|Hypercapnic Respiratory Failures|Hypoxemic Acute Respiratory Failure|Hypoxemic Respiratory Failure|Hypoxemic Respiratory Failures|Respiratory Depression|Respiratory Failure|Respiratory Failure, Hypercapnic|Respiratory Failure, Hypoxemic|Respiratory Failures|Ventilatory Depression	Respiratory tract disease
Respiratory Paralysis	MESH:D012133		Complete or severe weakness of the muscles of respiration. This condition may be associated with MOTOR NEURON DISEASES; PERIPHERAL NERVE DISEASES; NEUROMUSCULAR JUNCTION DISEASES; SPINAL CORD DISEASES; injury to the PHRENIC NERVE; and other disorders.	MESH:D010243|MESH:D012131	C08.618.846.812|C10.597.622.812|C23.888.592.636.812	C08.618.846|C10.597.622|C23.888.592.636	Diaphragmatic Paralysis|Muscle Paralyses, Respiratory|Muscle Paralysis, Respiratory|Paralysis, Diaphragmatic|Paralysis, Respiratory|Paralysis, Respiratory Muscle|Respiratory Muscle Paralysis	Nervous system disease|Respiratory tract disease|Signs and symptoms
Respiratory Syncytial Virus Infections	MESH:D018357	DO:DOID:1273	Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.	MESH:D018186	C01.925.782.580.600.550.750	C01.925.782.580.600.550	Infections, Respiratory Syncytial Virus|Respiratory Syncytial Virus Infection	Viral disease
Respiratory Tract Diseases	MESH:D012140		Diseases involving the RESPIRATORY SYSTEM.	MESH:C	C08	C	Disease, Respiratory Tract|Diseases, Respiratory Tract|Respiratory Tract Disease|Tract Disease, Respiratory|Tract Diseases, Respiratory	Respiratory tract disease
Respiratory Tract Fistula	MESH:D016156		An abnormal passage communicating between any component of the respiratory tract or between any part of the respiratory system and surrounding organs.	MESH:D005402|MESH:D012140	C08.702|C23.300.575.687	C08|C23.300.575	Fistula, Respiratory Tract|Fistulas, Respiratory Tract|Respiratory Tract Fistulas	Pathology (anatomical condition)|Respiratory tract disease
Respiratory Tract Infections	MESH:D012141		Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.	MESH:D007239|MESH:D012140	C01.748|C08.730	C01|C08	Infection, Respiratory Tract|Infections, Respiratory|Infections, Respiratory Tract|Infections, Upper Respiratory|Infections, Upper Respiratory Tract|Respiratory Infections|Respiratory Infection, Upper|Respiratory Tract Infection|Upper Respiratory Infections|Upper Respiratory Tract Infection|Upper Respiratory Tract Infections	Respiratory tract disease
Respiratory Tract Neoplasms	MESH:D012142		New abnormal growth of tissue in the RESPIRATORY SYSTEM.	MESH:D012140|MESH:D013899	C04.588.894.797|C08.785	C04.588.894|C08	Neoplasm, Respiratory Tract|Neoplasms, Respiratory Tract|Respiratory Tract Neoplasm|Tract Neoplasm, Respiratory|Tract Neoplasms, Respiratory	Cancer|Respiratory tract disease
Respiratory Underresponsiveness to Hypoxia and Hypercapnia	MESH:C564848			MESH:D012131	C08.618.846/C564848	C08.618.846		Respiratory tract disease
Respirovirus Infections	MESH:D010253		Infections with viruses of the genus RESPIROVIRUS, family PARAMYXOVIRIDAE. Host cell infection occurs by adsorption, via HEMAGGLUTININ, to the cell surface.	MESH:D018184	C01.925.782.580.600.600	C01.925.782.580.600	Infections, Respirovirus	Viral disease
Reticular Dystrophy Of Retinal Pigment Epithelium	MESH:C566721			MESH:D058499	C11.768.585.658/C566721	C11.768.585.658		Eye disease
Retinal Arterial Macroaneurysm	MESH:D000080346		An acquired dilation of the retinal artery often associated with systemic HYPERTENSION.	MESH:D000783|MESH:D058437	C11.768.346.500|C14.907.055.908|C14.907.489.815.500	C11.768.346|C14.907.055|C14.907.489.815	Arteriolar Macroaneurysm, Retinal|Macroaneurysm, Retinal|Macroaneurysm, Retinal Arterial|Macroaneurysm, Retinal Arteriolar|Retinal Arterial Macroaneurysms|Retinal Arteriolar Macroaneurysm|Retinal Arteriolar Macroaneurysms|Retinal Macroaneurysm|Retinal Macroaneurysms|Ruptured Retinal Arterial Macroaneurysm	Cardiovascular disease|Eye disease
RETINAL ARTERIES, TORTUOSITY OF	OMIM:180000	DO:DOID:0111547		MESH:D012166|MESH:D054079	C11.290.807/180000|C11.768.710/180000|C14.240.850/180000|C16.131.240.850/180000|C23.550.414.756.775/180000	C11.290.807|C11.768.710|C14.240.850|C16.131.240.850|C23.550.414.756.775	RATOR|RETINAL HEMORRHAGE WITH VASCULAR TORTUOSITY	Cardiovascular disease|Congenital abnormality|Eye disease|Pathology (process)
Retinal Artery Occlusion	MESH:D015356	DO:DOID:13094|DO:DOID:13098|DO:DOID:8483	Sudden ISCHEMIA in the RETINA due to blocked blood flow through the CENTRAL RETINAL ARTERY or its branches leading to sudden complete or partial loss of vision, respectively, in the eye.	MESH:D001157|MESH:D012164	C11.768.400|C14.907.137.780	C11.768|C14.907.137	Branch Retinal Artery Occlusion|Central Retinal Artery Occlusion|Occlusion, Retinal Artery|Occlusions, Retinal Artery|Retinal Artery Occlusions	Cardiovascular disease|Eye disease
Retinal Cone Dystrophy 1	MESH:C566719	OMIM:180020		MESH:D012162	C11.270.612/C566719|C11.768.585/C566719	C11.270.612|C11.768.585	Cone Dystrophy, Autosomal Dominant|RCD1|Retinal Cone Degeneration	Eye disease
Retinal Degeneration	MESH:D012162	DO:DOID:8466	A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)	MESH:D012164|MESH:D015785	C11.270.612|C11.768.585	C11.270|C11.768	Degeneration, Retinal|Degenerations, Retinal|Retinal Degenerations	Eye disease
Retinal Degeneration and Epilepsy	MESH:C564847			MESH:D004827|MESH:D012162	C10.228.140.490/C564847|C11.270.612/C564847|C11.768.585/C564847	C10.228.140.490|C11.270.612|C11.768.585		Eye disease|Nervous system disease
Retinal Degeneration, Autosomal Recessive, Clumped Pigment Type	MESH:C563527			MESH:D012162	C11.270.612/C563527|C11.768.585/C563527	C11.270.612|C11.768.585		Eye disease
Retinal Detachment	MESH:D012163	DO:DOID:5327	Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).	MESH:D012164	C11.768.648	C11.768	Detachment, Retinal|Detachments, Retinal|Retinal Detachments|Retinal Pigment Epithelial Detachment	Eye disease
Retinal Diseases	MESH:D012164	DO:DOID:5679	Diseases involving the RETINA.	MESH:D005128	C11.768	C11	Disease, Retinal|Diseases, Retinal|Retinal Disease	Eye disease
Retinal Drusen	MESH:D015593	DO:DOID:2569	Colloid or hyaline bodies lying beneath the retinal pigment epithelium. They may occur either secondary to changes in the choroid that affect the pigment epithelium or as an autosomal dominant disorder of the retinal pigment epithelium.	MESH:D012162	C11.768.585.585	C11.768.585	Drusen, Retinal	Eye disease
RETINAL DYSPLASIA, PRIMARY	OMIM:312550			MESH:D012164	C11.768/312550	C11.768	PRD	Eye disease
Retinal Dystrophies	MESH:D058499	DO:DOID:8501	A group of disorders involving predominantly the posterior portion of the ocular fundus, due to degeneration in the sensory layer of the RETINA; RETINAL PIGMENT EPITHELIUM; BRUCH MEMBRANE; CHOROID; or a combination of these tissues.	MESH:D012162	C11.768.585.658	C11.768.585	Dystrophies, Retinal|Dystrophy, Retinal|Retinal Dystrophy	Eye disease
RETINAL DYSTROPHY AND OBESITY	OMIM:616188			MESH:D009765|MESH:D058499	C11.768.585.658/616188|C18.654.726.750.500/616188|C23.888.144.699.500/616188	C11.768.585.658|C18.654.726.750.500|C23.888.144.699.500	RDOB	Eye disease|Nutrition disorder|Signs and symptoms
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME	OMIM:616108			MESH:D002386|MESH:D006130|MESH:D058499	C11.510.245/616108|C11.768.585.658/616108|C23.550.393/616108	C11.510.245|C11.768.585.658|C23.550.393	RDJCSS	Eye disease|Pathology (process)
Retinal Dystrophy, Reticular Pigmentary, of Posterior Pole	MESH:C564844			MESH:D058499	C11.768.585.658/C564844	C11.768.585.658		Eye disease
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES	OMIM:616079			MESH:D058499	C11.768.585.658/616079	C11.768.585.658	RDGCA	Eye disease
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	OMIM:617175			MESH:D058499	C11.768.585.658/617175	C11.768.585.658	RDEOA	Eye disease
Retinal Hemorrhage	MESH:D012166		Bleeding from the vessels of the retina.	MESH:D005130|MESH:D012164	C11.290.807|C11.768.710|C23.550.414.756.775	C11.290|C11.768|C23.550.414.756	Hemorrhage, Retinal|Retinal Hemorrhages	Eye disease|Pathology (process)
Retinal Necrosis Syndrome, Acute	MESH:D015882	DO:DOID:3611	Mild to fulminant necrotizing vaso-occlusive retinitis associated with a high incidence of retinal detachment and poor vision outcome.	MESH:D012173	C11.768.773.674	C11.768.773	Acute Retinal Necroses|Acute Retinal Necrosis|Necroses, Acute Retinal|Necrosis, Acute Retinal|Retinal Necroses, Acute|Retinal Necrosis, Acute	Eye disease
Retinal Neoplasms	MESH:D019572	DO:DOID:4645	Tumors or cancer of the RETINA.	MESH:D005134|MESH:D012164	C04.588.364.818|C11.319.475|C11.768.717	C04.588.364|C11.319|C11.768	Cancer of the Retina|Cancer, Retinal|Cancers, Retinal|Neoplasm, Retinal|Neoplasms, Retinal|Retinal Cancer|Retinal Cancers|Retinal Neoplasm|Retinal Tumor|Retinal Tumors|Tumor, Retinal|Tumors, Retinal	Cancer|Eye disease
Retinal Neovascularization	MESH:D015861		Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.	MESH:D009389|MESH:D012164	C11.768.725|C23.550.589.500.725	C11.768|C23.550.589.500	Disk Neovascularization, Optic|Neovascularization, Optic Disc|Neovascularization, Optic Disk|Neovascularization, Retinal|Neovascularization, Sea Fan|Optic Disc Neovascularization|Optic Disc Neovascularizations|Optic Disk Neovascularization|Optic Disk Neovascularizations|Sea Fan Neovascularization|Sea Fan Neovascularizations	Eye disease|Pathology (process)
Retinal Nonattachment And Falciform Detachment	MESH:C566717			MESH:D012163	C11.768.648/C566717	C11.768.648		Eye disease
Retinal Nonattachment, Nonsyndromic Congenital	MESH:C565633	OMIM:221900		MESH:D012164	C11.768/C565633	C11.768	Detachment of Retina, Congenital|NCRNA|PERSISTENT FETAL VASCULATURE|PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE|PHPVAR|RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT|RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL|RNANC	Eye disease
Retinal Perforations	MESH:D012167	DO:DOID:12514|DO:DOID:7633	Perforations through the whole thickness of the retina including the macula as the result of inflammation, trauma, degeneration, etc. The concept includes retinal breaks, tears, dialyses, and holes.	MESH:D012164	C11.768.740	C11.768	Break, Retinal|Breaks, Retinal|Dialyses, Retinal|Hole, Macular|Hole, Retinal|Holes, Macular|Holes, Retinal|Macular Hole|Macular Holes|Perforation, Retinal|Perforations, Retinal|Retinal Break|Retinal Breaks|Retinal Dialyse|Retinal Dialyses|Retinal Hole|Retinal Holes|Retinal Perforation|Retinal Tear|Retinal Tears|Tear, Retinal|Tears, Retinal	Eye disease
Retinal Telangiectasis	MESH:D058456	DO:DOID:7765|OMIM:300216	A group of rare, idiopathic, congenital retinal vascular anomalies affecting the retinal capillaries. It is characterized by dilation and tortuosity of retinal vessels and formation of multiple aneurysms, with different degrees of leakage and exudates emanating from the blood vessels.	MESH:D012164|MESH:D013684	C11.768.748|C14.907.823.502	C11.768|C14.907.823	Coat Disease|Coats Disease|Coats' Disease|Retinal Telangiectases|RETINAL TELANGIECTASIS|Telangiectases, Retinal|Telangiectasis, Retinal	Cardiovascular disease|Eye disease
Retinal Vasculitis	MESH:D031300	DO:DOID:11563	Inflammation of the retinal vasculature with various causes including infectious disease; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; BEHCET SYNDROME; and CHORIORETINITIS.	MESH:D012164|MESH:D014657	C11.768.757|C14.907.940.815	C11.768|C14.907.940	Vasculitis, Retinal	Cardiovascular disease|Eye disease
Retinal Vein Occlusion	MESH:D012170	DO:DOID:1727|DO:DOID:2450	Blockage of the RETINAL VEIN. Those at high risk for this condition include patients with HYPERTENSION; DIABETES MELLITUS; ATHEROSCLEROSIS; and other CARDIOVASCULAR DISEASES.	MESH:D012164|MESH:D014652|MESH:D020246	C11.768.760|C14.907.355.830.925.650|C14.907.760	C11.768|C14.907|C14.907.355.830.925	Branch Vein Occlusion|Branch Vein Occlusions|Central Retinal Vein Occlusion|Occlusion, Branch Vein|Occlusion, Retinal Vein|Retinal Branch Vein Occlusion|Retinal Vein Occlusions|Retinal Vein Thromboses|Retinal Vein Thrombosis|Thrombosis, Retinal Vein|Vein Occlusion, Branch|Vein Occlusion, Retinal|Vein Thrombosis, Retinal	Cardiovascular disease|Eye disease
Retinitis	MESH:D012173	DO:DOID:10176|DO:DOID:3612	Inflammation of the RETINA. It is rarely limited to the retina, but is commonly associated with diseases of the choroid (CHORIORETINITIS) and of the OPTIC DISK (neuroretinitis).	MESH:D012164	C11.768.773	C11.768	Neuroretinitis	Eye disease
Retinoblastoma	MESH:D012175	DO:DOID:4648|DO:DOID:768|OMIM:180200	A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)	MESH:D015785|MESH:D018302|MESH:D019572	C04.557.465.625.600.725|C04.557.470.670.725|C04.557.580.625.600.725|C04.588.364.818.760|C11.270.862|C11.319.475.760|C11.768.717.760	C04.557.465.625.600|C04.557.470.670|C04.557.580.625.600|C04.588.364.818|C11.270|C11.319.475|C11.768.717	Cancer, Retinoblastoma Eye|Cancers, Retinoblastoma Eye|Eye Cancer, Retinoblastoma|Eye Cancers, Retinoblastoma|Familial Retinoblastoma|Familial Retinoblastomas|Glioblastoma, Retinal|Glioblastomas, Retinal|Glioma, Retinal|Gliomas, Retinal|Hereditary Retinoblastoma|Hereditary Retinoblastomas|Neuroblastoma, Retinal|Neuroblastomas, Retinal|RB|RB1|Retinal Glioblastoma|Retinal Glioblastomas|Retinal Glioma|Retinal Gliomas|Retinal Neuroblastoma|Retinal Neuroblastomas|Retinoblastoma Eye Cancer|Retinoblastoma Eye Cancers|Retinoblastoma, Familial|Retinoblastoma, Hereditary|Retinoblastomas|Retinoblastomas, Familial|Retinoblastomas, Hereditary|Retinoblastoma, Sporadic|Retinoblastomas, Sporadic|Sporadic Retinoblastoma|Sporadic Retinoblastomas	Cancer|Eye disease
Retinopathy of Prematurity	MESH:D012178	DO:DOID:13025	A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)	MESH:D007235|MESH:D012164	C11.768.836|C16.614.521.731	C11.768|C16.614.521	Fibroplasia, Retrolental|Fibroplasias, Retrolental|Prematurity Retinopathies|Prematurity Retinopathy|Retrolental Fibroplasia|Retrolental Fibroplasias	Eye disease|Infant-newborn disease
Retinopathy, Pericentral Pigmentary, Dominant	MESH:C566713			MESH:D009755|MESH:D058499	C11.768.585.658/C566713|C11.966.671/C566713	C11.768.585.658|C11.966.671		Eye disease
Retinoschisis	MESH:D041441	DO:DOID:8465|OMIM:312700	A vitreoretinal dystrophy characterized by splitting of the neuroretinal layers. It occurs in two forms: degenerative retinoschisis and X chromosome-linked juvenile retinoschisis.	MESH:D012162	C11.768.585.865	C11.768.585	Congenital X-Linked Retinoschises|Congenital X Linked Retinoschisis|Congenital X-Linked Retinoschisis|Degenerative Retinoschises|Degenerative Retinoschisis|Juvenile Retinoschises|Juvenile Retinoschises, X-Linked|Juvenile Retinoschisis|Juvenile Retinoschisis, X-Linked|Retinoschises|Retinoschises, Congenital X-Linked|Retinoschises, Degenerative|Retinoschises, Juvenile|Retinoschises, X-Linked|Retinoschises, X-Linked Juvenile|RETINOSCHISIS 1, X-LINKED, JUVENILE|Retinoschisis, Congenital X-Linked|Retinoschisis, Degenerative|Retinoschisis, Juvenile|Retinoschisis, Juvenile, X Chromosome-Linked|Retinoschisis, Juvenile, X-Linked|Retinoschisis, X Linked|Retinoschisis, X-Linked|Retinoschisis X-Linked Juvenile|Retinoschisis, X-Linked Juvenile|RS|RS1|X-Linked Juvenile Retinoschises|X Linked Juvenile Retinoschisis|X-Linked Juvenile Retinoschisis|X-Linked Retinoschises|X-Linked Retinoschises, Congenital|X Linked Retinoschisis|X-Linked Retinoschisis|X-Linked Retinoschisis, Congenital|XLRS1	Eye disease
Retinoschisis, Autosomal Dominant	MESH:C000598640			MESH:D041441	C11.768.585.865/C000598640	C11.768.585.865	Autosomal dominant retinoschisis|Retinoschisis autosomal dominant	Eye disease
Retinoschisis of Fovea	MESH:C538369			MESH:D041441	C11.768.585.865/C538369	C11.768.585.865	Familial foveal retinoschisis|Foveal retinoschisis	Eye disease
Retrobulbar Hemorrhage	MESH:D019315		Hemorrhage within the orbital cavity, posterior to the eyeball.	MESH:D006470|MESH:D009916	C11.675.700|C23.550.414.960	C11.675|C23.550.414	Hemorrhage, Retrobulbar|Retrobulbar Hemorrhages	Eye disease|Pathology (process)
Retrocochlear Diseases	MESH:D012181	DO:DOID:2889	Pathological processes involving the VESTIBULOCOCHLEAR NERVE; BRAINSTEM; or CENTRAL NERVOUS SYSTEM. When hearing loss is due to retrocochlear pathology, it is called retrocochlear hearing loss.	MESH:D004427	C09.218.807	C09.218	Disease, Retrocochlear|Diseases, Retrocochlear|Hearing Loss, Retrocochlear|Retrocochlear Disease|Retrocochlear Hearing Loss	Ear-nose-throat disease
Retroperitoneal liposarcoma	MESH:C538370			MESH:D008080|MESH:D012186	C04.557.450.550.420/C538370|C04.557.450.795.465/C538370|C04.588.033.731/C538370	C04.557.450.550.420|C04.557.450.795.465|C04.588.033.731	Giant pelvic retroperitoneal liposarcoma|Pelvic retroperitoneal liposarcoma	Cancer
Retroperitoneal Neoplasms	MESH:D012186	DO:DOID:5875	New abnormal growth of tissue in the RETROPERITONEAL SPACE.	MESH:D000008	C04.588.033.731	C04.588.033	Neoplasm, Retroperitoneal|Neoplasms, Retroperitoneal|Retroperitoneal Neoplasm	Cancer
Retropharyngeal Abscess	MESH:D017703		An accumulation of purulent material in the space between the PHARYNX and the CERVICAL VERTEBRAE. This usually results from SUPPURATION of retropharyngeal LYMPH NODES in patients with UPPER RESPIRATORY TRACT INFECTIONS, perforation of the pharynx, or head and neck injuries.	MESH:D000038|MESH:D010612	C01.748.561.625|C01.830.025.780|C07.550.781.625|C08.730.561.625|C09.775.649.625	C01.748.561|C01.830.025|C07.550.781|C08.730.561|C09.775.649	Abscesses, Retropharyngeal|Abscess, Retropharyngeal|Retropharyngeal Abscesses	Ear-nose-throat disease|Mouth disease|Respiratory tract disease
Retroviridae Infections	MESH:D012192		Virus diseases caused by the RETROVIRIDAE.	MESH:D012327	C01.925.782.815	C01.925.782	Infection, Retroviridae|Infection, Retrovirus|Infections, Retroviridae|Infections, Retrovirus|Infections, XMRV|Infection, XMRV|Retroviridae Infection|Retrovirus Infection|Retrovirus Infections|Xenotropic MuLV related Virus Infection|Xenotropic MuLV-related Virus Infection|Xenotropic Murine Leukemia Virus related Virus Infection|Xenotropic Murine Leukemia Virus-related Virus Infection|XMRV Infection|XMRV Infections	Viral disease
Reversed halo sign	MESH:C000721353			MESH:D008171	C08.381/C000721353	C08.381	Atoll sign, pulmonary|Reverse halo sign	Respiratory tract disease
Revesz Debuse syndrome	MESH:C538371	OMIM:268130		MESH:D001851	C05.116.198/C538371|C18.452.104/C538371	C05.116.198|C18.452.104	DKCA5|DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 5|Exudative retinopathy with bone marrow failure|Revesz Syndrome	Metabolic disease|Musculoskeletal disease
Reye Syndrome	MESH:D012202	DO:DOID:14525	A form of encephalopathy with fatty infiltration of the LIVER, characterized by brain EDEMA and VOMITING that may rapidly progress to SEIZURES; COMA; and DEATH. It is caused by a generalized loss of mitochondrial function leading to disturbances in fatty acid and CARNITINE metabolism.	MESH:D001928|MESH:D005234	C06.552.241.649|C10.228.140.163.780|C18.452.132.780	C06.552.241|C10.228.140.163|C18.452.132	Adult Reye's Syndrome|Adult Reye Syndrome|Fatty Liver with Encephalopathy|Reye Johnson Syndrome|Reye-Johnson Syndrome|Reye Like Syndrome|Reye-Like Syndrome|Reye's Like Syndrome|Reye's-Like Syndrome|Reye's Syndrome|Reye's Syndrome, Adult|Reye Syndrome, Adult	Digestive system disease|Metabolic disease|Nervous system disease
REYNOLDS SYNDROME	OMIM:613471			MESH:D008105|MESH:D011928|MESH:D012595|MESH:D013684	C06.130.120.135.250.250/613471|C06.552.150.250/613471|C06.552.630.400/613471|C14.907.617.812/613471|C14.907.823/613471|C17.300.799/613471|C17.800.784/613471|C23.550.355.412.400/613471	C06.130.120.135.250.250|C06.552.150.250|C06.552.630.400|C14.907.617.812|C14.907.823|C17.300.799|C17.800.784|C23.550.355.412.400	PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA	Cardiovascular disease|Connective tissue disease|Digestive system disease|Pathology (process)|Skin disease
Rhabdoid Tumor	MESH:D018335	DO:DOID:3672	A rare but highly lethal childhood tumor found almost exclusively in infants. Histopathologically, it resembles RHABDOMYOSARCOMA but the tumor cells are not of myogenic origin. Although it arises primarily in the kidney, it may be found in other parts of the body. The rhabdoid cytomorphology is believed to be the expression of a very primitive malignant cell. (From Holland et al., Cancer Medicine, 3d ed, p2210)	MESH:D018193	C04.557.435.710	C04.557.435	Rhabdoid Tumors|Tumor, Rhabdoid|Tumors, Rhabdoid	Cancer
Rhabdoid Tumor Predisposition Syndrome 1	MESH:C563738	OMIM:609322		MESH:D001932|MESH:D007680|MESH:D018335	C04.557.435.710/C563738|C04.588.614.250.195/C563738|C04.588.945.947.535/C563738|C10.228.140.211/C563738|C10.551.240.250/C563738|C12.050.351.937.820.535/C563738|C12.050.351.968.419.473/C563738|C12.200.758.820.750/C563738|C12.200.777.419.473/C563738|C12.900.820.535/C563738|C12.950.419.473/C563738|C12.950.983.535/C563738	C04.557.435.710|C04.588.614.250.195|C04.588.945.947.535|C10.228.140.211|C10.551.240.250|C12.050.351.937.820.535|C12.050.351.968.419.473|C12.200.758.820.750|C12.200.777.419.473|C12.900.820.535|C12.950.419.473|C12.950.983.535	AT/RT, INCLUDED|Brain Tumor, Posterior Fossa, of Infancy, Familial|BRAIN TUMOR, POSTERIOR FOSSA, OF INFANCY, FAMILIAL MALIGNANT RHABDOID TUMOR, SOMATIC, INCLUDED|Malignant Rhabdoid Tumor, Somatic|RDT, INCLUDED|RHABDOID TUMOR, INCLUDED|RTPS1|TERATOID TUMOR, ATYPICAL, INCLUDED	Cancer|Nervous system disease|Urogenital disease (female)|Urogenital disease (male)
Rhabdoid Tumor Predisposition Syndrome 2	MESH:C567643	OMIM:613325		MESH:D018335	C04.557.435.710/C567643	C04.557.435.710	RTPS2	Cancer
Rhabdomyolysis	MESH:D012206		Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.	MESH:D009135	C05.651.807	C05.651	Rhabdomyolyses	Musculoskeletal disease
Rhabdomyolysis, Cerivastatin-Induced	MESH:C563387			MESH:D012206	C05.651.807/C563387	C05.651.807		Musculoskeletal disease
Rhabdomyoma	MESH:D012207		A benign tumor derived from striated muscle. It is extremely rare, generally occurring in the tongue, neck muscles, larynx, uvula, nasal cavity, axilla, vulva, and heart. These tumors are treated by simple excision. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1354)	MESH:D009214	C04.557.450.590.540.700	C04.557.450.590.540	Rhabdomyomas	Cancer
Rhabdomyosarcoma	MESH:D012208	DO:DOID:3247	A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)	MESH:D009217	C04.557.450.590.550.660|C04.557.450.795.550.660	C04.557.450.590.550|C04.557.450.795.550	Rhabdomyosarcomas	Cancer
Rhabdomyosarcoma 1	MESH:C537883	OMIM:268210		MESH:D012208	C04.557.450.590.550.660/C537883|C04.557.450.795.550.660/C537883	C04.557.450.590.550.660|C04.557.450.795.550.660	RHABDOMYOSARCOMA 1|Rhabdomyosarcoma Chromosomal Region|Rhabdomyosarcoma embryonal 1|Rhabdomyosarcoma, Embryonal, 1|RMS1|RMSCR|RMSE1	Cancer
Rhabdomyosarcoma, Alveolar	MESH:D018232	DO:DOID:4051|OMIM:268220	A form of RHABDOMYOSARCOMA occurring mainly in adolescents and young adults, affecting muscles of the extremities, trunk, orbital region, etc. It is extremely malignant, metastasizing widely at an early stage. Few cures have been achieved and the prognosis is poor. 'Alveolar' refers to its microscopic appearance simulating the cells of the respiratory alveolus. (Holland et al., Cancer Medicine, 3d ed, p2188)	MESH:D012208	C04.557.450.590.550.660.665|C04.557.450.795.550.660.665	C04.557.450.590.550.660|C04.557.450.795.550.660	Alveolar Rhabdomyosarcoma|Alveolar Rhabdomyosarcomas|Rhabdomyosarcoma 2|RHABDOMYOSARCOMA, ALVEOLAR|Rhabdomyosarcomas, Alveolar|RMS2|RMSA	Cancer
Rhabdomyosarcoma, Embryonal	MESH:D018233	DO:DOID:3246	A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The cells are smaller than those of other rhabdomyosarcomas and are of two basic cell types: spindle cells and round cells. This cancer is highly sensitive to chemotherapy and has a high cure rate with multi-modality therapy. (From Holland et al., Cancer Medicine, 3d ed, p2188)	MESH:D012208	C04.557.450.590.550.660.675|C04.557.450.795.550.660.675	C04.557.450.590.550.660|C04.557.450.795.550.660	Embryonal Rhabdomyosarcoma|Embryonal Rhabdomyosarcomas|Rhabdomyosarcomas, Embryonal	Cancer
Rhabdomyosarcoma, Embryonal, 2	MESH:C566709	OMIM:180295		MESH:D012208	C04.557.450.590.550.660/C566709|C04.557.450.795.550.660/C566709	C04.557.450.590.550.660|C04.557.450.795.550.660	RMSE2	Cancer
Rhabdomyosarcoma of the orbit	MESH:C537605	DO:DOID:3259		MESH:D009918|MESH:D018232	C04.557.450.590.550.660.665/C537605|C04.557.450.795.550.660.665/C537605|C04.588.149.721.656/C537605|C04.588.364.659/C537605|C05.116.231.754.659/C537605|C11.319.457/C537605|C11.675.659/C537605	C04.557.450.590.550.660.665|C04.557.450.795.550.660.665|C04.588.149.721.656|C04.588.364.659|C05.116.231.754.659|C11.319.457|C11.675.659		Cancer|Eye disease|Musculoskeletal disease
Rhabdoviridae Infections	MESH:D018353		Virus diseases caused by RHABDOVIRIDAE. Important infections include RABIES; EPHEMERAL FEVER; and vesicular stomatitis.	MESH:D018701	C01.925.782.580.830	C01.925.782.580	Infection, Rhabdoviridae|Infections, Rhabdoviridae|Rhabdoviridae Infection	Viral disease
Rheumatic Nodule	MESH:D012215		A small round or oval, mostly subcutaneous nodule made up chiefly of a mass of Aschoff bodies and seen in cases of rheumatic fever. It is differentiated from the RHEUMATOID NODULE which appears in rheumatoid arthritis, most frequently over bony prominences. (From Dorland, 27th ed)	MESH:D012213	C05.550.114.843.566|C05.799.825.566	C05.550.114.843|C05.799.825	Aschoff Bodies|Bodies, Aschoff|Nodule, Rheumatic|Nodules, Rheumatic|Rheumatic Nodules	Musculoskeletal disease
Rheumatoid Arthritis, Systemic Juvenile	MESH:C565798	OMIM:604302		MESH:D001171	C05.550.114.122/C565798|C05.799.056/C565798|C17.300.775.049/C565798|C20.111.198/C565798	C05.550.114.122|C05.799.056|C17.300.775.049|C20.111.198	Systemic Juvenile Rheumatoid Arthritis	Connective tissue disease|Immune system disease|Musculoskeletal disease
Rheumatoid Vasculitis	MESH:D056653		Necrotizing VASCULITIS of small and medium size vessels, developing as a complication in RHEUMATOID ARTHRITIS patients. It is characterized by peripheral vascular lesions, cutaneous ULCERS, peripheral GANGRENE, and MONONEURITIS MULTIPLEX.	MESH:D001172|MESH:D056647	C05.550.114.154.728|C05.799.114.728|C14.907.940.897.750|C17.300.775.099.728|C20.111.199.581	C05.550.114.154|C05.799.114|C14.907.940.897|C17.300.775.099|C20.111.199	Rheumatoid Vasculitides|Vasculitides, Rheumatoid|Vasculitis, Rheumatoid	Cardiovascular disease|Connective tissue disease|Immune system disease|Musculoskeletal disease
Rhinitis	MESH:D012220	DO:DOID:4483	Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.	MESH:D009668|MESH:D012141	C01.748.674|C08.460.799|C08.730.674|C09.603.799	C01.748|C08.460|C08.730|C09.603	Catarrh, Nasal|Catarrhs, Nasal|Nasal Catarrh|Nasal Catarrhs|Rhinitides	Ear-nose-throat disease|Respiratory tract disease
Rhinitis, Allergic	MESH:D065631	OMIM:607154	An inflammation of the NASAL MUCOSA triggered by ALLERGENS.	MESH:D012130|MESH:D012220	C08.460.799.315|C08.674.453|C09.603.799.315|C20.543.480.680.443	C08.460.799|C08.674|C09.603.799|C20.543.480.680	Allergic Rhinitides|Allergic Rhinitis|ALRH|Rhinitides, Allergic	Ear-nose-throat disease|Immune system disease|Respiratory tract disease
Rhinitis, Allergic, Perennial	MESH:D012221		Inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year. The causes are usually air-borne allergens, particularly dusts, feathers, molds, animal fur, etc.	MESH:D065631	C08.460.799.315.500|C08.674.453.500|C09.603.799.315.500|C20.543.480.680.443.500	C08.460.799.315|C08.674.453|C09.603.799.315|C20.543.480.680.443	Rhinitis, Allergic, Nonseasonal	Ear-nose-throat disease|Immune system disease|Respiratory tract disease
Rhinitis, Allergic, Seasonal	MESH:D006255		Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS.	MESH:D065631	C08.460.799.315.750|C08.674.453.750|C09.603.799.315.750|C20.543.480.680.443.750	C08.460.799.315|C08.674.453|C09.603.799.315|C20.543.480.680.443	Allergic Rhinitides, Seasonal|Allergic Rhinitis, Seasonal|Allergies, Pollen|Allergy, Pollen|Fever, Hay|Hayfever|Hay Fever|Pollen Allergies|Pollen Allergy|Pollinoses|Pollinosis|Rhinitides, Seasonal Allergic|Rhinitis, Seasonal Allergic|Seasonal Allergic Rhinitides|Seasonal Allergic Rhinitis	Ear-nose-throat disease|Immune system disease|Respiratory tract disease
Rhinitis, Atrophic	MESH:D012222	DO:DOID:4731	A chronic inflammation in which the NASAL MUCOSA gradually changes from a functional to a non-functional lining without mucociliary clearance. It is often accompanied by degradation of the bony TURBINATES, and the foul-smelling mucus which forms a greenish crust (ozena).	MESH:D012220	C08.460.799.649|C09.603.799.649	C08.460.799|C09.603.799	Atrophic Rhinitides|Atrophic Rhinitis|Ozena|Ozenas|Rhinitides, Atrophic	Ear-nose-throat disease|Respiratory tract disease
Rhinitis, Vasomotor	MESH:D012223	DO:DOID:4730	A form of non-allergic rhinitis that is characterized by nasal congestion and posterior pharyngeal drainage.	MESH:D012220	C08.460.799.910|C09.603.799.910	C08.460.799|C09.603.799	Rhinitides, Vasomotor|Vasomotor Rhinitides|Vasomotor Rhinitis	Ear-nose-throat disease|Respiratory tract disease
Rhinophyma	MESH:D012224		A manifestation of severe ROSACEA resulting in significant enlargement of the NOSE and occurring primarily in men. It is caused by hypertrophy of the SEBACEOUS GLANDS and surrounding CONNECTIVE TISSUE. The nose is reddened and marked with TELANGIECTASIS.	MESH:D012393|MESH:D012625	C17.800.716.500|C17.800.794.650	C17.800.716|C17.800.794	Rhinophymas	Skin disease
Rhizomelic syndrome	MESH:C537611			MESH:D001848	C05.116.099/C537611	C05.116.099	Familial rhizomelic dysplasia|Rhizomelic dysplasia, familial	Musculoskeletal disease
Rh-Null, Regulator Type	MESH:C564833	OMIM:268150		MESH:D006402	C15.378/C564833	C15.378	RH DEFICIENCY SYNDROME, INCLUDED|RHNR|Rh-Null Disease|RH-NULL DISEASE, REGULATOR TYPE RH-MOD, INCLUDED|RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	Blood disease
rhupus syndrome	MESH:C000717167			MESH:D001172|MESH:D008180	C05.550.114.154/C000717167|C05.799.114/C000717167|C17.300.480/C000717167|C17.300.775.099/C000717167|C20.111.199/C000717167|C20.111.590/C000717167	C05.550.114.154|C05.799.114|C17.300.480|C17.300.775.099|C20.111.199|C20.111.590		Connective tissue disease|Immune system disease|Musculoskeletal disease
Rickets	MESH:D012279	DO:DOID:10609	Disorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances.	MESH:D001851|MESH:D002128|MESH:D014808	C05.116.198.816|C18.452.104.816|C18.452.174.845|C18.654.521.500.133.770.734	C05.116.198|C18.452.104|C18.452.174|C18.654.521.500.133.770	Rachitides|Rachitis	Metabolic disease|Musculoskeletal disease|Nutrition disorder
Rickets, Hypophosphatemic	MESH:D063730		A disorder characterized by HYPOPHOSPHATEMIA; RICKETS; OSTEOMALACIA; resulting from lack of phosphate reabsorption by the kidneys and possible defects in vitamin D metabolism.	MESH:D012279|MESH:D017674	C05.116.198.816.875|C18.452.104.816.875|C18.452.174.845.875|C18.452.750.400.750|C18.654.521.500.133.770.734.875	C05.116.198.816|C18.452.104.816|C18.452.174.845|C18.452.750.400|C18.654.521.500.133.770.734	Acquired Vitamin D Resistant Rickets|Acquired Vitamin D-Resistant Rickets|Hypophosphatemia, Vitamin D-Resistant Rickets|Hypophosphatemic Ricket|Hypophosphatemic Rickets|Hypophosphatemic Vitamin D Resistant Rickets|Hypophosphatemic Vitamin D-Resistant Rickets|Ricket, Hypophosphatemic|Rickets, Vitamin D Resistant|Rickets, Vitamin D-Resistant|Vitamin D-Resistant Rickets	Metabolic disease|Musculoskeletal disease|Nutrition disorder
Right-sided bronchial isomerism	MESH:C000721324			MESH:D059446	C14.240.400.592/C000721324|C14.280.400.592/C000721324|C15.604.744.146/C000721324|C16.131.077.401/C000721324|C16.131.240.400.592/C000721324	C14.240.400.592|C14.280.400.592|C15.604.744.146|C16.131.077.401|C16.131.240.400.592	Bilateral right bronchi|Right bronchial isomerism|Right sided bronchial isomerism	Cardiovascular disease|Congenital abnormality|Lymphatic disease
Right ventricle hypoplasia	MESH:C535682			MESH:D006330	C14.240.400/C535682|C14.280.400/C535682|C16.131.240.400/C535682	C14.240.400|C14.280.400|C16.131.240.400	Hypoplasia of the right ventricle|Isolated hypoplasia of the right ventricle|Isolated right ventricular hypoplasia|Right ventricular hypoplasia|Right Ventricular Hypoplasia, Isolated	Cardiovascular disease|Congenital abnormality
Ring dermoid of cornea	MESH:C535684	DO:DOID:0111548|OMIM:180550		MESH:D003229|MESH:D003316|MESH:D003884	C04.182.201/C535684|C04.557.465.910.250/C535684|C11.187/C535684|C11.204/C535684	C04.182.201|C04.557.465.910.250|C11.187|C11.204	Bilateral, annular limbal dermoids with corneal and conjunctival extension|RDC|Ring dermoid syndrome	Cancer|Eye disease
Rippling muscle disease, 1	MESH:C535686	DO:DOID:0070308|OMIM:600332|OMIM:606072		MESH:D009135	C05.651/C535686|C10.668.491/C535686	C05.651|C10.668.491	LGMD1C, FORMERLY|MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C, FORMERLY|Rippling muscle disease|Rippling Muscle Disease 1|Rippling Muscle Disease 2|RMD|RMD1|RMD2	Musculoskeletal disease|Nervous system disease
RIV immunoglobulin variant protein, human	MESH:C484001			MESH:D006362	C15.378.147.780.490/C484001|C15.604.515.435/C484001|C20.683.780.490/C484001	C15.378.147.780.490|C15.604.515.435|C20.683.780.490	protein RIV, human	Blood disease|Immune system disease|Lymphatic disease
RNA Virus Infections	MESH:D012327		Diseases caused by RNA VIRUSES.	MESH:D014777	C01.925.782	C01.925	Infection, RNA Virus|Infections, RNA Virus|RNA Virus Infection|Virus Infection, RNA|Virus Infections, RNA	Viral disease
Rombo syndrome	MESH:C535870			MESH:D002280|MESH:D003490|MESH:D005148|MESH:D007039|MESH:D012878	C04.557.470.200.165/C535870|C04.557.470.565.165/C535870|C04.588.805/C535870|C17.800.271/C535870|C17.800.329.937/C535870|C17.800.882/C535870|C23.888.248/C535870	C04.557.470.200.165|C04.557.470.565.165|C04.588.805|C17.800.271|C17.800.329.937|C17.800.882|C23.888.248		Cancer|Signs and symptoms|Skin disease
Rosacea	MESH:D012393	DO:DOID:8881	A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).	MESH:D012871	C17.800.716	C17.800	Acne Rosacea|Erythematotelangiectatic Rosacea|Granulomatous Rosacea|Ocular Rosacea|Papulopustular Rosacea|Phymatous Rosacea|Rosacea, Erythematotelangiectatic|Rosacea, Granulomatous|Rosacea, Ocular|Rosacea, Papulopustular|Rosacea, Phymatous	Skin disease
Rosenthal-Kloepfer syndrome	MESH:C535654			MESH:D000172|MESH:D003318|MESH:D012536	C05.116.132.082/C535654|C10.228.140.617.738.250.100/C535654|C11.204.299/C535654|C17.800.738/C535654|C19.700.355.179/C535654	C05.116.132.082|C10.228.140.617.738.250.100|C11.204.299|C17.800.738|C19.700.355.179	Acromegaloid changes, cutis verticis gyrata and corneal leukoma|Acromegaloid Changes, Cutis Verticis Gyrata, And Corneal Leukoma	Endocrine system disease|Eye disease|Musculoskeletal disease|Nervous system disease|Skin disease
Roseolovirus Infections	MESH:D019349		Infection with ROSEOLOVIRUS, the most common in humans being EXANTHEMA SUBITUM, a benign disease of infants and young children.	MESH:D006566	C01.925.256.466.850	C01.925.256.466	Infection, Roseolovirus|Infections, Roseolovirus|Roseolovirus Infection	Viral disease
Rotator Cuff Tear Arthropathy	MESH:D000070656		Rapidly destructive shoulder joint and bone disease found mainly in elderly, and predominantly in women. It is characterized by SHOULDER PAIN; JOINT INSTABILITY; and the presence of crystalline CALCIUM PHOSPHATES in the SYNOVIAL FLUID. It is associated with ROTATOR CUFF INJURIES.	MESH:D000070657|MESH:D002805	C05.550.114.264.500|C05.550.354.250	C05.550.114.264|C05.550.354	Arthropathy, Cuff Tear|Cuff Tear Arthropathy|Milwaukee Shoulder|Milwaukee Shoulder Syndrome|Shoulder, Milwaukee	Musculoskeletal disease
Rotavirus Infections	MESH:D012400		Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.	MESH:D012088	C01.925.782.791.814	C01.925.782.791	Infection, Rotavirus|Infections, Rotavirus|Rotavirus Infection	Viral disease
Rubella	MESH:D012409	DO:DOID:8781	An acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM.	MESH:D018355	C01.925.782.930.700.700	C01.925.782.930.700	German Measles|Measles, German|Measles, Three Day|Measle, Three Day|Rubellas|Three Day Measle|Three Day Measles	Viral disease
Rubivirus Infections	MESH:D018355		Virus diseases caused by the RUBIVIRUS genus, of the family TOGAVIRIDAE.	MESH:D014036	C01.925.782.930.700	C01.925.782.930	Infection, Rubivirus|Infections, Rubivirus|Rubivirus Infection	Viral disease
Rubulavirus Infections	MESH:D019351		Infections with viruses of the genus RUBULAVIRUS, family PARAMYXOVIRIDAE.	MESH:D018184	C01.925.782.580.600.680	C01.925.782.580.600	Infection, Rubulavirus|Infections, Rubulavirus|Rubulavirus Infection	Viral disease
Rumination Syndrome	MESH:D000079562	DO:DOID:11507	A gastrointestinal disorder characterized by repetitive and effortless regurgitation of ingested food from the stomach to the oral cavity in the early POSTPRANDIAL PERIOD. It is associated with functional gastrointestinal pathology (e.g., increased intra-gastric pressure) and psychiatric disorders (e.g., anxiety, depression). It is not limited to infants and distinct from GERD and VOMITING.	MESH:D001068|MESH:D005767	C06.405.609|F03.400.968	C06.405|F03.400	Merycism|Rumination Disorder|Rumination Disorders|Rumination Syndromes	Digestive system disease|Mental disorder
Ruzicka Goerz Anton syndrome	MESH:C537192			MESH:D002573|MESH:D006313|MESH:D007057|MESH:D008607|MESH:D013964|MESH:D017880	C04.588.322.894/C537192|C04.588.443.915/C537192|C05.660.585/C537192|C09.218.458.341.887.432/C537192|C09.218.807.186.432/C537192|C10.228.140.068.432/C537192|C10.597.606.360/C537192|C10.597.751.418.341.887.432/C537192|C10.668.829.550.850.200/C537192|C14.907.863.200/C537192|C16.131.621.174/C537192|C16.131.621.585/C537192|C16.131.831.512/C537192|C16.614.492/C537192|C17.800.428.333/C537192|C17.800.804.512/C537192|C19.344.894/C537192|C19.874.788/C537192|C23.888.592.604.646/C537192|C23.888.592.763.393.341.887.432/C537192|F03.625.539/C537192	C04.588.322.894|C04.588.443.915|C05.660.585|C09.218.458.341.887.432|C09.218.807.186.432|C10.228.140.068.432|C10.597.606.360|C10.597.751.418.341.887.432|C10.668.829.550.850.200|C14.907.863.200|C16.131.621.174|C16.131.621.585|C16.131.831.512|C16.614.492|C17.800.428.333|C17.800.804.512|C19.344.894|C19.874.788|C23.888.592.604.646|C23.888.592.763.393.341.887.432|F03.625.539	Ichthyosis deafness mental retardation skeletal anomalies	Cancer|Cardiovascular disease|Congenital abnormality|Ear-nose-throat disease|Endocrine system disease|Infant-newborn disease|Mental disorder|Musculoskeletal disease|Nervous system disease|Signs and symptoms|Skin disease
Saal Bulas syndrome	MESH:C537193			MESH:D000015|MESH:D006228|MESH:D006330|MESH:D061085|MESH:D065630	C05.390.408/C537193|C05.660.585.988.425/C537193|C10.500.034/C537193|C14.240.400/C537193|C14.280.400/C537193|C16.131.077/C537193|C16.131.240.400/C537193|C16.131.433/C537193|C16.131.621.585.988.500/C537193|C16.131.666.034/C537193|C23.300.008/C537193|C23.300.707.960.500.116/C537193	C05.390.408|C05.660.585.988.425|C10.500.034|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.433|C16.131.621.585.988.500|C16.131.666.034|C23.300.008|C23.300.707.960.500.116	Ectrodactyly, diaphragmatic hernia, congenital heart defect, and agenesis of the corpus callosum	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)
Sackey Sakati Aur syndrome	MESH:C537219			MESH:D000015|MESH:D010198	C15.378.700/C537219|C16.131.077/C537219	C15.378.700|C16.131.077	Aur syndrome|Multiple dysmorphic features and pancytopenia|Pancytopenia multiple congenital anomalies	Blood disease|Congenital abnormality
Sacral Agenesis Syndrome	MESH:C566762			MESH:D008588|MESH:D013724	C04.557.465.910/C566762|C10.500.680.598/C566762|C16.131.666.680.598/C566762|C23.300.707.968/C566762	C04.557.465.910|C10.500.680.598|C16.131.666.680.598|C23.300.707.968	Sacral Agenesis, Hereditary, With Presacral Mass, Anterior Meningocele, And-Or Teratoma, And Anorectal Malformation	Cancer|Congenital abnormality|Nervous system disease|Pathology (anatomical condition)
Sacral meningocele conotruncal heart defects	MESH:C537223			MESH:D000015|MESH:D006330|MESH:D008591	C10.500.680.610/C537223|C14.240.400/C537223|C14.280.400/C537223|C16.131.077/C537223|C16.131.240.400/C537223|C16.131.666.680.610/C537223	C10.500.680.610|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.666.680.610	Kousseff syndrome	Cardiovascular disease|Congenital abnormality|Nervous system disease
Sacral plexopathy	MESH:C537224			MESH:D010523	C10.668.829/C537224	C10.668.829		Nervous system disease
Sacroiliitis	MESH:D058566		Inflammation of the SACROILIAC JOINT. It is characterized by lower back pain, especially upon walking, fever, UVEITIS; PSORIASIS; and decreased range of motion. Many factors are associated with and cause sacroiliitis including infection; injury to spine, lower back, and pelvis; DEGENERATIVE ARTHRITIS; and pregnancy.	MESH:D001168	C05.550.114.854	C05.550.114	Pyogenic Sacroiliitides|Pyogenic Sacroiliitis|Sacroiliitides|Sacroiliitides, Pyogenic|Sacroiliitides, Septic|Sacroiliitis, Pyogenic|Sacroiliitis, Septic|Septic Sacroiliitides|Septic Sacroiliitis	Musculoskeletal disease
Sagging rope sign	MESH:C000721355			MESH:D001847	C05.116/C000721355	C05.116	Hanging rope sign	Musculoskeletal disease
Sagittal Sinus Thrombosis	MESH:D020225	DO:DOID:3576	Formation or presence of a blood clot (THROMBUS) in the SUPERIOR SAGITTAL SINUS or the inferior sagittal sinus. Sagittal sinus thrombosis can result from infections, hematological disorders, CRANIOCEREBRAL TRAUMA; and NEUROSURGICAL PROCEDURES. Clinical features are primarily related to the increased intracranial pressure causing HEADACHE; NAUSEA; and VOMITING. Severe cases can evolve to SEIZURES or COMA.	MESH:D012851	C10.228.140.300.525.425.500.750|C14.907.253.566.350.500.750|C14.907.355.590.213.350.500.750	C10.228.140.300.525.425.500|C14.907.253.566.350.500|C14.907.355.590.213.350.500	Phlebitis, Sagittal Sinus, Septic|Sagittal Sinus Septic Phlebitis|Sagittal Sinus Thrombophlebitis|Sagittal Sinus Thromboses|Septic Phlebitis, Sagittal Sinus|Sinus Thrombophlebitis, Sagittal|Sinus Thromboses, Sagittal|Sinus Thrombosis, Sagittal|Thrombophlebitis, Sagittal Sinus|Thromboses, Sagittal Sinus|Thrombosis, Sagittal Sinus	Cardiovascular disease|Nervous system disease
Salivary Gland Adenoma, Pleomorphic	MESH:C563250	OMIM:181030		MESH:D008949|MESH:D012468	C04.557.435.090/C563250|C04.557.470.035.155/C563250|C04.588.443.591.824/C563250|C07.465.530.824/C563250|C07.465.815.718/C563250	C04.557.435.090|C04.557.470.035.155|C04.588.443.591.824|C07.465.530.824|C07.465.815.718	PSA|SGPA	Cancer|Mouth disease
Salivary Gland Neoplasms	MESH:D012468		Tumors or cancer of the SALIVARY GLANDS.	MESH:D009062|MESH:D012466	C04.588.443.591.824|C07.465.530.824|C07.465.815.718	C04.588.443.591|C07.465.530|C07.465.815	Cancer of Salivary Gland|Cancer of the Salivary Gland|Cancer, Salivary Gland|Cancers, Salivary Gland|Gland Neoplasm, Salivary|Gland Neoplasms, Salivary|Lymphadenoma, Non-Sebaceous|Lymphadenoma, Salivary Gland|Lymphadenoma, Sebaceous|Lymphadenomas, Non-Sebaceous|Lymphadenomas, Salivary Gland|Lymphadenomas, Sebaceous|Neoplasm, Salivary Gland|Neoplasms, Salivary Gland|Non-Sebaceous Lymphadenoma|Non Sebaceous Lymphadenomas|Non-Sebaceous Lymphadenomas|Salivary Gland Cancer|Salivary Gland Cancers|Salivary Gland Lymphadenoma|Salivary Gland Lymphadenomas|Salivary Gland Neoplasm|Sebaceous Lymphadenoma|Sebaceous Lymphadenomas	Cancer|Mouth disease
Salpingitis	MESH:D012488	DO:DOID:5733	Inflammation of the uterine salpinx, the trumpet-shaped FALLOPIAN TUBES, usually caused by ascending infections of organisms from the lower reproductive tract. Salpingitis can lead to tubal scarring, hydrosalpinx, tubal occlusion, INFERTILITY, and ectopic pregnancy (PREGNANCY, ECTOPIC)	MESH:D000292|MESH:D005184	C12.050.351.500.056.390.890|C12.050.351.500.056.750.875|C12.100.250.056.390.890|C12.100.250.056.750.875	C12.050.351.500.056.390|C12.050.351.500.056.750|C12.100.250.056.390|C12.100.250.056.750	Salpingitides	Urogenital disease (female)
Salter-Harris Fractures	MESH:D000072042		Fractures involving a GROWTH PLATE.	MESH:D000072039	C05.550.518.336.875|C26.289.336.875|C26.404.026.500	C05.550.518.336|C26.289.336|C26.404.026	Fracture, Growth Plate|Fractures, Growth Plate|Fractures, Salter-Harris|Growth Plate Fracture|Growth Plate Fractures|Growth Plate Injuries|Growth Plate Injury|Salter Harris Fractures	Musculoskeletal disease|Wounds and injuries
Sandifer syndrome	MESH:C537234			MESH:D005764|MESH:D014103	C06.405.117.119.500.484/C537234|C23.888.592.350.300.800/C537234	C06.405.117.119.500.484|C23.888.592.350.300.800	Sandifer's syndrome	Digestive system disease|Signs and symptoms
Sarcoidosis	MESH:D012507	DO:DOID:11335|OMIM:181000|OMIM:612387|OMIM:612388	An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.	MESH:D008232	C15.604.515.827	C15.604.515	Besnier Boeck Disease|Besnier-Boeck Disease|Besnier Boeck Schaumann Syndrome|Besnier-Boeck-Schaumann Syndrome|Boeck Disease|Boeck Sarcoid|Boeck's Disease|Boecks Disease|Boeck's Sarcoid|Boecks Sarcoid|Disease, Schaumann|Sarcoid, Boeck's|Sarcoidoses|SARCOIDOSIS|SARCOIDOSIS, SUSCEPTIBILITY TO, 1|SARCOIDOSIS, SUSCEPTIBILITY TO, 2|SARCOIDOSIS, SUSCEPTIBILITY TO, 3|Schaumann Disease|Schaumann's Syndrome|Schaumann's Syndromes|Schaumann Syndrome|SS1|SS2|SS3|Syndrome, Besnier-Boeck-Schaumann|Syndrome, Schaumann|Syndrome, Schaumann's	Lymphatic disease
Sarcoidosis, Pulmonary	MESH:D017565	DO:DOID:13406	Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)	MESH:D012507|MESH:D017563	C08.381.483.725|C15.604.515.827.725	C08.381.483|C15.604.515.827	Pulmonary Sarcoidoses|Pulmonary Sarcoidosis|Sarcoidoses, Pulmonary	Lymphatic disease|Respiratory tract disease
Sarcoma	MESH:D012509	DO:DOID:4235|DO:DOID:6193	A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.	MESH:D018204	C04.557.450.795	C04.557.450	Epithelioid Sarcoma|Epithelioid Sarcomas|Sarcoma, Epithelioid|Sarcomas|Sarcomas, Epithelioid|Sarcoma, Soft Tissue|Sarcoma, Spindle Cell|Sarcomas, Soft Tissue|Sarcomas, Spindle Cell|Soft Tissue Sarcoma|Soft Tissue Sarcomas|Spindle Cell Sarcoma|Spindle Cell Sarcomas	Cancer
Sarcoma 180	MESH:D012510		An experimental sarcoma of mice.	MESH:D012513	C04.557.450.795.830.780|C04.619.857.656	C04.557.450.795.830|C04.619.857	Crocker Sarcoma 180|Sarcoma 180, Crocker	Cancer
Sarcoma 37	MESH:D012511		An experimental sarcoma of mice.	MESH:D012513	C04.557.450.795.830.760|C04.619.857.573	C04.557.450.795.830|C04.619.857		Cancer
Sarcoma, Alveolar Soft Part	MESH:D018234	DO:DOID:4239|OMIM:606243	A variety of rare sarcoma having a reticulated fibrous stroma enclosing groups of sarcoma cells, which resemble epithelial cells and are enclosed in alveoli walled with connective tissue. It is a rare tumor, usually occurring between 15 and 35 years of age. It appears in the muscles of the extremities in adults and most commonly in the head and neck regions of children. Though slow-growing, it commonly metastasizes to the lungs, brain, bones, and lymph nodes. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1365)	MESH:D009379|MESH:D012509	C04.557.450.590.775|C04.557.450.795.775	C04.557.450.590|C04.557.450.795	Alveolar Soft Part Sarcoma|Alveolar Soft-Part Sarcoma|ASPS	Cancer
Sarcoma, Clear Cell	MESH:D018227	DO:DOID:4233	A sarcoma of young adults occurring in the lower extremities and acral regions. It is found intimately bound to tendons as a circumscribed but unencapsulated melanin-bearing tumor of neuroectodermal origin. Clear cell sarcoma is associated with a specific t(12;22)(q13;q12) translocation.	MESH:D009372|MESH:D012509	C04.557.450.565.800|C04.557.450.795.800	C04.557.450.565|C04.557.450.795	Clear Cell Sarcoma|Clear Cell Sarcoma of Soft Tissue|Clear Cell Sarcomas|Malignant Melanoma of Soft Parts|Melanoma, Malignant, of Soft Parts|Melanoma of Soft Parts|Sarcomas, Clear Cell	Cancer
Sarcoma, Endometrial Stromal	MESH:D018203	DO:DOID:4226	A highly malignant subset of neoplasms arising from the endometrial stroma. Tumors in this group infiltrate the stroma with a wide range of atypia cells and numerous mitoses. They are capable of widespread metastases (NEOPLASM METASTASIS).	MESH:D018193|MESH:D036821	C04.557.435.775|C04.557.450.795.332.500|C12.050.351.500.852.762.200.500.500|C12.050.351.937.418.875.200.374.500|C12.100.250.852.762.200.500.500|C12.900.418.875.200.374.500	C04.557.435|C04.557.450.795.332|C12.050.351.500.852.762.200.500|C12.050.351.937.418.875.200.374|C12.100.250.852.762.200.500|C12.900.418.875.200.374	Endometrial Stromal Sarcoma|Endometrial Stromal Sarcomas|Sarcomas, Endometrial Stromal|Stromal Sarcoma, Endometrial|Stromal Sarcomas, Endometrial	Cancer|Urogenital disease (female)
Sarcoma, Ewing	MESH:D012512	DO:DOID:3369|OMIM:612219	A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.	MESH:D012516	C04.557.450.565.575.650.800|C04.557.450.795.620.800	C04.557.450.565.575.650|C04.557.450.795.620	ASKIN TUMOR, INCLUDED|ES|Ewing Sarcoma|Ewing's Sarcoma|Ewings Sarcoma|Ewing's Tumor|Ewings Tumor|Ewing Tumor|NEUROEPITHELIOMA, PERIPHERAL, INCLUDED|PNE, INCLUDED|Sarcoma, Ewings|Sarcoma, Ewing's|Tumor, Ewing|Tumor, Ewing's	Cancer
Sarcoma, Experimental	MESH:D012513		Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA.	MESH:D009374|MESH:D012509	C04.557.450.795.830|C04.619.857	C04.557.450.795|C04.619	EHS Tumor|Engelbreth-Holm-Swarm Sarcoma|Experimental Sarcoma|Experimental Sarcomas|Jensen Sarcoma|Sarcoma, Engelbreth Holm Swarm|Sarcoma, Engelbreth-Holm-Swarm|Sarcoma, Jensen|Sarcomas, Experimental|Tumor, EHS	Cancer
Sarcoma, Kaposi	MESH:D012514	DO:DOID:8632|OMIM:148000	A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.	MESH:D006566|MESH:D009383|MESH:D012509	C01.925.256.466.860|C04.557.450.795.850|C04.557.645.750	C01.925.256.466|C04.557.450.795|C04.557.645	Kaposi Sarcoma|KAPOSI SARCOMA, SUSCEPTIBILITY TO|Kaposi's Sarcoma|Kaposis Sarcoma|MCD, INCLUDED|Multiple Idiopathic Pigmented Hemangiosarcoma|MULTIPLE IDIOPATHIC PIGMENTED HEMANGIOSARCOMA, SUSCEPTIBILITY TO MULTICENTRIC CASTLEMAN DISEASE, SUSCEPTIBILITY TO, INCLUDED|Sarcoma, Kaposi's	Cancer|Viral disease
Sarcoma, Myeloid	MESH:D023981	DO:DOID:8683	An extramedullary tumor of immature MYELOID CELLS or MYELOBLASTS. Granulocytic sarcoma usually occurs with or follows the onset of ACUTE MYELOID LEUKEMIA.	MESH:D007951|MESH:D012509	C04.557.337.539.775|C04.557.450.795.853	C04.557.337.539|C04.557.450.795	Chloroma|Chloromas|Extramedullary Myeloid Cell Tumor|Granulocytic Sarcoma|Granulocytic Sarcomas|Myeloid Cell Tumor, Extramedullary|Myeloid Sarcoma|Myeloid Sarcomas|Sarcoma, Granulocytic|Sarcomas, Granulocytic|Sarcomas, Myeloid	Cancer
Sarcoma, Small Cell	MESH:D018228	DO:DOID:3098	A sarcoma characterized by the presence of small cells, cells measuring 9-14 micrometers with a faint or indistinct rim of cytoplasm and an oval-to-elongated nucleus with relatively dense chromatin. (From Segen, Dictionary of Modern Medicine, 1992)	MESH:D009372|MESH:D012509	C04.557.450.565.825|C04.557.450.795.870	C04.557.450.565|C04.557.450.795	Cell Sarcoma, Small|Cell Sarcomas, Small|Sarcomas, Small Cell|Small Cell Sarcoma|Small Cell Sarcomas	Cancer
Sarcoma, Synovial	MESH:D013584	DO:DOID:5485|OMIM:300813	A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)	MESH:D009372|MESH:D012509	C04.557.450.565.835|C04.557.450.795.875	C04.557.450.565|C04.557.450.795	Sarcomas, Synovial|Synovial Sarcoma|Synovial Sarcomas|Synovioma|Synoviomas	Cancer
Sarcoma, Yoshida	MESH:D012517		An experimental sarcoma of rats.	MESH:D012513	C04.557.450.795.830.850|C04.619.857.822	C04.557.450.795.830|C04.619.857	Reticulum Cell Like Sarcoma, Yoshida|Reticulum Cell-Like Sarcoma, Yoshida|Yoshida Sarcoma	Cancer
Sarcopenia	MESH:D055948		Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.	MESH:D009133	C10.597.613.612.500|C23.300.070.500.500|C23.888.592.608.612.500	C10.597.613.612|C23.300.070.500|C23.888.592.608.612	Sarcopenias	Nervous system disease|Pathology (anatomical condition)|Signs and symptoms
Satoyoshi syndrome	MESH:C536616			MESH:D000505|MESH:D003967|MESH:D013035	C10.597.613.750/C536616|C17.800.329.937.122/C536616|C23.300.035/C536616|C23.888.592.608.750/C536616|C23.888.821.214/C536616	C10.597.613.750|C17.800.329.937.122|C23.300.035|C23.888.592.608.750|C23.888.821.214	Komuragaeri Disease|Muscle spasms, intermittent with alopecia, diarrhea, and skeletal abnormalities|Muscle Spasms, Intermittent, With Alopecia, Diarrhea, And Skeletal Abnormalities	Nervous system disease|Pathology (anatomical condition)|Signs and symptoms|Skin disease
Say Barber Miller syndrome	MESH:C536618			MESH:D000361|MESH:D008831	C05.660.207.620/C536618|C10.500.507.400.500/C536618|C15.378.147.142/C536618|C15.604.515.032/C536618|C16.131.621.207.620/C536618|C16.131.666.507.400.500/C536618|C20.673.088/C536618	C05.660.207.620|C10.500.507.400.500|C15.378.147.142|C15.604.515.032|C16.131.621.207.620|C16.131.666.507.400.500|C20.673.088	Microcephaly hypogammaglobulinemia abnormal immunity	Blood disease|Congenital abnormality|Immune system disease|Lymphatic disease|Musculoskeletal disease|Nervous system disease
Scalp Dermatoses	MESH:D012536	DO:DOID:3136	Skin diseases involving the SCALP.	MESH:D012871	C17.800.738	C17.800	Dermatoses, Scalp|Dermatosis, Scalp|Scalp Dermatosis	Skin disease
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY	OMIM:181405	DO:DOID:0111552		MESH:D009134	C10.228.854.468/181405|C10.574.562.500/181405|C10.668.467.500/181405	C10.228.854.468|C10.574.562.500|C10.668.467.500	AMYOTROPHY, NEUROGENIC SCAPULOPERONEAL, NEW ENGLAND TYPE|SPSMA	Nervous system disease
Schaap Taylor Baraitser syndrome	MESH:C536626			MESH:D002386|MESH:D006130|MESH:D006319|MESH:D006983	C09.218.458.341.887/C536626|C10.597.751.418.341.887/C536626|C11.510.245/C536626|C17.800.329.875/C536626|C23.550.393/C536626|C23.888.592.763.393.341.887/C536626	C09.218.458.341.887|C10.597.751.418.341.887|C11.510.245|C17.800.329.875|C23.550.393|C23.888.592.763.393.341.887	Cataracts, sensorineural deafness, hypogonadism, hypertrichosis and short stature	Ear-nose-throat disease|Eye disease|Nervous system disease|Pathology (process)|Signs and symptoms|Skin disease
Scheuermann Disease	MESH:D012544	DO:DOID:13300|OMIM:181440	A type of juvenile osteochondrosis affecting the fibrocartilaginous disc (INTERVERTEBRAL DISC) in the thoracic or thoracolumbar region of the SPINE. It is characterized by a forward concave SPINAL CURVATURE or KYPHOSIS.	MESH:D007738|MESH:D055035	C05.116.821.500.500|C05.116.900.800.500.500|C05.116.900.808.500	C05.116.821.500|C05.116.900.800.500|C05.116.900.808	Adolescent Hyperkyphoses|Adolescent Hyperkyphosis|Adolescent Kyphoses|Adolescent Kyphosis|Hyperkyphoses, Adolescent|Hyperkyphosis, Adolescent|Juvenile Kyphoses|Juvenile Kyphoses, Scheuermann|Juvenile Kyphosis|Juvenile Kyphosis, Scheuermann|Juvenile Osteochondrosis of Spine|Kyphoses, Adolescent|Kyphoses, Juvenile|Kyphoses, Scheuermann|Kyphoses, Scheuermann Juvenile|Kyphoses, Scheuermann's|Kyphosis, Adolescent|Kyphosis, Juvenile|Kyphosis, Scheuermann|Kyphosis, Scheuermann Juvenile|Kyphosis, Scheuermann's|Scheuermann Juvenile Kyphoses|Scheuermann Juvenile Kyphosis|Scheuermann Kyphoses|Scheuermann Kyphosis|Scheuermann's Disease|Scheuermanns Disease|Scheuermann's Kyphoses|Scheuermann's Kyphosis|Scheuermanns Kyphosis|SPINAL OSTEOCHONDROSIS|Spine Juvenile Osteochondroses|Spine Juvenile Osteochondrosis	Musculoskeletal disease
Schnitzler Syndrome	MESH:D019873	DO:DOID:4371	An extremely rare condition manifested as monoclonal IMMUNOGLOBULIN M dysproteinemia without features of lymphoproliferative disease, but with chronic urticaria, fever of unknown origin, disabling bone pain, hyperostosis, and increased erythrocyte sedimentation rate.	MESH:D008998	C20.683.780.640.700	C20.683.780.640		Immune system disease
Schofer Beetz Bohl syndrome	MESH:C535949			MESH:D001928|MESH:D002114|MESH:D003919|MESH:D008607	C10.228.140.163/C535949|C10.597.606.360/C535949|C12.050.351.968.419.135/C535949|C12.200.777.419.135/C535949|C12.950.419.135/C535949|C18.452.132/C535949|C18.452.174.130/C535949|C19.700.159/C535949|C23.888.592.604.646/C535949|F03.625.539/C535949	C10.228.140.163|C10.597.606.360|C12.050.351.968.419.135|C12.200.777.419.135|C12.950.419.135|C18.452.132|C18.452.174.130|C19.700.159|C23.888.592.604.646|F03.625.539		Endocrine system disease|Mental disorder|Metabolic disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Scholte syndrome	MESH:C536638			MESH:D000505|MESH:D007006|MESH:D008607	C10.597.606.360/C536638|C17.800.329.937.122/C536638|C19.391.482/C536638|C23.300.035/C536638|C23.888.592.604.646/C536638|F03.625.539/C536638	C10.597.606.360|C17.800.329.937.122|C19.391.482|C23.300.035|C23.888.592.604.646|F03.625.539	Early balding, patella luxation, acromicria and hypogonadism|Early Balding, Patella Luxation, Acromicria, And Hypogonadism	Endocrine system disease|Mental disorder|Nervous system disease|Pathology (anatomical condition)|Signs and symptoms|Skin disease
Sciatica	MESH:D012585		A condition characterized by pain radiating from the back into the buttock and posterior/lateral aspects of the leg. Sciatica may be a manifestation of SCIATIC NEUROPATHY; RADICULOPATHY (involving the SPINAL NERVE ROOTS; L4, L5, S1, or S2, often associated with INTERVERTEBRAL DISK DISPLACEMENT); or lesions of the CAUDA EQUINA.	MESH:D009437|MESH:D020426	C10.668.829.500.675.800|C10.668.829.600.800|C23.888.592.612.664.800	C10.668.829.500.675|C10.668.829.600|C23.888.592.612.664	Bilateral Sciatica|Bilateral Sciaticas|Neuralgia, Sciatic|Neuralgias, Sciatic|Sciatica, Bilateral|Sciatic Neuralgia|Sciatic Neuralgias	Nervous system disease|Signs and symptoms
Sciatic Neuropathy	MESH:D020426	DO:DOID:11446|DO:DOID:12528	Disease or damage involving the SCIATIC NERVE, which divides into the PERONEAL NERVE and TIBIAL NERVE (see also PERONEAL NEUROPATHIES and TIBIAL NEUROPATHY). Clinical manifestations may include SCIATICA or pain localized to the hip, PARESIS or PARALYSIS of posterior thigh muscles and muscles innervated by the peroneal and tibial nerves, and sensory loss involving the lateral and posterior thigh, posterior and lateral leg, and sole of the foot. The sciatic nerve may be affected by trauma; ISCHEMIA; COLLAGEN DISEASES; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1363)	MESH:D020422	C10.668.829.500.675	C10.668.829.500	Lesion of Sciatic Nerve|Nerve Disease, Sciatic|Nerve Diseases, Sciatic|Nerve Lesion, Sciatic|Nerve Lesions, Sciatic|Nerve Palsies, Sciatic|Nerve Palsy, Sciatic|Neuralgia-Neuritides, Sciatic Nerve|Neuralgia Neuritis, Sciatic Nerve|Neuralgia-Neuritis, Sciatic Nerve|Neuritides, Sciatic|Neuritis, Sciatic|Neuropathies, Sciatic|Neuropathy, Sciatic|Palsies, Sciatic Nerve|Palsy, Sciatic Nerve|Sciatic Nerve Disease|Sciatic Nerve Diseases|Sciatic Nerve Lesion|Sciatic Nerve Lesions|Sciatic Nerve Neuralgia-Neuritides|Sciatic Nerve Neuralgia-Neuritis|Sciatic Nerve Palsies|Sciatic Nerve Palsy|Sciatic Neuritides|Sciatic Neuritis|Sciatic Neuropathies	Nervous system disease
Scimitar Anomaly, Multiple Cardiac Malformations, and Craniofacial and Central Nervous System Abnormalities	MESH:C564262			MESH:D006330|MESH:D012587|MESH:D019465	C05.660.207/C564262|C08.381.844/C564262|C08.695.815/C564262|C14.240.400/C564262|C14.240.850.968/C564262|C14.280.400/C564262|C14.907.780/C564262|C16.131.240.400/C564262|C16.131.240.850.937/C564262|C16.131.621.207/C564262|C16.131.740.815/C564262	C05.660.207|C08.381.844|C08.695.815|C14.240.400|C14.240.850.968|C14.280.400|C14.907.780|C16.131.240.400|C16.131.240.850.937|C16.131.621.207|C16.131.740.815	Anomalous Pulmonary Venous Return, Multiple Cardiac Malformations, and Craniofacial and Central Nervous System Abnormalities	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Respiratory tract disease
Scimitar Syndrome	MESH:D012587	DO:DOID:4297|OMIM:106700	An anomalous pulmonary venous return in which the right PULMONARY VEIN is not connected to the LEFT ATRIUM but to the INFERIOR VENA CAVA. Scimitar syndrome is named for the crescent- or Turkish sword-like shadow in the chest radiography and is often associated with hypoplasia of the right lung and right pulmonary artery, and dextroposition of the heart.	MESH:D008171|MESH:D014652|MESH:D015619|MESH:D054079	C08.381.844|C08.695.815|C14.240.850.968|C14.907.780|C16.131.240.850.937|C16.131.740.815	C08.381|C08.695|C14.240.850|C14.907|C16.131.240.850|C16.131.740	Anomalous Pulmonary Venous Return|Anomaly, Scimitar|APVR|Pulmonary Venous Return Anomaly|Scimitar Anomaly|SCIMITAR SYNDROME|TAPVR|TAPVR1|Total Anomalous Pulmonary Venous Return|Total Anomalous Pulmonary Venous Return 1	Cardiovascular disease|Congenital abnormality|Respiratory tract disease
Scleral Diseases	MESH:D015422	DO:DOID:11343	General disorders of the sclera or white of the eye. They may include anatomic, embryologic, degenerative, or pigmentation defects.	MESH:D005128	C11.790	C11	Disease, Sclera|Disease, Scleral|Diseases, Sclera|Diseases, Scleral|Sclera Disease|Sclera Diseases|Scleral Disease	Eye disease
Scleredema Adultorum	MESH:D012592	DO:DOID:3140	A diffuse, non-pitting induration of the skin of unknown etiology that occurs most commonly in association with diabetes mellitus, predominantly in females. It typically begins on the face or head and spreads to other areas of the body, sometimes involving noncutaneous tissues. Often it is preceded by any of various infections, notably staphylococcal infections. The condition resolves spontaneously, usually within two years of onset. (From Dorland, 27th ed)	MESH:D012871|MESH:D017520	C17.300.550.750|C17.800.751	C17.300.550|C17.800	Buschke Scleredema|Buschke Scleredema Adultorum|Buschke Scleredema Diabeticorum|Buschke's Scleredema|Buschkes Scleredema|Diabeticorum, Scleredema|Diabeticorums, Scleredema|Scleredema|Scleredema Adultorum of Buschke|Scleredema, Buschke's|Scleredema Diabeticorum|Scleredema Diabeticorum of Buschke|Scleredema Diabeticorums|Scleredemas	Connective tissue disease|Skin disease
Scleritis	MESH:D015423	DO:DOID:13452	Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.	MESH:D015422	C11.790.500	C11.790	Episcleritides|Episcleritis|Necrotizing Scleritides|Necrotizing Scleritis|Scleritides|Scleritides, Necrotizing|Scleritis, Necrotizing	Eye disease
Sclerocornea	MESH:C565209	DO:DOID:0060252		MESH:D003316	C11.204/C565209	C11.204		Eye disease
Sclerocornea, Autosomal Dominant	MESH:C566692			MESH:D003316	C11.204/C566692	C11.204		Eye disease
Scleroderma, Diffuse	MESH:D045743	DO:DOID:1580	A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability.	MESH:D012595	C17.300.799.602|C17.800.784.602	C17.300.799|C17.800.784	Diffuse Cutaneous Systemic Sclerosis|Diffuse Scleroderma|Diffuse Systemic Scleroses|Diffuse Systemic Sclerosis|Progressive Scleroderma|Progressive Systemic Sclerosis|Scleroderma, Progressive|Sclerodermas, Sudden Onset|Scleroderma, Sudden Onset|Scleroses, Diffuse Systemic|Sclerosis, Diffuse Systemic|Sclerosis, Progressive Systemic|Sudden Onset Scleroderma|Sudden Onset Sclerodermas|Systemic Scleroses, Diffuse|Systemic Sclerosis, Diffuse|Systemic Sclerosis, Progressive	Connective tissue disease|Skin disease
SCLERODERMA, FAMILIAL PROGRESSIVE	OMIM:181750	DO:DOID:418		MESH:D012595	C17.300.799/181750|C17.800.784/181750	C17.300.799|C17.800.784	SYSTEMIC SCLEROSIS, SUSCEPTIBILITY TO CREST SYNDROME, INCLUDED	Connective tissue disease|Skin disease
Scleroderma, Limited	MESH:D045745	DO:DOID:1577	The least progressive form of SYSTEMIC SCLERODERMA with skin thickening restricted to the face, neck and areas distal to the elbows and/or knees, sparing the trunk. The CREST SYNDROME is a form of limited scleroderma.	MESH:D012595	C17.300.799.801|C17.800.784.801	C17.300.799|C17.800.784	Limited Scleroderma|Limited Systemic Scleroderma|Limited Systemic Sclerodermas|Scleroderma, Limited Systemic|Sclerodermas, Limited Systemic|Systemic Scleroderma, Limited|Systemic Sclerodermas, Limited	Connective tissue disease|Skin disease
Scleroderma, Localized	MESH:D012594	DO:DOID:419|DO:DOID:8472	A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules.	MESH:D003240|MESH:D012871	C17.300.787|C17.800.767	C17.300|C17.800	Circumscribed Scleroderma|Dermatosclerosis|Frontal Linear Scleroderma en Coup de Sabre|Linear Scleroderma|Localized Scleroderma|Morphea|Morpheas|Scleroderma, Circumscribed|Scleroderma, Linear|Sclerodermas, Localized	Connective tissue disease|Skin disease
Scleroderma, Systemic	MESH:D012595	DO:DOID:418	A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.	MESH:D003240|MESH:D012871	C17.300.799|C17.800.784	C17.300|C17.800	Sclerosis, Systemic|Systemic Scleroderma|Systemic Sclerosis	Connective tissue disease|Skin disease
Scleromyxedema	MESH:D053718		A connective tissue disorder characterized by widespread thickening of SKIN with a cobblestone-like appearance. It is caused by proliferation of FIBROBLASTS and deposition of MUCIN in the DERMIS in the absence of thyroid disease. Most scleromyxedema cases are associated with a MONOCLONAL GAMMOPATHY, immunoglobulin IgG-lambda.	MESH:D017520	C17.300.550.875	C17.300.550	Lichen Myxedematosus|Mucinosis, Papular|Myxedematosus, Lichen|Papular Mucinosis	Connective tissue disease
SCLEROSING CHOLANGITIS, NEONATAL	OMIM:617394			MESH:D007232|MESH:D015209	C06.130.120.200.110/617394|C16.614/617394	C06.130.120.200.110|C16.614	NSC	Digestive system disease|Infant-newborn disease
Sclerosing lymphocytic lobulitis	MESH:C537524			MESH:D001941|MESH:D008218|MESH:D012598	C15.378.553.475.604/C537524|C17.800.090/C537524|C23.550.823/C537524	C15.378.553.475.604|C17.800.090|C23.550.823	Sclerosing lymphocytic lobulitis of the breast	Blood disease|Pathology (process)|Skin disease
Sclerotylosis	MESH:C537526	OMIM:181600		MESH:D007642|MESH:D012594|MESH:D012878	C04.588.805/C537526|C17.300.787/C537526|C17.800.428/C537526|C17.800.767/C537526|C17.800.882/C537526	C04.588.805|C17.300.787|C17.800.428|C17.800.767|C17.800.882	HRZ|Huriez syndrome|Scleroatrophic and keratotic dermatosis of limbs|SCLEROTYLOSIS	Cancer|Connective tissue disease|Skin disease
Scoliosis	MESH:D012600	DO:DOID:0060249	An appreciable lateral deviation in the normally straight vertical line of the spine. (Dorland, 27th ed)	MESH:D013121	C05.116.900.800.875	C05.116.900.800	Scolioses	Musculoskeletal disease
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 1	OMIM:181800			MESH:D012600	C05.116.900.800.875/181800	C05.116.900.800.875	ADOLESCENT IDIOPATHIC SCOLIOSIS|ADOLESCENT ISOLATED SCOLIOSIS|AIS|IS1	Musculoskeletal disease
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 2	OMIM:607354			MESH:D012600	C05.116.900.800.875/607354	C05.116.900.800.875	IS2	Musculoskeletal disease
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3	OMIM:608765			MESH:D012600	C05.116.900.800.875/608765	C05.116.900.800.875	IS3	Musculoskeletal disease
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 4	OMIM:612238			MESH:D012600	C05.116.900.800.875/612238	C05.116.900.800.875	IS4	Musculoskeletal disease
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 5	OMIM:612239			MESH:D012600	C05.116.900.800.875/612239	C05.116.900.800.875	IS5	Musculoskeletal disease
Scotoma	MESH:D012607		A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA); OPTIC NERVE DISEASES, and other conditions.	MESH:D014786	C10.597.751.941.811|C11.966.811|C23.888.592.763.941.811	C10.597.751.941|C11.966|C23.888.592.763.941	Altitudinal Scotoma|Altitudinal Scotomas|Arcuate Scotoma|Arcuate Scotomas|Bjerrum Scotoma|Bjerrum Scotomas|Central Scotoma|Central Scotomas|Centrocecal Scotoma|Centrocecal Scotomas|Paracecal Scotoma|Paracecal Scotomas|Paracentral Scotoma|Paracentral Scotomas|Peripheral Scotoma|Peripheral Scotomas|Ring Scotoma|Ring Scotomas|Scintillating Scotoma|Scintillating Scotomas|Scotoma, Altitudinal|Scotoma, Arcuate|Scotoma, Bjerrum|Scotoma, Central|Scotoma, Centrocecal|Scotoma, Paracecal|Scotoma, Paracentral|Scotoma, Peripheral|Scotoma, Ring|Scotomas|Scotomas, Altitudinal|Scotomas, Arcuate|Scotomas, Bjerrum|Scotomas, Central|Scotomas, Centrocecal|Scotoma, Scintillating|Scotoma, Sector|Scotomas, Paracecal|Scotomas, Paracentral|Scotomas, Peripheral|Scotomas, Ring|Scotomas, Scintillating|Scotomas, Sector|Sector Scotoma|Sector Scotomas	Eye disease|Nervous system disease|Signs and symptoms
Scott Syndrome	MESH:C563120	DO:DOID:0111052|OMIM:262890		MESH:D001778	C15.378.100/C563120	C15.378.100	BDPLT7|Bleeding Abnormality due to Deficiency of Platelet Binding of Factor X|BLEEDING DISORDER, PLATELET-TYPE, 7|Prothrombin Consumption Deficiency|Prothrombin Consumption Inhibitor, Familial|Prothrombin Conversion Defect, Familial|SCTS	Blood disease
Scurvy	MESH:D012614	DO:DOID:13724|OMIM:240400	An acquired blood vessel disorder caused by severe deficiency of vitamin C (ASCORBIC ACID) in the diet leading to defective collagen formation in small blood vessels. Scurvy is characterized by bleeding in any tissue, weakness, ANEMIA, spongy gums, and a brawny induration of the muscles of the calves and legs.	MESH:D001206|MESH:D020141	C14.907.454.800|C15.378.463.515.800|C18.654.521.500.133.115.661	C14.907.454|C15.378.463.515|C18.654.521.500.133.115	GULO, NONFUNCTIONAL, INCLUDED|GULOP, INCLUDED|Hypoascorbemia|Hypoascorbemias|L-GULONOLACTONE OXIDASE, NONFUNCTIONAL, INCLUDED|Scorbutus|Scurvies|SCURVY|VITAMIN C, INABILITY TO SYNTHESIZE  L-GULONOLACTONE OXIDASE PSEUDOGENE, INCLUDED	Blood disease|Cardiovascular disease|Nutrition disorder
Sebaceous Gland Diseases	MESH:D012625		Diseases of the sebaceous glands such as sebaceous hyperplasia and sebaceous cell carcinoma (SEBACEOUS GLAND NEOPLASMS).	MESH:D012871	C17.800.794	C17.800	Disease, Sebaceous Gland|Diseases, Sebaceous Gland|Gland Disease, Sebaceous|Gland Diseases, Sebaceous|Sebaceous Gland Disease	Skin disease
Sebaceous gland hyperplasia, familial presenile	MESH:C537530			MESH:D005148|MESH:D006965	C17.800.271/C537530|C23.550.444/C537530	C17.800.271|C23.550.444		Pathology (process)|Skin disease
Sebaceous Gland Neoplasms	MESH:D012626	DO:DOID:5759	New abnormal growth of tissue in the SEBACEOUS GLANDS.	MESH:D012625|MESH:D012878	C04.588.805.578|C17.800.794.712|C17.800.882.712	C04.588.805|C17.800.794|C17.800.882	Neoplasm, Sebaceous Gland|Neoplasms, Sebaceous Gland|Sebaceous Gland Neoplasm	Cancer|Skin disease
Sebaceous Nevus Syndrome and Hemimegalencephaly	MESH:C563339			MESH:D054000|MESH:D065705	C04.557.665.560.700/C563339|C05.660.207.536.500/C563339|C10.500.507.400.249.500/C563339|C10.562.700/C563339|C16.131.077.633/C563339|C16.131.621.207.532.500/C563339|C16.131.666.507.400.249.500/C563339	C04.557.665.560.700|C05.660.207.536.500|C10.500.507.400.249.500|C10.562.700|C16.131.077.633|C16.131.621.207.532.500|C16.131.666.507.400.249.500		Cancer|Congenital abnormality|Musculoskeletal disease|Nervous system disease
Sebaceous Tumors, Somatic	MESH:C563610			MESH:D012626	C04.588.805.578/C563610|C17.800.794.712/C563610|C17.800.882.712/C563610	C04.588.805.578|C17.800.794.712|C17.800.882.712		Cancer|Skin disease
Seborrhea-Like Dermatitis with Psoriasiform Elements	MESH:C565217	OMIM:610227		MESH:D003872	C17.800.174/C565217	C17.800.174		Skin disease
Secretory breast carcinoma	MESH:C537535	DO:DOID:4922		MESH:D001943|MESH:D002277	C04.557.470.200/C537535|C04.588.180/C537535|C17.800.090.500/C537535	C04.557.470.200|C04.588.180|C17.800.090.500		Cancer|Skin disease
Secretory Component Deficiency	MESH:C562869			MESH:D017098	C15.378.147.333.500/C562869|C20.673.430.500/C562869	C15.378.147.333.500|C20.673.430.500	Iga Deficiency, Secretory	Blood disease|Immune system disease
Segawa syndrome, autosomal recessive	MESH:C537537	OMIM:605407		MESH:D020821	C10.228.662.300/C537537	C10.228.662.300	Autosomal Recessive Infantile Parkinsonism|Dopa-Responsive Dystonia, Autosomal Recessive|DOPA responsive dystonia, autosomal recessive|Dystonia, Dopa-Responsive, Autosomal Recessive|Dystonia, DOPA responsive, autosomal recessive|Dystonia, Dopa-Responsive, With Or Without Hyperphenylalaninemia, Autosomal Recessive|Parkinsonism, infantile, autosomal recessive|Th-Deficient Drd|Tyrosine Hydroxylase Deficiency	Nervous system disease
Seizures	MESH:D012640	DO:DOID:11832	Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or 'seizure disorder.'	MESH:D009461	C10.597.742|C23.888.592.742	C10.597|C23.888.592	Absence Seizure|Absence Seizure, Atonic|Absence Seizure, Generalized|Absence Seizures|Absence Seizures, Atonic|Absence Seizures, Generalized|Atonic Absence Seizure|Atonic Absence Seizures|Atonic Seizure|Atonic Seizures|Auditory Seizure|Auditory Seizures|Clonic Seizure|Clonic Seizures|Clonic Seizures, Tonic|Clonic Seizure, Tonic|Complex Partial Seizure|Complex Partial Seizures|Convulsion|Convulsion, Non Epileptic|Convulsion, Non-Epileptic|Convulsion, Petit Mal|Convulsions|Convulsions, Non-Epileptic|Convulsive Seizure|Convulsive Seizures|Epileptic Seizure|Epileptic Seizures|Focal Seizure|Focal Seizures|Generalized Absence Seizure|Generalized Absence Seizures|Generalized Seizure|Generalized Seizures|Generalized Tonic-Clonic Seizure|Generalized Tonic Clonic Seizures|Generalized Tonic-Clonic Seizures|Gustatory Seizure|Gustatory Seizures|Jacksonian Seizure|Motor Seizure|Motor Seizures|Myoclonic Seizure|Myoclonic Seizures|Non-Epileptic Convulsion|Non-Epileptic Convulsions|Nonepileptic Seizure|Non Epileptic Seizure|Non-Epileptic Seizure|Nonepileptic Seizures|Non Epileptic Seizures|Non-Epileptic Seizures|Olfactory Seizure|Olfactory Seizures|Partial Seizure|Partial Seizure, Complex|Partial Seizures|Partial Seizures, Complex|Petit Mal Convulsion|Seizure|Seizure, Absence|Seizure, Atonic|Seizure, Atonic Absence|Seizure, Auditory|Seizure, Clonic|Seizure, Complex Partial|Seizure, Convulsive|Seizure, Epileptic|Seizure, Focal|Seizure, Generalized|Seizure, Generalized Absence|Seizure, Generalized Tonic-Clonic|Seizure, Gustatory|Seizure, Jacksonian|Seizure, Motor|Seizure, Myoclonic|Seizure, Nonepileptic|Seizure, Non-Epileptic|Seizure, Olfactory|Seizure, Partial|Seizures, Auditory|Seizures, Clonic|Seizures, Convulsive|Seizure, Sensory|Seizures, Epileptic|Seizures, Focal|Seizures, Generalized|Seizures, Generalized Tonic-Clonic|Seizures, Gustatory|Seizure, Single|Seizures, Motor|Seizures, Nonepileptic|Seizures, Olfactory|Seizure, Somatosensory|Seizures, Sensory|Seizures, Somatosensory|Seizures, Tonic|Seizures, Tonic-Clonic|Seizures, Vertiginous|Seizures, Vestibular|Seizures, Visual|Seizure, Tonic|Seizure, Tonic Clonic|Seizure, Tonic-Clonic|Seizure, Vertiginous|Seizure, Vestibular|Seizure, Visual|Sensory Seizure|Sensory Seizures|Single Seizure|Single Seizures|Somatosensory Seizure|Somatosensory Seizures|Tonic Clonic Seizure|Tonic-Clonic Seizure|Tonic-Clonic Seizure, Generalized|Tonic Clonic Seizures|Tonic-Clonic Seizures|Tonic-Clonic Seizures, Generalized|Tonic Seizure|Tonic Seizures|Vertiginous Seizure|Vertiginous Seizures|Vestibular Seizure|Vestibular Seizures|Visual Seizure|Visual Seizures	Nervous system disease|Signs and symptoms
Seizures, Febrile	MESH:D003294		Seizures that occur during a febrile episode. It is a common condition, affecting 2-5% of children aged 3 months to five years. An autosomal dominant pattern of inheritance has been identified in some families. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy (i.e., a nonfebrile seizure disorder) following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. (From Menkes, Textbook of Child Neurology, 5th ed, p784)	MESH:D012640	C10.597.742.571|C23.888.592.742.571	C10.597.742|C23.888.592.742	Convulsion, Febrile|Convulsion, Fever|Convulsion, Pyrexial|Convulsions, Febrile|Convulsions, Fever|Convulsions, Pyrexial|Febrile Convulsion|Febrile Convulsions|Febrile Convulsion Seizure|Febrile Convulsion Seizures|Febrile Fit|Febrile Fits|Febrile Seizure|Febrile Seizures|Fever Convulsion|Fever Convulsions|Fever Seizure|Fever Seizures|Fit, Febrile|Fits, Febrile|Pyrexial Convulsion|Pyrexial Convulsions|Pyrexial Seizure|Pyrexial Seizures|Seizure, Febrile|Seizure, Febrile, Complex|Seizure, Febrile Convulsion|Seizure, Febrile, Simple|Seizure, Fever|Seizure, Pyrexial|Seizures, Febrile Convulsion|Seizures, Fever|Seizures, Pyrexial	Nervous system disease|Signs and symptoms
Sella Turcica, Bridged	MESH:C566689			MESH:D010900	C10.228.140.617.738/C566689|C19.700/C566689	C10.228.140.617.738|C19.700		Endocrine system disease|Nervous system disease
Semicircular Canal Dehiscence	MESH:D000084322		A vestibular disorder caused by a pathologic third window into the BONY LABYRINTH (in contrast to the normal ROUND WINDOW OF EAR and the OVAL WINDOW OF EAR). It can present with autophony, sound- or pressure-induced VERTIGO, and chronic disequilibrium among other vestibulocochlear symptoms.(From: Semin Neurol. 2020 Jan 27; 48: 58-65.)	MESH:D015837	C09.218.568.900.663	C09.218.568.900	Dehiscence of the Lateral Semicircular Canal|Dehiscence of the Posterior Semicircular Canal|Dehiscence of the Semicircular Canal|Dehiscence of the Superior Semicircular Canal|Lateral Canal Dehiscence Syndrome|Lateral Semicircular Canal Dehiscence|Lateral Semicircular Canal Dehiscence Syndrome|Posterior Canal Dehiscence Syndrome|Posterior Semicircular Canal Dehiscence|Posterior Semicircular Canal Dehiscence Syndrome|Semicircular Canal Dehiscence Syndrome|Superior Canal Dehiscence Syndrome|Superior Semicircular Canal Dehiscence|Superior Semicircular Canal Dehiscence Syndrome	Ear-nose-throat disease
Seminoma	MESH:D018239	DO:DOID:4440|DO:DOID:5842	A radiosensitive, malignant neoplasm of the testis, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. There are three variants: classical (typical), the most common type; anaplastic; and spermatocytic. The classical seminoma is composed of fairly well differentiated sheets or cords of uniform polygonal or round cells (seminoma cells), each cell having abundant clear cytoplasm, distinct cell membranes, a centrally placed round nucleus, and one or more nucleoli. In the female, a grossly and histologically identical neoplasm, known as dysgerminoma, occurs. (Dorland, 27th ed)	MESH:D018237	C04.557.465.330.800	C04.557.465.330	Seminomas	Cancer
Sensation Disorders	MESH:D012678		Disorders of the special senses (i.e., VISION; HEARING; TASTE; and SMELL) or somatosensory system (i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM).	MESH:D009461	C10.597.751|C23.888.592.763	C10.597|C23.888.592	Sensation Disorder|Senses Disorder, Special|Senses Disorders, Special|Sensory Disorder|Sensory Disorders|Special Senses Disorder|Special Senses Disorders	Nervous system disease|Signs and symptoms
Sensorineural Deafness With Mild Renal Dysfunction	MESH:C567544			MESH:D001477|MESH:D006319	C09.218.458.341.887/C567544|C10.597.751.418.341.887/C567544|C12.050.351.968.419.815.279/C567544|C12.200.777.419.815.279/C567544|C12.950.419.815.279/C567544|C19.053.800.604.249/C567544|C23.888.592.763.393.341.887/C567544	C09.218.458.341.887|C10.597.751.418.341.887|C12.050.351.968.419.815.279|C12.200.777.419.815.279|C12.950.419.815.279|C19.053.800.604.249|C23.888.592.763.393.341.887		Ear-nose-throat disease|Endocrine system disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Sensorineural Hearing Loss, Retinal Pigment Epithelium Lesions, Discolored Teeth	MESH:C566560			MESH:D006319|MESH:D014075	C07.793.735/C566560|C09.218.458.341.887/C566560|C10.597.751.418.341.887/C566560|C23.888.592.763.393.341.887/C566560	C07.793.735|C09.218.458.341.887|C10.597.751.418.341.887|C23.888.592.763.393.341.887		Ear-nose-throat disease|Mouth disease|Nervous system disease|Signs and symptoms
Sepsis-Associated Encephalopathy	MESH:D065166		Acute neurological dysfunction during severe SEPSIS in the absence of direct brain infection characterized by systemic inflammation and BLOOD BRAIN BARRIER perturbation.	MESH:D001927	C10.228.140.807	C10.228.140	Associated Delirium, Sepsis|Associated Deliriums, Sepsis|Associated Encephalopathies, Sepsis|Associated Encephalopathy, Sepsis|Delirium, Sepsis Associated|Delirium, Sepsis-Associated|Deliriums, Sepsis Associated|Deliriums, Sepsis-Associated|Encephalopathies, Sepsis Associated|Encephalopathies, Sepsis-Associated|Encephalopathy, Sepsis Associated|Encephalopathy, Sepsis-Associated|Sepsis Associated Delirium|Sepsis-Associated Delirium|Sepsis Associated Deliriums|Sepsis-Associated Deliriums|Sepsis Associated Encephalopathies|Sepsis-Associated Encephalopathies|Sepsis Associated Encephalopathy	Nervous system disease
Serotonin Syndrome	MESH:D020230		An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.	MESH:D064420	C25.100.875	C25.100	Serotonin Syndromes|Syndrome, Serotonin|Syndromes, Serotonin	
Sertoli Cell Tumor	MESH:D012707	DO:DOID:3577	Gonadal neoplasm composed entirely of SERTOLI CELLS or may have a component of GRANULOSA CELLS. Some of the Sertoli cell tumors produce ESTROGEN or ANDROGENS, but seldom in sufficient quantity to cause clinical symptoms such as FEMINIZATION or masculinization (VIRILISM).	MESH:D018310	C04.557.475.750.847.500|C04.588.322.762.500.500|C04.588.945.440.915.500.500|C12.100.500.260.937.500.500|C12.200.294.260.937.500.500|C12.200.758.409.937.500.500|C12.900.619.937.500.500|C19.344.762.500.500|C19.391.829.782.500.500	C04.557.475.750.847|C04.588.322.762.500|C04.588.945.440.915.500|C12.100.500.260.937.500|C12.200.294.260.937.500|C12.200.758.409.937.500|C12.900.619.937.500|C19.344.762.500|C19.391.829.782.500	Tumor, Sertoli Cell	Cancer|Endocrine system disease|Urogenital disease (male)
Sertoli-Leydig Cell Tumor	MESH:D018310	DO:DOID:2997	A sex cord-gonadal stromal tumor consists of LEYDIG CELLS; SERTOLI CELLS; and FIBROBLASTS in varying proportions and degree of differentiation. Most such tumors produce ANDROGENS in the Leydig cells, formerly known as androblastoma or arrhenoblastoma. Androblastomas occur in the TESTIS or the OVARY causing precocious masculinization in the males, and defeminization, or virilization (VIRILISM) in the females. In some cases, the Sertoli cells produce ESTROGENS.	MESH:D010051|MESH:D013736|MESH:D018312	C04.557.475.750.847|C04.588.322.455.648|C04.588.322.762.500|C04.588.945.440.915.500|C12.050.351.500.056.630.705.648|C12.050.351.937.418.685.648|C12.100.250.056.630.705.648|C12.100.500.260.937.500|C12.200.294.260.937.500|C12.200.758.409.937.500|C12.900.418.685.648|C12.900.619.937.500|C19.344.410.648|C19.344.762.500|C19.391.630.705.648|C19.391.829.782.500	C04.557.475.750|C04.588.322.455|C04.588.322.762|C04.588.945.440.915|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.100.500.260.937|C12.200.294.260.937|C12.200.758.409.937|C12.900.418.685|C12.900.619.937|C19.344.410|C19.344.762|C19.391.630.705|C19.391.829.782	Androblastoma|Androblastomas|Arrhenoblastoma|Arrhenoblastomas|Cell Tumor, Sertoli-Leydig|Cell Tumors, Sertoli-Leydig|Sertoli Leydig Cell Tumor|Sertoli Leydig Cell Tumors|Sertoli-Leydig Cell Tumors|Tumor, Sertoli-Leydig Cell|Tumors, Sertoli-Leydig Cell	Cancer|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
SeSAME syndrome	MESH:C557674	DO:DOID:0060484|OMIM:612780		MESH:D006319|MESH:D008607|MESH:D012640	C09.218.458.341.887/C557674|C10.597.606.360/C557674|C10.597.742/C557674|C10.597.751.418.341.887/C557674|C23.888.592.604.646/C557674|C23.888.592.742/C557674|C23.888.592.763.393.341.887/C557674|F03.625.539/C557674	C09.218.458.341.887|C10.597.606.360|C10.597.742|C10.597.751.418.341.887|C23.888.592.604.646|C23.888.592.742|C23.888.592.763.393.341.887|F03.625.539	EAST syndrome|Epilepsy, ataxia, sensorineural deafness and tubulopathy|Epilepsy, Ataxia, Sensorineural Deafness, And Tubulopathy|Seizures, sensorineural deafness, ataxia, mental retardation and electrolyte imbalance|Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, And Electrolyte Imbalance|SESAMES|SESAME SYNDROME	Ear-nose-throat disease|Mental disorder|Nervous system disease|Signs and symptoms
Setting-Sun Phenomenon, Familial Benign	MESH:C563470			MESH:D015835	C10.228.758/C563470|C10.292.562/C563470|C11.590/C563470	C10.228.758|C10.292.562|C11.590		Eye disease|Nervous system disease
Severe Acute Respiratory Syndrome	MESH:D045169	DO:DOID:2945	A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.	MESH:D012141|MESH:D018352	C01.748.730|C01.925.782.600.550.200.750|C08.730.730	C01.748|C01.925.782.600.550.200|C08.730	Respiratory Syndrome, Acute, Severe|Respiratory Syndrome, Severe Acute|SARS (Severe Acute Respiratory Syndrome)	Respiratory tract disease|Viral disease
Severe Dengue	MESH:D019595	DO:DOID:12206	A virulent form of dengue characterized by THROMBOCYTOPENIA and an increase in vascular permeability (grades I and II) and distinguished by a positive pain test (e.g., TOURNIQUET PAIN TEST). When accompanied by SHOCK (grades III and IV), it is called dengue shock syndrome.	MESH:D003715	C01.920.500.270.200|C01.925.081.270.200|C01.925.782.350.250.214.200|C01.925.782.417.214.200	C01.920.500.270|C01.925.081.270|C01.925.782.350.250.214|C01.925.782.417.214	Dengue Hemorrhagic Fever|Dengue, Severe|Dengue Shock Syndrome|Dengues, Severe|Fever, Philippine Hemorrhagic|Fever, Singapore Hemorrhagic|Fever, Thai Hemorrhagic|Hemorrhagic Dengue|Hemorrhagic Dengues|Hemorrhagic Fever, Dengue|Philippine Hemorrhagic Fever|Severe Dengues|Singapore Hemorrhagic Fever|Thai Hemorrhagic Fever	Viral disease
Severe Fever with Thrombocytopenia Syndrome	MESH:D000085142		A tick-borne infection with SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME BUNYAVIRUS of the genus Phlebovirus. It is associated with fever, THROMBOCYTOPENIA; LEUKOCYTOPENIA, and multiorgan dysfunction. It is found in parts of Asia including China, Japan, Korea and Vietnam and can be transmitted from infected domestic animals and humans.	MESH:D002044|MESH:D017282	C01.920.930.831|C01.925.782.147.905	C01.920.930|C01.925.782.147	Infection, SFTS Virus|Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection|SFTS Virus Infection|SFTS Virus Infections|Virus Infection, SFTS	Viral disease
Severe infantile axonal neuropathy	MESH:C537593			MESH:D011115	C10.668.829.800/C537593	C10.668.829.800		Nervous system disease
Sex Cord-Gonadal Stromal Tumors	MESH:D018312	DO:DOID:192	Neoplasms derived from the primitive sex cord or gonadal stromal cells of the embryonic GONADS. They are classified by their presumed histogenesis and differentiation. From the sex cord, there are SERTOLI CELL TUMOR and GRANULOSA CELL TUMOR; from the gonadal stroma, LEYDIG CELL TUMOR and THECOMA. These tumors may be identified in either the OVARY or the TESTIS.	MESH:D018309	C04.557.475.750	C04.557.475	Gynandroblastoma|Gynandroblastomas|Sex Cord Stromal Tumor|Sex Cord-Stromal Tumor|Sex Cord-Stromal Tumors|Tumor, Sex Cord-Stromal|Tumors, Sex Cord-Stromal	Cancer
Sexual Dysfunction, Physiological	MESH:D012735		Physiological disturbances in normal sexual performance in either the male or the female.	MESH:D000091662	C12.100.875	C12.100	Physiological Sexual Disorder|Physiological Sexual Disorders|Physiological Sexual Dysfunction|Physiological Sexual Dysfunctions|Sex Disorders|Sexual Disorder, Physiological|Sexual Disorders, Physiological|Sexual Dysfunctions, Physiological	
Sexually Transmitted Diseases, Viral	MESH:D015229		Viral diseases which are transmitted or propagated by sexual conduct.	MESH:D012749|MESH:D014777	C01.221.812.640|C01.778.640|C01.925.813|C12.100.937.640|C23.550.291.531.937.640	C01.221.812|C01.778|C01.925|C12.100.937|C23.550.291.531.937	Diseases, Viral Venereal|Disease, Viral Venereal|Sexually Transmitted Disease, Viral|Venereal Diseases, Viral|Venereal Disease, Viral|Viral Sexually Transmitted Disease|Viral Sexually Transmitted Diseases|Viral Venereal Disease|Viral Venereal Diseases	Pathology (process)|Viral disease
Sezary Syndrome	MESH:D012751	DO:DOID:8541	A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells).	MESH:D008232|MESH:D016410	C04.557.386.480.750.800.775|C15.604.515.569.480.750.800.775|C15.604.515.841|C20.683.515.761.480.750.800.775|C20.683.515.920	C04.557.386.480.750.800|C15.604.515|C15.604.515.569.480.750.800|C20.683.515|C20.683.515.761.480.750.800	Erythroderma, Sezary|Lymphoma, Sezary's|Sezary Erythroderma|Sezary Lymphoma|Sezary's Lymphoma|Sezarys Lymphoma|Syndrome, Sezary	Cancer|Immune system disease|Lymphatic disease
Shaken Baby Syndrome	MESH:D038642		Brain injuries resulted from vigorous shaking of an infant or young child held by the chest, shoulders, or extremities causing extreme cranial acceleration. It is characterized by the intracranial and intraocular hemorrhages with no evident external trauma. Serious cases may result in death.	MESH:D001930	C10.900.300.087.850|C26.915.300.200.825	C10.900.300.087|C26.915.300.200		Nervous system disease|Wounds and injuries
Shellfish Hypersensitivity	MESH:D000067208		Allergic reaction to SHELLFISH or shellfish products.	MESH:D005512	C20.543.480.370.763	C20.543.480.370	Allergies, Shellfish|Allergy, Shellfish|Hypersensitivities, Shellfish|Hypersensitivity, Shellfish|Shellfish Allergies|Shellfish Allergy|Shellfish Hypersensitivities	Immune system disease
Shellfish Poisoning	MESH:D057096		Poisoning from toxins present in bivalve mollusks that have been ingested. Four distinct types of shellfish poisoning are recognized based on the toxin involved.	MESH:D005517	C25.723.415.792	C25.723.415	Amnesic Shellfish Poisoning|Amnesic Shellfish Poisonings|Diarrhetic Shellfish Poisoning|Diarrhetic Shellfish Poisonings|Neurotoxic Shellfish Poisoning|Neurotoxic Shellfish Poisonings|Paralytic Shellfish Poisoning|Paralytic Shellfish Poisonings|Poisoning, Amnesic Shellfish|Poisoning, Diarrhetic Shellfish|Poisoning, Neurotoxic Shellfish|Poisoning, Paralytic Shellfish|Poisonings, Amnesic Shellfish|Poisonings, Diarrhetic Shellfish|Poisoning, Shellfish|Poisonings, Neurotoxic Shellfish|Poisonings, Paralytic Shellfish|Poisonings, Shellfish|Shellfish Poisoning, Amnesic|Shellfish Poisoning, Diarrhetic|Shellfish Poisoning, Neurotoxic|Shellfish Poisoning, Paralytic|Shellfish Poisonings|Shellfish Poisonings, Amnesic|Shellfish Poisonings, Diarrhetic|Shellfish Poisonings, Neurotoxic|Shellfish Poisonings, Paralytic	
Shock, Cardiogenic	MESH:D012770		Shock resulting from diminution of cardiac output in heart disease.	MESH:D009203|MESH:D012769	C14.280.647.500.750|C14.907.585.500.750|C23.550.513.355.750.750|C23.550.717.489.750.750|C23.550.835.550	C14.280.647.500|C14.907.585.500|C23.550.513.355.750|C23.550.717.489.750|C23.550.835	Cardiogenic Shock	Cardiovascular disease|Pathology (process)
Short Bowel Syndrome	MESH:D012778	DO:DOID:10605	A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.	MESH:D008286|MESH:D011183	C06.405.469.637.832|C23.550.767.882	C06.405.469.637|C23.550.767	Bowel Syndrome, Short|Bowel Syndromes, Short|Short Bowel Syndromes|Syndrome, Short Bowel|Syndromes, Short Bowel	Digestive system disease|Pathology (process)
Short Qt Syndrome	MESH:C580439			MESH:D001145	C14.280.067/C580439|C23.550.073/C580439	C14.280.067|C23.550.073		Cardiovascular disease|Pathology (process)
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS	OMIM:165800	DO:DOID:84		MESH:C580095|MESH:D006130|MESH:D010003	C05.116.791.668/C580095/165800|C05.550.114.606/165800|C05.799.613/165800|C23.550.393/165800	C05.116.791.668/C580095|C05.550.114.606|C05.799.613|C23.550.393	OD|OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS|SSOAOD	Musculoskeletal disease|Pathology (process)
Short Stature, Auditory Canal Atresia, Mandibular Hypoplasia, Skeletal Abnormalities	MESH:C566544			MESH:D001848	C05.116.099/C566544	C05.116.099	Sams	Musculoskeletal disease
Short Stature, Idiopathic, Autosomal	MESH:C565805	OMIM:604271		MESH:D004393	C05.116.099.343.445/C565805|C05.116.132.358/C565805|C10.228.140.617.738.300.300/C565805|C19.297.312/C565805|C19.700.482.311/C565805	C05.116.099.343.445|C05.116.132.358|C10.228.140.617.738.300.300|C19.297.312|C19.700.482.311	GHIP|Growth Hormone Deficiency, Isolated, Partial|GROWTH HORMONE INSENSITIVITY, PARTIAL|Growth Hormone, Insensitivity To, Partial|INCREASED RESPONSIVENESS TO GROWTH HORMONE, INCLUDED	Endocrine system disease|Musculoskeletal disease|Nervous system disease
Shoulder Dislocation	MESH:D012783		Displacement of the HUMERUS from the SCAPULA.	MESH:D000070599|MESH:D004204	C05.550.518.750|C26.289.750|C26.803.125	C05.550.518|C26.289|C26.803	Dislocation, Glenohumeral|Dislocations, Glenohumeral|Dislocation, Shoulder|Dislocations, Shoulder|Glenohumeral Dislocation|Glenohumeral Dislocations|Glenohumeral Subluxation|Glenohumeral Subluxations|Shoulder Dislocations|Subluxation, Glenohumeral|Subluxations, Glenohumeral	Musculoskeletal disease|Wounds and injuries
Shoulder Impingement Syndrome	MESH:D019534	DO:DOID:14276	Compression of the ROTATOR CUFF tendons and subacromial bursa between the HUMERAL HEAD and  the ACROMION of the SCAPULA. This condition is associated with subacromial BURSITIS, as well as rotator cuff (largely supraspinatus) and bicipital tendon INFLAMMATION.	MESH:D000070599|MESH:D007592	C05.550.840|C26.803.500	C05.550|C26.803	Coracohumeral Impingement|Coracohumeral Impingements|Coracohumeral Impingement Syndrome|Coracohumeral Impingement Syndromes|Coracoid Impingement Syndrome|Coracoid Impingement Syndromes|Impingement, Coracohumeral|Impingement, Posterosuperior Glenoid|Impingement, Rotator Cuff|Impingement, Shoulder|Impingements, Posterosuperior Glenoid|Impingements, Rotator Cuff|Internal Impingement Syndrome|Internal Impingement Syndromes|Outlet Impingement|Outlet Impingements|Outlet Impingement Syndrome|Outlet Impingement Syndromes|Posterosuperior Glenoid Impingement|Posterosuperior Glenoid Impingements|Rotator Cuff Impingement|Rotator Cuff Impingements|Rotator Cuff Impingement Syndrome|Shoulder Impingement|Shoulder Impingements|Shoulder Impingement Syndromes|Subacromial Impingement Syndrome|Subacromial Impingement Syndromes	Musculoskeletal disease|Wounds and injuries
Shoulder Pain	MESH:D020069		Unilateral or bilateral pain of the shoulder. It is often caused by physical activities such as work or sports participation, but may also be pathologic in origin.	MESH:D018771	C05.550.091.700|C23.888.592.612.094.700	C05.550.091|C23.888.592.612.094	Pain, Shoulder|Pains, Shoulder|Shoulder Pains	Musculoskeletal disease|Signs and symptoms
Shwachman-Diamond Syndrome	MESH:D000081003	OMIM:260400	An inherited syndrome characterized by EXOCRINE PANCREATIC INSUFFICIENCY; hematologic abnormalities (e.g., bone marrow hypoplasia), and skeletal abnormalities (e.g., metaphyseal chondroplasia). GERMLINE MUTATIONS in the SBDS gene are associated with Shwachman-Diamond Syndrome.	MESH:D000080984|MESH:D008052|MESH:D008068|MESH:D010188	C06.689.276.500|C15.378.190.223.500.875|C18.452.584.563.824|C18.452.584.718.875	C06.689.276|C15.378.190.223.500|C18.452.584.563|C18.452.584.718	Congenital Lipomatosis of Pancreas|LIPOMATOSIS OF PANCREAS, CONGENITAL|Metaphyseal Chondrodysplasia, Shwachman Type|Pancreas Congenital Lipomatoses|Pancreas Congenital Lipomatosis|Pancreatic Insufficiency and Bone Marrow Dysfunction|SDS|SDS1|Shwachman Bodian Diamond Syndrome|Shwachman-Bodian-Diamond Syndrome|Shwachman Bodian Syndrome|Shwachman-Bodian Syndrome|Shwachman Diamond Oski Syndrome|Shwachman-Diamond-Oski Syndrome|Shwachman Diamond Syndrome|SHWACHMAN-DIAMOND SYNDROME|SHWACHMAN-DIAMOND SYNDROME 1|Shwachman Syndrome	Blood disease|Digestive system disease|Metabolic disease
Shwartzman Phenomenon	MESH:D012790	DO:DOID:3825	Hemorrhagic necrosis that was first demonstrated in rabbits with a two-step reaction, an initial local (intradermal) or general (intravenous) injection of a priming endotoxin (ENDOTOXINS) followed by a second intravenous endotoxin injection (provoking agent) 24 h later. The acute inflammation damages the small blood vessels. The following intravascular coagulation leads to capillary and venous THROMBOSIS and NECROSIS. Shwartzman phenomenon can also occur in other species with a single injection of a provoking agent, and during infections or pregnancy. Its susceptibility depends on the status of IMMUNE SYSTEM, coagulation, FIBRINOLYSIS, and blood flow.	MESH:D014657|MESH:D020141	C14.907.454.810|C14.907.940.890|C15.378.463.515.810	C14.907.454|C14.907.940|C15.378.463.515	Phenomenon, Schwartzman|Phenomenon, Shwartzman|Schwartzman Phenomenon|Schwartzman Reaction|Schwartzman Reactions|Shwartzman Reaction	Blood disease|Cardiovascular disease
Shy-Drager Syndrome	MESH:D012791	DO:DOID:4752	A progressive neurodegenerative condition of the central and autonomic nervous systems characterized by atrophy of the preganglionic lateral horn neurons of the thoracic spinal cord. This disease is generally considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Affected individuals present in the fifth or sixth decade with ORTHOSTASIS and bladder dysfunction; and later develop FECAL INCONTINENCE; anhidrosis; ATAXIA; IMPOTENCE; and alterations of tone suggestive of basal ganglia dysfunction. (From Adams et al., Principles of Neurology, 6th ed, p536)	MESH:D007022|MESH:D019578	C10.177.575.550.750|C10.228.140.079.612.700|C10.228.662.550.700|C14.907.514.741	C10.177.575.550|C10.228.140.079.612|C10.228.662.550|C14.907.514	Autonomic Failure, Progressive|Autonomic Failures, Progressive|Dysautonomia Orthostatic Hypotension Syndrome|Dysautonomia-Orthostatic Hypotension Syndrome|Dysautonomia-Orthostatic Hypotension Syndromes|Dysautonomic Orthostatic Hypotension|Dysautonomic Orthostatic Hypotensions|Failure, Progressive Autonomic|Failures, Progressive Autonomic|Hypotension, Dysautonomic Orthostatic|Hypotensions, Dysautonomic Orthostatic|Hypotension Syndrome, Dysautonomia-Orthostatic|Hypotension Syndromes, Dysautonomia-Orthostatic|Idiopathic Orthostatic Hypotension, Shy Drager Type|Idiopathic Orthostatic Hypotension, Shy-Drager Type|Orthostatic Hypotension, Dysautonomic|Orthostatic Hypotensions, Dysautonomic|Progressive Autonomic Failure|Progressive Autonomic Failures|Shy Drager Syndrome|Syndrome, Dysautonomia Orthostatic Hypotension|Syndrome, Dysautonomia-Orthostatic Hypotension|Syndromes, Dysautonomia-Orthostatic Hypotension|Syndrome, Shy-Drager	Cardiovascular disease|Nervous system disease
Sick Sinus Syndrome	MESH:D012804	DO:DOID:13884	A condition caused by dysfunctions related to the SINOATRIAL NODE including impulse generation (CARDIAC SINUS ARREST) and impulse conduction (SINOATRIAL EXIT BLOCK). It is characterized by persistent BRADYCARDIA, chronic ATRIAL FIBRILLATION, and failure to resume sinus rhythm following CARDIOVERSION. This syndrome can be congenital or acquired, particularly after surgical correction for heart defects.	MESH:D001146|MESH:D006327	C14.280.067.093.249|C14.280.067.558.536|C14.280.123.500.536|C23.550.073.093.249|C23.550.073.425.440	C14.280.067.093|C14.280.067.558|C14.280.123.500|C23.550.073.093|C23.550.073.425	Dysfunction, Sinus Node|Dysfunctions, Sinus Node|Sick Sinus Node Syndrome|Sinus Node Disease|Sinus Node Diseases|Sinus Node Dysfunction|Syndrome, Sick Sinus	Cardiovascular disease|Pathology (process)
Sick Sinus Syndrome 1, Autosomal Recessive	MESH:C563907	OMIM:608567		MESH:D012804	C14.280.067.093.249/C563907|C14.280.067.558.536/C563907|C14.280.123.500.536/C563907|C23.550.073.093.249/C563907|C23.550.073.425.440/C563907	C14.280.067.093.249|C14.280.067.558.536|C14.280.123.500.536|C23.550.073.093.249|C23.550.073.425.440	SICK SINUS SYNDROME 1|Sick Sinus Syndrome, Congenital|Sinus Bradycardia Syndrome, Familial|Sinus Node Disease, Familial, Autosomal Recessive|Sinus Rhythm, Congenital Absence of|SSS1	Cardiovascular disease|Pathology (process)
Sick Sinus Syndrome 2, Autosomal Dominant	MESH:C563513	OMIM:163800		MESH:D012804	C14.280.067.093.249/C563513|C14.280.067.558.536/C563513|C14.280.123.500.536/C563513|C23.550.073.093.249/C563513|C23.550.073.425.440/C563513	C14.280.067.093.249|C14.280.067.558.536|C14.280.123.500.536|C23.550.073.093.249|C23.550.073.425.440	Atrial Fibrillation with Bradyarrhythmia|SICK SINUS SYNDROME 2|SICK SINUS SYNDROME 2 WITH OR WITHOUT CARDIAC NONCOMPACTION AND/OR ASCENDING AORTA DILATION|Sinus Bradycardia Syndrome, Familial, Autosomal Dominant|Sinus Node Disease, Familial, Autosomal Dominant|SSS2	Cardiovascular disease|Pathology (process)
Sideroblastic anemia, autosomal	MESH:C537334			MESH:D000756	C15.378.071.419/C537334|C15.378.190.625.070/C537334	C15.378.071.419|C15.378.190.625.070	Sideroblastic anemia, autosomal recessive inheritance	Blood disease
Siderosis	MESH:D012806	DO:DOID:10328	A form of pneumoconiosis resulting from inhalation of iron in the mining dust or welding fumes.	MESH:D011009	C08.381.483.581.750|C08.381.520.702.750|C24.800.773	C08.381.483.581|C08.381.520.702|C24.800	Sideroses	Occupational disease|Respiratory tract disease
Sigmoid Neoplasms	MESH:D012811	DO:DOID:12192|DO:DOID:1896	Tumors or cancer of the SIGMOID COLON.	MESH:D003110|MESH:D012810	C04.588.274.476.411.307.180.800|C06.301.371.411.307.180.800|C06.405.249.411.307.180.800|C06.405.469.158.356.180.800|C06.405.469.158.850.850|C06.405.469.491.307.180.800	C04.588.274.476.411.307.180|C06.301.371.411.307.180|C06.405.249.411.307.180|C06.405.469.158.356.180|C06.405.469.158.850|C06.405.469.491.307.180	Cancer of Sigmoid|Cancer of the Sigmoid|Cancer, Sigmoid|Cancer, Sigmoid Colon|Colon Cancer, Sigmoid|Colon Neoplasms, Sigmoid|Neoplasm, Sigmoid|Neoplasm, Sigmoid Colon|Neoplasms, Sigmoid|Neoplasms, Sigmoid Colon|Sigmoidal Cancer|Sigmoid Cancer|Sigmoid Colon Cancer|Sigmoid Colon Neoplasm|Sigmoid Colon Neoplasms|Sigmoid Neoplasm	Cancer|Digestive system disease
Silhouette sign	MESH:C000721350			MESH:D013568	C23/C000721350	C23		
Silicosiderosis	MESH:C537337			MESH:D008175|MESH:D012829	C04.588.894.797.520/C537337|C08.381.483.581.760/C537337|C08.381.520.702.760/C537337|C08.381.540/C537337|C08.785.520/C537337|C24.800.834/C537337	C04.588.894.797.520|C08.381.483.581.760|C08.381.520.702.760|C08.381.540|C08.785.520|C24.800.834	Hematite pneumoconiosis|Iron miners lung	Cancer|Occupational disease|Respiratory tract disease
Silicosis	MESH:D012829	DO:DOID:10325	A form of pneumoconiosis resulting from inhalation of dust containing crystalline form of SILICON DIOXIDE, usually in the form of quartz. Amorphous silica is relatively nontoxic.	MESH:D011009	C08.381.483.581.760|C08.381.520.702.760|C24.800.834	C08.381.483.581|C08.381.520.702|C24.800	Silicoses	Occupational disease|Respiratory tract disease
Silo Filler's Disease	MESH:D012832	DO:DOID:4374	A form of alveolitis or PNEUMONITIS caused by hypersensitivity to high level of inhaled nitrogen oxides, decomposition products of silage.	MESH:D000382|MESH:D000542	C08.381.483.125.682|C24.080.752	C08.381.483.125|C24.080	Disease, Silo Filler|Disease, Silo Fillers|Disease, Silo Filler's|Disease, Silo Fillers'|Silo Filler Disease|Silo Fillers Disease|Silo Fillers' Disease	Occupational disease|Respiratory tract disease
Singleton Merten syndrome	MESH:C537343	OMIM:182250		MESH:D001018|MESH:D003744|MESH:D009135|MESH:D010024|MESH:D018126|MESH:D061205	C05.116.198.579/C537343|C05.651/C537343|C07.650.800.255/C537343|C07.650.800.600/C537343|C07.793.700.255/C537343|C07.793.700.600/C537343|C10.668.491/C537343|C14.907.109/C537343|C16.131.850.800.255/C537343|C16.131.850.800.600/C537343|C18.452.104.579/C537343|C18.452.174.130.780/C537343	C05.116.198.579|C05.651|C07.650.800.255|C07.650.800.600|C07.793.700.255|C07.793.700.600|C10.668.491|C14.907.109|C16.131.850.800.255|C16.131.850.800.600|C18.452.104.579|C18.452.174.130.780	Merten-Singleton syndrome|SGMRT1|Singleton-Merten Syndrome|SINGLETON-MERTEN SYNDROME 1	Cardiovascular disease|Congenital abnormality|Metabolic disease|Mouth disease|Musculoskeletal disease|Nervous system disease
Single Umbilical Artery	MESH:D058529		Congenital abnormality where one, instead of the usual two, UMBILICAL ARTERY connects the fetus to the placenta.	MESH:D054079	C14.240.850.976|C16.131.240.850.952	C14.240.850|C16.131.240.850	Single Umbilical Arteries|Two Vessel Cord|Two Vessel Cords|Umbilical Artery, Single	Cardiovascular disease|Congenital abnormality
Sinoatrial Block	MESH:D012848		Disturbance in the atrial activation that is caused by transient failure of impulse conduction from the SINOATRIAL NODE to the HEART ATRIA. It is characterized by a delayed in heartbeat and pauses between P waves in an ELECTROCARDIOGRAM.	MESH:D006327	C14.280.067.558.750|C14.280.123.500.750|C23.550.073.425.780	C14.280.067.558|C14.280.123.500|C23.550.073.425	Block, Sinoatrial|Block, Sinoatrial Exit|Blocks, Sinoatrial|Blocks, Sinoatrial Exit|Exit Block, Sinoatrial|Exit Blocks, Sinoatrial|Sinoatrial Blocks|Sinoatrial Exit Block|Sinoatrial Exit Blocks	Cardiovascular disease|Pathology (process)
Sinonasal undifferentiated carcinoma	MESH:C537344			MESH:D002277|MESH:D008444	C04.557.470.200/C537344|C04.588.443.665.650.693.575/C537344|C08.460.669.693.575/C537344|C08.460.692.503.503/C537344|C08.785.600.693.575/C537344|C09.603.669.693.575/C537344|C09.603.692.503.503/C537344|C09.647.685.693.575/C537344	C04.557.470.200|C04.588.443.665.650.693.575|C08.460.669.693.575|C08.460.692.503.503|C08.785.600.693.575|C09.603.669.693.575|C09.603.692.503.503|C09.647.685.693.575		Cancer|Ear-nose-throat disease|Respiratory tract disease
Sinus Arrest, Cardiac	MESH:D054138		The omission of atrial activation that is caused by transient cessation of impulse generation at the SINOATRIAL NODE. It is characterized by a prolonged pause without P wave in an ELECTROCARDIOGRAM. Sinus arrest has been associated with sleep apnea (REM SLEEP-RELATED SINUS ARREST).	MESH:D001146	C14.280.067.093.500|C23.550.073.093.500	C14.280.067.093|C23.550.073.093	Cardiac Sinus Arrest|Cardiac Sinus Arrests|Cardiac Sinus Pause|Cardiac Sinus Pauses|Sinus Arrests, Cardiac|Sinus Pause, Cardiac|Sinus Pauses, Cardiac	Cardiovascular disease|Pathology (process)
Sinusitis	MESH:D012852		Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES.	MESH:D010254|MESH:D012141	C01.748.749|C08.460.692.752|C08.730.749|C09.603.692.752	C01.748|C08.460.692|C08.730|C09.603.692	Infection, Sinus|Infections, Sinus|Sinus Infection|Sinus Infections|Sinusitides	Ear-nose-throat disease|Respiratory tract disease
Sinus Node Disease and Myopia	MESH:C566690			MESH:D009216|MESH:D012804	C11.744.636/C566690|C14.280.067.093.249/C566690|C14.280.067.558.536/C566690|C14.280.123.500.536/C566690|C23.550.073.093.249/C566690|C23.550.073.425.440/C566690	C11.744.636|C14.280.067.093.249|C14.280.067.558.536|C14.280.123.500.536|C23.550.073.093.249|C23.550.073.425.440	Sick Sinus Syndrome and Myopia|SSS-Myopia Syndrome	Cardiovascular disease|Eye disease|Pathology (process)
Sinus Pericranii	MESH:D020779		Rare vascular anomaly involving a communication between the intracranial and extracranial venous circulation via diploe, the central spongy layer of cranial bone. It is often characterized by dilated venous structures on the scalp due to abnormal drainage from the intracranial venous sinuses. Sinus pericranii can be congenital or traumatic in origin.	MESH:D020785	C10.500.190.800|C14.240.850.875.750|C16.131.666.190.800	C10.500.190|C14.240.850.875|C16.131.666.190		Cardiovascular disease|Congenital abnormality|Nervous system disease
Sinus Tarsi Syndrome	MESH:C000604661			MESH:D005534	C05.360/C000604661|C17.800.321/C000604661	C05.360|C17.800.321		Musculoskeletal disease|Skin disease
Sinus Thrombosis, Intracranial	MESH:D012851	DO:DOID:3572	Formation or presence of a blood clot (THROMBUS) in the CRANIAL SINUSES, large endothelium-lined venous channels situated within the SKULL. Intracranial sinuses, also called cranial venous sinuses, include the superior sagittal, cavernous, lateral, petrous sinuses, and many others. Cranial sinus thrombosis can lead to severe HEADACHE; SEIZURE; and other neurological defects.	MESH:D020767	C10.228.140.300.525.425.500|C14.907.253.566.350.500|C14.907.355.590.213.350.500	C10.228.140.300.525.425|C14.907.253.566.350|C14.907.355.590.213.350	Cranial Sinus Thromboses|Cranial Sinus Thrombosis|Intracranial Sinus Thrombophlebitides|Intracranial Sinus Thrombophlebitis|Intracranial Sinus Thromboses|Intracranial Sinus Thrombosis|Petrous Sinus Thrombophlebitides|Petrous Sinus Thrombophlebitis|Petrous Sinus Thromboses|Petrous Sinus Thrombosis|Sinus Thrombophlebitides, Intracranial|Sinus Thrombophlebitides, Petrous|Sinus Thrombophlebitis, Intracranial|Sinus Thrombophlebitis, Petrous|Sinus Thromboses|Sinus Thromboses, Cranial|Sinus Thromboses, Intracranial|Sinus Thromboses, Petrous|Sinus Thrombosis|Sinus Thrombosis, Cranial|Sinus Thrombosis, Petrous|Thrombophlebitides, Intracranial Sinus|Thrombophlebitides, Petrous Sinus|Thrombophlebitis, Intracranial Sinus|Thrombophlebitis, Petrous Sinus|Thromboses, Cranial Sinus|Thromboses, Intracranial Sinus|Thromboses, Petrous Sinus|Thromboses, Sinus|Thrombosis, Cranial Sinus|Thrombosis, Intracranial Sinus|Thrombosis, Petrous Sinus|Thrombosis, Sinus|Venous Sinus Thrombosis, Cranial	Cardiovascular disease|Nervous system disease
Sister Mary Joseph's Nodule	MESH:D058288		Metastatic lesion of the UMBILICUS associated with intra-abdominal neoplasms especially of the GASTROINTESTINAL TRACT or OVARY.	MESH:D000008	C04.588.033.740	C04.588.033	Nodule, Sister Joseph's|Nodules, Sister Joseph's|Sister Joseph Nodule|Sister Joseph's Nodule|Sister Josephs Nodule|Sister Joseph's Nodules	Cancer
Sjögren-Mikulicz syndrome	MESH:C536669			MESH:D001172|MESH:D010309	C05.550.114.154/C536669|C05.799.114/C536669|C07.465.815.470.800/C536669|C07.465.815.793.500/C536669|C17.300.775.099/C536669|C20.111.199/C536669	C05.550.114.154|C05.799.114|C07.465.815.470.800|C07.465.815.793.500|C17.300.775.099|C20.111.199	Sjogren-Mikulicz syndrome	Connective tissue disease|Immune system disease|Mouth disease|Musculoskeletal disease
Sjogren's Syndrome	MESH:D012859	DO:DOID:12894|OMIM:270150	Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.	MESH:D001172|MESH:D014987|MESH:D015352	C05.550.114.154.774|C05.799.114.774|C07.465.815.929.669|C11.496.260.719|C17.300.775.099.774|C20.111.199.774	C05.550.114.154|C05.799.114|C07.465.815.929|C11.496.260|C17.300.775.099|C20.111.199	Sicca Syndrome|Sjogrens Syndrome|Sjogren Syndrome|Syndrome, Sicca|Syndrome, Sjogren's	Connective tissue disease|Eye disease|Immune system disease|Mouth disease|Musculoskeletal disease
Skeletal Dysplasia And Progressive Central Nervous System Degeneration, Lethal	MESH:C566514			MESH:D001848|MESH:D002493|MESH:D009410	C05.116.099/C566514|C10.228/C566514|C23.550.737/C566514	C05.116.099|C10.228|C23.550.737		Musculoskeletal disease|Nervous system disease|Pathology (process)
Skeletal Dysplasia With Delayed Epiphyseal And Carpal Bone Ossification	MESH:C566687			MESH:D001848	C05.116.099/C566687	C05.116.099		Musculoskeletal disease
Skin and Connective Tissue Diseases	MESH:D017437		A collective term for diseases of the skin and its appendages and of connective tissue.	MESH:C	C17	C		
Skin Diseases	MESH:D012871	DO:DOID:37	Diseases involving the DERMIS or EPIDERMIS.	MESH:D017437	C17.800	C17	Dermatoses|Dermatosis|Skin and Subcutaneous Tissue Disorders|Skin Disease	Skin disease
Skin Diseases, Eczematous	MESH:D017443		Any of a variety of eruptive skin disorders characterized by erythema, oozing, vesiculation, and scaling. Etiology is varied.	MESH:D012871	C17.800.815	C17.800	Disease, Eczematous Skin|Diseases, Eczematous Skin|Disorder, Eczematous|Disorders, Eczematous|Eczematous Disorder|Eczematous Disorders|Eczematous Skin Disease|Eczematous Skin Diseases|Skin Disease, Eczematous	Skin disease
Skin Diseases, Infectious	MESH:D012874		Skin diseases caused by bacteria, fungi, parasites, or viruses.	MESH:D007239|MESH:D012871	C01.800|C17.800.838	C01|C17.800	Disease, Infectious Skin|Diseases, Infectious Skin|Infectious Skin Disease|Infectious Skin Diseases|Skin Disease, Infectious	Skin disease
Skin Diseases, Metabolic	MESH:D012875		Diseases of the skin associated with underlying metabolic disorders.	MESH:D008659|MESH:D012871	C17.800.849|C18.452.880	C17.800|C18.452	Disease, Metabolic Skin|Diseases, Metabolic Skin|Metabolic Skin Disease|Metabolic Skin Diseases|Skin Disease, Metabolic	Metabolic disease|Skin disease
Skin Diseases, Papulosquamous	MESH:D017444		A group of dermatoses with distinct morphologic features. The primary lesion is most commonly a papule, usually erythematous, with a variable degree of scaling on the surface. Plaques form through the coalescing of primary lesions.	MESH:D012871	C17.800.859	C17.800	Disease, Papulosquamous Skin|Diseases, Papulosquamous Skin|Disorder, Papulosquamous|Disorders, Papulosquamous|Papulosquamous Disorder|Papulosquamous Disorders|Papulosquamous Skin Disease|Papulosquamous Skin Diseases|Skin Disease, Papulosquamous	Skin disease
Skin Diseases, Vascular	MESH:D017445	DO:DOID:9540	Skin diseases affecting or involving the cutaneous blood vessels and generally manifested as inflammation, swelling, erythema, or necrosis in the affected area.	MESH:D012871	C17.800.862	C17.800	Diseases, Vascular Skin|Disease, Vascular Skin|Skin Disease, Vascular|Vascular Skin Disease|Vascular Skin Diseases	Skin disease
Skin Diseases, Vesiculobullous	MESH:D012872	DO:DOID:2731|DO:DOID:8508	Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990)	MESH:D012871	C17.800.865	C17.800	Bullous Dermatoses|Bullous Skin Disease|Bullous Skin Diseases|Dermatoses, Bullous|Dermatoses, Subcorneal Pustular|Dermatoses, Vesiculobullous|Dermatosis, Subcorneal Pustular|Pustular Dermatoses, Subcorneal|Pustular Dermatosis, Subcorneal|Skin Disease, Bullous|Skin Diseases, Bullous|Skin Diseases, Vesicular|Skin Disease, Vesicular|Skin Disease, Vesiculobullous|Sneddon Wilkinson Disease|Sneddon-Wilkinson Disease|Subcorneal Pustular Dermatoses|Subcorneal Pustular Dermatosis|Vesicular Skin Disease|Vesicular Skin Diseases|Vesiculobullous Dermatoses|Vesiculobullous Skin Disease|Vesiculobullous Skin Diseases	Skin disease
Skin Diseases, Viral	MESH:D017193		Skin diseases caused by viruses.	MESH:D012874|MESH:D014777	C01.925.825|C17.800.838.790	C01.925|C17.800.838	Diseases, Viral Skin|Disease, Viral Skin|Skin Disease, Viral|Viral Skin Disease|Viral Skin Diseases	Skin disease|Viral disease
Skin Neoplasms	MESH:D012878	DO:DOID:3165|DO:DOID:4159	Tumors or cancer of the SKIN.	MESH:D009371|MESH:D012871	C04.588.805|C17.800.882	C04.588|C17.800	Cancer of Skin|Cancer of the Skin|Cancer, Skin|Cancers, Skin|Neoplasm, Skin|Neoplasms, Skin|Skin Cancer|Skin Cancers|Skin Neoplasm	Cancer|Skin disease
Skin Ulcer	MESH:D012883		An ULCER of the skin and underlying tissues.	MESH:D012871	C17.800.893	C17.800	Skin Ulcers|Ulcer, Skin|Ulcers, Skin	Skin disease
Skull Base Neoplasms	MESH:D019292	DO:DOID:3842	Neoplasms of the base of the skull specifically, differentiated from neoplasms of unspecified sites or bones of the skull (SKULL NEOPLASMS).	MESH:D012888	C04.588.149.721.828|C05.116.231.754.829	C04.588.149.721|C05.116.231.754	Neoplasm, Skull Base|Neoplasms, Skull Base|Skull Base Neoplasm	Cancer|Musculoskeletal disease
Skull Fracture, Basilar	MESH:D020205		Fractures which extend through the base of the SKULL, usually involving the PETROUS BONE. Battle's sign (characterized by skin discoloration due to extravasation of blood into the subcutaneous tissue behind the ear and over the mastoid process), CRANIAL NEUROPATHIES, TRAUMATIC; CAROTID-CAVERNOUS SINUS FISTULA; and CEREBROSPINAL FLUID OTORRHEA are relatively frequent sequelae of this condition. (Adams et al., Principles of Neurology, 6th ed, p876)	MESH:D012887	C10.900.300.918.150|C26.404.750.821|C26.915.300.745.300	C10.900.300.918|C26.404.750|C26.915.300.745	Basilar Skull Fracture|Basilar Skull Fractures|Battle Sign|Battle's Sign|Battles Sign|Fracture, Basilar Skull|Fracture, Frontobasilar Skull|Fractures, Basilar Skull|Fractures, Frontobasilar Skull|Frontobasilar Skull Fracture|Frontobasilar Skull Fractures|Sign, Battle|Sign, Battle's|Skull Fracture, Basilar, Childhood|Skull Fracture, Frontobasilar|Skull Fractures, Basilar|Skull Fractures, Frontobasilar|Skull Fracture, Transphenoid Basilar	Nervous system disease|Wounds and injuries
Skull Fracture, Depressed	MESH:D020204		A skull fracture characterized by inward depression of a fragment or section of cranial bone, often compressing the underlying dura mater and brain. Depressed cranial fractures which feature open skin wounds that communicate with skull fragments are referred to as compound depressed skull fractures.	MESH:D012887	C10.900.300.918.300|C26.404.750.890|C26.915.300.745.350	C10.900.300.918|C26.404.750|C26.915.300.745	Compound Depressed Skull Fracture|Compound Depressed Skull Fractures|Depressed Skull Fracture|Depressed Skull Fractures|Fracture, Depressed Skull|Fractures, Depressed Skull|Skull Fracture, Compound Depressed|Skull Fractures, Compound Depressed|Skull Fractures, Depressed	Nervous system disease|Wounds and injuries
Skull Fractures	MESH:D012887		Fractures of the skull which may result from penetrating or nonpenetrating head injuries or rarely BONE DISEASES (see also FRACTURES, SPONTANEOUS). Skull fractures may be classified by location (e.g., SKULL FRACTURE, BASILAR), radiographic appearance (e.g., linear), or based upon cranial integrity (e.g., SKULL FRACTURE, DEPRESSED).	MESH:D006259|MESH:D050723	C10.900.300.918|C26.404.750|C26.915.300.745	C10.900.300|C26.404|C26.915.300	Fracture, Non-Depressed Skull|Fracture, Skull|Fractures, Linear Skull|Fractures, Non-Depressed Skull|Fractures, Skull|Linear Skull Fracture|Linear Skull Fractures|Non Depressed Skull Fracture|Non-Depressed Skull Fracture|Non-Depressed Skull Fractures|Skull Fracture|Skull Fracture, Linear|Skull Fracture, Non Depressed|Skull Fracture, Non-Depressed|Skull Fractures, Linear|Skull Fractures, Non-Depressed	Nervous system disease|Wounds and injuries
Skull Neoplasms	MESH:D012888	DO:DOID:1863	Neoplasms of the bony part of the skull.	MESH:D001859	C04.588.149.721|C05.116.231.754	C04.588.149|C05.116.231	Neoplasm, Skull|Neoplasms, Skull|Skull Neoplasm	Cancer|Musculoskeletal disease
Slavotinek Pike Mills Hurst syndrome	MESH:C536672			MESH:D002386|MESH:D006130|MESH:D007859	C10.597.606.150.550/C536672|C11.510.245/C536672|C23.550.393/C536672|C23.888.592.604.150.550/C536672|F03.625.562/C536672	C10.597.606.150.550|C11.510.245|C23.550.393|C23.888.592.604.150.550|F03.625.562		Eye disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
Sleep Apnea, Central	MESH:D020182	DO:DOID:9220	A condition associated with multiple episodes of sleep apnea which are distinguished from obstructive sleep apnea (SLEEP APNEA, OBSTRUCTIVE) by the complete cessation of efforts to breathe. This disorder is associated with dysfunction of central nervous system centers that regulate respiration.	MESH:D012891	C08.618.085.852.800|C10.886.425.800.750.800	C08.618.085.852|C10.886.425.800.750	Alveolar Hypoventilation, Central|Alveolar Hypoventilations, Central|Apnea, Central|Apnea, Central Sleep|Apneas, Central|Apneas, Central Sleep|Apnea, Sleep, Central|Breathing, Central Sleep-Disordered|Breathings, Central Sleep-Disordered|Central Alveolar Hypoventilation|Central Alveolar Hypoventilation Syndrome|Central Apnea|Central Apneas|Central Sleep Apnea|Central Sleep Apnea, Primary|Central Sleep Apneas|Central Sleep Apnea, Secondary|Central Sleep Apnea Syndrome|Central Sleep Disordered Breathing|Central Sleep-Disordered Breathing|Central Sleep-Disordered Breathings|Hypoventilation, Central Alveolar|Hypoventilations, Central Alveolar|Newborn Primary Sleep Apneas|Ondine Syndrome|Primary Central Sleep Apnea|Primary Sleep Apneas of Newborn|Secondary Central Sleep Apnea|Sleep Apnea, Lethal Central|Sleep Apnea, Newborn, Primary|Sleep Apneas, Central|Sleep Disordered Breathing, Central|Sleep-Disordered Breathing, Central|Sleep-Disordered Breathings, Central	Nervous system disease|Respiratory tract disease
Sleep Apnea, Obstructive	MESH:D020181	DO:DOID:0050848	A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)	MESH:D012891	C08.618.085.852.850|C10.886.425.800.750.850	C08.618.085.852|C10.886.425.800.750	Apnea, Obstructive Sleep|Apneas, Obstructive Sleep|Obstructive Sleep Apnea|Obstructive Sleep Apneas|Obstructive Sleep Apnea Syndrome|OSAHS|Sleep Apnea Hypopnea Syndrome|Sleep Apneas, Obstructive|Sleep Apnea Syndrome, Obstructive|Syndrome, Obstructive Sleep Apnea|Syndrome, Sleep Apnea, Obstructive|Syndrome, Upper Airway Resistance, Sleep Apnea|Upper Airway Resistance Sleep Apnea Syndrome	Nervous system disease|Respiratory tract disease
Sleep Apnea Syndromes	MESH:D012891	DO:DOID:0050847|DO:DOID:0080302	Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.	MESH:D001049|MESH:D020919	C08.618.085.852|C10.886.425.800.750	C08.618.085|C10.886.425.800	Apnea, Sleep|Apneas, Sleep|Apnea Syndrome, Sleep|Apnea Syndromes, Sleep|Breathing, Sleep-Disordered|Hypersomnia with Periodic Respiration|Hypopnea, Sleep|Hypopneas, Sleep|Mixed Central and Obstructive Sleep Apnea|Mixed Sleep Apnea|Mixed Sleep Apneas|Sleep Apnea|Sleep Apnea, Mixed|Sleep Apnea, Mixed Central and Obstructive|Sleep Apneas|Sleep Apneas, Mixed|Sleep Apnea Syndrome|Sleep Disordered Breathing|Sleep-Disordered Breathing|Sleep Hypopnea|Sleep Hypopneas	Nervous system disease|Respiratory tract disease
Slipped Capital Femoral Epiphyses	MESH:D060048		A developmental deformity in which the metaphysis of the FEMUR moves proximally and anteriorly away from FEMUR HEAD (epiphysis) at the upper GROWTH PLATE. It is most common in male adolescents and is associated with a greater risk of early OSTEOARTHRITIS of the hip.	MESH:D004839|MESH:D010009	C05.116.099.708.928|C05.116.425.500	C05.116.099.708|C05.116.425	Adolescent Coxa Vara|Adolescent Coxa Varas|Bilateral Slipped Capital Femoral Epiphyses|Bilateral Slipped Capital Femoral Epiphysis|Coxa Vara, Adolescent|Epiphysiolysis Capitis Femoris|Slipped Capital Femoral Epiphysis|Slipped Femoral Capital Epiphyses|Unilateral Slipped Capital Femoral Epiphyses|Unilateral Slipped Capital Femoral Epiphysis	Musculoskeletal disease
Slow Virus Diseases	MESH:D012897		Diseases of viral origin, characterized by incubation periods of months to years, insidious onset of clinical manifestations, and protracted clinical course. Though the disease process is protracted, viral multiplication may not be unusually slow. Conventional viruses produce slow virus diseases such as SUBACUTE SCLEROSING PANENCEPHALITIS, progressive multifocal leukoencephalopathy (LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL), and AIDS. Diseases produced by unconventional agents were originally considered part of this group. They are now called PRION DISEASES.	MESH:D014777	C01.925.839	C01.925	Disease, Slow Virus|Diseases, Slow Virus|Slow Virus Disease|Virus Disease, Slow|Virus Diseases, Slow	Viral disease
Slti Salem syndrome	MESH:C536673			MESH:D000505|MESH:D007006	C17.800.329.937.122/C536673|C19.391.482/C536673|C23.300.035/C536673	C17.800.329.937.122|C19.391.482|C23.300.035	Hypogonadism and frontoparietal alopecia|Hypogonadotropic hypogonadism alopecia	Endocrine system disease|Pathology (anatomical condition)|Skin disease
Small Cell Lung Carcinoma	MESH:D055752	DO:DOID:5409	A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).	MESH:D002283	C04.588.894.797.520.109.220.624|C08.381.540.140.750|C08.785.520.100.220.750	C04.588.894.797.520.109.220|C08.381.540.140|C08.785.520.100.220	Carcinoma, Small Cell Lung|Oat Cell Carcinoma of Lung|Oat Cell Lung Cancer|Small Cell Cancer Of The Lung|Small Cell Lung Cancer	Cancer|Respiratory tract disease
Small Fiber Neuropathy	MESH:D000071075		Disorder of the peripheral nerves that primarily impair small nerve fibers. The affected small nerve fibers include myelinated A-delta fibers (see A FIBERS) and unmyelinated C FIBERS. Because these small fibers innervate skin and help control autonomic function, their neuropathy presents with neuropathic pain, reduced thermal and pain sensitivity, and autonomic dysfunction (e.g. abnormal sweating or facial flushing). Small fiber neuropathy can be idiopathic or associated with underlying diseases (e.g., AMYLOIDOSIS; DIABETES MELLITUS; SARCOIDOSIS; or VASCULITIS).	MESH:D010523	C10.668.829.860	C10.668.829	Neuropathies, Small Fiber|Neuropathies, Small Fibre|Neuropathy, Small Fiber|Neuropathy, Small Fibre|Small Fiber Neuropathies|Small Fibre Neuropathies|Small Fibre Neuropathy|Small Nerve Fiber Neuropathy	Nervous system disease
Smallpox	MESH:D012899	DO:DOID:8736|DO:DOID:9153	An acute, highly contagious, often fatal infectious disease caused by an orthopoxvirus characterized by a biphasic febrile course and distinctive progressive skin eruptions. Vaccination has succeeded in eradicating smallpox worldwide. (Dorland, 28th ed)	MESH:D011213	C01.925.256.743.826	C01.925.256.743	Alastrim|Minors, Variola|Minor, Variola|Variola|Variola Minor|Variola Minors|Variolas	Viral disease
smoker's inclusion bodies	MESH:C000719328			MESH:D017563	C08.381.483/C000719328	C08.381.483	smokers' inclusions	Respiratory tract disease
Smoldering Multiple Myeloma	MESH:D000075122		An asymptomatic and slow-growing PLASMA CELL dyscrasia characterized by presence of MYELOMA PROTEINS and clonal bone marrow plasma cells without end-organ damage (e.g., renal impairment). It is distinguished from MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE by a much higher risk of progression to symptomatic MULTIPLE MYELOMA.	MESH:D006942|MESH:D010265|MESH:D011230	C04.834.794|C15.378.147.542.820|C15.378.147.780.838|C20.683.460.820|C20.683.780.838	C04.834|C15.378.147.542|C15.378.147.780|C20.683.460|C20.683.780	Asymptomatic Multiple Myeloma|Asymptomatic Multiple Myelomas|Multiple Myeloma, Asymptomatic|Multiple Myelomas, Asymptomatic|Multiple Myeloma, Smoldering|Myeloma, Smoldering|Smoldering Multiple Myelomas|Smoldering Myeloma|Smoldering Myelomas	Blood disease|Cancer|Immune system disease
Smooth Muscle Tumor	MESH:D018235	DO:DOID:4310	A tumor composed of smooth muscle tissue, as opposed to leiomyoma, a tumor derived from smooth muscle.	MESH:D009379	C04.557.450.590.800	C04.557.450.590	Muscle Tumor, Smooth|Muscle Tumors, Smooth|Smooth Muscle Tumors|Tumor, Smooth Muscle|Tumors, Smooth Muscle	Cancer
Sneddon Syndrome	MESH:D018860	DO:DOID:13096|OMIM:182410	A systemic non-inflammatory arteriopathy primarily of middle-aged females characterized by the association of LIVEDO RETICULARIS, multiple thrombotic CEREBRAL INFARCTION; CORONARY DISEASE, and HYPERTENSION. Elevation of antiphospholipid antibody titers (see also ANTIPHOSPHOLIPID SYNDROME), cardiac valvulopathy, ISCHEMIC ATTACK, TRANSIENT; SEIZURES; DEMENTIA; and chronic ischemia of the extremities may also occur. Pathologic examination of affected arteries reveals non-inflammatory adventitial fibrosis, thrombosis, and changes in the media. (From Jablonski, Dictionary of Syndromes & Eponymic Diseases, 2d ed; Adams et al., Principles of Neurology, 6th ed, p861; Arch Neurol 1997 Jan;54(1):53-60)	MESH:D002561|MESH:D017445	C10.228.140.300.750|C14.907.253.774|C17.800.862.775	C10.228.140.300|C14.907.253|C17.800.862	Livedo Reticularis And Cerebrovascular Accidents|Livedo Reticularis, Systemic Involvement|SNDNS|Sneddon Champion Syndrome|Sneddon-Champion Syndrome|Syndrome, Sneddon|Syndrome, Sneddon-Champion	Cardiovascular disease|Nervous system disease|Skin disease
Snowflake vitreoretinal degeneration	MESH:C536677	DO:DOID:0111570|OMIM:193230		MESH:D012162	C11.270.612/C536677|C11.768.585/C536677	C11.270.612|C11.768.585	Snowflake degeneration in hereditary vitreoretinal degeneration|SNOWFLAKE VITREORETINAL DEGENERATION|SVD|Vitreoretinal degeneration, Snowflake type	Eye disease
SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1	OMIM:613508			MESH:D007010	C18.452.950.620/613508	C18.452.950.620	HYPONATREMIA, INCLUDED|SSQTL1	Metabolic disease
Soft Tissue Infections	MESH:D018461		Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the fecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites. (From Cecil Textbook of Medicine, 19th ed, p1688)	MESH:D007239	C01.820	C01	Infection, Soft Tissue|Infections, Soft Tissue|Soft Tissue Infection	
Soft Tissue Neoplasms	MESH:D012983	DO:DOID:0060123	Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.	MESH:D009371	C04.588.839	C04.588	Neoplasm, Soft Tissue|Neoplasms, Soft Tissue|Soft Tissue Neoplasm	Cancer
Sohval Soffer syndrome	MESH:C536679			MESH:D013733	C12.100.500.829/C536679|C12.200.294.829/C536679|C19.391.829/C536679	C12.100.500.829|C12.200.294.829|C19.391.829	Congenital testicular deficiency	Endocrine system disease|Urogenital disease (male)
Solitary Fibrous Tumor, Pleural	MESH:D054363	DO:DOID:2653	A rare neoplasm, usually benign, derived from mesenchymal fibroblasts located in the submesothelial lining of the PLEURA. It spite of its various synonyms, it has no features of mesothelial cells and is not related to malignant MESOTHELIOMA or asbestos exposure.	MESH:D010997|MESH:D054364	C04.557.450.565.590.797.750|C04.588.894.797.640.800	C04.557.450.565.590.797|C04.588.894.797.640	Benign Fibrous Mesothelioma|Benign Fibrous Mesotheliomas|Fibromas, Submesothelial|Fibroma, Submesothelial|Fibrous Mesothelioma|Fibrous Mesothelioma, Benign|Fibrous Mesothelioma, Localized|Fibrous Mesotheliomas|Fibrous Mesotheliomas, Benign|Fibrous Mesotheliomas, Localized|Fibrous Mesothelioma, Solitary|Fibrous Mesotheliomas, Solitary|Localized Fibrous Mesothelioma|Localized Fibrous Mesotheliomas|Localized Mesothelioma|Localized Mesotheliomas|Mesothelioma, Benign Fibrous|Mesothelioma, Fibrous|Mesothelioma, Localized|Mesothelioma, Localized Fibrous|Mesotheliomas, Benign Fibrous|Mesotheliomas, Fibrous|Mesotheliomas, Localized|Mesotheliomas, Localized Fibrous|Mesothelioma, Solitary Fibrous|Mesotheliomas, Solitary Fibrous|Solitary Fibrous Mesothelioma|Solitary Fibrous Mesotheliomas|Solitary Fibrous Tumor of the Pleura|Submesothelial Fibroma|Submesothelial Fibromas	Cancer
Solitary Fibrous Tumors	MESH:D054364		Rare neoplasms of mesenchymal origin, usually benign, and most commonly involving the PLEURA (see SOLITARY FIBROUS TUMOR, PLEURAL). They also are found in extrapleural sites.	MESH:D018218	C04.557.450.565.590.797	C04.557.450.565.590	Fibrous Tumor, Solitary|Fibrous Tumors, Solitary|Solitary Fibrous Tumor|Tumor, Solitary Fibrous|Tumors, Solitary Fibrous	Cancer
Solitary Kidney	MESH:D000075529		Either a single or a single functioning kidney due to NEPHRECTOMY, birth defects or other kidney diseases.	MESH:D014564|MESH:D020763	C12.050.351.875.846|C12.200.706.846|C12.800.846|C23.300.925	C12.050.351.875|C12.200.706|C12.800|C23.300	Functioning Kidney, Single|Functioning Kidneys, Single|Kidney, Single|Kidney, Single Functioning|Kidneys, Single|Kidneys, Single Functioning|Renal Agenesis, Unilateral|Renal Hypoplasia, Unilateral|Single Functioning Kidney|Single Functioning Kidneys|Single Kidney|Single Kidneys|Solitary Functioning Kidney|Unilateral Renal Agenesis|Unilateral Renal Hypoplasia	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Solitary Pulmonary Nodule	MESH:D003074	DO:DOID:5364	A single lung lesion that is characterized by a small round mass of tissue, usually less than 1 cm in diameter, and can be detected by chest radiography. A solitary pulmonary nodule can be associated with neoplasm, tuberculosis, cyst, or other anomalies in the lung, the CHEST WALL, or the PLEURA.	MESH:D008171	C08.381.884	C08.381	Coin Lesion, Pulmonary|Coin Lesions, Pulmonary|Lesion, Pulmonary Coin|Lesions, Pulmonary Coin|Nodule, Solitary Pulmonary|Nodules, Solitary Pulmonary|Pulmonary Coin Lesion|Pulmonary Coin Lesions|Pulmonary Nodule, Solitary|Pulmonary Nodules, Solitary|Solitary Pulmonary Nodules	Respiratory tract disease
Somatosensory Disorders	MESH:D020886		Disorders of sensory information received from superficial and deep regions of the body. The somatosensory system conveys neural impulses which pertain to proprioception, tactile sensation, thermal sensation, pressure sensation, and pain. PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL CORD DISEASES; and BRAIN DISEASES may be associated with impaired or abnormal somatic sensation.	MESH:D012678	C10.597.751.791|C23.888.592.763.770	C10.597.751|C23.888.592.763	Diminished, Pain Sensation|Diminished, Pinprick Sensation|Diminisheds, Pain Sensation|Diminisheds, Pinprick Sensation|Impairment, Light Touch Sensation|Light Touch Sensation Impairment|Pain Sensation Diminished|Pain Sensation Diminisheds|Pinprick Sensation Diminished|Pinprick Sensation Diminisheds|Position Sense Disorder|Position Sense Disorders|Proprioceptive Disorder|Proprioceptive Disorders|Sensation Diminished, Pain|Sensation Diminished, Pinprick|Sensation Diminisheds, Pain|Sensation Diminisheds, Pinprick|Sensation Disorder, Somatic|Sensation Disorders, Somatic|Sensation Disorders, Thermal|Sensation Disorder, Thermal|Sense Disorder, Position|Sense Disorders, Position|Somatic Sensation Disorder|Somatic Sensation Disorders|Somatosensory Disorder|Thermal Sensation Disorder|Thermal Sensation Disorders	Nervous system disease|Signs and symptoms
Somatostatinoma	MESH:D013005	DO:DOID:4430	A SOMATOSTATIN-secreting tumor derived from the pancreatic delta cells (SOMATOSTATIN-SECRETING CELLS). It is also found in the INTESTINE. Somatostatinomas are associated with DIABETES MELLITUS; CHOLELITHIASIS; STEATORRHEA; and HYPOCHLORHYDRIA. The majority of somatostatinomas have the potential for METASTASIS.	MESH:D018273|MESH:D018278	C04.557.465.625.650.240.695|C04.557.470.200.025.370.695|C04.588.274.761.500.500|C04.588.322.475.500.500|C06.301.761.500.500|C06.689.667.500.500|C19.344.421.500.500	C04.557.465.625.650.240|C04.557.470.200.025.370|C04.588.274.761.500|C04.588.322.475.500|C06.301.761.500|C06.689.667.500|C19.344.421.500	Somatostatinomas	Cancer|Digestive system disease|Endocrine system disease
Sonoda syndrome	MESH:C536680			MESH:D006130|MESH:D006330|MESH:D019465	C05.660.207/C536680|C14.240.400/C536680|C14.280.400/C536680|C16.131.240.400/C536680|C16.131.621.207/C536680|C23.550.393/C536680	C05.660.207|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207|C23.550.393		Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Pathology (process)
Spasm	MESH:D013035		An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.	MESH:D020879	C10.597.613.750|C23.888.592.608.750	C10.597.613|C23.888.592.608	Ciliary Body Spasm|Ciliary Body Spasms|Generalized Spasm|Generalized Spasms|Muscle Spasm|Muscle Spasms|Muscular Spasm|Muscular Spasms|Spasm, Ciliary Body|Spasm, Generalized|Spasm, Muscle|Spasm, Muscular|Spasms|Spasms, Ciliary Body|Spasms, Generalized|Spasms, Muscle|Spasms, Muscular	Nervous system disease|Signs and symptoms
Spasms, Infantile	MESH:D013036	DO:DOID:0050562	An epileptic syndrome characterized by the triad of infantile spasms, hypsarrhythmia, and arrest of psychomotor development at seizure onset. The majority present between 3-12 months of age, with spasms consisting of combinations of brief flexor or extensor movements of the head, trunk, and limbs. The condition is divided into two forms: cryptogenic (idiopathic) and symptomatic (secondary to a known disease process such as intrauterine infections; nervous system abnormalities; BRAIN DISEASES, METABOLIC, INBORN; prematurity; perinatal asphyxia; TUBEROUS SCLEROSIS; etc.). (From Menkes, Textbook of Child Neurology, 5th ed, pp744-8)	MESH:D000073376|MESH:D004829	C10.228.140.490.375.760|C10.228.140.490.493.875	C10.228.140.490.375|C10.228.140.490.493	Attack, Lightning|Attacks, Lightning|Attacks, Salaam|Cryptogenic Infantile Spasm|Cryptogenic Infantile Spasms|Cryptogenic West Syndrome|Hypsarrhythmia|Hypsarrhythmias|Infantile Spasm|Infantile Spasm, Cryptogenic|Infantile Spasms|Infantile Spasms, Cryptogenic|Infantile Spasms, Symptomatic|Infantile Spasm, Symptomatic|Jackknife Seizure|Jackknife Seizures|Lightning Attack|Lightning Attacks|Nodding Spasm|Nodding Spasms|Salaam Attacks|Salaam Seizures|Seizure, Jackknife|Seizures, Jackknife|Seizures, Salaam|Spasm, Cryptogenic Infantile|Spasm, Nodding|Spasms, Cryptogenic Infantile|Spasms, Nodding|Spasms, Symptomatic Infantile|Spasm, Symptomatic Infantile|Spasmus Nutans|Symptomatic Infantile Spasm|Symptomatic Infantile Spasms|Symptomatic West Syndrome|Syndrome, Cryptogenic West|Syndrome, Symptomatic West|Syndrome, West|West Syndrome|West Syndrome, Cryptogenic|West Syndrome, Symptomatic	Nervous system disease
Spastic Paraplegia 24, Autosomal Recessive	MESH:C564375			MESH:D010264	C10.597.622.669/C564375|C23.888.592.636.637/C564375	C10.597.622.669|C23.888.592.636.637		Nervous system disease|Signs and symptoms
Spastic Paraplegia 28, Autosomal Recessive	MESH:C563732	OMIM:609340		MESH:D010264	C10.597.622.669/C563732|C23.888.592.636.637/C563732	C10.597.622.669|C23.888.592.636.637	SPG28	Nervous system disease|Signs and symptoms
Spastic Paraplegia 30, Autosomal Recessive	MESH:C563677	OMIM:610357		MESH:D010264	C10.597.622.669/C563677|C23.888.592.636.637/C563677	C10.597.622.669|C23.888.592.636.637	SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT|SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE, INCLUDED|SPG30	Nervous system disease|Signs and symptoms
Spastic Paresis, Glaucoma, and Mental Retardation	MESH:C564809			MESH:D005901|MESH:D008607|MESH:D020336	C10.597.606.360/C564809|C10.597.636.500.500/C564809|C11.525.381/C564809|C23.888.592.604.646/C564809|C23.888.592.643.500.500/C564809|F03.625.539/C564809	C10.597.606.360|C10.597.636.500.500|C11.525.381|C23.888.592.604.646|C23.888.592.643.500.500|F03.625.539		Eye disease|Mental disorder|Nervous system disease|Signs and symptoms
Spastic Pseudosclerosis	MESH:C563024			MESH:D001927|MESH:D019636	C10.228.140/C563024|C10.574/C563024	C10.228.140|C10.574	Corticopallidodegeneration|Disseminated Encephalomyelopathy	Nervous system disease
SPATIAL VISUALIZATION, APTITUDE FOR	OMIM:313000			MESH:D014786	C10.597.751.941/313000|C11.966/313000|C23.888.592.763.941/313000	C10.597.751.941|C11.966|C23.888.592.763.941	VISUOSPATIAL/PERCEPTUAL ABILITIES;VSPA  TURNER SYNDROME-ASSOCIATED NEUROCOGNITIVE PHENOTYPE, INCLUDED	Eye disease|Nervous system disease|Signs and symptoms
Specific Granule Deficiency	MESH:C562873	OMIM:245480		MESH:D007960	C15.378.553/C562873	C15.378.553	Lactoferrin-Deficient Neutrophils|Neutrophil Lactoferrin Deficiency|SGD1|SPECIFIC GRANULE DEFICIENCY 1	Blood disease
Specific Language Disorder	MESH:D000080888		Language disorder that delays the mastery of oral language skills or  in children who have no hearing loss or other developmental delays.	MESH:D007805|MESH:D007859	C10.597.606.150.500.550.500|C23.888.592.604.150.500.550.500|C23.888.592.604.150.550.600	C10.597.606.150.500.550|C23.888.592.604.150.500.550|C23.888.592.604.150.550	Disorder, Specific Language|Disorders, Specific Language|Impairment, Specific Language|Impairments, Specific Language|Language Disorder, Specific|Language Disorders, Specific|Language Impairment, Specific|Language Impairments, Specific|Specific Language Disorders|Specific Language Impairment|Specific Language Impairments	Nervous system disease|Signs and symptoms
SPECIFIC LANGUAGE IMPAIRMENT 1	OMIM:606711	DO:DOID:0060244		MESH:D007805	C10.597.606.150.500.550/606711|C23.888.592.604.150.500.550/606711	C10.597.606.150.500.550|C23.888.592.604.150.500.550	SLI1|SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 16	Nervous system disease|Signs and symptoms
SPECIFIC LANGUAGE IMPAIRMENT 2	OMIM:606712	DO:DOID:0060244		MESH:D007805	C10.597.606.150.500.550/606712|C23.888.592.604.150.500.550/606712	C10.597.606.150.500.550|C23.888.592.604.150.500.550	SLI2|SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19	Nervous system disease|Signs and symptoms
SPECIFIC LANGUAGE IMPAIRMENT 3	OMIM:607134	DO:DOID:0060244		MESH:D007805	C10.597.606.150.500.550/607134|C23.888.592.604.150.500.550/607134	C10.597.606.150.500.550|C23.888.592.604.150.500.550	SLI3|SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 13	Nervous system disease|Signs and symptoms
Specific Language Impairment 4	MESH:C567288	OMIM:612514		MESH:D007805	C10.597.606.150.500.550/C567288|C23.888.592.604.150.500.550/C567288	C10.597.606.150.500.550|C23.888.592.604.150.500.550	SLI4	Nervous system disease|Signs and symptoms
SPECIFIC LANGUAGE IMPAIRMENT 5	OMIM:615432	DO:DOID:0060244		MESH:D007805	C10.597.606.150.500.550/615432|C23.888.592.604.150.500.550/615432	C10.597.606.150.500.550|C23.888.592.604.150.500.550	SLI5	Nervous system disease|Signs and symptoms
Speech Development, Delayed, With Facial Asymmetry, Strabismus, And Transverse Earlobe Crease	MESH:C566677			MESH:D007805|MESH:D013285|MESH:D019066	C10.292.562.887/C566677|C10.597.606.150.500.550/C566677|C11.590.810/C566677|C23.550.291.812/C566677|C23.888.592.604.150.500.550/C566677	C10.292.562.887|C10.597.606.150.500.550|C11.590.810|C23.550.291.812|C23.888.592.604.150.500.550		Eye disease|Nervous system disease|Pathology (process)|Signs and symptoms
Speech Disorders	MESH:D013064	DO:DOID:92	Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language.	MESH:D007806	C10.597.606.150.500.800|C23.888.592.604.150.500.800	C10.597.606.150.500|C23.888.592.604.150.500	Aprosodia|Aprosodias|Aprosodic Speech|Cluttering|Clutterings|Dysglossia|Dysglossias|Dyslalia|Dyslalias|Rhinolalia|Rhinolalias|Speech, Aprosodic|Verbal Fluency Disorder|Verbal Fluency Disorders	Nervous system disease|Signs and symptoms
Speech disturbance - use of faulty phrasing and unrelated words	MESH:C538446			MESH:D013064	C10.597.606.150.500.800/C538446|C23.888.592.604.150.500.800/C538446	C10.597.606.150.500.800|C23.888.592.604.150.500.800		Nervous system disease|Signs and symptoms
Spermatocele	MESH:D013088	DO:DOID:11997	A cystic dilation of the EPIDIDYMIS, usually in the head portion (caput epididymis). The cyst fluid contains dead SPERMATOZOA and can be easily differentiated from TESTICULAR HYDROCELE and other testicular lesions.	MESH:D003560|MESH:D005832	C12.100.500.731|C12.200.294.731|C23.300.306.750	C12.100.500|C12.200.294|C23.300.306	Cyst, Epididymal|Cysts, Epididymal|Epididymal Cyst|Epididymal Cysts|Spermatoceles	Pathology (anatomical condition)|Urogenital disease (male)
Sphenoid Sinusitis	MESH:D015524	DO:DOID:10794	Inflammation of the NASAL MUCOSA in the SPHENOID SINUS. Isolated sphenoid sinusitis is uncommon. It usually occurs in conjunction with other paranasal sinusitis.	MESH:D012852	C01.748.749.827|C08.460.692.752.827|C08.730.749.827|C09.603.692.752.827	C01.748.749|C08.460.692.752|C08.730.749|C09.603.692.752	Sinusitides, Sphenoid|Sinusitides, Sphenoidal|Sinusitis, Sphenoid|Sinusitis, Sphenoidal|Sphenoidal Sinusitides|Sphenoidal Sinusitis|Sphenoid Sinusitides	Ear-nose-throat disease|Respiratory tract disease
Spheroid body myopathy	MESH:C000598645			MESH:D020914	C05.651.575/C000598645|C10.668.491.550/C000598645	C05.651.575|C10.668.491.550	Autosomal dominant spheroid body myopathy	Musculoskeletal disease|Nervous system disease
Spinal Arterial Venous Malformations with Cutaneous Hemangiomas	MESH:C566282			MESH:D001165|MESH:D006391	C04.557.645.375/C566282|C14.240.850.750/C566282|C14.907.150/C566282|C16.131.240.850.750/C566282	C04.557.645.375|C14.240.850.750|C14.907.150|C16.131.240.850.750		Cancer|Cardiovascular disease|Congenital abnormality
Spinal Cord Compression	MESH:D013117		Acute and chronic conditions characterized by external mechanical compression of the SPINAL CORD due to extramedullary neoplasm; EPIDURAL ABSCESS; SPINAL FRACTURES; bony deformities of the vertebral bodies; and other conditions. Clinical manifestations vary with the anatomic site of the lesion and may include localized pain, weakness, sensory loss, incontinence, and impotence.	MESH:D013118|MESH:D013119	C10.228.854.761|C26.819.678	C10.228.854|C26.819	Compression, Spinal Cord|Compressions, Spinal Cord|Compressive Myelopathy|Conus Medullaris Syndrome|Conus Medullaris Syndromes|Extramedullary Spinal Cord Compression|Myelopathy, Compressive|Spinal Cord Compression, Extramedullary|Spinal Cord Compressions|Syndrome, Conus Medullaris|Syndromes, Conus Medullaris	Nervous system disease|Wounds and injuries
Spinal Cord Diseases	MESH:D013118	DO:DOID:319	Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.	MESH:D002493	C10.228.854	C10.228	Myelopathies|Myelopathy|Spinal Cord Disease|Spinal Cord Disorder|Spinal Cord Disorders	Nervous system disease
Spinal Cord Injuries	MESH:D013119		Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).	MESH:D013118|MESH:D014947|MESH:D020196	C10.228.854.763|C10.900.850|C26.819	C10.228.854|C10.900|C26	Contusion, Spinal Cord|Contusions, Spinal Cord|Cord Contusion, Spinal|Cord Contusions, Spinal|Cord Injuries, Spinal|Cord Injury, Spinal|Cord Laceration, Spinal|Cord Lacerations, Spinal|Cord Transection, Spinal|Cord Transections, Spinal|Cord Trauma, Spinal|Cord Traumas, Spinal|Injuries, Spinal Cord|Injury, Spinal Cord|Laceration, Spinal Cord|Lacerations, Spinal Cord|Myelopathies, Post-Traumatic|Myelopathies, Traumatic|Myelopathy, Post-Traumatic|Myelopathy, Traumatic|Post-Traumatic Myelopathies|Post Traumatic Myelopathy|Post-Traumatic Myelopathy|Spinal Cord Contusion|Spinal Cord Contusions|Spinal Cord Injury|Spinal Cord Laceration|Spinal Cord Lacerations|Spinal Cord Transection|Spinal Cord Transections|Spinal Cord Trauma|Spinal Cord Traumas|Transection, Spinal Cord|Transections, Spinal Cord|Trauma, Spinal Cord|Traumas, Spinal Cord|Traumatic Myelopathies|Traumatic Myelopathy	Nervous system disease|Wounds and injuries
Spinal Cord Ischemia	MESH:D020760	DO:DOID:178	Reduced blood flow to the spinal cord which is supplied by the anterior spinal artery and the paired posterior spinal arteries. This condition may be associated with ARTERIOSCLEROSIS, trauma, emboli, diseases of the aorta, and other disorders. Prolonged ischemia may lead to INFARCTION of spinal cord tissue.	MESH:D020758	C10.228.854.785.650|C14.907.790.550	C10.228.854.785|C14.907.790	Cord Ischemia, Spinal|Cord Ischemias, Spinal|Experimental Spinal Cord Ischemia|Ischemia, Spinal Cord|Ischemias, Spinal Cord|Ischemic Myelopathies|Ischemic Myelopathy|Myelopathies, Ischemic|Myelopathy, Ischemic|Spinal Cord Ischemia, Experimental|Spinal Cord Ischemias	Cardiovascular disease|Nervous system disease
Spinal Cord Neoplasms	MESH:D013120	DO:DOID:5612	Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.	MESH:D013118|MESH:D016543	C04.588.614.250.803|C10.228.854.765|C10.551.240.750	C04.588.614.250|C10.228.854|C10.551.240	Intradural Extramedullary Spinal Cord Neoplasms|Intradural-Extramedullary Spinal Cord Neoplasms|Intramedullary Spinal Cord Neoplasms|Intramedullary Spinal Cord Neoplasms, Primary|Neoplasm, Spinal Cord|Neoplasms, Spinal Cord|Primary Intramedullary Spinal Cord Neoplasms|Primary Spinal Cord Neoplasms, Intramedullary|Spinal Cord Neoplasm|Spinal Cord Neoplasms, Benign|Spinal Cord Neoplasms, Intradural Extramedullary|Spinal Cord Neoplasms, Intradural-Extramedullary|Spinal Cord Neoplasms, Intramedullary|Spinal Cord Neoplasms, Malignant|Spinal Cord Neoplasms, Primary Intramedullary|Spinal Cord Tumor|Spinal Cord Tumors|Tumor, Spinal Cord|Tumors, Spinal Cord	Cancer|Nervous system disease
Spinal Cord Vascular Diseases	MESH:D020758	DO:DOID:178	Pathological processes involving any of the BLOOD VESSELS feeding the SPINAL CORD, such as the anterior and paired posterior spinal arteries or their many branches. Disease processes may include ATHEROSCLEROSIS; EMBOLISM; and ARTERIOVENOUS MALFORMATIONS leading to ISCHEMIA or HEMORRHAGE into the spinal cord (hematomyelia).	MESH:D013118|MESH:D014652	C10.228.854.785|C14.907.790	C10.228.854|C14.907	Hematomyelia|Hematomyelias|Posterior Spinal Artery Syndrome|Vascular Diseases, Spinal Cord	Cardiovascular disease|Nervous system disease
Spinal Curvatures	MESH:D013121		Deformities of the SPINE characterized by abnormal bending or flexure in the vertebral column. They may be bending forward (KYPHOSIS), backward (LORDOSIS), or sideway (SCOLIOSIS).	MESH:D013122	C05.116.900.800	C05.116.900	Curvature, Spinal|Curvatures, Spinal|Spinal Curvature	Musculoskeletal disease
Spinal Diseases	MESH:D013122		Diseases involving the SPINE.	MESH:D001847	C05.116.900	C05.116	Disease, Spinal|Diseases, Spinal|Spinal Disease	Musculoskeletal disease
Spinal intradural arachnoid cysts	MESH:C536878			MESH:D013118|MESH:D016080	C04.182.044/C536878|C04.588.614.250.387.100/C536878|C10.228.854/C536878|C10.500.142.100/C536878|C10.551.240.375.100/C536878|C16.131.666.142.100/C536878	C04.182.044|C04.588.614.250.387.100|C10.228.854|C10.500.142.100|C10.551.240.375.100|C16.131.666.142.100	Arachnoid cysts, spinal intradural	Cancer|Congenital abnormality|Nervous system disease
Spinal muscular atrophy 4	MESH:C538417	OMIM:271150		MESH:D009134	C10.228.854.468/C538417|C10.574.562.500/C538417|C10.668.467.500/C538417	C10.228.854.468|C10.574.562.500|C10.668.467.500	SMA4|SPINAL MUSCULAR ATROPHY, ADULT FORM|SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL RECESSIVE|SPINAL MUSCULAR ATROPHY, TYPE IV	Nervous system disease
Spinal Muscular Atrophy, Distal, Autosomal Recessive, 3	MESH:C564626	DO:DOID:0111211|OMIM:607088		MESH:D009134	C10.228.854.468/C564626|C10.574.562.500/C564626|C10.668.467.500/C564626	C10.228.854.468|C10.574.562.500|C10.668.467.500	DHMN3|DHMN4|DSMA3|HMN3|HMN4|HMN III|HMN IV|Neuronopathy, Distal Hereditary Motor, Type III|Neuronopathy, Distal Hereditary Motor, Type IV|Neuropathy, Distal Hereditary Motor, Type IV	Nervous system disease
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	OMIM:614881	DO:DOID:0111214		MESH:D009134	C10.228.854.468/614881|C10.574.562.500/614881|C10.668.467.500/614881	C10.228.854.468|C10.574.562.500|C10.668.467.500	DSMA5	Nervous system disease
Spinal Muscular Atrophy, Distal, Congenital Nonprogressive	MESH:C563981	OMIM:600175		MESH:D009134	C10.228.854.468/C563981|C10.574.562.500/C563981|C10.668.467.500/C563981	C10.228.854.468|C10.574.562.500|C10.668.467.500	DHMN8|HMN8|NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII|NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII|Spinal Muscular Atrophy, Congenital Benign, with Contractures|SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE	Nervous system disease
Spinal Muscular Atrophy, Facioscapulohumeral Type	MESH:C566674			MESH:D009134	C10.228.854.468/C566674|C10.574.562.500/C566674|C10.668.467.500/C566674	C10.228.854.468|C10.574.562.500|C10.668.467.500	FSHSMA	Nervous system disease
Spinal muscular atrophy, Jerash type	MESH:C535715	DO:DOID:0111065|OMIM:605726		MESH:D009134	C10.228.854.468/C535715|C10.574.562.500/C535715|C10.668.467.500/C535715	C10.228.854.468|C10.574.562.500|C10.668.467.500	DSMA2|Hereditary motor neuropathy, Jerash type|HMNJ|Motor neuropathy, distal, Jerash type|Neuronopathy, Distal Hereditary Motor, Jerash Type|Neuropathy, distal hereditary motor, Jerash type|Spinal Muscular Atrophy, Distal, Autosomal Recessive, 2|SPINAL MUSCULAR ATROPHY, JERASH TYPE	Nervous system disease
SPINAL MUSCULAR ATROPHY, JOKELA TYPE	OMIM:615048			MESH:D009134	C10.228.854.468/615048|C10.574.562.500/615048|C10.668.467.500/615048	C10.228.854.468|C10.574.562.500|C10.668.467.500	SMAJ	Nervous system disease
Spinal Muscular Atrophy, Late-Onset, Finkel Type	MESH:C566673			MESH:D009134	C10.228.854.468/C566673|C10.574.562.500/C566673|C10.668.467.500/C566673	C10.228.854.468|C10.574.562.500|C10.668.467.500	Finkel Late-Adult Type SMA	Nervous system disease
Spinal Muscular Atrophy, Proximal, Adult, Autosomal Dominant	MESH:C566672	OMIM:182980		MESH:D009134	C10.228.854.468/C566672|C10.574.562.500/C566672|C10.668.467.500/C566672	C10.228.854.468|C10.574.562.500|C10.668.467.500	FINKEL LATE-ADULT TYPE SMA|SMAFK|SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE|SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANT	Nervous system disease
Spinal muscular atrophy, Ryukyuan type	MESH:C536881			MESH:D009134	C10.228.854.468/C536881|C10.574.562.500/C536881|C10.668.467.500/C536881	C10.228.854.468|C10.574.562.500|C10.668.467.500	Ryukyuan muscular atrophy	Nervous system disease
Spinal Muscular Atrophy, Segmental	MESH:C566670			MESH:D009134	C10.228.854.468/C566670|C10.574.562.500/C566670|C10.668.467.500/C566670	C10.228.854.468|C10.574.562.500|C10.668.467.500		Nervous system disease
Spinal Muscular Atrophy, Type IV	MESH:C563948	DO:DOID:0050529		MESH:D009134	C10.228.854.468/C563948|C10.574.562.500/C563948|C10.668.467.500/C563948	C10.228.854.468|C10.574.562.500|C10.668.467.500	Spinal Muscular Atrophy, Adult Form|Spinal Muscular Atrophy, Proximal, Adult, Autosomal Recessive	Nervous system disease
Spinal Neoplasms	MESH:D013125	DO:DOID:5612	New abnormal growth of tissue in the SPINE.	MESH:D001859|MESH:D013122	C04.588.149.828|C05.116.231.828|C05.116.900.801	C04.588.149|C05.116.231|C05.116.900	Neoplasm, Spinal|Neoplasms, Spinal|Spinal Neoplasm	Cancer|Musculoskeletal disease
Spinal Osteochondrosis	MESH:D055035		A bone disorder involving ossification centers (EPIPHYSES) of the VERTEBRAL COLUMN.	MESH:D013122|MESH:D055034	C05.116.821.500|C05.116.900.808	C05.116.821|C05.116.900	Osteochondroses, Spinal|Osteochondrosis of Spine|Osteochondrosis, Spinal|Spinal Osteochondroses|Spine Osteochondroses|Spine Osteochondrosis	Musculoskeletal disease
Spinal Osteophytosis	MESH:D013128		Outgrowth of immature bony processes or bone spurs (OSTEOPHYTE) from the VERTEBRAE, reflecting the presence of degenerative disease and calcification. It commonly occurs in cervical and lumbar SPONDYLOSIS.	MESH:D013122	C05.116.900.815	C05.116.900	Osteophytoses, Spinal|Osteophytosis, Spinal|Spinal Osteophytoses	Musculoskeletal disease
Spinal Stenosis	MESH:D013130	DO:DOID:6725	Narrowing of the spinal canal.	MESH:D013122	C05.116.900.825	C05.116.900	Spinal Stenoses|Stenoses, Spinal|Stenosis, Spinal	Musculoskeletal disease
Splenic Diseases	MESH:D013158	DO:DOID:2529	Diseases involving the SPLEEN.	MESH:D008206	C15.604.744	C15.604	Disease, Splenic|Diseases, Splenic|Splenic Disease	Lymphatic disease
Splenic Infarction	MESH:D013159	DO:DOID:2533	Insufficiency of arterial or venous blood supply to the spleen due to emboli, thrombi, vascular torsion, or pressure that produces a macroscopic area of necrosis. (From Stedman, 25th ed)	MESH:D007238|MESH:D013158|MESH:D014652	C14.907.795|C15.604.744.617|C23.550.513.355.937|C23.550.717.489.937	C14.907|C15.604.744|C23.550.513.355|C23.550.717.489	Infarction, Splenic|Infarctions, Splenic|Infarct of the Spleen|Infarct, Splenic|Infarcts, Splenic|Splenic Infarct|Splenic Infarctions|Splenic Infarcts	Cardiovascular disease|Lymphatic disease|Pathology (process)
Splenic Neoplasms	MESH:D013160	DO:DOID:672	Tumors or cancer of the SPLEEN.	MESH:D009371|MESH:D013158	C04.588.842|C15.604.744.680	C04.588|C15.604.744	Cancer of Spleen|Cancer of the Spleen|Cancer, Spleen|Cancer, Splenic|Cancers, Spleen|Cancers, Splenic|Neoplasm, Spleen|Neoplasm, Splenic|Neoplasms, Spleen|Neoplasms, Splenic|Spleen Cancer|Spleen Cancers|Spleen Neoplasm|Spleen Neoplasms|Splenic Cancer|Splenic Cancers|Splenic Neoplasm	Cancer|Lymphatic disease
Splenic Rupture	MESH:D013161		Rupture of the SPLEEN due to trauma or disease.	MESH:D000007|MESH:D012421|MESH:D013158	C15.604.744.742|C26.017.680|C26.761.555	C15.604.744|C26.017|C26.761	Rupture, Splenic|Ruptures, Splenic|Splenic Ruptures	Lymphatic disease|Wounds and injuries
Splenoportal Vascular Anomalies	MESH:C562761			MESH:D054079	C14.240.850/C562761|C16.131.240.850/C562761	C14.240.850|C16.131.240.850		Cardiovascular disease|Congenital abnormality
Splenosis	MESH:D017890		The spontaneous transplantation of splenic tissue to unusual sites after open splenic trauma, e.g., after automobile accidents, gunshot or stab wounds. The splenic pulp implants appear as red-blue nodules on the peritoneum, omentum, and mesentery, morphologically similar to multifocal pelvic endometriosis. (Segen, Dictionary of Modern Medicine, 1992)	MESH:D013161	C15.604.744.742.500|C26.017.680.500|C26.761.555.500	C15.604.744.742|C26.017.680|C26.761.555	Splenoses	Lymphatic disease|Wounds and injuries
Spondylarthritis	MESH:D025241		Inflammation of the joints of the SPINE, the intervertebral articulations.	MESH:D001168|MESH:D013166	C05.116.900.853.625|C05.550.114.865	C05.116.900.853|C05.550.114	Arthritis, Spinal|Spinal Arthritides|Spinal Arthritis|Spondylarthritides	Musculoskeletal disease
Spondylarthropathies	MESH:D025242	DO:DOID:1123	Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.	MESH:D025241	C05.116.900.853.625.800|C05.550.114.865.800	C05.116.900.853.625|C05.550.114.865	Bechterew Syndrome|Marie Strumpell Spondylitis|Marie-Strumpell Spondylitis|Spondylarthropathy|Spondylitis, Marie-Strumpell|Spondyloarthropathies|Spondyloarthropathy|Syndrome, Bechterew	Musculoskeletal disease
Spondylitis	MESH:D013166		Inflammation of the SPINE. This includes both arthritic and non-arthritic conditions.	MESH:D001850|MESH:D013122	C01.160.762|C05.116.165.762|C05.116.900.853	C01.160|C05.116.165|C05.116.900	Spondylitides	Musculoskeletal disease
Spondylitis, Ankylosing	MESH:D013167	DO:DOID:7147|OMIM:106300	A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.	MESH:D000089183	C05.116.900.853.625.800.744.500|C05.550.069.340.500|C05.550.114.865.800.744.500	C05.116.900.853.625.800.744|C05.550.069.340|C05.550.114.865.800.744	Ankylosing Spondylarthritides|Ankylosing Spondylarthritis|Ankylosing Spondylitis|ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO|Ankylosing Spondyloarthritides|Ankylosing Spondyloarthritis|Bechterew Disease|Bechterew's Disease|Bechterews Disease|BECHTEREW SYNDROME|Marie Struempell Disease|Marie-Struempell Disease|MARIE-STRUMPELL SPONDYLITIS|Rheumatoid Spondylitis|SPDA1|Spondylarthritides, Ankylosing|Spondylarthritis Ankylopoietica|Spondylarthritis, Ankylosing|Spondylitis Ankylopoietica|Spondylitis, Rheumatoid|Spondyloarthritides, Ankylosing|Spondyloarthritis Ankylopoietica|Spondyloarthritis, Ankylosing|SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	Musculoskeletal disease
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	OMIM:183840	DO:DOID:0080604		MESH:D013167	C05.116.900.853.625.800.744.500/183840|C05.550.069.340.500/183840|C05.550.114.865.800.744.500/183840	C05.116.900.853.625.800.744.500|C05.550.069.340.500|C05.550.114.865.800.744.500	SPDA2	Musculoskeletal disease
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3	OMIM:613238	DO:DOID:0080605		MESH:D013167	C05.116.900.853.625.800.744.500/613238|C05.550.069.340.500/613238|C05.550.114.865.800.744.500/613238	C05.116.900.853.625.800.744.500|C05.550.069.340.500|C05.550.114.865.800.744.500	SPDA3	Musculoskeletal disease
Spondylocostal Dysostosis 4, Autosomal Dominant	MESH:C565149			MESH:D004413	C05.116.099.370/C565149	C05.116.099.370	Costovertebral Segmentation Anomalies|Spondylocostal Dysplasia, Dominant Form|Spondylothoracic Dysostosis, Autosomal Dominant	Musculoskeletal disease
SPONDYLOCOSTAL DYSOSTOSIS 5	OMIM:122600	DO:DOID:0050568		MESH:D004413	C05.116.099.370/122600	C05.116.099.370	COSTOVERTEBRAL SEGMENTATION ANOMALIES|SCDO5|SCOLIOSIS, CONGENITAL, WITH OR WITHOUT RIB ANOMALIES|SPONDYLOCOSTAL DYSPLASIA|SPONDYLOTHORACIC DYSOSTOSIS|TACS	Musculoskeletal disease
Spondylocostal dysostosis, autosomal recessive	MESH:C535781	OMIM:277300|OMIM:608681|OMIM:609813|OMIM:613686|OMIM:616566		MESH:D004413	C05.116.099.370/C535781	C05.116.099.370	Autosomal recessive spondylocostal dysostosis|COSTOVERTEBRAL DYSPLASIA|JARCHO-LEVIN SYNDROME|SCDO1|SCDO2|SCDO3|SCDO4|SCDO6|SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE|Spondylocostal Dysostosis 2, Autosomal Recessive|Spondylocostal Dysostosis 3, Autosomal Recessive|SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE|SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE|SPONDYLOTHORACIC DYSOSTOSIS|SPONDYLOTHORACIC DYSPLASIA|VERTEBRAL ANOMALIES	Musculoskeletal disease
Spondylolisthesis	MESH:D013168	DO:DOID:6682	Forward displacement of a superior vertebral body over the vertebral body below.	MESH:D013169	C05.116.900.938.500.500	C05.116.900.938.500	Olistheses|Olisthesis|Spondylistheses|Spondylisthesis|Spondylolistheses	Musculoskeletal disease
Spondylolysis	MESH:D013169	DO:DOID:2300	Deficient development or degeneration of a portion of the VERTEBRA, usually in the pars interarticularis (the bone bridge between the superior and inferior facet joints of the LUMBAR VERTEBRAE) leading to SPONDYLOLISTHESIS.	MESH:D055009	C05.116.900.938.500	C05.116.900.938	Spondylolyses	Musculoskeletal disease
Spondylosis	MESH:D055009	DO:DOID:2247	A degenerative spinal disease that can involve any part of the VERTEBRA, the INTERVERTEBRAL DISK, and the surrounding soft tissue.	MESH:D013122	C05.116.900.938	C05.116.900	Cervical Spondylosis|Lumbarsacral Spondylosis|Spondylosis, Cervical|Spondylosis Deformans|Spondylosis, Lumbarsacral|Spondylosis, Thoracic|Thoracic Spondylosis	Musculoskeletal disease
Sprue, Tropical	MESH:D013182	DO:DOID:10607	A chronic malabsorption syndrome, occurring mainly in residents of or visitors to the tropics or subtropics. The failed INTESTINAL ABSORPTION of nutrients from the SMALL INTESTINE results in MALNUTRITION and ANEMIA that is due to FOLIC ACID deficiency.	MESH:D008286	C06.405.469.637.850|C18.452.603.850	C06.405.469.637|C18.452.603	Idiopathic Tropical Malabsorption Syndrome|Tropical Sprue	Digestive system disease|Metabolic disease
Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	DO:DOID:2876|DO:DOID:5515|DO:DOID:5520|OMIM:275355	The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.	MESH:D002294|MESH:D006258	C04.557.470.200.400.565|C04.588.443.177	C04.557.470.200.400|C04.588.443	Carcinoma, Squamous Cell of Head and Neck|Head and Neck Squamous Cell Carcinoma|Head And Neck Squamous Cell Carcinomas|HNSCC|Hypopharyngeal Squamous Cell Carcinoma|Laryngeal Squamous Cell Carcinoma|Oral Cavity Squamous Cell Carcinoma|Oral Squamous Cell Carcinoma|Oral Squamous Cell Carcinomas|Oral Tongue Squamous Cell Carcinoma|Oropharyngeal Squamous Cell Carcinoma|Squamous Cell Carcinoma, Head And Neck|Squamous Cell Carcinoma of Larynx|Squamous Cell Carcinoma of the Head and Neck|Squamous Cell Carcinoma of the Larynx|Squamous Cell Carcinoma of the Mouth|Squamous Cell Carcinoma of the Nasal Cavity	Cancer
Squamous Intraepithelial Lesions	MESH:D000081483		A cytological test finding that shows abnormal lesions of SQUAMOUS EPITHELIAL cells.	MESH:D065308	C23.149.688	C23.149	High Grade Squamous Intraepithelial Lesion|High-Grade Squamous Intraepithelial Lesion|High Grade Squamous Intraepithelial Lesions|High-Grade Squamous Intraepithelial Lesions|HSIL, High Grade Squamous Intraepithelial Lesion|HSIL, High Grade Squamous Intraepithelial Lesions|HSIL, High-Grade Squamous Intraepithelial Lesions|Intraepithelial Lesion, Squamous|Lesions, Squamous Intraepithelial|Low Grade Squamous Intraepithelial Lesion|Low-Grade Squamous Intraepithelial Lesion|Low Grade Squamous Intraepithelial Lesions|Low-Grade Squamous Intraepithelial Lesions|LSIL ASC-H|LSIL, Atypical Squamous Cells Cannot Exclude HSIL|LSIL, Low Grade Squamous Intraepithelial Lesion|LSIL, Low-Grade Squamous Intraepithelial Lesion|LSIL, Low Grade Squamous Intraepithelial Lesions|LSIL, Low-Grade Squamous Intraepithelial Lesions|Squamous Intraepithelial Lesion	
Squamous Intraepithelial Lesions of the Cervix	MESH:D065310		A cytological test finding often from PAP SMEARS that shows abnormal lesions of SQUAMOUS EPITHELIAL CELLS of the CERVIX. It is a diagnostic criterion used in the Bethesda System for UTERINE CERVICAL NEOPLASMS and represents the PAP TEST result that is abnormal. Although squamous intraepithelial lesions test result does not mean UTERINE CERVICAL NEOPLASMS it requires follow-ups (e.g., HPV DNA TESTS; and COLPOSCOPY).	MESH:D000081483|MESH:D002578	C04.834.818.500|C12.050.351.500.852.593.074.500|C12.100.250.852.593.074.500|C23.149.688.500	C04.834.818|C12.050.351.500.852.593.074|C12.100.250.852.593.074|C23.149.688		Cancer|Urogenital disease (female)
Staghorn Calculi	MESH:D000069856		Renal calculi with a characteristic shape like antlers of a deer, formed as it extends into multiple calices of the RENAL PELVIS. A large number of staghorn calculi as well as other URINARY CALCULI are composed of STRUVITE.	MESH:D007669	C12.050.351.968.419.600.500.500|C12.050.351.968.967.249.500.500|C12.050.351.968.967.500.503.500|C12.200.777.419.600.500.500|C12.200.777.967.249.500.500|C12.200.777.967.500.503.500|C12.950.419.600.500.500|C12.950.967.249.500.500|C12.950.967.500.503.500|C23.300.175.850.550.500	C12.050.351.968.419.600.500|C12.050.351.968.967.249.500|C12.050.351.968.967.500.503|C12.200.777.419.600.500|C12.200.777.967.249.500|C12.200.777.967.500.503|C12.950.419.600.500|C12.950.967.249.500|C12.950.967.500.503|C23.300.175.850.550	Calculi, Staghorn|Calculus, Staghorn|Staghorn Calculus	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Stargardt disease 3	MESH:C535805	OMIM:600110		MESH:D008268	C11.768.585.439/C535805	C11.768.585.439	Macular dystrophy, autosomal dominant, chromosome 6-linked,|Macular dystrophy with flecks, type 3|Stargardt-Like Macular Dystrophy, Autosomal Dominant|STGD3	Eye disease
Stargardt disease 4	MESH:C535521	OMIM:603786		MESH:D008268	C11.768.585.439/C535521	C11.768.585.439	STGD4	Eye disease
Status Asthmaticus	MESH:D013224	DO:DOID:9362	A sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts.	MESH:D001249	C08.127.108.880|C08.674.095.880|C20.543.480.680.095.880	C08.127.108|C08.674.095|C20.543.480.680.095	Asthmatic Crises|Asthmatic Crisis|Asthmatic Shock|Asthmatic Shocks|Asthmaticus, Status|Crises, Asthmatic|Crisis, Asthmatic|Shock, Asthmatic|Shocks, Asthmatic	Immune system disease|Respiratory tract disease
Status Epilepticus	MESH:D013226	DO:DOID:1824	A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)	MESH:D012640	C10.597.742.785|C23.888.592.742.785	C10.597.742|C23.888.592.742	Absence Status|Complex Partial Status Epilepticus|Electrographic Status Epilepticus|Generalized Convulsive Status Epilepticus|Generalized Status Epilepticus|Grand Mal Status Epilepticus|Non Convulsive Status Epilepticus|Non-Convulsive Status Epilepticus|Petit Mal Status|Simple Partial Status Epilepticus|Status, Absence|Status Epilepticus, Complex Partial|Status Epilepticus, Electrographic|Status Epilepticus, Generalized|Status Epilepticus, Generalized Convulsive|Status Epilepticus, Grand Mal|Status Epilepticus, Non Convulsive|Status Epilepticus, Non-Convulsive|Status Epilepticus, Simple Partial|Status Epilepticus, Subclinical|Status, Petit Mal|Subclinical Status Epilepticus	Nervous system disease|Signs and symptoms
Steatorrhea	MESH:D045602		A condition that is characterized by chronic fatty DIARRHEA, a result of abnormal DIGESTION and/or INTESTINAL ABSORPTION of FATS.	MESH:D008286	C06.405.469.637.887|C18.452.603.887	C06.405.469.637|C18.452.603		Digestive system disease|Metabolic disease
ST Elevation Myocardial Infarction	MESH:D000072657		A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).	MESH:D009203	C14.280.647.500.875|C14.907.585.500.875|C23.550.513.355.750.875|C23.550.717.489.750.875	C14.280.647.500|C14.907.585.500|C23.550.513.355.750|C23.550.717.489.750	ST Elevated Myocardial Infarction|STEMI|ST Segment Elevation Myocardial Infarction	Cardiovascular disease|Pathology (process)
Stenosis, Pulmonary Artery	MESH:D000071079		Narrowing of the PULMONARY ARTERIES.	MESH:D001157	C14.907.137.825	C14.907.137	Artery Stenoses, Pulmonary|Artery Stenosis, Pulmonary|Pulmonary Artery Stenoses|Pulmonary Artery Stenosis|Stenoses, Pulmonary Artery	Cardiovascular disease
Stenosis, Pulmonary Vein	MESH:D000071078		Narrowing of the PULMONARY VEIN.	MESH:D014652	C14.907.798	C14.907	Pulmonary Vein Stenoses|Pulmonary Vein Stenosis|Stenoses, Pulmonary Vein|Vein Stenoses, Pulmonary|Vein Stenosis, Pulmonary	Cardiovascular disease
Stevens-Johnson Syndrome	MESH:D013262	DO:DOID:0050426|OMIM:608579	Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.	MESH:D003875|MESH:D004892|MESH:D013280	C07.465.864.500|C17.800.174.600.900|C17.800.229.400.683|C17.800.865.475.683|C20.543.206.380.900|C25.100.468.380.900	C07.465.864|C17.800.174.600|C17.800.229.400|C17.800.865.475|C20.543.206.380|C25.100.468.380	Drug Induced Stevens Johnson Syndrome|Drug-Induced Stevens Johnson Syndrome|Drug-Induced Stevens-Johnson Syndrome|Drug-Induced Stevens-Johnson Syndromes|Epidermal Necrolyses, Toxic|Epidermal Necrolysis, Toxic|HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED|Lyell's Syndrome|Lyell's Syndromes|Lyell Syndrome|Mycoplasma Induced Stevens Johnson Syndrome|Mycoplasma-Induced Stevens Johnson Syndrome|Mycoplasma-Induced Stevens-Johnson Syndrome|Necrolyses, Toxic Epidermal|Necrolysis, Toxic Epidermal|Nonstaphylococcal Scalded Skin Syndrome|Scalded Skin Syndrome, Nonstaphylococcal|SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO|Stevens Johnson Syndrome|Stevens-Johnson Syndrome, Drug-Induced|Stevens-Johnson Syndrome, Mycoplasma-Induced|Stevens-Johnson Syndromes, Drug-Induced|STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED|Stevens Johnson Syndrome Toxic Epidermal Necrolysis|Stevens-Johnson Syndrome Toxic Epidermal Necrolysis|Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum|Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum|Syndrome, Lyell's|Syndrome, Mycoplasma-Induced Stevens-Johnson|Syndromes, Lyell's|Toxic Epidermal Necrolyses|Toxic Epidermal Necrolysis|Toxic Epidermal Necrolysis Stevens Johnson Syndrome|Toxic Epidermal Necrolysis Stevens-Johnson Syndrome|Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum|Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum|TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED	Immune system disease|Mouth disease|Skin disease
Stewart Treves syndrome	MESH:C537491	DO:DOID:2689		MESH:D006394|MESH:D008204	C04.557.375.480/C537491|C04.557.450.795.390/C537491|C04.557.450.795.480/C537491|C04.557.645.390/C537491	C04.557.375.480|C04.557.450.795.390|C04.557.450.795.480|C04.557.645.390	Angiosarcoma associated with chronic lymphedema|Lymphangiosarcoma following mastectomy|Postmastectomy extremity angiosarcoma	Cancer
Stickler syndrome, type 1	MESH:C537492	OMIM:108300		MESH:D001168|MESH:D003240|MESH:D006319|MESH:D012163	C05.550.114/C537492|C09.218.458.341.887/C537492|C10.597.751.418.341.887/C537492|C11.768.648/C537492|C17.300/C537492|C23.888.592.763.393.341.887/C537492	C05.550.114|C09.218.458.341.887|C10.597.751.418.341.887|C11.768.648|C17.300|C23.888.592.763.393.341.887	AOM|Arthroophthalmopathy, hereditary progressive|Hereditary Arthro-Ophthalmo-Dystrophy|Hereditary Arthro-Ophthalmopathy|Stickler Dysplasia|Stickler Syndrome|Stickler syndrome, membranous vitreous type|Stickler Syndrome, Type I|Stickler syndrome, vitreous type 1|STL1	Connective tissue disease|Ear-nose-throat disease|Eye disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Stickler syndrome, type 2	MESH:C537493	OMIM:604841		MESH:D003240|MESH:D020255	C11.980/C537493|C17.300/C537493	C11.980|C17.300	Stickler syndrome, beaded vitreous type|Stickler Syndrome, Type II|Stickler syndrome, vitreous type 2|STL2	Connective tissue disease|Eye disease
STICKLER SYNDROME, TYPE IV	OMIM:614134			MESH:D006319|MESH:D009216|MESH:D012162	C09.218.458.341.887/614134|C10.597.751.418.341.887/614134|C11.270.612/614134|C11.744.636/614134|C11.768.585/614134|C23.888.592.763.393.341.887/614134	C09.218.458.341.887|C10.597.751.418.341.887|C11.270.612|C11.744.636|C11.768.585|C23.888.592.763.393.341.887	STL4	Ear-nose-throat disease|Eye disease|Nervous system disease|Signs and symptoms
STICKLER SYNDROME, TYPE V	OMIM:614284			MESH:D006319|MESH:D009216|MESH:D012162|MESH:D012163	C09.218.458.341.887/614284|C10.597.751.418.341.887/614284|C11.270.612/614284|C11.744.636/614284|C11.768.585/614284|C11.768.648/614284|C23.888.592.763.393.341.887/614284	C09.218.458.341.887|C10.597.751.418.341.887|C11.270.612|C11.744.636|C11.768.585|C11.768.648|C23.888.592.763.393.341.887	STL5	Ear-nose-throat disease|Eye disease|Nervous system disease|Signs and symptoms
Stiff-Person Syndrome	MESH:D016750	DO:DOID:13366|OMIM:184850	A condition characterized by persistent spasms (SPASM) involving multiple muscles, primarily in the lower limbs and trunk. The illness tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that become continuous. Minor sensory stimuli, such as noise and light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. Respiration may become impaired in advanced cases. (Adams et al., Principles of Neurology, 6th ed, p1492; Neurology 1998 Jul;51(1):85-93)	MESH:D009468|MESH:D013118|MESH:D020274	C10.114.812|C10.228.854.790|C10.668.900|C20.111.258.850	C10.114|C10.228.854|C10.668|C20.111.258	Congenital Stiff Man Syndrome|Congenital Stiff-Man Syndrome|Congenital Stiff-Man Syndromes|Congenital Stiff-Person Syndrome|Congenital Stiff-Person Syndromes|Familial Hyperekplexia|Familial Hyperekplexias|Hereditary Hyperekplexia|Hereditary Hyperekplexias|Hyperekplexia, Familial|Hyperekplexia, Hereditary|Hyperekplexias, Familial|Hyperekplexias, Hereditary|Moersch Woltmann Syndrome|Moersch-Woltmann Syndrome|PER, INCLUDED|PERM, INCLUDED|SPS|Startle Syndrome|Startle Syndromes|Stiff-Baby Syndrome|Stiff-Baby Syndromes|Stiffman Syndrome|Stiff Man Syndrome|Stiff-Man Syndrome|Stiff-Man Syndrome, Congenital|Stiff-Man Syndromes, Congenital|Stiff Person Syndrome|Stiff-Person Syndrome, Congenital|Stiff-Person Syndromes, Congenital|Stiff Trunk Syndrome|Stiff-Trunk Syndrome|STIFF-TRUNK SYNDROME PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY, INCLUDED|Stiff-Trunk Syndromes|Syndrome, Congenital Stiff-Man|Syndrome, Congenital Stiff-Person|Syndrome, Moersch-Woltmann|Syndromes, Congenital Stiff-Man|Syndromes, Congenital Stiff-Person|Syndromes, Startle|Syndromes, Stiff-Baby|Syndromes, Stiff-Trunk|Syndrome, Startle|Syndrome, Stiff-Baby|Syndrome, Stiffman|Syndrome, Stiff-Man|Syndrome, Stiff-Person|Syndrome, Stiff-Trunk	Immune system disease|Nervous system disease
Still's Disease, Adult-Onset	MESH:D016706	DO:DOID:14256	Systemic-onset rheumatoid arthritis in adults. It differs from classical rheumatoid arthritis in that it is more often marked by acute febrile onset, and generalized lymphadenopathy and hepatosplenomegaly are more prominent.	MESH:D001172	C05.550.114.154.870|C05.799.114.870|C17.300.775.099.870|C20.111.199.870	C05.550.114.154|C05.799.114|C17.300.775.099|C20.111.199	Adult Onset Still Disease|Adult-Onset Still Disease|Adult Onset Still's Disease|Adult-Onset Still's Disease|Adult-Onset Stills Disease|Still Disease, Adult Onset|Still Disease, Adult-Onset|Still's Disease, Adult Onset|Stills Disease, Adult-Onset	Connective tissue disease|Immune system disease|Musculoskeletal disease
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET	OMIM:615934	DO:DOID:0111457		MESH:D014652	C14.907/615934	C14.907	SAVI	Cardiovascular disease
Stoll Alembik Dott syndrome	MESH:C537497			MESH:D005532|MESH:D006228|MESH:D010855|MESH:D013575|MESH:D018879	C05.330.495/C537497|C05.390.408/C537497|C05.500.460.606/C537497|C05.660.207.540.460.606/C537497|C05.660.585.512.380/C537497|C05.660.585.988.425/C537497|C07.320.440.606/C537497|C07.650.500.460.606/C537497|C10.597.606.358.800.600/C537497|C14.280.067.325.500/C537497|C14.280.123.375.500/C537497|C16.131.621.207.540.460.606/C537497|C16.131.621.585.512.500/C537497|C16.131.621.585.988.500/C537497|C16.131.850.500.460.606/C537497|C23.550.073.325.800/C537497|C23.888.592.604.359.800.600/C537497	C05.330.495|C05.390.408|C05.500.460.606|C05.660.207.540.460.606|C05.660.585.512.380|C05.660.585.988.425|C07.320.440.606|C07.650.500.460.606|C10.597.606.358.800.600|C14.280.067.325.500|C14.280.123.375.500|C16.131.621.207.540.460.606|C16.131.621.585.512.500|C16.131.621.585.988.500|C16.131.850.500.460.606|C23.550.073.325.800|C23.888.592.604.359.800.600	Ventricular extrasystoles with syncope, perodactyly, and robin sequence	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease|Nervous system disease|Pathology (process)|Signs and symptoms
Stoll Levy Francfort syndrome	MESH:C537498			MESH:D001848|MESH:D006314	C05.116.099/C537498|C09.218.458.341.562/C537498|C10.597.751.418.341.562/C537498|C23.888.592.763.393.341.562/C537498	C05.116.099|C09.218.458.341.562|C10.597.751.418.341.562|C23.888.592.763.393.341.562	Facioauriculoradial dysplasia|Phocomelia-ectrodactyly, ear malformation, deafness, and sinus arrhythmia	Ear-nose-throat disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Stomach Neoplasms	MESH:D013274	DO:DOID:10534|OMIM:137215|OMIM:613659	Tumors or cancer of the STOMACH.	MESH:D005770|MESH:D013272	C04.588.274.476.767|C06.301.371.767|C06.405.249.767|C06.405.748.789	C04.588.274.476|C06.301.371|C06.405.249|C06.405.748	Cancer, Gastric|Cancer of Stomach|Cancer of the Stomach|Cancers, Gastric|Cancers, Stomach|Cancer, Stomach|Gastric Cancer|Gastric Cancer, Familial Diffuse|GASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE, INCLUDED|GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR, INCLUDED|GASTRIC CANCER, HEREDITARY DIFFUSE|GASTRIC CANCER, INTESTINAL, INCLUDED|Gastric Cancers|Gastric Neoplasm|Gastric Neoplasms|HDGC|LBC, INCLUDED|Neoplasm, Gastric|Neoplasms, Gastric|Neoplasms, Stomach|Neoplasm, Stomach|Stomach Cancer|Stomach Cancers|Stomach Neoplasm	Cancer|Digestive system disease
Stomach Rupture	MESH:D013275		Bursting of the STOMACH.	MESH:D000007|MESH:D012421|MESH:D013272	C06.405.748.824|C26.017.809|C26.761.684	C06.405.748|C26.017|C26.761	Gastric Rupture|Gastric Ruptures|Rupture, Gastric|Ruptures, Gastric|Ruptures, Stomach|Rupture, Stomach|Stomach Ruptures	Digestive system disease|Wounds and injuries
Stomatitis, Herpetic	MESH:D013283		Stomatitis caused by Herpesvirus hominis. It usually occurs as acute herpetic stomatitis (or gingivostomatitis), an oral manifestation of primary herpes simplex seen primarily in children and adolescents.	MESH:D006561|MESH:D013280	C01.925.256.466.382.834|C07.465.864.937	C01.925.256.466.382|C07.465.864	Gingivostomatitides, Herpetic|Gingivostomatitis, Herpetic|Herpes Simplex, Oral|Herpetic Gingivostomatitides|Herpetic Gingivostomatitis|Herpetic Stomatitides|Herpetic Stomatitis|Oral Herpes Simplex|Simplex, Oral Herpes|Stomatitides, Herpetic	Mouth disease|Viral disease
Stormorken Syndrome	MESH:C566108	DO:DOID:0060354		MESH:D001791|MESH:D004410|MESH:D007057|MESH:D008881|MESH:D015877	C10.228.140.546.399.750/C566108|C10.597.606.150.500.300/C566108|C10.597.606.150.550.200/C566108|C10.597.690.362/C566108|C11.710.528/C566108|C15.378.140/C566108|C16.131.831.512/C566108|C16.614.492/C566108|C17.800.428.333/C566108|C17.800.804.512/C566108|C23.888.592.604.150.500.300/C566108|C23.888.592.604.150.550.200/C566108|C23.888.592.708.362/C566108|F03.625.562.400/C566108	C10.228.140.546.399.750|C10.597.606.150.500.300|C10.597.606.150.550.200|C10.597.690.362|C11.710.528|C15.378.140|C16.131.831.512|C16.614.492|C17.800.428.333|C17.800.804.512|C23.888.592.604.150.500.300|C23.888.592.604.150.550.200|C23.888.592.708.362|F03.625.562.400	Thrombocytopathy, Asplenia, and Miosis	Blood disease|Congenital abnormality|Eye disease|Infant-newborn disease|Mental disorder|Nervous system disease|Signs and symptoms|Skin disease
Strabismus	MESH:D013285	DO:DOID:9306|DO:DOID:9837|OMIM:185100	Misalignment of the visual axes of the eyes. In comitant strabismus the degree of ocular misalignment does not vary with the direction of gaze. In noncomitant strabismus the degree of misalignment varies depending on direction of gaze or which eye is fixating on the target. (Miller, Walsh & Hoyt's Clinical Neuro-Ophthalmology, 4th ed, p641)	MESH:D015835	C10.292.562.887|C11.590.810	C10.292.562|C11.590	Comitant Strabismus|Comitant Strabismus, Convergent|Concomitant Strabismus|Convergent Comitant Strabismus|Dissociated Vertical Deviation|Dissociated Vertical Deviations|Hypertropia|Hypertropias|Mechanical Strabismus|Noncomitant Strabismus|Nonconcomitant Strabismus|Non Concomitant Strabismus|Non-Concomitant Strabismus|Phoria|Phorias|Squint|STBMS1, INCLUDED|Strabismus, Comitant|Strabismus, Concomitant|Strabismus, Convergent Comitant|Strabismus, Mechanical|Strabismus, Noncomitant|Strabismus, Nonconcomitant|Strabismus, Non-Concomitant|STRABISMUS, SUSCEPTIBILITY TO|STRABISMUS, SUSCEPTIBILITY TO, 1, INCLUDED	Eye disease|Nervous system disease
Stratton-Parker Syndrome	MESH:C566105			MESH:D001006|MESH:D006330|MESH:D007021|MESH:D017880	C05.660.585/C566105|C06.198.050/C566105|C12.050.351.875.466/C566105|C12.100.500.494.400/C566105|C12.200.294.494.400/C566105|C12.200.706.516/C566105|C12.800.516/C566105|C14.240.400/C566105|C14.280.400/C566105|C16.131.240.400/C566105|C16.131.314.094/C566105|C16.131.621.585/C566105|C16.131.939.516/C566105	C05.660.585|C06.198.050|C12.050.351.875.466|C12.100.500.494.400|C12.200.294.494.400|C12.200.706.516|C12.800.516|C14.240.400|C14.280.400|C16.131.240.400|C16.131.314.094|C16.131.621.585|C16.131.939.516	Growth Hormone Deficiency with Wormian Bones, Cardiac Anomaly, and Brachycamptodactyly	Cardiovascular disease|Congenital abnormality|Digestive system disease|Musculoskeletal disease|Urogenital disease (female)|Urogenital disease (male)
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	OMIM:616922			MESH:D020955	C10.177.575.550.875/616922|C10.228.140.079.612.800/616922|C10.228.662.550.800/616922	C10.177.575.550.875|C10.228.140.079.612.800|C10.228.662.550.800	ADSD2	Nervous system disease
Striatonigral Degeneration	MESH:D020955	DO:DOID:4751	A sporadic neurodegenerative disease with onset in middle-age characterized clinically by Parkinsonian features (e.g., MUSCLE RIGIDITY; HYPOKINESIA; stooped posture) and HYPOTENSION. This condition is considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Pathologic features include a prominent loss of neurons in the zona compacta of the SUBSTANTIA NIGRA and PUTAMEN. (From Adams et al., Principles of Neurology, 6th ed, p1075-6)	MESH:D019578	C10.177.575.550.875|C10.228.140.079.612.800|C10.228.662.550.800	C10.177.575.550|C10.228.140.079.612|C10.228.662.550	Atrophies, Striatonigral|Atrophy, Striatonigral|Degeneration, Striatonigral|Striatonigral Atrophies|Striatonigral Atrophy|Striatonigral Degenerations	Nervous system disease
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	OMIM:617054			MESH:D020955	C10.177.575.550.875/617054|C10.228.140.079.612.800/617054|C10.228.662.550.800/617054	C10.177.575.550.875|C10.228.140.079.612.800|C10.228.662.550.800	LENK-PLOSKI SYNDROME|SNDC	Nervous system disease
Striatonigral degeneration infantile	MESH:C537500	OMIM:271930		MESH:D020955	C10.177.575.550.875/C537500|C10.228.140.079.612.800/C537500|C10.228.662.550.800/C537500	C10.177.575.550.875|C10.228.140.079.612.800|C10.228.662.550.800	Bilateral Striatal Necrosis, Infantile|IBSN|Infantile bilateral striatal necrosis|SNDI|Striatal degeneration familial|Striatal Degeneration, Familial|Striatonigral Degeneration, Infantile	Nervous system disease
Striatonigral Degeneration, Infantile, Mitochondrial	MESH:C564025			MESH:D020955	C10.177.575.550.875/C564025|C10.228.140.079.612.800/C564025|C10.228.662.550.800/C564025	C10.177.575.550.875|C10.228.140.079.612.800|C10.228.662.550.800	Bilateral Striatal Necrosis, Infantile, Mitochondrial|Infantile Bilateral Striatal Necrosis, Mitochondrial	Nervous system disease
Stroke	MESH:D020521	OMIM:606799	A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)	MESH:D002561	C10.228.140.300.775|C14.907.253.855	C10.228.140.300|C14.907.253	Acute Cerebrovascular Accident|Acute Cerebrovascular Accidents|Acute Stroke|Acute Strokes|Apoplexy|Apoplexy, Cerebrovascular|Brain Vascular Accident|Brain Vascular Accidents|Cerebral Stroke|Cerebral Strokes|Cerebrovascular Accident|Cerebrovascular Accident, Acute|Cerebrovascular Accidents|Cerebrovascular Accidents, Acute|Cerebrovascular Apoplexy|Cerebrovascular Stroke|Cerebrovascular Strokes|CVA (Cerebrovascular Accident)|CVAs (Cerebrovascular Accident)|STRK1|Stroke, Acute|Stroke, Cerebral|Stroke, Cerebrovascular|Strokes|Strokes, Acute|Strokes, Cerebral|Strokes, Cerebrovascular|STROKE, SUSCEPTIBILITY TO, 1|Vascular Accident, Brain|Vascular Accidents, Brain	Cardiovascular disease|Nervous system disease
Stroke, Lacunar	MESH:D059409		Stroke caused by lacunar infarction or other small vessel diseases of the brain. It features hemiparesis (see PARESIS), hemisensory, or hemisensory motor loss.	MESH:D000083244|MESH:D020520|MESH:D059345	C10.228.140.300.275.800|C10.228.140.300.775.400.750.500|C14.907.253.329.800|C14.907.253.855.400.750.500|C23.550.513.355.250.600|C23.550.717.489.250.600	C10.228.140.300.275|C10.228.140.300.775.400.750|C14.907.253.329|C14.907.253.855.400.750|C23.550.513.355.250|C23.550.717.489.250	Infarction, Lacunar|Infarctions, Lacunar|Infarct, Lacunar|Infarcts, Lacunar|Lacunar Infarct|Lacunar Infarction|Lacunar Infarctions|Lacunar Infarcts|Lacunar Stroke|Lacunar Strokes|Lacunar Syndrome|Lacunar Syndromes|Strokes, Lacunar|Syndrome, Lacunar|Syndromes, Lacunar	Cardiovascular disease|Nervous system disease|Pathology (process)
Struma Ovarii	MESH:D013330	DO:DOID:2640	A rare teratoid tumor of the ovary composed almost entirely of thyroid tissue, with large follicles containing abundant colloid. Occasionally there are symptoms of hyperthyroidism. 5-10% of struma ovarii become malignant, the only absolute criterion for which is the presence of metastasis. (Dorland, 27th ed; Segen, Dictionary of Modern Medicine, 1992)	MESH:D013724	C04.557.465.910.850	C04.557.465.910		Cancer
Stupor	MESH:D053608		A state of reduced sensibility and response to stimuli which is distinguished from COMA in that the person can be aroused by vigorous and repeated stimulation. The person is still conscious and can make voluntary movements. It can be induced by CENTRAL NERVOUS SYSTEM AGENTS. The word derives from Latin stupere and is related to stunned, stupid, dazed or LETHARGY.	MESH:D014474	C10.597.606.358.800.500|C23.888.592.604.359.800.500	C10.597.606.358.800|C23.888.592.604.359.800	Narcosis	Nervous system disease|Signs and symptoms
Sturge-Weber Syndrome	MESH:D013341	DO:DOID:0111563|OMIM:185300	A non-inherited congenital condition with vascular and neurological abnormalities. It is characterized by facial vascular nevi (PORT-WINE STAIN), and capillary angiomatosis of intracranial membranes (MENINGES; CHOROID). Neurological features include EPILEPSY; cognitive deficits; GLAUCOMA; and visual defects.	MESH:D000798|MESH:D006391|MESH:D020752	C04.557.645.375.850|C10.562.800|C14.907.077.850	C04.557.645.375|C10.562|C14.907.077	Angiomatosis, Meningo-Oculo-Facial|Angiomatosis Oculoorbital-Thalamic Syndrome|Encephalofacial Hemangiomatosis Syndrome|Hemangiomatosis Syndrome, Encephalofacial|Meningofacial Angiomatosis-Cerebral Calcification Syndrome|Meningo Oculo Facial Angiomatosis|Meningo-Oculo-Facial Angiomatosis|Neuroretinoangiomatosis|Parkes Weber Syndrome|Parkes-Weber Syndrome|Phakomatosis, Sturge Weber|Phakomatosis, Sturge-Weber|Sturge Disease|Sturge Kalischer Weber Syndrome|Sturge-Kalischer-Weber Syndrome|Sturge's Syndrome|Sturge Syndrome|Sturge Weber Dimitri Syndrome|Sturge-Weber-Dimitri Syndrome|Sturge Weber Krabbe Syndrome|Sturge-Weber-Krabbe Syndrome|Sturge-Weber Phakomatosis|Sturge Weber Syndrome|SWS|Syndrome, Encephalofacial Hemangiomatosis|Syndrome, Parkes Weber|Syndrome, Parkes-Weber|Syndrome, Sturge|Syndrome, Sturge-Kalischer-Weber|Syndrome, Sturge's|Syndrome, Sturge-Weber|Syndrome, Sturge-Weber-Dimitri|Syndrome, Sturge-Weber-Krabbe	Cancer|Cardiovascular disease|Nervous system disease
Stuttering	MESH:D013342	DO:DOID:0060243	A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual's age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. (From DSM-IV, 1994)	MESH:D013064	C10.597.606.150.500.800.750|C23.888.592.604.150.500.800.750	C10.597.606.150.500.800|C23.888.592.604.150.500.800	Acquired Stuttering|Adult Stuttering|Childhood Stuttering|Developmental Stuttering|Stammering|Stuttering, Acquired|Stuttering, Adult|Stuttering, Childhood|Stuttering, Developmental|Stuttering, Familial Persistent 1	Nervous system disease|Signs and symptoms
STUTTERING, FAMILIAL PERSISTENT, 1	OMIM:184450	DO:DOID:0060243		MESH:D013342	C10.597.606.150.500.800.750/184450|C23.888.592.604.150.500.800.750/184450	C10.597.606.150.500.800.750|C23.888.592.604.150.500.800.750	STAMMERING|STUT1	Nervous system disease|Signs and symptoms
Stuttering, Familial Persistent 2	MESH:C563756	OMIM:609261		MESH:D013342	C10.597.606.150.500.800.750/C563756|C23.888.592.604.150.500.800.750/C563756	C10.597.606.150.500.800.750|C23.888.592.604.150.500.800.750	STUT2|STUTTERING, FAMILIAL PERSISTENT, 2	Nervous system disease|Signs and symptoms
Subacute Combined Degeneration	MESH:D052879		A neuropathy due to VITAMIN B 12 DEFICIENCY or to excessive NITROUS OXIDE inhalation. It is associated with overproduction of the myelinolytic TUMOR NECROSIS FACTOR-ALPHA.	MESH:D003711|MESH:D009410|MESH:D013118|MESH:D014806|MESH:D019636	C10.228.854.811|C10.314.875|C10.574.910|C18.654.521.500.133.699.923.640|C23.550.737.625	C10.228.854|C10.314|C10.574|C18.654.521.500.133.699.923|C23.550.737	Neuropathy, Subacute Combined Degeneration|Subacute Combined Neuropathy Degeneration	Nervous system disease|Nutrition disorder|Pathology (process)
Subacute Sclerosing Panencephalitis	MESH:D013344	DO:DOID:8970	A rare, slowly progressive encephalitis caused by chronic infection with the MEASLES VIRUS. The condition occurs primarily in children and young adults, approximately 2-8 years after the initial infection. A gradual decline in intellectual abilities and behavioral alterations are followed by progressive MYOCLONUS; MUSCLE SPASTICITY; SEIZURES; DEMENTIA; autonomic dysfunction; and ATAXIA. DEATH usually occurs 1-3 years after disease onset. Pathologic features include perivascular cuffing, eosinophilic cytoplasmic inclusions, neurophagia, and fibrous gliosis. It is caused by the SSPE virus, which is a defective variant of MEASLES VIRUS. (From Adams et al., Principles of Neurology, 6th ed, pp767-8)	MESH:D008457|MESH:D012897|MESH:D018792	C01.207.245.340.600|C01.207.399.750.600|C01.925.182.525.600|C01.925.782.580.600.500.500.800|C01.925.839.862|C10.228.140.430.520.750.600|C10.228.228.245.340.600|C10.228.228.399.750.600|C10.586.250.520.750.600	C01.207.245.340|C01.207.399.750|C01.925.182.525|C01.925.782.580.600.500.500|C01.925.839|C10.228.140.430.520.750|C10.228.228.245.340|C10.228.228.399.750|C10.586.250.520.750	Encephalitis, Inclusion Body, Measles|Inclusion Body Encephalitis, Measles|Leukoencephalitides, Subacute Sclerosing|Leukoencephalitis, Subacute Sclerosing|Leukoencephalitis, Van Bogaert|Leukoencephalitis, Van Bogaerts|Leukoencephalitis, Van Bogaert's|Measles Inclusion Body Encephalitis|Panencephalitides, Subacute Sclerosing|Panencephalitis, Subacute Sclerosing|Sclerosing Leukoencephalitides, Subacute|Sclerosing Leukoencephalitis, Subacute|Sclerosing Panencephalitides, Subacute|Sclerosing Panencephalitis, Subacute|SSPE|Subacute Sclerosing Leukoencephalitides|Subacute Sclerosing Leukoencephalitis|Subacute Sclerosing Panencephalitides|Van Bogaert Leukoencephalitis|Van Bogaert's Leukoencephalitis|Van Bogaerts Leukoencephalitis	Nervous system disease|Viral disease
Subaortic Stenosis, Membranous	MESH:C564793			MESH:D006330|MESH:D021922	C14.240.400/C564793|C14.280.400/C564793|C14.280.484.048.750.070.210/C564793|C14.280.955.249.070.210/C564793|C16.131.240.400/C564793	C14.240.400|C14.280.400|C14.280.484.048.750.070.210|C14.280.955.249.070.210|C16.131.240.400		Cardiovascular disease|Congenital abnormality
Subarachnoid Hemorrhage	MESH:D013345		Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.	MESH:D020300	C10.228.140.300.535.800|C14.907.253.573.800|C23.550.414.913.850	C10.228.140.300.535|C14.907.253.573|C23.550.414.913	Aneurysmal Subarachnoid Hemorrhage|Aneurysmal Subarachnoid Hemorrhages|Hemorrhage, Aneurysmal Subarachnoid|Hemorrhage, Intracranial Subarachnoid|Hemorrhage, Perinatal Subarachnoid|Hemorrhages, Aneurysmal Subarachnoid|Hemorrhages, Intracranial Subarachnoid|Hemorrhages, Perinatal Subarachnoid|Hemorrhage, Spontaneous Subarachnoid|Hemorrhages, Spontaneous Subarachnoid|Hemorrhages, Subarachnoid|Hemorrhage, Subarachnoid|Intracranial Subarachnoid Hemorrhage|Intracranial Subarachnoid Hemorrhages|Perinatal Subarachnoid Hemorrhage|Perinatal Subarachnoid Hemorrhages|SAHs (Subarachnoid Hemorrhage)|SAH (Subarachnoid Hemorrhage)|Spontaneous Subarachnoid Hemorrhage|Spontaneous Subarachnoid Hemorrhages|Subarachnoid Hemorrhage, Aneurysmal|Subarachnoid Hemorrhage, Intracranial|Subarachnoid Hemorrhage, Perinatal|Subarachnoid Hemorrhages|Subarachnoid Hemorrhages, Aneurysmal|Subarachnoid Hemorrhages, Intracranial|Subarachnoid Hemorrhages, Perinatal|Subarachnoid Hemorrhage, Spontaneous|Subarachnoid Hemorrhages, Spontaneous	Cardiovascular disease|Nervous system disease|Pathology (process)
Subarachnoid Hemorrhage, Traumatic	MESH:D020206		Bleeding into the SUBARACHNOID SPACE due to CRANIOCEREBRAL TRAUMA. Minor hemorrhages may be asymptomatic; moderate to severe hemorrhages may be associated with INTRACRANIAL HYPERTENSION and VASOSPASM, INTRACRANIAL.	MESH:D013345|MESH:D020198|MESH:D020214	C10.228.140.300.535.450.650|C10.228.140.300.535.800.700|C10.900.300.837.800|C14.907.253.535.600|C14.907.253.573.400.700|C14.907.253.573.800.700|C26.915.300.490.700	C10.228.140.300.535.450|C10.228.140.300.535.800|C10.900.300.837|C14.907.253.535|C14.907.253.573.400|C14.907.253.573.800|C26.915.300.490	Hemorrhage, Post-Traumatic Subarachnoid|Hemorrhages, Post-Traumatic Subarachnoid|Hemorrhage, Traumatic Subarachnoid|Post Traumatic Subarachnoid Hemorrhage|Post-Traumatic Subarachnoid Hemorrhage|Post-Traumatic Subarachnoid Hemorrhages|Subarachnoid Hemorrhage, Post-Traumatic|Subarachnoid Hemorrhages, Post-Traumatic|Subarachnoid Hemorrhages, Traumatic|Traumatic Subarachnoid Hemorrhage|Traumatic Subarachnoid Hemorrhages	Cardiovascular disease|Nervous system disease|Wounds and injuries
Subclavian Steal Syndrome	MESH:D013349	DO:DOID:13002	A clinically significant reduction in blood supply to the BRAIN STEM and CEREBELLUM (i.e., VERTEBROBASILAR INSUFFICIENCY) resulting from reversal of blood flow through the VERTEBRAL ARTERY from occlusion or stenosis of the proximal subclavian or brachiocephalic artery. Common symptoms include VERTIGO; SYNCOPE; and INTERMITTENT CLAUDICATION of the involved upper extremity. Subclavian steal may also occur in asymptomatic individuals. (From J Cardiovasc Surg 1994;35(1):11-4; Acta Neurol Scand 1994;90(3):174-8)	MESH:D014715	C10.228.140.300.150.956.700|C14.907.253.092.956.700	C10.228.140.300.150.956|C14.907.253.092.956	Artery Stenoses, Subclavian|Artery Stenosis, Subclavian|Basilar Steal Syndrome|Basilar Steal Syndromes|Brachial Basilar Insufficiency Syndrome|Brachial-Basilar Insufficiency Syndrome|Brachial-Basilar Insufficiency Syndromes|Insufficiency Syndrome, Brachial-Basilar|Insufficiency Syndromes, Brachial-Basilar|Phenomenon, Subclavian Steal|Steal Phenomenon, Subclavian|Steal, Subclavian|Steal Syndrome, Basilar|Steal Syndromes, Basilar|Steal Syndromes, Subclavian|Steal Syndrome, Subclavian|Stenoses, Subclavian Artery|Stenosis, Subclavian Artery|Subclavian Artery Stenoses|Subclavian Artery Stenosis|Subclavian Carotid Artery Steal Syndrome|Subclavian-Carotid Artery Steal Syndrome|Subclavian Steal|Subclavian Steal Phenomenon|Subclavian Steal Syndromes|Syndrome, Brachial-Basilar Insufficiency|Syndromes, Brachial-Basilar Insufficiency	Cardiovascular disease|Nervous system disease
Subcutaneous panniculitis-like T-cell lymphoma	MESH:C537503			MESH:D015434|MESH:D016399	C04.557.386.480.750/C537503|C15.604.515.569.480.750/C537503|C17.300.710/C537503|C17.800.566/C537503|C20.683.515.761.480.750/C537503	C04.557.386.480.750|C15.604.515.569.480.750|C17.300.710|C17.800.566|C20.683.515.761.480.750		Cancer|Connective tissue disease|Immune system disease|Lymphatic disease|Skin disease
Subdural Effusion	MESH:D013353		Leakage and accumulation of CEREBROSPINAL FLUID in the subdural space which may be associated with an infectious process; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; INTRACRANIAL HYPOTENSION; and other conditions.	MESH:D001927|MESH:D020819	C01.207.709.675|C10.228.140.870|C10.228.228.709.675	C01.207.709|C10.228.140|C10.228.228.709	Cerebrospinal Fluid Effusion, Subdural|Cerebrospinal Fluid Leakage, Subdural|Effusion, Subdural|Hygroma, Subdural|Subdural Cerebrospinal Fluid Effusion|Subdural Cerebrospinal Fluid Leakage|Subdural Hygroma	Nervous system disease
Sublingual Gland Neoplasms	MESH:D013362		Neoplasms of the sublingual glands.	MESH:D012468	C04.588.443.591.824.882|C07.465.530.824.882|C07.465.815.718.870	C04.588.443.591.824|C07.465.530.824|C07.465.815.718	Gland Neoplasms, Sublingual|Gland Neoplasm, Sublingual|Neoplasms, Sublingual Gland|Neoplasm, Sublingual Gland|Sublingual Gland Neoplasm	Cancer|Mouth disease
Submandibular Gland Neoplasms	MESH:D013365		New abnormal growth of tissue in the SUBMANDIBULAR GLAND.	MESH:D012468|MESH:D013364	C04.588.443.591.824.885|C07.465.530.824.885|C07.465.815.718.885|C07.465.815.882.500	C04.588.443.591.824|C07.465.530.824|C07.465.815.718|C07.465.815.882	Gland Neoplasms, Submandibular|Gland Neoplasm, Submandibular|Neoplasms, Submandibular Gland|Neoplasm, Submandibular Gland|Submandibular Gland Neoplasm	Cancer|Mouth disease
Subungual exostoses	MESH:C535723			MESH:D001859|MESH:D005096|MESH:D009260	C04.588.149/C535723|C05.116.231/C535723|C05.116.540.310/C535723|C17.800.529/C535723	C04.588.149|C05.116.231|C05.116.540.310|C17.800.529	Dupuytren subungual exostosis|Exostosis, Dupuytren Subungual	Cancer|Musculoskeletal disease|Skin disease
Subvalvular aortic stenosis, Eisenberg type	MESH:C538550			MESH:D001020	C14.280.484.048.750.070/C538550|C14.280.955.249.070/C538550	C14.280.484.048.750.070|C14.280.955.249.070		Cardiovascular disease
Succinate-Coa Ligase Deficiency	MESH:C580473	DO:DOID:0080124|DO:DOID:0080128		MESH:D028361	C18.452.660/C580473	C18.452.660	Mitochondrial Dna Depletion, Encephalomyopathic Form, with Methylmalonic Aciduria|Mitochondrial Dna Depletion Syndrome, Encephalomyopathic Form, with Mild Methylmalonic Aciduria|Succinate-Coenzyme A Ligase Deficiency	Metabolic disease
Succinyl-CoA:3-oxoacid CoA transferase deficiency	MESH:C537527	OMIM:245050		MESH:D000138	C18.452.076.176/C537527	C18.452.076.176	3-Oxoacid Coa Transferase Deficiency|Ketoacidosis due to SCOT deficiency|SCOTD|SCOT deficiency|Succinyl-Coa:3-Ketoacid Coa Transferase Deficiency|Succinyl-Coa:3-Ketoacid Coa-Transferase Deficiency|SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY|Succinyl-Coa 3-Oxoacid Transferase Deficiency|Succinyl-Coa:Acetoacetate Transferase Deficiency	Metabolic disease
SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED	OMIM:617223			MESH:D016757|MESH:D020751	C14.280.383.220/617223|C23.550.260.322.250/617223|C25.775.100.087/617223	C14.280.383.220|C23.550.260.322.250|C25.775.100.087	SCFAI	Cardiovascular disease|Pathology (process)|Substance-related disorder
SUDDEN CARDIAC FAILURE, INFANTILE	OMIM:617222			MESH:D016757	C14.280.383.220/617222|C23.550.260.322.250/617222	C14.280.383.220|C23.550.260.322.250	SCFI	Cardiovascular disease|Pathology (process)
Sulfhemoglobinemia	MESH:D013436	DO:DOID:12451	A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. (Stedman, 25th ed)	MESH:D006402	C15.378.896	C15.378	Sulfhemoglobinemias	Blood disease
Sulfhemoglobinemia, Congenital	MESH:C566102			MESH:D013436	C15.378.896/C566102	C15.378.896		Blood disease
Sunburn	MESH:D013471		An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight.	MESH:D002056|MESH:D010787	C17.800.600.725|C26.200.855	C17.800.600|C26.200	Sunburns	Skin disease|Wounds and injuries
SUNCT Syndrome	MESH:D050798		A primary headache disorder that is characterized by frequent short-lasting, unilateral, neuralgiform pain attacks in the ocular area, with CONJUNCTIVA fluid-filling and tearing. SUNCT syndrome is usually resistant to treatment.	MESH:D051303	C10.228.140.546.399.937.875	C10.228.140.546.399.937	SUNCT Syndromes|Syndromes, SUNCT|Syndrome, SUNCT	Nervous system disease
Superinfection	MESH:D015163		A frequent complication of drug therapy for microbial infection. It may result from opportunistic colonization following immunosuppression by the primary pathogen and can be influenced by the time interval between infections, microbial physiology, or host resistance. Experimental challenge and in vitro models are sometimes used in virulence and infectivity studies.	MESH:D009894	C01.597.880|C01.610.684.880|C01.925.597.880	C01.597|C01.610.684|C01.925.597	Microbial Superinvasion|Microbial Superinvasions|Superinfections|Superinvasion, Microbial|Superinvasions, Microbial	Parasitic disease|Viral disease
Superior Vena Cava Syndrome	MESH:D013479		A condition that occurs when the obstruction of the thin-walled SUPERIOR VENA CAVA interrupts blood flow from the head, upper extremities, and thorax to the RIGHT ATRIUM. Obstruction can be caused by NEOPLASMS; THROMBOSIS; ANEURYSM; or external compression. The syndrome is characterized by swelling and/or CYANOSIS of the face, neck, and upper arms.	MESH:D014652	C14.907.800	C14.907	Superior Vena Cava Obstruction|Superior Vena Cava Thrombosis	Cardiovascular disease
SUPERNUMERARY DER(22)t(8	OMIM:613700			MESH:D004427|MESH:D008607|MESH:D014178	C09.218/613700|C10.597.606.360/613700|C23.550.210.870/613700|C23.888.592.604.646/613700|F03.625.539/613700	C09.218|C10.597.606.360|C23.550.210.870|C23.888.592.604.646|F03.625.539	22) SYNDROME	Ear-nose-throat disease|Mental disorder|Nervous system disease|Pathology (process)|Signs and symptoms
SUPPRESSOR OF TUMORIGENICITY 3	OMIM:191181			MESH:D002583	C04.588.945.418.948.850/191181|C12.050.351.500.852.593.131/191181|C12.050.351.500.852.762.850/191181|C12.050.351.937.418.875.850/191181|C12.100.250.852.593.131/191181|C12.100.250.852.762.850/191181|C12.900.418.875.850/191181	C04.588.945.418.948.850|C12.050.351.500.852.593.131|C12.050.351.500.852.762.850|C12.050.351.937.418.875.850|C12.100.250.852.593.131|C12.100.250.852.762.850|C12.900.418.875.850	CCTS|CERVICAL CARCINOMA, TUMOR-SUPPRESSOR GENE INVOLVED IN|ST3|TSHL|TUMOR-SUPPRESSOR GENE, HELA CELL TYPE	Cancer|Urogenital disease (female)
Supraglottitis	MESH:D059525		Inflammation of the EPIGLOTTIS and supraglottic structures including the PHARYNX; UVULA; base of tongue; and aryepiglottic folds. It is usually caused by HAEMOPHILUS INFLUENZAE in children but often by different organisms in adults.	MESH:D007818|MESH:D012141	C01.748.798|C08.360.840|C08.730.798|C09.400.840	C01.748|C08.360|C08.730|C09.400	Supraglottitides	Ear-nose-throat disease|Respiratory tract disease
Supranuclear Palsy, Progressive	MESH:D013494	DO:DOID:678|OMIM:601104	A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)	MESH:D001480|MESH:D009069|MESH:D009886|MESH:D024801	C10.228.140.079.882|C10.228.662.700|C10.292.562.750.500|C10.574.945.500|C10.597.622.447.690|C11.590.472.500|C23.888.592.636.447.690	C10.228.140.079|C10.228.662|C10.292.562.750|C10.574.945|C10.597.622.447|C11.590.472|C23.888.592.636.447	Ophthalmoplegia, Progressive Supranuclear|Palsy, Progressive Supranuclear|Progressive Supranuclear Ophthalmoplegia|Progressive Supranuclear Palsies|Progressive Supranuclear Palsy|Progressive Supranuclear Palsy 1|PSNP1|PSP|Richardson's Syndrome|Richardson Syndrome|Steele Richardson Olszewski Disease|Steele-Richardson-Olszewski Disease|Steele Richardson Olszewski Syndrome|Steele-Richardson-Olszewski Syndrome|Supranuclear Ophthalmoplegia, Progressive|Supranuclear Palsies, Progressive|Supranuclear Palsy, Progressive, 1	Eye disease|Nervous system disease|Signs and symptoms
Supranuclear Palsy, Progressive, 2	MESH:C563717	OMIM:609454		MESH:D013494	C10.228.140.079.882/C563717|C10.228.662.700/C563717|C10.292.562.750.500/C563717|C10.574.945.500/C563717|C10.597.622.447.690/C563717|C11.590.472.500/C563717|C23.888.592.636.447.690/C563717	C10.228.140.079.882|C10.228.662.700|C10.292.562.750.500|C10.574.945.500|C10.597.622.447.690|C11.590.472.500|C23.888.592.636.447.690	PSNP2	Eye disease|Nervous system disease|Signs and symptoms
Supranuclear Palsy, Progressive, 3	MESH:C567050	OMIM:610898		MESH:D013494	C10.228.140.079.882/C567050|C10.228.662.700/C567050|C10.292.562.750.500/C567050|C10.574.945.500/C567050|C10.597.622.447.690/C567050|C11.590.472.500/C567050|C23.888.592.636.447.690/C567050	C10.228.140.079.882|C10.228.662.700|C10.292.562.750.500|C10.574.945.500|C10.597.622.447.690|C11.590.472.500|C23.888.592.636.447.690	PSNP3	Eye disease|Nervous system disease|Signs and symptoms
Supratentorial Neoplasms	MESH:D015173	DO:DOID:1659	Primary and metastatic (secondary) tumors of the brain located above the tentorium cerebelli, a fold of dura mater separating the CEREBELLUM and BRAIN STEM from the cerebral hemispheres and DIENCEPHALON (i.e., THALAMUS and HYPOTHALAMUS and related structures). In adults, primary neoplasms tend to arise in the supratentorial compartment, whereas in children they occur more frequently in the infratentorial space. Clinical manifestations vary with the location of the lesion, but SEIZURES; APHASIA; HEMIANOPSIA; hemiparesis; and sensory deficits are relatively common features. Metastatic supratentorial neoplasms are frequently multiple at the time of presentation.	MESH:D001932	C04.588.614.250.195.885|C10.228.140.211.885|C10.551.240.250.700	C04.588.614.250.195|C10.228.140.211|C10.551.240.250	Benign Supratentorial Neoplasm|Benign Supratentorial Neoplasms|Cancers, Supratentorial|Cancer, Supratentorial|Malignant Supratentorial Neoplasm|Malignant Supratentorial Neoplasms|Neoplasm, Benign Supratentorial|Neoplasm, Malignant Supratentorial|Neoplasm, Primary Supratentorial|Neoplasms, Benign Supratentorial|Neoplasms, Malignant Supratentorial|Neoplasms, Primary Supratentorial|Neoplasms, Supratentorial|Neoplasm, Supratentorial|Primary Supratentorial Neoplasm|Primary Supratentorial Neoplasms|Supratentorial Cancer|Supratentorial Cancers|Supratentorial Neoplasm|Supratentorial Neoplasm, Benign|Supratentorial Neoplasm, Malignant|Supratentorial Neoplasm, Primary|Supratentorial Neoplasms, Benign|Supratentorial Neoplasms, Malignant|Supratentorial Neoplasms, Primary|Supratentorial Tumor|Supratentorial Tumors|Tumors, Supratentorial|Tumor, Supratentorial	Cancer|Nervous system disease
Supraumbilical midabdominal raphe and facial cavernous hemangiomas	MESH:C538144			MESH:D005153|MESH:D006392	C04.557.645.375.385/C538144|C04.588.443.392/C538144|C14.907.454.385/C538144|C15.378.463.515.385/C538144	C04.557.645.375.385|C04.588.443.392|C14.907.454.385|C15.378.463.515.385	Hemangiomas, Cavernous, of Face and Supraumbilical Midline Raphe|Hemangiomas cavernous of face supraumbilical midline raphe|Raphe, supraumbilical midline, with cavernous facial hemangiomas|Sternal nonunion with supraumbilical raphe	Blood disease|Cancer|Cardiovascular disease
Supravalvar aortic stenosis, eisenberg type	MESH:C538461			MESH:D021921	C14.280.484.048.750.535/C538461|C14.280.955.249.535/C538461	C14.280.484.048.750.535|C14.280.955.249.535		Cardiovascular disease
Surfactant Dysfunction	MESH:C580477			MESH:D017563	C08.381.483/C580477	C08.381.483	Interstitial Lung Disease Due To Surfactant Deficiency|Pulmonary Surfactant Metabolism Dysfunction|Surfactant Metabolism Deficiency	Respiratory tract disease
Surfactant Metabolism Dysfunction, Pulmonary, 1	MESH:C566882	OMIM:265120		MESH:D011649|MESH:D017563	C08.381.483/C566882|C08.381.719/C566882	C08.381.483|C08.381.719	Interstitial Lung Disease Due To Surfactant Protein B Deficiency|Interstitial Lung Disease, Nonspecific, Due To Surfactant Protein B Deficiency|Pulmonary Alveolar Proteinosis, Congenital, 1|SMDP1	Respiratory tract disease
Surfactant Metabolism Dysfunction, Pulmonary, 2	MESH:C567048	OMIM:610913		MESH:D011649|MESH:D017563	C08.381.483/C567048|C08.381.719/C567048	C08.381.483|C08.381.719	Desquamative Interstitial Pneumonitis Due To Surfactant Protein C Deficiency|Interstitial Lung Disease Due To Surfactant Protein C Deficiency|Pulmonary Alveolar Proteinosis, Congenital, 2|SMDP2	Respiratory tract disease
Surfactant Metabolism Dysfunction, Pulmonary, 3	MESH:C567046	OMIM:610921		MESH:D011649|MESH:D017563	C08.381.483/C567046|C08.381.719/C567046	C08.381.483|C08.381.719	Interstitial Lung Disease Due To ABCA3 Deficiency|Pulmonary Alveolar Proteinosis, Congenital, 3|SMDP3	Respiratory tract disease
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5	OMIM:614370	DO:DOID:12120		MESH:D011649	C08.381.719/614370	C08.381.719	CSF2RB DEFICIENCY|PAP DUE TO CSF2RB DEFICIENCY|PULMONARY ALVEOLAR PROTEINOSIS 5|SMDP5	Respiratory tract disease
Susac Syndrome	MESH:D055955		A rare disorder consisting of microangiopathy of brain, retina, and inner ear ARTERIOLES. It is characterized by the clinical triad of encephalopathy, BRANCH RETINAL ARTERY OCCLUSION and VERTIGO/hearing loss.	MESH:D002561|MESH:D004427|MESH:D005132|MESH:D009461|MESH:D014786|MESH:D015356	C09.218.855|C10.228.140.300.787|C10.597.825|C11.768.400.500|C11.966.858|C14.907.137.780.500|C23.888.307.750|C23.888.592.848	C09.218|C10.228.140.300|C10.597|C11.768.400|C11.966|C14.907.137.780|C23.888.307|C23.888.592	Retinocochleocerebral Vasculopathies|Retinocochleocerebral Vasculopathy|Susac's Syndrome|Susacs Syndrome|Syndrome, Susac|Syndrome, Susac's|Vasculopathies, Retinocochleocerebral|Vasculopathy, Retinocochleocerebral	Cardiovascular disease|Ear-nose-throat disease|Eye disease|Nervous system disease|Signs and symptoms
Sweat Gland Diseases	MESH:D013543	DO:DOID:1383	Diseases of the SWEAT GLANDS.	MESH:D012871	C17.800.946	C17.800	Diseases, Sweat Gland|Disease, Sweat Gland|Sweat Gland Disease	Skin disease
Sweat Gland Neoplasms	MESH:D013544	DO:DOID:2664	New abnormal growth of tissue in the SWEAT GLANDS.	MESH:D012878|MESH:D013543	C04.588.805.776|C17.800.882.743|C17.800.946.743	C04.588.805|C17.800.882|C17.800.946	Neoplasms, Sweat Gland|Neoplasm, Sweat Gland|Sweat Gland Neoplasm	Cancer|Skin disease
Sweating, Gustatory	MESH:D013547	DO:DOID:11599	An autonomic disorder characterized by excessive sweating of the forehead, upper lip, perioral region, or sternum subsequent to gustatory stimuli. The auriculotemporal syndrome features facial flushing or sweating limited to the distribution of the auriculotemporal nerve and may develop after trauma to the parotid gland, in association with PAROTID NEOPLASMS, or following their surgical removal. (From Ann Neurol 1997 Dec;42(6):973-5)	MESH:D001342|MESH:D006945	C10.177.825|C17.800.946.350.843	C10.177|C17.800.946.350	Auriculotemporal Nerve Syndrome|Auriculotemporal Syndrome|Baillarger Syndrome|Frey's Syndrome|Frey Syndrome|Gustatory Hyperhidroses|Gustatory Hyperhidrosis|Gustatory Sweating|Hyperhidroses, Gustatory|Hyperhidrosis, Gustatory|Salivosudoriparous Syndrome|Salivosudoriparous Syndromes|Syndrome, Auriculotemporal|Syndrome, Baillarger|Syndrome, Frey|Syndrome, Frey's|Syndrome, Salivosudoriparous|Syndromes, Salivosudoriparous|Syndrome, von Frey|Syndrome, von Frey's|von Frey's Syndrome|von Freys Syndrome|von Frey Syndrome	Nervous system disease|Skin disease
Sweet Syndrome	MESH:D016463		Condition characterized by large, rapidly extending, erythematous, tender plaques on the upper body usually accompanied by fever and dermal infiltration of neutrophilic leukocytes. It occurs mostly in middle-aged women, is often preceded by an upper respiratory infection, and clinically resembles ERYTHEMA MULTIFORME. Sweet syndrome is associated with LEUKEMIA.	MESH:D004890	C17.800.229.800	C17.800.229	Acute Febrile Neutrophilic Dermatosis|Dermatosis, Neutrophilic, Febrile, Acute|Disease, Gomm Button|Disease, Gomm-Button|Gomm Button Disease|Gomm-Button Disease|Neutrophilic Dermatosis, Acute Febrile|Sweet's Syndrome|Sweets Syndrome|Syndrome, Sweet|Syndrome, Sweet's	Skin disease
Symmastia	MESH:C538147			MESH:D001941	C17.800.090/C538147	C17.800.090	Medial confluence of the breasts	Skin disease
Syncope	MESH:D013575		A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)	MESH:D014474	C10.597.606.358.800.600|C23.888.592.604.359.800.600	C10.597.606.358.800|C23.888.592.604.359.800	Attack, Drop|Cardiogenic Syncope|Cardiogenic Syncopes|Carotid Sinus Syncope|Carotid Sinus Syncopes|Convulsive Syncope|Convulsive Syncopes|Deglutitional Syncope|Deglutitional Syncopes|Drop Attack|Drop Attacks|Effort Syncope|Effort Syncopes|Episode, Syncopal|Fainting|Hyperventilation Syncope|Hyperventilation Syncopes|Micturition Syncope|Micturition Syncopes|Postural Syncope|Postural Syncopes|Presyncope|Presyncopes|Situational Syncope|Situational Syncopes|Stokes-Adams Syncope|Stokes-Adams Syncopes|Syncopal Episode|Syncopal Episodes|Syncopal Vertigo|Syncope, Cardiogenic|Syncope, Carotid Sinus|Syncope, Convulsive|Syncope, Deglutitional|Syncope, Effort|Syncope, Hyperventilation|Syncope, Micturition|Syncope, Postural|Syncopes|Syncopes, Cardiogenic|Syncopes, Carotid Sinus|Syncopes, Convulsive|Syncopes, Deglutitional|Syncopes, Effort|Syncopes, Hyperventilation|Syncope, Situational|Syncopes, Micturition|Syncopes, Postural|Syncopes, Situational|Syncopes, Stokes-Adams|Syncope, Stokes Adams|Syncope, Stokes-Adams|Syncopes, Tussive|Syncope, Tussive|Tussive Syncope|Tussive Syncopes|Vertigos, Syncopal|Vertigo, Syncopal	Nervous system disease|Signs and symptoms
Syncope, Vasovagal	MESH:D019462		Loss of consciousness due to a reduction in blood pressure that is associated with an increase in vagal tone and peripheral vasodilation.	MESH:D013575|MESH:D054971	C10.177.575.600.800|C10.597.606.358.800.600.500|C23.888.592.604.359.800.600.500	C10.177.575.600|C10.597.606.358.800.600|C23.888.592.604.359.800.600	Cerebral Syncope|Cerebral Syncopes|Faint, Neurally Mediated|Faints, Neurally Mediated|Malignant Neurocardiogenic Syncope|Malignant Neurocardiogenic Syncopes|Neurally Mediated Faint|Neurally Mediated Faints|Neurocardiogenic Syncope|Neurocardiogenic Syncope, Malignant|Neurocardiogenic Syncopes|Neurocardiogenic Syncopes, Malignant|Neurogenic Syncope|Neurogenic Syncopes|Supine Syncope|Supine Syncopes|Syncope, Cerebral|Syncope, Malignant Neurocardiogenic|Syncope, Neurocardiogenic|Syncope, Neurogenic|Syncopes, Cerebral|Syncopes, Malignant Neurocardiogenic|Syncopes, Neurocardiogenic|Syncopes, Neurogenic|Syncopes, Supine|Syncope, Supine|Syncopes, Vasodepressor|Syncopes, Vasovagal|Syncope, Vasodepressor|Syncope, Vasovagal, Neurally-Mediated|Vasodepressor Syncope|Vasodepressor Syncopes|Vasovagal Syncope|Vasovagal Syncopes	Nervous system disease|Signs and symptoms
Synesthesia	MESH:D000080311	OMIM:612759	The experience of involuntary sensory cross activation where the presentation of a particular stimulus elicits a secondary sensory-perceptual experience. It most commonly occurs in the association of color with linguistic stimuli such as letters, numbers, words, or music, but can also occur between other senses. Although synesthesia can be acquired or transient due to trauma or drug use, there is also a strong genetic component, with a prevalence of about 1 in 2,000 individuals and a female to male ratio of 6:1.	MESH:D010468	C10.597.606.762.850	C10.597.606.762	Chromesthesia|Chromesthesias|Colored Hearing Synesthesia|Colored Hearing Synesthesias|Grapheme Color Synesthesia|Grapheme-Color Synesthesia|Grapheme-Color Synesthesias|Hearing Synesthesia, Colored|Hearing Synesthesias, Colored|Ideaesthesia|Ideaesthesias|Ideasthesia|Ideasthesias|Lexical Gustatory Synesthesia|Lexical-Gustatory Synesthesia|Lexical-Gustatory Synesthesias|Synesthesia, Colored Hearing|Synesthesia, Grapheme-Color|Synesthesia, Lexical-Gustatory|Synesthesias|Synesthesias, Colored Hearing|Synesthesias, Grapheme-Color|Synesthesias, Lexical-Gustatory|SYNSTH	Nervous system disease
Synkinesis	MESH:D046608		An involuntary movement accompanying a volitional movement. It often refers to facial movements that accompany FACIAL PARALYSIS.	MESH:D020820	C10.597.350.675|C23.888.592.350.675	C10.597.350|C23.888.592.350	Synkineses	Nervous system disease|Signs and symptoms
Synovial Cyst	MESH:D013581		Non-neoplastic tumor-like lesions at joints, developed from the SYNOVIAL MEMBRANE of a joint through the JOINT CAPSULE into the periarticular tissues. They are filled with SYNOVIAL FLUID with a smooth and translucent appearance. A synovial cyst can develop from any joint, but most commonly at the back of the knee, where it is known as POPLITEAL CYST.	MESH:D003560	C04.182.867	C04.182	Cysts, Synovial|Cyst, Synovial|Synovial Cysts	Cancer
Synovitis	MESH:D013585	DO:DOID:12225|DO:DOID:2703	Inflammation of the SYNOVIAL MEMBRANE.	MESH:D007592	C05.550.870	C05.550	Hypertrophies, Synovial|Hypertrophy, Synovial|Plica Syndrome|Plica Syndrome, Synovial|Synovial Hypertrophies|Synovial Hypertrophy|Synovial Plica Syndrome|Synovial Thickening|Synovial Thickenings|Synovitides|Thickenings, Synovial|Thickening, Synovial	Musculoskeletal disease
Synovitis, Pigmented Villonodular	MESH:D013586	DO:DOID:2702	Diffuse outgrowth arising from the SYNOVIAL MEMBRANE; SYNOVIAL BURSA; or TENDON sheath around the joint cavity, with extension to surrounding soft tissue. It is characterized by pigmented HEMOSIDERIN-containing MACROPHAGES; FOAM CELLS; and multinucleated GIANT CELLS. It usually occurs in the hands and feet, and around large joints, such as in the ankle and knee joints.	MESH:D000070779	C04.557.450.565.380.690.500|C05.550.870.445.500|C05.651.869.762.500	C04.557.450.565.380.690|C05.550.870.445|C05.651.869.762	Diffuse Tenosynovial Giant Cell Tumor|Pigmented Villonodular Synovitides|Pigmented Villonodular Synovitis|Synovitides, Pigmented Villonodular|Villonodular Synovitides, Pigmented|Villonodular Synovitis, Pigmented	Cancer|Musculoskeletal disease
Synucleinopathies	MESH:D000080874		Neurodegenerative disorders involving deposition of abnormal ALPHA-SYNUCLEIN in dopaminergic neurons and glial cells in the brain. Pathological aggregations of alpha-synuclein proteins results in LEWY BODIES and Lewy neurites; melanin granules in the SUBSTANTIA NIGRA and LOCUS COERULEUS; and glial cytoplasmic inclusions. Synucleinopathies are associated with mutation in the ALPHA-SYNUCLEIN (SNCA) gene on chromosome 4. PARKINSON DISEASE; LEWY BODY DISEASE with dementia; and MULTIPLE SYSTEM ATROPHY are prominent examples of synucleinopathy.	MESH:D019636|MESH:D057165	C10.574.928|C18.452.845.650	C10.574|C18.452.845	alpha Synucleinopathies|alpha-Synucleinopathies|alpha-Synucleinopathy|alpha Synuclein Pathologies|alpha Synuclein Pathology|a-Synucleinopathies|a-Synucleinopathy|Synucleinopathy	Metabolic disease|Nervous system disease
Syringoma	MESH:D018252	DO:DOID:2065	A benign tumor of the sweat glands which is usually multiple and results from malformation of sweat ducts. It is uncommon and more common in females than in males. It is most likely to appear at adolescence, and further lesions may develop during adult life. It does not appear to be hereditary. (Rook et al., Textbook of Dermatology, 4th ed, pp2407-8)	MESH:D006607	C04.557.470.035.175.800|C04.557.470.550.175.800	C04.557.470.035.175|C04.557.470.550.175	Syringomas	Cancer
Syringomas, Multiple	MESH:C566085			MESH:D018252	C04.557.470.035.175.800/C566085|C04.557.470.550.175.800/C566085	C04.557.470.035.175.800|C04.557.470.550.175.800		Cancer
Syringomyelia	MESH:D013595	DO:DOID:327	Longitudinal cavities in the spinal cord, most often in the cervical region, which may extend for multiple spinal levels. The cavities are lined by dense, gliogenous tissue and may be associated with SPINAL CORD NEOPLASMS; spinal cord traumatic injuries; and vascular malformations. Syringomyelia is marked clinically by pain and PARESTHESIA, muscular atrophy of the hands, and analgesia with thermoanesthesia of the hands and arms, but with the tactile sense preserved (sensory dissociation). Lower extremity spasticity and incontinence may also develop. (From Adams et al., Principles of Neurology, 6th ed, p1269)	MESH:D013118	C10.228.854.833	C10.228.854	Hydrosyringomyelia|Hydrosyringomyelias|Morvan Disease|Morvan Diseases|Morvan's Disease|Morvans Disease|Morvan's Diseases|Myelosyringoses|Myelosyringosis|Syringomyelias|Syringomyelus	Nervous system disease
Syringomyelia, Isolated	MESH:C566084			MESH:D013595	C10.228.854.833/C566084	C10.228.854.833		Nervous system disease
Systemic carnitine deficiency	MESH:C536778	DO:DOID:14365|OMIM:212140		MESH:D009135|MESH:D009202|MESH:D022124	C05.651/C536778|C10.668.491/C536778|C14.280.238/C536778|C23.550.421/C536778	C05.651|C10.668.491|C14.280.238|C23.550.421	Carnitine deficiency, primary|Carnitine deficiency, systemic, due to defect in renal reabsorption of carnitine|Carnitine deficiency, systemic primary|Carnitine Transporter Deficiency|Carnitine transporter, plasma-membrane, deficiency of|Carnitine uptake defect|Carnitine Uptake Deficiency|CDSP|CUD|Primary Carnitine Deficiency|Renal Carnitine Transport Defect|SCD|SYSTEMIC CARNITINE DEFICIENCY	Cardiovascular disease|Musculoskeletal disease|Nervous system disease|Pathology (process)
SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY TO, 1	OMIM:607279			MESH:D000743|MESH:D008180	C15.378.071.141/607279|C17.300.480/607279|C20.111.590/607279	C15.378.071.141|C17.300.480|C20.111.590	SLEH1|SYSTEMIC LUPUS ERYTHEMATOSUS, HEMOLYTIC ANEMIA-RELATED	Blood disease|Connective tissue disease|Immune system disease
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1	OMIM:607965			MESH:D008180|MESH:D009393	C12.050.351.968.419.570/607965|C12.200.777.419.570/607965|C12.950.419.570/607965|C17.300.480/607965|C20.111.590/607965	C12.050.351.968.419.570|C12.200.777.419.570|C12.950.419.570|C17.300.480|C20.111.590	SLEN1	Connective tissue disease|Immune system disease|Urogenital disease (female)|Urogenital disease (male)
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2	OMIM:607966			MESH:D008180|MESH:D009393	C12.050.351.968.419.570/607966|C12.200.777.419.570/607966|C12.950.419.570/607966|C17.300.480/607966|C20.111.590/607966	C12.050.351.968.419.570|C12.200.777.419.570|C12.950.419.570|C17.300.480|C20.111.590	SLEN2	Connective tissue disease|Immune system disease|Urogenital disease (female)|Urogenital disease (male)
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3	OMIM:607967			MESH:D008180|MESH:D009393	C12.050.351.968.419.570/607967|C12.200.777.419.570/607967|C12.950.419.570/607967|C17.300.480/607967|C20.111.590/607967	C12.050.351.968.419.570|C12.200.777.419.570|C12.950.419.570|C17.300.480|C20.111.590	SLEN3	Connective tissue disease|Immune system disease|Urogenital disease (female)|Urogenital disease (male)
Systemic necrotizing angiitis	MESH:C536779			MESH:D010488	C14.907.940.090.720/C536779|C14.907.940.897.500/C536779|C17.800.862.625/C536779	C14.907.940.090.720|C14.907.940.897.500|C17.800.862.625	Systemic necrotizing angitis	Cardiovascular disease|Skin disease
Systemic Vasculitis	MESH:D056647		A heterogeneous group of diseases characterized by inflammation and necrosis of the blood vessel walls.	MESH:D014657	C14.907.940.897	C14.907.940	Systemic Vasculitides|Vasculitides, Systemic|Vasculitis, Systemic	Cardiovascular disease
Tabatznik syndrome	MESH:C536784			MESH:D006228|MESH:D006330	C05.390.408/C536784|C05.660.585.988.425/C536784|C14.240.400/C536784|C14.280.400/C536784|C16.131.240.400/C536784|C16.131.621.585.988.500/C536784	C05.390.408|C05.660.585.988.425|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.585.988.500	Heart-hand syndrome 2	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Tachycardia	MESH:D013610		Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.	MESH:D000075224|MESH:D001145	C14.280.067.845|C14.280.123.875|C23.550.073.845	C14.280.067|C14.280.123|C23.550.073	Tachyarrhythmia|Tachyarrhythmias|Tachycardias	Cardiovascular disease|Pathology (process)
Tachycardia, Atrioventricular Nodal Reentry	MESH:D013611		Abnormally rapid heartbeats caused by reentry of atrial impulse into the dual (fast and slow) pathways of ATRIOVENTRICULAR NODE. The common type involves a blocked atrial impulse in the slow pathway which reenters the fast pathway in a retrograde direction and simultaneously conducts to the atria and the ventricles leading to rapid HEART RATE of 150-250 beats per minute.	MESH:D054139	C14.280.067.845.787.249|C14.280.123.875.787.249|C23.550.073.845.787.500	C14.280.067.845.787|C14.280.123.875.787|C23.550.073.845.787	Atrioventricular Nodal Reentrant Tachycardia|Atrioventricular Nodal Re Entrant Tachycardia|Atrioventricular Nodal Re-Entrant Tachycardia|Atrioventricular Nodal Reentry Tachycardia|Atrioventricular Reentrant Tachycardia|Atrioventricular Reentrant Tachycardias|AV Nodal Reentrant Tachycardia|Reentrant Tachycardia, Atrioventricular|Tachycardia, Atrioventricular Reentrant|Tachycardia, AV Nodal Reentrant	Cardiovascular disease|Pathology (process)
Tachycardia, Ectopic Atrial	MESH:D013612		Abnormally rapid heartbeats originating from one or more automatic foci (nonsinus pacemakers) in the HEART ATRIUM but away from the SINOATRIAL NODE. Unlike the reentry mechanism, automatic tachycardia speeds up and slows down gradually. The episode is characterized by a HEART RATE between 135 to less than 200 beats per minute and lasting 30 seconds or longer.	MESH:D013617	C14.280.067.845.880.315|C14.280.123.875.880.315|C23.550.073.845.880.315	C14.280.067.845.880|C14.280.123.875.880|C23.550.073.845.880	Atrial Ectopic Tachycardia|Atrial Ectopic Tachycardias|Atrial Tachycardia, Ectopic|Atrial Tachycardias, Ectopic|Ectopic Atrial Tachycardia|Ectopic Atrial Tachycardias|Ectopic Tachycardia, Atrial|Ectopic Tachycardias, Atrial|Tachycardia, Atrial Ectopic|Tachycardias, Atrial Ectopic|Tachycardias, Ectopic Atrial	Cardiovascular disease|Pathology (process)
Tachycardia, Ectopic Junctional	MESH:D013613		A rare form of supraventricular tachycardia caused by automatic, not reentrant, conduction initiated from sites at the atrioventricular junction, but not the ATRIOVENTRICULAR NODE. It usually occurs during myocardial infarction, after heart surgery, or in digitalis intoxication with a HEART RATE ranging from 140 to 250 beats per minute.	MESH:D013617	C14.280.067.845.880.320|C14.280.123.875.880.320|C23.550.073.845.880.320	C14.280.067.845.880|C14.280.123.875.880|C23.550.073.845.880	Ectopic Junctional Tachycardia|Ectopic Junctional Tachycardias|Ectopic Tachycardia, Junctional|Ectopic Tachycardias, Junctional|Junctional Ectopic Tachycardia|Junctional Ectopic Tachycardias|Junctional Tachycardia, Ectopic|Junctional Tachycardias, Ectopic|Tachycardia, Junctional Ectopic|Tachycardias, Ectopic Junctional|Tachycardias, Junctional Ectopic	Cardiovascular disease|Pathology (process)
Tachycardia, Hypertension, Microphthalmia, And Hyperglycinuria	MESH:C566880			MESH:D006973|MESH:D008850|MESH:D013610	C11.250.566/C566880|C14.280.067.845/C566880|C14.280.123.875/C566880|C14.907.489/C566880|C16.131.384.666/C566880|C23.550.073.845/C566880	C11.250.566|C14.280.067.845|C14.280.123.875|C14.907.489|C16.131.384.666|C23.550.073.845		Cardiovascular disease|Congenital abnormality|Eye disease|Pathology (process)
Tachycardia, Paroxysmal	MESH:D013614		Abnormally rapid heartbeats with sudden onset and cessation.	MESH:D013610	C14.280.067.845.695|C14.280.123.875.695|C23.550.073.845.695	C14.280.067.845|C14.280.123.875|C23.550.073.845	Paroxysmal Reciprocal Tachycardia|Paroxysmal Reciprocal Tachycardias|Paroxysmal Tachycardia|Paroxysmal Tachycardias|Reciprocal Tachycardia, Paroxysmal|Reciprocal Tachycardias, Paroxysmal|Tachycardia, Paroxysmal Reciprocal|Tachycardias, Paroxysmal|Tachycardias, Paroxysmal Reciprocal	Cardiovascular disease|Pathology (process)
Tachycardia, Reciprocating	MESH:D054139		Abnormally rapid heartbeats caused by reentrant conduction over the accessory pathways between the HEART ATRIA and the HEART VENTRICLES. The impulse can also travel in the reverse direction, as in some cases, atrial impulses travel to the ventricles over the accessory pathways and back to the atria over the BUNDLE OF HIS and the ATRIOVENTRICULAR NODE.	MESH:D013610	C14.280.067.845.787|C14.280.123.875.787|C23.550.073.845.787	C14.280.067.845|C14.280.123.875|C23.550.073.845	Reciprocal Tachycardia|Reciprocal Tachycardias|Reciprocating Tachycardia|Reciprocating Tachycardias|Tachycardia, Reciprocal|Tachycardias, Reciprocal|Tachycardias, Reciprocating	Cardiovascular disease|Pathology (process)
Tachycardia, Sinoatrial Nodal Reentry	MESH:D013615		Abnormally rapid heartbeats caused by reentry circuit in or around the SINOATRIAL NODE. It is characterized by sudden onset and offset episodes of tachycardia with a HEART RATE of 100-150 beats per minute. The P wave is identical to the sinus P wave but with a longer PR interval.	MESH:D054139	C14.280.067.845.787.500|C14.280.123.875.787.500|C23.550.073.845.787.750	C14.280.067.845.787|C14.280.123.875.787|C23.550.073.845.787	Sinoatrial Nodal Reentry Tachycardia|Sinus Node Reentrant Tachycardia|Tachycardia, SA Nodal Reentrant	Cardiovascular disease|Pathology (process)
Tachycardia, Sinus	MESH:D013616		Simple rapid heartbeats caused by rapid discharge of impulses from the SINOATRIAL NODE, usually between 100 and 180 beats/min in adults. It is characterized by a gradual onset and termination. Sinus tachycardia is common in infants, young children, and adults during strenuous physical activities.	MESH:D013617	C14.280.067.845.880.845|C14.280.123.875.880.845|C23.550.073.845.880.845	C14.280.067.845.880|C14.280.123.875.880|C23.550.073.845.880	Sinus Tachycardia|Sinus Tachycardias|Tachycardias, Sinus	Cardiovascular disease|Pathology (process)
Tachycardia, Supraventricular	MESH:D013617		A generic expression for any tachycardia that originates above the BUNDLE OF HIS.	MESH:D013610	C14.280.067.845.880|C14.280.123.875.880|C23.550.073.845.880	C14.280.067.845|C14.280.123.875|C23.550.073.845	Supraventricular Tachycardia|Supraventricular Tachycardias|Tachycardias, Supraventricular	Cardiovascular disease|Pathology (process)
Tachycardia, Ventricular	MESH:D017180		An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).	MESH:D013610	C14.280.067.845.940|C14.280.123.875.940|C23.550.073.845.940	C14.280.067.845|C14.280.123.875|C23.550.073.845	Idiopathic Ventricular Tachycardia|Idiopathic Ventricular Tachycardias|Nonsustained Ventricular Tachycardia|Nonsustained Ventricular Tachycardias|Paroxysmal Supraventricular Tachycardia|Paroxysmal Supraventricular Tachycardias|Supraventricular Tachycardia, Paroxysmal|Tachyarrhythmia, Ventricular|Tachycardia, Idiopathic Ventricular|Tachycardia, Nonsustained Ventricular|Tachycardia, Paroxysmal Supraventricular|Ventricular Tachyarrhythmia|Ventricular Tachyarrhythmias|Ventricular Tachycardia|Ventricular Tachycardia, Idiopathic|Ventricular Tachycardia, Nonsustained|Ventricular Tachycardias	Cardiovascular disease|Pathology (process)
Tachypnea	MESH:D059246		Increased RESPIRATORY RATE.	MESH:D012120|MESH:D012818	C08.618.961|C23.888.852.944	C08.618|C23.888.852	Tachypneas	Respiratory tract disease|Signs and symptoms
Takayasu Arteritis	MESH:D013625	DO:DOID:2508	A chronic inflammatory process that affects the AORTA and its primary branches, such as the brachiocephalic artery (BRACHIOCEPHALIC TRUNK) and CAROTID ARTERIES. It results in progressive arterial stenosis, occlusion, and aneurysm formation. The pulse in the arm is hard to detect. Patients with aortitis syndrome often exhibit retinopathy.	MESH:D001015|MESH:D001167|MESH:D017445	C14.907.109.239.650|C14.907.940.090.800|C17.800.862.875	C14.907.109.239|C14.907.940.090|C17.800.862	Aortitis Syndrome|Arteritides, Young Female|Arteritis, Takayasu|Arteritis, Takayasus|Arteritis, Takayasu's|Arteritis, Young Female|Disease, Takayasu|Female Arteritides, Young|Female Arteritis, Young|Pulseless Disease|Syndrome, Aortitis|Takayasu Disease|Takayasu's Arteritis|Takayasus Arteritis|Takayasu Syndrome|Young Female Arteritides|Young Female Arteritis	Cardiovascular disease|Skin disease
TAKENOUCHI-KOSAKI SYNDROME	OMIM:616737			MESH:D008607|MESH:D013921	C10.597.606.360/616737|C15.378.140.855/616737|C23.888.592.604.646/616737|F03.625.539/616737	C10.597.606.360|C15.378.140.855|C23.888.592.604.646|F03.625.539	MACROTHROMBOCYTOPENIA AND MENTAL RETARDATION SYNDROME|TKS	Blood disease|Mental disorder|Nervous system disease|Signs and symptoms
Takotsubo Cardiomyopathy	MESH:D054549		A transient left ventricular apical dysfunction or ballooning accompanied by electrocardiographic (ECG) T wave inversions. This abnormality is associated with high levels of CATECHOLAMINES, either administered or endogenously secreted from a tumor or during extreme stress.	MESH:D018487	C14.280.945.900.500	C14.280.945.900	Apical Ballooning Syndrome|Broken Heart Syndrome|Cardiomyopathy, Stress|Cardiomyopathy, Takotsubo|Cardiomyopathy, Tako-tsubo|Left Ventricular Apical Ballooning Syndrome|Stress Cardiomyopathy|Syndrome, Apical Ballooning|Syndrome, Broken Heart|Syndromes, Broken Heart|Syndromes, Tako-tsubo|Syndrome, Tako-tsubo|Tako tsubo Cardiomyopathy|Tako-tsubo Cardiomyopathy|Tako tsubo Syndrome|Tako-tsubo Syndrome|Takotsubo Syndrome|Tako-tsubo Syndromes|Transient Apical Ballooning Syndrome	Cardiovascular disease
Talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals	MESH:C536894			MESH:D010014|MESH:D013585	C05.116.264.579/C536894|C05.550.870/C536894	C05.116.264.579|C05.550.870		Musculoskeletal disease
Tang Hsi Ryu syndrome	MESH:C536897			MESH:D006529|MESH:D009422|MESH:D010859|MESH:D013163	C06.552.416/C536897|C10/C536897|C17.800.621/C536897|C23.300.775.525/C536897|C23.300.775.750/C536897|C23.550.755/C536897	C06.552.416|C10|C17.800.621|C23.300.775.525|C23.300.775.750|C23.550.755	Ascitis, splenomegaly, lymphadenopathy|Polyneuropathy hepatosplenomegaly hyperpigmentation|Syndrome of polyneuropathy, skin hyperpigmentation, oedema and hepatosplenomegaly	Digestive system disease|Nervous system disease|Pathology (anatomical condition)|Pathology (process)|Skin disease
Tardive Dyskinesia	MESH:D000071057		Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).	MESH:D004409	C10.228.662.262.500.500|C10.597.350.275.500|C23.888.592.350.275.500	C10.228.662.262.500|C10.597.350.275|C23.888.592.350.275	Dyskinesias, Tardive|Dyskinesia, Tardive|Dystonias, Tardive|Dystonia, Tardive|Tardive Dyskinesias|Tardive Dystonia|Tardive Dystonias	Nervous system disease|Signs and symptoms
Tarlov Cysts	MESH:D052958		Perineurial cysts commonly found in the SACRAL REGION. They arise from the PERINEURIUM membrane within the SPINAL NERVE ROOTS. The distinctive feature of the cysts is the presence of spinal nerve root fibers within the cyst wall, or the cyst cavity itself.	MESH:D003560|MESH:D010523	C04.182.872|C10.668.829.900	C04.182|C10.668.829	Cyst, Perineural|Cyst, Perineurial|Cyst, Sacral Perineural|Cysts, Perineural|Cysts, Perineurial|Cysts, Sacral Perineural|Cysts, Sacral Tarlov|Cysts, Tarlov|Cyst, Tarlov|Perineural Cyst|Perineural Cysts|Perineurial Cyst|Perineurial Cysts|Sacral Perineural Cyst|Sacral Perineural Cysts|Sacral Tarlov Cysts|Tarlov Cyst	Cancer|Nervous system disease
TARP syndrome	MESH:C536942	DO:DOID:0111780|OMIM:311900		MESH:D003025|MESH:D006330|MESH:D010855	C05.330.488.655.063/C536942|C05.330.495.681.063/C536942|C05.500.460.606/C536942|C05.660.207.540.460.606/C536942|C05.660.585.512.380.813.063/C536942|C07.320.440.606/C536942|C07.650.500.460.606/C536942|C14.240.400/C536942|C14.280.400/C536942|C16.131.240.400/C536942|C16.131.621.207.540.460.606/C536942|C16.131.621.585.512.500.681.063/C536942|C16.131.850.500.460.606/C536942	C05.330.488.655.063|C05.330.495.681.063|C05.500.460.606|C05.660.207.540.460.606|C05.660.585.512.380.813.063|C07.320.440.606|C07.650.500.460.606|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.540.460.606|C16.131.621.585.512.500.681.063|C16.131.850.500.460.606	Pierre Robin syndrome with congenital heart malformation and clubfoot|Talipes Equinovarus, Atrial Septal Defect, Robin Sequence, and Persistence of Left Superior Vena Cava|TARPS	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease
Tarsal Tunnel Syndrome	MESH:D013641	DO:DOID:12526	Entrapment of the distal branches of the posterior TIBIAL NERVE (which divides into the medial plantar, lateral plantar, and calcanial nerves) in the tarsal tunnel, which lies posterior to the internal malleolus and beneath the retinaculum of the flexor muscles of the foot. Symptoms include ankle pain radiating into the foot which tends to be aggravated by walking. Examination may reveal Tinel's sign (radiating pain following nerve percussion) over the tibial nerve at the ankle, weakness and atrophy of the small foot muscles, or loss of sensation in the foot. (From Foot Ankle 1990;11(1):47-52)	MESH:D009408|MESH:D020429	C10.668.829.500.700.800|C10.668.829.550.800	C10.668.829.500.700|C10.668.829.550	Entrapment Neuropathy, Tarsal Tunnel|Posterior Tibial Nerve Neuralgia|Syndromes, Tarsal Tunnel|Syndrome, Tarsal Tunnel|Tarsal Tunnel Entrapment Neuropathy|Tarsal Tunnel Syndromes|Tarsal Tunnel Tibial Neuropathy|Tibial Neuropathy, Tarsal Tunnel|Tunnel Syndromes, Tarsal|Tunnel Syndrome, Tarsal	Nervous system disease
Taste Disorders	MESH:D013651		Conditions characterized by an alteration in gustatory function or perception. Taste disorders are frequently associated with OLFACTION DISORDERS. Additional potential etiologies include METABOLIC DISEASES; DRUG TOXICITY; and taste pathway disorders (e.g., TASTE BUD diseases; FACIAL NERVE DISEASES; GLOSSOPHARYNGEAL NERVE DISEASES; and BRAIN STEM diseases).	MESH:D012678	C10.597.751.861|C23.888.592.763.861	C10.597.751|C23.888.592.763	Dysfunction, Taste|Metallic Taste|Metallic Tastes|Primary Taste Disorder|Primary Taste Disorders|Secondary Taste Disorder|Secondary Taste Disorders|Taste Disorder|Taste Disorder, Anterior Tongue|Taste Disorder, Posterior Tongue|Taste Disorder, Primary|Taste Disorder, Primary, Bitter|Taste Disorder, Primary, Salt|Taste Disorder, Primary, Sweet|Taste Disorder, Secondary|Taste Disorder, Secondary, Bitter|Taste Disorder, Secondary, Salt|Taste Disorder, Secondary, Sweet|Taste Disorders, Primary|Taste Disorders, Secondary|Taste Dysfunction|Taste, Metallic|Tastes, Metallic	Nervous system disease|Signs and symptoms
Tatsumi Factor Deficiency	MESH:C564787			MESH:D020147	C15.378.100.141/C564787	C15.378.100.141		Blood disease
Tauopathies	MESH:D024801	DO:DOID:680	Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.	MESH:D019636	C10.574.945	C10.574	Tauopathy	Nervous system disease
Tauopathy and Respiratory Failure	MESH:C563580			MESH:D012131|MESH:D013494	C08.618.846/C563580|C10.228.140.079.882/C563580|C10.228.662.700/C563580|C10.292.562.750.500/C563580|C10.574.945.500/C563580|C10.597.622.447.690/C563580|C11.590.472.500/C563580|C23.888.592.636.447.690/C563580	C08.618.846|C10.228.140.079.882|C10.228.662.700|C10.292.562.750.500|C10.574.945.500|C10.597.622.447.690|C11.590.472.500|C23.888.592.636.447.690		Eye disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
T-cell lymphoma 1A	MESH:C536782			MESH:D016399	C04.557.386.480.750/C536782|C15.604.515.569.480.750/C536782|C20.683.515.761.480.750/C536782	C04.557.386.480.750|C15.604.515.569.480.750|C20.683.515.761.480.750		Cancer|Immune system disease|Lymphatic disease
T-Cell OKT4 Deficiency	MESH:C566080			MESH:D007153|MESH:D007960	C15.378.553/C566080|C20.673/C566080	C15.378.553|C20.673		Blood disease|Immune system disease
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	OMIM:615387	DO:DOID:0111977		MESH:D007153	C20.673/615387	C20.673	IMD7|IMMUNODEFICIENCY 7|TCR-ALPHA/BETA DEFICIENCY	Immune system disease
TDP-43 Proteinopathies	MESH:D057177		Diseases characterized by the presence of abnormally phosphorylated, ubiquitinated, and cleaved DNA-binding protein TDP-43 in affected brain and spinal cord. Inclusions of the pathologic protein in neurons and glia, without the presence of AMYLOID, is the major feature of these conditions, thus making these proteinopathies distinct from most other neurogenerative disorders in which protein misfolding leads to brain amyloidosis. Both frontotemporal lobar degeneration and AMYOTROPHIC LATERAL SCLEROSIS exhibit this common method of pathogenesis and thus they may represent two extremes of a continuous clinicopathological spectrum of one disease.	MESH:D019636|MESH:D057165	C10.574.950|C18.452.845.800	C10.574|C18.452.845	Proteinopathies, TDP-43|Proteinopathy, TDP-43|TDP 43 Proteinopathies|TDP-43 Proteinopathy	Metabolic disease|Nervous system disease
Telangiectasia, Generalized Essential	MESH:C562998			MESH:D013684	C14.907.823/C562998	C14.907.823		Cardiovascular disease
Telangiectasia, Hereditary Benign	MESH:C562908	OMIM:187260		MESH:D013684	C14.907.823/C562908	C14.907.823	HBT|TELANGIECTASIA, GENERALIZED ESSENTIAL	Cardiovascular disease
Telangiectasia, Hereditary Hemorrhagic	MESH:D013683	DO:DOID:1270|OMIM:187300	An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.	MESH:D013684|MESH:D020141|MESH:D054079	C14.907.454.900|C14.907.823.780|C15.378.463.515.900|C16.131.240.850.968	C14.907.454|C14.907.823|C15.378.463.515|C16.131.240.850	Hemorrhagic Telangiectasia, Hereditary|Hereditary Hemorrhagic Telangiectasia|HHT|HHT1|ORW DISEASE|Osler Disease|Osler Rendu Disease|Osler-Rendu Disease|Osler Rendu Weber Disease|Osler-Rendu-Weber Disease|Osler's Disease|Osler Weber Rendu Syndrome|Osler-Weber-Rendu Syndrome|Rendu Osler Weber Disease|Rendu-Osler-Weber Disease|Telangiectasia, Hereditary Hemorrhagic, of Rendu, Osler, and Weber|Telangiectasia, Hereditary Hemorrhagic, Type 1|Weber Osler Disease|Weber-Osler Disease|Weber Osler Syndrome|Weber-Osler Syndrome	Blood disease|Cardiovascular disease|Congenital abnormality
Telangiectasia, Hereditary Hemorrhagic, Type 4	MESH:C565691	OMIM:610655		MESH:D013683	C14.907.454.900/C565691|C14.907.823.780/C565691|C15.378.463.515.900/C565691|C16.131.240.850.968/C565691	C14.907.454.900|C14.907.823.780|C15.378.463.515.900|C16.131.240.850.968	HHT4	Blood disease|Cardiovascular disease|Congenital abnormality
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5	OMIM:615506	DO:DOID:1270		MESH:D013683	C14.907.454.900/615506|C14.907.823.780/615506|C15.378.463.515.900/615506|C16.131.240.850.968/615506	C14.907.454.900|C14.907.823.780|C15.378.463.515.900|C16.131.240.850.968	HHT5	Blood disease|Cardiovascular disease|Congenital abnormality
Telangiectasia macularis eruptiva perstans	MESH:C000715747			MESH:D034701	C04.557.450.565.465.500/C000715747|C04.588.805.309/C000715747|C17.800.882.356/C000715747|C20.762.750.563/C000715747	C04.557.450.565.465.500|C04.588.805.309|C17.800.882.356|C20.762.750.563	Paucicellular mastocytosis|Telangiectasia macularis eruptive perstans|Telangiectatic cutaneous mastocytosis	Cancer|Immune system disease|Skin disease
Telangiectasis	MESH:D013684	DO:DOID:1272	Permanent dilation of preexisting blood vessels (CAPILLARIES; ARTERIOLES; VENULES) creating small focal red lesions, most commonly in the skin or mucous membranes. It is characterized by the prominence of skin blood vessels, such as vascular spiders.	MESH:D014652	C14.907.823	C14.907	Spider Vein|Spider Veins|Telangiectases|Telangiectasia|Telangiectasias|Vein, Spider|Veins, Spider	Cardiovascular disease
Telencephalic leukoencephalopathy	MESH:C536954			MESH:D056784	C10.228.140.695/C536954	C10.228.140.695		Nervous system disease
Tel Hashomer camptodactyly syndrome	MESH:C536953			MESH:D006228|MESH:D006344|MESH:D006628|MESH:D009135	C05.390.408/C536953|C05.651/C536953|C05.660.585.988.425/C536953|C10.668.491/C536953|C14.240.400.560.375/C536953|C14.280.400.560.375/C536953|C16.131.240.400.560.375/C536953|C16.131.621.585.988.500/C536953|C17.800.329.750/C536953|C23.888.971.468/C536953	C05.390.408|C05.651|C05.660.585.988.425|C10.668.491|C14.240.400.560.375|C14.280.400.560.375|C16.131.240.400.560.375|C16.131.621.585.988.500|C17.800.329.750|C23.888.971.468		Cardiovascular disease|Congenital abnormality|Musculoskeletal disease|Nervous system disease|Signs and symptoms|Skin disease
Temporal epilepsy, familial	MESH:C536956			MESH:D004833	C10.228.140.490.360.290/C536956|C10.228.140.490.493.375/C536956	C10.228.140.490.360.290|C10.228.140.490.493.375	Epilepsy, familial temporal lobe|Familial temporal lobe epilepsy	Nervous system disease
Temporomandibular ankylosis	MESH:C536957			MESH:D000844|MESH:D013705	C05.500.607.221.897/C536957|C05.550.069/C536957|C05.550.905/C536957|C05.651.243.897/C536957|C07.320.610.291.897/C536957|C07.678/C536957	C05.500.607.221.897|C05.550.069|C05.550.905|C05.651.243.897|C07.320.610.291.897|C07.678	Ankylosis of the temporomandibular joint (TMJ)|TMJ Ankylosis	Mouth disease|Musculoskeletal disease
Temporomandibular Joint Disorders	MESH:D013705		A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)	MESH:D007592|MESH:D009057|MESH:D017271	C05.500.607.221.897|C05.550.905|C05.651.243.897|C07.320.610.291.897|C07.678	C05.500.607.221|C05.550|C05.651.243|C07|C07.320.610.291	Diseases, Temporomandibular Joint|Diseases, TMJ|Disease, Temporomandibular Joint|Disease, TMJ|Disorders, Temporomandibular|Disorders, Temporomandibular Joint|Disorders, TMJ|Disorder, Temporomandibular|Disorder, Temporomandibular Joint|Disorder, TMJ|Joint Diseases, Temporomandibular|Joint Disease, Temporomandibular|Joint Disorders, Temporomandibular|Joint Disorder, Temporomandibular|Temporomandibular Disorder|Temporomandibular Disorders|Temporomandibular Joint Disease|Temporomandibular Joint Diseases|Temporomandibular Joint Disorder|TMJ Disease|TMJ Diseases|TMJ Disorder|TMJ Disorders	Mouth disease|Musculoskeletal disease
Temporomandibular Joint Dysfunction Syndrome	MESH:D013706		A symptom complex consisting of pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. The symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are uncertain but include occlusal dysharmony and psychophysiologic factors.	MESH:D009209|MESH:D013705	C05.500.607.221.897.897|C05.550.905.905|C05.651.243.897.897|C05.651.550.905|C07.320.610.291.897.897|C07.678.949	C05.500.607.221.897|C05.550.905|C05.651.243.897|C05.651.550|C07.320.610.291.897|C07.678	Costen's Syndrome|Costens Syndrome|Costen Syndrome|Joint Syndrome, Temporomandibular|Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint|Syndrome, Costen's|Syndrome, Temporomandibular Joint|Syndrome, TMJ|Temporomandibular Joint Syndrome|TMJ Syndrome	Mouth disease|Musculoskeletal disease
Tendinopathy	MESH:D052256	DO:DOID:971	Clinical syndrome describing overuse tendon injuries characterized by a combination of PAIN, diffuse or localized swelling, and impaired performance.	MESH:D009135|MESH:D013708	C05.651.869|C26.874.800	C05.651|C26.874	Tendinitides|Tendinitis|Tendinopathies|Tendinoses|Tendinosis|Tendonitides|Tendonitis|Tendonopathies|Tendonopathy|Tendonoses|Tendonosis	Musculoskeletal disease|Wounds and injuries
Tendon Entrapment	MESH:D053682		Narrowing or stenosis of a tendon's retinacular sheath. It occurs most often in the hand or wrist but can also be found in the foot or ankle. The most common types are DE QUERVAIN DISEASE and TRIGGER FINGER DISORDER.	MESH:D052256	C05.651.869.816	C05.651.869	Entrapments, Tendon|Entrapment, Tendon|Stenosing Tendovaginitides|Stenosing Tendovaginitis|Stenosing Tenosynovitides|Stenosing Tenosynovitis|Stenosing Tenovaginitides|Stenosing Tenovaginitis|Tendon Entrapments|Tendovaginitides, Stenosing|Tendovaginitis, Stenosing|Tenosynovitides, Stenosing|Tenosynovitis, Stenosing|Tenovaginitides, Stenosing|Tenovaginitis, Stenosing	Musculoskeletal disease
Tennis Elbow	MESH:D013716	DO:DOID:14087	A condition characterized by pain in or near the lateral humeral epicondyle or in the forearm extensor muscle mass as a result of unusual strain. It occurs due repetitive stresses on the elbow from activities such as tennis playing.	MESH:D000070639|MESH:D001134	C05.651.869.435.500|C26.088.890|C26.874.800.500.500	C05.651.869.435|C26.088|C26.874.800.500	Elbows, Tennis|Elbow, Tennis|Epicondylitides, Lateral|Epicondylitides, Lateral Humeral|Epicondylitis, Lateral|Epicondylitis, Lateral Humeral|Humeral Epicondylitides, Lateral|Humeral Epicondylitis, Lateral|Lateral Epicondylitides|Lateral Epicondylitis|Lateral Humeral Epicondylitides|Lateral Humeral Epicondylitis|Tennis Elbows	Musculoskeletal disease|Wounds and injuries
Tenosynovitis	MESH:D013717	DO:DOID:970	Inflammation of the synovial lining of a tendon sheath. Causes include trauma, tendon stress, bacterial disease (gonorrhea, tuberculosis), rheumatic disease, and gout. Common sites are the hand, wrist, shoulder capsule, hip capsule, hamstring muscles, and Achilles tendon. The tendon sheaths become inflamed and painful, and accumulate fluid. Joint mobility is usually reduced.	MESH:D052256	C05.651.869.870	C05.651.869	Tenosynovitides	Musculoskeletal disease
Tension-Type Headache	MESH:D018781		A common primary headache disorder, characterized by a dull, non-pulsatile, diffuse, band-like (or vice-like) PAIN of mild to moderate intensity in the HEAD; SCALP; or NECK. The subtypes are classified by frequency and severity of symptoms. There is no clear cause even though it has been associated with MUSCLE CONTRACTION and stress. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)	MESH:D051270	C10.228.140.546.399.875	C10.228.140.546.399	Headache, Idiopathic|Headache, Psychogenic|Headaches, Idiopathic|Headaches, Psychogenic|Headaches, Stress|Headaches, Tension|Headaches, Tension-Type|Headaches, Tension-Vascular|Headache, Stress|Headache, Tension|Headache, Tension-Type|Headache, Tension-Vascular|Idiopathic Headache|Idiopathic Headaches|Psychogenic Headache|Psychogenic Headaches|Stress Headache|Stress Headaches|Tension Headache|Tension Headaches|Tension Type Headache|Tension-Type Headaches|Tension Vascular Headache|Tension-Vascular Headache|Tension-Vascular Headaches	Nervous system disease
Teratocarcinoma	MESH:D018243	DO:DOID:3305	A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)	MESH:D009373	C04.557.465.900	C04.557.465	Teratocarcinomas	Cancer
Teratoid Tumor, Atypical	MESH:C563737			MESH:D013724|MESH:D018335	C04.557.435.710/C563737|C04.557.465.910/C563737	C04.557.435.710|C04.557.465.910		Cancer
Teratoma	MESH:D013724	DO:DOID:3307|DO:DOID:5563	A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)	MESH:D009373	C04.557.465.910	C04.557.465	Benign Teratoma|Benign Teratomas|Dysembryoma|Dysembryomas|Immature Teratoma|Immature Teratomas|Malignant Teratoma|Malignant Teratomas|Teratoid Tumor|Teratoid Tumors|Teratoma, Benign|Teratoma, Cystic|Teratoma, Immature|Teratoma, Malignant|Teratoma, Mature|Teratomas|Teratomas, Benign|Teratomas, Immature|Teratomas, Malignant|Tumors, Teratoid|Tumor, Teratoid	Cancer
Teratoma, Ovarian	MESH:C562731	DO:DOID:5117		MESH:D010051|MESH:D013724	C04.557.465.910/C562731|C04.588.322.455/C562731|C12.050.351.500.056.630.705/C562731|C12.050.351.937.418.685/C562731|C12.100.250.056.630.705/C562731|C12.900.418.685/C562731|C19.344.410/C562731|C19.391.630.705/C562731	C04.557.465.910|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.344.410|C19.391.630.705	Dermoid Cyst, Ovarian	Cancer|Endocrine system disease|Urogenital disease (female)
Teratoma, Testicular	MESH:C562472			MESH:D013724|MESH:D013736	C04.557.465.910/C562472|C04.588.322.762/C562472|C04.588.945.440.915/C562472|C12.100.500.260.937/C562472|C12.200.294.260.937/C562472|C12.200.758.409.937/C562472|C12.900.619.937/C562472|C19.344.762/C562472|C19.391.829.782/C562472	C04.557.465.910|C04.588.322.762|C04.588.945.440.915|C12.100.500.260.937|C12.200.294.260.937|C12.200.758.409.937|C12.900.619.937|C19.344.762|C19.391.829.782		Cancer|Endocrine system disease|Urogenital disease (male)
TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE	OMIM:615542			MESH:D003456|MESH:D006330|MESH:D058490	C12.050.351.875.253.096/615542|C12.100.500.829.258/615542|C12.200.294.829.258/615542|C12.200.706.258/615542|C12.200.706.316.096/615542|C12.800.258/615542|C12.800.316.096/615542|C14.240.400/615542|C14.280.400/615542|C16.131.240.400/615542|C16.131.939.258/615542|C16.131.939.316.096/615542|C19.391.119.096/615542|C19.391.829.258/615542	C12.050.351.875.253.096|C12.100.500.829.258|C12.200.294.829.258|C12.200.706.258|C12.200.706.316.096|C12.800.258|C12.800.316.096|C14.240.400|C14.280.400|C16.131.240.400|C16.131.939.258|C16.131.939.316.096|C19.391.119.096|C19.391.829.258	TACHD	Cardiovascular disease|Congenital abnormality|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Testicular Diseases	MESH:D013733	DO:DOID:2519	Pathological processes of the TESTIS.	MESH:D005832|MESH:D006058	C12.100.500.829|C12.200.294.829|C19.391.829	C12.100.500|C12.200.294|C19.391	Diseases, Testicular|Disease, Testicular|Testicular Disease	Endocrine system disease|Urogenital disease (male)
Testicular Germ Cell Tumor	MESH:C563236	DO:DOID:5557|OMIM:273300		MESH:D009373|MESH:D013736	C04.557.465/C563236|C04.588.322.762/C563236|C04.588.945.440.915/C563236|C12.100.500.260.937/C563236|C12.200.294.260.937/C563236|C12.200.758.409.937/C563236|C12.900.619.937/C563236|C19.344.762/C563236|C19.391.829.782/C563236	C04.557.465|C04.588.322.762|C04.588.945.440.915|C12.100.500.260.937|C12.200.294.260.937|C12.200.758.409.937|C12.900.619.937|C19.344.762|C19.391.829.782	EMBRYONAL CELL CARCINOMA, INCLUDED|ENDODERMAL SINUS TUMOR, INCLUDED|MALE GERM CELL TUMOR;MGCT SEMINOMA, INCLUDED|NONSEMINOMATOUS GERM CELL TUMORS, INCLUDED|SPERMATOCYTIC SEMINOMA, INCLUDED|TERATOMA, TESTICULAR, INCLUDED|TGCT	Cancer|Endocrine system disease|Urogenital disease (male)
Testicular Microlithiasis	MESH:C566478	OMIM:610441		MESH:D002137|MESH:D013733	C12.100.500.829/C566478|C12.200.294.829/C566478|C19.391.829/C566478|C23.300.175/C566478	C12.100.500.829|C12.200.294.829|C19.391.829|C23.300.175		Endocrine system disease|Pathology (anatomical condition)|Urogenital disease (male)
Testicular Neoplasms	MESH:D013736	DO:DOID:2998	Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.	MESH:D004701|MESH:D005834|MESH:D013733	C04.588.322.762|C04.588.945.440.915|C12.100.500.260.937|C12.200.294.260.937|C12.200.758.409.937|C12.900.619.937|C19.344.762|C19.391.829.782	C04.588.322|C04.588.945.440|C12.100.500.260|C12.200.294.260|C12.200.758.409|C12.900.619|C19.344|C19.391.829	Cancer of Testis|Cancer of the Testes|Cancer of the Testis|Cancers, Testicular|Cancers, Testis|Cancer, Testicular|Cancer, Testis|Neoplasms, Testicular|Neoplasms, Testis|Neoplasm, Testicular|Neoplasm, Testis|Rete Testis Tumor|Rete Testis Tumors|Testicular Cancer|Testicular Cancers|Testicular Neoplasm|Testicular Tumor|Testicular Tumors|Testis Cancer|Testis Cancers|Testis Neoplasm|Testis Neoplasms|Testis Tumor, Rete|Testis Tumors, Rete|Tumor of Rete Testis|Tumors, Testicular|Tumor, Testicular	Cancer|Endocrine system disease|Urogenital disease (male)
Tetany	MESH:D013746		A disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This condition is associated with unstable depolarization of axonal membranes, primarily in the peripheral nervous system. Tetany usually results from HYPOCALCEMIA or reduced serum levels of MAGNESIUM that may be associated with HYPERVENTILATION; HYPOPARATHYROIDISM; RICKETS; UREMIA; or other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1490)	MESH:D006996|MESH:D020879	C10.597.613.875|C18.452.174.509.700|C23.888.592.608.875	C10.597.613|C18.452.174.509|C23.888.592.608	Neonatal Tetanies|Neonatal Tetany|Spasmophilia|Spasmophilias|Tetanies|Tetanies, Neonatal|Tetanilla|Tetanillas|Tetany, Neonatal	Metabolic disease|Nervous system disease|Signs and symptoms
Tetralogy of Fallot	MESH:D013771	DO:DOID:6419|OMIM:187500	A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.	MESH:D006330	C14.240.400.849|C14.280.400.849|C16.131.240.400.849	C14.240.400|C14.280.400|C16.131.240.400	Fallot's Tetralogy|Fallots Tetralogy|Fallot Tetralogy|Tetralogy, Fallot|Tetralogy, Fallots|Tetralogy, Fallot's|TOF	Cardiovascular disease|Congenital abnormality
Tetralogy of fallot and glaucoma	MESH:C536501			MESH:D005901|MESH:D013771	C11.525.381/C536501|C14.240.400.849/C536501|C14.280.400.849/C536501|C16.131.240.400.849/C536501	C11.525.381|C14.240.400.849|C14.280.400.849|C16.131.240.400.849	Familial tetralogy of fallot and glaucoma	Cardiovascular disease|Congenital abnormality|Eye disease
Tetralogy Of Fallot Syndrome, Autosomal Recessive	MESH:C565314			MESH:D013771	C14.240.400.849/C565314|C14.280.400.849/C565314|C16.131.240.400.849/C565314	C14.240.400.849|C14.280.400.849|C16.131.240.400.849		Cardiovascular disease|Congenital abnormality
Tetraphocomelia-Thrombocytopenia Syndrome	MESH:C564771			MESH:D004480|MESH:D013921	C05.660.585.350/C564771|C15.378.140.855/C564771|C16.131.621.585.350/C564771	C05.660.585.350|C15.378.140.855|C16.131.621.585.350		Blood disease|Congenital abnormality|Musculoskeletal disease
Thalamic degeneration symmetrical infantile	MESH:C536504			MESH:D013786	C10.228.140.915/C536504	C10.228.140.915	Symmetrical infantile thalamic degeneration|Thalamic Degeneration, Symmetric Infantile	Nervous system disease
Thalamic Diseases	MESH:D013786	DO:DOID:4662	Disorders of the centrally located thalamus, which integrates a wide range of cortical and subcortical information. Manifestations include sensory loss, MOVEMENT DISORDERS; ATAXIA, pain syndromes, visual disorders, a variety of neuropsychological conditions, and COMA. Relatively common etiologies include CEREBROVASCULAR DISORDERS; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; BRAIN HYPOXIA; INTRACRANIAL HEMORRHAGES; and infectious processes.	MESH:D001927	C10.228.140.915	C10.228.140	Dejerine Roussy Syndrome|Dejerine-Roussy Syndrome|Diseases, Thalamic|Disease, Thalamic|Syndrome, Dejerine-Roussy|Syndromes, Thalamic|Syndrome, Thalamic|Thalamic Disease|Thalamic Syndrome|Thalamic Syndromes	Nervous system disease
Thecoma	MESH:D013798		A gonadal stromal neoplasm composed only of THECA CELLS, occurring mostly in the postmenopausal OVARY. It is filled with lipid-containing spindle cells and produces ESTROGENS that can lead to ENDOMETRIAL HYPERPLASIA; UTERINE HEMORRHAGE; or other malignancies in postmenopausal women and sexual precocity in girls. When tumors containing theca cells also contain FIBROBLASTS, they are identified as thecoma-fibroma tumors with less active hormone production.	MESH:D010051|MESH:D018312	C04.557.475.750.875|C04.588.322.455.765|C12.050.351.500.056.630.705.765|C12.050.351.937.418.685.765|C12.100.250.056.630.705.765|C12.900.418.685.765|C19.344.410.765|C19.391.630.705.765	C04.557.475.750|C04.588.322.455|C12.050.351.500.056.630.705|C12.050.351.937.418.685|C12.100.250.056.630.705|C12.900.418.685|C19.344.410|C19.391.630.705	Theca Cell Tumor|Theca Cell Tumors|Thecomas|Tumors, Theca Cell|Tumor, Theca Cell	Cancer|Endocrine system disease|Urogenital disease (female)
Thiamine responsive megaloblastic anemia syndrome	MESH:C536510	DO:DOID:0090117|OMIM:249270		MESH:D000749|MESH:D003920|MESH:D006319|MESH:D013832	C09.218.458.341.887/C536510|C10.597.751.418.341.887/C536510|C15.378.071.252.196/C536510|C18.452.394.750/C536510|C18.654.521.500.133.699.827/C536510|C19.246/C536510|C23.888.592.763.393.341.887/C536510	C09.218.458.341.887|C10.597.751.418.341.887|C15.378.071.252.196|C18.452.394.750|C18.654.521.500.133.699.827|C19.246|C23.888.592.763.393.341.887	Abboud syndrome|Megaloblastic Anemia, Thiamine-Responsive, With Diabetes Mellitus And Sensorineural Deafness|Rogers syndrome|THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA, DIABETES MELLITUS, AND DEAFNESS TYPE)|Thiamine-Responsive Anemia Syndrome|Thiamine-Responsive Megaloblastic Anemia Syndrome|Thiamine responsive myelodysplasia|Thiamine-Responsive Myelodysplasia|THMD1|TRMA	Blood disease|Ear-nose-throat disease|Endocrine system disease|Metabolic disease|Nervous system disease|Nutrition disorder|Signs and symptoms
THIOUREA TASTING	OMIM:171200			MESH:D013651	C10.597.751.861/171200|C23.888.592.763.861/171200	C10.597.751.861|C23.888.592.763.861	PHENYLTHIOCARBAMIDE TASTING, INCLUDED|PROP TASTING, INCLUDED|PROPYLTHIOURACIL TASTING, INCLUDED|PTC TASTING, INCLUDED|THIOT	Nervous system disease|Signs and symptoms
Thomas Jewett Raines syndrome	MESH:C536513			MESH:D000015|MESH:D008850|MESH:D014339|MESH:D019066	C11.250.566/C536513|C14.240.400.560.098.500/C536513|C14.280.400.560.098.500/C536513|C16.131.077/C536513|C16.131.240.400.560.098.500/C536513|C16.131.384.666/C536513|C23.550.291.812/C536513	C11.250.566|C14.240.400.560.098.500|C14.280.400.560.098.500|C16.131.077|C16.131.240.400.560.098.500|C16.131.384.666|C23.550.291.812		Cardiovascular disease|Congenital abnormality|Eye disease|Pathology (process)
Thomas syndrome	MESH:C536514			MESH:D000015|MESH:D002971|MESH:D006330	C07.465.409.225/C536514|C07.465.525.164/C536514|C07.650.525.164/C536514|C14.240.400/C536514|C14.280.400/C536514|C16.131.077/C536514|C16.131.240.400/C536514|C16.131.850.525.164/C536514	C07.465.409.225|C07.465.525.164|C07.650.525.164|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.850.525.164		Cardiovascular disease|Congenital abnormality|Mouth disease
Thompson Baraitser syndrome	MESH:C536515			MESH:D011625|MESH:D012131	C08.618.846/C536515|C11.187.781/C536515	C08.618.846|C11.187.781		Eye disease|Respiratory tract disease
Thoracic Diseases	MESH:D013896		Disorders affecting the organs of the thorax.	MESH:D012140	C08.846	C08	Diseases, Thoracic|Disease, Thoracic|Thoracic Disease	Respiratory tract disease
Thoracic Dysostosis, Isolated	MESH:C566063			MESH:D004413	C05.116.099.370/C566063	C05.116.099.370		Musculoskeletal disease
Thoracic Neoplasms	MESH:D013899	DO:DOID:5093	New abnormal growth of tissue in the THORAX.	MESH:D009371	C04.588.894	C04.588	Neoplasms, Thoracic|Neoplasm, Thoracic|Thoracic Neoplasm	Cancer
Thoracic Outlet Syndrome	MESH:D013901	DO:DOID:3103	A neurovascular syndrome associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the superior thoracic outlet. This may result from a variety of anomalies such as a CERVICAL RIB, anomalous fascial bands, and abnormalities of the origin or insertion of the anterior or medial scalene muscles. Clinical features may include pain in the shoulder and neck region which radiates into the arm, PARESIS or PARALYSIS of brachial plexus innervated muscles, PARESTHESIA, loss of sensation, reduction of arterial pulses in the affected extremity, ISCHEMIA, and EDEMA. (Adams et al., Principles of Neurology, 6th ed, pp214-5).	MESH:D009408|MESH:D014652	C10.668.829.550.850|C14.907.863	C10.668.829.550|C14.907	Aperture Syndrome, Thoracic Outlet|Arterial Thoracic Outlet Syndrome|Costoclavicular Syndrome|Costoclavicular Syndromes|Nerve Compression Syndrome, Thoracic Outlet|Neurogenic Thoracic Outlet Syndrome|Neurologic Syndrome, Thoracic Outlet|Neurovascular Syndrome, Thoracic Outlet|Outlet Syndromes, Thoracic|Outlet Syndrome, Thoracic|Scalenus Anticus Syndrome|Superior Thoracic Aperture Syndrome|Syndrome, Costoclavicular|Syndrome, Scalenus Anticus|Syndromes, Costoclavicular|Syndromes, Thoracic Outlet|Syndrome, Thoracic Outlet|Thoracic Outlet Nerve Compression Syndrome|Thoracic Outlet Neurologic Syndrome|Thoracic Outlet Neurovascular Syndrome|Thoracic Outlet Syndrome, Neurogenic|Thoracic Outlet Syndromes|Venous Thoracic Outlet Syndrome	Cardiovascular disease|Nervous system disease
Thoracopelvic Dysostosis	MESH:C566062			MESH:D004413	C05.116.099.370/C566062	C05.116.099.370		Musculoskeletal disease
Thromboangiitis Obliterans	MESH:D013919	DO:DOID:12918	A non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities. It is characterized by occlusive THROMBOSIS and FIBROSIS in the vascular wall leading to digital and limb ISCHEMIA and ulcerations. Thromboangiitis obliterans is highly associated with tobacco smoking.	MESH:D001157|MESH:D014657	C14.907.137.870|C14.907.940.905	C14.907.137|C14.907.940	Buerger Disease|Buerger's Disease|Buergers Disease|Disease, Buerger|Disease, Buerger's|Thromboangitis Obliterans	Cardiovascular disease
Thrombocythemia, Essential	MESH:D013920	DO:DOID:2224	A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.	MESH:D001778|MESH:D006474|MESH:D013922	C15.378.100.832|C15.378.140.860.800|C15.378.190.636.860.800|C15.378.463.825	C15.378.100|C15.378.140.860|C15.378.190.636.860|C15.378.463	Autosomal Dominant Thrombocytoses|Autosomal Dominant Thrombocytosis|Dominant Thrombocytoses, Autosomal|Dominant Thrombocytosis, Autosomal|Essential Thrombocythemia|Essential Thrombocythemias|Hemorrhagic Thrombocythemia|Hemorrhagic Thrombocythemias|Idiopathic Thrombocythemia|Idiopathic Thrombocythemias|Primary Thrombocythemia|Primary Thrombocythemias|Primary Thrombocytoses|Primary Thrombocytosis|Thrombocythemia, Hemorrhagic|Thrombocythemia, Idiopathic|Thrombocythemia, Primary|Thrombocythemias, Essential|Thrombocythemias, Hemorrhagic|Thrombocythemias, Idiopathic|Thrombocythemias, Primary|Thrombocytoses, Autosomal Dominant|Thrombocytoses, Primary|Thrombocytosis, Autosomal Dominant|Thrombocytosis, Primary	Blood disease
Thrombocytopenia	MESH:D013921	DO:DOID:1588	A subnormal level of BLOOD PLATELETS.	MESH:D001791	C15.378.140.855	C15.378.140	Thrombocytopenias|Thrombopenia|Thrombopenias	Blood disease
THROMBOCYTOPENIA 2	OMIM:188000	DO:DOID:1588		MESH:D013921	C15.378.140.855/188000	C15.378.140.855	THC2|THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 2	Blood disease
Thrombocytopenia 3	MESH:C567487	OMIM:273900		MESH:D013921	C15.378.140.855/C567487	C15.378.140.855	THC3|Thrombocytopenia, Autosomal Recessive, 3	Blood disease
Thrombocytopenia 4	MESH:C567438	OMIM:612004		MESH:D013921	C15.378.140.855/C567438	C15.378.140.855	THC4|Thrombocytopenia, Autosomal Dominant, 4	Blood disease
THROMBOCYTOPENIA 5	OMIM:616216			MESH:D013921	C15.378.140.855/616216	C15.378.140.855	THC5|THROMBOCYTOPENIA 5 WITH INCREASED SUSCEPTIBILITY TO MALIGNANCY|THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 5	Blood disease
THROMBOCYTOPENIA 6	OMIM:616937			MESH:D013921	C15.378.140.855/616937	C15.378.140.855	THC6|THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 6	Blood disease
Thrombocytopenia absent ulnar syndrome	MESH:C536944			MESH:D013921	C15.378.140.855/C536944	C15.378.140.855		Blood disease
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS	OMIM:617441			MESH:C536848|MESH:D000740|MESH:D013921	C15.378.071/617441|C15.378.140.855/617441|C15.378.190.636.765/C536848/617441	C15.378.071|C15.378.140.855|C15.378.190.636.765/C536848	THAMY	Blood disease
Thrombocytopenia, cyclic	MESH:C536899			MESH:D013921	C15.378.140.855/C536899	C15.378.140.855		Blood disease
Thrombocytopenia, Neonatal Alloimmune	MESH:D054098		A condition in newborns caused by immunity of the mother to PLATELET ALLOANTIGENS on the fetal platelets. The PLATELETS, coated with maternal ANTIBODIES, are destroyed and removed by the fetal MONONUCLEAR PHAGOCYTE SYSTEM. Affected infants may have INTRACRANIAL HEMORRHAGES.	MESH:D007232|MESH:D013921	C15.378.140.855.850|C16.614.899	C15.378.140.855|C16.614	Alloimmune Thrombocytopenia, Neonatal|Alloimmune Thrombocytopenias, Neonatal|Neonatal Alloimmune Thrombocytopenia|Neonatal Alloimmune Thrombocytopenias|Neonatal Thrombocytopenia|Neonatal Thrombocytopenias|Thrombocytopenia, Neonatal|Thrombocytopenias, Neonatal|Thrombocytopenias, Neonatal Alloimmune	Blood disease|Infant-newborn disease
Thrombocytopenia Robin sequence	MESH:C536898			MESH:D006130|MESH:D010855|MESH:D013921|MESH:D019066|MESH:D061085	C05.500.460.606/C536898|C05.660.207.540.460.606/C536898|C07.320.440.606/C536898|C07.650.500.460.606/C536898|C10.500.034/C536898|C15.378.140.855/C536898|C16.131.621.207.540.460.606/C536898|C16.131.666.034/C536898|C16.131.850.500.460.606/C536898|C23.300.008/C536898|C23.550.291.812/C536898|C23.550.393/C536898	C05.500.460.606|C05.660.207.540.460.606|C07.320.440.606|C07.650.500.460.606|C10.500.034|C15.378.140.855|C16.131.621.207.540.460.606|C16.131.666.034|C16.131.850.500.460.606|C23.300.008|C23.550.291.812|C23.550.393	Braddock Carey syndrome	Blood disease|Congenital abnormality|Mouth disease|Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)|Pathology (process)
Thrombocytopenia with Elevated Serum Iga and Renal Disease	MESH:C564051			MESH:D007674|MESH:D013921	C12.050.351.968.419/C564051|C12.200.777.419/C564051|C12.950.419/C564051|C15.378.140.855/C564051	C12.050.351.968.419|C12.200.777.419|C12.950.419|C15.378.140.855		Blood disease|Urogenital disease (female)|Urogenital disease (male)
Thrombocytosis	MESH:D013922	DO:DOID:2228|OMIM:187950|OMIM:601977|OMIM:614521	Increased numbers of platelets in the peripheral blood. (Dorland, 27th ed)	MESH:D001791|MESH:D009196	C15.378.140.860|C15.378.190.636.860	C15.378.140|C15.378.190.636	THCYT1|THCYT2|THCYT3|Thrombocythemia|THROMBOCYTHEMIA 1|THROMBOCYTHEMIA 2|THROMBOCYTHEMIA 3|Thrombocythemias|Thrombocytoses|THROMBOCYTOSIS 1|THROMBOCYTOSIS 3	Blood disease
Thrombocytosis, Benign Familial Microcytic	MESH:C566596			MESH:D013922	C15.378.140.860/C566596|C15.378.190.636.860/C566596	C15.378.140.860|C15.378.190.636.860		Blood disease
Thromboembolism	MESH:D013923		Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.	MESH:D016769	C14.907.355.590	C14.907.355	Thromboembolisms	Cardiovascular disease
Thromboinflammation	MESH:D000090882		Thrombosis with associated inflammation due to crosstalk between HEMOSTASIS and INNATE IMMUNE RESPONSES modulated by PLATELETS. It is associated with many diseases such as COVID-19; SICKLE CELL ANEMIA; and THROMBOPHLEBITIS.	MESH:D001778|MESH:D007249|MESH:D013927	C14.907.355.830.749|C15.378.100.876|C23.550.470.895	C14.907.355.830|C15.378.100|C23.550.470	Immunothrombosis	Blood disease|Cardiovascular disease|Pathology (process)
Thrombomodulin anomalies, familial	MESH:C536900			MESH:D019851	C15.378.925/C536900	C15.378.925		Blood disease
Thrombophilia	MESH:D019851	DO:DOID:2452|OMIM:188050	A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.	MESH:D006402	C15.378.925	C15.378	Hypercoagulabilities|Hypercoagulability|THPH1|THROMBOPHILIA DUE TO FACTOR 2 DEFECT|THROMBOPHILIA DUE TO THROMBIN DEFECT|Thrombophilias|VENOUS THROMBOEMBOLISM THROMBOSIS, PROTECTION AGAINST, INCLUDED|VENOUS THROMBOSIS	Blood disease
Thrombophilia Due To Elevated Histidine-Rich Glycoprotein	MESH:C567737	OMIM:613116		MESH:D019851	C15.378.925/C567737	C15.378.925	THPH11|THROMBOPHILIA DUE TO ELEVATED HISTIDINE-RICH GLYCOPROTEIN, INCLUDED|Thrombophilia Due To Histidine-Rich Glycoprotein Deficiency	Blood disease
Thrombophilia due to Thrombomodulin Defect	MESH:C566057	DO:DOID:0111908|OMIM:614486		MESH:D019851	C15.378.925/C566057	C15.378.925	THPH12	Blood disease
Thrombophilia, Familial, Due To Decreased Release Of Tissue Plasminogen Activator	MESH:C567341	DO:DOID:0111906		MESH:D019851	C15.378.925/C567341	C15.378.925	Hyperfibrinolysis, Familial, Due To Increased Release Of Tissue Plasminogen Activator	Blood disease
THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR;THPH9 HYPERFIBRINOLYSIS, FAMILIAL, DUE TO INCREASED RELEASE OF TISSUE PLASMINOGEN	OMIM:612348	DO:DOID:0111906		MESH:D019851	C15.378.925/612348	C15.378.925	ACTIVATOR, INCLUDED	Blood disease
Thrombophilia, hereditary	MESH:C540694			MESH:D019851	C15.378.925/C540694	C15.378.925		Blood disease
Thrombophilia, Hereditary, Due To Protein S Deficiency, Autosomal Dominant	MESH:C567347	OMIM:612336		MESH:D018455	C15.378.100.800/C567347|C15.378.147.890/C567347|C15.378.925.800/C567347	C15.378.100.800|C15.378.147.890|C15.378.925.800	THPH5|THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	Blood disease
Thrombophilia, Hereditary, Due To Protein S Deficiency, Autosomal Recessive	MESH:C567348	OMIM:614514		MESH:D018455	C15.378.100.800/C567348|C15.378.147.890/C567348|C15.378.925.800/C567348	C15.378.100.800|C15.378.147.890|C15.378.925.800	THPH6|THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE	Blood disease
Thrombophlebitis	MESH:D013924	DO:DOID:3875	Inflammation of a vein associated with a blood clot (THROMBUS).	MESH:D010689|MESH:D020246	C14.907.355.830.925.770|C14.907.617.718.788|C14.907.940.740.910	C14.907.355.830.925|C14.907.617.718|C14.907.940.740	Dolens, Phlegmasia Alba|Phlegmasia Alba Dolens|Thrombophlebitides	Cardiovascular disease
Thrombosis	MESH:D013927	DO:DOID:0060903	Formation and development of a thrombus or blood clot in the blood vessel.	MESH:D016769	C14.907.355.830	C14.907.355	Blood Clot|Blood Clots|Clot, Blood|Clots, Blood|Thromboses|Thrombus	Cardiovascular disease
Thrombotic Microangiopathies	MESH:D057049		Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.	MESH:D013921	C15.378.140.855.925	C15.378.140.855	Microangiopathies, Thrombotic|Microangiopathy, Thrombotic|Thrombotic Microangiopathy	Blood disease
Thrombotic Stroke	MESH:D000083244		A type of ischemic stroke resulting from obstruction due to a BLOOD CLOT formed within in a CEREBRAL ARTERY often associated with ATHEROSCLEROSIS. A stroke due to a blood clot in a cerebral vein is a venous infarction (see VENOUS INFARCTION, BRAIN).	MESH:D000083242	C10.228.140.300.775.400.750|C14.907.253.855.400.750	C10.228.140.300.775.400|C14.907.253.855.400	Acute Thrombotic Stroke|Acute Thrombotic Strokes|Stroke, Acute Thrombotic|Stroke, Thrombotic|Thrombotic Stroke, Acute|Thrombotic Strokes	Cardiovascular disease|Nervous system disease
Thrombotic thrombocytopenic purpura, acquired	MESH:C536901			MESH:D011697	C15.378.100.802.687.680/C536901|C15.378.140.855.925.750.680/C536901|C15.378.925.850/C536901|C23.550.414.950.687.680/C536901|C23.888.885.687.687.680/C536901	C15.378.100.802.687.680|C15.378.140.855.925.750.680|C15.378.925.850|C23.550.414.950.687.680|C23.888.885.687.687.680	Idiopathic thrombotic thrombocytopenic purpura|Moschowitz syndrome	Blood disease|Pathology (process)|Signs and symptoms
Thromboxane Synthetase Deficiency	MESH:C562866	OMIM:614158		MESH:D001778|MESH:D001791	C15.378.100/C562866|C15.378.140/C562866	C15.378.100|C15.378.140	BDPLT14|BLEEDING DISORDER, PLATELET-TYPE, 14|THROMBOXANE SYNTHETASE DEFICIENCY	Blood disease
Thumb deformity	MESH:C536903			MESH:D006226	C05.390/C536903	C05.390	Thumb absent or hypoplastic|Thumb hypoplastic	Musculoskeletal disease
Thumb Deformity And Alopecia	MESH:C566054			MESH:D000505	C17.800.329.937.122/C566054|C23.300.035/C566054	C17.800.329.937.122|C23.300.035		Pathology (anatomical condition)|Skin disease
Thymic aplasia	MESH:C536288			MESH:D007153	C20.673/C536288	C20.673	Immune Defect Due To Absence Of Thymus|Nezelof syndrome	Immune system disease
Thymic epithelial tumor	MESH:C536905			MESH:D009375|MESH:D013953	C04.557.470/C536905|C04.588.894.949/C536905|C15.604.861/C536905	C04.557.470|C04.588.894.949|C15.604.861	Epithelial tumor of thymus|Thymoma, adult	Cancer|Lymphatic disease
Thymoma	MESH:D013945	DO:DOID:3275|DO:DOID:3284	A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)	MESH:D013953|MESH:D018193	C04.557.435.850|C04.588.894.949.500|C15.604.861.800	C04.557.435|C04.588.894.949|C15.604.861	Carcinomas, Thymic|Carcinoma, Thymic|Thymic Carcinoma|Thymic Carcinomas|Thymomas	Cancer|Lymphatic disease
Thymoma, Familial	MESH:C564767	OMIM:274230		MESH:D013945	C04.557.435.850/C564767|C04.588.894.949.500/C564767|C15.604.861.800/C564767	C04.557.435.850|C04.588.894.949.500|C15.604.861.800	Thymic Neoplasia	Cancer|Lymphatic disease
Thymus Hyperplasia	MESH:D013952		Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis. (From Segen, Dictionary of Modern Medicine, 1992; Cecil Textbook of Medicine, 19th ed, p1486)	MESH:D008206	C15.604.816	C15.604	Gland Hyperplasias, Thymus|Gland Hyperplasia, Thymus|Hyperplasia of Thymus Gland|Hyperplasias, Thymic|Hyperplasia, Thymic|Hyperplasia, Thymus|Thymic Hyperplasia|Thymic Hyperplasias|Thymus Gland Hyperplasia|Thymus Gland Hyperplasias	Lymphatic disease
Thymus Neoplasms	MESH:D013953	DO:DOID:3277	Tumors or cancer of the THYMUS GLAND.	MESH:D008206|MESH:D013899	C04.588.894.949|C15.604.861	C04.588.894|C15.604	Cancer of the Thymus|Cancer of Thymus|Cancers, Thymic|Cancers, Thymus|Cancer, Thymic|Cancer, Thymus|Neoplasms, Thymic|Neoplasms, Thymus|Neoplasm, Thymic|Neoplasm, Thymus|Thymic Cancer|Thymic Cancers|Thymic Neoplasm|Thymic Neoplasms|Thymic Tumor|Thymic Tumors|Thymus Cancer|Thymus Cancers|Thymus Neoplasm|Thymus Tumor|Thymus Tumors|Tumors, Thymic|Tumors, Thymus|Tumor, Thymic|Tumor, Thymus	Cancer|Lymphatic disease
Thyrocerebral-retinal syndrome	MESH:C536908			MESH:D001927|MESH:D007674|MESH:D013959	C10.228.140/C536908|C12.050.351.968.419/C536908|C12.200.777.419/C536908|C12.950.419/C536908|C19.874/C536908	C10.228.140|C12.050.351.968.419|C12.200.777.419|C12.950.419|C19.874	Thyrocerebroretinal syndrome	Endocrine system disease|Nervous system disease|Urogenital disease (female)|Urogenital disease (male)
Thyroglossal Cyst	MESH:D013955		A cyst in the neck caused by persistence of portions of, or by lack of closure of, the primitive thyroglossal duct. (Dorland, 27th ed)	MESH:D003560	C04.182.902	C04.182	Cysts, Thyroglossal|Cysts, Thyroglossal Duct|Cysts, Thyrolingual|Cyst, Thyroglossal|Cyst, Thyroglossal Duct|Cyst, Thyrolingual|Thyroglossal Cysts|Thyroglossal Duct Cyst|Thyroglossal Duct Cysts|Thyrolingual Cyst|Thyrolingual Cysts	Cancer
Thyroglossal tract cyst	MESH:C536909			MESH:D013955	C04.182.902/C536909	C04.182.902	Familial thyroglossal duct cyst|Hereditary thyroglossal duct cysts|Thyroglossal Duct Cyst, Familial|Thyroglossal duct cysts familial	Cancer
Thyroid cancer, follicular	MESH:C572845	OMIM:188470		MESH:D018263	C04.557.470.200.025.060/C572845	C04.557.470.200.025.060	NMTC2|THYROID CANCER, NONMEDULLARY, 2	Cancer
Thyroid cancer, Hurthle cell	MESH:C536913	DO:DOID:8161|OMIM:607464		MESH:D013964|MESH:D018249	C04.557.470.035.140/C536913|C04.588.322.894/C536913|C04.588.443.915/C536913|C19.344.894/C536913|C19.874.788/C536913	C04.557.470.035.140|C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788	Follicular thyroid cancer, Hurthle cell type|Hurthle cell carcinoma of the thyroid|Hurthle Cell Thyroid Neoplasia|Thyroid cancer, follicular, Hurthle cell type|Thyroid carcinoma, Hurthle cell	Cancer|Endocrine system disease
Thyroid cancer, medullary	MESH:C536914	DO:DOID:3973		MESH:D013964|MESH:D018278	C04.557.465.625.650.240/C536914|C04.557.470.200.025.370/C536914|C04.557.580.625.650.240/C536914|C04.588.322.894/C536914|C04.588.443.915/C536914|C19.344.894/C536914|C19.874.788/C536914	C04.557.465.625.650.240|C04.557.470.200.025.370|C04.557.580.625.650.240|C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788	Medullary thyroid cancer (MTC)|Thyroid carcinoma, medullary	Cancer|Endocrine system disease
THYROID CANCER, NONMEDULLARY, 4	OMIM:616534			MESH:D013964	C04.588.322.894/616534|C04.588.443.915/616534|C19.344.894/616534|C19.874.788/616534	C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788	NMTC4	Cancer|Endocrine system disease
THYROID CANCER, NONMEDULLARY, 5	OMIM:616535			MESH:D013964	C04.588.322.894/616535|C04.588.443.915/616535|C19.344.894/616535|C19.874.788/616535	C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788	NMTC5	Cancer|Endocrine system disease
Thyroid Cancer, Papillary	MESH:D000077273	DO:DOID:3969|OMIM:188550	An ADENOCARCINOMA that originates from follicular cells of the THYROID GLAND and accounts for the majority of THYROID CANCER cases. Cells exhibit enlarged, oval, or elongated morphologies with clear, round, nuclei. Fusions of RET, NTRK1, TPM3, and PCM1 genes are associated with this cancer.	MESH:D000231|MESH:D013964	C04.557.470.200.025.085.612|C04.588.322.894.400|C04.588.443.915.400|C19.344.894.400|C19.874.788.400	C04.557.470.200.025.085|C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788	Cancer, Papillary Thyroid|Cancers, Papillary Thyroid|Carcinoma, Nonmedullary Thyroid|Carcinoma, Papillary Thyroid|Carcinomas, Nonmedullary Thyroid|Carcinomas, Papillary Thyroid|Familial Nonmedullary Thyroid Cancer|FAMILIAL NONMEDULLARY THYROID CANCER, PAPILLARY|NMTC1|Nonmedullary Thyroid Carcinoma|NONMEDULLARY THYROID CARCINOMA, PAPILLARY|Nonmedullary Thyroid Carcinomas|PACT|Papillary Carcinoma Of Thyroid|Papillary Thyroid Cancer|Papillary Thyroid Cancers|Papillary Thyroid Carcinoma|Papillary Thyroid Carcinomas|PTC|THYROID CANCER, NONMEDULLARY, 1|Thyroid Cancers, Papillary|Thyroid Carcinoma, Nonmedullary|Thyroid Carcinoma, Papillary|Thyroid Carcinomas, Nonmedullary|Thyroid Carcinomas, Papillary|TPC	Cancer|Endocrine system disease
Thyroid Carcinoma, Anaplastic	MESH:D065646		An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It is associated with CELL DEDIFFERENTIATION of THYROID CARCINOMA (e.g., FOLLICULAR THYROID CARCINOMA; PAPILLARY THYROID CANCER). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with DYSPHAGIA; NECK PAIN; bone pain; DYSPNEA; and NEUROLOGIC DEFICITS.	MESH:D002277	C04.557.470.200.725	C04.557.470.200	Anaplastic Thyroid Cancer|Anaplastic Thyroid Cancers|Anaplastic Thyroid Carcinoma|Anaplastic Thyroid Carcinomas|Cancer, Anaplastic Thyroid|Cancers, Anaplastic Thyroid|Carcinoma, Anaplastic Thyroid|Carcinomas, Anaplastic Thyroid|Thyroid Cancer, Anaplastic|Thyroid Cancers, Anaplastic|Thyroid Carcinomas, Anaplastic	Cancer
Thyroid Carcinoma, Nonmedullary 1	MESH:C565247	OMIM:606240		MESH:D013964	C04.588.322.894/C565247|C04.588.443.915/C565247|C19.344.894/C565247|C19.874.788/C565247	C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788	NMTC1, FORMERLY|NMTC3|Nonmedullary Thyroid Carcinoma 1|THYROID CANCER, NONMEDULLARY, 1, FORMERLY|THYROID CANCER, NONMEDULLARY, 3	Cancer|Endocrine system disease
Thyroid Carcinoma, Papillary, With Papillary Renal Neoplasia	MESH:C565310	OMIM:605642		MESH:D002291|MESH:D002292|MESH:D013964	C04.557.470.200.025.390/C565310|C04.557.470.200.360/C565310|C04.557.470.700.360/C565310|C04.588.322.894/C565310|C04.588.443.915/C565310|C04.588.945.947.535.160/C565310|C12.050.351.937.820.535.160/C565310|C12.050.351.968.419.473.160/C565310|C12.200.758.820.750.160/C565310|C12.200.777.419.473.160/C565310|C12.900.820.535.160/C565310|C12.950.419.473.160/C565310|C12.950.983.535.160/C565310|C19.344.894/C565310|C19.874.788/C565310	C04.557.470.200.025.390|C04.557.470.200.360|C04.557.470.700.360|C04.588.322.894|C04.588.443.915|C04.588.945.947.535.160|C12.050.351.937.820.535.160|C12.050.351.968.419.473.160|C12.200.758.820.750.160|C12.200.777.419.473.160|C12.900.820.535.160|C12.950.419.473.160|C12.950.983.535.160|C19.344.894|C19.874.788	PRN1|PTCPRN	Cancer|Endocrine system disease|Urogenital disease (female)|Urogenital disease (male)
Thyroiditis, Autoimmune	MESH:D013967	DO:DOID:7188|OMIM:608173|OMIM:608174|OMIM:608175|OMIM:608176	Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis.	MESH:D001327|MESH:D013966	C19.874.871.102|C20.111.809	C19.874.871|C20.111	AITD1|AITD2|AITD3|AITD4|AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 1|AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2|AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3|AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 4|Autoimmune Thyroiditides|Autoimmune Thyroiditis|Lymphocytic Thyroiditides|Lymphocytic Thyroiditis|Lymphomatous Thyroiditides|Lymphomatous Thyroiditis|Thyroiditides, Autoimmune|Thyroiditides, Lymphocytic|Thyroiditides, Lymphomatous|Thyroiditis, Lymphocytic|Thyroiditis, Lymphomatous	Endocrine system disease|Immune system disease
Thyroid Neoplasms	MESH:D013964	DO:DOID:1781|DO:DOID:2891|DO:DOID:3963	Tumors or cancer of the THYROID GLAND.	MESH:D004701|MESH:D006258|MESH:D013959	C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788	C04.588.322|C04.588.443|C19.344|C19.874	Adenomas, Thyroid|Adenoma, Thyroid|Cancer of the Thyroid|Cancer of Thyroid|Cancers, Thyroid|Cancer, Thyroid|Carcinomas, Thyroid|Carcinoma, Thyroid|Neoplasms, Thyroid|Neoplasm, Thyroid|Thyroid Adenoma|Thyroid Adenomas|Thyroid Cancer|Thyroid Cancers|Thyroid Carcinoma|Thyroid Carcinomas|Thyroid Neoplasm	Cancer|Endocrine system disease
Thyroid Nodule	MESH:D016606		A small circumscribed mass in the THYROID GLAND that can be of neoplastic growth or non-neoplastic abnormality. It lacks a well-defined capsule or glandular architecture. Thyroid nodules are often benign but can be malignant. The growth of nodules can lead to a multinodular goiter (GOITER, NODULAR).	MESH:D013964	C04.588.322.894.800|C04.588.443.915.800|C19.344.894.800|C19.874.788.800	C04.588.322.894|C04.588.443.915|C19.344.894|C19.874.788	Nodules, Thyroid|Nodule, Thyroid|Thyroid Nodules	Cancer|Endocrine system disease
Tibia, Absence of, with Congenital Deafness	MESH:C564764			MESH:D003638	C09.218.458.341.186/C564764|C10.597.751.418.341.186/C564764|C23.888.592.763.393.341.186/C564764	C09.218.458.341.186|C10.597.751.418.341.186|C23.888.592.763.393.341.186		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Tibia, Absence or Hypoplasia of, with Polydactyly, Retrocerebellar Arachnoid Cyst, and Other Anomalies	MESH:C563403			MESH:D000015|MESH:D016080|MESH:D017689	C04.182.044/C563403|C04.588.614.250.387.100/C563403|C05.660.585.600/C563403|C10.500.142.100/C563403|C10.551.240.375.100/C563403|C16.131.077/C563403|C16.131.621.585.600/C563403|C16.131.666.142.100/C563403	C04.182.044|C04.588.614.250.387.100|C05.660.585.600|C10.500.142.100|C10.551.240.375.100|C16.131.077|C16.131.621.585.600|C16.131.666.142.100		Cancer|Congenital abnormality|Musculoskeletal disease|Nervous system disease
Tibia absent polydactyly arachnoid cyst	MESH:C536918			MESH:D016080|MESH:D017689	C04.182.044/C536918|C04.588.614.250.387.100/C536918|C05.660.585.600/C536918|C10.500.142.100/C536918|C10.551.240.375.100/C536918|C16.131.621.585.600/C536918|C16.131.666.142.100/C536918	C04.182.044|C04.588.614.250.387.100|C05.660.585.600|C10.500.142.100|C10.551.240.375.100|C16.131.621.585.600|C16.131.666.142.100		Cancer|Congenital abnormality|Musculoskeletal disease|Nervous system disease
Tibial Neuropathy	MESH:D020429	DO:DOID:1187	Disease of the TIBIAL NERVE (also referred to as the posterior tibial nerve). The most commonly associated condition is the TARSAL TUNNEL SYNDROME. However, LEG INJURIES; ISCHEMIA; and inflammatory conditions (e.g., COLLAGEN DISEASES) may also affect the nerve. Clinical features include PARALYSIS of plantar flexion, ankle inversion and toe flexion as well as loss of sensation over the sole of the foot. (From Joynt, Clinical Neurology, 1995, Ch51, p32)	MESH:D020422	C10.668.829.500.700	C10.668.829.500	Internal Popliteal Neuropathies|Internal Popliteal Neuropathy|Lateral Plantar Neuropathies|Lateral Plantar Neuropathy|Medial Plantar Nerve Disease|Medial Plantar Neuropathies|Medial Plantar Neuropathy|Medial Popliteal Neuropathies|Medial Popliteal Neuropathy|Nerve Diseases, Tibial|Nerve Disease, Tibial|Neuropathies, Internal Popliteal|Neuropathies, Lateral Plantar|Neuropathies, Medial Plantar|Neuropathies, Medial Popliteal|Neuropathies, Posterior Tibial|Neuropathies, Tibial|Neuropathy, Internal Popliteal|Neuropathy, Lateral Plantar|Neuropathy, Medial Plantar|Neuropathy, Medial Popliteal|Neuropathy, Posterior Tibial|Neuropathy, Post-Traumatic Tibial|Neuropathy, Tibial|Plantar Neuropathy, Lateral|Plantar Neuropathy, Medial|Popliteal Neuropathies, Internal|Popliteal Neuropathies, Medial|Popliteal Neuropathy, Internal|Popliteal Neuropathy, Medial|Posterior Tibial Nerve Diseases|Posterior Tibial Neuropathies|Posterior Tibial Neuropathy|Post-Traumatic Tibial Neuropathies|Post-Traumatic Tibial Neuropathy|Tibial Nerve Disease|Tibial Nerve Diseases|Tibial Neuropathies|Tibial Neuropathies, Posterior|Tibial Neuropathies, Post-Traumatic|Tibial Neuropathy, Posterior|Tibial Neuropathy, Post Traumatic|Tibial Neuropathy, Post-Traumatic	Nervous system disease
Tick-Borne Diseases	MESH:D017282		Bacterial, viral, or parasitic diseases transmitted to humans and animals by the bite of infected ticks. The families Ixodidae and Argasidae contain many bloodsucking species that are important pests of man and domestic birds and mammals and probably exceed all other arthropods in the number and variety of disease agents they transmit. Many of the tick-borne diseases are zoonotic.	MESH:D000079426	C01.920.930	C01.920	Borne Diseases, Tick|Borne Disease, Tick|Diseases, Tick Borne|Diseases, Tick-Borne|Disease, Tick Borne|Disease, Tick-Borne|Infections, Tick Borne|Infections, Tick-Borne|Infection, Tick-Borne|Tick Borne Disease|Tick-Borne Disease|Tick Borne Diseases|Tick Borne Infection|Tick-Borne Infection|Tick Borne Infections|Tick-Borne Infections	
Tick Paralysis	MESH:D013985	DO:DOID:11285	Paralysis caused by a neurotropic toxin secreted by the salivary glands of ticks.	MESH:D013986	C25.723.127.789.500.707	C25.723.127.789.500	Paralyses, Tick|Paralysis, Tick|Tick Paralyses	
Tick Toxicoses	MESH:D013986		Toxicoses caused by toxic substances secreted by the salivary glands of ticks; include tick paralysis (neurotropic toxin), sweating sickness (dermotropic toxin), and Rhipicephalus appendiculatus toxicosis (leukotropic toxin).	MESH:D064927	C25.723.127.789.500	C25.723.127.789	Toxicoses, Tick	
Tics	MESH:D020323		Habitual, repeated, rapid contraction of certain muscles, resulting in stereotyped individualized actions that can be voluntarily suppressed for only brief periods. They often involve the face, vocal cords, neck, and less often the extremities. Examples include repetitive throat clearing, vocalizations, sniffing, pursing the lips, and excessive blinking. Tics tend to be aggravated by emotional stress. When frequent they may interfere with speech and INTERPERSONAL RELATIONS. Conditions which feature frequent and prominent tics as a primary manifestation of disease are referred to as TIC DISORDERS. (From Adams et al., Principles of Neurology, 6th ed, pp109-10)	MESH:D020820	C10.597.350.700|C23.888.592.350.700	C10.597.350|C23.888.592.350	Chorea, Habit|Choreas, Habit|Gestural Tic|Gestural Tics|Habit Chorea|Habit Choreas|Habit Spasm|Habit Spasms|Habituation Spasm|Habituation Spasms|Motor Tic|Motor Tics|Spasm, Habit|Spasm, Habituation|Spasms, Habit|Spasms, Habituation|Tic|Tic, Gestural|Tic, Motor|Tics, Gestural|Tics, Motor|Tics, Transient|Tics, Vocal|Tic, Transient|Tic, Vocal|Transient Tic|Transient Tics|Vocal Tic|Vocal Tics	Nervous system disease|Signs and symptoms
Timothy syndrome	MESH:C536962	DO:DOID:0060173|OMIM:601005		MESH:D001321|MESH:D008133|MESH:D013576	C05.116.099.370.894.819/C536962|C05.660.585.800/C536962|C05.660.906.819/C536962|C14.280.067.565/C536962|C14.280.123.625/C536962|C16.131.240.400.715/C536962|C16.131.621.585.800/C536962|C16.131.621.906.819/C536962|C23.550.073.547/C536962|F03.625.164.113.500/C536962	C05.116.099.370.894.819|C05.660.585.800|C05.660.906.819|C14.280.067.565|C14.280.123.625|C16.131.240.400.715|C16.131.621.585.800|C16.131.621.906.819|C23.550.073.547|F03.625.164.113.500	Long Qt Syndrome 8|Long QT syndrome with syndactyly|TS	Cardiovascular disease|Congenital abnormality|Mental disorder|Musculoskeletal disease|Pathology (process)
Tinnitus	MESH:D014012		A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.	MESH:D006311	C09.218.458.670|C10.597.751.418.670|C23.888.592.763.393.670	C09.218.458|C10.597.751.418|C23.888.592.763.393	Clicking Tinnitus|Induced Tinnitus, Noise|Leudet's Tinnitus|Leudet Tinnitus|Noise Induced Tinnitus|Objective Tinnitus|Pulsatile Tinnitus|Ringing Buzzing Tinnitus|Ringing-Buzzing-Tinnitus|Spontaneous Oto Acoustic Emission Tinnitus|Spontaneous Oto-Acoustic Emission Tinnitus|Subjective Tinnitus|Tensor Palatini Induced Tinnitus|Tensor Tympani Induced Tinnitus|Tinnitus, Clicking|Tinnitus, Leudet|Tinnitus, Leudets|Tinnitus, Leudet's|Tinnitus, Noise Induced|Tinnitus, Objective|Tinnitus of Vascular Origin|Tinnitus, Pulsatile|Tinnitus, Spontaneous Oto Acoustic Emission|Tinnitus, Spontaneous Oto-Acoustic Emission|Tinnitus, Subjective|Tinnitus, Tensor Palatini Induced|Tinnitus, Tensor Tympani Induced|Tinnitus, Vascular Origin|Vascular Origin Tinnitus	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
T-Lymphocytopenia	MESH:C536783			MESH:D008231	C15.378.553.546.605/C536783|C20.673.627/C536783	C15.378.553.546.605|C20.673.627		Blood disease|Immune system disease
T-Lymphocytopenia, Idiopathic CD4-Positive	MESH:D018344	DO:DOID:3109|OMIM:615518	Reproducible depletion of CD4+ lymphocytes below 300 per cubic millimeter in the absence of HIV infection or other known causes of immunodeficiency. This is a rare, heterogeneous syndrome and does not appear to be caused by a transmissible agent.	MESH:D008231	C15.378.553.546.605.800|C20.673.627.800	C15.378.553.546.605|C20.673.627	CD4 Positive T Lymphocytopenia, Idiopathic|CD4-Positive T-Lymphocytopenia, Idiopathic|CD4+ T Lymphocytopenia|CD4+ T-Lymphocytopenia|CD4+ T Lymphocytopenia, Idiopathic|CD4+ T-Lymphocytopenia, Idiopathic|CD4+ T-Lymphocytopenias|ICL|IDIOPATHIC CD4 LYMPHOPENIA|Idiopathic CD4 Positive T-Lymphocytopenia|Idiopathic CD4-Positive T-Lymphocytopenia|Idiopathic CD4+ T Lymphocytopenia|Idiopathic CD4+ T-Lymphocytopenia|IMD13|IMMUNODEFICIENCY 13|T-Lymphocytopenia, CD4+|T Lymphocytopenia, Idiopathic CD4+|T-Lymphocytopenia, Idiopathic CD4+|T Lymphocytopenia, Idiopathic CD4 Positive|T-Lymphocytopenias, CD4+	Blood disease|Immune system disease
Tn Syndrome	MESH:C562719	OMIM:300622		MESH:D001327	C20.111/C562719	C20.111	Galactosyltransferase Deficiency|TN POLYAGGLUTINATION SYNDROME|TNPS	Immune system disease
Toenail Dystrophy, Isolated	MESH:C564384	OMIM:607523		MESH:D009260|MESH:D009264	C17.800.529/C564384|C23.300.820/C564384	C17.800.529|C23.300.820	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8|NDNC8|TOENAIL DYSTROPHY, ISOLATED	Pathology (anatomical condition)|Skin disease
Togaviridae Infections	MESH:D014036		Virus diseases caused by the TOGAVIRIDAE.	MESH:D012327	C01.925.782.930	C01.925.782	Diseases, Togaviridae|Disease, Togaviridae|Infections, Togaviridae|Infections, Togavirus|Infection, Togaviridae|Infection, Togavirus|Togaviridae Disease|Togaviridae Diseases|Togaviridae Infection|Togavirus Infection|Togavirus Infections	Viral disease
Tolosa-Hunt Syndrome	MESH:D020333	DO:DOID:1278	An idiopathic syndrome characterized by the formation of granulation tissue in the anterior cavernous sinus or superior orbital fissure, producing a painful ophthalmoplegia. (Adams et al., Principles of Neurology, 6th ed, p271)	MESH:D015835	C10.292.562.900|C11.590.905	C10.292.562|C11.590	Tolosa Hunt Syndrome	Eye disease|Nervous system disease
Tongue Neoplasms	MESH:D014062	DO:DOID:8649	Tumors or cancer of the TONGUE.	MESH:D009062|MESH:D014060	C04.588.443.591.925|C07.465.530.925|C07.465.910.470	C04.588.443.591|C07.465.530|C07.465.910	Cancer of the Tongue|Cancer of Tongue|Cancers, Tongue|Cancer, Tongue|Neoplasms, Tongue|Neoplasm, Tongue|Tongue Cancer|Tongue Cancers|Tongue Neoplasm	Cancer|Mouth disease
Tonic Pupil	MESH:D015845		A pupillary abnormality characterized by a poor pupillary light reaction, reduced accommodation, iris sector palsies, an enhanced pupillary response to near effort that results in a prolonged, 'tonic' constriction, and slow pupillary redilation. This condition is associated with injury to the postganglionic parasympathetic innervation to the pupil. (From Miller et al., Clinical Neuro-Ophthalmology, 4th ed, pp492-500)	MESH:D011681	C10.597.690.575|C11.710.800|C23.888.592.708.575	C10.597.690|C11.710|C23.888.592.708	Adie Pupil|Adie's Pupil|Adies Pupil|Myotonic Pupil|Myotonic Pupils|Neuropathic Tonic Pupil|Neuropathic Tonic Pupils|Pupil, Adie|Pupil, Adie's|Pupil, Local Tonic|Pupillotonia|Pupillotonias|Pupil, Myotonic|Pupil, Neuropathic Tonic|Pupils, Adie's|Pupils, Local Tonic|Pupils, Myotonic|Pupils, Neuropathic Tonic|Pupils, Tonic|Pupil, Tonic|Tonic Pupil, Local|Tonic Pupil, Neuropathic|Tonic Pupils|Tonic Pupils, Local|Tonic Pupils, Neuropathic	Eye disease|Nervous system disease|Signs and symptoms
Tonic, sluggishly reacting pupil and hypoactive or absent tendon reflexes	MESH:C531601			MESH:D000270	C10.177.045/C531601|C10.292.562.700.250/C531601|C11.590.436.200/C531601|C11.710.800.180/C531601	C10.177.045|C10.292.562.700.250|C11.590.436.200|C11.710.800.180		Eye disease|Nervous system disease
Tonsillar Neoplasms	MESH:D014067	DO:DOID:8858	Tumors or cancer of the PALATINE TONSIL.	MESH:D009959	C04.588.443.665.710.684.800|C07.550.745.671.800|C09.647.710.685.800|C09.775.549.685.800	C04.588.443.665.710.684|C07.550.745.671|C09.647.710.685|C09.775.549.685	Cancer of the Tonsil|Cancer of Tonsil|Cancers, Tonsil|Cancers, Tonsillar|Cancer, Tonsil|Cancer, Tonsillar|Neoplasms, Tonsil|Neoplasms, Tonsillar|Neoplasm, Tonsil|Neoplasm, Tonsillar|Tonsil Cancer|Tonsil Cancers|Tonsillar Cancer|Tonsillar Cancers|Tonsillar Neoplasm|Tonsil Neoplasm|Tonsil Neoplasms	Cancer|Ear-nose-throat disease|Mouth disease
Tonsillitis	MESH:D014069	DO:DOID:10456	Inflammation of the tonsils, especially the PALATINE TONSILS but the ADENOIDS (pharyngeal tonsils) and lingual tonsils may also be involved. Tonsillitis usually is caused by bacterial infection. Tonsillitis may be acute, chronic, or recurrent.	MESH:D010612	C01.748.561.750|C07.550.781.750|C08.730.561.750|C09.775.649.750	C01.748.561|C07.550.781|C08.730.561|C09.775.649	Tonsillitides	Ear-nose-throat disease|Mouth disease|Respiratory tract disease
Toothache	MESH:D014098		Pain in the adjacent areas of the teeth.	MESH:D005157|MESH:D014076	C07.793.929|C23.888.592.612.330.500	C07.793|C23.888.592.612.330	Odontalgia|Odontalgias|Toothaches	Mouth disease|Signs and symptoms
Tooth Avulsion	MESH:D014084		Partial or complete displacement of a tooth from its alveolar support. It is commonly the result of trauma. (From Boucher's Clinical Dental Terminology, 4th ed, p312)	MESH:D018677	C07.793.850.725|C26.900.725	C07.793.850|C26.900	Avulsed Tooth|Avulsions, Tooth|Avulsion, Tooth|Dislocations, Tooth|Dislocation, Tooth|Luxations, Tooth|Luxation, Tooth|Tooth, Avulsed|Tooth Avulsions|Tooth Dislocation|Tooth Dislocations|Tooth Luxation|Tooth Luxations	Mouth disease|Wounds and injuries
Tooth Fractures	MESH:D014082		Break or rupture of a tooth or tooth root.	MESH:D018677	C07.793.850.750|C26.900.750	C07.793.850|C26.900	Fractures, Tooth|Fracture, Tooth|Tooth Fracture	Mouth disease|Wounds and injuries
Tooth Injuries	MESH:D018677		Traumatic or other damage to teeth including fractures (TOOTH FRACTURES) or displacements (TOOTH LUXATION).	MESH:D014076|MESH:D014947	C07.793.850|C26.900	C07.793|C26	Injuries, Teeth|Injuries, Tooth|Injury, Teeth|Injury, Tooth|Teeth Injuries|Teeth Injury|Tooth Injury	Mouth disease|Wounds and injuries
Torovirus Infections	MESH:D018176		Infections with viruses of the genus TOROVIRUS, family CORONAVIRIDAE.	MESH:D003333	C01.925.782.600.550.800	C01.925.782.600.550	Infections, Torovirus|Infection, Torovirus|Torovirus Infection	Viral disease
Torsades de Pointes	MESH:D016171		A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION.	MESH:D017180	C14.280.067.845.940.700|C14.280.123.875.940.700|C23.550.073.845.940.700	C14.280.067.845.940|C14.280.123.875.940|C23.550.073.845.940	de Pointes, Torsade|de Pointes, Torsades|Pointes, Torsade de|Pointes, Torsades de|Torsade de Pointes	Cardiovascular disease|Pathology (process)
Torus Palatinus and Torus Mandibularis	MESH:C566043			MESH:D005096	C05.116.540.310/C566043	C05.116.540.310		Musculoskeletal disease
Total Hypotrichosis, Mari type	MESH:C536973			MESH:D000505	C17.800.329.937.122/C536973|C23.300.035/C536973	C17.800.329.937.122|C23.300.035	Alopecia Universalis Congenita, Mari type|Hypotrichosis, Autosomal Recessive|Hypotrichosis, Localized, Autosomal Recessive, 2|Hypotrichosis, Total, Mari Type|Mari type Alopecia universalis congenita	Pathology (anatomical condition)|Skin disease
Toxemia	MESH:D014115		A condition produced by the presence of toxins or other harmful substances in the BLOOD.	MESH:D007239	C01.861	C01	Toxemias	
Toxic Optic Neuropathy	MESH:D000081028	DO:DOID:13329	Damage to the eye or its function (e.g., VISUAL IMPAIRMENT) due to OPTIC NERVE damage secondary to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.	MESH:D010335|MESH:D011832|MESH:D020221|MESH:D064420	C10.292.200.750.500|C10.292.700.475.500|C10.900.300.218.550.500|C11.640.530.500|C23.550.877|C25.100.937|C26.733.902	C10.292.200.750|C10.292.700.475|C10.900.300.218.550|C11.640.530|C23.550|C25.100|C26.733	Neuropathy, Toxic Optic|Ocular Toxicity|Optic Neuropathy, Toxic|Toxicity, Ocular|Toxic Optic Neuropathies	Eye disease|Nervous system disease|Pathology (process)|Wounds and injuries
Toxoplasmosis, Cerebral	MESH:D016781		Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3)	MESH:D001922|MESH:D014123|MESH:D020808	C01.207.090.800|C01.207.205.300.800|C01.610.105.300.800|C01.610.752.250.800.250|C01.830.025.160.800|C10.228.140.116.800|C10.228.228.090.800|C10.228.228.205.300.800	C01.207.090|C01.207.205.300|C01.610.105.300|C01.610.752.250.800|C01.830.025.160|C10.228.140.116|C10.228.228.090|C10.228.228.205.300	Central Nervous System Toxoplasmosis|Cerebral Toxoplasmosis|Intracranial Toxoplasmosis|Neurotoxoplasmosis|Toxoplasmoses, Cerebral|Toxoplasmosis, Central Nervous System|Toxoplasmosis, Intracranial	Nervous system disease|Parasitic disease
Tracheal Diseases	MESH:D014133	DO:DOID:3225	Diseases involving the TRACHEA.	MESH:D012140	C08.907	C08	Diseases, Tracheal|Disease, Tracheal|Tracheal Disease	Respiratory tract disease
Tracheal Neoplasms	MESH:D014134	DO:DOID:248	New abnormal growth of tissue in the TRACHEA.	MESH:D006258|MESH:D012142|MESH:D014133	C04.588.443.925|C04.588.894.797.760|C08.785.760|C08.907.563	C04.588.443|C04.588.894.797|C08.785|C08.907	Neoplasms, Tracheal|Neoplasm, Tracheal|Tracheal Neoplasm	Cancer|Respiratory tract disease
Tracheal Stenosis	MESH:D014135	DO:DOID:3227	A pathological narrowing of the TRACHEA.	MESH:D014133	C08.907.663	C08.907	Stenoses, Tracheal|Stenosis, Tracheal|Tracheal Stenoses	Respiratory tract disease
Tracheitis	MESH:D014136	DO:DOID:9392	INFLAMMATION of the TRACHEA that is usually associated with RESPIRATORY TRACT INFECTIONS.	MESH:D012141|MESH:D014133	C01.748.848|C08.730.848|C08.907.763	C01.748|C08.730|C08.907	Tracheitides	Respiratory tract disease
Tracheobronchial Stenosis, Congenital	MESH:C566362			MESH:D001982|MESH:D003251|MESH:D014135	C08.127/C566362|C08.907.663/C566362|C23.300.287/C566362	C08.127|C08.907.663|C23.300.287		Pathology (anatomical condition)|Respiratory tract disease
Tracheoesophageal Fistula	MESH:D014138		Abnormal passage between the ESOPHAGUS and the TRACHEA, acquired or congenital, often associated with ESOPHAGEAL ATRESIA.	MESH:D004937|MESH:D014133|MESH:D016156	C06.267.250.725|C06.405.117.367.725|C08.702.750|C08.907.863|C23.300.575.185.250.725	C06.267.250|C06.405.117.367|C08.702|C08.907|C23.300.575.185.250	Esophagotracheal Fistula|Esophagotracheal Fistulas|Fistula, Esophagotracheal|Fistulas, Esophagotracheal|Fistulas, Tracheoesophageal|Fistula, Tracheoesophageal|Tracheoesophageal Fistulas	Digestive system disease|Pathology (anatomical condition)|Respiratory tract disease
Tram track sign brain	MESH:C000721391			MESH:D013341	C04.557.645.375.850/C000721391|C10.562.800/C000721391|C14.907.077.850/C000721391	C04.557.645.375.850|C10.562.800|C14.907.077.850	Brain tram track sign	Cancer|Cardiovascular disease|Nervous system disease
Tram track sign chest	MESH:C000721392			MESH:D001987	C08.127.384/C000721392	C08.127.384	Chest tram track sign	Respiratory tract disease
tram track sign optic nerve	MESH:C000721389			MESH:D009901	C10.292.700/C000721389|C11.640/C000721389	C10.292.700|C11.640	Optic nerve tram track sign|tram track sign of optic nerve	Eye disease|Nervous system disease
Transfusion Reaction	MESH:D065227		Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.	MESH:D006402|MESH:D007154	C15.378.962|C20.920	C15.378|C20	Acute Hemolytic Transfusion Reaction|Allergic Reaction, Transfusion-Associated|Blood Transfusion Associated Adverse Reactions|Blood Transfusion-Associated Adverse Reactions|Circulatory Overloads, Transfusion-Associated|Circulatory Overload, Transfusion-Associated|Delayed Hemolytic Transfusion Reaction|Delayed Serologic Transfusion Reaction|Dyspnea, Transfusion-Associated|Febrile Non Hemolytic Transfusion Reaction|Febrile Non-Hemolytic Transfusion Reaction|Hemolytic Transfusion Reaction|Hemolytic Transfusion Reactions|Hypotensive Transfusion Reaction|Infection, Transfusion-Transmitted|Posttransfusion Purpura|Post Transfusion Purpura|Post-Transfusion Purpura|Posttransfusion Purpuras|Purpura, Posttransfusion|Purpura, Post-Transfusion|Reaction, Hemolytic Transfusion|Reaction, Hypotensive Transfusion|Reactions, Hemolytic Transfusion|TAGHD|Transfusion Associated Allergic Reaction|Transfusion-Associated Allergic Reaction|Transfusion Associated Circulatory Overload|Transfusion-Associated Circulatory Overload|Transfusion-Associated Circulatory Overloads|Transfusion Associated Dyspnea|Transfusion-Associated Dyspnea|Transfusion Associated Graft Vs. Host Disease|Transfusion-Associated Graft Vs. Host Disease|Transfusion Reaction, Hemolytic|Transfusion Reaction, Hypotensive|Transfusion Reactions|Transfusion Reactions, Hemolytic|Transfusion Reactions, Hypotensive|Transfusion Transmitted Infection|Transfusion-Transmitted Infection|Transfusion-Transmitted Infections	Blood disease|Immune system disease
Transfusion-Related Acute Lung Injury	MESH:D000073617		A rare but serious transfusion-related reaction in which fluid builds up in the lungs unrelated to excessively high infusion rate and/or volume (TRANSFUSION-ASSOCIATED CIRCULATORY OVERLOAD). Signs of Transfusion-Related Acute Lung Injury include pulmonary secretions; hypotension; fever; DYSPNEA; TACHYPNEA; TACHYCARDIA; and CYANOSIS.	MESH:D055371|MESH:D065227	C08.381.520.500.500|C15.378.962.500|C20.920.500	C08.381.520.500|C15.378.962|C20.920	Acute Lung Injury, Transfusion Related|Acute Lung Injury, Transfusion-Related|TRALI|Transfusion Related Acute Lung Injury	Blood disease|Immune system disease|Respiratory tract disease
Transient antero-apical dyskinesia	MESH:C538679			MESH:D054549	C14.280.945.900.500/C538679	C14.280.945.900.500		Cardiovascular disease
Transposition of Great Vessels	MESH:D014188		A congenital cardiovascular malformation in which the AORTA arises entirely from the RIGHT VENTRICLE, and the PULMONARY ARTERY arises from the LEFT VENTRICLE. Consequently, the pulmonary and the systemic circulations are parallel and not sequential, so that the venous return from the peripheral circulation is re-circulated by the right ventricle via aorta to the systemic circulation without being oxygenated in the lungs. This is a potentially lethal form of heart disease in newborns and infants.	MESH:D006330	C14.240.400.915|C14.280.400.915|C16.131.240.400.915	C14.240.400|C14.280.400|C16.131.240.400	Dextro Looped Transposition of the Great Arteries|Dextro-Looped Transposition of the Great Arteries|Great Arteries Transposition|Great Arteries Transpositions|Great Vessels Transposition|Great Vessels Transpositions|Transposition of Great Arteries	Cardiovascular disease|Congenital abnormality
Transposition of the Great Arteries, Dextro-Looped 1	MESH:C563853	OMIM:608808		MESH:D014188	C14.240.400.915/C563853|C14.280.400.915/C563853|C16.131.240.400.915/C563853	C14.240.400.915|C14.280.400.915|C16.131.240.400.915	DTGA|DTGA1|TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED	Cardiovascular disease|Congenital abnormality
Trauma, Nervous System	MESH:D020196		Traumatic injuries to the brain, cranial nerves, spinal cord, autonomic nervous system, or neuromuscular system, including iatrogenic injuries induced by surgical procedures.	MESH:D009422|MESH:D014947	C10.900|C26.915	C10|C26	Axonotmeses|Axonotmesis|Craniocervical Injuries|Craniocervical Injury|Injuries, Nervous System|Nervous System Injuries|Nervous System Injury|Nervous System Trauma|Nervous System Traumas|Neurotmeses|Neurotmesis	Nervous system disease|Wounds and injuries
Treft Sanborn Carey syndrome	MESH:C536544			MESH:D001259|MESH:D001763|MESH:D006319|MESH:D009135|MESH:D009886|MESH:D009896	C05.651/C536544|C09.218.458.341.887/C536544|C10.292.562.750/C536544|C10.292.700.225/C536544|C10.597.350.090/C536544|C10.597.622.447/C536544|C10.597.751.418.341.887/C536544|C10.668.491/C536544|C11.338.204/C536544|C11.590.472/C536544|C11.640.451/C536544|C23.888.592.350.090/C536544|C23.888.592.636.447/C536544|C23.888.592.763.393.341.887/C536544	C05.651|C09.218.458.341.887|C10.292.562.750|C10.292.700.225|C10.597.350.090|C10.597.622.447|C10.597.751.418.341.887|C10.668.491|C11.338.204|C11.590.472|C11.640.451|C23.888.592.350.090|C23.888.592.636.447|C23.888.592.763.393.341.887	Dominant optic atrophy, deafness, ptosis, ophthalmoplegia, dystaxia, and myopathy	Ear-nose-throat disease|Eye disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Tremor	MESH:D014202		Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.	MESH:D020820	C10.597.350.850|C23.888.592.350.850	C10.597.350|C23.888.592.350	Action Tremor|Action Tremors|Coarse Tremor|Coarse Tremors|Continuous Tremor|Continuous Tremors|Darkness Tremor|Darkness Tremors|Fine Tremor|Fine Tremors|Intention Tremor|Intention Tremors|Intermittent Tremor|Intermittent Tremors|Involuntary Quiver|Involuntary Quivers|Limb Tremor|Limb Tremors|Massive Tremor|Massive Tremors|Muscle Tremor|Muscle Tremors|Neonatal Tremor|Neonatal Tremors|Nerve Tremor|Nerve Tremors|Passive Tremor|Passive Tremors|Perioral Tremor|Perioral Tremors|Persistent Tremor|Persistent Tremors|Pill Rolling Tremor|Pill Rolling Tremors|Quiver, Involuntary|Quivers, Involuntary|Resting Tremor|Resting Tremors|Rest Tremor|Rest Tremors|Rolling Tremor, Pill|Rolling Tremors, Pill|Saturnine Tremor|Saturnine Tremors|Semirhythmic Tremor|Semirhythmic Tremors|Senile Tremor|Senile Tremors|Static Tremor|Static Tremors|Tremor, Action|Tremor, Coarse|Tremor, Continuous|Tremor, Darkness|Tremor, Fine|Tremor, Intention|Tremor, Intermittent|Tremor, Limb|Tremor, Massive|Tremor, Muscle|Tremor, Neonatal|Tremor, Nerve|Tremor, Passive|Tremor, Perioral|Tremor, Persistent|Tremor, Pill Rolling|Tremor, Rest|Tremor, Resting|Tremors|Tremors, Action|Tremor, Saturnine|Tremors, Coarse|Tremors, Continuous|Tremors, Darkness|Tremor, Semirhythmic|Tremor, Senile|Tremors, Fine|Tremors, Intention|Tremors, Intermittent|Tremors, Limb|Tremors, Massive|Tremors, Muscle|Tremors, Neonatal|Tremors, Nerve|Tremors, Passive|Tremors, Perioral|Tremors, Persistent|Tremors, Pill Rolling|Tremors, Rest|Tremors, Resting|Tremors, Saturnine|Tremors, Semirhythmic|Tremors, Senile|Tremors, Static|Tremor, Static	Nervous system disease|Signs and symptoms
Tremor hereditary essential, 1	MESH:C536545	OMIM:190300		MESH:D020329	C10.228.662.350/C536545	C10.228.662.350	ETM1|FET1|Tremor familial essential, 1|Tremor, Familial Essential, 1|Tremor, Hereditary Essential, 1	Nervous system disease
Tremor, Hereditary Essential, 3	MESH:C566949			MESH:D020329	C10.228.662.350/C566949	C10.228.662.350		Nervous system disease
TREMOR, HEREDITARY ESSENTIAL, 4	OMIM:614782	DO:DOID:0111431		MESH:D020329	C10.228.662.350/614782	C10.228.662.350	ETM4	Nervous system disease
TREMOR, HEREDITARY ESSENTIAL, 5	OMIM:616736	DO:DOID:0111432		MESH:D020329	C10.228.662.350/616736	C10.228.662.350	ETM5	Nervous system disease
Tremor, Hereditary Essential, And Idiopathic Normal Pressure Hydrocephalus	MESH:C567519			MESH:D006850|MESH:D020329	C10.228.140.602.750/C567519|C10.228.662.350/C567519	C10.228.140.602.750|C10.228.662.350	ETINPH	Nervous system disease
Trichiasis	MESH:D058457		A disease of the eye in which the eyelashes abnormally turn inwards toward the eyeball producing constant irritation caused by motion of the lids.	MESH:D005141	C11.338.912	C11.338	Trichiases	Eye disease
Trichilemmal Cyst 1	MESH:C566458	OMIM:609649		MESH:D004814	C04.182.254/C566458	C04.182.254	PILAR CYST|Tricholemmal Cyst|TRICY1	Cancer
Trichoepithelioma, Multiple Familial, 2	MESH:C567418	OMIM:612099		MESH:D012878	C04.588.805/C567418|C17.800.882/C567418	C04.588.805|C17.800.882	MFT2	Cancer|Skin disease
Trichoepitheliomas, Multiple Desmoplastic	MESH:C566034			MESH:D012878	C04.588.805/C566034|C17.800.882/C566034	C04.588.805|C17.800.882		Cancer|Skin disease
Trichofolliculoma	MESH:C536553			MESH:D005497|MESH:D012878|MESH:D018295	C04.182.300/C536553|C04.557.470.565/C536553|C04.588.805/C536553|C17.800.882/C536553	C04.182.300|C04.557.470.565|C04.588.805|C17.800.882	Congenital trichofolliculoma|Folliculo-sebaceous cystic hamartoma|Folliculosebaceous cystic hamartoma|Recurrent trichofolliculoma|Sebaceous trichofolliculoma	Cancer|Skin disease
Trichomonas Vaginitis	MESH:D014247	DO:DOID:0050269	Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS.	MESH:D014245|MESH:D014627	C01.610.752.890.633|C12.050.351.500.894.906.633|C12.100.250.894.906.633	C01.610.752.890|C12.050.351.500.894.906|C12.100.250.894.906	Human Trichomoniases|Human Trichomoniasis|Trichomonas Vaginitides|Trichomoniases, Human|Trichomoniasis, Human|Vaginitides, Trichomonas|Vaginitis, Trichomonas	Parasitic disease|Urogenital disease (female)
Trichorhinophalangeal Syndrome, Type I	MESH:C536820	DO:DOID:14743|OMIM:190350		MESH:D006201|MESH:D015826	C05.116.099.708.582/C536820|C17.800.329/C536820	C05.116.099.708.582|C17.800.329	Giedion syndrome|Trichorhinophalangeal dysplasia 1|Trichorhinophalangeal (TRP) syndrome 1|TRPS1|TRPS I	Musculoskeletal disease|Skin disease
Tricuspid Atresia	MESH:D018785	DO:DOID:0080169|OMIM:605067	Absence of the orifice between the RIGHT ATRIUM and RIGHT VENTRICLE, with the presence of an atrial defect through which all the systemic venous return reaches the left heart. As a result, there is left ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR) because the right ventricle is absent or not functional.	MESH:D006330|MESH:D006349	C14.240.400.920|C14.280.400.920|C14.280.484.845|C16.131.240.400.920	C14.240.400|C14.280.400|C14.280.484|C16.131.240.400	Absent Right Atrioventricular Connection|Atresias, Tricuspid|Atresias, Tricuspid Valve|Atresia, Tricuspid|Atresia, Tricuspid Valve|Tricuspid Atresias|Tricuspid Valve Atresia|Tricuspid Valve Atresias|Valve Atresias, Tricuspid|Valve Atresia, Tricuspid	Cardiovascular disease|Congenital abnormality
Tricuspid Valve Insufficiency	MESH:D014262	DO:DOID:4080	Backflow of blood from the RIGHT VENTRICLE into the RIGHT ATRIUM due to imperfect closure of the TRICUSPID VALVE.	MESH:D006349	C14.280.484.856	C14.280.484	Incompetence, Tricuspid|Incompetence, Tricuspid Valve|Insufficiency, Tricuspid Valve|Regurgitation, Tricuspid|Regurgitation, Tricuspid Valve|Tricuspid Incompetence|Tricuspid Regurgitation|Tricuspid Valve Incompetence|Tricuspid Valve Regurgitation|Valve Incompetence, Tricuspid|Valve Insufficiency, Tricuspid|Valve Regurgitation, Tricuspid	Cardiovascular disease
Tricuspid Valve Prolapse	MESH:D014263	DO:DOID:5644	Abnormal protrusion of one or more of the leaflets of TRICUSPID VALVE into the RIGHT ATRIUM during SYSTOLE. This allows the backflow of blood into right atrium leading to TRICUSPID VALVE INSUFFICIENCY; SYSTOLIC MURMURS. Its most common cause is not primary valve abnormality but rather the dilation of the RIGHT VENTRICLE and the tricuspid annulus.	MESH:D016127	C14.280.484.400.875	C14.280.484.400	Prolapses, Tricuspid Valve|Prolapse, Tricuspid Valve|Tricuspid Valve Prolapses|Valve Prolapses, Tricuspid|Valve Prolapse, Tricuspid	Cardiovascular disease
Tricuspid Valve Stenosis	MESH:D014264	DO:DOID:4078	The pathologic narrowing of the orifice of the TRICUSPID VALVE. This hinders the emptying of RIGHT ATRIUM leading to elevated right atrial pressure and systemic venous congestion. Tricuspid valve stenosis is almost always due to RHEUMATIC FEVER.	MESH:D006349	C14.280.484.911	C14.280.484	Stenoses, Tricuspid Valve|Stenosis, Tricuspid Valve|Tricuspid Valve Stenoses|Valve Stenoses, Tricuspid|Valve Stenosis, Tricuspid	Cardiovascular disease
Trigeminal Autonomic Cephalalgias	MESH:D051303		Primary headache disorders that show symptoms caused by the activation of the AUTONOMIC NERVOUS SYSTEM of the TRIGEMINAL NERVE. These autonomic features include redness and tearing of the EYE, nasal congestion or discharge, facial SWEATING and other symptoms. Most subgroups show unilateral cranial PAIN.	MESH:D051270	C10.228.140.546.399.937	C10.228.140.546.399	Cephalalgias, Trigeminal Autonomic|Cephalalgia, Trigeminal Autonomic|Trigeminal Autonomic Cephalalgia	Nervous system disease
Trigeminal Nerve Diseases	MESH:D020433		Diseases of the trigeminal nerve or its nuclei, which are located in the pons and medulla. The nerve is composed of three divisions: ophthalmic, maxillary, and mandibular, which provide sensory innervation to structures of the face, sinuses, and portions of the cranial vault. The mandibular nerve also innervates muscles of mastication. Clinical features include loss of facial and intra-oral sensation and weakness of jaw closure. Common conditions affecting the nerve include brain stem ischemia, INFRATENTORIAL NEOPLASMS, and TRIGEMINAL NEURALGIA.	MESH:D005156	C07.465.299.625.500|C10.292.319.625.700	C07.465.299.625|C10.292.319.625	Cranial Nerve V Diseases|Fifth Cranial Nerve Diseases|Idiopathic Trigeminal Neuropathies|Idiopathic Trigeminal Neuropathy|Neuropathies, Idiopathic Trigeminal|Neuropathies, Trigeminal|Neuropathy, Idiopathic Trigeminal|Neuropathy, Trigeminal|Raeder Paratrigeminal Syndrome|Syndrome, Raeder Paratrigeminal|Trigeminal Nerve Disease|Trigeminal Nerve Disorder|Trigeminal Nerve Disorders|Trigeminal Neuropathies|Trigeminal Neuropathies, Idiopathic|Trigeminal Neuropathy|Trigeminal Neuropathy, Idiopathic	Mouth disease|Nervous system disease
Trigeminal Nerve Injuries	MESH:D061221		Traumatic injuries to the TRIGEMINAL NERVE. It may result in extreme pain, abnormal sensation in the areas the nerve innervates on face, jaw, gums and tongue and can cause difficulties with speech and chewing. It is sometimes associated with various dental treatments.	MESH:D020209|MESH:D020433	C07.465.299.625.500.349|C10.292.200.875|C10.292.319.625.700.349|C10.900.300.218.775|C26.915.300.400.825	C07.465.299.625.500|C10.292.200|C10.292.319.625.700|C10.900.300.218|C26.915.300.400	Avulsions, Trigeminal Nerve|Avulsion, Trigeminal Nerve|Contusions, Trigeminal Nerve|Contusion, Trigeminal Nerve|Cranial Nerve V Injury|Fifth Cranial Nerve Injuries|Fifth Cranial Nerve Injury|Fifth-Nerve Palsies, Traumatic|Fifth Nerve Palsy, Traumatic|Fifth-Nerve Palsy, Traumatic|Fifth Nerve Trauma|Fifth-Nerve Trauma|Fifth-Nerve Traumas|Injuries, Trigeminal Nerve|Injury, Cranial Nerve V|Injury, Fifth Cranial Nerve|Injury, Trigeminal Nerve|Nerve Avulsions, Trigeminal|Nerve Avulsion, Trigeminal|Nerve Contusions, Trigeminal|Nerve Contusion, Trigeminal|Nerve Injuries, Trigeminal|Nerve Injury, Trigeminal|Nerve Transections, Trigeminal|Nerve Transection, Trigeminal|Nerve Traumas, Trigeminal|Nerve Trauma, Trigeminal|Neuropathies, Traumatic Trigeminal|Neuropathy, Traumatic Trigeminal|Palsies, Traumatic Fifth-Nerve|Palsy, Traumatic Fifth-Nerve|Transections, Trigeminal Nerve|Transection, Trigeminal Nerve|Trauma, Fifth-Nerve|Traumas, Fifth-Nerve|Traumas, Trigeminal Nerve|Traumatic Fifth-Nerve Palsies|Traumatic Fifth Nerve Palsy|Traumatic Fifth-Nerve Palsy|Traumatic Trigeminal Neuropathies|Traumatic Trigeminal Neuropathy|Trauma, Trigeminal Nerve|Trigeminal Nerve Avulsion|Trigeminal Nerve Avulsions|Trigeminal Nerve Contusion|Trigeminal Nerve Contusions|Trigeminal Nerve Injury|Trigeminal Nerve Transection|Trigeminal Nerve Transections|Trigeminal Nerve Trauma|Trigeminal Nerve Traumas|Trigeminal Neuropathies, Traumatic|Trigeminal Neuropathy, Traumatic	Mouth disease|Nervous system disease|Wounds and injuries
Trigeminal Neuralgia	MESH:D014277	DO:DOID:12098	A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)	MESH:D020433	C07.465.299.625.500.700|C10.292.319.625.700.700	C07.465.299.625.500|C10.292.319.625.700	Disease, Fothergill|Epileptiform Neuralgia|Epileptiform Neuralgias|Fothergill Disease|Idiopathic Trigeminal Neuralgia|Idiopathic Trigeminal Neuralgias|Neuralgia, Epileptiform|Neuralgia, Idiopathic Trigeminal|Neuralgia, Secondary Trigeminal|Neuralgia, Trifacial|Neuralgia, Trigeminal|Secondary Trigeminal Neuralgia|Secondary Trigeminal Neuralgias|Tic Doloureux|Tic Douloureux|Trifacial Neuralgia|Trifacial Neuralgias|Trigeminal Neuralgia, Idiopathic|Trigeminal Neuralgias|Trigeminal Neuralgia, Secondary	Mouth disease|Nervous system disease
Trigger Finger Disorder	MESH:D052582		A painful disability in the hand affecting the finger or thumb. It is caused by mechanical impingement of the digital flexor tendons as they pass through a narrowed retinacular pulley at the level of the metacarpal head. Thickening of the sheath and fibrocartilaginous metaplasia can occur, and nodules can form. (From Green's Operative Hand Surgery, 5th ed, p2137-58).	MESH:D053682	C05.651.869.816.800	C05.651.869.816	Digits, Trigger|Digit, Trigger|Entrapment, Flexor Tendon|Entrapments, Flexor Tendon|Finger, Snapping|Fingers, Snapping|Flexor Tendon Entrapment|Flexor Tendon Entrapments|Snapping Finger|Snapping Fingers|Tendon Entrapment, Flexor|Tendon Entrapments, Flexor|Thumbs, Trigger|Thumb, Trigger|Trigger Digit|Trigger Digits|Trigger Thumb|Trigger Thumbs	Musculoskeletal disease
Trilogy of Fallot	MESH:D014286		A combination of congenital heart defects consisting of three key features including ATRIAL SEPTAL DEFECTS; PULMONARY STENOSIS; and RIGHT VENTRICULAR HYPERTROPHY.	MESH:D006330	C14.240.400.960|C14.280.400.960|C16.131.240.400.960	C14.240.400|C14.280.400|C16.131.240.400	Fallot's Trilogy|Fallots Trilogy|Fallot Trilogy|Trilogy, Fallot's	Cardiovascular disease|Congenital abnormality
Triple Negative Breast Neoplasms	MESH:D064726		Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.	MESH:D001943	C04.588.180.788|C17.800.090.500.788	C04.588.180|C17.800.090.500	Breast Cancers, Triple-Negative|Breast Cancer, Triple-Negative|Breast Neoplasms, Triple-Negative|Breast Neoplasm, Triple-Negative|ER Negative PR Negative HER2 Negative Breast Cancer|ER-Negative PR-Negative HER2-Negative Breast Cancer|ER Negative PR Negative HER2 Negative Breast Neoplasms|ER-Negative PR-Negative HER2-Negative Breast Neoplasms|Triple Negative Breast Cancer|Triple-Negative Breast Cancer|Triple-Negative Breast Cancers|Triple Negative Breast Neoplasm|Triple-Negative Breast Neoplasm|Triple-Negative Breast Neoplasms	Cancer|Skin disease
Trismus	MESH:D014313		Spasmodic contraction of the masseter muscle resulting in forceful jaw closure. This may be seen with a variety of diseases, including TETANUS, as a complication of radiation therapy, trauma, or in association with neoplastic conditions.	MESH:D013035	C10.597.613.750.700|C23.888.592.608.750.700	C10.597.613.750|C23.888.592.608.750	Lockjaw|Lock Jaw|Masseter Muscle Spasm|Masseter Muscle Spasms|Masseter Spasm|Masseter Spasms|Muscle Spasm, Masseter|Muscle Spasms, Masseter|Spasm, Masseter|Spasm, Masseter Muscle|Spasms, Masseter|Spasms, Masseter Muscle	Nervous system disease|Signs and symptoms
TRITANOPIA	OMIM:190900	DO:DOID:11661		MESH:D003117	C10.597.751.941.256/190900|C11.270.151.500/190900|C11.966.256/190900|C23.888.592.763.941.256/190900	C10.597.751.941.256|C11.270.151.500|C11.966.256|C23.888.592.763.941.256	BLUE COLORBLINDNESS|CBT|COLORBLINDNESS, TRITAN|COLORBLINDNESS, TRITANOPIC	Eye disease|Nervous system disease|Signs and symptoms
Trochlea of the Humerus, Aplasia of	MESH:C566022			MESH:D001847	C05.116/C566022	C05.116		Musculoskeletal disease
Trochlear Nerve Diseases	MESH:D020432	DO:DOID:13864	Diseases of the fourth cranial (trochlear) nerve or its nucleus in the midbrain. The nerve crosses as it exits the midbrain dorsally and may be injured along its course through the intracranial space, cavernous sinus, superior orbital fissure, or orbit. Clinical manifestations include weakness of the superior oblique muscle which causes vertical DIPLOPIA that is maximal when the affected eye is adducted and directed inferiorly. Head tilt may be seen as a compensatory mechanism for diplopia and rotation of the visual axis. Common etiologies include CRANIOCEREBRAL TRAUMA and INFRATENTORIAL NEOPLASMS.	MESH:D003389	C10.292.850	C10.292	Cranial Nerve IV Diseases|Fourth Cranial Nerve Diseases|Fourth Cranial Nerve Palsy|Fourth Nerve Palsies|Fourth Nerve Palsy|Myokymias, Superior Oblique|Myokymia, Superior Oblique|Neurogenic Superior Oblique Palsy|Neuropathies, Trochlear|Neuropathy, Trochlear|Palsies, Fourth Nerve|Palsies, Trochlear Nerve|Palsy, Fourth Nerve|Palsy, Trochlear Nerve|Superior Oblique Myokymia|Superior Oblique Myokymias|Superior Oblique Palsy, Neurogenic|Trochlear Nerve Disease|Trochlear Nerve Disorder|Trochlear Nerve Disorders|Trochlear Nerve Palsies|Trochlear Nerve Palsy|Trochlear Neuropathies|Trochlear Neuropathy	Nervous system disease
Trochlear Nerve Injuries	MESH:D061247		Traumatic injuries to the TROCHLEAR NERVE.	MESH:D020209	C10.292.200.906|C10.900.300.218.831|C26.915.300.400.868	C10.292.200|C10.900.300.218|C26.915.300.400	Avulsions, Trochlear Nerve|Avulsion, Trochlear Nerve|Contusions, Trochlear Nerve|Contusion, Trochlear Nerve|Cranial Nerve IV Injury|Fourth Cranial Nerve Injuries|Fourth Cranial Nerve Injury|Fourth-Nerve Palsies, Traumatic|Fourth Nerve Palsy, Traumatic|Fourth-Nerve Palsy, Traumatic|Fourth Nerve Trauma|Fourth-Nerve Trauma|Fourth-Nerve Traumas|Injuries, Trochlear Nerve|Injury, Cranial Nerve IV|Injury, Fourth Cranial Nerve|Injury, Trochlear Nerve|Nerve Avulsions, Trochlear|Nerve Avulsion, Trochlear|Nerve Contusions, Trochlear|Nerve Contusion, Trochlear|Nerve Injuries, Trochlear|Nerve Injury, Trochlear|Nerve Transections, Trochlear|Nerve Transection, Trochlear|Nerve Traumas, Trochlear|Nerve Trauma, Trochlear|Neuropathies, Traumatic Trochlear|Neuropathy, Traumatic Trochlear|Palsies, Traumatic Fourth-Nerve|Palsy, Traumatic Fourth-Nerve|Transections, Trochlear Nerve|Transection, Trochlear Nerve|Trauma, Fourth-Nerve|Traumas, Fourth-Nerve|Traumas, Trochlear Nerve|Traumatic Fourth-Nerve Palsies|Traumatic Fourth Nerve Palsy|Traumatic Fourth-Nerve Palsy|Traumatic Trochlear Neuropathies|Traumatic Trochlear Neuropathy|Trauma, Trochlear Nerve|Trochlear Nerve Avulsion|Trochlear Nerve Avulsions|Trochlear Nerve Contusion|Trochlear Nerve Contusions|Trochlear Nerve Injury|Trochlear Nerve Transection|Trochlear Nerve Transections|Trochlear Nerve Trauma|Trochlear Nerve Traumas|Trochlear Neuropathies, Traumatic|Trochlear Neuropathy, Traumatic	Nervous system disease|Wounds and injuries
Trophoblastic Neoplasms	MESH:D014328	DO:DOID:4085	Trophoblastic growth, which may be gestational or nongestational in origin. Trophoblastic neoplasia resulting from pregnancy is often described as gestational trophoblastic disease to distinguish it from germ cell tumors which frequently show trophoblastic elements, and from the trophoblastic differentiation which sometimes occurs in a wide variety of epithelial cancers. Gestational trophoblastic growth has several forms, including HYDATIDIFORM MOLE and CHORIOCARCINOMA. (From Holland et al., Cancer Medicine, 3d ed, p1691)	MESH:D009373|MESH:D011252	C04.557.465.955|C04.850.908|C12.050.703.720.949	C04.557.465|C04.850|C12.050.703.720	Cancers, Trophoblast|Cancers, Trophoblastic|Cancer, Trophoblast|Cancer, Trophoblastic|Neoplasms, Trophoblast|Neoplasms, Trophoblastic|Neoplasm, Trophoblast|Neoplasm, Trophoblastic|Trophoblast Cancer|Trophoblast Cancers|Trophoblastic Cancer|Trophoblastic Cancers|Trophoblastic Neoplasm|Trophoblastic Tumor|Trophoblastic Tumors|Trophoblast Neoplasm|Trophoblast Neoplasms|Trophoblast Tumor|Trophoblast Tumors|Tumors, Trophoblast|Tumors, Trophoblastic|Tumor, Trophoblast|Tumor, Trophoblastic	Cancer|Pregnancy complication
Trophoblastic Tumor, Placental Site	MESH:D018245	DO:DOID:3596	An uncommon variant of CHORIOCARCINOMA. It is composed almost entirely of mononuclear cytotrophoblasts (TROPHOBLASTS). Because its secretion of hCG (CHORIONIC GONADOTROPIN) is low, a large tumor may develop before the hCG can be detected.	MESH:D002822	C04.557.465.955.207.875|C04.557.470.200.025.455.875|C04.850.908.208.875|C12.050.703.720.949.208.875	C04.557.465.955.207|C04.557.470.200.025.455|C04.850.908.208|C12.050.703.720.949.208	Placental Site Trophoblastic Tumor|Placental-Site Trophoblastic Tumor|Placental-Site Trophoblastic Tumors|Placental Trophoblastic Tumor|Placental Trophoblastic Tumors|Trophoblastic Tumor, Placental|Trophoblastic Tumor, Placental-Site|Trophoblastic Tumors, Placental|Trophoblastic Tumors, Placental-Site|Tumor, Placental-Site Trophoblastic|Tumor, Placental Trophoblastic|Tumors, Placental-Site Trophoblastic|Tumors, Placental Trophoblastic	Cancer|Pregnancy complication
Tropical Calcific Pancreatitis	MESH:C564276	OMIM:608189		MESH:D002114|MESH:D050500	C06.689.750.830/C564276|C18.452.174.130/C564276|C23.550.291.500.750/C564276	C06.689.750.830|C18.452.174.130|C23.550.291.500.750	TCP	Digestive system disease|Metabolic disease|Pathology (process)
Truncus Arteriosus, Persistent	MESH:D014339		A congenital anomaly caused by the failed development of TRUNCUS ARTERIOSUS into separate AORTA and PULMONARY ARTERY. It is characterized by a single arterial trunk that forms the outlet for both HEART VENTRICLES and gives rise to the systemic, pulmonary, and coronary arteries. It is always accompanied by a ventricular septal defect.	MESH:D001028	C14.240.400.560.098.500|C14.280.400.560.098.500|C16.131.240.400.560.098.500	C14.240.400.560.098|C14.280.400.560.098|C16.131.240.400.560.098	Arteriosus Communis, Truncus|Persistent Truncus Arteriosus|Truncus Arteriosus Communi|Truncus Arteriosus Communis	Cardiovascular disease|Congenital abnormality
Tubular Sweat Gland Adenomas	MESH:D000074009	DO:DOID:5439|DO:DOID:5445	Various tubular forms of benign tumors of the SWEAT GLAND with glandular differentiation. Common types include syringocystadenoma papilliferum of the head and neck, and hidradenoma papilliferum of the vulva area. Hidradenoma papilliferum may be derived from mammary-like glands of the vulva.	MESH:D006607	C04.557.470.035.175.900|C04.557.470.550.175.900	C04.557.470.035.175|C04.557.470.550.175	Anogenital Papillary Hidradenoma|Anogenital Papillary Hidradenomas|Hidradenoma, Anogenital Papillary|Hidradenoma, Papillary|Hidradenoma Papilliferum|Hidradenoma Papilliferums|Papillary Hidradenoma|Papillary Hidradenoma, Anogenital|Papillary Hidradenomas|Papillary Syringocystadenoma|Papillary Syringocystadenomas|Papilliferum, Hidradenoma|Papilliferum, Syringocystadenoma|Syringocystadenoma, Papillary|Syringocystadenoma Papilliferum|Syringocystadenoma Papilliferums	Cancer
TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 5	OMIM:617056			MESH:D007674|MESH:D033461	C12.050.351.968.419/617056|C12.200.777.419/617056|C12.950.419/617056|C23.550.449/617056	C12.050.351.968.419|C12.200.777.419|C12.950.419|C23.550.449	ADTKD5|HNFJ4|HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Tubulointerstitial nephritis and uveitis	MESH:C536922			MESH:D009395|MESH:D014605	C11.941.879/C536922|C12.050.351.968.419.570.643/C536922|C12.200.777.419.570.643/C536922|C12.950.419.570.643/C536922	C11.941.879|C12.050.351.968.419.570.643|C12.200.777.419.570.643|C12.950.419.570.643	Dobrin syndrome|TINU syndrome|Tubulointerstitial nephritis and uveitis syndrome|Tubulointerstitial Nephritis with Uveitis	Eye disease|Urogenital disease (female)|Urogenital disease (male)
Tucker syndrome	MESH:C536923			MESH:D001763|MESH:D014826	C08.360.931/C536923|C09.400.931/C536923|C10.292.887.800/C536923|C10.597.622.943/C536923|C11.338.204/C536923|C23.888.592.636.943/C536923	C08.360.931|C09.400.931|C10.292.887.800|C10.597.622.943|C11.338.204|C23.888.592.636.943	Congenital bilateral recurrent nerve paralysis and ptosis|Ptosis vocal cord paralysis|Vocal Cord Paralysis And Ptosis	Ear-nose-throat disease|Eye disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Tufted angioma	MESH:C536924			MESH:D006391|MESH:D012878	C04.557.645.375/C536924|C04.588.805/C536924|C17.800.882/C536924	C04.557.645.375|C04.588.805|C17.800.882	Angioma, tufted	Cancer|Skin disease
Tumor Lysis Syndrome	MESH:D015275		A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.	MESH:D008232	C15.604.515.880|C20.683.515.950	C15.604.515|C20.683.515	Syndromes, Tumor Lysis|Syndromes, Tumour Lysis|Syndrome, Tumor Lysis|Syndrome, Tumour Lysis|Tumor Lysis Syndromes|Tumour Lysis Syndrome|Tumour Lysis Syndromes	Immune system disease|Lymphatic disease
TUMOR PREDISPOSITION SYNDROME	OMIM:614327			MESH:D009369|MESH:D020022	C04/614327|C23.550.291.687.500/614327	C04|C23.550.291.687.500	TPDS	Cancer|Pathology (process)
TUMOR SUPPRESSOR GENE ON CHROMOSOME 11	OMIM:603040			MESH:D002289	C04.588.894.797.520.109.220.249/603040|C08.381.540.140.500/603040|C08.785.520.100.220.500/603040	C04.588.894.797.520.109.220.249|C08.381.540.140.500|C08.785.520.100.220.500	NONSMALL CELL LUNG CANCER SUPPRESSOR|TSG11	Cancer|Respiratory tract disease
Tumor Virus Infections	MESH:D014412		Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses.	MESH:D014777	C01.925.928	C01.925	Fibroma, Shope|Infections, Tumor Virus|Infection, Tumor Virus|Papilloma, Shope|Shope Fibroma|Shope Papilloma|Tumor Virus Infection	Viral disease
Tune Deafness	MESH:C566019			MESH:D001308	C09.218.807.186.094/C566019|C10.228.140.068.094/C566019|C10.597.606.762.200/C566019|C23.888.592.604.764.200/C566019|F03.615.250.100/C566019	C09.218.807.186.094|C10.228.140.068.094|C10.597.606.762.200|C23.888.592.604.764.200|F03.615.250.100	Amusia, Congenital|Dysmelodia	Ear-nose-throat disease|Mental disorder|Nervous system disease|Signs and symptoms
Twenty-Nail Dystrophy	MESH:C562907			MESH:D009260|MESH:D009264	C17.800.529/C562907|C23.300.820/C562907	C17.800.529|C23.300.820	Onychodystrophy Totalis, Isolated	Pathology (anatomical condition)|Skin disease
Tympanic Membrane Perforation	MESH:D018058		A temporary or persistent opening in the eardrum (TYMPANIC MEMBRANE). Clinical signs depend on the size, location, and associated pathological condition.	MESH:D004427|MESH:D014947	C09.218.903|C26.930	C09.218|C26	Eardrum Perforation|Membrane Perforation, Tympanic|Membrane Rupture, Tympanic|Perforation, Eardrum|Rupture, Tympanic Membrane|Tympanic Membrane Rupture	Ear-nose-throat disease|Wounds and injuries
TYPE 1 DIABETES MELLITUS, X-LINKED, SUSCEPTIBILITY TO	OMIM:300136			MESH:D003922	C18.452.394.750.124/300136|C19.246.267/300136|C20.111.327/300136	C18.452.394.750.124|C19.246.267|C20.111.327	DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO|IDDMX|INSULIN-DEPENDENT DIABETES MELLITUS, X-LINKED, SUSCEPTIBILITY TO|T1DX	Endocrine system disease|Immune system disease|Metabolic disease
Typical Teratoid Rhabdoid Tumor	MESH:C000597569			MESH:D013724|MESH:D018335	C04.557.435.710/C000597569|C04.557.465.910/C000597569	C04.557.435.710|C04.557.465.910	Teratoid Rhabdoid Tumor|Teratoma Rhabdoid Tumor|Typical Teratoma Rhabdoid Tumor|Typical Teratoma-Rhabdoid Tumor	Cancer
Ulnar Agenesis and Endocardial Fibroelastosis	MESH:C564756			MESH:D004695	C14.280.238.281/C564756	C14.280.238.281		Cardiovascular disease
Ulnar Nerve Compression Syndromes	MESH:D017769		Ulnar neuropathies caused by mechanical compression of the nerve at any location from its origin at the BRACHIAL PLEXUS to its terminations in the hand. Common sites of compression include the retroepicondylar groove, cubital tunnel at the elbow (CUBITAL TUNNEL SYNDROME), and Guyon's canal at the wrist. Clinical features depend on the site of injury, but may include weakness or paralysis of wrist flexion, finger flexion, and ulnar innervated intrinsic hand muscles, and impaired sensation over the ulnar aspect of the hand, fifth finger, and ulnar half of the ring finger. (Joynt, Clinical Neurology, 1995, Ch51, p43)	MESH:D009408|MESH:D012090|MESH:D020424	C10.668.829.500.850.600|C10.668.829.550.925|C26.844.150.957	C10.668.829.500.850|C10.668.829.550|C26.844.150	Compression, Ulnar Nerve|Entrapments, Ulnar Nerve|Entrapment Syndrome, Ulnar Nerve|Entrapment, Ulnar Nerve|External Compression Syndrome, Ulnar Nerve|Guyon Syndrome|Guyon Syndromes|Nerve Compression, Ulnar|Nerve Entrapment, Ulnar|Syndrome, Guyon|Syndromes, Guyon|Ulnar Nerve Compression|Ulnar Nerve Compressions|Ulnar Nerve Entrapment|Ulnar Nerve Entrapment at the Wrist|Ulnar Nerve Entrapments|Ulnar Nerve Entrapment Syndrome|Ulnar Nerve External Compression Syndrome	Nervous system disease|Wounds and injuries
Ulnar Neuropathies	MESH:D020424	DO:DOID:4613	Disease involving the ULNAR NERVE from its origin in the BRACHIAL PLEXUS to its termination in the hand. Clinical manifestations may include PARESIS or PARALYSIS of wrist flexion, finger flexion, thumb adduction, finger abduction, and finger adduction. Sensation over the medial palm, fifth finger, and ulnar aspect of the ring finger may also be impaired. Common sites of injury include the AXILLA, cubital tunnel at the ELBOW, and Guyon's canal at the wrist. (From Joynt, Clinical Neurology, 1995, Ch51 pp43-5)	MESH:D020422	C10.668.829.500.850	C10.668.829.500	Nerve Diseases, Ulnar|Nerve Disease, Ulnar|Nerve Palsies, Ulnar|Nerve Palsy, Ulnar|Neuritides, Ulnar|Neuritis, Ulnar|Neuropathies, Ulnar|Neuropathy, Ulnar|Palsies, Ulnar Nerve|Palsy, Ulnar Nerve|Ulnar Nerve Disease|Ulnar Nerve Diseases|Ulnar Nerve Palsies|Ulnar Nerve Palsy|Ulnar Neuritides|Ulnar Neuritis|Ulnar Neuropathy	Nervous system disease
Uncombable hair syndrome	MESH:C536939	OMIM:191480|OMIM:617251|OMIM:617252		MESH:D006201	C17.800.329/C536939	C17.800.329	Cheveux incoiffables|Pili trianguli et Canaliculi|UHS|UHS1|UHS2|UHS3|UNCOMBABLE HAIR SYNDROME|UNCOMBABLE HAIR SYNDROME 1|UNCOMBABLE HAIR SYNDROME 2|UNCOMBABLE HAIR SYNDROME 3|Unmanageable hair syndrome	Skin disease
Unconsciousness	MESH:D014474		Loss of the ability to maintain awareness of self and environment combined with markedly reduced responsiveness to environmental stimuli. (From Adams et al., Principles of Neurology, 6th ed, pp344-5)	MESH:D003244	C10.597.606.358.800|C23.888.592.604.359.800	C10.597.606.358|C23.888.592.604.359	Consciousness, Loss of|Loss of Consciousness|State, Unconscious|Unconscious State|Unconscious States	Nervous system disease|Signs and symptoms
Undifferentiated Connective Tissue Diseases	MESH:D000074079		Diseases that exhibit signs and symptoms suggestive of a connective tissue disease that do not fulfill clinical or diagnostic criteria for any one defined disease but overlap with criteria of multiple such diseases. Commonly overlapping diseases include systemic autoimmune connective tissue diseases such as RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; and SYSTEMIC SCLEROSIS.	MESH:D001327|MESH:D003240	C17.300.849|C20.111.904	C17.300|C20.111	Undifferentiated Connective Tissue Disease	Connective tissue disease|Immune system disease
Undritz Anomaly	MESH:C566014			MESH:D007960	C15.378.553/C566014	C15.378.553	Hypersegmentation of Nuclei of Polymorphonuclear Leukocytes	Blood disease
unicuspid aortic valve	MESH:C000655292			MESH:D006349	C14.280.484/C000655292	C14.280.484	acommissural aortic valve|acommissural UAV|acommissural unicuspid aortic valve|unicommissural aortic valve|unicommissural UAV|unicommissural unicuspid aortic valve|unicuspid acommissural aortic valve|unicuspid aortic valves|unicuspid unicommissural aortic valve	Cardiovascular disease
Unilateral Breast Neoplasms	MESH:D000069584		Tumors or cancer found specifically in one human BREAST, but not in both.	MESH:D001943	C04.588.180.800|C17.800.090.500.682	C04.588.180|C17.800.090.500	Breast Cancer, Left-Sided|Breast Cancer, Right-Sided|Breast Cancers, Left-Sided|Breast Cancers, Right-Sided|Breast Cancers, Unilateral|Breast Cancer, Unilateral|Breast Neoplasm, Left-Sided|Breast Neoplasm, Right-Sided|Breast Neoplasms, Left-Sided|Breast Neoplasms, Right-Sided|Breast Neoplasms, Unilateral|Breast Neoplasm, Unilateral|Left Sided Breast Cancer|Left-Sided Breast Cancer|Left-Sided Breast Cancers|Left Sided Breast Neoplasm|Left-Sided Breast Neoplasm|Left Sided Breast Neoplasms|Left-Sided Breast Neoplasms|Right Sided Breast Cancer|Right-Sided Breast Cancer|Right-Sided Breast Cancers|Right Sided Breast Neoplasm|Right-Sided Breast Neoplasm|Right Sided Breast Neoplasms|Right-Sided Breast Neoplasms|Unilateral Breast Cancer|Unilateral Breast Cancers	Cancer|Skin disease
Univentricular Heart	MESH:D000080039		Rare congenital heart malformation with a single ventricle (HEART VENTRICLES) instead of the usual two.	MESH:D006330	C14.240.400.990|C14.280.400.990|C16.131.240.400.975	C14.240.400|C14.280.400|C16.131.240.400	Complex Single Ventricle|Complex Single Ventricles|Univentricular Hearts|Ventricle, Complex Single	Cardiovascular disease|Congenital abnormality
Upper Extremity Deep Vein Thrombosis	MESH:D056824		DEEP VEIN THROMBOSIS of an upper extremity vein (e.g., AXILLARY VEIN; SUBCLAVIAN VEIN; and JUGULAR VEINS). It is associated with mechanical factors (Upper Extremity Deep Vein Thrombosis, Primary) secondary to other anatomic factors (Upper Extremity Deep Vein Thrombosis, Secondary). Symptoms may include sudden onset of pain, warmth, redness, blueness, and swelling in the arm.	MESH:D020246	C14.907.355.830.925.885	C14.907.355.830.925	Central Venous Catheter Thrombosis|Effort Induced Upper Extremity Deep Vein Thrombosis|Effort-Induced Upper Extremity Deep Vein Thrombosis|Effort Related Upper Extremity Deep Vein Thrombosis|Effort-Related Upper Extremity Deep Vein Thrombosis|Exercise Induced Upper Extremity Deep Vein Thrombosis|Exercise-Induced Upper Extremity Deep Vein Thrombosis|Idiopathic Upper Extremity Deep Vein Thrombosis|Paget Schroetter Syndrome|Paget-Schroetter Syndrome|Syndrome, Paget-Schroetter|Upper Extremity Deep Vein Thrombosis, Primary|Upper Extremity Deep Vein Thrombosis, Secondary	Cardiovascular disease
Urachal adenocarcinoma	MESH:C536474			MESH:D000230|MESH:D001749	C04.557.470.200.025/C536474|C04.588.945.947.960/C536474|C12.050.351.937.820.945/C536474|C12.050.351.968.829.707/C536474|C12.200.758.820.968/C536474|C12.200.777.829.813/C536474|C12.900.820.945/C536474|C12.950.829.707/C536474|C12.950.983.945/C536474	C04.557.470.200.025|C04.588.945.947.960|C12.050.351.937.820.945|C12.050.351.968.829.707|C12.200.758.820.968|C12.200.777.829.813|C12.900.820.945|C12.950.829.707|C12.950.983.945	Adenocarcinoma of the urachus	Cancer|Urogenital disease (female)|Urogenital disease (male)
Urachal cancer	MESH:C536475	DO:DOID:5958		MESH:D001749	C04.588.945.947.960/C536475|C12.050.351.937.820.945/C536475|C12.050.351.968.829.707/C536475|C12.200.758.820.968/C536475|C12.200.777.829.813/C536475|C12.900.820.945/C536475|C12.950.829.707/C536475|C12.950.983.945/C536475	C04.588.945.947.960|C12.050.351.937.820.945|C12.050.351.968.829.707|C12.200.758.820.968|C12.200.777.829.813|C12.900.820.945|C12.950.829.707|C12.950.983.945	Urachal carcinoma	Cancer|Urogenital disease (female)|Urogenital disease (male)
Urachal Cyst	MESH:D014496		Cyst occurring in a persistent portion of the urachus, presenting as an extraperitoneal mass in the umbilical region. It is characterized by abdominal pain, and fever if infected. It may rupture, leading to peritonitis, or it may drain through the umbilicus.	MESH:D003560	C04.182.946	C04.182	Cysts, Umbilical|Cysts, Urachal|Cyst, Umbilical|Cyst, Urachal|Umbilical Cyst|Umbilical Cysts|Urachal Cysts	Cancer
Ureteral Calculi	MESH:D014514		Stones in the URETER that are formed in the KIDNEY. They are rarely more than 5 mm in diameter for larger renal stones cannot enter ureters. They are often lodged at the ureteral narrowing and can cause excruciating renal colic.	MESH:D014545|MESH:D053039	C12.050.351.968.725.938.500|C12.050.351.968.967.374.500|C12.050.351.968.967.500.851|C12.200.777.725.938.500|C12.200.777.967.374.500|C12.200.777.967.500.851|C12.950.725.938.500|C12.950.967.374.500|C12.950.967.500.851|C23.300.175.850.750	C12.050.351.968.725.938|C12.050.351.968.967.374|C12.050.351.968.967.500|C12.200.777.725.938|C12.200.777.967.374|C12.200.777.967.500|C12.950.725.938|C12.950.967.374|C12.950.967.500|C23.300.175.850	Calculi, Ureteral|Calculus, Ureteral|Ureteral Calculus	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Ureteral Neoplasms	MESH:D014516	DO:DOID:11819|DO:DOID:11885	Cancer or tumors of the URETER which may cause obstruction leading to hydroureter, HYDRONEPHROSIS, and PYELONEPHRITIS. HEMATURIA is a common symptom.	MESH:D014515|MESH:D014571	C04.588.945.947.940|C12.050.351.937.820.875|C12.050.351.968.725.676|C12.200.758.820.875|C12.200.777.725.676|C12.900.820.875|C12.950.725.676|C12.950.983.875	C04.588.945.947|C12.050.351.937.820|C12.050.351.968.725|C12.200.758.820|C12.200.777.725|C12.900.820|C12.950.725|C12.950.983	Cancer of the Ureter|Cancer of Ureter|Cancers, Ureteral|Cancer, Ureteral|Neoplasms of Ureter|Neoplasms, Ureteral|Neoplasm, Ureteral|Ureteral Cancer|Ureteral Cancers|Ureteral Neoplasm|Ureter Cancer|Ureter, Cancer Of|Ureter Cancers|Ureter Neoplasm|Ureter Neoplasms	Cancer|Urogenital disease (female)|Urogenital disease (male)
Urethral Neoplasms	MESH:D014523	DO:DOID:730|DO:DOID:734	Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.	MESH:D014522|MESH:D014571	C04.588.945.947.945|C12.050.351.937.820.890|C12.050.351.968.767.601|C12.200.758.820.937|C12.200.777.767.601|C12.900.820.890|C12.950.767.601|C12.950.983.890	C04.588.945.947|C12.050.351.937.820|C12.050.351.968.767|C12.200.758.820|C12.200.777.767|C12.900.820|C12.950.767|C12.950.983	Cancer of the Urethra|Cancer of Urethra|Cancers, Urethra|Cancers, Urethral|Cancer, Urethra|Cancer, Urethral|Neoplasms, Urethra|Neoplasms, Urethral|Neoplasm, Urethra|Neoplasm, Urethral|Urethra Cancer|Urethra Cancers|Urethral Cancer|Urethral Cancers|Urethral Neoplasm|Urethra Neoplasm|Urethra Neoplasms	Cancer|Urogenital disease (female)|Urogenital disease (male)
Urethral obstruction sequence	MESH:C536477			MESH:D003251|MESH:D006869|MESH:D011535|MESH:D014524|MESH:D016104|MESH:D016491	C12.050.351.968.419.307/C536477|C12.050.351.968.767.700/C536477|C12.050.703.560/C536477|C12.200.777.419.307/C536477|C12.200.777.767.700/C536477|C12.950.419.307/C536477|C12.950.767.700/C536477|C14.907.617/C536477|C16.131.077.745/C536477|C23.300.287/C536477	C12.050.351.968.419.307|C12.050.351.968.767.700|C12.050.703.560|C12.200.777.419.307|C12.200.777.767.700|C12.950.419.307|C12.950.767.700|C14.907.617|C16.131.077.745|C23.300.287	Early urethral obstruction sequence	Cardiovascular disease|Congenital abnormality|Pathology (anatomical condition)|Pregnancy complication|Urogenital disease (female)|Urogenital disease (male)
Urinary Bladder Calculi	MESH:D001744	DO:DOID:11355	Stones in the URINARY BLADDER; also known as vesical calculi, bladder stones, or cystoliths.	MESH:D001745|MESH:D014545	C12.050.351.968.829.521|C12.050.351.968.967.500.925|C12.200.777.829.720|C12.200.777.967.500.925|C12.950.829.521|C12.950.967.500.925|C23.300.175.850.875	C12.050.351.968.829|C12.050.351.968.967.500|C12.200.777.829|C12.200.777.967.500|C12.950.829|C12.950.967.500|C23.300.175.850	Bladder Calculi|Bladder Calculi, Urinary|Bladder Calculus|Bladder Calculus, Urinary|Bladder Stone|Bladder Stones|Bladder Stones, Urinary|Bladder Stone, Urinary|Calculi, Bladder|Calculi of Urinary Bladder|Calculi, Urinary Bladder|Calculi, Vesical|Calculus, Bladder|Calculus, Urinary Bladder|Calculus, Vesical|Cystolith|Cystoliths|Stone, Bladder|Stones, Bladder|Stones, Urinary Bladder|Stone, Urinary Bladder|Urinary Bladder Calculus|Urinary Bladder Stone|Urinary Bladder Stones|Vesical Calculi|Vesical Calculus	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Urinary Bladder Fistula	MESH:D001747		An abnormal passage in the URINARY BLADDER or between the bladder and any surrounding organ.	MESH:D001745|MESH:D014548	C12.050.351.875.881.312|C12.050.351.968.829.548|C12.200.706.881.312|C12.200.777.829.733|C12.800.881.312|C12.950.829.548|C23.300.575.825.250	C12.050.351.875.881|C12.050.351.968.829|C12.200.706.881|C12.200.777.829|C12.800.881|C12.950.829|C23.300.575.825	Fistulas, Urinary Bladder|Fistulas, Vesical|Fistula, Urinary Bladder|Fistula, Vesical|Urinary Bladder Fistulas|Vesical Fistula|Vesical Fistulas	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Urinary Bladder Neoplasms	MESH:D001749	DO:DOID:11054|OMIM:109800	Tumors or cancer of the URINARY BLADDER.	MESH:D001745|MESH:D014571	C04.588.945.947.960|C12.050.351.937.820.945|C12.050.351.968.829.707|C12.200.758.820.968|C12.200.777.829.813|C12.900.820.945|C12.950.829.707|C12.950.983.945	C04.588.945.947|C12.050.351.937.820|C12.050.351.968.829|C12.200.758.820|C12.200.777.829|C12.900.820|C12.950.829|C12.950.983	Bladder Cancer|Bladder Cancers|Bladder Neoplasm|Bladder Neoplasms|Bladder Tumor|Bladder Tumors|Cancer, Bladder|Cancer of Bladder|Cancer of the Bladder|Cancer, Urinary Bladder|Malignant Tumor of Urinary Bladder|Neoplasm, Bladder|Neoplasms, Bladder|Neoplasm, Urinary Bladder|Tumor, Bladder|Tumors, Bladder|Urinary Bladder Cancer|Urinary Bladder Neoplasm	Cancer|Urogenital disease (female)|Urogenital disease (male)
Urinary Bladder, Neurogenic	MESH:D001750	DO:DOID:12143	Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.	MESH:D001745|MESH:D009461	C10.597.900|C12.050.351.968.829.760|C12.200.777.829.839|C12.950.829.760|C23.888.592.900	C10.597|C12.050.351.968.829|C12.200.777.829|C12.950.829|C23.888.592	Atonic Neurogenic Bladder|Bladder Disorder, Neurogenic|Bladder Neurogenesis|Bladder, Neurogenic|Neurogenesis, Bladder|Neurogenesis, Urinary Bladder|Neurogenic Bladder|Neurogenic Bladder, Atonic|Neurogenic Bladder Disorder|Neurogenic Bladder Disorders|Neurogenic Bladder, Spastic|Neurogenic Bladder, Uninhibited|Neurogenic Dysfunction of the Urinary Bladder|Neurogenic Urinary Bladder|Neurogenic Urinary Bladder, Atonic|Neurogenic Urinary Bladder Disorder|Neurogenic Urinary Bladder, Spastic|Neurogenic Urinary Bladder, Uninhibited|Neuropathic Bladder|Spastic Neurogenic Bladder|Uninhibited Neurogenic Bladder|Urinary Bladder Disorder, Neurogenic|Urinary Bladder Neurogenesis|Urinary Bladder Neurogenic Dysfunction	Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Urinary Calculi	MESH:D014545		Low-density crystals or stones in any part of the URINARY TRACT. Their chemical compositions often include CALCIUM OXALATE, magnesium ammonium phosphate (struvite), CYSTINE, or URIC ACID.	MESH:D002137|MESH:D052878	C12.050.351.968.967.500|C12.200.777.967.500|C12.950.967.500|C23.300.175.850	C12.050.351.968.967|C12.200.777.967|C12.950.967|C23.300.175	Calculi, Urinary|Calculus, Urinary|Stones, Urinary|Stones, Urinary Tract|Stone, Urinary|Stone, Urinary Tract|Urinary Calculus|Urinary Stone|Urinary Stones|Urinary Tract Stone|Urinary Tract Stones	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Urinary Fistula	MESH:D014548		An abnormal passage in any part of the URINARY TRACT between itself or with other organs.	MESH:D005402|MESH:D014564	C12.050.351.875.881|C12.200.706.881|C12.800.881|C23.300.575.825	C12.050.351.875|C12.200.706|C12.800|C23.300.575	Fistulas, Urinary|Fistula, Urinary|Urinary Fistulas	Pathology (anatomical condition)|Urogenital disease (female)|Urogenital disease (male)
Urofacial syndrome	MESH:C536480	DO:DOID:0050816|OMIM:236730|OMIM:615112		MESH:D014570|MESH:D019066	C12.050.351.968/C536480|C12.200.777/C536480|C12.950/C536480|C23.550.291.812/C536480	C12.050.351.968|C12.200.777|C12.950|C23.550.291.812	Facial Palsy, Partial, With Urinary Abnormalities|Hydronephrosis-Inverted Smile|Hydronephrosis with peculiar facial expression|Inverted smile and occult neuropathic bladder|Inverted Smile-Neurogenic Bladder|Ochoa syndrome|Partial facial palsy with urinary abnormalities|UFS|UFS1|UFS2|Urofacial Ochoa's syndrome|UROFACIAL SYNDROME|UROFACIAL SYNDROME 1|UROFACIAL SYNDROME 2	Pathology (process)|Urogenital disease (female)|Urogenital disease (male)
Urogenital Diseases	MESH:D000091642		Pathological processes of the URINARY TRACT and the reproductive system (GENITALIA).	MESH:C	C12	C	Disease, Genitourinary|Disease, Urogenital|Genitourinary Disease|Genitourinary Diseases|Urogenital Disease	
Urogenital Neoplasms	MESH:D014565		Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.	MESH:D000091642|MESH:D009371|MESH:D052776|MESH:D052801	C04.588.945|C12.050.351.937|C12.200.758|C12.900	C04.588|C12|C12.050.351|C12.200	Cancer, Genitourinary|Cancer, Genito-urinary|Cancers, Genitourinary|Cancers, Genito-urinary|Cancers, Urogenital|Cancer, Urogenital|Genito urinary Cancer|Genito-urinary Cancer|Genitourinary Cancer|Genito-urinary Cancers|Genitourinary Cancers|Genito-urinary Neoplasm|Genitourinary Neoplasm|Genito-urinary Neoplasms|Genitourinary Neoplasms|Neoplasm, Genitourinary|Neoplasm, Genito-urinary|Neoplasms, Genitourinary|Neoplasms, Genito-urinary|Neoplasms, Urogenital|Neoplasm, Urogenital|Urogenital Cancer|Urogenital Cancers|Urogenital Neoplasm	Cancer|Urogenital disease (female)|Urogenital disease (male)
Urologic Neoplasms	MESH:D014571	DO:DOID:731	Tumors or cancer of the URINARY TRACT in either the male or the female.	MESH:D014565|MESH:D014570	C04.588.945.947|C12.050.351.937.820|C12.200.758.820|C12.900.820|C12.950.983	C04.588.945|C12.050.351.937|C12.200.758|C12.900|C12.950	Cancer of the Urinary Tract|Cancer of Urinary Tract|Cancers, Urinary Tract|Cancers, Urologic|Cancers, Urological|Cancer, Urinary Tract|Cancer, Urologic|Cancer, Urological|Neoplasms, Urinary Tract|Neoplasms, Urologic|Neoplasms, Urological|Neoplasm, Urinary Tract|Neoplasm, Urologic|Neoplasm, Urological|Tract Neoplasms, Urinary|Tract Neoplasm, Urinary|Urinary Tract Cancer|Urinary Tract Cancers|Urinary Tract Neoplasm|Urinary Tract Neoplasms|Urological Cancer|Urological Cancers|Urological Neoplasm|Urological Neoplasms|Urologic Cancer|Urologic Cancers|Urologic Neoplasm	Cancer|Urogenital disease (female)|Urogenital disease (male)
Urticaria Pigmentosa	MESH:D014582	DO:DOID:12309	The most common form of cutaneous mastocytosis (MASTOCYTOSIS, CUTANEOUS) that occurs primarily in children. It is characterized by the multiple small reddish-brown pigmented pruritic macules and papules.	MESH:D010859|MESH:D034701	C04.557.450.565.465.500.850|C04.588.805.309.850|C17.800.621.893|C17.800.882.356.850|C20.762.750.563.850	C04.557.450.565.465.500|C04.588.805.309|C17.800.621|C17.800.882.356|C20.762.750.563	Cutaneous Mastocytoses, Maculopapular|Cutaneous Mastocytosis, Maculopapular|Maculopapular Cutaneous Mastocytoses|Maculopapular Cutaneous Mastocytosis	Cancer|Immune system disease|Skin disease
Uterine Cervical Diseases	MESH:D002577	DO:DOID:2253	Pathological processes of the UTERINE CERVIX.	MESH:D014591	C12.050.351.500.852.593|C12.100.250.852.593	C12.050.351.500.852|C12.100.250.852	Cervical Diseases, Uterine|Cervical Disease, Uterine|Cervix Disease|Cervix Diseases|Disease, Cervix|Diseases, Cervix|Diseases, Uterine Cervical|Disease, Uterine Cervical|Uterine Cervical Disease	Urogenital disease (female)
Uterine Cervical Dysplasia	MESH:D002578		Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.	MESH:D002577|MESH:D011230	C04.834.818|C12.050.351.500.852.593.074|C12.100.250.852.593.074	C04.834|C12.050.351.500.852.593|C12.100.250.852.593	Cervical Dysplasia, Uterine|Cervix Dysplasia|Dysplasia, Cervix|Dysplasia, Uterine Cervical	Cancer|Urogenital disease (female)
Uterine Cervical Erosion	MESH:D002579	DO:DOID:3456	Loss or destruction of the epithelial lining of the UTERINE CERVIX.	MESH:D002577	C12.050.351.500.852.593.112|C12.100.250.852.593.112	C12.050.351.500.852.593|C12.100.250.852.593	Cervical Erosion, Uterine|Cervix Erosion|Cervix Erosion, Uterine|Erosion, Cervix|Erosion, Uterine Cervical|Erosion, Uterine Cervix|Uterine Cervix Erosion	Urogenital disease (female)
Uterine Cervical Neoplasms	MESH:D002583	DO:DOID:4362|OMIM:603956	Tumors or cancer of the UTERINE CERVIX.	MESH:D002577|MESH:D014594	C04.588.945.418.948.850|C12.050.351.500.852.593.131|C12.050.351.500.852.762.850|C12.050.351.937.418.875.850|C12.100.250.852.593.131|C12.100.250.852.762.850|C12.900.418.875.850	C04.588.945.418.948|C12.050.351.500.852.593|C12.050.351.500.852.762|C12.050.351.937.418.875|C12.100.250.852.593|C12.100.250.852.762|C12.900.418.875	Cancer, Cervix|Cancer of Cervix|Cancer of the Cervix|Cancer of the Uterine Cervix|Cancers, Cervix|Cancers, Uterine Cervical|Cancer, Uterine Cervical|Cervical Cancer|Cervical Cancers, Uterine|Cervical Cancer, Uterine|Cervical Neoplasm|Cervical Neoplasms|Cervical Neoplasms, Uterine|Cervical Neoplasm, Uterine|Cervix Cancer|Cervix Neoplasm|Cervix Neoplasms|Neoplasm, Cervical|Neoplasm, Cervix|Neoplasms, Cervical|Neoplasms, Cervix|Neoplasms, Uterine Cervical|Neoplasm, Uterine Cervical|Uterine Cervical Cancer|Uterine Cervical Cancers|Uterine Cervical Neoplasm	Cancer|Urogenital disease (female)
Uterine Cervicitis	MESH:D002575	DO:DOID:2568	Inflammation of the UTERINE CERVIX.	MESH:D002577	C12.050.351.500.852.593.150|C12.100.250.852.593.150	C12.050.351.500.852.593|C12.100.250.852.593	Cervicitides|Cervicitides, Uterine|Cervicitis|Cervicitis, Uterine|Uterine Cervicitides	Urogenital disease (female)
Uterine Diseases	MESH:D014591	DO:DOID:345	Pathological processes involving any part of the UTERUS.	MESH:D005831	C12.050.351.500.852|C12.100.250.852	C12.050.351.500|C12.100.250	Disease, Endometrial|Diseases, Endometrial|Diseases, Uterine|Disease, Uterine|Endometrial Disease|Endometrial Diseases|Uterine Disease	Urogenital disease (female)
Uterine Hemorrhage	MESH:D014592		Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.	MESH:D006470|MESH:D014591	C12.050.351.500.852.691|C12.100.250.852.691|C23.550.414.993	C12.050.351.500.852|C12.100.250.852|C23.550.414	Bleedings, Vaginal|Bleeding, Uterine|Bleeding, Vaginal|Hemorrhage, Uterine|Uterine Bleeding|Uterine Bleedings|Uterine Hemorrhages|Vaginal Bleeding|Vaginal Bleedings	Pathology (process)|Urogenital disease (female)
Uterine Neoplasms	MESH:D014594	DO:DOID:363	Tumors or cancer of the UTERUS.	MESH:D005833|MESH:D014591	C04.588.945.418.948|C12.050.351.500.852.762|C12.050.351.937.418.875|C12.100.250.852.762|C12.900.418.875	C04.588.945.418|C12.050.351.500.852|C12.050.351.937.418|C12.100.250.852|C12.900.418	Cancer of the Uterus|Cancer of Uterus|Cancers, Uterine|Cancers, Uterus|Cancer, Uterine|Cancer, Uterus|Neoplasms, Uterine|Neoplasms, Uterus|Neoplasm, Uterine|Neoplasm, Uterus|Uterine Cancer|Uterine Cancers|Uterine Neoplasm|Uterus Cancer|Uterus Cancers|Uterus Neoplasm|Uterus Neoplasms	Cancer|Urogenital disease (female)
Uterine Perforation	MESH:D014595		A hole or break through the wall of the UTERUS, usually made by the placement of an instrument or INTRAUTERINE DEVICES.	MESH:D014597	C12.050.351.500.852.904.500|C12.100.250.852.904.500|C26.761.853.500	C12.050.351.500.852.904|C12.100.250.852.904|C26.761.853	Perforations, Uterine|Perforation, Uterine|Uterine Perforations	Urogenital disease (female)|Wounds and injuries
Uterine Prolapse	MESH:D014596		Downward displacement of the UTERUS. It is classified in various degrees: in the first degree the UTERINE CERVIX is within the vaginal orifice; in the second degree the cervix is outside the orifice; in the third degree the entire uterus is outside the orifice.	MESH:D014591|MESH:D056887	C12.050.351.500.852.833|C12.100.250.852.833|C23.300.842.624.750	C12.050.351.500.852|C12.100.250.852|C23.300.842.624	Prolapses, Uterine|Prolapses, Vaginal|Prolapse, Uterine|Prolapse, Vaginal|Uterine Prolapses|Vaginal Prolapse|Vaginal Prolapses	Pathology (anatomical condition)|Urogenital disease (female)
Uterine Retroversion	MESH:D060725		A condition in which the UTERUS is found tilted backward toward the spine. The uterus is more commonly found in a straight vertical or anteverted (tipped forward) position. Although retroverted uterus is a normal variant position without symptoms, it is sometimes associated with pain, discomfort and other pregnancy complications.	MESH:D014102|MESH:D014591	C12.050.351.500.852.900|C12.100.250.852.900|C23.300.970.750	C12.050.351.500.852|C12.100.250.852|C23.300.970	Gravid Uterus, Retroverted|Incarcerated Retroverted Uterus|Retroflexed Uterus|Retroflexions, Uterine|Retroflexion, Uterine|Retroversions, Uterine|Retroversion, Uterine|Retroverted Gravid Uterus|Retroverted Uterus|Retroverted Uterus, Incarcerated|Tipped Uterus|Uterine Retroflexion|Uterine Retroflexions|Uterine Retroversions|Uterus, Incarcerated Retroverted|Uterus, Retroflexed|Uterus, Retroverted|Uterus, Retroverted Gravid|Uterus, Tipped	Pathology (anatomical condition)|Urogenital disease (female)
Uterus Bicornis Bicollis With Partial Vaginal Septum And Unilateral Hematocolpos With Ipsilateral Renal Agenesis	MESH:C566010			MESH:D006399	C12.050.351.500.894.300/C566010|C12.100.250.894.300/C566010	C12.050.351.500.894.300|C12.100.250.894.300		Urogenital disease (female)
Uveal Diseases	MESH:D014603	DO:DOID:3480	Diseases of the uvea.	MESH:D005128	C11.941	C11	Diseases, Uveal|Disease, Uveal|Uveal Disease	Eye disease
Uveal Effusion Syndrome	MESH:D000080323		Rare disease characterized by suprachoroidal fluid accumulation between the CHOROID and the SCLERA, annular detachment of the CHOROID, often with secondary RETINAL DETACHMENT; OPTIC DISK EDEMA, and minimal signs of UVEITIS and INTRAOCULAR PRESSURE changes.	MESH:D000080324	C11.250.105.500|C11.941.160.241.500	C11.250.105|C11.941.160.241	Uveal Effusion Syndromes	Eye disease
Uveal melanoma	MESH:C536494	DO:DOID:6039|OMIM:155720|OMIM:606660|OMIM:606661		MESH:D008545|MESH:D014604	C04.557.465.625.650.510/C536494|C04.557.580.625.650.510/C536494|C04.557.665.510/C536494|C04.588.364.978/C536494|C11.319.494/C536494|C11.941.855/C536494	C04.557.465.625.650.510|C04.557.580.625.650.510|C04.557.665.510|C04.588.364.978|C11.319.494|C11.941.855	Melanoma of the Uvea|Melanoma, Uveal|MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1|MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2|UVM1|UVM2	Cancer|Eye disease
Uveal Neoplasms	MESH:D014604		Tumors or cancer of the UVEA.	MESH:D005134|MESH:D014603	C04.588.364.978|C11.319.494|C11.941.855	C04.588.364|C11.319|C11.941	Neoplasms, Uveal|Neoplasm, Uveal|Uveal Neoplasm	Cancer|Eye disease
Uveitis	MESH:D014605	DO:DOID:13141	Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)	MESH:D014603	C11.941.879	C11.941	Uveitides	Eye disease
Uveitis, Anterior	MESH:D014606	DO:DOID:1407	Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens (posterior synechiae). Intraocular pressure may be increased or reduced.	MESH:D015864	C11.941.879.780.880	C11.941.879.780	Anterior Uveitides|Anterior Uveitis|Uveitides, Anterior	Eye disease
Uveitis, Intermediate	MESH:D015867	DO:DOID:12732	Inflammation of the pars plana, ciliary body, and adjacent structures.	MESH:D014605	C11.941.879.900	C11.941.879	Chronic Cyclitis|Cyclitis, Chronic|Intermediate Uveitis	Eye disease
Uveitis, Posterior	MESH:D015866	DO:DOID:12574	Inflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis.	MESH:D015864	C11.941.879.780.900	C11.941.879.780	Posterior Uveitis	Eye disease
Uveomeningoencephalitic Syndrome	MESH:D014607	DO:DOID:12297	A syndrome characterized by bilateral granulomatous UVEITIS with IRITIS and secondary GLAUCOMA, premature ALOPECIA, symmetrical VITILIGO, poliosis circumscripta (a strand of depigmented hair), HEARING DISORDERS, and meningeal signs (neck stiffness and headache). Examination of the cerebrospinal fluid reveals a pattern consistent with MENINGITIS, ASEPTIC. (Adams et al., Principles of Neurology, 6th ed, p748; Surv Ophthalmol 1995 Jan;39(4):265-292)	MESH:D014605|MESH:D020274	C10.114.843|C11.941.879.980|C20.111.258.925	C10.114|C11.941.879|C20.111.258	Disease, Vogt-Koyanagi-Harada|Syndrome, Uveomeningoencephalitic|Syndrome, VKH|Syndrome, VKH (Vogt Koyanagi Harada)|Syndrome, Vogt Koyanagi Harada|Syndrome, Vogt-Koyanagi-Harada|Uveomeningoencephalitides|Uveomeningoencephalitis|VKH Syndrome|VKH Syndrome (Vogt Koyanagi Harada)|VKH (Vogt Koyanagi Harada) Syndrome|Vogt Koyanagi Harada Disease|Vogt-Koyanagi-Harada Disease|Vogt Koyanagi Harada Syndrome|Vogt-Koyanagi-Harada Syndrome	Eye disease|Immune system disease|Nervous system disease
Uveoparotid Fever	MESH:D014608	DO:DOID:13404	A manifestation of sarcoidosis marked by chronic inflammation of the parotid gland and the uvea.	MESH:D012507	C15.604.515.827.865	C15.604.515.827	Fevers, Uveoparotid|Fever, Uveoparotid|Heerfordt Syndrome|Syndrome, Heerfordt|Uveoparotid Fevers|Uveoparotitides|Uveoparotitis	Lymphatic disease
UV-Sensitive Syndrome	MESH:C563466	DO:DOID:0060240|OMIM:600630|OMIM:614621|OMIM:614640		MESH:D010787	C17.800.600/C563466	C17.800.600	UV-SENSITIVE SYNDROME 1|UV-SENSITIVE SYNDROME 2|UV-SENSITIVE SYNDROME 3|UVSS1|UVSS2|UVSS3	Skin disease
Vaccine-Preventable Diseases	MESH:D000079263		Diseases for which vaccines exist that can confer partial or complete protection. (World Health Organization vaccine-safety-training.org)	MESH:D007239	C01.918	C01	Diseases, Vaccine Preventable|Diseases, Vaccine-Preventable|Disease, Vaccine-Preventable|Preventable Diseases, Vaccine|Preventable Disease, Vaccine|Vaccine Preventable Disease|Vaccine-Preventable Disease|Vaccine Preventable Diseases	
Vaccinia	MESH:D014615	DO:DOID:3298	The cutaneous and occasional systemic reactions associated with vaccination using smallpox (variola) vaccine.	MESH:D011213	C01.925.256.743.929	C01.925.256.743	Vaccinias	Viral disease
VACTERL association	MESH:C536495			MESH:D006330|MESH:D017880	C05.660.585/C536495|C14.240.400/C536495|C14.280.400/C536495|C16.131.240.400/C536495|C16.131.621.585/C536495	C05.660.585|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.585	VACTEL Association|VACTERL Syndrome|Vertebral Anal Tracheoesophageal Esophageal Radial anomalies	Cardiovascular disease|Congenital abnormality|Musculoskeletal disease
Vaginal Discharge	MESH:D019522	DO:DOID:3767	A common gynecologic disorder characterized by an abnormal, nonbloody discharge from the genital tract.	MESH:D014623	C12.050.351.500.894.700|C12.100.250.894.700	C12.050.351.500.894|C12.100.250.894	Discharges, Vaginal|Discharge, Vaginal|Vaginal Discharges	Urogenital disease (female)
Vaginal Diseases	MESH:D014623	DO:DOID:121	Pathological processes of the VAGINA.	MESH:D005831	C12.050.351.500.894|C12.100.250.894	C12.050.351.500|C12.100.250	Diseases, Vaginal|Disease, Vaginal|Vaginal Disease	Urogenital disease (female)
Vaginal Fistula	MESH:D014624		An abnormal anatomical passage that connects the VAGINA to other organs, such as the bladder (VESICOVAGINAL FISTULA) or the rectum (RECTOVAGINAL FISTULA).	MESH:D005402|MESH:D014623	C12.050.351.500.894.767|C12.100.250.894.767|C23.300.575.925	C12.050.351.500.894|C12.100.250.894|C23.300.575	Fistulas, Vaginal|Fistula, Vaginal|Vaginal Fistulas	Pathology (anatomical condition)|Urogenital disease (female)
Vaginal Neoplasms	MESH:D014625	DO:DOID:119	Tumors or cancer of the VAGINA.	MESH:D005833|MESH:D014623	C04.588.945.418.955|C12.050.351.500.894.834|C12.050.351.937.418.937|C12.100.250.894.834|C12.900.418.937	C04.588.945.418|C12.050.351.500.894|C12.050.351.937.418|C12.100.250.894|C12.900.418	Cancer of the Vagina|Cancer of Vagina|Cancers, Vagina|Cancers, Vaginal|Cancer, Vagina|Cancer, Vaginal|Neoplasms, Vagina|Neoplasms, Vaginal|Neoplasm, Vagina|Neoplasm, Vaginal|Vagina Cancer|Vagina Cancers|Vaginal Cancer|Vaginal Cancers|Vaginal Neoplasm|Vagina Neoplasm|Vagina Neoplasms	Cancer|Urogenital disease (female)
Vaginismus	MESH:D052065		Recurrent or persistent involuntary SPASM of the outer muscles of the VAGINA, occurring during vaginal penetration.	MESH:D005831|MESH:D012735|MESH:D014623|MESH:D020018	C12.050.351.500.894.870|C12.050.351.500.919|C12.100.250.894.870|C12.100.250.919|C12.100.875.871|F03.835.900	C12.050.351.500|C12.050.351.500.894|C12.100.250|C12.100.250.894|C12.100.875|F03.835		Mental disorder|Urogenital disease (female)
Vaginitis	MESH:D014627	DO:DOID:2170	Inflammation of the vagina characterized by pain and a purulent discharge.	MESH:D014623	C12.050.351.500.894.906|C12.100.250.894.906	C12.050.351.500.894|C12.100.250.894	Vaginitides	Urogenital disease (female)
Vagus Nerve Diseases	MESH:D020421	DO:DOID:12491	Diseases of the tenth cranial nerve, including brain stem lesions involving its nuclei (solitary, ambiguus, and dorsal motor), nerve fascicles, and intracranial and extracranial course. Clinical manifestations may include dysphagia, vocal cord weakness, and alterations of parasympathetic tone in the thorax and abdomen.	MESH:D003389	C10.292.887	C10.292	Cranial Nerve X Diseases|Disorder, Pneumogastric Nerve|Disorders, Pneumogastric Nerve|Motor Disorder, Vagus Nerve|Neuropathies, Vagus|Neuropathy, Vagus|Pneumogastric Nerve Disorder|Pneumogastric Nerve Disorders|Sensory Disorder, Vagus Nerve|Tenth Cranial Nerve Diseases|Vagus Nerve Disease|Vagus Nerve Disorder|Vagus Nerve Disorders|Vagus Nerve Motor Disorder|Vagus Nerve Sensory Disorder|Vagus Neuropathies|Vagus Neuropathy	Nervous system disease
Vagus Nerve Injuries	MESH:D061223		Traumatic injuries to the VAGUS NERVE. Because the vagus nerve innervates multiple organs, injuries in the nerve fibers may result in any gastrointestinal organ dysfunction downstream of the injury site.	MESH:D020209|MESH:D020421	C10.292.200.937|C10.292.887.399|C10.900.300.218.887|C26.915.300.400.912	C10.292.200|C10.292.887|C10.900.300.218|C26.915.300.400	Avulsions, Vagus Nerve|Avulsion, Vagus Nerve|Contusions, Vagus Nerve|Contusion, Vagus Nerve|Cranial Nerve X Injury|Injuries, Vagus Nerve|Injury, Cranial Nerve X|Injury, Tenth Cranial Nerve|Injury, Vagus Nerve|Nerve Avulsions, Vagus|Nerve Avulsion, Vagus|Nerve Contusions, Vagus|Nerve Contusion, Vagus|Nerve Injuries, Vagus|Nerve Injury, Vagus|Nerve Transections, Vagus|Nerve Transection, Vagus|Nerve Traumas, Vagus|Nerve Trauma, Vagus|Neuropathies, Traumatic Vagus|Neuropathy, Traumatic Vagus|Palsies, Traumatic Tenth-Nerve|Palsy, Traumatic Tenth-Nerve|Tenth Cranial Nerve Injuries|Tenth Cranial Nerve Injury|Tenth-Nerve Palsies, Traumatic|Tenth Nerve Palsy, Traumatic|Tenth-Nerve Palsy, Traumatic|Tenth Nerve Trauma|Tenth-Nerve Trauma|Tenth-Nerve Traumas|Transections, Vagus Nerve|Transection, Vagus Nerve|Traumas, Tenth-Nerve|Traumas, Vagus Nerve|Trauma, Tenth-Nerve|Traumatic Tenth-Nerve Palsies|Traumatic Tenth Nerve Palsy|Traumatic Tenth-Nerve Palsy|Traumatic Vagus Neuropathies|Traumatic Vagus Neuropathy|Trauma, Vagus Nerve|Vagus Nerve Avulsion|Vagus Nerve Avulsions|Vagus Nerve Contusion|Vagus Nerve Contusions|Vagus Nerve Injury|Vagus Nerve Transection|Vagus Nerve Transections|Vagus Nerve Trauma|Vagus Nerve Traumas|Vagus Neuropathies, Traumatic|Vagus Neuropathy, Traumatic	Nervous system disease|Wounds and injuries
Van der Woude syndrome	MESH:C536528	DO:DOID:0060239|OMIM:119300		MESH:D000015|MESH:D002971|MESH:D002972|MESH:D003560	C04.182/C536528|C05.500.460.185/C536528|C05.660.207.540.460.185/C536528|C07.320.440.185/C536528|C07.465.409.225/C536528|C07.465.525.164/C536528|C07.465.525.185/C536528|C07.650.500.460.185/C536528|C07.650.525.164/C536528|C07.650.525.185/C536528|C16.131.077/C536528|C16.131.621.207.540.460.185/C536528|C16.131.850.500.460.185/C536528|C16.131.850.525.164/C536528|C16.131.850.525.185/C536528|C23.300.306/C536528	C04.182|C05.500.460.185|C05.660.207.540.460.185|C07.320.440.185|C07.465.409.225|C07.465.525.164|C07.465.525.185|C07.650.500.460.185|C07.650.525.164|C07.650.525.185|C16.131.077|C16.131.621.207.540.460.185|C16.131.850.500.460.185|C16.131.850.525.164|C16.131.850.525.185|C23.300.306	Cleft lip and-or palate with mucous cysts of lower lip|CLEFT LIP AND/OR PALATE WITH MUCOUS CYSTS OF LOWER LIP|Lip pit syndrome|Lip-Pit Syndrome|LPS|PIT|VAN DER WOUDE SYNDROME 1|VDWS|VWS1	Cancer|Congenital abnormality|Mouth disease|Musculoskeletal disease|Pathology (anatomical condition)
VAN DER WOUDE SYNDROME 1, MODIFIER OF	OMIM:604547			MESH:C536528	C04.182/C536528/604547|C05.500.460.185/C536528/604547|C05.660.207.540.460.185/C536528/604547|C07.320.440.185/C536528/604547|C07.465.409.225/C536528/604547|C07.465.525.164/C536528/604547|C07.465.525.185/C536528/604547|C07.650.500.460.185/C536528/604547|C07.650.525.164/C536528/604547|C07.650.525.185/C536528/604547|C16.131.077/C536528/604547|C16.131.621.207.540.460.185/C536528/604547|C16.131.850.500.460.185/C536528/604547|C16.131.850.525.164/C536528/604547|C16.131.850.525.185/C536528/604547|C23.300.306/C536528/604547	C04.182/C536528|C05.500.460.185/C536528|C05.660.207.540.460.185/C536528|C07.320.440.185/C536528|C07.465.409.225/C536528|C07.465.525.164/C536528|C07.465.525.185/C536528|C07.650.500.460.185/C536528|C07.650.525.164/C536528|C07.650.525.185/C536528|C16.131.077/C536528|C16.131.621.207.540.460.185/C536528|C16.131.850.500.460.185/C536528|C16.131.850.525.164/C536528|C16.131.850.525.185/C536528|C23.300.306/C536528	VWSM	Cancer|Congenital abnormality|Mouth disease|Musculoskeletal disease|Pathology (anatomical condition)
Vanishing White Matter Leukodystrophy with Ovarian Failure	MESH:C565836	OMIM:603896		MESH:D010049|MESH:D056784	C10.228.140.695/C565836|C12.050.351.500.056.630/C565836|C12.100.250.056.630/C565836|C19.391.630/C565836	C10.228.140.695|C12.050.351.500.056.630|C12.100.250.056.630|C19.391.630	CACH|CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION|CREE LEUKOENCEPHALOPATHY;CLE VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILURE, INCLUDED|LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER|Ovarioleukodystrophy|OVARIOLEUKODYSTROPHY, INCLUDED|VANISHING WHITE MATTER LEUKODYSTROPHY|VWM	Endocrine system disease|Nervous system disease|Urogenital disease (female)
Varicella, Severe Recurrent	MESH:C563458			MESH:D002644	C01.925.256.466.930.250/C563458	C01.925.256.466.930.250		Viral disease
Varicella Zoster Virus Infection	MESH:D000073618		Infection caused by HUMAN HERPES VIRUS 3 (e.g., CHICKENPOX and HERPES ZOSTER).	MESH:D006566	C01.925.256.466.930	C01.925.256.466	Congenital Varicella Syndrome	Viral disease
Varicocele	MESH:D014646	DO:DOID:12337	A condition characterized by the dilated tortuous veins of the SPERMATIC CORD with a marked left-sided predominance. Adverse effect on male fertility occurs when varicocele leads to an increased scrotal (and testicular) temperature and reduced testicular volume.	MESH:D005832|MESH:D014652	C12.100.500.936|C12.200.294.936|C14.907.903	C12.100.500|C12.200.294|C14.907	Varicoceles	Cardiovascular disease|Urogenital disease (male)
Varicose Ulcer	MESH:D014647		Skin breakdown or ulceration in the drainage area of a VARICOSE VEIN, usually in the leg.	MESH:D007871|MESH:D014648	C14.907.927.730|C17.800.893.592.730	C14.907.927|C17.800.893.592	Hypertension Ulcers, Venous|Hypertension Ulcer, Venous|Stasis Ulcer|Stasis Ulcers|Stasis Ulcers, Venous|Stasis Ulcer, Venous|Ulcers, Stasis|Ulcer, Stasis|Ulcers, Varicose|Ulcers, Venous|Ulcers, Venous Hypertension|Ulcers, Venous Stasis|Ulcer, Varicose|Ulcer, Venous|Ulcer, Venous Hypertension|Ulcer, Venous Stasis|Varicose Ulcers|Venous Hypertension Ulcer|Venous Hypertension Ulcers|Venous Stasis Ulcer|Venous Stasis Ulcers|Venous Ulcer|Venous Ulcers	Cardiovascular disease|Skin disease
Varicose Veins	MESH:D014648	DO:DOID:799|OMIM:192200	Enlarged and tortuous VEINS.	MESH:D014652	C14.907.927	C14.907	Varices|Varicose Vein|Varix|Veins, Varicose|Vein, Varicose	Cardiovascular disease
Vascular Calcification	MESH:D061205		Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels are associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.	MESH:D002114	C18.452.174.130.780	C18.452.174.130	Calcifications, Vascular|Calcification, Vascular|Calcinoses, Vascular|Calcinosis, Vascular|Vascular Calcifications|Vascular Calcinoses|Vascular Calcinosis	Metabolic disease
Vascular Depression	MESH:D000088323		Late-life depression associated with clinical or MRI defined cerebrovascular pathology.	MESH:D002561|MESH:D003866	C10.228.140.300.794|C14.907.253.896|F03.600.300.887	C10.228.140.300|C14.907.253|F03.600.300	Depression, Subcortical Ischemic|Depression, Vascular|Subcortical Ischemic Depression	Cardiovascular disease|Mental disorder|Nervous system disease
Vascular Diseases	MESH:D014652	DO:DOID:178	Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.	MESH:D002318	C14.907	C14	Diseases, Vascular|Disease, Vascular|Vascular Disease	Cardiovascular disease
Vascular Headaches	MESH:D014653		Secondary headache disorders attributed to a variety of cranial or cervical vascular disorders, such as BRAIN ISCHEMIA; INTRACRANIAL HEMORRHAGES; and CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS.	MESH:D002561|MESH:D051271	C10.228.140.300.800|C10.228.140.546.699.500|C14.907.253.937	C10.228.140.300|C10.228.140.546.699|C14.907.253	Cephalgias, Vascular|Cephalgia, Vascular|Headaches, Vascular|Headache, Vascular|Vascular Cephalgia|Vascular Cephalgias|Vascular Headache	Cardiovascular disease|Nervous system disease
Vascular Malformation, Primary Intraosseous	MESH:C564648	OMIM:606893		MESH:D054079	C14.240.850/C564648|C16.131.240.850/C564648	C14.240.850|C16.131.240.850	Hemangioma, Intraosseous|Vascular Malformation Osseous|VMOS|VMPI	Cardiovascular disease|Congenital abnormality
Vascular Malformations	MESH:D054079		A spectrum of congenital, inherited, or acquired abnormalities in BLOOD VESSELS that can adversely affect the normal blood flow in ARTERIES or VEINS. Most are congenital defects such as abnormal communications between blood vessels (fistula), shunting of arterial blood directly into veins bypassing the CAPILLARIES (arteriovenous malformations), formation of large dilated blood blood-filled vessels (cavernous angioma), and swollen capillaries (capillary telangiectases). In rare cases, vascular malformations can result from trauma or diseases.	MESH:D018376	C14.240.850|C16.131.240.850	C14.240|C16.131.240	Malformations, Vascular|Malformation, Vascular|Vascular Malformation	Cardiovascular disease|Congenital abnormality
Vascular Neoplasms	MESH:D019043	DO:DOID:175	Neoplasms located in the vasculature system, such as ARTERIES and VEINS. They are differentiated from neoplasms of vascular tissue (NEOPLASMS, VASCULAR TISSUE), such as ANGIOFIBROMA or HEMANGIOMA.	MESH:D012983|MESH:D014652	C04.588.839.750|C14.907.936	C04.588.839|C14.907	Neoplasms, Vascular|Neoplasm, Vascular|Vascular Neoplasm	Cancer|Cardiovascular disease
Vascular purpura	MESH:C537256			MESH:D011695	C14.907.940.777/C537256|C15.378.100.802.375/C537256|C15.378.463.515.580/C537256|C20.543.520.600/C537256|C23.550.414.950.375/C537256|C23.888.885.687.375/C537256	C14.907.940.777|C15.378.100.802.375|C15.378.463.515.580|C20.543.520.600|C23.550.414.950.375|C23.888.885.687.375		Blood disease|Cardiovascular disease|Immune system disease|Pathology (process)|Signs and symptoms
Vascular Ring	MESH:D000073872		Congenital vascular malformation in which the AORTA arch and its branches encircle the TRACHEA and ESOPHAGUS. Signs and symptoms include DYSPNEA; RESPIRATORY SOUNDS, especially with eating, DYSPHAGIA, persistent cough, and GASTROESOPHAGEAL REFLUX or may be asymptomatic. Two most common types are double aortic arch and right aortic arch. It may be associated with other anomalies (e.g., DIGEORGE SYNDROME).	MESH:D001015|MESH:D054079	C14.240.850.992|C14.907.109.239.825|C16.131.240.850.984	C14.240.850|C14.907.109.239|C16.131.240.850	Aortic Arch, Double|Double Aortic Arch|Right Aortic Arch Syndrome|Right Aortic Arch with Left Ligamentum Arteriosum|Vascular Rings	Cardiovascular disease|Congenital abnormality
Vascular System Injuries	MESH:D057772		Injuries to blood vessels caused by laceration, contusion, puncture, or crush and other types of injuries. Symptoms vary by site and mode of injuries and may include bleeding, bruising, swelling, pain, and numbness. It does not include injuries secondary to pathologic function or diseases such as ATHEROSCLEROSIS.	MESH:D014652|MESH:D014947	C14.907.937|C26.940	C14.907|C26	Injuries, Vascular|Injuries, Vascular System|Injury, Vascular|Injury, Vascular System|System Injuries, Vascular|System Injury, Vascular|Vascular Injuries|Vascular Injury|Vascular System Injury	Cardiovascular disease|Wounds and injuries
Vasculitis	MESH:D014657	DO:DOID:865	Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.	MESH:D014652	C14.907.940	C14.907	Angiitides|Angiitis|Vasculitides	Cardiovascular disease
Vasculitis, Central Nervous System	MESH:D020293	DO:DOID:2555|DO:DOID:525	Inflammation of blood vessels within the central nervous system. Primary vasculitis is usually caused by autoimmune or idiopathic factors, while secondary vasculitis is caused by existing disease process. Clinical manifestations are highly variable but include HEADACHE; SEIZURES; behavioral alterations; INTRACRANIAL HEMORRHAGES; TRANSIENT ISCHEMIC ATTACK; and BRAIN INFARCTION. (From Adams et al., Principles of Neurology, 6th ed, pp856-61)	MESH:D002561|MESH:D014657|MESH:D020274	C10.114.875|C10.228.140.300.850|C14.907.253.946|C14.907.940.907|C20.111.258.962	C10.114|C10.228.140.300|C14.907.253|C14.907.940|C20.111.258	Angiitis, Central Nervous System|Angiitis, Cerebral|Angiitis, Granulomatous|Arteritis, Granulomatous|Arteritis, Postzoster|Central Nervous System Angiitis|Central Nervous System Vasculitis|Cerebral Angiitis|Cerebral Vasculitis|CNS Vasculitis|CNS Vasculitis, Primary|CNS Vasculitis, Secondary|Granulomatous Angiitis|Granulomatous Arteritis|Postzoster Arteritis|Primary Central Nervous System Vasculitis|Primary CNS Vasculitis|Secondary CNS Vasculitis|Vasculitis, Cerebral|Vasculitis, CNS|Vasculitis, CNS, Secondary|Vasculitis, Primary CNS|Vasculitis, Secondary CNS	Cardiovascular disease|Immune system disease|Nervous system disease
Vasculitis, Leukocytoclastic, Cutaneous	MESH:D018366	DO:DOID:9809	Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.	MESH:D007105|MESH:D014657	C14.907.940.910|C20.543.520.910	C14.907.940|C20.543.520	Allergic Cutaneous Angiitides|Allergic Cutaneous Angiitis|Allergic Cutaneous Vasculitides|Allergic Cutaneous Vasculitis|Allergic Vasculitides, Cutaneous|Allergic Vasculitis, Cutaneous|Angiitides, Allergic Cutaneous|Angiitides, Cutaneous Leukocytoclastic|Angiitides, Hypersensitivity|Angiitis, Allergic Cutaneous|Angiitis, Cutaneous Leukocytoclastic|Angiitis, Hypersensitivity|Cutaneous Allergic Vasculitides|Cutaneous Allergic Vasculitis|Cutaneous Angiitides, Allergic|Cutaneous Angiitis, Allergic|Cutaneous Leukocytoclastic Angiitides|Cutaneous Leukocytoclastic Angiitis|Cutaneous Leukocytoclastic Vasculitides|Cutaneous Leukocytoclastic Vasculitis|Cutaneous Vasculitides, Allergic|Cutaneous Vasculitis, Allergic|Hypersensitivity Angiitides|Hypersensitivity Angiitis|Hypersensitivity Vasculitides|Hypersensitivity Vasculitis|Leukocytoclastic Angiitides, Cutaneous|Leukocytoclastic Angiitis, Cutaneous|Leukocytoclastic Vasculitides, Cutaneous|Leukocytoclastic Vasculitis, Cutaneous|Vasculitides, Allergic Cutaneous|Vasculitides, Cutaneous Allergic|Vasculitides, Cutaneous Leukocytoclastic|Vasculitides, Hypersensitivity|Vasculitis, Allergic Cutaneous|Vasculitis, Cutaneous Allergic|Vasculitis, Cutaneous Leukocytoclastic|Vasculitis, Hypersensitivity	Cardiovascular disease|Immune system disease
Vasculitis, Lymphocytic, Cutaneous Small Vessel	MESH:C565222			MESH:D014657	C14.907.940/C565222	C14.907.940		Cardiovascular disease
Vasculitis, Lymphocytic, Nodular	MESH:C566008			MESH:D008206|MESH:D014657	C14.907.940/C566008|C15.604/C566008	C14.907.940|C15.604		Cardiovascular disease|Lymphatic disease
Vasoplegia	MESH:D056987		Condition of low SYSTEMIC VASCULAR RESISTANCE that develops secondary to other conditions such as ANAPHYLAXIS; SEPSIS; SURGICAL SHOCK; and SEPTIC SHOCK. Vasoplegia that develops during or post surgery (e.g., CARDIOPULMONARY BYPASS) is called postoperative vasoplegic syndrome or vasoplegic syndrome.	MESH:D011183|MESH:D014652	C14.907.946|C23.550.767.962	C14.907|C23.550.767	Post operative Vasoplegic Syndrome|Post-operative Vasoplegic Syndrome|Postoperative Vasoplegic Syndrome|Post-operative Vasoplegic Syndromes|Syndrome, Post-operative Vasoplegic|Syndromes, Post-operative Vasoplegic|Vasoplegias|Vasoplegic Syndrome|Vasoplegic Syndrome, Post-operative|Vasoplegic Syndromes, Post-operative	Cardiovascular disease|Pathology (process)
Vasospasm, Intracranial	MESH:D020301	DO:DOID:13100	Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).	MESH:D002561	C10.228.140.300.900|C14.907.253.951	C10.228.140.300|C14.907.253	Angiospasm, Cerebral|Angiospasm, Intracranial|Angiospasms, Cerebral|Angiospasms, Intracranial|Artery Spasm, Cerebral|Artery Spasms, Cerebral|Cerebral Angiospasm|Cerebral Angiospasms|Cerebral Artery Spasm|Cerebral Artery Spasms|Cerebral Vasospasm|Cerebral Vasospasms|Cerebrovascular Spasm|Cerebrovascular Spasms|Intracranial Angiospasm|Intracranial Angiospasms|Intracranial Vascular Spasm|Intracranial Vascular Spasms|Intracranial Vasospasm|Intracranial Vasospasms|Spasm, Cerebral Artery|Spasm, Cerebrovascular|Spasm, Intracranial Vascular|Spasms, Cerebral Artery|Spasms, Cerebrovascular|Spasms, Intracranial Vascular|Vascular Spasm, Intracranial|Vascular Spasms, Intracranial|Vasospasm, Cerebral|Vasospasms, Cerebral|Vasospasms, Intracranial	Cardiovascular disease|Nervous system disease
VATER association	MESH:C536534	DO:DOID:14679|OMIM:192350		MESH:D001006|MESH:D006330	C06.198.050/C536534|C14.240.400/C536534|C14.280.400/C536534|C16.131.240.400/C536534|C16.131.314.094/C536534	C06.198.050|C14.240.400|C14.280.400|C16.131.240.400|C16.131.314.094	VATER/VACTERL ASSOCIATION|Vertebral defects, Anal atresia, Tracheoesophageal fistula with Esophageal atresia, and Radial dysplasia	Cardiovascular disease|Congenital abnormality|Digestive system disease
Vater Association With Hydrocephalus	MESH:C564752			MESH:D001006|MESH:D006330|MESH:D006849|MESH:D014138|MESH:D058627	C05.660.207.536/C564752|C06.198.050/C564752|C06.267.250.725/C564752|C06.405.117.367.725/C564752|C08.702.750/C564752|C08.907.863/C564752|C10.228.140.602/C564752|C10.500.507.400.249/C564752|C14.240.400/C564752|C14.280.400/C564752|C16.131.240.400/C564752|C16.131.314.094/C564752|C16.131.621.207.532/C564752|C16.131.666.507.400.249/C564752|C23.300.575.185.250.725/C564752	C05.660.207.536|C06.198.050|C06.267.250.725|C06.405.117.367.725|C08.702.750|C08.907.863|C10.228.140.602|C10.500.507.400.249|C14.240.400|C14.280.400|C16.131.240.400|C16.131.314.094|C16.131.621.207.532|C16.131.666.507.400.249|C23.300.575.185.250.725	Vater Association With Macrocephaly And Ventriculomegaly	Cardiovascular disease|Congenital abnormality|Digestive system disease|Musculoskeletal disease|Nervous system disease|Pathology (anatomical condition)|Respiratory tract disease
Vater-Like Defects with Pulmonary Hypertension, Laryngeal Webs, and Growth Deficiency	MESH:C564244			MESH:D006130|MESH:D006330|MESH:D006976	C08.381.423/C564244|C14.240.400/C564244|C14.280.400/C564244|C14.907.489.556/C564244|C16.131.240.400/C564244|C23.550.393/C564244	C08.381.423|C14.240.400|C14.280.400|C14.907.489.556|C16.131.240.400|C23.550.393		Cardiovascular disease|Congenital abnormality|Pathology (process)|Respiratory tract disease
VDAC Deficiency	MESH:C565767			MESH:D028361	C18.452.660/C565767	C18.452.660		Metabolic disease
Vector Borne Diseases	MESH:D000079426		Infectious diseases transmitted by DISEASE VECTORS.	MESH:D007239	C01.920	C01	Mosquito Borne Disease|Mosquito-Borne Disease|Mosquito Borne Diseases|Mosquito-Borne Diseases|Vectorborne Disease|Vector Borne Disease|Vector-Borne Disease|Vectorborne Diseases|Vector-Borne Diseases	
Vein of Galen aneurysm	MESH:C536535			MESH:D054080	C10.228.140.300.520.500/C536535|C10.500.190.500.500/C536535|C14.240.850.750.295.500/C536535|C14.240.850.875.500.500/C536535|C14.907.150.295.500/C536535|C14.907.253.560.400.500/C536535|C16.131.240.850.750.295.500/C536535|C16.131.240.850.875.500.500/C536535|C16.131.666.190.500.500/C536535	C10.228.140.300.520.500|C10.500.190.500.500|C14.240.850.750.295.500|C14.240.850.875.500.500|C14.907.150.295.500|C14.907.253.560.400.500|C16.131.240.850.750.295.500|C16.131.240.850.875.500.500|C16.131.666.190.500.500	Ectasia or varix of the vein of Galen|Galenic arteriovenous malformation|Galen vein aneurysm|Vein of Galen aneurysm malformation	Cardiovascular disease|Congenital abnormality|Nervous system disease
Vein of Galen Malformations	MESH:D054080		Congenital arteriovenous malformation involving the VEIN OF GALEN, a large deep vein at the base of the brain. The rush of arterial blood directly into the vein of Galen, without passing through the CAPILLARIES, can overwhelm the heart and lead to CONGESTIVE HEART FAILURE.	MESH:D002538	C10.228.140.300.520.500|C10.500.190.500.500|C14.240.850.750.295.500|C14.240.850.875.500.500|C14.907.150.295.500|C14.907.253.560.400.500|C16.131.240.850.750.295.500|C16.131.240.850.875.500.500|C16.131.666.190.500.500	C10.228.140.300.520|C10.500.190.500|C14.240.850.750.295|C14.240.850.875.500|C14.907.150.295|C14.907.253.560.400|C16.131.240.850.750.295|C16.131.240.850.875.500|C16.131.666.190.500	Galen Malformations Veins|Malformations Vein, Galen|Malformations Veins, Galen|Vein Of Galen Malformation	Cardiovascular disease|Congenital abnormality|Nervous system disease
Venous Insufficiency	MESH:D014689	DO:DOID:10128	Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.	MESH:D014652	C14.907.952	C14.907	Insufficiencies, Venous|Insufficiency, Venous|Venous Insufficiencies	Cardiovascular disease
Venous Malformations, Multiple Cutaneous and Mucosal	MESH:C563977	DO:DOID:0050792|OMIM:600195		MESH:D001165	C14.240.850.750/C563977|C14.907.150/C563977|C16.131.240.850.750/C563977	C14.240.850.750|C14.907.150|C16.131.240.850.750	Mucocutaneous Venous Malformations|Multiple Cutaneous and Mucosal Venous Malformations|VMCM|Vmcm1	Cardiovascular disease|Congenital abnormality
Venous Thromboembolism	MESH:D054556		Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.	MESH:D013923	C14.907.355.590.700	C14.907.355.590	Thromboembolism, Venous	Cardiovascular disease
Venous Thrombosis	MESH:D020246		The formation or presence of a blood clot (THROMBUS) within a vein.	MESH:D013927	C14.907.355.830.925	C14.907.355.830	Deep Vein Thromboses|Deep-Vein Thromboses|Deep Vein Thrombosis|Deep-Vein Thrombosis|Deep Venous Thromboses|Deep-Venous Thromboses|Deep Venous Thrombosis|Deep-Venous Thrombosis|Phlebothromboses|Phlebothrombosis|Thromboses, Deep Vein|Thromboses, Deep-Vein|Thromboses, Deep Venous|Thromboses, Deep-Venous|Thromboses, Venous|Thrombosis, Deep Vein|Thrombosis, Deep-Vein|Thrombosis, Deep Venous|Thrombosis, Deep-Venous|Thrombosis, Venous|Vein Thromboses, Deep|Vein Thrombosis, Deep|Venous Thromboses|Venous Thromboses, Deep|Venous Thrombosis, Deep	Cardiovascular disease
Ventilator-Induced Lung Injury	MESH:D055397		Lung damage that is caused by the adverse effects of PULMONARY VENTILATOR usage. The high frequency and tidal volumes produced by a mechanical ventilator can cause alveolar disruption and PULMONARY EDEMA.	MESH:D055370	C08.381.520.750	C08.381.520	Lung Injuries, Ventilator-Induced|Lung Injury, Ventilator Induced|Lung Injury, Ventilator-Induced|Ventilator-Induced Lung Injuries|Ventilator Induced Lung Injury	Respiratory tract disease
Ventricular Dysfunction	MESH:D018754		A condition in which HEART VENTRICLES exhibit impaired function.	MESH:D006331	C14.280.945	C14.280	Dysfunctions, Ventricular|Dysfunction, Ventricular|Ventricular Dysfunctions	Cardiovascular disease
Ventricular Dysfunction, Left	MESH:D018487		A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.	MESH:D018754	C14.280.945.900	C14.280.945	Dysfunction, Left Ventricular|Dysfunctions, Left Ventricular|Left Ventricular Dysfunction|Left Ventricular Dysfunctions|Ventricular Dysfunctions, Left	Cardiovascular disease
Ventricular Dysfunction, Right	MESH:D018497		A condition in which the RIGHT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE or MYOCARDIAL INFARCTION, and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the right ventricular wall.	MESH:D018754	C14.280.945.910	C14.280.945	Dysfunction, Right Ventricular|Dysfunctions, Right Ventricular|Right Ventricular Dysfunction|Right Ventricular Dysfunctions|Ventricular Dysfunctions, Right	Cardiovascular disease
Ventricular extrasystoles perodactyly Robin sequence	MESH:C536537			MESH:D006228|MESH:D006330|MESH:D010855	C05.390.408/C536537|C05.500.460.606/C536537|C05.660.207.540.460.606/C536537|C05.660.585.988.425/C536537|C07.320.440.606/C536537|C07.650.500.460.606/C536537|C14.240.400/C536537|C14.280.400/C536537|C16.131.240.400/C536537|C16.131.621.207.540.460.606/C536537|C16.131.621.585.988.500/C536537|C16.131.850.500.460.606/C536537	C05.390.408|C05.500.460.606|C05.660.207.540.460.606|C05.660.585.988.425|C07.320.440.606|C07.650.500.460.606|C14.240.400|C14.280.400|C16.131.240.400|C16.131.621.207.540.460.606|C16.131.621.585.988.500|C16.131.850.500.460.606		Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease
Ventricular Fibrillation	MESH:D014693		A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.	MESH:D001145	C14.280.067.922|C23.550.073.922	C14.280.067|C23.550.073	Fibrillations, Ventricular|Fibrillation, Ventricular|Ventricular Fibrillations	Cardiovascular disease|Pathology (process)
Ventricular Fibrillation, Paroxysmal Familial, 1	MESH:C567851			MESH:D014693	C14.280.067.922/C567851|C23.550.073.922/C567851	C14.280.067.922|C23.550.073.922		Cardiovascular disease|Pathology (process)
Ventricular Fibrillation, Paroxysmal Familial, 2	MESH:C567841			MESH:D014693	C14.280.067.922/C567841|C23.550.073.922/C567841	C14.280.067.922|C23.550.073.922		Cardiovascular disease|Pathology (process)
Ventricular Flutter	MESH:D054141		A potentially lethal cardiac arrhythmia characterized by an extremely rapid, hemodynamically unstable ventricular tachycardia (150-300 beats/min) with a large oscillating sine-wave appearance. If untreated, ventricular flutter typically progresses to VENTRICULAR FIBRILLATION.	MESH:D001145	C14.280.067.961|C23.550.073.961	C14.280.067|C23.550.073	Ventricular Flutters	Cardiovascular disease|Pathology (process)
Ventricular Outflow Obstruction	MESH:D014694		Occlusion of the outflow tract in either the LEFT VENTRICLE or the RIGHT VENTRICLE of the heart. This may result from CONGENITAL HEART DEFECTS, predisposing heart diseases, complications of surgery, or HEART NEOPLASMS.	MESH:D006331	C14.280.955	C14.280	Left Ventricular Outflow Obstruction|Obstructions, Ventricular Outflow|Obstruction, Ventricular Outflow|Outflow Obstruction, Left Ventricular|Outflow Obstruction, Right Ventricular|Outflow Obstructions, Ventricular|Outflow Obstruction, Ventricular|Right Ventricular Outflow Obstruction|Ventricular Outflow Obstruction, Left|Ventricular Outflow Obstruction, Right|Ventricular Outflow Obstructions	Cardiovascular disease
Ventricular Premature Complexes	MESH:D018879		A type of cardiac arrhythmia with premature contractions of the HEART VENTRICLES. It is characterized by the premature QRS complex on ECG that is of abnormal shape and great duration (generally >129 msec). It is the most common form of all cardiac arrhythmias. Premature ventricular complexes have no clinical significance except in concurrence with heart diseases.	MESH:D005117	C14.280.067.325.500|C14.280.123.375.500|C23.550.073.325.800	C14.280.067.325|C14.280.123.375|C23.550.073.325	Ectopic Beats, Ventricular|Ectopic Beat, Ventricular|Extrasystole, Ventricular|Premature Ventricular Beat|Premature Ventricular Beats|Premature Ventricular Complex|Premature Ventricular Contraction|Premature Ventricular Contractions|Ventricular Beat, Premature|Ventricular Beats, Premature|Ventricular Complex, Premature|Ventricular Contraction, Premature|Ventricular Contractions, Premature|Ventricular Ectopic Beat|Ventricular Ectopic Beats|Ventricular Extrasystole|Ventricular Extrasystoles|Ventricular Premature Complex	Cardiovascular disease|Pathology (process)
Ventricular Septal Rupture	MESH:D018658		Laceration or tearing of the VENTRICULAR SEPTUM, usually caused by MYOCARDIAL INFARCTION.	MESH:D006342	C14.280.470.475.900	C14.280.470.475	Septal Ruptures, Ventricular|Septal Rupture, Ventricular|Ventricular Septal Perforation|Ventricular Septal Ruptures	Cardiovascular disease
VENTRICULAR TACHYCARDIA, FAMILIAL	OMIM:192605			MESH:D017180	C14.280.067.845.940/192605|C14.280.123.875.940/192605|C23.550.073.845.940/192605	C14.280.067.845.940|C14.280.123.875.940|C23.550.073.845.940	VENTRICULAR TACHYCARDIA, FAMILIAL POLYMORPHIC	Cardiovascular disease|Pathology (process)
Ventriculomegaly With Defects Of The Radius And Kidney	MESH:C566565			MESH:D006849	C10.228.140.602/C566565	C10.228.140.602		Nervous system disease
Venular Insufficiency, Systemic	MESH:C566004			MESH:D014689	C14.907.952/C566004	C14.907.952		Cardiovascular disease
Verloove-Vanhorick Brubakk syndrome	MESH:C536541			MESH:D000015|MESH:D006330|MESH:D007569|MESH:D009056|MESH:D011254	C05.500.460/C536541|C05.660.207.540.460/C536541|C07.320.440/C536541|C07.465.525/C536541|C07.650.500.460/C536541|C07.650.525/C536541|C12.050.703.726/C536541|C14.240.400/C536541|C14.280.400/C536541|C16.131.077/C536541|C16.131.240.400/C536541|C16.131.621.207.540.460/C536541|C16.131.850.500.460/C536541|C16.131.850.525/C536541	C05.500.460|C05.660.207.540.460|C07.320.440|C07.465.525|C07.650.500.460|C07.650.525|C12.050.703.726|C14.240.400|C14.280.400|C16.131.077|C16.131.240.400|C16.131.621.207.540.460|C16.131.850.500.460|C16.131.850.525	Cleft Limb Heart Malformation Syndrome|Cleft-Limb-Heart Malformation Syndrome|Verloove Vanhorick Brubakk syndrome	Cardiovascular disease|Congenital abnormality|Mouth disease|Musculoskeletal disease|Pregnancy complication
Vertebral Artery Dissection	MESH:D020217		Splitting of the vessel wall in the VERTEBRAL ARTERY. Interstitial hemorrhage into the media of the vessel wall can lead to occlusion of the vertebral artery, aneurysm formation, or THROMBOEMBOLISM. Vertebral artery dissection is often associated with TRAUMA and injuries to the head-neck region but can occur spontaneously.	MESH:D000784|MESH:D020214	C10.228.140.300.350.875|C10.900.250.650|C14.907.055.050.575|C14.907.253.535.800|C26.915.200.600	C10.228.140.300.350|C10.900.250|C14.907.055.050|C14.907.253.535|C26.915.200	Artery Dissections, Vertebral|Artery Dissection, Vertebral|Dissecting Vertebral Artery Aneurysm|Dissections, Vertebral Artery|Dissection, Vertebral Artery|Spontaneous Vertebral Artery Dissection|Traumatic Vertebral Artery Dissection|Vertebral Artery Dissections|Vertebral Artery Dissection, Spontaneous|Vertebral Artery Dissection, Traumatic	Cardiovascular disease|Nervous system disease|Wounds and injuries
Vertebral Hypoplasia With Lumbar Kyphosis	MESH:C566002			MESH:D007738	C05.116.900.800.500/C566002	C05.116.900.800.500		Musculoskeletal disease
Vertebrobasilar Insufficiency	MESH:D014715	DO:DOID:13003|DO:DOID:13095|DO:DOID:223	Localized or diffuse reduction in blood flow through the vertebrobasilar arterial system, which supplies the BRAIN STEM; CEREBELLUM; OCCIPITAL LOBE; medial TEMPORAL LOBE; and THALAMUS. Characteristic clinical features include SYNCOPE; lightheadedness; visual disturbances; and VERTIGO. BRAIN STEM INFARCTIONS or other BRAIN INFARCTION may be associated.	MESH:D002545	C10.228.140.300.150.956|C14.907.253.092.956	C10.228.140.300.150|C14.907.253.092	Artery Insufficiencies, Basilar|Artery Insufficiencies, Vertebral|Artery Insufficiency, Basilar|Artery Insufficiency, Vertebral|Artery Ischemia, Basilar|Artery Ischemias, Basilar|Artery Ischemias, Vertebral|Artery Ischemia, Vertebral|Artery Stenoses, Basilar|Artery Stenoses, Vertebral|Artery Stenosis, Basilar|Artery Stenosis, Vertebral|Basilar Artery Insufficiencies|Basilar Artery Insufficiency|Basilar Artery Ischemia|Basilar Artery Ischemias|Basilar Artery Stenoses|Basilar Artery Stenosis|Basilar Insufficiencies|Basilar Insufficiency|Dolichoectasias, Vertebrobasilar|Dolichoectasia, Vertebrobasilar|Insufficiencies, Basilar|Insufficiencies, Basilar Artery|Insufficiencies, Vertebral Artery|Insufficiencies, Vertebrobasilar|Insufficiencies, Vertebro-Basilar|Insufficiency, Basilar|Insufficiency, Basilar Artery|Insufficiency, Vertebral Artery|Insufficiency, Vertebrobasilar|Insufficiency, Vertebro-Basilar|Ischemia, Basilar Artery|Ischemias, Basilar Artery|Ischemias, Vertebral Artery|Ischemias, Vertebrobasilar|Ischemias, Vertebro-Basilar|Ischemia, Vertebral Artery|Ischemia, Vertebrobasilar|Ischemia, Vertebro-Basilar|Stenoses, Basilar Artery|Stenoses, Vertebral Artery|Stenosis, Basilar Artery|Stenosis, Vertebral Artery|Vertebral Artery Insufficiencies|Vertebral Artery Insufficiency|Vertebral Artery Ischemia|Vertebral Artery Ischemias|Vertebral Artery Stenoses|Vertebral Artery Stenosis|Vertebrobasilar Dolichoectasia|Vertebrobasilar Dolichoectasias|Vertebrobasilar Insufficiencies|Vertebro-Basilar Insufficiencies|Vertebro Basilar Insufficiency|Vertebro-Basilar Insufficiency|Vertebrobasilar Ischemia|Vertebro Basilar Ischemia|Vertebro-Basilar Ischemia|Vertebrobasilar Ischemias|Vertebro-Basilar Ischemias	Cardiovascular disease|Nervous system disease
Vertigo	MESH:D014717	DO:DOID:2479	An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)	MESH:D009461|MESH:D015837	C09.218.568.900.883|C10.597.951|C23.888.592.958	C09.218.568.900|C10.597|C23.888.592	Brainstem Vertigo|Brain Stem Vertigo|Brainstem Vertigos|Brain Stem Vertigos|Central Nervous System Origin Vertigo|Central Origin Vertigo|Central Origin Vertigos|CNS Origin Vertigo|CNS Origin Vertigos|Constant Vertigo|Constant Vertigos|Essential Vertigo|Essential Vertigos|Intermittant Vertigo|Intermittant Vertigos|Origin Vertigo, Central|Origin Vertigo, CNS|Origin Vertigos, Central|Origin Vertigos, CNS|Paroxysmal Vertigo|Paroxysmal Vertigos|Peripheral Vertigo|Peripheral Vertigos|Positional Vertigo|Sensation, Spinning|Sensations, Spinning|Spinning Sensation|Spinning Sensations|Subjective Vertigo|Subjective Vertigos|Vertigo, Brainstem|Vertigo, Brain Stem|Vertigo, Central Nervous System Origin|Vertigo, Central Origin|Vertigo, CNS Origin|Vertigo, Constant|Vertigo, Essential|Vertigo, Intermittant|Vertigo, Paroxysmal|Vertigo, Peripheral|Vertigo, Positional|Vertigos|Vertigos, Brainstem|Vertigos, Brain Stem|Vertigos, Central Origin|Vertigos, CNS Origin|Vertigos, Constant|Vertigos, Essential|Vertigos, Intermittant|Vertigos, Paroxysmal|Vertigos, Peripheral|Vertigos, Subjective|Vertigo, Subjective	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Vertigo, Benign Recurrent, 1	MESH:C567620			MESH:D065635	C09.218.568.900.883.500/C567620|C10.597.951.500/C567620|C23.888.592.958.500/C567620	C09.218.568.900.883.500|C10.597.951.500|C23.888.592.958.500		Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Vertigo, Benign Recurrent, 2	MESH:C567749	OMIM:613106		MESH:D065635	C09.218.568.900.883.500/C567749|C10.597.951.500/C567749|C23.888.592.958.500/C567749	C09.218.568.900.883.500|C10.597.951.500|C23.888.592.958.500	BRV2	Ear-nose-throat disease|Nervous system disease|Signs and symptoms
Vesicovaginal Fistula	MESH:D014719		An abnormal anatomical passage between the URINARY BLADDER and the VAGINA.	MESH:D001747|MESH:D014624	C12.050.351.500.894.767.500|C12.050.351.875.881.312.733|C12.050.351.968.829.548.733|C12.100.250.894.767.500|C12.950.829.548.733|C23.300.575.825.250.775|C23.300.575.925.816	C12.050.351.500.894.767|C12.050.351.875.881.312|C12.050.351.968.829.548|C12.100.250.894.767|C12.950.829.548|C23.300.575.825.250|C23.300.575.925	Fistulae, Vesicovaginal|Fistulae, Vesico-Vaginal|Fistulas, Vesicovaginal|Fistulas, Vesico-Vaginal|Fistula, Vesicovaginal|Fistula, Vesico-Vaginal|Vesico Vaginal Fistula|Vesico-Vaginal Fistula|Vesicovaginal Fistulae|Vesico Vaginal Fistulae|Vesico-Vaginal Fistulae|Vesicovaginal Fistulas|Vesico-Vaginal Fistulas	Pathology (anatomical condition)|Urogenital disease (female)
Vestibular Diseases	MESH:D015837	DO:DOID:3426	Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.	MESH:D007759	C09.218.568.900	C09.218.568	Diseases, Vestibular|Disease, Vestibular|Vestibular Disease	Ear-nose-throat disease
Vestibular Neuronitis	MESH:D020338	DO:DOID:12683	Idiopathic inflammation of the VESTIBULAR NERVE, characterized clinically by the acute or subacute onset of VERTIGO; NAUSEA; and imbalance. The COCHLEAR NERVE is typically spared and HEARING LOSS and TINNITUS do not usually occur. Symptoms usually resolve over a period of days to weeks. (Adams et al., Principles of Neurology, 6th ed, p304)	MESH:D000160	C09.218.807.800.837|C10.292.910.850	C09.218.807.800|C10.292.910	Acute Peripheral Vestibulopathies|Acute Peripheral Vestibulopathy|Acute Vestibular Neuritides|Acute Vestibular Neuritis|Epidemic Neurolabyrinthitides|Epidemic Neurolabyrinthitis|Episodic Recurrent Vertigo|Episodic Recurrent Vertigos|Inflammations, Vestibular Nerve|Inflammation, Vestibular Nerve|Nerve Inflammations, Vestibular|Nerve Inflammation, Vestibular|Nerve Neuritides, Vestibular|Nerve Neuritis, Vestibular|Neuritides, Acute Vestibular|Neuritides, Recurrent Vestibular|Neuritides, Subacute Vestibular|Neuritides, Vestibular|Neuritides, Vestibular Nerve|Neuritis, Acute Vestibular|Neuritis, Recurrent Vestibular|Neuritis, Subacute Vestibular|Neuritis, Vestibular|Neuritis, Vestibular Nerve|Neurolabyrinthitides, Epidemic|Neurolabyrinthitis, Epidemic|Neuronitides, Vestibular|Neuronitis, Vestibular|Neuropathies, Vestibular|Neuropathy, Vestibular|Peripheral Vestibulopathies, Acute|Peripheral Vestibulopathy, Acute|Recurrent Vertigo, Episodic|Recurrent Vertigos, Episodic|Recurrent Vestibular Neuritides|Recurrent Vestibular Neuritis|Recurrent Vestibulopathies|Recurrent Vestibulopathy|Subacute Vestibular Neuritides|Subacute Vestibular Neuritis|Vertigo, Episodic Recurrent|Vertigos, Episodic Recurrent|Vestibular Nerve Inflammation|Vestibular Nerve Inflammations|Vestibular Nerve Neuritides|Vestibular Nerve Neuritis|Vestibular Neuritides|Vestibular Neuritides, Acute|Vestibular Neuritides, Recurrent|Vestibular Neuritides, Subacute|Vestibular Neuritis|Vestibular Neuritis, Acute|Vestibular Neuritis, Recurrent|Vestibular Neuritis, Subacute|Vestibular Neuronitides|Vestibular Neuropathies|Vestibular Neuropathy|Vestibulopathies, Acute Peripheral|Vestibulopathies, Recurrent|Vestibulopathy, Acute Peripheral|Vestibulopathy, Recurrent	Ear-nose-throat disease|Nervous system disease
Vestibulocochlear Dysfunction, Progressive	MESH:C536346			MESH:D000160	C09.218.807.800/C536346|C10.292.910/C536346	C09.218.807.800|C10.292.910	Familial progressive vestibulo-cochlear dysfunction|Familial progressive vestibulocochlear dysfunction|Vestibulocochlear dysfunction progressive familial	Ear-nose-throat disease|Nervous system disease
Vestibulocochlear Nerve Diseases	MESH:D000160	DO:DOID:12657	Pathological processes of the VESTIBULOCOCHLEAR NERVE, including the branches of COCHLEAR NERVE and VESTIBULAR NERVE. Common examples are VESTIBULAR NEURITIS, cochlear neuritis, and ACOUSTIC NEUROMA. Clinical signs are varying degree of HEARING LOSS; VERTIGO; and TINNITUS.	MESH:D003389|MESH:D012181	C09.218.807.800|C10.292.910	C09.218.807|C10.292	Acoustic Nerve Disease|Acoustic Nerve Diseases|Acoustic Nerve Disorder|Acoustic Nerve Disorders|Cochlear Nerve Disease|Cochlear Nerve Diseases|Cochlear Nerve Disorder|Cochlear Nerve Disorders|Cochlear Neuritides|Cochlear Neuritis|Cranial Nerve VIII Diseases|Cranial Nerve VIII Disorders|Eighth Cranial Nerve Diseases|Neuritides, Cochlear|Neuritis, Cochlear|Vestibular Nerve Disease|Vestibular Nerve Diseases|Vestibular Nerve Disorder|Vestibular Nerve Disorders|Vestibulocochlear Nerve Disease	Ear-nose-throat disease|Nervous system disease
Vestibulocochlear Nerve Injuries	MESH:D061285		Traumatic injuries to the VESTIBULOCOCHLEAR NERVE.	MESH:D000160|MESH:D020209	C09.218.807.800.918|C10.292.200.968|C10.292.910.925|C10.900.300.218.943|C26.915.300.400.956	C09.218.807.800|C10.292.200|C10.292.910|C10.900.300.218|C26.915.300.400	Avulsions, Vestibulocochlear Nerve|Avulsion, Vestibulocochlear Nerve|Contusions, Vestibulocochlear Nerve|Contusion, Vestibulocochlear Nerve|Cranial Nerve VIII Injury|Eighth Cranial Nerve Injuries|Eighth Cranial Nerve Injury|Eighth-Nerve Palsies, Traumatic|Eighth Nerve Palsy, Traumatic|Eighth-Nerve Palsy, Traumatic|Eighth Nerve Trauma|Eighth-Nerve Trauma|Eighth-Nerve Traumas|Injuries, Vestibulocochlear Nerve|Injury, Cranial Nerve VIII|Injury, Eighth Cranial Nerve|Injury, Vestibulocochlear Nerve|Nerve Avulsions, Vestibulocochlear|Nerve Avulsion, Vestibulocochlear|Nerve Contusions, Vestibulocochlear|Nerve Contusion, Vestibulocochlear|Nerve Injuries, Vestibulocochlear|Nerve Injury, Vestibulocochlear|Nerve Transections, Vestibulocochlear|Nerve Transection, Vestibulocochlear|Nerve Traumas, Vestibulocochlear|Nerve Trauma, Vestibulocochlear|Neuropathies, Traumatic Vestibulocochlear|Neuropathy, Traumatic Vestibulocochlear|Palsies, Traumatic Eighth-Nerve|Palsy, Traumatic Eighth-Nerve|Transections, Vestibulocochlear Nerve|Transection, Vestibulocochlear Nerve|Trauma, Eighth-Nerve|Traumas, Eighth-Nerve|Traumas, Vestibulocochlear Nerve|Traumatic Eighth-Nerve Palsies|Traumatic Eighth Nerve Palsy|Traumatic Eighth-Nerve Palsy|Traumatic Vestibulocochlear Neuropathies|Traumatic Vestibulocochlear Neuropathy|Trauma, Vestibulocochlear Nerve|Vestibulocochlear Nerve Avulsion|Vestibulocochlear Nerve Avulsions|Vestibulocochlear Nerve Contusion|Vestibulocochlear Nerve Contusions|Vestibulocochlear Nerve Injury|Vestibulocochlear Nerve Transection|Vestibulocochlear Nerve Transections|Vestibulocochlear Nerve Trauma|Vestibulocochlear Nerve Traumas|Vestibulocochlear Neuropathies, Traumatic|Vestibulocochlear Neuropathy, Traumatic	Ear-nose-throat disease|Nervous system disease|Wounds and injuries
Vibratory angioedema	MESH:C536347			MESH:D000799|MESH:D006969	C14.907.079/C536347|C17.800.862.945.066/C536347|C20.543.480.904.066/C536347|C20.543.480/C536347	C14.907.079|C17.800.862.945.066|C20.543.480|C20.543.480.904.066	Angioedema, vibratory	Cardiovascular disease|Immune system disease|Skin disease
Vipoma	MESH:D003969	DO:DOID:5574|DO:DOID:6977	A tumor that secretes VASOACTIVE INTESTINAL PEPTIDE, a neuropeptide that causes VASODILATION; relaxation of smooth muscles; watery DIARRHEA; HYPOKALEMIA; and HYPOCHLORHYDRIA. Vipomas, derived from the pancreatic ISLET CELLS, generally are malignant and can secrete other hormones. In most cases, Vipomas are located in the PANCREAS but can be found in extrapancreatic sites.	MESH:D018273|MESH:D018278	C04.557.465.625.650.240.847|C04.557.470.200.025.370.847|C04.588.274.761.500.750|C04.588.322.475.500.750|C06.301.761.500.750|C06.689.667.500.750|C19.344.421.500.750	C04.557.465.625.650.240|C04.557.470.200.025.370|C04.588.274.761.500|C04.588.322.475.500|C06.301.761.500|C06.689.667.500|C19.344.421.500	Cholera, Pancreatic|Diarrheogenic Islet Cell Tumor|Diarrheogenic Tumor|Diarrheogenic Tumors|Pancreatic Cholera|Pancreatic VIPoma|Pancreatic VIPomas|Syndrome, Verner-Morrison|Syndrome, Vipoma|Tumor, Diarrheogenic|Tumors, Diarrheogenic|Tumors, VIP-Secreting (VIPoma)|Tumor, VIP-Secreting (VIPoma)|Vasoactive Intestinal Peptide Producing Tumor|Vasoactive Intestinal Peptide-Producing Tumor|Vasoactive Intestinal Peptide (VIP) Tumor|Verner Morrison Syndrome|Verner-Morrison Syndrome|VIPoma, Pancreatic|Vipomas|VIPomas, Pancreatic|Vipoma Syndrome|VIP-Secreting Tumors (VIPoma)|VIP Secreting Tumor (VIPoma)|VIP-Secreting Tumor (VIPoma)|Watery Diarrhea, Hypokalemia, and Achlorhydria Syndrome|Watery Diarrhea Syndrome|Watery Diarrhea with Hypokalemic Alkalosis|WDHA|WDHA Syndrome|WDHA Syndromes|WDHH	Cancer|Digestive system disease|Endocrine system disease
Viremia	MESH:D014766		The presence of viruses in the blood.	MESH:D014777|MESH:D018805	C01.925.937|C23.550.470.790.500.900	C01.925|C23.550.470.790.500	Viremias	Pathology (process)|Viral disease
Virus Diseases	MESH:D014777	DO:DOID:934	A general term for diseases caused by viruses.	MESH:D007239	C01.925	C01	Diseases, Viral|Diseases, Virus|Disease, Viral|Disease, Virus|Infections, Viral|Infections, Virus|Infection, Viral|Infection, Virus|Viral Disease|Viral Diseases|Viral Infection|Viral Infections|Virus Disease|Virus Infection|Virus Infections	Viral disease
Visceral Prolapse	MESH:D014782		The prolapse or downward displacement of the VISCERA.	MESH:D005767|MESH:D056887	C06.405.937|C23.300.842.624.875	C06.405|C23.300.842.624	Prolapse, Visceral|Splanchnoptosis|Visceroptosis	Digestive system disease|Pathology (anatomical condition)
Vision Disorders	MESH:D014786		Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132).	MESH:D005128|MESH:D012678	C10.597.751.941|C11.966|C23.888.592.763.941	C10.597.751|C11|C23.888.592.763	Blindness, Day|Day Blindness|Disabilities, Vision|Disability, Vision|Disorders, Visual|Disorder, Visual|Hemeralopia|Hemeralopias|Impairments, Visual|Impairment, Visual|Macropsia|Macropsias|Metamorphopsia|Metamorphopsias|Micropsia|Micropsias|Vision Disabilities|Vision Disability|Vision Disorder|Visual Disorder|Visual Disorders|Visual Impairment|Visual Impairments	Eye disease|Nervous system disease|Signs and symptoms
Vision, Low	MESH:D015354		Vision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility. Low vision generally refers to visual disorders that are caused by diseases that cannot be corrected by refraction (e.g., MACULAR DEGENERATION; RETINITIS PIGMENTOSA; DIABETIC RETINOPATHY, etc.).	MESH:D014786	C10.597.751.941.905|C11.966.905|C23.888.592.763.941.848	C10.597.751.941|C11.966|C23.888.592.763.941	Diminished Vision|Low Vision|Reduced Vision|Subnormal Vision|Vision, Diminished|Vision, Reduced|Vision, Subnormal	Eye disease|Nervous system disease|Signs and symptoms
Vitamin K Deficiency	MESH:D014813	DO:DOID:11249	A nutritional condition produced by a deficiency of VITAMIN K in the diet, characterized by an increased tendency to hemorrhage (HEMORRHAGIC DISORDERS). Such bleeding episodes may be particularly severe in newborn infants. (From Cecil Textbook of Medicine, 19th ed, p1182)	MESH:D001361|MESH:D001778|MESH:D006474	C15.378.100.920|C15.378.463.841|C18.654.521.500.133.912	C15.378.100|C15.378.463|C18.654.521.500.133	Deficiencies, Vitamin K|Deficiency, Vitamin K|Vitamin K Deficiencies	Blood disease|Nutrition disorder
Vitamin K Deficiency Bleeding	MESH:D006475		Hemorrhage caused by vitamin K deficiency.	MESH:D007228|MESH:D007232|MESH:D014813	C15.378.100.920.360|C15.378.463.841.464|C16.614.940|C18.654.422.360|C18.654.521.500.133.912.360	C15.378.100.920|C15.378.463.841|C16.614|C18.654.422|C18.654.521.500.133.912	Hemorrhagic Disease of Newborn|Newborn Hemorrhagic Disease|Newborn Hemorrhagic Diseases	Blood disease|Infant-newborn disease|Nutrition disorder
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2	OMIM:607473	DO:DOID:0112174		MESH:D020147	C15.378.100.141/607473	C15.378.100.141	VKCFD2	Blood disease
Vitiligo	MESH:D014820	DO:DOID:12306	A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.	MESH:D017496	C17.800.621.440.895	C17.800.621.440		Skin disease
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	OMIM:193235	DO:DOID:9719		MESH:D018630	C11.768.890/193235	C11.768.890	ADNIV|PROLIFERATIVE VITREORETINOPATHY|PVR|VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY, AUTOSOMAL DOMINANT|VRNI	Eye disease
Vitreoretinopathy, Proliferative	MESH:D018630	DO:DOID:9719	Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.	MESH:D012164	C11.768.890	C11.768	Inflammatories, Vitreoretinopathy Neovascular|Inflammatory, Vitreoretinopathy Neovascular|Neovascular Inflammatories, Vitreoretinopathy|Neovascular Inflammatory, Vitreoretinopathy|Proliferative Vitreoretinopathies|Proliferative Vitreoretinopathy|Vitreoretinopathies, Proliferative|Vitreoretinopathy Neovascular Inflammatories|Vitreoretinopathy Neovascular Inflammatory	Eye disease
Vitreous Detachment	MESH:D020255	DO:DOID:9726	Detachment of the corpus vitreum (VITREOUS BODY) from its normal attachments, especially the retina, due to shrinkage from degenerative or inflammatory conditions, trauma, myopia, or senility.	MESH:D005128	C11.980	C11	Detachment, Posterior Vitreous|Detachments, Posterior Vitreous|Detachments, Vitreous|Detachment, Vitreous|Posterior Vitreous Detachment|Posterior Vitreous Detachments|Vitreous Detachment, Posterior|Vitreous Detachments|Vitreous Detachments, Posterior	Eye disease
Vitreous Hemorrhage	MESH:D014823		Hemorrhage into the VITREOUS BODY.	MESH:D005130	C11.290.960|C23.550.414.756.887	C11.290|C23.550.414.756	Hemorrhage, Vitreous|Vitreous Hemorrhages	Eye disease|Pathology (process)
Vocal Cord Dysfunction	MESH:D064706		A disorder characterized by an intermittent abnormal VOCAL CORDS movement toward the midline during inspiration or expiration resulting in upper AIRWAY OBSTRUCTION.	MESH:D007818|MESH:D012120	C08.360.895|C08.618.980|C09.400.895	C08.360|C08.618|C09.400	Dysfunctions, Vocal Cord|Dysfunction, Vocal Cord|Exercise Induced Vocal Cord Dysfunction|Exercise-Induced Vocal Cord Dysfunction|Paradoxical Vocal Fold Motion|Paradoxical Vocal Fold Motion Disorder|Vocal Cord Dysfunctions	Ear-nose-throat disease|Respiratory tract disease
Vocal cord dysfunction familial	MESH:C536354			MESH:D014826	C08.360.931/C536354|C09.400.931/C536354|C10.292.887.800/C536354|C10.597.622.943/C536354|C23.888.592.636.943/C536354	C08.360.931|C09.400.931|C10.292.887.800|C10.597.622.943|C23.888.592.636.943	Familial vocal cord dysfunction|Gerhardt syndrome|Laryngeal abductor paralysis|Plott syndrome|Vocal Cord Dysfunction, Familial	Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Vocal Cord Paralysis	MESH:D014826		Congenital or acquired paralysis of one or both VOCAL CORDS. This condition is caused by defects in the CENTRAL NERVOUS SYSTEM, the VAGUS NERVE and branches of LARYNGEAL NERVES. Common symptoms are VOICE DISORDERS including HOARSENESS or APHONIA.	MESH:D007818|MESH:D010243|MESH:D020421	C08.360.931|C09.400.931|C10.292.887.800|C10.597.622.943|C23.888.592.636.943	C08.360|C09.400|C10.292.887|C10.597.622|C23.888.592.636	Acquired Vocal Cord Palsy|Bilateral Vocal Cord Paresis|Congenital Vocal Cord Palsy|Laryngeal Nerve Palsy, Recurrent|Laryngeal Paralyses|Laryngeal Paralysis|Palsies, Vocal Cord|Palsies, Vocal Fold|Palsy, Vocal Cord|Palsy, Vocal Fold|Paralyses, Laryngeal|Paralyses, Vocal Cord|Paralysis, Laryngeal|Paralysis, Unilateral, Vocal Cord|Paralysis, Vocal Cord|Paralysis, Vocal Cord, Unilateral|Pareses, Vocal Cord|Paresis, Vocal Cord|Partial Paralysis (Paresis) Vocal Cords|Recurrent Laryngeal Nerve Palsy|Total Vocal Cord Paralysis|Unilateral Paralysis, Vocal Cord|Unilateral Vocal Cord Paralysis|Unilateral Vocal Cord Paresis|Vocal Cord Palsies|Vocal Cord Palsy|Vocal Cord Palsy, Congenital|Vocal Cord Paralyses|Vocal Cord Paralysis, Unilateral|Vocal Cord Pareses|Vocal Cord Paresis|Vocal Fold Palsies|Vocal Fold Palsy	Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Voice Disorders	MESH:D014832		Pathological processes that affect voice production, usually involving VOCAL CORDS and the LARYNGEAL MUCOSA. Voice disorders can be caused by organic (anatomical), or functional (emotional or psychological) factors leading to DYSPHONIA; APHONIA; and defects in VOICE QUALITY, loudness, and pitch.	MESH:D007818|MESH:D009461	C08.360.940|C09.400.940|C10.597.975|C23.888.592.979	C08.360|C09.400|C10.597|C23.888.592	Disturbances, Voice|Disturbance, Voice|Fatigues, Voice|Fatigue, Voice|Neurologic Voice Disorder|Neurologic Voice Disorders|Voice Disorder|Voice Disorder, Neurologic|Voice Disorders, Neurologic|Voice Disturbance|Voice Disturbances|Voice Fatigue|Voice Fatigues	Ear-nose-throat disease|Nervous system disease|Respiratory tract disease|Signs and symptoms
Vulvar Diseases	MESH:D014845	DO:DOID:2059	Pathological processes of the VULVA.	MESH:D005831	C12.050.351.500.944|C12.100.250.944	C12.050.351.500|C12.100.250	Diseases, Vulvar|Disease, Vulvar|Vulvar Disease	Urogenital disease (female)
Vulvar dysesthesia localized in the vestibule	MESH:C548479			MESH:D054515	C12.050.351.500.944.902.368/C548479|C12.100.250.944.902.368/C548479	C12.050.351.500.944.902.368|C12.100.250.944.902.368		Urogenital disease (female)
Vulvar Lichen Sclerosus	MESH:D007724		Atrophy and shriveling of the SKIN of the VULVA that is characterized by the whitish LICHEN SCLEROSUS appearance, inflammation, and PRURITUS.	MESH:D014845	C12.050.351.500.944.815|C12.100.250.944.815	C12.050.351.500.944|C12.100.250.944	Kraurosis Vulvae|Lichen Sclerosus of Vulva|Lichen Sclerosus, Vulvar|Sclerosus, Vulvar Lichen|Vulvae, Kraurosis|Vulva Lichen Sclerosus	Urogenital disease (female)
Vulvar Neoplasms	MESH:D014846	DO:DOID:1245	Tumors or cancer of the VULVA.	MESH:D005833|MESH:D014845	C04.588.945.418.968|C12.050.351.500.944.819|C12.050.351.937.418.968|C12.100.250.944.819|C12.900.418.968	C04.588.945.418|C12.050.351.500.944|C12.050.351.937.418|C12.100.250.944|C12.900.418	Cancer of the Vulva|Cancer of Vulva|Cancers, Vulva|Cancers, Vulvar|Cancer, Vulva|Cancer, Vulvar|Neoplasms, Vulva|Neoplasms, Vulvar|Neoplasm, Vulva|Neoplasm, Vulvar|Vulva Cancer|Vulva Cancers|Vulva Neoplasm|Vulva Neoplasms|Vulvar Cancer|Vulvar Cancers|Vulvar Neoplasm	Cancer|Urogenital disease (female)
Vulvar Vestibulitis	MESH:D054515		Inflammation of the vulvar vestibular region at the entrance of the VAGINA, generally involving surface mucosa and submucosal vestibular glands. It is characterized by ERYTHEMA and chronic recurrent pain in this area.	MESH:D014847	C12.050.351.500.944.902.368|C12.100.250.944.902.368	C12.050.351.500.944.902|C12.100.250.944.902	Vestibulitides, Vulvar|Vestibulitis, Vulvar|Vulvar Vestibulitides|Vulvar Vestibulitis Syndrome	Urogenital disease (female)
Vulvitis	MESH:D014847	DO:DOID:3901	Inflammation of the VULVA. It is characterized by PRURITUS and painful urination.	MESH:D014845	C12.050.351.500.944.902|C12.100.250.944.902	C12.050.351.500.944|C12.100.250.944	Vulvitides	Urogenital disease (female)
Vulvodynia	MESH:D056650		Complex pain syndrome with unknown etiology, characterized by constant or intermittent generalized vulva pain (Generalized vulvodynia) or localized burning sensations in the VESTIBULE area when pressure is applied (Vestibulodynia, or Vulvar Vestibulitis Syndrome). Typically, vulvar tissue with vulvodynia appears normal without infection or skin disease. Vulvodynia impacts negatively on a woman's quality of life as it interferes with sexual and daily activities.	MESH:D014845	C12.050.351.500.944.951|C12.100.250.944.951	C12.050.351.500.944|C12.100.250.944	Generalized Vulvodynia|Generalized Vulvodynias|Vestibulodynia|Vestibulodynias|Vulvodynia, Generalized|Vulvodynias|Vulvodynias, Generalized	Urogenital disease (female)
Vulvovaginitis	MESH:D014848	DO:DOID:2273	Inflammation of the VULVA and the VAGINA, characterized by discharge, burning, and PRURITUS.	MESH:D014627|MESH:D014847	C12.050.351.500.894.906.820|C12.050.351.500.944.902.737|C12.100.250.894.906.820|C12.100.250.944.902.737	C12.050.351.500.894.906|C12.050.351.500.944.902|C12.100.250.894.906|C12.100.250.944.902	Vulvovaginitides	Urogenital disease (female)
Vulvovaginitis, Allergic Seminal	MESH:C565993			MESH:D006967|MESH:D014848	C12.050.351.500.894.906.820/C565993|C12.050.351.500.944.902.737/C565993|C12.100.250.894.906.820/C565993|C12.100.250.944.902.737/C565993|C20.543/C565993	C12.050.351.500.894.906.820|C12.050.351.500.944.902.737|C12.100.250.894.906.820|C12.100.250.944.902.737|C20.543		Immune system disease|Urogenital disease (female)
Waaler Aarskog syndrome	MESH:C536461			MESH:D006849|MESH:D012600	C05.116.900.800.875/C536461|C10.228.140.602/C536461	C05.116.900.800.875|C10.228.140.602		Musculoskeletal disease|Nervous system disease
Waldenstrom Macroglobulinemia	MESH:D008258	DO:DOID:0060901|OMIM:153600|OMIM:610430	A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.	MESH:D008232|MESH:D010265|MESH:D020141|MESH:D054219	C04.557.595.925|C14.907.454.960|C15.378.147.780.925|C15.378.463.515.960|C15.604.515.925|C20.683.780.925	C04.557.595|C14.907.454|C15.378.147.780|C15.378.463.515|C15.604.515|C20.683.780	Familial Waldenstrom Macroglobulinaemia|Familial Waldenstrom's Macroglobulinaemia|Familial Waldenstroms Macroglobulinaemia|Lymphoma, Lymphocytic, Plasmacytoid|Lymphoma, Lymphoplasmacytoid|Lymphomas, Lymphoplasmacytoid|Lymphoplasmacytoid Lymphoma|Lymphoplasmacytoid Lymphomas|Macroglobulinaemia, Familial Waldenstrom's|Macroglobulinaemia, Waldenstrom's|Macroglobulinemia|Macroglobulinemia, Primary|Macroglobulinemia, Waldenstrom|Macroglobulinemia, Waldenstrom's|MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1|MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 2|Primary Macroglobulinemia|Waldenstrom Macroglobulinaemia|Waldenstrom's Macroglobulinaemia|Waldenstroms Macroglobulinaemia|Waldenstrom's Macroglobulinaemia, Familial|Waldenstrom's Macroglobulinemia|Waldenstroms Macroglobulinemia|WM1|WM2	Blood disease|Cancer|Cardiovascular disease|Immune system disease|Lymphatic disease
Wandering Spleen	MESH:D050805		A congenital or acquired condition in which the SPLEEN is not in its normal anatomical position but moves about in the ABDOMEN. This is due to laxity or absence of suspensory ligaments which normally provide peritoneal attachments to keep the SPLEEN in a fixed position. Clinical symptoms include ABDOMINAL PAIN, splenic torsion and ISCHEMIA.	MESH:D013158	C15.604.744.954	C15.604.744	Displaced Spleen|Displaced Spleens|Drifting Spleen|Drifting Spleens|Floating Spleen|Floating Spleens|Ptoses, Splenic|Ptosis, Splenic|Spleen, Displaced|Spleen, Drifting|Spleen, Floating|Spleens, Displaced|Spleens, Drifting|Spleens, Floating|Spleens, Wandering|Spleen, Wandering|Splenic Ptoses|Splenic Ptosis|Splenoptoses|Splenoptosis|Wandering Spleens	Lymphatic disease
Warburg Effect, Oncologic	MESH:D000082802		An observation in neoplastic cellular transformation, characterized by an increased glucose uptake via glycolytic activities resulting in an increased LACTATE production under aerobic microenvironment.	MESH:D002471	C04.697.098.500.580|C23.550.727.098.500.580	C04.697.098.500|C23.550.727.098.500	Aerobic Glycolysis, Oncologic|Glycolysis, Oncologic Aerobic|Oncologic Aerobic Glycolysis|Oncologic Warburg Effect	Cancer|Pathology (process)
Warts	MESH:D014860		Benign epidermal proliferations or tumors; some are viral in origin.	MESH:D014412|MESH:D017193|MESH:D030361	C01.925.256.650.810|C01.925.825.810|C01.925.928.914|C17.800.838.790.810	C01.925.256.650|C01.925.825|C01.925.928|C17.800.838.790	Verruca|Verrucas|Wart	Skin disease|Viral disease
Wasting Syndrome	MESH:D019282		A condition of involuntary weight loss of greater then 10% of baseline body weight. It is characterized by atrophy of muscles and depletion of lean body mass. Wasting is a sign of MALNUTRITION as a result of inadequate dietary intake, malabsorption, or hypermetabolism.	MESH:D008659|MESH:D009748	C18.452.915|C18.654.940	C18.452|C18.654	Wasting Disease|Wasting Diseases|Wasting Syndromes	Metabolic disease|Nutrition disorder
Waterborne Diseases	MESH:D000069578		Illnesses due to micro-organisms and chemicals in drinking water, those caused by organisms having part of their lifecycle in water or those with water-related vectors, and others spread by aerosols containing pathogens.	MESH:D007239	C01.936	C01	Diseases, Waterborne|Diseases, Water-related|Disease, Waterborne|Disease, Water-related|Waterborne Disease|Water-related Disease|Water related Diseases|Water-related Diseases	
Water-Electrolyte Imbalance	MESH:D014883		Disturbances in the body's WATER-ELECTROLYTE BALANCE.	MESH:D008659	C18.452.950	C18.452	Imbalances, Water-Electrolyte|Imbalance, Water-Electrolyte|Water Electrolyte Imbalance|Water-Electrolyte Imbalances	Metabolic disease
Water Intoxication	MESH:D014869		A condition resulting from the excessive retention of water with sodium depletion.	MESH:D011041|MESH:D014883	C18.452.950.932|C25.723.932	C18.452.950|C25.723		Metabolic disease
Watermelon stomach disease	MESH:C538665			MESH:D020252	C06.405.748.280/C538665|C14.907.075.280/C538665	C06.405.748.280|C14.907.075.280		Cardiovascular disease|Digestive system disease
Weber Klippel Trenaunay	MESH:C536889			MESH:D007715	C14.907.077.410/C536889	C14.907.077.410		Cardiovascular disease
Wegener-Like Granulomatosis	MESH:C566810			MESH:D014890	C08.381.483.950/C566810|C14.907.940.897.249.750/C566810|C20.111.193.875/C566810	C08.381.483.950|C14.907.940.897.249.750|C20.111.193.875		Cardiovascular disease|Immune system disease|Respiratory tract disease
Weismann Netter syndrome	MESH:C537082			MESH:D001848|MESH:D056305	C05.116.099/C537082|C05.116.511/C537082	C05.116.099|C05.116.511	Anterior bowing of legs with dwarfism|Bowing of legs, anterior, with dwarfism|Toxopachyosteose diaphysaire tibio-peroniere|Toxopachyosteosis|Toxopachyoteose diaphysaire tibio peroniere|Weismann Netter Stuhl syndrome|Weismann-Netter Syndrome	Musculoskeletal disease
Wellesley Carmen French syndrome	MESH:C536691			MESH:D002386|MESH:D006130	C11.510.245/C536691|C23.550.393/C536691	C11.510.245|C23.550.393	Cataract, Aberrant Oral Frenula, And Growth Retardation|Cataracts, aberrant oral frenula, and growth retardation	Eye disease|Pathology (process)
West Nile Fever	MESH:D014901	DO:DOID:2365|DO:DOID:2366|OMIM:610379	A mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352(9130):767-71)	MESH:D004671|MESH:D018177	C01.207.245.340.300.887|C01.207.399.750.300.887|C01.920.500.343.950|C01.925.081.343.950|C01.925.182.525.300.850|C01.925.782.310.950|C01.925.782.350.250.900|C10.228.140.430.520.750.300.887|C10.228.228.245.340.300.887|C10.228.228.399.750.300.887|C10.586.250.520.750.300.887	C01.207.245.340.300|C01.207.399.750.300|C01.920.500.343|C01.925.081.343|C01.925.182.525.300|C01.925.782.310|C01.925.782.350.250|C10.228.140.430.520.750.300|C10.228.228.245.340.300|C10.228.228.399.750.300|C10.586.250.520.750.300	Encephalitis, West Nile Fever|Infections, WNV|Infection, WNV|West Nile Fever Encephalitis|West Nile Fever Meningitis|West Nile Fever Meningoencephalitis|West Nile Fever Myelitis|West Nile Virus Infection|WEST NILE VIRUS, SUSCEPTIBILITY TO|WNV Infection|WNV Infections|WNV, SUSCEPTIBILITY TO	Nervous system disease|Viral disease
Wet Macular Degeneration	MESH:D057135		A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.	MESH:D008268	C11.768.585.439.622	C11.768.585.439	Degenerations, Wet Macular|Degeneration, Wet Macular|Macular Degenerations, Wet|Macular Degeneration, Wet|Wet Macular Degenerations	Eye disease
Wheat Hypersensitivity	MESH:D021182	DO:DOID:3660	Allergic reaction to wheat that is triggered by the immune system.	MESH:D005512	C20.543.480.370.850	C20.543.480.370	Allergies, Wheat|Allergy, Wheat|Hypersensitivities, Wheat|Hypersensitivity, Wheat|Wheat Allergies|Wheat Allergy|Wheat Hypersensitivities	Immune system disease
White Coat Hypertension	MESH:D059466		Phenomenon where BLOOD PRESSURE readings are elevated only when taken in clinical settings.	MESH:D006973	C14.907.489.907	C14.907.489	Clinic Hypertension, Isolated|Hypertension, Isolated Clinic|Hypertension, White Coat|Isolated Clinic Hypertension|Syndrome, White Coat|White Coat Syndrome	Cardiovascular disease
White Dot Syndromes	MESH:D000080363		A group of idiopathic multifocal posterior uveitis syndromes involving the CHOROID; RETINAL PIGMENT EPITHELIUM; and RETINA. They are characterized by multiple lesions of hypoautofluorescent dots in the FUNDUS OCULI and reduced VISUAL ACUITY. Several entities including BIRDSHOT CHORIORETINOPATHY are HLA-A ANTIGENS serotype A29 positive.	MESH:D015866	C11.941.879.780.900.650	C11.941.879.780.900	Acute Idiopathic Blind Spot Enlargement Syndrome|Acute Macular Neuroretinopathies|Acute Macular Neuroretinopathy|Acute Posterior Multifocal Placoid Pigment Epitheliopathy|APMPPE|Choroiditis, Serpiginous|Choroidopathy, Punctate Inner|Choroidopathy, Serpiginous|Diffuse Subretinal Fibrosis Uveitis|Inner Choroidopathy, Punctate|Macular Neuroretinopathy, Acute|MEWDS|Multiple Evanescent White Dot Syndrome|Neuroretinopathy, Acute Macular|Punctate Inner Choroidopathies|Punctate Inner Choroidopathy|Serpiginous Choroiditides|Serpiginous Choroiditis|Serpiginous Choroidopathies|Serpiginous Choroidopathy|White Dot Syndrome	Eye disease
White platelet syndrome	MESH:C536702			MESH:D001791	C15.378.140/C536702	C15.378.140		Blood disease
WHITE-SUTTON SYNDROME	OMIM:616364	DO:DOID:0070067		MESH:D012640	C10.597.742/616364|C23.888.592.742/616364	C10.597.742|C23.888.592.742	MENTAL RETARDATION, AUTOSOMAL DOMINANT 37|MRD37|WHSUS	Nervous system disease|Signs and symptoms
Whyte Murphy syndrome	MESH:C536054			MESH:D001847|MESH:D010026|MESH:D010859	C05.116.099.708.702/C536054|C05.116/C536054|C17.800.621/C536054|C23.550.755/C536054	C05.116|C05.116.099.708.702|C17.800.621|C23.550.755	Osteopathia striata associated with familial dermopathy and white forelock	Musculoskeletal disease|Pathology (process)|Skin disease
Winkelman Bethge Pfeiffer syndrome	MESH:C536710	OMIM:221750		MESH:D004393|MESH:D006319	C05.116.099.343.445/C536710|C05.116.132.358/C536710|C09.218.458.341.887/C536710|C10.228.140.617.738.300.300/C536710|C10.597.751.418.341.887/C536710|C19.297.312/C536710|C19.700.482.311/C536710|C23.888.592.763.393.341.887/C536710	C05.116.099.343.445|C05.116.132.358|C09.218.458.341.887|C10.228.140.617.738.300.300|C10.597.751.418.341.887|C19.297.312|C19.700.482.311|C23.888.592.763.393.341.887	CPHD3|Deafness, Sensorineural, With Pituitary Dwarfism|Pituitary Hormone Deficiency, Combined, 3|Pituitary Hormone Deficiency, Combined, With Rigid Cervical Spine|Sensorineural deafness with Pituitary dwarfism	Ear-nose-throat disease|Endocrine system disease|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Wis heavy-chain disease protein, human	MESH:C483997			MESH:D006362	C15.378.147.780.490/C483997|C15.604.515.435/C483997|C20.683.780.490/C483997	C15.378.147.780.490|C15.604.515.435|C20.683.780.490	gamma 3 heavy-chain disease protein WIS, human|myeloma protein Wis, human|protein WIS, human	Blood disease|Immune system disease|Lymphatic disease
Wissler's Syndrome	MESH:D014924	DO:DOID:3047	A rheumatic syndrome of possibly allergic origin, usually affecting children and adolescents, and characterized by high fever, exanthema, arthralgia, leukocytosis, and increased sedimentation rate.	MESH:D006967|MESH:D012213	C05.550.114.843.823|C05.799.825.823|C20.543.928	C05.550.114.843|C05.799.825|C20.543	Subsepsis Allergica|Subsepsis Hyperergica|Syndrome, Wissler-Fanconi|Syndrome, Wissler's|Wissler Fanconi Syndrome|Wissler-Fanconi Syndrome|Wisslers Syndrome|Wissler Syndrome	Immune system disease|Musculoskeletal disease
Wolffian tumor	MESH:C536741	DO:DOID:7514		MESH:D000236|MESH:D000291	C04.557.470.035/C536741|C12.050.351.500.056/C536741|C12.100.250.056/C536741	C04.557.470.035|C12.050.351.500.056|C12.100.250.056	FATWO Female adnexal tumor of probable Wolffian origin|Female adnexal tumor of probable Wolffian origin|Wolffian adenoma|Wolffian adnexal tumor	Cancer|Urogenital disease (female)
Wolff-Parkinson-White Syndrome	MESH:D014927	DO:DOID:384|OMIM:194200	A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.	MESH:D006330|MESH:D011226	C14.280.067.780.977|C14.280.123.750.977|C16.131.240.400.980	C14.280.067.780|C14.280.123.750|C16.131.240.400	ACCESSORY ATRIOVENTRICULAR PATHWAYS, INCLUDED|Anomalous Ventricular Excitation Syndrome|Auriculoventricular Accessory Pathway Syndrome|False Bundle-Branch Block Syndrome|Syndrome, Wolff-Parkinson-White|Syndrome, Wolf-Parkinson-White|Syndrome, WPW|Ventricular Pre-Excitation with Arrhythmia|Wolff Parkinson White Syndrome|Wolf Parkinson White Syndrome|Wolf-Parkinson-White Syndrome|WPW Syndrome|WPW SYNDROME PREEXCITATION SYNDROME, INCLUDED	Cardiovascular disease|Congenital abnormality
Wolfram Syndrome 2	MESH:C565733	OMIM:604928		MESH:D006319|MESH:D009896|MESH:D019588|MESH:D028361	C09.218.458.341.887/C565733|C10.292.700.225/C565733|C10.597.751.418.341.887/C565733|C11.640.451/C565733|C18.452.660/C565733|C23.888.069/C565733|C23.888.592.763.393.341.887/C565733	C09.218.458.341.887|C10.292.700.225|C10.597.751.418.341.887|C11.640.451|C18.452.660|C23.888.069|C23.888.592.763.393.341.887	WFS2	Ear-nose-throat disease|Eye disease|Metabolic disease|Nervous system disease|Signs and symptoms
Woodhouse Sakati syndrome	MESH:C536742	DO:DOID:0112264|OMIM:241080		MESH:D000505|MESH:D001145|MESH:D001480|MESH:D003920|MESH:D007006|MESH:D008607	C10.228.140.079/C536742|C10.597.606.360/C536742|C14.280.067/C536742|C17.800.329.937.122/C536742|C18.452.394.750/C536742|C19.246/C536742|C19.391.482/C536742|C23.300.035/C536742|C23.550.073/C536742|C23.888.592.604.646/C536742|F03.625.539/C536742	C10.228.140.079|C10.597.606.360|C14.280.067|C17.800.329.937.122|C18.452.394.750|C19.246|C19.391.482|C23.300.035|C23.550.073|C23.888.592.604.646|F03.625.539	Extrapyramidal Disorder, Progressive, With Primary Hypogonadism, Mental Retardation, and Alopecia|Hypogonadism, Alopecia, Diabetes Mellitus, Mental Retardation, and Extrapyramidal Syndrome|HYPOGONADISM, ALOPECIA, DIABETES MELLITUS, MENTAL RETARDATION, DEAFNESS, AND EXTRAPYRAMIDAL SYNDROME|WDSKS|Woodhouse-Sakati Syndrome	Cardiovascular disease|Endocrine system disease|Mental disorder|Metabolic disease|Nervous system disease|Pathology (anatomical condition)|Pathology (process)|Signs and symptoms|Skin disease
WOOLLY HAIR, AUTOSOMAL DOMINANT	OMIM:194300	DO:DOID:0111573		MESH:C536745	C17.800.329/C536745/194300	C17.800.329/C536745	ADWH	Skin disease
Woolly Hair, Autosomal Recessive	MESH:C564735	OMIM:616760		MESH:D006201	C17.800.329/C564735	C17.800.329	ARWH3|WOOLLY HAIR, AUTOSOMAL RECESSIVE 3|WOOLLY HAIR, AUTOSOMAL RECESSIVE 3, WITH HYPOTRICHOSIS	Skin disease
Woolly hair, congenital	MESH:C536745			MESH:D006201	C17.800.329/C536745	C17.800.329	Frizzy hair syndrome|Woolly hair syndrome	Skin disease
Worster Drought syndrome	MESH:C536747			MESH:D004401|MESH:D008607|MESH:D010244|MESH:D013341	C04.557.645.375.850/C536747|C10.562.800/C536747|C10.574.562.300/C536747|C10.597.606.150.500.800.150.200/C536747|C10.597.606.360/C536747|C10.668.467.300/C536747|C14.907.077.850/C536747|C23.888.592.604.150.500.800.150.200/C536747|C23.888.592.604.646/C536747|F03.625.539/C536747	C04.557.645.375.850|C10.562.800|C10.574.562.300|C10.597.606.150.500.800.150.200|C10.597.606.360|C10.668.467.300|C14.907.077.850|C23.888.592.604.150.500.800.150.200|C23.888.592.604.646|F03.625.539	Congenital suprabulbar paresis|Suprabulbar paresis congenital|Suprabulbar Paresis, Congenital|Worster-Drought Syndrome	Cancer|Cardiovascular disease|Mental disorder|Nervous system disease|Signs and symptoms
Wound Infection	MESH:D014946		Invasion of a wound by pathogenic microorganisms.	MESH:D007239	C01.947	C01	Infections, Wound|Infection, Wound|Wound Infections	
WT limb blood syndrome	MESH:C536751			MESH:D000015|MESH:D000741|MESH:D007938	C04.557.337/C536751|C15.378.071.085/C536751|C15.378.190.223.250/C536751|C16.131.077/C536751	C04.557.337|C15.378.071.085|C15.378.190.223.250|C16.131.077	Radial-ulnar hypoplasia with bone marrow failure and-or leukemia|WT Limb-Blood Syndrome	Blood disease|Cancer|Congenital abnormality
Xanthogranuloma, Juvenile	MESH:D014972	DO:DOID:4424	Benign disorder of infants and children caused by proliferation of HISTIOCYTES, macrophages found in tissues. These histiocytes, usually lipid-laden non-Langerhans cells, form multiple yellow-red nodules most often in the skin, the eye, and sometimes in the viscera. Patients appear to have normal lipid metabolism and are classified as a normolipemic non-Langerhans cell histiocytosis.	MESH:D012871|MESH:D015616	C15.604.250.410.900|C17.800.973	C15.604.250.410|C17.800	Juvenile Xanthogranuloma|Juvenile Xanthogranulomas|Juvenile Xanthoma|Juvenile Xanthomas|Nevoxanthoendothelioma|Nevoxanthoendotheliomas|Xanthogranulomas, Juvenile|Xanthoma, Juvenile|Xanthomas, Juvenile	Lymphatic disease|Skin disease
Xanthogranulomatous cholecystitis	MESH:C536762	DO:DOID:9766		MESH:D002764|MESH:D014973	C06.130.564.263/C536762|C18.452.584.750/C536762	C06.130.564.263|C18.452.584.750		Digestive system disease|Metabolic disease
Xanthogranulomatous sialadenitis	MESH:C536763			MESH:D006099|MESH:D010307|MESH:D012793|MESH:D014973	C04.588.443.591.824.695/C536763|C07.465.530.824.695/C536763|C07.465.815.470.770/C536763|C07.465.815.718.589/C536763|C07.465.815.793/C536763|C15.604.515.292/C536763|C18.452.584.750/C536763|C23.550.382/C536763	C04.588.443.591.824.695|C07.465.530.824.695|C07.465.815.470.770|C07.465.815.718.589|C07.465.815.793|C15.604.515.292|C18.452.584.750|C23.550.382	Sialadenitis, xanthogranulomatous	Cancer|Lymphatic disease|Metabolic disease|Mouth disease|Pathology (process)
Xanthomatosis	MESH:D014973	DO:DOID:3345	A condition marked by the development of widespread xanthomas, yellow tumor-like structures filled with lipid deposits. Xanthomas can be found in a variety of tissues including the SKIN; TENDONS; joints of KNEES and ELBOWS. Xanthomatosis is associated with disturbance of LIPID METABOLISM and formation of FOAM CELLS.	MESH:D052439	C18.452.584.750	C18.452.584	Xanthoma|Xanthomas|Xanthomatoses	Metabolic disease
Xerophthalmia	MESH:D014985	DO:DOID:10138	Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.	MESH:D003229|MESH:D015352	C11.187.810|C11.496.260.892	C11.187|C11.496.260	Xerophthalmias	Eye disease
Yellow Fever	MESH:D015004	DO:DOID:9682	An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus. The severe form is characterized by fever, HEMOLYTIC JAUNDICE, and renal damage.	MESH:D001102|MESH:D006482|MESH:D018177	C01.920.500.980|C01.925.081.980|C01.925.782.350.250.980|C01.925.782.417.881	C01.920.500|C01.925.081|C01.925.782.350.250|C01.925.782.417	Fevers, Yellow|Fever, Yellow|Yellow Fevers	Viral disease
Yorifuji Okuno syndrome	MESH:C536714			MESH:D003920|MESH:D006331|MESH:D008607|MESH:D009393	C10.597.606.360/C536714|C12.050.351.968.419.570/C536714|C12.200.777.419.570/C536714|C12.950.419.570/C536714|C14.280/C536714|C18.452.394.750/C536714|C19.246/C536714|C23.888.592.604.646/C536714|F03.625.539/C536714	C10.597.606.360|C12.050.351.968.419.570|C12.200.777.419.570|C12.950.419.570|C14.280|C18.452.394.750|C19.246|C23.888.592.604.646|F03.625.539	Pancreatic hypoplasia diabetes heart disease	Cardiovascular disease|Endocrine system disease|Mental disorder|Metabolic disease|Nervous system disease|Signs and symptoms|Urogenital disease (female)|Urogenital disease (male)
Young Hughes syndrome	MESH:C536715			MESH:D006130|MESH:D007006|MESH:D008607|MESH:D009765|MESH:D012729	C10.597.606.360/C536715|C18.654.726.750.500/C536715|C19.391.482/C536715|C23.550.210.815/C536715|C23.550.393/C536715|C23.888.144.699.500/C536715|C23.888.592.604.646/C536715|F03.625.539/C536715	C10.597.606.360|C18.654.726.750.500|C19.391.482|C23.550.210.815|C23.550.393|C23.888.144.699.500|C23.888.592.604.646|F03.625.539	Sex-linked mental retardation, short stature, obesity and hypogonadism	Endocrine system disease|Mental disorder|Nervous system disease|Nutrition disorder|Pathology (process)|Signs and symptoms
Young Syndrome	MESH:C536718			MESH:D009845|MESH:D012141	C01.748/C536718|C08.730/C536718|C12.100.500.430.508/C536718|C12.100.750.700.508/C536718|C12.200.294.430.508/C536718	C01.748|C08.730|C12.100.500.430.508|C12.100.750.700.508|C12.200.294.430.508	Azoospermia, obstructive, and chronic sinopulmonary infections|Azoospermia sinopulmonary infections|Barry-Perkins-Young syndrome|Sinusitis-infertility syndrome	Respiratory tract disease|Urogenital disease (male)
Yusho Disease	MESH:C536720			MESH:D011164	C18.452.811/C536720	C18.452.811		Metabolic disease
Zadik Barak Levin syndrome	MESH:C536721			MESH:D000015|MESH:D000848|MESH:D002972|MESH:D003884|MESH:D007037	C04.182.201/C536721|C04.557.465.910.250/C536721|C05.500.460.185/C536721|C05.660.207.540.460.185/C536721|C07.320.440.185/C536721|C07.465.525.185/C536721|C07.650.500.460.185/C536721|C07.650.525.185/C536721|C07.650.800.100/C536721|C07.793.700.100/C536721|C16.131.077/C536721|C16.131.621.207.540.460.185/C536721|C16.131.850.500.460.185/C536721|C16.131.850.525.185/C536721|C16.131.850.800.100/C536721|C19.874.482/C536721	C04.182.201|C04.557.465.910.250|C05.500.460.185|C05.660.207.540.460.185|C07.320.440.185|C07.465.525.185|C07.650.500.460.185|C07.650.525.185|C07.650.800.100|C07.793.700.100|C16.131.077|C16.131.621.207.540.460.185|C16.131.850.500.460.185|C16.131.850.525.185|C16.131.850.800.100|C19.874.482	Dermoid cysts, hypothyroidism, cleft palate, and hypodontia	Cancer|Congenital abnormality|Endocrine system disease|Mouth disease|Musculoskeletal disease
Zenker Diverticulum	MESH:D016672		A DIVERTICULUM at the upper end of the ESOPHAGUS through the cricopharyngeal muscle at the junction of the PHARYNX and the esophagus.	MESH:D004936	C06.405.205.282.750.625.900|C23.300.415.625.900	C06.405.205.282.750.625|C23.300.415.625	Diverticula, Esophago-Pharyngeal|Diverticula, Pharyngeal|Diverticula, Pharyngoesophageal|Diverticula, Pharyngo-Esophageal|Diverticula, Pharyngoesophageal Pulsion|Diverticula, Zenker's|Diverticulum, Esophagopharyngeal|Diverticulum, Esophago-Pharyngeal|Diverticulum, Pharyngeal|Diverticulum, Pharyngoesophageal|Diverticulum, Pharyngo-Esophageal|Diverticulum, Pharyngoesophageal Pulsion|Diverticulums, Esophagopharyngeal|Diverticulum, Zenker|Diverticulum, Zenker's|Esophago Pharyngeal Diverticula|Esophago-Pharyngeal Diverticula|Esophagopharyngeal Diverticulum|Esophago Pharyngeal Diverticulum|Esophago-Pharyngeal Diverticulum|Esophagopharyngeal Diverticulums|Pharyngeal Diverticula|Pharyngeal Diverticulum|Pharyngoesophageal Diverticula|Pharyngo Esophageal Diverticula|Pharyngo-Esophageal Diverticula|Pharyngoesophageal Diverticulum|Pharyngo Esophageal Diverticulum|Pharyngo-Esophageal Diverticulum|Pharyngoesophageal Pulsion Diverticula|Pharyngoesophageal Pulsion Diverticulum|Pulsion Diverticula, Pharyngoesophageal|Pulsion Diverticulum, Pharyngoesophageal|Zenker Diverticula|Zenker's Diverticula|Zenkers Diverticula|Zenker's Diverticulum|Zenkers Diverticulum	Digestive system disease|Pathology (anatomical condition)
Zika Virus Infection	MESH:D000071243	DO:DOID:0060478	A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is associated with congenital brain and ocular abnormalities, called Congenital Zika Syndrome, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME.	MESH:D001102|MESH:D018177	C01.920.500.990|C01.925.081.990|C01.925.782.350.250.990	C01.920.500|C01.925.081|C01.925.782.350.250	Congenital Zika Syndrome|Congenital Zika Virus Infection|Disease, Zika Virus|Fever, Zika|Infection, Zika Virus|Infection, ZikV|Virus Disease, Zika|Virus Infection, Zika|Zika Fever|Zika Virus Disease|ZikV Infection	Viral disease
Zollinger-Ellison Syndrome	MESH:D015043	DO:DOID:0050782	A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue (GASTRINOMA). This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.	MESH:D005770|MESH:D007410|MESH:D009384|MESH:D010437|MESH:D013272	C04.730.713.988|C06.301.371.883|C06.405.249.883|C06.405.469.275.800.924|C06.405.469.965|C06.405.748.586.924|C06.405.748.947	C04.730.713|C06.301.371|C06.405.249|C06.405.469|C06.405.469.275.800|C06.405.748|C06.405.748.586	Syndrome, Zollinger-Ellison|Zollinger Ellison Syndrome	Cancer|Digestive system disease
Zonular cataract and nystagmus	MESH:C536727			MESH:D002386|MESH:D009759	C10.292.562.675/C536727|C11.510.245/C536727|C11.590.400/C536727	C10.292.562.675|C11.510.245|C11.590.400	Nystagmus with congenital zonular cataract	Eye disease|Nervous system disease
Zoster Sine Herpete	MESH:D031368		HERPES ZOSTER but without eruption of vesicles. Patients exhibit the characteristic pain minus the skin rash, sometimes making diagnosis difficult.	MESH:D006562	C01.925.256.466.930.750.970	C01.925.256.466.930.750	Zoster Sine Eruptione	Viral disease
Zygomatic Fractures	MESH:D015051		Fractures of the zygoma.	MESH:D008446|MESH:D012887	C10.900.300.284.500.950|C26.404.750.959|C26.915.300.425.500.950	C10.900.300.284.500|C26.404.750|C26.915.300.425.500	Fractures, Zygomatic|Fracture, Zygomatic|Zygomatic Fracture	Nervous system disease|Wounds and injuries
